PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Tang, CC; Shan, LP; Wang, WM; Lu, G; Tare, RS; Lee, KKH				Tang, Cheng-cheng; Shan, Li Pik; Wang, Wu-ming; Lu, Gang; Tare, Rahul S.; Lee, Kenneth Ka Ho			Generation of a Bag1 homozygous knockout mouse embryonic stem cell line using CRISPR/Cas9	STEM CELL RESEARCH			English	Article								Bag1 transcribes a multifunctional protein that participates in many important biological processes such as cell apoptosis, proliferation, differentiation and embryo development. Despite numerous published studies, the role of Bag1 in the context of embryonic stem (ES) cells, has not been explored. To investigate the function of Bag1 in ES cells, we generated mutant Bag1(-/-) ES cells using the CRISPR/Cas9 system. We established that the Bag1 double knockout ES cell line maintained their pluripotency, possessed a normal karyotype and the ability to differentiate into all three germ layers. (C) 2017 The Authors. Published by Elsevier B.V.	[Tang, Cheng-cheng; Lee, Kenneth Ka Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Key Lab Regenerat Med, MOE, Hong Kong, Hong Kong, Peoples R China; [Tang, Cheng-cheng; Tare, Rahul S.; Lee, Kenneth Ka Ho] Chinese Univ Hong Kong, Univ Southampton Joint Lab Regenerat Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Shan, Li Pik] Chinese Univ Hong Kong, Sch Biomed Sci, Transgen Core Serv Ctr, Hong Kong, Hong Kong, Peoples R China; [Wang, Wu-ming; Lu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Tare, Rahul S.] Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat, Southampton SO16 6YD, Hants, England	Lee, KKH (reprint author), Chinese Univ Hong Kong, Sch Biomed Sci, Key Lab Regenerat Med, MOE, Hong Kong, Hong Kong, Peoples R China.	kaholee@cuhk.edu.hk		Tare, Rahul/0000-0001-8274-8837	Research Grant Council [CUHK 14100315]	This work was supported by Research Grant Council CUHK 14100315.	Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Wettstein Rahel, 2016, Methods Mol Biol, V1341, P321, DOI 10.1007/7651_2015_213	4	0	0	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	MAY	2017	21						29	31		10.1016/j.scr.2017.03.016				3	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	EW4MW	WOS:000402476600009	28677535	gold			2018-01-05	
J	Castano, J; Bueno, C; Jimenez-Delgado, S; Roca-Ho, H; Fraga, MF; Fernandez, AF; Nakanishi, M; Torres-Ruiz, R; Rodriguez-Perales, S; Menendez, P				Castano, Julio; Bueno, Clara; Jimenez-Delgado, Senda; Roca-Ho, Heleia; Fraga, Mario F.; Fernandez, Agustin F.; Nakanishi, Mahito; Torres-Ruiz, Raul; Rodriguez-Perales, Sandra; Menendez, Pablo			Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the "safe harbor" AAVS1 locus	STEM CELL RESEARCH			English	Article							PLURIPOTENT STEM-CELLS; HUMAN B-CELLS	We report the generation-characterization of a fetal liver (FL) B-cell progenitor (BCP)-derived human induced pluripotent stem cell (hiPSC) line CRISPR/Cas9-edited to carry/express a single copy of doxycycline-inducible Cas9 gene in the "safe locus" AAVS1 (iCas9-FL-BCP-hiPSC). Gene-edited iPSCs remained pluripotent after CRISPR/Cas9 genome-edition. Correct genomic integration of a unique copy of Cas9 was confirmed by PCR and Southern blot. Cas9 was robustly and specifically expressed on doxycycline exposure. T7-endonuclease assay demonstrated that iCas9 induces robust gene-edition when gRNAs against hematopoietic transcription factors were tested. This iCas9-FL-BCP-hiPSCwill facilitate gene-editing approaches for studies on developmental biology, drug screening and disease modeling. (C) 2017 The Authors. Published by Elsevier B.V.	[Castano, Julio; Bueno, Clara; Roca-Ho, Heleia; Torres-Ruiz, Raul; Menendez, Pablo] Univ Barcelona, Josep Carreras Leukemia Res Inst, Sch Med, Dept Biomed, Barcelona, Spain; [Castano, Julio; Bueno, Clara; Roca-Ho, Heleia; Menendez, Pablo] ISCIII, Ctr Networked Biomed Res Canc CIBERONC, Madrid, Spain; [Jimenez-Delgado, Senda] Ctr Regenerat Med Barcelona, Barcelona Biomed Res Pk, Barcelona, Spain; [Jimenez-Delgado, Senda] ISCIII, Ctr Networked Biomed Res Bioengn Biomat & Nanomed, Madrid, Spain; [Fraga, Mario F.] Univ Oviedo Principado Asturias, Nanomat & Nanotechnol Res Ctr CINN CSIC, Oviedo, Asturias, Spain; [Fernandez, Agustin F.] Univ Oviedo, Hosp Univ Cent Asturias HUCA FINBA, Inst Oncol Asturias IUOPA, Canc Epigenet Lab, Oviedo, Asturias, Spain; [Nakanishi, Mahito] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Rodriguez-Perales, Sandra] CNIO, Cytogenet Grp, Madrid, Spain; [Menendez, Pablo] ICREA, Barcelona, Spain	Castano, J; Menendez, P (reprint author), Univ Barcelona, Josep Carreras Leukemia Res Inst, Sch Med, Dept Biomed, Barcelona, Spain.	jcastano@carrerasresearch.org	Fernandez, Agustin/N-7302-2014	Fernandez, Agustin/0000-0002-3792-4085; Rodriguez-Perales, Sandra/0000-0001-7221-3636; Roca Ho, Heleia/0000-0001-7324-5234; Torres, Raul/0000-0001-9606-0398			Bueno C, 2016, LEUKEMIA, V30, P674, DOI 10.1038/leu.2015.294; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Munoz-Lopez A, 2016, STEM CELL REP, V7, P602, DOI 10.1016/j.stemcr.2016.08.013; Munoz-Lopez A, 2016, STEM CELLS, V34, P581, DOI 10.1002/stem.2303	4	0	0	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	MAY	2017	21						137	140		10.1016/j.scr.2017.04.011				4	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	EW4MW	WOS:000402476600024	28677529	gold			2018-01-05	
J	Chen, D; Gell, JJ; Tao, Y; Sosa, E; Clark, AT				Chen, Di; Gell, Joanna J.; Tao, Yu; Sosa, Enrique; Clark, Amander T.			Modeling human infertility with pluripotent stem cells	STEM CELL RESEARCH			English	Article						Human fertility is dependent upon the correct establishment and differentiation of the germline. This is because no other cell type in the body is capable of passing a genome and epigenome from parent to child. Terminally differentiated germline cells in the adult testis and ovary are called gametes. However the initial specification of; germline cells occurs in the embryo around the time of gastrulation. Most of our knowledge regarding the cell and molecular events that govern human germline specification involves extrapolating scientific principles from model organisms; most notably the mouse. However recent work using next generation sequencing; gene editing and differentiation of germline cells from pluripotent stem cells has revealed that the core molecular mechanisms that regulate human germline development are different from rodents. Here we will discuss the major molecular pathways required for human germline differentiation and how pluripotent stem cells have revolutionized our ability to study the earliest steps in human embryonic lineage specification in order to understand human fertility. (C) 2017 The Authors. Published by Elsevier BV	PRIMORDIAL GERM-CELLS; IN-VITRO; SPECIFICATION; FATE; MICE; DIFFERENTIATION; LINEAGE; MOUSE; GENE; INDUCTION		[Chen, Di; Tao, Yu; Sosa, Enrique; Clark, Amander T.] Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Gell, Joanna J.] Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Chen, Di; Gell, Joanna J.; Tao, Yu; Sosa, Enrique; Clark, Amander T.] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Gell, Joanna J.] David Geffen Sch Med, Los Angeles, CA 90095 USA; [Chen, Di; Tao, Yu; Sosa, Enrique; Clark, Amander T.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	Clark, AT (reprint author), Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clarka@ucla.edu			NIH [P01HD075795, R01HD079546]	This work was supported by funds from the NIH grant P01HD075795 and R01HD079546 to ATC.	Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Beddington RSP, 1992, DEV S, V1992, P157; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; CDC, 2012, SURV DAT COLL SYST C; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Felici M., 2013, OOGENESIS, P19; Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Irie Naoko, 2014, Reproductive Medicine and Biology, V13, P203, DOI 10.1007/s12522-014-0184-2; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lawson K.A., 1994, GERMLINE DEV, P68; Liu PT, 1999, NAT GENET, V22, P361; LUCKETT WP, 1978, AM J ANAT, V152, P59, DOI 10.1002/aja.1001520106                                                          ; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Moore K.L., 1977, DEV HUMAN, V1; Murakami K, 2016, NATURE, V529, P403, DOI 10.1038/nature16480; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nakamura T, 2016, NATURE, V537, P57, DOI [10.1038/nature19096, 10.1038/nature19322]; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Perrett RM, 2008, BIOL REPROD, V78, P852, DOI 10.1095/biolreprod.107.066175; Sasaki K, 2016, DEV CELL, V39, P169, DOI 10.1016/j.devcel.2016.09.007; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Silber SJ, 2008, HUM REPROD, V23, P1531, DOI 10.1093/humrep/den032; Sugawa F, 2015, EMBO J, V34, P1009, DOI 10.15252/embj.201488049; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Weber S., 2009, BIOL REPROD, P214; Witschi Emil, 1948, CONTRIBUTIONS TO EMBRYOLOGY [CARNEGIE INST OF WASHINGTON PUBL], V32, P67; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186	41	0	0	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	MAY	2017	21						187	192		10.1016/j.scr.2017.04.005				6	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	EW4MW	WOS:000402476600031	28431857				2018-01-05	
J	Honda, Y; Tsuchiya, K; Sumiyoshi, E; Haruta, N; Sugimoto, A				Honda, Yu; Tsuchiya, Kenta; Sumiyoshi, Eisuke; Haruta, Nami; Sugimoto, Asako			Tubulin isotype substitution revealed that isotype combination modulates microtubule dynamics in C. elegans embryos	JOURNAL OF CELL SCIENCE			English	Article						Tubulin isotypes; Microtubules; C. elegans	ALPHA-BETA-III; CAENORHABDITIS-ELEGANS; IN-VITRO; GENE; MUTATIONS; DROSOPHILA; MEC-7; MECHANISMS; PROTEINS; NEURONS	Microtubules (MTs) are polymers composed of alpha-and beta-tubulin heterodimers that are generally encoded by genes at multiple loci. Despite implications of distinct properties depending on the isotype, how these heterodimers contribute to the diverse MT dynamics in vivo remains unclear. Here, by using genome editing and depletion of tubulin isotypes following RNAi, we demonstrate that four tubulin isotypes (hereafter referred to as alpha 1, alpha 2, beta 1 and beta 2) cooperatively confer distinct MT properties in Caenorhabditis elegans early embryos. GFP insertion into each isotype locus reveals their distinct expression levels and MT incorporation rates. Substitution of isotype coding regions demonstrates that, under the same isotype concentration, MTs composed of beta 1 have higher switching frequency between growth and shrinkage compared with MTs composed of beta 2. Lower concentration of beta-tubulins results in slower growth rates, and the two alpha-tubulins distinctively affect growth rates of MTs composed of beta 1. Alteration of ratio and concentration of isotypes distinctively modulates both growth rate and switching frequency, and affects the amplitude of mitotic spindle oscillation. Collectively, our findings demonstrate that MT dynamics are modulated by the combination (ratio and concentration) of tubulin isotypes with distinct properties, which contributes to create diverse MT behaviors in vivo.	[Honda, Yu; Tsuchiya, Kenta; Sumiyoshi, Eisuke; Haruta, Nami; Sugimoto, Asako] Tohoku Univ, Grad Sch Life Sci, Lab Dev Dynam, Sendai, Miyagi 9808577, Japan	Sugimoto, A (reprint author), Tohoku Univ, Grad Sch Life Sci, Lab Dev Dynam, Sendai, Miyagi 9808577, Japan.	asugimoto@m.tohoku.ac.jp		Sugimoto, Asako/0000-0001-6001-4293; Sumiyoshi, Eisuke/0000-0001-7336-6095	Japan Society for the Promotion of Science [JP15H04369, JP14J03414]	This work was supported by Japan Society for the Promotion of Science [JP15H04369 to A.S. and JP14J03414 to Y.H.].	BANERJEE A, 1992, J BIOL CHEM, V267, P5625; Baran R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009655; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bode CJ, 2003, EMBO REP, V4, P94, DOI 10.1038/embor716; BRENNER S, 1974, GENETICS, V77, P71; Chakraborti S, 2016, CYTOSKELETON, V73, P521, DOI 10.1002/cm.21290; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; Cluet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093718; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Ellis GC, 2004, J CELL SCI, V117, P457, DOI 10.1242/jcs.00869; FACKENTHAL JD, 1993, DEV BIOL, V158, P213, DOI 10.1006/dbio.1993.1180; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukushige T, 1999, J CELL SCI, V112, P395; FUKUSHIGE T, 1993, J MOL BIOL, V234, P1290, DOI 10.1006/jmbi.1993.1685; Fulton C., 1976, SELECTIVE SYNTHESIS, P987; Gogonea CB, 1999, J MOL GRAPH MODEL, V17, P90, DOI 10.1016/S1093-3263(99)00025-X; HAMELIN M, 1992, EMBO J, V11, P2885; HOYLE HD, 1990, J CELL BIOL, V111, P1009, DOI 10.1083/jcb.111.3.1009                                                          ; Hurd DD, 2010, GENETICS, V185, P883, DOI 10.1534/genetics.110.116996; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Lockhead D, 2016, MOL BIOL CELL, V27, P3717, DOI 10.1091/mbc.E16-06-0473; Lu CG, 2004, MOL BIOL CELL, V15, P142, DOI 10.1091/mbc.E03-06-0418; Lu CG, 2005, GENETICS, V170, P115, DOI 10.1534/genetics.104.030106; LU Q, 1994, J BIOL CHEM, V269, P2041; Luduena RF, 2013, INT REV CEL MOL BIO, V302, P41, DOI 10.1016/B978-0-12-407699-0.00002-9; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Motegi F, 2006, DEV CELL, V10, P509, DOI 10.1016/j.devcel.2006.03.001; Pamula MC, 2016, J CELL BIOL, V213, P425, DOI 10.1083/jcb.201603050; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358                                                        ; Phillips JB, 2004, CELL MOTIL CYTOSKEL, V58, P112, DOI 10.1002/cm.20003; Praitis V, 2001, GENETICS, V157, P1217; Romaniello R, 2015, BRAIN DEV-JPN, V37, P273, DOI 10.1016/j.braindev.2014.06.002; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870                                                             ; SAVAGE C, 1994, J CELL SCI, V107, P2165; SCHATZ PJ, 1986, MOL CELL BIOL, V6, P3722, DOI 10.1128/MCB.6.11.3722                                                           ; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Spiro Z, 2014, DEVELOPMENT, V141, P2712, DOI 10.1242/dev.107508; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Toya M, 2011, NAT CELL BIOL, V13, P708, DOI 10.1038/ncb2242; Wright AJ, 2003, MOL BIOL CELL, V14, P4512, DOI 10.1091/mbc.E03-01-0017	44	4	4	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	MAY 1	2017	130	9					1652	1661		10.1242/jcs.200923				10	Cell Biology	Cell Biology	EW5ME	WOS:000402549400014	28302908				2018-01-05	
J	Martyn, GE; Quinlan, KGR; Crossley, M				Martyn, Gabriella E.; Quinlan, Kate G. R.; Crossley, Merlin			The regulation of human globin promoters by CCAAT box elements and the recruitment of NF-Y	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review						NF-Y; Haemoglobin; Globin genes; Transcription factor binding; CCAAT elements; Hereditary persistence of foetal haemoglobin; Globin switching; Sickle cell disease; Beta-thalassaemia	A-GAMMA-GLOBIN; NONDELETIONAL HEREDITARY PERSISTENCE; SILENT BETA-THALASSEMIA; DISTAL CACCC BOX; GREATER-THAN-C; FETAL-HEMOGLOBIN; GENE PROMOTER; TATA BOX; PRENATAL-DIAGNOSIS; TRANSCRIPTIONAL ACTIVATION	CCAAT boxes are motifs found within the proximal promoter of many genes, including the human globin genes. The highly conserved nature of CCAAT box motifs within, the promoter region of both alpha-like and beta-like globin genes emphasises the functional importance of the CCAAT sequence in globin gene regulation. Mutations within the beta-globin CCAAT box result in beta-thalassaemia, while mutations within the distal gamma-globin CCAAT box cause the Hereditary Persistence of Foetal Haemoglobin, a benign condition which results in continued gamma-globin expression during adult life. Understanding the transcriptional regulation of the globin genes is of particular interest, as reactivating the foetal gamma-globin gene alleviates the symptoms of beta-thalassaemia and sickle cell anaemia. NF-Y is considered to be the primary activating transcription factor which binds to globin CCAAT box motifs. Here we review recruitment of NF-Y to globin CCAAT boxes and the role NF-Y plays in regulating globin gene expression. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Martyn, Gabriella E.; Quinlan, Kate G. R.; Crossley, Merlin] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Crossley, M (reprint author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	m.crossley@unsw.edu.au		Quinlan, Kate/0000-0002-5722-8183; Crossley, Merlin/0000-0003-2057-3642	Australian Postgraduate Award; National Health and Medical Research Council [APP1098391]	GEM was supported by an Australian Postgraduate Award. This work was funded by the National Health and Medical Research Council Grant APP1098391 to MC.	Agouti I, 2008, EUR J HAEMATOL, V80, P346, DOI 10.1111/j.1600-0609.2007.01017.x; Aguilar-Martinez P, 2007, AM J HEMATOL, V82, P1088, DOI 10.1002/ajh.21000; Al Zadjali S, 2011, EUR J HAEMATOL, V87, P457, DOI 10.1111/j.1600-0609.2011.01687.x; Amato A, 2014, INT J LAB HEMATOL, V36, P13, DOI 10.1111/ijlh.12094; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P1154, DOI 10.1073/pnas.81.4.1154                                                          ; ANTONIOU M, 1995, NUCLEIC ACIDS RES, V23, P3473, DOI 10.1093/nar/23.17.3473; Badens C, 1999, HEMOGLOBIN, V23, P339, DOI 10.3109/03630269909090749; BAKLOUTI F, 1989, BLOOD, V74, P1817; Bauer DE, 2012, BLOOD, V120, P2945, DOI [10.1182/blood2012-06-292078, 10.1182/blood-2012-06-292078]; Bhattacharya A, 2003, CANCER RES, V63, P8167; Cadet E, 2009, HEMOGLOBIN, V33, P274, DOI 10.1080/03630260903081323; CAI SP, 1989, AM J HUM GENET, V45, P112; CHARNAY P, 1985, MOL CELL BIOL, V5, P1498, DOI 10.1128/MCB.5.6.1498                                                            ; Chen XW, 2007, ANN HEMATOL, V86, P653, DOI 10.1007/s00277-007-0312-8; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; COLEMAN MB, 1992, HEMOGLOBIN, V16, P399, DOI 10.3109/03630269209005691; COLLINS FS, 1985, NATURE, V313, P325, DOI 10.1038/313325a0; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P4894, DOI 10.1073/pnas.81.15.4894; Colosimo A, 2003, GENET TEST, V7, P269, DOI 10.1089/109065703322537322; Consortium EP, 2012, NATURE, V7414, P57, DOI DOI 10.1038/; COSTA FF, 1990, BLOOD, V76, P1896; Cottle RN, 2016, HUM GENET, V135, P993, DOI 10.1007/s00439-016-1696-0; DEBOER E, 1988, EMBO J, V7, P4203; DELVOYE NL, 1993, MOL CELL BIOL, V13, P6969, DOI 10.1128/MCB.13.11.6969                                                          ; DIAZCHICO JC, 1988, BLOOD, V71, P248; DIVOKY V, 1993, AM J HEMATOL, V42, P225, DOI 10.1002/ajh.2830420216; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001                                                 ; EFREMOV DG, 1991, HEMOGLOBIN, V15, P525, DOI 10.3109/03630269109027900                                                       ; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8                                                    ; Eng B, 2007, HEMOGLOBIN, V31, P129, DOI 10.1080/03630260701284624; Fang XD, 2004, J BIOL CHEM, V279, P5444, DOI 10.1074/jbc.M306241200; Fattore S., 1999, HUM MUTAT, V13, P340; FAUSTINO P, 1992, HUM GENET, V89, P573; FEI YJ, 1988, BIOCHEM BIOPH RES CO, V153, P741, DOI 10.1016/S0006-291X(88)81157-4                                                   ; Filipe A, 1999, EMBO J, V18, P687, DOI 10.1093/emboj/18.3.687; FUCHAROEN S, 1990, NUCLEIC ACIDS RES, V18, P5245, DOI 10.1093/nar/18.17.5245; GELINAS R, 1985, NATURE, V313, P323, DOI 10.1038/313323a0                                                                ; GELINAS R, 1986, BLOOD, V67, P1777; GIGLIONI B, 1984, EMBO J, V3, P2641; GILMAN JG, 1988, BLOOD, V72, P78; GILMAN JG, 1988, NUCLEIC ACIDS RES, V16, P10635, DOI 10.1093/nar/16.22.10635; GONZALEZREDONDO JM, 1989, BLOOD, V73, P1705; Gordon CT, 2005, BBA-GENE STRUCT EXPR, V1729, P74, DOI 10.1016/j.bbaexp.2005.03.004; GROSVELD F, 1993, BAILLIERE CLIN HAEM, V6, P31, DOI 10.1016/S0950-3536(05)80065-4; GUMUCIO DL, 1988, MOL CELL BIOL, V8, P5310, DOI 10.1128/MCB.8.12.5310                                                           ; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; HUANG SZ, 1986, HUM GENET, V74, P162, DOI 10.1007/BF00282081                                                              ; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Ibn Ayub M, 2010, GENET TEST MOL BIOMA, V14, P299, DOI 10.1089/gtmb.2009.0160; KATSUBE T, 1995, J BIOCHEM-TOKYO, V117, P68, DOI 10.1093/oxfordjournals.jbchem.a124723                                           ; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; Kiyama R, 2011, J MOL EVOL, V73, P101, DOI 10.1007/s00239-011-9459-y; KULOZIK AE, 1991, BLOOD, V77, P2054; Li DZ, 2009, ANN HEMATOL, V88, P1149, DOI 10.1007/s00277-009-0732-8; Liberati C, 1998, J BIOL CHEM, V273, P16880, DOI 10.1074/jbc.273.27.16880; Liberati C, 2001, J BIOL CHEM, V276, P41700, DOI 10.1074/jbc.M102987200; LIN LI, 1992, AM J HUM GENET, V50, P237; Manca L, 2008, IUBMB LIFE, V60, P94, DOI 10.1002/iub.4; MANTOVANI R, 1988, NUCLEIC ACIDS RES, V16, P7783, DOI 10.1093/nar/16.16.7783; MANTOVANI R, 1989, NUCLEIC ACIDS RES, V17, P6681, DOI 10.1093/nar/17.16.6681; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; MELONI A, 1992, BRIT J HAEMATOL, V80, P222, DOI 10.1111/j.1365-2141.1992.tb08904.x                                              ; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776                                                           ; Moi P, 2004, BRIT J HAEMATOL, V126, P881, DOI 10.1111/j.1365-2141.2004.05146.x; MOTUM PI, 1994, BRIT J HAEMATOL, V86, P219, DOI 10.1111/j.1365-2141.1994.tb03284.x; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; Noordermeer D, 2008, IUBMB LIFE, V60, P824, DOI 10.1002/iub.129; ONER R, 1991, BLOOD, V77, P1124; ORKIN SH, 1983, NUCLEIC ACIDS RES, V11, P4727, DOI 10.1093/nar/11.14.4727                                                          ; ORKIN SH, 1984, J BIOL CHEM, V259, P8679; OTTOLENGHI S, 1988, BLOOD, V71, P815; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; Partington GA, 1998, BRIT J HAEMATOL, V102, P940; PESCHLE C, 1985, NATURE, V313, P235, DOI 10.1038/313235a0; PONCZ M, 1982, J BIOL CHEM, V257, P5994; Refaldi C, 2007, Hum Genet, V121, P298; RISTALDI MS, 1990, BRIT J HAEMATOL, V74, P480, DOI 10.1111/j.1365-2141.1990.tb06338.x; Ronchi A, 1996, EMBO J, V15, P143; RONCHI AE, 1995, J BIOL CHEM, V270, P21934, DOI 10.1074/jbc.270.37.21934                                                        ; RUND D, 1991, P NATL ACAD SCI USA, V88, P310, DOI 10.1073/pnas.88.1.310                                                           ; Salehi R, 2010, HEMOGLOBIN, V34, P115, DOI 10.3109/03630260903554894; Sankaran VG, 2011, HEMATOL-AM SOC HEMAT, P459, DOI 10.1182/asheducation-2011.1.459; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; STOMING TA, 1989, BLOOD, V73, P329; SUPERTIFURGA G, 1988, EMBO J, V7, P3099; SURREY S, 1988, BLOOD, V71, P807; TAKIHARA Y, 1986, BLOOD, V67, P547; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tasiopouiou M, 2008, BLOOD CELL MOL DIS, V40, P320, DOI 10.1016/j.bcmd.2007.10.007; TATE VE, 1986, BLOOD, V68, P1389; Thein SL, 2009, BRIT J HAEMATOL, V145, P455, DOI 10.1111/j.1365-2141.2009.07650.x; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Vernimmen D, 2015, TRENDS GENET, V31, P696, DOI 10.1016/j.tig.2015.10.004; Vernimmen D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004668; Vernimmen D, 2009, BLOOD, V114, P4253, DOI 10.1182/blood-2009-03-213439; Wall L, 1996, J BIOL CHEM, V271, P16477, DOI 10.1074/jbc.271.28.16477                                                        ; Waye JS, 2011, HEMOGLOBIN, V35, P84, DOI 10.3109/03630269.2010.529744; WEATHERALL DJ, 1975, BRIT J HAEMATOL, V29, P205, DOI 10.1111/j.1365-2141.1975.tb01815.x                                              ; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893; WOOD WG, 1982, BRIT J HAEMATOL, V50, P401, DOI 10.1111/j.1365-2141.1982.tb01935.x; Zertal-Zidani S, 1999, HEMOGLOBIN, V23, P159, DOI 10.3109/03630269908996160                                                       ; Zhu XF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046286, 10.1371/journal.pone.0033013, 10.1371/journal.pone.0044405]	106	1	1	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		525	536		10.1016/j.bbagrm.2016.10.002				12	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500002	27718361				2018-01-05	
J	Sachini, N; Papamatheakis, J				Sachini, Nikoleta; Papamatheakis, Joseph			NF-Y and the immune response: Dissecting the complex regulation of MHC genes	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review						NF-Y; immune response; MHCII; transcriptional regulation	CLASS-II GENES; BARE-LYMPHOCYTE-SYNDROME; CCAAT-BINDING-FACTOR; NUCLEAR FACTOR-Y; TRANSCRIPTION FACTOR; DNA-BINDING; COOPERATIVE BINDING; IN-VIVO; X-BOX; CELL-PROLIFERATION	Nuclear Factor Y (NF-Y) was first described as one of the CCAAT binding factors. Although CCAAT motifs were found to be present in various genes, NF-Y attracted a lot of interest early on, due to its role in Major Histocompatibility Complex (MHC) gene regulation. MHC genes are crucial in immune response and show peculiar expression patterns. Among other conserved elements on MHC promoters, an NF-Y binding CCAAT box was found to contribute to MHC transcriptional regulation. NF-Y along with other DNA binding factors assembles in a stereo specific manner to form a multiprotein scaffold, the MHC enhanceosome, which is necessary but not sufficient to drive transcription. Transcriptional activation is achieved by the recruitment of yet another factor, the class II transcriptional activator (CIITA). In this review, we briefly discuss basic findings on MHCII transcription regulation and we highlight NF-Y different modes of function in MHCII gene activation. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Sachini, Nikoleta; Papamatheakis, Joseph] Fdn Res & Technol Hellas FORTH, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece; [Sachini, Nikoleta; Papamatheakis, Joseph] Univ Crete, Dept Biol, Iraklion 71409, Crete, Greece	Papamatheakis, J (reprint author), Fdn Res & Technol Hellas FORTH, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece.; Papamatheakis, J (reprint author), Univ Crete, Dept Biol, Iraklion 71409, Crete, Greece.	papamath@imbbforth.gr			ESPA-THALIS [MIS380247]; Fondation Sante grant; IMBB intramural funds	The authors would like to thank Dr. A. Kretsovali for critical suggestions. This work was funded by ESPA-THALIS grant MIS380247, Fondation Sante grant 2016 and IMBB intramural funds.	Arampatzi P, 2013, NUCLEIC ACIDS RES, V41, P2202, DOI 10.1093/nar/gks1365; Benasciutti E, 2014, J BONE MINER RES, V29, P290, DOI 10.1002/jbmr.2090; Benatti P, 2011, NUCLEIC ACIDS RES, V39, P5356, DOI 10.1093/nar/gkr128; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bhattacharya A, 2003, CANCER RES, V63, P8167; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5                                                   ; Cagliari A. C. T.-Z. Alexandro, 2011, EVOLUTIONARY HIST CB; Caretti G, 1999, MOL CELL BIOL, V19, P8591; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Chadban SJ, 1998, IMMUNOLOGY, V94, P72; Choi NM, 2011, CURR OPIN IMMUNOL, V23, P81, DOI 10.1016/j.coi.2010.09.007; Chu JSC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-130; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917                                                         ; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430                                                          ; DEDRICK RL, 1990, MOL CELL BIOL, V10, P593, DOI 10.1128/MCB.10.2.593                                                            ; DEPREVAL C, 1985, NATURE, V318, P291, DOI 10.1038/318291a0                                                                ; DeSandro A, 1999, AM J HUM GENET, V65, P279, DOI 10.1086/302519; DeSandro AM, 2000, MOL CELL BIOL, V20, P6587, DOI 10.1128/MCB.20.17.6587-6599.2000; Dolfini D, 2013, CELL DEATH DIFFER, V20, P676, DOI 10.1038/cdd.2013.13; Dolfini D, 2016, NUCLEIC ACIDS RES, V44, P4684, DOI 10.1093/nar/gkw096; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Donati G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002066; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Dustin J., 2005, MAJOR HISTOCOMPATIBI, P8; Elhasid R, 1996, BLOOD REV, V10, P242, DOI 10.1016/S0268-960X(96)90008-9; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Gialitakis M, 2006, NUCLEIC ACIDS RES, V34, P765, DOI 10.1093/nar/gkj462; Gialitakis M, 2010, MOL CELL BIOL, V30, P2046, DOI 10.1128/MCB.00906-09; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.immunol.10.1.13; Gnesutta Nerina, 2013, Transcription, V4, P114; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Gobin SJP, 2001, J IMMUNOL, V167, P5175, DOI 10.4049/jimmunol.167.9.5175                                                     ; Gomez JA, 2005, J IMMUNOL, V175, P1030, DOI 10.4049/jimmunol.175.2.1030                                                     ; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1                                                   ; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Jabrane-Ferrat N, 2002, MOL CELL BIOL, V22, P5616, DOI 10.1128/MCB.22.15.5616-5625.2002; Kabe Y, 2005, MOL CELL BIOL, V25, P512, DOI 10.1128/MCB.25.1.512-522.2005; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; KIM CG, 1990, J BIOL CHEM, V265, P13362; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Krawczyk M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000058; KRETSOVALI A, 1995, NUCLEIC ACIDS RES, V23, P2919, DOI 10.1093/nar/23.15.2919; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777                                                          ; Lange C, 2011, MOL BIOL EVOL, V28, P1687, DOI 10.1093/molbev/msq349; LouisPlence P, 1997, J IMMUNOL, V159, P3899; Ludigs K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005088; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MANTOVANI R, 1992, EMBO J, V11, P3315; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; Masternak K, 1998, NAT GENET, V20, P273; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; MORENO CS, 1995, J IMMUNOL, V155, P4313; Muhlethaler-Mottet A, 2004, J BIOL CHEM, V279, P40529, DOI 10.1074/jbc.M406585200; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Nagarajan U. M., IMMUNITY, V10; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Nekrep N, 2003, IMMUNITY, V18, P453, DOI 10.1016/S1074-7613(03)00086-4; O'Keefe GM, 1999, EUR J IMMUNOL, V29, P1275, DOI 10.1002/(SICI)1521-4141(199904)29:04<1275::AID-IMMU1275>3.0.CO;2-T; PiseMasison CA, 1997, MOL CELL BIOL, V17, P1236, DOI 10.1128/MCB.17.3.1236                                                           ; REITH W, 1994, J BIOL CHEM, V269, P20020; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554                                                           ; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331                                                ; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; RONCHI A, 1995, NUCLEIC ACIDS RES, V23, P4565, DOI 10.1093/nar/23.22.4565; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Scharer CD, 2015, NUCLEIC ACIDS RES, V43, P3128, DOI 10.1093/nar/gkv182; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496                                                            ; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/S0092-8674(05)80090-X; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STROMINGER JL, 1987, BRIT MED BULL, V43, P81, DOI 10.1093/oxfordjournals.bmb.a072178                                              ; THANOS D, 1988, P NATL ACAD SCI USA, V85, P3075, DOI 10.1073/pnas.85.9.3075; THANOS D, 1993, NUCLEIC ACIDS RES, V21, P6010, DOI 10.1093/nar/21.25.6010                                                          ; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; TROWSDALE J, 1985, EMBO J, V4, P2231; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; van den Elsen PJ, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00048; Villard J, 2000, MOL CELL BIOL, V20, P3364, DOI 10.1128/MCB.20.10.3364-3376.2000; Viten B.J., 1991, MOL CELL BIOL, V11, P2406; Wong D, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0494-z; WRIGHT KL, 1994, EMBO J, V13, P4042; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Zaidi SK, 2010, MOL CELL BIOL, V30, P4758, DOI 10.1128/MCB.00646-10; ZELEZNIKLE NJ, 1991, P NATL ACAD SCI USA, V88, P1873, DOI 10.1073/pnas.88.5.1873; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000; Zika E, 2005, CURR OPIN IMMUNOL, V17, P58, DOI 10.1016/j.coi.2004.11.008	98	1	1	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		537	542		10.1016/j.bbagrm.2016.10.013				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500003	27989934				2018-01-05	
J	Bolotin-Fukuhara, M				Bolotin-Fukuhara, M.			Thirty years of the HAP2/3/4/5 complex	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review						Transcriptional regulation; Respiratory metabolism; Yeast; Biomass; Xylose fermentation; Evolution	CCAAT-BINDING COMPLEX; YEAST SACCHAROMYCES-CEREVISIAE; REPLICATIVE LIFE-SPAN; FERRICYTOCHROME-C OXIDOREDUCTASE; UPSTREAM ACTIVATION SITE; FACTOR NF-Y; TRANSCRIPTIONAL REGULATION; KLUYVEROMYCES-LACTIS; GENE-EXPRESSION; MITOCHONDRIAL BIOGENESIS	Thirty years of study of the HAP complex have provided a pretty good picture of the complex components and put forward its original features. The HAP complex is a modular transcriptional activator in which the DNA-binding domain (composed of three proteins, Hap2p, Hap3p, and Hap5p) and the activation domain (one protein, Hap4p) are separated. I summarize what is known about these proteins and their assembly, and also examine the role of this key regulator. In addition to its well known action on mitochondrial biogenesis and function, it also plays, indirectly, additional roles on various other cellular functions, thus keeping the different pathways of the cell, well balanced. What is know of its regulation is also discussed as well as possible applications in biotechnology. However, many questions remain to be answered, especially concerning the regulation, modularity and evolution of the complex, which are discussed in the final section. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Bolotin-Fukuhara, M.] Univ Paris 11, INRA, CNRS,UFR Sci, AgroParisTech,Genet Quantitat & Evolut Le Mouton, Batiment 400, F-91405 Orsay, France	Bolotin-Fukuhara, M (reprint author), Univ Paris 11, INRA, CNRS,UFR Sci, AgroParisTech,Genet Quantitat & Evolut Le Mouton, Batiment 400, F-91405 Orsay, France.	monique.bolotin@u-psud.fr		Bolotin-Fukuhara, Monique/0000-0002-5285-5006			Avendano A, 2005, MOL MICROBIOL, V57, P291, DOI 10.1111/j.1365-2958.2005.04689.x; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; BETINA S, 1995, EUR J BIOCHEM, V229, P651, DOI 10.1111/j.1432-1033.1995.tb20510.x; Blom J, 2000, APPL ENVIRON MICROB, V66, P1970, DOI 10.1128/AEM.66.5.1970-1973.2000; Bourgarel D, 1999, MOL MICROBIOL, V31, P1205, DOI 10.1046/j.1365-2958.1999.01263.x                                                ; Bourges I, 2009, J MOL BIOL, V387, P1081, DOI 10.1016/j.jmb.2009.02.039; BOUROT S, 1995, GENE, V165, P97, DOI 10.1016/0378-1119(95)00478-O; BOWMAN SB, 1992, MOL GEN GENET, V231, P296; Brons JF, 2002, YEAST, V19, P923, DOI 10.1002/yea.886; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214                                                         ; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; CHIANG LC, 1981, APPL ENVIRON MICROB, V42, P284; CHODOSH LA, 1988, CELL, V53, P25, DOI 10.1016/0092-8674(88)90484-9; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; Chua G, 2004, CURR OPIN MICROBIOL, V7, P638, DOI 10.1016/j.mib.2004.10.009; DAIGNANFORNIER B, 1994, J BIOL CHEM, V269, P15469; DANG VD, 1994, YEAST, V10, P1273, DOI 10.1002/yea.320101004; Dang VD, 1996, MOL MICROBIOL, V22, P681, DOI 10.1046/j.1365-2958.1996.d01-1715.x; Dang VD, 1996, J BACTERIOL, V178, P1842, DOI 10.1128/jb.178.7.1842-1849.1996                                                 ; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Devic S, 2016, J CANCER, V7, P817, DOI 10.7150/jca.14274; DEWINDE JH, 1995, EUR J BIOCHEM, V233, P200; Dikicioglu D, 2008, APPL ENVIRON MICROB, V74, P5809, DOI 10.1128/AEM.00009-08; DORSMAN JC, 1990, CURR GENET, V17, P459, DOI 10.1007/BF00313072; Duefias-Sanchez R., 2010, INT J FOOD MICROBIOL, V143, P150; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; FlatteryOBrien JA, 1997, MOL MICROBIOL, V23, P303, DOI 10.1046/j.1365-2958.1997.2121581.x                                              ; FONDRAT C, 1994, CURR GENET, V25, P396, DOI 10.1007/BF00351777; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; FORSBURG SL, 1988, MOL CELL BIOL, V8, P647, DOI 10.1128/MCB.8.2.647                                                             ; Foster HA, 2013, EUKARYOT CELL, V12, P244, DOI 10.1128/EC.00214-12; FREIREPICOS MA, 1995, FEBS LETT, V360, P39, DOI 10.1016/0014-5793(95)00016-3                                                    ; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145; Grauslund M, 2000, CAN J MICROBIOL, V46, P1096, DOI 10.1139/cjm-46-12-1096; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4                                                    ; HAHN S, 1988, SCIENCE, V240, P317, DOI 10.1126/science.2832951                                                         ; HAHN S, 1988, MOL CELL BIOL, V8, P655, DOI 10.1128/MCB.8.2.655                                                             ; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haviernik P, 1996, FOLIA MICROBIOL, V41, P96, DOI 10.1007/BF02816356                                                              ; Hernandez H, 2011, MICROBIOL-SGM, V157, P879, DOI 10.1099/mic.0.044974-0; HINNEBUSCH AG, 1990, PROG NUCLEIC ACID RE, V38, P195; Hittinger CT, 2015, CURR OPIN GENET DEV, V35, P100, DOI 10.1016/j.gde.2015.10.008; Hon Thomas, 2000, Biochemical and Biophysical Research Communications, V273, P584, DOI 10.1006/bbrc.2000.2995; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Huber EM, 2012, STRUCTURE, V20, P1757, DOI 10.1016/j.str.2012.07.012; Jin YS, 2004, APPL ENVIRON MICROB, V70, P6816, DOI 10.1128/AEM.70.11.6816-6825.2004; Jin YS, 2002, APPL ENVIRON MICROB, V68, P1232, DOI 10.1128/AEM.68.3.1232-1239.2002; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KENG T, 1992, MOL GEN GENET, V234, P233; KENG T, 1987, P NATL ACAD SCI USA, V84, P9113, DOI 10.1073/pnas.84.24.9113; Kennedy MA, 1999, BBA-GENE STRUCT EXPR, V1445, P110, DOI 10.1016/S0167-4781(99)00035-4; Kim SR, 2013, BIOTECHNOL ADV, V31, P851, DOI 10.1016/j.biotechadv.2013.03.004; Koehler AN, 2003, J AM CHEM SOC, V125, P8420, DOI 10.1021/ja0352698                                                               ; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kwast KE, 1998, J EXP BIOL, V201, P1177; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lamas-Maceiras M, 2011, J IND MICROBIOL BIOT, V38, P43, DOI 10.1007/s10295-010-0827-1; Lascaris R, 2003, GENOME BIOL, V4; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Leadsham JE, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-92; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin Y., 2014, BIOTECHNOL BIOFUELS, V7; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; lizuka N., 1994, MOL CELL BIOL, V14, P7322, DOI DOI 10.1128/MC8.14.117322; Lodi T, 2002, MOL GENET GENOMICS, V266, P838, DOI 10.1007/s00438-001-0604-y; Lodi T, 1999, MOL GEN GENET, V262, P623, DOI 10.1007/s004380051125                                                           ; Lodi T, 1998, CURR GENET, V34, P12, DOI 10.1007/s002940050361                                                           ; Lu L, 2003, CURR GENET, V43, P263, DOI 10.1007/s00294-003-0398-z; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979                                                           ; MAITY SN, 1992, J BIOL CHEM, V267, P16574; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135                                                           ; Matsushika A, 2015, J IND MICROBIOL BIOT, V42, P1623, DOI 10.1007/s10295-015-1695-5; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; MATTOON JR, 1990, CURR GENET, V17, P179, DOI 10.1007/BF00312865; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; McNabb DS, 1997, MOL CELL BIOL, V17, P7008, DOI 10.1128/MCB.17.12.7008                                                          ; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; MERCADO JJ, 1992, FEBS LETT, V311, P110, DOI 10.1016/0014-5793(92)81379-Z; MULDER W, 1994, BBA-GENE STRUCT EXPR, V1219, P719, DOI 10.1016/0167-4781(94)90235-6; MULDER W, 1995, MOL MICROBIOL, V17, P813, DOI 10.1111/j.1365-2958.1995.mmi_17050813.x; Murphy JP, 2015, MOL CELL PROTEOMICS, V14, P2454, DOI 10.1074/mcp.M114.045849; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Nftfiez L, 2004, CURR GENET, V46, P147; NGUYEN C, 1995, GENE, V152, P113, DOI 10.1016/0378-1119(94)00684-K; Ocampo A, 2010, FASEB J, V24, P1431, DOI 10.1096/fj.09-148601; OECHSNER U, 1992, MOL GEN GENET, V232, P447; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4                                                    ; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; OLESEN JT, 1991, MOL CELL BIOL, V11, P611, DOI 10.1128/MCB.11.2.611                                                            ; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Petryk N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112263; PINA B, 1993, MOL CELL BIOL, V13, P5981, DOI 10.1128/MCB.13.10.5981                                                          ; Pinkham JL, 1997, CURR GENET, V31, P281, DOI 10.1007/s002940050207; PINKHAM JL, 1987, MOL CELL BIOL, V7, P578, DOI 10.1128/MCB.7.2.578                                                             ; PINKHAM JL, 1985, MOL CELL BIOL, V5, P3410, DOI 10.1128/MCB.5.12.3410                                                           ; Piper PW, 2006, MECH AGEING DEV, V127, P733, DOI 10.1016/j.mad.2006.05.004; Pumapatre K., 2002, CURR GENET, V42, P1; Qi K, 2014, APPL ENVIRON MICROB, V80, P3879, DOI 10.1128/AEM.00854-14; Raab AM, 2011, APPL ENVIRON MICROB, V77, P1981, DOI 10.1128/AEM.02219-10; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Rahner A, 1996, NUCLEIC ACIDS RES, V24, P2331, DOI 10.1093/nar/24.12.2331; Ramil E, 1998, EUR J BIOCHEM, V256, P67, DOI 10.1046/j.1432-1327.1998.2560067.x                                              ; Ramil E, 2000, MOL MICROBIOL, V37, P1116, DOI 10.1046/j.1365-2958.2000.02065.x                                                ; Rao AR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-160; REPETTO B, 1989, MOL CELL BIOL, V9, P2695, DOI 10.1128/MCB.9.6.2695                                                            ; Riego L, 2002, BIOCHEM BIOPH RES CO, V293, P79, DOI 10.1016/S0006-291X(02)00174-2; Roberts GG, 2009, YEAST, V26, P95, DOI 10.1002/yea.1655; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; ROSENKRANTZ M, 1994, MOL MICROBIOL, V13, P119, DOI 10.1111/j.1365-2958.1994.tb00407.x; Salusjarvi L, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-18; Scheffler IE, 1998, INT J BIOCHEM CELL B, V30, P1175, DOI 10.1016/S1357-2725(98)00086-7                                                   ; SCHLAEPFER IR, 1994, YEAST, V10, P227, DOI 10.1002/yea.320100209; SCHNEIDER JC, 1991, MOL CELL BIOL, V11, P4934, DOI 10.1128/MCB.11.10.4934                                                          ; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Schuurmans JM, 2008, FEMS YEAST RES, V8, P195, DOI 10.1111/j.1567-1364.2007.00319.x; Seino A, 2005, BBA-GENE STRUCT EXPR, V1681, P166, DOI 10.1016/j.bbaexp.2004.11.009; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Soontorngun N, 2007, MOL CELL BIOL, V27, P7895, DOI 10.1128/MCB.01055-07; Soontorngun N, 2012, BIOCHEM BIOPH RES CO, V423, P632, DOI 10.1016/j.bbrc.2012.05.151; Stebbins JL, 2004, EUKARYOT CELL, V3, P339, DOI 10.1128/EC.3.2.339-347.2004; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Sybirna K, 2005, CURR GENET, V47, P172, DOI 10.1007/s00294-004-0556-y; Sybirna K, 2010, YEAST, V27, P941, DOI 10.1002/yea.1802; TRAWICK JD, 1989, MOL CELL BIOL, V9, P5350, DOI 10.1128/MCB.9.12.5350                                                           ; TRAWICK JD, 1992, MOL CELL BIOL, V12, P2302, DOI 10.1128/MCB.12.5.2302                                                           ; TRAWICK JD, 1989, J BIOL CHEM, V264, P7005; TREININ M, 1993, CURR GENET, V23, P223, DOI 10.1007/BF00351500; TRUEBLOOD CE, 1988, MOL CELL BIOL, V8, P4537, DOI 10.1128/MCB.8.10.4537                                                           ; Tuncher A, 2005, J MOL BIOL, V352, P517, DOI 10.1016/j.jmb.2005.06.068; van Maris AJA, 2001, FEMS YEAST RES, V1, P139, DOI 10.1016/S1567-1356(01)00022-8; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119; Viola AM, 1999, CURR GENET, V36, P29, DOI 10.1007/s002940050469; Wahls WP, 2012, NUCLEIC ACIDS RES, V40, P9983, DOI 10.1093/nar/gks761; Watt R, 1997, MOL GEN GENET, V253, P439, DOI 10.1007/s004380050341                                                           ; Wong CM, 2003, FREE RADICAL BIO MED, V34, P585, DOI 10.1016/S0891-5849(02)01354-0; Wu WS, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S12-S10; XING YY, 1993, EMBO J, V12, P4647; XING YY, 1994, P NATL ACAD SCI USA, V91, P3009, DOI 10.1073/pnas.91.8.3009; Yang YL, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-90; ZITOMER RS, 1992, MICROBIOL REV, V56, P1; ZITOMER RS, 1979, P NATL ACAD SCI USA, V76, P3627, DOI 10.1073/pnas.76.8.3627                                                          	154	2	2	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		543	559		10.1016/j.bbagrm.2016.10.011				17	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500004	27989936				2018-01-05	
J	Hortschansky, P; Haas, H; Huber, EM; Groll, M; Brakhage, AA				Hortschansky, Peter; Haas, Hubertus; Huber, Eva M.; Groll, Michael; Brakhage, Axel A.			The CCAAT-binding complex (CBC) in Aspergillus species	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						CCAAT-binding complex; Hap complex; Aspergillus; HapX; gene regulation; iron; virulence; azole resistance	FACTOR NF-Y; TRANSCRIPTION FACTOR COMPLEX; OXIDATIVE STRESS-RESPONSE; SACCHAROMYCES-CEREVISIAE; DNA-BINDING; AMDS GENE; KLUYVEROMYCES-LACTIS; CANDIDA-ALBICANS; HAP COMPLEX; CBF/NF-Y	Background: The CCAAT binding complex (CBC), consisting of a heterotrimeric core structure, is highly conserved in eukaryotes and constitutes an important general transcriptional regulator. Scope of the review. In this review we discuss the scientific history and the current state of knowledge of the multiple gene regulatory functions, protein motifs and structure of the CBC in fungi with a special focus on Aspergillus species. Major conclusions and general significance. Initially identified as a transcriptional activator of respiration in Saccharomyces cerevisiae, in other fungal species the CBC was found to be involved in highly diverse pathways, but a general rationale for its involvement was missing. Subsequently, the CBC was found to sense reactive oxygen species through oxidative modifications of cysteine residues in order to mediate redox regulation. Moreover, via interaction with the iron-sensing bZIP transcription factor HapX, the CBC was shown to mediate adaptation to both iron starvation and iron excess. Due to the control of various pathways in primary and secondary metabolism the CBC is of crucial importance for fungal virulence in both animal and plant hosts as well as antifungal resistance. Consequently, CBC-mediated control affects biological processes that are of high interest in biotechnology, agriculture and infection medicine. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Hortschansky, Peter; Brakhage, Axel A.] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Mol & Appl Microbiol, Beutenbergstr 11A, D-07745 Jena, Germany; [Haas, Hubertus] Med Univ Innsbruck, Bioctr, Div Mol Biol, Innrain 80-82, A-6020 Innsbruck, Austria; [Huber, Eva M.; Groll, Michael] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, Lichtenbergstr 4, D-85748 Garching, Germany; [Brakhage, Axel A.] FSU, Dept Microbiol & Mol Biol, D-07745 Jena, Germany	Brakhage, AA (reprint author), FSU, Dept Microbiol & Mol Biol, D-07745 Jena, Germany.	axel.brakhage@leibniz-hki.de	Groll, Michael/F-5572-2015; Huber, Eva/J-3130-2015	Huber, Eva/0000-0001-8018-7204	joint D-A-CH program 'Novel molecular mechanisms of iron sensing and homeostasis in filamentous fungi' (Deutsche Forschungsgemeinschaft (DFG); Austrian Science Foundation [FWF-11346]	Work in the authors' laboratories was supported by the joint D-A-CH program 'Novel molecular mechanisms of iron sensing and homeostasis in filamentous fungi' (Deutsche Forschungsgemeinschaft (DFG) to MB, MG and PH, and Austrian Science Foundation (FWF-11346) to HH).	ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Baek YU, 2008, EUKARYOT CELL, V7, P1168, DOI 10.1128/EC.00108-08; Benatti P, 2016, ONCOTARGET, V7, P1633, DOI 10.18632/oncotarget.6453; Bergh KT, 1996, J BACTERIOL, V178, P3908, DOI 10.1128/jb.178.13.3908-3916.1996                                                ; Bhattacharya A, 2003, CANCER RES, V63, P8167; Bourgarel D, 1999, MOL MICROBIOL, V31, P1205, DOI 10.1046/j.1365-2958.1999.01263.x                                                ; Brakhage AA, 1999, FUNGAL GENET BIOL, V27, P243, DOI 10.1006/fgbi.1999.1136; Brakhage AA, 2009, PHYTOCHEMISTRY, V70, P1801, DOI 10.1016/j.phytochem.2009.09.011; Brault A, 2015, IUBMB LIFE, V67, P801, DOI 10.1002/iub.1441; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005                                             ; Camps SMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050034; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; CHEN HX, 1995, MOL GEN GENET, V249, P301, DOI 10.1007/BF00290531; Chen HX, 1998, GENETICS, V148, P123; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; Chung D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004487; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485                                                        ; DAVIS MA, 1989, TRENDS GENET, V5, P14, DOI 10.1016/0168-9525(89)90006-1                                                    ; DAVIS MA, 1993, GENETICA, V90, P133, DOI 10.1007/BF01435035; Deng HS, 2007, DEV BIOL, V308, P583, DOI 10.1016/j.ydbio.2007.05.021; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Edwards D, 1998, PLANT PHYSIOL, V117, P1015, DOI 10.1104/pp.117.3.1015                                                           ; del Dedo JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005106; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861                                                              ; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Gnesutta Nerina, 2013, Transcription, V4, P114; Gsaller F, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005775; Gsaller F, 2014, EMBO J, V33, P2261, DOI 10.15252/embj.201489468; Gsaller F, 2012, METALLOMICS, V4, P1262, DOI 10.1039/c2mt20179h; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; HAHN S, 1988, SCIENCE, V240, P317, DOI 10.1126/science.2832951                                                         ; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hortschansky P, 2015, J BIOL CHEM, V290, P6058, DOI 10.1074/jbc.M114.628677; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Huber EM, 2012, STRUCTURE, V20, P1757, DOI 10.1016/j.str.2012.07.012; HYNES MJ, 1994, ANTON LEEUW INT J G, V65, P179, DOI 10.1007/BF00871944; Johnson DC, 2005, EUKARYOT CELL, V4, P1662, DOI 10.1128/EC.4.10.1662-1676.2005; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kato M, 2005, BIOSCI BIOTECH BIOCH, V69, P663, DOI 10.1271/bbb.69.663; Kato M, 1998, MOL GEN GENET, V257, P404, DOI 10.1007/s004380050664                                                           ; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Krober A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150701; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Liang SG, 1998, J BIOL CHEM, V273, P31590, DOI 10.1074/jbc.273.47.31590; LITTLEJOHN TG, 1992, MOL GEN GENET, V235, P81, DOI 10.1007/BF00286184; Litzka O, 1996, EUR J BIOCHEM, V238, P675, DOI 10.1111/j.1432-1033.1996.0675w.x                                                ; Litzka O, 1998, EUR J BIOCHEM, V251, P758, DOI 10.1046/j.1432-1327.1998.2510758.x                                              ; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Luger K, 1997, NATURE, V389, P251; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8                                                   ; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; Matuoka K, 1999, EXP CELL RES, V253, P365, DOI 10.1006/excr.1999.4605; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; McNabb DS, 1997, MOL CELL BIOL, V17, P7008, DOI 10.1128/MCB.17.12.7008                                                          ; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Mendoza-Mendoza A, 2009, MOL MICROBIOL, V72, P683, DOI 10.1111/j.1365-2958.2009.06676.x; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Merhej J, 2015, MOL MICROBIOL, V96, P951, DOI 10.1111/mmi.12983; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; MULDER W, 1994, MOL GEN GENET, V245, P96, DOI 10.1007/BF00279755; Nakshatri H, 1996, J BIOL CHEM, V271, P28784, DOI 10.1074/jbc.271.46.28784                                                        ; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Narendja FM, 1999, MOL CELL BIOL, V19, P6523; NEHLIN JO, 1990, EMBO J, V9, P2891; NGUYEN C, 1995, GENE, V152, P113, DOI 10.1016/0378-1119(94)00684-K; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; OLESEN JT, 1991, MOL CELL BIOL, V11, P611, DOI 10.1128/MCB.11.2.611                                                            ; Papagiannopoulos P, 1996, MOL GEN GENET, V251, P412, DOI 10.1007/s004380050184; Petryk N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112263; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Ridenour JB, 2014, FUNGAL GENET BIOL, V69, P52, DOI 10.1016/j.fgb.2014.05.003; Rietzschel N, 2015, MOL CELL BIOL, V35, P370, DOI 10.1128/MCB.01033-14; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Sinha S, 1996, MOL CELL BIOL, V16, P328; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Stebbins JL, 2004, EUKARYOT CELL, V3, P339, DOI 10.1128/EC.3.2.339-347.2004; Steidl S, 1999, MOL CELL BIOL, V19, P99; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Steidl S, 2001, J MOL BIOL, V306, P643, DOI 10.1006/jmbi.2001.4412; Sybirna K, 2005, CURR GENET, V47, P172, DOI 10.1007/s00294-004-0556-y; Tanaka A, 2002, BBA-GENE STRUCT EXPR, V1576, P176, DOI 10.1016/S0167-4781(02)00286-5; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; Thon M, 2010, NUCLEIC ACIDS RES, V38, P1098, DOI 10.1093/nar/gkp1091; Tsukagoshi N, 2001, J GEN APPL MICROBIOL, V47, P1, DOI 10.2323/jgam.47.1; Tuncher A, 2005, J MOL BIOL, V352, P517, DOI 10.1016/j.jmb.2005.06.068; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; VANHEESWIJCK R, 1991, NUCLEIC ACIDS RES, V19, P2655, DOI 10.1093/nar/19.10.2655; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Weidner G, 2001, ARCH MICROBIOL, V175, P122, DOI 10.1007/s002030000246; XING YY, 1993, EMBO J, V12, P4647; Yoshioka Y, 2007, GENESIS, V45, P21, DOI 10.1002/dvg.20260; Zeilinger S, 1998, J BIOL CHEM, V273, P34463, DOI 10.1074/jbc.273.51.34463; Zeilinger S, 2003, MOL GENET GENOMICS, V270, P46, DOI 10.1007/s00438-003-0895-2	114	1	1	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		560	570		10.1016/j.bbagrm.2016.11.008				11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500005	27939757				2018-01-05	
J	Suske, G				Suske, Guntram			NF-Y and SP transcription factors-New insights in a long-standing liaison	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review						CCAAT box; GC box; Promoter elements/motifs; Nuclear factor NF-Y; Transcription factors SP1; SP2; SP3; Genome-wide analysis	BOX-BINDING-PROTEINS; FATTY-ACID SYNTHASE; LARGE GENE LISTS; DNA-BINDING; CHROMATIN ACCESSIBILITY; GLUCOCORTICOID-RECEPTOR; HETEROLOGOUS SUBUNITS; INTEGRATIVE ANALYSIS; CANCER-CELLS; MICE LACKING	For long it has been recognized that CCAAT boxes and GC-rich elements co-occur in many human and murine promoters within 100 bp upstream of the transcription start site. The trimeric transcription factor NF-Y is the major CCAAT box-binding factor, and members of the SP family of transcription factors are the major GC box-binding proteins. Recent chromatin immunoprecipitations coupled with high throughput sequencing (ChIP-seq) have examined binding of NF-Y and the ubiquitous SP factors SP1, SP2 and SP3 genome-wide, allowing for comprehensive comparison of NF-Y and SP factor actions in the context of chromatin. Here, I attempt a synthesis of the earlier single-promoter type of analysis with the more recent genome-wide studies. In particular, I also discuss different modes of genomic interactions between SP factors and NF-Y that have emerged recently, and identify a key technical issue, which needs to be taken into account in a critical evaluation of genome-wide studies. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Suske, Guntram] Philipps Univ Marburg, Inst Mol Biol & Tumor Res IMT, Emil Mannkopff Str 2, D-35032 Marburg, Germany	Suske, G (reprint author), Philipps Univ Marburg, Inst Mol Biol & Tumor Res IMT, Emil Mannkopff Str 2, D-35032 Marburg, Germany.	Suske@imt.uni-marburg.de		Suske, Guntram/0000-0002-4807-0513	Deutsche Forschungsgemeinschaft (DFG) [SU 102/8-2]	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG, SU 102/8-2). I thank Colin Dingwall, Florian Finkernagel, Bastian Stielow and Sara Volkel for discussions and for critically reading of the manuscript. I apologize to all colleagues whose work is not cited due to the limited scope of the article.	Baur F, 2010, PLOS ONE, V5, pA202, DOI 10.1371/journal.pone.0009587; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Benner C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003906; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655                                                          ; Burdach J, 2014, NUCLEIC ACIDS RES, V42, P276, DOI 10.1093/nar/gkt895; CHODOSH LA, 1988, CELL, V53, P25, DOI 10.1016/0092-8674(88)90484-9; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; Dolfini D, 2016, NUCLEIC ACIDS RES, V44, P4684, DOI 10.1093/nar/gkw096; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; DORN A, 1987, P NATL ACAD SCI USA, V84, P6249, DOI 10.1073/pnas.84.17.6249; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Foley JW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-720; Ge YB, 2002, BBA-GENE STRUCT EXPR, V1579, P73, DOI 10.1016/S0167-4781(02)00509-2; Ge YB, 2001, BIOCHEM J, V357, P97, DOI 10.1042/0264-6021:3570097; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Giannopoulou EG, 2013, GENOME RES, V23, P1295, DOI 10.1101/gr.149419.112; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; Guo Y., 2015, BIORXIV; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843; HATAMOCHI A, 1988, J BIOL CHEM, V263, P5940; Hedrick E, 2016, ONCOTARGET, V7, P22245, DOI 10.18632/oncotarget.7925; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jain D, 2015, NUCLEIC ACIDS RES, V43, P6959, DOI 10.1093/nar/gkv637; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206                                                         ; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251                                                          ; Krebs W, 2014, NUCLEIC ACIDS RES, V42, P13051, DOI 10.1093/nar/gku1078; Kruger I, 2007, DEV DYNAM, V236, P2235, DOI 10.1002/dvdy.21222; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Liang FQ, 2001, J BIOL CHEM, V276, P1516, DOI 10.1074/jbc.M006350200                                                          ; Lim K, 2009, BIOCHEM BIOPH RES CO, V382, P593, DOI 10.1016/j.bbrc.2009.03.075; Lim WF, 2016, NUCLEIC ACIDS RES, V44, P3118, DOI 10.1093/nar/gkv1380; Liu ZJ, 2014, CELL, V159, P358, DOI 10.1016/j.cell.2014.08.027; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726                                                          ; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; Meinders M, 2015, BLOOD, V125, P1957, DOI 10.1182/blood-2014-08-593343; Moorefield KS, 2006, MOL BIOL CELL, V17, P1711, DOI 10.1091/mbc.E05-11-1063; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Papantonis A, 2013, CHEM REV, V113, P8683, DOI 10.1021/cr300513p; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; Roder K, 1997, J BIOL CHEM, V272, P21616, DOI 10.1074/jbc.272.34.21616                                                        ; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 2000, Methods Mol Biol, V130, P175; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1                                                   ; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Terrados G, 2012, NUCLEIC ACIDS RES, V40, P7844, DOI 10.1093/nar/gks544; Teytelman Leonid, 2013, Proc Natl Acad Sci U S A, V110, P18602, DOI 10.1073/pnas.1316064110; Valin A, 2007, BIOCHEM SOC T, V35, P1393, DOI 10.1042/BST0351393; van Loo PF, 2003, BLOOD, V102, P858, DOI 10.1182/blood-2002-06-1848; van Loo,PF, 2007, MOL CELL BIOL, V27, P8571, DOI 10.1128/MCB.01350-07; Volkel S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005102; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; WRIGHT KL, 1995, J BIOL CHEM, V270, P20978, DOI 10.1074/jbc.270.36.20978                                                        ; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200                                                          ; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zuin J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004153	90	1	1	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		590	597		10.1016/j.bbagrm.2016.08.011				8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500008	27697431				2018-01-05	
J	Maity, SN				Maity, Sankar N.			NF-Y (CBF) regulation in specific cell types and mouse models	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review						CCAAT binding factor; NF-Y; Cell type specific; Conditional inactivation in mice; Tissue homeostasis	ENDOPLASMIC-RETICULUM STRESS; CCAAT-BINDING-FACTOR; NUCLEAR FACTOR-Y; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; MUSCLE DIFFERENTIATION; PROXIMAL PROMOTER; STEROL REGULATION; G(2)/M PROMOTERS; DOWN-REGULATION	The CCAAT-binding factor CBF/NF-Y is needed for cell proliferation and early embryonic development. NF-Y can regulate the expression of different cell type-specific genes that are activated by various physiological signaling pathways. Dysregulation of NF-Y was observed in pathogenic conditions in humans such as scleroderma, neurodegenerative disease, and cancer. Conditional inactivation of the NF-YA gene in mice demonstrated that NF-Y activity is essential for normal tissue homeostasis, survival, and metabolic function. Altogether, NF-Y is an essential transcription factor that plays a critical role in mammalian development, from the early stages to adulthood, and in human pathogenesis. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Maity, Sankar N.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77030 USA	Maity, SN (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Unit 0018-6,1515 Holcombe Blvd, Houston, TX 77030 USA.	smaity@mdanderson.org			National Institutes of Health [R01 AR46264]; Prostate Cancer Research Program of MD Anderson	The author thanks Ann Sutton for editing the manuscript. The author's work in this review was Supported previously by the National Institutes of Health (R01 AR46264) and is currently supported by the Prostate Cancer Research Program of MD Anderson.	Alabert C, 2006, ONCOGENE, V25, P3387, DOI 10.1038/sj.onc.1209385; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Basile V, 2016, BBA-GENE REGUL MECH, V1859, P627, DOI 10.1016/j.bbagrm.2016.02.011; Benatti P, 2011, NUCLEIC ACIDS RES, V39, P5356, DOI 10.1093/nar/gkr128; Bhattacharya A, 2003, CANCER RES, V63, P8167; Bungartz G, 2012, BLOOD, V119, P1380, DOI 10.1182/blood-2011-06-359406; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dolfini D, 2012, STEM CELLS, V30, P2450, DOI 10.1002/stem.1232; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Farina A, 1999, ONCOGENE, V18, P2818, DOI 10.1038/sj.onc.1202472; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Gudmundsson KO, 2014, METHODS MOL BIOL, V1194, P313, DOI 10.1007/978-1-4939-1215-5_17; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Hu QH, 2000, J BIOL CHEM, V275, P4435, DOI 10.1074/jbc.275.6.4435; Hu QH, 2006, NUCLEIC ACIDS RES, V34, P6272, DOI 10.1093/nar/gkl801; Huang SS, 2011, BRAIN, V134, P1943, DOI 10.1093/brain/awr146; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Imbriano C, 2012, BBA-REV CANCER, V1825, P131, DOI 10.1016/j.bbcan.2011.11.001; Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Lee LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035302; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Lu YH, 2015, MOL METAB, V4, P392, DOI 10.1016/j.molmet.2015.02.002; Luo R, 2008, J CELL BIOCHEM, V104, P1708, DOI 10.1002/jcb.21736; Luo R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00136; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8                                                   ; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Misawa H, 2003, GENESIS, V37, P44, DOI 10.1002/gene.10224; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; Peart MJ, 2006, CANCER CELL, V10, P173, DOI 10.1016/j.ccr.2006.08.014; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Saitta B, 2000, ARTHRITIS RHEUM, V43, P2219, DOI 10.1002/1529-0131(200010)43:10<2219::AID-ANR9>3.0.CO;2-N; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x; Soyal SM, 2015, TRENDS PHARMACOL SCI, V36, P406, DOI 10.1016/j.tips.2015.04.010; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Villard J, 2000, MOL CELL BIOL, V20, P3364, DOI 10.1128/MCB.20.10.3364-3376.2000; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Xiong SB, 2000, P NATL ACAD SCI USA, V97, P3948, DOI 10.1073/pnas.040574197; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yamanaka T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34575; Yamanaka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4354; Yang RL, 2015, IMMUNITY, V43, P251, DOI 10.1016/j.immuni.2015.07.017; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000	57	2	2	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		598	603		10.1016/j.bbagrm.2016.10.014				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500009	27815195				2018-01-05	
J	Gurtner, A; Manni, I; Piaggio, G				Gurtner, Aymone; Manni, Isabella; Piaggio, Giulia			NF-Y in cancer: Impact on cell transformation of a gene essential for proliferation	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review						NF-Y; CCAAT box; Cell proliferation; p53; Cancer; Anti-cancer drugs	NUCLEAR-FACTOR-Y; TOPOISOMERASE-II-ALPHA; CYCLIN B1 GENE; PYRROLOBENZODIAZEPINE-POLYAMIDE CONJUGATE; CCAAT-BINDING ACTIVITY; GAIN-OF-FUNCTION; TRANSCRIPTION FACTOR; DNA-BINDING; MUTANT P53; BREAST-CANCER	NF-Y is a ubiquitous heterotrimeric transcription factor with a binding affinity for the CCAAT consensus motif, one of the most common cis-acting element in the promoter and enhancer regions of eukaryote genes in direct (CCAAT) or reverse (ATTGG) orientation. NF-Y consists of three subunits, NF-YA, the regulatory subunit of the trimer, NF-YB, and NF-YC, all required for CCAAT binding. Growing evidence in cells and animal models support the notion that NF-Y, driving transcription of a plethora of cell cycle regulatory genes, is a key player in the regulation of proliferation. Proper control of cellular growth is critical for cancer prevention and uncontrolled proliferation is a hallmark of cancer cells. Indeed, during cell transformation aberrant molecular pathways disrupt mechanisms controlling proliferation and many growth regulatory genes are altered in tumors. Here, we review bioinformatics, molecular and functional evidence indicating the involvement of the cell cycle regulator NF-Y in cancer-associated pathways. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Gurtner, Aymone; Manni, Isabella; Piaggio, Giulia] Regina Elena Inst Canc Res, UOSD SAFU, Dept Res Adv Diagnost & Technol Innovat, Via Elio Chianesi 53, I-00144 Rome, Italy	Piaggio, G (reprint author), Regina Elena Inst Canc Res, UOSD SAFU, Dept Res Adv Diagnost & Technol Innovat, Via Elio Chianesi 53, I-00144 Rome, Italy.	giulia.piaggio@ifo.gov.it		gurtner, aymone/0000-0002-7661-9059; piaggio, giulia/0000-0003-2114-1892	AIRC [MFAG 11752, IG 13234]	We thank Silvia Soddu for interesting discussions on and critical reading of the manuscript and Tania Merlino for critical reading of the manuscript. We wish to thank members of the lab that, over the past years, have contributed to NF-Y studies. In particular, Andrea Farina, Paola Fuschi, Selvaggia Sciortino, Silvia D'Agostino, Frauke Goeman, Velia Emiliozzi, Giacoma Simonte, Simona Artuso and Emmanuela Falcone. We also thank our collaborators on NF-Y studies over the years: Roberto Mantovani, Keiko Ozato, Carlo Gaetano, Carol Imbriano, Paolo Ciana and Giovanni Blandino. We apologize with our colleagues whose valuable work could not be cited in this review. This work has been supported by grant from AIRC to A.G. (MFAG 11752), and to G.P. (IG 13234).	Adachi N, 2000, GENE, V245, P49, DOI 10.1016/S0378-1119(00)00040-8; Alabert C, 2006, ONCOGENE, V25, P3387, DOI 10.1038/sj.onc.1209385; Alam SK, 2016, CELL DEATH DIFFER, V23, P707, DOI 10.1038/cdd.2015.133; Arampatzi P, 2013, NUCLEIC ACIDS RES, V41, P2202, DOI 10.1093/nar/gks1365; Bajaj S, 2016, J BIOL CHEM, V291, P14231, DOI 10.1074/jbc.M116.731398; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Basile V, 2016, BBA-GENE REGUL MECH, V1859, P627, DOI 10.1016/j.bbagrm.2016.02.011; Belluti S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.287; Benatti P., 2016, ONCOTARGET; Benatti P, 2008, NUCLEIC ACIDS RES, V36, P1415, DOI 10.1093/nar/gkm1046; Benatti P, 2016, BBA-MOL CELL RES, V1863, P673, DOI 10.1016/j.bbamcr.2015.12.019; Benatti P, 2016, ONCOTARGET, V7, P1633, DOI 10.18632/oncotarget.6453; Benatti P, 2011, NUCLEIC ACIDS RES, V39, P5356, DOI 10.1093/nar/gkr128; Bhattacharya A, 2003, CANCER RES, V63, P8167; Bing F, 2016, ONCOTARGETS THER, V9, P2593, DOI 10.2147/OTT.S92350; Blum R, 2007, CANCER RES, V67, P3320, DOI 10.1158/0008-5472.CAN-06-4287; Bolognese F, 1999, ONCOGENE, V18, P1845, DOI 10.1038/sj.onc.1202494; Bonfanti M, 1999, ANTI-CANCER DRUG DES, V14, P179; Brucoli F, 2013, J MED CHEM, V56, P6339, DOI 10.1021/jm4001852; Bungartz G, 2012, BLOOD, V119, P1380, DOI 10.1182/blood-2011-06-359406; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Castro NE, 2014, J BIOL CHEM, V289, P29001, DOI 10.1074/jbc.M114.600783; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; Chae HD, 2011, BMB REP, V44, P553, DOI 10.5483/BMBRep.2011.44.8.553; CHANG ZF, 1994, J BIOL CHEM, V269, P17893; Chen PM, 2015, ONCOTARGET, V6, P14274, DOI 10.18632/oncotarget.3695                                                        ; Chia MC, 2008, CLIN CANCER RES, V14, P984, DOI 10.1158/1078-0432.CCR-07-0828; Cicchillitti L., 2016, CANC ONCO T IN PRESS; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Cui H, 2016, NEUROSCI LETT, V631, P40, DOI 10.1016/j.neulet.2016.08.003; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430                                                          ; Curtis DJ, 2001, LEUKEMIA, V15, P1932, DOI 10.1038/sj.leu.2402286                                                          ; Curtner A., 2010, CANCER RES, V70, P9711; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; De Amicis F, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0403-4; Deng GR, 2004, CANCER RES, V64, P2692, DOI 10.1158/0008-5472.CAN-03-3000; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Di Agostino S, 2016, EMBO REP, V17, P188, DOI 10.15252/embr.201540488; Dolfini D, 2013, CELL DEATH DIFFER, V20, P676, DOI 10.1038/cdd.2013.13; Dolfini D, 2016, NUCLEIC ACIDS RES, V44, P4684, DOI 10.1093/nar/gkw096; Dolfini D, 2012, STEM CELLS, V30, P2450, DOI 10.1002/stem.1232; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Domashenko AD, 2010, BLOOD, V116, P2676, DOI 10.1182/blood-2010-03-273441; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Falcone E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153658; Farina A, 1999, ONCOGENE, V18, P2818, DOI 10.1038/sj.onc.1202472; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Franks A, 2010, BIOORGAN MED CHEM, V18, P5553, DOI 10.1016/j.bmc.2010.06.041; Frontini M, 2004, CELL CYCLE, V3, P217; Garipov A, 2013, MOL CANCER RES, V11, P360, DOI 10.1158/1541-7786.MCR-12-0661; Gayvert KM, 2016, CELL REP, V15, P2348, DOI 10.1016/j.celrep.2016.05.037; Goeman F, 2012, MOL BIOL CELL, V23, P1467, DOI 10.1091/mbc.E12-01-0039; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Gu ZN, 1999, MOL CARCINOGEN, V24, P294, DOI 10.1002/(SICI)1098-2744(199904)24:4<294::AID-MC7>3.0.CO;2-Q; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Gusev Y, 2013, CANCER INFORM, V12, P31, DOI 10.4137/CIN.S10329; Halperin Y, 2009, NUCLEIC ACIDS RES, V37, P1566, DOI 10.1093/nar/gkn1064; Han L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.30; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hochhauser D, 2007, MOL CANCER THER, V6, P346, DOI 10.1158/1535-7163.MCT-06-0503; Hu QH, 2000, J BIOL CHEM, V275, P4435, DOI 10.1074/jbc.275.6.4435; Hu QH, 2006, NUCLEIC ACIDS RES, V34, P6272, DOI 10.1093/nar/gkl801; Huang XP, 2013, NEOPLASIA, V15, P952, DOI 10.1593/neo.13376; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Imbriano C, 2001, J BIOL CHEM, V276, P26332, DOI 10.1074/jbc.M101553200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Isaacs RJ, 1996, J BIOL CHEM, V271, P16741, DOI 10.1074/jbc.271.28.16741                                                        ; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Jeong JH, 2009, J CELL BIOCHEM, V106, P73, DOI 10.1002/jcb.21977; Jiang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127951; Jin S, 2000, P NATL ACAD SCI USA, V97, P6775, DOI 10.1073/pnas.97.12.6775; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377                                                           ; Katula KS, 1997, CELL GROWTH DIFFER, V8, P811; Kiakos K, 2015, CHEM BIOL, V22, P862, DOI 10.1016/j.chembiol.2015.06.005; Koessler H, 2004, BIOCHEM J, V384, P317, DOI 10.1042/BJ20040502; Korner K, 2001, J BIOL CHEM, V276, P9662, DOI 10.1074/jbc.M008696200; Kotecha M, 2008, MOL CANCER THER, V7, P1319, DOI 10.1158/1535-7163.MCT-07-0475; Kramer A, 1997, CANCER RES, V57, P5117; Kronung S.K., 2016, ONCOTARGET; Lagadec C, 2014, STEM CELLS, V32, P135, DOI 10.1002/stem.1537; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Lin SC, 2006, MOL IMMUNOL, V43, P1325, DOI 10.1016/j.molimm.2005.09.007; Lin YC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.527; Linhart C, 2005, CELL CYCLE, V4, P1788, DOI 10.4161/cc.4.12.2173                                                            ; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; LIWEBER M, 1994, J IMMUNOL, V153, P4122; Luo R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00136; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Ma HX, 2015, ONCOTARGET, V6, P1049, DOI 10.18632/oncotarget.2832                                                        ; Mackay H, 2008, BIOORGAN MED CHEM, V16, P2093, DOI 10.1016/j.bmc.2007.10.059; Mamat Suhana, 2011, Genes Cancer, V2, P979, DOI 10.1177/1947601911436009; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Manni I, 2008, MOL BIOL CELL, V19, P5203, DOI 10.1091/mbc.E08-03-0295; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135                                                           ; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Marziali G, 1999, BLOOD, V93, P519; Matsui T, 2004, J BIOL CHEM, V279, P25093, DOI 10.1074/jbc.M403232200; Matuoka K, 2000, BIOGERONTOLOGY, V1, P261, DOI 10.1023/A:1010094431748; Minuzzo M, 2005, MOL PHARMACOL, V68, P1496, DOI 10.1124/mol.105.013615; Minuzzo M, 2000, P NATL ACAD SCI USA, V97, P6780, DOI 10.1073/pnas.97.12.6780; Morachis JM, 2010, GENE DEV, V24, P135, DOI 10.1101/gad.1856710; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Niida A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-404; Panno ML, 2009, CURR CANCER DRUG TAR, V9, P469, DOI 10.2174/156800909788486786                                                      ; Pappa KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142229; Park SH, 2002, J BIOL CHEM, V277, P5168, DOI 10.1074/jbc.M106451200; Peng Y., 2007, ONCOGENE; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Puvvula PK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6323; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rizzi N, 2015, TOXICOL SCI, V145, P296, DOI 10.1093/toxsci/kfv056; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Sjin RMTT, 2002, BLOOD, V100, P80; Spallotta F, 2013, J BIOL CHEM, V288, P11004, DOI 10.1074/jbc.M112.441816; Su B, 2015, HEPATOLOGY, V61, P585, DOI 10.1002/hep.27551; Su M, 2005, J BIOL CHEM, V280, P38365, DOI 10.1074/jbc.M501609200; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Takenoyama M, 2006, INT J CANCER, V118, P1992, DOI 10.1002/ijc.21594; Tanaka H, 2003, CANCER RES, V63, P6942; Tanaka T, 2014, EUR J PHARMACOL, V741, P83, DOI 10.1016/j.ejphar.2014.07.035; Thomassen M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-394; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Tong YA, 2015, CANCER CELL, V27, P712, DOI 10.1016/j.ccell.2015.04.005; van der Watt PJ, 2016, MOL CANCER THER, V15, P560, DOI 10.1158/1535-7163.MCT-15-0052; van der Watt PJ, 2011, BBA-GENE REGUL MECH, V1809, P316, DOI 10.1016/j.bbagrm.2011.05.017; van Wageningen S, 2008, BLOOD, V111, P1634, DOI 10.1182/blood-2007-04-081125; Wang YT, 2015, BBA-GENE REGUL MECH, V1849, P1133, DOI 10.1016/j.bbagrm.2015.07.002; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Xu HM, 2012, BBA-MOL CELL RES, V1823, P818, DOI 10.1016/j.bbamcr.2012.01.002; Xu L, 2013, J VIROL, V87, P25, DOI 10.1128/JVI.01648-12; Yamanaka K, 2009, GENOMICS, V94, P219, DOI 10.1016/j.ygeno.2009.06.003; YANAGAWA Y, 1995, J BIOL CHEM, V270, P17521, DOI 10.1074/jbc.270.29.17521                                                        ; Yano K, 2012, INT J MOL MED, V29, P519, DOI 10.3892/ijmm.2011.876; Ying SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075695; Yokota S, 2010, INFECT IMMUN, V78, P468, DOI 10.1128/IAI.00903-09; YU LJ, 1995, CELL GROWTH DIFFER, V6, P1505; Yun J., 1999, J BIOL CHEM; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zhang HT, 2014, BBA-GENE REGUL MECH, V1839, P1330, DOI 10.1016/j.bbagrm.2014.09.015; Zhou YH, 1998, J NATL CANCER I, V90, P381, DOI 10.1093/jnci/90.5.381                                                           ; Zhou YL, 2003, J BIOL CHEM, V278, P462, DOI 10.1074/jbc.M203793200; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; Zuo ZG, 2016, EUR REV MED PHARMACO, V20, P3017; ZWICKER J, 1995, NUCLEIC ACIDS RES, V23, P3822, DOI 10.1093/nar/23.19.3822; ZWICKER J, 1995, EMBO J, V14, P4514	156	2	2	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		604	616		10.1016/j.bbagrm.2016.12.005				13	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500010	27939755				2018-01-05	
J	Pett, L; Kiakos, K; Satam, V; Patil, P; Laughlin-Toth, S; Gregory, M; Bowerman, M; Olson, K; Savagian, M; Lee, M; Lee, M; Wilson, WD; Hochhauser, D; Hartley, JA				Pett, Luke; Kiakos, Konstantinos; Satam, Vijay; Patil, Pravin; Laughlin-Toth, Sarah; Gregory, Matthew; Bowerman, Michael; Olson, Kevin; Savagian, Mia; Lee, Megan; Lee, Moses; Wilson, W. David; Hochhauser, Daniel; Hartley, John A.			Modulation of topoisomerase II alpha expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						DNA-binding polyamides; Sequence selectivity; Transcription factor-DNA interactions; Gene modulation; NF-Y; Topoisomerase II alpha (topo II alpha); Chemosensitisation	PYRROLE-IMIDAZOLE POLYAMIDE; DNA MINOR-GROOVE; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; IM POLYAMIDES; RECOGNITION; CELLS; PROMOTER; BOX	Background: Sequence specific polyamide HxIP 1, targeted to the inverted CCAAT Box 2 (ICB2) on the topoisomerase lice (topo lice) promoter can inhibit NF-Y binding, re-induce gene expression and increase sensitivity to etoposide. To enhance biological activity, diamino-containing derivatives (Hxl*P 2 and HxIP* 3) were synthesised incorporating an alkyl amino group at the N1-heterocyclic position of the imidazole/pyrrole. Methods: DNase I footprinting was used to evaluate DNA binding of the diamino Hx-polyamides, and their ability to disrupt the NF-Y:ICB2 interaction assessed using EMSAs. Topo Ila mRNA (RT-PCR) and protein (Immunoblotting) levels were measured following 18 h polyamide treatment of confluent A549 cells.gamma H2AX was used as a marker for etoposide-induced DNA damage after pre-treatment with HxIP* 3 and cell viability was measured using Cell-Titer GlaD. Results: Introduction of the N1-alkyl amino group reduced selectivity for the target sequence 5'-TACGAT-3' on the topo lice promoter, but increased DNA binding affinity. Confocal microscopy revealed both fluorescent diamino polyamides localised in the nucleus, yet Hxl*P 2 was unable to disrupt the NF-Y:ICB2 interaction and showed no effect against the downregulation of topo IIa. In contrast, inhibition of NF-Y binding by HxIP* 3 stimulated dose-dependent (0.1-2 mu M) re-induction of topo Ila and potentiated cytotoxicity of topo II poisons by enhancing DNA damage. Conclusions: Polyamide functionalisation at the N1-position offers a design strategy to improve drug-like properties. Dicationic HxIP* 3 increased topo Hce expression and chemosensitivity to topo II-targeting agents. General significance: Pharmacological modulation of topo Ila expression has the potential to enhance cellular sensitivity to clinically-used anticancer therapeutics. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Published by Elsevier B.V.	[Pett, Luke; Kiakos, Konstantinos; Hochhauser, Daniel; Hartley, John A.] UCL Canc Inst, Canc Res UK Drug DNA Interact Res Grp, London WC1E 6BT, England; [Satam, Vijay; Patil, Pravin; Gregory, Matthew; Bowerman, Michael; Olson, Kevin; Savagian, Mia; Lee, Megan; Lee, Moses] Hope Coll, Dept Chem, Holland, MI 49423 USA; [Laughlin-Toth, Sarah; Lee, Moses; Wilson, W. David] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Kiakos, Konstantinos] Univ Vienna, Res Platform Translat Canc Therapy Res, Waehringer Str 42, A-1090 Vienna, Austria	Hartley, JA (reprint author), UCL Canc Inst, Canc Res UK Drug DNA Interact Res Grp, London WC1E 6BT, England.	john.hartley@ucl.ac.uk			Cancer Research UK [C2259/A16569]; Medical Research Council; National Science Foundation [CHE 0809162]; National Institutes of Health [GM 111749]	This work was supported by a program grant from Cancer Research UK (C2259/A16569 to J.A.H and D.H), a Medical Research Council Doctoral Training Grant awarded to UCL (LP) and a grant from the National Science Foundation (CHE 0809162 to M.L and W.D.W). The biosensor-SPR work was supported by the National Institutes of Health for W.D.W (GM 111749).	Babu B, 2011, BIOCHEM BIOPH RES CO, V404, P848, DOI 10.1016/j.bbrc.2010.12.073; Best TP, 2003, P NATL ACAD SCI USA, V100, P12063, DOI 10.1073/pnas.2035074100; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chavda S, 2013, BIOORGAN MED CHEM, V21, P3907, DOI 10.1016/j.bmc.2013.04.001; Chavda S, 2011, BIOCHEMISTRY-US, V50, P3127, DOI 10.1021/bi102028a; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0                                                   ; Dingemans AMC, 1998, BBA-GENE STRUCT EXPR, V1400, P275, DOI 10.1016/S0167-4781(98)00141-9; Dolfini D, 2013, CELL DEATH DIFFER, V20, P676, DOI 10.1038/cdd.2013.13; Edelson BS, 2004, NUCLEIC ACIDS RES, V32, P2802, DOI 10.1093/nar/gkh609; Franks A, 2010, BIOORGAN MED CHEM, V18, P5553, DOI 10.1016/j.bmc.2010.06.041; HOCHHAUSER D, 1992, J BIOL CHEM, V267, P18961; Hochhauser D, 2007, MOL CANCER THER, V6, P346, DOI 10.1158/1535-7163.MCT-06-0503; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Isaacs RJ, 1996, J BIOL CHEM, V271, P16741, DOI 10.1074/jbc.271.28.16741                                                        ; Jacobs CS, 2009, J MED CHEM, V52, P7380, DOI 10.1021/jm900256f; Kageyama Y, 2006, ACTA ONCOL, V45, P317, DOI 10.1080/02841860500486648; Kiakos K., 2015, CHEM BIOL; Kielkopf CL, 1998, NAT STRUCT BIOL, V5, P104, DOI 10.1038/nsb0298-104; Kotecha M, 2008, MOL CANCER THER, V7, P1319, DOI 10.1158/1535-7163.MCT-07-0475; Lage H, 2000, BRIT J CANCER, V82, P488, DOI 10.1054/bjoc.1999.0947; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Le NM, 2006, BIOORG MED CHEM LETT, V16, P6161, DOI 10.1016/j.bmcl.2006.09.043; Ly LL, 2013, AM J CANCER RES, V3, P339; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Marziali G, 1999, BLOOD, V93, P519; Meier JL, 2012, NUCLEIC ACIDS RES, V40, P2345, DOI 10.1093/nar/gkr970; Nickols NG, 2007, ACS CHEM BIOL, V2, P561, DOI 10.1021/ch700110z; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Nickols NG, 2007, NUCLEIC ACIDS RES, V35, P363, DOI 10.1093/nar/gkl1042; Nickols NG, 2013, MOL CANCER THER, V12, P675, DOI 10.1158/1535-7163.MCT-12-1040; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Pett L, 2015, CURR TOP MED CHEM, V15, P1293, DOI 10.2174/1568026615666150413155431                                               ; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P1023, DOI 10.1073/pnas.1118506109; Satam V, 2012, BIOORG MED CHEM LETT, V22, P5898, DOI 10.1016/j.bmcl.2012.07.071; Satam V, 2012, BIOORGAN MED CHEM, V20, P693, DOI 10.1016/j.bmc.2011.12.010; Satz AL, 2000, BIOORGAN MED CHEM, V8, P1871, DOI 10.1016/S0968-0896(00)00116-4                                                   ; Satz AL, 2002, ACCOUNTS CHEM RES, V35, P86, DOI 10.1021/ar0101032; Son YS, 1998, CANCER CHEMOTH PHARM, V41, P353, DOI 10.1007/s002800050751; Synold TW, 2012, CANCER CHEMOTH PHARM, V70, P617, DOI 10.1007/s00280-012-1954-3; Takagaki T, 2011, BIOORGAN MED CHEM, V19, P5896, DOI 10.1016/j.bmc.2011.08.009; Taniguchi M, 2014, FEBS OPEN BIO, V4, P328, DOI 10.1016/j.fob.2014.03.004; Tolner B, 2001, MOL PHARMACOL, V59, P699; Wang H, 1997, BIOCHEM BIOPH RES CO, V237, P217, DOI 10.1006/bbrc.1997.7115; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wells G, 2006, J MED CHEM, V49, P5442, DOI 10.1021/jm051199z; White S, 1997, CHEM BIOL, V4, P569, DOI 10.1016/S1074-5521(97)90243-X; Yang F, 2013, P NATL ACAD SCI USA, V110, P1863, DOI 10.1073/pnas.1222035110	48	1	1	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		617	629		10.1016/j.bbagrm.2016.10.005				13	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500011	27750031				2018-01-05	
J	Yamaguchi, M; Ali, MS; Yoshioka, Y; Ly, LL; Yoshida, H				Yamaguchi, Masamitsu; Ali, Md. Saheb; Yoshioka, Yasuhide; Ly, Luong Linh; Yoshida, Hideki			NF-Y in invertebrates	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review						NF-Y; Drosophila; C. elegans; Development; Signal transduction	DROSOPHILA EYE DEVELOPMENT; T-BOX GENES; TRANSCRIPTION FACTOR; CAENORHABDITIS-ELEGANS; SCHISTOSOMA-MANSONI; DRUG DISCOVERY; HUMAN-DISEASE; G(2)/M PROMOTERS; JNK PATHWAY; P53 HOMOLOG	Both Drosophila melanogaster and Caenorhabditis elegans (C. elegans) are useful model organisms to study in vivo roles of NF-Y during development. Drosophila NF-Y (dNF-Y) consists of three subunits dNF-YA, dNF-YB and dNFYC In some tissues, dNF-YC-related protein Mes4 may replace dNF-YC in dNF-Y complex. Studies with eye imaginal disc-specific dNF-Y-knockdown flies revealed that dNF-Y positively regulates the sevenless gene encoding a receptor tyrosine kinase, a component of the ERK pathway and negatively regulates the Sensless gene encoding a transcription factor to ensure proper development of R7 photoreceptor cells together with proper R7 axon targeting. dNF-Y also controls the Drosophila Bcl-2 (debcl) to regulate apoptosis. In thorax development, dNF-Y is necessary for both proper Drosophila JNK (basket) expression and JNK signaling activity that is responsible for thorax development. Drosophila p53 gene was also identified as one of the dNF-Y target genes in this system. C elegans contains two forms of NF-YA subunit, CeNF-YA1 and CeNF-YA2. C elegans NF-Y (CeNF-Y) therefore consists of CeNF-YB, CeNF-YC and either CeNF-YA1 or CeNF-YA2. CeNF-Y negatively regulates expression of the Hox gene egl-5 (ortholog of Drosophila Abdominal-B) that is involved in tail patterning. CeNF-Y also negatively regulates expression of the tbx-2 gene that is essential for development of the pharyngeal muscles, specification of neural cell fate and adaptation in olfactory neurons. Negative regulation of the expression of egl-5 and tbx-2 by CeNF-Y provides new insight into the physiological meaning of negative regulation of gene expression by NF-Y during development. In addition, studies on NF-Y in platyhelminths are also summarized. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Yamaguchi, Masamitsu; Yoshida, Hideki] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Yamaguchi, Masamitsu; Yoshida, Hideki] Kyoto Inst Technol, Ctr Adv Insect Res, Sakyo Ku, Kyoto 6068585, Japan; [Ali, Md. Saheb] Bangladesh Jute Res Inst, Dhaka 1207, Bangladesh; [Yoshioka, Yasuhide] Setsunan Univ, Fac Sci & Engn, Neyagawa, Osaka, Japan; [Ly, Luong Linh] Hanoi Med Univ, Dept Physiol, Hanoi, Vietnam	Yamaguchi, M (reprint author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.	myamaguc@kit.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; JST; JSPS Core-to-Core Program, Asia-Africa Science Platforms; JSPS KAKENHI [16K07346]	This study was partially supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan, JST and the JSPS Core-to-Core Program, Asia-Africa Science Platforms, JSPS KAKENHI Grant Number 16K07346.	Aboobaker AA, 2003, CURR BIOL, V13, P37, DOI 10.1016/S0960-9822(02)01399-4; Abrahams A, 2010, IUBMB LIFE, V62, P92, DOI 10.1002/iub.275; Agnes F, 1999, DEVELOPMENT, V126, P5453; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; BASLER K, 1988, TRENDS GENET, V4, P74, DOI 10.1016/0168-9525(88)90044-3; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bodsky M. H., 2004, MOL CELL BIOL, V24, P1219; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI [10.1074/mcp.M600392-MCP200, 10.1038/nbt829]; Chowdhuri SR, 2006, DEV BIOL, V295, P664, DOI 10.1016/j.ydbio.2006.04.001; Colussi PA, 2000, J CELL BIOL, V148, P703, DOI 10.1083/jcb.148.4.703; Coustry F, 1998, BIOCHEM J, V331, P291, DOI 10.1042/bj3310291                                                               ; Deng HS, 2007, DEV BIOL, V308, P583, DOI 10.1016/j.ydbio.2007.05.021; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Fan Y, 2010, CELL DEATH DIFFER, V17, P912, DOI 10.1038/cdd.2009.182; Franchini A, 2005, J MOL HISTOL, V36, P139, DOI 10.1007/s10735-004-6017-6; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Kato T, 2009, CANCER RES, V69, P3597, DOI 10.1158/0008-5472.CAN-08-4368; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kenyon CJ, 1997, COLD SPRING HARB SYM, V62, P293; Kimble Judith, 2005, WormBook, P1; Kobetl RA, 2014, BIOMOL THER, V22, P371, DOI 10.4062/biomolther.2014.084; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; LI XY, 1992, NUCLEIC ACIDS RES, V20, P1087, DOI 10.1093/nar/20.5.1087; Lu JA, 2010, BBA-REV CANCER, V1806, P268, DOI 10.1016/j.bbcan.2010.07.001; Ly LL, 2013, GENE, V520, P106, DOI 10.1016/j.gene.2013.02.036; Ly LL, 2013, AM J CANCER RES, V3, P339; lyer H., 2016, PLOS GENET; Mann RS, 2004, NAT GENET, V36, P10, DOI 10.1038/ng0104-10; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Milton AC, 2015, G3-GENES GENOM GENET, V5, P1177, DOI 10.1534/g3.115.018101; Milton AC, 2013, DEV BIOL, V382, P38, DOI 10.1016/j.ydbio.2013.08.001; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Niimi T, 2004, J BIOL CHEM, V279, P38055, DOI 10.1074/jbc.M403724200; O'Reilly LP, 2014, ADV DRUG DELIVER REV, V69, P247, DOI 10.1016/j.addr.2013.12.001; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Rebollar E, 2006, FEBS LETT, V580, P642, DOI 10.1016/j.febslet.2005.12.083; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554                                                           ; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Rodriguez-Esteban G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1533-1; Serra E, 1996, PARASITOLOGY, V113, P457, DOI 10.1017/S003118200008152X                                                       ; Serra E, 1996, MOL BIOCHEM PARASIT, V83, P69, DOI 10.1016/S0166-6851(96)02751-X; Serra E, 1998, NUCLEIC ACIDS RES, V26, P3800, DOI 10.1093/nar/26.16.3800; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Tue Nguyen Trong, 2011, Gene, V473, P1, DOI 10.1016/j.gene.2010.10.009; Ugur B, 2016, DIS MODEL MECH, V9, P235, DOI 10.1242/dmm.023762; Wang YY, 2010, GENE DEV, V24, P2081, DOI 10.1101/gad.1951010; Wolff Tanya, 1993, P1277; Yoshioka Y, 2008, GENES CELLS, V13, P117, DOI 10.1111/j.1365-2443.2007.01155.x; Yoshioka Y, 2007, GENESIS, V45, P21, DOI 10.1002/dvg.20260; Yoshioka Y, 2012, BIOL OPEN, V1, P19, DOI 10.1242/bio.2011013; Zemzoumi K, 1996, MOL BIOCHEM PARASIT, V77, P161, DOI 10.1016/0166-6851(96)02590-X; Zhu XF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046286, 10.1371/journal.pone.0033013, 10.1371/journal.pone.0044405]	69	1	1	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		630	635		10.1016/j.bbagrm.2016.10.008				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500012	27793714				2018-01-05	
J	Swain, S; Myers, ZA; Siriwardana, CL; Holt, BF				Swain, Swadhin; Myers, Zachary A.; Siriwardana, Chamindika L.; Holt, Ben F., III			The multifaceted roles of NUCLEAR FACTOR-Y in Arabidopsis thaliana development and stress responses	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						NUCLEAR FACTORY (NF-Y); Plant development; Abiotic stress responses; Primary metabolism; Transcription factor	FLOWERING-LOCUS-T; BINDING TRANSCRIPTION FACTORS; ABSCISIC-ACID RESPONSES; STORAGE PROTEIN GENES; FACTOR NF-Y; CCAAT-BOX; LEAFY COTYLEDON1; EMBRYO DEVELOPMENT; DNA-BINDING; XYLOGLUCAN ENDOTRANSGLUCOSYLASE/HYDROLASE	NUCLEAR FACTOR-Y (NF-Y) is a heterotrimeric transcription factor (TF) consisting of evolutionarily distinct NF-YA, NF-YB and NF-YC subunits. The functional NF-Y heterotrimer binds to CCAAT elements in eukaryotic gene promoters and influences their expression. The genome of the model organism Arabidopsis thaliana encodes 10 distinct NF-YA, NF-YB, and NF-YC proteins, allowing for enormous combinatorial and functional diversity. Two decades of research have elucidated the importance of NF-Ys in plant growth, development and stress responses; however, the molecular mechanisms of action remain largely unexplored. Intriguingly, recent evidence suggests that NF-Ys are frequently associated with other groups of TFs, expanding the potential NF-Y combinatorial complexity. Further, information regarding the regulation of individual NF-Y subunits at the transcriptional and post-transcriptional level is beginning to emerge. In this review, we will identify developing trends within the NF-Y field and discuss recent progress towards a better understanding of NF-Y function, molecular action, and regulation in the context of Arabidopsis. This article is part of a Special Issue entitled: Nuclear Factor Yin Development and Disease, edited by Prof. Roberto Mantovani. Published by Elsevier B.V.	[Swain, Swadhin; Myers, Zachary A.; Siriwardana, Chamindika L.; Holt, Ben F., III] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	Holt, BF (reprint author), Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.	benholt@ou.edu		Holt, Ben/0000-0001-7182-9594	National Science Foundation [IOS 1149822]; University of Oklahoma Research Council; University of Oklahoma Office of the Dean for Arts and Sciences	The research described here was funded by the National Science Foundation (IOS 1149822, award to BFH, www.nsf.gov), the University of Oklahoma Research Council (award to BFH), and the University of Oklahoma Office of the Dean for Arts and Sciences (award to BFH). The National Science Foundation and the University of Oklahoma had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Our sincere thanks to two anonymous reviewers.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Leyva-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048138; Arguello-Astorga G, 1998, ANNU REV PLANT PHYS, V49, P525, DOI 10.1146/annurev.arplant.49.1.525; Ballif J, 2011, PLANT PHYSIOL BIOCH, V49, P579, DOI 10.1016/j.plaphy.2011.01.013; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bentsink Leonie, 2008, Arabidopsis Book, V6, pe0119, DOI 10.1199/tab.0119; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Calvenzani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042902; Cao S, 2014, PLANT CELL, V26, P1009, DOI 10.1105/tpc.113.120352; Casson SA, 2006, PLANT PHYSIOL, V142, P526, DOI 10.1104/pp.106.080895; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Edwards D, 1998, PLANT PHYSIOL, V117, P1015, DOI 10.1104/pp.117.3.1015                                                           ; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Folta KM, 1999, PLANT PHYSIOL, V120, P747, DOI 10.1104/pp.120.3.747                                                            ; Fornari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082043; Gangappa S.N., 2016, MOL PLANT; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Gao W, 2015, NUCLEIC ACIDS RES, V43, P607, DOI 10.1093/nar/gku1325; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; Hou XL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5601; Huang MK, 2015, PLANT CELL, V27, P3099, DOI 10.1105/tpc.15.00750; Huang MK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00955; Huang X, 2014, CURR OPIN PLANT BIOL, V21, P96, DOI 10.1016/j.pbi.2014.07.003; Huq E., 2002, EMBO J; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104                                                    ; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Junker A, 2012, PLANT J, V71, P427, DOI 10.1111/j.1365-313X.2012.04999.x; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P300, DOI 10.1093/pcp/pci031; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kumimoto RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059481; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Kusnetsov V, 1999, J BIOL CHEM, V274, P36009, DOI 10.1074/jbc.274.50.36009; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Li HC, 2005, PLANT J, V44, P1010, DOI 10.1111/j.1365-313X.2005.02602.x; Li L, 2015, P NATL ACAD SCI USA, V112, P14734, DOI 10.1073/pnas.1514670112; Li L, 2015, PLANT BIOTECHNOL J, V13, P177, DOI 10.1111/pbi.12238; Li L, 2009, PLANT J, V58, P485, DOI 10.1111/j.1365-313X.2009.03793.x; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061289; Li YJ, 2010, PLANT SCI, V178, P271, DOI 10.1016/j.plantsci.2010.01.007; Liu HC, 2011, PLANT CELL ENVIRON, V34, P738, DOI 10.1111/j.1365-3040.2011.02278.x; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Liu X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12768; Liu YB, 2007, PLANTA, V226, P1547, DOI 10.1007/s00425-007-0591-2; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4                                                   ; Luerssen K, 1998, PLANT J, V15, P755; Masiero S, 2002, J BIOL CHEM, V277, P26429, DOI 10.1074/jbc.M202546200; Mendes A, 2013, PLANT CELL, V25, P3104, DOI 10.1105/tpc.113.116343; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Miedes E, 2013, J EXP BOT, V64, P2481, DOI 10.1093/jxb/ert107; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Mu JY, 2013, MOL PLANT, V6, P188, DOI 10.1093/mp/sss061; Muller R, 2007, PLANT PHYSIOL, V143, P156, DOI 10.1104/pp.106.090167; Myers ZA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006333; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Nishizawa-Yokoi A, 2011, PLANT CELL PHYSIOL, V52, P933, DOI 10.1093/pcp/pcr045; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rider SD, 2003, PLANT J, V35, P33, DOI 10.1046/j.1365-313X.2003.01783.x; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sato H, 2016, PLANT BIOTECHNOL J, V14, P1756, DOI 10.1111/pbi.12535; Sato H, 2014, PLANT CELL, V26, P4954, DOI 10.1105/tpc.114.132928; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Shi HT, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29109; Shi HT, 2014, NEW PHYTOL, V203, P554, DOI 10.1111/nph.12812; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Siriwardana C., 2016, BIORXIV; Siriwardana CL, 2014, PLANT MOL BIOL REP, V32, P971, DOI 10.1007/s11105-014-0704-6; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571                                                ; Tian X., 2009, CHIN AGR SCI B; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; WEST MAL, 1994, PLANT CELL, V6, P1731; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; WRIGHT KL, 1994, EMBO J, V13, P4042; XING YY, 1993, EMBO J, V12, P4647; Xu F, 2016, FEBS LETT, V590, P541, DOI 10.1002/1873-3468.12076; Xu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111354; Xu MY, 2014, J EXP BOT, V65, P89, DOI 10.1093/jxb/ert353; Xu XS, 2015, TRENDS PLANT SCI, V20, P641, DOI 10.1016/j.tplants.2015.06.010; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yoshida T, 2011, MOL GENET GENOMICS, V286, P321, DOI 10.1007/s00438-011-0647-7; Yu D., 2016, PLANT PHYSL; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	126	1	1	5	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		636	644		10.1016/j.bbagrm.2016.10.012				9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500013	27989935				2018-01-05	
J	Zanetti, ME; Ripodas, C; Niebel, A				Eugenia Zanetti, Maria; Ripodas, Carolina; Niebel, Andreas			Plant NF-Y transcription factors: Key players in plant-microbe interactions, root development and adaptation to stress	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review							ARABIDOPSIS LEAFY COTYLEDON1; CELL-CYCLE PROMOTERS; MEDICAGO-TRUNCATULA; GENE-EXPRESSION; RHIZOBIAL INFECTION; NODULE DEVELOPMENT; CDK2-DEPENDENT PHOSPHORYLATION; SYSTEM ARCHITECTURE; DROUGHT RESISTANCE; EMBRYO DEVELOPMENT	NF-Ys are heterotrimeric transcription factors composed by the NF-YA, NF-YB and NF-YC subunits. In plants, NF-Y subunits are encoded by multigene families whose members show structural and functional diversifications. An increasing number of NF-Y genes has been shown to play key roles during different stages of root nodule and arbuscular mycorrhizal symbiosis, as well as during the interaction of plants with pathogenic microorganisms. Individual members of the NF-YA and NF-YB families have also been implicated in the development of primary and lateral roots. In addition, different members of the NF-YA and NF-YB gene families from mono- and dicotyledonous plants have been involved in plant responses to water and nutrient scarcity. This review presents the most relevant and striking results concerning these NF-Y subunits. A phylogenetic analysis of the functionally characterized NF-Y genes revealed that, across plant species, NF-Y proteins functioning in the same biological process tend to belong to common phylogenetic groups. Finally, we discuss the forthcoming challenges of plant NF-Y research, including the detailed dissection of expression patterns, the elucidation of functional specificities"as well as the characterization of the potential NF-Y-mediated epigenetic mechanisms by which they control the expression of their target genes. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Eugenia Zanetti, Maria] Univ Nacl La Plata, CCT La Plata, CONICET, Inst Biotecnol & Biol Mol,Fac Ciencias Exactas, Calle 115 & 49 S-N, RA-1900 La Plata, Buenos Aires, Argentina; [Ripodas, Carolina; Niebel, Andreas] Univ Toulouse, CNRS, INRA, LIPM, F-31326 Castanet Tolosan, France	Niebel, A (reprint author), Univ Toulouse, CNRS, INRA, LIPM, F-31326 Castanet Tolosan, France.	ezanetti@biol.unlp.edu.ar; andreas.niebel@toulouse.inra.fr		Zanetti, Maria Eugenia/0000-0001-9565-1743	ANPCyT, Argentina [PICT2013-0384, PICT2014-0321, PICT2010-2722]; CNRS-CONICET cooperative program [PICS06688]; French Laboratory of Excellence project "TULIP" [ANR-10-LABX-41, ANR-11-IDEX-55 0002-02];  [ANR-09-BLAN-0033-01];  [ANR-15-CE20-0012-01]	We thank Dr. Flavio Blanco, Melisse Castaingts and Joaquin Clua for critical comments on the manuscript. This work was financially supported by grants from ANPCyT, Argentina (PICT2013-0384, PICT2014-0321 and PICT2010-2722), from a CNRS-CONICET cooperative program (PICS06688) and by the ANR-09-BLAN-0033-01 "HAPIHUB" and ANR-15-CE20-0012-01 "NODCCAAT" grants. This work was in addition supported by the French Laboratory of Excellence project "TULIP" (ANR-10-LABX-41; ANR-11-IDEX-55 0002-02). MEZ is a member of the Comision Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) of Argentina. CR is postdoctoral fellow from ANR (NODCCAAT) and INRA Agreenskills (ID: 2843). AN is a member of the Centre National de la Recherche Fondamentale (CNRS).	Alam MM, 2015, PLANT BIOTECHNOL J, V13, P85, DOI 10.1111/pbi.12239; Reynoso MA, 2013, PLANT J, V73, P289, DOI 10.1111/tpj.12033; Amin NM, 2014, DEVELOPMENT, V141, P962, DOI 10.1242/dev.098327; Bailey-Serres J, 2013, ANNU REV PLANT BIOL, V64, P293, DOI 10.1146/annurev-arplant-050312-120035; Battaglia M, 2014, PLANT PHYSIOL, V164, P1430, DOI 10.1104/pp.113.230896; Baudin M, 2015, PLANT PHYSIOL, V169, P2761, DOI 10.1104/pp.15.01144; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Bimbaum K., 2003, SCIENCE, V302, P1956; Braun P, 2013, ANNU REV PLANT BIOL, V64, P161, DOI 10.1146/annurev-arplant-050312-120140; Breakspear A, 2014, PLANT CELL, V26, P4680, DOI 10.1105/tpc.114.133496; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Calvenzani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042902; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Corradi N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002600; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; De Smet I, 2012, PLANT CELL, V24, P15, DOI 10.1105/tpc.111.094292; Deal RB, 2011, NAT PROTOC, V6, P56, DOI 10.1038/nprot.2010.175; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.013612; Zanetti ME, 2010, PLANT CELL, V22, P4142, DOI 10.1105/tpc.110.079137; Feng ZJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01142; Fonouni-Farde C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12636; Gao W, 2015, NUCLEIC ACIDS RES, V43, P607, DOI 10.1093/nar/gku1325; Gatta R, 2011, EPIGENETICS-US, V6, P527, DOI 10.4161/epi.6.4.14852; Gaude N, 2012, PLANT J, V69, P510, DOI 10.1111/j.1365-313X.2011.04810.x; Geurts R, 2012, CURR OPIN PLANT BIOL, V15, P438, DOI 10.1016/j.pbi.2012.04.004; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; Hanemian M, 2016, NEW PHYTOL, V211, P502, DOI 10.1111/nph.13913; Hayashi M, 2014, CURR OPIN PLANT BIOL, V20, pV, DOI 10.1016/j.pbi.2014.07.008; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Hogekamp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-306; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Hou XL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5601; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jardinaud MF, 2016, PLANT PHYSIOL, V171, P2256, DOI 10.1104/pp.16.00711; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Junker A, 2012, PLANT J, V71, P427, DOI 10.1111/j.1365-313X.2012.04999.x; Kumimoto RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059481; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Laloum T, 2014, PLANT J, V79, P757, DOI 10.1111/tpj.12587; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Laporte P, 2014, J EXP BOT, V65, P481, DOI 10.1093/jxb/ert392; Lee DK, 2015, PLANT SCI, V241, P199, DOI 10.1016/j.plantsci.2015.10.006; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Lelandais-Briere C, 2016, MOL PLANT MICROBE IN, V29, P170, DOI 10.1094/MPMI-10-15-0240-FI; Leyva-Gonzalez M. A., 2012, PLOS ONE, V7; Li CX, 2011, PLANT J, V67, P763, DOI 10.1111/j.1365-313X.2011.04630.x; Li L, 2015, P NATL ACAD SCI USA, V112, P14734, DOI 10.1073/pnas.1514670112; Li S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2334-2; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Limpens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064377; Linkohr BI, 2002, PLANT J, V29, P751, DOI 10.1046/j.1365-313X.2002.01251.x; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4                                                   ; Ma XY, 2015, BIOENGINEERED, V6, P245, DOI 10.1080/21655979.2015.1054085; Ma XY, 2015, PLANT PHYSIOL BIOCH, V86, P34, DOI 10.1016/j.plaphy.2014.11.011; Manni I, 2008, MOL BIOL CELL, V19, P5203, DOI 10.1091/mbc.E08-03-0295; Masiero S, 2002, J BIOL CHEM, V277, P26429, DOI 10.1074/jbc.M202546200; Meschini EP, 2008, MOL PLANT MICROBE IN, V21, P459, DOI 10.1094/MPMI-21-4-0459; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Palmeros-Suarez PA, 2015, PLANT SCI, V240, P25, DOI 10.1016/j.plantsci.2015.08.010; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Pflieger D, 2011, PROTEOMICS, V11, P1824, DOI 10.1002/pmic.201000635; Quach T, 2015, MOL GENET GENOMICS, V290, P1095, DOI 10.1007/s00438-014-0978-2; Reis RS, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.27, 10.1038/NPLANTS.2014.27]; Rey T., 2016, FRONT PLANT IN PRESS; Ripodas C, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00761; Roux B, 2014, PLANT J, V77, P817, DOI 10.1111/tpj.12442; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Schaarschmidt S., 2013, GENOME BIOL, V14; Schmitz AM, 2014, J INTEGR PLANT BIOL, V56, P250, DOI 10.1111/jipb.12155; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00895; Singh K, 2012, FUNCT INTEGR GENOMIC, V12, P659, DOI 10.1007/s10142-012-0292-1; Smith S, 2012, PHILOS T R SOC B, V367, P1441, DOI 10.1098/rstb.2011.0234; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Soyano T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003352; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Tallafuss A, 2014, CURR GENOMICS, V15, P278, DOI 10.2174/1389202915666140602230106; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Xiao TT, 2014, DEVELOPMENT, V141, P3517, DOI 10.1242/dev.110775; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x	99	1	1	20	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		645	654		10.1016/j.bbagrm.2016.11.007				10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500014	27939756				2018-01-05	
J	Brambilla, V; Fornara, F				Brambilla, Vittoria; Fornara, Fabio			Y flowering? Regulation and activity of CONSTANS and CCT-domain proteins in Arabidopsis and crop species	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Review						Flowering; CONSTANS; NF-Y; Arabidopsis; Rice; Temperate cereals	NUCLEAR-FACTOR-Y; BINDING TRANSCRIPTION FACTOR; PSEUDO-RESPONSE-REGULATOR; LOCUS-T PROMOTER; NATURAL VARIATION; CIRCADIAN CLOCK; HEADING DATE; PHOTOPERIOD SENSITIVITY; BLUE-LIGHT; NF-Y	Changes in day length regulate the proper timing of flowering in several plant species. The genetic architecture of this process is based on CCT-domain proteins, many of which interact with NF-Y subunits to regulate transcription of target genes. In the model plant Arabidopsis thaliana, the CONSTANS CCT-domain protein is a central photoperiodic sensor. We will discuss how the diurnal rhythms of its transcription and protein accumulation are generated, and how the protein engages into multiple complexes to control production of a systemic flowering signal. Regulatory parallels will be drawn between Arabidopsis and major crops that indicate conservation of some CCT/NF-Y modules during plant evolution. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. (C) 2016 Elsevier B.V. All rights reserved.	[Brambilla, Vittoria] Univ Milan, Agroenergy, Terr, Dept Agr & Environm Sci Prod, Via Celoria 2, I-20133 Milan, Italy; [Fornara, Fabio] Univ Milan, Dept Biosci, Via Celoria 26, I-20133 Milan, Italy	Fornara, F (reprint author), Univ Milan, Dept Biosci, Via Celoria 26, I-20133 Milan, Italy.	fabio.fornara@unimi.it			European Research Council [260963]	This work was supported by a grant from the European Research Council (#260963) to F.F.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ayre BG, 2004, PLANT PHYSIOL, V135, P2271, DOI 10.1104/pp.104.040592; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Cao S, 2014, PLANT CELL, V26, P1009, DOI 10.1105/tpc.113.120352; Chen J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04085; David KM, 2006, FEBS LETT, V580, P1193, DOI 10.1016/j.febslet.2006.01.016; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Gao H, 2014, P NATL ACAD SCI USA, V111, P16337, DOI 10.1073/pnas.1418204111; Garner W. W., 1920, J AGR RES, V48, P553; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Gomez-Ariza J, 2015, J EXP BOT, V66, P2027, DOI 10.1093/jxb/erv004; Graeff M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005959; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hou XL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5601; Hwang YH, 2016, PLANT CELL REP, V35, P857, DOI 10.1007/s00299-015-1927-1; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Ishikawa R, 2011, MOL GENET GENOMICS, V285, P461, DOI 10.1007/s00438-011-0621-4; Ito S, 2012, P NATL ACAD SCI USA, V109, P3582, DOI 10.1073/pnas.1118876109; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Kim SK, 2016, PLANTA, V243, P563, DOI 10.1007/s00425-015-2426-x; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kippes N, 2016, THEOR APPL GENET, V129, P1417, DOI 10.1007/s00122-016-2713-3; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Lazaro A, 2015, PLANT CELL, V27, P2437, DOI 10.1105/tpc.15.00529; Li CX, 2011, PLANT J, V67, P763, DOI 10.1111/j.1365-313X.2011.04630.x; Li QP, 2016, J EXP BOT, V67, P1759, DOI 10.1093/jxb/erv566; Lian HL, 2011, GENE DEV, V25, P1023, DOI 10.1101/gad.2025111; Liang MX, 2012, PLANTA, V235, P779, DOI 10.1007/s00425-011-1539-0; Liu LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5558; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mulki MA, 2016, PLANT PHYSIOL, V170, P325, DOI 10.1104/pp.15.01350; Nemoto Y., 2016, PLANT J; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Sarid-Krebs L, 2015, PLANT J, V84, P451, DOI 10.1111/tpj.13022; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sheerin DJ, 2015, PLANT CELL, V27, P189, DOI 10.1105/tpc.114.134775; Shrestha R, 2014, ANN BOT-LONDON, V114, P1445, DOI 10.1093/aob/mcu032; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Song YH, 2014, P NATL ACAD SCI USA, V111, P17672, DOI 10.1073/pnas.1415375111; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang CQ, 2014, PLANT CELL, V26, P3589, DOI 10.1105/tpc.114.130252; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu F, 2016, FEBS LETT, V590, P541, DOI 10.1002/1873-3468.12076; Yang Y, 2015, PLANT CELL, V27, P2455, DOI 10.1105/tpc.15.00320; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yu D., 2016, PLANT PHYSL; Zhang BL, 2015, GENE DEV, V29, P975, DOI 10.1101/gad.251520.114; Zuo Z., 2011, ARABIDOPSIS	64	2	2	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	MAY	2017	1860	5			SI		655	660		10.1016/j.bbagrm.2016.10.009				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EW2WK	WOS:000402356500015	27793713				2018-01-05	
J	Beneke, T; Madden, R; Makin, L; Valli, J; Sunter, J; Gluenz, E				Beneke, Tom; Madden, Ross; Makin, Laura; Valli, Jessica; Sunter, Jack; Gluenz, Eva			A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids	ROYAL SOCIETY OPEN SCIENCE			English	Article						Leishmania; Trypanosoma; CRISPR; genome editing; T7 RNA polymerase	CENTRAL PAIR MICROTUBULES; TRYPANOSOMA-BRUCEI GENES; PLASMODIUM-FALCIPARUM; FLUORESCENT PROTEINS; LEISHMANIA-MEXICANA; BASAL BODY; SYSTEM; LIPOPHOSPHOGLYCAN; CULTIVATION; CHROMOSOME	Clustered regularly interspaced short palindromic repeats (CRISPR), CRISPR-associated gene 9 (Cas9) genome editing is set to revolutionize genetic manipulation of pathogens, including kinetoplastids. CRISPR technology provides the opportunity to develop scalable methods for highthroughput production of mutant phenotypes. Here, we report development of a CRISPR-Cas9 toolkit that allows rapid tagging and gene knockout in diverse kinetoplastid species without requiring the user to perform any DNA cloning. We developed a new protocol for single-guide RNA (sgRNA) delivery using PCR-generated DNA templates which are transcribed in vivo by T7 RNA polymerase and an online resource (LeishGEdit. net) for automated primer design. We produced a set of plasmids that allows easy and scalable generation of DNA constructs for transfections in just a few hours. We show how these tools allow knock-in of fluorescent protein tags, modified biotin ligase BirA*, luciferase, HaloTag and small epitope tags, which can be fused to proteins at the N-or C-terminus, for functional studies of proteins and localization screening. These tools enabled generation of null mutants in a single round of transfection in promastigote form Leishmania major, Leishmania mexicana and bloodstream form Trypanosoma brucei; deleted genes were undetectable in non-clonal populations, enabling for the first time rapid and large-scale knockout screens.	[Beneke, Tom; Madden, Ross; Makin, Laura; Valli, Jessica; Sunter, Jack; Gluenz, Eva] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Madden, Ross] Univ Dundee, Sch Life Sci, Dundee, Scotland	Gluenz, E (reprint author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.	eva.gluenz@path.ox.ac.uk		Gluenz, Eva/0000-0003-4346-8896; Madden, Ross/0000-0003-1448-8441	John Fell Oxford University Press (OUP) Research Fund [132/029]; MRC PhD studentships [15/16_MSD_836338, 13/14_MSD_OSS_363238]; Wellcome Trust PhD studentship [102052/Z/13/Z]; Wellcome Trust [WT066839MA, 104627/Z/14/Z]; Wellcome Trust grants	This study was supported by the John Fell Oxford University Press (OUP) Research Fund (project 132/029). E.G. is a Royal Society University Research Fellow, T.B. and J.V. are supported by MRC PhD studentships (T.B.: 15/16_MSD_836338; J.V.: 13/14_MSD_OSS_363238); L.M. is supported by a Wellcome Trust PhD studentship (102052/Z/13/Z). This work was supported by resources from Wellcome Trust grant nos. WT066839MA and 104627/Z/14/Z to Prof. Keith Gull and J.S. was also supported by these Wellcome Trust grants.	Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Beverley SM, 2003, NAT REV GENET, V4, P11, DOI 10.1038/nrg980; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; BRUN R, 1979, ACTA TROP, V36, P289; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; DUTCHER SK, 1984, J CELL BIOL, V98, P229, DOI 10.1083/jcb.98.1.229                                                            ; Dyer P, 2016, JOVE-J VIS EXP, V114, DOI [10.3791/54342, DOI 10.3791/54342]; Fiebig M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005186; Franco Luis H., 2012, Journal of Parasitology Research, P165126; Gadelha C, 2006, J CELL SCI, V119, P2405, DOI 10.1242/jcs.02969; Gaud A, 1997, MOL BIOCHEM PARASIT, V87, P113, DOI 10.1016/S0166-6851(97)00048-0; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Glover L, 2016, P NATL ACAD SCI USA, V113, P7225, DOI 10.1073/pnas.1600344113; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; ILG T, 1993, EUR J BIOCHEM, V217, P603, DOI 10.1111/j.1432-1033.1993.tb18283.x; Ilg T, 2000, EMBO J, V19, P1953, DOI 10.1093/emboj/19.9.1953; Kraeva N, 2014, MOL BIOCHEM PARASIT, V198, P11, DOI 10.1016/j.molbiopara.2014.11.002; Lander N, 2016, J BIOL CHEM, V291, P25505, DOI 10.1074/jbc.M116.749655; Lander N, 2016, J EUKARYOT MICROBIOL, V63, P679, DOI 10.1111/jeu.12338; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI DOI 10.1021/CB800025K; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Madeira dS, 2009, P NATL ACAD SCI USA, V106, P7583, DOI [10.1073/pnas.0901698106, DOI 10.1073/PNAS.0901698106]; Mony BM, 2014, NATURE, V505, P681, DOI 10.1038/nature12864; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Peng D, 2015, MBIO, V6, DOI 10.1128/mBio.02097-14; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sacks DL, 2000, P NATL ACAD SCI USA, V97, P406, DOI 10.1073/pnas.97.1.406; Schumann BG, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI DOI 10.1016/J.M0LBI0PARA.2010.09.002; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Smith EF, 1996, J CELL BIOL, V132, P359, DOI 10.1083/jcb.132.3.359; Sollelis L, 2015, CELL MICROBIOL, V17, P1405, DOI 10.1111/cmi.12456; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Sunter J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003566; Tran KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134432; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Webb H, 1997, J CELL BIOL, V139, P103, DOI 10.1083/jcb.139.1.103; Wheeler RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9964; Zhang C, 2014, MBIO, V5, DOI 10.1128/mBio.01414-14; Zhang WW, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00340-16, 10.1128/msphere.00340-16]; Zhang WW, 2015, MBIO, V6, DOI 10.1128/mBio.00861-15	58	5	5	6	6	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	2054-5703			ROY SOC OPEN SCI	R. Soc. Open Sci.	MAY	2017	4	5							UNSP 170095	10.1098/rsos.170095				16	Multidisciplinary Sciences	Science & Technology - Other Topics	EW5JL	WOS:000402541800034	28573017	gold			2018-01-05	
J	Fulcher, LJ; Hutchinson, LD; Macartney, TJ; Turnbull, C; Sapkota, GP				Fulcher, Luke J.; Hutchinson, Luke D.; Macartney, Thomas J.; Turnbull, Craig; Sapkota, Gopal P.			Targeting endogenous proteins for degradation through the affinity-directed protein missile system	OPEN BIOLOGY			English	Article						proteolysis; AdPROM; ubiquitination; SHP2; ASC; nanobody	CHRONIC MYELOID-LEUKEMIA; TYROSINE PHOSPHATASE; UBIQUITIN LIGASES; SHP2; STAT5; INHIBITION; ACTIVATION; DOMAINS; BINDING; CANCER	Targeted proteolysis of endogenous proteins is desirable as a research toolkit and in therapeutics. CRISPR/Cas9-mediated gene knockouts are irreversible and often not feasible for many genes. Similarly, RNAinterference approaches necessitate prolonged treatments, can lead to incomplete knockdowns and are often associated with off-target effects. Targeted proteolysis can overcome these limitations. In this report, we describe an affinity-directed protein missile (AdPROM) system that harbours the von Hippel-Lindau (VHL) protein, the substrate receptor of the Cullin2 (CUL2) E3 ligase complex, tethered to polypeptide binders that selectively bind and recruit endogenous target proteins to the CUL2-E3 ligase complex for ubiquitination and proteasomal degradation. By using synthetic monobodies that selectively bind the protein tyrosine phosphatase SHP2 and a camelid-derived VHH nanobody that selectively binds the human ASC protein, we demonstrate highly efficient AdPROM-mediated degradation of endogenous SHP2 and ASC in human cell lines. We show that AdPROM-mediated loss of SHP2 in cells impacts SHP2 biology. This study demonstrates for the first time that small polypeptide binders that selectively recognize endogenous target proteins can be exploited for AdPROM-mediated destruction of the target proteins.	[Fulcher, Luke J.; Hutchinson, Luke D.; Macartney, Thomas J.; Turnbull, Craig; Sapkota, Gopal P.] MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland	Sapkota, GP (reprint author), MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland.	g.sapkota@dundee.ac.uk			UK Medical Research Council (MRC) [MC_UU_12016/3]; UK MRC Prize PhD studentships; Queens College Scholarship, University of Dundee; UK MRC; Division of Signal Transduction Therapy (DSTT) at the University of Dundee (Boehringer-Ingelheim); Division of Signal Transduction Therapy (DSTT) at the University of Dundee (GlaxoSmithKline); Division of Signal Transduction Therapy (DSTT) at the University of Dundee (Merck-Serono)	This study was funded by the UK Medical Research Council (MRC) (grant number MC_UU_12016/3). L.J.F. and L.D.H. are supported by the UK MRC Prize PhD studentships. L.J.F. also receives funding from Queens College Scholarship, University of Dundee. G.P.S. is supported by the UK MRC and the pharmaceutical companies supporting the Division of Signal Transduction Therapy (DSTT) at the University of Dundee (Boehringer-Ingelheim, GlaxoSmithKline, Merck-Serono).	Al-Salihi MA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120082; Bever CS, 2016, ANAL BIOANAL CHEM, V408, P5985, DOI 10.1007/s00216-016-9585-x; Bruce DL, 2012, CELL SIGNAL, V24, P1999, DOI 10.1016/j.cellsig.2012.07.003; Bulatov E, 2015, BIOCHEM J, V467, P365, DOI 10.1042/BJ20141450; Bunda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9859; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; de Groot RP, 1999, BLOOD, V94, P1108; Deininger MWN, 2000, BLOOD, V96, P3343; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Fulcher LJ, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160255; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Herhaus L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0441; Hjort EE, 2016, ONCOTARGET, V7, P77635, DOI 10.18632/oncotarget.12749; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Mitra S, 2008, J CELL SCI, V121, P3335, DOI 10.1242/jcs.035691; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pines J, 2005, NAT CELL BIOL, V7, P731, DOI 10.1038/ncb0805-731; Roos-Mattjus P, 2004, ANN MED, V36, P285, DOI 10.1080/07853890310006324; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Sapkota GP, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130067; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0                                                   ; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0                                                                ; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Schmidt FI, 2016, J EXP MED, V213, P771, DOI 10.1084/jem.20151790; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Shuai K, 1996, ONCOGENE, V13, P247; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009; Vogt J, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130210; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498                                                          ; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216; Zhang J, 2015, J CELL MOL MED, V19, P2075, DOI 10.1111/jcmm.12618; Zhao YC, 2013, CURR PHARM DESIGN, V19, P3215, DOI 10.2174/13816128113199990300                                                    	42	1	1	5	10	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	2046-2441			OPEN BIOL	Open Biol	MAY	2017	7	5							170066	10.1098/rsob.170066				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EW5JD	WOS:000402540900006		gold			2018-01-05	
J	Schaefer, M; Kapoor, U; Jantsch, MF				Schaefer, Matthias; Kapoor, Utkarsh; Jantsch, Michael F.			Understanding RNA modifications: the promises and technological bottlenecks of the 'epitranscriptome'	OPEN BIOLOGY			English	Article						RNA; transcriptome; chemical modification; epigenetics	EDITING ENZYME ADAR1; SINGLE-NUCLEOTIDE-RESOLUTION; FUNCTIONAL 50S RIBOSOMES; NUCLEIC-ACID COMPLEXES; IN-VITRO TRANSCRIPTS; EMBRYONIC STEM-CELLS; MESSENGER-RNA; GENE-EXPRESSION; NONCODING RNA; POSTTRANSCRIPTIONAL MODIFICATIONS	The discovery of mechanisms that alter genetic information via RNA editing or introducing covalent RNA modifications points towards a complexity in gene expression that challenges long-standing concepts. Understanding the biology of RNA modifications represents one of the next frontiers in molecular biology. To this date, over 130 different RNA modifications have been identified, and improved mass spectrometry approaches are still adding to this list. However, only recently has it been possible to map selected RNA modifications at single-nucleotide resolution, which has created a number of exciting hypotheses about the biological function of RNA modifications, culminating in the proposition of the 'epitranscriptome'. Here, we review some of the technological advances in this rapidly developing field, identify the conceptual challenges and discuss approaches that are needed to rigorously test the biological function of specific RNA modifications.	[Schaefer, Matthias; Kapoor, Utkarsh; Jantsch, Michael F.] Med Univ Vienna, Ctr Anat & Cell Biol Med, Schwarzspanierstr 17-1, A-1090 Vienna, Austria	Schaefer, M (reprint author), Med Univ Vienna, Ctr Anat & Cell Biol Med, Schwarzspanierstr 17-1, A-1090 Vienna, Austria.	matthias.schaefer@meduniwien.ac.at	Jantsch, Michael/E-9122-2015	Jantsch, Michael/0000-0003-1747-0853; Schaefer, Matthias/0000-0003-1952-8115	Austrian Science Fund [P26845, P29094]	Funding was provided by Austrian Science Fund (grant nos. P26845 and P29094).	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Alon S, 2015, ELIFE, V4, DOI 10.7554/eLife.05198; Amort T, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1139-1; AMOS H, 1958, BIOCHIM BIOPHYS ACTA, V29, P444, DOI 10.1016/0006-3002(58)90214-2; Ayub M, 2013, NANO LETT, V13, P6144, DOI 10.1021/nl403469r; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Behm-Ansmant I., 2011, J NUCL ACIDS, V2011, DOI DOI 10.4061/2011/408053; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Birkedal U, 2015, ANGEW CHEM INT EDIT, V54, P451, DOI 10.1002/anie.201408362; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6; Cao G, 2015, NATURE, V526, P591, DOI [10.1038/nature15377, DOI 10.1038/NATURE15377]; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Castello A, 2015, TRENDS ENDOCRIN MET, V26, P746, DOI 10.1016/j.tem.2015.09.012; CASTLEMAN H, 1980, NUCLEIC ACIDS RES, V8, P4485, DOI 10.1093/nar/8.19.4485; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; CHAN JC, 1982, NUCLEIC ACIDS RES, V10, P3755, DOI 10.1093/nar/10.12.3755                                                          ; Charpentier E, 2014, CURR OPIN MICROBIOL, V19, P114, DOI 10.1016/j.mib.2014.07.001; Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chen T, 2015, CELL RES, V25, P459, DOI 10.1038/cr.2015.24; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573                                                              ; Cload ST, 1996, CHEM BIOL, V3, P1033, DOI 10.1016/S1074-5521(96)90169-6; COHN WE, 1960, J BIOL CHEM, V235, P1488; Colina C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000540; Conde J, 2015, TRENDS BIOTECHNOL, V33, P141, DOI 10.1016/j.tibtech.2014.12.005; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Dalpke AH, 2012, RNA BIOL, V9, P828, DOI 10.4161/rna.20206; David R, 2017, PLANT CELL, V29, P445, DOI 10.1105/tpc.16.00751; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dillman AA, 2013, NAT NEUROSCI, V16, P499, DOI 10.1038/nn.3332; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Duechler M, 2016, CELL MOL LIFE SCI, V73, P3075, DOI 10.1007/s00018-016-2217-y; Durdevic Z, 2013, BIOESSAYS, V35, P323, DOI 10.1002/bies.201200158; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Falnes Pal O, 2005, RNA Biol, V2, P14, DOI 10.4161/rna.2.1.1602; FERSHT AR, 1981, PROC R SOC SER B-BIO, V212, P351, DOI 10.1098/rspb.1981.0044; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Fu LJ, 2014, J AM CHEM SOC, V136, P11582, DOI 10.1021/ja505305z; Garalde DR, 2016, BIORXIV, DOI [10.1101/068809, DOI 10.1101/068809]; Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Gonzalez C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1446; Green R, 1999, BIOCHEMISTRY-US, V38, P1772, DOI 10.1021/bi982246a                                                               ; Grosjean H., 2009, DNA AND RNA MODIFICA; Gu C, 2014, FEBS LETT, V588, P4287, DOI 10.1016/j.febslet.2014.09.038; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756                                                            ; Helm M, 2017, NAT REV GENET, V18, P275, DOI 10.1038/nrg.2016.169; Higuchi M, 2000, NATURE, V406, P78; Hoernes TP, 2016, NUCLEIC ACIDS RES, V44, P852, DOI 10.1093/nar/gkv1182; Hood JL, 2014, MOL CELL NEUROSCI, V61, P97, DOI 10.1016/j.mcn.2014.06.001; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Huntley MA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2291-9; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Hussain S, 2013, MOL CELL BIOL, V33, P1561, DOI 10.1128/MCB.01523-12; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jockel S, 2012, J EXP MED, V209, P235, DOI 10.1084/jem.20111075; KANE SE, 1987, J BIOL CHEM, V262, P3422; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kellner S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku733; Kellner S, 2010, RNA BIOL, V7, P237, DOI 10.4161/rna.7.2.11468                                                           ; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Khoddami V, 2014, NAT PROTOC, V9, P337, DOI 10.1038/nprot.2014.014; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Legrand C, 2017, BIORXIV, DOI [10.1101/130419, DOI 10.1101/130419]; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Li XM, 2016, ADV ENG SOFTW, V93, P1, DOI 10.1016/j.advengsoft.2015.11.003; Li XY, 2017, NAT METHODS, V14, P23, DOI 10.1038/NMETH.4110; Li XY, 2015, NAT CHEM BIOL, V11, P592, DOI [10.1038/NCHEMBIO.1836, 10.1038/nchembio.1836]; Liao JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026463; Licht K, 2016, NUCLEIC ACIDS RES, V44, P6398, DOI 10.1093/nar/gkw325; Liddicoat BJ, 2016, WIRES RNA, V7, P157, DOI 10.1002/wrna.1322; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Limbach P. A., 2016, WILEY INTERDISCIP RE, V8, pe1367, DOI DOI 10.1002/WRNA.1367); Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Liu B, 2008, RNA BIOL, V5, P249, DOI 10.4161/rna.6916                                                                ; Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Lovejoy AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110799; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Martinez FJ, 2012, J MED GENET, V49, P380, DOI 10.1136/jmedgenet-2011-100686; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Meyer B, 2011, NUCLEIC ACIDS RES, V39, P1526, DOI 10.1093/nar/gkq931; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; Molinie B, 2016, NAT METHODS, V13, P692, DOI 10.1038/nmeth.3898; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Muller M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv980; MUNNS TW, 1979, J BIOL CHEM, V254, P4327; MUNNS TW, 1984, BIOCHEMISTRY-US, V23, P2958, DOI 10.1021/bi00308a017; NARAYAN P, 1994, NUCLEIC ACIDS RES, V22, P419, DOI 10.1093/nar/22.3.419; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Noon KR, 1998, J BACTERIOL, V180, P2883; O'Connell MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005687; OConnell MA, 1997, CURR BIOL, V7, pR437, DOI 10.1016/S0960-9822(06)00212-0                                                   ; Okamoto M, 2012, DNA CELL BIOL, V31, P660, DOI 10.1089/dna.2011.1446; OZBAN N, 1964, J EMBRYOL EXP MORPH, V12, P373; Patil A, 2012, CELL CYCLE, V11, P3656, DOI 10.4161/cc.21919; Peach SE, 2012, MOL CELL PROTEOMICS, V11, P128, DOI 10.1074/mcp.M111.015941; PERRY RP, 1974, J MOL BIOL, V82, P315, DOI 10.1016/0022-2836(74)90593-2; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Phelps K, 2012, ACS CHEM BIOL, V7, P100, DOI 10.1021/cb200422t; Picardi E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14941; Preston MA, 2013, RNA, V19, P243, DOI 10.1261/rna.035808.112; Reautschnig P, 2017, RNA BIOL, V14, P651, DOI 10.1080/15476286.2016.1208323; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Roundtree IA, 2016, CURR OPIN CHEM BIOL, V30, P46, DOI 10.1016/j.cbpa.2015.10.024; Rubio MAT, 2017, NATURE, V542, P494, DOI 10.1038/nature21396; Rula EY, 2008, J NEUROSCI, V28, P6196, DOI 10.1523/JNEUROSCI.0443-08.2008; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Sakurai M, 2014, GENOME RES, V24, P522, DOI 10.1101/gr.162537.113; Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Sarin LP, 2014, RNA BIOL, V11, P1555, DOI 10.4161/15476286.2014.992279; Schaefer M, 2015, METHOD ENZYMOL, V560, P297, DOI 10.1016/bs.mie.2015.03.007; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schirmer M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0976-y; Schwartz S, 2016, RNA, V22, P169, DOI 10.1261/rna.054502.115; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; SEAMAN E, 1972, J BIOL CHEM, V247, P5709; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3                                                   ; Semrad K, 2002, RNA, V8, P401, DOI 10.1017/S1355838202029722; Sharma S, 2015, TRENDS BIOCHEM SCI, V40, P560, DOI [10.1016/j.tibs.2015.07.005, 10.1016/j.tibs.2015.07.008]; Shukla S, 2010, CHEMMEDCHEM, V5, P328, DOI 10.1002/cmdc.200900444; Sibbritt T., 2013, REV RNA, V4, P397, DOI DOI 10.1002/WRNA.1166); Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Singh MS, 2016, CURR OPIN BIOTECH, V39, P28, DOI 10.1016/j.copbio.2015.12.011; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smith AM, 2014, FRONT BIOENG BIOTECH, V3, P91, DOI [10.3389/fbioe.2015.00091, DOI 10.3389/FBIOE.2015.00091]; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Stefl R, 2005, RNA, V11, P592, DOI 10.1261/rna.7276805; Stepper P, 2017, NUCLEIC ACIDS RES, V45, P1703, DOI 10.1093/nar/gkw1112; STOLLAR BD, 1981, ARTHRITIS RHEUM, V24, P1010; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Taliaferro JM, 2014, RNA BIOL, V11, P1040, DOI 10.4161/rna.32146; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Tserovski L, 2016, METHODS, V107, P110, DOI 10.1016/j.ymeth.2016.02.012; Tuorto F, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160287; Vera M, 2016, ANNU REV GENET, V50, P267, DOI 10.1146/annurev-genet-120215-034854; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0                                                    ; Widagdo J, 2016, J NEUROSCI, V36, P6771, DOI 10.1523/JNEUROSCI.4053-15.2016; Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316; Yang X, 2017, CELL RES, V27, P606, DOI 10.1038/cr.2017.55; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Yoon YJ, 2016, P NATL ACAD SCI USA, V113, pE6877, DOI 10.1073/pnas.1614267113; Zaringhalam M, 2016, METHODS, V107, P63, DOI 10.1016/j.ymeth.2016.03.001; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhao BXS, 2017, NATURE, V542, P475, DOI 10.1038/nature21355; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	190	2	2	11	16	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	2046-2441			OPEN BIOL	Open Biol	MAY	2017	7	5							170077	10.1098/rsob.170077				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EW5JD	WOS:000402540900008		gold			2018-01-05	
J	Devi, TS; Somayajulu, M; Kowluru, RA; Singh, LP				Devi, Takhellambam Swornalata; Somayajulu, Mallika; Kowluru, Renu Anjan; Singh, Lalit Pukhrambam			TXNIP regulates mitophagy in retinal Muller cells under high-glucose conditions: implications for diabetic retinopathy	CELL DEATH & DISEASE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; OXIDATIVE STRESS; AUTOPHAGY; PHOSPHORYLATION; MEMBRANE; PATHWAY; DAMAGE; MITOCHONDRIA; INFLAMMATION; PROGRESSION	Thioredoxin-interacting protein (TXNIP) is involved in oxidative stress and apoptosis in diabetic retinopathy. However, the role of TXNIP in the removal of damaged mitochondria (MT) via mitophagy, a process of macroautophagy, remains unexplored. Here we investigate the associated cellular and molecular mechanisms underlying mitophagy in retinal cells under diabetic conditions. For this, we maintained a rat Muller cell line (rMC1) under high-glucose (25 mM, HG) or low-glucose (5.5 mM, LG) condition for 5 days. Our data reveal that HG upregulates TXNIP in the cytosol as well as in the MT. Moreover, mitochondrial oxidative stress and membrane depolarization occur under prolonged hyperglycemia leading to fragmentation. These damaged MT are targeted to lysosome for mitophagic degradation, as is evident by co-localization of mitochondrial protein COXIV, a subunit of cytochrome c oxidase, with autophagosome marker LC3BII and the lysosomal membrane protein LAMP2A. In addition, under HG conditions, there is an accumulation of dynamin-related fission protein Drp1 and E3 ubiquitin ligase Parkin in damaged MT, suggesting their roles in mitochondrial fragmentation and ubiquitination, respectively, which is absent in LG conditions. Subsequently, ubiquitin receptors, optineurin and p62/sequestrome 1, bind to the damaged MT and target them to LC3BII autophagosomes. Conversely, TXNIP knockout via CRISPR/Cas9 and TXNIP gRNA prevents the HG-induced mitochondrial damage and mitophagy in rMC1. Last, TXNIP level is also significantly upregulated in the diabetic rat retina in vivo and induces radial glial fibrillary acidic protein expression, a marker for Muller glia activation, and the formation of LC3BII puncta, which are prevented by intravitreal injection of TXNIP siRNA. Therefore, TXNIP represents a potential target for preventing ocular complications of diabetes.	[Devi, Takhellambam Swornalata; Singh, Lalit Pukhrambam] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 East Canfield Ave,Scott Hall 8332, Detroit, MI 48201 USA; [Kowluru, Renu Anjan; Singh, Lalit Pukhrambam] Wayne State Univ, Sch Med, Dept Ophthalmol, 540 East Canfield Ave,Scott Hall 8332, Detroit, MI USA; [Somayajulu, Mallika] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Singh, LP (reprint author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 East Canfield Ave,Scott Hall 8332, Detroit, MI 48201 USA.; Singh, LP (reprint author), Wayne State Univ, Sch Med, Dept Ophthalmol, 540 East Canfield Ave,Scott Hall 8332, Detroit, MI USA.	ak1157@wayne.edu			Research to Prevent Blindness grant	NIH/NEI: EY023992 to LPS; EY014370, EY017313 and EY022230 to RAK; Core. P30EY004068 to the Department of Anatomy and Cell Biology; and unrestricted Research to Prevent Blindness grant to the Department of Ophthalmology. Language editing help from American Manuscript Editors is also acknowledged. Parts of this work were presented at the ARVO meeting, Seatle, WA, in May 2016, and NIH mitochondrial symposium at Bethesda, MD, in August 2016.	Agarwal S, 2015, J BIOL CHEM, V290, P21163, DOI 10.1074/jbc.M115.648998; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Balmer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074162; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Chourasia AH, 2015, EMBO REP, V16, P1145, DOI 10.15252/embr.201540759; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Devi TS, 2013, EXP CELL RES, V319, P1001, DOI 10.1016/j.yexcr.2013.01.012; Devi T. S., 2012, EXP DIABETES RES, V2012, DOI DOI 10.1155/2012/438238; Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kowluru RA, 2015, BBA-MOL BASIS DIS, V1852, P2474, DOI 10.1016/j.bbadis.2015.08.001; Lin YF, 2016, MOL CELL, V61, P677, DOI 10.1016/j.molcel.2016.02.004; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Moreau K, 2013, TRENDS BIOCHEM SCI, V38, P57, DOI 10.1016/j.tibs.2012.11.004; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Nishimura N, 2014, PEERJ, V2, DOI 10.7717/peerj.349; Pan JA, 2016, MOL CELL, V61, P720, DOI 10.1016/j.molcel.2016.02.007; Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818; Perrone L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.42; Perrone L, 2009, J CELL PHYSIOL, V221, P262, DOI 10.1002/jcp.21852; Piano I, 2016, FRONT CELL NEUROSCI, V10, DOI [10.3389/fnce1.2016.00042, 10.3389/fncel.2016.00042]; Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Romanello Vanina, 2015, Front Physiol, V6, P422, DOI 10.3389/fphys.2015.00422; Saha T, 2012, AUTOPHAGY, V8, P1643, DOI 10.4161/auto.21654; Santos JM, 2011, FREE RADICAL BIO MED, V51, P1849, DOI 10.1016/j.freeradbiomed.2011.08.017; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Singh L. P., 2013, J CLIN EXP OPHTHALMO, V4, P287, DOI [DOI 10.4172/2155-9570.1000287, 10.4172/2155-9570.1000287]; Sud N, 2016, CURR PHARM DESIGN, V22, P1; Sun JH, 2015, MOL PHARMACOL, V88, P437, DOI 10.1124/mol.115.098269; Yang LH, 2014, METHODS MOL BIOL, V1114, P245, DOI 10.1007/978-1-62703-761-7_16; Yang ZF, 2015, J BIOL CHEM, V290, P26549, DOI 10.1074/jbc.M115.658088; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Zhang CS, 2016, CELL METAB, V23, P399, DOI 10.1016/j.cmet.2016.02.017; Zhao LP, 2016, FEBS LETT, V590, P3202, DOI 10.1002/1873-3468.12359; Zhao Y, 2012, J CELL PHYSIOL, V227, P639, DOI 10.1002/jcp.22768; Zhong Q, 2011, INVEST OPHTH VIS SCI, V52, P8739, DOI 10.1167/iovs.11-8045	41	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	MAY	2017	8								e2777	10.1038/cddis.2017.190				12	Cell Biology	Cell Biology	EW0QG	WOS:000402195700043	28492550	gold			2018-01-05	
J	Okada, M; Miller, TC; Wen, L; Shi, YB				Okada, Morihiro; Miller, Thomas C.; Wen, Luan; Shi, Yun-Bo			A balance of Mad and Myc expression dictates larval cell apoptosis and adult stem cell development during Xenopus intestinal metamorphosis	CELL DEATH & DISEASE			English	Article							THYROID-HORMONE RECEPTOR; TRANSCRIPTION FACTOR NETWORK; C-MYC; AMPHIBIAN METAMORPHOSIS; EPITHELIAL-CELLS; LAEVIS METAMORPHOSIS; ANURAN METAMORPHOSIS; DIRECT ACTIVATION; TARGET GENES; IN-VIVO	The Myc/Mad/Max network has long been shown to be an important factor in regulating cell proliferation, death and differentiation in diverse cell types. In general, Myc-Max heterodimers activate target gene expression to promote cell proliferation, although excess of c-Myc can also induce apoptosis. In contrast, Mad competes against Myc to form Mad-Max heterodimers that bind to the same target genes to repress their expression and promote differentiation. The role of the Myc/Mad/Max network during vertebrate development, especially, the so-called postembryonic development, a period around birth in mammals, is unclear. Using thyroid hormone (T3)-dependent Xenopus metamorphosis as a model, we show here that Mad1 is induced by T3 in the intestine during metamorphosis when larval epithelial cell death and adult epithelial stem cell development take place. More importantly, we demonstrate that Mad1 is expressed in the larval cells undergoing apoptosis, whereas c-Myc is expressed in the proliferating adult stem cells during intestinal metamorphosis, suggesting that Mad1 may have a role in cell death during development. By using transcription activator-like effector nuclease-mediated gene-editing technology, we have generated Mad1 knockout Xenopus animals. This has revealed that Mad1 is not essential for embryogenesis or metamorphosis. On the other hand, consistent with its spatiotemporal expression profile, Mad1 knockout leads to reduced larval epithelial apoptosis but surprisingly also results in increased adult stem cell proliferation. These findings not only reveal a novel role of Mad1 in regulating developmental cell death but also suggest that a balance of Mad and Myc controls cell fate determination during adult organ development.	[Okada, Morihiro; Miller, Thomas C.; Wen, Luan; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, NIH, Bethesda, MD USA	Shi, YB (reprint author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, NIH, 18 Lib Dr, Bethesda, MD 20892 USA.	Shi@helix.nih.gov		Wen, Luan/0000-0001-5080-0469	Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health; Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the National Institutes of Health	This work was supported by the Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health. MO was supported in part by a Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the National Institutes of Health.	Amati Bruno, 1994, Current Opinion in Genetics and Development, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Amaya E, 1998, TRENDS GENET, V14, P253, DOI 10.1016/S0168-9525(98)01506-6; Austen M, 1997, CURR TOP MICROBIOL, V224, P123; AYER DE, 1993, GENE DEV, V7, P2110, DOI 10.1101/gad.7.11.2110; Bagamasbad PD, 2015, MOL ENDOCRINOL, V29, P856, DOI 10.1210/me.2014-1349; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dang CV, 1999, MOL CELL BIOL, V19, P1; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Fu LZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-81; Fujimoto K, 2012, ENDOCRINOLOGY, V153, P5082, DOI 10.1210/en.2012-1308; Fujimoto K, 2012, J BIOL CHEM, V287, P10039, DOI 10.1074/jbc.M111.335661; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653                                                ; Hasebe T, 2007, DEV DYNAM, V236, P2338, DOI 10.1002/dvdy.21252; Hasebe T, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-18; Hasebe T, 2011, STEM CELLS, V29, P154, DOI 10.1002/stem.560; HURLIN PJ, 1994, COLD SPRING HARB SYM, V59, P109, DOI 10.1101/SQB.1994.059.01.014                                                     ; Ishizuya-Oka A, 2007, DEV DYNAM, V236, P3358, DOI 10.1002/dvdy.21291; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Ishizuya-Oka A, 2009, FASEB J, V23, P2568, DOI 10.1096/fj.08-128124; ISHIZUYAOKA A, 1992, J MORPHOL, V213, P185, DOI 10.1002/jmor.1052130205; ISHIZUYAOKA A, 1992, ROUX ARCH DEV BIOL, V201, P322, DOI 10.1007/BF00592113; Juergens K, 2005, DEV DYNAM, V233, P1554, DOI 10.1002/dvdy.20470; KOSKINEN PJ, 1993, SEMIN CANCER BIOL, V4, P3; Kuchino Y, 1996, Prog Mol Subcell Biol, V16, P104; Lei Y, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-21; Luscher B, 2012, EUR J CELL BIOL, V91, P506, DOI 10.1016/j.ejcb.2011.07.005; Matsuura K, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-25; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; McMahon SB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014407; Nieminen AI, 2007, CELL CYCLE, V6, P2464, DOI 10.4161/cc.6.20.4917                                                            ; Nieuwkoop PD, 1965, FABER J NORMAL TABLE; Okada M, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0065-3; Okada M, 2015, ENDOCRINOLOGY, V156, P3381, DOI 10.1210/en.2015-1190; Okada M, 2013, ZOOL SCI, V30, P154, DOI 10.2108/zsj.30.154; PACKHAM G, 1995, BBA-REV CANCER, V1242, P11, DOI 10.1016/0304-419X(94)00015-T                                                    ; Pelengaris S, 2000, CURR OPIN GENET DEV, V10, P100, DOI 10.1016/S0959-437X(99)00046-5                                                   ; Pirity M, 2006, CURR TOP MICROBIOL, V302, P205; Shi YB, 2001, PROG NUCLEIC ACID RE, V65, P53; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9                                                   ; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-30; Sterling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047407; Sun GH, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-73; Sun GH, 2013, ENDOCRINOLOGY, V154, P4396, DOI 10.1210/en.2013-1432; Sun GH, 2012, INT J BIOL SCI, V8, P1217, DOI 10.7150/ijbs.5109; Sun GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013605; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; VASTRIK I, 1995, J CELL BIOL, V128, P1197, DOI 10.1083/jcb.128.6.1197; Wang XD, 2008, ENDOCRINOLOGY, V149, P5610, DOI 10.1210/en.2008-0751; Wen L, 2015, ENDOCRINOLOGY, V156, P721, DOI 10.1210/en.2014-1439	52	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	MAY	2017	8								e2787	10.1038/cddis.2017.198				10	Cell Biology	Cell Biology	EW0QG	WOS:000402195700050	28492553	gold			2018-01-05	
J	Yang, CC; Chen, YT; Chang, YF; Liu, H; Kuo, YP; Shih, CT; Liao, WC; Chen, HW; Tsai, WS; Tan, BCM				Yang, Chang-Ching; Chen, Yi-Tung; Chang, Yi-Feng; Liu, Hsuan; Kuo, Yu-Ping; Shih, Chieh-Tien; Liao, Wei-Chao; Chen, Hui-Wen; Tsai, Wen-Sy; Tan, Bertrand Chin-Ming			ADAR1-mediated 3 ' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response	CELL DEATH & DISEASE			English	Article							TO-INOSINE RNA; UBIQUITIN-LIGASE; MESSENGER-RNAS; PARALLEL DNA; HUMAN CANCER; ADAR1; NUCLEAR; TRANSCRIPTOME; IDENTIFICATION; DEAMINASES	Adenosine-to-inosine RNA editing constitutes a crucial component of the cellular transcriptome and critically underpins organism survival and development. While recent high-throughput approaches have provided comprehensive documentation of the RNA editome, its functional output remains mostly unresolved, particularly for events in the non-coding regions. Gene ontology analysis of the known RNA editing targets unveiled a preponderance of genes related to apoptosis regulation, among which proto-oncogenes XIAP and MDM2 encode two the most abundantly edited transcripts. To further decode this potential functional connection, here we showed that the main RNA editor ADAR1 directly targets this 3' UTR editing of XIAP and MDM2, and further exerts a negative regulation on the expression of their protein products. This post-transcriptional silencing role was mediated via the inverted Alu elements in the 3' UTR but independent of alteration in transcript stability or miRNA targeting. Rather, we discovered that ADAR1 competes transcript occupancy with the RNA shuttling factor STAU1 to facilitate nuclear retention of the XIAP and MDM2 mRNAs. As a consequence, ADAR1 may acquire functionality in part by conferring spatial distribution and translation efficiency of the target transcripts. Finally, abrogation of ADAR1 expression or catalytic activity elicited a XIAP-dependent suppression of apoptotic response, whereas ectopic expression reversed this protective effect on cell death. Together, our results extended the known functions of ADAR1 and RNA editing to the critical fine-tuning of the intracellular apoptotic signaling and also provided mechanistic explanation for ADAR1's roles in development and tumorigenesis.	[Yang, Chang-Ching; Chen, Yi-Tung; Liu, Hsuan; Kuo, Yu-Ping; Shih, Chieh-Tien; Chen, Hui-Wen; Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, 259 Wen Hwa First Rd, Taoyuan 333, Taiwan; [Yang, Chang-Ching; Chen, Yi-Tung; Kuo, Yu-Ping; Shih, Chieh-Tien; Chen, Hui-Wen; Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Dept Biomed Sci, 259 Wen Hwa First Rd, Taoyuan 333, Taiwan; [Chang, Yi-Feng; Liu, Hsuan; Liao, Wei-Chao; Tan, Bertrand Chin-Ming] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Liu, Hsuan] Chang Gung Univ, Coll Med, Dept Biochem, Taoyuan, Taiwan; [Liu, Hsuan; Tsai, Wen-Sy] Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Linkou, Taiwan; [Tsai, Wen-Sy] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Lin Kou Med Ctr, Dept Neurosurg, Linkou, Taiwan	Tan, BCM (reprint author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, 259 Wen Hwa First Rd, Taoyuan 333, Taiwan.; Tan, BCM (reprint author), Chang Gung Univ, Coll Med, Dept Biomed Sci, 259 Wen Hwa First Rd, Taoyuan 333, Taiwan.	btan@mail.cgu.edu.tw		Liao, Wei-Chao/0000-0002-4737-2675	Ministry of Science and Technology of Taiwan [MOST104-2320-B-182-029-MY3, MOST105-2314-B-182-061-MY4, MOST105-2320-B-182-017, MOST103-2811-B-182-024, MOST105-2632-B-182-001]; Chang Gung Memorial Hospital [CMRPD1C0843, CMRPD3E0152, CMRPG3D1511, CMRPG3D1512, CMRPG3D1513]; Biosignature Research [CIRPD3B0012, CIRPD3B0013]; National Health Research Institute of Taiwan [NHRI-EX105-10321SI]; Ministry of Education, Taiwan	We are grateful to members of the BC-MT laboratory for critical reading of the article and important discussions. This work was supported by grants from the Ministry of Science and Technology of Taiwan (MOST104-2320-B-182-029-MY3 and MOST105-2314-B-182-061-MY4 to BC-MT; MOST105-2320-B-182-017 to HL; MOST103-2811-B-182-024 to C-CY; MOST105-2632-B-182-001), Chang Gung Memorial Hospital (CMRPD1C0843 and CMRPD3E0152 to BC-MT; CMRPG3D1511, CMRPG3D1512 and CMRPG3D1513 to HL; Biosignature Research Grants CIRPD3B0012 and CIRPD3B0013 for supporting bioinformatics and computing resources), the National Health Research Institute of Taiwan (NHRI-EX105-10321SI), and the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004274; Chen L, 2013, P NATL ACAD SCI USA, V110, pE2741, DOI 10.1073/pnas.1218884110; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Galeano F, 2012, SEMIN CELL DEV BIOL, V23, P244, DOI 10.1016/j.semcdb.2011.09.003; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hsieh CL, 2014, CELL DEATH DIFFER, V21, P707, DOI 10.1038/cdd.2013.197; Hundley HA, 2008, RNA, V14, P2050, DOI 10.1261/rna.1165008; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lehmann KA, 1999, J MOL BIOL, V291, P1, DOI 10.1006/jmbi.1999.2914                                                          ; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Ma CH, 2011, BIOCHEM BIOPH RES CO, V406, P245, DOI 10.1016/j.bbrc.2011.02.025; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Paz-Yaacov N, 2010, P NATL ACAD SCI USA, V107, P12174, DOI 10.1073/pnas.1006183107; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Qiu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.125; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Shoshan E, 2015, NAT CELL BIOL, V17, P311, DOI 10.1038/ncb3110; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Wang QD, 2000, J NEUROCHEM, V74, P1290; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang T, 2013, NUCLEIC ACIDS RES, V41, P4743, DOI 10.1093/nar/gkt178; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	40	0	0	6	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	MAY	2017	8								e2833	10.1038/cddis.2017.12				13	Cell Biology	Cell Biology	EW0QG	WOS:000402195700002	28542129	gold			2018-01-05	
J	Zhang, JD; Zhang, CX; Cui, J; Ou, JY; Han, J; Qin, YF; Zhi, F; Wang, RF				Zhang, Jindong; Zhang, Chuanxia; Cui, Jun; Ou, Jiayu; Han, Jing; Qin, Yunfei; Zhi, Feng; Wang, Rong-Fu			TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination	CELL DEATH & DISEASE			English	Article							POSTTRANSLATIONAL MODIFICATION; MALIGNANT GLIOMA; DEGRADATION; MDM2; PROTEIN; TUMORIGENESIS; PROMOTES; SYSTEM	Tripartite motif-containing protein 45 (TRIM45) belongs to a large family of RING-finger-containing E3 ligases, which are highly expressed in the brain. However, little is known regarding the role of TRIM45 in cancer biology, especially in human glioma. Here, we report that TRIM45 expression is significantly reduced in glioma tissue samples. Overexpression of TRIM45 suppresses proliferation and tumorigenicity in glioblastoma cells in vitro and in vivo. In addition, CRISPR/Cas9-mediated knockout of TRIM45 promotes proliferation and inhibits apoptosis in glioblastoma cells. Further mechanistic analyses show that TRIM45 interacts with and stabilizes p53. TRIM45 conjugates K63-linked polyubiquitin chain to the C-terminal six lysine residues of p53, thereby inhibiting the availability of these residues to the K48-linked polyubiquitination that targets p53 for degradation. These findings suggest that TRIM45 is a novel tumor suppressor that stabilizes and activates p53 in glioma.	[Zhang, Jindong; Ou, Jiayu; Han, Jing] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Jindong; Cui, Jun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Chuanxia; Cui, Jun; Qin, Yunfei] Sun Yat Sen Univ, Minist Educ, Key Lab Gene Engn, State Key Lab Biocontrol,Sch Life Sci, Guangzhou 510006, Guangdong, Peoples R China; [Zhi, Feng] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, 185 Juqian Rd, Changzhou 213000, Peoples R China; [Wang, Rong-Fu] Houston Methodist Res Inst, Ctr Inflammat & Epigenet, 6670 Betner Ave, Houston, TX 77096 USA	Zhi, F (reprint author), Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, 185 Juqian Rd, Changzhou 213000, Peoples R China.; Wang, RF (reprint author), Houston Methodist Res Inst, Ctr Inflammat & Epigenet, 6670 Betner Ave, Houston, TX 77096 USA.; Cui, J (reprint author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Eastern Campus,Room 320,Bldg Sch Life Sci, Guangzhou 510006, Guangdong, Peoples R China.	cuij5@mail.sysu.edu.cn; danielzhif@163.com; rwang3@houstonmethodist.org			National Natural Science Foundation of China [91629101, 31522018, 81302197]; National Key Basic Research Program of China [2015CB859800, 2014CB910800, 2014CB745203]; Guangdong Natural Science Funds for Distinguished Young Scholar [S2013050014772]; Guangdong Innovative Research Team Program [2011Y035, 201001Y0104687244]; Fundamental Research Funds for the Central Universities [15lgjc02]; Training Program for Outstanding Young Teachers in Higher Education institutions of Guangdong Province [YQ2015001]; NCI [CA101795, DA030338]; NIDA, NIH; Jiangsu Provincial Special Programe of Medical Science [BL2014035]; Changzhou Science and Technology Support Program [CE20165048]; Changzhou High-Level Medical Talents Training Project [2016CZBJ006]; Changzhou Municipal Commisions of Health and Family Planning Major Scientific and Technological Project [ZD201620]	This work was supported by National Natural Science Foundation of China (91629101 and 31522018), National Key Basic Research Program of China (2015CB859800, 2014CB910800 and 2014CB745203), Guangdong Natural Science Funds for Distinguished Young Scholar (S2013050014772), Guangdong Innovative Research Team Program (Nos 2011Y035 and 201001Y0104687244), the Fundamental Research Funds for the Central Universities (15lgjc02), and the Training Program for Outstanding Young Teachers in Higher Education institutions of Guangdong Province (YQ2015001). R-FW was, in part, supported by grants (CA101795 and DA030338) from NCI and NIDA, NIH. FZ is partially supported by the National Natural Science Foundation of China (81302197), Jiangsu Provincial Special Programe of Medical Science (BL2014035), Changzhou Science and Technology Support Program (CE20165048), Changzhou High-Level Medical Talents Training Project (2016CZBJ006), and Changzhou Municipal Commisions of Health and Family Planning Major Scientific and Technological Project (ZD201620).	Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425                                                ; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690                                                          ; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4                                                   ; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Qin Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004358; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sato T, 2015, ONCOGENE, V34, P1280, DOI 10.1038/onc.2014.68; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V323, P9, DOI 10.1016/j.bbrc.2004.08.048; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874; 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385	37	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	MAY	2017	8								e2831	10.1038/cddis.2017.149				11	Cell Biology	Cell Biology	EW0QG	WOS:000402195700023	28542145	gold			2018-01-05	
J	Hu, R; Fan, ZY; Wang, BY; Deng, SL; Zhang, XS; Zhang, JL; Han, HB; Lian, ZX				Hu, R.; Fan, Z. Y.; Wang, B. Y.; Deng, S. L.; Zhang, X. S.; Zhang, J. L.; Han, H. B.; Lian, Z. X.			RAPID COMMUNICATION : Generation of FGF5 knockout sheep via the CRISPR/Cas9 system	JOURNAL OF ANIMAL SCIENCE			English	Article						Cas9; fibroblast growth factor 5; knockout; sheep; wool	HAIR LENGTH; MUTATIONS; GENE; LONG; REGULATOR; PHENOTYPE; BIOLOGY; CYCLE; CATS; MICE	Sheep are an important source of fiber production. Fibroblast growth factor 5 (FGF5) is a dominant inhibitor of length of the anagen phase of the hair cycle. Knockout or silencing of the FGF5 gene results in a wooly coat in mice, donkeys, dogs, and rabbits. In sheep breeding, wool length is one of the most important wool quality traits. However, traditional breeding cannot accurately and efficiently mediate an advanced genotype into the sheep genome. In this study, we generated 3 FGF5 knockout sheep via the 1-step clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system. Sequencing analysis confirmed that mutations in the FGF5 gene existed in all germ lines of 3 founders: besides the intact sequence, 3 kinds of deletions in the FGF5 gene (including 5, 13, and 33 bp) were detected. The changes in the primary and senior structure of the FGF5 protein due to the 3 deletions in founders suggested that the FGF5 protein was dysfunctional. In addition, the expression level of intact FGF5 mRNA in heterozygous individuals decreased compared with the wild types (P < 0.01). Functionally, we discovered that wool length in founders was significantly longer than in wild types (P < 0.05). Collectively, the FGF5 knockout sheep with the longer wool length phenotype will provide an efficient way for fast genetic improvement of sheep breeding and promote the development of wool industry.	[Hu, R.; Fan, Z. Y.; Han, H. B.; Lian, Z. X.] China Agr Univ, Beijing Key Lab Anim Genet Improvement, Beijing, Peoples R China; [Wang, B. Y.] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Deng, S. L.] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Zhang, X. S.; Zhang, J. L.] Tianjin Acad Agr Sci, Inst Anim Sci, Tianjin, Peoples R China	Han, HB; Lian, ZX (reprint author), China Agr Univ, Beijing Key Lab Anim Genet Improvement, Beijing, Peoples R China.	hanhong-bing@cau.edu.cn; lianzhx@cau.edu.cn			National Transgenic Creature Breeding Grand Project [2016ZX08008-003]	The authors would like to thank the National Transgenic Creature Breeding Grand Project (2016ZX08008-003) for research support. Appreciation is expressed to personnel at the Beijing Key Laboratory for Animal Genetic Improvement, China Agricultural University.	Allain D, 2010, ANIMAL, V4, P1472, DOI 10.1017/S1751731110000029; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Deng SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047118; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Higgins CA, 2014, P NATL ACAD SCI USA, V111, P10648, DOI 10.1073/pnas.1402862111; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kehler JS, 2007, J HERED, V98, P555, DOI 10.1093/jhered/esm072; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Legrand R, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0065-5; [李春笑 LI ChunXiao], 2008, [遗传, Hereditas(Beijing)], V30, P893, DOI 10.3724/SP.J.1005.2008.00893; Li QQ, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-22; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Roca AL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-232; Ryan AF, 2003, CURR TOP DEV BIOL, V57, P449, DOI 10.1016/S0070-2153(03)57014-4; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	27	2	2	7	10	AMER SOC ANIMAL SCIENCE	CHAMPAIGN	PO BOX 7410, CHAMPAIGN, IL 61826-7410 USA	0021-8812	1525-3163		J ANIM SCI	J. Anim. Sci.	MAY	2017	95	5					2019	2024		10.2527/jas2017.1503				6	Agriculture, Dairy & Animal Science	Agriculture	EW3FC	WOS:000402379700014	28727005				2018-01-05	
J	Yang, WY; Wang, GL; Li, J; Bates, PD; Wang, XM; Allen, DK				Yang, Wenyu; Wang, Geliang; Li, Jia; Bates, Philip D.; Wang, Xuemin; Allen, Doug K.			Phospholipase D zeta Enhances Diacylglycerol Flux into Triacylglycerol	PLANT PHYSIOLOGY			English	Article							PHOSPHATIDIC-ACID PHOSPHATASE; PLANT OIL COMPOSITION; UNUSUAL FATTY-ACIDS; ARABIDOPSIS-THALIANA; MICROSOMAL PREPARATIONS; DEVELOPING SEEDS; CAMELINA-SATIVA; ENDOPLASMIC-RETICULUM; BEAN COTYLEDONS; METABOLIC FLUX	Plant seeds are the primary source of triacylglycerols (TAG) for food, feed, fuel, and industrial applications. As TAG is produced from diacylglycerol (DAG), successful engineering strategies to enhance TAG levels have focused on the conversion of DAG to TAG. However, the production of TAG can be limited by flux through the enzymatic reactions that supply DAG. In this study, two Arabidopsis phospholipase D-zeta genes (AtPLD zeta 1 and AtPLD zeta 2) were coexpressed in Camelina sativa to test whether the conversion of phosphatidylcholine to DAG impacts TAG levels in seeds. The resulting transgenic plants produced 2% to 3% more TAG as a component of total seed biomass and had increased 18: 3 and 20: 1 fatty acid levels relative to wild type. Increased DAG and decreased PC levels were examined through the kinetics of lipid assembly by [C-14] acetate and [C-14] glycerol incorporation into glycerolipids. [C-14] acetate was rapidly incorporated into TAG in both wild-type and overexpression lines, indicating a significant flux of nascent and elongated acyl-CoAs into the sn-3 position of TAG. Stereochemical analysis revealed that newly synthesized fatty acids were preferentially incorporated into the sn-2 position of PC, but the sn-1 position of de novo DAG and indicated similar rates of nascent acyl groups into the Kennedy pathway and acyl editing. [C-14] glycerol studies demonstrated PC-derived DAG is the major source of DAG for TAG synthesis in both tissues. The results emphasize that the interconversions of DAG and PC pools can impact oil production and composition.	[Yang, Wenyu; Wang, Geliang; Li, Jia; Wang, Xuemin; Allen, Doug K.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Yang, Wenyu; Allen, Doug K.] USDA ARS, Plant Genet Res Unit, St Louis, MO 63132 USA; [Wang, Geliang; Wang, Xuemin] Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA; [Bates, Philip D.] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA	Wang, XM; Allen, DK (reprint author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.; Allen, DK (reprint author), USDA ARS, Plant Genet Res Unit, St Louis, MO 63132 USA.; Wang, XM (reprint author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	swang@danforthcenter.org; swang@danforthcenter.org; doug.allen@ars.usda.gov	Allen, Doug/M-2836-2013; Bates, Philip/I-7550-2013; Wang, Xuemin/M-2853-2013	Allen, Doug/0000-0001-8599-8946; Bates, Philip/0000-0002-1291-3363; wang, xuemin/0000-0002-6251-6745	USDA-ARS; US Department of Energy [DE-AR0000202]; National Science Foundation [MCB1412901, MCB1613923]	The authors acknowledge the USDA-ARS, US Department of Energy (grant no. DE-AR0000202), and National Science Foundation (grants no. MCB1412901 and No. MCB1613923) for funding support.	Albert D, 2008, J LEUKOCYTE BIOL, V83, P1019, DOI 10.1189/jlb.0807531; Allen DK, 2016, BBA-MOL CELL BIOL L, V1861, P1226, DOI 10.1016/j.bbalip.2016.03.017; Allen DK, 2016, CURR OPIN BIOTECH, V37, P45, DOI 10.1016/j.copbio.2015.10.002; Allen DK, 2015, PROG LIPID RES, V58, P97, DOI 10.1016/j.plipres.2015.02.002; Banas W, 2013, PLANTA, V237, P1627, DOI 10.1007/s00425-013-1870-8; Bao XM, 2000, PLANT J, V22, P39, DOI 10.1046/j.1365-313x.2000.00712.x; BARRON EJ, 1962, BIOCHIM BIOPHYS ACTA, V60, P329, DOI 10.1016/0006-3002(62)90408-0; Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; Bates PD, 2016, BBA-MOL CELL BIOL L, V1861, P1214, DOI 10.1016/j.bbalip.2016.03.021; Bates PD, 2014, P NATL ACAD SCI USA, V111, P1204, DOI 10.1073/pnas.1318511111; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; Bates PD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00147; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Cahoon EB, 2002, PLANT PHYSIOL, V128, P615, DOI 10.1104/pp.010768; Cahoon EB, 2006, PHYTOCHEMISTRY, V67, P1166, DOI 10.1016/j.phytochem.2006.04.013; Campbell MC, 2013, CROP PASTURE SCI, V64, P388, DOI 10.1071/CP13054; Christie W. W., 2003, LIPID ANAL; Craddock CP, 2015, PLANT CELL, V27, P1251, DOI 10.1105/tpc.15.00037; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; GRIFFITHS G, 1988, PHYTOCHEMISTRY, V27, P2089, DOI 10.1016/0031-9422(88)80102-X                                                    ; GRIFFITHS G, 1985, BIOCHEM J, V230, P379, DOI 10.1042/bj2300379                                                               ; Haslam RP, 2013, PLANT BIOTECHNOL J, V11, P157, DOI 10.1111/pbi.12012; HERMAN EM, 1980, PLANT PHYSIOL, V66, P1001, DOI 10.1104/pp.66.5.1001; Nguyen HT, 2015, PLANT BIOTECHNOL J, V13, P38, DOI 10.1111/pbi.12233; Ichihara K, 1996, LIPIDS, V31, P535, DOI 10.1007/BF02522648; Iskandarov U, 2013, CAMELINA EMERGING OI, V4; KATAVIC V, 1995, PLANT PHYSIOL, V108, P399, DOI 10.1104/pp.108.1.399; KENNEDY EP, 1961, FED PROC, V20, P934; Koo AJK, 2004, J BIOL CHEM, V279, P16101, DOI 10.1074/jbc.M311305200; KORNBERG A, 1953, J BIOL CHEM, V204, P345; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; KUNST L, 1992, PLANT PHYSIOL BIOCH, V30, P425; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Lee J, 2011, PLANT BIOTECHNOL J, V9, P359, DOI 10.1111/j.1467-7652.2010.00562.x; Li MY, 2015, PLANT BIOTECHNOL J, V13, P766, DOI 10.1111/pbi.12304; Li MY, 2006, PLANT PHYSIOL, V140, P761, DOI 10.1104/pp.105.070995; Li N, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002053; Li-Beisson Yonghua, 2013, Arabidopsis Book, V11, pe0161, DOI 10.1199/tab.0161; Liu J, 2015, PLANT BIOTECHNOL J, V13, P858, DOI 10.1111/pbi.12325; Lu CF, 2008, PLANT CELL REP, V27, P273, DOI 10.1007/s00299-007-0454-0; Lu CF, 2011, CURR OPIN BIOTECH, V22, P252, DOI 10.1016/j.copbio.2010.11.006; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; MARTIN TW, 1988, BIOCHIM BIOPHYS ACTA, V962, P282, DOI 10.1016/0005-2760(88)90258-5; Mietkiewska E, 2011, FEBS J, V278, P764, DOI 10.1111/j.1742-4658.2010.07995.x; Millar AA, 2000, TRENDS PLANT SCI, V5, P95, DOI 10.1016/S1360-1385(00)01566-1                                                   ; Oakes J, 2011, PLANT PHYSIOL, V155, P1146, DOI 10.1104/pp.110.167676; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Petrie JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085061; Pollard M, 2015, PHYTOCHEMISTRY, V118, P192, DOI 10.1016/j.phytochem.2015.07.021; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Ruiz-Lopez N, 2013, METAB ENG, V17, P30, DOI 10.1016/j.ymben.2013.03.001; Shi L, 2012, PLANT J, V69, P37, DOI 10.1111/j.1365-313X.2011.04768.x; Shockey J, 2016, PLANT PHYSIOL, V170, P163, DOI 10.1104/pp.15.01563; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; SLACK CR, 1983, BIOCHIM BIOPHYS ACTA, V754, P10, DOI 10.1016/0005-2760(83)90076-0; SLACK CR, 1985, BIOCHIM BIOPHYS ACTA, V833, P438, DOI 10.1016/0005-2760(85)90101-8; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; STYMNE S, 1981, LIPIDS, V16, P298, DOI 10.1007/BF02534953; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305                                                               ; Stymne S, 1987, TRIACYLGLYCEROL BIOS, V9; Tan HL, 2011, PLANT PHYSIOL, V156, P1577, DOI 10.1104/pp.111.175000; TAYLOR DC, 1995, J AM OIL CHEM SOC, V72, P305, DOI 10.1007/BF02541087                                                              ; Tjellstroem H, 2012, PLANT PHYSIOL, V158, P601, DOI 10.1104/pp.111.186122; van Erp H, 2014, PLANT PHYSIOL, V165, P30, DOI 10.1104/pp.114.236430; Vanhercke T, 2013, PLANT BIOTECHNOL J, V11, P197, DOI 10.1111/pbi.12023; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; WEISS SB, 1960, J BIOL CHEM, V235, P40; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Williams JP, 2000, BIOCHEM J, V349, P127, DOI 10.1042/0264-6021:3490127; Xu JY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-4; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x	77	1	1	10	10	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	MAY	2017	174	1					110	123		10.1104/pp.17.00026				14	Plant Sciences	Plant Sciences	EV8TP	WOS:000402057200011	28325849	gold			2018-01-05	
J	Sanchez-Pascuala, A; de Lorenzo, V; Nikel, PI				Sanchez-Pascuala, Alberto; de Lorenzo, Victor; Nikel, Pablo I.			Refactoring the Embden-Meyerhof-Parnas Pathway as a Whole of Portable GlucoBricks for Implantation of Glycolytic Modules in Gram Negative Bacteria	ACS SYNTHETIC BIOLOGY			English	Article						Escherichia coli; Pseudomonas putida; standardization; glycolysis; metabolic engineering; PHB	PSEUDOMONAS-PUTIDA KT2440; RECOMBINANT ESCHERICHIA-COLI; EUROPEAN VECTOR ARCHITECTURE; CENTRAL CARBON METABOLISM; ENTNER-DOUDOROFF PATHWAY; SYNTHETIC BIOLOGY; ETHANOL SYNTHESIS; ARCA MUTANTS; GLUCOSE; POLYHYDROXYALKANOATES	The Embden-Meyerhof-Parnas (EMP) pathway is generally considered to be the biochemical standard for glucose and catabolism. Alas, its native genomic organization the control of gene expression in Escherichia coli are both very intricate, which limits the portability of the EMP pathway to other biotechnologically important bacterial hosts that lack the route. In this work, the genes all the enzymes of the linear EMP route have encoding been individually recruited from the genome of E. coli K-12, edited in silico to remove their endogenous regulatory signals, and synthesized de novo following a standard (GlucoBrick) that enables their grouping in the form of functional modules at the user's will. After verifying their activity in several glycolytic mutants of E. colt, the versatility of these GlucoBricks was demonstrated in quantitative physiology tests and biochemical assays carried out in Pseudomonas putida KT2440 and P. aeruginosa PAO1 as the heterologous hosts. Specific configurations of GlucoBricks were also adopted to streamline the downward circulation of carbon from hexoses to pyruvate in E. coli recombinants, thereby resulting in a 3-fold increase of poly(3-hydroxybutyrate) synthesis from glucose. Refactoring whole metabolic blocks in the fashion described in this work thus eases the engineering of biochemical processes where the optimization of carbon traffic is facilitated by the operation of the EMP pathway which yields more ATP than other glycolytic routes such as the Entner Doudoroff pathway.	[Sanchez-Pascuala, Alberto; de Lorenzo, Victor; Nikel, Pablo I.] CSIC, Syst & Synthet Biol Program, CNB, Campus Cantoblanco, Madrid 28049, Spain; [Nikel, Pablo I.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark	de Lorenzo, V; Nikel, PI (reprint author), CSIC, Syst & Synthet Biol Program, CNB, Campus Cantoblanco, Madrid 28049, Spain.; Nikel, PI (reprint author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark.	vdlorenzo@cnb.csic.es; pabnik@biosustain.dtu.dk		Nikel, Pablo Ivan/0000-0002-9313-7481; de Lorenzo, Victor/0000-0002-6041-2731	CAMBIOS Project of the Spanish Ministry of Economy and Competitiveness [RTC 2014-1777-3]; EVOPROG [FP7-ICT-610730]; ARISYS [ERC-2012-ADG-322797]; EmPowerPutida of the European Union [EU-H2020-BIOTEC-2014-2015-6335536]; PROMPT Project of the Autonomous Community of Madrid [CAM-S2010/BMD-2414]; CSIC (Spain)	The authors are indebted to M. Chavarria (University of Costa Rica, Costa Rica), F. Corona-Pajares and J. L. Martinez (CNB-CSIC, Spain), and A. Sinskey (Massachusetts Institute of Technology, USA) for helpful discussions and for sharing materials. The skilful advice of F. Jovelin (GeneCust Europe) for in silico edition of DNA sequences is gratefully acknowledged. This work was supported by the CAMBIOS Project of the Spanish Ministry of Economy and Competitiveness (RTC 2014-1777-3), EVOPROG (FP7-ICT-610730), ARISYS (ERC-2012-ADG-322797), and EmPowerPutida (EU-H2020-BIOTEC-2014-2015-6335536) Contracts of the European Union, and the PROMPT Project of the Autonomous Community of Madrid (CAM-S2010/BMD-2414). A.S.P. was supported by a predoctoral fellowship from the JAE Programme (JAEpre CP) from CSIC (Spain).	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450; Antonovsky N, 2016, CELL, V166, P115, DOI 10.1016/j.cell.2016.05.064; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2012, NAT CHEM BIOL, V8, P509, DOI [10.1038/NCHEMBIO.971, 10.1038/nchembio.971]; Belda E, 2016, ENVIRON MICROBIOL, V18, P3403, DOI 10.1111/1462-2920.13230; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088368; Bernal V, 2016, APPL MICROBIOL BIOT, V100, P8985, DOI 10.1007/s00253-016-7832-x; BoschiMuller S, 1997, J BIOL CHEM, V272, P15106, DOI 10.1074/jbc.272.24.15106; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Calero P, 2016, ACS SYNTH BIOL, V5, P741, DOI 10.1021/acssynbio.6b00081; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Chang DE, 1999, J BACTERIOL, V181, P6656; Chavarria M., 2016, MSYSTEMS, V1; Chavarria M, 2013, ENVIRON MICROBIOL, V15, P1772, DOI 10.1111/1462-2920.12069; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chin JW, 2011, BIOTECHNOL PROGR, V27, P333, DOI 10.1002/btpr.559; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Chubukov V., 2016, SYST BIOL APPL, V2, P16009; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; CLARKE PH, 1982, A VAN LEEUW J MICROB, V48, P105, DOI 10.1007/BF00405197                                                              ; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Dvorak P, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0393-3; Emmerling M, 1999, METAB ENG, V1, P117, DOI 10.1006/mben.1998.0109; FRAENKEL DG, 1986, ANNU REV BIOCHEM, V55, P317, DOI 10.1146/annurev.biochem.55.1.317; Godoy MS, 2016, APPL ENVIRON MICROB, V82, P244, DOI 10.1128/AEM.02984-15; Gomez J. G. C., 2012, ADV APPL BIOTECHNOLO, P41; Green M.R., 2012, MOL CLONING LAB MANU; Hollinshead WD, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0630-y; Jahreis K, 2008, FEMS MICROBIOL REV, V32, P891, DOI 10.1111/j.1574-6976.2008.00125.x; Jullesson D, 2015, BIOTECHNOL ADV, V33, P1395, DOI 10.1016/j.biotechadv.2015.02.011; Kim J, 2013, ENV MICROBIOL REP, V5, P883, DOI 10.1111/1758-2229.12090; Kim SH, 2016, ACS SYNTH BIOL, V5, P1177, DOI 10.1021/acssynbio.5b00257; Klingner A, 2015, APPL ENVIRON MICROB, V81, P2408, DOI 10.1128/AEM.03157-14; Kuepper J, 2016, J MICROBIOL METH, V130, P92, DOI 10.1016/j.mimet.2016.09.001; Lee SY, 2015, NAT BIOTECHNOL, V33, P1061, DOI 10.1038/nbt.3365; Leong YK, 2014, J BIOTECHNOL, V180, P52, DOI 10.1016/j.jbiotec.2014.03.020; Li R, 2007, BIORESOURCE TECHNOL, V98, P2313, DOI 10.1016/j.biortech.2006.09.014; Lopez N. I., 2015, ADV APPL MICROBIOL, V93, P93; Martinez-Garcia E, 2017, METHODS MOL BIOL, V1498, P273, DOI 10.1007/978-1-4939-6472-7_18; Martinez-Garcia Esteban, 2014, Microb Cell Fact, V13, P159, DOI 10.1186/s12934-014-0159-3; Martinez-Garcia E, 2015, NUCLEIC ACIDS RES, V43, pD1183, DOI 10.1093/nar/gku1114; Martinez-Garcia Esteban, 2014, Front Bioeng Biotechnol, V2, P46, DOI 10.3389/fbioe.2014.00046; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Meyer D, 1997, J BACTERIOL, V179, P1298, DOI 10.1128/jb.179.4.1298-1306.1997                                                 ; Muller JEN, 2015, METAB ENG, V28, P190, DOI 10.1016/j.ymben.2014.12.008; Nike PI, 2016, CURR OPIN CHEM BIOL, V34, P20, DOI 10.1016/j.cbpa.2016.05.011; Nikel PI, 2010, J APPL MICROBIOL, V109, P492, DOI 10.1111/j.1365-2672.2010.04668.x; Nikel PI, 2015, J BIOL CHEM, V290, P25920, DOI 10.1074/jbc.M115.687749; Nikel PI, 2015, MBIO, V6, DOI 10.1128/mBio.00340-15; Nikel PI, 2014, NEW BIOTECHNOL, V31, P562, DOI 10.1016/j.nbt.2014.02.006; Nikel PI, 2014, NAT REV MICROBIOL, V12, P368, DOI 10.1038/nrmicro3253; Nikel PI, 2014, ENVIRON MICROBIOL, V16, P239, DOI 10.1111/1462-2920.12224; Nikel PI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0377; Nikel PI, 2013, METAB ENG, V15, P98, DOI 10.1016/j.ymben.2012.09.006; Nikel PI, 2013, J BIOTECHNOL, V163, P143, DOI 10.1016/j.jbiotec.2012.05.002; Nikel PI, 2010, APPL ENVIRON MICROB, V76, P7400, DOI 10.1128/AEM.02067-10; Nikel PI, 2009, J BACTERIOL, V191, P5538, DOI 10.1128/JB.00174-09; Nikel PI, 2006, APPL ENVIRON MICROB, V72, P2614, DOI 10.1128/AEM.72.4.2614-2620.2006; Nikel PI, 2016, HYDROCARBON LIPID MI, P39; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Park J, 2008, CELL MOL LIFE SCI, V65, P2875, DOI 10.1007/s00018-008-8123-1; Peekhaus N, 1998, J BACTERIOL, V180, P3495; Pfluger-Grau K, 2011, BBA-GEN SUBJECTS, V1810, P995, DOI 10.1016/j.bbagen.2011.01.002; Raab RM, 2005, ADV BIOCHEM ENG BIOT, V100, P1, DOI 10.1007/b136411; Ruiz JA, 2006, FEMS MICROBIOL LETT, V258, P55, DOI 10.1111/j.1574-6968.2006.00196.x; Ruiz JA, 2012, COMPUT STRUCT BIOTEC, V3; Selvamani RSV, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-58; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Smanski MJ, 2016, NAT REV MICROBIOL, V14, P135, DOI 10.1038/nrmicro.2015.24; Solomon KV, 2013, ACS SYNTH BIOL, V2, P126, DOI 10.1021/sb300055e; Stephanopoulos G, 2012, ACS SYNTH BIOL, V1, P514, DOI 10.1021/sb300094q; Sudarsan S, 2014, APPL ENVIRON MICROB, V80, P5292, DOI 10.1128/AEM.01643-14; Suriyamongkol P, 2007, BIOTECHNOL ADV, V25, P148, DOI 10.1016/j.biotechadv.2006.11.007; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; THOMSON J, 1979, J BACTERIOL, V137, P502; Trinh CT, 2015, METAB ENG, V32, P220, DOI 10.1016/j.ymben.2015.10.005; van der Werf MJ, 2008, MOL BIOSYST, V4, P315, DOI 10.1039/b717340g; Verhees CH, 2003, BIOCHEM J, V375, P231, DOI 10.1042/BJ20021472; Wu G, 2016, TRENDS BIOTECHNOL, V34, P652, DOI 10.1016/j.tibtech.2016.02.010; Yang Y, 1998, J BACTERIOL, V180, P4294	83	1	1	8	10	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAY	2017	6	5					793	805		10.1021/acssynbio.6b00230				13	Biochemical Research Methods	Biochemistry & Molecular Biology	EV8JN	WOS:000402026600006	28121421	gold			2018-01-05	
J	Liang, Y; Richardson, S; Yan, JW; Benites, VT; Cheng-Yue, C; Tran, T; Mortimer, J; Mukhopadhyay, A; Keasling, JD; Scheller, HV; Logue, D				Liang, Yan; Richardson, Sarah; Yan, Jingwei; Benites, Veronica T.; Cheng-Yue, Clarabelle; Thu Tran; Mortimer, Jenny; Mukhopadhyay, Aindrila; Keasling, Jay D.; Scheller, Henrik V.; Logue, Dominique			Endoribonuclease-Based Two-Component Repressor Systems for Tight Gene Expression Control in Plants	ACS SYNTHETIC BIOLOGY			English	Article						gene regulation; two-component repressor system; synthetic biology; endoribonuclease; Csy4; CRISPR/Cas9	FINGER TRANSCRIPTION FACTORS; CAP-BINDING PROTEIN; MESSENGER-RNA; TRANSGENE EXPRESSION; SYNTHETIC BIOLOGY; TRANSIENT EXPRESSION; ARABIDOPSIS-THALIANA; CRISPR ENDORIBONUCLEASE; REGULATORY ELEMENTS; TOBACCO PLANTS	Tight control and multifactorial regulation of gene expression are important challenges in genetic engineering and are critical for the development of regulatory circuits. Meeting these challenges will facilitate transgene expression regulation and support the fine-tuning of metabolic pathways to avoid the accumulation of undesired intermediates. By employing the endoribonuclease Csy4 and its recognition sequence from Pseudomonas aeruginosa and manipulating 5'UTR of mRNA, we developed a two-component expression repression system to tightly control synthesis of transgene products. We demonstrated that this regulatory device was functional in monocotyledonous and dicotyledonous plant species, and showed that it can be used to repress transgene expression by >400-fold and to synchronize transgene repression. In addition to tissue-specific transgene repression, this system offers stimuli-dependent expression control. Using a bioinformatics approach, we identified 54 orthologous systems from various bacteria, and then validated in planta the activity for a few of those systems, demonstrating the potential diversity of such a two-component repressor system.	[Liang, Yan; Richardson, Sarah; Yan, Jingwei; Benites, Veronica T.; Cheng-Yue, Clarabelle; Thu Tran; Mortimer, Jenny; Mukhopadhyay, Aindrila; Keasling, Jay D.; Scheller, Henrik V.; Logue, Dominique] Joint BioEnergy Inst, EmeryStn East, 5885 Hollis St,4th Floor, Emeryville, CA 94608 USA; [Liang, Yan; Richardson, Sarah; Yan, Jingwei; Benites, Veronica T.; Cheng-Yue, Clarabelle; Thu Tran; Mortimer, Jenny; Mukhopadhyay, Aindrila; Keasling, Jay D.; Scheller, Henrik V.; Logue, Dominique] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Dept Bioengn, Berkeley, CA 94720 USA; [Scheller, Henrik V.; Logue, Dominique] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Logue, Dominique] Univ Claude Bernard Lyon 1, Microbiol Adaptat & Pathogenie, INSA Lyon, CNRS,UMR5240, 10 Rue Raphael Dubois, F-69622 Villeurbanne, France	Logue, D (reprint author), Joint BioEnergy Inst, EmeryStn East, 5885 Hollis St,4th Floor, Emeryville, CA 94608 USA.; Logue, D (reprint author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA.; Logue, D (reprint author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.; Logue, D (reprint author), Univ Claude Bernard Lyon 1, Microbiol Adaptat & Pathogenie, INSA Lyon, CNRS,UMR5240, 10 Rue Raphael Dubois, F-69622 Villeurbanne, France.	dloque@lbl.gov		Richardson, Sarah/0000-0002-9820-9421; Mortimer, Jenny/0000-0001-6624-636X	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie Grant [659910]	We thank Dr. Guotian Li and Dr. Wei Tong for providing the rice seeds and Sabin Russell for editing this manuscript. This work was part of the DOE Early Career Award and the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research through Contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No. 659910.	ABRAMSON RD, 1988, J BIOL CHEM, V263, P5462; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; BellLelong DA, 1997, PLANT PHYSIOL, V113, P729, DOI 10.1104/pp.113.3.729; Bocobza SE, 2014, PLANT J, V79, P693, DOI 10.1111/tpj.12540; Borchardt EK, 2015, RNA, V21, P1921, DOI 10.1261/rna.051227.115; Brosnan CA, 2011, CURR OPIN PLANT BIOL, V14, P580, DOI 10.1016/j.pbi.2011.07.011; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Bruckner K, 2015, PLANT J, V82, P707, DOI 10.1111/tpj.12843; Cazzonelli CI, 2006, PLANTA, V224, P582, DOI 10.1007/s00425-006-0250-z; Cerny RE, 2003, PLANT MOL BIOL, V52, P357, DOI 10.1023/A:1023953130574; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coego A, 2014, PLANT J, V77, P944, DOI 10.1111/tpj.12443; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Du P, 2016, ACS SYNTH BIOL, V5, P74, DOI 10.1021/acssynbio.5b00130; Dugdale B, 2014, NAT PROTOC, V9, P1010, DOI 10.1038/nprot.2014.068; Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041; EBERT PR, 1987, P NATL ACAD SCI USA, V84, P5745, DOI 10.1073/pnas.84.16.5745; Eudes A, 2015, PLANT BIOTECHNOL J, V13, P1241, DOI 10.1111/pbi.12310; FROHBERG C, 1991, P NATL ACAD SCI USA, V88, P10470, DOI 10.1073/pnas.88.23.10470; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108                                                           ; GATZ C, 1992, PLANT J, V2, P397, DOI 10.1046/j.1365-313X.1992.t01-37-00999.x; Gonzalez TL, 2015, NUCLEIC ACIDS RES, V43, P7152, DOI 10.1093/nar/gkv655; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Guan X, 2002, P NATL ACAD SCI USA, V99, P13296, DOI 10.1073/pnas.192412899; Ham TS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks531; Haurwitz RE, 2012, EMBO J, V31, P2824, DOI 10.1038/emboj.2012.107; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hickey SF, 2012, NUCLEIC ACIDS RES, V40, P4701, DOI 10.1093/nar/gks032; Hieno A, 2014, NUCLEIC ACIDS RES, V42, pD1188, DOI 10.1093/nar/gkt1027; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Hugouvieux V, 2002, PLANT PHYSIOL, V130, P1276, DOI 10.1104/pp.009480; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kanoria S, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-85; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liu WS, 2015, TRENDS PLANT SCI, V20, P309, DOI 10.1016/j.tplants.2015.02.004; Liu WS, 2014, PLANT BIOTECHNOL J, V12, P1015, DOI 10.1111/pbi.12206; Lloyd JP, 2015, PLANT CELL, V27, P2133, DOI 10.1105/tpc.15.00051; Love J, 2000, PLANT J, V21, P579, DOI 10.1046/j.1365-313x.2000.00706.x; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Mahfouz MM, 2012, PLANT MOL BIOL, V78, P311, DOI 10.1007/s11103-011-9866-x; McGinnis KM, 2010, BRIEF FUNCT GENOMICS, V9, P111, DOI 10.1093/bfgp/elp052; Meshcheriakova YA, 2014, PLANT BIOTECHNOL J, V12, P718, DOI 10.1111/pbi.12175; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; Moore I, 1998, P NATL ACAD SCI USA, V95, P376, DOI 10.1073/pnas.95.1.376; MURTHY KGK, 1991, NUCLEIC ACIDS RES, V19, P2685, DOI 10.1093/nar/19.10.2685; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Padidam M, 2003, CURR OPIN PLANT BIOL, V6, P169, DOI 10.1016/S1369-5266(03)00005-0; Patron N, 2015, NEW PHYTOL, V208, P13, DOI 10.1111/nph.13532; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Qj L., 2012, NAT BIOTECHNOL, V30, P1002; Rose AB, 2004, PLANT J, V40, P744, DOI 10.1111/j.1365-313X.2004.02247.x; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Seyhan AA, 2016, MOL BIOSYST, V12, P295, DOI 10.1039/c5mb00506j; Shih PM, 2016, PLANT J, V87, P103, DOI 10.1111/tpj.13176; Singer SD, 2010, PLANT MOL BIOL, V74, P293, DOI 10.1007/s11103-010-9673-9; Smanski MJ, 2016, NAT REV MICROBIOL, V14, P135, DOI 10.1038/nrmicro.2015.24; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stege JT, 2002, PLANT J, V32, P1077, DOI 10.1046/j.1365-313X.2002.01492.x; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WEINMANN P, 1994, PLANT J, V5, P559; WILDE RJ, 1992, EMBO J, V11, P1251; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Zhou M, 2013, PLANT MOL BIOL, V83, P59, DOI 10.1007/s11103-013-0089-1	72	0	0	3	9	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAY	2017	6	5					806	816		10.1021/acssynbio.6b00295				11	Biochemical Research Methods	Biochemistry & Molecular Biology	EV8JN	WOS:000402026600007	28094975	gold			2018-01-05	
J	Mougiakos, I; Bosma, EF; Weenink, K; Vossen, E; Goijvaerts, K; van der Oost, J; van Kranenburg, R				Mougiakos, Ioannis; Bosma, Elleke F.; Weenink, Koen; Vossen, Eric; Goijvaerts, Kirsten; van der Oost, John; van Kranenburg, Richard			Efficient Genome Editing of a Facultative Thermophile Using Mesophilic spCas9	ACS SYNTHETIC BIOLOGY			English	Article						CRISPR/Cas9; bacteria; Bacillus smithii; thermophiles; genome editing; homologous recombination	L-LACTIC ACID; OPEN FERMENTATIVE PRODUCTION; CRISPR-CAS SYSTEMS; BACILLUS-SMITHII; CLOSTRIDIUM-BEIJERINCKII; ESCHERICHIA-COLI; GENE DELETION; ETHANOL-PRODUCTION; BACTERIA; TOOLKIT	Well-developed genetic tools for thermophilic microorganisms are scarce, despite their industrial and scientific relevance. Whereas highly efficient CRISPR/Cas9-based genome editing is on the rise in prokaryotes, it has never been employed in a thermophile. Here, we apply Streptococcus pyogenes Cas9 (spCas9)-based genome editing to a moderate thermophile, i.e., Bacillus smithii, including a gene deletion, gene knockout via insertion of premature stop codons, and gene insertion. We show that spCas9 is inactive in vivo above 42 degrees C, and we employ the wide temperature growth range of B. smithii as an induction system for spCas9 expression. Homologous recombination with plasmid-borne editing templates is performed at 45.55 degrees C, when spCas9 is inactive. Subsequent transfer to 37 degrees C allows for counterselection through production of active spCas9, which introduces lethal double-stranded DNA breaks to the nonedited cells. The developed method takes 4 days with 90, 100, and 20% efficiencies for gene deletion, knockout, and insertion, respectively. The major advantage of our system is the limited requirement for genetic parts: only one plasmid, one selectable marker, and a promoter are needed, and the promoter does not need to be inducible or well-characterized. Hence, it can be easily applied for genome editing purposes in both mesophilic and thermophilic nonmodel organisms with a limited genetic toolbox and ability to grow at, or tolerate, temperatures of 37 and at or above 42 degrees C.	[Mougiakos, Ioannis; Bosma, Elleke F.; Weenink, Koen; Vossen, Eric; Goijvaerts, Kirsten; van der Oost, John; van Kranenburg, Richard] Wageningen Univ, Lab Microbiol, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [van Kranenburg, Richard] Corbion, Arkelsedijk 46, NL-4206 AC Gorinchem, Netherlands; [Bosma, Elleke F.] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Kemitorvet B220, DK-2800 Lyngby, Denmark	van Kranenburg, R (reprint author), Wageningen Univ, Lab Microbiol, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.; van Kranenburg, R (reprint author), Corbion, Arkelsedijk 46, NL-4206 AC Gorinchem, Netherlands.	richard.vanluanenburg@wur.nl		van Kranenburg, Richard/0000-0001-5856-1546	Dutch Technology Foundation STW; Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs	The authors thank Dr. Ben Reeves for the kind donation of the pG2K vector and Prof. Dr. Oscar Kuipers for kindly providing E. coli TG90. This work was supported by the Dutch Technology Foundation STW, which is part of The Netherlands Organization for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs.	Abdel-Banat BMA, 2010, APPL MICROBIOL BIOT, V85, P861, DOI 10.1007/s00253-009-2248-5; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, CURR OPIN BIOTECH, V37, P61, DOI 10.1016/j.copbio.2015.10.003; Beckner M, 2011, LETT APPL MICROBIOL, V53, P387, DOI 10.1111/j.1472-765X.2011.03124.x; Bhalla A, 2013, BIORESOURCE TECHNOL, V128, P751, DOI 10.1016/j.biortech.2012.10.145; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/jb.175.11.3628-3635.1993                                                ; Bosma EF, 2013, CURR BIOTECHNOL, V2, P360, DOI DOI 10.2174/18722083113076660028; Bosma EF, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0172-8; Bosma EF, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0286-5; Bosma EF, 2015, APPL ENVIRON MICROB, V81, P1874, DOI 10.1128/AEM.03640-14; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Chung D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043844; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Currie DH, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-32; Huang H, 2016, ACS SYNTH BIOL, V5, P1355, DOI 10.1021/acssynbio.6b00044; Huang H, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv007; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kambam PKR, 2010, BIOFUELS-UK, V1, P729, DOI 10.4155/BFS.10.46; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kita A, 2013, BIOSCI BIOTECH BIOCH, V77, P301, DOI 10.1271/bbb.120720; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kovacs AT, 2010, APPL ENVIRON MICROB, V76, P4085, DOI 10.1128/AEM.03060-09; Li Q, 2016, BIOTECHNOL J, V11, P961, DOI 10.1002/biot.201600053; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Li YJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1044; Lin L, 2013, BIOTECHNOL ADV, V31, P827, DOI 10.1016/j.biotechadv.2013.03.003; Ma KD, 2014, BIORESOURCE TECHNOL, V151, P28, DOI 10.1016/j.biortech.2013.10.022; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MorelDeville F, 1996, MOL MICROBIOL, V19, P587, DOI 10.1046/j.1365-2958.1996.398936.x; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; NAKAMURA LK, 1988, INT J SYST BACTERIOL, V38, P63, DOI 10.1099/00207713-38-1-63                                                        ; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Olson DG, 2015, CURR OPIN BIOTECH, V33, P130, DOI 10.1016/j.copbio.2015.02.006; Ou MS, 2009, APPL BIOCHEM BIOTECH, V155, P379, DOI 10.1007/s12010-008-8509-4; Ouyang J, 2013, BIORESOURCE TECHNOL, V135, P475, DOI 10.1016/j.biortech.2012.09.096; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Qin JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004359; Reeve B, 2016, ACS SYNTH BIOL, V5, P1342, DOI 10.1021/acssynbio.5b00298; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Taylor MP, 2011, MICROB BIOTECHNOL, V4, P438, DOI 10.1111/j.1751-7915.2010.00246.x; Taylor MP, 2009, TRENDS BIOTECHNOL, V27, P398, DOI 10.1016/j.tibtech.2009.03.006; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6962, DOI 10.1128/jb.173.21.6962-6970.1991                                                ; Wang QZ, 2012, BIOTECHNOL BIOENG, V109, P1610, DOI 10.1002/bit.24427; Wang QZ, 2011, P NATL ACAD SCI USA, V108, P18920, DOI 10.1073/pnas.1111085108; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Xu J, 2015, J GENET GENOMICS, V42, P141, DOI 10.1016/j.jgg.2015.02.007; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Ye LD, 2013, BIORESOURCE TECHNOL, V132, P38, DOI 10.1016/j.biortech.2013.01.011; Zeldes BM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01209	59	2	2	9	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAY	2017	6	5					849	861		10.1021/acssynbio.6b00339				13	Biochemical Research Methods	Biochemistry & Molecular Biology	EV8JN	WOS:000402026600011	28146359	gold			2018-01-05	
J	Rideau, F; Le Roy, C; Descamps, ECT; Renaudin, H; Lartigue, C; Bebear, C				Rideau, Fabien; Le Roy, Chloe; Descamps, Elodie C. T.; Renaudin, Helene; Lartigue, Carole; Bebear, Cecile			Cloning, Stability, and Modification of Mycoplasma hominis Genome in Yeast	ACS SYNTHETIC BIOLOGY			English	Article						Mycoplasma hominis; transformation-associated recombination (TAR) cloning; yeast centromeric plasmid; genome stability; CRISPR/Cas9; Vaa	TRANSFORMATION-ASSOCIATED RECOMBINATION; SACCHAROMYCES-CEREVISIAE; SELECTIVE ISOLATION; ARTIFICIAL CHROMOSOMES; GENITALIUM GENOME; RIBOSOMAL-RNA; TAR CLONING; TRANSPLANTATION; CRISPR/CAS9; BACTERIA	Mycoplasma hominis is a minimal human pathogen that is responsible for genital and neonatal infections. Despite many attempts, there is no efficient genetic tool to manipulate this bacterium, limiting most investigations of its pathogenicity and its uncommon energy metabolism that relies on arginine. The recent cloning and subsequent engineering of other mycoplasma genomes in yeast opens new possibilities for studies of the genomes of genetically intractable organisms. Here, we report the successful one-step cloning of the M. hominis PG21 genome in yeast using the transformation-associated recombination (TAR) cloning method. At low passages, the M. hominis genome cloned into yeast displayed a conserved size. However, after similar to 60 generations in selective media, this stability was affected, and large degradation events were detected, raising questions regarding the stability of large heterologous DNA molecules cloned in yeast and the need to minimize host propagation. Taking these results into account, we selected early passage yeast clones and successfully modified the M. hominis PG21 genome using the CRISPR/Cas9 editing tool, available in Saccharomyces cerevisiae. Complete M. hominis PG21 genomes lacking the adhesion -related vaa gene were efficiently obtained.	[Rideau, Fabien; Le Roy, Chloe; Descamps, Elodie C. T.; Renaudin, Helene; Bebear, Cecile] Univ Bordeaux, USC EA3671, Mycoplasmal & Chlamydial Infect Humans, F-33000 Bordeaux, France; [Rideau, Fabien; Le Roy, Chloe; Descamps, Elodie C. T.; Renaudin, Helene; Bebear, Cecile] INRA, USC EA3671, Mycoplasmal & Chlamydial Infect Humans, F-33000 Bordeaux, France; [Lartigue, Carole] INRA, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France; [Lartigue, Carole] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France	Bebear, C (reprint author), Univ Bordeaux, USC EA3671, Mycoplasmal & Chlamydial Infect Humans, F-33000 Bordeaux, France.; Bebear, C (reprint author), INRA, USC EA3671, Mycoplasmal & Chlamydial Infect Humans, F-33000 Bordeaux, France.; Lartigue, C (reprint author), INRA, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France.; Lartigue, C (reprint author), Univ Bordeaux, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France.	carole.lartigue-prat@inra.fr; cecile.bebear@u-bordeaux.fr		Bebear, Cecile/0000-0001-6065-2332			Aleksandrova N. M., 2000, Genetika, V36, P309; Benders GA, 2010, NUCLEIC ACIDS RES, V38, P2558, DOI 10.1093/nar/gkq119; Chandran S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1180; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; HENRICH B, 1993, INFECT IMMUN, V61, P2945; Hopfe M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-185; Itaya M, 2008, NAT METHODS, V5, P41, DOI 10.1038/NMETH1143; Kannan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30714; Karas BJ, 2015, CHROMOSOME RES, V23, P57, DOI 10.1007/s10577-014-9455-3; Karas BJ, 2013, NAT METHODS, V10, P410, DOI [10.1038/NMETH.2433, 10.1038/nmeth.2433]; Karas BJ, 2012, ACS SYNTH BIOL, V1, P22, DOI 10.1021/sb200013j; KETNER G, 1994, P NATL ACAD SCI USA, V91, P6186, DOI 10.1073/pnas.91.13.6186; Kitzerow A, 1999, J MED MICROBIOL, V48, P485, DOI 10.1099/00222615-48-5-485                                                       ; Kouprina N, 1997, GENE, V197, P269, DOI 10.1016/S0378-1119(97)00271-0                                                   ; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Kouprina Natalay, 2004, Methods Mol Biol, V255, P69; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Labroussaa F, 2016, NUCLEIC ACIDS RES, V44, P8501, DOI 10.1093/nar/gkw688; Larionov V, 1996, P NATL ACAD SCI USA, V93, P13925, DOI 10.1073/pnas.93.24.13925; Larionov V, 1996, P NATL ACAD SCI USA, V93, P491, DOI 10.1073/pnas.93.1.491; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lartigue C, 2014, NUCLEIC ACIDS RES, V42, P8073, DOI 10.1093/nar/gku518; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Noskov VN, 2010, NUCLEIC ACIDS RES, V38, P2570, DOI 10.1093/nar/gkq099; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; Tagwerker C, 2012, NUCLEIC ACIDS RES, V40, P10375, DOI 10.1093/nar/gks823; Tsarmpopoulos I, 2016, ACS SYNTH BIOL, V5, P104, DOI [10.1021/acssyntio3b00196, 10.1021/acssynbio.5b00196]; Voelker LL, 1996, J BACTERIOL, V178, P6078, DOI 10.1128/jb.178.20.6078-6081.1996                                                ; Waites B. C., 2001, LAB DIAGNOSIS MYCOPL; Waites KB, 2009, SEMIN FETAL NEONAT M, V14, P190, DOI 10.1016/j.siny.2008.11.009; Wang HZ, 2003, VIRUS RES, V97, P57, DOI 10.1016/j.virusres.2003.07.001; Zhang QJ, 1997, MOL MICROBIOL, V25, P859, DOI 10.1111/j.1365-2958.1997.mmi509.x; Zhang QJ, 1996, INFECT IMMUN, V64, P2737	36	0	0	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAY	2017	6	5					891	901		10.1021/acssynbio.6b00379				11	Biochemical Research Methods	Biochemistry & Molecular Biology	EV8JN	WOS:000402026600015	28118540				2018-01-05	
J	Chari, R; Yeo, NC; Chavez, A; Church, GM				Chari, Raj; Yeo, Nan Cher; Chavez, Alejandro; Church, George M.			sgRNA Scorer 2.0: A Species-Independent Model To Predict CRISPR/Cas9 Activity	ACS SYNTHETIC BIOLOGY			English	Article						CRISPR; Cas9; sgRNA activity prediction; sgRNA scorer; genome engineering	STAPHYLOCOCCUS-AUREUS CAS9; OFF-TARGET; IN-VIVO; GENOME; CRISPR-CAS9; GENES; IDENTIFICATION; DESIGN; TOOL	It has been possible to create tools to predict single guide RNA (sgRNA) activity in the CRISPR/Cas9 system derived from Streptococcus pyogenes due to the large amount of data that has been generated in sgRNA library screens. However, with the discovery of additional CRISPR systems from different bacteria, which show potent activity in eukaryotic cells, the approach of generating large data sets for each of these systems to predict their activity is not tractable. Here, we present a new guide RNA tool that can predict sgRNA activity across multiple CRISPR systems. In addition to predicting activity for Cas9 from S. pyogenes and Streptococcus thermophilus CRISPR1, we experimentally demonstrate that our algorithm can predict activity for Cas9 from Staphylococcus aureus and S. thermophilus CRISPR3. We also have made available a new version of our software, sgRNA Scorer 2.0, which will allow users to identify sgRNA sites for any PAM sequence of interest.	[Chari, Raj; Yeo, Nan Cher; Chavez, Alejandro; Church, George M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Yeo, Nan Cher; Chavez, Alejandro; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Chari, R; Church, GM (reprint author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Church, GM (reprint author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	rchari@genetics.med.harvard.edu; gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969	NIH [RM1 HG008525, P50 HG005550]	This work was supported by NIH grants RM1 HG008525 and P50 HG005550.	Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Horlbeck M. A, 2016, ELIFE; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	18	2	2	7	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAY	2017	6	5					902	904		10.1021/acssynbio.6b00343				3	Biochemical Research Methods	Biochemistry & Molecular Biology	EV8JN	WOS:000402026600016	28146356				2018-01-05	
J	Drury, DW; Dapper, AL; Siniard, DJ; Zentner, GE; Wade, MJ				Drury, Douglas W.; Dapper, Amy L.; Siniard, Dylan J.; Zentner, Gabriel E.; Wade, Michael J.			CRISPR/Cas9 gene drives in genetically variable and nonrandomly mating wild populations	SCIENCE ADVANCES			English	Article							MUTAGENIC CHAIN-REACTION; RNA-GUIDED ENDONUCLEASE; GENOME-WIDE ANALYSIS; OFF-TARGET SITES; TRIBOLIUM-CASTANEUM; CAS9; VECTOR; MUTATIONS; BINDING; SYSTEM	Synthetic gene drives based on CRISPR/Cas9 have the potential to control, alter, or suppress populations of crop pests and disease vectors, but it is unclear how they will function in wild populations. Using genetic data from four populations of the flour beetle Tribolium castaneum, we show that most populations harbor genetic variants in Cas9 target sites, some of which would render them immune to drive (ITD). We show that even a rare ITD allele can reduce or eliminate the efficacy of a CRISPR/Cas9-based synthetic gene drive. This effect is equivalent to and accentuated by mild inbreeding, which is a characteristic of many disease-vectoring arthropods. We conclude that designing such drives will require characterization of genetic variability and the mating system within and among targeted populations.	[Drury, Douglas W.; Dapper, Amy L.; Siniard, Dylan J.; Zentner, Gabriel E.; Wade, Michael J.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Dapper, Amy L.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	Wade, MJ (reprint author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	mjwade@indiana.edu		Zentner, Gabriel/0000-0002-0801-7646	Indiana University startup funds [NIH R01 GM084238]; NSF Doctora lDissertation Improvement Grant [1311167]	This work was supported by Indiana University startup funds (G.E.Z.) and NIH R01 GM084238 (M.J.W.). The sequencing was supported by an NSF Doctora lDissertation Improvement Grant (1311167 to M.J.W and A.L.D).	Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; BULL JJ, 2017, EVOL MED PUBLIC HLTH, V2017, P1, DOI DOI 10.1093/EMPH/E0W030; BUSHLAND RC, 1955, SCIENCE, V122, P287, DOI 10.1126/science.122.3163.287; Chan SW, 2005, GENE, V353, P189, DOI 10.1016/j.gene.2005.04.025; Charlesworth B., 2010, ELEMENTS EVOLUTIONAR; Dobrovolskaia-Zavadskaia N, 1927, CR SOC BIOL, V97, P114; Donnelly MJ, 1999, HEREDITY, V83, P408, DOI 10.1038/sj.hdy.6885930; Doyle JJ, 1987, PHYTOCHEMISTRY B, V19, P11; Drury DW, 2011, J EVOLUTION BIOL, V24, P2678, DOI 10.1111/j.1420-9101.2011.02394.x; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; HIRAIZUMI Y, 1960, GENETICS, V45, P1071; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Krstic D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077904; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; LEWONTIN R. C., 1967, ANNU REV GENET, V1, P37, DOI 10.1146/annurev.ge.01.120167.000345; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00288; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4                                                   ; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Robert MA, 2014, EVOL APPL, V7, P1238, DOI 10.1111/eva.12219; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; TURNER BC, 1979, GENETICS, V93, P587; Unckless RL, 2015, GENETICS, V201, P425, DOI 10.1534/genetics.115.177592; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Vanderplank FL, 1944, NATURE, V154, P607, DOI 10.1038/154607a0                                                                ; Vazeille M, 2001, AM J TROP MED HYG, V65, P491, DOI 10.4269/ajtmh.2001.65.491                                                       ; WADE MJ, 1994, GENETICS, V138, P1309; Wu Xuebing, 2014, Quant Biol, V2, P59; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	41	5	5	10	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	MAY	2017	3	5							e1601910	10.1126/sciadv.1601910				7	Multidisciplinary Sciences	Science & Technology - Other Topics	EV7KW	WOS:000401955300006	28560324	gold			2018-01-05	
J	Lee, B; Sahoo, A; Marchica, J; Holzhauser, E; Chen, XL; Li, JL; Seki, T; Govindarajan, SS; Markey, FB; Batish, M; Lokhande, SJ; Zhang, SJ; Ray, A; Perera, RJ				Lee, Bongyong; Sahoo, Anupama; Marchica, John; Holzhauser, Erwin; Chen, Xiaoli; Li, Jian-Liang; Seki, Tatsuya; Govindarajan, Subramaniam Shyamala; Markey, Fatu Badiane; Batish, Mona; Lokhande, Sonali J.; Zhang, Shaojie; Ray, Animesh; Perera, Ranjan J.			The long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA molecules	SCIENCE ADVANCES			English	Article							BREAST-CANCER CELLS; PROSTATE-CANCER; CHROMATIN ISOLATION; POOR-PROGNOSIS; SPRY4-IT1; EXPRESSION; SMYD3; TRANSCRIPTION; MELANOMA; PROLIFERATION	Molecular mechanisms by which long noncoding RNA (lncRNA) molecules may influence cancerous condition are poorly understood. The aberrant expression of SPRIGHTLY lncRNA, encoded within the drosophila gene homolog Sprouty-4 intron, is correlated with a variety of cancers, including human melanomas. We demonstrate by SHAPE-seq and dChIRP that SPRIGHTLY RNA secondary structure has a core pseudoknotted domain. This lncRNA interacts with the intronic regions of six pre-mRNAs: SOX5, SMYD3, SND1, MEOX2, DCTN6, and RASAL2, all of which have cancer-related functions. Hemizygous knockout of SPRIGHTLY by CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 in melanoma cells significantly decreases SPRIGHTLY lncRNA levels, simultaneously decreases the levels of its interacting pre-mRNA molecules, and decreases anchorage-independent growth rate of cells and the rate of in vivo tumor growth in mouse xenografts. These results provide the first demonstration of an lncRNA's threedimensional coordinating role in facilitating cancer-related gene expression in human melanomas.	[Lee, Bongyong; Sahoo, Anupama; Marchica, John; Li, Jian-Liang; Seki, Tatsuya; Govindarajan, Subramaniam Shyamala; Perera, Ranjan J.] Sanford Burnham Prebys Med Discovery Inst, 6400 Sanger Rd, Orlando, FL 32827 USA; [Holzhauser, Erwin; Chen, Xiaoli; Zhang, Shaojie] Univ Cent Florida, Dept Comp Sci, Orlando, FL 32816 USA; [Seki, Tatsuya] Med & Biol Labs, Nagoya, Aichi 4600008, Japan; [Markey, Fatu Badiane; Batish, Mona] Rutgers State Univ, Rutgers Biomed & Hlth Sci, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Lokhande, Sonali J.; Ray, Animesh] Keck Grad Inst, 535 Watson Dr, Claremont, CA 91711 USA; [Ray, Animesh] CALTECH, Dept Biol & Biol Engn, Pasadena, CA 91125 USA	Perera, RJ (reprint author), Sanford Burnham Prebys Med Discovery Inst, 6400 Sanger Rd, Orlando, FL 32827 USA.	rperera@sbpdiscovery.org		Zhang, Shaojie/0000-0002-4051-5549; Ray, Animesh/0000-0002-0120-5820	NIH [CA165184, DP5 OD012160, NCI 5P30CA030199]; Florida Department of Health, Bankhead-Coley Cancer Research Program [5BC08]; U.S. Department of Defense (CDMRP) [LC150653]	This work was supported by NIH grants CA165184 and NCI 5P30CA030199 and Florida Department of Health, Bankhead-Coley Cancer Research Program 5BC08 to R.J.P. and NIH grant DP5 OD012160 to M.B. A.R. is funded by the U.S. Department of Defense (CDMRP #LC150653).	Aviran S, 2011, P NATL ACAD SCI USA, V108, P11069, DOI 10.1073/pnas.1106541108; Batish M, 2012, P NATL ACAD SCI USA, V109, P4645, DOI 10.1073/pnas.1111226109; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Braeutigam C, 2014, ONCOGENE, V33, P1082, DOI 10.1038/onc.2013.50; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dai B, 2015, ONCOL REP, V34, P2722, DOI 10.3892/or.2015.4239; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Emdad L, 2015, NEURO-ONCOLOGY, V17, P419, DOI 10.1093/neuonc/nou220; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Engreitz J.M., 2014, SCI ADV, V159, P188; Fransson S, 2007, GENE CHROMOSOME CANC, V46, P45, DOI 10.1002/gcc.20387; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Kuruma H, 2009, AM J PATHOL, V174, P2044, DOI 10.2353/ajpath.2009.080776; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lee B, 2014, J MOL DIAGN, V16, P615, DOI 10.1016/j.jmoldx.2014.06.009; Lin A, 2010, GENOME RES, V20, P1122, DOI 10.1101/gr.104216.109; Liu C, 2013, JNCI-J NATL CANCER I, V105, P1719, DOI 10.1093/jnci/djt304; Loughrey D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku909; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Markey FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093488; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Mazar J., 2011, PLOS ONE, V5; Mazar J, 2014, ONCOTARGET, V5, P8959, DOI 10.18632/oncotarget.1863                                                        ; Peng W, 2015, TUMOR BIOL, V36, P6751, DOI 10.1007/s13277-015-3376-4; Quinn JJ, 2015, METHODS MOL BIOL, V1262, P199, DOI 10.1007/978-1-4939-2253-6_12; Quinn JJ, 2014, NAT BIOTECHNOL, V32, P933, DOI 10.1038/nbt.2943; Raizer JJ, 2008, NEURO-ONCOLOGY, V10, P199, DOI 10.1215/15228517-2007-058; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Shi YG, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0318-0; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Stolt CC, 2008, NUCLEIC ACIDS RES, V36, P5427, DOI 10.1093/nar/gkn527; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; Vance KW, 2014, TRENDS GENET, V30, P348, DOI 10.1016/j.tig.2014.06.001; Vieira FQ, 2015, ONCOTARGET, V6, P13644, DOI 10.18632/oncotarget.3767                                                        ; Wang N, 2012, MOL BIOL REP, V39, P10497, DOI 10.1007/s11033-012-1933-0; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Xie HW, 2014, TUMOR BIOL, V35, P7743, DOI 10.1007/s13277-014-2013-y; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XL, 2015, INT J CLIN EXP PATHO, V8, P1954	52	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	MAY	2017	3	5							e1602505	10.1126/sciadv.1602505				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EV7KW	WOS:000401955300023	28508063	gold			2018-01-05	
J	Miyamoto, T; Lo, PHY; Saichi, N; Ueda, K; Hirata, M; Tanikawa, C; Matsuda, K				Miyamoto, Takafumi; Lo, Paulisally Hau Yi; Saichi, Naomi; Ueda, Koji; Hirata, Makoto; Tanikawa, Chizu; Matsuda, Koichi			Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53	SCIENCE ADVANCES			English	Article							BREAST-CANCER CELLS; ARGININE SUPPLEMENTATION; P53-DEPENDENT APOPTOSIS; TUMOR SUPPRESSION; AMINO-ACIDS; IN-VIVO; SYNTHETASE; GENE; THERAPY; ASS1	The transcription factor p53 is at the core of a built-in tumor suppression system that responds to varying degrees of stress input and is deregulated in most human cancers. Befitting its role in maintaining cellular fitness and fidelity, p53 regulates an appropriate set of target genes in response to cellular stresses. However, a comprehensive understanding of this scheme has not been accomplished. We show that argininosuccinate synthase 1 (ASS1), a citrulline-aspartate ligase in de novo arginine synthesis pathway, was directly transactivated by p53 in response to genotoxic stress, resulting in the rearrangement of arginine metabolism. Furthermore, we found that x-ray irradiation promoted the systemic induction of Ass1 and concomitantly increased plasma arginine levels in p53(+/+) mice but not in p53(-/-) mice. Notably, Ass1(+/-) mice exhibited hypersensitivity to whole-body irradiation owing to increased apoptosis in the small intestinal crypts. Analyses of ASS1-deficient cells generated using the CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9 (CRISPR-associated 9) system revealed that ASS1 plays a pivotal role in limiting Akt phosphorylation. In addition, aberrant activation of Akt resulting from ASS1 loss disrupted Akt-mediated cell survival signaling activity under genotoxic stress. Building on these results, we demonstrated that p53 induced an intrinsic Akt repressor, ASS1, and the perturbation of ASS1 expression rendered cells susceptible to genotoxic stress. Our findings uncover a new function of p53 in the regulation of Akt signaling and reveal how p53, ASS1, and Akt are interrelated to each other.	[Miyamoto, Takafumi; Lo, Paulisally Hau Yi; Hirata, Makoto; Tanikawa, Chizu; Matsuda, Koichi] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Lab Genome Technol, Tokyo, Japan; [Saichi, Naomi; Ueda, Koji] Japanese Fdn Cancer Res, Genome Ctr, Cancer Proteom Grp, Tokyo, Japan; [Matsuda, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Clin Genome Sequencing, Tokyo, Japan	Matsuda, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Clin Genome Sequencing, Tokyo, Japan.	kmatsuda@k.u-tokyo.ac.jp			Young Scientific Research [15K18397]; Takeda Science Foundation;  [16H01566];  [25134707]	Funding: The research was supported by Grant-in-Aid for Young Scientific Research (15K18397), Takeda Science Foundation, and Grant-in-Aid for Scientific Research on Innovative Areas (16H01566 and 25134707).	Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Ascierto PA, 2005, J CLIN ONCOL, V23, P7660, DOI 10.1200/JCO.2005.02.0933; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Blantz RC, 2000, ACTA PHYSIOL SCAND, V168, P21; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Cao B, 2013, METABOLOMICS, V9, P960, DOI 10.1007/s11306-013-0517-x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Engel K, 2009, HUM MUTAT, V30, P300, DOI 10.1002/humu.20847; Ensor CM, 2002, CANCER RES, V62, P5443; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gao XX, 2008, MOL BIOL CELL, V19, P4366, DOI 10.1091/mbc.E08-05-0449; Guerreiro JR, 2009, J BIOL CHEM, V284, P20022, DOI 10.1074/jbc.M109.021089; HAMMER JA, 1981, BIOCHEM J, V198, P53, DOI 10.1042/bj1980053                                                               ; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang HY, 2013, CLIN CANCER RES, V19, P2861, DOI 10.1158/1078-0432.CCR-12-2641; Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kelly MP, 2012, BRIT J CANCER, V106, P324, DOI 10.1038/bjc.2011.524; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Luo Y, 2014, CANCER RES, V74, P330, DOI 10.1158/0008-5472.CAN-13-1052; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Marshall Stephen, 2006, Sci STKE, V2006, pre7; McAlpine JA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-621; Medeiros JL, 2014, ANDROLOGY-US, V2, P943, DOI 10.1111/andr.134; Miura H, 2014, CELL STRUCT FUNCT, V39, P9, DOI 10.1247/csf.13018                                                               ; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; Morifuji M, 2010, J AGR FOOD CHEM, V58, P8788, DOI 10.1021/jf101912n; Pinto FCM, 2016, ACTA CIR BRAS, V31, P650, DOI 10.1590/S0102-865020160100000002; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Perez CJ, 2010, AM J PATHOL, V177, P1958, DOI 10.2353/ajpath.2010.100118; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Qiu FM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004761; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shan LL, 2013, J APPL PHYSIOL, V115, P1146, DOI 10.1152/japplphysiol.00225.2013; Shukla J, 2009, RADIAT RES, V171, P180, DOI 10.1667/RR1241.1; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Synakiewicz A, 2014, EXPERT OPIN INV DRUG, V23, P1517, DOI 10.1517/13543784.2014.934808; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Tanikawa C, 2009, CANCER RES, V69, P8761, DOI 10.1158/0008-5472.CAN-09-2280; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Tsai WB, 2009, MOL CANCER THER, V8, P3223, DOI 10.1158/1535-7163.MCT-09-0794; Ueda K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06232; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Wu GY, 1998, BIOCHEM J, V336, P1; Xiao F, 2016, ONCOTARGET, V7, P63679, DOI 10.18632/oncotarget.11626; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; YU YJ, 1995, J BIOCHEM-TOKYO, V117, P952, DOI 10.1093/oxfordjournals.jbchem.a124826                                           ; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584                                                          ; Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1208, DOI 10.1038/aps.2010.151; Zheng P, 2013, BRIT J NUTR, V109, P2253, DOI 10.1017/S0007114512004321	64	1	1	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	MAY	2017	3	5							e1603204	10.1126/sciadv.1603204				14	Multidisciplinary Sciences	Science & Technology - Other Topics	EV7KW	WOS:000401955300052	28560349	gold			2018-01-05	
J	Klein, M; Chandradoss, SD; Depken, M; Joo, C				Klein, Misha; Chandradoss, Stanley D.; Depken, Martin; Joo, Chirlmin			Why Argonaute is needed to make microRNA target search fast and reliable	SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY			English	Review						Argonaute; miRNA; Target Search; Lateral diffusion; Single molecule; FRET; Free-energy landscape; Theoretical model; RNA silencing; Search stability paradox; MicroRNA target prediction	FACILITATED DIFFUSION; BINDING-PROPERTIES; MISMATCH REPAIR; DNA INTERACTION; CRISPR RNA; PROTEIN; COMPLEX; RECOGNITION; MODEL; GUIDE	MicroRNA (miRNA) interferes with the translation of cognate messenger RNA (mRNA) by finding, preferentially binding, and marking it for degradation. To facilitate the search process, Argonaute (Ago) proteins come together with miRNA, forming a dynamic search complex. In this review we use the language of free-energy landscapes to discuss recent single-molecule and high-resolution structural data in the light of theoretical work appropriated from the study of transcription-factor search. We suggest that experimentally observed internal states of the Ago-miRNA search complex may have the explicit biological function of speeding up search while maintaining specificity. (C) 2016 The Authors. Published by Elsevier Ltd.	[Depken, Martin; Joo, Chirlmin] Delft Univ Technol, Kavli Inst NanoSci, NL-2629 HZ Delft, Netherlands; Delft Univ Technol, Dept BioNanoSci, NL-2629 HZ Delft, Netherlands	Depken, M; Joo, C (reprint author), Delft Univ Technol, Kavli Inst NanoSci, NL-2629 HZ Delft, Netherlands.	s.m.depken@tudelft.nl; c.joo@tudelft.nl		Joo, Chirlmin/0000-0003-2803-0335	European Research Council [309509]; TU Delft start up; Netherlands Organization for Scientific Research (NWO/OCW)	CJ. was funded by European Research Council under the European Union's Seventh Framework Programme [FP7/2007-2013]/ERC grant agreement no [309509]. M.D. was supported by a TU Delft start up grant. This work was supported by the Netherlands Organization for Scientific Research (NWO/OCW), as part of the Frontiers in Nanoscience program. We thank Aafke van den Berg and Tao ju (Thijs) Cui for critically reading and commenting on the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer M, 2012, BIOPHYS J, V102, P2321, DOI 10.1016/j.bpj.2012.04.008; Benichou O, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.138102; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Coppey M, 2004, BIOPHYS J, V87, P1640, DOI 10.1529/biophysj.104.045773; Deerberg A, 2013, P NATL ACAD SCI USA, V110, P17850, DOI 10.1073/pnas.1217838110; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Gao F, 2016, NAT BIOTECHNOL; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jo MH, 2015, MOL CELL, V59, P117, DOI 10.1016/j.molcel.2015.04.027; Jung SR, 2013, J AM CHEM SOC, V135, P16865, DOI 10.1021/ja403138d; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Murugan R, 2010, BIOPHYS J, V99, P353, DOI 10.1016/j.bpj.2010.04.026; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Ragunathan K, 2012, ELIFE, V1, DOI 10.7554/eLife.00067; Reingruber J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.020901; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Sasaki HM, 2012, NAT STRUCT MOL BIOL, V19, P657, DOI 10.1038/nsmb.2302; Schirle NT, 2015, ELIFE, V4, DOI 10.7554/eLife.07646; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yu S, 2013, J BIOL PHYS, V39, P565, DOI 10.1007/s10867-013-9310-3; Zandarashvili L, 2015, P NATL ACAD SCI USA, V112, pE5142, DOI 10.1073/pnas.1507726112; Zander A, 2014, RNA BIOL, V11, P45, DOI 10.4161/rna.27446; Zhou HX, 2011, P NATL ACAD SCI USA, V108, P8651, DOI 10.1073/pnas.1101555108; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029                                                          	59	3	3	5	8	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1084-9521			SEMIN CELL DEV BIOL	Semin. Cell Dev. Biol.	MAY	2017	65						20	28		10.1016/j.semcdb.2016.05.017				9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	EW2TO	WOS:000402349100003	27235676	gold			2018-01-05	
J	Lee, JH; Kim, SW; Park, TS				Lee, Jeong Hyo; Kim, Si Won; Park, Tae Sub			Myostatin gene knockout mediated by Cas9-D10A nickase in chicken DF1 cells without off-target effect	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Genome Editing; Cas9; Nickase; Myostatin; Knockout; Poultry	GERM-LINE TRANSMISSION; EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; GENERATION; SYSTEM; MICE; MUTATIONS; PIGGYBAC; CAS9	Objective: Based on rapid advancement of genetic modification techniques, genomic editing is expected to become the most efficient tool for improvement of economic traits in livestock as well as poultry. In this study, we examined and verified the nickase of mutated CRISPR-associated protein 9 (Cas9) to modulate the specific target gene in chicken DF1 cells. Methods: Chicken myostatin which inhibits muscle cell growth and differentiation during myogenesis was targeted to be deleted and mutated by the Cas9-D10A nickase. After co-transfection of the nickase expression vector with green fluorescent gene (GFP) gene and targeted multiplex guide RNAs (gRNAs), the GFP-positive cells were sorted out by fluorescence-activated cell sorting procedure. Results: Through the genotyping analysis of the knockout cells, the mutant induction efficiency was 100% in the targeted site. Number of the deleted nucleotides ranged from 2 to 39 nucleotide deletion. There was no phenotypic difference between regular cells and knockout cells. However, myostatin protein was not apparently detected in the knockout cells by Western blotting. Additionally, six off-target sites were predicted and analyzed but any non-specific mutation in the off-target sites was not observed. Conclusion: The knockout technical platform with the nickase and multiplex gRNAs can be efficiently and stablely applied to functional genomics study in poultry and finally adapted to generate the knockout poultry for agribio industry.	[Lee, Jeong Hyo; Kim, Si Won; Park, Tae Sub] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang 25354, South Korea; [Lee, Jeong Hyo; Kim, Si Won; Park, Tae Sub] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea	Park, TS (reprint author), Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang 25354, South Korea.; Park, TS (reprint author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea.	taesubpark@snu.ac.kr			Rural Development Administration, Republic of Korea [PJ01111401]	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01111401)" Rural Development Administration, Republic of Korea.	Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910                                                              ; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8927, DOI 10.1073/pnas.86.22.8927                                                         ; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, ANN NY ACAD SCI, V1271, P104, DOI 10.1111/j.1749-6632.2012.06744.x; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7                                                    ; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	24	0	0	6	6	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	MAY	2017	30	5					743	748		10.5713/ajas.16.0695				6	Agriculture, Dairy & Animal Science	Agriculture	EV8BR	WOS:000402005800016	27764916	gold			2018-01-05	
J	Juengst, ET				Juengst, Eric T.			Crowdsourcing the Moral Limits of Human Gene Editing?	HASTINGS CENTER REPORT			English	Article								In 2015, a flourish of alarums and excursions by the scientific community propelled CRISPR/Cas9 and other new gene-editing techniques into public attention. At issue were two kinds of potential gene-editing experiments in humans: those making inheritable germ-line modifications and those designed to enhance human traits beyond what is necessary for health and healing. The scientific consensus seemed to be that while research to develop safe and effective human gene editing should continue, society's moral uncertainties about these two kinds of experiments needed to be better resolved before clinical trials of either type should be attempted.In the United States, the National Academies of Science, Engineering and Medicine (NASEM) convened the Committee on Human Gene Editing: Scientific, Medical and Ethical Considerations to pursue that resolution. The committee's 2017 consensus report has been widely interpreted as opening the door to inheritable human genetic modification and holding a line against enhancement interventions. But on a close reading it does neither. There are two reasons for this eccentric conclusion, both of which depend upon the strength of the committee's commitment to engaging diverse public voices in the gene-editing policy-making process.	[Juengst, Eric T.] Univ N Carolina, Ctr Bioeth, Chapel Hill, NC 27515 USA	Juengst, ET (reprint author), Univ N Carolina, Ctr Bioeth, Chapel Hill, NC 27515 USA.						Anderson F. W., 1972, EW GENETICS FUTURE M, P110; Dresser R, 2004, MILBANK Q, V82, P195, DOI 10.1111/j.0887-378X.2004.00306.x                                                ; Dresser Rebecca, 2004, IRB, V26, P1, DOI 10.2307/3563945; Evans C., 2004, DESIGNING OUR DESCEN, P93; HOTCHKISS RD, 1965, J HERED, V56, P197, DOI 10.1093/oxfordjournals.jhered.a107414                                           ; Isgrig K, 2017, MOL THER, V25, P780, DOI 10.1016/j.ymthe.2017.01.007; Juengst E., 1998, DEMOCRACY SOCIAL VAL, P163; Juengst ET, 2003, HASTINGS CENT REP, V33, P21, DOI 10.2307/3528377; Juengst E., 2009, HUMAN ENHANCEMENT, P43; Kaebnick G. E., 2017, BIOETHICS FORUM; Kaiser J., 2017, SCIENCE; Kimmelman J., 2010, GENE TRANSFER ETHICS; Kozubek J., 2017, SCI AM BLOG     0217; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Lenoir N, 1999, Columbia Human Rights Law Rev, V30, P537; Mehlman M J, 1999, Wake Forest Law Rev, V34, P671; Mehlman M. J., 2009, PRICE PERFECTION IND; National Academies of Science Engineering and Medicine Committee on Human Gene Editing: Scientific Medical and Ethical Considerations, 2017, HUM GEN ED SCI MED E, P13; Niler E., 2017, WIRED MAGAZINE; Rasko J., 2006, ETHICS INHERITABLE G; Silvers, HUM RIGHTS; Silvers A, 2003, J LAW MED ETHICS, V31, P377, DOI 10.1111/j.1748-720X.2003.tb00101.x                                              ; Terry S., 2012, HLTH AFFAIRS BLOG; White G., 1994, KENNEDY INST ETHIC J, V3, P401; Whitehouse PJ, 2005, J AM GERIATR SOC, V53, P1417, DOI 10.1111/j.1532-5415.2005.53411.x; World Anti-Doping Association, 2007, WORLD ANT ASS COD 20	26	0	0	14	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0093-0334	1552-146X		HASTINGS CENT REP	Hastings Cent. Rep.	MAY-JUN	2017	47	3					15	23		10.1002/hast.701				9	Ethics; Health Care Sciences & Services; Medical Ethics; Social Sciences, Biomedical	Social Sciences - Other Topics; Health Care Sciences & Services; Medical Ethics; Biomedical Social Sciences	EV8KD	WOS:000402028200006	28543411				2018-01-05	
J	Zagorski, JW; Maser, TP; Liby, KT; Rockwell, CE				Zagorski, Joseph W.; Maser, Tyler P.; Liby, Karen T.; Rockwell, Cheryl E.			Nrf2-Dependent and -Independent Effects of tert-Butylhydroquinone, CDDO-Im, and H2O2 in Human Jurkat T Cells as Determined by CRISPR/Cas9 Gene Editing	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							TRANSCRIPTION FACTOR NRF2; CRISPR-CAS9 SYSTEM; OXIDATIVE STRESS; ACTIVATION; MICE; INDUCTION; EXPRESSION; INFLAMMATION; STIMULATION; PREVENTION	Nuclear factor erythroid 2-related factor 2 (Nrf2) is a stress-activated transcription factor activated by stimuli such as electrophilic compounds and other reactive xenobiotics. Previously, we have shown that the commonly used food additive and Nrf2 activator tert-butylhydroquinone (tBHQ) suppresses interleukin-2 (IL-2) production, CD25 expression, and NF kappa B activity in human Jurkat T cells. The purpose of the current studies was to determine whether these effects were dependent upon Nrf2 by developing a human Nrf2-null T cell model using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 technology. The current studies show that suppression of CD25 expression by tBHQ is partially dependent on Nrf2, whereas inhibition of IL-2 secretion is largely Nrf2-independent. Interestingly, tBHQ inhibited NFkB activation in an Nrf2-independent manner. This was an unexpected finding since Nrf2 inhibits NF kappa B activation in other models. These results led us to investigate another more potent Nrf2 activator, the synthetic triterpenoid 1[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im). Treatment of wild-type and Nrf2-null Jurkat T cells with CDDO-Im resulted in an Nrf2-dependent suppression of IL-2. Furthermore, susceptibility to reactive oxygen species was significantly enhanced in the Nrf2-null clones as determined by decreased mitochondrial membrane potential and cell viability. Importantly, this study is the first to describe the generation of a human Nrf2-null model, which is likely to have multiple applications in immunology and cancer biology. Collectively, this study demonstrates a role for Nrf2 in the effects of CDDO-Im on CD25 and IL-2 expression, whereas the effect of tBHQ on these parameters is complex and likely involves modulation of multiple stress-activated transcription factors, including NF kappa B and Nrf2.	[Zagorski, Joseph W.; Maser, Tyler P.; Liby, Karen T.; Rockwell, Cheryl E.] Michigan State Univ, Dept Pharmacol & Toxicol, Room B-346 Life Sci Bldg,1355 Bogue St, E Lansing, MI 48824 USA; [Zagorski, Joseph W.; Rockwell, Cheryl E.] Michigan State Univ, Inst Integrated Toxicol, E Lansing, MI 48824 USA; [Zagorski, Joseph W.; Rockwell, Cheryl E.] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA	Rockwell, CE (reprint author), Michigan State Univ, Dept Pharmacol & Toxicol, Room B-346 Life Sci Bldg,1355 Bogue St, E Lansing, MI 48824 USA.	rockwelc@msu.edu		Liby, Karen/0000-0003-3317-3437	National Institutes of Health [ES018885, ES024966, GM092715]	These studies were supported by the National Institutes of Health [Grants ES018885 and ES024966 to C.E.R. and GM092715 to J.W.Z.].	Cantrell DA, 1996, CANCER SURV, V27, P165; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943                                                        ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Johnson DA, 2010, TOXICOL SCI, V114, P237, DOI 10.1093/toxsci/kfp274; Kataoka K, 2001, J BIOL CHEM, V276, P34074, DOI 10.1074/jbc.M105383200; Katika MR, 2011, TOXICOL APPL PHARM, V254, P311, DOI 10.1016/j.taap.2011.04.021; Kaufmann KB, 2016, INT IMMUNOPHARMACOL, V35, P99, DOI 10.1016/j.intimp.2016.03.018; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Li J, 2004, PHYSIOL GENOMICS, V18, P261, DOI 10.1152/physiolgenomics.00209.2003; Liby K, 2008, CLIN CANCER RES, V14, P4556, DOI 10.1158/1078-0432.CCR-08-0040; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mane Viraj P, 2008, J Biomol Tech, V19, P342; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Morzadec C, 2014, FREE RADICAL BIO MED, V71, P133, DOI 10.1016/j.freeradbiomed.2014.03.006; Murugaiyan J, 2013, TOXICOL APPL PHARM, V269, P307, DOI 10.1016/j.taap.2013.03.032; Ogasawara Y, 2014, FREE RADICAL BIO MED, V69, P58, DOI 10.1016/j.freeradbiomed.2014.01.005; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rockwell CE, 2012, J IMMUNOL, V188, P1630, DOI 10.4049/jimmunol.1101712; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095; Shahidi F, 2000, NAHRUNG, V44, P158, DOI 10.1002/1521-3803(20000501)44:3<158::AID-FOOD158>3.0.CO;2-L; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1127/JCI25790; Turley AE, 2015, CYTOKINE, V71, P289, DOI 10.1016/j.cyto.2014.11.006; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; WHO, 1975, WHO FOOD ADDITIVES S; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Zagorski JW, 2013, TOXICOL SCI, V136, P63, DOI 10.1093/toxsci/kft172	41	0	0	6	6	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	MAY 1	2017	361	2					259	267		10.1124/jpet.116.238899				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EV6QM	WOS:000401895900007	28280124				2018-01-05	
J	Klap, C; Yeshayahou, E; Bolger, AM; Arazi, T; Gupta, SK; Shabtai, S; Usadel, B; Salts, Y; Barg, R				Klap, Chen; Yeshayahou, Ester; Bolger, Anthony M.; Arazi, Tzahi; Gupta, Suresh K.; Shabtai, Sara; Usadel, Bjoern; Salts, Yehiam; Barg, Rivka			Tomato facultative parthenocarpy results from SlAGAMOUS-LIKE 6 loss of function	PLANT BIOTECHNOLOGY JOURNAL			English	Article						ovary arrest; fruit set; SlAGL6; tomato fruit size; CRISPR/Cas9; Solyc01g093960	MADS-BOX GENES; FLORAL ORGAN IDENTITY; RICE ORYZA-SATIVA; FRUIT-DEVELOPMENT; LYCOPERSICON-ESCULENTUM; FLOWER DEVELOPMENT; REPRODUCTIVE DEVELOPMENT; SOLANUM-LYCOPERSICON; AGAMOUS SUBFAMILY; MERISTEM FATE	The extreme sensitivity of the microsporogenesis process to moderately high or low temperatures is a major hindrance for tomato (Solanum lycopersicum) sexual reproduction and hence year-round cropping. Consequently, breeding for parthenocarpy, namely, fertilization-independent fruit set, is considered a valuable goal especially for maintaining sustainable agriculture in the face of global warming. A mutant capable of setting high-quality seedless (parthenocarpic) fruit was found following a screen of EMS-mutagenized tomato population for yielding under heat stress. Next-generation sequencing followed by marker-assisted mapping and CRISPR/Cas9 gene knockout confirmed that a mutation in SlAGAMOUS-LIKE 6 (SlAGL6) was responsible for the parthenocarpic phenotype. The mutant is capable of fruit production under heat stress conditions that severely hamper fertilization-dependent fruit set. Different from other tomato recessive monogenic mutants for parthenocarpy, Slagl6 mutations impose no homeotic changes, the seedless fruits are of normal weight and shape, pollen viability is unaffected, and sexual reproduction capacity is maintained, thus making Slagl6 an attractive gene for facultative parthenocarpy. The characteristics of the analysed mutant combined with the gene's mode of expression imply SlAGL6 as a key regulator of the transition between the state of 'ovary arrest' imposed towards anthesis and the fertilization-triggered fruit set.	[Klap, Chen; Yeshayahou, Ester; Arazi, Tzahi; Gupta, Suresh K.; Shabtai, Sara; Salts, Yehiam; Barg, Rivka] Agr Res Org, Volcani Ctr, Inst Plant Sci, Rishon Leziyyon, Israel; [Bolger, Anthony M.; Usadel, Bjoern] Rhein Westfal TH Aachen, Inst Biol 1, Aachen, Germany; [Usadel, Bjoern] Forschungszentrum Julich, Inst Bio & Geowissensch IBG Plant Sci 2 2, Julich, Germany	Barg, R (reprint author), Agr Res Org, Volcani Ctr, Inst Plant Sci, Rishon Leziyyon, Israel.	rivkabarg@gmail.com	Usadel, Bjorn/E-1932-2011		Chief Scientist of the Israel Ministry of Agriculture and Rural Development [261-0925, 261-0916, 256-0980]	We are indebted to Mr. Moshe Gabay for outstanding handling of the plants, and the students Sharon Israeli, Aviram Trachtenberg, Marina Gorodner and Shira Corem for excellent technical assistance. We thank Y. Kapulnik and J Hirschenhoren for the M<INF>2</INF>-mutagenized seeds, Subha Damodharan for sharing RNA samples, the research groups of Y. Kapulnik, H. Kultai, N. Firon, E. Pressman and D. Granot from the ARO for participation in setting the mutagenized population screening experiment, A. Faigenboim and K. Machemer for bioinformatics assistance, M. Perel for meteorological data and A. Sherman and E. Grotewold for critically reviewing the manuscript. This work was supported by the Chief Scientist of the Israel Ministry of Agriculture and Rural Development grants no. 261-0925, 261-0916 and 256-0980. The authors declare no conflict of interests.	Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; Ariizumi T, 2013, BREEDING SCI, V63, P3, DOI 10.1270/jsbbs.63.3; Barg R, 1997, J EXP BOT, V48, P1919, DOI 10.1093/jexbot/48.316.1919; Bassel GW, 2008, J EXP BOT, V59, P585, DOI 10.1093/jxb/erm354; Beraldi D, 2004, THEOR APPL GENET, V108, P209, DOI 10.1007/s00122-003-1442-6; BESHIRELAHMADI A, 1979, J AM SOC HORTIC SCI, V104, P686; BOHNER J, 1988, PHYSIOL PLANTARUM, V72, P316, DOI 10.1111/j.1399-3054.1988.tb05839.x                                              ; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carmi N, 2003, PLANTA, V217, P726, DOI 10.1007/s00425-003-1052-1; Carrera E, 2012, PLANT PHYSIOL, V160, P1581, DOI 10.1104/pp.112.204552; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Chevalier C, 2014, J EXP BOT, V65, P2731, DOI 10.1093/jxb/ert366; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Damodharan S, 2016, PLANT J, V86, P458, DOI 10.1111/tpj.13127; DIAZ A V C, 1987, Journal of the American Society for Horticultural Science, V112, P634; Dreni L, 2016, J EXP BOT, V67, P1625, DOI 10.1093/jxb/erw046; Dreni L, 2014, NEW PHYTOL, V201, P717, DOI 10.1111/nph.12555; Duan YL, 2012, PLANT MOL BIOL, V80, P429, DOI 10.1007/s11103-012-9958-2; FALAVIGNA A, 1978, Genetica Agraria, V32, P159; Ficcadenti N, 1999, MOL BREEDING, V5, P463, DOI 10.1023/A:1009665409959; Firon N, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls024; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Gimenez E, 2016, PLANT MOL BIOL, V91, P513, DOI 10.1007/s11103-016-0485-4; Gorguet B, 2005, PLANT BIOLOGY, V7, P131, DOI 10.1055/s-2005-837494; Gorguet B, 2008, THEOR APPL GENET, V116, P755, DOI 10.1007/s00122-007-0708-9; Hazra P., 2010, INT J PLANT SCI, V1, P144; Huang XQ, 2012, PLANT CELL, V24, P2364, DOI 10.1105/tpc.112.099168; IMANISHI S, 1975, Journal of the Japanese Society for Horticultural Science, V44, P33; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Li HF, 2011, PLANT CELL, V23, P2536, DOI 10.1105/tpc.111.087262; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIN S, 1984, J HERED, V75, P62, DOI 10.1093/oxfordjournals.jhered.a109867                                           ; Lippman Z, 2001, GENETICS, V158, P413; Mazzucato A, 1998, DEVELOPMENT, V125, P107; Mazzucato A, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0222-8; Mesihovic A, 2016, PLANT REPROD, V29, P93, DOI 10.1007/s00497-016-0281-y; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; NUEZ F, 1986, Z PFLANZENZUCHT, V96, P200; Nunome T., 2014, P 18 EUCARPIA M AV F; Ohmori S, 2009, PLANT CELL, V21, P3008, DOI 10.1105/tpc.109.068742; Pan IL, 2010, J EXP BOT, V61, P1795, DOI 10.1093/jxb/erq046; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Pattison RJ, 2015, PLANT PHYSIOL, V168, P1684, DOI 10.1104/pp.15.00287; Perry F. E., 1915, OHIO NATURALIST, V15, P473; PHILOUZE J, 1989, AGRONOMIE, V9, P63, DOI 10.1051/agro:19890107; Philouze J., 1978, TOMATO GENET COOP RP, V28, P12; PICKEN AJF, 1984, J HORTIC SCI, V59, P1; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; Rijpkema AS, 2009, PLANT J, V60, P1, DOI 10.1111/j.1365-313X.2009.03917.x; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Saito T, 2011, PLANT CELL PHYSIOL, V52, P283, DOI 10.1093/pcp/pcr004; Sato S, 2006, ANN BOT-LONDON, V97, P731, DOI 10.1093/aob/mcl037; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schauer SE, 2009, PLANT J, V59, P987, DOI 10.1111/j.1365-313X.2009.03928.x; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Scutt CP, 2006, J EXP BOT, V57, P2143, DOI 10.1093/jxb/erj.188; Selleri L., 2011, THESIS; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Soressi G. P., 1975, REP TOMATO GENET COO, V25, P22; Tang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125355; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; VARDY E, 1989, EUPHYTICA, V41, P9, DOI 10.1007/BF00022405; VARGA A, 1976, Z PFLANZENPHYSIOL, V80, P95, DOI 10.1016/S0044-328X(76)80146-8                                                   ; Varga A, 1986, CRC HDB FRUIT SET DE, P461; Varoquaux F, 2000, TRENDS BIOTECHNOL, V18, P233, DOI 10.1016/S0167-7799(00)01448-7; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Wang PP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.188, 10.1038/nplants.2015.188]; Yao JL, 2001, P NATL ACAD SCI USA, V98, P1306, DOI 10.1073/pnas.031502498; Ye J, 2002, J FORENSIC SCI, V47, P593; Yoo SK, 2011, PLANT J, V65, P62, DOI 10.1111/j.1365-313X.2010.04402.x; Zahn LM, 2006, EVOL DEV, V8, P30, DOI 10.1111/j.1525-142X.2006.05073.x; Zhang JA, 2010, PLANT J, V64, P604, DOI 10.1111/j.1365-313X.2010.04354.x; Zhang SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23173	77	4	4	25	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	MAY	2017	15	5					634	647		10.1111/pbi.12662				14	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	EV7CJ	WOS:000401931600009	27862876	gold			2018-01-05	
J	Jiang, WZ; Henry, IM; Lynagh, PG; Comai, L; Cahoon, EB; Weeks, DP				Jiang, Wen Zhi; Henry, Isabelle M.; Lynagh, Peter G.; Comai, Luca; Cahoon, Edgar B.; Weeks, Donald P.			Significant enhancement of fatty acid composition in seeds of the allohexaploid, Camelina sativa, using CRISPR/Cas9 gene editing	PLANT BIOTECHNOLOGY JOURNAL			English	Article						Camelina sativa; gene editing; CRISPR/Cas9; allohexaploid; oleic acid; fatty acid composition	HIGH-OLEIC-ACID; BRASSICA-NAPUS; SOYBEAN OIL; ARABIDOPSIS; GENOME; DESATURASE; ACCUMULATION; PLANTS; FAD2; GENERATION	The CRISPR/Cas9 nuclease system is a powerful and flexible tool for genome editing, and novel applications of this system are being developed rapidly. Here, we used CRISPR/Cas9 to target the FAD2 gene in Arabidopsis thaliana and in the closely related emerging oil seed plant, Camelina sativa, with the goal of improving seed oil composition. We successfully obtained Camelina seeds in which oleic acid content was increased from 16% to over 50% of the fatty acid composition. These increases were associated with significant decreases in the less desirable polyunsaturated fatty acids, linoleic acid (i.e. a decrease from similar to 16% to <4%) and linolenic acid (a decrease from similar to 35% to <10%). These changes result in oils that are superior on multiple levels: they are healthier, more oxidatively stable and better suited for production of certain commercial chemicals, including biofuels. As expected, A. thaliana T-2 and T-3 generation seeds exhibiting these types of altered fatty acid profiles were homozygous for disrupted FAD2 alleles. In the allohexaploid, Camelina, guide RNAs were designed that simultaneously targeted all three homoeologous FAD2 genes. This strategy that significantly enhanced oil composition in T-3 and T-4 generation Camelina seeds was associated with a combination of germ-line mutations and somatic cell mutations in FAD2 genes in each of the three Camelina subgenomes.	[Jiang, Wen Zhi; Cahoon, Edgar B.; Weeks, Donald P.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Jiang, Wen Zhi; Cahoon, Edgar B.; Weeks, Donald P.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68583 USA; [Henry, Isabelle M.; Lynagh, Peter G.; Comai, Luca] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Henry, Isabelle M.; Lynagh, Peter G.; Comai, Luca] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA	Weeks, DP (reprint author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.; Weeks, DP (reprint author), Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68583 USA.	dweeks1@unl.edu	Comai, Luca/F-4279-2010	Comai, Luca/0000-0003-2642-6619	U.S. National Science Foundation [EPSCoR-1004094]; U.S. Department of Energy, Office of Science, OBER [DOEBER SC0012459]; NSF Plant Genome Program [1444612, 13-39385]; University of Nebraska Foundation [01133480]	We thank Aaron Duthoy and Andrew Blazek for technical assistance, Tara Nazarenus for assistance with fatty acid analyses and Dr. Avrahim Levy for his comments on an initial draft of the manuscript. This work was supported by the U.S. National Science Foundation (EPSCoR-1004094 to DPW and EBC), U.S. Department of Energy, Office of Science, OBER (DOEBER SC0012459 to EBC and LC) and NSF Plant Genome Program (award 1444612 to LC and 13-39385 to EBC) and the University of Nebraska Foundation (Account #01133480 to DPW). The authors declare they have no conflicts of interest.	Pham AT, 2012, THEOR APPL GENET, V125, P503, DOI 10.1007/s00122-012-1849-z; Belide S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00168; Broun P, 1998, PLANT J, V13, P201, DOI 10.1046/j.1365-313X.1998.00023.x; Broun P, 1997, PLANT PHYSIOL, V113, P933, DOI 10.1104/pp.113.3.933; Cahoon EB, 1999, P NATL ACAD SCI USA, V96, P12935, DOI 10.1073/pnas.96.22.12935; Chapman KD, 2001, J AM OIL CHEM SOC, V78, P941, DOI 10.1007/s11746-001-0368-y; Chapman KD, 2008, CROP SCI, V48, P1470, DOI 10.2135/cropsci2007.11.0618; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feldman M, 2012, GENETICS, V192, P763, DOI 10.1534/genetics.112.146316; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Frohlich A, 2005, IND CROP PROD, V21, P25, DOI 10.1016/j.indcrop.2003.12.004; Graef G, 2009, PLANT BIOTECHNOL J, V7, P411, DOI 10.1111/j.1467-7652.2009.00408.x; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Hutcheon C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-233; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Iskandarov U., 2014, PLANTS AND BIOENERGY, P131; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099225; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jung JH, 2011, PLANT CELL REP, V30, P1881, DOI 10.1007/s00299-011-1095-x; Kang JL, 2011, PLANT PHYSIOL BIOCH, V49, P223, DOI 10.1016/j.plaphy.2010.12.004; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106658; Lou Y, 2014, J BIOL CHEM, V289, P17996, DOI 10.1074/jbc.M114.572883; Lu CF, 2008, PLANT CELL REP, V27, P273, DOI 10.1007/s00299-007-0454-0; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Nguyen HT, 2013, PLANT BIOTECHNOL J, V11, P759, DOI 10.1111/pbi.12068; Petersen B, 2015, TRANSGENIC RES, V24, P381, DOI 10.1007/s11248-015-9862-z; Petolino JF, 2016, PLANT BIOTECHNOL J, V14, P503, DOI 10.1111/pbi.12457; Pilgeram A. L, 2007, ISSUES NEW CROPS NEW, P129; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Singh S, 2001, PLANTA, V212, P872, DOI 10.1007/s004250000456; Thambugala D, 2013, THEOR APPL GENET, V126, P2627, DOI 10.1007/s00122-013-2161-2; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Wells R, 2014, MOL BREEDING, V33, P349, DOI 10.1007/s11032-013-9954-5; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Zubr J, 1997, IND CROP PROD, V6, P113, DOI 10.1016/S0926-6690(96)00203-8	43	10	10	18	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	MAY	2017	15	5					648	657		10.1111/pbi.12663				10	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	EV7CJ	WOS:000401931600010	27862889	gold			2018-01-05	
J	Liu, X; Gallay, C; Kjos, M; Domenech, A; Slager, J; van Kessel, SP; Knoops, K; Sorg, RA; Zhang, JR; Veening, JW				Liu, Xue; Gallay, Clement; Kjos, Morten; Domenech, Arnau; Slager, Jelle; van Kessel, Sebastiaan P.; Knoops, Kevin; Sorg, Robin A.; Zhang, Jing-Ren; Veening, Jan-Willem			High-throughput CRISPRi phenotyping identifies new essential genes in Streptococcus pneumoniae	MOLECULAR SYSTEMS BIOLOGY			English	Article						bacterial cell wall; competence; DNA replication; gene essentiality; teichoic acid biosynthesis	SEQUENCE-SPECIFIC CONTROL; IN-VITRO RECONSTITUTION; CELL-DIVISION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; LIPOTEICHOIC ACID; TEICHOIC-ACIDS; CAS SYSTEM; EXPRESSION; TRANSFORMATION	Genome-wide screens have discovered a large set of essential genes in the opportunistic human pathogen Streptococcus pneumoniae. However, the functions of many essential genes are still unknown, hampering vaccine development and drug discovery. Based on results from transposon sequencing (Tn-seq), we refined the list of essential genes in S. pneumoniae serotype 2 strain D39. Next, we created a knockdown library targeting 348 potentially essential genes by CRISPR interference (CRISPRi) and show a growth phenotype for 254 of them (73%). Using high-content microscopy screening, we searched for essential genes of unknown function with clear phenotypes in cell morphology upon CRISPRi-based depletion. We show that SPD_1416 and SPD_1417 (renamed to MurT and GatD, respectively) are essential for peptidoglycan synthesis, and that SPD_1198 and SPD_1197 (renamed to TarP and TarQ, respectively) are responsible for the polymerization of teichoic acid (TA) precursors. This knowledge enabled us to reconstruct the unique pneumococcal TA biosynthetic pathway. CRISPRi was also employed to unravel the role of the essential Clp-proteolytic system in regulation of competence development, and we show that ClpX is the essential ATPase responsible for ClpP-dependent repression of competence. The CRISPRi library provides a valuable tool for characterization of pneumococcal genes and pathways and revealed several promising antibiotic targets.	[Liu, Xue; Gallay, Clement; Kjos, Morten; Domenech, Arnau; Slager, Jelle; van Kessel, Sebastiaan P.; Sorg, Robin A.; Veening, Jan-Willem] Univ Groningen, Ctr Synthet Biol, Mol Genet Grp Groningen, Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Liu, Xue; Zhang, Jing-Ren] Tsinghua Univ, Sch Med, Ctr Infect Dis Res, Beijing, Peoples R China; [Kjos, Morten] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Knoops, Kevin] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Cell Biol, Groningen, Netherlands; [Veening, Jan-Willem] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland	Veening, JW (reprint author), Univ Groningen, Ctr Synthet Biol, Mol Genet Grp Groningen, Biomol Sci & Biotechnol Inst, Groningen, Netherlands.; Veening, JW (reprint author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland.	Jan-Willem.Veening@unil.ch		Domenech, Arnau/0000-0002-0829-511X; Veening, Jan-Willem/0000-0002-3162-6634; Liu, Xue/0000-0001-6485-1865; Kjos, Morten/0000-0003-4448-9082	China Scholarship Council [201506210151]; "Marie Curie IF" grant (call H-MSCA-IF) [657546]; NWO VENI fellowship [563.14.003]; Research Council of Norway [250976/F20]; VIDI fellowship from the Netherlands Organization for Scientific Research, Earth and Life Sciences (NWO-ALW) [864.12.001]; ERC [337399-PneumoCell]; EMBO Young Investigator Program	We thank A. Zomer, P. Burghout, and P. Hermans for help with acquiring and analyzing the Tn-seq data. We thank K. Kuipers and M. I. de Jonge for providing the TEPC-15 antibodies and for the TA Western blotting protocol. V. Benes and B. Haase (GeneCore, EMBL, Heidelberg) are thanked for sequencing support. XL is supported by China Scholarship Council (No. 201506210151). ADP was supported by a "Marie Curie IF" grant (call H2020-MSCA-IF-2014, number 657546). KK is supported by a NWO VENI fellowship (563.14.003). MK is supported by a grant from the Research Council of Norway (250976/F20). Work in the Veening laboratory is supported by the EMBO Young Investigator Program, a VIDI fellowship (864.12.001) from the Netherlands Organization for Scientific Research, Earth and Life Sciences (NWO-ALW), and ERC Starting Grant 337399-PneumoCell.	Aprianto R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1054-5; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Baba M, 2008, METHOD ENZYMOL, V451, P133, DOI 10.1016/S0076-6879(08)03210-2; Bartual SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4842; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Briggs GS, 2012, J BACTERIOL, V194, P5162, DOI 10.1128/JB.00865-12; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Burghout P, 2013, J BACTERIOL, V195, P1573, DOI 10.1128/JB.01942-12; Charpentier E, 2000, MOL MICROBIOL, V37, P717, DOI 10.1046/j.1365-2958.2000.02011.x                                                ; Chastanet A, 2001, J BACTERIOL, V183, P7295, DOI 10.1128/JB.183.24.7295-7307.2001; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895; Chung KM, 2004, J BACTERIOL, V186, P5926, DOI 10.1128/JB.186.17.5926-5932.2004; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Damjanovic M, 2007, J BACTERIOL, V189, P7105, DOI 10.1128/JB.00681-07; de Jong A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1834-4; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; FISCHER W, 1993, EUR J BIOCHEM, V215, P851, DOI 10.1111/j.1432-1033.1993.tb18102.x                                              ; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Goranov AI, 2009, MOL MICROBIOL, V74, P454, DOI 10.1111/j.1365-2958.2009.06876.x; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; IKEDA M, 1989, J BACTERIOL, V171, P6375, DOI 10.1128/jb.171.11.6375-6378.1989                                                ; Irwin Chad R, 2012, Methods Mol Biol, V890, P23, DOI 10.1007/978-1-61779-876-4_2; Jerga A, 2009, J BIOL CHEM, V284, P15364, DOI 10.1074/jbc.C109.002410; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Kaur R, 2016, PEDIATR INFECT DIS J, V35, P901, DOI 10.1097/INF.0000000000001206; Kawai Y, 2006, MICROBIOL-SGM, V152, P1129, DOI 10.1099/mic.0.28497-0; Kharat AS, 2008, J BACTERIOL, V190, P5907, DOI 10.1128/JB.00628-08; KHATTAR MM, 1994, J BACTERIOL, V176, P7140; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; Kjos M, 2015, J BACTERIOL, V197, P807, DOI 10.1128/JB.02221-14; Kocaoglu O, 2015, ANTIMICROB AGENTS CH, V59, P3548, DOI 10.1128/AAC.05142-14; Kuipers K, 2016, MOL MICROBIOL, V101, P12, DOI 10.1111/mmi.13312; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li Y, 2013, INFECT IMMUN, V81, P4519, DOI 10.1128/IAI.00724-13; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; Maggi S, 2008, MICROBIOL-SGM, V154, P3042, DOI 10.1099/mic.0.2008/018697-0; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x                                                ; Massidda O, 2013, ENVIRON MICROBIOL, V15, P3133, DOI 10.1111/1462-2920.12189; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; McDonald KL, 2011, J MICROSC-OXFORD, V243, P227, DOI 10.1111/j.1365-2818.2011.03526.x; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Mobegi FM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-958; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; MORGAN, 1967, J BACTERIOL, V93, P1987; Morlot C, 2004, MOL MICROBIOL, V51, P1641, DOI 10.1046/j.1365-2958.2003.03953.x; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Noirclerc-Savoye M, 2003, PROTEIN EXPRES PURIF, V30, P18, DOI 10.1016/S1046-5828(03)00051-2; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; OCHMAN H, 1988, GENETICS, V120, P621; Peters J. M., 2016, MOL SYST BIOL, V165, P1493; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Prina E, 2015, LANCET, V386, P1097, DOI 10.1016/S0140-6736(15)60733-4; Prudhomme M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006113; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rajagopal M, 2017, CURR TOP MICROBIOL, V404, P1, DOI 10.1007/82_2015_5021; Reinscheid DJ, 2001, J BACTERIOL, V183, P1175, DOI 10.1128/JB.183.4.1175-1183.2001; Roggiani M, 2015, ANNU REV GENET, V49, P115, DOI 10.1146/annurev-genet-112414-054958; Sham LT, 2012, CURR OPIN MICROBIOL, V15, P194, DOI 10.1016/j.mib.2011.12.013; Sham LT, 2011, P NATL ACAD SCI USA, V108, pE1061, DOI 10.1073/pnas.1108323108; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Smits WK, 2011, J BACTERIOL, V193, P640, DOI 10.1128/JB.01253-10; Song JH, 2005, MOL CELLS, V19, P365; Sorg RA, 2016, THESIS; Sorg RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9773; Sorg RA, 2015, ACS SYNTH BIOL, V4, P228, DOI 10.1021/sb500229s; Thanassi JA, 2002, NUCLEIC ACIDS RES, V30, P3152, DOI 10.1093/nar/gkf418; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; van Opijnen T, 2012, GENOME RES, V22, P2541, DOI 10.1101/gr.137430.112; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Verhagen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089541; Vollmer W, 2001, MOL MICROBIOL, V39, P1610, DOI 10.1046/j.1365-2958.2001.02349.x                                                ; Wu KF, 2014, J BACTERIOL, V196, P3324, DOI 10.1128/JB.01696-14; Yan M, 2015, J INTEGR PLANT BIOL, V57, P613, DOI 10.1111/jipb.12295; Zapun A, 2013, ACS CHEM BIOL, V8, P2688, DOI 10.1021/cb400575t; Zhao H, 2016, J BACTERIOL, V198, P2925, DOI 10.1128/JB.00507-16; Zomer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043012; ZUSMAN DR, 1973, J BACTERIOL, V115, P1167	85	2	2	5	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-4292			MOL SYST BIOL	Mol. Syst. Biol.	MAY	2017	13	5							931	10.15252/msb.20167449				18	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV7KP	WOS:000401954600003	28490437	gold			2018-01-05	
J	Dhakal, P; Soares, MJ				Dhakal, Pramod; Soares, Michael J.			Single-step PCR-based genetic sex determination of rat tissues and cells	BIOTECHNIQUES			English	Article						rat; fetal; sex determination	Y-CHROMOSOME; DIMORPHISM; FETAL; ASSAY; MODEL; MICE	The advent of genome editing strategies has expanded the range of animal models available for gene manipulation and renewed research interest in the rat. Gender is a key variable for in vivo gene function analyses. Here, we present a simple PCR-based method to determine genetic sex in the rat.	[Dhakal, Pramod] Univ Kansas, Med Ctr, Inst Reprod Hlth & Regenerat Med, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Dhakal, Pramod] Univ Kansas, Med Ctr, Dept Pediat, Kansas City, KS 66160 USA	Dhakal, P (reprint author), Univ Kansas, Med Ctr, Inst Reprod Hlth & Regenerat Med, Dept Pathol & Lab Med, Kansas City, KS 66160 USA.; Dhakal, P (reprint author), Univ Kansas, Med Ctr, Dept Pediat, Kansas City, KS 66160 USA.	pdhakal@kumc.edu; msoares@kumc.edu			NIH [HD020676, HD079363]	We thank Regan Scott and Stacy McClure for assistance. This research was supported by the NIH (HD020676 and HD079363). This paper is subject to the NIH Public Access Policy.	An J, 1997, J ANDROL, V18, P289; Asanoma K, 2011, DEV BIOL, V351, P110, DOI 10.1016/j.ydbio.2010.12.038; AXBERG I, 1988, SCAND J IMMUNOL, V27, P271, DOI 10.1111/j.1365-3083.1988.tb02347.x; Bale TL, 2011, STRESS, V14, P348, DOI 10.3109/10253890.2011.586447; BRUCE NW, 1975, NATURE, V257, P62, DOI 10.1038/257062a0; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05                                                               ; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a                                                                 ; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895                                                         ; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; GOUT PW, 1980, CANCER RES, V40, P2433; Kalisch-Smith J. I., PLACENTA IN PRESS, DOI [10.1016/j.placenta.2016.12.008, DOI 10.1016/J.PLACENTA.2016.12.008]; KUNIEDA T, 1992, BIOL REPROD, V46, P692, DOI 10.1095/biolreprod46.4.692; Lambert JF, 2000, J NEUROSCI METH, V95, P127, DOI 10.1016/S0165-0270(99)00157-0                                                   ; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; Myatt L, 2014, ADV EXP MED BIOL, V814, P133, DOI 10.1007/978-1-4939-1031-1_12; Prudhomme J, 2016, CELL MOL LIFE SCI, V73, P757, DOI 10.1007/s00018-015-2086-9; Smalley E, 2016, NAT BIOTECHNOL, V34, P893, DOI 10.1038/nbt0916-893; Soares MJ, 2012, PLACENTA, V33, P233, DOI 10.1016/j.placenta.2011.11.026	19	0	0	4	4	BIOTECHNIQUES OFFICE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0736-6205	1940-9818		BIOTECHNIQUES	Biotechniques	MAY	2017	62	5					232	233		10.2144/000114548				2	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV4MJ	WOS:000401734100007	28528577	gold			2018-01-05	
J	Cheishvili, D; Christiansen, S; Stochinsky, R; Pepin, AS; Sapozhnikov, DM; Zhou, R; Schmeltzer, L; Dymov, S; Szyf, M				Cheishvili, David; Christiansen, Steffan; Stochinsky, Rebecca; Pepin, Anne-Sophie; Sapozhnikov, Daniel M.; Zhou, Rudy; Schmeltzer, Lauren; Dymov, Sergey; Szyf, Moshe			DNA methylation controls unmethylated transcription start sites in the genome in trans	EPIGENOMICS			English	Article						5-aza-2 '-deoxycytidine; CRISPR/Cas9; DNA methylation; DNMT1; HNF4A; Illumina 450k; RNAPII; RNAPII; Ser5; upstream regulators	NUCLEAR FACTOR 4-ALPHA; PROSTATE-CANCER; EXPRESSION; GENES; TUMOR; WIDE; PROLIFERATION; GLUTAMATE; MICRORNAS; PROTEINS	Aim: DNA methylation downregulates transcription. However, a large number of genes, which are unmethylated in the promoter region, are inactive. We tested the hypothesis that these genes are regulated by DNA methylation of upstream regulators. Methods: We inhibited DNMT1 with 5-aza-2'-deoxycytidine or depleted it with shRNA to map the transcription initiation positions controlled by DNMT1 using ChIPseq with RNApolIIser5 antibody. Ingenuity pathway analysis identified potential methylated upstream regulators. Their functional role in controlling unmethylated promoters was determined by CRISPR/Cas9 gene editing. Results: We show that a large group of unmethylated promoters is regulated by DNMT1 through DNA methylation dependent silencing of upstream regulators such as transcription factor HNF4A. Conclusion: The landscape of genes regulated by DNA methylation is more wide-ranging than genes downregulated by methylation of their own cis-regulatory sequences; regulation of unmethylated promoters is dependent on the methylation state of upstream trans regulators.	[Cheishvili, David; Christiansen, Steffan; Stochinsky, Rebecca; Pepin, Anne-Sophie; Sapozhnikov, Daniel M.; Zhou, Rudy; Schmeltzer, Lauren; Dymov, Sergey; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Christiansen, Steffan] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Szyf, Moshe] McGill Univ, Sch Med, Dept Pharmacol & Therapeut, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada; [Szyf, Moshe] Canadian Inst Adv Res, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	Szyf, M (reprint author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.; Szyf, M (reprint author), McGill Univ, Sch Med, Dept Pharmacol & Therapeut, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada.; Szyf, M (reprint author), Canadian Inst Adv Res, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca		Sapozhnikov, Daniel/0000-0001-5721-2782; Christiansen, Steffan Noe/0000-0002-8655-3452	Canadian Institute of Health Research [MOP-42411]; Israel Cancer Research Fund	The work was supported by a grant from the Canadian Institute of Health Research to M Szyf (MOP-42411). D Cheishvili was supported by a postdoctoral fellowship from the Israel Cancer Research Fund. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; BURNET FM, 1967, LANCET, V1, P1171; CEDAR H, 1982, COLD SPRING HARB SYM, V47, P605; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chen YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070324; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; D'Alessio AC, 2007, MOL CELL BIOL, V27, P7462, DOI 10.1128/MCB.01120-07; FOGH J, 1977, J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221                                                           ; FRADIN A, 1982, P NATL ACAD SCI-BIOL, V79, P5142, DOI 10.1073/pnas.79.17.5142                                                         ; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Koochekpour S, 2013, ASIAN J ANDROL, V15, P212, DOI 10.1038/aja.2012.145; Langmead B, 2010, CURRENT PROTOCOLS IN, V17; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lu H, 2010, TOXICOL SCI, V118, P380, DOI 10.1093/toxsci/kfq280; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Milutinovic S, 2000, J BIOL CHEM, V275, P6353, DOI 10.1074/jbc.275.9.6353; Mokry M, 2012, NUCLEIC ACIDS RES, V40, P148, DOI 10.1093/nar/gkr720; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; Kundaje A, 2015, NATURE, V518, P317, DOI DOI 10.1038/NATURE14248; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018                                                       ; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496                                                            ; Stefanska B, 2014, CLIN CANCER RES, V20, P3118, DOI 10.1158/1078-0432.CCR-13-0283; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; VARDIMON L, 1982, P NATL ACAD SCI-BIOL, V79, P1073, DOI 10.1073/pnas.79.4.1073; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	44	1	1	3	3	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1750-1911	1750-192X		EPIGENOMICS-UK	Epigenomics	MAY	2017	9	5					611	633		10.2217/epi-2016-0141				23	Genetics & Heredity	Genetics & Heredity	EV3FC	WOS:000401642200003	28470094				2018-01-05	
J	Ouellet, DL; Cherif, K; Rousseau, J; Tremblay, JP				Ouellet, D. L.; Cherif, K.; Rousseau, J.; Tremblay, J. P.			Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia	GENE THERAPY			English	Article							TIME PCR EXPERIMENTS; IN-VIVO; MUSCULAR-DYSTROPHY; RT-PCR; GENOME; THERAPY; EXPRESSION; EXPANSION; TARGET; GUIDELINES	The Friedreich ataxia is a monogenic disease due to a hyperexpanded GAA triplet located within the first intron of the frataxin gene that causes transcriptional issues. The resulting frataxin protein deficiency leads to a Fe-S cluster biosynthesis dysfunction in the mitochondria and to oxidative stress and cell death. Here we use the CRISPR-Cas9 system to remove the mutated GAA expansion and restore the frataxin gene transcriptional activity and protein level. Both YG8R and YG8sR mouse models and cell lines derived from these mice were used to CRISPR-edited successfully the GAA expansion in vitro and in vivo. Nevertheless, our results suggest the YG8sR as a better and more suitable model for the study of the CRISPR-Cas9 edition of the mutated frataxin gene.	[Ouellet, D. L.; Cherif, K.; Rousseau, J.; Tremblay, J. P.] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada; [Ouellet, D. L.; Cherif, K.; Rousseau, J.; Tremblay, J. P.] Univ Laval, CHU Quebec, Fac Med, Dept Med Mol, Quebec City, PQ, Canada	Tremblay, JP (reprint author), Laval Univ, CHU Quebec, Fac Med, Dept Mol Med,CR CHUQ, 2705 Laurier Blvd,Room P-09300, Quebec City, PQ G1V 4G2, Canada.	jacques-p.tremblay@crchul.ulaval.ca			Ataxia Canada Foundation; Association Francaise de l'Ataxie de Friedreich; Cell Network	This work was supported by grants to JPT from the The Cell Network, Ataxia Canada Foundation and Association Francaise de l'Ataxie de Friedreich.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Babady NE, 2007, MOL GENET METAB, V92, P23, DOI 10.1016/j.ymgme.2007.05.009; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byrne SM, 2014, NUCLEIC ACIDS RES, V43, pe21; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chapdelaine P, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.41; Chutake YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138437; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper JM, 2003, BIOFACTORS, V18, P163, DOI 10.1002/biof.5520180219                                                         ; Coppola G, 2006, NEUROBIOL DIS, V22, P302, DOI 10.1016/j.nbd.2005.11.014; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gray JT, 2011, METHODS MOL BIOL, V807, P25, DOI 10.1007/978-1-61779-370-7_2; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589                                                         ; He ZY, 2015, BIOTECHNOL BIOENG, V112, P1060, DOI 10.1002/bit.25490; Iyombe-Engembe JP, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.58; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Li YJ, 2015, HUM MOL GENET, V24, P6932, DOI 10.1093/hmg/ddv397; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Lynch DR, 2002, ARCH NEUROL-CHICAGO, V59, P743, DOI 10.1001/archneur.59.5.743; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Pandolfo M, 2006, J NEURAL TRANSM-SUPP, P143; Pandolfo M, 1999, ARCH NEUROL-CHICAGO, V56, P1201, DOI 10.1001/archneur.56.10.1201; Pandolfo M, 2002, ADV EXP MED BIOL, V516, P99; Pandolfo Massimo, 2012, Handb Clin Neurol, V103, P275, DOI 10.1016/B978-0-444-51892-7.00017-6; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichavant C, 2010, HUM GENE THER, V21, P1591, DOI 10.1089/hum.2010.024; Pook MA, 2001, NEUROGENETICS, V3, P185; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sachdeva M, 2015, CANCER GENE THER, V22, P509, DOI 10.1038/cgt.2015.54; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Virmouni SA, 2013, GENOTYPE PHENOTYPE C; Virmouni SA, 2015, DIS MODEL MECH, V8, P225, DOI 10.1242/dmm.018952; Virmouni SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107416; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471	52	1	1	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	MAY	2017	24	5					265	274		10.1038/gt.2016.89				10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	EV4RV	WOS:000401750000002	28024081				2018-01-05	
J	Wang, SH; Dong, S; Wang, PX; Tao, Y; Wang, Y				Wang, Shaohua; Dong, Sheng; Wang, Pixiang; Tao, Yong; Wang, Yi			Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article						CRISPR-Cas9; Clostridium saccharoperbutylacetonicum; buk; butanol; gRNA; genome engineering; pta	ENGINEERED CRISPR/CAS SYSTEM; SOLVENT-PRODUCING CLOSTRIDIA; BEIJERINCKII NCIMB 8052; BUTANOL PRODUCTION; BUTYRIC-ACID; CAS SYSTEMS; ACETOBUTYLICUM; RNA; FERMENTATION; DEGENERATION	Clostridium saccharoperbutylacetonicum N1-4 is well known as a hyperbutanol-producing strain. However, the lack of genetic engineering tools hinders further elucidation of its solvent production mechanism and development of more robust strains. In this study, we set out to develop an efficient genome engineering system for this microorganism based on the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR- associated 9 (CRISPR-Cas9) system. First, the functionality of the CRISPR-Cas9 system previously customized for Clostridium beijerinckii was evaluated in C. saccharoperbutylacetonicum by targeting pta and buk, two essential genes for acetate and butyrate production, respectively. pta and buk single and double deletion mutants were successfully obtained based on this system. However, the genome engineering efficiency was rather low (the mutation rate is <20%). Therefore, the efficiency was further optimized by evaluating various promoters for guide RNA (gRNA) expression. With promoter P (J23119), we achieved a mutation rate of 75% for pta deletion without serial subculturing as suggested previously for C. beijerinckii. Thus, this developed CRISPR-Cas9 system is highly desirable for efficient genome editing in C. saccharoperbutylacetonicum. Batch fermentation results revealed that both the acid and solvent production profiles were altered due to the disruption of acid production pathways; however, neither acetate nor butyrate production was eliminated with the deletion of the corresponding gene. The butanol production, yield, and selectivity were improved in mutants, depending on the fermentation medium. In the pta buk double deletion mutant, the butanol production in P2 medium reached 19.0 g/liter, which is one of the highest levels ever reported from batch fermentations. IMPORTANCE An efficient CRISPR-Cas9 genome engineering system was developed for C. saccharoperbutylacetonicum N1-4. This paves the way for elucidating the solvent production mechanism in this hyper-butanol-producing microorganism and developing strains with desirable butanol-producing features. This tool can be easily adapted for use in closely related microorganisms. As also reported by others, here we demonstrated with solid data that the highly efficient expression of gRNA is the key factor determining the efficiency of CRISPR-Cas9 for genome editing. The protocol developed in this study can provide essential references for other researchers who work in the areas of metabolic engineering and synthetic biology. The developed mutants can be used as excellent starting strains for development of more robust ones for desirable solvent production.	[Wang, Shaohua; Dong, Sheng; Wang, Pixiang; Tao, Yong; Wang, Yi] Auburn Univ, Dept Biosyst Engn, Auburn, AL 36849 USA; [Tao, Yong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Wang, Yi] Auburn Univ, Ctr Bioenergy & Bioprod, Auburn, AL 36849 USA	Wang, Y (reprint author), Auburn Univ, Dept Biosyst Engn, Auburn, AL 36849 USA.; Wang, Y (reprint author), Auburn Univ, Ctr Bioenergy & Bioprod, Auburn, AL 36849 USA.	yiwang3@auburn.edu					Al-Shorgani NKN, 2012, ANN MICROBIOL, V62, P1059, DOI 10.1007/s13213-011-0347-x; BAHL H, 1986, APPL ENVIRON MICROB, V52, P169; Bellido C, 2015, BIORESOURCE TECHNOL, V190, P332, DOI 10.1016/j.biortech.2015.04.082; Bruder MR, 2016, APPL ENVIRON MICROB, V82, P6109, DOI 10.1128/AEM.02128-16; Buehler EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158243; Chen CK, 1999, APPL MICROBIOL BIOT, V52, P170, DOI 10.1007/s002530051504; Chen CK, 1999, APPL ENVIRON MICROB, V65, P499; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cornillot E, 1997, J BACTERIOL, V179, P5442, DOI 10.1128/jb.179.17.5442-5447.1997                                                ; Croux C, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0432-2; Dash S, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw004; del Cerro C, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GENOMEA.00070-13; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Green EM, 2011, CURR OPIN BIOTECH, V22, P337, DOI 10.1016/j.copbio.2011.02.004; Gutschner T, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-71; Herman NA, 2016, APPL ENV MICROBIOL; HONGO M, 1965, AGR BIOL CHEM TOKYO, V29, P1135, DOI 10.1080/00021369.1965.10858521                                                  ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang He, 2015, Acta Biochim Biophys Sin (Shanghai), V47, P231, DOI 10.1093/abbs/gmv007; HUSEMANN MHW, 1988, BIOTECHNOL BIOENG, V32, P843, DOI 10.1002/bit.260320702; Jang YS, 2012, MBIO, V3, DOI 10.1128/mBio.00314-12; Jang YS, 2012, BIOTECHNOL J, V7, P186, DOI 10.1002/biot.201100059; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y., 2015, ICIC EL, V9, P81, DOI DOI 10.1128/AEM.04023-14; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson JL, 1997, INT J SYST BACTERIOL, V47, P420, DOI 10.1099/00207713-47-2-420                                                       ; JONES DT, 1986, MICROBIOL REV, V50, P484; KEIS S, 1995, INT J SYST BACTERIOL, V45, P693, DOI 10.1099/00207713-45-4-693                                                       ; Keis S, 2001, INT J SYST EVOL MICR, V51, P2095, DOI 10.1099/00207713-51-6-2095                                                      ; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Lehmann D, 2012, APPL MICROBIOL BIOT, V94, P743, DOI 10.1007/s00253-011-3852-8; Lesiak JM, 2014, J BIOTECHNOL, V188, P97, DOI 10.1016/j.jbiotec.2014.07.005; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li Q, 2016, BIOTECHNOL J, V11, P961, DOI 10.1002/biot.201600053; Li YC, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-2; Liu J, 2016, APPL MICROBIOL BIOT, V100, P4985, DOI 10.1007/s00253-016-7299-9; Liu S, 2009, BIOTECHNOL, V26, P117, DOI DOI 10.1016/J.NBT.2009.06.984; Liu XG, 2006, ENZYME MICROB TECH, V38, P521, DOI 10.1016/j.enzmictec.2005.07.008; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MERMELSTEIN LD, 1993, APPL ENVIRON MICROB, V59, P1077; Nakayama SI, 2008, APPL MICROBIOL BIOT, V78, P483, DOI 10.1007/s00253-007-1323-z; Nakayama S, 2007, J GEN APPL MICROBIOL, V53, P53, DOI 10.2323/jgam.53.53                                                              ; Peters J. M., 2016, APPL ENVIRON MICROB, V165, P1493, DOI DOI 10.1016/J.CELL.2016.05.003; Poehlein A., 2014, GENOME ANNOUNC, V2, DOI DOI 10.1128/GENOMEA.01056-14; Pyne ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep25666; Pyne ME, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0163-1; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ren XW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-409; Shaheen R, 2000, J MOL MICROB BIOTECH, V2, P115; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Tashiro Y, 2004, J BIOSCI BIOENG, V98, P263; Tashiro Y, 2007, J BIOSCI BIOENG, V104, P238, DOI 10.1263/jbb.104.238; Thang VH, 2010, APPL BIOCHEM BIOTECH, V161, P157, DOI 10.1007/s12010-009-8770-1; Wang Y, 2016, METHOD ENZYMOL, V575, P271, DOI 10.1016/bs.mie.2016.03.014; Wang Y., 2012, THESIS; Wang Y, 2016, BIOTECHNOL BIOENG, V113, P2739, DOI 10.1002/bit.26020; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Wang Y, 2013, APPL ENVIRON MICROB, V79, P5853, DOI 10.1128/AEM.00971-13; Wiktor J, 2016, NUCLEIC ACIDS RES, V44, P3801, DOI 10.1093/nar/gkw214; Xu T, 2014, APPL ENVIRON MICROB, V80, P1544, DOI 10.1128/AEM.03786-13; Yoo M, 2015, MBIO, V6, DOI 10.1128/mBio.01808-15; ZHANG YS, 2016, FEMS MICROBIOL LETT, V27; Zhu Y, 2005, BIOTECHNOL BIOENG, V90, P154, DOI 10.1002/bit.20354; Motoyoshi H., 1960, US patent, Patent No. [2945786 US A, 2945786]	68	2	2	12	12	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	MAY	2017	83	10							UNSP e00233-17	10.1128/AEM.00233-17				16	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	EV0VW	WOS:000401465400005					2018-01-05	
J	Tian, JJ; Hu, J; Chen, ML; Yin, HC; Miao, P; Bai, PL; Yin, J				Tian, Jingjing; Hu, Jia; Chen, Mingli; Yin, Huancai; Miao, Peng; Bai, Pengli; Yin, Jian			The use of mrp1-deficient (Danio rerio) zebrafish embryos to investigate the role of Mrp1 in the toxicity of cadmium chloride and benzo[a]pyrene	AQUATIC TOXICOLOGY			English	Article						Multi-resistance associated protein 1; CRISPR/Cas9; Zebrafish embryo; Cadmium chloride; Benzo[a]pyrene	EARLY-LIFE STAGES; P-GLYCOPROTEIN; DEVELOPMENTAL TOXICITY; DREISSENA-POLYMORPHA; ABC TRANSPORTERS; OXIDATIVE STRESS; GENE-EXPRESSION; TR-RATS; GLUTATHIONE; EXPOSURE	Previous studies in our lab have revealed that both P-glycoprotein (Pgp) and multi-resistance associated protein (Mrp) 1 played important roles in the detoxification of heavy metals and polycyclic aromatic hydrocarbon (PAH) in zebrafish embryos. This paper aims to extend this research by using mrp1/-deficient model to illustrate the individual function of Mrp1. In this respect, CRISPR/Cas9 system was employed to generate a frameshift mutation in zebrafish mrp1 causing premature translational stops in Mrp1. Significant reduction on the efflux function of Mrps was found in mutant zebrafish embryos, which correlated well with the significantly enhanced accumulation and toxicity of cadmium chloride (CdCl2) and benzo[a]pyrene (B alpha P), indicating the protective role of the corresponding protein. The different alteration on the accumulation and toxicity of Cd2+ and B alpha P could be attributed to the fact that Cd2+ and its metabolites were mainly excreted by Mrp1, while B alpha P was primarily pumped out by Pgp. More importantly, the compensation mechanism for the absence of Mrp1, including elevated glutathione (GSH) level and up-regulated expression of pgp and mrp2 were also found. Thus, mrp1-deficient zebrafish embryo could be a useful tool in the investigation of Mrp1 functions in the early life stages of aquatic organisms. However, compensation mechanism should be taken into consideration in the interpretation of results obtained with mrpl-deficient fish. (C) 2017 Elsevier B.V. All rights reserved.	[Tian, Jingjing; Chen, Mingli; Yin, Huancai; Miao, Peng; Bai, Pengli; Yin, Jian] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, CAS Key Lab Biomed Diagnost, 88 Keling Rd, Suzhou 215163, Jiangsu, Peoples R China; [Hu, Jia] Soochow Univ, Med Coll, Sch Biol & Basic Med Sci, Suzhou 215123, Jiangsu, Peoples R China; [Yin, Huancai] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Yin, J (reprint author), Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, CAS Key Lab Biomed Diagnost, 88 Keling Rd, Suzhou 215163, Jiangsu, Peoples R China.	yinj@sibet.ac.cn			National Natural Science Foundation of China [21307154]; Natural Science Foundation of Jiangsu Province [BK2015020272]; Industry-university Collaboration Project of Jiangsu Province [BY2015040-01, BY2016049-02]; Hi Tech Research and Development (863) Program of China [2014AA020905]	This work was supported by grants from the National Natural Science Foundation of China (No. 21307154), Natural Science Foundation of Jiangsu Province (No. BK2015020272), Industry-university Collaboration Project of Jiangsu Province (No. BY2015040-01 & BY2016049-02), and partly by the Hi Tech Research and Development (863) Program of China (No. 2014AA020905).	Berry JP, 2007, COMP BIOCHEM PHYS C, V145, P61, DOI 10.1016/j.cbpc.2006.07.011; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Brown DR, 2015, ENVIRON SCI POLLUT R, V22, P8329, DOI 10.1007/s11356-014-3969-2; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chatel A, 2012, MUTAGENESIS, V27, P703, DOI 10.1093/mutage/ges036; Chromcova L, 2012, NEUROENDOCRINOL LETT, V33, P60; Collery RF, 2016, INVEST OPHTH VIS SCI, V57, P6805, DOI 10.1167/iovs.16-19593; Costa J, 2013, ENVIRON TOXICOL PHAR, V36, P611, DOI 10.1016/j.etap.2013.05.017; Cunha V, 2016, ENVIRON SCI POLLUT R, V23, P10615, DOI 10.1007/s11356-016-6547-y; Deng J, 2015, J PHARMACOL EXP THER, V355, P272, DOI 10.1124/jpet.115.225490; Ellis LCJ, 2014, TOXICOL IN VITRO, V28, P1165, DOI 10.1016/j.tiv.2014.05.010; Faria M, 2011, AQUAT TOXICOL, V101, P78, DOI 10.1016/j.aquatox.2010.09.004; Ferreira M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00266; Ferreira RS, 2012, J TOXICOL ENV HEAL A, V75, P1023, DOI 10.1080/15287394.2012.697813; Gerlach CV, 2014, AQUAT TOXICOL, V154, P71, DOI 10.1016/j.aquatox.2014.05.007; Hoffmann K, 2007, EPILEPSIA, V48, P631, DOI 10.1111/j.1528-1167.2006.00939.x; Huang LX, 2014, CHEMOSPHERE, V108, P55, DOI 10.1016/j.chemosphere.2014.02.078; Hur D, 2013, COMP BIOCHEM PHYS B, V165, P49, DOI 10.1016/j.cbpb.2013.03.001; Joshi G, 2007, J NEUROSCI RES, V85, P497, DOI 10.1002/jnr.21158; Kropf C, 2016, COMP BIOCHEM PHYS C, V185, P45, DOI 10.1016/j.cbpc.2016.02.006; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Liu GD, 2016, GENE, V578, P210, DOI 10.1016/j.gene.2015.12.034; Liu J., 2016, HUM GENET; Long Y, 2011, MOL BIOL REP, V38, P1703, DOI 10.1007/s11033-010-0283-z; Long Y, 2011, COMP BIOCHEM PHYS C, V153, P381, DOI 10.1016/j.cbpc.2011.01.002; Long Y, 2011, COMP BIOCHEM PHYS C, V153, P310, DOI 10.1016/j.cbpc.2010.12.001; Long Y, 2011, COMP BIOCHEM PHYS B, V158, P46, DOI 10.1016/j.cbpb.2010.09.005; Lorico A, 1997, CANCER RES, V57, P5238; Lu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111664; Luckenbach T, 2014, COMP BIOCHEM PHYS C, V165, P28, DOI 10.1016/j.cbpc.2014.05.002; Matovic V, 2011, ARH HIG RADA TOKSIKO, V62, P65, DOI 10.2478/10004-1254-62-2011-2075; Pavlaki MD, 2016, ENVIRON POLLUT, V215, P203, DOI 10.1016/j.envpol.2016.05.010; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Tan SW, 2014, ECOTOX ENVIRON SAFE, V108, P258, DOI 10.1016/j.ecoenv.2014.07.011; Tilton F, 2008, TOXICOL SCI, V106, P103, DOI 10.1093/toxsci/kfn145; Voelker D, 2008, AQUAT TOXICOL, V86, P112, DOI 10.1016/j.aquatox.2007.10.007; Wang L, 2011, FOOD CHEM TOXICOL, V49, P3407, DOI 10.1016/j.fct.2011.06.015; Watanabe K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-101; Wiegand C, 1999, ENVIRON TOXICOL, V14, P89; Yin HC, 2016, J APPL TOXICOL, V36, P925, DOI 10.1002/jat.3225; Yin J, 2014, J ZHEJIANG UNIV-SC B, V15, P766, DOI 10.1631/jzus.B1400091; Yuan LL, 2014, ECOTOX ENVIRON SAFE, V106, P86, DOI 10.1016/j.ecoenv.2014.04.018; Zaja R, 2013, ENVIRON SCI TECHNOL, V47, P4813, DOI 10.1021/es400334t; Zhu MT, 2008, TOXICOLOGY, V247, P102, DOI 10.1016/j.tox.2008.02.011; Zhu XQ, 2009, PLACENTA, V30, P670, DOI 10.1016/j.placenta.2009.05.010	46	0	0	9	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-445X	1879-1514		AQUAT TOXICOL	Aquat. Toxicol.	MAY	2017	186						123	133		10.1016/j.aquatox.2017.03.004				11	Marine & Freshwater Biology; Toxicology	Marine & Freshwater Biology; Toxicology	EU9UV	WOS:000401386100013	28282619				2018-01-05	
J	Adib, A; Kalaee, MMK; Shoushtari, MM; Khalili, K				Adib, Arash; Kalaee, Milad Mahmoudian Kafshgar; Shoushtari, Mohammad Mahmoudian; Khalili, Keivan			Using of gene expression programming and climatic data for forecasting flow discharge by considering trend, normality, and stationarity analysis	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Stationarity; Gene expression programming; Trend; Time series; Kasilian watershed	TIME-SERIES; UNIT-ROOT; MANN-KENDALL; SMOOTH BREAKS; TESTS; PRECIPITATION; MODELS; ESTIMATORS; HYPOTHESIS; COUNTRIES	In this research, the main hydrological characteristics (such as trend, stationarity, and normalization of hydrological data) of the Kasilian watershed are considered from 1970 to 2009. For forecasting of discharge, gene expression programming (GEP) method is applied. Normality and stationarity of time series are necessary for application of GEP method. For this purpose, third edition of Mann-Kendall trend test and skewness test are used for detection of trend and normalization of data, respectively. Also, five methods are applied for detection of stationarity of data. Modified Mann-Kendall trend test and Theil and Sen's median slope method illustrate that annual and monthly precipitation data have slight decreasing trend, annual and monthly discharge data have insignificant decreasing trend, and annual and monthly temperature data have an increasing trend. Skewness test illustrates that annual, monthly, and daily discharge and precipitation data are not normal. By using logarithm function, skewness is minimized and symmetry of data is improved. After normalization of time series by logarithm function, five methods are applied for testing of stationarity of time series. These methods show that different normalized time series are stationarity and stationarity of time series is improved by elimination of periodic properties of data. For forecasting of daily discharge by GEP method, 85% of data are used for training and 15% of data are used for testing. By using data of 3 days ago, the GEP has the best efficiency. Coefficient of correlation (CC), root mean square error (RMSE), mean absolute error (MAE), and mean absolute relative error (MARE) are 0.9, 0.495 lit/s, 0.288 lit/s, and 0.053, respectively.	[Adib, Arash; Kalaee, Milad Mahmoudian Kafshgar; Shoushtari, Mohammad Mahmoudian] Shahid Chamran Univ, Engn Fac, Civil Engn Dept, Ahwaz, Iran; [Khalili, Keivan] Urmia Univ, Agr Fac, Water Dept, Orumiyeh, Iran	Adib, A (reprint author), Shahid Chamran Univ, Engn Fac, Civil Engn Dept, Ahwaz, Iran.	arashadib@yahoo.com					Abadi L. Z., 2011, DESERT, V16, P103; Ahn H, 2000, J HYDROL, V234, P82, DOI 10.1016/S0022-1694(00)00242-0; Ay M, 2015, THEOR APPL CLIMATOL, V120, P617, DOI 10.1007/s00704-014-1198-8; Aytek A, 2008, J HYDROL, V351, P288, DOI 10.1016/j.jhydrol.2007.12.005; Becheri IG, 2016, STAT PROBABIL LETT, V108, P1, DOI 10.1016/j.spl.2015.09.019; Becker R, 2006, J TIME SER ANAL, V27, P381, DOI 10.1111/j.1467-9892.2006.00478.x; Caner M, 2013, J STAT PLAN INFER, V143, P691, DOI 10.1016/j.jspi.2012.10.009; Christopoulos DK, 2010, J INT MONEY FINANC, V29, P1076, DOI 10.1016/j.jimonfin.2010.02.003; Cobaner M, 2016, NIGDE U J ENG SCI, V5, P177; Cobaner M, 2016, J AM WATER WORKS ASS, V108, pE335, DOI 10.5942/jawwa.2016.108.0078; Croitoru AE, 2013, GLOBAL PLANET CHANGE, V111, P127, DOI 10.1016/j.gloplacha.2013.09.004; de la Casa AC, 2012, ATMOS RES, V113, P140, DOI 10.1016/j.atmosres.2012.05.003; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348                                                                 ; Elliott G, 1996, ECONOMETRICA, V64, P813, DOI 10.2307/2171846                                                                 ; Enders W, 2012, OXFORD B ECON STAT, V74, P574, DOI 10.1111/j.1468-0084.2011.00662.x; Ferreira C, 2006, GENE EXPRESSION PROG, V21; Gocic M, 2013, GLOBAL PLANET CHANGE, V100, P172, DOI 10.1016/j.gloplacha.2012.10.014; Guven A, 2009, J EARTH SYST SCI, V118, P137, DOI 10.1007/s12040-009-0022-9                                                       ; Haktanir T, 2015, J HYDROL ENG, V20, DOI 10.1061/(ASCE)HE.1943-5584.0001246; Haktanir T, 2014, J HYDROL ENG, V19, DOI 10.1061/(ASCE)HE.1943-5584.0000973; Hamed KH, 1998, J HYDROL, V204, P182, DOI 10.1016/S0022-1694(97)00125-X                                                   ; Hamed KH, 2008, J HYDROL, V349, P350, DOI 10.1016/j.jhydrol.2007.11.009; Hess A, 2001, ATMOS ENVIRON, V35, P5211, DOI 10.1016/S1352-2310(01)00342-9; Kendall M. G., 1975, RANK CORRELATION MET; Khu ST, 2001, J AM WATER RESOUR AS, V37, P439, DOI 10.1111/j.1752-1688.2001.tb00980.x                                              ; Kumar S, 2009, J HYDROL, V374, P171, DOI 10.1016/j.jhydrol.2009.06.012; Kumar V, 2011, HYDROL RES, V42, P290, DOI 10.2166/nh.2011.067; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y                                                    ; Lu YC, 2010, MATH COMPUT SIMULAT, V80, P2019, DOI 10.1016/j.matcom.2010.02.010; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187                                                                 ; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.2307/2336182; SAID SE, 1984, BIOMETRIKA, V71, P599; Sayemuzzaman M, 2014, ATMOS RES, V137, P183, DOI 10.1016/j.atmosres.2013.10.012; SCHWERT GW, 1989, J BUS ECON STAT, V7, P147, DOI 10.2307/1391432                                                                 ; Sen PK, 1968, AM STAT ASS J, V63, P1379, DOI 10.1080/01621459.1968.10480934; Shamaei E, 2016, APPL SOFT COMPUT, V45, P187, DOI 10.1016/j.asoc.2016.03.009; Some'e BS, 2012, ATMOS RES, V113, P1, DOI 10.1016/j.atmosres.2012.04.016; Su CW, 2012, ECON MODEL, V29, P2719, DOI 10.1016/j.econmod.2012.06.017; Su CW, 2011, INT REV ECON FINANC, V20, P839, DOI 10.1016/j.iref.2011.03.004; Subash N, 2011, ATMOS RES, V99, P479, DOI 10.1016/j.atmosres.2010.11.020; Tabari H, 2011, ATMOS RES, V100, P132, DOI 10.1016/j.atmosres.2011.01.005; Taxak A. K., 2014, WEATHER CLIM EXTREM, V4, P50, DOI DOI 10.1016/J.WACE.2014.04.005; Tekleab S, 2013, PHYS CHEM EARTH, V61-62, P32, DOI 10.1016/j.pce.2013.04.017; Theil H., 1950, NEDERLANDSCHE AKAD W, V53, P521; Theil H., 1950, NEDERL AKAD WETENSCH, V53, P386; THEIL H., 1950, NEDERLANDSCHE AKAD W, V53, P1397; Visser H, 2004, ATMOS ENVIRON, V38, P4135, DOI 10.1016/j.atmosenv.2004.04.014; Wang J, 2015, INT REV ECON FINANC, V37, P157, DOI 10.1016/j.iref.2014.11.020; Yue S, 2002, HYDROL PROCESS, V16, P1807, DOI 10.1002/hyp.1095	49	0	0	8	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	MAY	2017	10	9							208	10.1007/s12517-017-2995-z				14	Geosciences, Multidisciplinary	Geology	EU8XY	WOS:000401323000011					2018-01-05	
J	Militello, KT; Lazatin, JC				Militello, Kevin T.; Lazatin, Justine C.			Discovery of Escherichia coli CRISPR sequences in an undergraduate laboratory	BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION			English	Article						CRISPR; Cas; spacer; repeat	CAS ADAPTIVE IMMUNITY; SPACER ACQUISITION; REPEATS; DNA; PROKARYOTES; ELEMENTS; GENE; IDENTIFICATION; DEFENSE; RNAS	Clustered regularly interspaced short palindromic repeats (CRISPRs) represent a novel type of adaptive immune system found in eubacteria and archaebacteria. CRISPRs have recently generated a lot of attention due to their unique ability to catalog foreign nucleic acids, their ability to destroy foreign nucleic acids in a mechanism that shares some similarity to RNA interference, and the ability to utilize reconstituted CRISPR systems for genome editing in numerous organisms. In order to introduce CRISPR biology into an undergraduate upper-level laboratory, a five-week set of exercises was designed to allow students to examine the CRISPR status of uncharacterized Escherichia coli strains and to allow the discovery of new repeats and spacers. Students started the project by isolating genomic DNA from E. coli and amplifying the iap CRISPR locus using the polymerase chain reaction (PCR). The PCR products were analyzed by Sanger DNA sequencing, and the sequences were examined for the presence of CRISPR repeat sequences. The regions between the repeats, the spacers, were extracted and analyzed with BLASTN searches. Overall, CRISPR loci were sequenced from several previously uncharacterized E. coli strains and one E. coli K-12 strain. Sanger DNA sequencing resulted in the discovery of 36 spacer sequences and their corresponding surrounding repeat sequences. Five of the spacers were homologous to foreign (non-E. coli) DNA. Assessment of the laboratory indicates that improvements were made in the ability of students to answer questions relating to the structure and function of CRISPRs. Future directions of the laboratory are presented and discussed. (c) 2016 by The International Union of Biochemistry and Molecular Biology, 45(3):262-269, 2017.	[Militello, Kevin T.; Lazatin, Justine C.] SUNY Coll Geneseo, Dept Biol, Geneseo, NY 14454 USA	Militello, KT (reprint author), SUNY Coll Geneseo, 1 Coll Circle,ISC 357, Geneseo, NY 14454 USA.	militello@geneseo.edu					Adame V, 2016, BIOCHEM MOL BIOL EDU, V44, P263, DOI 10.1002/bmb.20950; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Diez-Villasenor C, 2010, MICROBIOL-SGM, V156, P1351, DOI 10.1099/mic.0.036046-0; Garcia-Gutierrez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131935; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kerfeld CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001014; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Militello KT, 2012, FEMS MICROBIOL LETT, V328, P78, DOI 10.1111/j.1574-6968.2011.02482.x; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Yin Shuang, 2013, Appl Environ Microbiol, V79, P5710, DOI 10.1128/AEM.00950-13; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	27	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-8175	1539-3429		BIOCHEM MOL BIOL EDU	Biochem. Mol. Biol. Educ.	MAY-JUN	2017	45	3					262	269		10.1002/bmb.21025				8	Biochemistry & Molecular Biology; Education, Scientific Disciplines	Biochemistry & Molecular Biology; Education & Educational Research	EV0MH	WOS:000401433700008	27677251	gold			2018-01-05	
J	Annette, B; Ramesh, K; Reddy, PH				Boles, Annette; Kandimalla, Ramesh; Reddy, P. Hemachandra			Dynamics of diabetes and obesity: Epidemiological perspective	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Review						Alzheimer's disease; Diabetes; Obesity; FTO	CARDIOVASCULAR RISK-FACTORS; STIFF-MAN SYNDROME; IMPAIRED GLUCOSE-TOLERANCE; GLYCOGEN-SYNTHASE KINASE-3; SELF-MANAGEMENT EDUCATION; INSULIN-RECEPTOR GENE; ALZHEIMERS-DISEASE; KLINEFELTERS-SYNDROME; LIFE-STYLE; METABOLIC SYNDROME	The purpose of this review article is to understand the current literature on obesity, diabetes and therapeutic avenues across the world. Diabetes is a chronic lifestyle condition that affects millions of people worldwide and it is a major health concern in our society. Diabetes and obesity are associated with various conditions, including non modifiable and modifiable risk factors. Early detectable markers are not well established to detect pre-diabetes and as a result, it becomes diabetes. Several published epidemiological studies were assessed and the findings were summarized. Resources from published studies were used to identify criteria used for pre-diabetes, the role of diet in pre-diabetics and potential risks and characteristics associated with pre-diabetes. Preventive strategies are needed to combat diabetes. Individuals diagnosed with pre-diabetes need detailed education, need to fully understand the risk factors and have the ability to manage diabetes. Interventions exist that include chronic disease self-management programs, lifestyle interventions and pharmacological strategies. Obesity plays a large role in causing pre-diabetes and diabetes. Critical analysis of existing epidemiological research data suggests that additional research is needed to determine the efficacy of interventions. This article is part of a Special Issue entitled: Oxidative Stress and Mitochondrial Quality in Diabetes/Obesity and Critical Illness Spectrum of Diseases edited by P. Hemachandra Reddy. (C) 2017 Elsevier B.V. All rights reserved.	[Boles, Annette; Reddy, P. Hemachandra] Community Outreach & Educ, 6630 S Quaker Ave,Suite E, Lubbock, TX 79413 USA; [Kandimalla, Ramesh; Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Garrison Inst Aging, 3601 4th St,MS 9424, Lubbock, TX 79430 USA; [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA; [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, 3601 4th St, Lubbock, TX 79430 USA; [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Dept Neurol, 3601 4th St, Lubbock, TX 79430 USA; [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Speech Dept, 3601 4th St, Lubbock, TX 79430 USA; [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Language & Hearing Sci Dept, 3601 4th St, Lubbock, TX 79430 USA; [Reddy, P. Hemachandra] Dept Publ Hlth, 3601 4th St,MS 9424, Lubbock, TX 79430 USA	Ramesh, K (reprint author), Texas Tech Univ, Hlth Sci Ctr, Garrison Inst Aging, 3601 4th St,MS 9424, Lubbock, TX 79430 USA.; Annette, B (reprint author), Texas Tech Univ, Hlth Sci Ctr, Garrison Inst Aging, 6630 S Quaker Ste E,MS 7495, Lubbock, TX 79413 USA.	annette.boles@ttuhsc.edu; ramesh.kandimalla@ttuhsc.edu	Kandimalla, Ramesh/O-4047-2017	Kandimalla, Ramesh/0000-0002-3313-4393	NIH grants [AG042178, AG047812]; Garrison Family Foundation	NIH grants (AG042178, AG047812) & the Garrison Family Foundation support this work.	Adane AA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4234; Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; Alam F., 2016, CURR PHARM DES; AmericanDiabetesAssociation, 2009, DIABETES CARE S1, V32, pS62; Appelman Y, 2015, ATHEROSCLEROSIS, V241, P211, DOI 10.1016/j.atherosclerosis.2015.01.027; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Babey Susan H, 2016, Policy Brief UCLA Cent Health Policy Res, P1; BAEKKESKOV S, 1982, NATURE, V298, P167, DOI 10.1038/298167a0; Bakalov VK, 2009, J CLIN ENDOCR METAB, V94, P3289, DOI 10.1210/jc.2009-0384; Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296; Barbagallo M, 2014, WORLD J DIABETES, V5, P889, DOI 10.4239/wjd.v5.i6.889; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Bian X, 2016, DIABETES, V65, P285, DOI 10.2337/db15-0179; Bock G, 2006, DIABETES, V55, P3536, DOI 10.2337/db06-0319; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469                                                        ; Bojesen A, 2010, MOL HUM REPROD, V16, P396, DOI 10.1093/molehr/gaq016; Boles AN, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00085; Cai XP, 2012, CHINESE MED J-PEKING, V125, P937, DOI 10.3760/cma.j.issn.0366-6999.2012.05.036; Callea M, 2013, MINERVA PEDIATR, V65, P251; Catalano KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108693; Chawla Aastha, 2016, Indian J Endocrinol Metab, V20, P546, DOI 10.4103/2230-8210.183480; Dailey George, 2011, Diabetes Technol Ther, V13 Suppl 1, pS65, DOI 10.1089/dia.2011.0019; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; DeFronzo RA, 2011, J CLIN ENDOCR METAB, V96, P2354, DOI 10.1210/jc.2011-0246; de la Monte SM, 2008, J DIABETES SCI TECHN, V2, P1101, DOI DOI 10.1177/193229680800200619; Dezayee ZMI, 2012, J RES MED SCI, V17, P855; Dugan JA, 2016, JAAPA-J AM ACAD PHYS, V29, P13, DOI 10.1097/01.JAA.0000475460.77476.f6; Edelman D, 2002, J GEN INTERN MED, V17, P23, DOI 10.1046/j.1525-1497.2002.10420.x; Enuh H, 2014, CLIN MED INSIGHT-CAS, V7, P139, DOI 10.4137/CCRep.S16941; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Faerch K, 2016, CURR DIABETES REV, V12, P30, DOI 10.2174/1573399811666150416122903; Falciglia M, 2007, CURR OPIN CLIN NUTR, V10, P498, DOI 10.1097/MCO.0b013e3281a3bf0a                                                    ; Feldman AZ, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0765-z; Fernandes JD, 2016, DIABETES RES CLIN PR, V117, P48, DOI 10.1016/j.diabres.2016.04.016; Fradkin JE, 2012, HEALTH AFFAIR, V31, P12, DOI 10.1377/hlthaff.2011.1150; Franz MJ, 2014, DIABETES METAB SYNDR, V7, P65, DOI 10.2147/DMSO.S45140; Fukuoka Y, 2015, DIABETES RES CLIN PR, V109, P157, DOI 10.1016/j.diabres.2015.04.015; Funnell MM, 2010, DIABETES CARE, V33, pS89, DOI 10.2337/dc10-S089; Golden SH, 2012, J CLIN ENDOCR METAB, V97, pE1579, DOI 10.1210/jc.2012-2043; Gomes RC, 2016, SCAND J GASTROENTERO, V51, P178, DOI 10.3109/00365521.2015.1079645; Goppert D, 2000, DEUT MED WOCHENSCHR, V125, P826, DOI 10.1055/s-2000-7008; Gravholt CH, 2011, ACTA PAEDIATR, V100, P871, DOI 10.1111/j.1651-2227.2011.02233.x; Haliloglu B., 2016, CLIN ENDOCRINOL OXF; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; Harris MI, 2000, DIABETES METAB RES, V16, P230, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR122>3.3.CO;2-N; Heuvel-Borsboom H, 2016, NETH J MED, V74, P193; Hojlund K, 2006, DIABETOLOGIA, V49, P1827, DOI 10.1007/s00125-006-0312-6; Hojlund K, 2014, DAN MED J, V61; Hojlund K, 2012, EUR J ENDOCRINOL, V166, P511, DOI 10.1530/EJE-11-0790; Hsu JL, 2012, NEUROIMAGE, V59, P1098, DOI 10.1016/j.neuroimage.2011.09.041; Huttly WJ, 2016, PRENATAL DIAG, V36, P192, DOI 10.1002/pd.4722; Inzucchi SE, 2012, NEW ENGL J MED, V367, P542, DOI 10.1056/NEJMcp1103643; Jellinger K.A., 2015, J ALZHEIMERS DIS PAR, V5, P193; Jiang-Feng M, 2012, FERTIL STERIL, V98, P1331, DOI 10.1016/j.fertnstert.2012.07.1122; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; Kandimalla R, 2016, BBA-MOL BASIS DIS, V1862, P814, DOI 10.1016/j.bbadis.2015.12.018; Kawamura T, 2012, J DIABETES INVEST, V3, P413, DOI 10.1111/j.2040-1124.2012.00234.x; Kim C, 2014, DIABETIC MED, V31, P292, DOI 10.1111/dme.12382; Kim C, 2012, DIABETIC MED, V29, P278, DOI 10.1111/j.1464-5491.2011.03415.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393; Kosseifi Semaan G, 2010, Tenn Med, V103, P43; Kota Sunil Kumar, 2013, Indian J Hum Genet, V19, P358, DOI 10.4103/0971-6866.120818; Kuljis RO, 2011, J ALZHEIMERS DIS, V25, P29, DOI 10.3233/JAD-2011-101392; Lappalainen T, 2012, BRIT J NUTR, V108, P1859, DOI 10.1017/S0007114511007410; Lichiardopol Corina, 2007, Rom J Intern Med, V45, P299; Lorber D, 2014, DIABETES METAB SYNDR, V7, P169, DOI 10.2147/DMSO.S61438; Lorenzo C, 2010, DIABETES CARE, V33, P2104, DOI 10.2337/dc10-0679; Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006; Luchsinger JA, 2015, DIABETES RES CLIN PR, V108, pE63, DOI 10.1016/j.diabres.2015.02.023; Ma DL, 2015, J NEUROCHEM, V135, P301, DOI 10.1111/jnc.13248; Maqbool M, 2016, EUR J MED CHEM, V107, P63, DOI 10.1016/j.ejmech.2015.10.018; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; Mittal K., 2016, DIABETOL METAB SYNDR; Moleres A, 2012, BRIT J NUTR, V107, P533, DOI 10.1017/S0007114511003424; Nakagami T, 2010, DIABETES RES CLIN PR, V87, P126, DOI 10.1016/j.diabres.2009.11.001; Nan HL, 2013, CHINESE MED J-PEKING, V126, P196, DOI 10.3760/cma.j.issn.0366-6999.20122789; Narayanaswami V., 2016, PHARMACOL THERAPEUT, V7258, P30194; Moreno CN, 2014, ENDOCRINOL NUTR, V61, P439; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Obara-Moszynska M., 2016, PEDIAT ENDOCRINOL DI, V20, P75; Okwechime IO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145781; Lopez AP, 2016, DIABETES RES CLIN PR, V118, P38, DOI 10.1016/j.diabres.2016.04.057; Panimolle F, 2016, ENDOCRINE, V52, P157, DOI 10.1007/s12020-015-0613-y; [Панков Ю.А. Pankov Y.A.], 2016, [Биомедицинская химия, Biomeditsinskaya Khimiya, Biomeditsinskaya khimiya], V62, P5, DOI 10.18097/PBMC20166201005; Pantalone KM, 2012, DIABETES OBES METAB, V14, P803, DOI 10.1111/j.1463-1326.2012.01604.x; Pantalone KM, 2015, BMJ OPEN DIABETES RE, V3, DOI 10.1136/bmjdrc-2015-000093; Patel S, 2004, BIOCHEM SOC T, V32, P803, DOI 10.1042/BST0320803                                                              ; Peiris H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006033; Poudel A, 2015, ENDOCRINE, V49, P693, DOI 10.1007/s12020-015-0534-9; Precechtelova J, 2014, J PATHOG, DOI 10.1155/2014/738512; Pu J, 2013, RES SOC ADMIN PHARM, V9, P790, DOI 10.1016/j.sapharm.2012.11.005; Pugazhenthi S., 2016, BIOCH BIOPHYS ACTA; Qu ZS, 2014, SCI WORLD J, DOI 10.1155/2014/878123; Razquin C, 2010, EUR J NUTR, V49, P311, DOI 10.1007/s00394-009-0090-2; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P1913, DOI 10.1016/j.bbadis.2013.06.012; Rooney B, 2011, FEBS LETT, V585, P531, DOI 10.1016/j.febslet.2011.01.004; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Salpeter SR, 2008, AM J MED, V121, P149, DOI 10.1016/j.amjmed.2007.09.016; Sherr D, 2013, AM J PREV MED, V44, pS390, DOI 10.1016/j.amepre.2012.12.013; Shimizu F, 2013, NEUROBIOL AGING, V34, P1902, DOI 10.1016/j.neurobiolaging.2013.01.012; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sonestedt E, 2012, J CLIN ENDOCR METAB, V97, pE810, DOI 10.1210/jc.2011-2444; Spanakis EK, 2013, CURR DIABETES REP, V13, P814, DOI 10.1007/s11892-013-0421-9; Spencer L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011263.pub2; Stanford KI, 2015, DIABETES, V64, P2361, DOI 10.2337/db15-0227; Stoeckel Luke E, 2016, F1000Res, V5, P353, DOI 10.12688/f1000research.8300.2; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Teychenne M, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0266-5; Tieu J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007222.pub3; Tieu J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007222.pub2; Triplitt C, 2015, EXPERT OPIN PHARMACO, V16, P2819, DOI 10.1517/14656566.2015.1114098; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Tuso Phillip, 2014, Perm J, V18, P88, DOI 10.7812/TPP/14-002; Vlaar EMA, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-8; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; Walikonis JE, 1998, MAYO CLIN PROC, V73, P1161, DOI 10.4065/73.12.1161                                                              ; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028962; World Health Organization, 1985, TECH REP SER; Wojcik JL, 2016, OBESITY, V24, P123, DOI 10.1002/oby.21312; Wojcik M, 2015, NEUROENDOCRINOL LETT, V36, P583; Yang J, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0095-5; Young BA, 2008, AM J MANAG CARE, V14, P15; Ziegler B, 1996, ACTA DIABETOL, V33, P225; [Anonymous], 2014, DIABETES CARE S1, V37; 2004, DIABETES CARE S1, V27, pS5	127	2	2	7	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	MAY	2017	1863	5			SI		1026	1036		10.1016/j.bbadis.2017.01.016				11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EU5BO	WOS:000401046800002					2018-01-05	
J	Sandhir, R; Halder, A; Sunkaria, A				Sandhir, Rajat; Halder, Avishek; Sunkaria, Aditya			Mitochondria as a centrally positioned hub in the innate immune response	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Review						inflammasome:innate immune response; Inflammation; Mitochondria; NLRP3	NLRP3 INFLAMMASOME ACTIVATION; NF-KAPPA-B; INTERLEUKIN-1-BETA CONVERTING-ENZYME; ALZHEIMERS-DISEASE; ADAPTER PROTEIN; RIG-I; ANTIVIRAL RESPONSES; PARKINSONS-DISEASE; BRAIN-INJURY; AMYLOID-BETA	Mitochondria are vital organelles involved in numerous cellular functions ranging from energy metabolism to cell survival. Emerging evidence suggests that mitochondria provide a platform for signaling pathways involved in innate immune response. Mitochondrial ROS (mtROS) production, mitochondrial DNA (mtDNA) release, mitochondrial antiviral signaling protein (MAVS) are key triggers in the activation of innate immune response following variety of stress signals that include infection, tissue damage and metabolic dysregulation. The process is mediated through pattern recognition receptors (PRRs) that consist of retinoic acid inducible gene like receptors (RLRs), c-type lectin receptors (CLRs), toll type receptors (TLRs) and nuclear oligomerization-domain like receptors (NLRs). These signals converge to form a multiprotein complex called inflammasome that leads to caspase-1 activation to promote processing of precursor cytokines (pro-IL1 beta and pro-IL-18) to active cytokines (IL-1 beta and IL-18). It appears that mitochondria induced inflammasome activation contributes to inflammatory process in many diverse disorders. Therefore, strategies aimed at modulating mitochondria mediated inflammasome activation might be beneficial in many pathophysiological conditions. This article is part of a Special Issue entitled: Oxidative Stress and Mitochondrial Quality in Diabetes/Obesity and Critical Illness Spectrum of Diseases- edited by P. Hemachandra Reddy. (C) 2016 Elsevier B.V. All rights reserved.	[Sandhir, Rajat; Halder, Avishek; Sunkaria, Aditya] Panjab Univ, Dept Biochem, Chandigarh, India	Sandhir, R (reprint author), Panjab Univ, Dept Biochem, Chandigarh, India.	sandhir@pu.ac.in			University Grants Commission, New Delhi [F.4-7/2015/DRS-I(SAP-II)]; Department of Science & Technology, Govt of India under the Promotion of University Research and Scientific Excellence grant (PURSE, Phase II)	The financial assistance provided by the University Grants Commission, New Delhi under the Special Assistance Program [F.4-7/2015/DRS-I(SAP-II)] is acknowledged. The financial assistance provided by the Department of Science & Technology, Govt of India under the Promotion of University Research and Scientific Excellence grant (PURSE, Phase II) is also acknowledged.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Albers DS, 2000, J NEUROCHEM, V74, P878, DOI 10.1046/j.1471-4159.2000.740878.x                                               ; Antico Arciuch Valeria Gabriela, 2012, Antioxid Redox Signal, V16, P1150, DOI 10.1089/ars.2011.4085; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Brookes P.S., 2007, HDB NEUROCHEMISTRY M, V4, P519; Brookes P.S., 2007, HDB NEUROCHEMISTRY M, V5, P519; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; BUTTERWORTH RF, 1990, METAB BRAIN DIS, V5, P179, DOI 10.1007/BF00997071; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen LJ, 2015, NEUROBIOL AGING, V36, P2533, DOI 10.1016/j.neurobiolaging.2015.05.018; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Chouard T, 2010, NATURE, V468, P213, DOI 10.1038/468213a; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; David CN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005643; De Filippis L, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0221-7; Du RH, 2016, REDOX BIOL, V9, P178, DOI 10.1016/j.redox.2016.08.006; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fitzgerald DC, 2007, VET IMMUNOL IMMUNOP, V116, P59, DOI 10.1016/j.vetimm.2006.12.008; Franceschini A, 2015, FASEB J, V29, P2450, DOI 10.1096/fj.14-268714; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gao JF, 2015, FREE RADICAL BIO MED, V89, P322, DOI 10.1016/j.freeradbiomed.2015.09.002; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gibson GE, 2003, NEUROCHEM INT, V43, P129, DOI 10.1016/S0197-0186(02)00225-5; Gibson GE, 2000, ANN NEUROL, V48, P297, DOI 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z; Gilkerson R., 2014, J CLIN IMMUNOL IMMUN, V1, P1; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206                                                    ; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Gustin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130624; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI, V69, P4215, DOI 10.1007/s00018-012-1140-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Haroon S, 2016, CURR OPIN GENET DEV, V38, P68, DOI 10.1016/j.gde.2016.04.004; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Heinen A, 2007, AM J PHYSIOL-CELL PH, V292, pC148, DOI 10.1152/ajpcell.00215.2006; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270; Kawana N., 2013, CLIN EXP NEUROIMMUNO, V4, P296; Kim HK, 2016, J PSYCHIATR RES, V72, P43, DOI 10.1016/j.jpsychires.2015.10.015; Kim MJ, 2016, AUTOPHAGY, V12, P1272, DOI 10.1080/15548627.2016.1183081; Klivenyi P, 2004, J NEUROCHEM, V88, P1352, DOI 10.1046/j.1471-4159.2003.02263.x; Koshiba T, 2013, BBA-MOL CELL RES, V1833, P225, DOI 10.1016/j.bbamcr.2012.03.005; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu PH, 2015, BIOCHEM BIOPH RES CO, V468, P319, DOI 10.1016/j.bbrc.2015.10.105; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Lorenz G, 2014, NEPHROL DIAL TRANSPL, V29, P41, DOI 10.1093/ndt/gft332; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230                                                         ; Iyer S. S., 2013, IMMUNITY, V39, P311, DOI DOI 10.1016/J.IMMUNI.2013.08.001; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mastrogiacomo F, 1996, ANN NEUROL, V39, P592, DOI 10.1002/ana.410390508; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mirrione MM, 2010, NEUROBIOL DIS, V39, P85, DOI 10.1016/j.nbd.2010.04.001; Moreira PI, 2002, J NEUROSCI RES, V69, P257, DOI 10.1002/jnr.10282; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Nash B, 2011, J NEUROSCI, V31, P13028, DOI 10.1523/JNEUROSCI.1449-11.2011; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Putra ABN, 2014, MOL IMMUNOL, V58, P32, DOI 10.1016/j.molimm.2013.11.003; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Reikine S, 2014, PATTERN RECOGN, V5, P342, DOI DOI 10.3389/FIMMU.2014.00342; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rodriguez-Muela N, 2015, CELL DEATH DIFFER, V22, P476, DOI 10.1038/cdd.2014.203; Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shao BZ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00262; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shpargel Karl B, 2008, Cleve Clin J Med, V75 Suppl 2, pS77; Smith K, 2010, NATURE, V468, P160, DOI 10.1038/468160a; Stanker LH, 2010, J IMMUNOL, V185, P729, DOI 10.4049/jimmunol.0902930; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Suzuki M, 2014, CELL HOST MICROBE, V16, P581, DOI 10.1016/j.chom.2014.09.015; Tang ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009172; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212; Terwel D, 1998, J NEUROL SCI, V161, P47, DOI 10.1016/S0022-510X(98)00240-8; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0                                                                ; Weinstein JR, 2010, FUTUR NEUROL, V5, P227, DOI 10.2217/FNL.10.1; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wi SM, 2014, J BIOL CHEM, V289, P35205, DOI 10.1074/jbc.M114.597187; Wiens KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005809; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0                                                                ; Won JH, 2015, J BIOL CHEM, V290, P27425, DOI 10.1074/jbc.M115.667063; Woyda-Ploszczyca Andrzej, 2008, Postepy Biochem, V54, P188; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yazlovitskaya EM, 2006, CANCER RES, V66, P11179, DOI 10.1158/0008-5472.CAN-06-2740; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0094-3	115	3	3	5	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	MAY	2017	1863	5			SI		1090	1097		10.1016/j.bbadis.2016.10.020				8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EU5BO	WOS:000401046800008	27794419				2018-01-05	
J	Paes, BCMF; Moco, PD; Pereira, CG; Porto, GS; Russo, EMD; Reis, LCJ; Covas, DT; Picanco-Castro, V				Martins Fernandes Paes, Barbara Cristina; Moco, Pablo Diego; Pereira, Cristiano Goncalves; Porto, Geciane Silveira; de Sousa Russo, Elisa Maria; Junqueira Reis, Luiza Cunha; Covas, Dimas Tadeu; Picanco-Castro, Virginia			Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation	CELL BIOLOGY AND TOXICOLOGY			English	Review						Blood cells; Clinical trials; Hematopoietic differentiation; Induced pluripotent stem cells; Patent landscape	PLURIPOTENT STEM-CELLS; JUVENILE MYELOMONOCYTIC LEUKEMIA; MESENCHYMAL STROMAL CELLS; BLOOD MONONUCLEAR-CELLS; HUMAN PERIPHERAL-BLOOD; PROGENITOR CELLS; GENE CORRECTION; T-CELLS; PATIENT SAMPLES; GENERATION	Ten years have passed since the first publication announcing the generation of induced pluripotent stem cells (iPSCs). Issues related to ethics, immune rejection, and cell availability seemed to be solved following this breakthrough. The development of iPSC technology allows advances in in vitro cell differentiation for cell therapy purpose and other clinical applications. This review provides a perspective on the iPSC potential for cell therapies, particularly for hematological applications. We discuss the advances in in vitro hematopoietic differentiation, the possibilities to employ iPSC in hematology studies, and their potential clinical application in hematologic diseases. The generation of red blood cells and functional T cells and the genome editing technology applied to mutation correction are also covered. We highlight some of the requirements and obstacles to be overcome before translating these cells from research to the clinic, for instance, iPSC variability, genotoxicity, the differentiation process, and engraftment. Also, we evaluate the patent landscape and compile the clinical trials in the field of pluripotent stem cells. Currently, we know much more about iPSC than in 2006, but there are still challenges that must be solved. A greater understanding of molecular mechanisms underlying the generation of hematopoietic stem cells is necessary to produce suitable and transplantable hematopoietic stem progenitor cells from iPSC.	[Martins Fernandes Paes, Barbara Cristina; Moco, Pablo Diego; Covas, Dimas Tadeu] Univ Sao Paulo, Ribeirao Preto Med Sch, Sao Paulo, Brazil; [Martins Fernandes Paes, Barbara Cristina; Moco, Pablo Diego; Covas, Dimas Tadeu] Univ Sao Paulo, Ctr Cell Based Therapy CTC, Sao Paulo, Brazil; [Martins Fernandes Paes, Barbara Cristina; Moco, Pablo Diego; de Sousa Russo, Elisa Maria; Junqueira Reis, Luiza Cunha; Covas, Dimas Tadeu; Picanco-Castro, Virginia] Reg Blood Ctr Ribeiro Preto, Rua Tenente Catao Roxo 2501, BR-14051140 Sao Paulo, Brazil; [de Sousa Russo, Elisa Maria; Junqueira Reis, Luiza Cunha] Univ Sao Paulo, Ribeiro Preto Pharmaceut Sci Sch, Sao Paulo, Brazil; [Pereira, Cristiano Goncalves; Porto, Geciane Silveira] Univ Sao Paulo, Sch Econ Business Adm & Accounting Ribeirao Preto, Sao Paulo, Brazil	Picanco-Castro, V (reprint author), Reg Blood Ctr Ribeiro Preto, Rua Tenente Catao Roxo 2501, BR-14051140 Sao Paulo, Brazil.	virginia.picanco@hemocentro.fmrp.usp.br	Covas, Dimas/C-5431-2013; Porto, Geciane/F-9571-2012	Covas, Dimas/0000-0002-7364-2595; Porto, Geciane/0000-0001-6104-3627; Pereira, Cristiano Goncalves/0000-0003-0364-7793; Martins Fernandes Paes, Barbara Cristina/0000-0002-6002-7972; Moco, Pablo/0000-0001-9405-4242	Sao Paulo Research Foundation (FAPESP) [13/08135-2, 14/22500-8, 16/08373-9, 16/08374-5]	This work is supported in part by Sao Paulo Research Foundation (FAPESP), grant nos. 13/08135-2, 14/22500-8, 16/08373-9, and 16/08374-5. We would like to thank Sandra Navarro for drawing the figures.	Abed S, 2015, HAEMATOLOGICA, V100, pE428, DOI 10.3324/haematol.2015.127373; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Amabile G, 2013, BLOOD, V121, P1255, DOI 10.1182/blood-2012-06-434407; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Baghbaderani BA, 2015, STEM CELL REP, V5, P647, DOI 10.1016/j.stemcr.2015.08.015; Bedel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071596; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Briquet A, 2010, HAEMATOL-HEMATOL J, V95, P47, DOI 10.3324/haematol.2009.008524; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Cerdan C, 2012, STEM CELLS DEV, V21, P2866, DOI 10.1089/scd.2012.0053; Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Connelly JP, 2014, BLOOD, V124, P1926, DOI 10.1182/blood-2014-01550525; Dorn I, 2015, HAEMATOLOGICA, V100, P32, DOI 10.3324/haematol.2014.108068; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Escobedo-Cousin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138623; Fernandez-Garcia M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0155-5; Fujita A, 2016, STEM CELLS, V34, P1541, DOI 10.1002/stem.2335; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gandre-Babbe S, 2013, BLOOD, V121, P4925, DOI 10.1182/blood-2013-01-478412; Garcon L, 2013, BLOOD, V122, P912, DOI 10.1182/blood-2013-01-478321; Ge JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134878; Goh PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081622; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Gori JL, 2015, J CLIN INVEST, V125, P1243, DOI 10.1172/JCI79328; Gu B, 2013, BLOOD, V122; Hafez M, 2012, GENOME, V55, P553, DOI [10.1139/G2012-049, 10.1139/g2012-049]; Hermanson DL, 2016, STEM CELLS, V34, P93, DOI 10.1002/stem.2230; Hirata S, 2013, J CLIN INVEST, V123, P3802, DOI 10.1172/JCI64721; Hong SG, 2013, MOL THER, V21, P272, DOI 10.1038/mt.2012.255; Hosoi M, 2014, EXP HEMATOL, V42, P816, DOI 10.1016/j.exphem.2014.03.010; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Iizuka H, 2015, EXP HEMATOL, V43, P849, DOI 10.1016/j.exphem.2015.05.004; Izawa K, 2014, BLOOD, V124; Jia B, 2014, LIFE SCI, V108, P22, DOI 10.1016/j.lfs.2014.05.004; Kang XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131128; Kappler-Gratias S, 2011, TRANSFUSION, V51, P36, DOI 10.1111/j.1537-2995.2010.02802.x; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598                                                          ; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473                                                            ; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Koyanagi-Aoi M, 2013, P NATL ACAD SCI USA, V110, P20569, DOI 10.1073/pnas.1319061110; KRIKEN Garber, 2015, NAT BIOTECHNOL NATUR, V33, P890; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321                                                      ; Lapillonne H, 2010, HAEMATOL-HEMATOL J, V95, P1651, DOI 10.3324/haematol.2010.023556; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P219, DOI 10.1111/j.1749-6632.2009.04606.x; Liang HC-Y, 2013, METHOD MOL BIOL, P119; Liu J, 2015, EXP CELL RES, V338, P203, DOI 10.1016/j.yexcr.2015.08.004; Liu XD, 2014, CELL TRANSPLANT, V23, P1087, DOI 10.3727/096368912X661319; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Mathews DJH, 2013, CELL STEM CELL, V12, P508, DOI 10.1016/j.stem.2013.04.015; Minami E, 2007, FASEB J, V21, P1291, DOI 10.1096/fj.07-0503ufm; Morishima T, 2014, HAEMATOLOGICA, V99, P19, DOI 10.3324/haematol.2013.083873; Mulero-Navarro S, 2015, CELL REP, V13, P504, DOI 10.1016/j.celrep.2015.09.019; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nayak RC, 2015, J CLIN INVEST, V125, P3103, DOI 10.1172/JCI80924; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Ng ES, 2008, CURR PROTOC STEM CEL; Nishizawa M, 2016, CELL STEM CELL, V19, P341, DOI 10.1016/j.stem.2016.06.019; Niu XH, 2016, J BIOL CHEM, V291, P16576, DOI 10.1074/jbc.M116.719237; Ohmine S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt87; Olivier EN, 2006, EXP HEMATOL, V34, P1635, DOI 10.1016/j.exphem.2006.07.003; Park CY, 2015, CELL STEM CELL, V17, P213, DOI 10.1016/j.stem.2015.07.001; Peyrard T, 2011, TRANSFUS MED REV, V25, P206, DOI 10.1016/j.tmrv.2011.01.002; Pick M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055530; Pineault N, 2013, METHOD MOL BIOL, P205; Priest CA, 2015, REGEN MED, V10, P939, DOI 10.2217/rme.15.57; Ramos-Mejia V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035824; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao MS, 2013, STEM CELL RES THER, V4, DOI [10.1186/1757-6512-4-98, 10.1186/scrt309]; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; RIKEN-Foundation for Biomedical Research and Innovation, 2013, RIKEN IBRI; Roberts M, 2014, NAT BIOTECHNOL, V32, P742, DOI 10.1038/nbt.2975; Rodrigues GMC, 2015, BIOTECHNOL J, V10, P1103, DOI 10.1002/biot.201400535; Rowe RG, 2016, CELL STEM CELL, V18, P707, DOI 10.1016/j.stem.2016.05.016; Sakurai M, 2014, LEUKEMIA, V28, P2344, DOI 10.1038/leu.2014.136; Sayed N, 2016, J AM COLL CARDIOL, V67, P2161, DOI 10.1016/j.jacc.2016.01.083; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Scott CT, 2005, NAT BIOTECHNOL, V23, P915, DOI 10.1038/nbt0805-915; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Simonson OE, 2015, ANN MED, V47, P370, DOI 10.3109/07853890.2015.1051579; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Stephenson E, 2012, NAT PROTOC, V7, P1366, DOI 10.1038/nprot.2012.080; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Suknuntha K, 2015, STEM CELL RES, V15, P678, DOI 10.1016/j.scr.2015.10.015; Sun N, 2014, BIOTECHNOL BIOENG, V111, P1048, DOI 10.1002/bit.25018; Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Themeli M, 2013, NAT BIOTECHNOL, V31, P928, DOI 10.1038/nbt.2678; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Todorova D, 2016, STEM CELLS, V34, P510, DOI 10.1002/stem.2227; Tulpule A, 2013, CELL STEM CELL, V12, P727, DOI 10.1016/j.stem.2013.04.002; Ugwu NI, 2015, NIGER J CLIN PRACT, V18, P522, DOI 10.4103/1119-3077.154204; University hospitalMedical Information Network (UMIN) Center, 2016, UMIN CTR CLIN TRIAL; U. S. Food and Drug Administration, 2015, FACTS CURR GOOD MAN; U. S. Food and Drug Administration, 2012, FDA WARNS STEM CELL; Vanhee S, 2015, HAEMATOLOGICA, V100, P157, DOI 10.3324/haematol.2014.112144; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang Y, 2013, STEM CELL RES, V11, P1103, DOI 10.1016/j.scr.2013.07.011; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Yazdanbakhsh K, 2012, BLOOD, V120, P528, DOI 10.1182/blood-2011-11-327361; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI [10.1126/science.1151526, 10.1126/science.1172482]; Zhao K, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0276-z	116	1	1	2	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0742-2091	1573-6822		CELL BIOL TOXICOL	Cell Biol. Toxicol.	MAY	2017	33	3					233	250		10.1007/s10565-016-9377-2				18	Cell Biology; Toxicology	Cell Biology; Toxicology	EU3LV	WOS:000400933300003	28039590				2018-01-05	
J	Yang, X; Li, YM; Li, LY; Liu, J; Wu, M; Ye, M				Yang, Xiao; Li, Yiming; Li, Lianyun; Liu, Juan; Wu, Min; Ye, Mei			SnoRNAs are involved in the progression of ulcerative colitis and colorectal cancer	DIGESTIVE AND LIVER DISEASE			English	Article						Biomarkers; Colorectal cancer; IBD; SnoRNAs	SMALL NUCLEOLAR RNAS; CELL LUNG-CANCER; PROSTATE-CANCER; BIOMARKERS; SIGNATURES; GENES; U50	Background and aim: Emerging evidences indicate that small nucleolar RNAs (snoRNAs) are important regulatory molecules involved in various pathophysiological processes including inflammation and cancer. In the current study, we investigate whether snoRNAs dysregulate in colorectal cancer (CRC) and intestinal inflammation and contribute the pathogenesis of CRC. Methods: We analyzed the snoRNAs expression profile in CRC patients by GeneChipR Array and validated candidate snoRNAs expression in 44 CRC tissues, as well as in 28 ulcerative colitis (UC) and 28 healthy controls using reverse transcription quantitative polymerase chain reaction. Furthermore, we analyzed the correlation between snoRNAs expression and clinical characteristics of CRC and evaluated the diagnosis and differentiation efficiencies of the snoRNAs in CRC and UC. Results: The expression of snoRA15, snoRA41 displayed increased, whereas snoRD33 was down-regulated in CRC compared with matched non-cancerous tissues. When compared to healthy control, the three snoRNAs are all upregulated in lesion tissue of UC and CRC, which showed an increasingly trend from healthy control to UC and CRC. Conclusions: The identified three snoRNAs might contribute the carcinogenesis of colorectal cancer and involve in the progress from chronic intestinal inflammation to malignant tumor. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Yang, Xiao; Li, Yiming; Liu, Juan; Ye, Mei] Wuhan Univ, Zhongnan Hosp, Dept Geriatr, Div Gastroenterol, Wuhan 430071, Hubei, Peoples R China; [Li, Lianyun; Wu, Min] Wuhan Univ, Coll Life Sci, Wuhan 430071, Hubei, Peoples R China	Ye, M (reprint author), Wuhan Univ, Zhongnan Hosp, Dept Geriatr, Div Gastroenterol, Wuhan 430071, Hubei, Peoples R China.	wumeiye08@163.com		Li, Lianyun/0000-0003-4194-3059	National Natural Science Foundation of China [81270468]; Wuhan University School of Medicine	This project was supported by a grant from the National Natural Science Foundation of China (No.81270468) and the Innovation Seed Fund of Wuhan University School of Medicine.	Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Bell DW, 2010, J PATHOL, V220, P231, DOI 10.1002/path.2645; Bratkovic T, 2011, CELL MOL LIFE SCI, V68, P3843, DOI 10.1007/s00018-011-0762-y; Chang LS, 2002, BIOCHEM BIOPH RES CO, V299, P196, DOI 10.1016/S0006-291X(02)02623-2                                                   ; Choi JK, 2016, J CANCER, V7, P681, DOI 10.7150/jca.14264; Crea F, 2014, CANCER METAST REV, V33, P1, DOI 10.1007/s10555-013-9455-3; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Ferreira HJ, 2012, RNA BIOL, V9, P881, DOI 10.4161/rna.19353; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Kang JU, 2013, MOL MED REP, V8, P1373, DOI 10.3892/mmr.2013.1686; LeBeau AM, 2015, CANCER RES, V75, P1225, DOI 10.1158/0008-5472.CAN-14-2185; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Liao JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-198; Mannoor K, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-104; Mannoor K, 2012, BBA-REV CANCER, V1826, P121, DOI 10.1016/j.bbcan.2012.03.005; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Sawada G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139808; Son JW, 2011, CANCER LETT, V311, P29, DOI 10.1016/j.canlet.2011.06.021; Stepanov GA, 2015, BIOMED RES INT, DOI 10.1155/2015/206849; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316	22	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	MAY	2017	49	5					545	551		10.1016/j.dld.2016.12.029				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	EU5LG	WOS:000401072200016	28110922				2018-01-05	
J	Kania, E; Pajak, B; O'Prey, J; Gonzalez, PS; Litwiniuk, A; Urbanska, K; Ryan, KM; Orzechowski, A				Kania, Elzbieta; Pajak, Beata; O'Prey, Jim; Gonzalez, Pablo Sierra; Litwiniuk, Anna; Urbanska, Kaja; Ryan, Kevin M.; Orzechowski, Arkadiusz			Verapamil treatment induces cytoprotective autophagy by modulating cellular metabolism	FEBS JOURNAL			English	Article						autophagy; cancer; cell death; lactate; verapamil	CANCER-CELLS; IN-VITRO; APOPTOSIS; GLUCOSE; RESISTANCE; INHIBITION; STRESS; GROWTH; DEATH; HYPERTHERMIA	Verapamil, an L-type calcium channel blocker, has been used successfully to treat cardiovascular diseases. Interestingly, we have recently shown that treatment of cancer cells with verapamil causes an effect on autophagy. As autophagy is known to modulate chemotherapy responses, this prompted us to explore the impact of verapamil on autophagy and cell viability in greater detail. We report here that verapamil causes an induction of autophagic flux in a number or tumor cells and immortalized normal cells. Moreover, we found that inhibition of autophagy in COLO 205 cells, via treatment with the chloroquine (CQ) or by CRISPR/Cas9-mediated disruption of the autophagy genes Atg7 and Atg5, causes an upregulation of apoptotic markers in response to verapamil. In search of a mechanism for this effect and because autophagy can often mitigate metabolic stress, we examined the impact of verapamil on cellular metabolism. This revealed that in normal prostate cells, verapamil diminishes glucose and glycolytic intermediate levels leading to adenosine 5'-triphosphate (ATP) depletion. In contrast, in COLO 205 cells it enhances aerobic glycolysis and maintains ATP. Importantly, we found that the autophagic response in these cells is related to the activity of L-lactate dehydrogenase A (LDHA, EC 1.1.1.27), as inhibition of LDHA reduces both basal and verapamil-induced autophagy and consequently decreases cell viability. In summary, these findings not only identify a novel mechanism of cytoprotective autophagy induction but they also highlight the potential of using verapamil together with inhibitors of autophagy for the treatment of malignant disease.	[Kania, Elzbieta; Pajak, Beata; Orzechowski, Arkadiusz] Polish Acad Sci, Mossakowski Med Res Ctr, Electron Microscopy Platform, Warsaw, Poland; [Pajak, Beata] Kaczkowski Mil Inst Hyg & Epidemiol, Independent Lab Genet & Mol Biol, Warsaw, Poland; [O'Prey, Jim; Gonzalez, Pablo Sierra; Ryan, Kevin M.] Canc Res UK, Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland; [Litwiniuk, Anna] Ctr Postgrad Med Educ, Dept Neuroendocrinol, Warsaw, Poland; [Urbanska, Kaja; Orzechowski, Arkadiusz] Warsaw Univ Life Sci SGGW, Warsaw, Poland; [Kania, Elzbieta] Katholieke Univ Leuven, Lab Mol & Cellular Signaling, Dept Cellular & Mol Med, Campus Gasthuisberg O-N-1,Bus 802, B-3000 Leuven, Belgium	Ryan, KM (reprint author), Canc Res UK, Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.; Orzechowski, A (reprint author), Polish Acad Sci, Mossakowski Med Res Ctr, A Pawinskiego 5, PL-02106 Warsaw, Poland.	k.ryan@beatson.gla.ac.uk; orzechowski_arkadiusz@wp.pl			National Science Centre in Poland [UMO-2012/05/N/NZ7/00767, NN401031538]; Cancer Research UK Beatson Institute	We thank Malgorzata Frontczak-Baniewicz, Joanna Kruss, and Ryszard Strzalkowski for their help in TEM experiments. Special thanks to Gillian Mackayand, Niels Van Den Broek for the support in LC-MS analysis and Margaret O'Prey for her help in confocal microscopy imaging. Many thanks also to the Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, KU Leuven and especially to Jan B. Parys and Geert Bultynck for their support with the revisions of the paper. This work was supported by National Science Centre in Poland (grant No UMO-2012/05/N/NZ7/00767 and grant No NN401031538). Miss Elzbieta Kania held an EMBO Short Term Fellowship at the Cancer Research UK Beatson Institute in 2015.	Ahn JH, 2012, BIOCHEM BIOPH RES CO, V417, P857, DOI 10.1016/j.bbrc.2011.12.061; Ardizzone TD, 2002, AM J PHYSIOL-CELL PH, V283, pC579, DOI 10.1152/ajpcell.00451.2001; Bell LA, 2006, ONCOGENE, V25, P5656, DOI 10.1038/sj.onc.1209580; Biazik J, 2015, AUTOPHAGY, V11, P439, DOI 10.1080/15548627.2015.1017178; Biazik J, 2015, METHODS, V75, P44, DOI 10.1016/j.ymeth.2014.11.013; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Cao QZ, 2005, WORLD J GASTROENTERO, V11, P2255, DOI 10.3748/wjg.v11.i15.2255                                                        ; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fan PS, 2012, CELL BIOCHEM BIOPHYS, V62, P59, DOI 10.1007/s12013-011-9259-4; Garcia-Cano J, 2015, ONCOTARGET, V6, P15551, DOI 10.18632/oncotarget.3902                                                        ; Goldsmith J, 2014, METHOD ENZYMOL, V542, P25, DOI 10.1016/B978-0-12-416618-9.00002-9; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010; Khodneva Y, 2016, DIABETES RES CLIN PR, V115, P115, DOI 10.1016/j.diabres.2016.01.021; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2014, AUTOPHAGY, V10, P549, DOI 10.4161/auto.28448; Levine B, 2015, J CLIN INVEST, V125, P14, DOI 10.1172/JCI73938; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Liu X, 2016, CURR BIOL, V26, P150, DOI 10.1016/j.cub.2015.11.054; Louters Larry L, 2010, J Med Toxicol, V6, P100, DOI 10.1007/s13181-010-0072-z; Macintosh RL, 2013, SEMIN CANCER BIOL, V23, P344, DOI 10.1016/j.semcancer.2013.05.006; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Meister S, 2010, NEOPLASIA, V12, P550, DOI 10.1593/neo.10228; Metlagel Z, 2014, AUTOPHAGY, V10, P522, DOI 10.4161/auto.27594; Ozpolat B, 2015, CANCER MANAG RES, V7, P291, DOI 10.2147/CMAR.S34859; Pajak B, 2012, PHARMACOL REP, V64, P991; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Piya S, 2016, BLOOD, V128, P1260, DOI 10.1182/blood-2016-01-692244; Qiu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.84; Rolando M, 2016, AUTOPHAGY, V12, P1053, DOI 10.1080/15548627.2016.1166325; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Shchepotin IB, 1997, ANTICANCER RES, V17, P2213; Shchepotin IB, 1997, INT J HYPERTHER, V13, P547, DOI 10.3109/02656739709023553; Strigun A, 2011, J BIOTECHNOL, V155, P299, DOI 10.1016/j.jbiotec.2011.07.028; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Tcherniuk SO, 2015, CANCER LETT, V361, P97, DOI 10.1016/j.canlet.2015.02.040; Trompier D, 2004, CANCER RES, V64, P4950, DOI 10.1158/0008-5472.CAN-04-0143; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; Wang SY, 2011, INT J BIOCHEM CELL B, V43, P1263, DOI 10.1016/j.biocel.2011.05.010; Wilkinson S, 2011, AUTOPHAGY, V7, P1295, DOI 10.4161/auto.7.11.16646; Wu H, 2016, ONCOTARGET, V7, P40621, DOI 10.18632/oncotarget.9746; Xu DQ, 2016, AUTOPHAGY, V12, P1047, DOI 10.1080/15548627.2016.1163459; Xu GL, 2012, DIABETES, V61, P848, DOI 10.2337/db11-0955; Yoshida GJ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0221-y; Yu XL, 2015, FASEB J, V29, P394, DOI 10.1096/fj.14-252841; Zhao L, 2016, INT J ONCOL, V49, P99, DOI 10.3892/ijo.2016.3512	52	1	1	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	MAY	2017	284	9					1370	1387		10.1111/febs.14064				18	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EU8ZD	WOS:000401326100010	28342290				2018-01-05	
J	Shapiro, B				Shapiro, Beth			Pathways to de-extinction: how close can we get to resurrection of an extinct species?	FUNCTIONAL ECOLOGY			English	Article						ancient DNA; cloning; de-extinction; genome engineering; paleogenomics; somatic cell nuclear transfer	MITOCHONDRIAL GENOME SEQUENCE; PRIMORDIAL GERM-CELLS; NUCLEAR TRANSFER; WOOLLY MAMMOTH; MATERNAL CONTROL; MAMMALIAN-CELLS; SOMATIC-CELLS; MOUSE CELLS; DNA; CLONING	1. De-extinction, the idea that extinct species might soon be resurrected, receives considerable attention in both popular and scientific literature, in particular with regard to its potential ecological and ethical consequences. 2. Here, I review the three main pathways that are being considered at present for de-extinction: back-breeding, cloning via somatic cell nuclear transfer (SCNT) and genetic engineering. I present the state of the art in each pathway and discuss the limitations of each approach as a mechanism to resurrect extinct species. 3. Back-breeding aims to concentrate ancestral traits that persist within a population into a single individual using selective breeding. In back-breeding, ancestral phenotypes may be resurrected after many generations, but the genes that underlie these phenotypes may differ from those that were present in the extinct species. 4. Cloning aims to create genetically identical copies of an extinct species from preserved somatic cells. These somatic cells are fused with egg cells from a closely related and living donor species, which causes cellular reprogramming and embryogenesis, a scientific process known as SCNT. The developing embryo is then brought to term within a surrogate host. Because biological remains degrade post-mortem, cloning of long-dead organisms is not likely to be feasible. 5. Genetic engineering aims to edit the genome sequence within cells of living species so that these genome sequences closely resemble that of a closely related extinct species. This approach draws on recent advances in both ancient DNA and genome editing technologies and is a particularly promising approach to de-extinction. After the genome of a living cell is edited, that living cell can then be used for SCNT. 6. Because the phenotype of an organism is the consequence of the interaction between its genotype and the environment in which it develops and lives, even species with cloned nuclear genomes will not be exact copies of the extinct species on which they are modelled. We should therefore consider de-extinction as a means to create ecological proxies for extinct species.	[Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, 1156 High St, Santa Cruz, CA 95064 USA; [Shapiro, Beth] Univ Calif Santa Cruz, UCSC Genom Inst, 1156 High St, Santa Cruz, CA 95064 USA	Shapiro, B (reprint author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, 1156 High St, Santa Cruz, CA 95064 USA.; Shapiro, B (reprint author), Univ Calif Santa Cruz, UCSC Genom Inst, 1156 High St, Santa Cruz, CA 95064 USA.	beth.shapiro@ucsc.edu		Shapiro, Beth/0000-0002-2733-7776	Gordon and Betty Moore Foundation	B.S. was funded by a grant from the Gordon and Betty Moore Foundation. I thank P. Seddon and P. Heintzman for comments on an earlier draft of this manuscript. I have no conflicts of interest to declare.	Teh AL, 2014, GENOME RES, V24, P1064, DOI 10.1101/gr.171439.113; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046                                                                  ; Callaway E, 2015, NATURE, V521, P18, DOI 10.1038/nature.2015.17462; Campbell KL, 2010, NAT GENET, V42, P536, DOI 10.1038/ng.574; Carlin N. F., 2014, STANFORD ENV LAW J, V33, P3; Corlett RT, 2016, TRENDS ECOL EVOL, V31, P453, DOI 10.1016/j.tree.2016.02.017; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Donlan C. Josh, 2014, FRONTIERS BIOGEOGRAP, V6, P25; Doran TJ, 2016, TRANSGENIC RES, V25, P307, DOI 10.1007/s11248-016-9926-8; Dosch R, 2015, CRIT REV BIOCHEM MOL, V50, P54, DOI 10.3109/10409238.2014.985816; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Folch J, 2009, THERIOGENOLOGY, V71, P1026, DOI 10.1016/j.theriogenology.2008.11.005; Friese C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001825; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Hess MW, 1998, AM J PHYS ANTHROPOL, V106, P521; He-suk C., 2015, THE KOREA HERALD; Hung CM, 2014, P NATL ACAD SCI USA, V111, P10636, DOI 10.1073/pnas.1401526111; IUCN/SSC, IUCN SSC GU IN PRESS; Kjelland ME, 2014, AVIAN BIOL RES, V7, P131, DOI 10.3184/175815514X14065426847114; Lanza R P, 2000, Cloning, V2, P79, DOI 10.1089/152045500436104; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Li JS, 2008, BIOL REPROD, V79, P588, DOI 10.1095/biolreprod.108.069583; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Loi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002978; Loi P, 2007, TRENDS BIOTECHNOL, V25, P195, DOI 10.1016/j.tibtech.2007.03.007; Lynch VJ, 2015, CELL REP, V12, P217, DOI 10.1016/j.celrep.2015.06.027; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Marsden CD, 2016, P NATL ACAD SCI USA, V113, P152, DOI 10.1073/pnas.1512501113; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ono T, 2008, J REPROD DEVELOP, V54, P486, DOI 10.1262/jrd.20112; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Palkopoulou E, 2015, CURR BIOL, V25, P1395, DOI 10.1016/j.cub.2015.04.007; Park SDE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0790-2; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Prufer K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r47; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Pyle Cynthia M., 1994, Archives of Natural History, V21, P275, DOI 10.3366/anh.1994.21.3.275; Seddon PJ, 2014, TRENDS ECOL EVOL, V29, P140, DOI 10.1016/j.tree.2014.01.007; Shapiro B, 2014, SCIENCE, V343, DOI 10.1126/science.1236573; Shapiro B, 2003, QUATERNARY RES, V60, P94, DOI 10.1016/S0033-5894(03)0009-7; Shapiro B., 2016, POPULATION PALEOGENO; Shapiro B, 2015, CLONE MAMMOTH SCI DE; Sherkow JS, 2013, SCIENCE, V340, P32, DOI 10.1126/science.1236965; Stokstad E, 2015, SCIENCE, V350, P1144, DOI 10.1126/science.350.6265.1144; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; vansVuure C., 2005, RETRACING AUROCHS HI; Verma G, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0043-y; Wakayama S, 2008, P NATL ACAD SCI USA, V105, P17318, DOI 10.1073/pnas.0806166105; Whitworth KM, 2010, MOL REPROD DEV, V77, P1001, DOI 10.1002/mrd.21242; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442	63	8	8	77	83	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-8463	1365-2435		FUNCT ECOL	Funct. Ecol.	MAY	2017	31	5					996	1002		10.1111/1365-2435.12705				7	Ecology	Environmental Sciences & Ecology	EU2JP	WOS:000400855300003		gold			2018-01-05	
J	Holsclaw, JK; Sekelsky, J				Holsclaw, Julie Korda; Sekelsky, Jeff			Annealing of Complementary DNA Sequences During Double-Strand Break Repair in Drosophila Is Mediated by the Ortholog of SMARCAL1	GENETICS			English	Article						SDSA; DSB repair; SMARCAL1; Drosophila; homologous recombination	TARGETED GENE REPLACEMENT; INDUCED GAP REPAIR; IN-VIVO; MITOTIC CROSSOVERS; GENOME STABILITY; FANCM HELICASE; BLM HELICASE; DSB REPAIR; DAMAGE; BRCA2	DNA double-strand breaks (DSBs) pose a serious threat to genomic integrity. If unrepaired, they can lead to chromosome fragmentation and cell death. If repaired incorrectly, they can cause mutations and chromosome rearrangements. DSBs are repaired using end-joining or homology-directed repair strategies, with the predominant form of homology-directed repair being synthesis-dependent strand annealing (SDSA). SDSA is the first defense against genomic rearrangements and information loss during DSB repair, making it a vital component of cell health and an attractive target for chemotherapeutic development. SDSA has also been proposed to be the primary mechanism for integration of large insertions during genome editing with CRISPR/Cas9. Despite the central role for SDSA in genome stability, little is known about the defining step: annealing. We hypothesized that annealing during SDSA is performed by the annealing helicase SMARCAL1, which can anneal RPA-coated single DNA strands during replication-associated DNA damage repair. We used unique genetic tools in Drosophila melanogaster to test whether the fly ortholog of SMARCAL1, Marcal1, mediates annealing during SDSA. Repair that requires annealing is significantly reduced in Marcal1 null mutants in both synthesis-dependent and synthesis-independent (single-strand annealing) assays. Elimination of the ATP-binding activity of Marcal1 also reduced annealing-dependent repair, suggesting that the annealing activity requires translocation along DNA. Unlike the null mutant, however, the ATP-binding defect mutant showed reduced end joining, shedding light on the interaction between SDSA and end-joining pathways.	[Holsclaw, Julie Korda; Sekelsky, Jeff] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Sekelsky, Jeff] Univ N Carolina, Dept Biol, CB 3280,303 Fordham Hall, Chapel Hill, NC 27599 USA; [Sekelsky, Jeff] Univ N Carolina, Integrat Program Biol & Genome, Chapel Hill, NC 27599 USA	Sekelsky, J (reprint author), Univ N Carolina, Dept Biol, CB 3280,303 Fordham Hall, Chapel Hill, NC 27599 USA.	sekelsky@unc.edu		Sekelsky, Jeff/0000-0002-4424-677X	National Institute of General Medical Sciences [1-R01 GM-061252, 1-R35 GM-118127, 5-T32 GM-007092, F31 GM-113550]	We thank E. Buzhardt and A. Cook for preliminary Marcal1 null P{w<SUP>a</SUP>} data acquisition. This work was supported by grants from the National Institute of General Medical Sciences to J.S. (1-R01 GM-061252 and 1-R35 GM-118127). J.K.H. was supported in part by National Institute of General Medical Sciences grants 5-T32 GM-007092 and F31 GM-113550.	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Andersen SL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002315; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; Baradaran-Heravi A, 2012, AM J MED GENET A, V158A, P2204, DOI 10.1002/ajmg.a.35532; Baradaran-Heravi A, 2012, HUM MOL GENET, V21, P2572, DOI 10.1093/hmg/dds083; Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bhargava R, 2016, TRENDS GENET, V32, P566, DOI 10.1016/j.tig.2016.06.007; Bhat KP, 2015, J BIOL CHEM, V290, P4110, DOI 10.1074/jbc.M114.627083; Brough R, 2008, DNA REPAIR, V7, P10, DOI 10.1016/j.dnarep.2007.07.013; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Coleman MA, 2000, GENOMICS, V65, P274, DOI 10.1006/geno.2000.6174; Garcia AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r121; Ghosal G, 2011, EMBO REP, V12, P574, DOI 10.1038/embor.2011.74; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guo XG, 2015, G3-GENES GENOM GENET, V5, P2801, DOI 10.1534/g3.115.023317; Gupta M, 2015, FEBS J, V282, P3841, DOI 10.1111/febs.13382; Hammond EM, 2003, MUTAT RES-FUND MOL M, V532, P205, DOI 10.1016/j.mrfmmm.2003.08.017; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ivanov EL, 1996, GENETICS, V142, P693; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jensen Ryan B., 2013, Yale Journal of Biology and Medicine, V86, P479; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kassavetis GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098173; Khade NV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158436; Kuo HK, 2014, GENETICS, V198, P935, DOI 10.1534/genetics.114.168096; KURKULOS M, 1994, GENETICS, V136, P1001; LaFave MC, 2014, GENETICS, V196, P107, DOI 10.1534/genetics.113.158618; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lou S, 2002, J MED GENET, V39, P922, DOI 10.1136/jmg.39.12.922; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Maede Y, 2014, MOL CANCER THER, V13, P214, DOI 10.1158/1535-7163.MCT-13-0551; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; McVey M, 2004, GENETICS, V167, P699, DOI 10.1534/genetics.103.025411; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Morimoto M., 2016, GENEREVIEWS; Mukherjee S, 2009, DNA REPAIR, V8, P803, DOI 10.1016/j.dnarep.2009.03.004; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613                                                           ; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045                                                           ; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; POVIRK LF, 1994, MUTAT RES-REV GENET, V318, P205, DOI 10.1016/0165-1110(94)90015-9; Qi Z, 2016, METHODS, V105, P62, DOI 10.1016/j.ymeth.2016.03.027; RADFORD IR, 1985, INT J RADIAT BIOL, V48, P45, DOI 10.1080/09553008514551051; Reuter M, 2014, J CELL BIOL, V207, P599, DOI 10.1083/jcb.201405014; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423                                                          ; Rodgers K, 2016, J CELL PHYSIOL, V231, P15, DOI 10.1002/jcp.25053; Romero NE, 2016, GENETICS, V204, P531, DOI 10.1534/genetics.116.192534; Rong YS, 2003, GENETICS, V165, P1831; Sage E., 2016, FREE RADIC BIOL MED, DOI [10.1016/j.freeradbiomed.2016.12.008, DOI 10.1016/J.FREERADBI0MED.2016.12.008]; Sarbajna S, 2014, GENE DEV, V28, P1124, DOI 10.1101/gad.238303.114; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Thomas AM, 2013, G3-GENES GENOM GENET, V3, P91, DOI 10.1534/g3.112.003996; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; van Schendel R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006368; Waters CA, 2014, DNA REPAIR, V17, P39, DOI 10.1016/j.dnarep.2014.02.008; Williams GJ, 2014, DNA REPAIR, V17, P110, DOI 10.1016/j.dnarep.2014.02.009; Wright WD, 2014, MOL CELL, V53, P420, DOI 10.1016/j.molcel.2013.12.027; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Xie S, 2014, FEBS J, V281, P3382, DOI 10.1111/febs.12867; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Yu Amy Marie, 2010, Nucleic Acids Res, V38, P5706, DOI 10.1093/nar/gkq379; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Zapotoczny G., 2017, G3-GENES GENOM GENET, DOI [10.1534/g3.116.037390, DOI 10.1534/G3.116.037390]; Zhang L., 2012, J APPL MATH, V2012, P1	74	1	1	10	10	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAY	2017	206	1					467	480		10.1534/genetics.117.200238				14	Genetics & Heredity	Genetics & Heredity	EU6EW	WOS:000401127800032	28258182				2018-01-05	
J	Yamamoto, Y; Makiyama, T; Harita, T; Sasaki, K; Wuriyanghai, Y; Hayano, M; Nishiuchi, S; Kohjitani, H; Hirose, S; Chen, JR; Yokoi, F; Ishikawa, T; Ohno, S; Chonabayashi, K; Motomura, H; Yoshida, Y; Horie, M; Makita, N; Kimura, T				Yamamoto, Yuta; Makiyama, Takeru; Harita, Takeshi; Sasaki, Kenichi; Wuriyanghai, Yimin; Hayano, Mamoru; Nishiuchi, Suguru; Kohjitani, Hirohiko; Hirose, Sayako; Chen, Jiarong; Yokoi, Fumika; Ishikawa, Taisuke; Ohno, Seiko; Chonabayashi, Kazuhisa; Motomura, Hideki; Yoshida, Yoshinori; Horie, Minoru; Makita, Naomasa; Kimura, Takeshi			Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation	HUMAN MOLECULAR GENETICS			English	Article							PLURIPOTENT STEM-CELLS; DUCHENNE MUSCULAR-DYSTROPHY; RYANODINE RECEPTOR; CARDIAC-ARRHYTHMIAS; HUMAN FIBROBLASTS; CALCIUM-CHANNELS; SODIUM-CHANNELS; SINOATRIAL NODE; MOLECULAR-BASIS; CA2+ RELEASE	Calmodulin is a ubiquitous Ca2+ sensor molecule encoded by three distinct calmodulin genes, CALM1-3. Recently, mutations in CALM1-3 have been reported to be associated with severe early-onset long-QT syndrome (LQTS). However, the underlying mechanism through which heterozygous calmodulin mutations lead to severe LQTS remains unknown, particularly in human cardiomyocytes. We aimed to establish an LQTS disease model associated with a CALM2 mutation (LQT15) using human induced pluripotent stem cells (hiPSCs) and to assess mutant allele-specific ablation by genome editing for the treatment of LQT15. We generated LQT15-hiPSCs from a 12-year-old boy with LQTS carrying a CALM2-N98S mutation and differentiated these hiPSCs into cardiomyocytes (LQT15-hiPSC-CMs). Action potentials (APs) and L-type Ca2+ channel (LTCC) currents in hiPSC-CMs were analyzed by the patch-clamp technique and compared with those of healthy controls. Furthermore, we performed mutant allele-specific knockout using a CRISPR-Cas9 system and analyzed electrophysiological properties. Electrophysiological analyses revealed that LQT15-hiPSC-CMs exhibited significantly lower beating rates, prolonged AP durations, and impaired inactivation of LTCC currents compared with control cells, consistent with clinical phenotypes. Notably, ablation of the mutant allele rescued the electrophysiological abnormalities of LQT15-hiPSC-CMs, indicating that the mutant allele caused dominant-negative suppression of LTCC inactivation, resulting in prolonged AP duration. We successfully recapitulated the disease phenotypes of LQT15 and revealed that inactivation of LTCC currents was impaired in CALM2-N98S hiPSC model. Additionally, allele-specific ablation using the latest genome-editing technology provided important insights into a promising therapeutic approach for inherited cardiac diseases.	[Yamamoto, Yuta; Makiyama, Takeru; Harita, Takeshi; Sasaki, Kenichi; Wuriyanghai, Yimin; Hayano, Mamoru; Nishiuchi, Suguru; Kohjitani, Hirohiko; Hirose, Sayako; Chen, Jiarong; Yokoi, Fumika; Kimura, Takeshi] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [Wuriyanghai, Yimin; Ohno, Seiko; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 5202192, Japan; [Ishikawa, Taisuke; Makita, Naomasa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Physiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan; [Chonabayashi, Kazuhisa; Yoshida, Yoshinori] Kyoto Univ, Dept Life Sci Frontiers, Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [Motomura, Hideki] Nagasaki Univ Hosp, Dept Pediat, Nagasaki 8528501, Japan	Makiyama, T (reprint author), Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.; Makita, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Physiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.; Yoshida, Y (reprint author), Kyoto Univ, Dept Life Sci Frontiers, Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	makiyama@kuhp.kyoto-u.ac.jp; yoshinor@cira.kyoto-u.ac.jp; makitan@nagasaki-u.ac.jp			JSPS [25461054]; Suzuken Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology [15H04823]; Japan Agency for Medical Research and Development, AMED [15km0305015h0101]	JSPS KAKENHI (grant number 25461054), Suzuken Memorial Foundation, Grant-in-Aid for Scientific Research (grant no. 15H04823) from the Ministry of Education, Culture, Sports, Science and Technology, and research grant from the Japan Agency for Medical Research and Development, AMED (grant no. 15km0305015h0101).	Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Ciampa EJ, 2011, J BIOL CHEM, V286, P4141, DOI 10.1074/jbc.M110.158865; Cordeiro JM, 2013, J MOL CELL CARDIOL, V60, P36, DOI 10.1016/j.yjmcc.2013.03.014; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5                                                    ; Doss MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040288; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Horii T, 2013, INT J MOL SCI, V14, P19774, DOI 10.3390/ijms141019774; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Janse MJ, 1998, CARDIOVASC RES, V39, P165, DOI 10.1016/S0008-6363(97)00313-1                                                   ; Kaese Sven, 2013, Herzschrittmacherther Elektrophysiol, V24, P84, DOI 10.1007/s00399-013-0260-z; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Limpitikul WB, 2017, CIRC RES, V120, P39, DOI 10.1161/CIRCRESAHA.116.309283; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Marsman RF, 2014, J AM COLL CARDIOL, V63, P259, DOI [10.1016/j.jacc.2013.0.7.091, 10.1016/j.jacc.2013.07.091]; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Mizusawa Y, 2014, CIRC J, V78, P2827, DOI 10.1253/circj.CJ-14-0905; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Muller M, 2013, STEM CELLS INT, V2013; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Peersen OB, 1997, PROTEIN SCI, V6, P794; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6                                                   ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rigg L, 2003, CARDIOVASC RES, V57, P497, DOI 10.1016/S0008-6363(02)00668-5; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Sondergaard MT, 2015, J BIOL CHEM, V290, P26151, DOI 10.1074/jbc.M115.676627; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Van Petegem F, 2012, BIOPHYS J, V103, P2243, DOI 10.1016/j.bpj.2012.10.020; Vinogradova TM, 2000, CIRC RES, V87, P760; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3                                                    ; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yin G, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000996	52	2	2	6	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	MAY 1	2017	26	9					1670	1677		10.1093/hmg/ddx073				8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	EU3EU	WOS:000400912200007	28335032				2018-01-05	
J	Das, D; Smith, N; Wang, X; Morgan, IM				Das, Dipon; Smith, Nathan; Wang, Xu; Morgan, Iain M.			The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2	JOURNAL OF VIROLOGY			English	Article						C33a cells; CRISPR/Cas9; DNA replication; E1; E2; papillomavirus; SIRT1	DNA-DAMAGE RESPONSE; S-PHASE CHECKPOINT; FUNCTIONAL-LINK; PROTEIN TOPBP1; TIP60; TRANSACTIVATION; QUANTITATION; EXPRESSION; STABILITY; REPAIR	Human papillomaviruses (HPV) replicate their genomes in differentiating epithelium using the viral proteins E1 and E2 in association with host proteins. While the roles of E1 and E2 in this process are understood, the host factors involved and how they interact with and regulate E1-E2 are not. Our previous work identified the host replication and repair factor TopBP1 as an E2 partner protein essential for optimal E1-E2 replication and for the viral life cycle. The role of TopBP1 in host DNA replication is regulated by the class III deacetylase SIRT1; activation of the DNA damage response prevents SIRT1 deacetylation of TopBP1, resulting in a switch from DNA replication to repair functions for this protein and cell cycle arrest. Others have demonstrated an essential role for SIRT1 in regulation of the HPV31 life cycle; here, we report that SIRT1 can directly regulate HPV16 E1-E2-mediated DNA replication. SIRT1 is part of the E1-E2 DNA replication complex and is recruited to the viral origin of replication in an E1-E2-dependent manner. CRISPR/Cas9 was used to generate C33a clones with undetectable SIRT1 expression and lack of SIRT1 elevated E1-E2 DNA replication, in part due to increased acetylation and stabilization of the E2 protein in the absence of SIRT1. The results demonstrate that SIRT1 is a member of, and can regulate, the HPV16 replication complex. We discuss the potential role of this protein in the viral life cycle. IMPORTANCE HPV are causative agents in a number of human diseases, and currently only the symptoms of these diseases are treated. To identify novel therapeutic approaches for combating these diseases, the viral life cycle must be understood in more detail. This report demonstrates that a cellular enzyme, SIRT1, is part of the HPV16 DNA replication complex and is brought to the viral genome by the viral proteins E1 and E2. Using gene editing technology (CRISPR/Cas9), the SIRT1 gene was removed from cervical cancer cells. The consequence of this was that viral replication was elevated, probably due to a stabilization of the viral replication factor E2. The overall results demonstrate that an enzyme with known inhibitors, SIRT1, plays an important role in controlling how HPV16 makes copies of itself. Targeting this enzyme could be a new therapeutic approach for combating HPV spread and disease.	[Das, Dipon; Smith, Nathan; Wang, Xu; Morgan, Iain M.] Virginia Commonwealth Univ, Sch Dent, VCU Philips Inst Oral Hlth Res, Dept Oral & Craniofacial Mol Biol, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Morgan, Iain M.] VCU Massey Canc Ctr, Richmond, VA 23298 USA	Morgan, IM (reprint author), Virginia Commonwealth Univ, Sch Dent, VCU Philips Inst Oral Hlth Res, Dept Oral & Craniofacial Mol Biol, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Morgan, IM (reprint author), VCU Massey Canc Ctr, Richmond, VA 23298 USA.	immorgan@vcu.edu			VCU Philips Institute for Oral Health Research; NCI Designated Massey Cancer Center grant [P30 CA016059]	This work was funded with a faculty start-up package to I.M.M. from the VCU Philips Institute for Oral Health Research and with NCI Designated Massey Cancer Center grant P30 CA016059.	Anacker DC, 2014, J VIROL, V88, P8528, DOI 10.1128/JVI.00517-14; Boner W, 2002, J BIOL CHEM, V277, P22297, DOI 10.1074/jbc.M202163200; BOUVARD V, 1994, EMBO J, V13, P5451; Bristol ML, 2016, VIRUSES, V8, pE175; Chappell WH, 2016, J VIROL, V90, P2639, DOI 10.1128/JVI.02495-15; Donaldson MM, 2012, J VIROL, V86, P12806, DOI 10.1128/JVI.01002-12; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Gauson EJ, 2015, J VIROL, V89, P4980, DOI 10.1128/JVI.00335-15; Gillespie KA, 2012, J VIROL, V86, P9520, DOI 10.1128/JVI.00247-12; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; Hong SY, 2015, J VIROL, V89, P4668, DOI 10.1128/JVI.03455-14; Kadaja M, 2007, EMBO J, V26, P2180, DOI 10.1038/sj.emboj.7601665; King LE, 2011, VIROLOGY, V414, P26, DOI 10.1016/j.virol.2011.03.002; King LE, 2010, VIROLOGY, V406, P95, DOI 10.1016/j.virol.2010.06.033; Langsfeld ES, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005181; Lim DS, 2000, NATURE, V404, P613; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Liu TZ, 2014, MOL CELL, V56, P681, DOI 10.1016/j.molcel.2014.10.007; McBride AA, 2013, VIROLOGY, V445, P57, DOI [10.1016/j.viro1.2013.06.006, 10.1016/j.virol.2013.06.006]; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; Morgan IM, 2005, METH MOLEC MED, V119, P349; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Quinlan EJ, 2013, J VIROL, V87, P1497, DOI 10.1128/JVI.02771-12; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003777; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003321; Stubenrauch F, 1998, J VIROL, V72, P8115; Taylor ER, 2003, VIROLOGY, V315, P103, DOI 10.1016/S0042-6822(03)00588-9; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang RH, 2014, INT J BIOL SCI, V10, P1193, DOI 10.7150/ijbs.11066; Wardlaw CP, 2014, DNA REPAIR, V22, P165, DOI 10.1016/j.dnarep.2014.06.004; Xue YZ, 2010, CANCER RES, V70, P5316, DOI 10.1158/0008-5472.CAN-09-3789; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yang Hui, 2015, Critical Reviews in Oncogenesis, V20, P49; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yuan Z, 2007, CELL CYCLE, V6, P2869, DOI 10.4161/cc.6.23.5026                                                            ; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhao S, 2000, NATURE, V405, P473; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	43	1	1	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAY	2017	91	10							UNSP e00102-17	10.1128/JVI.00102-17				15	Virology	Virology	EU7PS	WOS:000401227300005					2018-01-05	
J	Liang, LY; Liu, RM; Garst, AD; Lee, T; Nogue, VSI; Beckham, GT; Gill, RT				Liang, Liya; Liu, Rongming; Garst, Andrew D.; Lee, Thomas; Nogue, Violeta Sanchez I.; Beckham, Gregg T.; Gill, Ryan T.			CRISPR EnAbled Trackable genome Engineering for isopropanol production in Escherichia coli	METABOLIC ENGINEERING			English	Article						Isopropanol; CRISPR EnAbled Trackable genome; Engineering; RBS library; Engineered Escherichia coli; Proteomic analysis	PROTEIN EXPRESSION; BIOFUELS PRODUCTION; SYNTHETIC BIOLOGY; PATHWAY; TRANSLATION; BACTERIA; DESIGN; SITES	Isopropanol is an important target molecule for sustainable production of fuels and chemicals. Increases in DNA synthesis and synthetic biology capabilities have resulted in the development of a range of new strategies for the more rapid design, construction, and testing of production strains. Here, we report on the use of such capabilities to construct and test 903 different variants of the isopropanol production pathway in Escherichia coli. We first constructed variants to explore the effect of codon optimization, copy number, and translation initiation rates on isopropanol production. The best strain (PA06) produced isopropanol at titers of 17.5 g/L, with a yield of 0.62 (mol/mol), and maximum productivity of 0.40 g/L/h. We next integrated the isopropanol synthetic pathway into the genome and then used the CRISPR EnAbled Trackable genome Engineering (CREATE) strategy to generate an additional 640 individual RBS library variants for further evaluation. After testing each of these variants, we constructed a combinatorial library containing 256 total variants from four different RBS levels for each gene. The best producing variant, PA14, produced isopropanol at titers of 7.1 g/L at 24 h, with a yield of 0.75 (mol/mol), and maximum productivity of 0.62 g/L/h (which was 0.22 g/L/h above the parent strain PA07). We demonstrate the ability to rapidly construct and test close to similar to 1000 designer strains and identify superior performers.	[Liang, Liya; Liu, Rongming; Gill, Ryan T.] Univ Colorado, Renewable & Sustainable Energy Inst RASEI, Boulder, CO 80303 USA; [Garst, Andrew D.] Muse Biotechnol Inc, 4001 Discovery Dr, Boulder, CO 80303 USA; [Lee, Thomas] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; [Nogue, Violeta Sanchez I.; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA	Gill, RT (reprint author), Univ Colorado, Renewable & Sustainable Energy Inst RASEI, Boulder, CO 80303 USA.	rtg@colorado.edu		Sanchez i Nogue, Violeta/0000-0002-5873-095X	Department of Energy United States grant [DE-FOA-0000996]	We thank the support by the Department of Energy United States grant (DE-FOA-0000996).	Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Bermejo LL, 1998, APPL ENVIRON MICROB, V64, P1079; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Coussement P, 2014, METAB ENG, V23, P70, DOI 10.1016/j.ymben.2014.02.012; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Farasat I, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20134955; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garst AD, 2017, NAT BIOTECHNOL, V35, P48, DOI 10.1038/nbt.3718; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hanai T, 2007, APPL ENVIRON MICROB, V73, P7814, DOI 10.1128/AEM.01140-07; Inokuma K., 2010, BIOSCI BIOENG, V110, P696; Jiang Y., 2015, ICIC EL, V9, P81, DOI DOI 10.1128/AEM.04023-14; Jojima T, 2008, APPL MICROBIOL BIOT, V77, P1219, DOI 10.1007/s00253-007-1246-8; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; LEE I, 1995, J AM OIL CHEM SOC, V72, P1155, DOI 10.1007/BF02540982; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Ng CY, 2015, METAB ENG, V29, P86, DOI 10.1016/j.ymben.2015.03.001; Osburn OL, 1937, J BIOL CHEM, V121, P685; Prior JE, 2010, BIOTECHNOL BIOENG, V106, P326, DOI 10.1002/bit.22695; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ran FA, 2013, CELL, V155, P479, DOI 10.1016/j.cell.2013.09.040; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Stephanopoulos G, 2012, ACS SYNTH BIOL, V1, P514, DOI 10.1021/sb300094q; Survase SA, 2011, APPL MICROBIOL BIOT, V91, P1305, DOI 10.1007/s00253-011-3322-3; Tamakawa H, 2013, APPL MICROBIOL BIOT, V97, P6231, DOI 10.1007/s00253-013-4964-0; Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024	39	3	3	11	22	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7176	1096-7184		METAB ENG	Metab. Eng.	MAY	2017	41						1	10		10.1016/j.ymben.2017.02.009				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EV3ZD	WOS:000401696800001	28216108				2018-01-05	
J	Zhao, WT; Wang, Z; Sun, ZW; Wang, S; Wu, MJ; Zheng, LR				Zhao, Wenting; Wang, Zhen; Sun, Zewei; Wang, Shuai; Wu, Mingjie; Zheng, Liangrong			Lentivirus-mediated overexpression of CD97/ADGRE5 reverses dysregulated high glucose-induced endothelial cell migration	MOLECULAR MEDICINE REPORTS			English	Article						cluster of differentiation 97; high glucose; migration; cell division cycle 42; actin-related protein 2	SECRETIN RECEPTOR SUPERFAMILY; 7-SPAN TRANSMEMBRANE MOLECULE; VASCULAR-DISEASE; EGF-TM7 RECEPTOR; CD97; EXPRESSION; ACTIVATION; GENE; PERMEABILITY; DYSFUNCTION	Elevated blood glucose levels contribute to a series of complications in patients with diabetes mellitus, including chronic ulcers and accelerated atherosclerosis. Dysregulated endothelial migration induced by high glucose is important in vascular-associated complications. In the present study, cluster of differentiation (CD) 97/adhesion G protein-coupled receptor 5 (ADGRE5), a member of the G protein-coupled receptor protein family, stimulated angiogenesis was investigated to determine its role in cell models of diabetes mellitus using lentivirus-mediated overexpression and siRNA transfection. The results revealed reduced expression in high glucose-treated human umbilical vein endothelial cells and in the endothelium of diabetic mice. Among the three CD97 isoforms, the majority of the expression of CD97 (EGF1,2,5) in the endothelial cells was regulated by high levels of glucose. Using stable lentivirus-mediated transfection and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, the present study constructed CD97-overexpression and CD97-knockout endothelial cell lines. Migration assays showed that the lentivirus-mediated overexpression of CD97/ADGRE5 improved the inhibition of high glucose-induced endothelial cell migration. In addition, using cytoskeleton staining, it was found that CD97 promoted membrane ruffling and lamellipodia formation. Cell division cycle 42, a small GTP-binding protein, and its downstream factor, actin-related protein 2, were involved in CD97-induced actin reorganization in endothelial cells. Additionally, the use of transcription factor filter plate assays revealed that the nuclear translocation of signal transducer and activator of transcription 1 stimulated by high glucose contributed to the inhibited transcription of CD97. In conclusion, the present study established that the overexpression of CD97 improved high glucose-induced dysfunction of endothelial cell migration. These findings provide insight to assist in identifying therapeutic targets with potential to ameliorate certain vascular complications of diabetes.	[Zhao, Wenting; Wang, Zhen; Sun, Zewei; Wang, Shuai; Wu, Mingjie; Zheng, Liangrong] Zhejiang Univ, Dept Cardiol, Affiliated Hosp 1, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China	Zheng, LR (reprint author), Zhejiang Univ, Dept Cardiol, Affiliated Hosp 1, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	zlrylnn@126.com					Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Aust G, 1997, CANCER RES, V57, P1798; BASSENGE E, 1992, BRIT J CLIN PHARMACO, V34, pS37, DOI 10.1111/j.1365-2125.1992.tb04147.x                                              ; CAMPANINI M, 1991, J HYPERTENS, V9, pS200; COHEN RA, 1995, PROG CARDIOVASC DIS, V38, P105, DOI 10.1016/S0033-0620(05)80002-7                                                   ; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; DeMeyer GRY, 1997, PROG CARDIOVASC DIS, V39, P325, DOI 10.1016/S0033-0620(97)80031-X; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1996, GENOMICS, V32, P144, DOI 10.1006/geno.1996.0092; Hamuro M, 2002, ATHEROSCLEROSIS, V162, P277, DOI 10.1016/S0021-9150(01)00719-5                                                   ; Jaspars LH, 2001, TISSUE ANTIGENS, V57, P325, DOI 10.1034/j.1399-0039.2001.057004325.x; KARIO K, 1995, ARTERIOSCL THROM VAS, V15, P1114, DOI 10.1161/01.ATV.15.8.1114                                                        ; Kwakkenbos MJ, 2004, IMMUNOGENETICS, V55, P655, DOI 10.1007/s00251-003-0625-2; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125                                                     ; Li P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064678; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKnight AJ, 1996, IMMUNOL TODAY, V17, P283, DOI 10.1016/0167-5699(96)80546-9; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4                                                   ; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574                                                     ; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Wobus M, 2008, GENE, V413, P67, DOI 10.1016/j.gene.2008.01.021; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B	26	0	0	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY	2017	15	5					3048	3054		10.3892/mmr.2017.6417				7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	EU5JZ	WOS:000401068700084	28358422	green_published			2018-01-05	
J	Stallaert, W; van der Westhuizen, ET; Schonegge, AM; Plouffe, B; Hogue, M; Lukashova, V; Inoue, A; Ishida, S; Aoki, J; Le Gouill, C; Bouvier, M				Stallaert, Wayne; van der Westhuizen, Emma T.; Schonegge, Anne-Marie; Plouffe, Bianca; Hogue, Mireille; Lukashova, Viktoria; Inoue, Asuka; Ishida, Satoru; Aoki, Junken; Le Gouill, Christian; Bouvier, Michel			Purinergic Receptor Transactivation by the beta(2)-Adrenergic Receptor Increases Intracellular Ca2+ in Nonexcitable Cells	MOLECULAR PHARMACOLOGY			English	Article							BETA-ADRENERGIC-RECEPTORS; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; ADENOSINE PATHWAY; CYCLIC-AMP; EXTRACELLULAR ATP; ADENYLYL-CYCLASE; P2Y(11) RECEPTOR; PHOSPHOLIPASE-C; SMOOTH-MUSCLE	The beta(2) adrenergic receptor (beta(2)AR) increases intracellular Ca2+ in a variety of cell types. By combining pharmacological and genetic manipulations, we reveal a novel mechanism through which the beta(2)AR promotes Ca2+$ mobilization (pEC(50) = 7.32 +/- 0.10) in nonexcitable human embryonic kidney (HEK) 293S cells. Downregulation of Gs with sustained cholera toxin pretreatment and the use of Gs-null HEK293 (Delta Gs-HEK293) cells generated using the clustered regularly interspaced short palindromic repeat-associated protein-9 nuclease (CRISPR/Cas9) system, combined with pharmacological modulation of cAMP formation, revealed a Gs-dependent but cAMP-independent increase in intracellular Ca2+ following beta(2)AR stimulation. The increase in cytoplasmic Ca2+ was inhibited by P2Y purinergic receptor antagonists as well as a dominant-negative mutant form of Gq, a Gq-selective inhibitor, and an inositol 1,4,5-trisphosphate (IP3) receptor antagonist, suggesting a role for this Gq-coupled receptor family downstream of the beta(2)AR activation. Consistent with this mechanism, beta(2)AR stimulation promoted the extracellular release of ATP, and pretreatment with apyrase inhibited the beta(2) AR-promoted Ca2+ mobilization. Together, these data support a model whereby the beta(2)AR stimulates a Gs-dependent release of ATP, which transactivates Gq-coupled P2Y receptors through an inside-out mechanism, leading to a Gq-and IP3 dependent Ca2+ mobilization from intracellular stores. Given that beta(2)AR and P2Y receptors are coexpressed in various tissues, this novel signaling paradigm could be physiologically important and have therapeutic implications. In addition, this study reports the generation and validation of HEK293 cells deleted of Gs using the CRISPR/Cas9 genome editing technology that will undoubtedly be powerful tools to study Gs-dependent signaling.	[Stallaert, Wayne; van der Westhuizen, Emma T.; Schonegge, Anne-Marie; Plouffe, Bianca; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ, Canada; [Stallaert, Wayne; van der Westhuizen, Emma T.; Schonegge, Anne-Marie; Plouffe, Bianca; Hogue, Mireille; Lukashova, Viktoria; Le Gouill, Christian; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, POB 6128, Montreal, PQ H3C 3J7, Canada; [Inoue, Asuka; Ishida, Satoru; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan; [Aoki, Junken] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	Bouvier, M (reprint author), Univ Montreal, Inst Res Immunol & Canc, POB 6128, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca		/0000-0001-9165-8526	Canadian Institutes for Health Research (CIHR) [MOP 11215]; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency; Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology; Vanier Canada Graduate Scholarship from CIHR; CIHR; Canadian Hypertension Society; Fonds de la Recherche en Sante du Quebec (FRSQ); National Health and Medical Research Council Australia [GNT-1013819]; FRSQ; Canada Research Chair in Signal Transduction and Molecular Pharmacology	This work was supported, in part, by Canadian Institutes for Health Research (CIHR) [Grant MOP 11215 to M.B.] and grants from Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency [to A. I.], and Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology [to J.A.]. W.S. was supported by the Vanier Canada Graduate Scholarship from CIHR. E.T.v.d.W. was supported by postdoctoral research fellowships from CIHR, Canadian Hypertension Society, Fonds de la Recherche en Sante du Quebec (FRSQ), and National Health and Medical Research Council Australia [Grant GNT-1013819]. A.-M.S. was supported by postdoctoral research fellowships from FRSQ, and B.P. was supported by postdoctoral research fellowships from CIHR. M.B. holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology.	Adriaensen D, 2004, CURR OPIN PHARMACOL, V4, P207, DOI 10.1016/j.coph.2004.01.010; Andre C, 1996, EUR J BIOCHEM, V241, P417, DOI 10.1111/j.1432-1033.1996.00417.x; Baker JG, 2004, MOL PHARMACOL, V65, P986, DOI 10.1124/mol.65.4.986                                                            ; Barnes PJ, 1998, AM J RESP CRIT CARE, V158, pS123, DOI 10.1164/ajrccm.158.supplement_2.13tac800                                        ; Basoglu OK, 2005, CHEST, V128, P1905, DOI 10.1378/chest.128.4.1905; Benitah JP, 2010, J MOL CELL CARDIOL, V48, P26, DOI 10.1016/j.yjmcc.2009.07.026; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; Braun K, 2001, N-S ARCH PHARMACOL, V364, P285, DOI 10.1007/s002100100463; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B                                                    ; Cazzola M, 2013, AM J RESP CRIT CARE, V187, P690, DOI 10.1164/rccm.201209-1739PP; Christ T, 2009, BRIT J PHARMACOL, V156, P62, DOI 10.1111/j.1476-5381.2008.00015.x; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DEBLASI A, 1990, DRUG EXP CLIN RES, V16, P107; Duarte T, 2012, J PHARMACOL EXP THER, V341, P820, DOI 10.1124/jpet.112.192997; Dubey RK, 2001, HYPERTENSION, V37, P1095, DOI 10.1161/01.HYP.37.4.1095                                                        ; Dubey RK, 1996, HYPERTENSION, V28, P765, DOI 10.1161/01.HYP.28.5.765                                                         ; El-Ajouz S, 2012, BRIT J PHARMACOL, V165, P390, DOI 10.1111/j.1476-5381.2011.01534.x; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Giembycz MA, 2006, EUR RESPIR J, V27, P1286, DOI 10.1183/09031936.06.00112605; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Guan YB, 2011, ARCH PHARM RES, V34, P1719, DOI 10.1007/s12272-011-1016-0; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jackson EK, 1996, J HYPERTENS, V14, P19; Kassack MU, 2004, EUR J MED CHEM, V39, P345, DOI 10.1016/j.ejmech.2004.01.007; Keller MJ, 2014, FEBS LETT, V588, P4686, DOI 10.1016/j.febslet.2014.10.041; Kim J, 2002, J BIOL CHEM, V277, P32116, DOI 10.1074/jbc.M204895200; LAW SF, 1993, J BIOL CHEM, V268, P10721; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7                                                   ; Lemieux S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-391; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Moore DJ, 2001, BBA-GENE STRUCT EXPR, V1521, P107, DOI 10.1016/S0167-4781(01)00291-3; Mortaz E, 2010, EUR J PHARMACOL, V638, P1, DOI 10.1016/j.ejphar.2010.04.019; Nicholas AP, 1996, TRENDS PHARMACOL SCI, V17, P245, DOI 10.1016/S0165-6147(96)10022-5; Ostrom RS, 2000, J BIOL CHEM, V275, P11735, DOI 10.1074/jbc.275.16.11735; Perez-Schindler J, 2013, EUR J PHARMACOL, V698, P39, DOI 10.1016/j.ejphar.2012.11.001; Qi AD, 2001, BRIT J PHARMACOL, V132, P318, DOI 10.1038/sj.bjp.0703788                                                          ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Rider CF, 2011, J PHARMACOL EXP THER, V338, P860, DOI 10.1124/jpet.111.181016; Salathe Matthias, 2002, Journal of Allergy and Clinical Immunology, V110, pS275, DOI 10.1067/mai.2002.129412; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sitkauskiene Brigita, 2005, Current Drug Targets - Inflammation and Allergy, V4, P157, DOI 10.2174/1568010053586309; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Sumi Y, 2010, AM J PHYSIOL-CELL PH, V299, pC1118, DOI 10.1152/ajpcell.00122.2010; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; van der Weyden L, 2000, MOL CELL BIOCHEM, V213, P75, DOI 10.1023/A:1007168215748; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.physiol.53.1.395; Zhang ZS, 2001, J PHARMACOL EXP THER, V298, P188	58	1	1	1	3	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	MAY 1	2017	91	5					533	+		10.1124/mol.116.106419				27	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EU5UT	WOS:000401100200009	28280061				2018-01-05	
J	Yin, XJ; Biswal, AK; Dionora, J; Perdigon, KM; Balahadia, CP; Mazumdar, S; Chater, C; Lin, HC; Coe, RA; Kretzschmar, T; Gray, JE; Quick, PW; Bandyopadhyay, A				Yin, Xiaojia; Biswal, Akshaya K.; Dionora, Jacqueline; Perdigon, Kristel M.; Balahadia, Christian P.; Mazumdar, Shamik; Chater, Caspar; Lin, Hsiang-Chun; Coe, Robert A.; Kretzschmar, Tobias; Gray, Julie E.; Quick, Paul W.; Bandyopadhyay, Anindya			CRISPR-Cas9 and CRISPR-Cpf1 mediated targeting of a stomatal developmental gene EPFL9 in rice	PLANT CELL REPORTS			English	Article						CRISPR; Cas9; Cpf1; Stomata; Rice; OsEPFL9	RNA-GUIDED ENDONUCLEASE; CAS SYSTEM; HUMAN-CELLS; GENOME; PLANTS; MUTAGENESIS; GENERATION; NUCLEASES; TALENS; DESIGN	Key message CRISPR-Cas9/Cpf1 system with its unique gene targeting efficiency, could be an important tool for functional study of early developmental genes through the generation of successful knockout plants. Abstract The introduction and utilization of systems biology approaches have identified several genes that are involved in early development of a plant and with such knowledge a robust tool is required for the functional validation of putative candidate genes thus obtained. The development of the CRISPR-Cas9/Cpf1 genome editing system has provided a convenient tool for creating loss of function mutants for genes of interest. The present study utilized CRISPR/Cas9 and CRISPR-Cpf1 technology to knock out an early developmental gene EPFL9 (Epidermal Patterning Factor like-9, a positive regulator of stomatal development in Arabidopsis) orthologue in rice. Germ-line mutants that were generated showed edits that were carried forward into the T2 generation when Cas9-free homozygous mutants were obtained. The homozygous mutant plants showed more than an eightfold reduction in stomatal density on the abaxial leaf surface of the edited rice plants. Potential off-target analysis showed no significant off-target effects. This study also utilized the CRISPR-LbCpf1 (Lachnospiracae bacterium Cpf1) to target the same OsEPFL9 gene to test the activity of this class-2 CRISPR system in rice and found that Cpf1 is also capable of genome editing and edits get transmitted through generations with similar phenotypic changes seen with CRISPR-Cas9. This study demonstrates the application of CRISPR-Cas9/Cpf1 to precisely target genomic locations and develop transgene-free homozygous heritable gene edits and confirms that the loss of function analysis of the candidate genes emerging from different systems biology based approaches, could be performed, and therefore, this system adds value in the validation of gene function studies.	[Yin, Xiaojia; Biswal, Akshaya K.; Dionora, Jacqueline; Perdigon, Kristel M.; Balahadia, Christian P.; Mazumdar, Shamik; Lin, Hsiang-Chun; Coe, Robert A.; Kretzschmar, Tobias; Quick, Paul W.; Bandyopadhyay, Anindya] Int Rice Res Inst, DAPO, Manila 7777, Philippines; [Chater, Caspar; Gray, Julie E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Biswal, Akshaya K.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC USA; [Chater, Caspar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca, Morelos, Mexico; [Quick, Paul W.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Bandyopadhyay, A (reprint author), Int Rice Res Inst, DAPO, Manila 7777, Philippines.	a.bandyopadhyay@irri.org		Chater, Caspar/0000-0003-2058-2020			Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Datta K, 2006, METH MOL B, V343, P201; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hunt L, 2010, NEW PHYTOL, V186, P609, DOI 10.1111/j.1469-8137.2010.03200.x; Jiang W, 2013, NUCLEIC ACIDS RES, V41, P1; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Komor AC, 2016, NATURE, V61, P5985, DOI DOI 10.1038/NATUREL7946; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Kumar V, 2015, J EXP BOT, V66, P47, DOI 10.1093/jxb/eru429; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Plosky BS, 2016, MOL CELL, V62, P477, DOI 10.1016/j.molcel.2016.05.006; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rychel AL, 2010, J PLANT RES, V123, P275, DOI 10.1007/s10265-010-0330-9; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Sauer NJ, 2016, PLANT PHYSIOL, V170, P1917, DOI 10.1104/pp.15.01696; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Takata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065183; van Campen JC, 2016, PLANT PHYSIOL, V170, P1655, DOI 10.1104/pp.15.01624; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Xie K, 2014, MOL PLANT, V1, P1; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Yan M, 2015, J INTEGR PLANT BIOL, V57, P613, DOI 10.1111/jipb.12295; Yoshida R, 2010, BIOINFORMATICS, V26, pi589, DOI 10.1093/bioinformatics/btq389; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617	44	3	3	52	72	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	MAY	2017	36	5					745	757		10.1007/s00299-017-2118-z				13	Plant Sciences	Plant Sciences	EV2EL	WOS:000401567700009	28349358				2018-01-05	
J	Brown, RB; Madrid, NJ; Suzuki, H; Ness, SA				Brown, Roger B.; Madrid, Nathaniel J.; Suzuki, Hideaki; Ness, Scott A.			Optimized approach for Ion Proton RNA sequencing reveals details of RNA splicing and editing features of the transcriptome	PLOS ONE			English	Article							C-MYB; CELL; DATABASE; SEQ; DIFFERENTIATION; PROTEINS; LEUKEMIA	RNA-sequencing (RNA-seq) has become the standard method for unbiased analysis of gene expression but also provides access to more complex transcriptome features, including alternative RNA splicing, RNA editing, and even detection of fusion transcripts formed through chromosomal translocations. However, differences in library methods can adversely affect the ability to recover these different types of transcriptome data. For example, some methods have bias for one end of transcripts or rely on low-efficiency steps that limit the complexity of the resulting library, making detection of rare transcripts less likely. We tested several commonly used methods of RNA-seq library preparation and found vast differences in the detection of advanced transcriptome features, such as alternatively spliced isoforms and RNA editing sites. By comparing several different protocols available for the Ion Proton sequencer and by utilizing detailed bioinformatics analysis tools, we were able to develop an optimized random primer based RNA-seq technique that is reliable at uncovering rare transcript isoforms and RNA editing features, as well as fusion reads from oncogenic chromosome rearrangements. The combination of optimized libraries and rapid Ion Proton sequencing provides a powerful platform for the transcriptome analysis of research and clinical samples.	[Brown, Roger B.; Madrid, Nathaniel J.; Suzuki, Hideaki; Ness, Scott A.] Univ New Mexico, Hlth Sci Ctr, Div Mol Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Ness, Scott A.] Univ New Mexico, UNM Comprehens Canc Ctr, Albuquerque, NM 87131 USA	Ness, SA (reprint author), Univ New Mexico, Hlth Sci Ctr, Div Mol Med, Dept Internal Med, Albuquerque, NM 87131 USA.; Ness, SA (reprint author), Univ New Mexico, UNM Comprehens Canc Ctr, Albuquerque, NM 87131 USA.	sness@salud.unm.edu		Ness, Scott/0000-0001-6965-8909	National Institutes of Health [5R01CA170250, 5R01DE023222, 2P30CA118100, 5T32AI007538]	This work was supported by the National Institutes of Health 5R01CA170250, 5R01DE023222, 2P30CA118100, 5T32AI007538.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Brayer KJ, 2016, CANCER DISCOV, V6, P176, DOI 10.1158/2159-8290.CD-15-0859; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Crews LA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0370-3; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; George OL, 2014, CANCERS, V6, P2049, DOI 10.3390/cancers6042049; Han L, 2015, CANCER CELL, V28, P1; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Kiran AM, 2013, NUCLEIC ACIDS RES, V41, pD258, DOI 10.1093/nar/gks961; Lei WL, 2005, BLOOD, V105, P3855, DOI 10.1182/blood-2004-08-3342; Liu F, 2006, ONCOGENE, V25, P795, DOI 10.1038/sj.onc.1209105; Ness SA, SCRIPTS ANAL RNA SEQ; Nigita Giovanni, 2015, Front Bioeng Biotechnol, V3, P37, DOI 10.3389/fbioe.2015.00037; O'Rourke JP, 2008, MOL CELL BIOL, V28, P2091, DOI 10.1128/MCB.01870-07; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Reynolds AP, SAMPLE PERFORMS MEMO; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Rushton JJ, 2001, BLOOD CELL MOL DIS, V27, P459, DOI 10.1006/bcmd.2001.0405; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LL, 2016, CANCER CELL, V30, P750, DOI 10.1016/j.ccell.2016.10.005; Yuan YX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2745-8; Zhou Y, 2011, FRONT BIOSCI-LANDMRK, V16, P1109, DOI 10.2741/3738; Zhou YE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022880; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	31	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176675	10.1371/journal.pone.0176675				15	Multidisciplinary Sciences	Science & Technology - Other Topics	ET9RJ	WOS:000400645000044	28459821	gold			2018-01-05	
J	Qin, H; Xiao, H; Zou, G; Zhou, ZH; Zhong, JJ				Qin, Hao; Xiao, Han; Zou, Gen; Zhou, Zhihua; Zhong, Jian-Jiang			CRISPR-Cas9 assisted gene disruption in the higher fungus Ganoderma species	PROCESS BIOCHEMISTRY			English	Article						Higher fungi; Traditional Chinese medicinal mushroom; Gene disruption; CRISPR-Cas9; Ganoderma lucidum	SACCHAROMYCES-CEREVISIAE; PLEUROTUS-OSTREATUS; MEDICINAL MUSHROOM; LUCIDUM; OVEREXPRESSION; STRAINS; SYSTEMS; LINGZHI; CELLS	Mushrooms, as an important group of higher fungi, are regarded as promising cell factories for production of bioactive secondary metabolites, but there is a lack of methods of genetic manipulation, such as gene disruption, which hinders the studies on biosynthesis and its regulation of those useful natural products. In this study, the CRISPR-Cas9 assisted gene disruption was established for the first time in mushrooms by taking Ganoderma species as typical examples. With double strand break (DSB) introduced by CRISPR-Cas9, non-homologous end joining (NHEJ) was induced and further assisted the gene disruption. As proof of concept, the ura3 gene of G. lucidum 260125 and G. lingzhi was successfully disrupted by the codon-optimized Cas9 and in vitro transcribed gRNA. This work may help to provide a widely applicable approach of gene disruption in higher fungi. (C) 2017 Elsevier Ltd. All rights reserved.	[Qin, Hao; Xiao, Han; Zhong, Jian-Jiang] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Joint Int Res Lab Metab & Dev Sci, Sch Life Sci & Biotechnol, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Qin, Hao; Xiao, Han; Zhong, Jian-Jiang] Shanghai Jiao Tong Univ, Lab Mol Biochem Engn, Sch Life Sci & Biotechnol, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Zou, Gen; Zhou, Zhihua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Key Lab Synthet Biol, 300 Fenglin Rd, Shanghai 200032, Peoples R China	Xiao, H; Zhong, JJ (reprint author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Joint Int Res Lab Metab & Dev Sci, Sch Life Sci & Biotechnol, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.; Xiao, H; Zhong, JJ (reprint author), Shanghai Jiao Tong Univ, Lab Mol Biochem Engn, Sch Life Sci & Biotechnol, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	smallhan@sjtu.edu.cn; jjzhong@sjtu.edu.cn	Zhong, Jian-Jiang/D-8707-2012	Zhong, Jian-Jiang/0000-0002-2265-9338	National Natural Science Foundation of China [31600071]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of the Ministry of Education of China	This work was supported by the National Natural Science Foundation of China (no. 31600071) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars of the Ministry of Education of China.	Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Cheng SJ, 2013, INT J ONCOL, V42, P1869, DOI 10.3892/ijo.2013.1902; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Jong JF, 2010, FEMS MICROBIOL LETT, V310, P91, DOI 10.1111/j.1574-6968.2010.02052.x; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Li G, 2006, FEMS MICROBIOL LETT, V256, P203, DOI 10.1111/j.1574-6968.2006.00110.x; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Ohm RA, 2010, WORLD J MICROB BIOT, V26, P1919, DOI 10.1007/s11274-010-0356-0; Salame TM, 2013, APPL ENVIRON MICROB, V79, P2405, DOI 10.1128/AEM.03849-12; Salame TM, 2012, APPL ENVIRON MICROB, V78, P5341, DOI 10.1128/AEM.01234-12; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Wei ZH, 2014, BIOPROC BIOSYST ENG, V37, P1789, DOI 10.1007/s00449-014-1152-2; Xiao H, 2016, TRENDS BIOTECHNOL, V34, P242, DOI 10.1016/j.tibtech.2015.12.007; Xu JW, 2012, APPL ENVIRON MICROB, V78, P7968, DOI 10.1128/AEM.01263-12; Xu JW, 2010, APPL MICROBIOL BIOT, V87, P457, DOI 10.1007/s00253-010-2576-5; You RX, 2014, PHYTOTHER RES, V28, P1837, DOI 10.1002/ptr.5209; Yu XY, 2014, INT J MED MUSHROOMS, V16, P161, DOI 10.1615/IntJMedMushr.v16.i2.60                                                  ; Zhang DH, 2017, PHYTOCHEMISTRY, V134, P46, DOI 10.1016/j.phytochem.2016.11.006; Zhong JJ, 2009, ADV BIOCHEM ENG BIOT, V113, P79, DOI 10.1007/10_2008_26; Zhou LW, 2015, PHYTOCHEMISTRY, V114, P7, DOI 10.1016/j.phytochem.2014.09.023	26	2	2	19	25	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-5113	1873-3298		PROCESS BIOCHEM	Process Biochem.	MAY	2017	56						57	61		10.1016/j.procbio.2017.02.012				5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering, Chemical	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering	EU9TT	WOS:000401383300007					2018-01-05	
J	Palacios, JM; Pazos, A; Hoyer, D				Palacios, Jose M.; Pazos, Angel; Hoyer, Daniel			A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment	PSYCHOPHARMACOLOGY			English	Review						5-HT2C receptor; GPCR; GWAS; Receptor autoradiography; In situ hybridization; Species differences; Human brain; RNA editing; Receptor homomers; Heteromers; Depression; Anxiety; Obesity; Smoking; cessation; Spinal cord injury; Drug addictions; Schizophrenia; Suicide; Mesulergine; Agomelatine; Lorcaserin; Vabicaserin; Sertindole	SEROTONIN 2C RECEPTOR; VENTRAL TEGMENTAL AREA; BEHAVIORAL SATIETY SEQUENCE; SPINAL-CORD-INJURY; PRE-MESSENGER-RNA; INDUCED LOCOMOTOR-ACTIVITY; INDUCED WEIGHT-GAIN; FLUORESCENCE CORRELATION SPECTROSCOPY; PRECIPITATED WITHDRAWAL SYMPTOMS; 50-KHZ ULTRASONIC VOCALIZATIONS	This paper is a personal account on the discovery and characterization of the 5-HT2C receptor (first known as the 5-HT1C receptor) over 30 years ago and how it translated into a number of unsuspected features for a G protein-coupled receptor (GPCR) and a diversity of clinical applications. The 5-HT2C receptor is one of the most intriguing members of the GPCR superfamily. Initially referred to as 5-HT1CR, the 5-HT2CR was discovered while studying the pharmacological features and the distribution of [H-3]mesulergine-labelled sites, primarily in the brain using radioligand binding and slice autoradiography. Mesulergine (SDZ CU-085), was, at the time, best defined as a ligand with serotonergic and dopaminergic properties. Autoradiographic studies showed remarkably strong [H-3]mesulergine-labelling to the rat choroid plexus. [H-3]mesulergine-labelled sites had pharmacological properties different from, at the time, known or purported 5-HT receptors. In spite of similarities with 5-HT2 binding, the new binding site was called 5-HT1C because of its very high affinity for 5-HT itself. Within the following 10 years, the 5-HT1CR (later named 5-HT2C) was extensively characterised pharmacologically, anatomically and functionally: it was one of the first 5-HT receptors to be sequenced and cloned. The 5-HT2CR is a GPCR, with a very complex gene structure. It constitutes a rarity in the GPCR family: many 5-HT2CR variants exist, especially in humans, due to RNA editing, in addition to a few 5-HT2CR splice variants. Intense research led to therapeutically active 5-HT2C receptor ligands, both antagonists (or inverse agonists) and agonists: keeping in mind that a number of antidepressants and antipsychotics are 5-HT2CR antagonists/inverse agonists. Agomelatine, a 5-HT2CR antagonist is registered for the treatment of major depression. The agonist Lorcaserin is registered for the treatment of aspects of obesity and has further potential in addiction, especially nicotine/ smoking. There is good evidence that the 5-HT2CR is involved in spinal cord injury-induced spasms of the lower limbs, which can be treated with 5-HT2CR antagonists/inverse agonists such as cyproheptadine or SB206553. The 5-HT2CR may play a role in schizophrenia and epilepsy. Vabicaserin, a 5-HT2CR agonist has been in development for the treatment of schizophrenia and obesity, but was stopped. As is common, there is potential for further indications for 5-HT2CR ligands, as suggested by a number of preclinical and/or genome-wide association studies (GWAS) on depression, suicide, sexual dysfunction, addictions and obesity. The 5-HT2CR is clearly affected by a number of established antidepressants/antipsychotics and may be one of the culprits in antipsychotic-induced weight gain.	[Palacios, Jose M.] Frontera Biotechnol SL, Barcelona 08013, Spain; [Pazos, Angel] Univ Cantabria, Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Biomed & Biotecnol Cantabria, IBBTEC,CSIC,SODERCAN, Santander 39011, Spain; [Hoyer, Daniel] Univ Melbourne, Sch Biomed Sci, Dept Pharmacol & Therapeut, Fac Med Dent & Hlth Sci, Parkville, Vic 3010, Australia; [Hoyer, Daniel] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia; [Hoyer, Daniel] Scripps Res Inst, Dept Mol Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA	Hoyer, D (reprint author), Univ Melbourne, Sch Biomed Sci, Dept Pharmacol & Therapeut, Fac Med Dent & Hlth Sci, Parkville, Vic 3010, Australia.; Hoyer, D (reprint author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia.; Hoyer, D (reprint author), Scripps Res Inst, Dept Mol Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	d.hoyer@unimelb.edu.au					Abramowski D, 1995, NEUROPHARMACOLOGY, V34, P1635, DOI 10.1016/0028-3908(95)00138-7; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5729, DOI 10.1111/bph.13347; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1449, DOI 10.1111/bph.12444; Aloyo VJ, 2009, PHARMACOL THERAPEUT, V121, P160, DOI 10.1016/j.pharmthera.2008.10.010; Anastasio NC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.131; Anastasio NC, 2015, ACS CHEM NEUROSCI, V6, P1248, DOI 10.1021/acschemneuro.5b00094; Anastasio NC, 2014, NEUROPSYCHOPHARMACOL, V39, P360, DOI 10.1038/npp.2013.199; Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; Bankson MG, 2002, NEUROPSYCHOPHARMACOL, V26, P40, DOI 10.1016/S0893-133X(01)00345-1; Basile VS, 2002, LANCET, V360, P1790, DOI 10.1016/S0140-6736(02)11706-5; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Becamel C, 2001, J BIOL CHEM, V276, P12974, DOI 10.1074/jbc.M008089200; BENJAMIN D, 1990, LIFE SCI, V47, P195, DOI 10.1016/0024-3205(90)90320-Q; Bennett MR, 2000, NEUROPHARMACOLOGY, V39, P523, DOI 10.1016/S0028-3908(99)00137-9; Berg KA, 1999, MOL PHARMACOL, V55, P863; Berg KA, 2003, FASEB J, V17, pA1021; BERG KA, 1994, MOL PHARMACOL, V46, P477; Berg KA, 1998, ANN NY ACAD SCI, V861, P104, DOI 10.1111/j.1749-6632.1998.tb10180.x; Berg KA, 2001, BRIT J PHARMACOL, V134, P386, DOI 10.1038/sj.bjp.0704255; Berg KA, 1998, MOL PHARMACOL, V54, P94; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; Berg KA, 2008, J PHARMACOL EXP THER, V324, P1084, DOI 10.1124/jpet.107.131524; Berg Kelly A., 2009, P155, DOI 10.1007/978-1-60327-335-0_9; BERGEN SS, 1964, AM J DIS CHILD, V108, P270, DOI 10.1001/archpedi.1964.02090010272008                                            ; Berglund ED, 2013, J CLIN INVEST, V123, P5061, DOI 10.1172/JCI70338; Besson M, 2013, NEUROPSYCHOPHARMACOL, V38, P1963, DOI 10.1038/npp.2013.95; Bigford GE, 2012, J BIOL CHEM, V287, P11049, DOI 10.1074/jbc.M111.277806; Bilkei-Gorzo A, 1998, PSYCHOPHARMACOLOGY, V136, P291, DOI 10.1007/s002130050568                                                           ; Blundell JE, 1999, SCHWEIZ MED WSCHR, V129, P182; Bombail V, 2014, EUR J NEUROSCI, V40, P3663, DOI 10.1111/ejn.12727; Bonhaus DW, 1997, NEUROPHARMACOLOGY, V36, P621, DOI 10.1016/S0028-3908(97)00049-X; BRADLEY PB, 1986, NEUROPHARMACOLOGY, V25, P563, DOI 10.1016/0028-3908(86)90207-8; Brennan TJ, 1997, NAT GENET, V16, P387, DOI 10.1038/ng0897-387; Bromidge SM, 1997, J MED CHEM, V40, P3494, DOI 10.1021/jm970424c; Bubar MJ, 2007, NEUROSCIENCE, V146, P286, DOI 10.1016/j.neuroscience.2006.12.071; Bubar MJ, 2006, CURR TOP MED CHEM, V6, P1971, DOI 10.2174/156802606778522131                                                      ; Bubar MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020508; Bubar MJ, 2008, PROG BRAIN RES, V172, P319, DOI 10.1016/S0079-6123(08)00916-3; Burbassi S, 2008, PSYCHOPHARMACOLOGY, V196, P15, DOI 10.1007/s00213-007-0916-7; Burke LK, 2016, MOL METAB, V5, P245, DOI 10.1016/j.molmet.2016.01.005; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; BuydensBranchey L, 1997, BIOL PSYCHIAT, V41, P1071, DOI 10.1016/S0006-3223(96)00182-5; Campbell BM, 2003, BRAIN RES, V993, P1, DOI 10.1016/S0006-8993(03)03384-5; Canton H, 1996, MOL PHARMACOL, V50, P799; Carmel L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002663; Cathala A, 2015, ADDICT BIOL, V20, P445, DOI 10.1111/adb.12137; Chinuck RS, 2007, J HUM NUTR DIET, V20, P526, DOI 10.1111/j.1365-277X.2007.00824.x; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; Clifton PG, 2000, PSYCHOPHARMACOLOGY, V152, P256, DOI 10.1007/s002130000504; CLOSSE A, 1983, LIFE SCI, V32, P2485, DOI 10.1016/0024-3205(83)90375-2; CONN PJ, 1986, P NATL ACAD SCI USA, V83, P4086, DOI 10.1073/pnas.83.11.4086; CONN PJ, 1986, J NEUROCHEM, V47, P1754, DOI 10.1111/j.1471-4159.1986.tb13085.x; Cremers TIFH, 2007, NEUROPSYCHOPHARMACOL, V32, P1550, DOI 10.1038/sj.npp.1301287; Cremers TIFH, 2004, NEUROPSYCHOPHARMACOL, V29, P1782, DOI 10.1038/sj.npp.1300474; Cryan JF, 2000, J PHARMACOL EXP THER, V295, P1120; Cunningham KA, 2014, NEUROPHARMACOLOGY, V76, P460, DOI 10.1016/j.neuropharm.2013.06.030; Cunningham KA, 2013, ACS CHEM NEUROSCI, V4, P110, DOI 10.1021/cn300072u; Cunningham KA, 2011, NEUROPHARMACOLOGY, V61, P513, DOI 10.1016/j.neuropharm.2011.04.034; Dalton GL, 2006, PSYCHOPHARMACOLOGY, V185, P45, DOI 10.1007/s00213-005-0212-3; Davis JD, 2001, PHYSIOL BEHAV, V72, P393, DOI 10.1016/S0031-9384(00)00442-X; De Luca V, 2007, HUM PSYCHOPHARM CLIN, V22, P463, DOI 10.1002/hup.868; Yamashita PSD, 2011, NEUROPHARMACOLOGY, V60, P216, DOI 10.1016/j.neuropharm.2010.09.001; Di Giovanni G, 2001, NEUROSCIENCE, V103, P111, DOI 10.1016/S0306-4522(00)00561-3; Di Giovanni G, 1999, NEUROSCIENCE, V91, P587, DOI 10.1016/S0306-4522(98)00655-1; Di Giovanni G, 2016, PHARMACOL THERAPEUT, V157, P125, DOI 10.1016/j.pharmthera.2015.11.009; Di Matteo M, 2000, BRAIN RES, V865, P85; Di Narzo AF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12615; Di Narzo AF, 2014, HUM MOL GENET, V23, P4801, DOI 10.1093/hmg/ddu195; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DOODS HN, 1988, J CARDIOVASC PHARM, V11, P432, DOI 10.1097/00005344-198804000-00008; DOYLE VM, 1986, N-S ARCH PHARMACOL, V333, P98, DOI 10.1007/BF00506510; Dracheva S, 2008, MOL PSYCHIATR, V13, P1001, DOI 10.1038/sj.mp.4002081; Dracheva S, 2003, J NEUROCHEM, V87, P1402, DOI 10.1046/j.1471-4159.2003.02115.x; Dracheva S, 2008, NEUROREPORT, V19, P379, DOI 10.1097/WNR.0b013e3282f556d2; Dracheva S, 2009, NEUROPSYCHOPHARMACOL, V34, P2237, DOI 10.1038/npp.2009.51; Du YZ, 2007, GENE, V391, P186, DOI 10.1016/j.gene.2006.12.023; Du YZ, 2006, GENE, V382, P39, DOI 10.1016/j.gene.2006.06.007; Dunlop J, 2005, J PHARMACOL EXP THER, V313, P862, DOI 10.1124/jpet.104.075382; Dunlop J, 2006, CNS DRUG REV, V12, P167, DOI 10.1111/j.1527-3458.2006.00167.x; Dunlop J, 2011, J PHARMACOL EXP THER, V337, P673, DOI 10.1124/jpet.111.179572; [Anonymous], EMA6336762014; [Anonymous], EMA6951342016; ENGEL G, 1984, J RECEPTOR RES, V4, P113, DOI 10.3109/10799898409042543                                                       ; ENGEL G, 1986, N-S ARCH PHARMACOL, V332, P1, DOI 10.1007/BF00633189; ENGEL G, 1981, N-S ARCH PHARMACOL, V317, P277, DOI 10.1007/BF00501307; ENZ A, 1984, J NEURAL TRANSM, V60, P225, DOI 10.1007/BF01249095; FARGIN A, 1988, NATURE, V335, P358, DOI 10.1038/335358a0; Filip M, 2002, PHARMACOL BIOCHEM BE, V71, P745, DOI 10.1016/S0091-3057(01)00741-9; Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75; Fitzgerald LW, 1999, NEUROPSYCHOPHARMACOL, V21, pS82, DOI 10.1016/S0893-133X(99)00004-4; Fletcher PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1402, DOI 10.1038/sj.npp.1301509; Fletcher PJ, 2012, NEUROPHARMACOLOGY, V62, P2288, DOI 10.1016/j.neuropharm.2012.01.023; Fletcher PJ, 2011, NEUROPHARMACOLOGY, V61, P468, DOI 10.1016/j.neuropharm.2011.02.025; Fletcher PJ, 2004, NEUROPSYCHOPHARMACOL, V29, P308, DOI 10.1038/sj.npp.1300319; Fletcher PJ, 2002, PSYCHOPHARMACOLOGY, V162, P282, DOI 10.1007/s00213-002-1104-4; Fletcher PJ, 2002, NEUROPSYCHOPHARMACOL, V27, P576; Flomen R, 2004, NUCLEIC ACIDS RES, V32, P2113, DOI 10.1093/nar/gkh536; FOGUET M, 1992, EMBO J, V11, P3481; FOGUET M, 1992, NEUROREPORT, V3, P345, DOI 10.1097/00001756-199204000-00014; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; GADDUM JH, 1957, BRIT J PHARM CHEMOTH, V12, P323, DOI 10.1111/j.1476-5381.1957.tb00142.x                                              ; Gatch MB, 2003, LIFE SCI, V73, P1347, DOI 10.1016/S0024-3205(03)00422-3; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Gavarini S, 2006, MOL BIOL CELL, V17, P4619, DOI 10.1091/mbc.E06-03-0218; Giger RKA, 2006, CHIMIA, V60, P83, DOI 10.2533/000942906777675164                                                      ; Gobert A, 2000, SYNAPSE, V36, P205, DOI 10.1002/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D                  ; GOZLAN H, 1983, NATURE, V305, P140, DOI 10.1038/305140a0; Grauer SM, 2009, PSYCHOPHARMACOLOGY, V204, P37, DOI 10.1007/s00213-008-1433-z; Graves SM, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-65; Grottick AJ, 2000, J PHARMACOL EXP THER, V295, P1183; Grottick AJ, 2001, PSYCHOPHARMACOLOGY, V157, P292, DOI 10.1007/s002130100801                                                           ; Grottick AJ, 2015, PSYCHOPHARMACOLOGY, V232, P1973, DOI 10.1007/s00213-014-3829-2; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Hackler EA, 2007, J PHARMACOL EXP THER, V320, P1023, DOI 10.1124/jpet.106.113357; Hackler EA, 2006, NEUROSCI RES, V55, P96, DOI 10.1016/j.neures.2006.02.005; Halford JCG, 2000, ANN MED, V32, P222, DOI 10.3109/07853890008998829                                                       ; Halford JCG, 1998, PHARMACOL BIOCHEM BE, V61, P159, DOI 10.1016/S0091-3057(98)00032-X; Halford JCG, 1997, PHARMACOL BIOCHEM BE, V56, P41, DOI 10.1016/S0091-3057(96)00152-9                                                   ; Harada K, 2006, EUR J PHARMACOL, V553, P171, DOI 10.1016/j.ejphar.2006.09.042; Hartig PR, 1996, TRENDS PHARMACOL SCI, V17, P103, DOI 10.1016/0165-6147(96)30002-3; Harvey-Lewis C, 2016, NEUROPHARMACOLOGY, V101, P237, DOI 10.1016/j.neuropharm.2015.09.028; Hayasaka Y, 2015, J AFFECT DISORDERS, V180, P179, DOI 10.1016/j.jad.2015.03.021; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Heisler LK, 1998, ANN NY ACAD SCI, V861, P74, DOI 10.1111/j.1749-6632.1998.tb10175.x; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heisler LK, 2000, J NEUROSCI, V20, part. no.; Heisler LK, 2007, J NEUROSCI, V27, P6956, DOI 10.1523/JNEUROSCI.2584-06.2007; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Herrick-Davis K, 2000, J PHARMACOL EXP THER, V295, P226; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Herrick-Davis K, 2004, BIOCHEMISTRY-US, V43, P13963, DOI 10.1021/bi048398p; Herrick-Davis K, 2007, EUR J PHARMACOL, V568, P45, DOI 10.1016/j.ejphar.2007.04.030; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Herrick-Davis K, 2015, MOL PHARMACOL, V87, P660, DOI 10.1124/mol.114.096636; Herrick-Davis K, 2013, EXP BRAIN RES, V230, P375, DOI 10.1007/s00221-013-3622-1; Herrick-Davis K, 2013, MOL PHARMACOL, V84, P630, DOI 10.1124/mol.113.087072; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Herrick-Davis K, 2011, RECEPT SER, P129, DOI 10.1007/978-1-60761-941-3_7; Hewitt KN, 2002, PHARMACOL BIOCHEM BE, V71, P691, DOI 10.1016/S0091-3057(01)00709-2; Hietala J, 2001, PSYCHOPHARMACOLOGY, V157, P180, DOI 10.1007/s002130100814; Higgins GA, 2012, NEUROPSYCHOPHARMACOL, V37, P1177, DOI 10.1038/npp.2011.303; Higgs S, 2016, PSYCHOPHARMACOLOGY, V233, P417, DOI 10.1007/s00213-015-4112-x; HJORTH S, 1982, J NEURAL TRANSM, V55, P169, DOI 10.1007/BF01276574                                                              ; HOFFMAN BJ, 1989, FEBS LETT, V247, P453, DOI 10.1016/0014-5793(89)81390-0; Howell LL, 2015, PHARMACOL REV, V67, P176, DOI 10.1124/pr.114.009514; Howes SR, 2000, PSYCHOPHARMACOLOGY, V151, P55, DOI 10.1007/s002130000451                                                           ; HOYER D, 1988, TRENDS PHARMACOL SCI, V9, P89, DOI 10.1016/0165-6147(88)90174-5; HOYER D, 1986, NEUROSCI LETT, V69, P269, DOI 10.1016/0304-3940(86)90492-1; HOYER D, 1988, EUR J PHARMACOL, V150, P181, DOI 10.1016/0014-2999(88)90766-2; HOYER D, 1988, J RECEPTOR RES, V8, P59, DOI 10.3109/10799898809048978                                                       ; HOYER D, 1986, BRAIN RES, V376, P85, DOI 10.1016/0006-8993(86)90902-9; HOYER D, 1988, EUR J PHARMACOL, V147, P145, DOI 10.1016/0014-2999(88)90645-0; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8                                                   ; HOYER D, 1989, TRENDS PHARMACOL SCI, V10, P130, DOI 10.1016/0165-6147(89)90159-4; HOYER D, 1994, PHARMACOL REV, V46, P157; HOYER D, 1982, N-S ARCH PHARMACOL, V318, P319, DOI 10.1007/BF00501172; HOYER D, 1986, BRAIN RES, V376, P97, DOI 10.1016/0006-8993(86)90903-0; HOYER D, 1985, EUR J PHARMACOL, V118, P13, DOI 10.1016/0014-2999(85)90658-2; HOYER D, 1985, EUR J PHARMACOL, V118, P1, DOI 10.1016/0014-2999(85)90657-0; HOYER D, 1989, N-S ARCH PHARMACOL, V339, P252; HOYER D, 1990, NEUROPSYCHOPHARMACOL, V3, P371; HOYER D, 1988, NEUROSCI LETT, V85, P357, DOI 10.1016/0304-3940(88)90592-7; HUMPHREY PPA, 1993, TRENDS PHARMACOL SCI, V14, P233, DOI 10.1016/0165-6147(93)90016-D; Husch A, 2012, J NEUROSCI, V32, P13145, DOI 10.1523/JNEUROSCI.2995-12.2012; Isaac M, 2005, CURR TOP MED CHEM, V5, P59, DOI 10.2174/1568026053386980; Ishii Y, 2003, PHYSIOL BEHAV, V80, P37, DOI 10.1016/S0031-9384(03)00207-5; Iwamoto K, 2005, NEUROSCI RES, V53, P69, DOI 10.1016/j.neures.2005.06.001; Iwamoto K, 2003, NEUROSCI LETT, V346, P169, DOI 10.1016/S0304-3940(03)00608-6; Iwamoto K, 2011, RECEPT SER, P157, DOI 10.1007/978-1-60761-941-3_8; Jakus R, 2003, EXP NEUROL, V184, P964, DOI 10.1016/S0014-4886(03)00352-2; Jenck F, 1998, Expert Opin Investig Drugs, V7, P1587, DOI 10.1517/13543784.7.10.1587; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Juruena MF, 2011, J CENT NERV SYST DIS, V3, P75, DOI 10.4137/JCNSD.S5729; KAHN RS, 1991, BIOL PSYCHIAT, V30, P1139, DOI 10.1016/0006-3223(91)90184-N; KALKMAN HO, 1986, EUR J PHARMACOL, V129, P139, DOI 10.1016/0014-2999(86)90345-6; Kalkman HO, 1984, J HYPERTENSION S3, V2, P143; Kamal M, 2015, J BIOL CHEM, V290, P11537, DOI 10.1074/jbc.M114.559542; Kasper J, 2013, EUR J PHARMACOL, V718, P98, DOI 10.1016/j.ejphar.2013.09.008; Kennett G, 2000, EUR J PHARMACOL, V387, P197, DOI 10.1016/S0014-2999(99)00706-2; KENNETT GA, 1988, PSYCHOPHARMACOLOGY, V96, P93, DOI 10.1007/BF02431539; KENNETT GA, 1994, PSYCHOPHARMACOLOGY, V114, P90, DOI 10.1007/BF02245448                                                              ; Kennett GA, 1997, NEUROPHARMACOLOGY, V36, P609, DOI 10.1016/S0028-3908(97)00038-5; Kennett GA, 1996, BRIT J PHARMACOL, V117, P427, DOI 10.1111/j.1476-5381.1996.tb15208.x                                              ; KENNETT GA, 1989, EUR J PHARMACOL, V164, P445, DOI 10.1016/0014-2999(89)90252-5; Kirk SL, 2009, PSYCHOPHARMACOLOGY, V207, P119, DOI 10.1007/s00213-009-1639-8; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Kleene R, 2015, J CELL SCI, V128, P4642, DOI 10.1242/jcs.176941; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; LADURON PM, 1984, BIOCHEM PHARMACOL, V33, P833, DOI 10.1016/0006-2952(84)90436-2; Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321; LEE MA, 1994, DRUG ALCOHOL DEPEN, V35, P217, DOI 10.1016/0376-8716(94)90077-9                                                    ; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Leggio GM, 2009, J NEUROCHEM, V111, P614, DOI 10.1111/j.1471-4159.2009.06356.x; Levin ED, 2011, J PHARMACOL EXP THER, V338, P890, DOI 10.1124/jpet.111.183525; LEYSEN JE, 1978, NATURE, V272, P168, DOI 10.1038/272168a0; LINDVALLAXELSSON M, 1988, EXP NEUROL, V99, P362, DOI 10.1016/0014-4886(88)90154-9                                                    ; Liu SJ, 2012, ADDICT BEHAV, V37, P193, DOI 10.1016/j.addbeh.2011.10.003; Liu SJ, 2011, AM J DRUG ALCOHOL AB, V37, P117, DOI 10.3109/00952990.2010.543204; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351                                                        ; Lopez-Gimenez JF, 2001, SYNAPSE, V42, P12, DOI 10.1002/syn.1095; LOWY MT, 1988, BIOL PSYCHIAT, V23, P818, DOI 10.1016/0006-3223(88)90070-4; LUBBERT H, 1987, P NATL ACAD SCI USA, V84, P4332, DOI 10.1073/pnas.84.12.4332; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5                                                   ; Lyddon R, 2013, WORLD J BIOL PSYCHIA, V14, P590, DOI 10.3109/15622975.2011.630406; Maillet JC, 2008, PROG BRAIN RES, V172, P407, DOI 10.1016/S0079-6123(08)00920-5; Manvich DF, 2012, J PHARMACOL EXP THER, V342, P761, DOI 10.1124/jpet.112.195156; Manvich DF, 2012, J PHARMACOL EXP THER, V341, P424, DOI 10.1124/jpet.111.186981; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; MARKSTEIN R, 1986, N-S ARCH PHARMACOL, V333, P335, DOI 10.1007/BF00500006                                                              ; MARKSTEIN R, 1983, EUR J PHARMACOL, V95, P101, DOI 10.1016/0014-2999(83)90272-8; Marquis KL, 2007, J PHARMACOL EXP THER, V320, P486, DOI 10.1124/jpet.106.106989; Martin CBP, 2013, MOL PSYCHIATR, V18, P656, DOI 10.1038/mp.2012.171; Martin CBP, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu056; Martin CBP, 2014, NEUROSCI BIOBEHAV R, V42, P208, DOI 10.1016/j.neubiorev.2014.03.001; Martin JR, 1998, J PHARMACOL EXP THER, V286, P913; Maurel S, 1999, EUR J PHARMACOL, V370, P217, DOI 10.1016/S0014-2999(99)00125-9                                                   ; McCorvy JD, 2015, PHARMACOL THERAPEUT, V150, P129, DOI 10.1016/j.pharmthera.2015.01.009; Meltzer HY, 1999, NEUROPSYCHOPHARMACOL, V21, pS106, DOI 10.1016/S0893-133X(99)00046-9; MENGOD G, 1990, NEUROSCIENCE, V35, P577, DOI 10.1016/0306-4522(90)90330-7                                                    ; Mengod G, 2010, HBK BEHAV NEUROSCI, V21, P123, DOI 10.1016/B978-0-12-374634-4.00006-X; MIDDLEMISS DN, 1983, EUR J PHARMACOL, V90, P151, DOI 10.1016/0014-2999(83)90230-3; Milatovich Athena, 1992, Human Molecular Genetics, V1, P681, DOI 10.1093/hmg/1.9.681; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Millan MJ, 2011, INT J NEUROPSYCHOPH, V14, P768, DOI 10.1017/S1461145710001045; Millan MJ, 2005, PSYCHOPHARMACOLOGY, V177, P448, DOI 10.1007/s00213-004-1962-z; Millan MJ, 2003, J PHARMACOL EXP THER, V306, P954, DOI 10.1124/jpet.103.051797; Millan MJ, 2005, THERAPIE, V60, P441, DOI 10.2515/therapie:2005065; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Miller KJ, 2005, MOL INTERV, V5, P282, DOI 10.1124/mi.5.5.8; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; Moreau JL, 1996, EUR NEUROPSYCHOPHARM, V6, P169, DOI 10.1016/0924-977X(96)00015-6; Moya PR, 2007, J PHARMACOL EXP THER, V321, P1054, DOI 10.1124/jpet.106.117507; Murotani T, 2011, NEUROPHARMACOLOGY, V61, P228, DOI 10.1016/j.neuropharm.2011.04.003; Murray KC, 2011, J NEUROPHYSIOL, V105, P731, DOI 10.1152/jn.00774.2010; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Navailles S, 2013, EXP BRAIN RES, V230, P525, DOI 10.1007/s00221-013-3562-9; Navailles S, 2004, NEUROPSYCHOPHARMACOL, V29, P319, DOI 10.1038/sj.npp.1300329; Navailles S, 2008, NEUROPSYCHOPHARMACOL, V33, P237, DOI 10.1038/sj.npp.1301414; Navailles S, 2013, INT J NEUROPSYCHOPH, V16, P593, DOI 10.1017/S1461145712000417; Neisewander JL, 2007, BEHAV PHARMACOL, V18, P791, DOI 10.1097/FBP.0b013e3282f1c94b; Nic Dhonnchadha Brid Aine, 2003, Behav Brain Res, V140, P203, DOI 10.1016/S0166-4328(02)00311-X; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Niswender CM, 2001, NEUROPSYCHOPHARMACOL, V24, P478, DOI 10.1016/S0893-133X(00)00223-2; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Nonogaki K, 2008, BIOCHEM BIOPH RES CO, V372, P186, DOI 10.1016/j.bbrc.2008.05.010; NOZULAK J, 1995, J MED CHEM, V38, P28, DOI 10.1021/jm00001a007; O'Neill MF, 1999, PHARMACOL BIOCHEM BE, V63, P237, DOI 10.1016/S0091-3057(98)00240-8                                                   ; PALACIOS JM, 1986, BRAIN RES, V380, P151, DOI 10.1016/0006-8993(86)91439-3                                                    ; Palacios JM, 1990, VISUALIZATION SEROTO, P383; Palacios JM, 2010, PATHOPHYSIOLOGY CENT, DOI [10.1007/978-1-60761-941-3_1, DOI 10.1007/978-1-60761-941-3_1]; Parker LL, 2003, J BIOL CHEM, V278, P21576, DOI 10.1074/jbc.M210973200; Parsons LH, 1996, BEHAV BRAIN RES, V73, P225; PARSONS LH, 1993, BRAIN RES, V606, P195, DOI 10.1016/0006-8993(93)90984-U; Patkar AA, 2006, PSYCHOPHARMACOLOGY, V185, P123, DOI 10.1007/s00213-005-0261-7; PAZOS A, 1984, EUR J PHARMACOL, V106, P531, DOI 10.1016/0014-2999(84)90056-6; PAZOS A, 1985, BRAIN RES, V346, P231, DOI 10.1016/0006-8993(85)90857-1; PAZOS A, 1987, NEUROSCIENCE, V21, P97, DOI 10.1016/0306-4522(87)90326-5; PAZOS A, 1987, NEUROSCIENCE, V21, P123, DOI 10.1016/0306-4522(87)90327-7; PAZOS A, 1985, BRAIN RES, V346, P205, DOI 10.1016/0006-8993(85)90856-X; PAZOS A, 1984, EUR J PHARMACOL, V106, P539, DOI 10.1016/0014-2999(84)90057-8; PEDIGO NW, 1981, J NEUROCHEM, V36, P220, DOI 10.1111/j.1471-4159.1981.tb02397.x                                              ; Pelloux Y, 2012, NEUROPSYCHOPHARMACOL, V37, P2505, DOI 10.1038/npp.2012.111; PEROUTKA SJ, 1979, MOL PHARMACOL, V16, P687; Peyron C, 1998, NEUROSCIENCE, V82, P443; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Pooley EC, 2004, AM J MED GENET B, V126B, P124, DOI 10.1002/ajmg.b.20143; Price RD, 2000, MOL PHARMACOL, V58, P859; Price RD, 2001, J BIOL CHEM, V276, P44663, DOI 10.1074/jbc.M106745200                                                          ; PRISCO S, 1995, BRIT J PHARMACOL, V116, P1923, DOI 10.1111/j.1476-5381.1995.tb16684.x                                              ; PRITCHETT DB, 1988, EMBO J, V7, P4135; Qiu J, 2007, MOL PHARMACOL, V72, P885, DOI 10.1124/mol.107.038083; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Rauser L, 2001, J PHARMACOL EXP THER, V299, P83; Reynolds GP, 2005, PROG NEURO-PSYCHOPH, V29, P1021, DOI 10.1016/j.pnpbp.2005.03.019; Reynolds GP, 2003, AM J PSYCHIAT, V160, P677, DOI 10.1176/appi.ajp.160.4.677                                                      ; Rezvani AH, 2014, PHARMACOL BIOCHEM BE, V125, P8, DOI 10.1016/j.pbb.2014.07.017; Rippberger H, 2015, CURR NEUROPHARMACOL, V13, P220, DOI 10.2174/1570159X1302150525124408                                                ; ROCHA B, 1994, EUR J PHARMACOL, V262, P125, DOI 10.1016/0014-2999(94)90035-3; ROCHA B, 1993, NEUROSCIENCE, V56, P687, DOI 10.1016/0306-4522(93)90365-M; Rocha BA, 2002, J NEUROSCI, V22, P10039; Rosenzweig-Lipson S, 2007, DRUG NEWS PERSPECT, V20, P565, DOI 10.1358/dnp.2007.20.9.1162244; Rosenzweig-Lipson S, 2007, PSYCHOPHARMACOLOGY, V192, P159, DOI 10.1007/s00213-007-0710-6; Rosenzweig-Lipson Sharon, 2012, Handb Exp Pharmacol, P147, DOI 10.1007/978-3-642-25758-2_6; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Ruedi-Bettschen D, 2015, PSYCHOPHARMACOLOGY, V232, P2959, DOI 10.1007/s00213-015-3932-z; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; SALTZMAN AG, 1991, BIOCHEM BIOPH RES CO, V181, P1469, DOI 10.1016/0006-291X(91)92105-S; Schellekens H, 2015, ACS CHEM NEUROSCI, V6, P1186, DOI 10.1021/cn500318q; SCHOEFFTER P, 1990, J PHARMACOL EXP THER, V252, P387; SCHOEFFTER P, 1988, N-S ARCH PHARMACOL, V337, P602; SCHOEFFTER P, 1989, N-S ARCH PHARMACOL, V340, P285; Serrats J, 2005, J CHEM NEUROANAT, V29, P83, DOI 10.1016/j.jchemneu.2004.03.010; SEVY S, 1994, PSYCHIAT RES, V53, P219, DOI 10.1016/0165-1781(94)90051-5; Shen JHQ, 2014, J PSYCHIATR RES, V53, P14, DOI 10.1016/j.jpsychires.2014.02.012; Shen ML, 2013, NUCLEIC ACIDS RES, V41, P3819, DOI 10.1093/nar/gkt063; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Siuciak JA, 2007, NEUROPHARMACOLOGY, V52, P279, DOI 10.1016/j.neuropharm.2006.07.024; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Smith SR, 2009, OBESITY, V17, P494, DOI 10.1038/oby.2008.537; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; Sodhi MSK, 2005, MOL PHARMACOL, V68, P711, DOI 10.1124/mol.105.014134; Somerville EM, 2007, EUR J NEUROSCI, V25, P3115, DOI 10.1111/j.1460-9568.2007.05567.x; Southwick SM, 1997, ARCH GEN PSYCHIAT, V54, P749; STAM NJ, 1994, EUR J PHARM-MOLEC PH, V269, P339, DOI 10.1016/0922-4106(94)90042-6                                                    ; Steed E, 2011, BEHAV BRAIN RES, V220, P9, DOI 10.1016/j.bbr.2011.01.026; Strong PV, 2011, NEUROSCIENCE, V197, P132, DOI 10.1016/j.neuroscience.2011.09.041; Strong PV, 2009, PSYCHOPHARMACOLOGY, V203, P665, DOI 10.1007/s00213-008-1413-3; Sullivan LC, 2015, CURR PHARM DESIGN, V21, P3732, DOI 10.2174/1381612821666150605111236; Swinford-Jackson SE, 2016, NEUROSCIENCE, V324, P50, DOI 10.1016/j.neuroscience.2016.02.052; Tecott Laurence H, 2003, CNS Spectr, V8, P584; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Templeman Lucy A, 2005, Pharmacogenet Genomics, V15, P195, DOI 10.1097/01213011-200504000-00002; Thomas JM, 2014, PSYCHOPHARMACOLOGY, V231, P2449, DOI 10.1007/s00213-013-3409-x; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Tomkins DM, 2002, PHARMACOL BIOCHEM BE, V71, P735, DOI 10.1016/S0091-3057(01)00710-9; Tsai SJ, 2002, LANCET, V360, P1790, DOI 10.1016/S0140-6736(02)11705-3                                                   ; VANDEKAR LD, 1979, BRAIN RES, V162, P45, DOI 10.1016/0006-8993(79)90754-6                                                    ; Venzi M, 2016, NEUROPHARMACOLOGY, V108, P292, DOI 10.1016/j.neuropharm.2016.04.016; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Voigt JP, 2015, BEHAV BRAIN RES, V277, P14, DOI 10.1016/j.bbr.2014.08.065; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wade JM, 2008, ENDOCRINOLOGY, V149, P955, DOI 10.1210/en.2007-0927; WAEBER C, 1988, EUR J PHARMACOL, V151, P351, DOI 10.1016/0014-2999(88)90825-4; Wallace TJM, 2011, PHARMACOGN PERS MED, V4, P83, DOI 10.2147/PGPM.S11866; Wang B, 2006, BIOCHEM BIOPH RES CO, V351, P418, DOI 10.1016/j.bbrc.2006.10.033; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wang QD, 2000, J NEUROCHEM, V74, P1290; WANG Y, 1995, PSYCHOPHARMACOLOGY, V120, P134, DOI 10.1007/BF02246185; Watanabe Y, 2014, INT J NEUROPSYCHOPH, V17, P739, DOI 10.1017/S1461145713001545; Werry TD, 2005, J NEUROCHEM, V93, P1603, DOI 10.1111/j.1471-4159.2005.03161.x; Werry TD, 2008, BIOCHEM PHARMACOL, V76, P1276, DOI 10.1016/j.bcp.2008.08.024; Winstanley CA, 2004, PSYCHOPHARMACOLOGY, V176, P376, DOI 10.1007/s00213-004-1884-9; Wirshing DA, 1999, J CLIN PSYCHIAT, V60, P358, DOI 10.4088/JCP.v60n0602                                                            ; Wohr M, 2015, PSYCHOPHARMACOLOGY, V232, P1817, DOI 10.1007/s00213-014-3814-9; Wood MD, 2001, NEUROPHARMACOLOGY, V41, P186, DOI 10.1016/S0028-3908(01)00054-5                                                   ; Wu X, 2015, NEUROSCI LETT, V607, P23, DOI 10.1016/j.neulet.2015.09.013; Xie EZ, 1996, GENOMICS, V35, P551, DOI 10.1006/geno.1996.0397                                                          ; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; YAGALOFF KA, 1985, J NEUROSCI, V5, P3178; Yan CL, 2015, BRIT J PHARMACOL, V172, P3510, DOI 10.1111/bph.13141; Yang WD, 2004, MOL BRAIN RES, V124, P70, DOI 10.1016/j.molbrainres.2004.02.010; Yoshimoto K, 2012, EUR J NEUROSCI, V35, P1368, DOI 10.1111/j.1460-9568.2012.08037.x; YU L, 1991, MOL BRAIN RES, V11, P143, DOI 10.1016/0169-328X(91)90116-F; Yuan X, 2000, DIABETOLOGIA, V43, P373, DOI 10.1007/s001250050056                                                           ; Zhang GL, 2016, NEUROPHARMACOLOGY, V101, P246, DOI 10.1016/j.neuropharm.2015.09.031; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008; Zhu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043227	352	1	1	8	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	MAY	2017	234	9-10					1395	1418		10.1007/s00213-017-4545-5				24	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	EU2JQ	WOS:000400855400008	28265714				2018-01-05	
J	Tumburu, L; Thein, SL				Tumburu, Laxminath; Thein, Swee Lay			Genetic control of erythropoiesis	CURRENT OPINION IN HEMATOLOGY			English	Review						erythroid traits; erythropoiesis; genetic variants	RED-BLOOD-CELL; GENOME-WIDE ASSOCIATION; DIAMOND-BLACKFAN ANEMIA; FETAL-HEMOGLOBIN LEVELS; TRANSFERRIN RECEPTOR 2; FACTOR KLF1 CAUSES; ERYTHROID-DIFFERENTIATION; DYSERYTHROPOIETIC ANEMIA; INHERITED MUTATION; BETA-THALASSEMIA	Purpose of review The discovery of several genetic variants associated with erythroid traits and subsequent elucidation of their functional mechanisms are exemplars of the power of the new genetic and genomic technology. The present review highlights findings from recent genetic studies related to the control of erythropoiesis and dyserythropoiesis, and fetal hemoglobin, an erythroid-related trait. Recent findings Identification of the genetic modulators of erythropoiesis involved two approaches: genome-wide association studies (GWASs) using single nucleotide polymorphism (SNP) arrays that revealed the common genetic variants associated with erythroid phenotypes (hemoglobin, red cell count, MCV, MCH) and fetal hemoglobin; and massive parallel sequencing such as whole genome sequencing (WGS) and whole exome sequencing (WES) that led to the discovery of the rarer variants (GFI1B, SBDS, RPS19, PKLR, EPO, EPOR, KLF1, GATA1). Functional and genomic studies aided by computational approaches and gene editing technology refined the regions encompassing the putative causative SNPs and confirmed their regulatory role at different stages of erythropoiesis. Summary Five meta-analysis of GWASs identified 17 genetic loci associated with erythroid phenotypes, which are potential regulators of erythropoiesis. Some of these loci showed pleiotropy associated with multiple erythroid traits, suggesting undiscovered molecular mechanisms and challenges underlying erythroid biology. Other sequencing strategies (WGS and WES) further elucidated the role of rare variants in dyserythropoiesis. Integration of common and rare variant studies with functional assays involving latest genome-editing technologies will significantly improve our understanding of the genetics underlying erythropoiesis and erythroid disorders.	[Tumburu, Laxminath; Thein, Swee Lay] NHLBI, NIH, Sickle Cell Branch, 10 Ctr Dr,Bldg 10,Room 6S241 MSC 1589, Bethesda, MD 20892 USA	Thein, SL (reprint author), NHLBI, NIH, Sickle Cell Branch, 10 Ctr Dr,Bldg 10,Room 6S241 MSC 1589, Bethesda, MD 20892 USA.	sl.thein@nih.gov			National Heart, Lungs, and Blood Institute, NIH	This work was supported by the Intramural Research Program of the National Heart, Lungs, and Blood Institute, NIH.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Alves LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021358; An P, 2012, HUM MOL GENET, V21, P2124, DOI 10.1093/hmg/dds028; Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Auer PL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0138-2; Bakker WJ, 2007, MOL CELL BIOL, V27, P3839, DOI 10.1128/MCB.01662-06; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Bony V, 1999, BRIT J HAEMATOL, V107, P263, DOI 10.1046/j.1365-2141.1999.01721.x; Borg J, 2011, HAEMATOL-HEMATOL J, V96, P635, DOI 10.3324/haematol.2011.043265; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; Brendel C, 2016, J CLIN INVEST, V126, P3868, DOI 10.1172/JCI87885; Camaschella C, 2016, INT J LAB HEMATOL, V38, P20, DOI 10.1111/ijlh.12505; Camaschella C, 2013, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2013.1.1; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chami N, 2016, AM J HUM GENET, V99, P8, DOI 10.1016/j.ajhg.2016.05.007; Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087; Chou ST, 2006, GENEREVIEWS; Dal Colletto G M, 1993, Acta Genet Med Gemellol (Roma), V42, P245; DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495; Ding KY, 2012, MAYO CLIN PROC, V87, P461, DOI 10.1016/j.mayocp.2012.01.016; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/twin.2.4.250; Forejtnikova H, 2010, BLOOD, V116, P5357, DOI 10.1182/blood-2010-04-281360; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Garner C, 2000, BLOOD, V95, P342; Giani FC, 2016, CELL STEM CELL, V18, P73, DOI 10.1016/j.stem.2015.09.015; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; Hollanda LM, 2006, NAT GENET, V38, P807, DOI 10.1038/ng1825; Jawaid K, 2010, BLOOD CELL MOL DIS, V45, P140, DOI 10.1016/j.bcmd.2010.05.006; Jiang J, 2006, BLOOD, V108, P1077, DOI 10.1182/blood-2006-01-008912; Johnson RM, 1999, PEDIATR RES, V45, P106, DOI 10.1203/00006450-199901000-00018; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kim AR, 2016, BLOOD, V128; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kralovics R, 2001, AM J HEMATOL, V68, P115, DOI 10.1002/ajh.1162                                                                ; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu D, 2014, BLOOD, V124, P803, DOI 10.1182/blood-2014-03-561779; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Luc S, 2016, CELL REP, V16, P3181, DOI 10.1016/j.celrep.2016.08.064; Magor GW, 2015, BLOOD, V125, P2405, DOI 10.1182/blood-2014-08-590968; MARCHESI SL, 1987, J CLIN INVEST, V80, P191, DOI 10.1172/JCI113047; Matzhold EM, 2016, TRANSFUSION, V56, P2739, DOI 10.1111/trf.13768; Matzhold EM, 2015, TRANSFUSION, V55, P1589, DOI 10.1111/trf.13025; McLachlan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156914; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Moura IC, 2015, CURR OPIN HEMATOL, V22, P193, DOI 10.1097/MOH.0000000000000133; Mtatiro SN, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0148-3; Nai A, 2015, BLOOD, V125, P1170, DOI 10.1182/blood-2014-08-596254; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480                                                                   ; Ogasawara K, 1996, BLOOD, V88, P2732; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paglialunga F, 2004, BLOOD, V104, P3148, DOI 10.1182/blood-2004-03-0835; Percy MJ, 2007, HEMATOLOGY, V12, P131, DOI 10.1080/10245330601111979; Perkins A, 2016, BLOOD, V127, P1856, DOI 10.1182/blood-2016-01-694331; Polfus LM, 2016, AM J HUM GENET, V99, P481, DOI 10.1016/j.ajhg.2016.06.016; Ramos P, 2011, BLOOD, V117, P1379, DOI 10.1182/blood-2010-09-307462; Roy NBA, 2016, BRIT J HAEMATOL, V175, P318, DOI 10.1111/bjh.14221; Sankaran VG, 2013, BLOOD, V122, P3845, DOI 10.1182/blood-2013-09-528315; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sano R, 2012, BLOOD, V119, P5301, DOI 10.1182/blood-2011-10-387167; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; SIEFF C, 1982, BLOOD, V60, P703; Singleton BK, 2008, BLOOD, V112, P2081, DOI 10.1182/blood-2008-03-145672; Smith EC, 2016, HUM MOL GENET, V25, pR99, DOI 10.1093/hmg/ddw170; Smith EC, 2016, BLOOD, V128, P2338, DOI 10.1182/blood-2016-08-736249; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Suzuki M, 2014, MOL CELL BIOL, V34, P3560, DOI 10.1128/MCB.00714-14; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Vatopoulou T, 2014, BLOOD, V124; WHITFIELD J B, 1985, Genetic Epidemiology, V2, P133, DOI 10.1002/gepi.1370020204; Yang DY, 2016, HUM MUTAT, V37, P216, DOI 10.1002/humu.22935; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; Zhai PF, 2014, J BIOL CHEM, V289, P22600, DOI 10.1074/jbc.M114.547380; Zhang FL, 2012, J CELL MOL MED, V16, P1889, DOI 10.1111/j.1582-4934.2011.01484.x	89	0	0	10	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1065-6251	1531-7048		CURR OPIN HEMATOL	Curr. Opin. Hematol.	MAY	2017	24	3					173	182		10.1097/MOH.0000000000000333				10	Hematology	Hematology	EU3KV	WOS:000400929700004	28212192				2018-01-05	
J	Gandhi, S; Haeussler, M; Razy-Krajka, F; Christiaen, L; Stolfi, A				Gandhi, Shashank; Haeussler, Maximilian; Razy-Krajka, Florian; Christiaen, Lionel; Stolfi, Alberto			Evaluation and rational design of guide RNAs for efficient CRISPR/Cas9-mediated mutagenesis in Ciona	DEVELOPMENTAL BIOLOGY			English	Article						sgRNA; Cardiopharyngeal mesoderm; Tunicate	PHARYNGEAL MUSCLE SPECIFICATION; OFF-TARGET; HUMAN-CELLS; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; NUCLEASE SPECIFICITY; READ ALIGNMENT; GENOME BROWSER; INTESTINALIS; CAS9	The CRISPR/Cas9 system has emerged as an important tool for various genome engineering applications. A current obstacle to high throughput applications of CRISPR/Cas9 is the imprecise prediction of highly active single guide RNAs (sgRNAs). We previously implemented the CRISPR/Cas9 system to induce tissue-specific mutations in the tunicate Ciona. In the present study, we designed and tested 83 single guide RNA (sgRNA) vectors targeting 23 genes expressed in the cardiopharyngeal progenitors and surrounding tissues of Ciona embryo. Using high-throughput sequencing of mutagenized alleles, we identified guide sequences that correlate with sgRNA mutagenesis activity and used this information for the rational design of all possible sgRNAs targeting the Ciona transcriptome. We also describe a one-step cloning-free protocol for the assembly of sgRNA expression cassettes. These cassettes can be directly electroporated as unpurified PCR products into Ciona embryos for sgRNA expression in vivo, resulting in high frequency of CRISPR/Cas9-mediated mutagenesis in somatic cells of electroporated embryos. We found a strong correlation between the frequency of an Ebf loss-of-function phenotype and the mutagenesis efficacies of individual Ebf-targeting sgRNAs tested using this method. We anticipate that our approach can be scaled up to systematically design and deliver highly efficient sgRNAs for the tissue-specific investigation of gene functions in Ciona.	[Gandhi, Shashank; Razy-Krajka, Florian; Christiaen, Lionel; Stolfi, Alberto] NYU, Dept Biol, New York, NY 10003 USA; [Haeussler, Maximilian] Univ Calif Santa Cruz, Santa Cruz Genom Inst, MS CBSE, Santa Cruz, CA 95064 USA; [Gandhi, Shashank] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Christiaen, L; Stolfi, A (reprint author), NYU, Dept Biol, New York, NY 10003 USA.	lc121@nyu.edu; stolfidobranchia@gmail.com		Christiaen, Lionel/0000-0001-5930-5667; Gandhi, Shashank/0000-0002-4081-4338	NYU Biology Masters Research Grant; Leducq Foundation [15CVD01]; NIH [K99 HD084814, R01 GM096032]	We are grateful to Farhana Salek, Kristyn Milian, and Aakarsha Pandey for technical assistance; Tara Rock for advice on next-generation sequencing; Rahul Satija for sequencing the libraries and for his invaluable insights into the sgRNA sequence analysis; Justin S. Bois, Shyam Saladi, Elena K. Perry, and the High Performance Computing team at NYU for their help troubleshooting the bioinformatic analysis. This work was funded by an NIH K99 HD084814 award to A.S., NIH R01 GM096032 award to L.C., award 15CVD01 from the Leducq Foundation to L.C., and an NYU Biology Masters Research Grant to S.G.	Abdul-Wajid S, 2015, CELL REP, V13, P829, DOI 10.1016/j.celrep.2015.09.035; Aken BL, 2016, DATABASE; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Bellas J, 2003, WATER RES, V37, P4613, DOI 10.1016/S0043-1354(03)00396-8; Brozovic M, 2016, NUCLEIC ACIDS RES, V44, pD808, DOI 10.1093/nar/gkv966; Brunetti R, 2015, J ZOOL SYST EVOL RES, V53, P186, DOI 10.1111/jzs.12101; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Christiaen L., 2009, COLD SPRING HARB PRO; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cota CD, 2015, DEV CELL, V34, P505, DOI 10.1016/j.devcel.2015.07.001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Diogo R, 2015, NATURE, V520, P466, DOI 10.1038/nature14435; Doench J. G., 2014, NAT BIOTECHNOL; Doench J. G., 2016, NAT BIOTECHNOL; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fusi N., 2015, BIORXIV021568; Gagnon J. A., 2014, EFFICIENT MUTAGENESI; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Hirano T, 1997, DEV BIOL, V192, P199, DOI 10.1006/dbio.1997.8772; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hoshino Z. i., 1967, UNUSUALLY ROBUST CIO; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Housden BE, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3729; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaplan N, 2015, CURR OPIN GENET DEV, V32, P119, DOI 10.1016/j.gde.2015.02.008; Kawai N, 2012, DEV GROWTH DIFFER, V54, P535, DOI 10.1111/j.1440-169X.2012.01355.x; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6                                                    ; Nishiyama A, 2008, DEV GROWTH DIFFER, V50, P521, DOI [10.1111/j.1440-169x.2008.01039.x, 10.1111/j.1440-169X.2008.01039.x]; Paix A, 2014, GENETICS, V198, P1347, DOI 10.1534/genetics.114.170423; Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; Razy-Krajka F, 2014, DEV CELL, V29, P263, DOI 10.1016/j.devcel.2014.04.001; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rothbacher U, 2007, DEVELOPMENT, V134, P4023, DOI 10.1242/dev.010850                                                              ; Roy S., 2014, J BIOMOL TECH S, V25, pS13; Ryan K, 2016, ELIFE, V5, DOI 10.7554/eLife.16962; Sanjana N. E., 2016, BIORXIV049130; Sasaki H, 2014, DEV GROWTH DIFFER, V56, P499, DOI 10.1111/dgd.12149; Sasakura Y, 2010, MOL GENET GENOMICS, V283, P99, DOI 10.1007/s00438-009-0500-4; Satoh N., 2013, DEV GENOMICS ASCIDIA; Satou Y, 2005, ZOOL SCI, V22, P837, DOI 10.2108/zsj.22.837                                                              ; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097                                                          ; Segade F, 2016, EVODEVO, V7, DOI 10.1186/s13227-016-0056-4; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Stolfi A, 2014, DEVELOPMENT, V141, P4115, DOI 10.1242/dev.114488; Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181; Tolkin T, 2016, DEVELOPMENT, V143, P3852, DOI 10.1242/dev.136267; Treen N, 2014, DEVELOPMENT, V141, P481, DOI 10.1242/dev.099572; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang W, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001725; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	81	1	1	4	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	MAY 1	2017	425	1					8	20		10.1016/j.ydbio.2017.03.003				13	Developmental Biology	Developmental Biology	ET5FT	WOS:000400310300002	28341547				2018-01-05	
J	Jacob, AE; Amack, JD; Turner, CE				Jacob, Andrew E.; Amack, Jeffrey D.; Turner, Christopher E.			Paxillin genes and actomyosin contractility regulate myotome morphogenesis in zebrafish	DEVELOPMENTAL BIOLOGY			English	Article						Extracellular matrix; Genome editing; Myotendinous junction; Somite; Cell adhesion	CEREBRAL VASCULAR STABILITY; FOCAL ADHESION KINASE; EXTRACELLULAR-MATRIX; INTEGRIN ADHESOME; SKELETAL-MUSCLE; CELL-ADHESION; MYOTENDINOUS JUNCTION; LD4 MOTIF; PROTEIN; BOUNDARIES	Paxillin (Pxn) is a key adapter protein and signaling regulator at sites of cell-extracellular matrix (ECM) adhesion. Here, we investigated the role of Pxn during vertebrate development using the zebrafish embryo as a model system. We have characterized two Pxn genes, pxna and pxnb, in zebrafish that are maternally supplied and expressed in multiple tissues. Gene editing and antisense gene knockdown approaches were used to uncover Pxn functions during zebrafish development. While mutation of either pxna or pxnb alone did not cause gross embryonic phenotypes, double mutants lacking maternally supplied pxna or pxnb displayed defects in cardiovascular, axial, and skeletal muscle development. Transient knockdown of Pxn proteins resulted in similar defects. Irregular myotome shape and ECM composition were observed, suggesting an "inside-out" signaling role for Paxillin genes in the development of myotendinous junctions. Inhibiting non-muscle Myosin-II during somitogenesis altered the subcellular localization of Pxn protein and phenocopied pxn gene loss-of-function.This indicates that Paxillin genes are effectors of actomyosin contractility-driven morphogenesis of trunk musculature in zebrafish. Together, these results reveal new functions for Pxn during muscle development and provide novel genetic models to elucidate Pxn functions.	[Jacob, Andrew E.; Amack, Jeffrey D.; Turner, Christopher E.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, 750 East Adams St, Syracuse, NY 13210 USA	Amack, JD; Turner, CE (reprint author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, 750 East Adams St, Syracuse, NY 13210 USA.	amackj@upstate.edu; turnerce@upstate.edu			National Institutes of Health [NIH R01 GM047607, NIH R01 HL095690]	This work was supported by the National Institutes of Health (NIH R01 GM047607 to Christopher E. Turner and NIH R01 HL095690 to Jeffrey D. Amack).	Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Bataille L, 2010, DEV CELL, V19, P317, DOI 10.1016/j.devcel.2010.07.008; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Campbell LJ, 2011, METHODS MOL BIOL, V730, P3, DOI 10.1007/978-1-61779-074-4_2; Chen JN, 1997, DEVELOPMENT, V124, P4373; Corallo D, 2013, DEVELOPMENT, V140, P4594, DOI 10.1242/dev.094078; Costa ML, 2008, CELL MOTIL CYTOSKEL, V65, P801, DOI 10.1002/cm.20301; Crawford BD, 2005, DEV BIOL, V286, P405, DOI 10.1016/j.ydbio.2005.06.035; Crawford BD, 2003, MOL BIOL CELL, V14, P3065, DOI 10.1091/mbc.E02-08-0537; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dickover M, 2014, DEV BIOL, V389, P182, DOI 10.1016/j.ydbio.2014.02.014; Dietrich AC, 2014, DEV CELL, V30, P367, DOI 10.1016/j.devcel.2014.06.020; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Goody MF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001409; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Haga Y, 2009, TRANSGENIC RES, V18, P669, DOI 10.1007/s11248-009-9259-y; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002                                                   ; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Henry CA, 2005, DEV BIOL, V287, P346, DOI 10.1016/j.ydbio.2005.08.049; Hirth S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150323; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Huveneers S, 2007, INT J RADIAT BIOL, V83, P743, DOI 10.1080/09553000701481808; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jacob AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165266; Jenkins MH, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0089-3; Julich D, 2015, DEV CELL, V34, P33, DOI 10.1016/j.devcel.2015.05.005; Julich D, 2009, DEVELOPMENT, V136, P2913, DOI 10.1242/dev.038935; Keow JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043434; Kim HR, 2009, DEV DYNAM, V238, P56, DOI 10.1002/dvdy.21812; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu J, 2007, P NATL ACAD SCI USA, V104, P13990, DOI 10.1073/pnas.0700825104; Liu J, 2012, DEV BIOL, V363, P95, DOI 10.1016/j.ydbio.2011.12.022; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075                                                           ; Pignatelli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046228; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Raeker MO, 2010, DEV BIOL, V337, P432, DOI 10.1016/j.ydbio.2009.11.018; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Rost F, 2014, J EXP BIOL, V217, P3870, DOI 10.1242/jeb.102202; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002; Snow CJ, 2009, GENE EXPR PATTERNS, V9, P37, DOI 10.1016/j.gep.2008.08.003; Snow CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000219; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Sztal TE, 2012, HUM MOL GENET, V21, P4718, DOI 10.1093/hmg/dds312; Theodosiou M, 2016, ELIFE, V5, DOI 10.7554/eLife.10130; TURNER CE, 1991, EXP CELL RES, V192, P651, DOI 10.1016/0014-4827(91)90090-H                                                    ; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Warner A, 2011, MOL BIOL CELL, V22, P2551, DOI 10.1091/mbc.E10-12-0941; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu Q, 2015, FASEB J, V29, P4989, DOI 10.1096/fj.15-273409; Yagi R, 2001, EMBO REP, V2, P814, DOI 10.1093/embo-reports/kve178; Yu JXA, 2011, DEV BIOL, V349, P225, DOI 10.1016/j.ydbio.2010.10.027; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zhang WW, 2016, J PHYSIOL-LONDON, V594, P4879, DOI 10.1113/JP272132	73	1	1	3	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	MAY 1	2017	425	1					70	84		10.1016/j.ydbio.2017.03.012				15	Developmental Biology	Developmental Biology	ET5FT	WOS:000400310300007	28315297				2018-01-05	
J	David, A; Vincent, M; Arrigoni, PP; Barbarot, S; Pistorius, MA; Isidor, B; Frampas, E				David, A.; Vincent, M.; Arrigoni, P. P.; Barbarot, S.; Pistorius, M. A.; Isidor, B.; Frampas, E.			Radiographic presentation of musculoskeletal involvement in Werner syndrome (adult progeria)	DIAGNOSTIC AND INTERVENTIONAL IMAGING			English	Review						Werner syndrome; Musculoskeletal system; Soft-tissue calcification; Adult progeria; X-ray	MANIFESTATIONS; CALCIFICATION; OSTEOPOROSIS; DIAGNOSIS; GENETICS; PATIENT; BONE	Werner syndrome (i.e., adult progeria) is a rare autosomal recessive disorder caused by mutations of the WRN gene, which is characterized by the premature appearance of features associated with normal aging and cancer predisposition. Patients with Werner syndrome can present with musculoskeletal complaints, associated with suggestive radiographic features with a potential prognostic or therapeutic impact. This review illustrates the main radiographic features of Werner syndrome, focusing on the musculoskeletal system, such as soft-tissue calcification, muscular atrophy, osteoporosis, foot deformities, osteitis and osteomyelitis, and bone or soft-tissues malignancies. The identification of these features by radiologists can therefore be useful in the clinical screening of Werner syndrome. (C) 2016 Editions franc, aises de radiologie. Published by Elsevier Masson SAS. All rights reserved.	[David, A.; Arrigoni, P. P.; Frampas, E.] CHU Nantes, Serv Cent Radiol & Imagerie Med, Hotel Dieu, 1 Pl Alexis Ricordeau, F-44093 Nantes 1, France; [Vincent, M.; Isidor, B.] CHU Nantes, Hop Mere Enfant, Unite Genet Clin, 7 Quai Moncousu, F-44000 Nantes, France; [Barbarot, S.] CHU Nantes, Hotel Dieu, Clin Dermatol, 1 Pl Alexis Ricordeau, F-44093 Nantes, France; [Pistorius, M. A.] CHU Nantes, Hotel Dieu, Med Interne, 1 Pl Alexis Ricordeau, F-44093 Nantes 1, France	David, A (reprint author), CHU Nantes, Serv Cent Radiol & Imagerie Med, Hotel Dieu, 1 Pl Alexis Ricordeau, F-44093 Nantes 1, France.	art.dav44@gmail.com					Bjonberg A, 1976, WERNERS SYNDROME MAL, V56, P149; Black A S, 1985, J Foot Surg, V24, P243; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001                                                ; ESCALANTE A, 1989, SEMIN ARTHRITIS RHEU, V19, P1, DOI 10.1016/0049-0172(89)90082-6                                                    ; Futami K, 2008, CANCER SCI, V99, P843, DOI 10.1111/j.1349-7006.2008.00778.x; Goto M, 2000, CLIN EXP RHEUMATOL, V18, P760; GOTO M, 1989, RADIOLOGY, V172, P841, DOI 10.1148/radiology.172.3.2772198                                                 ; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5; Honjo S, 2005, J AM GERIATR SOC, V577, P237; Honjo S, 2008, REJUV RES, V11, P809, DOI 10.1089/rej.2007.0649; JACOBSON HG, 1960, RADIOLOGY, V74, P373, DOI 10.1148/74.3.373                                                                ; Laroche M, 1997, REV RHUM, V64, P843; Leone A, 2005, SKELETAL RADIOL, V34, P47, DOI 10.1007/s00256-004-0792-8; Matsumoto T, 1997, HUM GENET, V100, P123, DOI 10.1007/s004390050477; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Noda Shinji, 2011, J Am Acad Dermatol, V65, pe54, DOI 10.1016/j.jaad.2011.03.013; Oshima J, 2016, AGEING RES REV; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Ozturk M, 2006, CLIN EXP DERMATOL, V31, P615, DOI 10.1111/j.1365-2230.2006.02130.x; RUBIN CD, 1992, J AM GERIATR SOC, V40, P1161, DOI 10.1111/j.1532-5415.1992.tb01808.x                                              ; RUBIN CD, 1994, ANN INTERN MED, V121, P665, DOI 10.7326/0003-4819-121-9-199411010-00007; Shiraki M, 1998, ENDOCR J, V45, P505, DOI 10.1507/endocrj.45.505                                                          ; Takemoto M, 2013, GERIATR GERONTOL INT, V13, P475, DOI 10.1111/j.1447-0594.2012.00913.x; Taupin T, 2016, DIAGN INTERV IMAG, V97, P325, DOI 10.1016/j.diii.2015.09.013; Uhrhammer NA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9435; Walton NP, 2000, J BONE JOINT SURG BR, V82B, P885, DOI 10.1302/0301-620X.82B6.10457; Werner O., 1904, UBERT KATARAKT VERBI, P1	28	0	0	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	2211-5684			DIAGN INTERV IMAG	Diagn. Interv. Imaging	MAY	2017	98	5					373	378		10.1016/j.diii.2016.10.007				6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	EU0AS	WOS:000400672100002	27931782				2018-01-05	
J	Goldberg, L; Abutbul-Amitai, M; Paret, G; Nevo-Caspi, Y				Goldberg, Lior; Abutbul-Amitai, Mor; Paret, Gideon; Nevo-Caspi, Yael			Alternative Splicing of STAT3 Is Affected by RNA Editing	DNA AND CELL BIOLOGY			English	Article						STAT3; A-to-I RNA editing; Alu elements; alternative splicing; ADAR enzyme	GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; SIGNAL TRANSDUCER; NUCLEAR RETENTION; MESSENGER-RNA; CELLS; CANCER; EXONS; BETA; PHOSPHORYLATION	A-to-I RNA editing, carried out by adenosine deaminase acting on RNA (ADAR) enzymes, is an epigenetic phenomenon of posttranscriptional modifications on pre-mRNA. RNA editing in intronic sequences may influence alternative splicing of flanking exons. We have previously shown that conditions that induce editing result in elevated expression of signal transducer and activator of transcription 3 (STAT3), preferentially the alternatively-spliced STAT3 beta isoform. Mechanisms regulating alternative splicing of STAT3 have not been elucidated. STAT3 undergoes A-to-I RNA editing in an intron residing in proximity to the alternatively spliced exon. We hypothesized that RNA editing plays a role in regulating alternative splicing toward STAT3 beta. In this study we extend our observation connecting RNA editing to the preferential induction of STAT3 beta expression. We study the involvement of ADAR1 in STAT3 editing and reveal the connection between editing and alternative splicing of STAT3. Deferoaxamine treatment caused the induction in STAT3 RNA editing and STAT3 beta expression. Silencing ADAR1 caused a decrease in STAT3 editing and expression with a preferential decrease in STAT3 beta. Cells transfected with a mutated minigene showed preferential splicing toward the STAT3 beta transcript. Editing in the STAT3 intron is performed by ADAR1 and affects STAT3 alternative splicing. These results suggest that RNA editing is one of the molecular mechanisms regulating the expression of STAT3 beta.	[Goldberg, Lior; Abutbul-Amitai, Mor; Paret, Gideon; Nevo-Caspi, Yael] Sheba Med Ctr, Safra Childrens Hosp, Dept Pediat Crit Care Med, IL-5262100 Tel Hashomer, Israel; [Goldberg, Lior; Abutbul-Amitai, Mor; Paret, Gideon] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Nevo-Caspi, Y (reprint author), Sheba Med Ctr, Safra Childrens Hosp, Dept Pediat Crit Care Med, IL-5262100 Tel Hashomer, Israel.	yael.caspi@sheba.health.gov.il					Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Borik S, 2011, INTENS CARE MED, V37, P1664, DOI 10.1007/s00134-011-2296-z; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221                                                        ; Daniel C, 2015, CELL MOL LIFE SCI, V72, P4063, DOI 10.1007/s00018-015-1990-3; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Huang Y, 2007, J BIOL CHEM, V282, P34958, DOI 10.1074/jbc.M704548200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817                                                         ; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kang SH, 2010, NEUROSURGERY, V67, P1386, DOI 10.1227/NEU.0b013e3181f1c0cd; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Lee J, 2013, J MOL MED, V91, P965, DOI 10.1007/s00109-013-1013-5; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Marino F, 2014, AM J CANCER RES, V4, P484; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Muh SJ, 2002, J BIOL CHEM, V277, P50143, DOI 10.1074/jbc.M207409200; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Nevo-Caspi Y, 2011, SHOCK, V35, P585, DOI 10.1097/SHK.0b013e31820fe4b7; Ng IHW, 2012, BIOCHEM J, V447, P125, DOI 10.1042/BJ20120941; Nigita G, 2016, NUCLEIC ACIDS RES, V44, P6298, DOI 10.1093/nar/gkw532; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pawlus MR, 2014, ONCOGENE, V33, P1670, DOI 10.1038/onc.2013.115; Pervouchine DD, 2012, RNA, V18, P1, DOI 10.1261/rna.029249.111; Qi Qian-Rong, 2014, World J Biol Chem, V5, P231, DOI 10.4331/wjbc.v5.i2.231; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Ryman K, 2007, RNA, V13, P1071, DOI 10.1261/rna.404407; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.069408; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Solomon O, 2013, RNA, V19, P591, DOI 10.1261/rna.038042.112; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zammarchi F, 2011, P NATL ACAD SCI USA, V108, P17779, DOI 10.1073/pnas.1108482108; Zeng HL, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-32; Zhang YH, 2000, HUM MUTAT, V15, P316, DOI 10.1002/(SICI)1098-1004(200004)15:4<316::AID-HUMU3>3.0.CO;2-9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	0	0	3	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1044-5498	1557-7430		DNA CELL BIOL	DNA Cell Biol.	MAY	2017	36	5					367	376		10.1089/dna.2016.3575				10	Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity	ET9RP	WOS:000400645700005	28278381				2018-01-05	
J	Awwad, SW; Abu-Zhayia, ER; Guttmann-Raviv, N; Ayoub, N				Awwad, Samah W.; Abu-Zhayia, Enas R.; Guttmann-Raviv, Noga; Ayoub, Nabieh			NELF-E is recruited to DNA double-strand break sites to promote transcriptional repression and repair	EMBO REPORTS			English	Article						double-strand breaks; NELF-E; PARP1; RNA polymerase II	RNA-POLYMERASE-II; PROTEOME-WIDE IDENTIFICATION; SENSITIVITY-INDUCING FACTOR; NEGATIVE ELONGATION-FACTOR; CELL-CYCLE PROGRESSION; DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; HISTONE DEMETHYLASE; BINDING-PROTEINS; GENOTOXIC STRESS	Double-strand breaks (DSBs) trigger rapid and transient transcription pause to prevent collisions between repair and transcription machineries at damage sites. Little is known about the mechanisms that ensure transcriptional block after DNA damage. Here, we reveal a novel role of the negative elongation factor NELF in blocking transcription activity nearby DSBs. We show that NELF-E and NELF-A are rapidly recruited to DSB sites. Furthermore, NELF-E recruitment and its repressive activity are both required for switching off transcription at DSBs. Remarkably, using I-SceI endonuclease and CRISPR-Cas9 systems, we observe that NELF-E is preferentially recruited, in a PARP1-dependent manner, to DSBs induced upstream of transcriptionally active rather than inactive genes. Moreover, the presence of RNA polymerase II is a prerequisite for the preferential recruitment of NELF-E to DNA break sites. Additionally, we demonstrate that NELF-E is required for intact repair of DSBs. Altogether, our data identify the NELF complex as a new component in the DNA damage response.	[Awwad, Samah W.; Abu-Zhayia, Enas R.; Guttmann-Raviv, Noga; Ayoub, Nabieh] Technion Israel Inst Technol, Dept Biol, Haifa, Israel	Ayoub, N (reprint author), Technion Israel Inst Technol, Dept Biol, Haifa, Israel.	ayoubn@technion.ac.il			Israel Science Foundation (ISF); Israel Cancer Association; Binational Science Foundation (BSF); Israel Cancer Research Fund (ICRF); Joint Lower Saxony (Niedersachsen)-Israeli Research Fund; Neubauer Family Foundation; VATAT Fellowship	We are grateful to Akira Yasui for the plasmids and the U2OS-TRE-I-Sce-19 cell line. We thank Ofer Mandelboim and Mohammad Diab for helping in the generation of the lentiviruses used in this study. We thank Prathamesh Nadar-Ponniah for expressing and purifying the GST-NELF-E fusions and Samer Shalaby for helping in the statistical analysis. We are grateful to Maayan Duvshani-Eshet, Nitzan Dahan, Efrat Barak, and Shay Kirzner, from the Life Sciences and Engineering Infrastructure Unit at the Technion, for their help in the microscopy and flow cytometry-related works. We thank Hanan Khoury-Haddad for her critical reading of the manuscript. This study is supported by grants from the Israel Science Foundation (ISF), the Israel Cancer Association, the Binational Science Foundation (BSF), the Israel Cancer Research Fund (ICRF), Joint Lower Saxony (Niedersachsen)-Israeli Research Fund. N. Ayoub is supported by a Neubauer Family Foundation. Samah W. Awwad and Enas R. Abu-Zhayia are supported by the VATAT Fellowship for outstanding minority PhD student.	Adam S, 2014, EXP CELL RES, V329, P148, DOI 10.1016/j.yexcr.2014.07.017; Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Elia AEH, 2015, MOL CELL, V59, P867, DOI 10.1016/j.molcel.2015.05.006; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Gong FD, 2015, GENE DEV, V29, P197, DOI 10.1101/gad.252189.114; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Ipenberg I, 2013, J BIOL CHEM, V288, P14681, DOI 10.1074/jbc.C113.462770; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kakarougkas A, 2014, MOL CELL, V55, P723, DOI 10.1016/j.molcel.2014.06.028; Khoury-Haddad H, 2015, CELL CYCLE, V14, P950, DOI 10.1080/15384101.2015.1014147; Khoury-Haddad H, 2014, P NATL ACAD SCI USA, V111, pE728, DOI 10.1073/pnas.1317585111; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MAYNE LV, 1982, CANCER RES, V42, P1473; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020                                                           ; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rafalska-Metcalf IU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010272; REEVES WH, 1989, J BIOL CHEM, V264, P5047; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797                                                          ; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shahar OD, 2012, ONCOGENE, V31, P3495, DOI 10.1038/onc.2011.516; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Sims Robert J. III, 2004, Genes & Development, V18, P2437, DOI 10.1101/gad.1235904; Sousa FG, 2012, CARCINOGENESIS, V33, P1433, DOI 10.1093/carcin/bgs132; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512; Ui A, 2015, MOL CELL, V58, P468, DOI 10.1016/j.molcel.2015.03.023; Vos SM, 2016, ELIFE, V5, DOI 10.7554/eLife.14981; Wickramasinghe VO, 2016, MOL CELL, V61, P496, DOI 10.1016/j.molcel.2016.02.001; Williams LH, 2015, MOL CELL, V58, P311, DOI 10.1016/j.molcel.2015.02.003; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; YANEVA M, 1989, J BIOL CHEM, V264, P13407; Yavuzer U, 1998, GENE DEV, V12, P2188, DOI 10.1101/gad.12.14.2188; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Young LC, 2013, J BIOL CHEM, V288, P21376, DOI 10.1074/jbc.M113.491514	67	1	1	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	MAY	2017	18	5					745	764		10.15252/embr.201643191				20	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	ET7AQ	WOS:000400446100011	28336775				2018-01-05	
J	Park, KH; An, Y; Jung, TY; Baek, IY; Noh, H; Ahn, WC; Hebert, H; Song, JJ; Kim, JH; Oh, BH; Woo, EJ				Park, Kwang-Hyun; An, Yan; Jung, Tae-Yang; Baek, In-Young; Noh, Haemin; Ahn, Woo-Chan; Hebert, Hans; Song, Ji-Joon; Kim, Jeong-Hoon; Oh, Byung-Ha; Woo, Eui-Jeon			RNA activation-independent DNA targeting of the Type III CRISPR-Cas system by a Csm complex	EMBO REPORTS			English	Article						CRISPR; Csm complex; DNase; RNase; Thermococcus onnurineus	CRYSTAL-STRUCTURE; EFFECTOR COMPLEX; STRUCTURAL BASIS; IMMUNE-SYSTEM; CMR COMPLEX; CLEAVAGE; RECOGNITION; CASCADE; INTERFERENCE; PROKARYOTES	The CRISPR-Cas system is an adaptive and heritable immune response that destroys invading foreign nucleic acids. The effector complex of the Type III CRISPR-Cas system targets RNA and DNA in a transcription-coupled manner, but the exact mechanism of DNA targeting by this complex remains elusive. In this study, an effector Csm holocomplex derived from Thermococcus onnurineus is reconstituted with a minimalistic combination of Csm1(1)2(1)3(3)4(1)5(1), and shows RNA targeting and RNA-activated single-stranded DNA (ssDNA) targeting activities. Unexpectedly, in the absence of an RNA transcript, it cleaves ssDNA containing a sequence complementary to the bound crRNA guide region in a manner dependent on the HD domain of the Csm1 subunit. This nuclease activity is blocked by a repeat tag found in the host CRISPR loci. The specific cleavage of ssDNA without a target RNA suggests a novel ssDNA targeting mechanism of the Type III system, which could facilitate the efficient and complete degradation of foreign nucleic acids.	[Park, Kwang-Hyun; An, Yan; Baek, In-Young; Ahn, Woo-Chan; Woo, Eui-Jeon] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Jung, Tae-Yang; Noh, Haemin; Ahn, Woo-Chan; Song, Ji-Joon; Oh, Byung-Ha] Korea Adv Inst Sci & Technol, Inst Biocentury, Dept Biol Sci, Daejeon, South Korea; [Jung, Tae-Yang; Hebert, Hans] Karolinska Inst, Dep Biosci & Nutr, Huddinge, Sweden; [Jung, Tae-Yang; Hebert, Hans] KTH Royal Inst Technol, Sch Technol & Hlth, Huddinge, Sweden; [Kim, Jeong-Hoon] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Woo, Eui-Jeon] Univ Sci & Technol, Dep Analyt Biosci, Daejeon, South Korea	Woo, EJ (reprint author), Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea.; Oh, BH (reprint author), Korea Adv Inst Sci & Technol, Inst Biocentury, Dept Biol Sci, Daejeon, South Korea.; Woo, EJ (reprint author), Univ Sci & Technol, Dep Analyt Biosci, Daejeon, South Korea.	bhoh@kaist.ac.kr; ejwoo@kribb.re.kr		Song, Ji-Joon/0000-0001-7120-6311	Marine and Extreme Genome Research Center programme from the Ministry of Land, Transport and Maritime Affairs; National Research Foundation of Korea [NRF-2014K1A3A1A49069194/NRF-2015R1A2A2A03006970]; KRIBB Research Initiative Programme; STINT-NRF special exchange grant [2014K2A3A1000137]; KAIST Institute	We thank Dr. Kang Sung-Gyun in KIOST for providing the genomic DNA of T. onnurineus NA1. This work was partly supported by the Marine and Extreme Genome Research Center programme from the Ministry of Land, Transport and Maritime Affairs and partly by the National Research Foundation of Korea (Grant Number: NRF-2014K1A3A1A49069194/NRF-2015R1A2A2A03006970) and KRIBB Research Initiative Programme. J.-J.S. and H.H. were supported by a STINT-NRF special exchange grant (2014K2A3A1000137). T.-Y.J. is a recipient of a postdoc fellowship from KAIST Institute.	Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Benda C, 2014, MOL CELL, V56, P43, DOI 10.1016/j.molcel.2014.09.002; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cao LY, 2016, INT J MED MICROBIOL, V306, P686, DOI 10.1016/j.ijmm.2016.08.005; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Jung TY, 2015, STRUCTURE, V23, P782, DOI 10.1016/j.str.2015.01.021; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Zhang J, 2016, NUCLEIC ACIDS RES, V44, P1789, DOI 10.1093/nar/gkw020; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	43	0	0	5	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	MAY	2017	18	5					826	840		10.15252/embr.201643700				15	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	ET7AQ	WOS:000400446100016	28364023				2018-01-05	
J	El Mouridi, S; Lecroisey, C; Tardy, P; Mercier, M; Leclercq-Blondel, A; Zariohi, N; Boulin, T				El Mouridi, Sonia; Lecroisey, Claire; Tardy, Philippe; Mercier, Marine; Leclercq-Blondel, Alice; Zariohi, Nora; Boulin, Thomas			Reliable CRISPR/Cas9 Genome Engineering in Caenorhabditis elegans Using a Single Efficient sgRNA and an Easily Recognizable Phenotype	G3-GENES GENOMES GENETICS			English	Article						CRISPR/Cas9 genome engineering; Caenorhabditis elegans; mScarlet; dpy-10; coconversion	C. ELEGANS; FLUORESCENT PROTEINS; HOMOLOGOUS RECOMBINATION; SYSTEM; CRISPR-CAS9; DESIGN; INACTIVATION; CONVERSION; MUTATION; TOOLKIT	CRISPR/Cas9 genome engineering strategies allow the directed modification of the Caenorhabditis elegans genome to introduce point mutations, generate knock-out mutants, and insert coding sequences for epitope or fluorescent tags. Three practical aspects, however, complicate such experiments. First, the efficiency and specificity of single-guide RNAs (sgRNA) cannot be reliably predicted. Second, the detection of animals carrying genome edits can be challenging in the absence of clearly visible or selectable phenotypes. Third, the sgRNA target site must be inactivated after editing to avoid further double-strand break events. We describe here a strategy that addresses these complications by transplanting the protospacer of a highly efficient sgRNA into a gene of interest to render it amenable to genome engineering. This sgRNA targeting the dpy-10 gene generates genome edits at comparatively high frequency. We demonstrate that the transplanted protospacer is cleaved at the same time as the dpy-10 gene. Our strategy generates scarless genome edits because it no longer requires the introduction of mutations in endogenous sgRNA target sites. Modified progeny can be easily identified in the F1 generation, which drastically reduces the number of animals to be tested by PCR or phenotypic analysis. Using this strategy, we reliably generated precise deletion mutants, transcriptional reporters, and translational fusions with epitope tags and fluorescent reporter genes. In particular, we report here the first use of the new red fluorescent protein mScarlet in a multicellular organism. wrmScarlet, a C. elegans-optimized version, dramatically surpassed TagRFP-T by showing an eightfold increase in fluorescence in a direct comparison.	[El Mouridi, Sonia; Lecroisey, Claire; Tardy, Philippe; Mercier, Marine; Leclercq-Blondel, Alice; Zariohi, Nora; Boulin, Thomas] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS UMR 5310, Inst NeuroMyoGene,INSERM,U1217, F-69622 Villeurbanne, France	Boulin, T (reprint author), Univ Claude Bernard Lyon 1, CNRS UMR 5310, INSERM, Inst NeuroMyoGene,U1217, 8 Rue Raphael Dubois, F-69622 Villeurbanne, France.	thomas.boulin@univ-lyon1.fr		Boulin, Thomas/0000-0002-1734-1915; el mouridi, sonia/0000-0002-3674-3151; Mercier, Marine/0000-0003-1508-8845	National Institutes of Health [U41 HG002223]; Fondation Fyssen; European Research Council	We thank J.-L. Bessereau, I. Katic, and members of the Bessereau team for helpful discussion, M. Jospin for comments on the manuscript, and M. D'Alessandro for constructing pMD8. pCFJ90 was a gift of C. Frokjaer-Jensen. We thank Wormbase, which is supported by National Institutes of Health grant U41 HG002223. This work was supported by a research grant from Fondation Fyssen (T.B.) and an European Research Council Starting Grant (Project Kelegans) (T.B.). This work is dedicated to the memory of Christian Boulin.	Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Boulin T, 2012, WIRES DEV BIOL, V1, P114, DOI 10.1002/wdev.1; Chai YP, 2012, NAT PROTOC, V7, P2090, DOI 10.1038/nprot.2012.128; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Dickinson DJ, 2016, GENETICS, V202, P885, DOI 10.1534/genetics.115.182162; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Frokjaer-Jensen C, 2013, GENETICS, V195, P635, DOI 10.1534/genetics.113.156521; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/nmeth.1454, 10.1038/NMETH.1454]; Ge DT, 2016, G3-GENES GENOM GENET, V6, P3197, DOI 10.1534/g3.116.032557; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Heppert JK, 2016, MOL BIOL CELL, V27, P3385, DOI 10.1091/mbc.E16-01-0063; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Katic I, 2015, G3-GENES GENOM GENET, V5, P1649, DOI 10.1534/g3.115.019273; Katic I, 2013, GENETICS, V195, P1173, DOI 10.1534/genetics.113.155754; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Kunkel MT, 2000, J NEUROSCI, V20, P7517; LEVY AD, 1993, MOL BIOL CELL, V4, P803; Norris AD, 2015, GENETICS, V201, P449, DOI 10.1534/genetics.115.180679; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Paix A, 2014, GENETICS, V198, P1347, DOI 10.1534/genetics.114.170423; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Schwartz ML, 2016, GENETICS, V202, P1277, DOI 10.1534/genetics.115.184275; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Ward JD, 2015, GENETICS, V199, P363, DOI 10.1534/genetics.114.172361; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhao P, 2014, CELL RES, V24, P247, DOI 10.1038/cr.2014.9	40	2	2	3	5	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	MAY	2017	7	5					1429	1437		10.1534/g3.117.040824				9	Genetics & Heredity	Genetics & Heredity	EU1YN	WOS:000400822200005	28280211	gold			2018-01-05	
J	Williams, BO; Warman, ML				Williams, Bart O.; Warman, Matthew L.			CRISPR/CAS9 Technologies	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						GENE EDITING; MOLECULAR BIOLOGY; ANIMAL MODELS	CRISPR-CAS9 NUCLEASES; MUSCULAR-DYSTROPHY; CAS SYSTEMS; MOUSE MODEL; STEM-CELLS; GENOME; ENDONUCLEASE; PROKARYOTES; EXPRESSION; IMMUNITY	The Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) pathway is revolutionizing biological research. Modifications to this primitive prokaryotic immune system now enable scientists to efficiently edit DNA or modulate gene expression in living eukaryotic cells and organisms. Thus, many laboratories can now perform important experiments that previously were considered scientifically risky or too costly. Here, we describe the components of the CRISPR/Cas system that have been engineered for use in eukaryotes. We also explain how this system can be used to genetically modify cell lines and model organisms, or regulate gene expression in order to search for new participants in biological pathways. (c) 2017 American Society for Bone and Mineral Research.	[Williams, Bart O.] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Warman, Matthew L.] Boston Childrens Hosp, Orthopaed Res Labs, Boston, MA 02115 USA	Williams, BO (reprint author), Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA.; Warman, ML (reprint author), Boston Childrens Hosp, Orthopaed Res Labs, Boston, MA 02115 USA.	bart.williams@vai.org; matthew.warman@childrens.harvard.edu	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301	NIH [AR053293, AR068668, AR062326, AR053237, AR064231]	This work was supported by grants from the NIH (AR053293 and AR068668 to BOW; AR062326, AR053237, and AR064231 to MLW). We thank Ms. Nicole Ethen for creating each of the figures and Dr. Benjamin Kleinstiver for his thoughtful comments.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; ARBER W, 1965, ANNU REV MICROBIOL, V19, P365, DOI 10.1146/annurev.mi.19.100165.002053; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Lambert LJ, 2016, DIS MODEL MECH, V9, P1169, DOI 10.1242/dmm.025247; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Padilla-Nash HM, 2012, GENE CHROMOSOME CANC, V51, P353, DOI 10.1002/gcc.21921; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sui TT, 2016, HUM MOL GENET, V25, P2661, DOI 10.1093/hmg/ddw125; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Willems B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131768; Yang MZ, 2014, BONE, V69, P118, DOI 10.1016/j.bone.2014.09.005; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	40	0	0	8	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	MAY	2017	32	5					883	888		10.1002/jbmr.3086				6	Endocrinology & Metabolism	Endocrinology & Metabolism	ET8YL	WOS:000400590900001	28230927	gold			2018-01-05	
J	Ferdinandusse, S; Falkenberg, KD; Koster, J; Mooyer, PA; Jones, R; van Roermund, CWT; Pizzino, A; Schrader, M; Wanders, RJA; Vanderver, A; Waterham, HR				Ferdinandusse, Sacha; Falkenberg, Kim D.; Koster, Janet; Mooyer, Petra A.; Jones, Richard; van Roermund, Carlo W. T.; Pizzino, Amy; Schrader, Michael; Wanders, Ronald J. A.; Vanderver, Adeline; Waterham, Hans R.			ACBD5 deficiency causes a defect in peroxisomal very long-chain fatty acid metabolism	JOURNAL OF MEDICAL GENETICS			English	Article							HUMAN SKIN FIBROBLASTS; MASS-SPECTROMETRY; BETA-OXIDATION; GAS-CHROMATOGRAPHY; PRISTANIC ACID; ACYL-COENZYME; DISORDERS; MUTATIONS; THROMBOCYTOPENIA; BIOGENESIS	Background Acyl-CoA binding domain containing protein 5 (ACBD5) is a peroxisomal membrane protein with a cytosolic acyl-CoA binding domain. Because of its acyl-CoA binding domain, ACBD5 has been assumed to function as an intracellular carrier of acyl-CoA esters. In addition, a role for ACBD5 in pexophagy has been suggested. However, the precise role of ACBD5 in peroxisomal metabolism and/or functioning has not yet been established. Previously, a genetic ACBD5 deficiency was identified in three siblings with retinal dystrophy and white matter disease. We identified a pathogenic mutation in ACBD5 in another patient and studied the consequences of the ACBD5 defect in patient material and in ACBD5-deficient HeLa cells to uncover this role. Methods We studied a girl who presented with progressive leukodystrophy, syndromic cleft palate, ataxia and retinal dystrophy. We performed biochemical, cell biological and molecular studies in patient material and in ACBD5-deficient HeLa cells generated by CRISPR-Cas9 genome editing. Results We identified a homozygous deleterious indel mutation in ACBD5, leading to complete loss of ACBD5 protein in the patient. Our studies showed that ACBD5 deficiency leads to accumulation of very long-chain fatty acids (VLCFAs) due to impaired peroxisomal beta-oxidation. No effect on pexophagy was found. Conclusions Our investigations strongly suggest that ACBD5 plays an important role in sequestering C26-CoA in the cytosol and thereby facilitates transport into the peroxisome and subsequent beta-oxidation. Accordingly, ACBD5 deficiency is a novel single peroxisomal enzyme deficiency caused by impaired VLCFA metabolism, leading to retinal dystrophy and white matter disease.	[Ferdinandusse, Sacha; Falkenberg, Kim D.; Koster, Janet; Mooyer, Petra A.; van Roermund, Carlo W. T.; Wanders, Ronald J. A.; Waterham, Hans R.] Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, Amsterdam, Netherlands; [Jones, Richard] Kennedy Krieger Inst, Baltimore, MD USA; [Pizzino, Amy; Vanderver, Adeline] Childrens Natl Hlth Syst, Dept Neurol, Washington, DC USA; [Schrader, Michael] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England	Ferdinandusse, S; Waterham, HR (reprint author), F0 220 Acad Med Ctr, Lab Genet Metab Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	S.Ferdinandusse@amc.nl; H.R.Waterham@amc.uva.nl		Vanderver, Adeline/0000-0002-6290-6751	Marie Curie Initial Training Networks (ITN) action [FP7-2012-PERFUME-316-723]; Biotechnology and Biological Sciences Research Council [BB/K006231/1, BB/N01541X/1]	Supported in part by funding through the Marie Curie Initial Training Networks (ITN) action to KDF, MS and HRW (FP7-2012-PERFUME-316-723). MS is supported by the Biotechnology and Biological Sciences Research Council (BB/K006231/1; BB/N01541X/1).	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Baroy T, 2015, HUM MOL GENET, V24, P5845, DOI 10.1093/hmg/ddv305; Buchert R, 2014, AM J HUM GENET, V95, P602, DOI 10.1016/j.ajhg.2014.10.003; Dacremont G, 1995, J INHERIT METAB DIS, V18, P76, DOI 10.1007/BF00711430; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Ferdinandusse S, 2007, HUM MUTAT, V28, P904, DOI 10.1002/humu.20535; Ferdinandusse S, 2016, J INHERIT METAB DIS, V39, P531, DOI 10.1007/s10545-016-9922-4; Gronemeyer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057395; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Kemp S, 2004, CLIN CHEM, V50, P1824, DOI 10.1373/clinchem.2004.038539; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Klouwer FCC, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0368-9; Nazarko TY, 2014, J CELL BIOL, V204, P541, DOI 10.1083/jcb.201307050; Pippucci T, 2011, AM J HUM GENET, V88, P115, DOI 10.1016/j.ajhg.2010.12.006; Punzo F, 2010, J THROMB HAEMOST, V8, P2085, DOI 10.1111/j.1538-7836.2010.03979.x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RASMUSSEN JT, 1994, BIOCHEM J, V299, P165, DOI 10.1042/bj2990165                                                               ; Ratbi I, 2015, AM J HUM GENET, V97, P535, DOI 10.1016/j.ajhg.2015.08.011; Simonsen AC, 2003, FEBS LETT, V552, P253, DOI 10.1016/S0014-5793(03)00970-0; Vanderver A, 1993, GENEREVIEWS R; Vreken P, 1998, J CHROMATOGR B, V713, P281, DOI 10.1016/S0378-4347(98)00186-8; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200	25	2	2	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-2593	1468-6244		J MED GENET	J. Med. Genet.	MAY	2017	54	5					330	337		10.1136/jmedgenet-2016-104132				8	Genetics & Heredity	Genetics & Heredity	ET1IX	WOS:000400022200005	27799409				2018-01-05	
J	Leal, SM; Gulley, ML				Leal, Sixto M., Jr.; Gulley, Margaret L.			Current and Emerging Molecular Tests for Human Papillomavirus-Related Neoplasia in the Genomic Era	JOURNAL OF MOLECULAR DIAGNOSTICS			English	Review							SQUAMOUS-CELL CARCINOMAS; OROPHARYNGEAL CANCER; CERVICAL-CANCER; NECK CANCERS; PROGNOSTIC-SIGNIFICANCE; RETROVIRAL RESTRICTION; CLINICAL-PERFORMANCE; HPV VACCINATION; MESSENGER-RNA; HEAD	Laboratory tests have a key role in preventing human papillomavirus (HPV) driven carcinomas and in guiding therapeutic interventions. An understanding of the virology, immunology, and carcinogenesis of HPV is essential for choosing appropriate diagnostic test modalities and developing new and even more effective cancer prevention strategies. HPV infects basal epithelial cells on multiple surfaces and induces carcinoma primarily in the cervix and the oropharynx. HPV types are stratified as high risk or Low risk based on their carcinogenic potential. During oncogenesis, HPV interferes with cell cycle regulation and incites DNA damage responses that thwart apoptosis and enable mutations to accumulate. Such mutations are an adverse effect of innate and adaptive antiviral immune responses that up-regulate DNA-editing enzymes, with natural selection of cells having a chromosomally integrated viral genome lacking expression of viral proteins targeted by the immune system. Infected cancers share a similar mutation signature, reflecting the effect of apolipoprotein B mRNA-editing catalytic poly peptide enzyme DNA-editing enzymes. It is feasible that genomic tests for characteristic mutations or methylation signatures, along with tests for dysregulated HPV gene expression, add value in predicting behavior of premalignant lesions. Furthermore, these tumor markers in cell-free DNA of plasma or body fluids may one day assist in early detection or monitoring cancer burden during treatment.	[Leal, Sixto M., Jr.; Gulley, Margaret L.] Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC USA	Gulley, ML (reprint author), Univ N Carolina, Dept Pathol & Lab Med, 160 Med Dr, Chapel Hill, NC 27599 USA.	margaret_gulley@med.unc.edu			NIH [UL1 TR001111]; Lineberger Comprehensive Cancer Center; University of North Carolina at Chapel Hill Department of Pathology and Laboratory Medicine	Supported by NIH grant UL1 TR001111 (M.L.G.), the Lineberger Comprehensive Cancer Center, and the University of North Carolina at Chapel Hill Department of Pathology and Laboratory Medicine.	Ahn SM, 2014, JAMA OTOLARYNGOL, V140, P846, DOI 10.1001/jamaoto.2014.1338; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; American College of Obstetricians and Gynecologists, 2016, OBSTET GYNECOL, V127, pe1; American College of Obstetricians and Gynecologists, 2013, OBSTET GYNECOL, V122, P1338; Ambulos Nicholas P Jr, 2016, J Biomol Tech, V27, P46, DOI 10.7171/jbt.16-2702-004; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; *ASCUS LSIL TRIAG, 2003, AM J OBSTET GYNECOL, V188, P1383; Bartholomew DA, 2011, J CLIN VIROL, V51, P38, DOI 10.1016/j.jcv.2011.01.016; Beachler DC, 2015, J INFECT DIS, V212, P1588, DOI 10.1093/infdis/jiv273; Bishop JA, 2015, SEMIN DIAGN PATHOL, V32, P344, DOI 10.1053/j.semdp.2015.02.013; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10; Bzhalava D, 2015, VIROLOGY, V476, P341, DOI 10.1016/j.virol.2014.12.028; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Cancer Genome Atlas Network, 2015, NATURE, V517, P576, DOI DOI 10.1038/NATURE14129; Castle PE, 2009, J CLIN MICROBIOL, V47, P3344, DOI 10.1128/JCM.00725-09; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chenevert J, 2012, HUM PATHOL, V43, P17, DOI 10.1016/j.humpath.2011.03.009; Clinton LK, 2015, AM J CLIN PATHOL, V144, P844, DOI 10.1309/AJCPUXLP7XD8OQYY; Conway C, 2012, J MOL DIAGN, V14, P104, DOI 10.1016/j.jmoldx.2011.10.003; Cuschieri K, 2014, INT J CANCER, V135, P2721, DOI 10.1002/ijc.28902; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; Dahlstrom KR, 2015, CANCER-AM CANCER SOC, V121, P3455, DOI 10.1002/cncr.29538; Day SP, 2009, J CLIN VIROL, V45, pS63, DOI 10.1016/S1386-6532(09)70010-1; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Dockter J, 2009, J CLIN VIROL, V45, pS55, DOI 10.1016/S1386-6532(09)70009-5; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; Evans MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091142; Ewald PW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0224; Fensterl V, 2015, ANNU REV VIROL, V2, P549, DOI 10.1146/annurev-virology-100114-055249; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; Guimera N, 2013, HISTOPATHOLOGY, V63, P287, DOI 10.1111/his.12137; Guo YL, 2016, PATHOL ONCOL RES, V22, P549, DOI 10.1007/s12253-015-0029-2; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hehnrich A, 2011, MOL CELL, V44, P966; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Henderson S, 2015, TRENDS MOL MED, V21, P274, DOI 10.1016/j.molmed.2015.02.007; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Hu Z, 2015, NAT GENET, V47, P158, DOI 10.1038/ng.3178; Jang MK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004117; Kelesidis T, 2011, AM J CLIN PATHOL, V136, P119, DOI 10.1309/AJCP03HUQYZMWATP; Kerr DA, 2016, ARCH PATHOL LAB MED, V140, P844, DOI 10.5858/arpa.2015-0272-OA; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; Kostareli E, 2013, J CLIN INVEST, V123, P2488, DOI 10.1172/JCI67010; Lai S, 2016, ANN CLIN LAB SCI, V46, P132; Liu SZ, 2015, ORAL ONCOL, V51, P862, DOI 10.1016/j.oraloncology.2015.06.014; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Maxwell JH, 2016, ANNU REV MED, V67, P91, DOI 10.1146/annurev-med-051914-021907; Mazul AL, 2016, ORAL ONCOL, V61, P98, DOI 10.1016/j.oraloncology.2016.08.019; Mitra A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16865; Montgomery ND, 2016, APPL IMMUNOHISTO M M, V24, P490, DOI 10.1097/PAI.0000000000000215; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Ndiaye C, 2014, LANCET ONCOL, V15, P1319, DOI 10.1016/S1470-2045(14)70471-1; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Parfenov M, 2014, P NATL ACAD SCI USA, V111, P15544, DOI 10.1073/pnas.1416074111; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Pfister DG, 2015, J NATL COMPR CANC NE, V13, P847, DOI 10.6004/jnccn.2015.0102                                                         ; Ratnam S, 2011, J CLIN MICROBIOL, V49, P557, DOI 10.1128/JCM.02147-10; Schiffman M, 2011, J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Steenbergen RDM, 2014, NAT REV CANCER, V14, P395, DOI 10.1038/nrc3728; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Takes RP, 2015, ORAL ONCOL, V51, P1057, DOI 10.1016/j.oraloncology.2015.10.011; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Trimble CL, 2015, J VIROL, V386, P2078, DOI DOI 10.1016/S0140-6736(15)00239-1; Tumell AS, 2012, J GEN VIROL, V93, P2076; van der Sluis TC, 2015, CURR OPIN IMMUNOL, V35, P9, DOI 10.1016/j.coi.2015.05.002; Wang YX, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8507; Wang Z, 2014, J VIROL, V88, P1308, DOI 10.1128/JVI.03091-13; Ward MJ, 2015, HEAD NECK-J SCI SPEC, V37, P1002, DOI 10.1002/hed.23697; Yi X, 2014, AM J CLIN PATHOL, V141, P796, DOI 10.1309/AJCP9P2KJSXEKCJB; Yim E, 2016, AM HEAD NECK SOC 9 I; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	80	0	0	6	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-1578	1943-7811		J MOL DIAGN	J. Mol. Diagn.	MAY	2017	19	3					366	377		10.1016/j.jmoldx.2017.01.006				12	Pathology	Pathology	ET5HF	WOS:000400314100002	28325688				2018-01-05	
J	Kim, K; Ryu, SM; Kim, ST; Baek, G; Kim, D; Lim, K; Chung, E; Kim, S; Kim, JS				Kim, Kyoungmi; Ryu, Seuk-Min; Kim, Sang-Tae; Baek, Gayoung; Kim, Daesik; Lim, Kayeong; Chung, Eugene; Kim, Sunghyun; Kim, Jin-Soo			Highly efficient RNA-guided base editing in mouse embryos	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; CAS9; ENDONUCLEASES; MICE; SPECIFICITY; MUTAGENESIS; NICKASES; KNOCKOUT	Base editors (BEs) composed of a cytidine deaminase fused to CRISPR-Cas9 convert cytidine to uridine, leading to single-base-pair substitutions in eukaryotic cells. We delivered BE mRNA or ribonucleoproteins targeting the Dmd or Tyr gene via electroporation or microinjection into mouse zygotes. F0 mice showed nonsense mutations with an efficiency of 44-57% and allelic frequencies of up to 100%, demonstrating an efficient method to generate mice with targeted point mutations.	[Kim, Kyoungmi; Ryu, Seuk-Min; Kim, Sang-Tae; Baek, Gayoung; Lim, Kayeong; Chung, Eugene; Kim, Sunghyun; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea; [Ryu, Seuk-Min; Kim, Daesik; Lim, Kayeong; Chung, Eugene; Kim, Sunghyun; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Kim, JS (reprint author), Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea.; Kim, JS (reprint author), Seoul Natl Univ, Dept Chem, Seoul, South Korea.	jskim01@snu.ac.kr			Institute for Basic Science [IBS-R021-D1]	This work was supported by the Institute for Basic Science (IBS-R021-D1 to J.-S.K.).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li J, 2016, MOL PLANT; Lu Y., MOL PLANT; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Nishida K., SCIENCE; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477	15	18	18	22	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2017	35	5					435	+		10.1038/nbt.3816				4	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EU1UJ	WOS:000400809800016	28244995				2018-01-05	
J	Zong, Y; Wang, YP; Li, C; Zhang, R; Chen, KL; Ran, YD; Qiu, JL; Wang, DW; Gao, CX				Zong, Yuan; Wang, Yanpeng; Li, Chao; Zhang, Rui; Chen, Kunling; Ran, Yidong; Qiu, Jin-Long; Wang, Daowen; Gao, Caixia			Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion	NATURE BIOTECHNOLOGY			English	Article							TARGETED MUTAGENESIS; FUNCTIONAL GENOMICS; MAMMALIAN-CELLS; CROP PLANTS; RNA; EFFICIENT; SYSTEM; CAS9; DNA	Targeted base editing in plants without the need for a foreign DNA donor or double-stranded DNA cleavage would accelerate genome modification and breeding in a wide array of crops. We used a CRISPR-Cas9 nickase-cytidine deaminase fusion to achieve targeted conversion of cytosine to thymine from position 3 to 9 within the protospacer in both protoplasts and regenerated rice, wheat and maize plants at frequencies of up to 43.48%.	[Zong, Yuan; Wang, Yanpeng; Li, Chao; Zhang, Rui; Chen, Kunling; Wang, Daowen; Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Zong, Yuan; Wang, Yanpeng; Li, Chao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ran, Yidong] Genovo Biotechnol Co Ltd, Tianjin, Peoples R China; [Qiu, Jin-Long] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China	Gao, CX (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	cxgao@genetics.ac.cn			National Key Research and Development Program of China [2016YFD0101804]; National Transgenic Science and Technology Program [2016ZX08010-002]; Chinese Academy of Sciences [KFZD-SW-107, GJHZ1602]; National Natural Science Foundation of China [31570369]	We acknowledge P. Liu for deep sequencing analysis and T. Li for technical support in flow cytometry. This work was supported by grants from the National Key Research and Development Program of China (2016YFD0101804), the National Transgenic Science and Technology Program (2016ZX08010-002), the Chinese Academy of Sciences KFZD-SW-107 and GJHZ1602 and the National Natural Science Foundation of China (31570369).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Feng B, 2010, J CEREAL SCI, V52, P387, DOI 10.1016/j.jcs.2010.06.019; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Henikoff S, 2003, ANNU REV PLANT BIOL, V54, P375, DOI 10.1143/annurev.arplant.54.031902.135009; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang QN, 2016, J INTEGR PLANT BIOL, V58, P12, DOI 10.1111/jipb.12372; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kurowska M, 2011, J APPL GENET, V52, P371, DOI 10.1007/s13353-011-0061-1; Li J, 2016, MOL PLANT; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lu Y, 2016, MOL PLANT; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Ren B., 2016, SCI CHINA LIFE SCI; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	25	25	26	73	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2017	35	5					438	+		10.1038/nbt.3811				4	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EU1UJ	WOS:000400809800017	28244994				2018-01-05	
J	Shimatani, Z; Kashojiya, S; Takayama, M; Terada, R; Arazoe, T; Ishii, H; Teramura, H; Yamamoto, T; Komatsu, H; Miura, K; Ezura, H; Nishida, K; Ariizumi, T; Kondo, A				Shimatani, Zenpei; Kashojiya, Sachiko; Takayama, Mariko; Terada, Rie; Arazoe, Takayuki; Ishii, Hisaki; Teramura, Hiroshi; Yamamoto, Tsuyoshi; Komatsu, Hiroki; Miura, Kenji; Ezura, Hiroshi; Nishida, Keiji; Ariizumi, Tohru; Kondo, Akihiko			Targeted base editing in rice and tomato using a CRISPR-Cas9 cytidine deaminase fusion	NATURE BIOTECHNOLOGY			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; HOMOLOGOUS RECOMBINATION; EFFICIENT; CLEAVAGE	We applied a fusion of CRISPR-Cas9 and activation-induced cytidine deaminase (Target-AID) for point mutagenesis at genomic regions specified by single guide RNAs (sgRNAs) in two crop plants. In rice, we induced multiple herbicide-resistance point mutations by multiplexed editing using herbicide selection, while in tomato we generated marker-free plants with homozygous heritable DNA substitutions, demonstrating the feasibility of base editing for crop improvement.	[Shimatani, Zenpei; Arazoe, Takayuki; Ishii, Hisaki; Teramura, Hiroshi; Nishida, Keiji; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Kobe, Hyogo, Japan; [Kashojiya, Sachiko; Takayama, Mariko; Teramura, Hiroshi; Yamamoto, Tsuyoshi; Komatsu, Hiroki; Miura, Kenji; Ariizumi, Tohru] Univ Tsukuba, Fac Life & Environm Sci, Gene Res Ctr, Tsukuba, Ibaraki, Japan; [Terada, Rie] Meijo Univ, Lab Genet & Breeding Sci, Fac Agr, Nagoya, Aichi, Japan; [Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo, Japan	Nishida, K; Kondo, A (reprint author), Kobe Univ, Grad Sch Sci Technol & Innovat, Kobe, Hyogo, Japan.; Ariizumi, T (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Gene Res Ctr, Tsukuba, Ibaraki, Japan.; Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo, Japan.	keiji_nishida@people.kobe-u.ac.jp; ariizumi.toru.ge@u.tsukuba.ac.jp; ezura.hiroshi.fa@u.tsukuba.ac.jp	Miura, Kenji/C-2803-2011; Kondo, Akihiko/A-2130-2015	Miura, Kenji/0000-0003-1262-2176; 	Cabinet Office, Government of Japan; Bio-oriented Technology Research Advancement Institution, NARO; Ministry of Education, Culture, Sports and Technology (MEXT) of Japan; Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED); JSPS KAKENHI [26119710, 16K14654]; New Energy and Industrial Technology Development Organization (NEDO)	Plant CRISPR vectors pCAS9-TPC and pChimera were kindly provided by F. Fauser, S. Schiml, and H. Puchta at Karlsruhe Institute of Technology via M. Endo and S. Toki. We thank Y. Iida, R. Ohta, Y. Ueke and M. Suzuki for technical assistance. This work was supported by the Cabinet Office, Government of Japan, Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) and partly supported by a Special Coordination Fund for Promoting Science and Technology, Creation of Innovative Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe) from the Ministry of Education, Culture, Sports and Technology (MEXT) of Japan, by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED), by JSPS KAKENHI grant numbers 26119710 and 16K14654 and by the New Energy and Industrial Technology Development Organization (NEDO).	Ariizumi T, 2013, BREEDING SCI, V63, P3, DOI 10.1270/jsbbs.63.3; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fleishon S, 2011, NEW PHYTOL, V190, P609, DOI 10.1111/j.1469-8137.2010.03616.x; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li J., MOL PLANT; Lu Y., MOL PLANT; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Nishida K, 2016, SCIENCE, V102, P553; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Shimatani Z, 2009, MOL GENET GENOMICS, V281, P329, DOI 10.1007/s00438-008-0410-x; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Terada R, 2004, PLANT CELL REP, V22, P653, DOI 10.1007/s00299-003-0752-0; Terada R, 2002, NAT BIOTECHNOL, V20, P1030, DOI 10.1038/nbt737; Dang TT, 2013, PLANT CELL PHYSIOL, V54, P2058, DOI 10.1093/pcp/pct147; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109                                                              ; Yu Q, 2014, PEST MANAG SCI, V70, P1340, DOI 10.1002/ps.3710	18	15	15	40	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2017	35	5					441	+		10.1038/nbt.3833				6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EU1UJ	WOS:000400809800018	28346401				2018-01-05	
J	Weinberg, BH; Pham, NTH; Caraballo, LD; Lozanoski, T; Engel, A; Bhatia, S; Wong, WW				Weinberg, Benjamin H.; Pham, N. T. Hang; Caraballo, Leidy D.; Lozanoski, Thomas; Engel, Adrien; Bhatia, Swapnil; Wong, Wilson W.			Large-scale design of robust genetic circuits with multiple inputs and outputs for mammalian cells	NATURE BIOTECHNOLOGY			English	Article							SYNTHETIC BIOLOGY APPLICATIONS; DIRECTED EVOLUTION; ESCHERICHIA-COLI; HIGH SPECIFICITY; LOGIC GATES; RECOMBINASE; CONSTRUCTION; CANCER; MICE; CRE	Engineered genetic circuits for mammalian cells often require extensive fine-tuning to perform as intended. We present a robust, general, scalable system, called 'Boolean logic and arithmetic through DNA excision' (BLADE), to engineer genetic circuits with multiple inputs and outputs in mammalian cells with minimal optimization. The reliability of BLADE arises from its reliance on recombinases under the control of a single promoter, which integrates circuit signals on a single transcriptional layer. We used BLADE to build 113 circuits in human embryonic kidney and Jurkat T cells and devised a quantitative, vector-proximity metric to evaluate their performance. Of 113 circuits analyzed, 109 functioned (96.5%) as intended without optimization. The circuits, which are available through Addgene, include a 3-input, two-output full adder; a 6-input, one-output Boolean logic look-up table; circuits with small-molecule-inducible control; and circuits that incorporate CRISPR-Cas9 to regulate endogenous genes. BLADE enables execution of sophisticated cellular computation in mammalian cells, with applications in cell and tissue engineering.	[Weinberg, Benjamin H.; Pham, N. T. Hang; Caraballo, Leidy D.; Lozanoski, Thomas; Engel, Adrien; Wong, Wilson W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Weinberg, Benjamin H.; Pham, N. T. Hang; Caraballo, Leidy D.; Lozanoski, Thomas; Engel, Adrien; Wong, Wilson W.] Boston Univ, Biol Design Ctr, Boston, MA 02215 USA; [Engel, Adrien] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Bhatia, Swapnil] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA	Wong, WW (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Wong, WW (reprint author), Boston Univ, Biol Design Ctr, Boston, MA 02215 USA.	wilwong@bu.edu		Bhatia, Swapnil/0000-0003-1079-7570	NSF [DGE-1247312]; NIH/NIGMS fellowship [T32-GM008764]; National Science Foundation Expeditions in Computing Award part of the "Living Computing Project" [1522074]; NIH Director's New Innovator Award [1DP2CA186574]; NSF Expedition in Computing [1522074]; NSF CAREER [162457]; NSF BBSRC [1614642]; Boston University College of Engineering Dean's Catalyst Award	B.H.W. acknowledges funding from the NSF Graduate Research Fellowship Program (DGE-1247312) and an NIH/NIGMS fellowship (T32-GM008764). S.B. was supported in part by the National Science Foundation Expeditions in Computing Award No. 1522074, which is part of the "Living Computing Project" (https://www.programmingbiology.org/). W.W.W. acknowledges funding from the NIH Director's New Innovator Award (1DP2CA186574), NSF Expedition in Computing (1522074), NSF CAREER (162457), NSF BBSRC (1614642), and Boston University College of Engineering Dean's Catalyst Award. We thank C. Bashor, D. Chakravarti, N. Patel, and S. Slomovic for suggestions on the manuscript; A. Belkina and T. Haddock for flow cytometry assistance; J. Torella for help with UNS-guided assembly; and M. Park and J. Eyckmans for RT-qPCR assistance. A. Nagy for the kind gift of the Dre construct.	Appleton E, 2014, NAT METHODS, V11, P657, DOI [10.1038/NMETH.2939, 10.1038/nmeth.2939]; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; Bogorad IW, 2013, NATURE, V502, P693, DOI 10.1038/nature12575; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/nmeth.2926, 10.1038/NMETH.2926]; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chaikind B, 2016, NUCLEIC ACIDS RES, V44, P9758, DOI 10.1093/nar/gkw707; Chakravarti D, 2015, TRENDS BIOTECHNOL, V33, P449, DOI 10.1016/j.tibtech.2015.05.001; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Courbet A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3601; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Gaber R, 2014, NAT CHEM BIOL, V10, P203, DOI [10.1038/NCHEMBIO.1433, 10.1038/nchembio.1433]; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131                                                                ; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Guinn M, 2014, ACS SYNTH BIOL, V3, P627, DOI 10.1021/sb4001596; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; Jayanthi S, 2013, ACS SYNTH BIOL, V2, P431, DOI 10.1021/sb300098w; Johnson RC., 2002, MOBILE DNA, P230; Karpinski J, 2016, NAT BIOTECHNOL, V34, P401, DOI 10.1038/nbt.3467; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Huynh L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035529; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.3.CO;2-2; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rodrigo G, 2013, ACS SYNTH BIOL, V2, P230, DOI 10.1021/sb300084h; Roquet N, 2016, SCIENCE, V353, P363, DOI 10.1126/science.aad8559; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Shaikh AC, 2000, J MOL BIOL, V302, P27, DOI 10.1006/jmbi.2000.3967; SHANNON CE, 1949, BELL SYST TECH J, V28, P59, DOI 10.1002/j.1538-7305.1949.tb03624.x                                              ; Sirk SJ, 2014, NUCLEIC ACIDS RES, V42, P4755, DOI 10.1093/nar/gkt1389; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Slomovic S, 2015, NAT METHODS, V12, P1085, DOI [10.1038/NMETH.3585, 10.1038/nmeth.3585]; Stanton BC, 2014, NAT CHEM BIOL, V10, P99, DOI 10.1038/nchembio.1411; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Torella JP, 2014, NAT PROTOC, V9, P2075, DOI 10.1038/nprot.2014.145; Torella JP, 2014, NUCLEIC ACIDS RES, V42, P681, DOI 10.1093/nar/gkt860; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Wei P, 2012, NATURE, V488, P384, DOI 10.1038/nature11259; Xie M, 2016, SCIENCE, V354, P1296, DOI 10.1126/science.aaf4006; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/NMETH.3147, 10.1038/nmeth.3147]	50	8	8	19	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2017	35	5					453	+		10.1038/nbt.3805				12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EU1UJ	WOS:000400809800020	28346402	green_accepted			2018-01-05	
J	Han, K; Jeng, EE; Hess, GT; Morgens, DW; Li, A; Bassik, MC				Han, Kyuho; Jeng, Edwin E.; Hess, Gaelen T.; Morgens, David W.; Li, Amy; Bassik, Michael C.			Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; INTERACTION NETWORKS; SYNTHETIC LETHALITY; INTERACTION MAPS; MAMMALIAN-CELLS; RNAI SCREENS; BCL-XL; GENOME; TARGET; THERAPY	Identification of effective combination therapies is critical to address the emergence of drug-resistant cancers, but direct screening of all possible drug combinations is infeasible. Here we introduce a CRISPR-based double knockout (CDKO) system that improves the efficiency of combinatorial genetic screening using an effective strategy for cloning and sequencing paired single guide RNA (sgRNA) libraries and a robust statistical scoring method for calculating genetic interactions (GIs) from CRISPR-deleted gene pairs. We applied CDKO to generate a large-scale human GI map, comprising 490,000 double-sgRNAs directed against 21,321 pairs of drug targets in K562 leukemia cells and identified synthetic lethal drug target pairs for which corresponding drugs exhibit synergistic killing. These included the BCL2L1 and MCL1 combination, which was also effective in imatinib-resistant cells. We further validated this system by identifying known and previously unidentified GIs between modifiers of ricin toxicity. This work provides an effective strategy to screen synergistic drug combinations in high-throughput and a CRISPR-based tool to dissect functional GI networks.	[Han, Kyuho; Jeng, Edwin E.; Hess, Gaelen T.; Morgens, David W.; Li, Amy; Bassik, Michael C.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Jeng, Edwin E.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Bassik, Michael C.] Stanford Univ, Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA	Bassik, MC (reprint author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Bassik, MC (reprint author), Stanford Univ, Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA.	bassik@stanford.edu			NIH Director's New Innovator Award Program NIH/NHGRI [1DP2HD084069-01, T32 HG000044]; NIH/NCI [1U01CA199261-02]; Stanford ChEM-H; Walter V. and Idun Berry award; NIH [2T32CA009302]; Hubert Shaw and Sandra Lui Stanford Graduate Fellowship	We thank S. Collins and members of the Bassik laboratory for helpful discussions and critical reading of the manuscript, A. Sockell and L. Tonkin for technical assistance in deep sequencing, and M. Porteus and S. Mantri for CD34<SUP>+</SUP> HSPCs. We thank M. Cleary, J. Duque-Afonso, and P. Jackson for helpful discussions regarding drug combination assays. We thank M. Kampmann, M. Horlbeck, L. Gilbert, and J. Weissman for helpful discussions, and L. Bruhn, C. Carstens, P. Sheffield, and B. Borgo of Agilent technologies for oligonucleotide synthesis and helpful discussions. GM12892 cells were a gift from S. B. Montgomery. The work was funded by the NIH Director's New Innovator Award Program (project no. 1DP2HD084069-01) NIH/NHGRI (training grant T32 HG000044 to D.W.M.), NIH/NCI 1U01CA199261-02, and a seed grant from Stanford ChEM-H. K.H. is supported by the Walter V. and Idun Berry award. E.E.J. was supported by the NIH (2T32CA009302) and a Hubert Shaw and Sandra Lui Stanford Graduate Fellowship.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Austin CJD, 2013, INT J BIOCHEM CELL B, V45, P1212, DOI 10.1016/j.biocel.2013.03.004; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bassi ZI, 2013, P NATL ACAD SCI USA, V110, P9782, DOI 10.1073/pnas.1301328110; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bixby D, 2011, LEUKEMIA, V25, P7, DOI 10.1038/leu.2010.238; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chonghaile TN, 2014, CANCER DISCOV, V4, P1074, DOI 10.1158/2159-8290.CD-14-0353; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Collins SR, 2009, NAT METHODS, V6, P721, DOI 10.1038/nmeth1009-721; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863                                                        ; Fischer U, 2015, ELIFE, V4, DOI 10.7554/eLife.05745; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hong HY, 2012, BIOCHEM BIOPH RES CO, V420, P293, DOI 10.1016/j.bbrc.2012.02.152; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kampmann M, 2014, NAT PROTOC, V9, P1825, DOI 10.1038/nprot.2014.103; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Ko TK, 2014, ONCOTARGET, V5, P9033, DOI 10.18632/oncotarget.1925                                                        ; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561; Lord CJ, 2015, ANNU REV MED, V66, P455, DOI 10.1146/annurev-med-050913-022545; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Moreau D, 2011, DEV CELL, V21, P231, DOI 10.1016/j.devcel.2011.06.014; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Morgens D.W., 2017, NAT COMMUN IN PRESS; Opferman JT, 2016, FEBS J, V283, P2661, DOI 10.1111/febs.13472; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Riabinska A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005814; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/NMETH.2398, 10.1038/nmeth.2398]; Sack LM, 2016, G3-GENES GENOM GENET, V6, P2781, DOI 10.1534/g3.116.030973; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saurabh K, 2014, ONCOTARGET, V5, P8503, DOI 10.18632/oncotarget.2330                                                        ; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Srivas R, 2016, MOL CELL, V63, P514, DOI 10.1016/j.molcel.2016.06.022; Sultana R, 2012, INT J CANCER, V131, P2433, DOI 10.1002/ijc.27512; Sun XC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006667; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022993; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Wong ASL, 2015, NAT BIOTECHNOL, V33, P952, DOI 10.1038/nbt.3326; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	77	8	8	10	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2017	35	5					463	+		10.1038/nbt.3834				15	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EU1UJ	WOS:000400809800021	28319085	green_accepted			2018-01-05	
J	Kim, D; Lim, K; Kim, ST; Yoon, SH; Kim, K; Ryu, SM; Kim, JS				Kim, Daesik; Lim, Kayeong; Kim, Sang-Tae; Yoon, Sun-heui; Kim, Kyoungmi; Ryu, Seuk-Min; Kim, Jin-Soo			Genome-wide target specificities of CRISPR RNA-guided programmable deaminases	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; NUCLEASE SPECIFICITY; MAMMALIAN-CELLS; DIGENOME-SEQ; CAS9; DNA; ENDONUCLEASES; CLEAVAGE; RIBONUCLEOPROTEINS	Cas9-linked deaminases, also called base editors, enable targeted mutation of single nucleotides in eukaryotic genomes. However, their off-target activity is largely unknown. Here we modify digested-genome sequencing (Digenome-seq) to assess the specificity of a programmable deaminase composed of a Cas9 nickase (nCas9) and the deaminase APOBEC1 in the human genome. Genomic DNA is treated with the base editor and a mixture of DNA-modifying enzymes in vitro to produce DNA double-strand breaks (DSBs) at uracil-containing sites. Off-target sites are then computationally identified from whole genome sequencing data. Testing seven different single guide RNAs (sgRNAs), we find that the rAPOBEC1-nCas9 base editor is highly specific, inducing cytosine-to-uracil conversions at only 18 +/- 9 sites in the human genome for each sgRNA. Digenome-seq is sensitive enough to capture off-target sites with a substitution frequency of 0.1%. Notably, off-target sites of the base editors are often different from those of Cas9 alone, calling for independent assessment of their genome-wide specificities.	[Kim, Daesik; Lim, Kayeong; Yoon, Sun-heui; Ryu, Seuk-Min; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Lim, Kayeong; Kim, Sang-Tae; Kim, Kyoungmi; Ryu, Seuk-Min; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea; [Kim, Jin-Soo] Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea	Kim, D; Kim, JS (reprint author), Seoul Natl Univ, Dept Chem, Seoul, South Korea.; Kim, JS (reprint author), Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea.; Kim, JS (reprint author), Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea.	dskim89@snu.ac.kr; jskim01@snu.ac.kr			Institute for Basic Science [IBS-R021-D1]; ToolGen, Inc. [0409-20160107]	This research was supported by grants from the Institute for Basic Science (IBS-R021-D1) to J.-S.K. and ToolGen, Inc. (0409-20160107) to D.K. The plasmid encoding the His<INF>6</INF>-rAPOBEC1-XTEN-dCas9 protein (pET28b-BE1) was a gift from David Liu.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim K, 2017, NAT BIOTECHNOL; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Nishida Keiji, 2016, Science (Washington D C), V353, P1248; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330	24	12	12	15	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2017	35	5					475	+		10.1038/nbt.3852				7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EU1UJ	WOS:000400809800022	28398345				2018-01-05	
J	Wang, LX; Yi, F; Fu, LN; Yang, JP; Wang, S; Wang, ZX; Suzuki, K; Sun, L; Xu, XL; Yu, Y; Qiao, J; Belmonte, JCI; Yang, Z; Yuan, Y; Qu, J; Liu, GH				Wang, Lixia; Yi, Fei; Fu, Lina; Yang, Jiping; Wang, Si; Wang, Zhaoxia; Suzuki, Keiichiro; Sun, Liang; Xu, Xiuling; Yu, Yang; Qiao, Jie; Belmonte, Juan Carlos Izpisua; Yang, Ze; Yuan, Yun; Qu, Jing; Liu, Guang-Hui			CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs	PROTEIN & CELL			English	Article						ALS; CRISPR/Cas9; gene correction; iPSC disease modeling		Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease with cellular and molecular mechanisms yet to be fully described. Mutations in a number of genes including SOD1 and FUS are associated with familial ALS. Here we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts of familial ALS patients bearing SOD1(+/A272C) and FUS+/G1566A mutations, respectively. We further generated gene corrected ALS iPSCs using CRISPR/Cas9 system. Genome-wide RNA sequencing (RNA-seq) analysis of motor neurons derived from SOD1(+/A272C) and corrected iPSCs revealed 899 aberrant transcripts. Our work may shed light on discovery of early biomarkers and pathways dysregulated in ALS, as well as provide a basis for novel therapeutic strategies to treat ALS.	[Wang, Lixia; Fu, Lina; Yang, Jiping; Wang, Si; Xu, Xiuling; Liu, Guang-Hui] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Lixia; Qu, Jing] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Wang, Lixia; Fu, Lina; Yang, Jiping; Wang, Si; Qu, Jing; Liu, Guang-Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yi, Fei] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Wang, Zhaoxia; Yuan, Yun] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China; [Suzuki, Keiichiro; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Suzuki, Keiichiro] Univ Catolica San Antonio Murcia UCAM, Campus Jeronimos,N 135 Guadalupe, Murcia 30107, Spain; [Yu, Yang; Qiao, Jie] Peking Univ, Hosp 3, Dept Gynecol & Obstet, Beijing 100191, Peoples R China; [Sun, Liang; Yang, Ze] Minist Hlth, Beijing Hosp, Beijing 100730, Peoples R China; [Liu, Guang-Hui] Jinan Univ, Inst Aging & Regenerat Med, Key Lab Regenerat Med, Minist Educ, Guangzhou 510632, Guangdong, Peoples R China; [Liu, Guang-Hui] Capital Med Univ, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Liu, GH (reprint author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Qu, J (reprint author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Qu, J; Liu, GH (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Yuan, Y (reprint author), Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.; Liu, GH (reprint author), Jinan Univ, Inst Aging & Regenerat Med, Key Lab Regenerat Med, Minist Educ, Guangzhou 510632, Guangdong, Peoples R China.; Liu, GH (reprint author), Capital Med Univ, Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.	yuanyun2002@126.com; qujing@ioz.ac.cn; ghliu@ibp.ac.cn			National Basic Research Program of China (973 Program) [2015CB964800, 2014CB964600, 2014CB910503]; National High Technology Research and Development Program of China [2015AA020307]; CAS [XDA01020312, KJZDEW-TZ-L05, CXJJ-16M271]; National Natural Science Foundation of China [1625009, 81330008, 31222039, 81371342, 81300261, 81300677, 81271266, 81471414, 81422017, 81401159, 31671429, 81601233, 81671377, 31601109, 31601158]; Beijing Natural Science Foundation [7141005, 5142016]; Program of Beijing Municipal Science and Technology Commission [Z151100003915072]; Key Research Program of the Chinese Academy of Sciences [KJZDEW-TZ-L05]; Thousand Young Talents Program of China; State Key Laboratory of Stem Cell and Reproductive Biology [2016SRLabKF13]; UCAM; G. Harold and LeilaY. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Moxie Foundation	This work was supported by the National Basic Research Program of China (973 Program) (Nos. 2015CB964800, 2014CB964600, and 2014CB910503), the National High Technology Research and Development Program of China (2015AA020307), CAS (XDA01020312, KJZDEW-TZ-L05, and CXJJ-16M271), the National Natural Science Foundation of China (Grant Nos. 81625009, 81330008, 31222039, 81371342, 81300261, 81300677, 81271266, 81471414, 81422017, 81401159, 31671429, 81601233, 81671377,31601109, and 31601158), Beijing Natural Science Foundation (7141005 and 5142016), Program of Beijing Municipal Science and Technology Commission (Z151100003915072), Key Research Program of the Chinese Academy of Sciences (KJZDEW-TZ-L05), the Thousand Young Talents Program of China, and the State Key Laboratory of Stem Cell and Reproductive Biology (2016SRLabKF13). The Lab of J.C.I.B. was supported by UCAM, the G. Harold and LeilaY. Mathers Charitable Foundation, the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002) and the Moxie Foundation.		0	2	2	3	4	HIGHER EDUCATION PRESS	BEIJING	NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA	1674-800X	1674-8018		PROTEIN CELL	Protein Cell	MAY	2017	8	5					365	378		10.1007/s13238-017-0397-3				14	Cell Biology	Cell Biology	ET9TR	WOS:000400651900005	28401346	gold			2018-01-05	
J	Guo, JY; Ma, DC; Huang, RJ; Ming, J; Ye, M; Kee, K; Xie, Z; Na, J				Guo, Jianying; Ma, Dacheng; Huang, Rujin; Ming, Jia; Ye, Min; Kee, Kehkooi; Xie, Zhen; Na, Jie			An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells	PROTEIN & CELL			English	Article						CRISPR; transcription activation; human pluripotent stem cells; NANOG; pluripotency		Human pluripotent stem cells (hPSCs) are an important system to study early human development, model human diseases, and develop cell replacement therapies. However, genetic manipulation of hPSCs is challenging and a method to simultaneously activate multiple genomic sites in a controllable manner is sorely needed. Here, we constructed a CRISPR-ON system to efficiently upregulate endogenous genes in hPSCs. A doxycycline (Dox) inducible dCas9-VP64-p65-Rta (dCas9-VPR) transcription activator and a reverse Tet transactivator (rtTA) expression cassette were knocked into the two alleles of the AAVS1 locus to generate an iVPR hESC line. We showed that the dCas9-VPR level could be precisely and reversibly controlled by the addition and withdrawal of Dox. Upon transfection of multiplexed gRNA plasmid targeting the NANOG promoter and Dox induction, we were able to control NANOG gene expression from its endogenous locus. Interestingly, an elevated NANOG level promoted na < ve pluripotent gene expression, enhanced cell survival and clonogenicity, and enabled hESCs to integrate with the inner cell mass (ICM) of mouse blastocysts in vitro. Thus, iVPR cells provide a convenient platform for gene function studies as well as high-throughput screens in hPSCs.	[Guo, Jianying; Huang, Rujin; Ming, Jia; Ye, Min; Kee, Kehkooi; Na, Jie] Tsinghua Univ, Ctr Stem Cell Biol, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Ma, Dacheng; Xie, Zhen] Tsinghua Univ, Ctr Synthet & Syst Biol, Dept Automat, TNLIST,MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Ma, Dacheng; Xie, Zhen] Tsinghua Univ, Ctr Synthet & Syst Biol, Dept Automat, TNLIST,Bioinformat Div, Beijing 100084, Peoples R China	Na, J (reprint author), Tsinghua Univ, Ctr Stem Cell Biol, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.	jie.na@tsinghua.edu.cn			National Basic Research Program (973 Program) [2012CB966701]; National Natural Science Foundation of China [31171381]; core facilities of the Tsinghua-Peking University Center for Life Sciences; TNLIST Interdisciplinary research foundation [042003171]	This work was supported by the National Basic Research Program (973 Program) (No. 2012CB966701), the National Natural Science Foundation of China (Grant No. 31171381 to J.N.), and core facilities of the Tsinghua-Peking University Center for Life Sciences. TNLIST Interdisciplinary research foundation grant 042003171 (to Z.X. and N.J.). We thank Dr. Danwei Huangfu for the AAVS1 homologous recombineering donor plasmids and Dr. Xiaohua Shen lab for assistance in Southern blot.		0	4	4	9	10	HIGHER EDUCATION PRESS	BEIJING	NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA	1674-800X	1674-8018		PROTEIN CELL	Protein Cell	MAY	2017	8	5					379	393		10.1007/s13238-016-0360-8				15	Cell Biology	Cell Biology	ET9TR	WOS:000400651900006	28116670	gold			2018-01-05	
J	El-Sayed, ASA; Abdel-Ghany, SE; Ali, GS				El-Sayed, Ashraf S. A.; Abdel-Ghany, Salah E.; Ali, Gul Shad			Genome editing approaches: manipulating of lovastatin and taxol synthesis of filamentous fungi by CRISPR/Cas9 system	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Genome engineering; CRISPR/Cas9; Filamentous fungi; Secondary metabolites; Lovastatin; Taxol; Metabolic engineering	ENCODED HOMING ENDONUCLEASE; RNA-GUIDED ENDONUCLEASE; DOUBLE-STRAND BREAKS; ASPERGILLUS-FUMIGATUS; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; SECONDARY METABOLISM; TAL EFFECTORS; CAS SYSTEMS; HOMOLOGOUS RECOMBINATION	Filamentous fungi are prolific repertoire of structurally diverse secondary metabolites of remarkable biological activities such as lovastatin and paclitaxel that have been approved by FDA as drugs for hypercholesterolemia and cancer treatment. The clusters of genes encoding lovastatin and paclitaxel are cryptic at standard laboratory cultural conditions (Kennedy et al. Science 284:1368-1372, 1999; Bergmann et al. Nature Chem Biol 3:213-217, 2007). The expression of these genes might be triggered in response to nutritional and physical conditions; nevertheless, the overall yield of these metabolites does not match the global need. Consequently, overexpression of the downstream limiting enzymes and/or blocking the competing metabolic pathways of these metabolites could be the most successful technologies to enhance their yield. This is the first review summarizing the different strategies implemented for fungal genome editing, molecular regulatory mechanisms, and prospective of clustered regulatory interspaced short palindromic repeat/Cas9 system in metabolic engineering of fungi to improve their yield of lovastatin and taxol to industrial scale. Thus, elucidating the putative metabolic pathways in fungi for overproduction of lovastatin and taxol was the ultimate objective of this review.	[El-Sayed, Ashraf S. A.; Abdel-Ghany, Salah E.] Zagazig Univ, Dept Bot & Microbiol, Fac Sci, Zagazig 44519, Egypt; [El-Sayed, Ashraf S. A.; Ali, Gul Shad] Univ Florida IFAS, Mid Florida Res & Educ Ctr, Apopka, FL USA; [Abdel-Ghany, Salah E.] Colorado State Univ, Ft Collins, CO 80523 USA	El-Sayed, ASA (reprint author), Zagazig Univ, Dept Bot & Microbiol, Fac Sci, Zagazig 44519, Egypt.; El-Sayed, ASA; Ali, GS (reprint author), Univ Florida IFAS, Mid Florida Res & Educ Ctr, Apopka, FL USA.	ashrafzu@ufl.edu; gsali@ufl.edu					Abdelmohsen UR, 2015, BIOTECHNOL ADV, V33, P798, DOI 10.1016/j.biotechadv.2015.06.003; Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; ALBERTS AW, 1988, AM J CARDIOL, V62, pJ10, DOI 10.1016/0002-9149(88)90002-1; Ali GS, 2016, APPL ENVIRON MICROB, V82, P478, DOI 10.1128/AEM.02662-15; Ames BD, 2012, P NATL ACAD SCI USA, V109, P11144, DOI 10.1073/pnas.1113029109; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; AOYAMA Y, 1984, J BIOL CHEM, V259, P1661; Askenazi M, 2003, NAT BIOTECHNOL, V21, P150, DOI 10.1038/nbt781; Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Beerli RR, 2000, J BIOL CHEM, V275, P32617, DOI 10.1074/jbc.M005108200; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1                                                               ; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110                                                                ; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Bizukojc Marcin, 2009, Biotechnology Journal, V4, P647, DOI 10.1002/biot.200800289; Bladt TT, 2013, MOLECULES, V18, P11338, DOI 10.3390/molecules180911338; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7                                                   ; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Caruso M, 2000, ANN MICROBIOL, V50, P3; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; CHAPPELL J, 1995, PLANT PHYSIOL, V109, P1337, DOI 10.1104/pp.109.4.1337                                                           ; Cheng L., 2014, CRIT REV MICROBIOL, P1, DOI [10.1007/s10584-014-1254-51-17, DOI 10.1007/S10584-014-1254-51-17]; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crawford JM, 2010, NAT REV MICROBIOL, V8, P879, DOI 10.1038/nrmicro2465; Croteau Rodney, 2006, Phytochemistry Reviews, V5, P75, DOI 10.1007/s11101-005-3748-2; Cueto M, 2001, J NAT PROD, V64, P1444, DOI 10.1021/np0102713; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; Davidson Michael H, 2007, Curr Atheroscler Rep, V9, P78, DOI 10.1007/BF02693932; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Djulic A, 2011, FUNGAL BIOL-UK, V115, P633, DOI 10.1016/j.funbio.2011.03.007; Do R, 2009, CLIN GENET, V75, P19, DOI 10.1111/j.1399-0004.2008.01099.x; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; El-Sayed AS, 2013, J MICROBIOL BIOTECHN, V23, P499, DOI 10.4014/jmb.1208.08070; El-Sayed ASA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144304; El-Sayed ASA, 2015, ENZYME MICROB TECH, V81, P31, DOI 10.1016/j.enzmictec.2015.08.004; Engels B, 2008, METAB ENG, V10, P201, DOI 10.1016/j.ymben.2008.03.001; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Flores-Bustamante ZR, 2010, J ANTIBIOT, V63, P460, DOI 10.1038/ja.2010.83; Fulci V, 2007, CURR OPIN MICROBIOL, V10, P199, DOI 10.1016/j.mib.2007.03.016; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Ganem B, 2007, J ORG CHEM, V72, P3981, DOI 10.1021/jo070129s; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gimble FS, 2003, J MOL BIOL, V334, P993, DOI 10.1016/j.jmb.2003.01.013; GIMBLE FS, 1993, J BIOL CHEM, V268, P21844; Gogarten JP, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-94; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gong B, 2014, P NATL ACAD SCI USA, V111, P16359, DOI 10.1073/pnas.1410806111; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hammond SM, 2000, NATURE, V404, P293; Hatoum-Aslan A, 2014, CURR OPIN MICROBIOL, V17, P82, DOI 10.1016/j.mib.2013.12.001; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heath PJ, 1997, NAT STRUCT BIOL, V4, P468, DOI 10.1038/nsb0697-468; Heinig U, 2013, FUNGAL DIVERS, V60, P161, DOI 10.1007/s13225-013-0228-7; Heintze Jacob, 2013, Frontiers in Genetics, V4, P193, DOI 10.3389/fgene.2013.00193; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hendrickson L, 1999, CHEM BIOL, V6, P429, DOI 10.1016/S1074-5521(99)80061-1; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hildenbrand MF, 2005, BIOPHYS J, V88, P3360, DOI 10.1529/biophysj.104.050112; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873                                                          ; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jankele R, 2014, BRIEF FUNCT GENOMICS, V13, P409, DOI 10.1093/bfgp/elu013; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Jiang DW, 2013, BIOTECHNOL ADV, V31, P1562, DOI 10.1016/j.biotechadv.2013.08.005; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joffrion TM, 2010, FEMS MICROBIOL LETT, V311, P1, DOI 10.1111/j.1574-6968.2010.02007.x; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kang A, 2016, METAB ENG, V34, P25, DOI 10.1016/j.ymben.2015.12.002; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368                                                   ; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Kuo CY, 2004, APPL MICROBIOL BIOT, V65, P593, DOI 10.1007/s00253-004-1635-1; Kusari S, 2014, TRENDS BIOTECHNOL, V32, P304, DOI 10.1016/j.tibtech.2014.03.011; Kusari S, 2013, PHYTOCHEMISTRY, V91, P81, DOI 10.1016/j.phytochem.2012.07.021; Lee SY, 2009, DRUG DISCOV TODAY, V14, P78, DOI 10.1016/j.drudis.2008.08.004; Lee S, 2008, J BACTERIOL, V190, P3808, DOI 10.1128/JB.01939-07; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li JY, 1998, MYCOL RES, V102, P461, DOI 10.1017/S0953756297005078; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Li YC, 2009, APPL MICROBIOL BIOT, V83, P233, DOI 10.1007/s00253-009-1856-4; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Liao WY, 2012, J NAT PROD, V75, P630, DOI 10.1021/np200866z; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malik S, 2011, PROCESS BIOCHEM, V46, P23, DOI 10.1016/j.procbio.2010.09.004; Manavathu EK, 1998, J ANTIMICROB CHEMOTH, V41, P615, DOI 10.1093/jac/41.6.615                                                            ; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meyer V, 2008, BIOTECHNOL ADV, V26, P177, DOI 10.1016/j.biotechadv.2007.12.001; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moretti A, 2013, INT J FOOD MICROBIOL, V167, P57, DOI 10.1016/j.ijfoodmicro.2013.06.033; Mulder KCL, 2015, BIOTECHNOL ADV, V33, P648, DOI 10.1016/j.biotechadv.2015.04.001; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Nemudryi AA, 2014, ACTA NATURAE, V6, P19; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; O'Connor SE, 2015, ANNU REV GENET, V49, P71, DOI 10.1146/annurev-genet-120213-092053; Ogura K, 1998, CHEM REV, V98, P1263, DOI 10.1021/cr9600464                                                               ; Ola ARB, 2013, J NAT PROD, V76, P2094, DOI 10.1021/np400589h; Olivier LM, 2000, BBA-MOL CELL BIOL L, V1529, P89, DOI 10.1016/S1388-1981(00)00139-6; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; Park JH, 2008, TRENDS BIOTECHNOL, V26, P404, DOI 10.1016/j.tibtech.2008.05.001; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pereira M, 2010, BBA-MOL CELL BIOL L, V1801, P1163, DOI 10.1016/j.bbalip.2010.06.007; Pickens LB, 2011, ANNU REV CHEM BIOMOL, V2, P211, DOI 10.1146/annurev-chembioeng-061010-114209; Pingoud A, 2007, NAT BIOTECHNOL, V25, P743, DOI 10.1038/nbt0707-743; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Ryu YG, 2006, APPL ENVIRON MICROB, V72, P7132, DOI 10.1128/AEM.01308-06; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SELKER EU, 1987, MOL CELL BIOL, V7, P1032, DOI 10.1128/MCB.7.3.1032                                                            ; SHARMA A, 1993, CANCER RES, V53, P5877; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Shiba Y, 2007, METAB ENG, V9, P160, DOI 10.1016/j.ymben.2006.10.005; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Silva GH, 1999, J MOL BIOL, V286, P1123, DOI 10.1006/jmbi.1998.2519; SMITH DJ, 1990, EMBO J, V9, P2743; SMITH DJ, 1989, MOL GEN GENET, V216, P492, DOI 10.1007/BF00334395; Soliman SSM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00003; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Suryanarayanan T. S., 2009, Fungal Biology Reviews, V23, P9, DOI 10.1016/j.fbr.2009.07.001; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Voytas DF, 2013, PLANT BIOLOGY, V64, P327, DOI DOI 10.1146/ANNUREV-ARPLANT-042811-105552; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Wende W, 1996, NUCLEIC ACIDS RES, V24, P4123, DOI 10.1093/nar/24.21.4123; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wriessnegger T, 2013, PROG LIPID RES, V52, P277, DOI 10.1016/j.plipres.2013.03.001; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xie XK, 2007, METAB ENG, V9, P379, DOI 10.1016/j.ymben.2007.05.006; Xie XK, 2007, APPL ENVIRON MICROB, V73, P2054, DOI 10.1128/AEM.02820-06; Xu W, 2013, ANGEW CHEM INT EDIT, V52, P6472, DOI 10.1002/anie.201302406; Zha WJ, 2009, METAB ENG, V11, P192, DOI 10.1016/j.ymben.2009.01.005; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang P, 2009, FEMS MICROBIOL LETT, V293, P155, DOI 10.1111/j.1574-6968.2009.01481.x; ZHAO L, 2007, THE EMBO J, V26, P2432, DOI DOI 10.1038/SJ.EMBOJ.7601672	224	0	0	27	33	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	MAY	2017	101	10					3953	3976		10.1007/s00253-017-8263-z				24	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ET2AA	WOS:000400069500002	28389711				2018-01-05	
J	Dong, B; Hu, HH; Li, ZF; Cheng, RQ; Meng, DM; Wang, JP; Fan, ZC				Dong, Bin; Hu, He-He; Li, Zhen-Fang; Cheng, Rong-Qiang; Meng, De-Mei; Wang, Junping; Fan, Zhen-Chuan			A novel bicistronic expression system composed of the intraflagellar transport protein gene ift25 and FMDV 2A sequence directs robust nuclear gene expression in Chlamydomonas reinhardtii	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Chlamydomonas reinhardtii; Nuclear transgene expression; Intraflagellar transport IFT25 gene; FMDV 2A; Bioreactor	HIGH-LEVEL EXPRESSION; VIRAL DIARRHEA VIRUS; HEAT-SHOCK-PROTEIN; ALGA CHLAMYDOMONAS; GREEN-ALGA; COMPLEX B; CHLORELLA-ELLIPSOIDEA; MULTIPLE PROTEINS; CRYSTAL-STRUCTURE; REPORTER GENE	Chlamydomonas reinhardtii offers a great promise for large-scale production of multiple recombinant proteins of pharmaceutical and industrial interest. However, the nuclear-encoding transgenes usually are expressed at a low level, which severely hampers the use of this alga in molecular farming. In this study, the promoter of the endogenous intraflagellar transport 25 (IFT25) gene of C. reinhardtii was tested for its ability to drive the expression of green fluorescent protein (GFP), which functions as a readout for target gene expression. IFT25 promoter (IFT25P) alone was not able to drive GFP expression to a detectable level. IFT25P, however, can drive robust IFT25-GFP fusion protein expression when the intron-containing IFT25 gene was inserted between IFT25P and GFP cDNA. When an extended version of foot-and-mouth virus 2A protease (2A(E)) sequence was further inserted between the intron-containing IFT25 gene and the GFP cDNA, discrete GFP protein was observed to release from the IFT25-2A(E)-GFP polyprotein via 2A self-cleaving with a cleavage efficacy of approximately 99%. The monomer GFP was accumulated to a level of as high as 0.68% of total soluble proteins. To test whether the newly developed bicistronic IFT25P-IFT25-2A(E) expression system can be used to overexpress heterologous proteins of different origins and sizes, we inserted codon-optimized cDNAs encoding a Trichoderma reesei xylanase1 (25 kDa) and a Lachnospiraceae bacterium ND2006 type V CRISPR-Cas protein LbCpf1 (147 kDa) to the vector and found that the production of xylanase1 and LbCpf1 was as high as 0.69 and 0.49% of total soluble protein. Our result showed that IFT25P-IFT25-2A(E) system is more efficient to drive nuclear gene expression in C. reinhardtii than other conventionally used promoters, thus representing a novel efficient recombinant protein expression tool and has the potential to be scaled for commercial production of nuclear-encoded recombinant proteins of different sizes and origins in C. reinhardtii.	[Dong, Bin; Hu, He-He; Li, Zhen-Fang; Cheng, Rong-Qiang; Meng, De-Mei; Wang, Junping; Fan, Zhen-Chuan] Tianjin Univ Sci & Technol, Int Collaborat Res Ctr Hlth Biotechnol, Key Lab Food Nutr & Safety, Minist Educ China,Inst Hlth Biotechnol,Coll Food, Tianjin 300457, Peoples R China; [Fan, Zhen-Chuan] Obesita & Algaegen LLC, College Stn, TX 77845 USA; [Fan, Zhen-Chuan] Tianjin Univ Sci & Technol, Inst Hlth Biotechnol, Tianjin Econ & Technol Dev Area, Rm 334,Yifu Bldg,29 13rd St, Tianjin 300457, Peoples R China	Fan, ZC (reprint author), Tianjin Univ Sci & Technol, Int Collaborat Res Ctr Hlth Biotechnol, Key Lab Food Nutr & Safety, Minist Educ China,Inst Hlth Biotechnol,Coll Food, Tianjin 300457, Peoples R China.; Fan, ZC (reprint author), Obesita & Algaegen LLC, College Stn, TX 77845 USA.; Fan, ZC (reprint author), Tianjin Univ Sci & Technol, Inst Hlth Biotechnol, Tianjin Econ & Technol Dev Area, Rm 334,Yifu Bldg,29 13rd St, Tianjin 300457, Peoples R China.	fanzhen@tust.edu.cn			International Center for Genetic Engineering and Biotechnology (ICGEB) Collaborative Research Program (CRP) [CRP/CHN15-01]; Natural Science Foundation of Tianjin City [13JCYBJC41900]; Tianjin University of Science Technology [20130420, 20140789]; National Natural Science Foundation of China [31503544]; National Key Research and Development Program of China [2016YFD0401202]; Obesita & Algaegen LLC, USA	This work was supported jointly by grants from International Center for Genetic Engineering and Biotechnology (ICGEB) Collaborative Research Program (CRP) (#CRP/CHN15-01 to Fan ZC), Natural Science Foundation of Tianjin City (#13JCYBJC41900 to Fan ZC), Tianjin University of Science & Technology (#20130420 and #20140789 to Fan ZC), National Natural Science Foundation of China (#31503544 to Meng DM), National Key Research and Development Program of China (#2016YFD0401202 to Wang J), and Obesita & Algaegen LLC, USA.	Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Bellyei S, 2007, APOPTOSIS, V12, P97, DOI 10.1007/s10495-006-0486-x; Bellyei S, 2007, EUR J CELL BIOL, V86, P161, DOI 10.1016/j.ejcb.2006.12.004; Bhogaraju S, 2011, EMBO J, V30, P1907, DOI 10.1038/emboj.2011.110; BLANKENSHIP JE, 1992, MOL CELL BIOL, V12, P5268, DOI 10.1128/MCB.12.11.5268                                                          ; Butanaev A.M., 1994, Molekulyarnaya Biologiya (Moscow), V28, P1061; Cerutti H, 1997, PLANT CELL, V9, P925, DOI 10.1105/tpc.9.6.925                                                             ; Cerutti H, 1997, GENETICS, V145, P97; Chow KC, 1999, PLANT CELL REP, V18, P778, DOI 10.1007/s002990050660                                                           ; DAVIES JP, 1992, NUCLEIC ACIDS RES, V20, P2959, DOI 10.1093/nar/20.12.2959; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; De Wilde C, 2000, PLANT MOL BIOL, V43, P347, DOI 10.1023/A:1006464304199; Diaz-Santos E, 2013, BIOTECHNOL PROGR, V29, P319, DOI 10.1002/btpr.1690; DUMAS P, 1994, EMBO J, V13, P2483; Eichler-Stahlberg A, 2009, PLANTA, V229, P873, DOI 10.1007/s00425-008-0879-x; Fan ZC, 2012, VIRUS RES, V163, P341, DOI 10.1016/j.virusres.2011.10.022; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Fan ZC, 2008, VIRUS RES, V138, P97, DOI 10.1016/j.virusres.2008.08.015; FERNANDEZ E, 1989, P NATL ACAD SCI USA, V86, P6449, DOI 10.1073/pnas.86.17.6449; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469                                                           ; Gong YM, 2011, J IND MICROBIOL BIOT, V38, P1879, DOI 10.1007/s10295-011-1032-6; Griesbeck C, 2006, MOL BIOTECHNOL, V34, P213, DOI 10.1385/MB:34:2:213; HALL LM, 1993, GENE, V124, P75, DOI 10.1016/0378-1119(93)90763-S; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; Heitzer M, 2007, BIOTECHNIQUES, V43, P324, DOI 10.2144/000112556; Huang THW, 2007, TOXICOL APPL PHARM, V218, P30, DOI 10.1016/j.taap.2006.10.013; JARVIS EE, 1991, CURR GENET, V19, P317, DOI 10.1007/BF00355062                                                              ; Keady BT, 2012, DEV CELL, V22, P940, DOI 10.1016/j.devcel.2012.04.009; Kim DH, 2002, MAR BIOTECHNOL, V4, P63, DOI 10.1007/s1012601-0070-x; Kong F, 2015, J BIOSCI BIOENG, V120, P239, DOI 10.1016/j.jbiosc.2015.01.005; KOZMINSKI KG, 1993, CELL MOTIL CYTOSKEL, V25, P158, DOI 10.1002/cm.970250205; Kumar A, 2013, ALGAL RES, V2, P321, DOI 10.1016/j.algal.2013.09.002; Kumar SV, 2004, PLANT SCI, V166, P731, DOI 10.1016/j.plantsci.2003.11.012; Lauersen KJ, 2015, APPL MICROBIOL BIOT, V99, P3491, DOI 10.1007/s00253-014-6354-7; Lauersen KJ, 2013, J BIOTECHNOL, V167, P101, DOI 10.1016/j.jbiotec.2012.10.010; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; Leon-Banares R, 2004, TRENDS BIOTECHNOL, V22, P45, DOI 10.1016/j.tibtech.2003.11.003; Lerche K, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-65; Lumbreras V, 1998, PROTIST, V149, P23, DOI 10.1016/S1434-4610(98)70006-9; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; Meng DM, 2016, PROTEIN EXPRES PURIF, V127, P35, DOI 10.1016/j.pep.2016.07.001; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; Plucinak TM, 2015, PLANT J, V82, P717, DOI 10.1111/tpj.12844; Posten C, 2009, J BIOTECHNOL, V142, P64, DOI 10.1016/j.jbiotec.2009.03.015; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; RANDOLPHANDERSON BL, 1993, MOL GEN GENET, V236, P235, DOI 10.1007/BF00277118; Rasala BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043349; Rasala Beth A, 2011, Bioeng Bugs, V2, P50, DOI 10.4161/bbug.2.1.13423; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Roberts LO, 1998, RNA, V4, P520, DOI 10.1017/S1355838298971989; Ruecker O, 2008, MOL GENET GENOMICS, V280, P153, DOI 10.1007/s00438-008-0352-3; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x                                                ; Shao N, 2008, CURR GENET, V53, P381, DOI 10.1007/s00294-008-0189-7; Shaver S, 2010, EPIGENETICS-US, V5, P301, DOI 10.4161/epi.5.4.11608                                                           ; Shi YZ, 2010, NAT NANOTECHNOL, V5, P80, DOI [10.1038/nnano.2009.303, 10.1038/NNANO.2009.303]; Shimogawara K, 1998, GENETICS, V148, P1821; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3                                                   ; Specht E, 2010, BIOTECHNOL LETT, V32, P1373, DOI 10.1007/s10529-010-0326-5; Specht EA, 2015, BIOTECHNOL J, V10, P473, DOI 10.1002/biot.201400172; Tang DKH, 1995, BIOCHEM MOL BIOL INT, V36, P1025; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159                                                   ; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	70	0	0	6	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	MAY	2017	101	10					4227	4245		10.1007/s00253-017-8177-9				19	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ET2AA	WOS:000400069500023	28238082				2018-01-05	
J	Brunger, JM; Zutshi, A; Willard, VP; Gersbach, CA; Guilak, F				Brunger, Jonathan M.; Zutshi, Ananya; Willard, Vincent P.; Gersbach, Charles A.; Guilak, Farshid			CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues	ARTHRITIS & RHEUMATOLOGY			English	Article							ZINC-FINGER NUCLEASES; POSTTRAUMATIC ARTHRITIS; INHIBIT CHONDROGENESIS; ARTICULAR CHONDROCYTES; I RECEPTOR; CARTILAGE; GENE; TRANSCRIPTION; DELIVERY; THERAPY	Objective. Proinflammatory cytokines such as interleukin-1 (IL-1) are found in elevated levels in diseased or injured tissues and promote rapid tissue degradation while preventing stem cell differentiation. This study was undertaken to engineer inflammation-resistant murine induced pluripotent stem cells (iPSCs) through deletion of the IL-1 signaling pathway and to demonstrate the utility of these cells for engineering replacements for diseased or damaged tissues. Methods. Targeted deletion of the IL-1 receptor type I (IL-1RI) gene in murine iPSCs was achieved using the RNA-guided, site-specific clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 genome engineering system. Clonal cell populations with homozygous and heterozygous deletions were isolated, and loss of receptor expression and cytokine signaling was confirmed by flow cytometry and transcriptional reporter assays, respectively. Cartilage was engineered from edited iPSCs and tested for its ability to resist IL-1-mediated degradation in gene expression, histologic, and biomechanical assays after a 3-day treatment with 1 ng/ml of IL-1 alpha. Results. Three of 41 clones isolated possessed the IL-1RI(+/-) genotype. Four clones possessed the IL-1RI(-/-) genotype, and flow cytometry confirmed loss of IL-1RI on the surface of these cells, which led to an absence of NF-kappa B transcription activation after IL-1 alpha treatment. Cartilage engineered from homozygous null clones was resistant to cytokine-mediated tissue degradation. In contrast, cartilage derived from wild-type and heterozygous clones exhibited significant degradative responses, highlighting the need for complete IL-1 blockade. Conclusion. This work demonstrates proof-of-concept of the ability to engineer custom-designed stem cells that are immune to proinflammatory cytokines (i.e., IL-1) as a potential cell source for cartilage tissue engineering.	[Brunger, Jonathan M.; Zutshi, Ananya; Gersbach, Charles A.] Duke Univ, Durham, NC USA; [Willard, Vincent P.] Cytex Therapeut, Durham, NC USA; [Guilak, Farshid] Washington Univ, St Louis, MO USA; [Guilak, Farshid] Shriners Hosp Children, St Louis, MO USA	Gersbach, CA (reprint author), Duke Univ, FCIEMAS, Dept Biomed Engn, Room 1427,101 Sci Dr,Box 90281, Durham, NC 27708 USA.; Guilak, F (reprint author), Washington Univ, Shriners Hosp Children, Dept Orthopaed Surg, Campus Box 8233,McKinley Res Bldg,Room 3121, St Louis, MO 63110 USA.	charles.gersbach@duke.edu; guilak@wustl.edu			Nancy Taylor Foundation for Chronic Diseases; NIH [AR-061042, AR-50245, AR-48852, AG-15768, AR-48182, OD-008586]; NSF (CAREER Award) [CBET-1151035]; Collaborative Research Center of the AO Foundation; Arthritis Foundation	Supported by the Nancy Taylor Foundation for Chronic Diseases, the NIH (grants AR-061042, AR-50245, AR-48852, AG-15768, AR-48182, and OD-008586), the NSF (CAREER Award CBET-1151035), the Collaborative Research Center of the AO Foundation, and the Arthritis Foundation.	Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890; Blasioli DJ, 2014, BIOMATERIALS, V35, P1185, DOI 10.1016/j.biomaterials.2013.10.050; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2; Buckwalter JA, 2007, BIOMED HEALTH RES, V70, P1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cucchiarini M, 2005, MOL THER, V12, P229, DOI 10.1016/j.ymthe.2005.03.012; Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Evans CH, 2013, TRANSL RES, V161, P205, DOI 10.1016/j.trsl.2013.01.002; Furman BD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4591; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hedbom E, 2002, CELL MOL LIFE SCI, V59, P45, DOI 10.1007/s00018-002-8404-z                                                       ; Heldens GTH, 2012, TISSUE ENG PT A, V18, P45, DOI [10.1089/ten.tea.2011.0083, 10.1089/ten.TEA.2011.0083]; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18                                                            ; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kimmerling KA, 2015, EUR CELLS MATER, V29, P124, DOI 10.22203/eCM.v029a10                                                            ; Labow M, 1997, J IMMUNOL, V159, P2452; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Lima EG, 2008, TISSUE ENG PT A, V14, P1721, DOI 10.1089/ten.tea.2007.0347; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599; Matthews GL, 2013, RHEUM DIS CLIN N AM, V39, P177, DOI 10.1016/j.rdc.2012.10.006; McNulty AL, 2013, J ORTHOP RES, V31, P1039, DOI 10.1002/jor.22334; McNulty AL, 2011, CONNECT TISSUE RES, V52, P523, DOI 10.3109/03008207.2011.597902; Moutos FT, 2016, P NATL ACAD SCI USA, V113, pE4513, DOI 10.1073/pnas.1601639113; Otero M, 2012, J BIOL CHEM, V287, P3559, DOI 10.1074/jbc.M111.265744; Ousterout DG, 2015, MOL THER, V23, P523, DOI [10.1038/mt.2074.234, 10.1038/mt.2014.234]; Peng H, 2008, J CELL PHYSIOL, V215, P562, DOI 10.1002/jcp.21338; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Ramos-Casals M, 2008, BEST PRACT RES CL RH, V22, P847, DOI 10.1016/j.berh.2008.09.008; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Schukur L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4964; Shi SL, 2013, J CELL BIOCHEM, V114, P908, DOI 10.1002/jcb.24430; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Willard VP, 2014, ARTHRITIS RHEUMATOL, V66, P3062, DOI 10.1002/art.38780; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775	48	3	3	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	MAY	2017	69	5					1111	1121		10.1002/art.39982				11	Rheumatology	Rheumatology	ET1ZQ	WOS:000400068300025	27813286	gold			2018-01-05	
J	Ren, JT; Liu, XJ; Fang, CY; Jiang, SG; June, CH; Zhao, YB				Ren, Jiangtao; Liu, Xiaojun; Fang, Chongyun; Jiang, Shuguang; June, Carl H.; Zhao, Yangbing			Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition	CLINICAL CANCER RESEARCH			English	Article							CHIMERIC-ANTIGEN-RECEPTOR; ZINC-FINGER NUCLEASES; MESSENGER-RNA; HIV-1 INFECTION; TUMOR; LEUKEMIA; CRISPR/CAS9; STEM; IMMUNOTHERAPY; SPECIFICITY	Purpose: Using gene-disrupted allogeneic T cells as universal effector cells provides an alternative and potentially improves current chimeric antigen receptor (CAR) T-cell therapy against cancers and infectious diseases. Experimental Design: The CRISPR/Cas9 system has recently emerged as a simple and efficient way for multiplex genome engineering. By combining lentiviral delivery of CAR and electro-transfer of Cas9 mRNA and gRNAs targeting endogenous TCR, beta-2 microglobulin (B2M) and PD1 simultaneously, to generate gene-disrupted allogeneic CAR T cells deficient of TCR, HLA class I molecule and PD1. Results: The CRISPR gene-edited CAR T cells showed potent antitumor activities, both in vitro and in animal models and were as potent as non-gene-edited CAR T cells. In addition, the TCR and HLA class I double deficient T cells had reduced alloreactivity and did not cause graft-versus-host disease. Finally, simultaneous triple genome editing by adding the disruption of PD1 led to enhanced in vivo antitumor activity of the gene-disrupted CAR T cells. Conclusions: Gene-disrupted allogeneic CAR and TCR T cells could provide an alternative as a universal donor to autologous T cells, which carry difficulties and high production costs. Gene-disrupted CAR and TCR T cells with disabled checkpoint molecules may be potent effector cells against cancers and infectious diseases. (C) 2016 AACR.	[Ren, Jiangtao; Liu, Xiaojun; Fang, Chongyun; Jiang, Shuguang; June, Carl H.; Zhao, Yangbing] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [June, Carl H.; Zhao, Yangbing] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [June, Carl H.; Zhao, Yangbing] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA	June, CH (reprint author), Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.; June, CH (reprint author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; June, CH (reprint author), Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; Zhao, YB (reprint author), Univ Penn, Sch Med, Ctr Cellular Immunotherapies, 3400 Civ Ctr Blvd,TRC 421,RM08-122, Philadelphia, PA 19104 USA.	cjune@exchange.upenn.edu; Yangbing@exchange.upenn.edu	Ren, Jiangtao/J-4985-2017		US NIH [2R01CA120409]	This work was supported by a US NIH grant (2R01CA120409; to C.H. June and Y. Zhao).	Abate-Daga D, 2014, HUM GENE THER, V25, P1003, DOI 10.1089/hum.2013.209; Barrett DM, 2011, HUM GENE THER, V22, P1575, DOI 10.1089/hum.2011.070; Beane JD, 2015, MOL THER, V23, P1380, DOI 10.1038/mt.2015.71; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Berdien B, 2014, GENE THER, V21, P539, DOI 10.1038/gt.2014.26; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi EI, 2008, IMMUNOLOGY, V124, P215, DOI 10.1111/j.1365-2567.2007.02757.x; Choi EI, 2008, J VIROL, V82, P6758, DOI 10.1128/JVI.02277-07; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kochenderfer JN, 2009, J IMMUNOTHER, V32, P689, DOI 10.1097/CJI.0b013e3181ac6138; Leyton JV, 2009, PROTEIN ENG DES SEL, V22, P209, DOI 10.1093/protein/gzn055; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Moon EK, 2014, CLIN CANCER RES, V20, P4262, DOI 10.1158/1078-0432.CCR-13-2627; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Valton J, 2015, MOL THER, V23, P1507, DOI 10.1038/mt.2015.104; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Wang W, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1016/J.GR.2014.02.002; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845                                                     ; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880	42	27	27	35	53	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	MAY 1	2017	23	9					2255	2266		10.1158/1078-0432.CCR-16-1300				12	Oncology	Oncology	ET4QW	WOS:000400270900015	27815355	gold			2018-01-05	
J	Gunaltay, S; Ghiboub, M; Hultgren, O; Hornquist, EH				Gunaltay, Sezin; Ghiboub, Mohammed; Hultgren, Olof; Hornquist, Elisabeth Hultgren			Reduced IL-37 Production Increases Spontaneous Chemokine Expressions in Colon Epithelial Cells	DIGESTIVE DISEASES AND SCIENCES			English	Article						IL-37; Chemokines; CRISPR/Cas9	INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; COLLAGENOUS COLITIS; CROHNS-DISEASE; RECEPTOR; CASPASE-1; FLAGELLIN; CYTOKINE; IMMUNITY; IL-1F7B	Microscopic colitis, comprising collagenous colitis and lymphocytic colitis, is a common cause of chronic diarrhea. Previously, we showed enhanced chemokine productions in microscopic colitis patients, indicating dysregulated immune cell chemotaxis in the immunopathogenesis. We also showed decreased mRNA of IL-37, mainly regarded as an anti-inflammatory cytokine, in the colonic mucosa of these patients, potentially an important factor for the chronicity of the colitis. Our aim in this study was to understand the possible role of IL-37 in chemokine production using a cell line model. A colon epithelial cell line, T84, was stimulated with the TLR5 ligand flagellin. IL-37 protein production was reduced 20% using the CRISPR/Cas9 system, and the changes in chemokine mRNA and protein expressions were compared to cells transfected with empty plasmid. The 20% reduction in IL-37 protein levels spontaneously increased CCL5, CXCL8, CXCL10, and CXCL11 mRNA and protein expressions. CCL2 mRNA and protein levels were enhanced upon TLR5 stimulation. CCL3, CCL20, and CX(3)CL1 mRNA expressions were increased either spontaneously or following TLR5 stimulation, whereas CCL4 and CCL22 mRNA expressions were significantly decreased. Even a minor decrease in the ability of colon epithelial cells to produce IL-37 results in altered chemokine expression, mainly an increase in the production of several chemokines. Our results indicate that a decreased IL-37 expression by colon epithelial cells may be an important factor for increasing the recruitment of immune cells and subsequently developing microscopic colitis.	[Gunaltay, Sezin; Ghiboub, Mohammed; Hornquist, Elisabeth Hultgren] Orebro Univ, Sch Med Sci, Fac Med & Hlth, S-70182 Orebro, Sweden; [Ghiboub, Mohammed] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands; [Hultgren, Olof] Orebro Univ, Fac Med & Hlth, Dept Microbiol & Immunol, S-70182 Orebro, Sweden	Gunaltay, S (reprint author), Orebro Univ, Sch Med Sci, Fac Med & Hlth, S-70182 Orebro, Sweden.	sezin.gunaltay@oru.se		Gunaltay, Sezin/0000-0002-9635-0341	Swedish Society of Medicine (Bengt Ihre Foundation) [SLS-176271/2011, 98031/2010]; Orebro University Hospital Research Foundation (Nyckelfonden); Orebro County Council Research Committee; Orebro University	This study was supported by grants from the Swedish Society of Medicine (Bengt Ihre Foundation, Grants SLS-176271/2011, 98031/2010), the Orebro University Hospital Research Foundation (Nyckelfonden), and the Orebro County Council Research Committee. Sezin Gunaltay's salary is covered by a grant from Orebro University. We are very grateful to Maximilian W. Schenk at the Division of Signaling and Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, for help with the CRISPR/Cas9 system experimental setup and optimizations.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Agarwal S, 2010, ANN ALLERG ASTHMA IM, V104, P210, DOI DOI 10.1016/J.ANAI.2009.11.009; Agarwal S, 2010, ANN ALLERG ASTHMA IM, V104, P183, DOI 10.1016/j.anai.2009.11.009; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Bannon C, 2009, BIOCHEM J, V423, P119, DOI 10.1042/BJ20090392; Bohr J, 2014, CLIN EXP GASTROENTER, V7, P273, DOI 10.2147/CEG.S63905; Bufler P, 2004, BIOCHEM J, V381, P503, DOI 10.1042/BJ20040217                                                              ; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204; Egesten A, 2007, INT J COLORECTAL DIS, V22, P1421, DOI 10.1007/s00384-007-0370-3; Fonseca-Camarillo G, 2015, CYTOKINE, V75, P389, DOI 10.1016/j.cyto.2015.04.009; Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217; Goranzon C, 2013, J Crohns Colitis, V7, pe434, DOI 10.1016/j.crohns.2013.02.007; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gunaltay S, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/132458; Gunaltay S, 2014, WORLD J GASTROENTERO, V20, P12249, DOI 10.3748/wjg.v20.i34.12249; Harrison LM, 2008, INFECT IMMUN, V76, P5524, DOI 10.1128/IAI.00843-08; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hogan SP, 2004, CURR ALLERGY ASTHM R, V4, P74, DOI 10.1007/s11882-004-0047-8                                                       ; Imaeda H, 2013, CLIN EXP IMMUNOL, V172, P410, DOI 10.1111/cei.12061; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jugde F, 2001, EUR CYTOKINE NETW, V12, P468; Kumar S, 2002, CYTOKINE, V18, P61, DOI 10.1006/cyto.2002.0873; Kumawat AK, 2013, MOL IMMUNOL, V55, P355, DOI 10.1016/j.molimm.2013.03.007; Kvedaraite E, 2016, GUT, V65, P1632, DOI 10.1136/gutjnl-2014-309014; Levy AM, 2001, AM J GASTROENTEROL, V96, P1522; Li Yan, 2014, QINGNIAN YANJIU, V37, P37, DOI DOI 10.1371/J0URNAL.P0NE.0107183; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Mabbott NA, 2015, BIOGERONTOLOGY, V16, P133, DOI 10.1007/s10522-014-9498-z; Mahajan D, 2012, ADV ANAT PATHOL, V19, P28, DOI 10.1097/PAP.0b013e31823d7705; Mantovani A, 2000, J LEUKOCYTE BIOL, V68, P400; Nishida Y, 2002, HEPATO-GASTROENTEROL, V49, P678; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477                                                     ; Skovdahl HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141710; SOZZANI S, 1994, J IMMUNOL, V152, P3615; Uguccioni M, 1999, AM J PATHOL, V155, P331, DOI 10.1016/S0002-9440(10)65128-0; van Aubel RAMH, 2007, MOL IMMUNOL, V44, P3702, DOI 10.1016/j.molimm.2007.04.001; Verma R, 2014, J STEROID BIOCHEM, V141, P1, DOI 10.1016/j.jsbmb.2013.12.012; Watson Robert O, 2008, PLoS Pathog, V4, pe14, DOI 10.1371/journal.ppat.0040014; Weidlich S, 2014, J PEDIATR GASTR NUTR, V59, pE18, DOI 10.1097/MPG.0000000000000387; Xu WD, 2015, AUTOIMMUN REV, V14, P1170, DOI 10.1016/j.autrev.2015.08.006; Ye Z, 2014, CURR MOL MED, V14, P535, DOI 10.2174/1566524014666140414210831                                               ; Yoshino Y, 2013, LIFE SCI, V92, P211, DOI 10.1016/j.lfs.2012.11.017; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhao JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05177; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480	56	0	0	4	8	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	MAY	2017	62	5					1204	1215		10.1007/s10620-016-4422-9				12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	ES8NW	WOS:000399814900016	28044228	gold			2018-01-05	
J	Carpenter, MR; Kalburge, SS; Borowski, JD; Peters, MC; Colwell, RR; Boyd, EF				Carpenter, Megan R.; Kalburge, Sai S.; Borowski, Joseph D.; Peters, Molly C.; Colwell, Rita R.; Boyd, E. Fidelma			CRISPR-Cas and Contact-Dependent Secretion Systems Present on Excisable Pathogenicity Islands with Conserved Recombination Modules	JOURNAL OF BACTERIOLOGY			English	Article						CRISPR-Cas; type III secretion; Vibrio cholerae; pathogenicity islands	COMPARATIVE GENOMIC ANALYSIS; VIBRIO-CHOLERAE; REPEATS; SEQUENCE; REVEALS; GENES; IDENTIFICATION; EXCISION; BACTERIA; STRAINS	Pathogenicity islands (PAIs) are mobile integrated genetic elements that contain a diverse range of virulence factors. PAIs integrate into the host chromosome at a tRNA locus that contains their specific bacterial attachment site, attB, via integrase-mediated site-specific recombination generating attL and attR sites. We identified conserved recombination modules (integrases and att sites) previously described in choleragenic Vibrio cholerae PAIs but with novel cargo genes. Clustered regularly interspaced short palindromic repeat (CRISPR)-associated proteins (Cas proteins) and a type VI secretion system (T6SS) gene cluster were identified at the Vibrio pathogenicity island 1 (VPI-1) insertion site in 19 V. cholerae strains and contained the same recombination module. Two divergent type I-F CRISPR-Cas systems were identified, which differed in Cas protein homology and content. The CRISPR repeat sequence was identical among all V. cholerae strains, but the CRISPR spacer sequences and the number of spacers varied. In silico analysis suggests that the CRISPR-Cas systems were active against phages and plasmids. A type III secretion system (T3SS) was present in 12 V. cholerae strains on a 68-kb island inserted at the same tRNA-serine insertion site as VPI-2 and contained the same recombination module. Bioinformatics analysis showed that two divergent T3SSs exist among the strains examined. Both the CRISPR and T3SS islands excised site specifically from the bacterial chromosome as complete units, and the cognate integrases were essential for this excision. These data demonstrated that identical recombination modules that catalyze integration and excision from the chromosome can acquire diverse cargo genes, signifying a novel method of acquisition for both CRISPR-Cas systems and T3SSs. IMPORTANCE This work demonstrated the presence of CRISPR-Cas systems and T3SSs on PAIs. Our work showed that similar recombination modules can associate with different cargo genes and catalyze their incorporation into bacterial chromosomes, which could convert a strain into a pathogen with very different disease pathologies. Each island had the ability to excise from the chromosome as distinct, complete units for possible transfer. Evolutionary analysis of these regions indicates that they were acquired by horizontal transfer and that PAIs are the units of transfer. Similar to the case for phage evolution, PAIs have a modular structure where different functional regions are acquired by identical recombination modules.	[Carpenter, Megan R.; Kalburge, Sai S.; Borowski, Joseph D.; Peters, Molly C.; Boyd, E. Fidelma] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Colwell, Rita R.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Boyd, EF (reprint author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	fboyd@udel.edu			University of Delaware	M.R.C. was funded by a University of Delaware graduate fellowship award.	Almagro-Moreno S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-306; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Azarian T, 2014, MBIO, V5, DOI 10.1128/mBio.01824-14; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BASLER M, 2015, PHILOS T R SOC LON B, V370, P1679; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Box AM, 2016, J BACTERIOL, V198, P578, DOI 10.1128/JB.00747-15; Carpenter MR, 2016, J BACTERIOL, V198, P766, DOI 10.1128/JB.00704-15; Chakraborty Sajib, 2009, In Silico Biology, V9, P245, DOI 10.3233/ISB-2009-0402; Chen Y, 2007, INFECT IMMUN, V75, P2645, DOI 10.1128/IAI.01317-06; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; DE SN, 1959, NATURE, V183, P1533, DOI 10.1038/1831533a0; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Gladney L. M., 2014, GENOME ANNOUNC, V2, DOI 10.1128/genomeA.01188-14; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gunderson FF, 2013, MBIO, V4, DOI 10.1128/mBio.00074-13; Haley BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086264; Haley BJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-154; Heidelberg JF, 2000, NATURE, V406, P477; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487                                                          ; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hille F, 2016, PHILOS T R SOC LON B; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jermyn WS, 2002, MICROBIOL-SGM, V148, P3681, DOI 10.1099/00221287-148-11-3681                                                    ; KAPER JB, 1984, NATURE, V308, P655, DOI 10.1038/308655a0                                                                ; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Labbate M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36891; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McDonald ND, 2016, MBIO, V7, DOI 10.1128/mBio.02237-15; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Morita M, 2013, MICROBIOL IMMUNOL, V57, P334, DOI 10.1111/1348-0421.12039; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; NEI M, 1989, MOL BIOL EVOL, V6, P290; Okada N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-302; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Rajanna C, 2003, J BACTERIOL, V185, P6893, DOI 10.1128/JB.185.23.6893-6901.2003; Rao CT, 2016, CELL MICROBIOL, V18, P1319, DOI 10.1111/cmi.12586; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Taviani E, 2010, FEMS MICROBIOL LETT, V308, P130, DOI 10.1111/j.1574-6968.2010.02008.x; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; van Belkum A, 2015, MBIO, V6, DOI 10.1128/mBio.01796-15; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910                                                   	60	2	2	4	5	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	MAY	2017	199	10							UNSP e00842-16	10.1128/JB.00842-16				20	Microbiology	Microbiology	ET1GT	WOS:000400016300009					2018-01-05	
J	Rajagopalan, R; Kroos, L				Rajagopalan, Ramya; Kroos, Lee			The dev Operon Regulates the Timing of Sporulation during Myxococcus xanthus Development	JOURNAL OF BACTERIOLOGY			English	Article						CRISPR-Cas; Myxococcus xanthus; bacterial development; dev operon; gene regulation; signaling; sporulation	FRUITING BODY MORPHOGENESIS; CRISPR-CAS SYSTEMS; SER/THR KINASE CASCADE; COMBINATORIAL REGULATION; TRANSCRIPTION FACTORS; MYXCOCCUS-XANTHUS; SPORE FORMATION; FRUA; EXPRESSION; GENE	Myxococcus xanthus undergoes multicellular development when starved. Thousands of rod-shaped cells coordinate their movements and aggregate into mounds in which cells differentiate into spores. Mutations in the dev operon impair development. The dev operon encompasses a clustered regularly interspaced short palindromic repeat-associated (CRISPR-Cas) system. Null mutations in devI, a small gene at the beginning of the dev operon, suppress the developmental defects caused by null mutations in the downstream devR and devS genes but failed to suppress defects caused by a small in-frame deletion in devT. We provide evidence that the original mutant has a second-site mutation. We show that devT null mutants exhibit developmental defects indistinguishable from devR and devS null mutants, and a null mutation in devI suppresses the defects of a devT null mutation. The similarity of DevTRS proteins to components of the CRISPR-associated complex for antiviral defense (Cascade), together with our molecular characterization of dev mutants, support a model in which DevTRS form a Cascade-like subcomplex that negatively autoregulates dev transcript accumulation and prevents DevI overproduction that would strongly inhibit sporulation. Our results also suggest that DevI transiently inhibits sporulation when regulated normally. The mechanism of transient inhibition may involve MrpC, a key transcription factor, whose translation appears to be weakly inhibited by DevI. Finally, our characterization of a devI devS mutant indicates that very little exo transcript is required for sporulation, which is surprising since Exo proteins help form the polysaccharide spore coat. IMPORTANCE CRISPR-Cas systems typically function as adaptive immune systems in bacteria. The dev CRISPR-Cas system of M. xanthus has been proposed to prevent bacteriophage infection during development, but how dev controls sporulation has been elusive. Recent evidence supported a model in which DevR and DevS prevent overproduction of DevI, a predicted 40-residue inhibitor of sporulation. We provide genetic evidence that DevT functions together with DevR and DevS to prevent DevI overproduction. We also show that spores form about 6 h earlier in mutants lacking devI than in the wild type. Only a minority of natural isolates appear to have a functional dev promoter and devI, suggesting that a functional dev CRISPR-Cas system evolved recently in niches where delayed sporulation and/or protection from bacteriophage infection proved advantageous.	[Rajagopalan, Ramya; Kroos, Lee] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Kroos, L (reprint author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	kroos@msu.edu			NSF [MCB-1411272]; Michigan State University AgBioResearch	This research was supported by NSF grant MCB-1411272 and by salary support for L.K. from Michigan State University AgBioResearch.	Boysen A, 2002, J BACTERIOL, V184, P1540, DOI 10.1128/JB.184.6.1540-1546.2002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Campbell A, 2015, J BACTERIOL, V197, P240, DOI 10.1128/JB.02310-14; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HAGEN TJ, 1990, J BACTERIOL, V172, P15; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Higgs PI, 2008, J BACTERIOL, V190, P4416, DOI 10.1128/JB.00265-08; Holkenbrink C, 2014, J BIOL CHEM, V289, P32364, DOI 10.1074/jbc.M114.595504; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; KIM SK, 1990, CELL, V61, P19, DOI 10.1016/0092-8674(90)90211-V                                                    ; KROOS L, 1987, GENE DEV, V1, P840, DOI 10.1101/gad.1.8.840; Kroos L, 2008, J BACTERIOL, V190, P4373, DOI 10.1128/JB.00580-08; Kroos L, 2017, TRENDS GENET, V33, P3, DOI 10.1016/j.tig.2016.10.006; KUNER JM, 1982, J BACTERIOL, V151, P458; Lee B, 2012, J BACTERIOL, V194, P3058, DOI 10.1128/JB.06756-11; Lee JS, 2011, J BACTERIOL, V193, P1681, DOI 10.1128/JB.01541-10; Licking E, 2000, J BACTERIOL, V182, P3553, DOI 10.1128/JB.182.12.3553-3558.2000; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mittal S, 2009, P NATL ACAD SCI USA, V106, P1965, DOI 10.1073/pnas.0808516106; Mittal S, 2009, J BACTERIOL, V191, P2753, DOI 10.1128/JB.01818-08; Muller FD, 2012, MOL MICROBIOL, V83, P486, DOI 10.1111/j.1365-2958.2011.07944.x; Muller FD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-264; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; OCONNOR KA, 1991, J BACTERIOL, V173, P3318, DOI 10.1128/jb.173.11.3318-3333.1991                                                ; Overgaard M, 2006, J BACTERIOL, V188, P4384, DOI 10.1128/JB.00189-06; Peters JM, 2015, CURR OPIN MICROBIOL, V27, P121, DOI 10.1016/j.mib.2015.08.007; Rajagopalan R, 2015, J BACTERIOL, V197, P1249, DOI 10.1128/JB.02542-14; Rajagopalan R, 2014, J BACTERIOL, V196, P2736, DOI 10.1128/JB.01692-14; Robinson M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1123; Schramm A, 2012, J BIOL CHEM, V287, P25060, DOI 10.1074/jbc.M112.387241; Son BJ, 2011, J BACTERIOL, V193, P2756, DOI 10.1128/JB.00205-11; Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400; Tan IS, 2015, DEV CELL, V34, P682, DOI 10.1016/j.devcel.2015.08.009; THONYMEYER L, 1993, J BACTERIOL, V175, P7450; Ueki T, 2005, J BACTERIOL, V187, P8504, DOI 10.1128/JB.187.24.8504-8506.2005; Ueki T, 2005, J BIOL CHEM, V280, P32279, DOI 10.1074/jbc.M507191200; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Ueki T, 2003, P NATL ACAD SCI USA, V100, P8782, DOI 10.1073/pnas.1533026100; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Viswanathan P, 2007, J BACTERIOL, V189, P3738, DOI 10.1128/JB.00187-07; Wartel M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001728; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; WIREMAN JW, 1977, J BACTERIOL, V129, P796; Yang Z, 2014, MYXOBACTERIA GENOMIC; Yoder-Himes DR, 2006, J BACTERIOL, V188, P5167, DOI 10.1128/JB.00318-06	48	0	0	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	MAY	2017	199	10							UNSP e00788-16	10.1128/JB.00788-16				19	Microbiology	Microbiology	ET1GT	WOS:000400016300007					2018-01-05	
J	Karanovic, J; Ivkovic, M; Jovanovic, VM; Svikovic, S; Pantovic-Stefanovic, M; Brkusanin, M; Damjanovic, A; Brajuskovic, G; Savic-Pavicevic, D				Karanovic, Jelena; Ivkovic, Maja; Jovanovic, Vladimir M.; Svikovic, Sasa; Pantovic-Stefanovic, Maja; Brkusanin, Milos; Damjanovic, Aleksandar; Brajuskovic, Goran; Savic-Pavicevic, Dusanka			Effect of childhood general traumas on suicide attempt depends on TPH2 and ADARB1 variants in psychiatric patients	JOURNAL OF NEURAL TRANSMISSION			English	Article						Suicide attempted; Tryptophan hydroxylase; rs4290270; RNA editing; Child abuse; Gene-environment interaction	DORSAL RAPHE NUCLEUS; MESSENGER-RNA EXPRESSION; TRYPTOPHAN-HYDROXYLASE; MAJOR DEPRESSION; ENVIRONMENT INTERACTION; BEHAVIOR; DISORDERS; SEROTONIN; RISK; ASSOCIATION	Suicidal behavior has been associated with a deficient serotonin neurotransmission which is likely a consequence of individual genetic architecture, exposure to environmental factors and interactions of those factors. We examined whether the interaction of child abuse, TPH2 (tryptophan hydroxylase 2) variant rs4290270, affecting alternative splicing and editing of TPH2 pre-mRNAs, and ADARB1 (adenosine deaminase acting on RNA B1) variants rs4819035 and rs9983925 may influence the risk for suicide attempt in psychiatric patients. TPH2 rs4290270 was genotyped in 165 suicide attempters and 188 suicide non-attempters diagnosed with major depressive disorder, bipolar disorder and schizophrenia. Genotyping data for ADARB1 variants were taken over from our previous study. Child abuse before the age of 18 years was assessed using the Early Trauma Inventory-Self Report. Generalized linear models and backward selection were applied to identify the main and interacting effects of environmental and genetic factors, including psychiatric diagnoses, patients' gender and age as covariates. Childhood general traumas were independently associated with suicide attempt. Two-way interaction between TPH2 rs4290270 and general traumas revealed that TT homozygotes with a history of general traumas had an increased risk for suicide attempt. Three-way interaction of general traumas, TPH2 rs4290270 and ADARB1 rs4819035 indicated that the highest predisposition to suicide attempt was observed in individuals who experienced general traumas and were TT homozygote for rs4290270 and TT homozygote for rs4819035. Our findings suggest that the risk for suicide attempt in psychiatric patients exposed to an adverse childhood environment may depend on TPH2 and ADARB1 variants.	[Karanovic, Jelena; Svikovic, Sasa; Brkusanin, Milos; Brajuskovic, Goran; Savic-Pavicevic, Dusanka] Univ Belgrade, Ctr Human Mol Genet, Fac Biol, Studentski Trg 16,POB 43, Belgrade 11000, Serbia; [Ivkovic, Maja; Pantovic-Stefanovic, Maja; Damjanovic, Aleksandar] Clin Ctr Serbia, Psychiat Clin, Pasterova 2, Belgrade 11000, Serbia; [Ivkovic, Maja; Damjanovic, Aleksandar] Univ Belgrade, Sch Med, Subotica 8, Belgrade 11000, Serbia; [Jovanovic, Vladimir M.] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Genet Res, Bulevar Despota Stefana 142, Belgrade 11000, Serbia	Savic-Pavicevic, D (reprint author), Univ Belgrade, Ctr Human Mol Genet, Fac Biol, Studentski Trg 16,POB 43, Belgrade 11000, Serbia.	duska@bio.bg.ac.rs		Brajuskovic, Goran/0000-0002-3935-6755; Brkusanin, Milos/0000-0002-4316-9231; Jovanovic, Vladimir/0000-0002-8056-5065; Savic-Pavicevic, Dusanka/0000-0002-2079-4077	Ministry of Education, Science and Technological Development, Republic of Serbia [173016]	This study was supported by a grant from the Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No. 173016). The Ministry of Education, Science and Technological Development had no further role in the study design, in the collection, analyses, and interpretation of data, in the writing of the manuscript or in the decision to submit the manuscript for publication.	Abumaria N, 2008, CELL MOL NEUROBIOL, V28, P331, DOI 10.1007/s10571-007-9259-5; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Antypa N, 2013, EUR NEUROPSYCHOPHARM, V23, P1125, DOI 10.1016/j.euroneuro.2013.03.013; Bach-Mizrachi H, 2008, MOL PSYCHIATR, V13, P507, DOI 10.1038/sj.mp.4002143; Bach-Mizrachi H, 2006, NEUROPSYCHOPHARMACOL, V31, P814, DOI 10.1038/sj.npp.1300897; Boldrini M, 2005, BRAIN RES, V1041, P19, DOI 10.1016/j.brainres.2005.01.083; Booij L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0251; Bortolato M, 2013, NEUROSCIENCE, V236, P160, DOI 10.1016/j.neuroscience.2013.01.015; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Brezo J, 2008, BRIT J PSYCHIAT, V193, P134, DOI 10.1192/bjp.bp.107.037994; Brodsky BS, 2008, PSYCHIAT CLIN N AM, V31, P223, DOI 10.1016/j.psc.2008.02.002; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Calcagno V., 2013, GLMULTI MODEL SELECT; Dracheva S, 2008, MOL PSYCHIATR, V13, P1001, DOI 10.1038/sj.mp.4002081; First M. B., 1996, STRUCTURED CLIN INTE; Gardner KL, 2009, NEUROSCIENCE, V163, P991, DOI 10.1016/j.neuroscience.2009.07.055; Gonzalez JR, 2014, SNPASSOC SNPS BASED; Grohmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008956; Haghighi F, 2008, MOL PSYCHIATR, V13, P813, DOI 10.1038/sj.mp.4002127; Hale MW, 2011, J CHEM NEUROANAT, V41, P219, DOI 10.1016/j.jchemneu.2011.05.002; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Karanovic J, 2015, WORLD J BIOL PSYCHIA, V16, P261, DOI 10.3109/15622975.2014.1000374; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Lele SR, 2015, RESOURCESELECTION RE; Lenth R., 2015, LSMEANS LEAST SQUARE; Lopez-Narvaez ML, 2015, COMPR PSYCHIAT, V61, P72, DOI 10.1016/j.comppsych.2015.05.002; Lim JE, 2007, MOL PSYCHIATR, V12, P491, DOI 10.1038/sj.mp.4001923; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5                                                   ; Lyddon R, 2013, WORLD J BIOL PSYCHIA, V14, P590, DOI 10.3109/15622975.2011.630406; Mandelli L, 2013, NEUROSCI BIOBEHAV R, V37, P2375, DOI 10.1016/j.neubiorev.2013.07.011; Mann JJ, 2008, J AFFECT DISORDERS, V106, P117, DOI 10.1016/j.jad.2007.05.031; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Murphy TM, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-22; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schwartz S., 2006, GENES BEHAV SOCIAL E, P310; Silberberg G, 2012, HUM MOL GENET, V21, P311, DOI 10.1093/hmg/ddr461; Simmons M, 2010, NEUROREPORT, V21, P993, DOI 10.1097/WNR.0b013e32833f11c3; Turecki G, 2012, TRENDS NEUROSCI, V35, P14, DOI 10.1016/j.tins.2011.11.008; Underwood MD, 1999, BIOL PSYCHIAT, V46, P473, DOI 10.1016/S0006-3223(99)00043-8; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; World Health Organization, 2014, PREV SUIC GLOB IMP	45	0	0	5	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	MAY	2017	124	5					621	629		10.1007/s00702-017-1677-z				9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	ES9PM	WOS:000399891600010	28084537				2018-01-05	
J	Hermle, T; Braun, DA; Helmstadter, M; Hubert, TB; Hildebrandt, F				Hermle, Tobias; Braun, Daniela A.; Helmstaedter, Martin; Hubert, Tobias B.; Hildebrandt, Friedhelm			Modeling Monogenic Human Nephrotic Syndrome in the Drosophila Garland Cell Nephrocyte	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							STEROID-RESISTANT; VANILLIC ACID; SLIT DIAPHRAGM; DEFICIENCY; ENDOCYTOSIS; SNS; RHO; NEPHROPATHY; DYSFUNCTION; FILTRATION	Steroid-resistant nephrotic syndrome is characterized by podocyte dysfunction. Drosophila garland cell nephrocytes are podocyte-like cells and thus provide a potential in vivo model in which to study the pathogenesis of nephrotic syndrome. However, relevant pathomechanisms of nephrotic syndrome have not been studied in nephrocytes. Here, we discovered that two Drosophila slit diaphragm proteins, orthologs of the human genes encoding nephrin and nephrin-like protein 1, colocalize within a fingerprint-like staining pattern that correlates with ultrastructural morphology. Using RNAi and conditional CRISPR/Cas9 in nephrocytes, we found this pattern depends on the expression of both orthologs. Tracer endocytosis by nephrocytes required Cubilin and reflected size selectivity analogous to that of glomerular function. Using RNAi and tracer endocytosis as a functional read-out, we screened Drosophila orthologs of human monogenic causes of nephrotic syndrome and observed conservation of the central pathogenetic alterations. We focused on the coenzyme Q(10) (CoQ(10)) biosynthesis gene Coq2, the silencing of which disrupted slit diaphragm morphology. Restoration of CoQ(10) synthesis by vanillic acid partially rescued the phenotypic and functional alterations induced by Coq2-RNAi. Notably, Coq2 colocalized with mitochondria, and Coq2 silencing increased the formation of reactive oxygen species (ROS). Silencing of ND75, a subunit of the mitochondria! respiratory chain that controls ROS formation independently of CoQ(10), phenocopied the effect of Coq2-RNAi. Moreover, the ROS scavenger glutathione partially rescued the effects of Coq2-RNAi. In conclusion, Drosophila garland cell nephrocytes provide a model with which to study the pathogenesis of nephrotic syndrome, and ROS formation may be a pathomechanism of COQ2-nephropathy.	[Hermle, Tobias; Braun, Daniela A.; Hildebrandt, Friedhelm] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA; [Helmstaedter, Martin; Hubert, Tobias B.] Univ Med Ctr Freiburg, Div Renal, Freiburg, Germany; [Helmstaedter, Martin; Hubert, Tobias B.] Univ Freiburg, Fac Med, Freiburg, Germany; [Hubert, Tobias B.] Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	Hermle, T; Hildebrandt, F (reprint author), Harvard Med Sch, Boston Childrens Hosp, 300 Longwood Ave Enders 561, Boston, MA 02115 USA.	tobias.hermle@childrens.harvard.edu; friedhelm.hildebrandt@childrens.harvard.edu	Braun, Daniela/R-2259-2017	Braun, Daniela/0000-0003-3146-1566	National Institutes of Health [DK076683, DK086542]; Deutsche Forschungsgemeinschaft (DFG) [HE 7456/1-1]; DFG; European Research Council	This research was supported by grants from the National Institutes of Health (DK076683 and DK086542) to F.H. and by a Research Fellowship from the Deutsche Forschungsgemeinschaft (DFG) to T.H. (HE 7456/1-1). T.B.H. was supported by the DFG and European Research Council.	Andreenkova O V, 2015, Genetika, V51, P263; Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000; Bour BA, 2000, GENE DEV, V14, P1498; Das R, 2014, AM J PHYSIOL-RENAL, V306, pF155, DOI 10.1152/ajprenal.00438.2013; Denholm B, 2009, CURR OPIN GENET DEV, V19, P526, DOI 10.1016/j.gde.2009.08.006; Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Doimo M, 2014, BBA-MOL BASIS DIS, V1842, P1, DOI 10.1016/j.bbadis.2013.10.007; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI [10.1172/JCI79504, 10.1122/JCI79504]; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Giglio S, 2015, J AM SOC NEPHROL, V26, P230, DOI 10.1681/ASN.2013111155; Gitzinger M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1251; Gleixner EM, 2014, CELL REP, V8, P10, DOI 10.1016/j.celrep.2014.05.035; Hamano Y, 2002, J BIOL CHEM, V277, P31154, DOI 10.1074/jbc.M204806200; Helmstadter M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040300; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Kumar S, 2011, REDOX REP, V16, P208, DOI 10.1179/1351000211Y.0000000009; Lovric S, 2016, NEPHROL DIAL TRANSPL, V31, P1802, DOI 10.1093/ndt/gfv355; McCarthy HJ, 2013, CLIN J AM SOC NEPHRO, V8, P637, DOI 10.2215/CJN.07200712; Na JB, 2015, CELL REP, V12, P636, DOI 10.1016/j.celrep.2015.06.056; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Quinzii CM, 2013, FASEB J, V27, P612, DOI 10.1096/fj.12-209361; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Sarov M, 2016, ELIFE, V5, DOI 10.7554/eLife.12068; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; SEILER MW, 1975, SCIENCE, V189, P390, DOI 10.1126/science.1145209; Stanley A, 2014, ANTIOXID REDOX SIGN, V20, P2026, DOI 10.1089/ars.2013.5713; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Trautmann A, 2015, CLIN J AM SOC NEPHRO, V10, P592, DOI 10.2215/CJN.06260614; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tutor AS, 2014, DEVELOPMENT, V141, P367, DOI 10.1242/dev.099408; Vivante A, 2016, NAT REV NEPHROL, V12, P133, DOI 10.1038/nrneph.2015.205; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P209, DOI 10.1681/ASN.2012080795; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P191, DOI 10.1681/ASN.2012080769; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	44	3	3	3	3	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	MAY	2017	28	5					1521	1533		10.1681/ASN.2016050517				13	Urology & Nephrology	Urology & Nephrology	ET4BX	WOS:000400225100022	27932481				2018-01-05	
J	Borchardt, EK; Meganck, RM; Vincent, HA; Ball, CB; Ramos, SBV; Moorman, NJ; Marzluff, WF; Asokan, A				Borchardt, Erin K.; Meganck, Rita M.; Vincent, Heather A.; Ball, Christopher B.; Ramos, Silvia B. V.; Moorman, Nathaniel J.; Marzluff, William F.; Asokan, Aravind			Inducing circular RNA formation using the CRISPR endoribonuclease Csy4	RNA			English	Article						CRISPR; Csy4; circular RNA; splicing regulation; gene regulation	MESSENGER-RNAS; BIOGENESIS; EXPRESSION; PROTEINS; REPEATS	Circular RNAs (circRNAs) are highly stable, covalently closed RNAs that are regulated in a spatiotemporal manner and whose functions are largely unknown. These molecules have the potential to be incorporated into engineered systems with broad technological implications. Here we describe a switch for inducing back-splicing of an engineered circRNA that relies on the CRISPR endoribonuclease, Csy4, as an activator of circularization. The endoribonuclease activity and 3' end-stabilizing properties of Csy4 are particularly suited for this task. Coexpression of Csy4 and the circRNA switch allows for the removal of downstream competitive splice sites and stabilization of the 5' cleavage product. This subsequently results in back-splicing of the 5' cleavage product into a circRNA that can translate a reporter protein from an internal ribosomal entry site (IRES). Our platform outlines a straightforward approach toward regulating splicing and could find potential applications in synthetic biology as well as in studying the properties of different circRNAs.	[Borchardt, Erin K.; Meganck, Rita M.] Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Borchardt, Erin K.; Meganck, Rita M.; Asokan, Aravind] Univ North Carolina Chapel Hill, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Vincent, Heather A.; Moorman, Nathaniel J.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ball, Christopher B.; Ramos, Silvia B. V.; Marzluff, William F.; Asokan, Aravind] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Moorman, Nathaniel J.; Asokan, Aravind] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Marzluff, William F.] Univ North Carolina Chapel Hill, IBGS, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA	Asokan, A (reprint author), Univ North Carolina Chapel Hill, Gene Therapy Ctr, Chapel Hill, NC 27599 USA.; Asokan, A (reprint author), Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.; Asokan, A (reprint author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Asokan, A (reprint author), Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu			National Institutes of Health [R01HL089221, P01HL112761, GM29832, 5T32GM007092]	We thank Dr. Zefeng Wang for providing the circGFP plasmid. This study was supported by National Institutes of Health grants awarded to A.A. (R01HL089221; P01HL112761) and W.F.M. (GM29832). E.K.B. and R.M.M. were partially supported by a National Institutes of Health training grant awarded to the Curriculum in Genetics and Molecular Biology (5T32GM007092).	Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Borchardt EK, 2015, RNA, V21, P1921, DOI 10.1261/rna.051227.115; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344                                                         ; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Ebbesen K, 2015, BIOCHIM BIOPHYS ACTA, V1859, P163; Enuka Y, 2016, NUCLEIC ACIDS RES, V44, P1370, DOI 10.1093/nar/gkv1367; Groher F, 2014, BBA-GENE REGUL MECH, V1839, P964, DOI 10.1016/j.bbagrm.2014.05.005; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kramer MC, 2015, GENE DEV, V29, P2168, DOI 10.1101/gad.270421.115; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Lee HY, 2013, P NATL ACAD SCI USA, V110, P5416, DOI 10.1073/pnas.1302807110; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Liang JC, 2011, MOL CELL, V43, P915, DOI 10.1016/j.molcel.2011.08.023; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Slevin MK, 2014, MOL CELL, V53, P1020, DOI 10.1016/j.molcel.2014.02.027; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wang Y, 2015, RNA, V21, P172, DOI 10.1261/rna.048272.114; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2016, CELL REP, V15, P611, DOI 10.1016/j.celrep.2016.03.058	34	0	0	4	5	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	MAY	2017	23	5					619	627		10.1261/rna.056838.116				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ET2RZ	WOS:000400123100003	28223408	gold			2018-01-05	
J	Lei, SY; Chen, XW; Wang, J; Zhou, L; Zhang, YL; Zhang, GQ; Lu, GQ; Wang, CH				Lei, Shuangyong; Chen, Xiaowen; Wang, Jun; Zhou, Lu; Zhang, Youliang; Zhang, Guoqi; Lu, Guoqing; Wang, Chenghui			An integrated and comprehensive transcriptome reveals immune-related genes and signal pathways in topmouth culter (Culter alburnus)	AQUACULTURE RESEARCH			English	Article						topmouth culter (Culter alburnus); transcriptome; annotation; immune-related pathways; genetic breeding	TOLL-LIKE RECEPTORS; RNA-SEQ; AQUACULTURE ANIMALS; EXPRESSION ANALYSIS; DENDRITIC CELLS; INNATE IMMUNITY; CHINA; DIVERSITY; ZEBRAFISH; ANTIGEN	Topmouth culter (Culter alburnus) is an important freshwater species in China. In recent years, the population of topmouth culter has declined sharply due to the increasing pollution, overfishing and habitat destruction. It may lead to adverse effects, including weakening health, causing disease, and reducing the quality of topmouth culter. It is urgent to conduct resource management, protection and genetic improvement strategies in topmouth culter, especially develop genetic breeding program with disease resistance. In this study, we applied RNA-seq technology to de novo assemble a comprehensive transcriptome, and to discover immune-related genes and pathways in topmouth culter. A total of 102017 transcripts were assembled with an average length of 945bp, of which 45482 protein coding sequences were predicted. BLAST search resulted in 53575 and 45602 transcripts with homologous sequences in NCBI-NR and UniProt respectively. Further functional analysis identified 24052 transcripts in Gene Ontology (GO) categories and 19260 transcripts in KEGG pathways. Significantly, 13 immune-related pathways with 524 immune-related genes were identified. Our data provided an integrated and comprehensive transcriptome resource for topmouth culter, which could be essential for further research in selective breeding of disease resistance, functional genomics, and genome editing of topmouth culter.	[Lei, Shuangyong; Chen, Xiaowen; Wang, Jun; Wang, Chenghui] Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Fisheries Germplasm Resources, Shanghai 201306, Peoples R China; [Zhou, Lu; Zhang, Youliang; Zhang, Guoqi] Songjiang Aquat Bred Farm, Shanghai, Peoples R China; [Lu, Guoqing] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	Wang, CH (reprint author), Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Fisheries Germplasm Resources, Shanghai 201306, Peoples R China.; Lu, GQ (reprint author), Univ Nebraska, Dept Biol, Omaha, NE 68182 USA.	glu3@unomaha.edu; wangch@shou.edu.cn			Shanghai Agriculture Committee Program [2013D10]; Innovation project of Shanghai Ocean University Graduate Education [A1-0209-15-0903-10]	This work was supported by the Shanghai Agriculture Committee Program (No. 2013D10) and Innovation project of Shanghai Ocean University Graduate Education (A1-0209-15-0903-10). We would like to thank Wucheng Yue for his assistance in RNA isolation, and the Holland Computing Center (HCC) at the University of Nebraska for computational support and technical assistance.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Banyer J, 1999, REV IMMUNOGENET, V2, P359; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bondad-Reantaso MG, 2007, ASSESSMENT FRESHWATE; Cao XJ, 2011, ANAT HISTOL EMBRYOL, V40, P292, DOI 10.1111/j.1439-0264.2011.01069.x; Chen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011546; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen Y., 1998, FAUNA SINICA OSTEICH; Cheng P., 2006, THESIS; Covello JM, 2009, FISH SHELLFISH IMMUN, V26, P773, DOI 10.1016/j.fsi.2009.03.012; Davis MM, 2002, CELL, V110, P285, DOI 10.1016/S0092-8674(02)00865-6; Feliciani C, 1996, CRIT REV ORAL BIOL M, V7, P300, DOI 10.1177/10454411960070040101                                                    ; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gao Y, 2012, VET IMMUNOL IMMUNOP, V148, P78, DOI 10.1016/j.vetimm.2011.04.007; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gold MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000957; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Hu TJ, 2003, WATER FISH, V23, P20; Huang W, 2013, MOL BIOL REP, V40, P751, DOI 10.1007/s11033-012-1958-4; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293                                                ; Liu F. R., 2006, SHANDONG FISHERIES, V23, P23; Meeker ND, 2010, IMMUNOGENETICS, V62, P23, DOI 10.1007/s00251-009-0407-6; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mu YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097471; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Palti Y, 2010, DEV COMP IMMUNOL, V34, P219, DOI 10.1016/j.dci.2009.10.002; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qi PZ, 2015, BIOCHEM SYST ECOL, V61, P232, DOI 10.1016/j.bse.2015.06.023; Qi PZ, 2013, BIOCHEM SYST ECOL, V50, P390, DOI 10.1016/j.bse.2013.04.010; [覃亮 QIN Liang], 2009, [应用生态学报, The Journal of Applied Ecology], V20, P1952; Ren L, 2014, GENE, V552, P265, DOI 10.1016/j.gene.2014.09.053; Ruan GL, 2010, COMP BIOCHEM PHYS B, V155, P77, DOI 10.1016/j.cbpb.2009.10.005; Shaw PJ, 2010, EUR J IMMUNOL, V40, P624, DOI 10.1002/eji.200940211; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Suzuki T, 2004, DEV COMP IMMUNOL, V28, P993, DOI 10.1016/j.dci.2004.04.005; Takano T., 2011, DIS ASIAN AQUACULTUR, P197; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Townsend MJ, 2000, J CELL SCI, V10, P3549; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang KW, 2014, BIOMED RES INT, DOI 10.1155/2014/910260; Wang W, 2007, BIOCHEM SYST ECOL, V35, P662, DOI 10.1016/j.bse.2007.04.008; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Zhang QY, 2015, SCI CHINA LIFE SCI, V58, P156, DOI 10.1007/s11427-015-4802-y; Zhang R, 2013, MOL BIOL REP, V40, P5657, DOI 10.1007/s11033-013-2667-3; Zhang YB, 2012, DEV COMP IMMUNOL, V38, P193, DOI 10.1016/j.dci.2012.06.003; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001	65	1	1	12	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-557X	1365-2109		AQUAC RES	Aquac. Res.	MAY	2017	48	5					2231	2242		10.1111/are.13060				12	Fisheries	Fisheries	ER5RK	WOS:000398859900024					2018-01-05	
J	Anttonen, AK; Laari, A; Kousi, M; Yang, YWJ; Jaaskelainen, T; Somer, M; Siintola, E; Jakkula, E; Muona, M; Tegelberg, S; Lonnqvist, T; Pihko, H; Valanne, L; Paetau, A; Lun, MP; Hastbacka, J; Kopra, O; Joensuu, T; Katsanis, N; Lehtinen, MK; Palvimo, JJ; Lehesjoki, AE				Anttonen, Anna-Kaisa; Laari, Anni; Kousi, Maria; Yang, Yawei J.; Jaaskelainen, Tiina; Somer, Mirja; Siintola, Eija; Jakkula, Eveliina; Muona, Mikko; Tegelberg, Saara; Lonnqvist, Tuula; Pihko, Helena; Valanne, Leena; Paetau, Anders; Lun, Melody P.; Hastbacka, Johanna; Kopra, Outi; Joensuu, Tarja; Katsanis, Nicholas; Lehtinen, Maria K.; Palvimo, Jorma J.; Lehesjoki, Anna-Elina			ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar granule neuron loss	BRAIN			English	Article						PEHO syndrome; progressive encephalopathy; ZNHIT3; cerebellum	THYROID-HORMONE RECEPTOR; SYNDROME PROGRESSIVE ENCEPHALOPATHY; OPTIC ATROPHY; SEVERE IMPAIRMENT; OXIDATIVE-STRESS; EDEMA; HYPSARRHYTHMIA; DIFFERENTIATION; HYPOARRHYTHMIA; COACTIVATOR	Progressive encephalopathy with oedema, hypsarrhythmia, and optic atrophy (PEHO) syndrome is an early childhood onset, severe autosomal recessive encephalopathy characterized by extreme cerebellar atrophy due to almost total granule neuron loss. By combining homozygosity mapping in Finnish families with Sanger sequencing of positional candidate genes and with exome sequencing a homozygous missense substitution of leucine for serine at codon 31 in ZNHIT3 was identified as the primary cause of PEHO syndrome. ZNHIT3 encodes a nuclear zinc finger protein previously implicated in transcriptional regulation and in small nucleolar ribonucleoprotein particle assembly and thus possibly to pre-ribosomal RNA processing. The identified mutation affects a highly conserved amino acid residue in the zinc finger domain of ZNHIT3. Both knockdown and genome editing of znhit3 in zebrafish embryos recapitulate the patients' cerebellar defects, microcephaly and oedema. These phenotypes are rescued by wild-type, but not mutant human ZNHIT3 mRNA, suggesting that the patient missense substitution causes disease through a loss-of-function mechanism. Transfection of cell lines with ZNHIT3 expression vectors showed that the PEHO syndrome mutant protein is unstable. Immunohistochemical analysis of mouse cerebellar tissue demonstrated ZNHIT3 to be expressed in proliferating granule cell precursors, in proliferating and post-mitotic granule cells, and in Purkinje cells. Knockdown of Znhit3 in cultured mouse granule neurons and ex vivo cerebellar slices indicate that ZNHIT3 is indispensable for granule neuron survival and migration, consistent with the zebrafish findings and patient neuropathology. These results suggest that loss-of-function of a nuclear regulator protein underlies PEHO syndrome and imply that establishment of its spatiotemporal interaction targets will be the basis for developing therapeutic approaches and for improved understanding of cerebellar development.	[Anttonen, Anna-Kaisa; Laari, Anni; Siintola, Eija; Muona, Mikko; Tegelberg, Saara; Hastbacka, Johanna; Joensuu, Tarja; Lehesjoki, Anna-Elina] Folkhalsan Inst Genet, Haartmaninkatu 8, Helsinki 00290, Finland; [Anttonen, Anna-Kaisa; Laari, Anni; Muona, Mikko; Tegelberg, Saara; Kopra, Outi; Joensuu, Tarja; Lehesjoki, Anna-Elina] Univ Helsinki, Neurosci Ctr, Viikinkaari 4, Helsinki 00790, Finland; [Anttonen, Anna-Kaisa; Laari, Anni; Muona, Mikko; Tegelberg, Saara; Kopra, Outi; Joensuu, Tarja; Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, Mol Neurol, Haartmaninkatu 8, FIN-00290 Helsinki, Finland; [Anttonen, Anna-Kaisa] Univ Helsinki, Med & Clin Genet, Haartmaninkatu 8, FIN-00290 Helsinki, Finland; [Anttonen, Anna-Kaisa] Helsinki Univ Hosp, Haartmaninkatu 8, Helsinki 00290, Finland; [Kousi, Maria; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Carmichael Bldg,300 North Duke St,Suite 48-118, Durham, NC 27701 USA; [Yang, Yawei J.] Howard Hughes Med Inst, Div Genet, BCH 3150,300 Longwood Ave, Boston, MA 02115 USA; [Yang, Yawei J.] Harvard Med Sch, Program Biol & Biomed Sci, Childrens Hosp Boston, Manton Ctr Orphan Dis Res, BCH 3150,300 Longwood Ave, Boston, MA 02115 USA; [Yang, Yawei J.] Harvard Med Sch, Harvard MIT Div Hlth Sci & Technol, BCH 3150,300 Longwood Ave, Boston, MA 02115 USA; [Jaaskelainen, Tiina; Pihko, Helena] Univ Eastern Finland, Inst Biomed, Yliopistonranta 1, Kuopio 70210, Finland; [Jaaskelainen, Tiina] Univ Eastern Finland, Inst Dent, Yliopistonranta 1, Kuopio 70210, Finland; [Somer, Mirja] Rinnekoti Fdn, Norio Ctr, Kornetintie 8, Helsinki 00380, Finland; [Jakkula, Eveliina; Muona, Mikko] Univ Helsinki, Inst Mol Med Finland, Haartmaninkatu 8, FIN-00290 Helsinki, Finland; [Lonnqvist, Tuula; Pihko, Helena] Univ Helsinki, Dept Pediat Neurol, Childrens Hosp, Lastenlinnantie 2, FIN-00290 Helsinki, Finland; [Lonnqvist, Tuula; Pihko, Helena] Helsinki Univ Hosp, Lastenlinnantie 2, FIN-00290 Helsinki, Finland; [Valanne, Leena] HUS Med Imaging Ctr, Dept Radiol, Haartmaninkatu 4, Helsinki 00290, Finland; [Paetau, Anders] Helsinki Univ Hosp, Dept Pathol, Haartmaninkatu 3, Helsinki 00290, Finland; [Lun, Melody P.] Boston Childrens Hosp, Dept Pathol, BCH 3108,300 Longwood Ave, Boston, MA 02115 USA; [Lun, Melody P.] Boston Univ, Sch Med, Dept Pathol & Lab Med, 670 Albany St, Boston, MA 02118 USA; [Hastbacka, Johanna] Univ Helsinki, Dept Pediat, Childrens Hosp, Stenbackinkatu 11, FIN-00290 Helsinki, Finland; [Hastbacka, Johanna] Helsinki Univ Hosp, Stenbackinkatu 11, FIN-00290 Helsinki, Finland; [Hastbacka, Johanna] Univ Helsinki, Dept Perioperat Intens Care & Pain Med, FIN-00290 Helsinki, Finland	Lehesjoki, AE (reprint author), Folkhalsan Inst Genet, Haartmaninkatu 8, Helsinki 00290, Finland.	anna-elina.lehesjoki@helsinki.fi			Folkhalsan Research Foundation; Sloan Research Fellowship; Arvo and Lea Ylppo Foundation; Doctoral Programme in Biomedicine University of Helsinki; Emil Aaltonen Foundation; Foundation for Pediatric Research; Ulla Hjelt fund; Helsinki University Central Hospital Research Fund; Academy of Finland; Sigrid Juselius Foundation	This project was funded by Folkhalsan Research Foundation (to A.-E.L.), Sloan Research Fellowship (to M.K.L.), Arvo and Lea Ylppo Foundation (to A.-K.A.), Doctoral Programme in Biomedicine University of Helsinki (to M.M.), Emil Aaltonen Foundation (to A.-K.A.), Foundation for Pediatric Research, Ulla Hjelt fund (to J.H.), and Helsinki University Central Hospital Research Fund (to A.-K.A. and J.H.). M.K.L. is a NYSCF - Robertson Investigator. J.J.P. laboratory is supported by the Academy of Finland and the Sigrid Juselius Foundation.	Alfadhel M, 2011, J CHILD NEUROL, V26, P851, DOI 10.1177/0883073810396582; Anttonen AK, 2015, NEUROLOGY, V85, P306, DOI 10.1212/WNL.0000000000001787; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)0222-2; Bizarro J, 2014, J CELL BIOL, V207, P463, DOI 10.1083/jcb.201404160; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Chitty LS, 1996, CLIN DYSMORPHOL, V5, P143, DOI 10.1097/00019605-199604000-00006                                                ; Christensen R, 2011, DEVELOPMENT, V138, P5257, DOI 10.1242/dev.069062; Cuadrado A, 2010, EMBO J, V29, P2014, DOI 10.1038/emboj.2010.85; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Fauquier T, 2014, DEVELOPMENT, V141, P166, DOI 10.1242/dev.103226; Fauquier T, 2011, DEV BIOL, V356, P350, DOI 10.1016/j.ydbio.2011.05.657; Field MJ, 2003, AM J MED GENET A, V122A, P6, DOI 10.1002/ajmg.a.20216; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Gawlinski P, 2016, PEDIATR NEUROL, V60, P83, DOI 10.1016/j.pediatrneurol.2016.03.011; GIULIAN D, 1986, J NEUROSCI, V6, P2163; HALTIA M, 1993, ACTA NEUROPATHOL, V85, P241; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; He FH, 2007, PROTEIN SCI, V16, P1577, DOI 10.1110/ps.062635107; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750                                                                   ; Caraballo RH, 2011, PEDIATR NEUROL, V44, P259, DOI 10.1016/j.pediatrneurol.2010.11.007; Horn S, 2010, MOL CELL ENDOCRINOL, V315, P19, DOI 10.1016/j.mce.2009.09.008; Iwahashi H, 2002, DIABETES, V51, P910, DOI 10.2337/diabetes.51.4.910                                                       ; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Koppen A, 2009, MOL CELL PROTEOMICS, V8, P2212, DOI 10.1074/mcp.M900209-MCP200; Langlois S, 2016, EUR J HUM GENET, V24, P949, DOI 10.1038/ejhg.2015.217; LEE JW, 1995, MOL ENDOCRINOL, V9, P243, DOI 10.1210/me.9.2.243; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Longman C, 2003, CLIN DYSMORPHOL, V12, P133, DOI 10.1097/01.mcd.0000059769.40218.d2; Nahorski MS, 2016, BRAIN, V139, P1036, DOI 10.1093/brain/aww014; Portella AC, 2010, MOL CELL NEUROSCI, V44, P68, DOI 10.1016/j.mcn.2010.02.004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Riviere JB, 2011, AM J HUM GENET, V89, P219, DOI 10.1016/j.ajhg.2011.06.013; Rothe B, 2014, NUCLEIC ACIDS RES, V42, P10731, DOI 10.1093/nar/gku612; SALONEN R, 1991, CLIN GENET, V39, P287; Schulte EC, 2014, AM J HUM GENET, V95, P85, DOI 10.1016/j.ajhg.2014.06.005; SOMER M, 1993, EPILEPSIA, V34, P727, DOI 10.1111/j.1528-1157.1993.tb00453.x                                              ; SOMER M, 1993, AM J NEURORADIOL, V14, P861; SOMER M, 1993, NEURO-OPHTHALMOLOGY, V13, P65, DOI 10.3109/01658109309037006                                                       ; SOMER M, 1993, J MED GENET, V30, P932, DOI 10.1136/jmg.30.11.932; Somer M, 1993, THE PEHO SYNDROME; Walker S D, 2011, Acta Neurol Scand Suppl, P72, DOI 10.1111/j.1600-0404.2011.01602.x; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939	45	3	3	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAY	2017	140		5				1267	1279		10.1093/brain/awx040				13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	ET2AE	WOS:000400069900018	28335020				2018-01-05	
J	Cabral, T; DiCarlo, JE; Justus, S; Sengillo, JD; Xu, Y; Tsang, SH				Cabral, Thiago; DiCarlo, James E.; Justus, Sally; Sengillo, Jesse D.; Xu, Yu; Tsang, Stephen H.			CRISPR applications in ophthalmologic PINION genome surgery	CURRENT OPINION IN OPHTHALMOLOGY			English	Review						adeno-associated virus; CRISPR-Cas; embryonic stem cells; induced pluripotent stem cells; precision medicine	GUIDED CAS9 NUCLEASE; RETINITIS-PIGMENTOSA; IN-VIVO; PRECLINICAL MODEL; GENE-EXPRESSION; DNA CLEAVAGE; HUMAN-CELLS; STEM-CELLS; RNA; SYSTEM	Purpose of review The present review seeks to summarize and discuss the application of clustered regularly interspaced short palindromic repeats (CRISPR)-associated systems (Cas) for genome editing, also called genome surgery, in the field of ophthalmology. Recent findings Precision medicine is an emerging approach for disease treatment and prevention that takes into account the variability of an individual's genetic sequence. Various groups have used CRISPR-Cas genome editing to make significant progress in mammalian preclinical models of eye disease, the basic science of eye development in zebrafish, the in vivo modification of ocular tissue, and the correction of stem cells with therapeutic applications. In addition, investigators have creatively used the targeted mutagenic potential of CRISPR-Cas systems to target pathogenic alleles in vitro. Summary Over the past year, CRISPR Cas genome editing has been used to correct pathogenic mutations in vivo and in transplantable stem cells. Although off-target mutagenesis remains a concern, improvement in CRISPRCas technology and careful screening for undesired mutations will likely lead to clinical eye therapeutics employing CRISPR-Cas systems in the near future.	[Cabral, Thiago; DiCarlo, James E.; Justus, Sally; Sengillo, Jesse D.; Xu, Yu; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Med Ctr, Jonas Childrens Vis Care, 635 West 165th St,5th Floor, New York, NY 10032 USA; [Cabral, Thiago; DiCarlo, James E.; Justus, Sally; Sengillo, Jesse D.; Xu, Yu; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Med Ctr, Bernard & Shirlee Brown Glaucoma Lab, 635 West 165th St,5th Floor, New York, NY 10032 USA; [Cabral, Thiago; DiCarlo, James E.; Justus, Sally; Sengillo, Jesse D.; Xu, Yu; Tsang, Stephen H.] New York Presbyterian Hosp, Edward S Harkness Eye Inst, 635 West 165th St,5th Floor, New York, NY 10032 USA; [Cabral, Thiago; Sengillo, Jesse D.] Univ Fed Espirito Santo, Dept Ophthalmol, Vitoria, Brazil; [Cabral, Thiago] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Sengillo, Jesse D.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Xu, Yu] Shanghai Jiao Tong Univ, Dept Ophthalmol, Xin Hua Hosp, Shanghai, Peoples R China; [Tsang, Stephen H.] Columbia Univ, Inst Human Nutr, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY 10032 USA	Tsang, SH (reprint author), Columbia Univ, Dept Ophthalmol, Med Ctr, Jonas Childrens Vis Care, 635 West 165th St,5th Floor, New York, NY 10032 USA.; Tsang, SH (reprint author), Columbia Univ, Dept Ophthalmol, Med Ctr, Bernard & Shirlee Brown Glaucoma Lab, 635 West 165th St,5th Floor, New York, NY 10032 USA.; Tsang, SH (reprint author), New York Presbyterian Hosp, Edward S Harkness Eye Inst, 635 West 165th St,5th Floor, New York, NY 10032 USA.	sht2@columbia.edu			National Institutes of Health [5P30EY019007, R01EY018213, R01EY024698, 1R01EY026682, R21AG050437]; National Cancer Institute Core [5P30CA013696]; Research to Prevent Blindness (RPB) Physician-Scientist Award; RPB, New York, NY, USA; ICO-Retina Research Foundation Helmerich Fellowships; Retina Research Foundation; ICO Foundation (International Council of Ophthalmology); RPB medical student fellowship; Tistou and Charlotte Kerstan Foundation; Schneeweiss Stem Cell Fund, New York State [C029572]; Foundation Fighting Blindness New York Regional Research Center Grant [C-NY05-0705-0312]; Gebroe Family Foundation	The Jonas Children's Vision Project and Bernard & Slurlee Brown Glaucoma Laboratory are supported by the National Institutes of Health [5P30EY019007, R01EY018213, R01EY024698, 1R01EY026682, R21AG050437], National Cancer Institute Core [5P30CA013696], the Research to Prevent Blindness (RPB) Physician-Scientist Award, unrestricted grants from RPB, New York, NY, USA. T.C. is supported by the ICO-Retina Research Foundation Helmerich Fellowships, which is sponsored by the Retina Research Foundation in cooperation with the ICO Foundation (International Council of Ophthalmology). is supported by the RPB medical student fellowship. S.H.T. is a member of the RD-CURE Consortium and is supported by the Tistou and Charlotte Kerstan Foundation, the Schneeweiss Stem Cell Fund, New York State [C029572], the Foundation Fighting Blindness New York Regional Research Center Grant [C-NY05-0705-0312] and the Gebroe Family Foundation.	Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Brenner M, 2010, MOL THER, V18, P451, DOI 10.1038/mt.2010.12; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Duan YJ, 2016, J BIOL CHEM, V291, P16339, DOI 10.1074/jbc.M116.729467; Flowers GP, 2014, DEVELOPMENT, V141, P2165, DOI 10.1242/dev.105072; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Govindan G, 2016, J CELL PHYSIOL, V231, P2380, DOI 10.1002/jcp.25367; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Guo XY, 2015, CELL RES, V25, P767, DOI 10.1038/cr.2015.64; Guttmacher AE, 2003, NEW ENGL J MED, V349, P996, DOI 10.1056/NEJMe038132                                                             ; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keeler CE, 1928, J GEN PHYSIOL, V11, P361, DOI 10.1085/jgp.11.4.361                                                            ; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JJ, 2002, INVEST OPHTH VIS SCI, V43, P3117; Li Y, 2016, METHOD MOL BIOL, V1352, P77; Li Y, 2016, ADV EXP MED BIOL, V854, P549, DOI 10.1007/978-3-319-17121-0_73; Li Y, 2014, MOL THER, V22, P1688, DOI 10.1038/mt.2014.100; Li Y, 2012, MOL MED, V18, P1312, DOI 10.2119/molmed.2012.00242; Liu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep19675; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249                                                          ; Peng Y, 2014, DEVELOPMENT, V141, P4042, DOI 10.1242/dev.102186; Priglinger CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146887; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Richardson R, 2017, EYE, V31, P68, DOI 10.1038/eye.2016.198; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Scanga HL, 2014, PEDIATR CLIN N AM, V61, P555, DOI 10.1016/j.pcl.2014.03.005; Sluch VM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16595; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stricklett PK, 1999, AM J PHYSIOL-RENAL, V276, pF651; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Taylor SM, 2015, INVEST OPHTH VIS SCI, V56, P7496, DOI 10.1167/iovs.15-17616; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vandenberghe LH, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017442; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang NK, 2010, TRANSPLANTATION, V89, P911, DOI 10.1097/TP.0b013e3181d45a61; Willett K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00261; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wu WH, 2016, MOL THER, V24, P1388, DOI 10.1038/mt.2016.107; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yanik M, 2017, PROG RETIN EYE RES, V56, P1, DOI 10.1016/j.preteyeres.2016.09.001; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Yin LL, 2015, GENETICS, V200, P431, DOI 10.1534/genetics.115.176917; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	74	0	0	4	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-8738	1531-7021		CURR OPIN OPHTHALMOL	Curr. Opin. Ophthalmol.	MAY	2017	28	3					252	259		10.1097/ICU.0000000000000359				8	Ophthalmology	Ophthalmology	ES2XI	WOS:000399390800008	28141764				2018-01-05	
J	Bottai, G; Truffi, M; Corsi, F; Santarpia, L				Bottai, Giulia; Truffi, Marta; Corsi, Fabio; Santarpia, Libero			Progress in nonviral gene therapy for breast cancer and what comes next?	EXPERT OPINION ON BIOLOGICAL THERAPY			English	Review						Breast cancer; gene therapy; nonviral nanovectors; immunotherapy; vaccine; clinical trials	SMALL INTERFERING RNA; LOW-DOSE DOXORUBICIN; P-GP SIRNA; CO-DELIVERY; COMBINATION THERAPY; T-CELLS; POLYMERIC NANOPARTICLES; GOLD NANOPARTICLES; THERANOSTIC AGENTS; PRESENT CHALLENGES	Introduction: The possibility of correcting defective genes and modulating gene expression through gene therapy has emerged as a promising treatment strategy for breast cancer. Furthermore, the relevance of tumor immune microenvironment in supporting the oncogenic process has paved the way for novel immunomodulatory applications of gene therapy.Areas covered: In this review, the authors describe the most relevant delivery systems, focusing on nonviral vectors, along with the description of the major approaches used to modify target cells, including gene transfer, RNA interference (RNAi), and epigenetic regulation. Furthermore, they highlight innovative therapeutic strategies and the application of gene therapy in clinical trials for breast cancer.Expert opinion: Gene therapy has the potential to impact breast cancer research. Further efforts are required to increase the clinical application of RNAi-based therapeutics, especially in combination with conventional treatments. Innovative strategies, including genome editing and stem cell-based systems, may contribute to translate gene therapy into clinical practice. Immune-based approaches have emerged as an attractive therapeutic opportunity for selected breast cancer patients. However, several challenges need to be addressed before considering gene therapy as an actual option for the treatment of breast cancer.	[Bottai, Giulia; Santarpia, Libero] IRCCS Clin & Res Inst Humanitas, Oncol Expt Therapeut, Via Manzoni 56, I-20089 Milan, Italy; [Truffi, Marta] Univ Milan, Luigi Sacco Hosp, Lab Nanomed, Dept Biomed & Clin Sci, Milan, Italy; [Corsi, Fabio] Univ Milan, Lab Nanomed, Div Surg, Dept Biomed & Clin Sci, Milan, Italy	Santarpia, L (reprint author), IRCCS Clin & Res Inst Humanitas, Oncol Expt Therapeut, Via Manzoni 56, I-20089 Milan, Italy.; Corsi, F (reprint author), Univ Milan, Dept Biomed & Clin Sci L Sacco, I-20157 Milan, Italy.	fabio.corsi@unimi.it; libero.santarpia@humanitasresearch.it	Corsi, Fabio/E-9204-2017	Corsi, Fabio/0000-0002-6469-4086	Associazione Italiana Ricerca sul Cancro [AIRC] [6251]; Fondazione Italiana Ricerca sul Cancro [FIRC] [18328]; Fondazione Regionale per la Ricerca Biomedica (NANODRUG platform project)	This work was supported by Associazione Italiana Ricerca sul Cancro [AIRC Grant 6251 to L Santarpia] and Fondazione Italiana Ricerca sul Cancro [FIRC fellowship 18328 to G Bottai]. Furthermore, F Corsi and M Truffi are supported by the Fondazione Regionale per la Ricerca Biomedica (NANODRUG platform project).	Alinejad V, 2016, BIOMED PHARMACOTHER, V83, P229, DOI 10.1016/j.biopha.2016.06.037; Arami S, 2016, BIOLOGICALS, V44, P487, DOI 10.1016/j.biologicals.2016.09.005; Bai M, 2015, ONCOTARGET, V6, P43779, DOI 10.18632/oncotarget.6085; Bottai G, 2016, NPJ BREAST CANCER, V2, P1, DOI 10.1038/npjbcancer.2016.33; Bottai G, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0783-4; Bottai G, 2014, EXPERT OPIN BIOL TH, V14, P1667, DOI 10.1517/14712598.2014.950650; Brignone C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-71; Cappello P, 2003, CANCER RES, V63, P2518; Chen BY, 2015, CANCER LETT, V356, P506, DOI 10.1016/j.canlet.2014.09.034; Chen G, 2014, CANCER IMMUNOL RES, V2, P949, DOI 10.1158/2326-6066.CIR-14-0058; Chiang CLL, 2015, VACCINES, V3, P344, DOI 10.3390/vaccines3020344; Chira S, 2015, ONCOTARGET, V6, P30675, DOI 10.18632/oncotarget.5169; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Conde J, 2016, NAT MATER, V15, P353, DOI [10.1038/nmat4497, 10.1038/NMAT4497]; De Mattos-Arruda L, 2015, ONCOTARGET, V6, P37269, DOI 10.18632/oncotarget.5495; Devulapally R, 2015, MOL PHARMACEUT, V12, P2080, DOI 10.1021/mp500852s; Devulapally R, 2015, ACS NANO, V9, P2290, DOI 10.1021/nn507465d; Ding YP, 2017, BIOMATERIALS, V113, P243, DOI 10.1016/j.biomaterials.2016.10.053; Domchek SM, 2007, CANCER RES, V67, P10546, DOI 10.1158/0008-5472.CAN-07-2765; Dong DW, 2015, CANCER LETT, V359, P178, DOI 10.1016/j.canlet.2015.01.011; Dwyer RM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt25; Ekin A, 2014, J GENE MED, V16, P331, DOI 10.1002/jgm.2810; Elazar V, 2010, INT J CANCER, V126, P1749, DOI 10.1002/ijc.24890; Essand M, 2013, J INTERN MED, V273, P166, DOI 10.1111/joim.12020; Finlay J., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/382745; Gandhi NS, 2014, J CONTROL RELEASE, V194, P238, DOI 10.1016/j.jconrel.2014.09.001; Ge YJ, 2016, NAT CELL BIOL, V18, P111, DOI 10.1038/ncb3275; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Gu S, 2016, ONCOTARGET, V7, P14727, DOI 10.18632/oncotarget.7409; Gujrati M, 2016, ADV HEALTHC MATER, V5, P2882, DOI 10.1002/adhm.201600677; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Hardie J, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/37/374001; Hayward SL, 2016, J BIOMED NANOTECHNOL, V12, P554, DOI 10.1166/jbn.2016.2194; Higgins M, 2017, BREAST CANCER RES TR, V162, P479, DOI 10.1007/s10549-017-4130-y; Iorio MV, 2011, BREAST, V20, pS63, DOI 10.1016/S0960-9776(11)70297-1; Iwamura K, 2012, GENE THER, V19, P959, DOI 10.1038/gt.2011.185; Jadidi-Niaragh F, 2016, TUMOR BIOL, V37, P8403, DOI 10.1007/s13277-015-4732-0; Jiang K, 2015, BIOMATERIALS, V59, P77, DOI 10.1016/j.biomaterials.2015.04.030; Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565; Karyampudi L, 2014, CANCER RES, V74, P2974, DOI 10.1158/0008-5472.CAN-13-2564; Kaushal N, 2015, MOL PHARMACEUT, V12, P2406, DOI 10.1021/acs.molpharmaceut.5b00114; Khaled SZ, 2016, BIOMATERIALS, V87, P57, DOI 10.1016/j.biomaterials.2016.01.052; Khan FA, 2016, ONCOTARGET, V7, P52541, DOI 10.18632/oncotarget.9646; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Kleivi S. K., 2015, CLIN CANCER RES, V21, P1207, DOI DOI 10.1158/1078-0432.CCR-14-2011; Kobold S, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv146; LaFountaine JS, 2015, INT J PHARMACEUT, V494, P180, DOI 10.1016/j.ijpharm.2015.08.029; Lee J, 2014, CANCER LETT, V347, P46, DOI 10.1016/j.canlet.2014.02.006; Li MH, 2015, J BIOMAT SCI-POLYM E, V26, P813, DOI 10.1080/09205063.2015.1057991; Li SY, 2015, J CONTROL RELEASE, V205, P7, DOI 10.1016/j.jconrel.2014.11.011; Li TT, 2015, INT J NANOMED, V10, P4279, DOI 10.2147/IJN.S85095; Li YH, 2016, ACS APPL MATER INTER, V8, P26613, DOI 10.1021/acsami.6b09991; Lichty BD, 2014, NAT REV CANCER, V14, P559, DOI 10.1038/nrc3770; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu L, 2015, INT J CLIN EXP PATHO, V8, P6674; Lowenfeld L, 2017, CLIN CANCER RES, V23, P2961, DOI 10.1158/1078-0432.CCR-16-1924; Makkouk A, 2015, CANCER RES, V75, P5, DOI 10.1158/0008-5472.CAN-14-2538; Mann K, 2016, CANCER GENE THER, V23, P221, DOI 10.1038/cgt.2016.21; McCracken MN, 2015, CLIN CANCER RES, V21, P3597, DOI 10.1158/1078-0432.CCR-14-2520; McCrudden CM, 2014, APPL CLIN GENET, V7, P209, DOI 10.2147/TACG.S54992; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Mittendorf EA, 2014, ANN ONCOL, V25, P1735, DOI 10.1093/annonc/mdu211; Mittendorf EA, 2016, ONCOTARGET, V7, P66192, DOI 10.18632/oncotarget.11751; Nastiuk KL, 2016, ADV DRUG DELIVER REV, V98, P35, DOI 10.1016/j.addr.2015.12.005; Norell H, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-53; Ozpolat B, 2014, ADV DRUG DELIVER REV, V66, P110, DOI 10.1016/j.addr.2013.12.008; Pahle J, 2016, EXPERT OPIN BIOL TH, V16, P443, DOI 10.1517/14712598.2016.1134480; Paladini L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0375-2; Palanca-Wessels MC, 2016, ONCOTARGET, V7, P9562, DOI 10.18632/oncotarget.7076; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Parvani JG, 2015, CANCER RES, V75, P2316, DOI 10.1158/0008-5472.CAN-14-3485; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Qian JM, 2015, ACTA BIOMATER, V15, P102, DOI 10.1016/j.actbio.2014.12.018; Rajput S, 2015, MOL PHARMACEUT, V12, P4214, DOI 10.1021/acs.molpharmaceut.5b00692; Ren XL, 2016, BIOCONJUGATE CHEM, V27, P66, DOI 10.1021/acs.bioconjchem.5b00650; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Santarpia L, 2016, ONCOLOGIST, V21, P1063, DOI 10.1634/theoncologist.2015-0369; Savas P, 2016, NAT REV CLIN ONCOL, V13, P228, DOI 10.1038/nrclinonc.2015.215; Shen H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3413; Shu D, 2015, ACS NANO, V9, P9731, DOI 10.1021/acsnano.5b02471; Shumway NM, 2009, BIODRUGS, V23, P277, DOI 10.2165/11313490-000000000-00000; Stoff-Khalili MA, 2006, CANCER GENE THER, V13, P633, DOI 10.1038/sj.cgt.7700929; Subramanian N, 2015, NUCLEIC ACID THER, V25, P317, DOI 10.1089/nat.2015.0550; Talluri SV, 2016, DRUG DELIV, V23, P1291, DOI 10.3109/10717544.2015.1092183; Tang S, 2015, BIOMATERIALS, V48, P1, DOI 10.1016/j.biomaterials.2015.01.049; Tang ZH, 2016, PROG POLYM SCI, V60, P86, DOI 10.1016/j.progpolymsci.2016.05.005; Tangudu NK, 2015, MOL CANCER THER, V14, P1259, DOI 10.1158/1535-7163.MCT-14-0970; Tekie FSM, 2015, INT J BIOL MACROMOL, V81, P828, DOI 10.1016/j.ijbiomac.2015.09.014; Tiptiri-Kourpeti A, 2016, PHARMACOL THERAPEUT, V165, P32, DOI 10.1016/j.pharmthera.2016.05.004; Truffi M, 2016, J NANOMATER, V2016, P16; Vago R, 2016, PHARMACOL RES, V111, P619, DOI 10.1016/j.phrs.2016.07.007; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Wang K, 2015, CURR MED CHEM, V22, P4118, DOI 10.2174/0929867322666151001121601; White MK, 2016, ONCOTARGET, V7, P12305, DOI 10.18632/oncotarget.7104; Wu Y, 2016, COLLOID SURFACE B, V138, P60, DOI 10.1016/j.colsurfb.2015.11.041; Xie Y, 2013, CANCER GENE THER, V20, P590, DOI 10.1038/cgt.2013.60; Yang H, 2015, J BIOMED NANOTECHNOL, V11, P2124, DOI 10.1166/jbn.2015.2168; Yao YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003601; Yhee JY, 2015, J CONTROL RELEASE, V198, P1, DOI 10.1016/j.jconrel.2014.11.019; Yi L, 2016, BBA-REV CANCER, V1866, P197, DOI 10.1016/j.bbcan.2016.09.002; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin TJ, 2015, BIOMATERIALS, V61, P10, DOI 10.1016/j.biomaterials.2015.05.022; Yonezawa A, 2015, CLIN CANCER RES, V21, P3113, DOI 10.1158/1078-0432.CCR-15-0263; Yoo B, 2015, CANCER RES, V75, P4407, DOI 10.1158/0008-5472.CAN-15-0888; Yu MZ, 2016, EUR J PHARM SCI, V92, P39, DOI 10.1016/j.ejps.2016.06.020; Zheng XF, 2013, INT J CANCER, V132, P967, DOI 10.1002/ijc.27710; Zhou HY, 2015, INT J NANOMED, V10, P4255, DOI 10.2147/IJN.S73269; Zhou ZL, 2017, NANOMED-NANOTECHNOL, V13, P403, DOI 10.1016/j.nano.2016.07.016; Zuckerman JE, 2015, NAT REV DRUG DISCOV, V14, P843, DOI 10.1038/nrd4685	110	1	1	6	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1471-2598	1744-7682		EXPERT OPIN BIOL TH	Expert Opin. Biol. Ther.	MAY	2017	17	5					595	611		10.1080/14712598.2017.1305351				17	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	ES4GR	WOS:000399490700008	28330383				2018-01-05	
J	Suh, DH; Kim, M; Kim, K; Kim, HJ; Lee, KH; Kim, JW				Suh, Dong Hoon; Kim, Miseon; Kim, Kidong; Kim, Hak Jae; Lee, Kyung-Hun; Kim, Jae-Weon			Major clinical research advances in gynecologic cancer in 2016: 10-year special edition	JOURNAL OF GYNECOLOGIC ONCOLOGY			English	Review						Precision Medicine; Artificial Intelligence; Genital Neoplasms; Female; Ovarian Neoplasms; Breast Neoplasms	REDUCING SALPINGO-OOPHORECTOMY; BRCA2 MUTATION CARRIERS; QUALITY-OF-LIFE; PHASE-III TRIAL; 16/18 AS04-ADJUVANTED VACCINE; RANDOMIZED CONTROLLED VIVIANE; PACLITAXEL PLUS CARBOPLATIN; PRIMARY PERITONEAL CANCER; RECURRENT OVARIAN-CANCER; ADVANCED CERVICAL-CANCER	In 2016, 13 topics were selected as major research advances in gynecologic oncology. For ovarian cancer, study results supporting previous ones regarding surgical preventive strategies were reported. There were several targeted agents that showed comparable responses in phase III trials, including niraparib, cediranib, and nintedanib. On the contrary to our expectations, dose-dense weekly chemotherapy regimen failed to prove superior survival outcomes compared with conventional triweekly regimen. Single-agent non-platinum treatment to prolong platinum-free-interval in patients with recurrent, partially platinum-sensitive ovarian cancer did not improve and even worsened overall survival (OS). For cervical cancer, we reviewed robust evidences of larger-scaled population-based study and cost-effectiveness of nonavalent vaccine for expanding human papillomavirus (HPV) vaccine coverage. Standard of care treatment of locally advanced cervical cancer (LACC) was briefly reviewed. For uterine corpus cancer, new findings about appropriate surgical wait time from diagnosis to surgery were reported. Advantages of minimally invasive surgery over conventional laparotomy were reconfirmed. There were 5 new gene regions that increase the risk of developing endometrial cancer. Regarding radiation therapy, Post-Operative Radiation Therapy in Endometrial Cancer (PORTEC)-3 quality of life (QOL) data were released and higher local control rate of image-guided adaptive brachytherapy was reported in LACC. In addition, 4 general oncology topics followed: chemotherapy at the end-of-life, immunotherapy with reengineering T-cells, actualization of precision medicine, and artificial intelligence (AI) to make personalized cancer therapy real. For breast cancer, adaptively randomized trials, extending aromatase inhibitor therapy, and ribociclib and palbociclib were introduced.	[Suh, Dong Hoon; Kim, Miseon; Kim, Kidong] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea; [Kim, Hak Jae] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Lee, Kyung-Hun] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Jae-Weon] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea	Kim, JW (reprint author), Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea.	kjwksh@snu.ac.kr		Kim, Jae-Weon/0000-0003-1835-9436; Kim, Miseon/0000-0002-5118-9275; KIM, KIDONG/0000-0001-9254-6024			Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Bailey HH, 2016, J CLIN ONCOL, V34, P1803, DOI 10.1200/JCO.2016.67.2014; Benard VB, 2016, JAMA ONCOL IN PRESS; Bruzzone M, 2016, J CLIN ONCOL S, V34; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Carey LA, 2016, NEW ENGL J MED, V375, P83, DOI 10.1056/NEJMe1603691; Chan JK, 2016, NEW ENGL J MED, V374, P2603, DOI 10.1056/NEJMc1603849; Chen R Falchook A, 2016, J CLIN ONCOL S, V34; Cheng THT, 2016, NAT GENET, V48, P667, DOI 10.1038/ng.3562; Cirillo PM, 2016, INT J CANCER, V139, P1009, DOI 10.1002/ijc.30144; Coleman RL, 2016, GYNECOL ONCOL, V141, P1, DOI 10.1016/j.ygyno.2016.03.017; de Boer SM, 2016, LANCET ONCOL, V17, P1114, DOI 10.1016/S1470-2045(16)30120-6; Domchek SM, 2006, LANCET ONCOL, V7, P223, DOI 10.1016/S1470-2045(06); Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; du Bois A, 2016, LANCET ONCOL, V17, P78, DOI 10.1016/S1470-2045(15)00366-6; Durham DP, 2016, P NATL ACAD SCI USA, V113, P5107, DOI 10.1073/pnas.1515528113; Finch A, 2006, JAMA-J AM MED ASSOC, V296, P185, DOI 10.1001/jama.296.2.185; Finch A, 2013, PSYCHO-ONCOLOGY, V22, P212, DOI 10.1002/pon.2041; Finch APM, 2014, J CLIN ONCOL, V32, P1547, DOI 10.1200/JCO.2013.53.2820; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Fokdal L, 2016, RADIOTHER ONCOL, V120, P434, DOI 10.1016/j.radonc.2016.03.020; Frimer M, 2016, GYNECOL ONCOL, V141, P101, DOI 10.1016/j.ygyno.2015.12.034; Garcia C, 2016, OBSTET GYNECOL, V128, P277, DOI 10.1097/AOG.0000000000001531; Goss PE, 2016, NEW ENGL J MED, V375, P209, DOI 10.1056/NEJMoa1604700; Grisham RN, 2014, INT J GYNECOL CANCER, V24, P1010, DOI 10.1097/IGC.0000000000000190; Han SL, 2017, CANCER LETT, V390, P188, DOI 10.1016/j.canlet.2016.12.037; Hartmann LC, 2016, NEW ENGL J MED, V374, P454, DOI 10.1056/NEJMra1503523; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Howitt BE, 2016, JAMA ONCOL, V2, P518, DOI 10.1001/jamaoncol.2015.6326; Huh W, 2016, J CLIN ONCOL S, V34; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119                                                            ; Kauff ND, 2008, J CLIN ONCOL, V26, P1331, DOI 10.1200/JCO.2007.13.9626; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; Kim K, 2008, KOREAN J GYNECOL ONC, V19, P1; Kim K, 2009, J GYNECOL ONCOL, V20, P203, DOI 10.3802/jgo.2009.20.4.203; Kim Kidong, 2008, J Gynecol Oncol, V19, P209, DOI 10.3802/jgo.2008.19.4.209; Kyrgiou M, 2016, GYNECOL ONCOL, V141, P29, DOI 10.1016/j.ygyno.2015.12.032; Ledermann JA, 2016, LANCET, V387, P1066, DOI 10.1016/S0140-6736(15)01167-8; Lee AW, 2016, OBSTET GYNECOL, V127, P828, DOI 10.1097/AOG.0000000000001387; Matulonis UA, 2009, J CLIN ONCOL, V27, P5601, DOI 10.1200/JCO.2009.23.2777; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Mitamura T, 2016, GYNECOL ONCOL, V141, P80, DOI 10.1016/j.ygyno.2015.12.033; Murakami R, 2016, GYNECOL ONCOL, V141, P49, DOI 10.1016/j.ygyno.2016.02.027; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; Nout RA, 2010, LANCET, V375, P816, DOI 10.1016/S0140-6736(09)62163-2; OTT PA, 2016, J CLIN ONCOL S, V34; Park JW, 2016, NEW ENGL J MED, V375, P11, DOI 10.1056/NEJMoa1513750; Patel JM, 2016, ONCOTARGET, V7, P22064, DOI 10.18632/oncotarget.8017; Perales-Puchalt A, 2017, CLIN CANCER RES, V23, P441, DOI 10.1158/1078-0432.CCR-16-0492; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pignata S, 2016, J CLIN ONCOL, V34; Prigerson HG, 2015, JAMA ONCOL, V1, P778, DOI 10.1001/jamaoncol.2015.2378; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Rauh-Hain JA, 2017, JAMA ONCOL, V3, P76, DOI 10.1001/jamaoncol.2016.4411; Rebbeck TR, 2009, J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158                                                            ; Robin TP, 2016, GYNECOL ONCOL, V143, P319, DOI 10.1016/j.ygyno.2016.09.009; Rochigneux P, 2016, ANN ONCOL IN PRESS; Rugo HS, 2016, NEW ENGL J MED, V375, P23, DOI 10.1056/NEJMoa1513749; Schnipper LE, 2012, J CLIN ONCOL, V30, P1715, DOI 10.1200/JCO.2012.42.8375; Shalowitz DI, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.11.1050; Shu CA, 2016, JAMA ONCOL, V2, P1434, DOI 10.1001/jamaoncol.2016.1820; Skinner SR, 2014, LANCET, V384, P2213, DOI 10.1016/S0140-6736(14)60920-X; Strohl AE, 2016, GYNECOL ONCOL, V141, P511, DOI 10.1016/j.ygyno.2016.04.014; Sugiyama T, 2016, J CLIN ONCOL, V34, P2881, DOI 10.1200/JCO.2016.66.9010; Suh DH, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e53; Suh DH, 2015, J GYNECOL ONCOL, V26, P156, DOI 10.3802/jgo.2015.26.2.156; Suh DH, 2014, J GYNECOL ONCOL, V25, P236, DOI 10.3802/jgo.2014.25.3.236; Suh DH, 2013, J GYNECOL ONCOL, V24, P66, DOI 10.3802/jgo.2013.24.1.66; Suh DH, 2012, J GYNECOL ONCOL, V23, P53, DOI 10.3802/jgo.2012.23.1.53; Suh DH, 2010, J GYNECOL ONCOL, V21, P209, DOI 10.3802/jgo.2010.21.4.209; Takakura S, 2010, INT J GYNECOL CANCER, V20, P240, DOI 10.1111/IGC.0b013e3181cafb47; Tannock IF, 2016, NEW ENGL J MED, V375, P1289, DOI 10.1056/NEJMsb1607705; Uzilov AV, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0313-0; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Walker JL, 2012, J CLIN ONCOL, V30, P695, DOI 10.1200/JCO.2011.38.8645; Welch HG, 2016, NEW ENGL J MED, V375, P1438, DOI 10.1056/NEJMoa1600249; Wentzensen N, 2016, J CLIN ONCOL, V34, P2888, DOI 10.1200/JCO.2016.66.8178; Wheeler CM, 2016, LANCET INFECT DIS, V16, P1154, DOI 10.1016/S1473-3099(16)30120-7; Wright AA, 2016, J CLIN ONCOL, V34, P3460, DOI 10.1200/JCO.2016.68.6907; Wright AA, 2016, GYNECOL ONCOL, V143, P3, DOI 10.1016/j.ygyno.2016.05.022; Wright JD, 2016, AM J OBSTET GYNECOL, V215	83	5	5	7	15	KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY	SEOUL	102-HO, 55-5, NONHYEON-DONG, GANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2005-0380	2005-0399		J GYNECOL ONCOL	J. Gynecol. Oncol.	MAY	2017	28	3							e45	10.3802/jgo.2017.28.e45				25	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	ES2ZN	WOS:000399396700010	28382802	gold			2018-01-05	
J	Spraggon, L; Martelotto, LG; Hmeljak, J; Hitchman, TD; Wang, J; Wang, L; Slotkin, EK; Fan, PD; Reis, JS; Ladanyi, M				Spraggon, Lee; Martelotto, Luciano G.; Hmeljak, Julija; Hitchman, Tyler D.; Wang, Jiang; Wang, Lu; Slotkin, Emily K.; Fan, Pang-Dian; Reis-Filho, Jorge S.; Ladanyi, Marc			Generation of conditional oncogenic chromosomal translocations using CRISPR-Cas9 genomic editing and homology-directed repair	JOURNAL OF PATHOLOGY			English	Article						CRISPR-Cas9; genomic editing; chromosomal translocations; homology-directed repair; oncogene; Ewing sarcoma; desmoplastic small round cell tumour (DSRCT)	ROUND-CELL TUMOR; HUMAN STEM-CELLS; EWING SARCOMA; GENE; REARRANGEMENTS; CANCER; FUSION; EWS; ONCOPROTEIN; TECHNOLOGY	Chromosomal rearrangements encoding oncogenic fusion proteins are found in a wide variety of malignancies. The use of programmable nucleases to generate specific double-strand breaks in endogenous loci, followed by non-homologous end joining DNA repair, has allowed several of these translocations to be generated as constitutively expressed fusion genes within a cell population. Here, we describe a novel approach that combines CRISPR-Cas9 technology with homology-directed repair to engineer, capture, and modulate the expression of chromosomal translocation products in a human cell line. We have applied this approach to the genetic modelling of t(11;22)(q24;q12) and t(11;22)(p13;q12), translocation products of the EWSR1 gene and its 3 ' fusion partners FLI1 and WT1, present in Ewing's sarcoma and desmoplastic small round cell tumour, respectively. Our innovative approach allows for temporal control of the expression of engineered endogenous chromosomal rearrangements, and provides a means to generate models to study tumours driven by fusion genes. Copyright (C) 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.	[Spraggon, Lee; Martelotto, Luciano G.; Hmeljak, Julija; Hitchman, Tyler D.; Wang, Jiang; Wang, Lu; Fan, Pang-Dian; Reis-Filho, Jorge S.; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Slotkin, Emily K.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Reis-Filho, Jorge S.; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA	Spraggon, L; Ladanyi, M (reprint author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	spraggol@mskcc.org; ladanyim@mskcc.org		Martelotto, Luciano/0000-0002-9625-1183	Alex's Lemonade Stand Innovation Award; Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute [2P30CA008748-48]	We thank Professor Nick Hastie, Dr Jason Huse, and Dr Alex Kentsis for critical reading of the manuscript. We thank Dr Huichun Tai for technical assistance. We thank Mr Ethan Rai-Spraggon and Ms Anya Rai-Spraggon for advice and support throughout the course of this work. We also thank Dr Maria Jasin and Dr Fabio Vanoli for helpful and constructive comments. We wish to thank the following for reagents: pSpCas9(BB)-2A-GFP (PX458) was a gift from Dr Feng Zhang (Addgene plasmid # 48138) and pCAG-Cre: GFP was a gift from Dr Connie Cepko (Addgene plasmid # 13776). This work was supported in part by an Alex's Lemonade Stand Innovation Award (to ML). Research reported in this publication was supported in part by a Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute (grant No 2P30CA008748-48).	Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Gerald WL, 1998, J CLIN ONCOL, V16, P3028, DOI 10.1200/JCO.1998.16.9.3028                                                      ; GERALD WL, 1995, P NATL ACAD SCI USA, V92, P1028, DOI 10.1073/pnas.92.4.1028; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Kang HJ, 2014, CANCER RES, V74, P4526, DOI 10.1158/0008-5472.CAN-13-3663; LADANYI M, 1994, CANCER RES, V54, P2837; Lagutina IV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004951; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Liu J, 2015, NAT PROTOC, V10, P1842, DOI 10.1038/nprot.2015.117; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Park H, 2016, SCI REP-UK, V6, DOI 10.1038/srep32297; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Richardson C, 2000, NATURE, V405, P697; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Sanchez G, 2008, P NATL ACAD SCI USA, V105, P6004, DOI 10.1073/pnas.0710748105; Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008; Selvanathan SP, 2015, P NATL ACAD SCI USA, V112, pE1307, DOI 10.1073/pnas.1500536112; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548                                                                ; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437	30	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3417	1096-9896		J PATHOL	J. Pathol.	MAY	2017	242	1					102	112		10.1002/path.4883				11	Oncology; Pathology	Oncology; Pathology	ES6QT	WOS:000399674800011	28188619				2018-01-05	
J	Guedan, A; Swieboda, D; Charles, M; Toussaint, M; Johnston, SL; Asfor, A; Panjwani, A; Tuthill, TJ; Danahay, H; Raynham, T; Mousnier, A; Solari, R				Guedan, Anabel; Swieboda, Dawid; Charles, Mark; Toussaint, Marie; Johnston, Sebastian L.; Asfor, Amin; Panjwani, Anusha; Tuthill, Tobias J.; Danahay, Henry; Raynham, Tony; Mousnier, Aurelie; Solari, Roberto			Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication	JOURNAL OF VIROLOGY			English	Article						Golgi membrane; protein kinase D; antiviral; picornavirus; rhinovirus; viral replication	OXYSTEROL-BINDING PROTEIN; MOUTH-DISEASE VIRUS; D-MEDIATED PHOSPHORYLATION; ENTEROVIRUS REPLICATION; PICORNAVIRUS REPLICATION; SECRETORY PATHWAY; GOLGI-APPARATUS; III-BETA; IN-VIVO; C-MU	Picornavirus replication is known to cause extensive remodeling of Golgi and endoplasmic reticulum membranes, and a number of the host proteins involved in the viral replication complex have been identified, including oxysterol binding protein (OSBP) and phosphatidylinositol 4-kinase III beta (PI4KB). Since both OSBP and PI4KB are substrates for protein kinase D (PKD) and PKD is known to be involved in the control of Golgi membrane vesicular and lipid transport, we hypothesized that PKD played a role in viral replication. We present multiple lines of evidence in support of this hypothesis. First, infection of HeLa cells with human rhinovirus (HRV) induced the phosphorylation of PKD. Second, PKD inhibitors reduced HRV genome replication, protein expression, and titers in a concentration-dependent fashion and also blocked the replication of poliovirus (PV) and foot-and-mouth disease virus (FMDV) in a variety of cells. Third, HRV replication was significantly reduced in HeLa cells overexpressing wild-type and mutant forms of PKD1. Fourth, HRV genome replication was reduced in HAP1 cells in which the PKD1 gene was knocked out by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9. Although we have not identified the molecular mechanism through which PKD regulates viral replication, our data suggest that this is not due to enhanced interferon signaling or an inhibition of clathrin-mediated endocytosis, and PKD inhibitors do not need to be present during viral uptake. Our data show for the first time that targeting PKD with small molecules can inhibit the replication of HRV, PV, and FMDV, and therefore, PKD may represent a novel antiviral target for drug discovery. IMPORTANCE Picornaviruses remain an important family of human and animal pathogens for which we have a very limited arsenal of antiviral agents. HRV is the causative agent of the common cold, which in itself is a relatively trivial infection; however, in asthma and chronic obstructive pulmonary disease (COPD) patients, this virus is a major cause of exacerbations resulting in an increased use of medication, worsening symptoms, and, frequently, hospital admission. Thus, HRV represents a substantial health care and economic burden for which there are no approved therapies. We sought to identify a novel host target as a potential anti-HRV therapy. HRV infection induces the phosphorylation of PKD, and inhibitors of this kinase effectively block HRV replication at an early stage of the viral life cycle. Moreover, PKD inhibitors also block PV and FMDV replication. This is the first description that PKD may represent a target for antiviral drug discovery.	[Guedan, Anabel; Swieboda, Dawid; Toussaint, Marie; Johnston, Sebastian L.; Mousnier, Aurelie; Solari, Roberto] Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Asfor, Amin; Panjwani, Anusha; Tuthill, Tobias J.] Pirbright Inst, Pirbright, Surrey, England; [Charles, Mark; Raynham, Tony] CRT Discovery Labs, Cambridge, England; [Danahay, Henry] Univ Sussex, Enterprise Therapeut, Sussex Innovat Ctr, Brighton, E Sussex, England; [Mousnier, Aurelie] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland	Solari, R (reprint author), Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	r.solari@imperial.ac.uk	Institute, Pirbright/K-4476-2014		National Heart and Lung Institute Foundation [1048073]; MRC [MC_PC_15028, MR/M004821/1, MR/K020811/1]; GlaxoSmithKline; Chair from Asthma UK [CH11SJ]; MRC Centre [G1000758]; BBSRC [BB/L004828/1]	A.G. was supported by a Ph.D. fellowship from the National Heart and Lung Institute Foundation (registered charity no. 1048073) and by an MRC grant (MC_PC_15028). Salary for R.S. was provided by GlaxoSmithKline. R.S., D.S., and A.M. were supported by an MRC grant (MR/M004821/1). S. L. J. is supported by a Chair from Asthma UK (CH11SJ). This work was supported by MRC Centre grant G1000758. A. A., A. P., and T. J. T. were supported by BBSRC grant BB/L004828/1 and MRC grant MR/K020811/1. The Pirbright Institute receives strategic funding from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We declare no conflicts of interests.	Aicart-Ramos C, 2016, J BIOL CHEM, V291, P23516, DOI 10.1074/jbc.M116.735399; Albulescu L, 2015, ANTIVIR RES, V117, P110, DOI 10.1016/j.antiviral.2015.02.013; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Arita M, 2008, J GEN VIROL, V89, P2518, DOI 10.1099/vir.0.2008/002915-0; Arita M, 2014, MICROBIOL IMMUNOL, V58, P239, DOI 10.1111/1348-0421.12144; Arita M, 2013, J VIROL, V87, P4252, DOI 10.1128/JVI.03546-12; Arita M, 2011, J VIROL, V85, P2364, DOI 10.1128/JVI.02249-10; Arita M, 2009, J GEN VIROL, V90, P1869, DOI 10.1099/vir.0.012096-0; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0                                                   ; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Barnard DL, 2006, CURR PHARM DESIGN, V12, P1379, DOI 10.2174/138161206776361129                                                      ; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Belov GA, 2005, J VIROL, V79, P7207, DOI 10.1128/JVI.79.11.7207.7216.2005; Belov GA, 2007, J VIROL, V81, P9259, DOI 10.1128/JVI.00840-07; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Belov GA, 2016, CURR OPIN VIROL, V19, P1, DOI 10.1016/j.coviro.2016.05.003; Belov GA, 2014, J VIROL, V88, P9478, DOI 10.1128/JVI.00922-14; Berryman S, 2016, J GEN VIROL, V97, P1841, DOI 10.1099/jgv.0.000485; Borges S, 2015, MOL CANCER THER, V14, P1306, DOI 10.1158/1535-7163.MCT-14-0945; Danahay H, 2002, AM J PHYSIOL-LUNG C, V282, pL226, DOI 10.1152/ajplung.00311.2001                                                      ; Deakin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107490; Dorobantu CM, 2015, J VIROL, V89, P1913, DOI 10.1128/JVI.02830-14; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Ellard FM, 1999, J GEN VIROL, V80, P1911, DOI 10.1099/0022-1317-80-8-1911                                                     ; Ellwanger K, 2013, IUBMB LIFE, V65, P98, DOI 10.1002/iub.1116; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Fuchs R., 2012, ADV VIROL, V2012, DOI DOI 10.1155/2012/826301; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Greninger AL, 2012, J VIROL, V86, P3605, DOI 10.1128/JVI.06778-11; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ilnytska O, 2013, CELL HOST MICROBE, V14, P281, DOI 10.1016/j.chom.2013.08.002; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Johannes L, 2011, TRAFFIC, V12, P956, DOI 10.1111/j.1600-0854.2011.01200.x; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kunkel MT, 2015, CHEM BIOL, V22, P98, DOI 10.1016/j.chembiol.2014.11.014; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Loundras EA, 2016, J GEN VIROL, V97, P2221, DOI 10.1099/jgv.0.000527; Malhotra V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005280; McKinlay MA, 2014, J INFECT DIS, V210, pS447, DOI 10.1093/infdis/jiu043; Mousnier A, 2014, J VIROL, V88, P11671, DOI 10.1128/JVI.01170-14; Nchoutmboube J, 2015, TRENDS MICROBIOL, V23, P183, DOI 10.1016/j.tim.2015.02.008; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Ochi N, 2011, J CELL PHYSIOL, V226, P1074, DOI 10.1002/jcp.22421; Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; Rollinger JM, 2011, MED RES REV, V31, P42, DOI 10.1002/med.20176; Roulin PS, 2014, CELL HOST MICROBE, V16, P677, DOI 10.1016/j.chom.2014.10.003; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Ruiz-Saenz J, 2009, INTERVIROLOGY, V52, P201, DOI 10.1159/000226121; Siltz LAF, 2014, J VIROL, V88, P11091, DOI 10.1128/JVI.01877-14; Spickler Catherine, 2013, Antimicrob Agents Chemother, V57, P3358, DOI 10.1128/AAC.00303-13; Strating JRPM, 2015, CELL REP, V10, P600, DOI 10.1016/j.celrep.2014.12.054; Valente C, 2012, NAT CELL BIOL, V14, P343, DOI 10.1038/ncb2445; van der Schaar HM, 2013, ANTIMICROB AGENTS CH, V57, P4971, DOI 10.1128/AAC.01175-13; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6                                                   ; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Zheng H, 2011, J BIOL CHEM, V286, P35733, DOI 10.1074/jbc.M111.263608; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10; ZIBERT A, 1990, J VIROL, V64, P2467; Carr J. L., 2008, [No title captured], Patent No. [WO2007125331 A3, 2007125331, 2007125331 A3]; Blackaby WP, 2009, European patent WO, Patent No. [2008074997 A8, 2008074997]	69	1	1	4	6	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAY	2017	91	9							UNSP e00217	10.1128/JVI.00217-17				21	Virology	Virology	ES4BP	WOS:000399474400013		gold			2018-01-05	
J	Matsumoto, Y; Ohta, K; Kolakofsky, D; Nishio, M				Matsumoto, Yusuke; Ohta, Keisuke; Kolakofsky, Daniel; Nishio, Machiko			A Point Mutation in the RNA-Binding Domain of Human Parainfluenza Virus Type 2 Nucleoprotein Elicits Abnormally Enhanced Polymerase Activity	JOURNAL OF VIROLOGY			English	Article						human parainfluenza virus type 2; encapsidation; nucleoprotein; polymerase	VESICULAR STOMATITIS-VIRUS; RESPIRATORY SYNCYTIAL VIRUS; L-PROTEIN; ANTIGENOMIC PROMOTER; GENOME REPLICATION; CRYSTAL-STRUCTURE; 5 REQUIRES; COMPLEX; TRANSCRIPTION; IDENTIFICATION	The genome RNA of human parainfluenza virus type 2 (hPIV2) that acts as the template for the polymerase complex is entirely encapsidated by the nucleoprotein (NP). Recently, the crystal structure of NP of PIV5, a virus closely related to hPIV2, was resolved in association with RNA. Ten amino acids that contact the bound RNA were identified and are strictly conserved between PIV5 and hPIV2 NP. Mutation of hPIV2 NP Q202 (which contacts a base rather than the RNA backbone) to various amino acids resulted in an over 30-fold increase of polymerase activity as evidenced by a minireplicon assay, even though the RNA-binding affinity was unaltered. Using various modified minireplicons, we found that the enhanced reporter gene expression could be accounted for by increased minigenome replication, whereas mRNA synthesis itself was not affected by Q202 mutation. Moreover, the enhanced activities were still observed in minigenomes partially lacking the leader sequence and which were not of hexamer genome length. Unexpectedly, recombinant hPIV2 possessing the NP Q202A mutation could not be recovered from cDNA. IMPORTANCE We examined the importance of amino acids in the putative RNAbinding domain of hPIV2 NP for polymerase activity using minireplicons. Abnormally enhanced genome replication was observed upon substitution mutation of the NP Q202 position to various amino acids. Surprisingly, this mutation enabled polymerase to use minigenomes that were partially lacking the leader sequence and not of hexamer genome length. This mutation does not affect fundamental properties of NP, e.g., recognition of gene junctional and editing signals. However, the strongly enhanced polymerase activity may not be viable for the infectious life cycle. This report highlights the potential of the polymerase complex with point mutations in NP and helps our detailed understanding of the molecular basis of gene expression.	[Matsumoto, Yusuke; Ohta, Keisuke; Nishio, Machiko] Wakayama Med Univ, Sch Med, Dept Microbiol, Wakayama, Japan; [Kolakofsky, Daniel] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, Geneva, Switzerland	Matsumoto, Y (reprint author), Wakayama Med Univ, Sch Med, Dept Microbiol, Wakayama, Japan.	ymatsu@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [16K19143]	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (16K19143).	Alayyoubi M, 2015, P NATL ACAD SCI USA, V112, pE1792, DOI 10.1073/pnas.1503941112; Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Buchholz UJ, 1999, J VIROL, V73, P251; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Hoffman MA, 2000, VIROLOGY, V269, P201, DOI 10.1006/viro.2000.0223                                                          ; Keller MA, 2001, J VIROL, V75, P3993, DOI 10.1128/JVI.75.8.3993-3998.2001; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Kolakofsky D, 1998, J VIROL, V72, P891; Kolakofsky D, 2016, VIROLOGY, V498, P94, DOI 10.1016/j.virol.2016.08.018; Lamb RA, 2013, FIELDS VIROLOGY, V1, P957; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; Luo M, 2007, VIRUS RES, V129, P246, DOI 10.1016/j.virusres.2007.07.011; Matsumoto Y, 2016, J GEN VIROL, V97, P1520, DOI 10.1099/jgv.0.000479; Matsumoto Y, 2015, MICROBIOL IMMUNOL, V59, P676, DOI 10.1111/1348-0421.12329; Murphy SK, 1999, J VIROL, V73, P805; Murphy SK, 1998, J VIROL, V72, P10; Nishio M, 1999, J GEN VIROL, V80, P2017, DOI 10.1099/0022-1317-80-8-2017                                                     ; Nishio M, 2000, VIROLOGY, V273, P241, DOI 10.1006/viro.2000.0429; Nishio M, 1997, J GEN VIROL, V78, P1303, DOI 10.1099/0022-1317-78-6-1303                                                     ; Nishio M, 2005, J VIROL, V79, P8591, DOI 10.1128/JVI.79.13.8591-8601.2005; Nishio M, 2008, J VIROL, V82, P6130, DOI 10.1128/JVI.02635-07; Nishio M, 2011, J VIROL, V85, P725, DOI 10.1128/JVI.01226-10; Ogino T, 2011, VIRUS RES, V162, P100, DOI 10.1016/j.virusres.2011.09.012; Rahmeh AA, 2010, P NATL ACAD SCI USA, V107, P20075, DOI 10.1073/pnas.1013559107; Rassa JC, 2000, VIROLOGY, V274, P438, DOI 10.1006/viro.2000.0494; Reguera J, 2016, CURR OPIN STRUC BIOL, V36, P75, DOI 10.1016/j.sbi.2016.01.002; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; Tapparel C, 1998, J VIROL, V72, P3117; Tapparel C, 1997, J VIROL, V71, P9588; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tekes G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002073; Thierry E, 2016, MOL CELL, V61, P125, DOI 10.1016/j.molcel.2015.11.016; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61	34	1	1	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAY	2017	91	9							UNSP e02203	10.1128/JVI.02203-16				14	Virology	Virology	ES4BP	WOS:000399474400027					2018-01-05	
J	Maayah, ZH; Althurwi, HN; El-Sherbeni, AA; Abdelhamid, G; Siraki, AG; El-Kadi, AOS				Maayah, Zaid H.; Althurwi, Hassan N.; El-Sherbeni, Ahmed A.; Abdelhamid, Ghada; Siraki, Arno G.; El-Kadi, Ayman O. S.			The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Hypertrophy; Cytochrome P450 1B1; Mid-chain hydroxyeicosatetraenoic acids	ARYL-HYDROCARBON RECEPTOR; SALT-INDUCED HYPERTENSION; ARACHIDONIC-ACID; ANGIOTENSIN-II; HEART-FAILURE; GENE-EXPRESSION; CARDIOVASCULAR-DISEASES; VENTRICULAR HYPERTROPHY; CELLULAR HYPERTROPHY; NATRIURETIC PEPTIDE	Numerous experimental studies have demonstrated the role of cytochrome P450 1B1 (CYP1B1) and its associated mid-chain hydroxyeicosatetraenoic acids (mid-chain HETEs) metabolite in the pathogenesis of cardiac hypertrophy. However, the ability of isoproterenol (ISO) to induce cardiac hypertrophy through mid-chain HETEs has not been investigated yet. Therefore, we hypothesized that ISO induces cardiac hypertrophy through the induction of CYP1B1 and its associated mid-chain HETE metabolites. To test our hypothesis, Sprague-Dawley rats were treated with ISO (5 mg/kg i.p.) for 12 and 72 h whereas, human ventricular cardiomyocytes RL-14 cells were exposed to 100 mu M ISO in the presence and absence of 0.5 mu M tetramethoxystilbene (TMS) a selective CYP1B1 inhibitor, or 25 nM CYP1B1-siRNA. Moreover, RL-14 cells were transiently transfected with the CRISPR-CYP1B1 plasmid. Thereafter, real-time PCR, western blot analysis, and liquid chromatography-electrospray ionization mass spectroscopy were used to determine the level of gene expression, protein expression, and mid-chain HETEs, respectively. Our results showed that ISO induced CYP1B1 protein expression and the level of cardiac mid-chain HETEs in vivo at pre-hypertrophic and hypertrophic stage. In vitro, inhibition of CYP1B1 using TMS or CYP1B1-siRNA significantly attenuates ISO-induced hypertrophy. Furthermore, overexpression of CYP1B1 significantly induced cellular hypertrophy and mid-chain HETEs metabolite. Mechanistically, the protective effect of TMS against cardiac hypertrophy was mediated through the modulation of superoxide anion, mitogen-activated protein kinases (MAPKs), and nuclear factor-kappa B (NF-kappa B). In conclusion, our study provides the first evidence that CYP1B1 and its associated mid-chain HETE metabolites are directly involved in the ISO-induced cardiac hypertrophy.	[Maayah, Zaid H.; Althurwi, Hassan N.; El-Sherbeni, Ahmed A.; Abdelhamid, Ghada; Siraki, Arno G.; El-Kadi, Ayman O. S.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Katz Grp 2142J, Rexall Ctr Pharm & Hlth Res, Edmonton, AB T6G 2E1, Canada; [Althurwi, Hassan N.] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Pharmacol, Al Kharj, Saudi Arabia; [Abdelhamid, Ghada] Univ Helwan, Fac Pharm, Dept Pharmacol & Toxicol, Helwan, Egypt	El-Kadi, AOS (reprint author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Katz Grp 2142J, Rexall Ctr Pharm & Hlth Res, Edmonton, AB T6G 2E1, Canada.	aelkadi@ualberta.ca			Canadian Institutes of Health Research [106665]; Izaak Walton Killam Memorial Scholarship; Alberta Innovates-Health Solutions studentship; Egyptian Government Scholarship; Alberta Innovates Health Solution Graduate Student Scholarship	This work was supported by a grant from the Canadian Institutes of Health Research [Grant 106665] to A.O.S.E. Z.H.M. is the recipient Izaak Walton Killam Memorial Scholarship and Alberta Innovates Health Solution Graduate Student Scholarship. AAE is the recipient of Egyptian Government Scholarship and Alberta Innovates-Health Solutions studentship.	Aboutabl ME, 2009, BRIT J PHARMACOL, V158, P1808, DOI 10.1111/j.1476-5381.2009.00461.x; Althurwi HN, 2015, DRUG METAB DISPOS, V43, P1254, DOI 10.1124/dmd.115.063776; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499                                                           ; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Berenji K, 2005, AM J PHYSIOL-HEART C, V289, pH8, DOI 10.1152/ajpheart.01303.2004; Bhattacharya N, 2010, INT J CANCER, V127, P404, DOI 10.1002/ijc.25054; BURHOP KE, 1988, CIRC RES, V62, P687; Carreno JE, 2006, REV ESP CARDIOL, V59, P473, DOI 10.1016/S1885-5857(06)60796-2                                                   ; Chen J, 2002, J INVEST DERMATOL, V119, P1261, DOI 10.1046/j.1523-1747.2002.19611.x                                                ; Cheng TH, 2004, N-S ARCH PHARMACOL, V369, P239, DOI 10.1007/s00210-003-0849-6; Choudhary D, 2004, DRUG METAB DISPOS, V32, P840, DOI 10.1124/dmd.32.8.840; Chun YJ, 2001, CANCER RES, V61, P8164; Cox EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092903; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1                                                   ; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5                                                   ; El-Sherbeni AA, 2014, DRUG METAB DISPOS, V42, P1498, DOI 10.1124/dmd.114.057836; El-Sherbeni AA, 2014, BIOCHEM PHARMACOL, V87, P456, DOI 10.1016/j.bcp.2013.11.015; Elshenawy OH, 2013, CURR DRUG METAB, V14, P706, DOI 10.2174/1389200211314060007                                                     ; Elshenawy OH, 2013, VASC PHARMACOL, V58, P326, DOI 10.1016/j.vph.2012.12.002; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365                                                           ; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Hu XT, 2015, PHYTOTHER RES, V29, P1295, DOI 10.1002/ptr.5376; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; Jennings BL, 2014, CARDIOVASC DRUG THER, V28, P145, DOI 10.1007/s10557-014-6510-4; Jennings BL, 2012, HYPERTENSION, V60, P1510, DOI 10.1161/HYPERTENSIONAHA.112.202606; Jennings BL, 2012, HYPERTENSION, V59, P348, DOI 10.1161/HYPERTENSIONAHA.111.183301; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Kiriazis H, 2000, ANNU REV PHYSIOL, V62, P321, DOI 10.1146/annurev.physiol.62.1.321; Kopf PG, 2008, CARDIOVASC TOXICOL, V8, P181, DOI 10.1007/s12012-008-9027-x; Korashy HM, 2006, DRUG METAB REV, V38, P411, DOI 10.1080/03602530600632063; Latini R, 2002, J CARD FAIL, V8, P288, DOI 10.1054/jcaf.2002.127769; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265                                                            ; Li SF, 2008, MOL BIOL REP, V35, P489, DOI 10.1007/s11033-007-9112-4; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x                                             ; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locher MR, 2011, AM J PHYSIOL-HEART C, V300, pH869, DOI 10.1152/ajpheart.00452.2010; Maayah ZH, 2016, PHARMACOL RES, V105, P28, DOI 10.1016/j.phrs.2015.12.016; Maayah ZH, 2016, ARCH TOXICOL, V90, P359, DOI 10.1007/s00204-014-1419-z; Maayah ZH, 2016, ARCH TOXICOL, V90, P119, DOI 10.1007/s00204-015-1620-8; Maayah ZH, 2015, CELL BIOL TOXICOL, V31, P241, DOI 10.1007/s10565-015-9308-7; Maayah ZH, 2015, J PHARMACOL TOX MET, V71, P33, DOI 10.1016/j.vascn.2014.11.005; Maayah ZH, 2014, ARCH TOXICOL, V88, P725, DOI 10.1007/s00204-013-1159-5; Maayah ZH, 2013, ARCH TOXICOL, V87, P847, DOI 10.1007/s00204-012-0996-y; Malik KU, 2012, PROSTAG OTH LIPID M, V98, P69, DOI 10.1016/j.prostaglandins.2011.12.003; MESZAROS J, 1990, ACTA BIOL HUNG, V41, P289; Molojavyi A, 2010, PHYSIOL GENOMICS, V41, P137, DOI 10.1152/physiolgenomics.90297.2008; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Nakamura K, 1998, CIRCULATION, V98, P794; Nieves D, 2006, J LIPID RES, V47, P2681, DOI 10.1194/jlr.M600212-JLR200; NOZAWA K, 1990, AM J PHYSIOL, V259, pH1774; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; Oyama N, 2005, CIRC J, V69, P987, DOI 10.1253/circj.69.987                                                            ; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001                                                      ; Sahan-Firat S, 2010, AM J PHYSIOL-HEART C, V299, pH1891, DOI 10.1152/ajpheart.00655.2010; Sambrook J, 1989, MOL CLONING LAB MANU; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Thum T, 2002, FASEB J, V16, P1537, DOI 10.1096/fj.02-0138com; Tse MMY, 2013, VASC PHARMACOL, V58, P363, DOI 10.1016/j.vph.2013.02.004; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; WALLUKAT G, 1994, J BIOL CHEM, V269, P29055; Wassmann S, 2001, MOL PHARMACOL, V59, P646; Wen YS, 2003, TRENDS CARDIOVAS MED, V13, P129, DOI 10.1016/S1050-1738(03)00027-6                                                   ; Wen YS, 2001, CIRC RES, V88, P70; Xie ZJ, 1999, J BIOL CHEM, V274, P19323, DOI 10.1074/jbc.274.27.19323; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103; Zhang Weihua, 2003, Exp Clin Cardiol, V8, P173; Zordoky BNM, 2008, DRUG METAB DISPOS, V36, P2277, DOI 10.1124/dmd.108.023077; Zordoky BNM, 2010, TOXICOL IN VITRO, V24, P863, DOI 10.1016/j.tiv.2009.12.002; Zordoky BNM, 2010, PHARMACOL THERAPEUT, V125, P446, DOI 10.1016/j.pharmthera.2009.12.002; Zordoky BNM, 2010, TOXICOL APPL PHARM, V242, P38, DOI 10.1016/j.taap.2009.09.012	74	0	0	1	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	MAY	2017	429	1-2					151	165		10.1007/s11010-017-2943-y				15	Cell Biology	Cell Biology	ES0WK	WOS:000399249600013	28251434				2018-01-05	
J	Maharjan, N; Kunzli, C; Buthey, K; Saxena, S				Maharjan, Niran; Kunzli, Christina; Buthey, Kilian; Saxena, Smita			C9ORF72 Regulates Stress Granule Formation and Its Deficiency Impairs Stress Granule Assembly, Hypersensitizing Cells to Stress	MOLECULAR NEUROBIOLOGY			English	Article						C9ORF72; ALS; Motor neuron degeneration; Stress granules; Cell recovery	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; REPEAT EXPANSION; HEXANUCLEOTIDE REPEAT; GGGGCC REPEAT; DEMENTIA; PROTEINS; NEURODEGENERATION; TRANSLATION; BODIES	Hexanucleotide repeat expansions in the C9ORF72 gene are causally associated with frontotemporal lobar dementia (FTLD) and/or amyotrophic lateral sclerosis (ALS). The physiological function of the normal C9ORF72 protein remains unclear. In this study, we characterized the subcellular localization of C9ORF72 to processing bodies (P-bodies) and its recruitment to stress granules (SGs) upon stress-related stimuli. Gain of function and loss of function experiments revealed that the long isoform of C9ORF72 protein regulates SG assembly. CRISPR/Cas9-mediated knockdown of C9ORF72 completely abolished SG formation, negatively impacted the expression of SG-associated proteins such as TIA-1 and HuR, and accelerated cell death. Loss of C9ORF72 expression further compromised cellular recovery responses after the removal of stress. Additionally, mimicking the pathogenic condition via the expression of hexanucleotide expansion upstream of C9ORF72 impaired the expression of the C9ORF72 protein, caused an abnormal accumulation of RNA foci, and led to the spontaneous formation of SGs. Our study identifies a novel function for normal C9ORF72 in SG assembly and sheds light into how the mutant expansions might impair SG formation and cellular-stress-related adaptive responses.	[Maharjan, Niran; Kunzli, Christina; Buthey, Kilian; Saxena, Smita] Univ Bern, Inst Cell Biol, Baltzerstr 4, CH-3012 Bern, Switzerland; [Maharjan, Niran] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	Saxena, S (reprint author), Univ Bern, Inst Cell Biol, Baltzerstr 4, CH-3012 Bern, Switzerland.	smita.saxena@izb.unibe.ch		Saxena, Smita/0000-0003-4574-4591	Synapsis Foundation; Frick foundation for ALS research; Swiss National Science Foundation [150756]	This work was supported by the Synapsis Foundation, Frick foundation for ALS research, and Swiss National Science Foundation Professorship grant (150756), to S.S. We thank Gabor Morotz, Kings College London, UK, for help with cortical neuron cultures.	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Ciura S, 2013, ANN NEUROL, V74, P180, DOI 10.1002/ana.23946; Cooper-Knock J, 2014, BRAIN, V137, P2040, DOI 10.1093/brain/awu120; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Farg MA, 2014, HUM MOL GENET, V23, P3579, DOI 10.1093/hmg/ddu068; Figley MD, 2014, J NEUROSCI, V34, P8083, DOI 10.1523/JNEUROSCI.0543-14.2014; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Giordana MT, 2011, NEUROL SCI, V32, P9, DOI 10.1007/s10072-010-0439-6; Jamison JT, 2008, NEUROSCIENCE, V154, P504, DOI 10.1016/j.neuroscience.2008.03.057; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088                                                           ; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Liscic RM, 2007, ARCH NEUROL-CHICAGO, V64, P535, DOI 10.1001/archneur.64.4.535; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077                                                           ; Mackenzie IR, 2013, ACTA NEUROPATHOL, V126, P859, DOI 10.1007/s00401-013-1181-y; McGurk L., 2014, EXP NEUROL, V73, P837, DOI [10.1097/NEN.0000000000000102, DOI 10.1097/NEN.0000000000000102]; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V118, P605, DOI 10.1007/s00401-009-0581-5; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; O'Rourke J.G., 2015, NEURON, V88, P892, DOI DOI 10.1016/J.NEUR0N.2015.10.027; Peters O.M., 2015, NEURON, V88, P902, DOI DOI 10.1016/J.NEUR0N.2015.11.018; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615                                                          ; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Seguin SJ, 2014, CELL DEATH DIFFER, V21, P1838, DOI 10.1038/cdd.2014.103; Strober W., 2001, TRYPAN BLUE EXCLUSIO, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS21]; Tao ZT, 2015, HUM MOL GENET, V24, P2426, DOI 10.1093/hmg/ddv005; Therrien M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083450; Waite AJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.016; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zou T, 2011, CELL MOL NEUROBIOL, V31, P541, DOI 10.1007/s10571-011-9647-8	41	7	7	11	14	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAY	2017	54	4					3062	3077		10.1007/s12035-016-9850-1				16	Neurosciences	Neurosciences & Neurology	ES1QY	WOS:000399303300062	27037575				2018-01-05	
J	Nemazee, D				Nemazee, David			Mechanisms of central tolerance for B cells	NATURE REVIEWS IMMUNOLOGY			English	Review							BRUTONS TYROSINE KINASE; LAMBDA-LIGHT-CHAIN; RECOMBINATION-ACTIVATING GENES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIGEN-RECEPTOR; ALLELIC EXCLUSION; HEAVY-CHAIN; NEGATIVE SELECTION; IG-KAPPA; IN-VIVO	Immune tolerance hinders the potentially destructive responses of lymphocytes to host tissues. Tolerance is regulated at the stage of immature B cell development (central tolerance) by clonal deletion, involving apoptosis, and by receptor editing, which reprogrammes the specificity of B cells through secondary recombination of antibody genes. Recent mechanistic studies have begun to elucidate how these divergent mechanisms are controlled. Single-cell antibody cloning has revealed defects of B cell central tolerance in human autoimmune diseases and in several human immunodeficiency diseases caused by single gene mutations, which indicates the relevance of B cell tolerance to disease and suggests possible genetic pathways that regulate tolerance.	[Nemazee, David] Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	Nemazee, D (reprint author), Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	nemazee@scripps.edu			US Department of Health & Human Services, National Institutes of Health (NIH) [R37AI059714, R01AI128836, R01AI073148]	The author thanks current and former members of his laboratory, The Scripps Research Institute Department of Immunology and Microbial Science, and the following funding sources: US Department of Health & Human Services, National Institutes of Health (NIH) grants R37AI059714, R01AI128836 and R01AI073148.	Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; ALT FW, 1984, EMBO J, V3, P1209; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Aoki-Ota M, 2012, J IMMUNOL, V188, P2305, DOI 10.4049/jimmunol.1103484; Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91                                                           ; Bai L, 2007, MOL CELL BIOL, V27, P5957, DOI 10.1128/MCB.02273-06; Duong BH, 2011, J IMMUNOL, V187, P5596, DOI 10.4049/jimmunol.1102479; Barreto V, 2000, J IMMUNOL, V164, P893, DOI 10.4049/jimmunol.164.2.893                                                      ; Bartlett A, 2013, J IMMUNOL, V191, P3605, DOI 10.4049/jimmunol.1202892; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; Bednarski JJ, 2016, J EXP MED, V213, P209, DOI 10.1084/jem.20151048; Benhamou D, 2016, CELL REP, V16, P419, DOI 10.1016/j.celrep.2016.05.084; Benschop RJ, 2001, J IMMUNOL, V167, P4172, DOI 10.4049/jimmunol.167.8.4172                                                     ; Bounab Y, 2013, CURR OPIN IMMUNOL, V25, P313, DOI 10.1016/j.coi.2013.04.001; BrensingKuppers J, 1997, GENE, V191, P173, DOI 10.1016/S0378-1119(97)00056-5; Buhl AM, 1997, IMMUNOL REV, V160, P127, DOI 10.1111/j.1600-065X.1997.tb01033.x                                              ; Busman-Sahay K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054938; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cantaert T, 2015, IMMUNITY, V43, P884, DOI 10.1016/j.immuni.2015.10.002; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129                                                          ; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chamberlain N, 2016, J CLIN INVEST, V126, P282, DOI 10.1172/JCI83840; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Cheng SH, 2009, CELL RES, V19, P196, DOI 10.1038/cr.2008.284; Chumley MJ, 2000, J IMMUNOL, V164, P4586, DOI 10.4049/jimmunol.164.9.4586                                                     ; Clark AG, 2013, AUTOIMMUNITY, V46, P188, DOI 10.3109/08916934.2012.746671; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Cornall RJ, 2000, P NATL ACAD SCI USA, V97, P1713, DOI 10.1073/pnas.97.4.1713                                                          ; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Corti D, 2011, CURR OPIN IMMUNOL, V23, P430, DOI 10.1016/j.coi.2011.04.006; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0                                                                ; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Derudder E, 2009, NAT IMMUNOL, V10, P647, DOI 10.1038/ni.1732; Dingjan GM, 2001, J EXP MED, V193, P1169, DOI 10.1084/jem.193.10.1169                                                         ; Duong BH, 2010, J EXP MED, V207, P173, DOI 10.1084/jem.20091873; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Fang W, 1998, IMMUNITY, V9, P35, DOI 10.1016/S1074-7613(00)80586-5; Fields ML, 2003, CURR OPIN IMMUNOL, V15, P709, DOI 10.1016/j.coi.2003.09.016; FRIPPIAT JP, 1995, HUM MOL GENET, V4, P983; Fujimoto M, 2000, IMMUNITY, V13, P47, DOI 10.1016/S1074-7613(00)00007-8; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Gazumyan A, 2006, J EXP MED, V203, P1785, DOI 10.1084/jem.20060221; Gonzalez-Martin A, 2016, NAT IMMUNOL, V17, P433, DOI 10.1038/ni.3385; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Gunti S, 2015, J INFECT DIS, V212, pS42, DOI 10.1093/infdis/jiu512; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Han A, 2003, IMMUNITY, V19, P621, DOI 10.1016/S1074-7613(03)00275-9; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3                                                    ; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Hayashi K, 2004, J IMMUNOL, V173, P5980, DOI 10.4049/jimmunol.173.10.5980                                                    ; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Henry-Bonami RA, 2013, J IMMUNOL, V190, P5992, DOI 10.4049/jimmunol.1201359; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; HIETER PA, 1981, NATURE, V294, P536, DOI 10.1038/294536a0; Hippen KL, 2005, J IMMUNOL, V175, P909, DOI 10.4049/jimmunol.175.2.909                                                      ; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; Imamura Y, 2009, J BIOL CHEM, V284, P9804, DOI 10.1074/jbc.M809051200; Infantino S, 2010, J EXP MED, V207, P711, DOI 10.1084/jem.20091303; Isnardi I, 2008, IMMUNITY, V29, P746, DOI 10.1016/j.immuni.2008.09.015; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Keren Z, 2004, J BIOL CHEM, V279, P13418, DOI 10.1074/jbc.M311970200; Kinnunen T, 2013, J CLIN INVEST, V123, P2737, DOI 10.1172/JCI68775; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Klasener K, 2014, ELIFE, V3, DOI 10.7554/eLife.02069; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3                                                   ; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Kometani K, 2011, J EXP MED, V208, P1447, DOI 10.1084/jem.20102665; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455                                                           ; Kuraoka M, 2011, P NATL ACAD SCI USA, V108, P11560, DOI 10.1073/pnas.1102571108; Lai MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12207; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lamoureux JL, 2007, J EXP MED, V204, P2853, DOI 10.1084/jem.20071268; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Lang J, 2016, J EXP MED, V213, P93, DOI 10.1084/jem.20151039; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Foreman AL, 2007, AUTOIMMUN REV, V6, P387, DOI 10.1016/j.autrev.2006.12.005; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu Y, 2007, J IMMUNOL, V179, P1340, DOI 10.4049/jimmunol.179.2.1340                                                     ; Llorian M, 2007, J IMMUNOL, V178, P1981, DOI 10.4049/jimmunol.178.4.1981                                                     ; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; Lutz J, 2011, P NATL ACAD SCI USA, V108, P10644, DOI 10.1073/pnas.1019224108; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507                                                     ; Macauley MS, 2013, J CLIN INVEST, V123, P3074, DOI 10.1172/JCI69187; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Malkiel S, 2016, ARTHRITIS RHEUMATOL, V68, P2210, DOI 10.1002/art.39710; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151                                                         ; Meffre E, 2011, ANN NY ACAD SCI, V1246, P1, DOI 10.1111/j.1749-6632.2011.06347.x; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Meng WZ, 2012, J CLIN IMMUNOL, V32, P551, DOI 10.1007/s10875-012-9663-6; Middendorp S, 2004, J IMMUNOL, V172, P1371, DOI 10.4049/jimmunol.172.3.1371                                                     ; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.08036441; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Mukherjee S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003220; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039                                                         ; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0                                                                ; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Nickerson KM, 2013, J IMMUNOL, V190, P1447, DOI 10.4049/jimmunol.1202115; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601                                                     ; Niiro H, 2012, BLOOD, V119, P2263, DOI 10.1182/blood-2011-04-351965; Novak R, 2010, J IMMUNOL, V185, P3239, DOI 10.4049/jimmunol.1001430; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Oellerich T, 2011, EMBO J, V30, P3620, DOI 10.1038/emboj.2011.251; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Otipoby KL, 2015, P NATL ACAD SCI USA, V112, P12145, DOI 10.1073/pnas.1516428112; Packard Thomas A, 2013, F1000Prime Rep, V5, P40, DOI 10.12703/P5-40; PATEL KJ, 1993, CELL, V74, P939, DOI 10.1016/0092-8674(93)90473-4; Pathak S, 2008, MOL CELL BIOL, V28, P2815, DOI 10.1128/MCB.01946-07; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7                                                   ; Pelanda R, 2014, CURR OPIN IMMUNOL, V27, P53, DOI [10.1016/j.col.2014.01.012, 10.1016/j.coi.2014.01.012]; Pewzner-Jung Y, 1998, J IMMUNOL, V161, P4634; PRAK EL, 1994, J EXP MED, V180, P1805, DOI 10.1084/jem.180.5.1805                                                          ; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Ramsey LB, 2011, IMMUNOL LETT, V135, P74, DOI 10.1016/j.imlet.2010.09.018; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Robinson WH, 2016, CURR OPIN RHEUMATOL, V28, P168, DOI 10.1097/BOR.0000000000000250; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6                                                   ; Romberg N, 2013, J CLIN INVEST, V123, P4283, DOI 10.1172/JCI69854; Rowland SL, 2010, J EXP MED, V207, P607, DOI 10.1084/jem.20091673; Ruer-Laventie J, 2015, IMMUN INFLAMM DIS, V3, P265, DOI 10.1002/iid3.65; Saadoun D, 2013, ARTHRITIS RHEUM-US, V65, P1085, DOI 10.1002/art.37828; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; Sauer AV, 2012, J CLIN INVEST, V122, P2141, DOI 10.1172/JCI61788; Schickel J. N., 2016, SCI IMMUNOL, V1; Schlissel M, 2002, SEMIN IMMUNOL, V14, P207, DOI 10.1016/S1044-5323(02)00044-1; Schram BR, 2008, J IMMUNOL, V180, P4728, DOI 10.4049/jimmunol.180.7.4728                                                     ; Schweighoffer E, 2003, IMMUNITY, V18, P523, DOI 10.1016/S1074-7613(03)00082-7                                                   ; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286                                                    ; Shivtiel S, 2002, EUR J IMMUNOL, V32, P2264, DOI 10.1002/1521-4141(200208)32:8<2264::AID-IMMU2264>3.0.CO;2-E; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stanford SM, 2014, NAT REV RHEUMATOL, V10, P602, DOI 10.1038/nrrheum.2014.109; Steinel NC, 2013, J EXP MED, V210, P233, DOI 10.1084/jem.20121605; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8                                                   ; STORB U, 1987, ANNU REV IMMUNOL, V5, P151, DOI 10.1146/annurev.iy.05.040187.001055; Sun A, 2015, P NATL ACAD SCI USA, V112, pE458, DOI 10.1073/pnas.1418001112; Teodorovic LS, 2014, P NATL ACAD SCI USA, V111, pE2797, DOI 10.1073/pnas.1402159111; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009                                                          ; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Townsend CL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00388; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; Ubelhart R, 2015, NAT IMMUNOL, V16, P534, DOI 10.1038/ni.3141; Vela JL, 2008, IMMUNITY, V28, P161, DOI 10.1016/j.immuni.2007.12.011; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332                                                    ; Verkoczy L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004073; Verkoczy LK, 2004, CURR OPIN IMMUNOL, V16, P808, DOI 10.1016/j.coi.2004.09.017; Vince N, 2011, J ALLERGY CLIN IMMUN, V127, P538, DOI 10.1016/j.jaci.2010.10.019; Walter JE, 2010, J EXP MED, V207, P1541, DOI 10.1084/jem.20091927; Wang Y, 2002, IMMUNITY, V17, P501, DOI 10.1016/S1074-7613(02)00426-0                                                   ; Wardemann H, 2004, J EXP MED, V200, P191, DOI 10.1084/jem.2004.0818; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791                                                           ; WINGER L, 1983, P NATL ACAD SCI-BIOL, V80, P4484, DOI 10.1073/pnas.80.14.4484; Yachimovich-Cohen N, 2003, EUR J IMMUNOL, V33, P2469, DOI 10.1002/eji.200324025; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhang Y, 1998, EMBO J, V17, P7304, DOI 10.1093/emboj/17.24.7304; Zou XG, 2003, J IMMUNOL, V170, P1354, DOI 10.4049/jimmunol.170.3.1354                                                     	191	5	6	5	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAY	2017	17	5					281	294		10.1038/nri.2017.19				14	Immunology	Immunology	ET1SY	WOS:000400050400007	28368006	green_accepted			2018-01-05	
J	Osterberg, JT; Xiang, W; Olsen, LI; Edenbrandt, AK; Vedel, SE; Christiansen, A; Landes, X; Andersen, MM; Pagh, P; Sandoe, P; Nielsen, J; Christensen, SB; Thorsen, BJ; Kappel, K; Gamborg, C; Palmgren, M				Osterberg, Jeppe Thulin; Xiang, Wen; Olsen, Lene Irene; Edenbrandt, Anna Kristina; Vedel, Suzanne Elizabeth; Christiansen, Andreas; Landes, Xavier; Andersen, Martin Marchman; Pagh, Peter; Sandoe, Peter; Nielsen, John; Christensen, Soren Brogger; Thorsen, Bo Jellesmark; Kappel, Klemens; Gamborg, Christian; Palmgren, Michael			Accelerating the Domestication of New Crops: Feasibility and Approaches	TRENDS IN PLANT SCIENCE			English	Review							GENETICALLY-MODIFIED FOOD; WILLINGNESS-TO-PAY; RICE DOMESTICATION; GREEN-REVOLUTION; CONSUMER ACCEPTANCE; PROVIDES TOOLS; GRAIN; SECURITY; GENOME; GENE	The domestication of new crops would promote agricultural diversity and could provide a solution to many of the problems associated with intensive agriculture. We suggest here that genome editing can be used as a new tool by breeders to accelerate the domestication of semi-domesticated or even wild plants, building a more varied foundation for the sustainable provision of food and fodder in the future. We examine the feasibility of such plants from biological, social, ethical, economic, and legal perspectives.	[Osterberg, Jeppe Thulin; Olsen, Lene Irene; Palmgren, Michael] Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark; [Xiang, Wen; Pagh, Peter] Univ Copenhagen, Ctr Publ Regulat & Adm, Fac Law, Studiestr 6, DK-1455 Copenhagen K, Denmark; [Edenbrandt, Anna Kristina; Vedel, Suzanne Elizabeth; Thorsen, Bo Jellesmark; Gamborg, Christian] Univ Copenhagen, Dept Food & Resource Econ, Rolighedsvej 23, DK-1958 Frederiksberg C, Denmark; [Christiansen, Andreas; Landes, Xavier; Andersen, Martin Marchman; Kappel, Klemens] Univ Copenhagen, Dept Media Cognit & Commun, Karen Blixens Vej 4, DK-2300 Copenhagen S, Denmark; [Sandoe, Peter] Univ Copenhagen, Dept Large Anim Sci, DK-1870 Frederiksberg C, Denmark; [Nielsen, John; Christensen, Soren Brogger] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen Osterbro, Denmark	Palmgren, M (reprint author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@plen.ku.dk	Thorsen, Bo Jellesmark/K-8770-2014; Gamborg, Christian/L-7392-2014; Palmgren, Michael/A-9808-2013	Thorsen, Bo Jellesmark/0000-0002-3305-8343; Gamborg, Christian/0000-0003-3150-8280; Palmgren, Michael/0000-0002-9982-6114; Kappel, Klemens/0000-0001-7176-6976; Sandoe, Peter/0000-0003-0397-3273; Nielsen, John/0000-0002-2854-8188; Andersen, Martin Marchman/0000-0002-1710-213X; Christensen, Soren Brogger/0000-0002-5773-6874; Christiansen, Andreas/0000-0001-7187-4520	University of Copenhagen Excellence Program for Interdisciplinary Research [KU2016]	This work was supported by the University of Copenhagen Excellence Program for Interdisciplinary Research (KU2016).	Agar N, 1997, ETHICS, V108, P147, DOI 10.1086/233791                                                                  ; Altesor P, 2014, J CHEM ECOL, V40, P599, DOI 10.1007/s10886-014-0447-8; Altpeter F, 2016, PLANT CELL, V28, P1510, DOI 10.1105/tpc.16.00196; Andersen MM, 2015, TRENDS PLANT SCI, V20, P426, DOI 10.1016/j.tplants.2015.04.011; Bagley Margo A., 2013, NAGOYA PROTOCOL SYNT; Begemann F., 2012, RECOMMENDATIONS IMPL; Belamkar V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34908; Bernard JC, 2010, J AGR RESOUR ECON, V35, P457; Bessho-Uehara K, 2016, P NATL ACAD SCI USA, V113, P8969, DOI 10.1073/pnas.1604849113; Bruschi V, 2015, FOOD QUAL PREFER, V46, P79, DOI 10.1016/j.foodqual.2015.07.008; Burton M, 2001, EUR REV AGRIC ECON, V28, P479, DOI 10.1093/erae/28.4.479; Callicot JB., 1980, ENVIRON ETHICS, V2, P311, DOI DOI 10.5840/ENVIROETHICS19802424; Carvajal-Larenas FE, 2016, CRIT REV FOOD SCI, V56, P1454, DOI 10.1080/10408398.2013.772089; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Chen KY, 2007, SCIENCE, V318, P643, DOI 10.1126/science.1148428; Convention on Biological Diversity, 2011, NAG PROT ACC GEN RES; Cooley D, 2004, ETHICS ENV, V9, P46; Council of the European Communities, 1994, OFFICIAL J EUROPEA L, V227, P1; Council of the European Union, 2014, OFFICIAL J EUROPEA L, V150, P59; Cox TS, 2010, CROP PASTURE SCI, V61, P513, DOI 10.1071/CP09201; Dannenberg A, 2009, ECOL ECON, V68, P2182, DOI 10.1016/j.ecolecon.2009.03.008; DeHaan LR, 2016, CROP SCI, V56, P917, DOI 10.2135/cropsci2015.06.0356; Dorn KM, 2015, DNA RES, V22, P121, DOI 10.1093/dnares/dsu045; Dorn KM, 2013, PLANT J, V75, P1028, DOI 10.1111/tpj.12267; Ebert AW, 2014, SUSTAINABILITY-BASEL, V6, P319, DOI 10.3390/su6010319; ELLIOT R, 1982, INQUIRY, V25, P81, DOI 10.1080/00201748208601955                                                       ; European Commission EU citizens' attitudes towards alcohol, 2010, SPEC EUR; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fowler C, 2004, ANNU REV ENV RESOUR, V29, P143, DOI 10.1146/annurev.energy.29.062403.102203; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gonzalez C, 2009, J AGR ECON, V60, P604, DOI 10.1111/j.1477-9552.2009.00219.x; GOODPASTER KE, 1978, J PHILOS, V75, P308, DOI 10.2307/2025709                                                                 ; Gruber K., 2016, NAT PLANTS, V2; Gruere G., 2006, 154 EPT INT FOOD POL; Gudmundsson Gardar, 1996, Vegetation History and Archaeobotany, V5, P13, DOI 10.1007/BF00189431; Hartung F, 2014, PLANT J, V78, P742, DOI 10.1111/tpj.12413; Hilscher J, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600173; Hua L, 2015, PLANT CELL, V27, P1875, DOI 10.1105/tpc.15.00260; International Union for the Protection of New Varieties of Plants (UPOV), 1991, INT CONVENTION PROTE; Ivarson E, 2016, PLANT CELL REP, V35, P2055, DOI 10.1007/s00299-016-2016-9; Jacobsen SE, 2013, AGRON SUSTAIN DEV, V33, P651, DOI 10.1007/s13593-013-0138-9; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Jorgensen K, 2005, PLANT PHYSIOL, V139, P363, DOI 10.1104/pp.105.065904; Kagan Shelly, 1998, NORMATIVE ETHICS; Kang YJ, 2016, PLANT BIOTECHNOL J, V14, P1057, DOI 10.1111/pbi.12449; Kannangara R, 2011, PLANT J, V68, P287, DOI 10.1111/j.1365-313X.2011.04695.x; Kantar MB, 2016, ANNU REV PLANT BIOL, V67, P703, DOI 10.1146/annurev-arplant-043015-112311; Kantarski T, 2017, THEOR APPL GENET, V130, P137, DOI 10.1007/s00122-016-2799-7; Kaye-Blake W, 2005, AUST J AGR RESOUR EC, V49, P413, DOI 10.1111/j.1467-8489.2005.00311.x; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kronberger N, 2014, SCI COMMUN, V36, P106, DOI 10.1177/1075547013500773; Kunkel G., 1984, PLANTS HUMAN CONSUMP; Laffaldano B., 2016, IND CROP PROD, V89, P356; Langridge P, 2014, PLANT PHYSIOL, V166, P1682, DOI 10.1104/pp.114.252601; Lawson C., 2015, J INTELLECTUAL PROPE, V7, P526; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; LIN Z, 2012, NAT LANG ENG, V1, P1; Lusk JL, 2005, J AGR RESOUR ECON, V30, P28; Malory S, 2011, PLANT BIOTECHNOL J, V9, P1131, DOI 10.1111/j.1467-7652.2011.00640.x; Massawe F, 2016, TRENDS PLANT SCI, V21, P365, DOI 10.1016/j.tplants.2016.02.006; Mayes S, 2012, J EXP BOT, V63, P1075, DOI 10.1093/jxb/err396; McKersie B, 2015, J EXP BOT, V66, P3435, DOI 10.1093/jxb/eru547; Michael TP, 2015, CURR OPIN PLANT BIOL, V24, P71, DOI 10.1016/j.pbi.2015.02.002; Mielby H, 2013, AGR HUM VALUES, V30, P471, DOI 10.1007/s10460-013-9430-1; Mijatovic D, 2013, INT J AGR SUSTAIN, V11, P95, DOI 10.1080/14735903.2012.691221; Nour-Eldin HH, 2013, CURR OPIN BIOTECH, V24, P263, DOI 10.1016/j.copbio.2012.09.006; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Olsen KM, 2013, ANNU REV PLANT BIOL, V64, P47, DOI 10.1146/annurev-arplant-050312-120048; Onyango BM, 2004, J AGR RESOUR ECON, V29, P567; Padulosi S, 2011, CROP ADAPTATION TO CLIMATE CHANGE, P507; Palmgren MG, 2015, TRENDS PLANT SCI, V20, P155, DOI 10.1016/j.tplants.2014.11.003; Peter F., 2009, DEMOCRATIC LEGITIMAC; Pingali PL, 2012, P NATL ACAD SCI USA, V109, P12302, DOI 10.1073/pnas.0912953109; Pourkheirandish M, 2015, CELL, V162, P527, DOI 10.1016/j.cell.2015.07.002; Qu CM, 2015, GENES-BASEL, V6, P1215, DOI 10.3390/genes6041215; Runck BC, 2014, CROP SCI, V54, P1939, DOI 10.2135/cropsci2014.03.0195; Shapter FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082641; Siebenhuner B, 2005, ECOL ECON, V53, P507, DOI 10.1016/j.ecolecon.2004.10.012; Siipi H, 2015, J AGR ENVIRON ETHIC, V28, P807, DOI 10.1007/s10806-015-9568-5; Smale M, 2004, GENET RESOUR CROP EV, V51, P121, DOI 10.1023/B:GRES.0000020678.82581.76; Smith J., 2015, EUROPEAN ALLIANCE PL; SMITH RA, 1987, VET HUM TOXICOL, V29, P155; Snapp SS, 2010, P NATL ACAD SCI USA, V107, P20840, DOI 10.1073/pnas.1007199107; Stetter MG, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00816; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Taylor P. W., 2011, RESPECT FOR NATURE; United Nations, 1969, VIENN CONV LAW TREAT; United Nations, 1992, CONV BIOL DIV CBD; FAO, 1997, STAT WORLDS PLANT GE; Food and Agriculture Organization of the UN, 2016, INT TREAT PLANT GEN; Vega-Galvez A, 2010, J SCI FOOD AGR, V90, P2541, DOI 10.1002/jsfa.4158; Visser B., 2013, Crop genetic resources as a global commons: challenges in international law and governance, P265; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Weale A, 2010, NEW BIOTECHNOL, V27, P582, DOI 10.1016/j.nbt.2010.08.013; Winands-Kalkuhl S., 2015, Journal of Natural Resources Policy Research, V7, P305; WINK M, 1984, PLANTA, V161, P519, DOI 10.1007/BF00407083; Wollenweber B, 2005, CURR OPIN PLANT BIOL, V8, P337, DOI 10.1016/j.pbi.2005.03.001; World Bank, 2008, 2008 WORLD BANK	101	2	3	17	33	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1360-1385	1878-4372		TRENDS PLANT SCI	Trends Plant Sci.	MAY	2017	22	5					373	384		10.1016/j.tplants.2017.01.004				12	Plant Sciences	Plant Sciences	ET1SV	WOS:000400050100006	28262427				2018-01-05	
J	Bastet, A; Robaglia, C; Gallois, JL				Bastet, Anna; Robaglia, Christophe; Gallois, Jean-Luc			eIF4E Resistance: Natural Variation Should Guide Gene Editing	TRENDS IN PLANT SCIENCE			English	Review							TRANSLATION INITIATION-FACTORS; POTATO-VIRUS-Y; MESSENGER-RNA TRANSLATION; VENOUS-MOTTLE-VIRUS; ARABIDOPSIS-THALIANA; RECESSIVE RESISTANCE; POTYVIRUS INFECTION; FACTOR 4E; PEPPER; TOMATO	eIF4E translation initiation factors have emerged as major susceptibility factors for RNA viruses. Natural eIF4E-based resistance alleles are found in many species and are mostly variants that maintain the translation function of the protein. eIF4E genes represent major targets for engineering viral resistance, and gene-editing technologies can be used to make up for the lack of natural resistance alleles in some crops, often by knocking out eIF4E susceptibility factors. However, we report here how redundancy among eIF4E genes can restrict the efficient use of knockout alleles in breeding. We therefore discuss how gene-editing technologies can be used to design de novo functional alleles, using knowledge about the natural evolution of eIF4E genes in different species, to drive resistance to viruses without affecting plant physiology.	[Bastet, Anna; Gallois, Jean-Luc] INRA, GAFL, F-84140 Montfavet, France; [Bastet, Anna; Robaglia, Christophe] Aix Marseille Univ, Biol Vegetale & Microbiol Environm UMR 7265, Lab Genet & Biophys Plantes, F-28513009 Marseille, France; [Bastet, Anna; Robaglia, Christophe] CNRS, UMR Biol Vegetale & Microbiol Environm 7265, F-13009 Marseille, France; [Bastet, Anna; Robaglia, Christophe] CEA, Biosci & Biotechnol Inst Aix Marseille, F-13009 Marseille, France	Gallois, JL (reprint author), INRA, GAFL, F-84140 Montfavet, France.	jean-luc.gallois@inra.fr					Garcia JA, 2014, MOL PLANT PATHOL, V15, P226, DOI 10.1111/mpp.12083; Ashby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015873; Blancke S, 2015, TRENDS PLANT SCI, V20, P414, DOI 10.1016/j.tplants.2015.03.011; Browning Karen S, 2015, Arabidopsis Book, V13, pe0176, DOI 10.1199/tab.0176; Callot C, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27940; Cavatorta J, 2011, PLANT BIOTECHNOL J, V9, P1014, DOI 10.1111/j.1467-7652.2011.00622.x; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Chen LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100457; Contreras-Paredes CA, 2013, MOL PLANT MICROBE IN, V26, P461, DOI 10.1094/MPMI-09-12-0225-R; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Eskelin K, 2011, J VIROL, V85, P9210, DOI 10.1128/JVI.00052-11; Frydryskova K, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0072-x; Gallois JL, 2010, J GEN VIROL, V91, P288, DOI 10.1099/vir.0.015321-0; Galvez LC, 2014, PLANT SCI, V228, P11, DOI 10.1016/j.plantsci.2014.07.006; Gao ZH, 2004, PLANT J, V40, P376, DOI 10.1111/j.1365-313X.2004.02215.x; Gauffier C, 2016, PLANT J, V85, P717, DOI 10.1111/tpj.13136; German-Retana S, 2008, J VIROL, V82, P7601, DOI 10.1128/JVI.00209-08; Ho JJD, 2016, TRENDS BIOCHEM SCI, V41, P821, DOI 10.1016/j.tibs.2016.05.009; Hwang J, 2009, MOL CELLS, V27, P329, DOI 10.1007/s10059-009-0042-y; Ibiza VP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-631; Kang BC, 2007, PLANT BIOTECHNOL J, V5, P526, DOI 10.1111/j.1467-7652.2007.00262.x; Lebaron C, 2016, J GEN VIROL, V97, P3063, DOI 10.1099/jgv.0.000609; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Leonard S, 2002, J GEN VIROL, V83, P2085, DOI 10.1099/0022-1317-83-8-2085                                                     ; Li JY, 2016, BIOMED RES INT, DOI 10.1155/2016/4241293; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lu Y, 2016, MOL PLANT; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Mazier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029595; Miras M., 2016, MOL PLANT PATHOL; Nicaise V, 2007, FEBS LETT, V581, P1041, DOI 10.1016/j.febslet.2007.02.007; Nicaise V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00660; Nieto C, 2006, PLANT J, V48, P452, DOI 10.1111/j.1365-313X.2006.202885.x; Patrick RM, 2014, PLANT PHYSIOL, V164, P1820, DOI 10.1104/pp.113.227785; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Poulicard N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006214; Pyott DE, 2016, MOL PLANT PATHOL, V17, P1276, DOI 10.1111/mpp.12417; Quenouille J, 2014, HEREDITY, V112, P579, DOI 10.1038/hdy.2013.138; Quenouille J, 2016, MOL PLANT PATHOL, V17, P296, DOI 10.1111/mpp.12277; Reinbold C, 2013, MOL PLANT MICROBE IN, V26, P257, DOI 10.1094/MPMI-07-12-0174-R; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Rodriguez-Hernandez AM, 2012, MOL PLANT PATHOL, V13, P755, DOI 10.1111/j.1364-3703.2012.00785.x; Ruffel S, 2006, J GEN VIROL, V87, P2089, DOI 10.1099/vir.0.81817-0; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Sato M, 2005, FEBS LETT, V579, P1167, DOI 10.1016/j.febslet.2004.12.086; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Martinez-Silva AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031606; van Schie CCN, 2014, ANNU REV PHYTOPATHOL, V52, P551, DOI 10.1146/annurev-phyto-102313-045854; Wang AM, 2012, MOL PLANT PATHOL, V13, P795, DOI 10.1111/j.1364-3703.2012.00791.x; Wang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050627; Xu X, 2010, EMBO REP, V11, P299, DOI 10.1038/embor.2010.18	55	5	5	35	59	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1360-1385	1878-4372		TRENDS PLANT SCI	Trends Plant Sci.	MAY	2017	22	5					411	419		10.1016/j.tplants.2017.01.008				9	Plant Sciences	Plant Sciences	ET1SV	WOS:000400050100009	28258958				2018-01-05	
J	Sosicka, P; Maszczak-Seneczko, D; Bazan, B; Shauchuk, Y; Kaczmarek, B; Olczak, M				Sosicka, Paulina; Maszczak-Seneczko, Dorota; Bazan, Bozena; Shauchuk, Yauhen; Kaczmarek, Beata; Olczak, Mariusz			An insight into the orphan nucleotide sugar transporter SLC35A4	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Nucleotide sugar transporters; SLC35A subfamily; Golgi apparatus; Endoplasmic reticulum; Glycosylation	UDP-GALACTOSE TRANSPORTER; N-ACETYLGLUCOSAMINE TRANSPORTER; SIALIC-ACID TRANSPORTER; GDP-FUCOSE TRANSPORTER; HAMSTER OVARY CELLS; GOLGI-APPARATUS; MOLECULAR-CLONING; SUBCELLULAR-LOCALIZATION; TRANSMEMBRANE TOPOLOGY; FUNCTIONAL EXPRESSION	SLC35A4 has been classified in the SLC35A subfamily based on amino acid sequence homology. Most of the proteins belonging to the SLC35 family act as transporters of nucleotide sugars. In this study, the subcellular localization of endogenous SLC35A4 was determined via immunofluorescence staining, and it was demonstrated that SLC35A4 localizes mainly to the Golgi apparatus. In silico topology prediction suggests that SLC35A4 has an uneven number of transmembrane domains and its N-terminus is directed towards the Golgi lumen. However, an experimental assay refuted this prediction: SLC35A4 has an even number of transmembrane regions with both termini facing the cytosol. In vivo interaction analysis using the FLIM-FRET approach revealed that SLC35A4 neither forms homomers nor associates with other members of the SLC35A subfamily except SLC35A5. Additional assays demonstrated that endogenous SLC35A4 is 10 to 40 nm proximal to SLC35A2 and SLC35A3. To determine SLC35A4 function SLC35A4 knock-out cells were generated with the CRISPR-Cas9 approach. Although no significant changes in glycosylation were observed, the introduced mutation influenced the subcellular distribution of the SLC35A2/SLC35A3 complexes. Additional FLIM-FRET experiments revealed that overexpression of SLC35A4-BFP together with SLC35A3 and the SLC35A2-Golgi splice variant negatively affects the interaction between the two latter proteins. The results presented here strongly indicate a modulatory role for SLC35A4 in intracellular trafficking of SLC35A2/SLC35A3 complexes. (C) 2017 Elsevier B.V. All rights reserved.	[Sosicka, Paulina; Maszczak-Seneczko, Dorota; Bazan, Bozena; Shauchuk, Yauhen; Kaczmarek, Beata; Olczak, Mariusz] Univ Wroclaw, Fac Biotechnol, Lab Biochem, 14A F Joliot Curie St, PL-50383 Wroclaw, Poland	Olczak, M (reprint author), Univ Wroclaw, Fac Biotechnol, Lab Biochem, 14A F Joliot Curie St, PL-50383 Wroclaw, Poland.	Mariusz.Olczak@uwr.edu.pl		Olczak, Mariusz/0000-0001-8629-6364	National Science Centre (NCN), Krakow, Poland [2014/15/N/NZ1/00492, 2014/15/B/NZ3/00372]	This work was supported by grant no. 2014/15/N/NZ1/00492 and no. 2014/15/B/NZ3/00372 from the National Science Centre (NCN), Krakow, Poland.	Abe M, 1999, FEBS LETT, V458, P309, DOI 10.1016/S0014-5793(99)01177-1                                                   ; Abeijon C, 1996, P NATL ACAD SCI USA, V93, P5963, DOI 10.1073/pnas.93.12.5963                                                         ; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; BRILES EB, 1977, J BIOL CHEM, V252, P1107; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051                                                         ; Chamorey AL, 2002, EUR CYTOKINE NETW, V13, P154; Chan KF, 2016, BIOTECHNOL J, V11, P399, DOI 10.1002/biot.201500331; COATES SW, 1980, J BIOL CHEM, V255, P9225; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Dorre K, 2015, J INHERIT METAB DIS, V38, P931, DOI 10.1007/s10545-015-9828-6; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; Edvardson S, 2013, J MED GENET, V50, P733, DOI 10.1136/jmedgenet-2013-101753; Fagerberg L, 2011, J PROTEOME RES, V10, P3766, DOI 10.1021/pr200379a; FERNELL WR, 1953, ANALYST, V78, P80, DOI 10.1039/an9537800080; FIELD MC, 1995, GLYCOBIOLOGY, V5, P463, DOI 10.1093/glycob/5.5.463; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888                                                         ; Hadley B, 2014, COMPUT STRUCT BIOTEC, V10, P23, DOI 10.1016/j.csbj.2014.05.003; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; HANSSON GC, 1986, EMBO J, V5, P483; HARA T, 1989, J BIOCHEM-TOKYO, V106, P236, DOI 10.1093/oxfordjournals.jbchem.a122838                                           ; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hoffmann P, 2010, RAPID COMMUN MASS SP, V24, P2295, DOI 10.1002/rcm.4636; Stoffel W., 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Ishida N, 1998, J BIOCHEM, V124, P171, DOI 10.1093/oxfordjournals.jbchem.a022076                                           ; Ishida N, 1999, J BIOCHEM-TOKYO, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437                                           ; Kabuss R, 2005, GLYCOBIOLOGY, V15, P905, DOI 10.1093/glycob/cwi085; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/88289; Martinez-Duncker I, 2005, BLOOD, V105, P2671, DOI 10.1182/blood-2004-09-3509; Maszczak-Seneczko D, 2015, J BIOL CHEM, V290, P15475, DOI 10.1074/jbc.M115.636670; Maszczak-Seneczko D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.460543; Maszczak-Seneczko D, 2012, FEBS LETT, V586, P4082, DOI 10.1016/j.febslet.2012.10.016; Maszczak-Seneczko D, 2011, ACTA BIOCHIM POL, V58, P413; Maszczak-Seneczko D, 2011, FEBS LETT, V585, P3090, DOI 10.1016/j.febslet.2011.08.038; Maszczak-Seneczko D., 2016, METHOD MOL BIOL, P133; Meng RH, 2012, BLOOD, V120, P404, DOI 10.1182/blood-2011-11-389551; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319                                                           ; Ng BG, 2013, AM J HUM GENET, V92, P632, DOI 10.1016/j.ajhg.2013.03.012; Olczak M, 2006, BBA-MOL CELL RES, V1763, P82, DOI 10.1016/j.bbamcr.2005.12.006; Perez-Marquez J, 2002, J NEUROBIOL, V52, P166, DOI 10.1002/neu.10076; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Pugielli L, 1999, J BIOL CHEM, V274, P35596; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Schachter H., 1994, MOL GLYCOBIOLOGY, P88; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Sosicka P, 2014, BIOCHEM BIOPH RES CO, V454, P486, DOI 10.1016/j.bbrc.2014.10.098; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; STANLEY P, 1980, J CELL BIOL, V85, P60, DOI 10.1083/jcb.85.1.60                                                             ; Toma L, 1996, J BIOL CHEM, V271, P3897; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ulloa-Aguirre A, 2003, BIOL REPROD, V69, P379, DOI 10.1095/biolreprod.103.016915; VANDENEIJNDEN DH, 1993, CURR OPIN STRUC BIOL, V3, P711, DOI 10.1016/0959-440X(93)90054-O                                                    ; Varki A, 2009, ESSENTIAL GLYCOBIOLO; Varki A., 2009, CURR PROTOC PROTEIN, V57; Wei ZB, 2016, AUTOPHAGY, V12, P1168, DOI 10.1080/15548627.2016.1179402; Yoshioka S, 1997, J BIOCHEM-TOKYO, V122, P691; Zhang PQ, 2012, GLYCOBIOLOGY, V22, P897, DOI 10.1093/glycob/cws064; Zhang Z, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004124	70	0	0	1	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	MAY	2017	1864	5					825	838		10.1016/j.bbamcr.2017.02.002				14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	ER5UW	WOS:000398870300008	28167211				2018-01-05	
J	Mehrotra, R; Renganaath, K; Kanodia, H; Loake, GJ; Mehrotra, S				Mehrotra, Rajesh; Renganaath, Kaushik; Kanodia, Harsh; Loake, Gary J.; Mehrotra, Sandhya			Towards combinatorial transcriptional engineering	BIOTECHNOLOGY ADVANCES			English	Review						Promoters; Transcription factors; Gene expression; Synthetic biology; Transcriptional engineering; Tale; CRISPR	UPSTREAM ACTIVATION SITES; SYNTHETIC GENE NETWORKS; DNA-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; ZINC-FINGER; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; TAL EFFECTORS; YARROWIA-LIPOLYTICA; HYBRID PROMOTERS; YEAST PROMOTERS	The modular nature of the transcriptional unit makes it possible to design robust modules with predictable input-output characteristics using a 'parts-off a shelf' approach. Customized regulatory circuits composed of multiple such transcriptional units have immense scope for application indiverse fields of basic and applied research. Synthetic transcriptional engineering seeks to construct such genetic cascades. Here, we discuss the three principle strands of transcriptional engineering: promoter and transcriptional factor engineering, and programming inducibilty into synthetic modules. In this context, we review the scope and limitations of some recent technologies that seek to achieve these ends. Our discussion emphasizes a requirement for rational combinatorial engineering principles and the promise this approach holds for the future development of this field. (C) 2017 Elsevier Inc. All rights reserved.	[Mehrotra, Rajesh; Renganaath, Kaushik; Kanodia, Harsh; Mehrotra, Sandhya] Birla Inst Technol & Sci BITS Pilani, Dept Biol Sci, Pilani 333031, Rajasthan, India; [Loake, Gary J.] Univ Edinburgh, Inst Mol Plant Sci, Sch Biol Sci, Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland	Mehrotra, R (reprint author), Birla Inst Technol & Sci BITS Pilani, Dept Biol Sci, Pilani 333031, Rajasthan, India.	rmehrotra@pilani.bits-pilani.ac.in			BBSRC	We would like to thank Prof. PK Gupta (CCS University, Meerut, India) for proofreading the manuscript and providing valuable suggestions. Research in the Loake lab is supported by the BBSRC. RM is thankful to Indian National Science academy and Royal Society of Edinburgh for support as bilateral exchange fellow to visit Loake lab. RM and SM are thankful to Department of Biological Sciences, BITS, Pilani for infrastructure support.	Agmon N, 2015, ACS SYNTH BIOL, V4, P853, DOI 10.1021/sb500372z; ALBER T, 1982, Journal of Molecular and Applied Genetics, V1, P419; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Ang J, 2013, BIOPHYS J, V104, P505, DOI 10.1016/j.bpj.2012.12.015; Ang J, 2010, J THEOR BIOL, V266, P723, DOI 10.1016/j.jtbi.2010.07.034; Baker D, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0606-44                                               ; BASSEL J, 1971, J BACTERIOL, V108, P179; Bhattacharjee S, 2013, BIOMED RES INT, DOI 10.1155/2013/407263; BITTER GA, 1984, GENE, V32, P263, DOI 10.1016/0378-1119(84)90002-7; Blackburn MC, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1497; Blazeck J, 2013, APPL MICROBIOL BIOT, V97, P3037, DOI 10.1007/s00253-012-4421-5; Blazeck J, 2013, BIOTECHNOL J, V8, P46, DOI 10.1002/biot.201200120; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brewster RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002811; Bruckner K, 2015, PLANT J, V82, P707, DOI 10.1111/tpj.12843; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Chen XJ, 2016, NUCLEIC ACIDS RES, V44, P2677, DOI 10.1093/nar/gkv1343; Choo Y, 2000, CURR OPIN STRUC BIOL, V10, P411, DOI 10.1016/S0959-440X(00)00107-X; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curran KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5002; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; de Lange O, 2015, NUCLEIC ACIDS RES, V43, P10065, DOI 10.1093/nar/gkv1053; de Lange O, 2014, NUCLEIC ACIDS RES, V42, P7436, DOI 10.1093/nar/gku329; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; DENIS CL, 1983, J BIOL CHEM, V258, P1165; Didovyk A, 2016, ACS SYNTH BIOL, V5, P81, DOI [10.1021/acssynbio5b00147, 10.1021/acssynbio.5b00147]; DOUGLAS HC, 1964, GENETICS, V49, P837; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; GATIGNOL A, 1990, GENE, V91, P35, DOI 10.1016/0378-1119(90)90159-O; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Green A. A., 2014, BIOPHYS J, V159, P925; GUARENTE L, 1984, P NATL ACAD SCI-BIOL, V81, P7860, DOI 10.1073/pnas.81.24.7860; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; He WJ, 2006, HUM GENE THER, V17, P949, DOI 10.1089/hum.2006.17.949                                                         ; HITZEMAN RA, 1981, NATURE, V293, P717, DOI 10.1038/293717a0; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; HOLLAND MJ, 1978, BIOCHEMISTRY-US, V17, P4900, DOI 10.1021/bi00616a007; Jensen PR, 1998, BIOTECHNOL BIOENG, V58, P191, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<191::AID-BIT11>3.0.CO;2-G; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Jeppsson M, 2003, YEAST, V20, P1263, DOI 10.1002/yea.1043; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834                                                           ; Jusiak B, 2016, TRENDS BIOTECHNOL, V34, P535, DOI 10.1016/j.tibtech.2015.12.014; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kabadi AM, 2014, METHODS, V69, P188, DOI 10.1016/j.ymeth.2014.06.014; KELLERMANN E, 1986, NUCLEIC ACIDS RES, V14, P8963, DOI 10.1093/nar/14.22.8963; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/NMETH.2969, 10.1038/nmeth.2969]; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kumar S, 2015, PLANT MOL BIOL, V87, P341, DOI 10.1007/s11103-015-0281-6; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Le Bec C, 2006, GENE THER, V13, P805, DOI 10.1038/sj.gt.3302724; Leavitt JM, 2016, BIOTECHNOL J, V11, P866, DOI 10.1002/biot.201600029; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77                                                   ; Lemken ML, 2005, WORLD J GASTROENTERO, V11, P5295, DOI 10.3748/wjg.v11.i34.5295                                                        ; Li YQ, 2015, NAT CHEM BIOL, V11, P207, DOI 10.1038/nchembio.1736; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085755; Liu WS, 2016, CURR OPIN BIOTECH, V37, P36, DOI 10.1016/j.copbio.2015.10.001; Liu WS, 2013, PLANT BIOTECHNOL J, V11, P43, DOI 10.1111/pbi.12005; Liu WS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-108; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lundqvist M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv036; Ma AN, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-20; Madzak C, 2000, J MOL MICROB BIOTECH, V2, P207; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mazumder M, 2014, NUCLEIC ACIDS RES, V42, P9514, DOI 10.1093/nar/gku651; MCALISTER L, 1985, J BIOL CHEM, V260, P5019; McIsaac RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1313; McIsaac RS, 2011, MOL BIOL CELL, V22, P4447, DOI 10.1091/mbc.E11-05-0466; Mehrotra R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-203; Mehrotra R, 2011, PLANT MOL BIOL, V75, P527, DOI 10.1007/s11103-011-9755-3; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Mercer AC, 2014, ACS SYNTH BIOL, V3, P723, DOI 10.1021/sb400114p; Meyer P, 1996, ANNU REV PLANT PHYS, V47, P23, DOI 10.1146/annurev.arplant.47.1.23                                                 ; Mitchell LA, 2015, NUCLEIC ACIDS RES, V43, P6620, DOI 10.1093/nar/gkv466; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Mogno I, 2010, GENOME RES, V20, P1391, DOI 10.1101/gr.106732.110; Molina C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-25; Moore R, 2014, ACS SYNTH BIOL, V3, P708, DOI 10.1021/sb400137b; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Nevoigt E, 2007, BIOTECHNOL BIOENG, V96, P550, DOI 10.1002/bit.21129; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; NISHIZAWA M, 1989, MOL CELL BIOL, V9, P442, DOI 10.1128/MCB.9.2.442                                                             ; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; OGDEN JE, 1986, MOL CELL BIOL, V6, P4335, DOI 10.1128/MCB.6.12.4335                                                           ; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313                                                ; Patel S, 2014, ACS NANO, V8, P8959, DOI 10.1021/nn501589f; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Polstein LR, 2012, J AM CHEM SOC, V134, P16480, DOI 10.1021/ja3065667; Purcell O, 2014, ACS SYNTH BIOL, V3, P737, DOI 10.1021/sb400134k; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rajkumar AS, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw553; Rao CV, 2012, CURR OPIN BIOTECH, V23, P689, DOI 10.1016/j.copbio.2011.12.015; Redden H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8810; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rogers JK, 2015, NUCLEIC ACIDS RES, V43, P7648, DOI 10.1093/nar/gkv616; Tekamp-olson P., 1992, ENHANCED YEAST TRANS; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schlabach MR, 2010, P NATL ACAD SCI USA, V107, P2538, DOI 10.1073/pnas.0914803107; SENGSTAG C, 1988, GENE, V67, P223, DOI 10.1016/0378-1119(88)90399-X; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Siegl T, 2013, METAB ENG, V19, P98, DOI 10.1016/j.ymben.2013.07.006; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; Solem C, 2002, APPL ENVIRON MICROB, V68, P2397, DOI 10.1128/AEM.68.5.2397-2403.2002; Stella S, 2014, ACTA CRYSTALLOGR F, V70, P87, DOI 10.1107/S2053230X13033037; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Taylor ND, 2016, NAT METHODS, V13, P177, DOI [10.1038/NMETH.3696, 10.1038/nmeth.3696]; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Venter M, 2007, TRENDS PLANT SCI, V12, P118, DOI 10.1016/j.tplants.2007.01.002; Venter M, 2009, J CELL MOL MED, V13, P270, DOI 10.1111/j.1582-4934.2008.00371.x; Vilar JMG, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100058; Vogl T, 2014, ACS SYNTH BIOL, V3, P188, DOI 10.1021/sb400091p; Wang BS, 2001, NAT STRUCT BIOL, V8, P589, DOI 10.1038/89617; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; Wolfe SA, 2000, STRUCT FOLD DES, V8, P739, DOI 10.1016/S0969-2126(00)00161-1                                                   ; Xi LQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-346; Yang K, 2016, BIOINFORMATICS, V32, P937, DOI 10.1093/bioinformatics/btv664; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	147	0	0	21	38	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0734-9750	1873-1899		BIOTECHNOL ADV	Biotechnol. Adv.	MAY-JUN	2017	35	3					390	405		10.1016/j.biotechadv.2017.03.006				16	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ES3LN	WOS:000399431200005	28300614				2018-01-05	
J	Oba, A; Shimada, S; Akiyama, Y; Nishikawaji, T; Mogushi, K; Ito, H; Matsumura, S; Aihara, A; Mitsunori, Y; Ban, D; Ochiai, T; Kudo, A; Asahara, H; Kaida, A; Miura, M; Tanabe, M; Tanaka, S				Oba, Atsushi; Shimada, Shu; Akiyama, Yoshimitsu; Nishikawaji, Taketo; Mogushi, Kaoru; Ito, Hiromitsu; Matsumura, Satoshi; Aihara, Arihiro; Mitsunori, Yusuke; Ban, Daisuke; Ochiai, Takanori; Kudo, Atsushi; Asahara, Hiroshi; Kaida, Atsushi; Miura, Masahiko; Tanabe, Minoru; Tanaka, Shinji			ARID2 modulates DNA damage response in human hepatocellular carcinoma cells	JOURNAL OF HEPATOLOGY			English	Article						Hepatocellular carcinoma; ARID2; DNA damage response; Nucleotide excision repair; SWI/SNF; XPC; CRISPR/Cas9; XPG; Benzo[a]pyrene	NUCLEOTIDE EXCISION-REPAIR; PARP INHIBITORS; CANCER; MUTATIONS; MELANOMA; METASTASIS; LANDSCAPE; PATHWAYS; BLOCKADE; GENE	Background & Aims: Recent genomic studies have identified frequent mutations of AT-rich interactive domain 2 (ARID2) in hepatocellular carcinoma (HCC), but it is not still understood how ARID2 exhibits tumor suppressor activities. Methods: We established the ARID2 knockout human HCC cell lines by using CRISPR/Cas9 system, and investigated the gene expression profiles and biological functions. Results: Bioinformatic analysis indicated that UV-response genes were negatively regulated in the ARID2 knockout cells, and they were sensitized to UV irradiation. ARID2 depletion attenuated nucleotide excision repair (NER) of DNA damage sites introduced by exposure to UV as well as chemical compounds known as carcinogens for HCC, benzo[a]pyrene and FeCl3, since xeroderma pigmentosum complementation group G (XPG) could not accumulate without ARID2. By using large-scale public data sets, we validated that ARID2 knockout could lead to similar molecular changes between in vitro and in vivo settings. A higher number of somatic mutations in the ARID2-mutated subtypes than that in the ARID2 wild-type across various types of cancers including HCC was observed. Conclusions: We provide evidence that ARID2 knockout could contribute to disruption of NER process through inhibiting the recruitment of XPG, resulting in susceptibility to carcinogens and potential hypermutation. These findings have implications for therapeutic targets in cancers harboring ARID2 mutations. Lay summary: Recent genomic studies have identified frequent mutations of ARID2, a component of the SWItch/Sucrose NonFermentable (SWI/SNF) complex, in hepatocellular carcinoma, but it is not still understood how ARID2 exhibits tumor suppressor activities. In current study, we provided evidence that ARID2 knockout could contribute to disruption of DNA repair process, resulting in susceptibility to carcinogens and potential hypermutation. These findings have far-reaching implications for therapeutic targets in cancers harboring ARID2 mutations. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Oba, Atsushi; Shimada, Shu; Akiyama, Yoshimitsu; Nishikawaji, Taketo; Mogushi, Kaoru; Tanaka, Shinji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Oncol, Tokyo, Japan; [Oba, Atsushi; Ito, Hiromitsu; Matsumura, Satoshi; Aihara, Arihiro; Mitsunori, Yusuke; Ban, Daisuke; Ochiai, Takanori; Kudo, Atsushi; Tanabe, Minoru; Tanaka, Shinji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan; [Asahara, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Syst Biomed, Tokyo, Japan; [Kaida, Atsushi; Miura, Masahiko] Tokyo Med & Dent Univ, Grad Sch Dent Sci, Dept Oral Hlth Sci, Tokyo, Japan	Tanaka, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Oncol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	tanaka.monc@tmd.ac.jp		Mogushi, Kaoru/0000-0002-2618-8684	Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Project for Cancer Research and Therapeutic Evolution (P-CREATE); Japan Agency for Medical Research and Development (AMED); Princess Takamatsu Cancer Research Fund; Ministry of Education, Culture, Sports, Science & Technology of Japan; Health & Labour Sciences Research Grant from the Ministry of Health Labour & Welfare of Japan	This work was supported by Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Project for Cancer Research and Therapeutic Evolution (P-CREATE); Japan Agency for Medical Research and Development (AMED); a Research Grant from the Princess Takamatsu Cancer Research Fund; a Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Research (A) from the Ministry of Education, Culture, Sports, Science & Technology of Japan, and a Health & Labour Sciences Research Grant from the Ministry of Health Labour & Welfare of Japan.	Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Freitas AA, 2011, MUTAT RES-REV MUTAT, V728, P12, DOI 10.1016/j.mrrev.2011.05.001; Fujimoto A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7120; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kanchi KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4156; Khanna A, 2015, CANCER RES, V75, P2133, DOI 10.1158/0008-5472.CAN-14-3247; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Kulms D, 2002, ONCOGENE, V21, P5844, DOI 10.1038/sj.onc.1205743; Lee JM, 2014, ANN ONCOL, V25, P32, DOI 10.1093/annonc/mdt384; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Morgan MA, 2015, CLIN CANCER RES, V21, P2898, DOI 10.1158/1078-0432.CCR-13-3229; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Romero OA, 2014, ONCOGENE, V33, P2681, DOI 10.1038/onc.2013.227; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tanaka S, 2006, J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Tanaka S, 2012, SEMIN ONCOL, V39, P486, DOI 10.1053/j.seminoncol.2012.05.005; Tanaka S, 2011, HEPATOLOGY, V54, P1273, DOI 10.1002/hep.24536; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Zhao H, 2011, ONCOTARGET, V2, P886; Zhao Q, 2009, J BIOL CHEM, V284, P30424, DOI 10.1074/jbc.M109.044982	36	0	0	4	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	MAY	2017	66	5					942	951		10.1016/j.jhep.2016.12.026				10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	ES0DM	WOS:000399196300012	28238438				2018-01-05	
J	Grice, LF; Gauthier, MEA; Roper, KE; Fernandez-Busquets, X; Degnan, SM; Degnan, BM				Grice, Laura F.; Gauthier, Marie E. A.; Roper, Kathrein E.; Fernandez-Busquets, Xavier; Degnan, Sandie M.; Degnan, Bernard M.			Origin and Evolution of the Sponge Aggregation Factor Gene Family	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						aggregation factor; intron phase; allorecognition; polymorphism; Porifera; RNA editing	UNIQUE PROTEOGLYCAN COMPLEX; CELL-ADHESION; GEODIA-CYDONIUM; MICROCIONA-PROLIFERA; HYDRACTINIA-SYMBIOLONGICARPUS; HISTOCOMPATIBILITY LOCUS; AMPHIMEDON-QUEENSLANDICA; CIRCULAR PROTEOGLYCANS; APHROCALLISTES-VASTUS; PHASE DISTRIBUTION	Although discriminating self from nonself is a cardinal animal trait, metazoan allorecognition genes do not appear to be homologous. Here, we characterize the Aggregation Factor (AF) gene family, which encodes putative allorecognition factors in the demosponge Amphimedon queenslandica, and trace its evolution across 24 sponge (Porifera) species. The AF locus in Amphimedon is comprised of a cluster of five similar genes that encode Calx-beta and Von Willebrand domains and a newly defined Wreath domain, and are highly polymorphic. Further AF variance appears to be generated through individualistic patterns of RNA editing. The AF gene family varies between poriferans, with protein sequences and domains diagnostic of the AF family being present in Amphimedon and other demosponges, but absent from other sponge classes. Within the demosponges, AFs vary widely with no two species having the same AF repertoire or domain organization. The evolution of AFs suggests that their diversification occurs via high allelism, and the continual and rapid gain, loss and shuffling of domains over evolutionary time. Given the marked differences in metazoan allorecognition genes, we propose the rapid evolution of AFs in sponges provides a model for understanding the extensive diversification of self-nonself recognition systems in the animal kingdom.	[Grice, Laura F.; Gauthier, Marie E. A.; Roper, Kathrein E.; Degnan, Sandie M.; Degnan, Bernard M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Fernandez-Busquets, Xavier] Inst Bioengn Catalonia IBEC, Nanomalaria Grp, Barcelona, Spain; [Fernandez-Busquets, Xavier] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Inst Global Hlth, Barcelona, Spain; [Fernandez-Busquets, Xavier] Univ Barcelona, Nanosci & Nanotechnol Inst IN2UB, Barcelona, Spain	Degnan, BM (reprint author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	b.degnan@uq.edu.au		Grice, Laura/0000-0002-9813-4722	Australian Research Council [DP0985995, FL110100044]	This work was supported by the Australian Research Council (grant numbers DP0985995 to S.D. and FL110100044 to B.D.). We thank Federico Gaiti, Kevin Kocot and Selene Fernandez-Valverde for generation and assembly of some of the transcriptomes included in this analysis, andWilliam Hatleberg for providing genome-wide Pfam annotation results for Amphimedon queenslandica. We also thank Maja Adamska and Marcin Adamski for access to genomic data for Sycon ciliatum prior to publication.	AMANO S, 1990, BIOL BULL, V179, P272, DOI 10.2307/1542318; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Cadavid LF, 2004, GENETICS, V167, P357, DOI 10.1534/genetics.167.1.357; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Casazza A, 2007, ADV EXP MED BIOL, V600, P90; CAULDWELL CB, 1973, BIOCHEMISTRY-US, V12, P3051, DOI 10.1021/bi00740a017; DAY AJ, 1989, PROGRESS IN IMMUNOLOGY, VOL 7, P209; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; DUNHAM P, 1983, P NATL ACAD SCI-BIOL, V80, P4756, DOI 10.1073/pnas.80.15.4756; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; FEDOROV A, 1992, NUCLEIC ACIDS RES, V20, P2553, DOI 10.1093/nar/20.10.2553; Fedorov A, 1998, J MOL EVOL, V46, P263, DOI 10.1007/PL00006302; Fernandez-Busquets X, 2003, CELL MOL LIFE SCI, V60, P88, DOI 10.1007/s000180300006                                                           ; Fernandez-Busquets X, 1999, MICROSC RES TECHNIQ, V44, P204, DOI 10.1002/(SICI)1097-0029(19990215)44:4<204::AID-JEMT2>3.0.CO;2-I                 ; Fernandez-Busquets X, 2002, DEV COMP IMMUNOL, V26, P313, DOI 10.1016/S0145-305X(01)00079-9; Fernandez-Busquets X, 1998, J BIOL CHEM, V273, P29545, DOI 10.1074/jbc.273.45.29545                                                        ; Fernandez-Busquets X, 2009, MOL BIOL EVOL, V26, P2551, DOI 10.1093/molbev/msp170; Fernandez-Valverde SL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1588-z; FernandezBusquets X, 1997, J BIOL CHEM, V272, P27839, DOI 10.1074/jbc.272.44.27839; FernandezBusquets X, 1996, J BIOL CHEM, V271, P23558, DOI 10.1074/jbc.271.38.23558                                                        ; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Fortunato SAV, 2014, NATURE, V514, P620, DOI 10.1038/nature13881; Galtsoff PS, 1925, J EXP ZOOL, V42, P183, DOI 10.1002/jez.1400420109                                                          ; Gauthier M, 2008, DEV COMP IMMUNOL, V32, P1270, DOI 10.1016/j.dci.2008.04.002; Gloria-Soria A, 2012, MOL BIOL EVOL, V29, P3921, DOI 10.1093/molbev/mss197; Grice LF, 2015, ADV MAR GENOMICS, V2, P395, DOI 10.1007/978-94-017-9642-2_19; Grice LF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0279-3; Gundacker D, 2001, GLYCOBIOLOGY, V11, P21, DOI 10.1093/glycob/11.1.21; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; HENKART P, 1973, BIOCHEMISTRY-US, V12, P3045, DOI 10.1021/bi00740a016; HILDEMANN WH, 1979, SCIENCE, V204, P420, DOI 10.1126/science.441730; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; HUMBERTDAVID N, 1993, EUR J BIOCHEM, V216, P255, DOI 10.1111/j.1432-1033.1993.tb18140.x; HUMPHREYS T, 1960, BIOL BULL, V119, P294; Jarchow J, 2000, J STRUCT BIOL, V132, P95, DOI 10.1006/jsbi.2000.4309; JUMBLATT JE, 1980, BIOCHEMISTRY-US, V19, P1038, DOI 10.1021/bi00546a032; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Karadge UB, 2015, CURR BIOL, V25, P2845, DOI 10.1016/j.cub.2015.09.030; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Lee BTK, 2003, NUCLEIC ACIDS RES, V31, P3533, DOI 10.1093/nar/gkg561; Leys SP, 1999, J EXP BIOL, V202, P1139; Leys SP, 2008, COLD SPRING HARB PRO, V2008; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; McKitrick TR, 2010, SEMIN IMMUNOL, V22, P34, DOI 10.1016/j.smim.2009.12.001; MISEVIC GN, 1990, J CELL BIOCHEM, V43, P307, DOI 10.1002/jcb.240430403; MISEVIC GN, 1993, J BIOL CHEM, V268, P4922; Mokady O, 1996, GENETICS, V143, P823; Moore AD, 2014, BIOINFORMATICS, V30, P282, DOI 10.1093/bioinformatics/btt640; MOSCONA AA, 1968, DEV BIOL, V18, P250, DOI 10.1016/0012-1606(68)90035-3; MULLER WEG, 1994, BIOL CHEM H-S, V375, P53, DOI 10.1515/bchm3.1994.375.1.53; MULLER WEG, 1976, BIOCHIM BIOPHYS ACTA, V418, P217, DOI 10.1016/0005-2787(76)90071-X                                                    ; MULLER WEG, 1982, INT REV CYTOL, V77, P129, DOI 10.1016/S0074-7696(08)62466-3                                                   ; MULLER WEG, 1984, DIFFERENTIATION, V26, P30, DOI 10.1111/j.1432-0436.1984.tb01369.x; MULLER WEG, 1987, J BIOL CHEM, V262, P9850; MULLER WEG, 1973, EXP CELL RES, V80, P95, DOI 10.1016/0014-4827(73)90279-6; Muller WEG, 1999, MICROSC RES TECHNIQ, V44, P219, DOI 10.1002/(SICI)1097-0029(19990215)44:4<219::AID-JEMT3>3.0.CO;2-7; Mungpakdee S, 2014, GENOME BIOL EVOL, V6, P1408, DOI 10.1093/gbe/evu109; Nicotra ML, 2009, CURR BIOL, V19, P583, DOI 10.1016/j.cub.2009.02.040; Nydam ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065980; Nydam ML, 2013, DEV COMP IMMUNOL, V41, P128, DOI 10.1016/j.dci.2013.03.004; Nyholm SV, 2006, IMMUNITY, V25, P163, DOI 10.1016/j.immuni.2006.04.011; PATTHY L, 1988, J MOL BIOL, V202, P689, DOI 10.1016/0022-2836(88)90550-5; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9                                                    ; PFEIFER K, 1993, J CELL SCI, V106, P545; Powell AE, 2007, GENETICS, V177, P2101, DOI 10.1534/genetics.107.075689; Powell AE, 2011, G3-GENES GENOM GENET, V1, P499, DOI 10.1534/g3.111.001149; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2                                                   ; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Riesgo A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-376; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; RINKEVICH B, 1995, P ROY SOC B-BIOL SCI, V259, P319, DOI 10.1098/rspb.1995.0047; Rosa SFP, 2010, CURR BIOL, V20, P1122, DOI 10.1016/j.cub.2010.04.050; ROTTMANN M, 1987, EMBO J, V6, P3939; Sabella C, 2007, J IMMUNOL, V179, P5927, DOI 10.4049/jimmunol.179.9.5927                                                     ; SCHRODER HC, 1988, J BIOL CHEM, V263, P16334; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Smith LC, 2010, ADV EXP MED BIOL, V708, P260; SMITH LC, 1986, PROC R SOC SER B-BIO, V226, P445, DOI 10.1098/rspb.1986.0003; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stangegaard M, 2006, BIOTECHNIQUES, V40, P649, DOI 10.2144/000112153; Thacker RW, 2013, INTEGR COMP BIOL, V53, P373, DOI 10.1093/icb/ict071; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Voskoboynik A, 2013, SCIENCE, V341, P384, DOI 10.1126/science.1238036; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiens M, 2005, J BIOL CHEM, V280, P27949, DOI 10.1074/jbc.M504049200; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; Wimmer W, 1999, CELL ADHES COMMUN, V7, P111, DOI 10.3109/15419069909034395                                                       	95	1	1	7	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	MAY	2017	34	5					1083	1099		10.1093/molbev/msx058				17	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	ES2QP	WOS:000399373300005	28104746	gold			2018-01-05	
J	Titeux, M; Izmiryan, A; Hovnanian, A				Titeux, Matthias; Izmiryan, Araksya; Hovnanian, Alain			The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; PLURIPOTENT STEM-CELLS; VII COLLAGEN; BONE-MARROW; IN-VIVO; HEDGEHOG PATHWAY; ALOPECIA-AREATA; SKIN INTEGRITY; NEVUS SYNDROME; HUMAN HOMOLOG	Stunning technological advances in genomics have led to spectacular breakthroughs in the understanding of the underlying defects, biological pathways and therapeutic targets of skin diseases leading to new therapeutic interventions. Next-generation sequencing has revolutionized the identification of disease-causing genes and has a profound impact in deciphering gene and protein signatures in rare and frequent skin diseases. Gene addition strategies have shown efficacy in junctional EB and in recessive dystrophic EB (RDEB). TALENs and Cripsr/Cas9 have emerged as highly efficient new tools to edit genomic sequences to creat new models and to correct or disrupt mutated genes to treat human diseases. Therapeutic approaches have not been limited to DNA modification and strategies at the mRNA, protein and cellular levels have also emerged, some of which have already proven clinical efficacy in RDEB. Improved understanding of the pathogenesis of skin disorders has led to the development of specific drugs or repurposing of existing medicines as in basal cell nevus syndrome, alopecia areata, melanoma and EB simplex. These discoveries pave the way for improved targeted personalized medicine for rare and frequent diseases. It is likely that a growing number of orphan skin diseases will benefit from combinatory new therapies in a near future.	[Titeux, Matthias; Izmiryan, Araksya; Hovnanian, Alain] INSERM UMR 1163, Paris, France; [Titeux, Matthias; Izmiryan, Araksya; Hovnanian, Alain] Imagine Inst, Paris, France; [Titeux, Matthias; Izmiryan, Araksya; Hovnanian, Alain] Univ Paris Descartes Sorbonne Cite, Paris, France; [Hovnanian, Alain] Necker Hosp Sick Children, Dept Genet, Paris, France	Hovnanian, A (reprint author), INSERM UMR 1163, Imagine Inst, 24 Blvd Montparnasse, F-75015 Paris, France.	alain.hovnanian@inserm.fr	Titeux, Matthias/K-8411-2017; Hovnanian, Alain/I-4711-2017	Hovnanian, Alain/0000-0003-3412-7512			Abdul-Wahab A, 2014, SEMIN CUTAN MED SURG, V33, P83, DOI 10.12788/j.sder.0085                                                            ; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Aikawa E, 2015, SCI REP-UK, V5, DOI 10.1038/srep11008; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Aufenvenne K, 2013, AM J HUM GENET, V93, P620, DOI 10.1016/j.ajhg.2013.08.003; Casal ML, 2007, AM J HUM GENET, V81, P1050, DOI 10.1086/521988; Chamorro C, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2016.19; Chen YJ, 2015, CELL STEM CELL, V17, P233, DOI 10.1016/j.stem.2015.06.001; Conget P, 2010, CYTOTHERAPY, V12, P429, DOI 10.3109/14653241003587637; Cui XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13286; Epstein EH, 2015, J INVEST DERMATOL, V135, P2341, DOI 10.1038/jid.2015.245; Georgiadis C, 2016, J INVEST DERMATOL, V136, P284, DOI 10.1038/JID.2015.364; Goto M, 2006, J INVEST DERMATOL, V126, P2614, DOI 10.1038/sj.jid.5700435; Guo HT, 2013, J MOL MED, V91, P1177, DOI 10.1007/s00109-013-1066-5; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iinuma S, 2015, J IMMUNOL, V194, P1996, DOI 10.4049/jimmunol.1400914; Inkeles MS, 2015, J INVEST DERMATOL, V135, P151, DOI 10.1038/jid.2014.352; Izmiryan A, 2016, J INVEST DERMATOL, V136, P872, DOI 10.1016/j.jid.2015.11.028; Jackow J, 2016, J INVEST DERMATOL, V136, P1346, DOI 10.1016/j.jid.2016.02.811; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668                                                   ; Kim SH, 2010, MATRIX BIOL, V29, P629, DOI 10.1016/j.matbio.2010.07.002; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kuhl T, 2015, MOL THER, V23, P1368, DOI 10.1038/mt.2015.58; Kuttner V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.17; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Leachman SA, 2010, MOL THER, V18, P442, DOI 10.1038/mt.2009.273; Li QL, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2014.182; Li QL, 2011, DIS MODEL MECH, V4, P777, DOI 10.1242/dmm.007146; Lister JA, 2014, J INVEST DERMATOL, V134, P133, DOI 10.1038/jid.2013.293; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Nakajima K, 2012, DEV GROWTH DIFFER, V54, P777, DOI 10.1111/dgd.12006; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nystrom A, 2015, EMBO MOL MED, V7, P1211, DOI 10.15252/emmm.201505061; Odorisio T, 2014, HUM MOL GENET, V23, P3907, DOI 10.1093/hmg/ddu102; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Petrof G, 2015, J INVEST DERMATOL, V135, P2319, DOI 10.1038/jid.2015.158; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Postel R, 2013, J INVEST DERMATOL, V133, P2180, DOI 10.1038/jid.2013.154; Remington J, 2009, MOL THER, V17, P26, DOI 10.1038/mt.2008.234; Richardson R, 2013, J INVEST DERMATOL, V133, P1655, DOI 10.1038/jid.2013.16; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Savignac M, 2014, J INVEST DERMATOL, V134, P1961, DOI 10.1038/jid.2014.8; Sebastiano V, 2014, SCI TRANSL MED, V6; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shinkuma S, 2016, P NATL ACAD SCI USA, V113, P5676, DOI 10.1073/pnas.1512028113; Siprashvili Z, 2016, JAMA-J AM MED ASSOC, V316, P1808, DOI 10.1001/jama.2016.15588; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Tan X, 2015, J MED CHEM, V58, P598, DOI 10.1021/jm500988d; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Titeux M, 2010, MOL THER, V18, P1509, DOI 10.1038/mt.2010.91; Tolar J, 2013, LANCET, V382, P1214, DOI 10.1016/S0140-6736(13)61897-8; Tolar J, 2011, J INVEST DERMATOL, V131, P848, DOI 10.1038/jid.2010.346; Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012; Turczynski S, 2016, J INVEST DERMATOL, V136, P2387, DOI 10.1016/j.jid.2016.07.029; Uitto J, 2016, J INVEST DERMATOL, V136, P352, DOI 10.1016/j.jid.2015.10.050; Uitto J, 2011, J INVEST DERMATOL, V131, P1597, DOI 10.1038/jid.2011.125; Umegaki-Arao N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009342; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vanden Oever Michael J, 2014, F1000Prime Rep, V6, P35, DOI 10.12703/P6-35; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501; Wally V, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-69; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Webber BR, 2015, MOL THER, V23, P987, DOI 10.1038/mt.2015.47; Wenzel D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010083; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Woodley DT, 2013, J INVEST DERMATOL, V133, P1910, DOI 10.1038/jid.2013.10; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645	81	0	0	4	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	MAY	2017	137	5					E123	E129		10.1016/j.jid.2016.08.038				7	Dermatology	Dermatology	ER6DN	WOS:000398895200016	28411843				2018-01-05	
J	Rutkowski, TP; Schroeder, JP; Gafford, GM; Warren, ST; Weinshenker, D; Caspary, T; Mulle, JG				Rutkowski, Timothy P.; Schroeder, Jason P.; Gafford, Georgette M.; Warren, Stephen T.; Weinshenker, David; Caspary, Tamara; Mulle, Jennifer G.			Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders	JOURNAL OF NEUROSCIENCE RESEARCH			English	Review						CNVs; genetics; schizophrenia; CRISPR; behavioral assays	3Q29 MICRODELETION SYNDROME; AUTISM SPECTRUM DISORDERS; 22Q11.2 DELETION SYNDROME; DIGEORGE-SYNDROME REGION; LATENT INHIBITION MODEL; PLURIPOTENT STEM-CELLS; ZINC-FINGER NUCLEASES; REACTION-TIME-TASK; CHROMOSOMAL REARRANGEMENTS; INTELLECTUAL DISABILITY	Recent studies show that the complex genetic architecture of schizophrenia (SZ) is driven in part by polygenic components, or the cumulative effect of variants of small effect in many genes, as well as rare single-locus variants with large effect sizes. Here we discuss genetic aberrations known as copy number variants (CNVs), which fall in the latter category and are associated with a high risk for SZ and other neuropsychiatric disorders. We briefly review recurrent CNVs associated with SZ, and then highlight one CNV in particular, a recurrent 1.6-Mb deletion on chromosome 3q29, which is estimated to confer a 40-fold increased risk for SZ. Additionally, we describe the use of genetic mouse models, behavioral tools, and patient-derived induced pluripotent stem cells as a means to study CNVs in the hope of gaining mechanistic insight into their respective disorders. Taken together, the genomic data connecting CNVs with a multitude of human neuropsychiatric disease, our current technical ability to model such chromosomal anomalies in mouse, and the existence of precise behavioral measures of endophenotypes argue that the time is ripe for systematic dissection of the genetic mechanisms underlying such disease. (c) 2016 Wiley Periodicals, Inc.	[Rutkowski, Timothy P.; Schroeder, Jason P.; Gafford, Georgette M.; Warren, Stephen T.; Weinshenker, David; Caspary, Tamara; Mulle, Jennifer G.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Mulle, Jennifer G.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Mulle, JG (reprint author), Emory Univ, Rollins Sch Publ Hlth, Room 4053,1518 Clifton Rd, Atlanta, GA 30322 USA.	jmulle@emory.edu			NIGMS [R01 GM097331]	Grant information: NIGMS R01 GM097331.	Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169; Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; ANDREASEN NC, 1995, LANCET, V346, P477, DOI 10.1016/S0140-6736(95)91325-4; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Arbogast T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005709; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Barneveld PS, 2011, SCHIZOPHR RES, V126, P231, DOI 10.1016/j.schres.2010.09.004; Bassett A.S., 2008, CURR PSYCHIAT REP, V10, P148, DOI DOI 10.1007/S11920-008-0026-1; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Biswas AB, 2016, RES DEV DISABIL, V53-54, P242, DOI 10.1016/j.ridd.2016.02.010; Blumenthal I, 2014, AM J HUM GENET, V94, P870, DOI 10.1016/j.ajhg.2014.05.004; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Brereton AV, 2006, J AUTISM DEV DISORD, V36, P863, DOI 10.1007/s10803-006-0125-y; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chisholm K, 2015, NEUROSCI BIOBEHAV R, V55, P173, DOI 10.1016/j.neubiorev.2015.04.012; Chudasama Y, 2004, PSYCHOPHARMACOLOGY, V174, P86, DOI 10.1007/s00213-004-1805-y; Clayton-Smith J, 2010, CLIN DYSMORPHOL, V19, P128, DOI 10.1097/MCD.0b013e32833a1e3c; Clissold RL, 2016, KIDNEY INT, V90, P203, DOI 10.1016/j.kint.2016.03.027; Cobb W, 2010, EUR J MED GENET, V53, P415, DOI 10.1016/j.ejmg.2010.08.009; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Coppola A, 2013, EUR J MED GENET, V56, P614, DOI 10.1016/j.ejmg.2013.08.008; Cox DM, 2015, CLIN DYSMORPHOL, V24, P89, DOI 10.1097/MCD.0000000000000077; Cox DM, 2015, INT J MOL SCI, V16, P4068, DOI 10.3390/ijms16024068; Crespi BJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-15; Crider A, 1997, SCHIZOPHRENIA BULL, V23, P63, DOI 10.1093/schbul/23.1.63                                                          ; Dasouki MJ, 2011, AM J MED GENET A, V155A, P1654, DOI 10.1002/ajmg.a.34080; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; Digilio MC, 2009, AM J MED GENET A, V149A, P1777, DOI 10.1002/ajmg.a.32965; Drew LJ, 2011, INT J DEV NEUROSCI, V29, P259, DOI 10.1016/j.ijdevneu.2010.09.007; Escudero I, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0502-8; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Farrell MS, 2015, MOL PSYCHIATR, V20, P555, DOI 10.1038/mp.2015.16; Forstner AJ, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00047; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fumagalli F, 2009, CNS DRUGS, V23, P603, DOI 10.2165/00023210-200923070-00005; Gao R, 2015, CURR MOL MED, V15, P146, DOI 10.2174/1566524015666150303003028                                               ; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Glassford MR, 2016, AM J MED GENET A, V170, P999, DOI 10.1002/ajmg.a.37537; Green EK, 2016, MOL PSYCHIATR, V21, P89, DOI 10.1038/mp.2014.174; Grozeva D, 2012, SCHIZOPHR RES, V135, P1, DOI 10.1016/j.schres.2011.11.004; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; HESTON LL, 1966, BRIT J PSYCHIAT, V112, P819, DOI 10.1192/bjp.112.489.819                                                         ; Hill SK, 2010, EXPERT REV NEUROTHER, V10, P43, DOI 10.1586/ERN.09.143; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Hvoslef-Eide M, 2015, PSYCHOPHARMACOLOGY, V232, P3853, DOI 10.1007/s00213-015-4007-x; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jablensky AV, 2005, AM J PSYCHIAT, V162, P79, DOI 10.1176/appi.ajp.162.1.79; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; Joshi G, 2013, J AUTISM DEV DISORD, V43, P1314, DOI 10.1007/s10803-012-1679-5; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kane JM, 2016, AM J PSYCHIAT, V173, P362, DOI 10.1176/appi.ajp.2015.15050632; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; KETY SS, 1971, AM J PSYCHIAT, V128, P302, DOI 10.1176/ajp.128.3.302                                                           ; KETY SS, 1976, BEHAV GENET, V6, P219, DOI 10.1007/BF01065721                                                              ; KETY SS, 1994, ARCH GEN PSYCHIAT, V51, P442; Kimura H, 2015, SCHIZOPHRENIA BULL, V41, P744, DOI 10.1093/schbul/sbu147; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Konstantareas MM, 2001, J AUTISM DEV DISORD, V31, P19, DOI 10.1023/A:1005605528309; Kotlar AV, 2015, EUR J MED GENET, V58, P704, DOI 10.1016/j.ejmg.2015.10.008; Kuang SQ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002118; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lett TA, 2014, BIOL PSYCHIAT, V75, P361, DOI 10.1016/j.biopsych.2013.07.026; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2                                                   ; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43903; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Liu CH, 2011, HUM GENET, V130, P623, DOI 10.1007/s00439-011-0980-2; Lubow RE, 2005, SCHIZOPHRENIA BULL, V31, P139, DOI 10.1093/schbul/sbi005; Luigetti M, 2014, J NEUROL SCI, V341, P46, DOI 10.1016/j.jns.2014.03.046; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maillard AM, 2015, MOL PSYCHIATR, V20, P140, DOI 10.1038/mp.2014.145; Makinen J, 2008, NORD J PSYCHIAT, V62, P334, DOI 10.1080/08039480801959307; Marino MD, 2005, BEHAV BRAIN RES, V161, P197, DOI 10.1016/j.bbr.2005.02.005; Matson JL, 2009, RES DEV DISABIL, V30, P1107, DOI 10.1016/j.ridd.2009.06.003; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13                                                          ; Millan MJ, 2016, NAT REV DRUG DISCOV, V15, P485, DOI 10.1038/nrd.2016.28; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Mochida S, 1998, P NATL ACAD SCI USA, V95, P14523, DOI 10.1073/pnas.95.24.14523; Monks S, 2014, SCHIZOPHR RES, V153, P231, DOI 10.1016/j.schres.2014.01.020; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Morgan VA, 2008, BRIT J PSYCHIAT, V193, P364, DOI 10.1192/bjp.bp.107.044461; Mulle JG, 2015, MOL PSYCHIATR, V20, P1028, DOI 10.1038/mp.2015.76; Mulle JG, 2014, BIOL PSYCHIAT, V75, P371, DOI 10.1016/j.biopsych.2013.05.040; Mulle JG, 2012, CURR OPIN GENET DEV, V22, P238, DOI 10.1016/j.gde.2012.02.011; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Naf D, 2001, HUM MOL GENET, V10, P91, DOI 10.1093/hmg/10.2.91                                                             ; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861                                                         ; OWEN AM, 1993, BRAIN, V116, P1159, DOI 10.1093/brain/116.5.1159; OWEN MJ, 1992, PSYCHOL MED, V22, P289, DOI 10.1017/S0033291700030221                                                       ; Palumbo P, 2014, GENE, V538, P373, DOI 10.1016/j.gene.2014.01.050; Perry W, 2000, SCHIZOPHR RES, V46, P167, DOI 10.1016/S0920-9964(99)00229-7; Piskorowski RA, 2016, NEURON, V89, P163, DOI 10.1016/j.neuron.2015.11.036; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Prasad SE, 2008, DEV DISABIL RES REV, V14, P26, DOI 10.1002/ddrr.5; Preti A, 2000, PSYCHIAT RES, V96, P127, DOI 10.1016/S0165-1781(00)00185-2; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Quintero-Rivera F, 2010, AM J MED GENET A, V152A, P2459, DOI 10.1002/ajmg.a.33573; Ramalingam A, 2011, J HUM GENET, V56, P541, DOI 10.1038/jhg.2011.42; Rees E, 2014, MOL PSYCHIATR, V19, P37, DOI 10.1038/mp.2013.156; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rimer M, 2005, NEUROREPORT, V16, P271, DOI 10.1097/00001756-200502280-00014; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1107/s00213-002-1154-7; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; RUSSELL LB, 1989, P NATL ACAD SCI USA, V86, P3704, DOI 10.1073/pnas.86.10.3704                                                         ; Russell LB., 1954, EFFECTS RAD MAMMALIA; RUSSELL WL, 1951, COLD SPRING HARB SYM, V16, P327, DOI 10.1101/SQB.1951.016.01.024                                                     ; Sagar A, 2013, AM J MED GENET A, V161A, P845, DOI 10.1002/ajmg.a.35754; Sakaguchi G, 1999, EUR J NEUROSCI, V11, P4262, DOI 10.1046/j.1460-9568.1999.00855.x; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Schimenti JC, 2000, GENOME RES, V10, P1043, DOI 10.1101/gr.10.7.1043                                                            ; Scholes KE, 2010, PSYCHOPHYSIOLOGY, V47, P223, DOI 10.1111/j.1469-8986.2009.00927.x; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297                                                  ; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Sorensen HJ, 2014, SCHIZOPHR RES, V153, P214, DOI 10.1016/j.schres.2014.01.008; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1                                                   ; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stewart LR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-154; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stubbs L, 1997, METHODS, V13, P397, DOI 10.1006/meth.1997.0546                                                          ; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sullivan S, 2013, J AM ACAD CHILD PSY, V52, P806, DOI 10.1016/j.jaac.2013.05.010; Szatkiewicz JP, 2014, MOL PSYCHIATR, V19, P762, DOI 10.1038/mp.2014.40; Tai DJC, 2016, NAT NEUROSCI, V19, P517, DOI 10.1038/nn.4235; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tcheremissine OV, 2012, EXPERT OPIN INV DRUG, V21, P7, DOI 10.1517/13543784.2012.634798; Torres F, 2016, J MED GENET, V53, P73, DOI 10.1136/jmedgenet-2015-103366; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Uezato A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-2; Urban AE, 2015, NAT GENET, V47, P100, DOI 10.1038/ng.3204; Velleman Shelley L, 2011, Perspect Lang Learn Educ, V18, P108; Veltman JA, 2010, NAT GENET, V42, P192, DOI 10.1038/ng0310-192; Vinas-Jornet M, 2014, MOL GENET GENOM MED, V2, P512, DOI 10.1002/mgg3.105; WAHLSTEN D, 1982, BRAIN RES, V239, P329, DOI 10.1016/0006-8993(82)90513-3; Walch L, 2013, TRAFFIC, V14, P964, DOI 10.1111/tra.12089; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weiner I, 2003, PSYCHOPHARMACOLOGY, V169, P257, DOI 10.1007/s00213-002-1313-x; Weinshenker D, 2002, P NATL ACAD SCI USA, V99, P13873, DOI 10.1073/pnas.212519999; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; WENDER PH, 1974, ARCH GEN PSYCHIAT, V30, P121; Wijshake T, 2014, BBA-MOL BASIS DIS, V1842, P1942, DOI 10.1016/j.bbadis.2014.04.020; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yamaguchi Y, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00219; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007; You Y, 1997, NAT GENET, V15, P285, DOI 10.1038/ng0397-285; Yu T, 2010, MAMM GENOME, V21, P258, DOI 10.1007/s00335-010-9262-x; Yu YE, 2006, GENETICS, V173, P297, DOI 10.1534/genetics.105.054833; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564                                                                ; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zheng BH, 2001, METHODS, V24, P81, DOI 10.1006/meth.2001.1160; Ziats MN, 2016, GENET MED, V18, P1111, DOI 10.1038/gim.2016.9	185	2	2	24	54	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY	2017	95	5					1144	1160		10.1002/jnr.23970				17	Neurosciences	Neurosciences & Neurology	EP7UV	WOS:000397583600005	27859486				2018-01-05	
J	Chiu, J; Valente, KN; Levy, NE; Min, L; Lenhoff, AM; Lee, KH				Chiu, Josephine; Valente, Kristin N.; Levy, Nicholas E.; Min, Lie; Lenhoff, Abraham M.; Lee, Kelvin H.			Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						polysorbate; CRISPR; CHO cell; host cell protein; lipase	CRISPR CAS9; GUINEA-PIG; FATTY-ACID; C-III; DEGRADATION; APOLIPOPROTEIN; IDENTIFICATION; IMPURITIES; HYDROLYSIS; PROTEOMICS	While the majority of host cell protein (HCP) impurities are effectively removed in typical downstream purification processes, a small population of HCPs are particularly challenging. Previous studies have identified HCPs that are challenging for a variety of reasons. Lipoprotein lipase (LPL)a Chinese hamster ovary (CHO) HCP that functions to hydrolyze esters in triglycerideswas one of ten HCPs identified in previous studies as being susceptible to retention in downstream processing. LPL may degrade polysorbate 80 (PS-80) and polysorbate 20 (PS-20) in final product formulations due to the structural similarity between polysorbates and triglycerides. In this work, recombinant LPL was found to have enzymatic activity against PS-80 and PS-20 in a range of solution conditions that are typical of mAb formulations. LPL knockout CHO cells were created with CRISPR and TALEN technologies and resulting cell culture harvest fluid demonstrated significantly reduced polysorbate degradation without significant impact on cell viability when compared to wild-type samples. Biotechnol. Bioeng. 2017;114: 1006-1015. (C) 2016 Wiley Periodicals, Inc.	[Chiu, Josephine; Valente, Kristin N.; Levy, Nicholas E.; Min, Lie; Lenhoff, Abraham M.; Lee, Kelvin H.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA; [Chiu, Josephine; Valente, Kristin N.; Min, Lie; Lee, Kelvin H.] Delaware Biotechnol Inst, Delaware, OH 19711 USA	Lee, KH (reprint author), Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA.; Lee, KH (reprint author), Delaware Biotechnol Inst, Delaware, OH 19711 USA.	KHL@udel.edu			National Science Foundation [CBET-0966644, CBET-1144726, MCB-1412365]; National Institutes of Health [P20 GM103446, T32 GM008550]	Contract grant sponsor: National Science Foundation; Contract grant numbers: CBET-0966644; CBET-1144726; MCB-1412365; Contract grant sponsor: National Institutes of Health; Contract grant numbers: P20 GM103446; T32 GM008550	Aboulaich N, 2014, BIOTECHNOL PROGR, V30, P1114, DOI 10.1002/btpr.1948; Bobik A, 2008, CIRCULATION, V118, P702, DOI 10.1161/CIRCULATIONAHA.108.794081; BRAUN JEA, 1992, BIOCHEM J, V287, P337, DOI 10.1042/bj2870337                                                               ; Brinkrolf K, 2013, NAT BIOTECHNOL, V31, P694, DOI 10.1038/nbt.2645; Champion K, 2005, BIOPROCESS INT, V3, P52; Choi YS, 2013, J CHROMATOGR B, V930, P129, DOI 10.1016/j.jchromb.2013.05.003; Christiansen A, 2010, EUR J PHARM SCI, V41, P376, DOI 10.1016/j.ejps.2010.07.005; Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011; Dixit N, 2016, J PHARM SCI-US, V105, P1657, DOI 10.1016/j.xphs.2016.02.029; Doneanu CE, 2012, MABS-AUSTIN, V4, P24, DOI 10.4161/mabs.4.1.18748; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao SX, 2011, BIOTECHNOL BIOENG, V108, P977, DOI 10.1002/bit.22982; Grav LM, 2015, BIOTECHNOL J, V10, P1446, DOI 10.1002/biot.201500027; Gutierrez AH, 2012, HUM VACC IMMUNOTHER, V8, P1172, DOI 10.4161/hv.22378; Ha E, 2002, J PHARM SCI, V91, P2252, DOI 10.1002/jps.10216; Hall T, 2016, J PHARM SCI-US, V105, P1633, DOI 10.1016/j.xphs.2016.02.022; Hanania NA, 2015, THORAX, V70, P748, DOI 10.1136/thoraxjnl-2014-206719; Jin M, 2010, BIOTECHNOL BIOENG, V105, P306, DOI 10.1002/bit.22532; Joucla G, 2013, J CHROMATOGR B, V942, P126, DOI 10.1016/j.jchromb.2013.10.033; Kerwin BA, 2008, J PHARM SCI-US, V97, P2924, DOI 10.1002/jps.21190; Khossravi M, 2002, PHARMACEUT RES, V19, P634, DOI 10.1023/A:1015306112979; Kishore RSK, 2011, J PHARM SCI-US, V100, P721, DOI 10.1002/jps.22290; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Larsson M, 2013, J BIOL CHEM, V288, P33997, DOI 10.1074/jbc.M113.495366; Lee HJ, 2011, ADV DRUG DELIVER REV, V63, P1160, DOI 10.1016/j.addr.2011.06.015; Levy NE, 2016, BIOTECHNOL BIOENG, V113, P1260, DOI 10.1002/bit.25882; Levy NE, 2014, BIOTECHNOL BIOENG, V111, P904, DOI 10.1002/bit.25158; Lutz EP, 2001, J CLIN INVEST, V107, P1183, DOI 10.1172/JCI11774; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mahler HC, 2009, J PHARM SCI-US, V98, P4525, DOI 10.1002/jps.21776; Marichal-Gallardo PA, 2012, BIOTECHNOL PROGR, V28, P899, DOI 10.1002/btpr.1567; MCCONATHY WJ, 1992, J LIPID RES, V33, P995; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; NILSSONEHLE P, 1980, ANNU REV BIOCHEM, V49, P667, DOI 10.1146/annurev.bi.49.070180.003315                                             ; Pereira EB, 2003, BRAZ J CHEM ENG, V20, P343, DOI 10.1590/S0104-66322003000400002; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; PRASAD KN, 1980, LIFE SCI, V27, P1351, DOI 10.1016/0024-3205(80)90397-5; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Robert F, 2009, BIOTECHNOL BIOENG, V104, P1132, DOI 10.1002/bit.22494; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; SCHMID G, 1991, J BIOTECHNOL, V17, P155, DOI 10.1016/0168-1656(91)90006-H; SEMB H, 1989, J BIOL CHEM, V264, P4195; SHIRAI K, 1983, J LIPID RES, V24, P721; Singh SK, 2012, BIOLOGICALS, V40, P364, DOI 10.1016/j.biologicals.2012.06.001; Sun T, 2015, ENG LIFE SCI, V15, P660, DOI 10.1002/elsc.201400218; US Food and Drug Administration/Center for Drug Evaluation and Research, 1999, GUID IND Q6B SPEC TE; Valente KN, 2015, BIOTECHNOL BIOENG, V112, P1232, DOI 10.1002/bit.25515; Valente KN, 2014, BIOTECHNOL J, V9, P87, DOI 10.1002/biot.201300190; Wang X, 2009, BIOTECHNOL BIOENG, V103, P446, DOI 10.1002/bit.22304; WICHA MS, 1979, CANCER RES, V39, P426; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zhang LY, 2005, J BIOL CHEM, V280, P42580, DOI 10.1074/jbc.M507252200	52	1	1	10	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	MAY	2017	114	5					1006	1015		10.1002/bit.26237				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EQ1AR	WOS:000397802200008	27943242	gold			2018-01-05	
J	Sekiba, K; Yamagami, M; Otsuka, M; Suzuki, T; Kishikawa, T; Ishibashi, R; Ohno, M; Sato, M; Koike, K				Sekiba, Kazuma; Yamagami, Mari; Otsuka, Motoyuki; Suzuki, Tatsunori; Kishikawa, Takahiro; Ishibashi, Rei; Ohno, Motoko; Sato, Masaya; Koike, Kazuhiko			Transcriptional activation of the MICA gene with an engineered CRISPR-Cas9 system	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						MICA; CRISPR; microRNA; Transcriptional activation	NK CELLS; T-CELLS; NKG2D; ENDONUCLEASE; HEPATOCYTES; EXPRESSION; MICRORNAS; DELIVERY; RECEPTOR; PROTEIN	Major histocompatibility complex class I polypeptide-related sequence A (MICA) is a prototypical NKG2D ligand. Because immune cells, such as natural killer (NK) cells, recognize virally infected or transformed cells and eliminate them through the interaction between NKG2D receptors on NK cells and NKG2D ligands on pathogenic cells, MICA expression levels are associated with NK cell-mediated immunity. Here, we report that an engineered clustered regularly interspaced short palindromic repeats-Cas9-related complex targeting MICA gene promoter sequences activates transcription of the MICA gene from its endogenous locus. Inhibiting microRNA function, which targets the 3' untranslated region of the MICA gene, enhances this activation. These results demonstrate that the combination of Cas9-based transcriptional activators and simultaneous modulation of microRNA function may be a powerful tool for enhancing MICA protein expression and efficient anti-pathogenic cell immunity. (C) 2017 Elsevier Inc. All rights reserved.	[Sekiba, Kazuma; Yamagami, Mari; Otsuka, Motoyuki; Suzuki, Tatsunori; Kishikawa, Takahiro; Ishibashi, Rei; Ohno, Motoko; Sato, Masaya; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan	Otsuka, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	otsukamo-tky@umin.ac.jp		Otsuka, Motoyuki/0000-0003-2869-2881	Ministry of Education, Culture, Sports, Science and Technology, Japan [16H05149, 16KT0109, 26860492, 26460984, 15H04807]; Research Program on Hepatitis from AMED; project MIRAI, Relay for life Japan, the Japan Cancer Society	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (#16H05149, #16KT0109, #26860492, #26460984 and #15H04807) (to M.Otsuka, M.Otsuka, T.K., M.S. and K.K.), by the Research Program on Hepatitis from AMED (to M.Otsuka and K.K.), and by the grant from the project MIRAI, Relay for life Japan, the Japan Cancer Society (to M.O.).	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727                                                    ; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Eleme K, 2004, J EXP MED, V199, P1005, DOI 10.1084/jem.20032194; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Goto K., 2016, SCI REP, V6; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jinushi M, 2005, J HEPATOL, V43, P1013, DOI 10.1016/j.jhep.2005.05.026; Kishikawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02739; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Maccalli C, 2009, CANCER IMMUNOL IMMUN, V58, P801, DOI 10.1007/s00262-008-0635-x; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ohno M, 2014, ONCOTARGET, V5, P5581, DOI 10.18632/oncotarget.2143                                                        ; PEABODY DS, 1993, EMBO J, V12, P595; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Yamada T, 2003, NAT BIOTECHNOL, V21, P885, DOI 10.1038/nbt843	21	0	0	3	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	APR 29	2017	486	2					521	525		10.1016/j.bbrc.2017.03.076				5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	ES1AV	WOS:000399261200046	28322797				2018-01-05	
J	Gootenberg, JS; Abudayyeh, OO; Lee, JW; Essletzbichler, P; Dy, AJ; Joung, J; Verdine, V; Donghia, N; Daringer, NM; Freije, CA; Myhrvold, C; Bhattacharyya, RP; Livny, J; Regev, A; Koonin, EV; Hung, DT; Sabeti, PC; Collins, JJ; Zhang, F				Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Lee, Jeong Wook; Essletzbichler, Patrick; Dy, Aaron J.; Joung, Julia; Verdine, Vanessa; Donghia, Nina; Daringer, Nichole M.; Freije, Catherine A.; Myhrvold, Cameron; Bhattacharyya, Roby P.; Livny, Jonathan; Regev, Aviv; Koonin, Eugene V.; Hung, Deborah T.; Sabeti, Pardis C.; Collins, James J.; Zhang, Feng			Nucleic acid detection with CRISPR-Cas13a/C2c2	SCIENCE			English	Article							CIRCULATING TUMOR DNA; CRISPR-CAS SYSTEMS; ZIKA VIRUS; AMPLIFICATION; PROTEINS	Rapid, inexpensive, and sensitive nucleic acid detection may aid point-of-care pathogen detection, genotyping, and disease monitoring. The RNA-guided, RNA-targeting clustered regularly interspaced short palindromic repeats (CRISPR) effector Cas13a (previously known as C2c2) exhibits a "collateral effect" of promiscuous ribonuclease activity upon target recognition. We combine the collateral effect of Cas13a with isothermal amplification to establish a CRISPR-based diagnostic (CRISPR-Dx), providing rapid DNA or RNA detection with attomolar sensitivity and single-base mismatch specificity. We use this Cas13a-based molecular detection platform, termed Specific High-Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK), to detect specific strains of Zika and Dengue virus, distinguish pathogenic bacteria, genotype human DNA, and identify mutations in cell-free tumor DNA. Furthermore, SHERLOCK reaction reagents can be lyophilized for cold-chain independence and long-term storage and be readily reconstituted on paper for field applications.	[Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Essletzbichler, Patrick; Dy, Aaron J.; Joung, Julia; Verdine, Vanessa; Freije, Catherine A.; Myhrvold, Cameron; Bhattacharyya, Roby P.; Livny, Jonathan; Regev, Aviv; Hung, Deborah T.; Sabeti, Pardis C.; Collins, James J.; Zhang, Feng] Broad Inst & MIT Harvard, Cambridge, MA 02142 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Essletzbichler, Patrick; Joung, Julia; Verdine, Vanessa; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Essletzbichler, Patrick; Joung, Julia; Verdine, Vanessa; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Essletzbichler, Patrick; Dy, Aaron J.; Joung, Julia; Verdine, Vanessa; Collins, James J.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Abudayyeh, Omar O.; Collins, James J.] MIT, Dept Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lee, Jeong Wook; Donghia, Nina; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Dy, Aaron J.; Daringer, Nichole M.; Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Freije, Catherine A.; Myhrvold, Cameron; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Regev, Aviv] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Sabeti, Pardis C.] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Collins, JJ; Zhang, F (reprint author), Broad Inst & MIT Harvard, Cambridge, MA 02142 USA.; Zhang, F (reprint author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Collins, JJ; Zhang, F (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (reprint author), MIT, Dept Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (reprint author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Collins, JJ (reprint author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jimjc@mit.edu; zhang@broadinstitute.org		Gootenberg, Jonathan/0000-0003-2757-2175; /0000-0003-0705-0177; /0000-0003-0319-5416; Abudayyeh, Omar/0000-0002-7979-3220; Essletzbichler, Patrick/0000-0003-2237-0005	Paul and Daisy Soros Fellowship; National Defense Science and Engineering Fellowship; U.S. Department of Energy Computational Science Graduate Fellowship; NIH through a National Institute of Allergies and Infectious Diseases grant [R01AI117043]; NSF Graduate Research Fellowship; Air Force Office of Scientific Research grant [FA9550-14-1-0060]; M. and L. Benioff; J. and A. Bekenstein; Howard Hughes Medical Institute; Defense Threat Reduction Agency grant [HDTRA1-14-1-0006]; Paul G. Allen Frontiers Group; Wyss Institute; NIH through National Institute of Mental Health grants [5DP1-MH100706, 1R01-MH110049]; NSF; New York Stem Cell; Simons Foundation; Vallee Foundation; Paul G. Allen Family Foundation	We thank F. Chen, V. Rusu, R. Gupta, D. Daniels, C. Garvie, I. Finkelstein, V. Adalsteinsson, A. Das, E. S. Lander, R. Macrae, and R. Belliveau for discussions and support. Human genotyping data were collected with the informed consent of the subjects and in consent with the guidelines of the approved Massachusetts Institute of Technology (MIT) institutional review board (IRB) protocol IRB-4062. O.O.A. is supported by a Paul and Daisy Soros Fellowship and a National Defense Science and Engineering Fellowship. J.S.G. is supported by a U.S. Department of Energy Computational Science Graduate Fellowship. R.P.B, J.L, and D.T.H. are supported by the NIH through a National Institute of Allergies and Infectious Diseases grant (R01AI117043). A.J.D. is supported by an NSF Graduate Research Fellowship and an Air Force Office of Scientific Research grant (FA9550-14-1-0060). Zika work was partially funded by M. and L. Benioff to P.C.S., and antibiotic resistance work was partially funded by J. and A. Bekenstein to D.T.H. A. R. is supported by the Howard Hughes Medical Institute. J. J. C. is supported by the Defense Threat Reduction Agency grant HDTRA1-14-1-0006, the Paul G. Allen Frontiers Group, and the Wyss Institute. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by the NIH through National Institute of Mental Health grants (5DP1-MH100706 and 1R01-MH110049); the NSF; the Howard Hughes Medical Institute; the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and J. and P. Poitras, R. Metcalfe, and D. Cheng. A. R. is a member of the Scientific Advisory Board for ThermoFisher Scientific. J. S. G., O.O.A., R.P.B., A. R., E.V.K., D.T.H., P. C. S., J. J. C., and F.Z. have filed patent applications relating to the work in this manuscript, including J. S. G., O.O.A., E.V.K., and F.Z. on international application no. PCT/US2016/038258 filed 18 June 2015 (CRISPR-C2c2 systems and uses thereof); J. S. G., O.O.A., and F.Z. on U.S. provisional patent application no. 62/351,662 filed 17 June 2016 (CRISPR-C2c2 systems and diagnostic uses thereof); J. S. G., O.O.A., J. J. C., and F.Z. on U.S. provisional patent application no. 62/432,553 filed 9 December 2016 (SHERLOCK diagnostic); J. S. G., O.O.A., P. C. S., J. J. C., and F.Z. on U.S. provisional patent application no. 62/471,917 filed 15 March 2017 (viral application of SHERLOCK); J. S. G., O.O.A., A. R., J. J. C., and F.Z. on U.S. provisional patent application no. 62/471,931 filed 15 March 2017 (mutation detection with SHERLOCK); J. S. G., O.O.A., R.P.B., D.T.H., J. J. C., and F.Z. on U.S. provisional patent application no. 62/471,936 filed 15 March 2017 (bacterial applications of SHERLOCK); and J. S. G., O.O.A., J. J. C., and F.Z. on U.S. provisional patent application no. 62/471,940 filed 15 March 2017 (devices). Each patent application relates to CRISPR-C2c2 systems, specific uses, and improved uses thereof for diagnostic application filed by Broad, Harvard, Massachusetts General Hospital, MIT, and NIH. Cas13a/C2c2 expression plasmids are available from Addgene under a Uniform Biological Material Transfer Agreement.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Barletta JM, 2004, AM J CLIN PATHOL, V122, P20, DOI 10.1309/529T2WDNEB6X8VUN; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Du Y, 2017, ANGEW CHEM INT EDIT, V56, P992, DOI 10.1002/anie.201609108; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Green A. A., 2014, SCI PROGRESS-UK, V159, P925, DOI DOI 10.1016/J.CELL.2014.10.002;; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Paz-Bailey G., 2017, NEW ENGL J MED; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Qin Z, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0092-4; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Song LA, 2013, ANAL CHEM, V85, P1932, DOI 10.1021/ac303426b; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	24	24	24	94	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2017	356	6336					438	+		10.1126/science.aam9321				5	Multidisciplinary Sciences	Science & Technology - Other Topics	ET2YU	WOS:000400143000054	28408723				2018-01-05	
J	Sugano, SS; Suzuki, H; Shimokita, E; Chiba, H; Noji, S; Osakabe, Y; Osakabe, K				Sugano, Shigeo S.; Suzuki, Hiroko; Shimokita, Eisuke; Chiba, Hirofumi; Noji, Sumihare; Osakabe, Yuriko; Osakabe, Keishi			Genome editing in the mushroom-forming basidiomycete Coprinopsis cinerea, optimized by a high-throughput transformation system	SCIENTIFIC REPORTS			English	Article							COPRINUS-CINEREUS; SCHIZOPHYLLUM-COMMUNE; LENTINUS-EDODES; GENE; EXPRESSION; MORPHOGENESIS; INTRONS; MUTANTS; MARKER; FUNGI	Mushroom-forming basidiomycetes produce a wide range of metabolites and have great value not only as food but also as an important global natural resource. Here, we demonstrate CRISPR/Cas9-based genome editing in the model species Coprinopsis cinerea. Using a high-throughput reporter assay with cryopreserved protoplasts, we identified a novel promoter, CcDED1(pro), with seven times stronger activity in this assay than the conventional promoter GPD2. To develop highly efficient genome editing using CRISPR/Cas9 in C. cinerea, we used the CcDED1(pro) to express Cas9 and a U6-snRNA promoter from C. cinerea to express gRNA. Finally, CRISPR/Cas9-mediated GFP mutagenesis was performed in a stable GFP expression line. Individual genome-edited lines were isolated, and loss of GFP function was detected in hyphae and fruiting body primordia. This novel method of high-throughput CRISPR/Cas9-based genome editing using cryopreserved protoplasts should be a powerful tool in the study of edible mushrooms.	[Sugano, Shigeo S.; Suzuki, Hiroko; Shimokita, Eisuke; Chiba, Hirofumi; Noji, Sumihare; Osakabe, Yuriko; Osakabe, Keishi] Tokushima Univ, Ctr Collaborat Agr Ind & Commerce, Tokushima, Japan; [Shimokita, Eisuke] Tokushima Prefectural Agr Forestry & Fisheries Te, Tokushima, Japan; [Chiba, Hirofumi; Osakabe, Yuriko; Osakabe, Keishi] Tokushima Univ, Fac Biosci & Bioind, Tokushima, Japan	Osakabe, K (reprint author), Tokushima Univ, Ctr Collaborat Agr Ind & Commerce, Tokushima, Japan.; Osakabe, K (reprint author), Tokushima Univ, Fac Biosci & Bioind, Tokushima, Japan.	kosakabe@tokushima-u.ac.jp			Otsuka Pharmaceutical Factory, Inc.,; Tokushima University	We thank M. Fukuhara for her technical assistance. We also thank all the members of Setsuro Fujii Memorial Institute of Medical Science for facilities in this research. We appreciate S. Sawatsubashi for his helpful suggestions for luciferase assays, and H. Muraguchi, Y. Sakamoto, and T. Nakazawa for their critical comments on this manuscript. This work was supported by a donation from Otsuka Pharmaceutical Factory, Inc., a funding for innovative distinctive projects from Tokushima University.	Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P2543, DOI 10.1002/bit.25662; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; BINNINGER DM, 1987, EMBO J, V6, P835; Burns C, 2005, FUNGAL GENET BIOL, V42, P191, DOI 10.1016/j.fgb.2004.11.005; Burns C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001135; Castanera R, 2015, APPL ENVIRON MICROB, V81, P4120, DOI 10.1128/AEM.00402-15; Cheng CK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-195; Collins CM, 2010, J MICROBIOL METH, V82, P156, DOI 10.1016/j.mimet.2010.05.007; Cummings WJ, 1999, CURR GENET, V36, P371, DOI 10.1007/s002940050512; Dornte B., 2012, Current Trends in Biotechnology and Pharmacy, V6, P340; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Ishizaki T, 1999, FEMS MICROBIOL LETT, V171, P141, DOI 10.1016/S0378-1097(98)00591-6; Kamada T, 2002, BIOESSAYS, V24, P449, DOI 10.1002/bies.10083; Kim S, 2015, MYCOBIOLOGY, V43, P1, DOI 10.5941/MYCO.2015.43.1.1; Lastra CCL, 2001, CAN J BOT, V79, P861; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Matsu-ura T., 2015, FUNGAL BIOL BIOTECHN, V2, P2, DOI DOI 10.1186/S40694-015-0015-1; Muraguchi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141586; Murata Y, 1998, GENETICS, V149, P1753; Nakazawa T, 2011, FUNGAL GENET BIOL, V48, P939, DOI 10.1016/j.fgb.2011.06.003; Ohm RA, 2011, MOL MICROBIOL, V81, P1433, DOI 10.1111/j.1365-2958.2011.07776.x; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; RAO PS, 1969, J BACTERIOL, V100, P1222; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholtmeijer K, 2001, APPL ENVIRON MICROB, V67, P481, DOI 10.1128/AEM.67.1.481-483.2001; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; SPECHT CA, 1988, EXP MYCOL, V12, P357, DOI 10.1016/0147-5975(88)90027-8                                                    ; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Vyas V. K., 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Walti MA, 2006, EUKARYOT CELL, V5, P732, DOI 10.1128/EC.5.4.732-744.2006; Yamazaki T, 2000, MOL GEN GENET, V263, P262, DOI 10.1007/s004380051167; Yu L, 1998, J PHARM SCI, V87, P774, DOI 10.1021/js970224o                                                               	34	1	1	22	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 28	2017	7								1260	10.1038/s41598-017-00883-5				9	Multidisciplinary Sciences	Science & Technology - Other Topics	ET4KA	WOS:000400247600019	28455526	gold			2018-01-05	
J	Crespillo-Casado, A; Chambers, JE; Fischer, PM; Marciniak, SJ; Ron, D				Crespillo-Casado, Ana; Chambers, Joseph E.; Fischer, Peter M.; Marciniak, Stefan J.; Ron, David			PPP1R15A-mediated dephosphorylation of eIF2 alpha is unaffected by Sephin1 or Guanabenz	ELIFE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; INDUCED GENE-EXPRESSION; TRANSLATION INITIATION; ER-STRESS; PHOSPHATASE; INHIBITION; SUBUNIT; GADD34; CELLS	Dephosphorylation of translation initiation factor 2 (eIF2 alpha) terminates signalling in the mammalian integrated stress response (ISR) and has emerged as a promising target for modifying the course of protein misfolding diseases. The [(o-chlorobenzylidene) amino] guanidines (Guanabenz and Sephin1) have been proposed to exert protective effects against misfolding by interfering with eIF2 alpha-P dephosphorylation through selective disruption of a PP1-PPP1R15A holophosphatase complex. Surprisingly, they proved inert in vitro affecting neither stability of the PP1-PPP1R15A complex nor substrate-specific dephosphorylation. Furthermore, eIF2 alpha-P dephosphorylation, assessed by a kinase shut-off experiment, progressed normally in Sephin1-treated cells. Consistent with its role in defending proteostasis, Sephin1 attenuated the IRE1 branch of the endoplasmic reticulum unfolded protein response. However, repression was noted in both wildtype and Ppp1r15a deleted cells and in cells rendered ISR-deficient by CRISPR editing of the Eif2s1 locus to encode a non-phosphorylatable eIF2 alpha (eIF2 alpha(S51A)). These findings challenge the view that [(o-chlorobenzylidene) amino] guanidines restore proteostasis by interfering with eIF2 alpha-P dephosphorylation.	[Crespillo-Casado, Ana; Chambers, Joseph E.; Marciniak, Stefan J.; Ron, David] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Fischer, Peter M.] Univ Nottingham, Sch Pharm, Div Biomol Sci & Med Chem, Nottingham, England; [Fischer, Peter M.] Univ Nottingham, Ctr Biomol Sci, Nottingham, England	Crespillo-Casado, A; Ron, D (reprint author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.	ac880@cam.ac.uk; dr360@medschl.cam.ac.uk		Marciniak, Stefan/0000-0001-8472-7183; Fischer, Peter/0000-0002-5866-9271; Ron, David/0000-0002-3014-5636	Wellcome [200848/Z/16/Z, 100140]	Wellcome 200848/Z/16/Z David Ron; Wellcome 100140 David Ron	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Abdulkarim B, 2015, DIABETES, V64, P3951, DOI 10.2337/db15-0477; Avezov E, 2013, J CELL BIOL, V201, P337, DOI 10.1083/jcb.201211155; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brown SM, 1997, J VIROL, V71, P2; Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Chambers JE, 2015, ELIFE, V4, DOI 10.7554/eLife.04872; Chen RM, 2015, ELIFE, V4, DOI 10.7554/eLife.04871; Choy MS, 2015, CELL REP, V11, P1885, DOI 10.1016/j.celrep.2015.05.043; Choy MS, 2014, P NATL ACAD SCI USA, V111, P4097, DOI 10.1073/pnas.1317395111; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876                                                         ; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8                                                   ; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112                                                            ; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011                                                          ; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reid DW, 2016, MOL CELL BIOL, V36, P1868, DOI 10.1128/MCB.00190-16; Ron D., 2007, TRANSLATIONAL CONTRO, P345; Sakoff JA, 2004, CURR PHARM DESIGN, V10, P1139, DOI 10.2174/1381612043452686                                                        ; Scorsone KA, 1987, J BIOL CHEM, V262, P8; Sekine Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166278; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Wang LJ, 2014, HUM MOL GENET, V23, P2629, DOI 10.1093/hmg/ddt658; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yu P, 2004, CELL CYCLE, V3, P75; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	43	4	4	2	2	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	APR 27	2017	6								e26109	10.7554/eLife.26109				29	Biology	Life Sciences & Biomedicine - Other Topics	EU5IO	WOS:000401065000001		gold			2018-01-05	
J	Yamayoshi, A; Miyoshi, D; Zouzumi, YK; Matsuyama, Y; Ariyoshi, J; Shimada, N; Murakami, A; Wada, T; Maruyama, A				Yamayoshi, Asako; Miyoshi, Daisuke; Zouzumi, Yu-ki; Matsuyama, Yohei; Ariyoshi, Jumpei; Shimada, Naohiko; Murakami, Akira; Wada, Takehiko; Maruyama, Atsushi			Selective and Robust Stabilization of Triplex DNA Structures Using Cationic Comb-type Copolymers	JOURNAL OF PHYSICAL CHEMISTRY B			English	Article							HELIX FORMATION; FORMING SEQUENCES; MAMMALIAN-CELLS; NUCLEIC-ACIDS; CONFORMATIONS; FRAGMENTS	DNA sequences capable of forming triplexes induce DNA,double strand breaks that have attracted attention in genome editing technologies (e.g., CRISPR/Cas9 system, TALEN, and ZEN). Therefore, novel fUnctional tools that stabilize triplex DNA Structures' must be further investigated to spark renewed interest. In this study, we investigated the unique, character of cationic col-Ph-type 'copolymers for the selective stabilization of triplex DNA. The melting temperature (Tm) of triplex DNA increased from 24.5 to 73.0 degrees C (ATm = 48.5 degrees C) by the addition of poly(allylamine)-graft-dextran (PAA-g-Dex) under physiological.. conditions (at pH 7.0), while PAA-g-Dex did not stabilize but rather destabilized the DNA duplex. On the other hand, poly(Oysine)-graft-dextran (PLL-g-Dex) stabilized both the duplex and triplex structures at pH 7.0. Thermodynamic parameters evaluated by isothermal titration calorimetry (ITC) revealed that the binding constant (K-a) for the intermolecular triplex formation in the presence of PAA-g-Dex was 1.1 X 10(9) M-1 at 25 degrees C Which is more than 10 times larger than that in the4Dresence of PLL-g-Dex (8.6 x 10(7) M-1). Stabilizing activity and selectivity of cationic copolymers toward DNA assemblies were-successfully controlled by selecting appropriate"backbone structures of the copolymer. Various functional molecules that stabilize DNA duplexes-have been developed and used in biological research. However, there are few cationic polymers that stabilize triplex DNA selectively. This study indicates that PAA-g-Dex has great potential to regulate the biological activities of triplex DNA.	[Yamayoshi, Asako] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Yamayoshi, Asako; Ariyoshi, Jumpei] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Miyoshi, Daisuke; Zouzumi, Yu-ki] Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Chuo Ku, 7-1-20 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan; [Matsuyama, Yohei; Ariyoshi, Jumpei; Murakami, Akira] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Shimada, Naohiko; Maruyama, Atsushi] Tokyo Inst Technol, Dept Life Sci & Technol, Midori Ku, 4259 B-57 Nagatsuta, Yokohama, Kanagawa 2268501, Japan; [Wada, Takehiko] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan	Yamayoshi, A (reprint author), Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan.; Yamayoshi, A (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.; Miyoshi, D (reprint author), Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Chuo Ku, 7-1-20 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.; Maruyama, A (reprint author), Tokyo Inst Technol, Dept Life Sci & Technol, Midori Ku, 4259 B-57 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	asakoy@kuchem.kyoto-u.ac.jp; miyoshi@center.konan-u.ac.jp; amaruyama@bio.titech.ac.jp	Yamayoshi, Asako/Q-2486-2016	Shimada, Naohiko/0000-0002-1664-1721	JSPS KAKENHI [15K05564, 15H03840, 16K14042, 15H01807]; Japan Science and Technology Agency (JST);  [20163039];  [20164023];  [15H00804]	This paper was supported by JSPS KAKENHI (Grant Number 15K05564 for A.Y., 15H03840 and 16K14042 for D.M., 15H01807 for A.M.) and was also supported by Grant-in-Aid for a Network Joint Research Center for Materials and Devices of Japan (20163039 for A.Y. and 20164023 for A.M.). We also acknowledge financial support from Grants-in-Aid for Scientific Research on Innovative Areas "Molecular Robotics" (No. 15H00804 for N.S.) and the Center of Innovation (COI) Program, Japan Science and Technology Agency (JST).	Asensio JL, 1998, J MOL BIOL, V275, P811, DOI 10.1006/jmbi.1997.1520                                                          ; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; MANZINI G, 1990, J MOL BIOL, V213, P833, DOI 10.1016/S0022-2836(05)80267-0; Maruyama A, 1999, COLLOID SURFACE B, V16, P273, DOI 10.1016/S0927-7765(99)00078-8                                                   ; Maruyama A, 1997, BIOCONJUGATE CHEM, V8, P735, DOI 10.1021/bc9701048; Maruyama A, 1998, BIOCONJUGATE CHEM, V9, P292, DOI 10.1021/bc9701510                                                               ; Miyoshi D, 2014, CHEMMEDCHEM, V9, P2156, DOI 10.1002/cmdc.201402157; Miyoshi D, 2009, J AM CHEM SOC, V131, P3522, DOI 10.1021/ja805972a; Moriyama R, 2011, BIOMATERIALS, V32, P7671, DOI 10.1016/j.biomaterials.2011.06.056; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463                                                         ; SAGLIO G, 1993, GENE CHROMOSOME CANC, V8, P1, DOI 10.1002/gcc.2870080102; Sato YI, 2005, BIOMATERIALS, V26, P703, DOI 10.1016/j.biomaterials.2004.03.018; SCHROTH GP, 1995, NUCLEIC ACIDS RES, V23, P1977, DOI 10.1093/nar/23.11.1977; Tiwari MK, 2016, NUCLEIC ACIDS RES, V44, P7742, DOI 10.1093/nar/gkw515; Tiwari MK, 2013, NUCLEIC ACIDS RES, V41, P8979, DOI 10.1093/nar/gkt670; Vorlickova M, 1996, BIOPHYS J, V71, P1530, DOI 10.1016/S0006-3495(96)79355-4                                                   ; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; Yamaguchi N, 2016, CHEM COMMUN, V52, P7446, DOI 10.1039/c6cc02237e; YANG JT, 1968, BIOCHEM BIOPH RES CO, V33, P739, DOI 10.1016/0006-291X(68)90221-0                                                    	21	0	0	6	11	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1520-6106			J PHYS CHEM B	J. Phys. Chem. B	APR 27	2017	121	16					4015	4022		10.1021/acs.jpcb.7b01926				8	Chemistry, Physical	Chemistry	ET8FK	WOS:000400534200011	28362093				2018-01-05	
J	Rafeeq, MM; Murad, HAS				Rafeeq, Misbahuddin M.; Murad, Hussam Aly Sayed			Cystic fibrosis: current therapeutic targets and future approaches	JOURNAL OF TRANSLATIONAL MEDICINE			English	Review						Chloride; Sweat; Respiratory; Hereditary; CFTR	TRANSMEMBRANE CONDUCTANCE REGULATOR; G551D MUTATION; LUNG-DISEASE; DOUBLE-BLIND; CFTR; IVACAFTOR; PLACEBO; TRIAL; GUIDELINES; RESCUE	Objectives: Study of currently approved drugs and exploration of future clinical development pipeline therapeutics for cystic fibrosis, and possible limitations in their use. Methods: Extensive literature search using individual and a combination of key words related to cystic fibrosis therapeutics. Key findings: Cystic fibrosis is an autosomal recessive disorder due to mutations in CFTR gene leading to abnormality of chloride channels in mucus and sweat producing cells. Respiratory system and GIT are primarily involved but eventually multiple organs are affected leading to life threatening complications. Management requires drug therapy, extensive physiotherapy and nutritional support. Previously, the focus was on symptomatic improvement and complication prevention but recently the protein rectifiers are being studied which are claimed to correct underlying structural and functional abnormalities. Some improvement is observed by the corrector drugs. Other promising approaches are gene therapy, targeting of cellular interactomes, and newer drugs for symptomatic improvement. Conclusions: The treatment has a long way to go as most of the existing therapeutics is for older children. Other limiting factors include mutation class, genetic profile, drug interactions, adverse effects, and cost. Novel approaches like gene transfer/gene editing, disease modeling and search for alternative targets are warranted.	[Rafeeq, Misbahuddin M.; Murad, Hussam Aly Sayed] King Abdulaziz Univ, Fac Med, Dept Pharmacol, Rabigh Campus, Jeddah 21589, Saudi Arabia; [Murad, Hussam Aly Sayed] Ain Shams Univ, Dept Pharmacol, Fac Med, Cairo 11562, Egypt	Rafeeq, MM (reprint author), King Abdulaziz Univ, Fac Med, Dept Pharmacol, Rabigh Campus, Jeddah 21589, Saudi Arabia.	marafeeq@kau.edu.sa	RAFEEQ, MISBAHUDDIN/D-7339-2012				ABELIOVICH D, 1992, AM J HUM GENET, V51, P951; Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; Antunovic SS, 2013, CLIN PHARMACOL THER, V93, P86, DOI 10.1038/clpt.2012.183; Borowitz D, 2009, J PEDIATR-US, V155, pS73, DOI 10.1016/j.jpeds.2009.09.001; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Colombo C, 2011, J CYST FIBROS, V10, pS24, DOI 10.1016/S1569-1993(11)60005-2; Cystic Fibrosis Foundation Annual Patient Registry Report, 2014, CYSTIC FIBROSIS FDN; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Davies JC, 2014, 28 ANN N AM C CYST F; Davis PB, 1993, CYSTIC FIBROSIS, P193; Fanen P, 2001, ATLAS GENETIC CYTOGE; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Griese M, 2008, EUR RESPIR J, V32, P783, DOI 10.1183/09031936.00146807; Guggino WB, 2004, AM J RESP CRIT CARE, V170, P815, DOI 10.1164/rccm.200403-381WS; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; Houwen RH, 2010, J PEDIATR GASTR NUTR, V50, P38, DOI 10.1097/MPG.0b013e3181a6e01d; JOHNSON LG, 1995, J CLIN INVEST, V95, P1377, DOI 10.1172/JCI117789                                                               ; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; KHOSHOO V, 1994, AM J GASTROENTEROL, V89, P153; Konstan MW, 2011, J CYST FIBROS, V10, P54, DOI 10.1016/j.jcf.2010.10.003; Kopeikin Z, 2014, J CYST FIBROS, V13, P508, DOI 10.1016/j.jcf.2014.04.003; Lubamba B, 2011, EUR RESPIR J, V37, P72, DOI 10.1183/09031936.00013510; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Lukacs GL, 2003, NEW ENGL J MED, V349, P1401, DOI 10.1056/NEJMp038113                                                             ; McIlwaine MP, 2013, THORAX, V68, P746, DOI 10.1136/thoraxjnl-2012-202915; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5                                                   ; Moskowitz SM, CFTR RELATED DISORDE; Moss RB, 2002, CHEST, V121, P55, DOI 10.1378/chest.121.1.55; NS30 Pharma, N30 PHARM ANN 1 PAT; Orenstein DM, 2002, J PEDIATR-US, V140, P156, DOI 10.1067/mpd.2002.120269; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Quan JM, 2001, J PEDIATR-US, V139, P813, DOI 10.1067/mpd.2001.118570; Ramsey B, 2014, 28 ANN N AM C CYST F; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Reis FJ, 1998, J PEDIAT RIO J S1, V74, pS76; Robinson M, 1996, AM J RESP CRIT CARE, V153, P1503, DOI 10.1164/ajrccm.153.5.8630593                                                    ; Rosenfeld M, 2014, 28 ANN N AM C CYST F; Rowe SM, 2014, AM J RESP CRIT CARE, V190, P175, DOI 10.1164/rccm.201404-0703OC; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088                                                    ; Salvatore D, 2002, PEDIATR PULM, V34, P11, DOI 10.1002/ppul.10117; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Stern RC, 2000, AM J GASTROENTEROL, V95, P1932; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Taylor-Cousar JL, 2015, J CYST FIBROS, V14, P228, DOI 10.1016/j.jcf.2014.10.006; Tosco A, 2016, CELL DEATH DIFFER, V23, P1380, DOI 10.1038/cdd.2016.22; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Kalydeco (ivacaftor), 2012, KAL IV PROD INF; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Whiting P, 2014, HEALTH TECHNOL ASSES, V18, P100; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC	53	2	2	7	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1479-5876			J TRANSL MED	J. Transl. Med.	APR 27	2017	15								84	10.1186/s12967-017-1193-9				9	Medicine, Research & Experimental	Research & Experimental Medicine	ET9FK	WOS:000400612500001	28449677	gold			2018-01-05	
J	Kamoshita, M; Kato, T; Fujiwara, K; Namiki, T; Matsumura, K; Hyon, SH; Ito, J; Kashiwazaki, N				Kamoshita, Maki; Kato, Tsubasa; Fujiwara, Katsuyoshi; Namiki, Takafumi; Matsumura, Kazuaki; Hyon, Suong-Hyu; Ito, Junya; Kashiwazaki, Naomi			Successful vitrification of pronuclear-stage pig embryos with a novel cryoprotective agent, carboxylated epsilon-poly-L-lysine	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ZINC-FINGER NUCLEASES; SUCCESSFUL CRYOPRESERVATION; DEVELOPMENTAL ABILITY; BOAR SPERMATOZOA; CURRENT PROGRESS; PORCINE OOCYTES; MOUSE OOCYTES; CUMULUS CELLS; KNOCKOUT	Vitrification is a powerful tool for the efficient production of offspring derived from cryopreserved oocytes or embryos in mammalian species including domestic animals. Genome editing technologies such as transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 are now available even for domestic species, suggesting that the vitrification of embryos at the pronuclear stage (PN) will be more important because they could provide genomic host cells to be targeted by TALENs or CRISPR/Cas9. Although we reported the successful production of piglets derived from vitrified PN embryos by a solid-surface vitrification method with glutathione supplementation, further improvements are required. The cryoprotective agent (CPA) carboxylated epsilon-poly-L-lysine (COOH-PLL) was introduced in 2009. COOH-PLL reduces the physical and physiological damage caused by cryopreservation in mammalian stem cells and the vitrification of mouse oocytes and embryos. Those results suggested that vitrification of COOH-PLL may help improve the developmental ability of pig embryos vitrified at the PN stage. However, it remains unclear whether COOH-PLL is available as a CPA for the vitrification of embryos in domestic species. In this study, we evaluated COOH-PLL as a CPA with ethylene glycol (EG) and Cryotop as a device for the vitrification of PN pig embryos. Exposure to vitrification solution supplemented with COOHPLL up to 30% did not decrease developmental ability to the 2-cell stage and the blastocyst stage. After warming, most of the vitrified embryos survived regardless of the concentration of COOH-PLL (76.0 +/- 11.8% to 91.8 +/- 4.6%). However, the vitrified embryos without COOH-PLL showed a lower development rate up to the blastocyst stage (1.3 +/- 1.0%) compared to the fresh embryos (28.4 +/- 5.0%) (p < 0.05). In contrast, supplementation of 20% (w/v) COOH-PLL in the vitrification solution dramatically improved the developmental ability to blastocysts of the vitrified embryos (19.4 +/- 4.6%) compared to those without COOH-PLL (p<0.05). After the transfer of embryos vitrified with 30% (v/v) EG and 20% (w/v) COOHPLL, we successfully obtained 15 piglets from 8 recipients. Taken together, our present findings demonstrate for the first time that COOH-PLL is an effective CPA for embryo vitrification pig. COOH-PLL is a promising CPA for further improvements in the vitrification of oocytes and embryos in mammalian species.	[Kamoshita, Maki; Kato, Tsubasa; Fujiwara, Katsuyoshi; Namiki, Takafumi; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Lab Anim Reprod, Sagamihara, Kanagawa, Japan; [Matsumura, Kazuaki] Japan Adv Inst Sci & Technol, Nomi, Japan; [Hyon, Suong-Hyu] Kyoto Inst Technol, Ctr Fiber & Text Sci, Kyoto, Japan; [Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan	Ito, J (reprint author), Azabu Univ, Grad Sch Vet Sci, Lab Anim Reprod, Sagamihara, Kanagawa, Japan.; Ito, J (reprint author), Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan.	itoj@azabu-u.ac.jp			JSPS KAKENHI Grant [JP25242050, JP25660215, JP15H04584]; Azabu University Research Services Division; Interuniversity Bio-Backup Project (IBBP)	This work was supported in part by Grants-in-Aid for Scientific Research from JSPS KAKENHI Grant Number JP25242050 (SH.H. and K.M.), JP25660215 (N.K.) and JP15H04584 (J.I.). This research was partially supported by a research project grant awarded by the Azabu University Research Services Division to J.I. and N.K.. This work was also supported by Collaborative Research Project organized by the Interuniversity Bio-Backup Project (IBBP) to KM..	BRINSTER RL, 1980, NATURE, V283, P499, DOI 10.1038/283499a0                                                                ; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Eroglu A, 2009, BIOL REPROD, V80, P70, DOI 10.1095/biolreprod.108.070383; Fujiwara K, 2017, ANIM SCI J, V88, P180, DOI 10.1111/asj.12666; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hirose M, 2013, ANIM SCI J, V84, P693, DOI 10.1111/asj.12061; Hisamatsu S, 2015, ANIM SCI J, V86, P132, DOI 10.1111/asj.12259; Ito J, 2010, ANIM SCI J, V81, P34, DOI 10.1111/j.1740-0929.2009.00699.x; Kikuchi K, 1998, THERIOGENOLOGY, V50, P615, DOI 10.1016/S0093-691X(98)00166-6; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Kohaya N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058063; Kohaya N, 2011, J REPROD DEVELOP, V57, P675, DOI 10.1262/jrd.11-066H; KONO T, 1988, CRYOBIOLOGY, V25, P170, DOI 10.1016/0011-2240(88)90011-9; Kuwayama M, 2008, FERTIL STERIL, V90, P281; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Lagares MA, 2009, CRYOLETTERS, V30, P408; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Mandawala AA, 2016, THERIOGENOLOGY, V86, P1637, DOI 10.1016/j.theriogenology.2016.07.018; Matsumura K, 2016, ACS BIOMATER SCI ENG, V2, P1023, DOI 10.1021/acsbiomaterials.6b00150; Matsumura K, 2010, CELL TRANSPLANT, V19, P691, DOI 10.3727/096368910X508780; Matsumura K, 2009, BIOMATERIALS, V30, P4842, DOI 10.1016/j.biomaterials.2009.05.025; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618                                                      ; NAGASHIMA H, 1995, NATURE, V374, P416, DOI 10.1038/374416a0                                                                ; Ogawa B, 2010, J REPROD DEVELOP, V56, P356, DOI 10.1262/jrd.10-005H                                                             ; PETTERS RM, 1993, J REPROD FERTIL, P61; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Seita Y, 2009, CRYOBIOLOGY, V59, P226, DOI 10.1016/j.cryobiol.2009.07.007; Shibao Y, 2014, CRYOBIOLOGY, V68, P200, DOI [10.1016/j.cryobio1.2014.01.008, 10.1016/j.cryobiol.2014.01.008]; SMORAG Z, 1989, THERIOGENOLOGY, V31, P1227, DOI 10.1016/0093-691X(89)90092-7                                                    ; Somfai T, 2009, BIOL REPROD, V80, P42, DOI 10.1095/biolreprod.108.070235; Somfai T, 2012, J REPROD DEVELOP, V58, P17, DOI 10.1262/jrd.11-140N; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki K, 2002, INT J ANDROL, V25, P84, DOI 10.1046/j.1365-2605.2002.00330.x; Vajta G, 2000, ANIM REPROD SCI, V60, P357, DOI 10.1016/S0378-4320(00)00097-X; Vajta G., 2000, ANIM REPROD SCI, V2, P60; Vorontsov DA, 2014, J PHYS CHEM B, V118, P10240, DOI 10.1021/jp507697q; Watanabe H, 2013, PLOS ONE, V23; Watanabe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083613; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Wu J, 2017, CELL, V26; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Wu J, 2015, CELL STEM CELL, V17, P509, DOI 10.1016/j.stem.2015.10.009; Zeron Y, 1999, CRYOBIOLOGY, V38, P35, DOI 10.1006/cryo.1998.2139                                                          	46	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2017	12	4							e0176711	10.1371/journal.pone.0176711				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ET6EL	WOS:000400383600123	28448636	gold			2018-01-05	
J	Lee, BH; Neela, PH; Kent, MS; Zehnder, AM				Lee, Becky H.; Neela, Poornima H.; Kent, Michael S.; Zehnder, Ashley M.			IQGAP1 is an oncogenic target in canine melanoma	PLOS ONE			English	Article							MALIGNANT MELANOMAS; EXPRESSION PATTERN; KINASE INTERACTION; CELL-LINES; CANCER; INHIBITOR; TUMOR; DOGS; OVEREXPRESSION; CARCINOMAS	Canine oral mucosal melanoma is an aggressive malignant neoplasm and is characterized by local infiltration and a high metastatic potential. The disease progression is similar to that of human oral melanomas. Whereas human cutaneous melanoma is primarily driven by activating mutations in Braf (60%) or Nras (20%), human mucosal melanoma harbors these mutations much less frequently. This makes therapeutic targeting and research modeling of the oral form potentially different from that of the cutaneous form in humans. Similarly, research has found only rare Nras mutations and no activating Braf mutations in canine oral melanomas, but they are still reliant on MAPK signaling. IQGAP1 is a signaling scaffold that regulates oncogenic ERK1/2 MAPK signaling in human Ras- and Raf-driven cancers, including melanomas. To investigate whether IQGAP1 is a potential target in canine melanoma, we examined the expression and localization of IQGAP1 in primary canine melanomas and canine oral melanoma cell lines obtained from the University of California-Davis. Using CRISPR/Cas9 knockout of IQGAP1, we examined effects on downstream ERK1/2 pathway activity and assayed proliferation of cell lines when treated with a peptide that blocks the interaction between IQGAP1 and ERK1/2. We observed that canine IQGAP1 is expressed and localizes to a similar extent in both human and canine melanoma by qPCR, Western blot, and immunofluorescence. Deletion of IQGAP1 reduces MAPK pathway activation in cell lines, similar to effects seen in human Braf (V600E) cell lines. Additionally, we demonstrated reduced proliferation when these cells are treated with a blocking peptide in vitro.	[Lee, Becky H.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Neela, Poornima H.; Zehnder, Ashley M.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Kent, Michael S.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Lee, Becky H.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Zehnder, Ashley M.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	Zehnder, AM (reprint author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.; Zehnder, AM (reprint author), Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA.	azehnder.dvm@grnail.corn		Kent, Michael/0000-0002-7703-7720			Aina OH, 2011, VET IMMUNOL IMMUNOP, V143, P11, DOI 10.1016/j.vetimm.2011.05.018; Fowles JS, 2015, VET COMP ONCOL, V13, P288, DOI 10.1111/vco.12044; Gillard M, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12170; Hayashi H, 2010, INT J CANCER, V126, P2563, DOI 10.1002/ijc.24987; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Jin J, 2012, LARYNGOSCOPE, V122, P2640, DOI 10.1002/lary.23541; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kent MS, 2009, AM J VET RES, V70, P263, DOI 10.2460/ajvr.70.2.263; Koenig A, 2002, VET PATHOL, V39, P458, DOI 10.1354/vp.39-4-458; Kol A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9116; Kurenova E, 2014, CELL CYCLE, V13, P2542, DOI 10.4161/15384101.2015.941760; Kurenova E, 2013, ONCOTARGET, V4, P1632, DOI 10.18632/oncotarget.1365                                                        ; Liu LS, 2013, INT J DERMATOL, V52, P523, DOI 10.1111/j.1365-4632.2012.05829.x; Luan Z, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-38; Mayr B, 2003, VET J, V165, P169, DOI 10.1016/S1090-0233(02)00245-9; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; Nakamura H, 2005, ONCOL REP, V13, P427; Phillips JC, 2012, AM J VET RES, V73, P272, DOI 10.2460/ajvr.73.2.272; Proulx DR, 2003, VET RADIOL ULTRASOUN, V44, P352, DOI 10.1111/j.1740-8261.2003.tb00468.x; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shelly S, 2005, MAMM GENOME, V16, P211, DOI 10.1007/s00335-004-2441-x; Simpson RM, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12185; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015; [Anonymous], NIH SUPPORTED CLIN T	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2017	12	4							e0176370	10.1371/journal.pone.0176370				13	Multidisciplinary Sciences	Science & Technology - Other Topics	ET5FI	WOS:000400309200053	28445541	gold			2018-01-05	
J	Ashdown, GW; Burn, GL; Williamson, DJ; Pandzic, E; Peters, R; Holden, M; Ewers, H; Shao, L; Wiseman, PW; Owen, DM				Ashdown, George W.; Burn, Garth L.; Williamson, David J.; Pandzic, Elvis; Peters, Ruby; Holden, Michael; Ewers, Helge; Shao, Lin; Wiseman, Paul W.; Owen, Dylan M.			Live-Cell Super-resolution Reveals F-Actin and Plasma Membrane Dynamics at the T Cell Synapse	BIOPHYSICAL JOURNAL			English	Article							SPATIOTEMPORAL IMAGE CORRELATION; ALPHA-ACTININ; IMMUNOLOGICAL SYNAPSE; STRUCTURED ILLUMINATION; CRYOELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; RECEPTOR MICROCLUSTERS; LYMPHOCYTE-ACTIVATION; IMMUNE SYNAPSES; RETROGRADE FLOW	The cortical actin cytoskeleton has been shown to be critical for the reorganization and heterogeneity of plasma membrane components of many cells, including T cells. Building on previous studies at the T cell immunological synapse, we quantitatively assess the structure and dynamics of this meshwork using live-cell superresolution fluorescence microscopy and spatio-temporal image correlation spectroscopy. We show for the first time, to our knowledge, that not only does the dense actin cortex flow in a retrograde fashion toward the synapse center, but the plasma membrane itself shows similar behavior. Furthermore, using two-color, live-cell superresolution cross-correlation spectroscopy, we demonstrate that the two flows are correlated and, in addition, we show that coupling may extend to the outer leaflet of the plasma membrane by examining the flow of GPI-anchored proteins. Finally, we demonstrate that the actin flow is correlated with a third component, alpha-actinin, which upon CRISPR knockout led to reduced plasma membrane flow directionality despite increased actin flow velocity. We hypothesize that this apparent cytoskeletal-membrane coupling could provide a mechanism for driving the observed retrograde flow of signaling molecules such as the TCR, Lck, ZAP70, LAT, and SLP76.	[Ashdown, George W.; Burn, Garth L.; Williamson, David J.; Peters, Ruby; Holden, Michael; Owen, Dylan M.] Kings Coll London, Dept Phys, London, England; [Ashdown, George W.; Burn, Garth L.; Williamson, David J.; Peters, Ruby; Holden, Michael; Owen, Dylan M.] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Burn, Garth L.] Max Planck Inst Infect Biol, Berlin, Germany; [Pandzic, Elvis] Univ New South Wales, Mark Wainwright Analyt Ctr, Sydney, NSW, Australia; [Ewers, Helge] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Shao, Lin] Howard Hughes Med Inst, Adv Imaging Ctr, Janelia Res Campus, Ashburn, VA USA; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ, Canada	Owen, DM (reprint author), Kings Coll London, Dept Phys, London, England.; Owen, DM (reprint author), Kings Coll London, Randall Div Cell & Mol Biophys, London, England.	dylan.owen@kcl.ac.uk			European Research Council [337187]; Marie-Curie Career Integration grant [334303]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation	D.M.O. acknowledges European Research Council grant No. 337187 and Marie-Curie Career Integration grant No. 334303. P.W.W. acknowledges the Natural Sciences and Engineering Research Council of Canada's Discovery Grant program. Two-channel TIRF-SIM microscopy was performed at the Advanced Imaging Center, Janelia Research Campus, jointly sponsored by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation.	Ashdown G., 2015, JOVE-J VIS EXP, V106; Ashdown GW, 2014, BIOPHYS J, V107, pL21, DOI 10.1016/j.bpj.2014.09.018; Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Bashour KT, 2014, MOL CELL BIOL, V34, P955, DOI 10.1128/MCB.00842-13; Beemiller P, 2012, NAT IMMUNOL, V13, P787, DOI 10.1038/ni.2364; Benninger RKP, 2009, BIOPHYS J, V96, pL13, DOI 10.1016/j.bpj.2008.10.005; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Chichili GR, 2012, J BIOL CHEM, V287, P24186, DOI 10.1074/jbc.M111.320747; Comrie WA, 2015, J CELL BIOL, V208, P457, DOI 10.1083/jcb.201406120; Dinic J, 2013, BBA-BIOMEMBRANES, V1828, P1102, DOI 10.1016/j.bbamem.2012.12.004; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Gordon-Alonso M, 2012, J IMMUNOL, V189, P689, DOI 10.4049/jimmunol.1103708; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hampton CM, 2007, J MOL BIOL, V368, P92, DOI 10.1016/j.jmb.2007.01.071; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Heinemann F, 2013, BIOPHYS J, V104, P1465, DOI 10.1016/j.bpj.2013.02.042; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kelly DF, 2005, J STRUCT BIOL, V149, P290, DOI 10.1016/j.jsb.2004.11.010; Kelly DF, 2006, J MOL BIOL, V357, P562, DOI 10.1016/j.jmb.2005.12.076; Kiuchi T, 2015, NAT METHODS, V12, P743, DOI [10.1038/nmeth.3466, 10.1038/NMETH.3466]; KUCIK DF, 1990, J CELL BIOL, V111, P1617, DOI 10.1083/jcb.111.4.1617; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Mace EM, 2014, P NATL ACAD SCI USA, V111, P6708, DOI 10.1073/pnas.1314975111; Machta BB, 2011, BIOPHYS J, V100, P1668, DOI 10.1016/j.bpj.2011.02.029; MCGREGOR A, 1994, BIOCHEM J, V301, P225, DOI 10.1042/bj3010225                                                               ; Murugesan S, 2016, J CELL BIOL, V215, P383, DOI 10.1083/jcb.201603080; Owen DM, 2010, MOL MEMBR BIOL, V27, P178, DOI 10.3109/09687688.2010.495353; Raghupathy R, 2015, CELL, V161, P581, DOI 10.1016/j.cell.2015.03.048; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Ritter AT, 2015, IMMUNITY, V42, P864, DOI 10.1016/j.immuni.2015.04.013; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X                                                   ; Toplak T, 2012, BIOPHYS J, V103, P1672, DOI 10.1016/j.bpj.2012.08.060; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011878	50	2	2	6	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	APR 25	2017	112	8					1703	1713		10.1016/j.bpj.2017.01.038				11	Biophysics	Biophysics	ET7UX	WOS:000400505800018	28445761				2018-01-05	
J	Wang, K; Liang, C				Wang, Kai; Liang, Chun			CRF: detection of CRISPR arrays using random forest	PEERJ			English	Article						Repeat detection; Random forest; Machine learning; CRISPR; Data visualization	SECONDARY STRUCTURES; PALINDROMIC REPEATS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; IDENTIFICATION; SEQUENCE; PROKARYOTES; RNA; SYSTEMS; COMPLEX	CRISPRs (clustered regularly interspaced short palindromic repeats) are particular repeat sequences found in wide range of bacteria and archaea genornes. Several tools are available for detecting CRISPR arrays in the genomes of both domains. Here we developed a new web-based CRISPR detection tool named CRF (CRISPR Finder by Random Forest). Different from other CRISPR detection tools, a random forest classifier was used in CRF to filter out invalid CRISPR arrays from all putative candidates and accordingly enhanced detection accuracy. In CRF, particularly, triplet elements that combine both sequence content and structure information were extracted from CRISPR repeats for classifier training. The classifier achieved high accuracy and sensitivity. Moreover, CRF offers a highly interactive web interface for robust data visualization that is not available among other CRISPR detection tools. After detection, the query sequence, CRISPR array architecture, and the sequences and secondary structures of CRISPR repeats and spacers can be visualized for visual examination and validation. CRF is freely available at http://bioinfolab.miamioh.edu/crf/home.php.	[Wang, Kai; Liang, Chun] Miami Univ, Dept Biol, Oxford, OH 45056 USA	Liang, C (reprint author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	liangc@miannoh.edu			Committee on Faculty Research (CRF) Program, Miami University, Oxford, Ohio, USA; Department of Biology, Miami University, Oxford, Ohio, USA; Office for the Advancement of Research & Scholarship (OARS), Miami University, Oxford, Ohio, USA	This project is funded by the Committee on Faculty Research (CRF) Program, the Office for the Advancement of Research & Scholarship (OARS), and the Department of Biology, Miami University, Oxford, Ohio, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163                                                              ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kurtz S, 2003, VMATCH LARGE SCALE S; Andy L., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516; Mayer C, 2008, PHOBOS TANDEM REPEAT; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Skennerton CT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt183; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; Wang K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0419-6; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310	26	0	0	5	5	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	APR 25	2017	5								e3219	10.7717/peerj.3219				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ET5DG	WOS:000400303800003	28462029	gold			2018-01-05	
J	Ichikawa, HT; Cooper, JC; Lo, L; Potter, J; Terns, RM; Terns, MP				Ichikawa, H. Travis; Cooper, John C.; Lo, Leja; Potter, Jason; Terns, Rebecca M.; Terns, Michael P.			Programmable type III-A CRISPR-Cas DNA targeting modules	PLOS ONE			English	Article							ADAPTIVE IMMUNE-SYSTEMS; STREPTOCOCCUS-THERMOPHILUS; CRYSTAL-STRUCTURE; RNA CLEAVAGE; CSM COMPLEX; RECOGNITION; DEGRADATION; DEFENSE; BIOLOGY	The CRISPR-Cas systems provide invader defense in a wide variety of prokaryotes, as well as technologies for many powerful applications. The Type III-A or Csm CRISPR-Cas system is one of the most widely distributed across prokaryotic phyla, and cleaves targeted DNA and RNA molecules. In this work, we have constructed modules of Csm systems from 3 bacterial species and heterologously expressed the functional modules in E. coli. The modules include a Cas6 protein and a CRISPR locus for crRNA production, and Csm effector complex proteins. The expressed modules from L. lactis, S. epidermidis and S. thermophilus specifically eliminate invading plasmids recognized by the crRNAs of the systems. Characteristically, activation of plasmid targeting activity depends on transcription of the plasmid sequence recognized by the crRNA. Activity was not observed when transcription of the crRNA target sequence was blocked, or when the opposite strand or a non-target sequence was transcribed. Moreover, the Csm module can be programmed to recognize plasmids with novel target sequences by addition of appropriate crRNA coding sequences to the module. These systems provide a platform for investigation of Type III-A CRISPR-Cas systems in E. coli, and for introduction of programmable transcription-activated DNA targeting into novel organisms.	[Ichikawa, H. Travis; Cooper, John C.; Lo, Leja; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Potter, Jason] Thermo Fisher Sci, Carlsbad, CA USA; [Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Terns, Michael P.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	Terns, RM; Terns, MP (reprint author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Terns, MP (reprint author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.; Terns, MP (reprint author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	rterns@bmb.uga.edu; mterns@uga.edu		Terns, Michael/0000-0001-8330-1789	Life Technologies/Thermo Fisher Scientific; National Institutes of Health [R01 GM099876, R35 GM118160]	This work was generously funded by a Sponsored Research Agreement from Life Technologies/Thermo Fisher Scientific, and the National Institutes of Health R01 GM099876 to MPT and RMT, and R35 GM118160 to MPT. (tittps /Avww nig rT1S nih goy/Pages/default aspx). Life Technologies/Thermo Fisher Scientific. The funder provided support in the form of salaries for authors [HTI, JCC and LJ]. The specific roles of these authors are articulated in the 'author contributions' section. Life Technologies/Thermo Fisher Scientific played a role in study design, data analysis, decision to publish and preparation of the manuscript.	Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Diez-Villasenor C, 2010, MICROBIOL-SGM, V156, P1351, DOI 10.1099/mic.0.036046-0; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Goldberg GW, 2014, NATURE; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jung TY, 2015, STRUCTURE, V23, P782, DOI 10.1016/j.str.2015.01.021; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Millen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051663; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; Numata T, 2015, J MOL BIOL, V427, P259, DOI 10.1016/j.jmb.2014.09.029; Ramia NF, 2014, NUCLEIC ACIDS RES, V42, P1129, DOI 10.1093/nar/gkt914; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Terns RM, 2014, TRENDS GENET, V30, P111, DOI 10.1016/j.tig.2014.01.003; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2017	12	4							e0176221	10.1371/journal.pone.0176221				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ET5FE	WOS:000400308800035	28441427	gold			2018-01-05	
J	Kapusi, E; Corcuera-Gomez, M; Melnik, S; Stoger, E				Kapusi, Eszter; Corcuera-Gomez, Maria; Melnik, Stanislav; Stoger, Eva			Heritable Genomic Fragment Deletions and Small Indels in the Putative ENGase Gene Induced by CRISPR/Cas9 in Barley	FRONTIERS IN PLANT SCIENCE			English	Article						barley; Hordeum vulgare; genome editing; crop; cereals; induced mutation; CRISPR/Cas	RNA-GUIDED ENDONUCLEASE; TARGETED MUTAGENESIS; CRISPRCAS SYSTEM; CAS9 NUCLEASE; HUMAN-CELLS; PLANTS; DNA; ARABIDOPSIS; SPECIFICITY; GENERATION	Targeted genome editing with the CRISPR/Cas9 system has been used extensively for the selective mutation of plant genes. Here we used CRISPR/Cas9 to disrupt the putative barley (Hordeum vulgare cv. "Golden Promise") endo-N-acetyl-beta-D-glucosaminidase (ENGase) gene. Five single guide RNAs (sgRNAs) were designed for different target sites in the upstream part of the ENGase coding region. Targeted fragment deletions were induced by co-bombarding selected combinations of sgRNA with wild-type cas9 using separate plasmids, or by co-infection with separate Agrobacterium tumefaciens cultures. Genotype screening was carried out in the primary transformants (T0) and their T1 progeny to confirm the presence of site-specific small insertions and deletions (indels) and genomic fragment deletions between pairs of targets. Cas9-induced mutations were observed in 78% of the plants, a higher efficiency than previously reported in barley. Notably, there were differences in performance among the five sgRNAs. The induced indels and fragment deletions were transmitted to the T1 generation, and transgene free (sgRNA: cas9 negative) genome-edited homozygous ENGase knock outs were identified among the T1 progeny. We have therefore demonstrated that mutant barley lines with a disrupted endogenous ENGase and defined fragment deletions can be produced efficiently using the CRISPR/Cas9 system even when this requires co-transformation with multiple plasmids by bombardment or Agrobacterium-mediated transformation. We confirm the specificity and heritability of the mutations and the ability to efficiently generate homozygous mutant T1 plants.	[Kapusi, Eszter; Corcuera-Gomez, Maria; Melnik, Stanislav; Stoger, Eva] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria	Stoger, E (reprint author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	eva.stoger@boku.ac.at			Austrian Science Fund FWF [W1224, I1461-B16]	The authors would like to acknowledge financial support by the Austrian Science Fund FWF (W1224 and I1461-B16).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fischl RM, 2011, PLANT MOL BIOL, V77, P275, DOI 10.1007/s11103-011-9808-7; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hensel G, 2004, TRANSGENIC CROPS OF THE WORLD: ESSENTIAL PROTOCOLS, P35; Hensel G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140476; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson RA, 2015, PLANT MOL BIOL, V87, P143, DOI 10.1007/s11103-014-0266-x; Kapusi E, 2013, PLANT MOL BIOL, V81, P149, DOI 10.1007/s11103-012-9988-9; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654                                                         ; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manova V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00885; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Pacher M, 2017, PLANT J, V90, P819, DOI 10.1111/tpj.13469; Pallotta MA, 2000, THEOR APPL GENET, V101, P1100, DOI 10.1007/s001220051585; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Podevin N, 2013, TRENDS BIOTECHNOL, V31, P375, DOI 10.1016/j.tibtech.2013.03.004; Rademacher T, 2008, PLANT BIOTECHNOL J, V6, P189, DOI 10.1111/j.1467-7652.2007.00306.x; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Vamvaka E, 2016, PLANT BIOTECHNOL J, V14, P97, DOI 10.1111/pbi.12360; Vuylsteker C, 2000, J EXP BOT, V51, P839, DOI 10.1093/jexbot/51.346.839; WAN YC, 1994, PLANT PHYSIOL, V104, P37, DOI 10.1104/pp.104.1.37                                                             ; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu CF, 2017, TRENDS PLANT SCI, V22, P38, DOI 10.1016/j.tplants.2016.08.009	54	2	2	17	23	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	APR 25	2017	8								540	10.3389/fpls.2017.00540				11	Plant Sciences	Plant Sciences	ET1QB	WOS:000400042800001	28487703	gold			2018-01-05	
J	Lee, S; Luo, W; Shah, T; Yin, CH; O'Connell, T; Chung, TH; Perkins, SL; Miles, RR; Ayello, J; Morris, E; Harrison, L; van de Ven, C; Cairo, MS				Lee, Sanghoon; Luo, Wen; Shah, Tishi; Yin, Changhong; O'Connell, Timmy; Chung, Tae-Hoon; Perkins, Sherrie L.; Miles, Rodney R.; Ayello, Janet; Morris, Erin; Harrison, Lauren; van de Ven, Carmella; Cairo, Mitchell S.			The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL	ONCOTARGET			English	Article						DLEU1; tumor suppressor; chemoimmunotherapy; genome editing; B-NHL	CHRONIC LYMPHOCYTIC-LEUKEMIA; NON-HODGKIN-LYMPHOMA; TUMOR-SUPPRESSOR GENE; ONCOLOGY GROUP-REPORT; MANTLE-CELL LYMPHOMA; TARGETING BTK; CHILDREN; ADOLESCENTS; RITUXIMAB; 13Q14	Following a multivariant analysis we demonstrated that children and adolescents with Burkitt lymphoma (BL) and a 13q14.3 deletion have a significant decrease in event free survival (EFS) despite identical short intensive multi-agent chemotherapy. However, how this deletion in the 13q14.3 region is associated with a significant decrease in EFS in children and adolescents with BL is largely unknown. The gene Deleted in Lymphocytic Leukemia 1 (DLEU1) is located in the region of 13q14.3. Here, we report that DLEU1 expression is implicated in the regulation of BL programmed cell death, cell proliferation, and expression of apoptotic genes in transcription activator-like effector nuclease (TALEN) s-induced DLEU1 knockdown and DLEU1 overexpressing BL cell lines. Furthermore, NSG mice xenografted with DLEU1 knockdown BL cells had significantly shortened survival (p < 0.05 and p < 0.005), whereas those xenografted with DLEU1 overexpressing BL cells had significantly improved survival (p < 0.05 and p < 0.0001), following treatment with rituximab and/or cyclophosphamide. These data suggest that DLEU1 may in part function as a tumor suppressor gene and confer chemoimmunotherapy resistance in children and adolescents with BL.	[Lee, Sanghoon; Luo, Wen; Shah, Tishi; Yin, Changhong; O'Connell, Timmy; Ayello, Janet; Morris, Erin; Harrison, Lauren; van de Ven, Carmella; Cairo, Mitchell S.] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA; [Lee, Sanghoon; Cairo, Mitchell S.] New York Med Coll, Dept Cell Biol, Valhalla, NY 10595 USA; [Lee, Sanghoon; Cairo, Mitchell S.] New York Med Coll, Dept Anat, Valhalla, NY 10595 USA; [O'Connell, Timmy; Cairo, Mitchell S.] New York Med Coll, Dept Microbiol, Valhalla, NY 10595 USA; [O'Connell, Timmy; Cairo, Mitchell S.] New York Med Coll, Dept Immunol, Valhalla, NY 10595 USA; [Chung, Tae-Hoon] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Perkins, Sherrie L.; Miles, Rodney R.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Perkins, Sherrie L.; Miles, Rodney R.] Univ Utah, ARUP Labs, Salt Lake City, UT USA; [Cairo, Mitchell S.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Cairo, Mitchell S.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA	Cairo, MS (reprint author), New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA.; Cairo, MS (reprint author), New York Med Coll, Dept Cell Biol, Valhalla, NY 10595 USA.; Cairo, MS (reprint author), New York Med Coll, Dept Anat, Valhalla, NY 10595 USA.; Cairo, MS (reprint author), New York Med Coll, Dept Microbiol, Valhalla, NY 10595 USA.; Cairo, MS (reprint author), New York Med Coll, Dept Immunol, Valhalla, NY 10595 USA.; Cairo, MS (reprint author), New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA.; Cairo, MS (reprint author), New York Med Coll, Dept Med, Valhalla, NY 10595 USA.	mitchell_cairo@nymc.edu			Pediatric Cancer Research Foundation; Hyundai Hope on Wheels; St. Baldrick's Foundation	Funding was provided by grants from the Pediatric Cancer Research Foundation, Hyundai Hope on Wheels, and St. Baldrick's Foundation (Mitchell S Cairo, MD).	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088                                                   ; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cairo MS, 2007, BLOOD, V109, P2736, DOI 10.1182/blood-2006-07-036665; Cairo MS, 2012, J CLIN ONCOL, V30, P387, DOI 10.1200/JCO.2010.33.3369; Cairo MS, 2011, GENOMIC PATHWAYS POT, V118, P1587; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Carlson D. F., 2012, NUCL ACIDS, V1, pe3, DOI [10.1038/MTNA.2011.5, DOI 10.1038/MTNA.2011.5]; Chen E, 2006, ONCOGENE, V25, P5752, DOI 10.1038/sj.onc.1209573; Chu YY, 2015, CANCER IMMUNOL RES, V3, P333, DOI 10.1158/2326-6066.CIR-14-0114; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Day N, 2008, CANCER RES; Dennis Glynn Jr, 2003, Genome Biol, V4, pP3, DOI 10.1186/gb-2003-4-5-p3; DEWEERS M, 1994, J BIOL CHEM, V269, P23857; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Gerrard M, 2008, BRIT J HAEMATOL, V141, P840, DOI 10.1111/j.1365-2141.2008.07144.x; Goldman S, 2013, LEUKEMIA, V27, P1174, DOI 10.1038/leu.2012.255; Goldman S, 2014, BRIT J HAEMATOL, V167, P394, DOI 10.1111/bjh.13040; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Ivanov DV, 2003, FEBS LETT, V539, P156, DOI 10.1016/S0014-5793(03)00211-4; Kheirallah S, 2010, BLOOD, V115, P985, DOI 10.1182/blood-2009-08-237537; Klapper W, 2008, BLOOD, V112, P1374, DOI 10.1182/blood-2008-01-136465; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Lee S, 2004, ONCOGENE, V23, P2287, DOI 10.1038/sj.onc.1207385; Lee S, 2015, CANC RES; Lee S, 2007, CANCER LETT, V245, P44, DOI 10.1016/j.canlet.2005.10.045; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Liu Y, 1997, ONCOGENE, V15, P2463, DOI 10.1038/sj.onc.1201643; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/NMETH.2366, 10.1038/nmeth.2366]; Migliazza A, 2001, BLOOD, V97, P2098, DOI 10.1182/blood.V97.7.2098; Nelson M, 2010, BRIT J HAEMATOL, V148, P600, DOI 10.1111/j.1365-2141.2009.07967.x; Niazi F, 2012, RNA, V18, P825, DOI 10.1261/rna.029520.111; Patte C, 2007, BLOOD, V109, P2773, DOI 10.1182/blood-2006-07-036673; Poirel HA, 2009, LEUKEMIA, V23, P323, DOI 10.1038/leu.2008.312; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958                                                          ; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Joung JK, 2011, CURR PROTOC MOL BIOL, V12, P13, DOI [10.1002/0471142727.mb1213s96, DOI 10.1002/0471142727.MB1213S96]; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stilgenbauer S, 1998, ONCOGENE, V16, P1891, DOI 10.1038/sj.onc.1201764; Suzuki E, 2007, ONCOGENE, V26, P6184, DOI 10.1038/sj.onc.1210448; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Young RM, 2013, NAT REV DRUG DISCOV, V12, P229, DOI 10.1038/nrd3937	48	0	0	2	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	APR 25	2017	8	17					27839	27853		10.18632/oncotarget.15711				15	Oncology; Cell Biology	Oncology; Cell Biology	ET1SU	WOS:000400050000017	28427156	gold			2018-01-05	
J	Kitazawa, S; Ebara, S; Ando, A; Baba, Y; Satomi, Y; Soga, T; Hara, T				Kitazawa, Satoshi; Ebara, Shunsuke; Ando, Ayumi; Baba, Yuji; Satomi, Yoshinori; Soga, Tomoyoshi; Hara, Takahito			Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors	ONCOTARGET			English	Article						SDHB; metabolism; c-Myc; BET; TCA cycle	C-MYC; RENAL-CARCINOMA; GENE-MUTATIONS; MALIGNANT PHEOCHROMOCYTOMAS; PYRUVATE CARBOXYLATION; GERMLINE SDHB; PARAGANGLIOMA; METABOLISM; EXPRESSION; HETEROZYGOSITY	Mutations in succinate dehydrogenase B (SDHB) gene are frequently observed in several tumors and associated with poor prognosis in these tumors. Therefore, drugs effective for SDHB-deficient tumors could fulfill an unmet medical need. In addition, such drugs would have an advantage in that selection of patients with SDHB- mutant cancer could increase the probability of success in clinical trials. Currently, however, the characteristics of SDHB-deficient cancers are not completely understood. Here, we established SDHB knockout cancer cell lines from human colon cancer HCT116 cells using the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 knockout system, and clarified its metabolic characteristics. In the SDHB knockout cells, succinate was accumulated and fumarate was decreased. The oxygen consumption rate was decreased while the extracellular acidification rate was increased in the SDHB knockout cells. Accordingly, an enhanced glycolysis pathway in the SDHB knockout cells was demonstrated by metabolomics analysis. Tracer experiments showed bidirectional metabolic flow in the tricarboxylic acid (TCA) cycle, possibly to maintain the necessary amounts of metabolites in the SDHB knockout cells. The proliferation of SDHB knockout cells was suppressed by a glycolysis inhibitor but not by a mitochondrial inhibitor. Additionally, partial dependence on glutaminolysis was observed in the SDHB knockout cells. Compound screening revealed that a bromodomain and extra-terminal (BET) inhibitor, which downregulated c-Myc, suppressed the growth of the SDHB knockout cells more potently than that of control cells. These findings provide an understanding of the metabolic characteristics of SDHB-deficient cancer and its vulnerabilities, which may lead to new therapeutic options.	[Kitazawa, Satoshi; Ebara, Shunsuke; Baba, Yuji; Hara, Takahito] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa 2518555, Japan; [Ando, Ayumi; Satomi, Yoshinori] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Integrated Technol Res Labs, Fujisawa, Kanagawa 2518555, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan	Hara, T (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa 2518555, Japan.	takahito.hara@takeda.com	Soga, Tomoyoshi/B-8105-2014	Soga, Tomoyoshi/0000-0001-9502-2509; Satomi, Yoshinori/0000-0002-8991-1040	Takeda Pharmaceutical Company Limited, Japan	This article was wholly supported by Takeda Pharmaceutical Company Limited, Japan.	Amar L, 2007, J CLIN ENDOCR METAB, V92, P3822, DOI 10.1210/jc.2007-0709; Aspuria PJP, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-21; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; BROWN J, 1962, METABOLISM, V11, P1098; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961                                                        ; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Doyle LA, 2012, HISTOPATHOLOGY, V61, P801, DOI 10.1111/j.1365-2559.2012.04300.x; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fish PV, 2012, J MED CHEM, V55, P9831, DOI 10.1021/jm3010515; Ghigna MR, 2016, ENDOCR PATHOL, V19, P1; Gill AJ, 2014, AM J SURG PATHOL, V38, P1588, DOI 10.1097/PAS.0000000000000292; Gimenez-Roqueplo AP, 2003, CANCER RES, V63, P5615; Habano W, 2003, ONCOL REP, V10, P1375; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Kang HT, 2006, LIFE SCI, V78, P1392, DOI 10.1016/j.lfs.2005.07.001; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477                                                         ; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; Malinoc A, 2012, ENDOCR-RELAT CANCER, V19, P283, DOI 10.1530/ERC-11-0324; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ozluk Y, 2015, HUM PATHOL, V46, P1951, DOI 10.1016/j.humpath.2015.07.027; Pantaleo MA, 2014, EUR J HUM GENET, V22, P32, DOI 10.1038/ejhg.2013.80; Prasad P, 2009, CANCER GENET CYTOGEN, V192, P82, DOI 10.1016/j.cancergencyto.2009.04.009; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0; Vanharanta S, 2004, AM J HUM GENET, V74, P153, DOI 10.1086/381054; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Williamson SR, 2015, MODERN PATHOL, V28, P80, DOI 10.1038/modpathol.2014.86; Wu S, 2015, Cell Death Discov, V1, P15057, DOI 10.1038/cddiscovery.2015.57; Zhang DC, 2013, TUMOR BIOL, V34, P2337, DOI 10.1007/s13277-013-0781-4	35	0	0	2	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	APR 25	2017	8	17					28922	28938		10.18632/oncotarget.15959				17	Oncology; Cell Biology	Oncology; Cell Biology	ET1SU	WOS:000400050000107	28423651	gold			2018-01-05	
J	Yeung, ATY; Hale, C; Lee, AH; Gill, EE; Bushell, W; Parry-Smith, D; Goulding, D; Pickard, D; Roumeliotis, T; Choudhary, J; Thomson, N; Skarnes, WC; Dougan, G; Hancock, REW				Yeung, Amy T. Y.; Hale, Christine; Lee, Amy H.; Gill, Erin E.; Bushell, Wendy; Parry-Smith, David; Goulding, David; Pickard, Derek; Roumeliotis, Theodoros; Choudhary, Jyoti; Thomson, Nick; Skarnes, William C.; Dougan, Gordon; Hancock, Robert E. W.			Exploiting induced pluripotent stem cell-derived macrophages to unravel host factors influencing Chlamydia trachomatis pathogenesis	NATURE COMMUNICATIONS			English	Article							REACTIVE ARTHRITIS; REITERS-SYNDROME; GENE-EXPRESSION; INFECTION; APOPTOSIS; GROWTH; TISSUE; IL-10; MICE	Chlamydia trachomatis remains a leading cause of bacterial sexually transmitted infections and preventable blindness worldwide. There are, however, limited in vitro models to study the role of host genetics in the response of macrophages to this obligate human pathogen. Here, we describe an approach using macrophages derived from human induced pluripotent stem cells (iPSdMs) to study macrophage-Chlamydia interactions in vitro. We show that iPSdMs support the full infectious life cycle of C. trachomatis in a manner that mimics the infection of human blood-derived macrophages. Transcriptomic and proteomic profiling of the macrophage response to chlamydial infection highlighted the role of the type I interferon and interleukin 10-mediated responses. Using CRISPR/Cas9 technology, we generated biallelic knockout mutations in host genes encoding IRF5 and IL-10RA in iPSCs, and confirmed their roles in limiting chlamydial infection in macrophages. This model can potentially be extended to other pathogens and tissue systems to advance our understanding of host-pathogen interactions and the role of human genetics in influencing the outcome of infections.	[Yeung, Amy T. Y.; Hale, Christine; Bushell, Wendy; Parry-Smith, David; Goulding, David; Pickard, Derek; Roumeliotis, Theodoros; Choudhary, Jyoti; Thomson, Nick; Skarnes, William C.; Dougan, Gordon; Hancock, Robert E. W.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Lee, Amy H.; Gill, Erin E.; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V6T 1Z4, Canada; [Dougan, Gordon] Addenbrookes Hosp, Dept Med, Box 157,Hills Rd, Cambridge CB2 0QQ, England	Hancock, REW (reprint author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.; Hancock, REW (reprint author), Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V6T 1Z4, Canada.	bob@hancocklab.com	Choudhary, Jyoti/S-1232-2017	Choudhary, Jyoti/0000-0003-0881-5477; Thomson, Nicholas/0000-0002-4432-8505; Lee, Amy/0000-0003-3250-3246	Wellcome Trust; Canadian Institutes for Health Research (CIHR) [MOP-363437]	This work was supported by The Wellcome Trust. REWH would like to acknowledge funding from the Canadian Institutes for Health Research (CIHR, funding reference number MOP-363437) for the work reported here and personal support from the Canada Research Chair program and University of British Columbia Killam Professorship. We thank Dr Ian Clarke for providing us with the C. trachomatis strains Sweden F plasmid minus (SWFP -) and SWFP - transformed with plasmid pGFP::SW2. We thank Theresa Feltwell, Louise Ellison and Dr Helena Smith for sharing Chlamydia propagation protocols. We thank Drs Rey Carabeo and Tristan Thwaites for teaching us how to perform density gradient purification of Chlamydia. We thank Gareth Griffiths and Katie Andrews for help with genotyping.	Abdelsamed H, 2013, FUTURE MICROBIOL, V8, P1129, DOI 10.2217/fmb.13.80; Alasoo K., 2015, SCI REP, V30, P12524; Azenabor AA, 2010, COMP IMMUNOL MICROB, V33, P513, DOI 10.1016/j.cimid.2009.09.002; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; BEUTLER AM, 1995, AM J MED SCI, V310, P206, DOI 10.1097/00000441-199511000-00006; Bressan RB, 2017, DEVELOPMENT, V144, P635, DOI 10.1242/dev.140855; Buchacher T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143593; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161; Carter John D, 2012, Int J Clin Rheumtol, V7, P627; Davila SJ, 2014, J IMMUNOL, V192, P4284, DOI 10.4049/jimmunol.1303238; Fields KA, 2013, INFECT IMMUN, V81, P3045, DOI 10.1128/IAI.00497-13; Foroushani ABK, 2013, PEERJ, V1, DOI 10.7717/peerj.229; Geng YM, 2000, J IMMUNOL, V164, P5522, DOI 10.4049/jimmunol.164.10.5522                                                    ; Gerard HC, 1998, J RHEUMATOL, V25, P734; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; Gracey E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069421; Hafner L, 2008, MUCOSAL IMMUNOL, V1, P116, DOI 10.1038/mi.2007.19; Hakimi H, 2014, INFLAMMATION, V37, P818, DOI 10.1007/s10753-013-9801-1; Hale C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124307; Herweg JA, 2016, FEBS J, V283, P608, DOI 10.1111/febs.13609; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Humphrys MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080597; Igietseme JU, 1999, IMMUNOLOGY, V98, P510, DOI 10.1046/j.1365-2567.1999.00926.x; Koblish HK, 2010, MOL CANCER THER, V9, P489, DOI 10.1158/1535-7163.MCT-09-0628; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Nagarajan UM, 2005, J IMMUNOL, V175, P450, DOI 10.4049/jimmunol.175.1.450                                                      ; NANAGARA R, 1995, ARTHRITIS RHEUM, V38, P1410, DOI 10.1002/art.1780381008; Odero MD, 2000, GENE CHROMOSOME CANC, V29, P333, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1040>3.0.CO;2-Z; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Prantner D, 2011, INFECT IMMUN, V79, P3922, DOI 10.1128/IAI.00140-11; Rihl M, 2006, ANN RHEUM DIS, V65, P281, DOI 10.1136/ard.2005.044966; Rodel J, 1999, MED MICROBIOL IMMUN, V187, P205, DOI 10.1007/s004300050094; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453; Schmidt SV, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00384; Sharif R, 2012, ANN RHEUM DIS, V71, P1197, DOI 10.1136/annrheumdis-2011-200901; Sharma M, 2009, FEMS IMMUNOL MED MIC, V55, P154, DOI 10.1111/j.1574-695X.2008.00515.x; Streeter I, 2017, NUCLEIC ACIDS RES, V45, pD691, DOI 10.1093/nar/gkw928; Sun HS, 2012, J LEUKOCYTE BIOL, V92, P815, DOI 10.1189/jlb.0711336; Taraktchoglou M, 2001, INFECT IMMUN, V69, P968, DOI 10.1128/IAI.69.2.968-976.2001; Tate PH, 2011, METHODS, V53, P331, DOI 10.1016/j.ymeth.2010.12.025; Vanhee S, 2015, HAEMATOLOGICA, V100, P157, DOI 10.3324/haematol.2014.112144; Virok D, 2003, J INFECT DIS, V188, P1310, DOI 10.1086/379047                                                                  ; Wang YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059195; Weiss M., 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/245804, DOI 10.1155/2013/245804]; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052	46	2	2	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR 25	2017	8								15013	10.1038/ncomms15013				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ET1ZB	WOS:000400066700001	28440293	gold			2018-01-05	
J	Malzahn, A; Lowder, L; Qi, YP				Malzahn, Aimee; Lowder, Levi; Qi, Yiping			Plant genome editing with TALEN and CRISPR	CELL AND BIOSCIENCE			English	Review						Plant genome editing; TALEN; CRISPR; Cas9; Cpf1; NHEJ; HDR	ZINC-FINGER NUCLEASES; EFFICIENT TARGETED MUTAGENESIS; DOUBLE-STRAND BREAKS; DNA-BINDING SPECIFICITY; SEQUENCE-SPECIFIC NUCLEASES; SITE-DIRECTED MUTAGENESIS; HERBICIDE-RESISTANT RICE; POTATO SOLANUM-TUBEROSUM; RNA-GUIDED ENDONUCLEASE; GOSSYPIUM-HIRSUTUM L.	Genome editing promises giant leaps forward in advancing biotechnology, agriculture, and basic research. The process relies on the use of sequence specific nucleases (SSNs) to make DNA double stranded breaks at user defined genomic loci, which are subsequently repaired by two main DNA repair pathways: non-homologous end joining (NHEJ) and homology directed repair (HDR). NHEJ can result in frameshift mutations that often create genetic knockouts. These knockout lines are useful for functional and reverse genetic studies but also have applications in agriculture. HDR has a variety of applications as it can be used for gene replacement, gene stacking, and for creating various fusion proteins. In recent years, transcription activator-like effector nucleases and clustered regularly interspaced palindromic repeats (CRISPR) and CRISPR associated protein 9 or CRISPR from Prevotella and Francisella 1 have emerged as the preferred SSNs for research purposes. Here, we review their applications in plant research, discuss current limitations, and predict future research directions in plant genome editing.	[Malzahn, Aimee; Qi, Yiping] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Lowder, Levi] East Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Qi, Yiping] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA	Qi, YP (reprint author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	yiping@umd.edu			North Carolina Biotechnology Center and Syngenta Biotechnology [2016-CFG-8003]; University of Maryland-College Park	This work is supported by a Collaborative Funding Grant from North Carolina Biotechnology Center and Syngenta Biotechnology (2016-CFG-8003) and a startup fund from University of Maryland-College Park to YQ.	Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Andersson M, 2017, PLANT CELL REP, V36, P117, DOI 10.1007/s00299-016-2062-3; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Basak J, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fnhum.2015.01001, 10.3389/fpls.2015.01001]; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Blanvillain-Baufume S, 2017, PLANT BIOTECHNOL J, V15, P306, DOI 10.1111/pbi.12613; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Budhagatapalli N, 2015, G3-GENES GENOM GENET, V5, P1857, DOI 10.1534/g3.115.018762; Butler NM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01045; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Cai YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136064; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; Char SN, 2015, PLANT BIOTECHNOL J, V13, P1002, DOI 10.1111/pbi.12344; Chen XG, 2017, SCI REP-UK, V7, DOI 10.1038/srep44304; Chen YY, 2017, SCI CHINA LIFE SCI, V60, P520, DOI 10.1007/s11427-017-9021-5; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Collonnier C, 2017, PLANT BIOTECHNOL J, V15, P122, DOI 10.1111/pbi.12596; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Demorest ZL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0906-1; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; Duan YB, 2016, PLANT MOL BIOL, V90, P49, DOI 10.1007/s11103-015-0393-z; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Endo M, 2016, PLANT PHYSIOL, V170, P667, DOI 10.1104/pp.15.01663; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Feng C, 2016, J GENET GENOMICS, V43, P37, DOI 10.1016/j.jgg.2015.10.002; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Forner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121056; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Gurushidze M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092046; Gutierrez C, 1999, CELL MOL LIFE SCI, V56, P313, DOI 10.1007/s000180050433; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hu XX, 2016, MOL PLANT, V9, P943, DOI 10.1016/j.molp.2016.03.003; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Iaffaldano B, 2016, IND CROP PROD, V89, P356, DOI 10.1016/j.indcrop.2016.05.029; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Janga MR, 2017, PLANT MOL BIOL, V94, P349, DOI 10.1007/s11103-017-0599-3; Ji X, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.144, 10.1038/nplants.2015.144]; Jia YX, 2016, NEW PHYTOL, V212, P345, DOI 10.1111/nph.14088; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099225; Jiang WZ, 2016, PLANT BIOTECHNOL J, DOI [10.1111/pbi.12663, DOI 10.1111/PBI.12663.]; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson RA, 2015, PLANT MOL BIOL, V87, P143, DOI 10.1007/s11103-014-0266-x; Johnson RA, 2013, PLANT MOL BIOL, V82, P207, DOI 10.1007/s11103-013-0052-1; Jung JH, 2016, PLANT MOL BIOL, V92, P131, DOI 10.1007/s11103-016-0499-y; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kaya H, 2017, PLANT CELL PHYSL, DOI [10.1093/pcp/pcx034, DOI 10.1093/PCP/PCX034.]; Kaya H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26871; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim H, 2016, J INTEGR PLANT BIOL, V58, P705, DOI 10.1111/jipb.12474; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Klap C, 2017, PLANT BIOTECHNOL J, V15, P634, DOI 10.1111/pbi.12662; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/srep43320; Li C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43902; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li J, 2016, PLANT BIOTECHNOL J, V14, P533, DOI 10.1111/pbi.12403; Li JY, 2017, MOL PLANT, V10, P526, DOI 10.1016/j.molp.2016.12.001; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li P, 2017, PLANT J, V89, P85, DOI 10.1111/tpj.13324; Li QL, 2016, J GENET GENOMICS, V43, P415, DOI 10.1016/j.jgg.2016.04.011; Li T, 2016, J GENET GENOMICS, V43, P297, DOI 10.1016/j.jgg.2016.03.005; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Li XF, 2017, J GENET GENOMICS, V44, P175, DOI 10.1016/j.jgg.2017.02.001; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lin S, 2016, MOL PLANT, V9, P1546, DOI 10.1016/j.molp.2016.09.003; Liu LT, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006085; [刘婷婷 Liu Tingting], 2015, [遗传, Hereditas(Beijing)], V37, P1044, DOI 10.16288/j.yczz.15-303; Liu X, 2015, GENOM PROTEOM BIOINF, V13, P137, DOI 10.1016/j.gpb.2015.02.003; Liu YQ, 2017, PLANT CELL REP, V36, P919, DOI 10.1007/s00299-017-2123-2; Lopez-Obando M, 2016, G3-GENES GENOM GENET, V6, P3647, DOI 10.1534/g3.116.033266; Lor VS, 2014, PLANT PHYSIOL, V166, P1288, DOI 10.1104/pp.114.247593; Lowder L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2076.07683; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Luo S, 2015, MOL PLANT, V8, P1425, DOI 10.1016/j.molp.2015.05.012; Ma L, 2017, PLANT CELL PHYSIOL, V58, P863, DOI 10.1093/pcp/pcx040; Ma L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143877; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mahfouz MM, 2012, PLANT MOL BIOL, V78, P311, DOI 10.1007/s11103-011-9866-x; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Makarova KS, 2017, CELL, V168, P946, DOI 10.1016/j.cell.2017.02.018; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mercx S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00040; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Morineau C, 2017, PLANT BIOTECHNOL J, V15, P729, DOI 10.1111/pbi.12671; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nekrasov V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00578-x; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nicolia A, 2015, J BIOTECHNOL, V204, P17, DOI 10.1016/j.jbiotec.2015.03.021; Nishida K, 2016, SCIENCE, V353, P8729; Nishizawa-Yokoi A, 2016, PLANT PHYSIOL, V170, P653, DOI 10.1104/pp.15.01542; Ordon J, 2017, PLANT J, V89, P155, DOI 10.1111/tpj.13319; Osakabe Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26685; Pan CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24765; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Pastwa E, 2003, ACTA BIOCHIM POL, V50, P891; Paul JW, 2016, PLANT CELL REP, V35, P1417, DOI 10.1007/s00299-016-1985-z; Peng AH, 2017, PLANT BIOTECHNOL J, V15, P1509, DOI 10.1111/pbi.12733; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Pyott DE, 2016, MOL PLANT PATHOL, V17, P1276, DOI 10.1111/mpp.12417; Qi YP, 2016, MUTAT RES-FUND MOL M, V783, P9, DOI 10.1016/j.mrfmmm.2015.12.002; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ren B, 2017, SCI CHINA LIFE SCI, V60, P516, DOI 10.1007/s11427-016-0406-x; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Ryder P, 2017, PLANT CELL REP, V36, P1005, DOI 10.1007/s00299-017-2125-0; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Sauer NJ, 2016, PLANT PHYSIOL, V170, P1917, DOI 10.1104/pp.15.01696; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Segal DJ, 2003, BIOCHEMISTRY-US, V42, P2137, DOI 10.1021/bi026806o; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Steinert J, 2016, PLANT CELL REP, V35, P1429, DOI 10.1007/s00299-016-1981-3; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Subburaj S, 2016, PLANT CELL REP, V35, P1535, DOI 10.1007/s00299-016-1937-7; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Sun YW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00298; Sun YW, 2016, MOL PLANT, V9, P628, DOI 10.1016/j.molp.2016.01.001; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Tang F, 2016, PLANT PHYSIOL, V170, P26, DOI 10.1104/pp.15.01661; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Ueta R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00501-4; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Veillet F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01899; Wang C, 2015, J GENET GENOMICS, V42, P703, DOI 10.1016/j.jgg.2015.09.011; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01333; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; Wang MG, 2017, MOL PLANT, V10, P1007, DOI 10.1016/j.molp.2017.03.002; Wang MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122755; Wang QT, 2016, PLANT J, V88, P1071, DOI 10.1111/tpj.13307; Wang SH, 2015, PLANT CELL REP, V34, P1473, DOI 10.1007/s00299-015-1816-7; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wolt JD, 2016, PLANT BIOTECHNOL J, V14, P510, DOI 10.1111/pbi.12444; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu C, 2016, GENE DEV, V30, P2048, DOI 10.1101/gad.288415.116; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yamauchi T, 2017, PLANT CELL, V29, P775, DOI 10.1105/tpc.16.00976; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Yin XJ, 2017, PLANT CELL REP, V36, P745, DOI 10.1007/s00299-017-2118-z; Yuan JY, 2017, NEW PHYTOL, V216, P373, DOI 10.1111/nph.14510; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20315; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep41993; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z; Zhao CZ, 2016, PLANT PHYSIOL, V171, P2744, DOI 10.1104/pp.16.00533; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890; Zheng XL, 2016, PLANT CELL REP, V35, P1545, DOI 10.1007/s00299-016-1967-1; Zhou H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37395; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhou XJ, 2017, J EXP BOT, V68, P1265, DOI 10.1093/jxb/erx026; Zhou XH, 2015, NEW PHYTOL, V208, P298, DOI 10.1111/nph.13470; Zhu JJ, 2016, J GENET GENOMICS, V43, P25, DOI 10.1016/j.jgg.2015.10.006; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	231	3	3	33	45	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2045-3701			CELL BIOSCI	Cell Biosci.	APR 24	2017	7								21	10.1186/s13578-017-0148-4				18	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV2LQ	WOS:000401587000001	28451378	gold			2018-01-05	
J	Zerbini, F; Zanella, I; Fraccascia, D; Konig, E; Irene, C; Frattini, LF; Tomasi, M; Fantappie, L; Ganfini, L; Caproni, E; Parri, M; Grandi, A; Grandi, G				Zerbini, Francesca; Zanella, Ilaria; Fraccascia, Davide; Koenig, Enrico; Irene, Carmela; Frattini, Luca F.; Tomasi, Michele; Fantappie, Laura; Ganfini, Luisa; Caproni, Elena; Parri, Matteo; Grandi, Alberto; Grandi, Guido			Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli	MICROBIAL CELL FACTORIES			English	Article						CRISPR-Cas9; High-throughput genome editing; Synthetic biology	GRAM-NEGATIVE BACTERIA; HOMOLOGOUS RECOMBINATION; BACILLUS-SUBTILIS; STRUCTURAL GENE; SYSTEM; REPLACEMENT; GENOME; REPAIR; OLIGONUCLEOTIDES; LEVANSUCRASE	Background: The exploitation of the CRISPR/Cas9 machinery coupled to lambda (lambda) recombinase-mediated homologous recombination (recombineering) is becoming the method of choice for genome editing in E. coli. First proposed by Jiang and co-workers, the strategy has been subsequently fine-tuned by several authors who demonstrated, by using few selected loci, that the efficiency of mutagenesis (number of mutant colonies over total number of colonies analyzed) can be extremely high (up to 100%). However, from published data it is difficult to appreciate the robustness of the technology, defined as the number of successfully mutated loci over the total number of targeted loci. This information is particularly relevant in high-throughput genome editing, where repetition of experiments to rescue missing mutants would be impractical. This work describes a "brute force" validation activity, which culminated in the definition of a robust, simple and rapid protocol for single or multiple gene deletions. Results: We first set up our own version of the CRISPR/Cas9 protocol and then we evaluated the mutagenesis efficiency by changing different parameters including sequence of guide RNAs, length and concentration of donor DNAs, and use of single stranded and double stranded donor DNAs. We then validated the optimized conditions targeting 78 "dispensable" genes. This work led to the definition of a protocol, featuring the use of double stranded synthetic donor DNAs, which guarantees mutagenesis efficiencies consistently higher than 10% and a robustness of 100%. The procedure can be applied also for simultaneous gene deletions. Conclusions: This work defines for the first time the robustness of a CRISPR/Cas9-based protocol based on a large sample size. Since the technical solutions here proposed can be applied to other similar procedures, the data could be of general interest for the scientific community working on bacterial genome editing and, in particular, for those involved in synthetic biology projects requiring high throughput procedures.	[Zerbini, Francesca; Zanella, Ilaria; Fraccascia, Davide; Koenig, Enrico; Irene, Carmela; Frattini, Luca F.; Tomasi, Michele; Fantappie, Laura; Ganfini, Luisa; Caproni, Elena; Grandi, Guido] Univ Trento, CIBIO, Synthet & Struct Vaccinol Unit, Via Sommar 9, I-38123 Trento, Italy; [Parri, Matteo; Grandi, Alberto] Toscana Life Sci Sci Pk, Via Fiorentina 1, I-53100 Siena, Italy	Grandi, G (reprint author), Univ Trento, CIBIO, Synthet & Struct Vaccinol Unit, Via Sommar 9, I-38123 Trento, Italy.	guido.grandi@unitn.it			Advanced ERC Grant [OMVac 340915]	The project has been supported by the Advanced ERC Grant OMVac 340915 assigned to Guido Grandi.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrangou R, 2016, CURR OPIN BIOTECH, V37, P61, DOI 10.1016/j.copbio.2015.10.003; Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Choi KR, 2016, BIOTECHNOL ADV, V34, P1180, DOI 10.1016/j.biotechadv.2016.08.002; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898                                                          ; Fantappie L, 2014, J EXTRACELL VESICLES, V3, P3; GAY P, 1983, J BACTERIOL, V153, P1424; GAY P, 1985, J BACTERIOL, V164, P918; Hale L, 2010, BIOTECHNIQUES, V48, P223, DOI 10.2144/000113366; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Meddows TR, 2004, MOL MICROBIOL, V52, P119, DOI 10.1111/j.1365-2958.2003.03970.x; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Murphy KC, 2000, GENE, V246, P321, DOI 10.1016/S0378-1119(00)00071-8; Murphy KC, 1998, J BACTERIOL, V180, P2063; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Singh V, 2017, GENE, V599, P1, DOI 10.1016/j.gene.2016.11.008; STEINMETZ M, 1983, MOL GEN GENET, V191, P138, DOI 10.1007/BF00330901                                                              ; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Wright DG, 2016, MUTAGENESIS; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu DG, 2003, P NATL ACAD SCI USA, V100, P7207, DOI 10.1073/pnas.1232375100; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	35	4	4	17	26	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2859			MICROB CELL FACT	Microb. Cell. Fact.	APR 24	2017	16								68	10.1186/s12934-017-0681-1				18	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ES9JL	WOS:000399872500001	28438207	gold			2018-01-05	
J	Shah, PK; Tanner, MR; Kovacevic, I; Rankin, A; Marshall, TE; Noblett, N; Tran, NN; Roenspies, T; Hung, J; Chen, ZQ; Slatculescu, C; Perkins, TJ; Bao, ZR; Colavita, A				Shah, Pavak K.; Tanner, Matthew R.; Kovacevic, Ismar; Rankin, Aysha; Marshall, Teagan E.; Noblett, Nathaniel; Nhan Nguyen Tran; Roenspies, Tony; Hung, Jeffrey; Chen, Zheqian; Slatculescu, Cristina; Perkins, Theodore J.; Bao, Zhirong; Colavita, Antonio			PCP and SAX-3/Robo Pathways Cooperate to Regulate Convergent Extension-Based Nerve Cord Assembly in C. elegans	DEVELOPMENTAL CELL			English	Article							PLANAR CELL POLARITY; CAENORHABDITIS-ELEGANS; MYOSIN-II; ZEBRAFISH GASTRULATION; CRISPR-CAS9 SYSTEM; FATE SPECIFICATION; MULTIPLE ASPECTS; AXON GUIDANCE; NEURAL PLATE; MORPHOGENESIS	Formation and resolution of multicellular rosettes can drive convergent extension (CE) type cell rear-rangements during tissue morphogenesis. Rosette dynamics are regulated by both planar cell polarity (PCP)-dependent and -independent pathways. Here we show that CE is involved in ventral nerve cord (VNC) assembly in Caenorhabditis elegans. We show that a VANG-1/Van Gogh and PRKL-1/Prickle containing PCP pathway and a Slit-independent SAX-3/Robo pathway cooperate to regulate, via rosette intermediaries, the intercalation of post-mitotic neuronal cell bodies during VNC formation. We show that VANG-1 and SAX-3 are localized to contracting edges and rosette foci and act to specify edge contraction during rosette formation and to mediate timely rosette resolution. Simultaneous loss of both pathways severely curtails CE resulting in a shortened, anteriorly displaced distribution of VNC neurons at hatching. Our results establish rosette-based CE as an evolutionarily conserved mechanism of nerve cord morphogenesis and reveal a role for SAX-3/Robo in this process.	[Tanner, Matthew R.; Rankin, Aysha; Noblett, Nathaniel; Roenspies, Tony; Hung, Jeffrey; Slatculescu, Cristina; Colavita, Antonio] Ottawa Hosp Res Inst, Neurosci Program, Ottawa, ON K1H 8M5, Canada; [Tanner, Matthew R.; Rankin, Aysha; Noblett, Nathaniel; Hung, Jeffrey; Chen, Zheqian; Colavita, Antonio] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Colavita, Antonio] Univ Ottawa, Mind Res Inst, Ottawa, ON K1H 8M5, Canada; [Perkins, Theodore J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Roenspies, Tony; Hung, Jeffrey; Bao, Zhirong] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Colavita, A (reprint author), Ottawa Hosp Res Inst, Neurosci Program, Ottawa, ON K1H 8M5, Canada.; Colavita, A (reprint author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.; Colavita, A (reprint author), Univ Ottawa, Mind Res Inst, Ottawa, ON K1H 8M5, Canada.; Bao, ZR (reprint author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	baoz@mskcc.org; acolavita@ohri.ca		Shah, Pavak/0000-0002-2603-5995	CIHR [123513]; NSERC [312460-2012]; NIH [R01 GM097576, R24 OD016474]; MSK Cancer Center Support/Core Grant [P30 CA008748]	This work was supported by CIHR Grant 123513 and NSERC Discovery Grant 312460-2012 to A.C., NIH grants (R01 GM097576 and R24 OD016474) to Z.B., and the MSK Cancer Center Support/Core Grant (P30 CA008748). We thank Dr. Jennifer Zallen and Justin Evans for comments on the manuscript and Dr. Monica Colaiacovo for CRISPR/Cas9 reagents. Some strains were provided by the CGC, Dr. Kang Shen, Dr. Shohei Mitani, (National Bioresource Project, Japan) and the Gene Knockout Consortium (University of British Columbia and the University of Oklahoma). We thank WormBase.	Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Asan A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005950; Bernadskaya YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002863; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Blockus H, 2016, DEVELOPMENT, V143, P3037, DOI 10.1242/dev.132829; Devenport D, 2016, SEMIN CELL DEV BIOL, V55, P99, DOI 10.1016/j.semcdb.2016.03.012; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Du Z, 2014, CELL, V156, P359, DOI 10.1016/j.cell.2013.11.046; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Ghenea S, 2005, DEVELOPMENT, V132, P3679, DOI 10.1242/dev.01947; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301                                                           ; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Hallam S, 2000, DEVELOPMENT, V127, P4239; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Harding MJ, 2014, DEVELOPMENT, V141, P2549, DOI 10.1242/dev.101444; Hoffmann M, 2010, DEV BIOL, V339, P268, DOI 10.1016/j.ydbio.2009.12.002; Jiang D, 2005, CURR BIOL, V15, P79; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Lee JY, 2012, CURR BIOL, V22, P956, DOI 10.1016/j.cub.2012.03.068; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Mentink RA, 2014, DEV CELL, V31, P188, DOI 10.1016/j.devcel.2014.08.008; Murray A, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-16; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Nagaoka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06940; Najarro EH, 2012, J NEUROSCI, V32, P4196, DOI 10.1523/JNEUROSCI.3094-11.2012; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Ossipova O, 2015, BIOL OPEN, V4, P722, DOI 10.1242/bio.201511676; Oteiza P, 2010, DEVELOPMENT, V137, P3459, DOI 10.1242/dev.049981; Pare AC, 2014, NATURE, V515, P523, DOI 10.1038/nature13953; Preibisch S, 2014, NAT METHODS, V11, P645, DOI [10.1038/NMETH.2929, 10.1038/nmeth.2929]; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Roszko I, 2015, DEVELOPMENT, V142, P2508, DOI 10.1242/dev.119032; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; Sawa Hitoshi, 2013, WormBook, P1, DOI 10.1895/wormbook.1.7.2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Steimel A, 2010, DEVELOPMENT, V137, P3663, DOI 10.1242/dev.054320; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tatin F, 2013, DEV CELL, V26, P31, DOI 10.1016/j.devcel.2013.05.015; Tzur YB, 2013, GENETICS, V195, P1181, DOI 10.1534/genetics.113.156075; Wang Y, 2013, GLIA, V61, P710, DOI 10.1002/glia.22464; Wernike D, 2016, DEV BIOL, V412, P261, DOI 10.1016/j.ydbio.2016.02.023; Williams M, 2014, DEV CELL, V29, P34, DOI 10.1016/j.devcel.2014.02.007; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	46	1	1	5	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1534-5807	1878-1551		DEV CELL	Dev. Cell	APR 24	2017	41	2					195	+		10.1016/j.devcel.2017.03.024				12	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	ET0VP	WOS:000399983000010	28441532				2018-01-05	
J	Fink, JJ; Robinson, TM; Germain, ND; Sirois, CL; Bolduc, KA; Ward, AJ; Rigo, F; Chamberlain, SJ; Levine, ES				Fink, James J.; Robinson, Tiwanna M.; Germain, Noelle D.; Sirois, Carissa L.; Bolduc, Kaitlyn A.; Ward, Amanda J.; Rigo, Frank; Chamberlain, Stormy J.; Levine, Eric S.			Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells	NATURE COMMUNICATIONS			English	Article							ADULT HUMAN FIBROBLASTS; LONG-TERM POTENTIATION; MOUSE MODEL; UBIQUITIN LIGASE; DOPAMINERGIC-NEURONS; RETT-SYNDROME; UBE3A; PLASTICITY; DEFICITS; EXPRESSION	Angelman syndrome (AS) is a neurogenetic disorder caused by deletion of the maternally inherited UBE3A allele and is characterized by developmental delay, intellectual disability, ataxia, seizures and a happy affect. Here, we explored the underlying pathophysiology using induced pluripotent stem cell-derived neurons from AS patients and unaffected controls. AS-derived neurons showed impaired maturation of resting membrane potential and action potential firing, decreased synaptic activity and reduced synaptic plasticity. These patient-specific differences were mimicked by knocking out UBE3A using CRISPR/Cas9 or by knocking down UBE3A using antisense oligonucleotides. Importantly, these phenotypes could be rescued by pharmacologically unsilencing paternal UBE3A expression. Moreover, selective effects of UBE3A disruption at late stages of in vitro development suggest that changes in action potential firing and synaptic activity may be secondary to altered resting membrane potential. Our findings provide a cellular phenotype for investigating pathogenic mechanisms underlying AS and identifying novel therapeutic strategies.	[Fink, James J.; Robinson, Tiwanna M.; Bolduc, Kaitlyn A.; Levine, Eric S.] Univ Connecticut, Sch Med, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA; [Germain, Noelle D.; Sirois, Carissa L.; Chamberlain, Stormy J.] Univ Connecticut, Sch Med, Dept Genet & Genome Sci, 263 Farmington Ave, Farmington, CT 06030 USA; [Ward, Amanda J.; Rigo, Frank] Ionis Pharmaceut, Carlsbad, CA 92010 USA	Levine, ES (reprint author), Univ Connecticut, Sch Med, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	eslevine@uchc.edu		levine, eric/0000-0002-2535-9509; Chamberlain, Stormy/0000-0003-4720-9680	NIH [NS078753, MH094896]; Angelman Syndrome Foundation; Autism Speaks; Dup15q Alliance; CT Regenerative Medicine Research Fund	This work was supported by NIH Grants NS078753 and MH094896 (to E.S.L.), the Angelman Syndrome Foundation (to E.S.L.), Autism Speaks (to E.S.L.), the Dup15q Alliance (to J.J.F.) and the CT Regenerative Medicine Research Fund (to E.S.L. and S.J.C.). We thank Dr Jon Covault and Dr Richard Lieberman for providing control cell lines, Dr Mason Yeh for help with cell counts, Dr Xin-Ming Ma for help with immunocytochemistry, and Dr Evan Jellison for help with flow cytometry.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bardy C, 2016, MOL PSYCHIATR, V21, P1573, DOI 10.1038/mp.2016.158; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Belinsky GS, 2011, STEM CELLS DEV, V20, P1733, DOI 10.1089/scd.2010.0501; Boisvert EM, 2013, JOVE-J VIS EXP, V74; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Chamberlain SJ, 2010, J NEUROSCI, V30, P9958, DOI 10.1523/JNEUROSCI.1728-10.2010; Chamberlain SJ, 2010, NEUROBIOL DIS, V39, P13, DOI 10.1016/j.nbd.2010.03.011; Cheron G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00221; Chinchalongporn V, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0129-y; Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Devlin AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6999; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Feldman D. E., 2009, REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Ganguly K, 2013, NEURON, V80, P729, DOI 10.1016/j.neuron.2013.10.028; Germain ND, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-44; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kaphzan H, 2013, CELL REP, V4, P405, DOI 10.1016/j.celrep.2013.07.005; Kaphzan H, 2012, BIOL PSYCHIAT, V72, P182, DOI 10.1016/j.biopsych.2012.01.021; Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011; Lieberman R, 2015, ALCOHOL CLIN EXP RES, V39, P1654, DOI 10.1111/acer.12807; Lieberman R, 2012, ALCOHOL CLIN EXP RES, V36, P1678, DOI 10.1111/j.1530-0277.2012.01792.x; Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207; Liu Y, 2013, ANN NEUROL, V74, P128, DOI 10.1002/ana.23897; LOSSIE AC, 2001, AM J MED GENET, V38, P834; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mardirossian S, 2009, EXP NEUROL, V220, P341, DOI 10.1016/j.expneurol.2009.08.035; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Meng LY, 2015, NATURE, V518, P409, DOI 10.1038/nature13975; Odawara A, 2016, BIOCHEM BIOPH RES CO, V469, P856, DOI 10.1016/j.bbrc.2015.12.087; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pignatelli M, 2014, J NEUROSCI, V34, P4558, DOI 10.1523/JNEUROSCI.1846-13.2014; Piochon C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6586; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang X, 2013, STEM CELL RES, V11, P743, DOI 10.1016/j.scr.2013.05.002; Valdez C, 2015, BIOL OPEN, V4, P776, DOI 10.1242/bio.20148045; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Williams CA, 2005, BRAIN DEV-JPN, V27, P88, DOI 10.1016/j.braindev.2003.09.014; Wu Ye, 2007, Zhonghua Er Ke Za Zhi, V45, P906; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Yum MS, 2013, BRAIN DEV-JPN, V35, P245, DOI 10.1016/j.braindev.2012.04.006; Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	66	0	0	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR 24	2017	8								15038	10.1038/ncomms15038				14	Multidisciplinary Sciences	Science & Technology - Other Topics	ET2YB	WOS:000400140700001	28436452	gold			2018-01-05	
J	Wang, HC; Luo, LF; Yang, DQ				Wang, Hongcheng; Luo, Lingfei; Yang, Deqin			Loss of Gspt1l disturbs the patterning of the brain central arteries in zebrafish	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Gspt1l; Vegfa; Unfolded protein response; Central artery; Zebrafish	UNFOLDED PROTEIN RESPONSE; FACTOR-A EXPRESSION; ER STRESS; IN-VIVO; ANGIOGENESIS; VEGF; CONTRIBUTES; HINDBRAIN; NETWORK; PATHWAY	The cranial vasculature is crucial for the survival and development of the central nervous system and is closely related to brain pathologies. Characterizations of the underlying mechanisms by which cranial vessels acquire their stereotypic patterning remain to be the key interest in the cerebrovascular research. In this report, we show an interesting zebrafish cq37 mutant displaying aberrant patterning of the central arteries. Genetic mapping results indicate that the gene responsible for cq37 encodes G1 to S phase transition 1, like (Gspt1l) with a nonsense mutation. Complementation studies with a CRISPR-generated allele, as well as mRNA rescues, together strongly demonstrate that gspt1l is the cq37 gene. Zebrafish gspt1l is broadly expressed in the brain with enhanced expression in hindbrain during central artery sprouting. Further studies reveal that vascular endothelial growth factor (VEGF) signaling and unfolded protein response (UPR) pathway are activated in gspt1l(cq37) mutants. In addition, expression analysis shows that vegfa and activating transcription factor-4 (atf4) are strongly upregulated in regions of gspt1l expression. Our results suggest that loss of Gspt1l activates the UPR pathway, which in turn induces ectopic expression of vegfa via Atf4, thus disturbing the patterning of the central arteries. (C) 2017 Elsevier Inc. All rights reserved.	[Wang, Hongcheng; Luo, Lingfei] Southwest Univ, Sch Life Sci, Lab Mol Dev Biol, Key Lab Freshwater Fish Reprod & Dev,Minist Educ, Chongqing 400715, Peoples R China; [Yang, Deqin] Chongqing Med Univ, Affiliated Hosp Stomatol, Dept Endodont & Operat Dent, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing 401147, Peoples R China	Yang, DQ (reprint author), Chongqing Med Univ, Affiliated Hosp Stomatol, Dept Endodont & Operat Dent, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing 401147, Peoples R China.; Luo, LF (reprint author), Southwest Univ, Sch Life Sci, 2 Tiansheng Rd, Chongqing 400715, Peoples R China.	lluo@swu.edu.cn; proyangdeqin@foxmail.com			National Key Basic Research Program of China [2015CB942800]; National Natural Science Foundation of China [91539201, 31371473, 31571508]; 111 Program [B14037]	This work was supported by the National Key Basic Research Program of China (2015CB942800), National Natural Science Foundation of China (91539201, 31371473, 31571508), and the 111 Program (B14037).	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881; Castranova D, 2016, ARTERIOSCL THROM VAS, V36, P655, DOI 10.1161/ATVBAHA.115.307087; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26608; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; Du HS, 2011, ONCOL REP, V26, P495, DOI 10.3892/or.2011.1297; Duan QL, 2016, AGING CELL, V15, P625, DOI 10.1111/acel.12460; Fong GH, 2009, J MOL MED-JMM, V87, P549, DOI 10.1007/s00109-009-0458-z; Fujita M, 2011, DEVELOPMENT, V138, P1705, DOI 10.1242/dev.058776; He JB, 2014, GASTROENTEROLOGY, V146, P789, DOI 10.1053/j.gastro.2013.11.045; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Liu C, 2016, IMMUNITY, V44, P1162, DOI 10.1016/j.immuni.2016.03.008; Lu HQ, 2013, DEV CELL, V24, P543, DOI 10.1016/j.devcel.2013.01.021; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Miri M, 2012, MED ONCOL, V29, P1581, DOI 10.1007/s12032-011-0111-x; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pereira ER, 2014, J BIOL CHEM, V289, P3352, DOI 10.1074/jbc.M113.507194; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schuermann A, 2014, SEMIN CELL DEV BIOL, V31, P106, DOI 10.1016/j.semcdb.2014.04.037; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Ulrich F, 2011, DEV BIOL, V357, P134, DOI 10.1016/j.ydbio.2011.06.037; Wang XQ, 2013, INVEST OPHTH VIS SCI, V54, P5995, DOI 10.1167/iovs.13-12117; Wang YG, 2012, CANCER RES, V72, P5396, DOI 10.1158/0008-5472.CAN-12-0474; Zheng XC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0206-3	27	0	0	4	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	APR 22	2017	486	1					156	162		10.1016/j.bbrc.2017.03.018				7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	ER5YN	WOS:000398880900025	28285134				2018-01-05	
J	King, JJ; Larijani, M				King, Justin J.; Larijani, Mani			A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrodinger's CATalytic Pocket	FRONTIERS IN IMMUNOLOGY			English	Review						lymphoma; antibodies; DNA mutations; leukocytes; enzymes and coenzymes; HIV infections	SINGLE-STRANDED-DNA; CLASS-SWITCH RECOMBINATION; INDUCED DEOXYCYTIDINE DEAMINASE; RNA-EDITING ENZYME; VIF-BINDING DOMAIN; CRYSTAL-STRUCTURE; SOMATIC HYPERMUTATION; HIV-1 VIF; C-TERMINUS; B-CELLS	Activation-induced cytidine deaminase (AID) and its relative APOBEC3 cytidine deam-inases boost immune response by mutating immune or viral genes. Because of their genome-mutating activities, AID/APOBECs are also drivers of tumorigenesis. Due to highly charged surfaces, extensive non-specific protein-protein/nucleic acid interactions, formation of polydisperse oligomers, and general insolubility, structure elucidation of these proteins by X-ray crystallography and NMR has been challenging. Hence, almost all available AID/APOBEC structures are of mutated and/or truncated versions. In 2015, we reported a functional structure for AID using a combined computational-biochemical approach. In so doing, we described a new regulatory mechanism that is a first for human DNA/RNA-editing enzymes. This mechanism involves dynamic closure of the catalytic pocket. Subsequent X-ray and NMR studies confirmed our discovery by showing that other APOBEC3s also close their catalytic pockets. Here, we highlight catalytic pocket closure as an emerging and important regulatory mechanism of AID/APOBEC3s. We focus on three sub-topics: first, we propose that variable pocket closure rates across AID/APOBEC3s underlie differential activity in immunity and cancer and review supporting evidence. Second, we discuss dynamic pocket closure as an ever-present internal regulator, in contrast to other proposed regulatory mechanisms that involve extrinsic binding partners. Third, we compare the merits of classical approaches of X-ray and NMR, with that of emerging computational-biochemical approaches, for structural elucidation specifically for AID/APOBEC3s.	[King, Justin J.; Larijani, Mani] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Program, St John, NF, Canada	Larijani, M (reprint author), Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Program, St John, NF, Canada.	mlarijani@mun.ca			Canadian Cancer Society Research Institute (CCSRI); Canadian Institutes of Health Research (CIHR) [MOP111132]; CIHR Frederick Banting and Charles Best Canada Doctoral Scholarship	The highlighted work was supported by a Canadian Cancer Society Research Institute (CCSRI) Innovation operating grant and Canadian Institutes of Health Research (CIHR) operating grant (MOP111132) to ML. JK is supported by a CIHR Frederick Banting and Charles Best Canada Doctoral Scholarship.	Abdouni H, 2013, NUCLEIC ACIDS RES, V41, P5457, DOI 10.1093/nar/gkt212; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alinikula J, 2014, CELL, V159, P1490, DOI 10.1016/j.cell.2014.12.007; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Barreto VM, 2011, DEV COMP IMMUNOL, V35, P991, DOI 10.1016/j.dci.2011.02.005; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Belanger K, 2015, VIROLOGY, V483, P141, DOI 10.1016/j.virol.2015.04.019; Bohn MF, 2015, STRUCTURE, V23, P903, DOI 10.1016/j.str.2015.03.016; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100; Burns MB, 2015, BIOMED J, V38, P102, DOI 10.4103/2319-4170.148904; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2016, BIOCHEMISTRY-US, V55, P2944, DOI 10.1021/acs.biochem.6b00382; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2011, METHODS MOL BIOL, V718, P185, DOI 10.1007/978-1-61779-018-8_12; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Coker HA, 2006, METHOD ENZYMOL, V408, P156, DOI 10.1016/S0076-6879(06)08010-4; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Dancyger AM, 2012, FASEB J, V26, P1517, DOI 10.1096/fj.11-198135; Delker RK, 2013, P NATL ACAD SCI USA, V110, P1029, DOI 10.1073/pnas.1214538110; Demorest ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011660; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Faltas BM, 2016, NAT GENET, V48, P1490, DOI 10.1038/ng.3692; Fu Y, 2015, BIOCHEM J, V471, P25, DOI 10.1042/BJ20150382; Furukawa Ayako, 2009, Nucleic Acids Symp Ser (Oxf), P87, DOI 10.1093/nass/nrp044; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Garbuzynskiy SO, 2005, PROTEINS, V60, P139, DOI 10.1002/prot.20491; Goncalves Joao, 2004, Retrovirology, V1, P28, DOI 10.1186/1742-4690-1-28; Hasler J, 2011, P NATL ACAD SCI USA, V108, P18366, DOI 10.1073/pnas.1106729108; Han L, 2010, J IMMUNOL, V185, P1379, DOI 10.4049/jimmunol.1001643; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris R, 2008, NAT BIOTECHNOL, V26, P1089, DOI 10.1038/nbt1008-1089; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Hu WJ, 2015, P NATL ACAD SCI USA, V112, P5791, DOI 10.1073/pnas.1506167112; Jeevan-Raj BP, 2011, J EXP MED, V208, P1649, DOI 10.1084/jem.20110118; Kanehiro Y, 2012, P NATL ACAD SCI USA, V109, P1216, DOI 10.1073/pnas.1120368109; King JJ, 2015, STRUCTURE, V23, P615, DOI 10.1016/j.str.2015.01.016; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Klemm L, 2009, CANCER CELL, V16, P232, DOI 10.1016/j.ccr.2009.07.030; Knisbacher BA, 2016, TRENDS GENET, V32, P16, DOI 10.1016/j.tig.2015.10.005; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kouno T, 2015, NAT STRUCT MOL BIOL, V22, P485, DOI 10.1038/nsmb.3033; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kracker S, 2015, J ALLERGY CLIN IMMUN, V135, P998, DOI 10.1016/j.jaci.2014.08.030; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Krzysiak TC, 2012, BIOCHEMISTRY-US, V51, P2008, DOI 10.1021/bi300021s; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Larijani M, 2007, MOL CELL BIOL, V27, P20, DOI 10.1128/MCB.00824-06; Larijani M, 2012, SEMIN IMMUNOL, V24, P255, DOI 10.1016/j.smim.2012.05.003; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu Q, 2008, BIOCHEMISTRY-US, V47, P13966, DOI 10.1021/bi801642q; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; Lu XX, 2015, J BIOL CHEM, V290, P4010, DOI 10.1074/jbc.M114.624262; MacDuff DA, 2006, MOL IMMUNOL, V43, P1099, DOI 10.1016/j.molimm.2005.07.024; Maeda K, 2013, J IMMUNOL, V191, P6030, DOI 10.4049/jimmunol.1302057; Mak CH, 2013, J BIOL CHEM, V288, P29786, DOI 10.1074/jbc.M113.506550; Malinen AM, 2012, NUCLEIC ACIDS RES, V40, P7442, DOI 10.1093/nar/gks383; Martin A, 2002, NATURE, V415, P802; Marx A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18191; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Monajemi M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-35; Munoz DP, 2013, P NATL ACAD SCI USA, V110, pE2977, DOI 10.1073/pnas.1301021110; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470                                                        ; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakashima M, 2016, J VIROL, V90, P1034, DOI 10.1128/JVI.02369-15; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okazaki I, 2011, P NATL ACAD SCI USA, V108, P7920, DOI 10.1073/pnas.1104423108; Orthwein A, 2012, EMBO J, V31, P679, DOI 10.1038/emboj.2011.417; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Parsa JY, 2007, MOL IMMUNOL, V44, P567, DOI 10.1016/j.molimm.2006.02.003; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Pham P, 2016, DNA REPAIR, V43, P48, DOI 10.1016/j.dnarep.2016.05.029; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramiro Almudena, 2007, Adv Immunol, V94, P75, DOI 10.1016/S0065-2776(06)94003-6; Ranjit S, 2011, J IMMUNOL, V187, P2464, DOI 10.4049/jimmunol.1101406; Rebhandl Stefan, 2015, Oncoscience, V2, P320; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9                                                   ; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2014, BIOESSAYS, V36, P382, DOI 10.1002/bies.201300140; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Santa-Marta M, 2005, J BIOL CHEM, V280, P8765, DOI 10.1074/jbc.M409309200; Santa-Marta M, 2007, MOL IMMUNOL, V44, P583, DOI 10.1016/j.molimm.2006.02.005; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Shaban NM, 2016, J MOL BIOL, V428, P2307, DOI 10.1016/j.jmb.2016.04.026; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Shi K, 2015, J BIOL CHEM, V290, P28120, DOI 10.1074/jbc.M115.679951; Shlyakhtenko LS, 2013, J STRUCT BIOL, V184, P217, DOI 10.1016/j.jsb.2013.09.008; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Starrett GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12918; Stavrou S, 2015, J IMMUNOL, V195, P4565, DOI 10.4049/jimmunol.1501504; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uchimura Y, 2011, J EXP MED, V208, P2385, DOI 10.1084/jem.20110856; Valera MS, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0181-5; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; Wang XX, 2012, J VIROL, V86, P3777, DOI 10.1128/JVI.06594-11; Wichroski MJ, 2006, PLOS PATHOG, V2, P374, DOI 10.1371/journal.ppat.0020041; Willmann KL, 2012, J EXP MED, V209, P2099, DOI 10.1084/jem.20112145; Wittkopp CJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005865; Xiao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12193; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	132	2	2	5	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	APR 21	2017	8								351	10.3389/fimmu.2017.00351				11	Immunology	Immunology	ES8VM	WOS:000399835000001	28439266	gold			2018-01-05	
J	Ikeda, T; Shimoda, M; Ebrahimi, D; VandeBerg, JL; Harris, RS; Koito, A; Maeda, K				Ikeda, Terumasa; Shimoda, Mayuko; Ebrahimi, Diako; VandeBerg, John L.; Harris, Reuben S.; Koito, Atsushi; Maeda, Kazuhiko			Opossum APOBEC1 is a DNA mutator with retrovirus and retroelement restriction activity	SCIENTIFIC REPORTS			English	Article							B MESSENGER-RNA; INHIBIT LINE-1 RETROTRANSPOSITION; EDITING ENZYME APOBEC1; L1 RETROTRANSPOSITION; CYTIDINE DEAMINASES; IN-VIVO; DIFFERENTIAL INHIBITION; CATALYTIC SUBUNIT; PROTEIN; BINDING	APOBEC3s (A3s) are single-stranded DNA cytosine deaminases that provide innate immune defences against retroviruses and mobile elements. A3s are specific to eutherian mammals because no direct homologs exist at the syntenic genomic locus in metatherian (marsupial) or prototherian (monotreme) mammals. However, the A3s in these species have the likely evolutionary precursors, the antibody gene deaminase AID and the RNA/DNA editing enzyme APOBEC1 (A1). Here, we used cell culture-based assays to determine whether opossum A1 restricts the infectivity of retroviruses including human immunodeficiency virus type 1 (HIV-1) and the mobility of LTR/non-LTR retrotransposons. Opossum A1 partially inhibited HIV-1, as well as simian immunodeficiency virus (SIV), murine leukemia virus (MLV), and the retrotransposon MusD. The mechanism of inhibition required catalytic activity, except for human LINE1 (L1) restriction, which was deamination-independent. These results indicate that opossum A1 functions as an innate barrier to infection by retroviruses such as HIV-1, and controls LTR/non-LTR retrotransposition in marsupials.	[Ikeda, Terumasa; Koito, Atsushi] Kumamoto Univ, Dept Retrovirol & Self Def, Fac Life Sci, Kumamoto 8608556, Japan; [Ikeda, Terumasa; Ebrahimi, Diako; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Ikeda, Terumasa; Ebrahimi, Diako; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Ikeda, Terumasa; Ebrahimi, Diako; Harris, Reuben S.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Shimoda, Mayuko] Kumamoto Univ, Grad Sch Med Sci, Dept Immunol, Kumamoto 8608556, Japan; [Shimoda, Mayuko; Maeda, Kazuhiko] Osaka Univ, Res Inst Microbial Dis, Lab Host Def, Osaka 5650871, Japan; [Shimoda, Mayuko; Maeda, Kazuhiko] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Lab Host Def, Osaka 5650871, Japan; [VandeBerg, John L.] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, Brownsville, TX 78520 USA; [Harris, Reuben S.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA	Ikeda, T (reprint author), Kumamoto Univ, Dept Retrovirol & Self Def, Fac Life Sci, Kumamoto 8608556, Japan.; Ikeda, T (reprint author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.; Ikeda, T (reprint author), Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA.; Ikeda, T (reprint author), Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA.; Maeda, K (reprint author), Osaka Univ, Res Inst Microbial Dis, Lab Host Def, Osaka 5650871, Japan.; Maeda, K (reprint author), Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Lab Host Def, Osaka 5650871, Japan.	tikeda@umn.edu; kazmaeda@biken.osaka-u.ac.jp			JSPS KAKENHI [23590546, 26460580]; Global Centers of Excellence (COE) Program Global Education Research Center Aiming to Control AIDS; JSPS Research Fellowship for Young Scientists and Postdoctoral Fellowship; Okukubo Memorial Fund for Medical Research at Kumamoto University School of Medicine; SENSHIN Medical Research Foundation; NIH NIAID [R37 AI064046]; NIH NCI [CA206309]	We thank Drs N. Gilbert, T. Heidmann, N.R. Landau, and E.T. Luning Prak for providing reagents. We also thank Ms. E. Kamada for secretarial assistance, Ms. K. Fukuda for technical assistance, and M. Araki, T. Ohsugi, and A. Sarai for valuable comments. This study was supported, in part, by JSPS KAKENHI (grant number 23590546 to A. K.; 26460580 to K. M), Global Centers of Excellence (COE) Program Global Education Research Center Aiming to Control AIDS, JSPS Research Fellowship for Young Scientists and Postdoctoral Fellowship (to T. I.), Okukubo Memorial Fund for Medical Research at Kumamoto University School of Medicine (to T. I.), SENSHIN Medical Research Foundation (to K. M.), NIH NIAID R37 AI064046 (to R.S.H.), and NIH NCI CA206309 (to R.S.H.). R.S.H. in an Investigator of the Howard Hughes Medical Institute.	Barrett BS, 2014, VIROLOGY, V468, P601, DOI 10.1016/j.virol.2014.09.006; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Blanc V, 2010, WIRES SYST BIOL MED, V2, P594, DOI 10.1002/wsbm.82; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Burns M. B., 2013, NATURE; Chester A, 2000, BBA-GENE STRUCT EXPR, V1494, P1, DOI 10.1016/S0167-4781(00)00219-0                                                   ; Esnault C, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e49                                                           ; Fossat N, 2014, EMBO REP, V15, P903, DOI 10.15252/embr.201438450; Fujino T, 1999, NUCLEIC ACIDS RES, V27, P2662, DOI 10.1093/nar/27.13.2662                                                          ; FUNAHASHI T, 1995, J LIPID RES, V36, P414; Gee P, 2011, J VIROL, V85, P9726, DOI 10.1128/JVI.05288-11; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Gonzalez MC, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-96; Goodier JL, 2004, HUM MOL GENET, V13, P1041, DOI 10.1093/hmg/ddh118; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; HADJIAGAPIOU C, 1994, NUCLEIC ACIDS RES, V22, P1874, DOI 10.1093/nar/22.10.1874                                                          ; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9                                                   ; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; HIGGINS JR, 1992, J MED PRIMATOL, V21, P265; Hohjoh H, 1997, J MOL BIOL, V271, P7, DOI 10.1006/jmbi.1997.1159; Ikeda T, 2008, NUCLEIC ACIDS RES, V36, P6859, DOI 10.1093/nar/gkn802; Ikeda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep19035; Ikeda T, 2011, NUCLEIC ACIDS RES, V39, P5538, DOI 10.1093/nar/gkr124; Jonsson SR, 2006, NUCLEIC ACIDS RES, V34, P5683, DOI 10.1093/nar/gkl721; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; KOITO A, 1988, AIDS RES HUM RETROV, V4, P409, DOI 10.1089/aid.1988.4.409                                                          ; Koito A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00028; Koito A, 2012, WIRES RNA, V3, P529, DOI 10.1002/wrna.1117; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Lindic N, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-156; Lovsin N, 2009, ANN NY ACAD SCI, V1178, P268, DOI 10.1111/j.1749-6632.2009.05006.x; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4                                                   ; MARTIN SL, 1993, MOL CELL BIOL, V13, P5383, DOI 10.1128/MCB.13.9.5383                                                           ; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; NAKAMUTA M, 1995, J BIOL CHEM, V270, P13042, DOI 10.1074/jbc.270.22.13042                                                        ; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petit V, 2009, J MOL BIOL, V385, P65, DOI 10.1016/j.jmb.2008.10.043; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Prohaska KM, 2014, WIRES RNA, V5, P493, DOI 10.1002/wrna.1226; Renard M, 2010, J MOL BIOL, V400, P323, DOI 10.1016/j.jmb.2010.05.029; Salter JD, 2016, TRENDS BIOCHEM SCI, V41, P578, DOI 10.1016/j.tibs.2016.05.001; Severi F, 2011, MOL BIOL EVOL, V28, P1125, DOI 10.1093/molbev/msq338; Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Tervo HM, 2010, J VIROL, V84, P12300, DOI 10.1128/JVI.01607-10; Yang Y, 1997, P NATL ACAD SCI USA, V94, P13075, DOI 10.1073/pnas.94.24.13075	51	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 21	2017	7								46719	10.1038/srep46719				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ET0UK	WOS:000399979300001	28429755	gold			2018-01-05	
J	Islam, MF; Watanabe, A; Wong, L; Lazarou, C; Vizeacoumar, FS; Abuhussein, O; Hill, W; Uppalapati, M; Geyer, CR; Vizeacoumar, FJ				Islam, Md. Fahmid; Watanabe, Atsushi; Wong, Lai; Lazarou, Conor; Vizeacoumar, Frederick S.; Abuhussein, Omar; Hill, Wayne; Uppalapati, Maruti; Geyer, C. Ronald; Vizeacoumar, Franco J.			Enhancing the throughput and multiplexing capabilities of next generation sequencing for efficient implementation of pooled shRNA and CRISPR screens	SCIENTIFIC REPORTS			English	Article							GENETIC INTERACTION MAP; FUNCTIONAL GENOMICS; MAMMALIAN-CELLS; CANCER-CELLS; LIBRARIES; REVEALS; DISPLAY; PCR; DNA; VULNERABILITIES	Next generation sequencing is becoming the method of choice for functional genomic studies that use pooled shRNA or CRISPR libraries. A key challenge in sequencing these mixed-oligo libraries is that they are highly susceptible to hairpin and/or heteroduplex formation. This results in polyclonal, low quality, and incomplete reads and reduces sequencing throughput. Unfortunately, this challenge is significantly magnified in low-to-medium throughput bench-top sequencers as failed reads significantly perturb the maximization of sequence coverage and multiplexing capabilities. Here, we report a methodology that can be adapted to maximize the coverage on a bench-top, Ion PGM System for smaller shRNA libraries with high efficiency. This ligation-based, half-shRNA sequencing strategy minimizes failed sequences and is also equally amenable to high-throughput sequencers for increased multiplexing. Towards this, we also demonstrate that our strategy to reduce heteroduplex formation improves multiplexing capabilities of pooled CRISPR screens using Illumina NextSeq 500. Overall, our method will facilitate sequencing of pooled shRNA or CRISPR libraries from genomic DNA and maximize sequence coverage.	[Islam, Md. Fahmid; Wong, Lai] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Watanabe, Atsushi; Lazarou, Conor; Vizeacoumar, Frederick S.; Hill, Wayne; Uppalapati, Maruti; Geyer, C. Ronald; Vizeacoumar, Franco J.] Univ Saskatchewan, Dept Pathol, Saskatoon, SK S7N 0W8, Canada; [Watanabe, Atsushi] Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Akita, Japan; [Abuhussein, Omar; Vizeacoumar, Franco J.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 5C9, Canada; [Vizeacoumar, Franco J.] Saskatchewan Canc Agcy, Canc Res, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada	Geyer, CR; Vizeacoumar, FJ (reprint author), Univ Saskatchewan, Dept Pathol, Saskatoon, SK S7N 0W8, Canada.; Vizeacoumar, FJ (reprint author), Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 5C9, Canada.; Vizeacoumar, FJ (reprint author), Saskatchewan Canc Agcy, Canc Res, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	ron.geyer@usask.ca; franco.vizeacoumar@usask.ca			NSERC Discovery Grant [RGPIN-2014-04110]; Cancer Research Society [19190]; Prostate Cancer Canada Movember Discovery Grant [D2015-14]	We thank the members of the Vizeacoumar and the Geyer laboratories for critical review of this manuscript and sharing their experiences. This work is supported by the operating grants from the NSERC Discovery Grant (RGPIN-2014-04110), Cancer Research Society (#19190) and Prostate Cancer Canada Movember Discovery Grant (D2015-14) to F.J.V.	Bajrami I, 2014, CANCER RES, V74, P287, DOI 10.1158/0008-5472.CAN-13-2541; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Blakely K, 2011, METHODS MOL BIOL, V781, P161, DOI 10.1007/978-1-61779-276-2_9; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; Brandariz-Fontes C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08056; Brough R, 2011, CURR OPIN GENET DEV, V21, P34, DOI 10.1016/j.gde.2010.10.009; Cermelli S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014209; Gorbacheva T, 2015, BIOTECHNIQUES, V58, P200, DOI 10.2144/000114277; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hoshiyama H, 2012, J BIOMOL SCREEN, V17, P258, DOI 10.1177/1087057111423101; Jalali-Yazdi F, 2016, ANGEW CHEM INT EDIT, V55, P4007, DOI 10.1002/anie.201600077; Kieleczawa Jan, 2006, J Biomol Tech, V17, P207; Kieleczawa Jan, 2005, J Biomol Tech, V16, P220; Koike-Yusa H., 2013, NAT BIOTECHNOL; Lawson M. V., 2004, FINITE AUTOMATA, P98; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106658; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Matochko WL, 2015, METHODS MOL BIOL, V1248, P249, DOI 10.1007/978-1-4939-2020-4_17; McIntyre GJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-1; Meyer M, 2010, COLD SPRING HARB PRO, V2010, P5448, DOI DOI 10.1101/PDB.PR0T5448; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paul JM, 2014, TRENDS MOL MED, V20, P704, DOI 10.1016/j.molmed.2014.09.009; Paul JM, 2016, ONCOTARGET; Ravn U, 2013, METHODS, V60, P99, DOI 10.1016/j.ymeth.2013.03.001; Rebollo IR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku940; Ruano G, 1992, PCR Methods Appl, V2, P112; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083                                                           ; Tolle Fabian, 2016, Methods Mol Biol, V1380, P77, DOI 10.1007/978-1-4939-3197-2_6; Van Blarcom T, 2015, J MOL BIOL, V427, P1513, DOI 10.1016/j.jmb.2014.09.020; van der Meer R, 2014, CLIN CANCER RES, V20, P3211, DOI 10.1158/1078-0432.CCR-13-3116; Vizeacoumar FJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.54; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	42	0	0	4	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 21	2017	7								1040	10.1038/s41598-017-01170-z				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ET0SD	WOS:000399972900039	28432350	gold			2018-01-05	
J	Ludman, M; Burgyan, J; Fatyol, K				Ludman, Marta; Burgyan, Jozsef; Fatyol, Karoly			Crispr/Cas9 Mediated Inactivation of Argonaute 2 Reveals its Differential Involvement in Antiviral Responses	SCIENTIFIC REPORTS			English	Article							POTATO-VIRUS-X; RNA SILENCING SUPPRESSOR; DICER-LIKE PROTEINS; NICOTIANA-BENTHAMIANA; MOSAIC-VIRUS; ARABIDOPSIS; PLANTS; DEFENSE; MECHANISMS; RESISTANCE	RNA silencing constitutes an important antiviral mechanism in plants. Small RNA guided Argonaute proteins fulfill essential role in this process by acting as executors of viral restriction. Plants encode multiple Argonaute proteins of which several exhibit antiviral activities. A recent addition to this group is AGO2. Its involvement in antiviral responses is established predominantly by studies employing mutants of Arabidopsis thaliana. In the virological model plant, Nicotiana benthamiana, the contribution of AGO2 to antiviral immunity is much less certain due to the lack of appropriate genetic mutants. Previous studies employed various RNAi based tools to down-regulate AGO2 expression. However, these techniques have several disadvantages, especially in the context of antiviral RNA silencing. Here, we have utilized the CRISPR/Cas9 technology to inactivate the AGO2 gene of N. benthamiana. The ago2 plants exhibit differential sensitivities towards various viruses. AGO2 is a critical component of the plants' immune responses against PVX, TuMV and TCV. In contrast, AGO2 deficiency does not significantly influence the progression of tombusvirus and CMV infections. In summary, our work provides unequivocal proof for the virus-specific antiviral role of AGO2 in a plant species other than A. thaliana for the first time.	[Ludman, Marta; Burgyan, Jozsef; Fatyol, Karoly] Natl Agr Res & Innovat Ctr, Agr Biotechnol Inst, Szent Gyorgyi Albert U 4, H-2100 Godollo, Hungary	Burgyan, J; Fatyol, K (reprint author), Natl Agr Res & Innovat Ctr, Agr Biotechnol Inst, Szent Gyorgyi Albert U 4, H-2100 Godollo, Hungary.	burgyan@abc.hu; kfatyol@gmail.com			Agricultural Ministry of Hungary [BJ032, BJ045]; Hungarian Scientific Research Fund [NK105850, K112737]	We thank Jen Sheen for providing the plant codon optimized SpCas9 expression vector, Peter Moffett for the PVX-GFP binary plasmid and James Carrington for the TuMV-GFP binary plasmid. We also thank Anita Schamberger for helpful discussions and critically reading the manuscript. This work was funded by Agricultural Ministry of Hungary [BJ032], [BJ045]; Hungarian Scientific Research Fund [NK105850], [K112737].	Andika IB, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1039214; Andika IB, 2015, PLANT J, V81, P781, DOI 10.1111/tpj.12770; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bhattacharjee S, 2009, PLANT J, V58, P940, DOI 10.1111/j.1365-313X.2009.03832.x; Brosseau C, 2015, PLANT CELL, V27, P1742, DOI 10.1105/tpc.15.00264; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Carbonell A, 2015, CURR OPIN PLANT BIOL, V27, P111, DOI 10.1016/j.pbi.2015.06.013; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Clemente T, 2006, AGROBACTERIUM PROTOC, P143; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Csorba T, 2015, VIROLOGY, V479, P85, DOI 10.1016/j.virol.2015.02.028; de Alba AEM, 2013, BBA-GENE REGUL MECH, V1829, P1300, DOI 10.1016/j.bbagrm.2013.10.005; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fatyol K, 2016, NUCLEIC ACIDS RES, V44, P1384, DOI 10.1093/nar/gkv1371; Garcia-Ruiz H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004755; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Hamera S, 2012, PLANT J, V69, P104, DOI 10.1111/j.1365-313X.2011.04774.x; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Komatsu K, 2010, MOL PLANT MICROBE IN, V23, P283, DOI 10.1094/MPMI-23-3-0283; Kontra L, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005935; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Maniatis T., 1982, MOL CLONING LAB MANU; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nakasugi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091776; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Odokonyero D, 2015, VIROLOGY, V486, P209, DOI [10.1016/j.virol.2015.09.008, 10.1016/j.viro1.2015.09.008]; Olah E, 2016, ARCH VIROL, V161, P2387, DOI 10.1007/s00705-016-2921-9; Palukaitis P, 2016, MOL PLANT MICROBE IN, V29, P181, DOI 10.1094/MPMI-10-15-0232-FI; Peart JR, 2002, PLANT J, V29, P569, DOI 10.1046/j.1365-313X.2002.029005569.x; Poulsen C, 2013, PLANT CELL, V25, P22, DOI 10.1105/tpc.112.105643; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Scholthof HB, 2006, NAT REV MICROBIOL, V4, P405, DOI 10.1038/nrmicro1395; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Shimura H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002021; Smith NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002022; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838; Thomas CL, 2003, VIROLOGY, V306, P33, DOI 10.1016/S0042-6822(02)00018-1; Vaistij FE, 2009, PLANT PHYSIOL, V149, P1399, DOI 10.1104/pp.108.132688; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vaucheret H, 2001, J CELL SCI, V114, P3083; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang XC, 2012, J VIROL, V86, P6847, DOI 10.1128/JVI.00497-12; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	60	0	0	12	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 21	2017	7								1010	10.1038/s41598-017-01050-6				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ET0SD	WOS:000399972900009	28432338	gold			2018-01-05	
J	Bi, P; Ramirez-Martinez, A; Li, H; Cannavino, J; McAnally, JR; Shelton, JM; Sanchez-Ortiz, E; Bassel-Duby, R; Olson, EN				Bi, Pengpeng; Ramirez-Martinez, Andres; Li, Hui; Cannavino, Jessica; McAnally, John R.; Shelton, John M.; Sanchez-Ortiz, Efrain; Bassel-Duby, Rhonda; Olson, Eric N.			Control of muscle formation by the fusogenic micropeptide myomixer	SCIENCE			English	Article							MYOBLAST FUSION; SKELETAL-MUSCLE; STEM-CELLS; MYOGENESIS; MECHANISMS; MYOMAKER; LESSONS; GENOME	Skeletal muscle formation occurs through fusion of myoblasts to form multinucleated myofibers. From a genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) loss-of-function screen for genes required for myoblast fusion and myogenesis, we discovered an 84-amino acid muscle-specific peptide that we call Myomixer. Myomixer expression coincides with myoblast differentiation and is essential for fusion and skeletal muscle formation during embryogenesis. Myomixer localizes to the plasma membrane, where it promotes myoblast fusion and associates with Myomaker, a fusogenic membrane protein. Myomixer together with Myomaker can also induce fibroblast-fibroblast fusion and fibroblast-myoblast fusion. We conclude that the Myomixer-Myomaker pair controls the critical step in myofiber formation during muscle development.	[Bi, Pengpeng; Ramirez-Martinez, Andres; Li, Hui; Cannavino, Jessica; McAnally, John R.; Sanchez-Ortiz, Efrain; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Bi, Pengpeng; Ramirez-Martinez, Andres; Li, Hui; Cannavino, Jessica; McAnally, John R.; Sanchez-Ortiz, Efrain; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Sen Paul D Wellstone Muscular Dystrophy Cooperat, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	Olson, EN (reprint author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.; Olson, EN (reprint author), Univ Texas Southwestern Med Ctr Dallas, Sen Paul D Wellstone Muscular Dystrophy Cooperat, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu		BI, PENGPENG/0000-0002-9871-6773	NIH [AR-067294, HL-130253, DK-099653, HD-087351]; Robert A. Welch Foundation [1-0025]	We are grateful to J. Cabrera for graphics, B. Chen for CRISPR library data processing, W. Ye for chromatin immunoprecipitation sequencing data analysis, and N. Grishin and J. Pei for bioinformatic analysis of Myomixer orthologs. We thank K. White in the Histopathology Core for technical assistance. We also thank H. Zhou, L. Amoasii, A. Bookout, Z. Wang, and N. Liu for biological materials and other members of the Olson laboratory for technical advice. This work was supported by grants from the NIH (AR-067294, HL-130253, DK-099653, and HD-087351) and the Robert A. Welch Foundation (grant 1-0025 to E.N.O.).	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Anderson DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaj1460; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Chen YM, 2005, ACTA BIOCH BIOPH SIN, V37, P789, DOI 10.1111/j.1745-7270.2005.00120.x; Demonbreun AR, 2015, SEMIN CELL DEV BIOL, V45, P48, DOI 10.1016/j.semcdb.2015.10.026; Doles JD, 2015, CURR OPIN GENET DEV, V34, P24, DOI 10.1016/j.gde.2015.06.006; Fong AP, 2012, DEV CELL, V22, P721, DOI 10.1016/j.devcel.2012.01.015; Krauss RS, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a029298; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Nelson BR, 2014, CIRC RES, V114, P18, DOI 10.1161/CIRCRESAHA.113.302716; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Simionescu A, 2011, ADV EXP MED BIOL, V713, P113, DOI 10.1007/978-94-007-0763-4_8; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	23	12	12	11	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2017	356	6335					323	327		10.1126/science.aam9361				5	Multidisciplinary Sciences	Science & Technology - Other Topics	ES4XQ	WOS:000399540100063	28386024				2018-01-05	
J	Karlsen, C; Hjerde, E; Klemetsen, T; Willassen, NP				Karlsen, Christian; Hjerde, Erik; Klemetsen, Terje; Willassen, Nils Peder			Pan genome and CRISPR analyses of the bacterial fish pathogen Moritella viscosa	BMC GENOMICS			English	Article						Moritella viscosa; CRISPR-Cas; Mobile genetic element; Atlantic salmon pathogen	SALMON SALMO-SALAR; PROVIDES ACQUIRED-RESISTANCE; CONJUGATIVE PLASMIDS; VIBRIO-VISCOSUS; ALIIVIBRIO-WODANIS; ESCHERICHIA-COLI; SERINE-PROTEASE; GENE-TRANSFER; WINTER ULCER; CAS SYSTEMS	Background: Winter-ulcer Moritella viscosa infections continue to be a significant burden in Atlantic salmon (Salmo salar L.) farming. M. viscosa comprises two main clusters that differ in genetic variation and phenotypes including virulence. Horizontal gene transfer through acquisition and loss of mobile genetic elements (MGEs) is a major driving force of bacterial diversification. To gain insight into genomic traits that could affect sublineage evolution within this bacterium we examined the genome sequences of twelve M. viscosa strains. Matches between M. viscosa clustered, regularly interspaced, short palindromic, repeats and associated cas genes (CRISPR-Cas) were analysed to correlate CRISPR-Cas with adaptive immunity against MGEs. Results: The comparative genomic analysis of M. viscosa isolates from across the North Atlantic region and from different fish species support delineation of M. viscosa into four phylogenetic lineages. The results showed that M. viscosa carries two distinct variants of the CRISPR-Cas subtype I-F systems and that CRISPR features follow the phylogenetic lineages. A subset of the spacer content match prophage and plasmid genes dispersed among the M. viscosa strains. Further analysis revealed that prophage and plasmid-like element distribution were reflected in the content of the CRISPR-spacer profiles. Conclusions: Our data suggests that CRISPR-Cas mediated interactions with MGEs impact genome properties among M. viscosa, and that patterns in spacer and MGE distributions are linked to strain relationships.	[Karlsen, Christian] Norwegian Univ Life Sci NMBU, Dept Food Safety & Infect Biol, Pb 8146 Dep0033, Oslo, Norway; [Karlsen, Christian] Nofima AS, Div Aquaculture, POB 210, N-1431 As, Norway; [Hjerde, Erik; Klemetsen, Terje; Willassen, Nils Peder] Univ Tromso, Fac Sci & Technol, Dept Chem, N-9037 Tromso, Norway; [Willassen, Nils Peder] Univ Tromso, Norwegian Struct Biol Ctr, N-9037 Tromso, Norway	Karlsen, C (reprint author), Norwegian Univ Life Sci NMBU, Dept Food Safety & Infect Biol, Pb 8146 Dep0033, Oslo, Norway.; Karlsen, C (reprint author), Nofima AS, Div Aquaculture, POB 210, N-1431 As, Norway.	christian.karlsen@nofima.no			Norwegian Research Council [HAVBRUK-216196/E40]; Nofima	This work was founded by the Norwegian Research Council (grant no. HAVBRUK-216196/E40).; Nofima provided support in the form of salary for author CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Benediktsdottir E, 2007, LETT APPL MICROBIOL, V45, P115, DOI 10.1111/j.1472-765X.2007.02161.x; Benediktsdottir E, 2000, INT J SYST EVOL MICR, V50, P479, DOI 10.1099/00207713-50-2-479                                                       ; Benediktsdottir E, 1998, J FISH DIS, V21, P19; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bjornsdottir B, 2011, J FISH DIS, V34, P333, DOI 10.1111/j.1365-2761.2011.01246.x; Bodelon G, 2013, FEMS MICROBIOL REV, V37, P204, DOI 10.1111/j.1574-6976.2012.00347.x; Bruno DW, 1998, DIS AQUAT ORGAN, V34, P161, DOI 10.3354/dao034161; Cai F, 2013, RNA BIOL, V10, P687, DOI 10.4161/rna.24571; Cochran PK, 1998, APPL ENVIRON MICROB, V64, P2308; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; FINN RD, 2015, NUCLEIC ACIDS RES, V44, pD279, DOI DOI 10.1093/NAR/GKV1344; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Gadwal S, 2014, J BIOL CHEM, V289, P8288, DOI 10.1074/jbc.M113.525261; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581                                                                ; Griebel T, 2008, BIOINFORMATICS, V24, P2399, DOI 10.1093/bioinformatics/btn364; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grove S, 2010, DIS AQUAT ORGAN, V93, P51, DOI 10.3354/dao02271; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; He LM, 2012, J CELL BIOCHEM, V113, P2464, DOI 10.1002/jcb.24121; Hjerde E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1669-z; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907; Karlsen C, 2014, MICROB PATHOGENESIS, V77, P53, DOI 10.1016/j.micpath.2014.09.014; Karlsen C, 2014, VET MICROBIOL, V171, P112, DOI 10.1016/j.vetmic.2014.03.011; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kottara A, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0642-z; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Levin BR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001171; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lim MS, 2011, J BACTERIOL, V193, P3722, DOI 10.1128/JB.00314-11; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Lunder T, 2000, INT J SYST EVOL MICR, V50, P427, DOI 10.1099/00207713-50-2-427                                                       ; LUNDER T, 1995, DIS AQUAT ORGAN, V23, P39, DOI 10.3354/dao023039                                                               ; Maniv I, 2016, J BACTERIOL, V198, P941, DOI 10.1128/JB.00897-15; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Mokrousov Igor, 2007, Biotechnology Journal, V2, P901, DOI 10.1002/biot.20070035; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Parisien A, 2008, J APPL MICROBIOL, V104, P1, DOI 10.1111/j.1365-2672.2007.03498.x; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Richter C, 2013, BIOCHEM SOC T, V41, P1468, DOI 10.1042/BST20130151; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rosch TC, 2014, APPL ENVIRON MICROB, V80, P1349, DOI 10.1128/AEM.03154-13; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; van Belkum A, 2015, MBIO, V6, DOI 10.1128/mBio.01796-15; Vinuesa P, 2015, METHODS MOL BIOL, V1231, P203, DOI 10.1007/978-1-4939-1720-4_14; Westra ER, 2013, RNA BIOL, V10, P749, DOI 10.4161/rna.24202; Whitman KA, 2000, AQUACULTURE ASS CANA, V4, P115; Wietz M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-936; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl1031; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847                                                 ; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zielke RA, 2014, INFECT IMMUN, V82, P2788, DOI 10.1128/IAI.01292-13	70	0	0	6	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	APR 20	2017	18								313	10.1186/s12864-017-3693-7				13	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	ET9JQ	WOS:000400623900006	28427330	gold			2018-01-05	
J	Xiang, GH; Zhang, XY; An, CR; Cheng, C; Wang, HY				Xiang, Guanghai; Zhang, Xingying; An, Chenrui; Cheng, Chen; Wang, Haoyi			Temperature effect on CRISPR-Cas9 mediated genome editing	JOURNAL OF GENETICS AND GENOMICS			English	Article						CRISPR-Cas9; Hyperthermia; Genome editing; Mammalian cells	ZINC-FINGER NUCLEASES; CAS9 NUCLEASES; SPECIFICITY	Zinc-finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR-Cas9) are the most commonly used genome editing tools. Previous studies demonstrated that hypothermia treatment increased the mutation rates induced by ZFNs and TALENs in mammalian cells. Here, we characterize the effect of different culture temperatures on CRISPR-Cas9 mediated genome editing and find that the genome editing efficiency of CRISPR-Cas9 is significantly hampered by hypothermia treatment, unlike ZFN and TALEN. In addition, hyperthermia culture condition enhances genome editing by CRISPR-Cas9 in some cell lines, due to the higher enzyme activity and sgRNA expression level at higher temperature. Our study has implications on CRISPR-Cas9 applications in a broad spectrum of species, many of which do not live at 37 degrees C. Copyright (C) 2017, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.	[Xiang, Guanghai; Zhang, Xingying; An, Chenrui; Cheng, Chen; Wang, Haoyi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Xiang, Guanghai; Zhang, Xingying; An, Chenrui; Wang, Haoyi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Cheng, Chen] Univ Sci & Technol China, Hefei 230026, Peoples R China	Wang, HY (reprint author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Wang, HY (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wanghaoyi@ioz.ac.cn		Wang, Haoyi/0000-0003-2135-1769	National Natural Science Foundation of China [31471215]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01010409]; National High-Tech Research and Development Program [2015AA020307]; Young Thousand Talent Project; Young Scientist Scholarship of State Key Laboratory of Stem Cell and Reproductive Biology	We would like to thank Mark Wanner (the Jackson Laboratory) for critical review and comments on the manuscript. We thank members of the Wang Lab for assistance and helpful discussions during the planning and preparation of this manuscript, especially Dr. Wanyou Feng for helping perform the Western blot assay. This work was supported by the National Natural Science Foundation of China (No. 31471215), Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01010409), and National High-Tech Research and Development Program (No. 2015AA020307). H.W. was supported by the "Young Thousand Talent Project". G.H.X. was supported by the Young Scientist Scholarship of State Key Laboratory of Stem Cell and Reproductive Biology.	Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang WB, 2016, J GENET GENOMICS, V43, P319, DOI 10.1016/j.jgg.2016.02.004; Wiles MV, 2015, MAMM GENOME, V26, P501, DOI 10.1007/s00335-015-9565-z; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	19	0	0	2	4	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1673-8527	1873-5533		J GENET GENOMICS	J. Genet. Genomics	APR 20	2017	44	4					199	205		10.1016/j.jgg.2017.03.004				7	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	ET8YZ	WOS:000400592500003	28412228				2018-01-05	
J	Hua, YF; Wang, C; Huang, J; Wang, KJ				Hua, Yufeng; Wang, Chun; Huang, Jian; Wang, Kejian			A simple and efficient method for CRISPR/Cas9-induced mutant screening	JOURNAL OF GENETICS AND GENOMICS			English	Article						ACT-PCR; CRISPR/Cas9; Genome editing; Mutant screening	SYSTEM; MULTIPLEX; RICE; ELECTROPHORESIS; ANIMALS	The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system provides a technological breakthrough in mutant generation. Several methods such as the polymerase chain reaction (PCR)/restriction enzyme (RE) assay, T7 endonuclease I (T7EI) assay, Surveyor nuclease assay, PAGE-based genotyping assay, and high-resolution melting (HRM) analysis-based assay have been developed for screening CRISPR/Cas9-induced mutants. However, these methods are time and labour-intensive and may also be sequence-limited or require very expensive equipment. Here, we described a cost-effective and sensitive screening technique based on conventional PCR, annealing at critical temperature PCR (ACT-PCR), for identifying mutants. ACT-PCR requires only a single PCR step followed by agarose gel electrophoresis. We demonstrated that ACT-PCR accurately distinguished CRISPR/Cas9-induced mutants from wild type in both rice and zebrafish. Moreover, the method can be adapted for accurately determining mutation frequency in cultured cells. The simplicity of ACT-PCR makes it particularly suitable for rapid, large-scale screening of CRISPR/Cas9-induced mutants in both plants and animals. Copyright (C) 2017, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.	[Hua, Yufeng; Wang, Chun; Wang, Kejian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Huang, Jian] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China	Wang, KJ (reprint author), Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.	wangkejian@caas.cn		Wang, Kejian/0000-0002-8385-6714	National Natural Science Foundation of China [31271681, 3140101312]; Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	We thank Prof. Jixian Zhai (Southern University of Science and Technology, China) for critical reviewing the manuscript. This study was supported by the National Natural Science Foundation of China (Nos. 31271681 and 3140101312) and the Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences.	Chenouard V, 2016, J GENET GENOMICS, V43, P341, DOI 10.1016/j.jgg.2016.04.005; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hu XX, 2016, MOL PLANT, V9, P943, DOI 10.1016/j.molp.2016.03.003; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Kc R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32048; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Ma XL, 2015, MOL PLANT, V8, P1285, DOI 10.1016/j.molp.2015.02.012; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Ramlee MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15587; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen L., 2017, SCI CHINA LIFE SCI; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; Wang C, 2015, J GENET GENOMICS, V42, P703, DOI 10.1016/j.jgg.2015.09.011; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	17	1	1	18	28	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1673-8527	1873-5533		J GENET GENOMICS	J. Genet. Genomics	APR 20	2017	44	4					207	213		10.1016/j.jgg.2017.03.005				7	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	ET8YZ	WOS:000400592500004	28416245				2018-01-05	
J	Harrod, A; Fulton, J; Nguyen, VTM; Periyasamy, M; Ramos-Garcia, L; Lai, CF; Metodieva, G; de Giorgio, A; Williams, RL; Santos, DB; Gomez, PJ; Lin, ML; Metodiev, MV; Stebbing, J; Castellano, L; Magnani, L; Coombes, RC; Buluwela, L; Ali, S				Harrod, A.; Fulton, J.; Nguyen, V. T. M.; Periyasamy, M.; Ramos-Garcia, L.; Lai, C-F; Metodieva, G.; de Giorgio, A.; Williams, R. L.; Santos, D. B.; Gomez, P. J.; Lin, M-L; Metodiev, M. V.; Stebbing, J.; Castellano, L.; Magnani, L.; Coombes, R. C.; Buluwela, L.; Ali, S.			Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; LIGAND-BINDING DOMAIN; ER-ALPHA; ENDOCRINE RESISTANCE; POSTMENOPAUSAL WOMEN; ANTITUMOR-ACTIVITY; GENE-EXPRESSION; RETINOIC ACID; TYROSINE 537; PHOSPHORYLATION	Drugs that inhibit estrogen receptor-a (ER) activity have been highly successful in treating and reducing breast cancer progression in ER-positive disease. However, resistance to these therapies presents a major clinical problem. Recent genetic studies have shown that mutations in the ER gene are found in > 20% of tumours that progress on endocrine therapies. Remarkably, the great majority of these mutations localize to just a few amino acids within or near the critical helix 12 region of the ER hormone binding domain, where they are likely to be single allele mutations. Understanding how these mutations impact on ER function is a prerequisite for identifying methods to treat breast cancer patients featuring such mutations. Towards this end, we used CRISPR-Cas9 genome editing to make a single allele knock-in of the most commonly mutated amino acid residue, tyrosine 537, in the estrogen-responsive MCF7 breast cancer cell line. Genomic analyses using RNA-seq and ER ChIP-seq demonstrated that the Y537S mutation promotes constitutive ER activity globally, resulting in estrogen-independent growth. MCF7-Y537S cells were resistant to the antiestrogen tamoxifen and fulvestrant. Further, we show that the basal transcription factor TFIIH is constitutively recruited by ER-Y537S, resulting in ligand-independent phosphorylation of Serine 118 (Ser118) by the TFIIH kinase, cyclin-dependent kinase (CDK)7. The CDK7 inhibitor, THZ1 prevented Ser118 phosphorylation and inhibited growth of MCF7-Y537S cells. These studies confirm the functional importance of ER mutations in endocrine resistance, demonstrate the utility of knock-in mutational models for investigating alternative therapeutic approaches and highlight CDK7 inhibition as a potential therapy for endocrine-resistant breast cancer mediated by ER mutations.	[Harrod, A.; Fulton, J.; Nguyen, V. T. M.; Periyasamy, M.; Ramos-Garcia, L.; Lai, C-F; de Giorgio, A.; Williams, R. L.; Santos, D. B.; Gomez, P. J.; Lin, M-L; Stebbing, J.; Castellano, L.; Magnani, L.; Coombes, R. C.; Buluwela, L.; Ali, S.] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England; [Metodieva, G.; Metodiev, M. V.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester, Essex, England	Buluwela, L; Ali, S (reprint author), Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	l.buluwela@imperial.ac.uk; simak.ali@imperial.ac.uk			Breast Cancer Now [2014MayPR234]; Cancer Research UK [C37/A18784]; Cancer Research UK Imperial Centre	This work was funded by grants from Breast Cancer Now (2014MayPR234) and Cancer Research UK (C37/A18784). AH is supported by a PhD studentship from the Cancer Research UK Imperial Centre. We thank M Jones and L Game, MRC CSC Genomics Facility, Imperial College London. This study is dedicated to the memory of Professor Susan Malcolm.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Ali S, 2009, CANCER RES, V69, P6208, DOI 10.1158/0008-5472.CAN-09-0301; Anghel SI, 2000, J BIOL CHEM, V275, P20867, DOI 10.1074/jbc.M002098200; Arnold SF, 1997, MOL ENDOCRINOL, V11, P48, DOI 10.1210/me.11.1.48; ARNOLD SF, 1995, J BIOL CHEM, V270, P30205; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI [10.1016/S1470-2045(10)70257-6, 10.1016/S1470.2045(10)70257.6]; Eng FCS, 1997, MOL CELL BIOL, V17, P4644, DOI 10.1128/MCB.17.8.4644                                                           ; Eng FCS, 1998, J BIOL CHEM, V273, P28371, DOI 10.1074/jbc.273.43.28371; Fanning SW, 2016, ELIFE, V5, DOI 10.7554/eLife.12792; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Garner F, 2015, ANTI-CANCER DRUG, V26, P948, DOI 10.1097/CAD.0000000000000271; Guttery DS, 2015, CLIN CHEM, V61, P974, DOI 10.1373/clinchem.2015.238717; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herynk MH, 2004, ENDOCR REV, V25, P869, DOI 10.1210/er.2003-0010; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lai A, 2015, J MED CHEM, V58, P4888, DOI 10.1021/acs.jmedchem.5b00054; Lai CF, 2013, NUCLEIC ACIDS RES, V41, P10228, DOI 10.1093/nar/gkt827; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCormack P, 2008, CLIN BREAST CANCER, V8, P347, DOI 10.3816/CBC.2008.n.040; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Nguyen VTM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10044; Oesterreich S, 2013, NAT GENET, V45, P1415, DOI 10.1038/ng.2831; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207                                                     ; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Piccart M., 2013, ANN ONCOL, V24, P25; Pritchard KI, 2010, BREAST CANCER RES TR, V123, P453, DOI 10.1007/s10549-010-1022-9; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Schiavon G, 2015, SCI TRANSL MED; Segal CV, 2014, CLIN CANCER RES, V20, P1724, DOI 10.1158/1078-0432.CCR-14-0067; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skliris GP, 2010, ENDOCR-RELAT CANCER, V17, P589, DOI 10.1677/ERC-10-0030; Tharun IM, 2015, ACS CHEM BIOL, V10, P475, DOI 10.1021/cb5007097; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Wang PL, 2016, CLIN CANCER RES, V22, P1130, DOI 10.1158/1078-0432.CCR-15-1534; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Weir HM, 2016, CANCER RES, V76, P3307, DOI 10.1158/0008-5472.CAN-15-2357; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; White R, 1997, EMBO J, V16, P1427, DOI 10.1093/emboj/16.6.1427; Wittmann BM, 2007, CANCER RES, V67, P9549, DOI 10.1158/0008-5472.CAN-07-1590; Yudt MR, 1999, BIOCHEMISTRY-US, V38, P14146, DOI 10.1021/bi9911132; Zhang QX, 1997, CANCER RES, V57, P1244; Zhao CQ, 2003, J BIOL CHEM, V278, P27278, DOI 10.1074/jbc.M303840200	64	5	5	3	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2286	2296		10.1038/onc.2016.382				11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	WOS:000399782700009	27748765	gold			2018-01-05	
J	Swarts, DC; van der Oost, J; Jinek, M				Swarts, Daan C.; van der Oost, John; Jinek, Martin			Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a	MOLECULAR CELL			English	Article							CRISPR-CAS SYSTEMS; HUMAN-CELLS; CRYSTAL-STRUCTURE; CPF1 NUCLEASES; RECOGNITION; ENDONUCLEASE; COMPLEX; CLEAVAGE; SEQUENCE; IMMUNITY	The CRISPR-associated protein Cas12a (Cpf1), which has been repurposed for genome editing, possesses two distinct nuclease activities: endoribonuclease activity for processing its own guide RNAs and RNA-guided DNase activity for target DNA cleavage. To elucidate the molecular basis of both activities, we determined crystal structures of Francisella novicida Cas12a bound to guide RNA and in complex with an R-loop formed by a non-cleavable guide RNA precursor and a full-length target DNA. Corroborated by biochemical experiments, these structures reveal the mechanisms of guide RNA processing and pre-ordering of the seed sequence in the guide RNA that primes Cas12a for target DNA binding. Furthermore, the R-loop complex structure reveals the strand displacement mechanism that facilitates guide-target hybridization and suggests a mechanism for double-stranded DNA cleavage involving a single active site. Together, these insights advance our mechanistic understanding of Cas12a enzymes and may contribute to further development of genome editing technologies.	[Swarts, Daan C.; Jinek, Martin] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [van der Oost, John] Wageningen Univ, Dept Agrotechnol & Food Sci, Lab Microbiol, NL-6708 WE Wageningen, Netherlands	Jinek, M (reprint author), Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.	jinek@bioc.uzh.ch		Jinek, Martin/0000-0002-7601-210X	Swiss National Science Foundation (SNSF) [SNSF 31003A_149393]; Netherlands Organization for Scientific Research (NWO) CW-TOP grant [714.015.001]; long-term postdoctoral fellowship from the European Molecular Biology Organization (EMBO) [ALTF 179-2015]	We are grateful to Meitian Wang, Vincent Olieric, and Takashi Tomizaki at the Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland) for assistance with X-ray diffraction measurements. We thank S. Chardia, P. Mohanraju, R. Pritchard, and S. Halter for technical assistance. We thank M. Clerici and C. Garcia-Doval for help with X-ray data processing and members of the Jinek group for discussions and critical reading of the manuscript. This work was supported by a Swiss National Science Foundation (SNSF) Project Grant to M.J. (SNSF 31003A_149393), by a Netherlands Organization for Scientific Research (NWO) CW-TOP grant (714.015.001) to J.v.d.O., and by a long-term postdoctoral fellowship from the European Molecular Biology Organization (EMBO) to D.C.S. (ALTF 179-2015).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Charpentier E, 2014, CURR OPIN MICROBIOL, V19, P114, DOI 10.1016/j.mib.2014.07.001; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Das U, 2013, NUCLEIC ACIDS RES, V41, P355, DOI 10.1093/nar/gks977; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fu BXH, 2014, NUCLEIC ACIDS RES, V42, P13778, DOI 10.1093/nar/gku1102; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2013, ACTA CRYSTALLOGR D, V69, P2244, DOI 10.1107/S0907444913017770; Toth E, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0147-0; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Xu R, 2016, PLANT BIOTECHNOL J; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	61	9	9	10	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	APR 20	2017	66	2					221	+		10.1016/j.molcel.2017.03.016				17	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	ES5CF	WOS:000399553100008	28431230				2018-01-05	
J	Treiber, T; Treiber, N; Plessmann, U; Harlander, S; Daiss, JL; Eichner, N; Lehmann, G; Schall, K; Urlaub, H; Meister, G				Treiber, Thomas; Treiber, Nora; Plessmann, Uwe; Harlander, Simone; Daiss, Julia-Lisa; Eichner, Norbert; Lehmann, Gerhard; Schall, Kevin; Urlaub, Henning; Meister, Gunter			A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis	MOLECULAR CELL			English	Article							SEQUENCE DETERMINANTS; LIN28-LET-7 PATHWAY; SECONDARY STRUCTURE; GENE-REGULATION; PRE-MICRORNA; HNRNP A1; URIDYLATION; RECOGNITION; DROSOPHILA; TARGET	During microRNA (miRNA) biogenesis, two endonucleolytic reactions convert stem-loop-structured precursors into mature miRNAs. These processing steps can be posttranscriptionally regulated by RNA-binding proteins (RBPs). Here, we have used a proteomics-based pull-down approach to map and characterize the interactome of a multitude of pre-miRNAs. We identify similar to 180 RBPs that interact specifically with distinct pre-miRNAs. For functional validation, we combined RNAi and CRISPR/Cas-mediated knockout experiments to analyze RBP-dependent changes in miRNA levels. Indeed, a large number of the investigated candidates, including splicing factors and other mRNA processing proteins, have effects on miRNA processing. As an example, we show that TRIM71/LIN41 is a potent regulator of miR-29a processing and its inactivation directly affects miR-29a targets. We provide an extended database of RBPs that interact with pre-miRNAs in extracts of different cell types, highlighting a widespread layer of co- and posttranscriptional regulation of miRNA biogenesis.	[Treiber, Thomas; Treiber, Nora; Harlander, Simone; Daiss, Julia-Lisa; Eichner, Norbert; Lehmann, Gerhard; Schall, Kevin; Meister, Gunter] Univ Regensburg, Biochem Ctr Regensburg BZR, Lab RNA Biol, D-93053 Regensburg, Germany; [Plessmann, Uwe; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany	Meister, G (reprint author), Univ Regensburg, Biochem Ctr Regensburg BZR, Lab RNA Biol, D-93053 Regensburg, Germany.	gunter.meister@ur.de			DFG [SFB960, SPP1935]; European Research Council (ERC grant "moreRNAs"); Bavarian Systems-Biology Network (BioSysNet)	We thank S. Ammon and C. Friederich for technical assistance and support and G. Wulczyn for reagents. Our research is supported by grants from the DFG (SFB960, SPP1935), the European Research Council (ERC grant "moreRNAs"), and the Bavarian Systems-Biology Network (BioSysNet). G.M. is a co-founder of siTOOLs Biotech.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burge RG, 2014, BIOCHEMISTRY-US, V53, P1495, DOI 10.1021/bi401675h; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Choudhury NR, 2014, CELL REP, V9, P1265, DOI 10.1016/j.celrep.2014.10.017; Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112; Choudhury NR, 2012, BIOCHEM SOC T, V40, P789, DOI 10.1042/BST20120053; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Connerty P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010031; Contrant M, 2014, NUCLEIC ACIDS RES, V42, P7981, DOI 10.1093/nar/gku424; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Du P, 2015, CELL, V162, P885, DOI 10.1016/j.cell.2015.07.008; Dueck A, 2014, BIOL CHEM, V395, P611, DOI 10.1515/hsz-2014-0116; Edwards J, 2011, NUCLEIC ACIDS RES, V39, P8638, DOI 10.1093/nar/gkr510; Faehnle CR, 2014, NATURE, V514, P252, DOI 10.1038/nature13553; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Good PJ, 2000, J BIOL CHEM, V275, P28583, DOI 10.1074/jbc.M003083200; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hurteau GJ, 2006, CELL CYCLE, V5, P1951, DOI 10.4161/cc.5.17.3133; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Loedige I, 2015, CELL REP, V13, P1206, DOI 10.1016/j.celrep.2015.09.068; Michlewski G, 2010, ADV EXP MED BIOL, V700, P28; Morlando M, 2012, EMBO J, V31, P4502, DOI 10.1038/emboj.2012.319; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Oellerich T, 2011, EMBO J, V30, P3620, DOI 10.1038/emboj.2011.251; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436                                                            ; Thornton JE, 2014, NUCLEIC ACIDS RES, V42, P11777, DOI 10.1093/nar/gku805; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Treiber T, 2012, THROMB HAEMOSTASIS, V107, P605, DOI 10.1160/TH11-12-0836; Triboulet R, 2015, CELL REP, V13, P260, DOI 10.1016/j.celrep.2015.08.086; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Wu SL, 2015, NUCLEIC ACIDS RES, V43, P8516, DOI 10.1093/nar/gkv779; Xiong XP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005475; Zeng YX, 2016, MOL CELL, V61, P153, DOI 10.1016/j.molcel.2015.11.020; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018	57	4	4	7	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	APR 20	2017	66	2					270	+		10.1016/j.molcel.2017.03.014				25	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	ES5CF	WOS:000399553100012	28431233				2018-01-05	
J	Xie, SQ; Duan, JL; Li, BX; Zhou, P; Hon, GC				Xie, Shiqi; Duan, Jialei; Li, Boxun; Zhou, Pei; Hon, Gary C.			Multiplexed Engineering and Analysis of Combinatorial Enhancer Activity in Single Cells	MOLECULAR CELL			English	Article							LOCUS-CONTROL REGION; SUPER-ENHANCERS; GENE-EXPRESSION; IDENTITY GENES; BINDING-SITES; RNA-SEQ; TRANSCRIPTION; GENOME; ELEMENTS; DISSECTION	The study of enhancers has been hampered by the scarcity of methods to systematically quantify their endogenous activity. We develop Mosaic-seq to systematically perturb enhancers and measure their endogenous activities at single-cell resolution. Mosaic-seq uses a CRISPR barcoding system to jointly measure a cell's transcriptome and its sgRNA modulators, thus quantifying the effects of dCas9-KRAB-mediated enhancer repression in single cells. Applying Mosaic-seq to 71 constituent enhancers from 15 super-enhancers, our analysis of 51,448 sgRNA-induced transcriptomes finds that only a small number of constituents are major effectors of target gene expression. Binding of p300 and RNAPII are key features of these constituents. We determine two key parameters of enhancer activity in single cells: their penetrance in a population and their contribution to expression in these cells. Through combinatorial interrogation, we find that simultaneous repression of multiple weak constituents can alter super-enhancer activity in a manner greatly exceeding repression of individual constituents.	[Xie, Shiqi; Duan, Jialei; Li, Boxun; Zhou, Pei; Hon, Gary C.] Univ Texas Southwestern Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Lab Regulatory Genom, Div Basic Reprod Biol Res,Dept Obstet & Gynecol, Dallas, TX 75390 USA	Hon, GC (reprint author), Univ Texas Southwestern Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Lab Regulatory Genom, Div Basic Reprod Biol Res,Dept Obstet & Gynecol, Dallas, TX 75390 USA.	gary.hon@utsouthwestern.edu		Xie, Shiqi/0000-0002-0516-3621	Cancer Prevention Research Institute of Texas (CPRIT) [RR140023]; American Heart Association fellowship [16POST29910007]	We gratefully acknowledge Steven McCarroll for extensive protocols on Dropseq. Wealso thank Charles Gersbach for his gift of the pLV hU6-sgRNA-hUbC-dCas9-KRAB-T2a-Puro construct, Rickard Sandberg for his gift of Tn5 transposase plasmid, W. Lee Kraus for critical reading of this manuscript, and the journal reviewers whose comments have significantly improved this manuscript. This work is supported by the Cancer Prevention Research Institute of Texas (CPRIT) grant RR140023 (to G.C.H.) and an American Heart Association fellowship 16POST29910007 (to S.X.). The authors acknowledge the BioHPC computational infrastructure at UT Southwestern as well as the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing HPC and storage resources that have contributed to the research results reported within this paper (https://www.tacc.utexas.edu). The authors also acknowledge UT Southwestern's McDermott Center and the Children's Research Institute for providing next-generation sequencing services for this work.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; Bungert J, 1999, MOL CELL BIOL, V19, P3062; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fedosyuk H, 2007, BLOOD CELL MOL DIS, V39, P44, DOI 10.1016/j.bcmd.2007.02.006; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gasperini M, 2016, NAT PROTOC, V11, P1782, DOI 10.1038/nprot.2016.135; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Hicks SC, 2015, BIORXIV; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Hou ZG, 2015, SCI REP-UK, V5, DOI 10.1038/srep09570; Inoue F, 2017, GENOME RES, V27, P38, DOI 10.1101/gr.212092.116; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Levings PP, 2002, EUR J BIOCHEM, V269, P1589, DOI 10.1046/j.1432-1327.2002.02797.x; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Young R. A., 2013, CELL, V153, P320; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Kundaje A, 2015, NATURE, V518, P317, DOI DOI 10.1038/NATURE14248; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Savic D, 2015, GENOME RES, V25, P1791, DOI 10.1101/gr.191593.115; Schubeler D, 2001, P NATL ACAD SCI USA, V98, P11432, DOI 10.1073/pnas.201394698; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P10032, DOI 10.1093/nar/gkt826	53	7	7	7	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	APR 20	2017	66	2					285	+		10.1016/j.molcel.2017.03.007				20	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	ES5CF	WOS:000399553100013	28416141				2018-01-05	
J	Mohler, K; Mann, R; Bullwinkle, TJ; Hopkins, K; Hwang, L; Reynolds, NM; Gassaway, B; Aerni, HR; Rinehart, J; Polymenis, M; Faull, K; Ibba, M				Mohler, Kyle; Mann, Rebecca; Bullwinkle, Tammy J.; Hopkins, Kyle; Hwang, Lin; Reynolds, Noah M.; Gassaway, Brandon; Aerni, Hans-Rudolf; Rinehart, Jesse; Polymenis, Michael; Faull, Kym; Ibba, Michael			Editing of misaminoacylated tRNA controls the sensitivity of amino acid stress responses in Saccharomyces cerevisiae	NUCLEIC ACIDS RESEARCH			English	Article							TRANSLATION QUALITY-CONTROL; GCN4 TRANSLATION; PROTEIN-KINASE; GENETIC-CODE; CELL-SIZE; MISTRANSLATION; SYNTHETASE; YEAST; ACTIVATION; PHENYLALANINE	Amino acid starvation activates the protein kinase Gcn2p, leading to changes in gene expression and translation. Gcn2p is activated by deacylated tRNA, which accumulates when tRNA aminoacylation is limited by lack of substrates or inhibition of synthesis. Pairing of amino acids and deacylated tRNAs is catalyzed by aminoacyl-tRNA synthetases, which use quality control pathways to maintain substrate specificity. Phenylalanyl-tRNA synthetase (PheRS) maintains specificity via an editing pathway that targets non-cognate Tyr-tRNA(Phe). While the primary role of aaRS editing is to prevent misaminoacylation, we demonstrate editing of misaminoacylated tRNA is also required for detection of amino acid starvation by Gcn2p. Ablation of PheRS editing caused accumulation of Tyr-tRNA(Phe) (5%), but not deacylated tRNA(Phe) during amino acid starvation, limiting Gcn2p kinase activity and suppressing Gcn4p-dependent gene expression. While the PheRS-editing ablated strain grew 50% slower and displayed a 27-fold increase in the rate of mistranslation of Phe codons as Tyr compared to wild type, the increase in mis-translation was insufficient to activate an unfolded protein stress response. These findings show that during amino acid starvation a primary role of aaRS quality control is to help the cell mount an effective stress response, independent of the role of editing in maintaining translational accuracy.	[Mohler, Kyle; Mann, Rebecca; Bullwinkle, Tammy J.; Hopkins, Kyle; Reynolds, Noah M.; Ibba, Michael] Ohio State Univ, Dept Microbiol, 318 West 12th Ave, Columbus, OH 43210 USA; [Mohler, Kyle; Ibba, Michael] Ohio State Univ, Ctr RNA Biol, 484 West 12th Ave, Columbus, OH 43210 USA; [Hwang, Lin; Faull, Kym] UCLA, Pasarow Mass Spectrometry Lab, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci,David Geffen Sch Med, 760 Westwood Plaza, Los Angeles, CA 90024 USA; [Gassaway, Brandon; Aerni, Hans-Rudolf; Rinehart, Jesse] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Gassaway, Brandon; Aerni, Hans-Rudolf; Rinehart, Jesse] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA; [Polymenis, Michael] Texas A&M Univ, Biochem & Biophys, Rm 333,2128 TAMU, College Stn, TX 77843 USA	Ibba, M (reprint author), Ohio State Univ, Dept Microbiol, 318 West 12th Ave, Columbus, OH 43210 USA.; Ibba, M (reprint author), Ohio State Univ, Ctr RNA Biol, 484 West 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu			National Science Foundation [MCB1412611, MCB141277 3, DGE1122492]; Ohio State University Center for RNA Biology Fellowships; NIH [T32 GMGM086252]	National Science Foundation [MCB1412611, MCB141277 3 and DGE1122492]; Ohio State University Center for RNA Biology Fellowships (to K.M.); NIH Training Grants [T32 GMGM086252 to K.M.]. Funding for open access charge. National Science Foundation.	Amiram M, 2015, NAT BIOTECHNOL, V33, P1272, DOI 10.1038/nbt.3372; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bullwinkle T., 2014, ELIFE; Bullwinkle TJ, 2016, P NATL ACAD SCI USA, V113, P2252, DOI 10.1073/pnas.1525206113; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Goossens A, 2001, J BIOL CHEM, V276, P30753, DOI 10.1074/jbc.M102960200; GRANT CM, 1989, MOL MICROBIOL, V3, P215, DOI 10.1111/j.1365-2958.1989.tb01810.x; Grosshans H, 2000, GENE DEV, V14, P830; Gu WF, 2005, MOL CELL BIOL, V25, P8191, DOI 10.1128/MCB.25.18.8191-8201.2005; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1988, TRENDS GENET, V4, P169, DOI 10.1016/0168-9525(88)90023-6; Hoose SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002590; Joo YJ, 2011, EMBO J, V30, P859, DOI 10.1038/emboj.2010.332; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Kotik-Kogan O, 2005, STRUCTURE, V13, P1799, DOI 10.1016/j.str.2005.08.013; Lageix S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004991; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Ling J, 2007, RNA, V13, P1881, DOI 10.1261/rna.684107; Link A.J., 2004, CURR PROTOC PROTEIN, DOI [10.1002/0471140864.ps2301s34, DOI 10.1002/0471140864.PS2301S34]; Marbach I, 2001, J BIOL CHEM, V276, P16944, DOI 10.1074/jbc.M100383200; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Meyerovich M, 2010, P NATL ACAD SCI USA, V107, P11543, DOI 10.1073/pnas.0912989107; Moghal A, 2014, FEBS LETT, V588, P4305, DOI 10.1016/j.febslet.2014.08.035; Mohler K, 2017, METHODS, V113, P127, DOI 10.1016/j.ymeth.2016.09.003; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Qiu HF, 2000, MOL CELL BIOL, V20, P2505, DOI 10.1128/MCB.20.7.2505-2516.2000; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Ribas de Pouplana L, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI DOI 10.1016/J.TIBS.2014.06.002.EPUB; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Starosta AL, 2014, FEMS MICROBIOL REV, V38, P1172, DOI 10.1111/1574-6976.12083; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Truong SK, 2013, G3-GENES GENOM GENET, V3, P1525, DOI 10.1534/g3.113.007062; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Zaborske JM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-29	45	1	1	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	APR 20	2017	45	7					3985	3996		10.1093/nar/gkx077				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ES3SD	WOS:000399448400040	28168297	gold			2018-01-05	
J	Chen, J; Cai, TX; Zheng, CW; Lin, XW; Wang, GJ; Liao, SY; Wang, XX; Gan, HY; Zhang, DQ; Hu, XJ; Wang, S; Li, Z; Feng, YM; Yang, FQ; Han, CS				Chen, Jian; Cai, Tanxi; Zheng, Chunwei; Lin, Xiwen; Wang, Guojun; Liao, Shangying; Wang, Xiuxia; Gan, Haiyun; Zhang, Daoqin; Hu, Xiangjing; Wang, Si; Li, Zhen; Feng, Yanmin; Yang, Fuquan; Han, Chunsheng			MicroRNA-202 maintains spermatogonial stem cells by inhibiting cell cycle regulators and RNA binding proteins	NUCLEIC ACIDS RESEARCH			English	Article							MOUSE MALE GERMLINE; RETINOIC ACID; TRANSITION PROTEIN-2; TESTIS TISSUES; SELF-RENEWAL; SPERMATOGENESIS; DIFFERENTIATION; EXPRESSION; MICE; PROLIFERATION	miRNAs play important roles during mammalian spermatogenesis. However, the function of most miRNAs in spermatogenesis and the underlying mechanisms remain unknown. Here, we report that miR-202 is highly expressed in mouse spermatogonial stem cells (SSCs), and is oppositely regulated by Glial cell-Derived Neurotrophic Factor (GDNF) and retinoic acid (RA), two key factors for SSC self-renewal and differentiation. We used inducible CRISPR-Cas9 to knockout miR-202 in cultured SSCs, and found that the knockout SSCs initiated premature differentiation accompanied by reduced stem cell activity and increased mitosis and apoptosis. Target genes were identified with iTRAQ-based proteomic analysis and RNA sequencing, and are enriched with cell cycle regulators and RNA-binding proteins. Rbfox2 and Cpeb1 were found to be direct targets of miR-202 and Rbfox2 but not Cpeb1, is essential for the differentiation of SSCs into meiotic cells. Accordingly, an SSC fate-regulatory network composed of signaling molecules of GDNF and RA, miR-202 and diverse downstream effectors has been identified.	[Chen, Jian; Zheng, Chunwei; Lin, Xiwen; Wang, Guojun; Liao, Shangying; Wang, Xiuxia; Gan, Haiyun; Zhang, Daoqin; Hu, Xiangjing; Wang, Si; Li, Zhen; Feng, Yanmin; Han, Chunsheng] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Chen, Jian; Cai, Tanxi; Zheng, Chunwei; Zhang, Daoqin; Hu, Xiangjing; Feng, Yanmin; Yang, Fuquan; Han, Chunsheng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Cai, Tanxi; Yang, Fuquan] Chinese Acad Sci, Key Lab Prot & Peptide Pharmaceut, Inst Biophys, Beijing 100101, Peoples R China; [Cai, Tanxi; Yang, Fuquan] Chinese Acad Sci, Lab Prote, Inst Biophys, Beijing 100101, Peoples R China; [Gan, Haiyun] Columbia Univ, Med Ctr, Irving Canc Res Ctr, New York, NY 10032 USA; [Wang, Si] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Han, CS (reprint author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Yang, FQ; Han, CS (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Yang, FQ (reprint author), Chinese Acad Sci, Key Lab Prot & Peptide Pharmaceut, Inst Biophys, Beijing 100101, Peoples R China.; Yang, FQ (reprint author), Chinese Acad Sci, Lab Prote, Inst Biophys, Beijing 100101, Peoples R China.	fqyang@sun5.ibp.ac.cn; hancs@ioz.ac.cn			Ministry of Science and Technology of China [2013CB945001, 2015CB943002, 2016YFC1000600, 2012CB966803, 2014CBA02003]; National Natural Science Foundation of China [31271379, 31471349, 31670185]; Novo Nordisk-CAS Research Fund [NNCAS-2015-11]	Ministry of Science and Technology of China [2013CB945001, 2015CB943002, 2016YFC1000600, 2012CB966803 and 2014CBA02003]; National Natural Science Foundation of China [31271379, 31471349, 31670185]; Novo Nordisk-CAS Research Fund [NNCAS-2015-11]. Funding for open access charge: Ministry of Science and Technology of China [2016YFC1000600, 2015CB943002, 2013CB945001, 2012CB966803 and 2014CBA02003].	Bao JQ, 2012, J BIOL CHEM, V287, P21686, DOI 10.1074/jbc.M111.328054; Bisio A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-552; Bjork JK, 2010, DEVELOPMENT, V137, P3177, DOI 10.1242/dev.050955; Bruscoli S, 2012, J BIOL CHEM, V287, P1242, DOI 10.1074/jbc.M111.316372; Busada JT, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135145; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chalmel F, 2015, REPRODUCTION, V150, pR149, DOI 10.1530/REP-15-0073; Chang YF, 2012, P NATL ACAD SCI USA, V109, P5750, DOI 10.1073/pnas.1117837109; Cheng CL, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/1851829; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dai LS, 2011, J BIOL CHEM, V286, P44306, DOI 10.1074/jbc.M111.282756; De Rooij DG, 2012, J ANDROL, V33, P1085, DOI 10.2164/jandrol.112.016832; Fu HJ, 2006, MOL BIOTECHNOL, V32, P197, DOI 10.1385/MB:32:3:197; Gan HY, 2011, RNA, V17, P1191, DOI 10.1261/rna.2648411; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Gropp M, 2006, METHOD ENZYMOL, V420, P64, DOI 10.1016/S0076-6879(06)20005-3; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He ZP, 2013, STEM CELLS, V31, P2205, DOI 10.1002/stem.1474; Holt JE, 2016, ADV EXP MED BIOL, V886, P95, DOI 10.1007/978-94-017-7417-8_6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hukema RK, 2014, CELL CYCLE, V13, P2600, DOI 10.4161/15384101.2014.943112; Huszar JM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103747; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI [10.1095/biolreprod.103.017012, 10.1095/biloreprod.103.017012]; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Liao HF, 2014, DEVELOPMENT, V141, P2402, DOI 10.1242/dev.105130; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Manku G, 2015, REPRODUCTION, V149, pR139, DOI 10.1530/REP-14-0431; Marcon E, 2008, CHROMOSOME RES, V16, P243, DOI 10.1007/s10577-007-1190-6; McIver SC, 2012, HUM REPROD UPDATE, V18, P44, DOI 10.1093/humupd/dmr041; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sambrook J, 2006, CSH PROTOC, V2006, P2006, DOI [10.1101/pdb.prot4027, DOI 10.1101/PDB.PROT4455]; Smorag L, 2012, BIOL CELL, V104, P677, DOI 10.1111/boc.201200014; Stanton J.-A.L., 2010, PLOS ONE, V5; Sun ZW, 2014, MOL CELL BIOCHEM, V397, P277, DOI 10.1007/s11010-014-2195-z; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313; Tong MH, 2011, BIOL REPROD, V85, P189, DOI 10.1095/biolreprod.110.089458; Wang S, 2015, STEM CELLS DEV, V24, P471, DOI 10.1089/scd.2014.0376; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/RFP-07-0056; Yan NH, 2009, J ASSIST REPROD GEN, V26, P179, DOI 10.1007/s10815-009-9305-y; Yang QE, 2013, DEVELOPMENT, V140, P280, DOI 10.1242/dev.087403; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Zhang Y., 2014, ABSTR APPL ANAL, V2014, P6, DOI DOI 10.3390/SU6052961; Zhang Y, 2012, CELL RES, V22, P773, DOI 10.1038/cr.2012.17; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zimmermann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107023	57	6	6	10	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	APR 20	2017	45	7					4142	4157		10.1093/nar/gkw1287				16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ES3SD	WOS:000399448400052	27998933	gold			2018-01-05	
J	Anantharaman, A; Tripathi, V; Khan, A; Yoon, JH; Singh, DK; Gholamalamdari, O; Guang, SM; Ohlson, J; Wahlstedt, H; Ohman, M; Jantsch, MF; Conrad, NK; Ma, J; Gorospe, M; Prasanth, SG; Prasanth, KV				Anantharaman, Aparna; Tripathi, Vidisha; Khan, Abid; Yoon, Je-Hyun; Singh, Deepak K.; Gholamalamdari, Omid; Guang, Shuomeng; Ohlson, Johan; Wahlstedt, Helene; Ohman, Marie; Jantsch, Michael F.; Conrad, Nicholas K.; Ma, Jian; Gorospe, Myriam; Prasanth, Supriya G.; Prasanth, Kannanganattu V.			ADAR2 regulates RNA stability by modifying access of decay-promoting RNA-binding proteins	NUCLEIC ACIDS RESEARCH			English	Article							EDITING ENZYME ADAR1; MESSENGER-RNA; GENE-EXPRESSION; ADENOSINE DEAMINASES; HUMAN TRANSCRIPTOME; REPRODUCIBLE CHANGES; NUCLEAR RETENTION; WIDE ANALYSIS; HUR; SITES	Adenosine deaminases acting on RNA (ADARs) catalyze the editing of adenosine residues to inosine (A-to-I) within RNA sequences, mostly in the introns and UTRs (un-translated regions). The significance of editing within non-coding regions of RNA is poorly understood. Here, we demonstrate that association of ADAR2 with RNA stabilizes a subset of transcripts. ADAR2 interacts with and edits the 3' UTR of nuclear-retained Cat2 transcribed nuclear RNA (Ctn RNA). In absence of ADAR2, the abundance and half-life of Ctn RNA are significantly reduced. Furthermore, ADAR2-mediated stabilization of Ctn RNA occurred in an editing-independent manner. Unedited Ctn RNA shows enhanced interaction with the RNA-binding proteins HuR and PARN [Poly(A) specific ribonuclease deadenylase]. HuR and PARN destabilize Ctn RNA in absence of ADAR2, indicating that ADAR2 stabilizes Ctn RNA by antagonizing its degradation by PARN and HuR. Transcriptomic analysis identified other RNAs that are regulated by a similar mechanism. In summary, we identify a regulatory mechanism whereby ADAR2 enhances target RNA stability by limiting the interaction of RNA-destabilizing proteins with their cognate substrates.	[Anantharaman, Aparna; Tripathi, Vidisha; Khan, Abid; Singh, Deepak K.; Gholamalamdari, Omid; Prasanth, Supriya G.; Prasanth, Kannanganattu V.] Univ Illinois, Dept Cell & Dev Biol, 601 S Goodwin Ave, Urbana, IL 61801 USA; [Yoon, Je-Hyun; Gorospe, Myriam] NIA, Lab Genet, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Guang, Shuomeng; Ma, Jian] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ohlson, Johan; Wahlstedt, Helene; Ohman, Marie] Stockholm Univ, WennerGren Inst, Dept Mol Biosci, Svante Arrheniusvag 20C, SE-10691 Stockholm, Sweden; [Jantsch, Michael F.] Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria; [Jantsch, Michael F.] Med Univ Vienna, Dept Med Biochem, A-1090 Vienna, Austria; [Conrad, Nicholas K.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Tripathi, Vidisha] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India	Prasanth, KV (reprint author), Univ Illinois, Dept Cell & Dev Biol, 601 S Goodwin Ave, Urbana, IL 61801 USA.	kumarp@illinois.edu	Jantsch, Michael/E-9122-2015; Ahman, Marie/N-8561-2015	Jantsch, Michael/0000-0003-1747-0853; Ahman, Marie/0000-0002-6636-5841; Singh, Deepak/0000-0002-1265-7988; Khan, Abid/0000-0003-0968-8705	National Institute of Health [1RO1GM088252, 1RO1GM099669]; American Cancer Society [RSG-11-174-01-RMC]; National Science Foundation [1243372]; National Institute on Aging-Intramural Research Program, National Institute of Health [Z01-AG000511]; NIGMS, NIH [RO1GM088252]	National Institute of Health [1RO1GM088252 to K.V.P., 1RO1GM099669 to S.G.P.]; American Cancer Society [RSG-11-174-01-RMC to K.V.P.]; National Science Foundation career [1243372 to S.G.P.]; National Institute on Aging-Intramural Research Program, National Institute of Health [Z01-AG000511 to J.H.Y., M.G.]. Funding for open access charge: NIGMS, NIH [RO1GM088252].	Atasoy U, 1998, J CELL SCI, V111, P3145; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Berndt H, 2012, RNA, V18, P958, DOI 10.1261/rna.032292.112; Cammas A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5190; Capshew CR, 2012, NUCLEIC ACIDS RES, V40, P8637, DOI 10.1093/nar/gks590; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chang N, 2010, MOL CELL BIOL, V30, P3875, DOI 10.1128/MCB.00169-10; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chen LL, 2012, CURR TOP MICROBIOL, V353, P111, DOI 10.1007/82_2011_149; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Daniel C, 2012, NUCLEIC ACIDS RES, V40, P9876, DOI 10.1093/nar/gks691; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371                                                               ; Elbarbary R. A., 2013, GENES DEV, V27; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Heale BSE, 2009, EMBO J, V28, P3145, DOI [10.1038/sj.emboj.2009.244, 10.1038/emboj.2009.244]; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Higuchi M, 2000, NATURE, V406, P78; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; Hu SB, 2015, GENE DEV, V29, P630, DOI 10.1101/gad.257048.114; Hundley HA, 2008, RNA, V14, P2050, DOI 10.1261/rna.1165008; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kundu P, 2012, NUCLEIC ACIDS RES, V40, P5088, DOI 10.1093/nar/gks148; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002901; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mallela A, 2012, CRIT REV BIOCHEM MOL, V47, P493, DOI 10.3109/10409238.2012.714350; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795                                                        ; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Mukherjee N, 2011, MOL CELL, V43, P327, DOI [10.1016/j.molcel.2011.06.007, 10.1016/j.molce1.2011.06.007]; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Nowotarski SL, 2010, J BIOL CHEM, V285, P31885, DOI 10.1074/jbc.M110.148767; Ohlson J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/bar/gnil169; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Ryman K, 2007, RNA, V13, P1071, DOI 10.1261/rna.404407; Scheckel C, 2016, ELIFE, V5, DOI 10.7554/eLife.10421; Soundararajan R, 2015, ONCOTARGET, V6, P35726, DOI 10.18632/oncotarget.6132; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ulbricht RJ, 2014, BIOESSAYS, V36, P730, DOI 10.1002/bies.201400055; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Vesely C, 2014, NUCLEIC ACIDS RES, V42, P12155, DOI 10.1093/nar/gku844; Vesely C, 2012, GENOME RES, V22, P1468, DOI 10.1101/gr.133025.111; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027	62	4	4	1	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	APR 20	2017	45	7					4189	4201		10.1093/nar/gkw1304				13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ES3SD	WOS:000399448400055	28053121	gold			2018-01-05	
J	Dudakovic, A; Gluscevic, M; Paradise, CR; Dudakovic, H; Khani, F; Thaler, R; Ahmed, FS; Li, XD; Dietz, AB; Stein, GS; Montecino, MA; Deyle, DR; Westendorf, JJ; Van Wijnen, AJ				Dudakovic, Amel; Gluscevic, Martina; Paradise, Christopher R.; Dudakovic, Halil; Khani, Farzaneh; Thaler, Roman; Ahmed, Farah S.; Li, Xiaodong; Dietz, Allan B.; Stein, Gary S.; Montecino, Martin A.; Deyle, David R.; Westendorf, Jennifer J.; van Wijnen, Andre J.			Profiling of human epigenetic regulators using a semi-automated real-time qPCR platform validated by next generation sequencing	GENE			English	Article						Mesenchymal stem cell; Adipose-tissue derived stromal cells; Epigenetics; Histone; Epigenetic regulators; Deacetylase; Methyltransferase	MESENCHYMAL STEM-CELLS; HISTONE DEACETYLASE INHIBITOR; BONE-MINERAL DENSITY; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; OSTEOGENIC DIFFERENTIATION; CHROMATIN-STRUCTURE; OSTEOCALCIN GENE; RUNX2 PROMOTER; STROMAL CELLS	Epigenetic mechanisms control phenotypic commitment of mesenchymal stromal/stem cells (MSCs) into osteogenic, chondrogenic or adipogenic lineages. To investigate enzymes and chromatin binding proteins controlling the epigenome, we developed a hybrid expression screening strategy that combines semi-automated real-time qPCR (RT-qPCR), next generation RNA sequencing (RNA-seq), and a novel data management application (FileMerge). This strategy was used to interrogate expression of a large cohort (n> 300) of human epigenetic regulators (EpiRegs) that generate, interpret and/or edit the histone code. We find that EpiRegs with similar enzymatic functions are variably expressed and specific isoforms dominate over others in human MSCs. This principle is exemplified by analysis of key histone acetyl transferases (HATs) and deacetylases (HDACs), H3 lysine methyltransferases (e.g., EHMTs) and demethylases (KDMs), as well as bromodomain (BRDs) and chromobox (CBX) proteins. Our results show gender-specific expression of H3 lysine 9 [H3K9] demethylases (e.g., KDM5D and UTY) as expected and upregulation of distinct EpiRegs (n > 30) during osteogenic differentiation of MSCs (e.g., HDAC5 and HDAC7). The functional significance of HDAC5 in osteogenic lineage commitment of MSCs was functionally validated using panobinostat (LBH-589). This pan-deacetylase inhibitor suppresses osteoblastic differentiation as evidenced by reductions in bone-specific mRNA markers (e.g., ALPL), alkaline phosphatase activity and calcium deposition (i.e., Alizarin Red staining). Thus, our RT-qPCR platform identifies candidate EpiRegs by expression screening, predicts biological outcomes of their corresponding inhibitors, and enables manipulation of the human epigenome using molecular or pharmacological approaches to control stem cell differentiation. (C) 2017 Elsevier B.V. All rights reserved.	[Dudakovic, Amel; Gluscevic, Martina; Paradise, Christopher R.; Khani, Farzaneh; Thaler, Roman; Ahmed, Farah S.; Li, Xiaodong; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Biochem & Mol Biol, Rochester, MN USA; [van Wijnen, Andre J.] Mayo Clin, Physiol & Biomed Engn, Rochester, MN USA; [Dudakovic, Halil] Mayo Clin, Informat Technol, Rochester, MN USA; [Dietz, Allan B.] Mayo Clin, Lab Med & Pathol, Rochester, MN USA; [Deyle, David R.] Mayo Clin, Med Genet, Rochester, MN USA; [Stein, Gary S.] Univ Vermont Med Sch, Dept Biochem, Burlington, VT USA; [Montecino, Martin A.] Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago, Chile; [Montecino, Martin A.] Univ Andres Bello, Fac Med, Santiago, Chile	Van Wijnen, AJ (reprint author), 200 First St SW, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu		Dietz, Allan/0000-0003-3410-9621	National Institutes of Health [F32 AR066508, R01 AR049069, R01 AR068103, R01 DE020194, R01 AR039588]; Fondo de Finaciamiento de Centros de Investigacion en Areas Prioritarias [15090007]; Fondo Nacional de Ciencia y Tecnologia [FONDECYT 1130706]; Center for Regenerative Medicine at Mayo Clinic	This work was supported, in whole or in part, by National Institutes of Health grants F32 AR066508 (AD), R01 AR049069 (AJvW), R01 AR068103 (JJW), R01 DE020194 (JJW), and R01 AR039588 (GSS), as well as by grants from Fondo de Finaciamiento de Centros de Investigacion en Areas Prioritarias (15090007; to MM) and Fondo Nacional de Ciencia y Tecnologia (FONDECYT 1130706; to MM). Additional support was provided by intramural grants from the Center for Regenerative Medicine at Mayo Clinic. We also appreciate the generous philanthropic support of William H. and Karen J. Eby.	Bajpe PK, 2015, ONCOGENE, V34, P531, DOI 10.1038/onc.2013.588; Barutcu AR, 2014, NUCLEIC ACIDS RES, V42, P10360, DOI 10.1093/nar/gku712; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Boluk A, 2004, PHARMACOL RES, V50, P93, DOI 10.1016/j.phrs.2003.11.011; Bradley EW, 2015, PHYSIOL REV, V95, P1359, DOI 10.1152/physrev.00004.2015; Camilleri ET, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0370-8; Cellot S, 2013, BLOOD, V122, P1545, DOI 10.1182/blood-2013-04-496281; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Cori F., 2001, J BIOL CHEM, V276, P46515; Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Di Bernardo G, 2009, STEM CELLS DEV, V18, P573, DOI 10.1089/scd.2008.0172; Dudakovic A., 2015, J BIOL CHEM; Dudakovic A, 2016, J BIOL CHEM, V291, P24594, DOI 10.1074/jbc.M116.740571; Dudakovic A, 2015, J CELL PHYSIOL, V230, P52, DOI 10.1002/jcp.24680; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Elliott JO, 2007, SEIZURE-EUR J EPILEP, V16, P22, DOI 10.1016/j.seizure.2006.10.001; Farzaneh K., 2016, J CELL BIOCH; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474                                                              ; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Hu XQ, 2013, STEM CELLS DEV, V22, P248, DOI 10.1089/scd.2012.0105; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Hui TQ, 2014, J ENDODONT, V40, P1132, DOI 10.1016/j.joen.2014.01.031; IWAMI K, 1993, INT J BIOCHEM, V25, P1631, DOI 10.1016/0020-711X(93)90522-G                                                    ; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jing H., 2015, MOL THER; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee JY, 2006, MOL CELLS, V22, P182; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Liu LH, 2012, BIOINFORMATICS, V28, P2205, DOI 10.1093/bioinformatics/bts340; Mader EK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-20; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Pike J. W., 2015, BONE; Pratap J, 2010, MOL CANCER THER, V9, P3210, DOI 10.1158/1535-7163.MCT-10-0572; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Riester S. M., 2016, STEM CELLS TRANSLATI; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Senn SM, 2010, EPILEPSIA, V51, P984, DOI 10.1111/j.1528-1167.2009.02516.x; Shen J, 2003, MOL ENDOCRINOL, V17, P743, DOI 10.1210/me.2002-0122; Shen JL, 2002, J BIOL CHEM, V277, P20284, DOI 10.1074/jbc.M112440200; SHETH RD, 1995, J PEDIATR-US, V127, P256, DOI 10.1016/S0022-3476(95)70304-7; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; St John HC, 2014, MOL ENDOCRINOL, V28, P1150, DOI 10.1210/me.2014-1091; Tai PWL, 2014, GENE, V550, P1, DOI 10.1016/j.gene.2014.05.044; Thaler R., 2016, J BIOL CHEM; Varela N, 2016, J CELL PHYSIOL, V231, P1001, DOI 10.1002/jcp.25188; Vestergaard P, 2004, EPILEPSIA, V45, P1330, DOI 10.1111/j.0013-9580.2004.18804.x                                                ; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640                                                         ; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	68	0	0	3	22	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	APR 20	2017	609						28	37		10.1016/j.gene.2017.01.019				10	Genetics & Heredity	Genetics & Heredity	EM9CS	WOS:000395609400004	28132772				2018-01-05	
J	Dubin, AE; Murthy, S; Lewis, AH; Brosse, L; Cahalan, SM; Grandl, J; Coste, B; Patapoutian, A				Dubin, Adrienne E.; Murthy, Swetha; Lewis, Amanda H.; Brosse, Lucie; Cahalan, Stuart M.; Grandl, Jorg; Coste, Bertrand; Patapoutian, Ardem			Endogenous Piezo1 Can Confound Mechanically Activated Channel Identification and Characterization	NEURON			English	Article							MECHANOSENSITIVE CURRENTS; CELLS	A gold standard for characterizing mechanically activated (MA) currents is via heterologous expression of candidate channels in naive cells. Two recent studies described MA channels using this paradigm. TMEM150c was proposed to be a component of an MA channel partly based on a heterologous expression approach (Hong et al., 2016). In another study, Piezo1's N-terminal "propeller" domain was proposed to constitute an intrinsic mechanosensitive module based on expression of a chimera between a pore-forming domain of the mechanically insensitive ASIC1 channel and Piezo1 (Zhao et al., 2016). When we attempted to replicate these results, we found each construct conferred modest MA currents in a small fraction of naive HEK cells similar to the published work. Strikingly, these MA currents were not detected in cells in which endogenous Piezo1 was CRISPR/Cas9 inactivated. These results highlight the importance of choosing cells lacking endogenous MA channels to assay the mechanotransduction properties of various proteins. This Matters Arising paper is in response to Hong et al. (2016) and Zhao et al. (2016) in Neuron. See also the response papers by Hong et al. (2017) and Zhao et al. (2017) published concurrently with this Matters Arising.	[Dubin, Adrienne E.; Murthy, Swetha; Cahalan, Stuart M.; Patapoutian, Ardem] Scripps Res Inst, Howard Hughes Med Inst, Dept Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Lewis, Amanda H.; Grandl, Jorg] Duke Univ, Dept Neurobiol, Sch Med, 311 Res Dr,Box 3209, Durham, NC 27710 USA; [Brosse, Lucie; Coste, Bertrand] Aix Marseille Univ, CNRS, CRN2M, Marseille, France; [Cahalan, Stuart M.] Vertex Pharmaceut Inc, 11010 Torreyana Rd, San Diego, CA 92121 USA	Patapoutian, A (reprint author), Scripps Res Inst, Howard Hughes Med Inst, Dept Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	ardem@scripps.edu			National Institutes of Health [R01NS083174, R21DE025329, F32NS094088]; European Research Council/ERC [678610]	We thank Maria Florendo and Tess Whitwam for help with preparing and verifying cDNA constructs, and Dr. Kara Marshall for her careful reading of the manuscript and valuable comments. We are grateful to Drs. Bailong Xiao and Uhtaek Oh for providing the mP1-mASIC1-mRuby (C-terminal fusion) and TMEM150c-ires-AcGFP constructs, respectively. Correspondence and requests for materials should be addressed to A.P. (ardem@scripps.edu). This work was supported by grants from the National Institutes of Health grant R01NS083174 awarded to A.P., R21DE025329 awarded to A.E.D., F32NS094088 awarded to A.L, and funding from the European Research Council/ERC Grant Agreement n. 678610 to L.B. and B.C. A.P. is an investigator of the Howard Hughes Medical Institute.	Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Ge JP, 2015, NATURE, V527, P64, DOI 10.1038/nature15247; Grunder S., 2010, INT J PHYSL PATH PHA, V2, P73; Hong GS, 2017, NEURON, V94, P271, DOI 10.1016/j.neuron.2017.03.038; Hong GS, 2016, NEURON, V91, P107, DOI 10.1016/j.neuron.2016.05.029; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; Lukacs V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9329; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Peyronnet R, 2013, EMBO REP, V14, P1143, DOI 10.1038/embor.2013.170; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Servin-Vences MR, 2017, ELIFE, V6, DOI 10.7554/eLife.21074; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zhao QC, 2017, NEURON, V94, P274, DOI 10.1016/j.neuron.2017.03.040; Zhao QC, 2016, NEURON, V89, P1248, DOI 10.1016/j.neuron.2016.01.046	17	9	9	8	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2017	94	2					266	+		10.1016/j.neuron.2017.03.039				7	Neurosciences	Neurosciences & Neurology	ES3TF	WOS:000399451400009	28426961				2018-01-05	
J	Hong, GS; Lee, B; Oh, U				Hong, Gyu-Sang; Lee, Byeongjun; Oh, Uhtaek			Evidence for Mechanosensitive Channel Activity of Tentonin 3/TMEM150C	NEURON			English	Article							PIEZO2; MECHANOTRANSDUCTION; MECHANISMS	Mechanosensation is essential for various physiological processes, and it is mediated by mechanotransduction channels. Recently, we reported that TMEM150C/Tentonin 3 (TTN3) confers mechanically activated currents with slow inactivation kinetics in several cell types, including dorsal root ganglion neurons (Hong et al., 2016). The accompanying Matters Arising by Dubin, Murthy, and colleagues confirms that naive heterologous cells demonstrate a mechanically activated current, but finds that this response is absent in CRISPR-Cas9 Piezo1 knockout cell lines and suggests that TTN3 is a modulator of Piezo1. We present and discuss evidence based on co-expression of TTN3 and Peizo1 and mutant variants of the pore region of TTN3 to support that TTN3 is a pore-forming unit, not an amplifying adaptor for Piezo1 activity. This Matters Arising Response paper, along with Zhao et al. (2017), addresses the Matters Arising from Dubin et al. (2017), published concurrently in this issue of Neuron.	[Hong, Gyu-Sang; Lee, Byeongjun; Oh, Uhtaek] Korea Inst Sci & Technol, Brain Sci Inst, Sensory Res Ctr, CRI, Seoul 02792, South Korea; [Oh, Uhtaek] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea	Oh, U (reprint author), Korea Inst Sci & Technol, Brain Sci Inst, Sensory Res Ctr, CRI, Seoul 02792, South Korea.; Oh, U (reprint author), Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea.	utoh@kist.re.kr			National Research Foundation of Korea; Ministry of Science, ICT, and Future Planning [2011-0018358]	We thank Prof. John N. Wood, FRS, University College London for the generous gift of hPiezo1 cDNA and its validation. This study was supported by the National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning (2011-0018358).	Arreola J, 2003, J PHYSIOL-LONDON, V547, P197, DOI 10.1113/jphysiol.2002.028373; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Dubin AE, 2017, NEURON, V94, P266, DOI 10.1016/j.neuron.2017.03.039; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; Ghil SH, 2000, J NEUROCHEM, V74, P151, DOI 10.1046/j.1471-4159.2000.0740151.x                                              ; Hong GS, 2016, NEURON, V91, P708, DOI 10.1016/j.neuron.2016.07.019; Jin Y, 2015, ANGLE ORTHOD, V85, P87, DOI 10.2319/123113-955.1; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Zhao QC, 2017, NEURON, V94, P274, DOI 10.1016/j.neuron.2017.03.040	14	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2017	94	2					271	+		10.1016/j.neuron.2017.03.038				5	Neurosciences	Neurosciences & Neurology	ES3TF	WOS:000399451400010	28426962				2018-01-05	
J	Li, M; Au, LYC; Douglah, D; Chong, A; White, BJ; Ferree, PM; Akbari, OS				Li, Ming; Au, Lauren Yun Cook; Douglah, Deema; Chong, Abigail; White, Bradley J.; Ferree, Patrick M.; Akbari, Omar S.			Generation of heritable germline mutations in the jewel wasp Nasonia vitripennis using CRISPR/Cas9	SCIENTIFIC REPORTS			English	Article							MELANOGASTER-CINNABAR GENE; SELFISH B-CHROMOSOME; PATERNAL SEX-RATIO; DROSOPHILA-MELANOGASTER; AEDES-AEGYPTI; GENOME; MUTAGENESIS; INSIGHTS; CRISPR-CAS9; EMBRYO	The revolutionary RNA-guided endonuclease CRISPR/Cas9 system has proven to be a powerful tool for gene editing in a plethora of organisms. Here, utilizing this system we developed an efficient protocol for the generation of heritable germline mutations in the parasitoid jewel wasp, Nasonia vitripennis, a rising insect model organism for the study of evolution, development of axis pattern formation, venom production, haplo-diploid sex determination, and host-symbiont interactions. To establish CRISPRdirected gene editing in N. vitripennis, we targeted a conserved eye pigmentation gene cinnabar, generating several independent heritable germline mutations in this gene. Briefly, to generate these mutants, we developed a protocol to efficiently collect N. vitripennis eggs from a parasitized flesh fly pupa, Sarcophaga bullata, inject these eggs with Cas9/guide RNA mixtures, and transfer injected eggs back into the host to continue development. We also describe a flow for screening mutants and establishing stable mutant strains through genetic crosses. Overall, our results demonstrate that the CRISPR/Cas9 system is a powerful tool for genome manipulation in N. vitripennis, with strong potential for expansion to target critical genes, thus allowing for the investigation of several important biological phenomena in this organism.	[Li, Ming; Chong, Abigail; White, Bradley J.; Akbari, Omar S.] Univ Calif Riverside, Inst Integrat Genome Biol, Dept Entomol, Riverside, CA 92521 USA; [Li, Ming; Chong, Abigail; White, Bradley J.; Akbari, Omar S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside Ctr Dis Vector Res, Riverside, CA 92521 USA; [Au, Lauren Yun Cook; Douglah, Deema; Ferree, Patrick M.] Pitzer & Scripps Coll, WM Keck Sci Dept, 925 Mills Ave, Claremont, CA 91711 USA	Akbari, OS (reprint author), Univ Calif Riverside, Inst Integrat Genome Biol, Dept Entomol, Riverside, CA 92521 USA.; Akbari, OS (reprint author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside Ctr Dis Vector Res, Riverside, CA 92521 USA.; Ferree, PM (reprint author), Pitzer & Scripps Coll, WM Keck Sci Dept, 925 Mills Ave, Claremont, CA 91711 USA.	pferree@kecksci.claremont.edu; omar.akbari@ucr.edu		Akbari, Omar/0000-0002-6853-9884	generous University of California, Riverside (UCR) laboratory start-up funds; USDA National Institute of Food and Agriculture (NIFA) Hatch project [1009509]; NSF CAREER award [NSF1451839]	This work was supported by generous University of California, Riverside (UCR) laboratory start-up funds to O.S.A., and a USDA National Institute of Food and Agriculture (NIFA) Hatch project (1009509) to O.S.A., and an NSF CAREER award (NSF1451839) to P.M.F.	Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1597, DOI 10.1534/g3.113.007583; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Beukeboom L, 2003, CURR BIOL, V13, pR860, DOI 10.1016/j.cub.2003.10.042                                                       ; Beukeboom LW, 2010, J GENET, V89, P333, DOI 10.1007/s12041-010-0045-7; Bi HL, 2016, INSECT SCI, V23, P469, DOI 10.1111/1744-7917.12341; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Cornel AJ, 1997, INSECT BIOCHEM MOLEC, V27, P993, DOI 10.1016/S0965-1748(97)00084-2; Danneels EL, 2010, TOXINS, V2, P494, DOI 10.3390/toxins2040494; Davis RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-109; de Graaf DC, 2010, INSECT MOL BIOL, V19, P11, DOI 10.1111/j.1365-2583.2009.00914.x; Desjardins CA, 2013, G3-GENES GENOM GENET, V3, P205, DOI 10.1534/g3.112.004739; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ferree PM, 2008, CURR BIOL, V18, P1409, DOI 10.1016/j.cub.2008.07.093; Ferree PM, 2015, G3-GENES GENOM GENET, V5, P2647, DOI 10.1534/g3.115.021386; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402                                                          ; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Kohno H, 2016, ZOOL SCI, V33, P505, DOI 10.2108/zs160043; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Lynch JA, 2006, DEV GENES EVOL, V216, P493, DOI 10.1007/s00427-006-0076-5; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot2006.70; Lynch JA, 2015, GENETICS, V199, P897, DOI 10.1534/genetics.112.147512; NUR U, 1988, SCIENCE, V240, P512, DOI 10.1126/science.3358129                                                         ; Ozuak O, 2014, CURR BIOL, V24, P2393, DOI 10.1016/j.cub.2014.08.035; PATON DR, 1978, BIOCHEM GENET, V16, P855, DOI 10.1007/BF00483738; Pultz MA, 2005, DEVELOPMENT, V132, P3705, DOI 10.1242/dev.01939; Rosenberg MI, 2014, ELIFE, V3, DOI 10.7554/eLife.01440; Sackton TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083984; Sethuraman N, 2005, J MED ENTOMOL, V42, P716, DOI 10.1603/0022-2585(2005)042[0716:TDMCGI]2.0.CO;2; Shuker David, 2003, Bioessays, V25, P1247, DOI 10.1002/bies.10367; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Werren JH, 2003, GENETICA, V117, P85, DOI 10.1023/A:1022368700752; Werren J. H., 2009, COLD SPRING HARB PRO, V2009; Werren J. H., 2009, COLD SPRING HARB PRO; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; WHITING AR, 1967, Q REV BIOL, V42, P333, DOI 10.1086/405402; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Zwier MV, 2012, INSECT MOL BIOL, V21, P129, DOI 10.1111/j.1365-2583.2011.01121.x	43	2	2	12	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 19	2017	7								901	10.1038/s41598-017-00990-3				7	Multidisciplinary Sciences	Science & Technology - Other Topics	ES4UC	WOS:000399529600001	28424460	gold			2018-01-05	
J	Estoppey, D; Lee, CM; Janoschke, M; Lee, BH; Wan, KF; Dong, HP; Mathys, P; Filipuzzi, I; Schuhmann, T; Riedl, R; Aust, T; Galuba, O; McAllister, G; Russ, C; Spiess, M; Bouwmeester, T; Bonamy, GMC; Hoepfner, D				Estoppey, David; Lee, Chia Min; Janoschke, Marco; Lee, Boon Heng; Wan, Kah Fei; Dong, Hongping; Mathys, Philippe; Filipuzzi, Ireos; Schuhmann, Tim; Riedl, Ralph; Aust, Thomas; Galuba, Olaf; McAllister, Gregory; Russ, Carsten; Spiess, Martin; Bouwmeester, Tewis; Bonamy, Ghislain M. C.; Hoepfner, Dominic			The Natural Product Cavinafungin Selectively Interferes with Zika and Dengue Virus Replication by Inhibition of the Host Signal Peptidase	CELL REPORTS			English	Article							ENDOPLASMIC-RETICULUM; VASOPRESSIN PRECURSOR; IDENTIFICATION; PROTEINS; GENE; DISSECTION; MECHANISM; MUTANTS; SCREENS; TISSUES	Flavivirus infections by Zika and dengue virus impose a significant global healthcare threat with no US Food and Drug Administration (FDA)-approved vaccination or specific antiviral treatment available. Here, we present the discovery of an anti-flaviviral natural product named cavinafungin. Cavinafungin is a potent and selectively active compound against Zika and all four dengue virus serotypes. Unbiased, genomewide genomic profiling in human cells using a novel CRISPR/Cas9 protocol identified the endoplasmicreticulum- localized signal peptidase as the efficacy target of cavinafungin. Orthogonal profiling in S. cerevisiae followed by the selection of resistant mutants pinpointed the catalytic subunit of the signal peptidase SEC11 as the evolutionary conserved target. Biochemical analysis confirmed a rapid block of signal sequence cleavage of both host and viral proteins by cavinafungin. This study provides an effective compound against the eukaryotic signal peptidase and independent confirmation of the recently identified critical role of the signal peptidase in the replicative cycle of flaviviruses.	[Estoppey, David; Mathys, Philippe; Filipuzzi, Ireos; Schuhmann, Tim; Riedl, Ralph; Aust, Thomas; Galuba, Olaf; Bouwmeester, Tewis; Hoepfner, Dominic] Novartis Pharma AG, Novartis Inst BioMed Res, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland; [Lee, Chia Min; Lee, Boon Heng; Wan, Kah Fei; Dong, Hongping; Bonamy, Ghislain M. C.] Novartis Inst Trop Dis, 10 Biopolis Rd,Chromos 05-01, Singapore 138670, Singapore; [Janoschke, Marco; Spiess, Martin; Hoepfner, Dominic] Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland; [McAllister, Gregory; Russ, Carsten] Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA	Hoepfner, D (reprint author), Novartis Pharma AG, Novartis Inst BioMed Res, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland.; Bonamy, GMC (reprint author), Novartis Inst Trop Dis, 10 Biopolis Rd,Chromos 05-01, Singapore 138670, Singapore.; Hoepfner, D (reprint author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	bonamgh1@gmail.com; dominic.hoepfner@novartis.com		Bonamy, Ghislain/0000-0002-2826-5225; Spiess, Martin/0000-0001-7139-0550			Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Craney A, 2015, BIOORG MED CHEM LETT, V25, P4761, DOI 10.1016/j.bmcl.2015.07.072; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Cui JQ, 2015, J BIOL CHEM, V290, P28131, DOI 10.1074/jbc.M115.692350; Estoppey D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42728; Fang H, 1997, J BIOL CHEM, V272, P13152, DOI 10.1074/jbc.272.20.13152                                                        ; Friberg MA, 2004, J BIOL CHEM, V279, P19441, DOI 10.1074/jbc.M310249200; Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791                                                                    ; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Huang Z, 2013, CELL REP, V3, P577, DOI 10.1016/j.celrep.2013.01.019; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3                                                   ; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Jones DC, 2010, BIOCHEM PHARMACOL, V80, P1478, DOI 10.1016/j.bcp.2010.07.038; Junne T, 2015, J CELL SCI, V128, P1217, DOI 10.1242/jcs.165746; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159                                                        ; Mullins C, 1996, J BIOL CHEM, V271, P29094, DOI 10.1074/jbc.271.46.29094                                                        ; Ortiz-Lopez FJ, 2015, J NAT PROD, V78, P468, DOI 10.1021/np500854j; Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004; SHELNESS GS, 1993, J BIOL CHEM, V268, P5201; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635                                                              ; Xie XP, 2014, VIROLOGY, V450, P250, DOI 10.1016/j.virol.2013.12.025; Yang ZG, 2015, INT J MED SCI, V12, P256, DOI 10.7150/ijms.10735; Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106; Young PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099135; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625	42	3	3	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	APR 18	2017	19	3					451	460		10.1016/j.celrep.2017.03.071				10	Cell Biology	Cell Biology	EU6GS	WOS:000401133100002	28423309	gold			2018-01-05	
J	Peng, YQ; Tang, LS; Yoshida, S; Zhou, YD				Peng, Ying-Qian; Tang, Luo-Sheng; Yoshida, Shigeo; Zhou, Ye-Di			Applications of CRISPR/Cas9 in retinal degenerative diseases	INTERNATIONAL JOURNAL OF OPHTHALMOLOGY			English	Article						CRISPR/Cas9; gene therapy; genome editing; retinal degeneration; retinitis pigmentosa; leber congenital amaurosis	INDEPENDENT DNA-REPAIR; RETINITIS-PIGMENTOSA; GENE-THERAPY; ANIMAL-MODELS; CAS9 ENDONUCLEASE; KNOCKOUT PIGS; BREAK REPAIR; TARGET DNA; CELLS; MUTATIONS	Gene therapy is a potentially effective treatment for retinal degenerative diseases. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has been developed as a new genome-editing tool in ophthalmic studies. Recent advances in researches showed that CRISPR/Cas9 has been applied in generating animal models as well as gene therapy in vivo of retinitis pigmentosa (RP) and leber congenital amaurosis (LCA). It has also been shown as a potential attempt for clinic by combining with other technologies such as adeno-associated virus (AAV) and induced pluripotent stem cells (iPSCs). In this review, we highlight the main points of further prospect of using CRISPR/Cas9 in targeting retinal degeneration. We also emphasize the potential applications of this technique in treating retinal degenerative diseases.	[Peng, Ying-Qian; Tang, Luo-Sheng; Zhou, Ye-Di] Cent S Univ, Dept Ophthalmol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Yoshida, Shigeo] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka 8128582, Japan	Zhou, YD (reprint author), Cent S Univ, Dept Ophthalmol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.	zhouyedi@csu.edu.cn					Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Arno G, 2016, AM J HUM GENET, V99, P1305, DOI 10.1016/j.ajhg.2016.10.008; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Cereso N, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.11; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Da Costa R, 2016, INVEST OPHTH VIS SCI, V57, P5326, DOI 10.1167/iovs.16-19701; Dalkara D, 2016, HUM GENE THER, V27, P134, DOI 10.1089/hum.2015.147; Day TP, 2014, ADV EXP MED BIOL, V801, P687, DOI 10.1007/978-1-4614-3209-8_86; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Finotti Alessia, 2016, Stem Cell Investig, V3, P66; Gebler C, 2017, J NATL CANC I, V109; Hafler BP, 2016, SEMIN OPHTHALMOL, V31, P49, DOI 10.3109/08820538.2015.1114856; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hufnagel RB, 2012, GRAEF ARCH CLIN EXP, V250, P1117, DOI 10.1007/s00417-012-2028-2; Hung SSC, 2016, PROG RETIN EYE RES, V53, P1, DOI 10.1016/j.preteyeres.2016.05.001; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Janssen MJ, 2016, EUR J PHARMACOL, V790, P99, DOI 10.1016/j.ejphar.2016.07.037; Jinwei Z, 2015, YI CHUAN, V37, P1011; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kang JT, 2016, REPROD DOMEST ANIM, V51, P970, DOI 10.1111/rda.12775; Kawamura N, 2015, ONCOTARGET, V6, P22361, DOI 10.18632/oncotarget.4293; Kim J, 2016, ADV DRUG DELIV REV; Latella MC, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2016.92; Lee PC, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.98; Liang WC, 2017, J CELL BIOCHEM, V118, P530, DOI 10.1002/jcb.25722; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13350; Lopez-Obando M, 2016, G3 BETHESDA; Lyraki R, 2016, BIOCHEM SOC T, V44, P1235, DOI 10.1042/BST20160148; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Minkenberg B, 2017, PLANT J, V89, P636, DOI 10.1111/tpj.13399; Naert T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35264; Nafissi N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00355; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nowak JZ, 2014, ACTA POL PHARM, V71, P900; Parinot C, 2016, ADV EXP MED BIOL, V854, P259, DOI 10.1007/978-3-319-17121-0_35; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Petersen B, 2016, XENOTRANSPLANTATION, V23, P338, DOI 10.1111/xen.12258; Rakoczy EP, 2015, LANCET, V386, P2395, DOI 10.1016/S0140-6736(15)00345-1; Rivas MA, 2009, HISTOL HISTOPATHOL, V24, P1295, DOI 10.14670/HH-24.1295; Roy A, 2015, AM J PHYSIOL-RENAL, V308, pF366, DOI 10.1152/ajprenal.00612.2014; Saayman S, 2015, EXPERT OPIN BIOL TH, V15, P819, DOI 10.1517/14712598.2015.1036736; Savic N, 2016, TRANSL RES, V168, P15, DOI 10.1016/j.trsl.2015.09.008; Scholl HPN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2838; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sundaramurthy S, 2016, J HUM GENET, V61, P951, DOI 10.1038/jhg.2016.83; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tsubura A, 2010, HISTOL HISTOPATHOL, V25, P933, DOI 10.14670/HH-25.933; Tu ZC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0031-x; Veleri S, 2015, DIS MODEL MECH, V8, P109, DOI 10.1242/dmm.017913; Wang JJ, 2016, CANCER SCI, V107, P1888, DOI 10.1111/cas.13082; Wu WH, 2016, MOL THER, V24, P1388, DOI 10.1038/mt.2016.107; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Yang WL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00030; Yao SH, 2015, HUM GENE THER, V26, P463, DOI 10.1089/hum.2015.067; Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zheng A, 2015, EXPERT OPIN BIOL TH, V15, P391, DOI 10.1517/14712598.2015.1006192; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	67	0	0	15	19	IJO PRESS	XI AN	NO 269 YOUYI EAST RD, XI AN, 710054, PEOPLES R CHINA	2222-3959	2227-4898		INT J OPHTHALMOL-CHI	Int. J. Ophthalmol.	APR 18	2017	10	4					646	651		10.18240/ijo.2017.04.23				6	Ophthalmology	Ophthalmology	ES6BK	WOS:000399631100023	28503441	gold			2018-01-05	
J	Fu, Q; Li, SY; Wang, ZF; Shan, WY; Ma, JJ; Cheng, YQ; Wang, HG; Yan, YX; Sun, JH				Fu, Qiang; Li, Shiyu; Wang, Zhaofei; Shan, Wenya; Ma, Jingjiao; Cheng, Yuqiang; Wang, Hengan; Yan, Yaxian; Sun, Jianhe			H-NS Mutation-Mediated CRISPR-Cas Activation inhibits Phage Release and Toxin Production of Escherichia coli Stx2 Phage Lysogen	FRONTIERS IN MICROBIOLOGY			English	Article						Escherichia coli; H-NS; CRISPR-Cas; Stx2 phage; Shiga toxin	QUORUM SENSING CONTROLS; ADAPTIVE IMMUNITY; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; SHIGA TOXIN; IN-VITRO; SYSTEMS; VIRULENCE; DNA; BACTERIOPHAGE	Shiga toxin-converting bacteriophages (Stx phages) carry the stx gene and convert nonpathogenic bacterial strains into shiga toxin-producing bacteria. There is limited understanding of the effect that an Escherichia coli (E.coli) clustered regularly interspaced short palindromic repeats (CRISPR)-Cas adaptive immune system has on Stx phage lysogen. We investigated heat-stable nucleoid-structuring (H-NS) mutation-mediated CRISPR-Cas activation and its effect on E.coli Stx2 phage lysogen. The Delta hns mutant (MG1655 Delta hns) of the E.coli K-12 strain MG1655 was obtained. The Delta hns mutant lysogen that was generated after Stx phage lysogenic infection had a repressed growth status and showed subdued group behavior, including biofilm formation and swarming motility, in comparison to the wild-type strain. The de-repression effect of the H-NS mutation on CRISPR-Cas activity was then verified. The results showed that cas gene expression was upregulated and the transformation efficiency of the wild-type CRISPR plasmids was decreased, which may indicate activation of the CRISPR-Cas system. Furthermore, the function of CRISIPR-Cas on Stx2 phage lysogen was investigated by activating the CRISPR-Cas system, which contains an insertion of the protospacer regions of the Stx2 phage Min27. The phage release and toxin production of four lysogens harboring the engineered CRISPRs were investigated. Notably, in the supernatant of the Delta hns mutant lysogen harboring the Min27 spacer, both the progeny phage release and the toxin production were inhibited after mitomycin C induction. These observations demonstrate that the H-NS mutation-activated CRISPR-Cas system plays a role in modifying the effects of the Stx2 phage lysogen. Our findings indicated that H-NS mutation-mediated CRISPR-Cas activation in E.coli protects bacteria against Stx2 phage lysogeny by inhibiting the phage release and toxin production of the lysogen.	[Fu, Qiang; Li, Shiyu; Wang, Zhaofei; Shan, Wenya; Ma, Jingjiao; Cheng, Yuqiang; Wang, Hengan; Yan, Yaxian; Sun, Jianhe] Shanghai Jiao Tong Univ, Shanghai Key Lab Vet Biotechnol, Minist Agr, Key Lab Urban Agr South,Sch Agr & Biol, Shanghai, Peoples R China	Yan, YX; Sun, JH (reprint author), Shanghai Jiao Tong Univ, Shanghai Key Lab Vet Biotechnol, Minist Agr, Key Lab Urban Agr South,Sch Agr & Biol, Shanghai, Peoples R China.	yanyaxian@sjtu.edu.cn; sunjhe@sjtu.edu.cn			National Natural Science Foundation of China [31272580, 31372500, 31672524, 31571932]	We are indebted to Dr. Daxin Peng of Yangzhou University for providing the lambda recombination system. This research was supported by grants from the National Natural Science Foundation of China (31272580, 31372500, 31672524, 31571932).	Allison HE, 2003, INFECT IMMUN, V71, P3409, DOI 10.1128/IAI.71.6.3409-3418.2003; Barrangou R, 2015, CURR OPIN IMMUNOL, V32, P36, DOI 10.1016/j.coi.2014.12.008; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Brescia CC, 2004, J MOL BIOL, V339, P505, DOI 10.1016/j.jmb.2004.03.067; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorman CJ, 2014, PLASMID, V75, P1, DOI 10.1016/j.plasmid.2014.06.004; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Fu Q, 2017, RES MICROBIOL, V168, P147, DOI 10.1016/j.resmic.2016.10.002; Fu Qiang, 2015, Weishengwu Xuebao, V55, P251; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Heussler GE, 2015, MBIO, V6, DOI 10.1128/mBio.00129-15; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Hoyland-Kroghsbo NM, 2013, MBIO, V4, DOI 10.1128/mBio.00362-12; KLEANTHOUS H, 1990, ARCH DIS CHILD, V65, P722, DOI 10.1136/adc.65.7.722                                                            ; Kruger A, 2015, MICROBIOL-SGM, V161, P451, DOI 10.1099/mic.0.000003; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Majsec K, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0643-5; Medina-Aparicio L, 2011, J BACTERIOL, V193, P2396, DOI 10.1128/JB.01480-10; Pacheco AR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00081; Patterson AG, 2016, MOL CELL, V64, P1102, DOI 10.1016/j.molcel.2016.11.012; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Schembri MA, 2001, INFECT IMMUN, V69, P1322, DOI 10.1128/IAI.69.3.1322-1328.2001                                                 ; Sheng LN, 2016, APPL ENVIRON MICROB, V82, P6531, DOI 10.1128/AEM.01702-16; Skyberg JA, 2007, J APPL MICROBIOL, V102, P548, DOI 10.1111/j.1365-2672.2006.03076.x; Smith MJ, 2009, INFECT IMMUN, V77, P2730, DOI 10.1128/IAI.00005-09; Su L K, 2010, Mol Biol (Mosk), V44, P60; Toutain CM, 2005, J BACTERIOL, V187, P771, DOI 10.1128/JB.187.2.771-777.2005; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang SH, 2011, INFECT IMMUN, V79, P279, DOI 10.1128/IAI.00821-10; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Yin Shuang, 2013, Appl Environ Microbiol, V79, P5710, DOI 10.1128/AEM.00950-13; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	39	0	0	6	11	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	APR 18	2017	8								652	10.3389/fmicb.2017.00652				11	Microbiology	Microbiology	ES2RD	WOS:000399374700001	28458663	gold			2018-01-05	
J	Jin, C; Yuan, FL; Gu, YL; Li, X; Liu, MF; Shen, XM; Liu, B; Zhu, MQ				Jin, Cheng; Yuan, Feng-Lai; Gu, Yuan-Long; Li, Xia; Liu, Min-Feng; Shen, Xiao-Min; Liu, Bo; Zhu, Mao-Qun			Over-expression of ASIC1a promotes proliferation via activation of the beta-catenin/LEF-TCF axis and is associated with disease outcome in liver cancer	ONCOTARGET			English	Article						ASIC1a; beta-catenin; CRISPR/CAS9; liver cancer; proliferation	CELL-MIGRATION; GLIOMA-CELLS; ION CHANNELS; APOPTOSIS; PROTEIN; CONTRIBUTES; METASTASIS; PATHWAYS; SUBUNITS; INVASION	Acid-sensing ion channels 1a (ASIC1a) has been reported to promote migration and invasion in liver cancer. However, the clinical significance and molecular mechanism of ASIC1a in liver cancer remain unknown. In the study, we found that ASIC1a is frequently up-regulated in liver cancer tissues. The over-expression of ASIC1a is associated with advanced clinical stage and poor prognosis. The proproliferative of ASIC1a is pH dependent. Knockout of ASIC1a by CRISPR/CAS9 inhibited liver cancer cell proliferation and tumorigenicity in vitro and in vivo through beta-catenin degradation and LEF-TCF inactivation. Our results indicated a potential diagnostic marker and chemotherapeutic target for liver cancer.	[Jin, Cheng; Gu, Yuan-Long; Liu, Min-Feng; Shen, Xiao-Min; Liu, Bo; Zhu, Mao-Qun] Nantong Univ, Dept Hepatobiliary Pancreat Ctr, Hosp 3, Wuxi 214041, Jiangsu, Peoples R China; [Yuan, Feng-Lai; Li, Xia] Nantong Univ, Dept Res Inst, Hosp 3, Wuxi 214041, Jiangsu, Peoples R China	Jin, C (reprint author), Nantong Univ, Dept Hepatobiliary Pancreat Ctr, Hosp 3, Wuxi 214041, Jiangsu, Peoples R China.	jingcheng1008@163.com			National Natural Science Foundation of China [81301805]; scientific research project of Wuxi [YGZX1305, Z1503]	This study was supported by grants from the National Natural Science Foundation of China (No: 81301805) and the scientific research project of Wuxi (No: YGZX1305 and No: Z1503).	Berdiev BK, 2002, J BIOL CHEM, V277, P45734, DOI 10.1074/jbc.M208995200; Bondarava M, 2009, PFLUG ARCH EUR J PHY, V458, P675, DOI 10.1007/s00424-009-0649-z; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Chen W, 2015, CA CANC J CLIN; Chu XP, 2014, TRANSL STROKE RES, V5, P69, DOI 10.1007/s12975-013-0305-y; Farhana L, 2005, CANCER RES, V65, P4909, DOI 10.1158/0008-5472.CAN-04-4124; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gupta SC, 2015, ONCOGENE, DOI [10.1038/onc.2015.477, DOI 10.1038/0NC.2015.477]; Hashim AI, 2011, NMR BIOMED, V24, P582, DOI 10.1002/nbm.1644; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002                                                 ; Jin C, 2015, TUMOR BIOL, V36, P4309, DOI 10.1007/s13277-015-3070-6; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kapoor N, 2011, AM J PHYSIOL-CELL PH, V300, pC1246, DOI 10.1152/ajpcell.00199.2010; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; Kweon HJ, 2013, BMB REP, V46, P295, DOI 10.5483/BMBRep.2013.46.6.121; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Muhammad R, 2012, GASTROENTEROLOGY, V142, pS384; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449                                                           ; Peck-Radosavljevic M, 2014, LIVER CANCER, V3, P125, DOI 10.1159/000343868; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Shen K, 2012, BIOCHEM PHARMACOL, V84, P320, DOI 10.1016/j.bcp.2012.04.017; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Thrasivoulou C, 2013, J BIOL CHEM, V288, P35651, DOI 10.1074/jbc.M112.437913; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Weng XC, 2007, ACTA PHARMACOL SIN, V28, P1731, DOI 10.1111/j.1745-7254.2007.00708.x; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	35	2	2	0	0	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	APR 18	2017	8	16					25977	25988		10.18632/oncotarget.10774				12	Oncology; Cell Biology	Oncology; Cell Biology	ES8PQ	WOS:000399819700015	27462920	gold			2018-01-05	
J	Garcia-Tunon, I; Hernandez-Sanchez, M; Ordonez, JL; Alonso-Perez, V; Alamo-Quijada, M; Benito, R; Guerrero, C; Hernandez-Rivas, JM; Sanchez-Martin, M				Garcia-Tunon, Ignacio; Hernandez-Sanchez, Maria; Luis Ordonez, Jose; Alonso-Perez, Veronica; Alamo-Quijada, Miguel; Benito, Rocio; Guerrero, Carmen; Maria Hernandez-Rivas, Jesus; Sanchez-Martin, Manuel			The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia	ONCOTARGET			English	Article						CRISPR/Cas9; genome edition; BCR/ABL; leukemia	STEM-CELL CLONES; BCR-ABL; GENE-EXPRESSION; CHRONIC PHASE; CRISPR-CAS9; MUTATION; MOUSE; SPECIFICITY; TALEN; RESISTANCE	CRISPR/Cas9 technology was used to abrogate p210 oncoprotein expression in the Boff-p210 cell line, a pro-B line derived from interlukin-3-dependent Baf/3, that shows IL-3-independence arising from the constitutive expression of BCR-ABL p210. Using this approach, pools of Boff-p210-edited cells and single edited cell-derived clones were obtained and functionally studied in vitro. The loss of p210 expression in Boff-p210 cells resulted in the loss of ability to grow in the absence of IL-3, as the Baf/3 parental line, showing significantly increased apoptosis levels. Notably, in a single edited cell-derived clone carrying a frame-shift mutation that prevents p210 oncoprotein expression, the effects were even more drastic, resulting in cell death. These edited cells were injected subcutaneously in immunosuppressed mice and tumor growth was followed for three weeks. BCR/ABL-edited cells developed smaller tumors than those originating from unedited Boff-p210 parental cells. Interestingly, the single edited cell-derived clone was unable to develop tumors, similar to what is observed with the parental Baf/3 cell line. CRISPR/Cas9 genomic editing technology allows the ablation of the BCR/ABL fusion gene, causing an absence of oncoprotein expression, and blocking its tumorigenic effects in vitro and in the in vivo xenograft model of CML. The future application of this approach in in vivo models of CML will allow us to more accurately assess the value of CRISPR/Cas9 technology as a new therapeutic tool that overcomes resistance to the usual treatments for CML patients.	[Garcia-Tunon, Ignacio; Hernandez-Sanchez, Maria; Luis Ordonez, Jose; Alonso-Perez, Veronica; Alamo-Quijada, Miguel; Benito, Rocio; Maria Hernandez-Rivas, Jesus] USAL CSIC, Ctr Invest Canc IBMCC, Unidad Diagnost Mol & Celular Canc, Salamanca, Spain; [Guerrero, Carmen; Maria Hernandez-Rivas, Jesus; Sanchez-Martin, Manuel] Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain; [Maria Hernandez-Rivas, Jesus] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain; [Sanchez-Martin, Manuel] Univ Salamanca, Nucleus, Serv Transgenesis, Salamanca, Spain; [Guerrero, Carmen] Inst Biol Mol & Celular Canc USAL CSIC, Salamanca, Spain; [Sanchez-Martin, Manuel] Univ Salamanca, Dept Med, Salamanca, Spain	Hernandez-Rivas, JM (reprint author), USAL CSIC, Ctr Invest Canc IBMCC, Unidad Diagnost Mol & Celular Canc, Salamanca, Spain.; Hernandez-Rivas, JM; Sanchez-Martin, M (reprint author), Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain.; Hernandez-Rivas, JM (reprint author), Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain.; Sanchez-Martin, M (reprint author), Univ Salamanca, Nucleus, Serv Transgenesis, Salamanca, Spain.; Sanchez-Martin, M (reprint author), Univ Salamanca, Dept Med, Salamanca, Spain.	jmhr@usal.es; adolsan@usal.es	Ordonez, Jose Luis/B-6069-2017; Benito, Rocio/B-4271-2017; Guerrero, Carmen/F-1776-2010	Ordonez, Jose Luis/0000-0002-3791-4215; Benito, Rocio/0000-0001-9781-4198; Guerrero, Carmen/0000-0002-8747-6831	Consejeria de Educacion, Junta de Castilla y Leon, Fondos FEDER [SA085U16, JCYL-EDU/346/2013]; ISCIII-FEDER Spanish Cancer Network [RD12/0036/0069]; Fondo de Investigaciones Sanitarias (FIS) of the Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) "Una manera de hacer Europa" [PI15/01471]	This work was supported in part by a grant from the Consejeria de Educacion, Junta de Castilla y Leon, Fondos FEDER (SA085U16 to JMHR and JCYL-EDU/346/2013 PhD scholarship to MHS), the ISCIII-FEDER Spanish Cancer Network (RD12/0036/0069) and the Fondo de Investigaciones Sanitarias (FIS) of the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (ERDF) "Una manera de hacer Europa" (grant PI15/01471).	BEDI A, 1994, BLOOD, V83, P2038; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bhamidipati PK, 2013, THER ADV HEMATOL, V4, P103, DOI 10.1177/2040620712468289; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312                                                         ; Deininger MWN, 2000, BLOOD, V96, P3343; Deutsch E, 2001, BLOOD, V97, P2084, DOI 10.1182/blood.V97.7.2084                                                        ; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306                                                     ; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2013, NUCLEIC ACIDS RES, V41, P3937, DOI 10.1093/nar/gkt071; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Gutierrez-Berzal J, 2006, EXP CELL RES, V312, P938, DOI 10.1016/j.yexcr.2005.12.007; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hughes TP, 2015, LEUKEMIA, V29, P1832, DOI 10.1038/leu.2015.168; Jabbour E, 2013, CL LYMPH MYELOM LEUK, V13, P646, DOI 10.1016/j.clml.2013.05.012; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Koptyra M, 2008, LEUKEMIA, V22, P1969, DOI 10.1038/leu.2008.78; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Ordonez JL, 2015, ONCOTARGET, V6, P18875, DOI 10.18632/oncotarget.4303; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Melo JV, 2004, HEMATOL ONCOL CLIN N, V18, P545, DOI 10.1016/j.hoc.2004.03.008; Melo JV, 1996, BLOOD, V88, P2375; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nemudryi AA, 2014, ACTA NATURAE, V6, P19; Niu JW, 2014, MOL BIOTECHNOL, V56, P681, DOI 10.1007/s12033-014-9771-z; NOWELL P C, 1962, Blut, V8, P65; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PALACIOS R, 1984, NATURE, V309, P126, DOI 10.1038/309126a0; Perez-Caro M, 2007, ONCOGENE, V26, P1702, DOI 10.1038/sj.onc.1209968; Radich J, 2010, SEMIN HEMATOL, V47, P354, DOI 10.1053/j.seminhematol.2010.06.008; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SanchezGarcia I, 1997, J MOL BIOL, V267, P225, DOI 10.1006/jmbi.1996.0779; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schultze N, 1996, NAT BIOTECHNOL, V14, P499, DOI 10.1038/nbt0496-499; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Valletta S, 2015, ONCOTARGET, V6, P44061, DOI 10.18632/oncotarget.6392; Vanden Bempt M, 2016, LEUKEMIA, V30, P1913, DOI 10.1038/leu.2016.62; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Yee JK, 2016, FEBS J, V283, P3239, DOI 10.1111/febs.13760; Zhang H, 2016, BRIT J HAEMATOL, V175, P208, DOI 10.1111/bjh.14297	58	0	0	3	5	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	APR 18	2017	8	16					26027	26040		10.18632/oncotarget.15215				14	Oncology; Cell Biology	Oncology; Cell Biology	ES8PQ	WOS:000399819700019	28212528	gold			2018-01-05	
J	Li, YY; Li, SY; Chen, MY; Peng, GX; Tan, ZY; An, QL				Li, Yuanyuan; Li, Shuying; Chen, Mingyue; Peng, Guixiang; Tan, Zhiyuan; An, Qianli			Complete genome sequence of Kosakonia oryzae type strain Ola 51(T)	STANDARDS IN GENOMIC SCIENCES			English	Article						Endophyte; Kosakonia; Nitrogen fixation; Plant growth-promoting bacteria	SP NOV.; FAMILY ENTEROBACTERIACEAE; COMB. NOV; RADICINCITANS; GROWTH; PLANT; ENDOPHYTE; ARACHIDIS; BACTERIA; PROPOSAL	Strain Ola 51(T) (=LMG 24251(T) = CGMCC 1.7012(T)) is the type strain of the species Kosakonia oryzae and was isolated from surface-sterilized roots of the wild rice species Oryza latifolia grown in Guangdong, China. Here we summarize the features of the strain Ola 51T and describe its complete genome sequence. The genome contains one circular chromosome of 5,303,342 nucleotides with 54.01% GC content, 4773 protein-coding genes, 16 rRNA genes, 76 tRNA genes, 13 ncRNA genes, 48 pseudo genes, and 1 CRISPR array.	[Li, Yuanyuan; Li, Shuying; Chen, Mingyue; An, Qianli] Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Peng, Guixiang] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou 510642, Guangdong, Peoples R China; [Tan, Zhiyuan] South China Agr Univ, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China	An, QL (reprint author), Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou, Zhejiang, Peoples R China.; Tan, ZY (reprint author), South China Agr Univ, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China.	zytan@scau.edu.cn; an@zju.edu.cn		An, Qianli/0000-0001-6641-8977	National Natural Science Foundation of China [31171504, 31370052, 31471449]; Zhejiang Provincial Natural Science Foundation of China [LY14C010002]; Science and Technology Planning Project of Guangdong Province [2014A030313459, 2014A050503058]; State Key Laboratory of Rice Biology, China	This work was supported by the National Natural Science Foundation of China (31171504, 31370052 and 31471449), Zhejiang Provincial Natural Science Foundation of China (LY14C010002), Science and Technology Planning Project of Guangdong Province (2014A030313459 and 2014A050503058), and the State Key Laboratory of Rice Biology, China.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berger B, 2015, AGRON SUSTAIN DEV, V35, P1521, DOI 10.1007/s13593-015-0324-z; Bergottini VM, 2015, BIOL FERT SOILS, V51, P749, DOI 10.1007/s00374-015-1012-5; Bergottini VM, 2015, GENOME ANNOUNC, V3; Brady C, 2013, SYST APPL MICROBIOL, V36, P309, DOI 10.1016/j.syapm.2013.03.005; Chen MY, 2014, STAND GENOMIC SCI, V9, DOI 10.4056/sigs.5779977; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Garrity GM, 2005, BERGEYS MANUAL SYS B, V2, P1; Garrity GM, 2001, BERGEYS MANUAL SYSTE, V1, P155; Gu CT, 2014, INT J SYST EVOL MICR, V64, P2650, DOI 10.1099/ijs.0.064709-0; Hardoim PR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-164; Inoue K, 2000, CURR MICROBIOL, V41, P417, DOI 10.1007/s002840010160; Kampfer P, 2016, SYST APPL MICROBIOL, V39, P1, DOI 10.1016/j.syapm.2015.09.004; Kampfer P, 2005, SYST APPL MICROBIOL, V28, P213, DOI 10.1016/j.syapm.2004.12.007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Li CY, 2016, INT J SYST EVOL MICR; Lin L, 2012, MICROBES ENVIRON, V27, P391, DOI 10.1264/jsme2.ME11275; Madhaiyan M, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GENOMEA.00544-13; Madhaiyan M, 2010, INT J SYST EVOL MICR, V60, P1559, DOI 10.1099/ijs.0.013664-0; Meng X, 2015, GENOME ANNOUNC, V3, DOI DOI 10.1128/GENOMEA.00594-15; Oren A, 2015, INT J SYST EVOL MICR, V65, P3761, DOI 10.1099/ijsem.0.000663; Peng GX, 2009, INT J SYST EVOL MICR, V59, P1650, DOI 10.1099/ijs.0.65484-0; Rahn O., 1937, ZENTRALBL BAKTERIOL, V96, P273; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; SKERMAN VBD, 1980, INT J SYST BACTERIOL, V30, P225, DOI 10.1099/00207713-30-1-225                                                       ; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Suhaimi NSM, 2014, FEMS MICROBIOL LETT, V358, P11, DOI 10.1111/1574-6968.12537; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Witzel K, 2012, J BACTERIOL, V194, P5469, DOI 10.1128/JB.01193-12; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Zhu B, 2013, INT J SYST EVOL MICR, V63, P2577, DOI 10.1099/ijs.0.045500-0; [Anonymous], 2005, INT J SYST EVOL MICR, V55, P2235, DOI 10.1099/ijs.0.64108-0	38	0	0	2	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1944-3277			STAND GENOMIC SCI	Stand. Genomic Sci.	APR 17	2017	12								28	10.1186/s40793-017-0240-8				7	Genetics & Heredity; Microbiology	Genetics & Heredity; Microbiology	ES1JR	WOS:000399284400001	28428833	gold			2018-01-05	
J	Choi, S; Kim, H; Paek, E				Choi, Seunghyuk; Kim, Hyunwoo; Paek, Eunok			ACTG: novel peptide mapping onto gene models	BIOINFORMATICS			English	Article							RNA-SEQ; DATABASE	In many proteogenomic applications, mapping peptide sequences onto genome sequences can be very useful, because it allows us to understand origins of the gene products. Existing software tools either take the genomic position of a peptide start site as an input or assume that the peptide sequence exactly matches the coding sequence of a given gene model. In case of novel peptides resulting from genomic variations, especially structural variations such as alternative splicing, these existing tools cannot be directly applied unless users supply information about the variant, either its genomic position or its transcription model. Mapping potentially novel peptides to genome sequences, while allowing certain genomic variations, requires introducing novel gene models when aligning peptide sequences to gene structures. We have developed a new tool called ACTG (Amino aCids To Genome), which maps peptides to genome, assuming all possible single exon skipping, junction variation allowing three edit distances from the original splice sites, exon extension and frame shift. In addition, it can also consider SNVs (single nucleotide variations) during mapping phase if a user provides the VCF (variant call format) file as an input.	[Choi, Seunghyuk; Paek, Eunok] Hanyang Univ, Dept Comp Sci, Seoul, South Korea; [Kim, Hyunwoo] Korea Inst Sci & Technol Informat, Sci Data Technol Lab, Daejeon 34141, South Korea	Paek, E (reprint author), Hanyang Univ, Dept Comp Sci, Seoul, South Korea.	eunokpaek@hanyang.ac.kr			National Research Foundation of Korea [NRF-2012M3A9B9036676, NRF-2014R1A2A1A11054147, NRF-2012M3A9D1054452]; Brain Korea 21 Plus Project	This work was supported by the National Research Foundation of Korea [NRF-2012M3A9B9036676, NRF-2014R1A2A1A11054147, NRF-2012M3A9D1054452] and the Brain Korea 21 Plus Project.	Askenazi M, 2016, J PROTEOME RES, V15, P795, DOI 10.1021/acs.jproteome.5b00870; Gascoigne DK, 2012, BIOINFORMATICS, V28, P3042, DOI 10.1093/bioinformatics/bts582; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Park H, 2014, PROTEOMICS, V14, P2742, DOI 10.1002/pmic.201400225; Sheynkman GM, 2013, MOL CELL PROTEOMICS, V12, P2341, DOI 10.1074/mcp.O113.028142; Woo S, 2014, J PROTEOME RES, V13, P21, DOI 10.1021/pr400294c; Zhou WD, 2015, NAT METHODS, V12, P1002, DOI 10.1038/nmeth.3622	8	1	1	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	APR 15	2017	33	8					1218	1220		10.1093/bioinformatics/btw787				3	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	EU4FT	WOS:000400985900016	28031186				2018-01-05	
J	Bulstrode, H; Johnstone, E; Marques-Torrejon, MA; Ferguson, KM; Bressan, RB; Blin, C; Grant, V; Gogolok, S; Gangoso, E; Gagrica, S; Ender, C; Fotaki, V; Sproul, D; Bertone, P; Pollard, SM				Bulstrode, Harry; Johnstone, Ewan; Marques-Torrejon, Maria Angeles; Ferguson, Kirsty M.; Bressan, Raul Bardini; Blin, Carla; Grant, Vivien; Gogolok, Sabine; Gangoso, Ester; Gagrica, Sladjana; Ender, Christine; Fotaki, Vassiliki; Sproul, Duncan; Bertone, Paul; Pollard, Steven M.			Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators	GENES & DEVELOPMENT			English	Article						glioblastoma; cell cycle; epigenetics; dedifferentiation; neural stem cell; astrocyte	ADHERENT CULTURE; SELF-RENEWAL; DIFFERENTIATION; MOUSE; PROLIFERATION; INTEGRATION; PROGENITOR; SURVIVAL; CANCER; GLIOMA	Glioblastoma multiforme (GBM) is an aggressive brain tumor driven by cells with hallmarks of neural stem (NS) cells. GBM stem cells frequently express high levels of the transcription factors FOXG1 and SOX2. Here we show that increased expression of these factors restricts astrocyte differentiation and can trigger dedifferentiation to a proliferative NS cell state. Transcriptional targets include cell cycle and epigenetic regulators (e.g., Foxo3, Plk1, Mycn, Dnmt1, Dnmt3b, and Tet3). Foxo3 is a critical repressed downstream effector that is controlled via a conserved FOXG1/SOX2-bound cis-regulatory element. Foxo3 loss, combined with exposure to the DNA methylation inhibitor 5-azacytidine, enforces astrocyte dedifferentiation. DNA methylation profiling in differentiating astrocytes identifies changes at multiple polycomb targets, including the promoter of Foxo3. In patient-derived GBM stem cells, CRISPR/Cas9 deletion of FOXG1 does not impact proliferation in vitro; however, upon transplantation in vivo, FOXG1-null cells display increased astrocyte differentiation and up-regulate FOXO3. In contrast, SOX2 ablation attenuates proliferation, and mutant cells cannot be expanded in vitro. Thus, FOXG1 and SOX2 operate in complementary but distinct roles to fuel unconstrained self-renewal in GBM stem cells via transcriptional control of core cell cycle and epigenetic regulators.	[Bulstrode, Harry; Marques-Torrejon, Maria Angeles; Ferguson, Kirsty M.; Bressan, Raul Bardini; Blin, Carla; Grant, Vivien; Gogolok, Sabine; Gangoso, Ester; Pollard, Steven M.] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Bulstrode, Harry; Marques-Torrejon, Maria Angeles; Ferguson, Kirsty M.; Bressan, Raul Bardini; Blin, Carla; Grant, Vivien; Gogolok, Sabine; Gangoso, Ester; Pollard, Steven M.] Univ Edinburgh, Edinburgh Canc Res UK Canc Ctr, Edinburgh EH16 4UU, Midlothian, Scotland; [Johnstone, Ewan; Bertone, Paul] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge CB2 1QR, England; [Gagrica, Sladjana; Ender, Christine] UCL, Dept Canc Biol, UCL Canc Inst, London WC1E 6BT, England; [Fotaki, Vassiliki] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Sproul, Duncan] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Sproul, Duncan] Univ Edinburgh, Edinburgh Canc Res Ctr, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	Pollard, SM (reprint author), Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland.; Pollard, SM (reprint author), Univ Edinburgh, Edinburgh Canc Res UK Canc Ctr, Edinburgh EH16 4UU, Midlothian, Scotland.	steven.pollard@ed.ac.uk	Bertone, Paul/A-6600-2013	Bertone, Paul/0000-0001-5059-4829; Gangoso, Ester/0000-0003-4851-9680	Wellcome Trust Clinician Research Training Fellowship; Biotechnology and Biological Sciences Research Council; EMBO; Cancer Research UK [A19680]; Science Without Borders Program (CAPES, Brazil); Medical Research Council University	We thank Gillian Morrison and Keisuke Kaji for helpful comments on the manuscript. We thank Richard Clark at the Edinburgh Clinical Research Facility for conducting the RRBS and helpful discussion on its data analysis. We thank Huseyin Besir and the EMBL Protein Expression and Purification Facility (Heidelberg, Germany) as well as Alan Sawyer and the EMBL Monoclonal Antibody Facility (Monterotondo, Italy) for custom protein and antibody production. H.B. was supported by a Wellcome Trust Clinician Research Training Fellowship. E.J. was supported by the Biotechnology and Biological Sciences Research Council. M.A.M.-T. is supported by an EMBO training fellowship. K.F. is supported by a studentship from Cancer Research UK (A19680). R.B. is supported by a studentship from the Science Without Borders Program (CAPES, Brazil). D.S. is a Cancer Research UK Career Development Fellow (reference C47648/A20837), and work in his laboratory is also supported by a Medical Research Council University grant to the MRC Human Genetics Unit. S.M.P. is a Cancer Research UK Senior Research Fellow (A17368). H.B. and S.M.P. conceived the study. P.B., H.B., R.B., S. Gogolok, S. Gagrica, V.F., and D.S. provided the methodology. H.B., E.J, and D. S. performed the final analysis. H. B., E.J., M.A.M.-T., K.F., R. B., C.B., V.G., S. Gogolok, S. Gagrica, and C.E. performed the investigation. H. B. and S.M.P. wrote the original draft. H. B., E.J., and S.M.P. visualized the study. S.M.P. and P.B. supervised. H. B. and S.M.P. were the project administrators. H. B., P.B., and S.M.P. acquired the funding.	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6                                                   ; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bressan RB, 2017, DEVELOPMENT, V144, P635, DOI 10.1242/dev.140855; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Caren H, 2015, STEM CELL REP, V5, P829, DOI 10.1016/j.stemcr.2015.09.014; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Engstrom PG, 2012, GENOME MED, V4, DOI 10.1186/gm377; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201; Kishi M, 2000, DEVELOPMENT, V127, P791; Liu F, 2015, MOL CELL, V60, P307, DOI 10.1016/j.molcel.2015.09.002; Lodato MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003288; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Mateo JL, 2015, GENOME RES, V25, P41, DOI 10.1101/gr.173435.114; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mencarelli MA, 2010, J MED GENET, V47, P49, DOI 10.1136/jmg.2009.067884; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Pancrazi L, 2015, P NATL ACAD SCI USA, V112, P13910, DOI 10.1073/pnas.1515190112; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Singh SK, 2003, CANCER RES, V63, P5821; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Verginelli F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3956; Vezzali R, 2016, ONCOTARGET, V7, P37436, DOI 10.18632/oncotarget.9545; Webb AE, 2013, CELL REP, V4, P477, DOI 10.1016/j.celrep.2013.06.035; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7                                                    ; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002	42	1	1	1	2	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	APR 15	2017	31	8					757	773		10.1101/gad.293027.116				17	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	EU8TE	WOS:000401310600005	28465359	gold			2018-01-05	
J	Van Nostrand, EL; Gelboin-Burkhart, C; Wang, R; Pratt, GA; Blue, SM; Yeo, GW				Van Nostrand, Eric L.; Gelboin-Burkhart, Chelsea; Wang, Ruth; Pratt, Gabriel A.; Blue, Steven M.; Yeo, Gene W.			CRISPR/Cas9-mediated integration enables TAG-eCLIP of endogenously tagged RNA binding proteins	METHODS			English	Article						CLIP-seq; eCLIP; RNA binding protein; CRISPR/Cas9; Protein tagging	CLIP; PURIFICATION; PARTICLES; COMPLEXES; DISCOVERY; PEPTIDE; EPITOPE; SITES; SEQ	Identification of in vivo direct RNA targets for RNA binding proteins (RBPs) provides critical insight into their regulatory activities and mechanisms. Recently, we described a methodology for enhanced crosslinking and immunoprecipitation followed by high-throughput sequencing (eCLIP) using antibodies against endogenous RNA binding proteins. However, in many cases it is desirable to profile targets of an RNA binding protein for which an immunoprecipitation-grade antibody is lacking. Here we describe a scalable method for using CRISPR/Cas9-mediated homologous recombination to insert a peptide tag into the endogenous RNA binding protein locus. Further, we show that TAG-eCLIP performed using tag specific antibodies can yield the same robust binding profiles after proper control normalization as eCLIP with antibodies against endogenous proteins. Finally, we note that antibodies against commonly used tags can immunoprecipitate significant amounts of antibody-specific RNA, emphasizing the need for paired controls alongside each experiment for normalization. TAG-eCLIP enables eCLIP profiling of new native proteins where no suitable antibody exists, expanding the RBP-RNA interaction landscape. (C) 2016 Elsevier Inc. All rights reserved.	[Van Nostrand, Eric L.; Gelboin-Burkhart, Chelsea; Wang, Ruth; Pratt, Gabriel A.; Blue, Steven M.; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Van Nostrand, Eric L.; Gelboin-Burkhart, Chelsea; Wang, Ruth; Pratt, Gabriel A.; Blue, Steven M.; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Van Nostrand, Eric L.; Gelboin-Burkhart, Chelsea; Wang, Ruth; Pratt, Gabriel A.; Blue, Steven M.; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Pratt, Gabriel A.; Yeo, Gene W.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Yeo, Gene W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Yeo, Gene W.] ASTAR, Mol Engn Lab, Singapore, Singapore	Yeo, GW (reprint author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	geneyeo@ucsd.edu			National Institute of Health [HG004659, HG007005, NS075449]; National Science Foundation Graduate Research Fellowship	The authors would like to thank members of the Yeo lab for insightful discussions and critical reading of the manuscript, particularly S. Aigner. This work was supported by grants from the National Institute of Health [HG004659, HG007005 and NS075449 to G.W.Y.]. E.L.V.N. is a Merck Fellow of the Damon Runyon Cancer Research Foundation [DRG-2172-13]. G.A.P. is supported by the National Science Foundation Graduate Research Fellowship. G.W.Y. is an Alfred P. Sloan Research Fellow.	BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BARNETT SF, 1989, MOL CELL BIOL, V9, P492, DOI 10.1128/MCB.9.2.492                                                             ; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5                                                   ; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gerstberger S, 2014, ADV EXP MED BIOL, V825, P1, DOI 10.1007/978-1-4939-1221-6_1; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HANKE T, 1995, J VIROL METHODS, V53, P149, DOI 10.1016/0166-0934(95)00003-D                                                    ; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; MUNRO S, 1984, EMBO J, V3, P3087; Nussbacher JK, 2015, TRENDS NEUROSCI, V38, P226, DOI 10.1016/j.tins.2015.02.003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Savic D, 2015, GENOME RES, V25, P1581, DOI 10.1101/gr.193540.115; Sundararaman B, 2016, MOL CELL, V61, P903, DOI 10.1016/j.molcel.2016.02.012; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085                                                        ; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095                                                         ; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]	22	3	3	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	APR 15	2017	118						50	59		10.1016/j.ymeth.2016.12.007				10	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EU5DW	WOS:000401052800006	28003131				2018-01-05	
J	Zheng, X; Li, SY; Zhao, GP; Wang, J				Zheng, Xuan; Li, Shi-Yuan; Zhao, Guo-Ping; Wang, Jin			An efficient system for deletion of large DNA fragments in Escherichia coli via introduction of both Cas9 and the non-homologous end joining system from Mycobacterium smegmatis	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						CRISPR; NHEJ; Genome editing; Large fragment deletion; E. coli	BACILLUS-SUBTILIS; BACTERIAL GENOME; CRISPR-CAS; GENETIC MANIPULATIONS; REPAIR PATHWAYS; STRUCTURAL GENE; LAMBDA-RED; LIGASE-D; EXPRESSION; MECHANISM	Accompanied with the internal non-homologous end joining (NHEJ) system, Cas9 can be used to easily inactivate a gene or delete a fragment through introduction of DNA double-stranded breaks (DSBs) in eukaryotic cells. While in most prokaryotes (e.g. Escherichia coli), due to the lack of NHEJ, homologous recombination (HR) is required for repair of DSBs, which is less convenient. Here, a markerless system was developed for rapid gene inactivation or fragment deletion in E. coli via introduction of both Cas9 and a bacterial NHEJ system. Three bacterial NHEJ systems, i.e. Mycobacterium smegmatis (Msm), Mycobacterium tuberculosis (Mtb) and Bacillus subtilis (Bs), were tested in E. coli, and the MsmNHEJ system showed the best efficiency. With the employment of Cas9 and MsmNHEJ, we efficiently mutated lacZ gene, deleted gInALG operon and two large DNA fragments (67 kb and 123 kb) in E. coli, respectively. Moreover, the system was further designed to allow for continuous inactivation of genes or deletion of DNA fragments in E. coli. We envision this system can be extended to other bacteria, especially those with low HR efficiency. (C) 2017 Elsevier Inc. All rights reserved.	[Zheng, Xuan; Li, Shi-Yuan; Zhao, Guo-Ping; Wang, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Zheng, Xuan] Henan Univ, Sch Life Sci, Kaifeng 475004, Peoples R China; [Li, Shi-Yuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol & Li KaShing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Wang, J (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.	wangj01@hotmail.com			National Natural Science Foundation of China [31430004, 31421061]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19040200]	This work was supported by grants from the National Natural Science Foundation of China (31430004, 31421061) and the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB19040200).	Altenbuchner J, 2016, APPL ENVIRON MICROB, V82, P5421, DOI 10.1128/AEM.01453-16; Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Chayot R, 2010, P NATL ACAD SCI USA, V107, P2141, DOI 10.1073/pnas.0906355107; Choi KR, 2016, BIOTECHNOL ADV, V34, P1180, DOI 10.1016/j.biotechadv.2016.08.002; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Enyeart PJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.41; Fukiya S, 2004, FEMS MICROBIOL LETT, V234, P325, DOI 10.1016/j.femsle.2004.03.042; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; GAY P, 1983, J BACTERIOL, V153, P1424; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Hao HH, 2016, ANAL BIOCHEM, V509, P118, DOI 10.1016/j.ab.2016.07.008; Hirokawa Y, 2013, J BIOSCI BIOENG, V116, P52, DOI 10.1016/j.jbiosc.2013.01.010; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y., 2015, ICIC EL, V9, P81, DOI DOI 10.1128/AEM.04023-14; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Korycka-Machala M, 2006, FEMS MICROBIOL LETT, V258, P83, DOI 10.1111/j.1574-6968.2006.00199.x; Krishnakumar R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku509; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malyarchuk S, 2007, DNA REPAIR, V6, P1413, DOI 10.1016/j.dnarep.2007.04.004; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; REITZER LJ, 1986, CELL, V45, P785, DOI 10.1016/0092-8674(86)90553-2                                                    ; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Santos CNS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3503; Selle K, 2015, TRENDS MICROBIOL, V23, P225, DOI 10.1016/j.tim.2015.01.008; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Standage-Beier K, 2015, ACS SYNTH BIOL, V4, P1217, DOI 10.1021/acssynbio.5b00132; STEINMETZ M, 1983, MOL GEN GENET, V191, P138, DOI 10.1007/BF00330901                                                              ; Su TY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37895; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang FY, 2016, TRENDS CELL BIOL, V26, P875, DOI 10.1016/j.tcb.2016.08.004; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zheng Q., 2014, FEBS J, V57, P115	51	2	2	12	25	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	APR 15	2017	485	4					768	774		10.1016/j.bbrc.2017.02.129				7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EQ1NS	WOS:000397837400011	28257845				2018-01-05	
J	Liao, LQ; Song, M; Li, X; Tang, LL; Zhang, T; Zhang, LX; Pan, YH; Chouchane, L; Ma, XJ				Liao, Liqiu; Song, Mei; Li, Xin; Tang, Lili; Zhang, Tuo; Zhang, Lixing; Pan, Yihang; Chouchane, Lotfi; Ma, Xiaojing			E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer	CANCER RESEARCH			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR GENE; E-CADHERIN; HYPERPLASTIC-DISCS; CISPLATIN RESISTANCE; PROGNOSTIC INDICATOR; MOLECULAR-MECHANISMS; RECEPTOR EXPRESSION; ENDOMETRIAL CANCER; DISTANT METASTASES	Patients with triple-negative breast cancers (TNBC) are at high risk for recurrence and metastasis at an early time despite standard treatment, underscoring the need for novel therapeutic modalities. Here, we report for the first time a distinctive and profound role of the E3 ubiquitin ligase UBR5 in the growth and metastasis of TNBC. An analysis of primary TNBC specimen by whole-exon sequencing revealed strong gene amplifications of UBR5 associated with the disease. UBR5 overexpression in TNBC tissues was confirmed at mRNA and protein levels. CRISPR/Cas9-mediated deletion of ubr5 in an experimental murine mammary carcinoma model of TNBC dramatically abrogated tumor growth and metastasis in vivo, which could be reversed completely via reconstitution with wild-type UBR5 but not a catalytically inactive mutant. Loss of UBR5 caused an impairment in angiogenesis within the tumor, associated with increased apoptosis, necrosis, and growth arrest. Absence of UBR5 in the tumor triggered aberrant epithelial-to-mesenchymal transition, principally via abrogated expression of E-cadherin, which resulted in severely reduced tumor metastasis to secondary organs. Use of NOD/SCID mice revealed that tumor-derived UBR5 facilitated tumor growth in a manner completely dependent upon immune cells in the microenvironment, whereas it promoted metastasis in a tumor cell-autonomous fashion. Our findings unveil UBR5 as a novel and critical regulator of tumor growth, metastasis, and immune response and highlight the potential for UBR5 as an effective therapeutic target for the treatment of highly aggressive breast and ovarian cancers that fail conventional therapy. (C) 2017 AACR.	[Liao, Liqiu; Li, Xin; Tang, Lili; Ma, Xiaojing] Cent S Univ, Xiangya Hosp, Hunan Clin Meditech Res Ctr Breast Canc, Dept Breast Surg, Changsha, Hunan, Peoples R China; [Song, Mei; Zhang, Tuo; Ma, Xiaojing] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA; [Zhang, Lixing; Ma, Xiaojing] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Sheng Yushou Ctr Cell Biol & Immunol, State Key Lab Microbial Metab, Shanghai, Peoples R China; [Pan, Yihang] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Chouchane, Lotfi] Qatar Fdn, Weill Cornell Med Qatar, Lab Genet Med & Immunol, Doha, Qatar	Ma, XJ (reprint author), Weill Cornell Med, 1300 York Ave, New York, NY 10065 USA.	xim2002@med.cornell.edu			New York State Department of Public Health [C028251]; National Natural Science Foundation of China [31370903]; Qatar National Research Foundation [NPRP 7-136-3-031]	This work was supported by New York State Department of Public Health grant C028251 (X. Ma), National Natural Science Foundation of China No. 31370903 (X. Ma), Qatar National Research Foundation NPRP 7-136-3-031 (L. Chouchane and X. Ma).	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Beck B, 2015, CELL STEM CELL, V16, P67, DOI 10.1016/j.stem.2014.12.002; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Bolt MJ, 2015, ONCOGENE, V34, P154, DOI 10.1038/onc.2013.550; Bradley A, 2014, CARCINOGENESIS, V35, P1100, DOI 10.1093/carcin/bgt489; Byrd N, 2002, DEVELOPMENT, V129, P361; Callaghan MJ, 1998, ONCOGENE, V17, P3479; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen HW, 2013, BBA-GENE REGUL MECH, V1829, P1309, DOI 10.1016/j.bbagrm.2013.10.006; Chu K, 2013, ONCOTARGET, V4, P446, DOI 10.18632/oncotarget.872                                                         ; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Foote RL, 2005, INT J RADIAT ONCOL, V61, P745, DOI 10.1016/j.ijrobp.2004.07.674; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Giatromanolaki A, 2008, GYNECOL ONCOL, V110, P216, DOI 10.1016/j.ygyno.2008.04.021; Gonzalez MA, 1999, J PATHOL, V187, P523, DOI 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO;2-3; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Gupta S, 2007, ACTA ONCOL, V46, P792, DOI 10.1080/02841860701233443; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Ito K, 2016, CANCER RES, V76, P4406, DOI 10.1158/0008-5472.CAN-15-3445; Jeschke U, 2007, ANTICANCER RES, V27, P1969; Kohlberger PD, 1997, GYNECOL ONCOL, V64, P404, DOI 10.1006/gyno.1996.4565; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; LIPPONEN P, 1994, J PATHOL, V174, P101, DOI 10.1002/path.1711740206; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Ngan E, 2013, J CELL SCI, V126, P1981, DOI 10.1242/jcs.118315; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Ozguven BY, 2011, POL J PATHOL, V62, P19; Park D, 2007, APMIS, V115, P52, DOI 10.1111/j.1600-0463.2007.apm_524.x                                              ; Parker C, 2001, BRIT J CANCER, V85, P1958, DOI 10.1054/bjoc.2001.2178; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Pulaski B.A., 2001, CURR PROTOC IMMUNOL, V20, P2, DOI DOI 10.1002/0471142735.IM2002S39; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Rizwan Asif, 2015, NPJ Breast Cancer, V1, P15017, DOI 10.1038/npjbcancer.2015.17; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Shearer R. F., 2015, CANCER RES, V13; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568	54	0	1	2	8	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	APR 15	2017	77	8					2090	2101		10.1158/0008-5472.CAN-16-2409				12	Oncology	Oncology	ER9ZQ	WOS:000399186100025	28330927				2018-01-05	
J	Wen, Y; Liao, G; Pritchard, T; Zhao, TT; Connelly, JP; Pruett-Miller, SM; Blanc, V; Davidson, NO; Madison, BB				Wen, Yahong; Liao, Grace; Pritchard, Thomas; Zhao, Ting-Ting; Connelly, Jon P.; Pruett-Miller, Shondra M.; Blanc, Valerie; Davidson, Nicholas O.; Madison, Blair B.			A stable but reversible integrated surrogate reporter for assaying CRISPR/Cas9-stimulated homology-directed repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEASE-INDUCED MUTATIONS; HUMAN GENOME; HUMAN-CELLS; PIGGYBAC TRANSPOSASE; MOUSE GENOME; CRISPR-CAS9; GENES; ENRICHMENT; SYSTEMS; CAS9	The discovery and application of CRISPR/Cas9 technology for genome editing has greatly accelerated targeted mutagenesis in a variety of organisms. CRISPR/Cas9-mediated site-specific cleavage is typically exploited for the generation of insertions or deletions (indels) after aberrant dsDNA repair via the endogenous non-homology end-joining (NHEJ) pathway or, alternatively, for enhancing homology-directed repair to facilitate the generation of a specific mutation (or "knock-in"). However, there is a need for efficient cellular assays that can measure Cas9/guide RNA activity. Reliable methods for enriching and identifying desired mutants are also lacking. Here we describe a method using the Piggybac transposon for stable genomic integration of an H2B-GFP reporter or a hygromycin resistance gene for assaying Cas9 target cleavage and homology-directed repair. The H2B-GFP fusion protein provides increased stability and an obvious pattern of nuclear localization. This method, called SRIRACCHA (i.e. a (s) under bar table, but (r) under bar eversible, (i) under bar ntegrated (r) under bar eporter for (a) under bar ssaying (C) under bar RISPR/(c) under bar as-stimulated (H) under bar DR (a) under bar ctivity), enables the enrichment of mutants via selection of GFP-positive or hygromycin-resistant mammalian cells (immortalized or non-immortalized) as a surrogate for the modification of the endogenous target site. Currently available hyperactive Piggybac transposase mutants allow both delivery and removal of the surrogate reporters, with minimal risk of generating undesirable mutations. This assay permits rapid screening for efficient guide RNAs and the accelerated identification of mutant clones and is applicable to many cell types. We foresee the utility of this approach in contexts in which the maintenance of genomic integrity is essential, for example, when engineering cells for therapeutic purposes.	[Wen, Yahong; Liao, Grace; Pritchard, Thomas; Blanc, Valerie; Davidson, Nicholas O.; Madison, Blair B.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA; [Connelly, Jon P.; Pruett-Miller, Shondra M.] Washington Univ, Dept Genet, GEiC, St Louis, MO 63110 USA; [Zhao, Ting-Ting] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang 110001, Peoples R China	Madison, BB (reprint author), Washington Univ, Sch Med, Dept Med, Div Gastroenterol, 923 CSRB NTA,660 S Euclid Blvd, St Louis, MO 63110 USA.	bmadison@wustl.edu			National Institutes of Health [K01 DK093885, R03 DK108764, P30 DK052574]; Cancer Research Foundation Young Investigator Award; Siteman Investment Program at the Siteman Cancer Center; Digestive Disease Research Core Center (ARAC and Murine Cores)	This work was supported by National Institutes of Health Grants K01 DK093885, R03 DK108764, and P30 DK052574 Pilot (to B. B. M.) and HL-38180, DK-56260, and DK-52574 (to N. O. D.). This work was also supported by a Cancer Research Foundation Young Investigator Award and the Siteman Investment Program at the Siteman Cancer Center (to B. B. M.) and by the Digestive Disease Research Core Center (ARAC and Murine Cores) (to N. O. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; He ZY, 2016, J BIOTECHNOL, V221, P49, DOI 10.1016/j.jbiotec.2016.01.009; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056476; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YH, 2014, METHODS, V69, P108, DOI 10.1016/j.ymeth.2014.04.012; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Madison BB, 2013, GENE DEV, V27, P2233, DOI 10.1101/gad.224659.113; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; Prado FL, 2003, CURR GENET, V42, P185, DOI 10.1007/s00294-002-0346-3; Qiu P, 2004, BIOTECHNIQUES, V36, P702; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren CH, 2015, CELL MOL LIFE SCI, V72, P2763, DOI 10.1007/s00018-015-1874-6; Rulten SL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600209; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Schwank G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076871; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang YM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5564; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735	61	0	0	4	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 14	2017	292	15					6148	6162		10.1074/jbc.M117.777722				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ES4XE	WOS:000399538700012	28228480				2018-01-05	
J	Zou, M; Bhatia, A; Dong, H; Jayaprakash, P; Guo, J; Sahu, D; Hou, Y; Tsen, F; Tong, C; O'Brien, K; Situ, AJ; Schmidt, T; Chen, M; Ying, Q; Ulmer, TS; Woodley, DT; Li, W				Zou, M.; Bhatia, A.; Dong, H.; Jayaprakash, P.; Guo, J.; Sahu, D.; Hou, Y.; Tsen, F.; Tong, C.; O'Brien, K.; Situ, A. J.; Schmidt, T.; Chen, M.; Ying, Q.; Ulmer, T. S.; Woodley, D. T.; Li, W.			Evolutionarily conserved dual lysine motif determines the non-chaperone function of secreted Hsp90alpha in tumour progression	ONCOGENE			English	Article							CANCER-CELL INVASION; MONOCLONAL-ANTIBODY; MOLECULAR CHAPERONE; IN-VIVO; PROTEIN; HSP90-ALPHA; MIGRATION; GROWTH; METASTASIS; MOTILITY	Both intracellular and extracellular heat shock protein-90 (Hsp90) family proteins (alpha and beta) have been shown to support tumour progression. The tumour-supporting activity of the intracellular Hsp90 is attributed to their N-terminal ATPase-driven chaperone function. What molecular entity determines the extracellular function of secreted Hsp90 and the distinction between Hsp90 alpha and Hsp90 beta was unclear. Here we demonstrate that CRISPR/Case9 knocking out Hsp90 alpha nullifies tumour cells' ability to migrate, invade and metastasize without affecting the cell survival and growth. Knocking out Hsp90 beta leads to tumour cell death. Extracellular supplementation with recombinant Hsp90 alpha, but not Hsp90 alpha, protein recovers tumourigenicity of the Hsp90 alpha-knockout cells. Sequential mutagenesis identifies two evolutionarily conserved lysine residues, lys-270 and lys-277, in the Hsp90 alpha subfamily that determine the extracellular Hsp90 alpha function. Hsp90 beta subfamily lacks the dual lysine motif and the extracellular function. Substitutions of gly-262 and thr-269 in Hsp90 beta with lysines convert Hsp90 beta to a Hsp90 alpha-like protein. Newly constructed monoclonal antibody, 1G6-D7, against the dual lysine region of secreted Hsp90 alpha inhibits both de novo tumour formation and expansion of already formed tumours in mice. This study suggests an alternative therapeutic approach to target Hsp90 in cancer, that is, the tumour-secreted Hsp90 alpha, instead of the intracellular Hsp90 alpha and Hsp90 beta.	[Zou, M.; Bhatia, A.; Dong, H.; Jayaprakash, P.; Guo, J.; Sahu, D.; Hou, Y.; Tsen, F.; O'Brien, K.; Chen, M.; Woodley, D. T.; Li, W.] Dept Dermatol, Los Angeles, CA USA; [Zou, M.; Bhatia, A.; Dong, H.; Jayaprakash, P.; Guo, J.; Sahu, D.; Hou, Y.; Tsen, F.; O'Brien, K.; Chen, M.; Woodley, D. T.; Li, W.] Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Tong, C.; Ying, Q.] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Tong, C.; Ying, Q.] Dept Cell & Neurobiol, Los Angeles, CA USA; [Situ, A. J.; Schmidt, T.; Ulmer, T. S.] Univ Southern Calif, Keck Med Ctr, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Situ, A. J.; Schmidt, T.; Ulmer, T. S.] Univ Southern Calif, Keck Med Ctr, Zilkha Neurogenet Inst, Los Angeles, CA USA; [Chen, M.; Woodley, D. T.; Li, W.] Greater Los Angeles Vet Affairs Heath Care Syst, Dept Med Res, Los Angeles, CA USA; [Zou, M.; Dong, H.] Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou 510515, Guangdong, Peoples R China	Li, W (reprint author), Univ Southern Calif, Dept Dermatol, 1441 Eastlake Ave, Los Angeles, CA 90089 USA.	wli@usc.edu			NIH [GM066193, GM067100, AR059853, AR33625]; VA Merit Award [I01 BX002028]; National Cancer Institute [P30CA014089]	This work is supported by NIH grants GM066193, GM067100 and AR059853 (to WL), AR33625 (MC and DTW) and VA Merit Award I01 BX002028 (to DTW). The project described was also supported in part by award number P30CA014089 from the National Cancer Institute (to USC).	ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661                                                           ; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Devarakonda CV, 2015, BMC CANCER, V5, P614; Dong HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20605; Drysdale MJ, 2006, CURR OPIN DRUG DISC, V9, P483; El Hamidieh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042722; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Imai T, 2011, P NATL ACAD SCI USA, V108, P16363, DOI 10.1073/pnas.1108372108; Li W, 2004, MOL BIOL CELL, V15, P294; Li W, 2012, BBA-MOL CELL RES, V1823, P730, DOI 10.1016/j.bbamcr.2011.09.009; Liu R, 2013, CLIN CANCER RES, V19, P6802, DOI 10.1158/1078-0432.CCR-13-1106; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCready J, 2014, CANCERS, V6, P1031, DOI 10.3390/cancers6021031; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nolan KD, 2015, J BIOL CHEM, V290, P8271, DOI 10.1074/jbc.M115.637496; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Sahu D, 2012, MOL BIOL CELL, V23, P602, DOI 10.1091/mbc.E11-06-0575; Semenza G.L., 2003, CANCER, V3, P721, DOI DOI 10.1038/NRC1187; Shi YK, 2014, CLIN CANCER RES, V20, P6016, DOI 10.1158/1078-0432.CCR-14-0174; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Tsen F, 2013, MOL CELL BIOL, V33, P4947, DOI 10.1128/MCB.00559-13; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Voss AK, 2000, DEVELOPMENT, V127, P1; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WOODLEY DT, 1988, J CELL PHYSIOL, V136, P140, DOI 10.1002/jcp.1041360118                                                          ; Workman P, 2004, TRENDS MOL MED, V10, P47, DOI 10.1016/j.molmed.2003.12.005; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079                                                           ; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Zagouri F, 2011, IN VIVO, V25, P669	41	4	4	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 13	2017	36	15					2160	2171		10.1038/onc.2016.375				12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DK	WOS:000399782500011	27721406	gold			2018-01-05	
J	Heijstra, BD; Leang, C; Juminaga, A				Heijstra, Bjorn D.; Leang, Ching; Juminaga, Alex			Gas fermentation: cellular engineering possibilities and scale up	MICROBIAL CELL FACTORIES			English	Review						Climate change; GHG; Waste gas; Syngas; Fermentation; Gas contaminants; Carbon recycling; Carbon capture and utilization; Scale up	CARBON-MONOXIDE DEHYDROGENASE; COMPLETE GENOME SEQUENCE; CRISPR-CAS SYSTEMS; CLOSTRIDIUM-LJUNGDAHLII; ACETOBACTERIUM-WOODII; MOORELLA-THERMOACETICA; SYNGAS FERMENTATION; ESCHERICHIA-COLI; MASS-TRANSFER; HETEROLOGOUS EXPRESSION	Low carbon fuels and chemicals can be sourced from renewable materials such as biomass or from industrial and municipal waste streams. Gasification of these materials allows all of the carbon to become available for product generation, a clear advantage over partial biomass conversion into fermentable sugars. Gasification results into a synthesis stream (syngas) containing carbon monoxide (CO), carbon dioxide -(CO2), hydrogen -(H-2) and nitrogen -(N-2). Autotrophy-the ability to fix carbon such as -CO2 is present in all domains of life but photosynthesis alone is not keeping up with anthropogenic -CO2 output. One strategy is to curtail the gaseous atmospheric release by developing waste and syngas conversion technologies. Historically microorganisms have contributed to major, albeit slow, atmospheric composition changes. The current status and future potential of anaerobic gas-fermenting bacteria with special focus on acetogens are the focus of this review.	[Heijstra, Bjorn D.; Leang, Ching; Juminaga, Alex] LanzaTech Inc, 8045 Lamon Ave,Suite 400, Skokie, IL 60077 USA	Heijstra, BD (reprint author), LanzaTech Inc, 8045 Lamon Ave,Suite 400, Skokie, IL 60077 USA.	bjorn.heijstra@lanzatech.com			Khosla Ventures; Qiming Venture Partners; Softbank China; Malaysian Life Sciences Capital Fund; Mitsui; Primetals; CICC Growth Capital Fund I, L.P.; New Zealand Superannuation Fund	We thank the following investors in LanzaTech's technology: Sir Stephen Tindall, Khosla Ventures, Qiming Venture Partners, Softbank China, the Malaysian Life Sciences Capital Fund, Mitsui, Primetals, CICC Growth Capital Fund I, L.P. and the New Zealand Superannuation Fund.	Ahmed A, 2007, BIOTECHNOL BIOENG, V97, P1080, DOI 10.1002/bit.21305; Al-Hinai MA, 2012, APPL ENVIRON MICROB, V78, P8112, DOI 10.1128/AEM.02214-12; Baek CH, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0014-2013; Baidoo EE, 2012, MICROB SYST BIOL MET, DOI [10.1007/978-1-61779-827-6_9, DOI 10.1007/978-1-61779-827-6_9]; Bajracharya S, 2016, ENVIRON SCI POLLUT R, V23, P22292, DOI 10.1007/s11356-016-7196-x; Banerjee A, 2014, APPL ENVIRON MICROB, V80, P2410, DOI 10.1128/AEM.03666-13; Barton NR, 2015, J IND MICROBIOL BIOT, V42, P349, DOI 10.1007/s10295-014-1541-1; Batth TS, 2014, METAB ENG, V26, P48, DOI 10.1016/j.ymben.2014.08.004; Bengelsdorf FR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01036; Bertsch J, 2015, APPL ENVIRON MICROB, V81, P5949, DOI 10.1128/AEM.01772-15; Biggs BW, 2014, CURR OPIN BIOTECH, V29, P156, DOI 10.1016/j.copbio.2014.05.005; Boateng AA, 2007, BIOMASS BIOENERG, V31, P153, DOI 10.1016/j.biombioe.2006.08.001; Boock JT, 2015, CURR OPIN BIOTECH, V36, P189, DOI 10.1016/j.copbio.2015.08.013; Bredwell MD, 1999, BIOTECHNOL PROGR, V15, P834, DOI 10.1021/bp990108m; Brown SD, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-40; Brunk E, 2016, CELL SYST, V2, P335, DOI 10.1016/j.cels.2016.04.004; Buelens LC, 2016, SCIENCE, V354, P449, DOI 10.1126/science.aah7161; Chen J, 2016, METAB ENG, V38, P389, DOI 10.1016/j.ymben.2016.10.002; Chen J, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0259-2; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cui GZ, 2012, J MICROBIOL METH, V89, P201, DOI 10.1016/j.mimet.2012.02.015; Datar RP, 2004, BIOTECHNOL BIOENG, V86, P587, DOI 10.1002/bit.20071; de Klerk A, 2013, FISCHER TROPSCH TECH, P53; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Drake HL, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P354, DOI 10.1007/0-387-30742-7_13; Du JJ, 2014, ENERGIES, V7, P2421, DOI 10.3390/en7042421; Du YM, 2015, BIOTECHNOL BIOENG, V112, P705, DOI 10.1002/bit.25489; Fast AG, 2012, CURR OPIN CHEM ENG, V1, P380, DOI 10.1016/j.coche.2012.07.005; Feng X, 2012, MICROBIAL SYSTEMS BI, P309; Freestone TS, 2016, BIOTECHNOL BIOENG, V113, P384, DOI 10.1002/bit.25719; Global SCS, 2013, NEWSROOM; Glomsrod S, 2016, SCI TOTAL ENVIRON, V568, P236, DOI 10.1016/j.scitotenv.2016.06.005; Griffin DW, 2012, ENVIRON PROG SUSTAIN, V31, P219, DOI 10.1002/ep.11613; Ha SW, 2007, J BIOL CHEM, V282, P10639, DOI 10.1074/jbc.M610641200; Handler RM, 2014, AICHE NAT M; Handler RM, 2016, IND ENG CHEM RES, V55, P3253, DOI 10.1021/acs.iecr.5b03215; HE SH, 1989, BIOCHEM BIOPH RES CO, V161, P127, DOI 10.1016/0006-291X(89)91570-2; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1321; Heveling J, 1998, APPL CATAL A-GEN, V173, P1, DOI 10.1016/S0926-860X(98)00147-1                                                   ; Hillson NJ, 2014, METHODS MOL BIOL, V1116, P245, DOI 10.1007/978-1-62703-764-8_17; Huang H, 2016, ACS SYNTH BIOL, V5, P1355, DOI 10.1021/acssynbio.6b00044; HYMAN MR, 1988, ANAL BIOCHEM, V173, P207, DOI 10.1016/0003-2697(88)90181-9                                                    ; Islam MA, 2015, INTEGR BIOL-UK, V7, P869, DOI 10.1039/c5ib00095e; Jaramillo P, 2008, ENVIRON SCI TECHNOL, V42, P7559, DOI 10.1021/es8002074; Jeschek M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11163; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y., 2015, ICIC EL, V9, P81, DOI DOI 10.1128/AEM.04023-14; Jones SW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12800; Kahn B, WORLD PASSES 400 PPM; Karnholz A, 2002, APPL ENVIRON MICROB, V68, P1005, DOI 10.1128/AEM.68.2.1005-1009.2002; Kattel S, 2016, J AM CHEM SOC, V138, P12440, DOI 10.1021/jacs.6b05791; Kawasaki S, 2009, APPL ENVIRON MICROB, V75, P1021, DOI 10.1128/AEM.01425-08; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; KIMMEL DE, 1991, APPL BIOCHEM BIOTECH, V28-9, P457, DOI 10.1007/BF02922625; Kita A, 2013, J BIOSCI BIOENG, V115, P347, DOI 10.1016/j.jbiosc.2012.10.013; Kopke M, 2014, APPL ENVIRON MICROB, V80, P3394, DOI 10.1128/AEM.00301-14; Kopke M, 2011, APPL ENVIRON MICROB, V77, P5467, DOI 10.1128/AEM.00355-11; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Kopke M, 2013, KOPKE M, Patent No. WO 2013/115659 A2; Kopke M, 2011, BIOFUEL PRODUCTION R, P451; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/nmeth.2918, 10.1038/NMETH.2918]; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600                                          ; Landels A, 2015, CURR OPIN BIOTECH, V35, P111, DOI 10.1016/j.copbio.2015.05.001; Lane J., 2015, BIOFUELS DIG; Lane J, 2016, BIOFUELS DIG; Lane J., 2014, MEND WHY INEOS BIO I; Lane J, 2016, COSKATAAS TECHNOLOGY; Leang C, 2013, APPL ENVIRON MICROB, V79, P1102, DOI 10.1128/AEM.02891-12; Lechner A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023903; Lee SH, 2016, J MICROBIOL BIOTECHN, V26, P725, DOI 10.4014/jmb.1512.12012; Liew FM, 2013, BIOFUEL PRODUCTION R, P125; Liew F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00694; Lin JY, 2010, ENVIRON SCI TECHNOL, V44, P3719, DOI 10.1021/es1001538; Liu WS, 2015, APPL MICROBIOL BIOT, V99, P2093, DOI 10.1007/s00253-015-6400-0; Luo YZ, 2016, NAT PROD REP, V33, P174, DOI 10.1039/c5np00085h; Maitlis PM, 2013, FUELS FEED; Manes PC, 2001, APPL MICROBIOL BIOT, V57, P751, DOI 10.1007/s00253-001-0828-0                                                       ; Marcellin E, 2016, GREEN CHEM, V18, P3020, DOI 10.1039/c5gc02708j; Mei Y, 2016, J GENET GENOMICS, V43, P63, DOI 10.1016/j.jgg.2016.01.001; MERMELSTEIN LD, 1993, APPL ENVIRON MICROB, V59, P1077; Mock J, 2015, J BACTERIOL, V197, P2965, DOI 10.1128/JB.00399-15; Mohammadi M, 2011, RENEW SUST ENERG REV, V15, P4255, DOI 10.1016/j.rser.2011.07.124; Molitor B, 2016, BIORESOUR T IN PRESS; Mueller A, 2013, MUELLER A, Patent No. US20130330809 A1; Mukherjee A, 2015, CURR OPIN BIOTECH, V31, P16, DOI 10.1016/j.copbio.2014.07.010; Munasinghe PC, 2012, BIORESOURCE TECHNOL, V122, P130, DOI 10.1016/j.biortech.2012.03.053; Munasinghe PC, 2010, BIORESOURCE TECHNOL, V101, P5013, DOI 10.1016/j.biortech.2009.12.098; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Nagarajan H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-118; Nagaraju S, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0638-3; Abubackar HN, 2011, BIOFUEL BIOPROD BIOR, V5, P93, DOI 10.1002/bbb.256; Ng YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056051; Oberortner E, 2015, ACS SYNTH BIOL, V4, P757, DOI 10.1021/sb500352b; OREMLAND RS, 1975, APPL MICROBIOL, V30, P707; Orgill JJ, 2013, BIORESOURCE TECHNOL, V133, P340, DOI 10.1016/j.biortech.2013.01.124; Paddon CJ, 2014, NAT REV MICROBIOL, V12, P355, DOI 10.1038/nrmicro3240; Paterson N, 2005, ENERG FUEL, V19, P1016, DOI 10.1021/ef049688h; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Poehlein A, 2015, MBIO, V6, DOI 10.1128/mBio.01168-15; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Pyne ME, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-50; Quinn JY, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002310; RAGSDALE SW, 1983, J BACTERIOL, V155, P1224; Roh H, 2011, J BACTERIOL, V193, P307, DOI 10.1128/JB.01217-10; Sakimoto KK, 2016, SCIENCE, V351, P74, DOI 10.1126/science.aad3317; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sapp M, 2016, INEOS BIOSELLING 8 M; Schiel-Bengelsdorf B, 2012, FEBS LETT, V586, P2191, DOI 10.1016/j.febslet.2012.04.043; Schill SR, 2013, ETHANOL PRODUCER MAG; Shima S, 2011, FEBS LETT, V585, P353, DOI 10.1016/j.febslet.2010.12.014; SIKKEMA J, 1995, MICROBIOL REV, V59, P201; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Stern AM, 2014, ADV APPL MICROBIOL, V87, P187, DOI 10.1016/B978-0-12-800261-2.00005-0; STRATZ M, 1994, APPL ENVIRON MICROB, V60, P1033; Straub M, 2014, J BIOTECHNOL, V178, P67, DOI 10.1016/j.jbiotec.2014.03.005; Tan Y, 2013, MOL BIOSYST, V9, P2775, DOI 10.1039/c3mb70232d; Teng L, 2015, J MICROBIOL METH, V119, P37, DOI 10.1016/j.mimet.2015.09.018; Thackeray F., 2002, PETROLEUM EC, V69, P10; Tracy BP, 2012, CURR OPIN BIOTECH, V23, P364, DOI 10.1016/j.copbio.2011.10.008; Ueki T, 2014, MBIO, P5; United Nations, 2015, AD PAR AGR, P32; Ungerman AJ, 2007, BIOTECHNOL PROGR, V23, P613, DOI 10.1021/bp060311z; Utturkar SM, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.14; Virgin Lane J., 2016, BIOFUELS DIG; Walker DJF, 2016, METHOD PRODUCING REC, Patent No. US9315830B2; Wang VCC, 2013, J AM CHEM SOC, V135, P2198, DOI 10.1021/ja308493k; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Whitham JM, 2015, APPL ENVIRON MICROB, V81; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zahn J, 2015, RECENT ADV FERMENT T; Zhao ZS, 2016, WATER RES, V106, P339, DOI 10.1016/j.watres.2016.10.018; Liew F. M., 2011, Recombinant Microorganism and Methods of Production Thereof, Patent No. [US2011/0236941 A1, 20110236941, US 20110236941 A1]; Haselbeck R, 2011, US patent, Patent No. [20,110,229,946 A1, 20110229946]	135	1	1	16	26	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2859			MICROB CELL FACT	Microb. Cell. Fact.	APR 12	2017	16								60	10.1186/s12934-017-0676-y				11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ES2NV	WOS:000399366100001	28403896	gold			2018-01-05	
J	Stockley, JH; Evans, K; Matthey, M; Volbracht, K; Agathou, S; Mukanowa, J; Burrone, J; Karadottir, RT				Stockley, John H.; Evans, Kimberley; Matthey, Moritz; Volbracht, Katrin; Agathou, Sylvia; Mukanowa, Jana; Burrone, Juan; Karadottir, Ragnhildur T.			Surpassing light-induced cell damage in vitro with novel cell culture media	SCIENTIFIC REPORTS			English	Article							FLUORESCENCE MICROSCOPY; HIPPOCAMPAL-NEURONS; GLUTATHIONE; MONOCHLOROBIMANE; SUSCEPTIBILITY; PHOTOTOXICITY; CRISPR-CAS9; ACTIVATION; ASTROCYTES; VIABILITY	Light is extensively used to study cells in real time (live cell imaging), separate cells using fluorescence activated cell sorting (FACS) and control cellular functions with light sensitive proteins (Optogenetics). However, photo-sensitive molecules inside cells and in standard cell culture media generate toxic by-products that interfere with cellular functions and cell viability when exposed to light. Here we show that primary cells from the rat central nervous system respond differently to photo-toxicity, in that astrocytes and microglia undergo morphological changes, while in developing neurons and oligodendrocyte progenitor cells (OPCs) it induces cellular death. To prevent photo-toxicity and to allow for long-term photo-stimulation without causing cellular damage, we formulated new photo-inert media called MEMO and NEUMO, and an antioxidant rich and serum free supplement called SOS. These new media reduced the detrimental effects caused by light and allowed cells to endure up to twenty times more light exposure without adverse effects, thus bypassing the optical constraints previously limiting experiments.	[Stockley, John H.; Evans, Kimberley; Matthey, Moritz; Volbracht, Katrin; Agathou, Sylvia; Karadottir, Ragnhildur T.] Univ Cambridge, Wellcome Trust Med Res Council, Cambridge Stem Cell Inst, Cambridge CB2 1QR, England; [Stockley, John H.; Evans, Kimberley; Matthey, Moritz; Volbracht, Katrin; Agathou, Sylvia; Karadottir, Ragnhildur T.] Univ Cambridge, Dept Vet Med, Cambridge CB2 1QR, England; [Mukanowa, Jana; Burrone, Juan] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; [Stockley, John H.] Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge Biomed Campus,Clifford Allbutt Bldg, Cambridge CB2 0AH, England; [Stockley, John H.] Dept Paediat, Cambridge Biomed Campus,Clifford Allbutt Bldg, Cambridge CB2 0AH, England	Stockley, JH; Karadottir, RT (reprint author), Univ Cambridge, Wellcome Trust Med Res Council, Cambridge Stem Cell Inst, Cambridge CB2 1QR, England.; Stockley, JH; Karadottir, RT (reprint author), Univ Cambridge, Dept Vet Med, Cambridge CB2 1QR, England.; Stockley, JH (reprint author), Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge Biomed Campus,Clifford Allbutt Bldg, Cambridge CB2 0AH, England.; Stockley, JH (reprint author), Dept Paediat, Cambridge Biomed Campus,Clifford Allbutt Bldg, Cambridge CB2 0AH, England.	js810@medschl.cam.ac.uk; rk385@cam.ac.uk		Stockley, John/0000-0002-7385-8310; Karadottir, Ragnhildur Thora/0000-0001-9675-2722	Wellcome Trust [091543/Z/10/Z]; Isaac Newton Trust; Royal Society	Funding was provided by grants from the Wellcome Trust (091543/Z/10/Z), Isaac Newton Trust and The Royal Society. The authors would like to thank Michael Jones and Charlotte Marris of Cell Guidance Systems and Rachel Atfield and Laura Donnelly of Cambridge Enterprise for their support.	Allen BD, 2015, LEARN MEMORY, V22, P232, DOI 10.1101/lm.038026.114; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Bogdanov AM, 2009, NAT METHODS, V6, P859, DOI 10.1038/nmeth1209-859; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514                                                           ; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chatterjee S, 1999, GLIA, V27, P152; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Cheng KP, 2016, SCI REP-UK, V6, DOI 10.1038/srep21172; Chiarelli-Neto O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113266; Christie IN, 2013, NEUROIMAGE, V66, P634, DOI 10.1016/j.neuroimage.2012.10.074; Cox S, 2015, DEV BIOL, V401, P175, DOI 10.1016/j.ydbio.2014.11.025; Cox S, 2012, NAT METHODS, V9, P195, DOI 10.1038/NMETH.1812; Crawford AH, 2014, EXP NEUROL, V260, P50, DOI 10.1016/j.expneurol.2014.04.027; Crawford AH, 2016, CELL REP, V15, P761, DOI 10.1016/j.celrep.2016.03.069; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Dringen R, 1999, J NEUROSCI, V19, P562; [Anonymous], 2013, NAT METHODS, V10, P1135, DOI DOI 10.1038/NMETH.2760; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; Frost EE, 2000, METH MOL B, V139, P265; Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Grzelak A, 2001, FREE RADICAL BIO MED, V30, P1418, DOI 10.1016/S0891-5849(01)00545-7; Henriques R, 2011, BIOPOLYMERS, V95, P322, DOI 10.1002/bip.21586; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278; Ji N, 2008, CURR OPIN NEUROBIOL, V18, P605, DOI 10.1016/j.conb.2009.03.009; Karunarathne WKA, 2015, J CELL SCI, V128, P15, DOI 10.1242/jcs.154435; Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085; Langeveld CH, 1996, NEUROREPORT, V7, P1833, DOI 10.1097/00001756-199607290-00029; Liu Z, 2015, MOL CELL, V58, P644, DOI 10.1016/j.molcel.2015.02.033; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/NMAT3776, 10.1038/nmat3776]; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09669; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Rodriguez-Pena A, 1999, J NEUROBIOL, V40, P497, DOI 10.1002/(SICI)1097-4695(19990915)40:4<497::AID-NEU7>3.0.CO;2-#                  ; Sachar M, 2016, J PHARMACOL EXP THER, V356, P267, DOI 10.1124/jpet.115.228130; Schneckenburger H, 2012, J MICROSC-OXFORD, V245, P311, DOI 10.1111/j.1365-2818.2011.03576.x; Sokolik C, 2015, CELL SYST, V1, P117, DOI 10.1016/j.cels.2015.08.001; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Nakanishi K, 2000, INVEST OPHTH VIS SCI, V41, P1981; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Tinevez JY, 2012, METHOD ENZYMOL, V506, P291, DOI 10.1016/B978-0-12-391856-7.00039-1; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Waldchen S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15348; Wagner M, 2010, INT J MOL SCI, V11, P956, DOI 10.3390/ijms11030956; WANG RJ, 1976, IN VITRO CELL DEV B, V12, P19; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Yawo H, 2013, DEV GROWTH DIFFER, V55, P474, DOI 10.1111/dgd.12053; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Zimmer M, 2009, CHEM SOC REV, V38, P2823, DOI 10.1039/b904023d	55	1	1	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 12	2017	7								849	10.1038/s41598-017-00829-x				11	Multidisciplinary Sciences	Science & Technology - Other Topics	ER9ZP	WOS:000399186000013	28405003	gold			2018-01-05	
J	Saarimaki-Vire, J; Balboa, D; Russell, MA; Saarikettu, J; Kinnunen, M; Keskitalo, S; Malhi, A; Valensisi, C; Andrus, C; Eurola, S; Grym, H; Ustinov, J; Wartiovaara, K; Hawkins, RD; Silvennoinen, O; Varjosalo, M; Morgan, NG; Otonkoski, T				Saarimaki-Vire, Jonna; Balboa, Diego; Russell, Mark A.; Saarikettu, Juha; Kinnunen, Matias; Keskitalo, Salla; Malhi, Amrinder; Valensisi, Cristina; Andrus, Colin; Eurola, Solja; Grym, Heli; Ustinov, Jarkko; Wartiovaara, Kirmo; Hawkins, R. David; Silvennoinen, Olli; Varjosalo, Markku; Morgan, Noel G.; Otonkoski, Timo			An Activating STAT3 Mutation Causes Neonatal Diabetes through Premature Induction of Pancreatic Differentiation	CELL REPORTS			English	Article							PLURIPOTENT STEM-CELLS; BETA-LIKE CELLS; IN-VITRO; ENDOCRINE PANCREAS; PROGENITOR CELLS; KNOCKOUT MICE; GENERATION; NEUROGENIN3; EXPRESSION; REVEALS	Activating germline mutations in STAT3 were recently identified as a cause of neonatal diabetes mellitus associated with beta-cell autoimmunity. We have investigated the effect of an activating mutation, STAT3(K392R,) on pancreatic development using induced pluripotent stem cells (iPSCs) derived from a patient with neonatal diabetes and pancreatic hypoplasia. Early pancreatic endoderm differentiated similarly from STAT3(K392R) and healthy-control cells, but in later stages, NEUROG3 expressionwas upregulated prematurely in STAT3(K392R) cells together with insulin (INS) and glucagon (GCG). RNA sequencing (RNA-seq) showed robust NEUROG3 downstream targets upregulation. STAT3 mutation correction with CRISPR/Cas9 reversed completely the disease phenotype. STAT3(K392R) -activating properties were not explained fully by altered DNA-binding affinity or increased phosphorylation. Instead, reporter assays demonstrated NEUROG3 promoter activation by STAT3 in pancreatic cells. Furthermore, proteomic and immunocytochemical analyses revealed increased nuclear translocation of STAT3(K392R). Collectively, our results demonstrate that the STAT3(K392R) mutation causes premature endocrine differentiation through direct induction of NEUROG3 expression.	[Saarimaki-Vire, Jonna; Balboa, Diego; Eurola, Solja; Grym, Heli; Ustinov, Jarkko; Wartiovaara, Kirmo; Otonkoski, Timo] Univ Helsinki, Fac Med, Res Programs Unit, Mol Neurol & Biomed Stem Cell Ctr, Helsinki 00014, Finland; [Russell, Mark A.; Malhi, Amrinder; Morgan, Noel G.] Univ Exeter, Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Saarikettu, Juha; Silvennoinen, Olli] Univ Tampere, Fac Med & Life Sci, Tampere 33014, Finland; [Saarikettu, Juha; Silvennoinen, Olli] Tampere Univ Hosp, Tampere 33014, Finland; [Kinnunen, Matias; Keskitalo, Salla; Varjosalo, Markku] Univ Helsinki, Inst Biotechnol, Mol Syst Biol Res Grp, Helsinki 00014, Finland; [Valensisi, Cristina; Andrus, Colin; Hawkins, R. David] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Dept Genome Sci,Dept Med,Div Med Genet, Seattle, WA 98109 USA; [Otonkoski, Timo] Univ Helsinki, Childrens Hosp, Helsinki 00290, Finland; [Otonkoski, Timo] Helsinki Univ Hosp, Helsinki 00290, Finland; [Wartiovaara, Kirmo] Univ Helsinki, Cent Hosp, HUSLAB, Clin Genet, Haartmaninkatu 4, Helsinki 00290, Finland	Saarimaki-Vire, J; Otonkoski, T (reprint author), Univ Helsinki, Fac Med, Res Programs Unit, Mol Neurol & Biomed Stem Cell Ctr, Helsinki 00014, Finland.; Otonkoski, T (reprint author), Univ Helsinki, Childrens Hosp, Helsinki 00290, Finland.; Otonkoski, T (reprint author), Helsinki Univ Hosp, Helsinki 00290, Finland.	jonna.saarimaki@helsinki.fi; timo.otonkoski@helsinki.fi		Balboa, Diego/0000-0002-4784-5452; Varjosalo, Markku/0000-0002-1340-9732	Academy of Finland [257157]; Sigrid Juselius Foundation; Novo Nordisk Foundation [NNF16OC0021090, NNF15OC0016426, NNF13OC0005565, NNF14OC0010719]; EU 7FP Integrated project BETACURE; Diabetes Research Foundation; Diabetes UK	Anni Laitinen, Eila Korhonen, HazemIbrahim, Vaino Lithovius, NooraAarnio, Jessica Chaffey, and Niina Siiskonen are thanked for their professional technical assistance. Wethank Elena Senis (Vall d'Hebron Institute of Oncology) for advice on T7 endonuclease assay. We are grateful to Ras Trokovic and Milla Mikkola for providing iPSC (HEL72.1, HEL72A, and HEL72D) lines. D.B. is a member of the Doctoral School of Health Sciences at University of Helsinki. This project was funded by the Academy of Finland (grant number 257157) Sigrid Juselius Foundation, Novo Nordisk Foundation (grant numbers NNF16OC0021090, NNF15OC0016426, NNF14OC0010719, and NNF13OC0005565), the EU 7FP Integrated project BETACURE, the Diabetes Research Foundation, and Diabetes UK.	Achuta VS, 2017, DEV NEUROBIOL, V77, P438, DOI 10.1002/dneu.22419; Afelik S, 2013, WIRES DEV BIOL, V2, P531, DOI 10.1002/wdev.99; Apelqvist A, 1999, NATURE, V400, P877; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Franco E, 2015, PEDIATR CLIN N AM, V62, P1037, DOI 10.1016/j.pcl.2015.04.012; De Vas MG, 2015, DEVELOPMENT, V142, P871, DOI 10.1242/dev.110759; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Gorogawa S, 2004, BIOCHEM BIOPH RES CO, V319, P1159, DOI 10.1016/j.bbrc.2004.05.095; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gutteridge A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056024; Haapaniemi EM, 2015, BLOOD, V125, P639, DOI 10.1182/blood-2014-04-570101; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jennings RE, 2015, DEVELOPMENT, V142, P3126, DOI 10.1242/dev.120063; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Kampjarvi K, 2016, PROSTATE, V76, P22, DOI 10.1002/pros.23092; Kaucher AV, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097386; Kim YS, 2012, MOL CELLS, V34, P193, DOI 10.1007/s10059-012-0109-z; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kostromina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071277; Kostromina E, 2010, ENDOCRINOLOGY, V151, P2050, DOI 10.1210/en.2009-1199; Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Lee JY, 2005, BIOCHEM BIOPH RES CO, V334, P764, DOI 10.1016/j.bbrc.2005.06.162; Lemper M, 2015, CELL DEATH DIFFER, V22, P1117, DOI 10.1038/cdd.2014.193; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Masjkur J, 2016, DIABETES, V65, P314, DOI 10.2337/db15-1099; McGrath PS, 2015, DIABETES, V64, P2497, DOI 10.2337/db14-1412; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Nostro MC, 2015, STEM CELL REP, V4, P591, DOI 10.1016/j.stemcr.2015.02.017; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Otonkoski T, 2000, DIABETOLOGIA, V43, P1235, DOI 10.1007/s001250051518                                                           ; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Pinney SE, 2011, J CLIN ENDOCR METAB, V96, P1960, DOI 10.1210/jc.2011-0029; Puri S, 2015, CELL STEM CELL, V16, P18, DOI 10.1016/j.stem.2014.11.001; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Rubio-Cabezas O, 2011, DIABETES, V60, P1349, DOI 10.2337/db10-1008; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Timofeeva OA, 2012, J BIOL CHEM, V287, P14192, DOI 10.1074/jbc.M111.323899; Toivonen S, 2013, EXP CELL RES, V319, P2535, DOI 10.1016/j.yexcr.2013.07.007; Toivonen S, 2013, STEM CELL TRANSL MED, V2, P83, DOI 10.5966/sctm.2012-0047; Trokovic R, 2015, STEM CELL RES, V15, P266, DOI 10.1016/j.scr.2015.05.012; Trokovic R, 2015, STEM CELL RES, V15, P263, DOI 10.1016/j.scr.2015.05.013; Valdez IA, 2016, CELL REP, V15, P460, DOI 10.1016/j.celrep.2016.03.036; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009	63	2	2	7	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	APR 11	2017	19	2					281	294		10.1016/j.celrep.2017.03.055				14	Cell Biology	Cell Biology	EU6GO	WOS:000401132600006	28402852	gold			2018-01-05	
J	Zonari, E; Desantis, G; Petrillo, C; Boccalatte, FE; Lidonnici, MR; Kajaste-Rudnitski, A; Aiuti, A; Ferrari, G; Naldini, L; Gentner, B				Zonari, Erika; Desantis, Giacomo; Petrillo, Carolina; Boccalatte, Francesco E.; Lidonnici, Maria Rosa; Kajaste-Rudnitski, Anna; Aiuti, Alessandro; Ferrari, Giuliana; Naldini, Luigi; Gentner, Bernhard			Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy	STEM CELL REPORTS			English	Article							HUMAN CORD BLOOD; BONE-MARROW; LENTIVIRAL VECTOR; ENGRAFTMENT; TRANSPLANTATION; MICE; TRANSDUCTION; ACTIVATION; SAFETY	Ex vivo gene therapy based on CD34(+) hematopoietic stem cells (HSCs) has shown promising results in clinical trials, but genetic engineering to high levels and in large scale remains challenging. We devised a sorting strategy that captures more than 90% of HSC activity in less than 10% of mobilized peripheral blood (mPB) CD34(+) cells, and modeled a transplantation protocol based on highly purified, genetically engineered HSCs co-infused with uncultured progenitor cells. Prostaglandin E-2 stimulation allowed near-complete transduction of HSCs with lentiviral vectors during a culture time of less than 38 hr, mitigating the negative impact of standard culture on progenitor cell function. Exploiting the pyrimidoindole derivative UM171, we show that transduced mPB CD34(+)CD38(-) cells with repopulating potential could be expanded ex vivo. Implementing these findings in clinical gene therapy protocols will improve the efficacy, safety, and sustainability of gene therapy and generate new opportunities in the field of gene editing.	[Zonari, Erika; Desantis, Giacomo; Petrillo, Carolina; Boccalatte, Francesco E.; Lidonnici, Maria Rosa; Kajaste-Rudnitski, Anna; Aiuti, Alessandro; Ferrari, Giuliana; Naldini, Luigi; Gentner, Bernhard] San Raffaele Telethon Inst Gene Therapy SR TIGET, I-20132 Milan, Italy; [Petrillo, Carolina; Aiuti, Alessandro; Ferrari, Giuliana; Naldini, Luigi] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Aiuti, Alessandro] IRCSS Osped San Raffaele, Pediat Immunohematol & Bone Marrow Transplantat U, I-20132 Milan, Italy; [Gentner, Bernhard] IRCSS Osped San Raffaele, Hematol & Bone Marrow Transplantat Unit, I-20132 Milan, Italy	Gentner, B (reprint author), San Raffaele Telethon Inst Gene Therapy SR TIGET, I-20132 Milan, Italy.; Gentner, B (reprint author), IRCSS Osped San Raffaele, Hematol & Bone Marrow Transplantat Unit, I-20132 Milan, Italy.	gentner.bernhard@hsr.it	Boccalatte, Francesco/M-3511-2017; AIUTI, ALESSANDRO/K-3918-2016	AIUTI, ALESSANDRO/0000-0002-5398-1717	Telethon Foundation [TELE16-C1, TELE16-C3]; Telethon-GSK Alliance (AGSK-HSC); Italian Ministry of Health [NET-2011-02350069]; John Goldman Clinical Research Fellowship from the European Hematology Association	We thank Oriana Meo, Matteo Maria Naldini, Andrea Cosentino, Cheruku Patali Shikhi, Lucia Sergi Sergi, Ivan Cuccovillo, and Tiziana Plati for help with experiments; C. Villa, E. Canonico, M. Romano , M. Zambelli, and C. Parisi for help with sorting and cell manipulation; MolMed S.p.A. for providing the lentiviral vector pseudotyped with RD114-TR envelope; Francois-Loic Cosset from Inserm-ENS Lyon, France, for the BaEV-TR envelope construct; Guy Sauvageau for friendly discussions on HSC expansion. This research was supported by grants from the Telethon Foundation (TELE16-C1 to B.G., TELE16-C3 to A.K.R.), the Telethon-GSK Alliance (AGSK-HSC), the Italian Ministry of Health (NET-2011-02350069) and a John Goldman Clinical Research Fellowship from the European Hematology Association to B.G.	Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Baldwin K, 2015, STEM CELLS, V33, P1532, DOI 10.1002/stem.1957; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Glimm H, 2000, BLOOD, V96, P4185; Glimm H, 2001, J CLIN INVEST, V107, P199, DOI 10.1172/JCI11519; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Gordon PR, 2003, BONE MARROW TRANSPL, V31, P17, DOI 10.1038/sj.bmt.1703792; Heffner G, 2016, MOL THER, V24, pS89, DOI 10.1016/S1525-0016(16)33038-6                                                   ; Kallinikou K, 2012, BRIT J HAEMATOL, V158, P778, DOI 10.1111/j.1365-2141.2012.09219.x; Kerre TCC, 2001, J IMMUNOL, V167, P3692, DOI 10.4049/jimmunol.167.7.3692                                                     ; Kiernan J., 2016, TRANSFUS MED REV; Larochelle A, 2012, BLOOD, V119, P1848, DOI 10.1182/blood-2011-08-371583; Lidonnici M.R., 2016, HAEMATOLOGICA; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; McKenzie JL, 2007, EXP HEMATOL, V35, P1429, DOI 10.1016/j.exphem.2007.05.017; Michallet M, 2000, EXP HEMATOL, V28, P858, DOI 10.1016/S0301-472X(00)00169-7                                                   ; Miller PH, 2016, EXP HEMATOL, V44, P635, DOI 10.1016/j.exphem.2016.04.003; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Negrin RS, 2000, BIOL BLOOD MARROW TR, V6, P262, DOI 10.1016/S1083-8791(00)70008-5; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Palchaudhuri R, 2016, NAT BIOTECHNOL, V34, P738, DOI 10.1038/nbt.3584; Petrillo C, 2015, MOL THER, V23, P352, DOI 10.1038/mt.2014.193; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Wang CX, 2014, BLOOD, V124, P913, DOI 10.1182/blood-2013-12-546218	37	8	8	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	APR 11	2017	8	4					977	990		10.1016/j.stemcr.2017.02.010				14	Cell & Tissue Engineering; Cell Biology	Cell Biology	EU6FJ	WOS:000401129100015	28330619	gold			2018-01-05	
J	Park, S; Gianotti-Sommer, A; Molina-Estevez, FJ; Vanuytsel, K; Skvir, N; Leung, A; Rozelle, SS; Shaikho, EM; Weir, I; Jiang, ZH; Luo, HY; Chui, DHK; Figueiredo, MS; Alsultan, A; Al-Ali, A; Sebastiani, P; Steinberg, MH; Mostoslavsky, G; Murphy, GJ				Park, Seonmi; Gianotti-Sommer, Andreia; Molina-Estevez, Francisco Javier; Vanuytsel, Kim; Skvir, Nick; Leung, Amy; Rozelle, Sarah S.; Shaikho, Elmutaz Mohammed; Weir, Isabelle; Jiang, Zhihua; Luo, Hong-Yuan; Chui, David H. K.; Figueiredo, Maria Stella; Alsultan, Abdulraham; Al-Ali, Amein; Sebastiani, Paola; Steinberg, Martin H.; Mostoslavsky, Gustavo; Murphy, George J.			A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem Cells	STEM CELL REPORTS			English	Article							BETA-GLOBIN; CRISPR/CAS9; GENERATION; HEMOGLOBIN; CASSETTE; GENE	Sickle cell anemia affects millions of people worldwide and is an emerging global health burden. As part of a large NIH-funded NextGen Consortium, we generated a diverse, comprehensive, and fully characterized library of sickle-cell-disease-specific induced pluripotent stem cells (iPSCs) from patients of different ethnicities, beta-globin gene (HBB) haplotypes, and fetal hemoglobin (HbF) levels. iPSCs stand to revolutionize the way we study human development, model disease, and perhaps eventually, treat patients. Here, we describe this unique resource for the study of sickle cell disease, including novel haplotype-specific polymorphisms that affect disease severity, as well as for the development of patient-specific therapeutics for this phenotypically diverse disorder. As a complement to this library, and as proof of principle for future cell-and gene-based therapies, we also designed and employed CRISPR/Cas gene editing tools to correct the sickle hemoglobin (HbS) mutation.	[Park, Seonmi; Gianotti-Sommer, Andreia; Molina-Estevez, Francisco Javier; Vanuytsel, Kim; Skvir, Nick; Leung, Amy; Rozelle, Sarah S.; Mostoslavsky, Gustavo; Murphy, George J.] Boston Univ, Dept Med, Ctr Regenerat Med CReM, Sch Med, 670 Albany St,2nd Floor, Boston, MA 02118 USA; [Park, Seonmi; Gianotti-Sommer, Andreia; Molina-Estevez, Francisco Javier; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Med, Sect Gastroenterol, Boston, MA 02118 USA; [Vanuytsel, Kim; Skvir, Nick; Leung, Amy; Rozelle, Sarah S.; Chui, David H. K.; Steinberg, Martin H.; Murphy, George J.] Boston Univ, Sch Med, Dept Med, Sect Hematol Oncol, Boston, MA 02118 USA; [Shaikho, Elmutaz Mohammed] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Weir, Isabelle; Sebastiani, Paola] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02118 USA; [Jiang, Zhihua; Luo, Hong-Yuan; Chui, David H. K.] Boston Med Ctr, Hemoglobin Diagnost Reference Lab, Boston, MA 02118 USA; [Figueiredo, Maria Stella] Escola Paulista Med, Hematol & Blood Transfus Div, BR-04023062 Sao Paulo, Brazil; [Alsultan, Abdulraham] King Saud Univ, Dept Pediat, Coll Med, Sickle Cell Dis Res Ctr, Riyadh 12372, Saudi Arabia; [Al-Ali, Amein] Univ Dammam, Ctr Res & Med Consultat, Dammam 34212, Saudi Arabia; [Steinberg, Martin H.] Boston Med Ctr, Ctr Excellence Sickle Cell Dis, Boston, MA 02118 USA	Mostoslavsky, G; Murphy, GJ (reprint author), Boston Univ, Dept Med, Ctr Regenerat Med CReM, Sch Med, 670 Albany St,2nd Floor, Boston, MA 02118 USA.; Mostoslavsky, G (reprint author), Boston Univ, Sch Med, Dept Med, Sect Gastroenterol, Boston, MA 02118 USA.; Murphy, GJ (reprint author), Boston Univ, Sch Med, Dept Med, Sect Hematol Oncol, Boston, MA 02118 USA.	gmostosl@bu.edu; gjmurphy@bu.edu		Shaikho, Elmutaz/0000-0001-6835-3839; Molina-Estevez, F. Javier/0000-0001-9565-2199	NextGen Consortium from the NIH/NHLBI [U01HL107443]; University of Dammam [SP 11/2011]; Office of Collaboration and Knowledge Exchange, University of Dammam; Training grant for Biostatistics [5T32GM074905]; Training Grant for Hematology [5T32 HL007501]	This work was funded by the NextGen Consortium U01HL107443 from the NIH/NHLBI, the University of Dammam, SP 11/2011, Office of Collaboration and Knowledge Exchange, University of Dammam, Training grant for Biostatistics 5T32GM074905, and Training Grant for Hematology 5T32 HL007501. Anthony Akimbami, MD, MPH, assisted with sample collection.	Alsultan A, 2012, AM J HEMATOL, V87, P824, DOI 10.1002/ajh.23239; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Kauf TL, 2009, AM J HEMATOL, V84, P323, DOI 10.1002/ajh.21408; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Little S, 2001, CURR PROTOC HUM GENE, P9, DOI DOI 10.1002/0471142905.HG0908S07; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Ngo DA, 2012, BRIT J HAEMATOL, V156, P259, DOI 10.1111/j.1365-2141.2011.08916.x; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Smith BW, 2013, BLOOD, V122, P376, DOI 10.1182/blood-2012-11-466722; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sommer A. G., 2012, J VIS EXP; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P1, DOI 10.1017/CBO9780511596582	18	2	2	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	APR 11	2017	8	4					1076	1085		10.1016/j.stemcr.2016.12.017				10	Cell & Tissue Engineering; Cell Biology	Cell Biology	EU6FJ	WOS:000401129100022	28111279	gold			2018-01-05	
J	Shathasivam, P; Kollara, A; Spybey, T; Park, S; Clarke, B; Ringuette, MJ; Brown, TJ				Shathasivam, Premalatha; Kollara, Alexandra; Spybey, Thomasina; Park, Soyeon; Clarke, Blaise; Ringuette, Maurice J.; Brown, Theodore J.			VEPH1 expression decreases vascularisation in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation	BRITISH JOURNAL OF CANCER			English	Article						VEPH1; ovarian cancer; neovascularisation; necrosis; AKT; VEGF; IL-8; TGF-beta	VASCULOGENIC MIMICRY; CELL-SURVIVAL; ANGIOGENESIS; RECEPTOR; COMPLEX; SYSTEM; PHOSPHORYLATION; IDENTIFICATION; CONSENSUS; MELANOMA	Background: VEPH1 is amplified in several cancers including ovarian but its impact on tumour progression is unknown. Previous work has shown that VEPH1 inhibits TGFb signalling while its Drosophila ortholog increases tissue growth, raising the possibility that VEPH1 could impact tumour growth or progression. Methods: A CRISPR approach was used to disrupt VEPH1 expression in ovarian cancer ES-2 cells, while VEPH1-negative SKOV3 cells were stably transfected with VEPH1 cDNA. The impact of altered VEPH1 expression was assessed using in vitro and in vivo assays and mechanistic studies were performed in vitro. Results: VEPH1 expression in SKOV3 cells resulted in a reduced tumour growth rate associated with increased necrotic area, and decreased microvessel density and VEGF-A levels relative to tumours formed by mock-transfected cells. VEPH1 expression also decreased VEGFA and IL8 expression in SKOV3 cells and was associated with decreased activated AKT levels. These effects were not observed in ES-2 cells, which bear a BRAFV600E activating mutation that leads to constitutively increased IL8 and VEGFA expression. Conclusions: VEPH1 expression in SKOV3 ovarian cancer cells inhibits AKT activation to decrease VEGFA and IL8 expression, which leads to decreased tumour vascularisation and progression.	[Shathasivam, Premalatha; Kollara, Alexandra; Spybey, Thomasina; Park, Soyeon; Brown, Theodore J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 60 Murray St, Toronto, ON M5T 3L9, Canada; [Shathasivam, Premalatha; Kollara, Alexandra; Spybey, Thomasina; Brown, Theodore J.] Univ Toronto, Dept Obstet & Gynecol, 123 Edward St, Toronto, ON M5G 1E2, Canada; [Spybey, Thomasina; Brown, Theodore J.] Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Clarke, Blaise] Univ Hlth Network, Dept Lab Med, 190 Elizabeth St, Toronto, ON M5G 2C4, Canada; [Ringuette, Maurice J.] Univ Toronto, Dept Cell & Syst Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada	Brown, TJ (reprint author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 60 Murray St, Toronto, ON M5T 3L9, Canada.; Brown, TJ (reprint author), Univ Toronto, Dept Obstet & Gynecol, 123 Edward St, Toronto, ON M5G 1E2, Canada.; Brown, TJ (reprint author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	brown@lunenfeld.ca			CIHR [MOP74726, MOP106679]; NSERC [RGPIN312475-11]	Funded by CIHR grants MOP74726 and MOP106679 and NSERC grant RGPIN312475-11. We thank Suan Chin Yeo for lively discussions.	Alvero AB, 2009, STEM CELLS, V27, P2405, DOI 10.1002/stem.191; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Backman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097997; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Beaufort CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103988; Bottos A, 2012, P NATL ACAD SCI USA, V109, pE353, DOI 10.1073/pnas.1105026109; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Hernandez P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-13; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Khalili JS, 2012, CLIN CANCER RES, V18, P5329, DOI 10.1158/1078-0432.CCR-12-1632; Kollara A, 2010, J STEROID BIOCHEM, V118, P51, DOI 10.1016/j.jsbmb.2009.09.017; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804                                                            ; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369                                                     ; Liao S, 2011, CLIN CANCER RES, V17, P1415, DOI 10.1158/1078-0432.CCR-10-2429; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Millimagg D, 2009, INT J ONCOL, V35, P1423, DOI 10.3892/ijo_00000460; Muto E, 2004, BIOCHIMIE, V86, P523, DOI 10.1016/j.biochi.2004.07.010; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; PUY L, 1995, J STEROID BIOCHEM, V55, P197, DOI 10.1016/0960-0760(95)00165-V; Qian J, 2008, J THORAC ONCOL, V3, P212, DOI 10.1097/JTO.0b013e3181663544; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seftor REB, 2012, AM J PATHOL, V181, P1115, DOI [10.1016/j.ajpath.2012.7.013, 10.1016/j.ajpath.2012.07.013]; Shathasivam P, 2015, P NATL ACAD SCI USA, V112, pE3000, DOI 10.1073/pnas.1504671112; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Ursini-Siegel J, 2012, ONCOGENE, V31, P5038, DOI 10.1038/onc.2012.4; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1                                                   ; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Whipple CA, 2014, BRIT J CANCER, V111, P1625, DOI 10.1038/bjc.2014.452; Ylipaa A, 2011, CANCER-AM CANCER SOC, V117, P380, DOI 10.1002/cncr.25594; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	39	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0007-0920	1532-1827		BRIT J CANCER	Br. J. Cancer	APR 11	2017	116	8					1065	1076		10.1038/bjc.2017.51				12	Oncology	Oncology	ES4EW	WOS:000399483700018	28301874				2018-01-05	
J	Zaidi, SSEA; Mansoor, S				Zaidi, Syed Shan-e-Ali; Mansoor, Shahid			Viral Vectors for Plant Genome Engineering	FRONTIERS IN PLANT SCIENCE			English	Review						CRISPR/Cas9; DNA replicon; geminivirus; genome engineering; Tobacco rattle virus (TRV)	CRISPR/CAS9 SYSTEM; VIRUS-RESISTANCE; IMMUNE-SYSTEM; DNA REPLICONS; GEMINIVIRUSES; GENE; RECOMBINATION; INTERFERENCE; EXPRESSION; SATELLITES	Recent advances in genome engineering (GE) has made it possible to precisely alter DNA sequences in plant cells, providing specifically engineered plants with traits of interest. Gene targeting efficiency depends on the delivery-method of both sequence-specific nucleases and repair templates, to plant cells. Typically, this is achieved using Agrobacterium mediated transformation or particle bombardment, both of which transform only a subset of cells in treated tissues. The alternate in planta approaches, stably integrating nuclease-encoding cassettes and repair templates into the plant genome, are time consuming, expensive and require extra regulations. More efficient GE reagents delivery methods are clearly needed if GE is to become routine, especially in economically important crops that are difficult to transform. Recently, autonomously replicating virus-based vectors have been demonstrated as efficient means of delivering GE reagents in plants. Both DNA viruses (Bean yellow dwarf virus, Wheat dwarf virus and Cabbage leaf curl virus) and RNA virus (Tobacco rattle virus) have demonstrated efficient gene targeting frequencies in model plants (Nicotiana benthamiana) and crops (potato, tomato, rice, and wheat). Here we discuss the recent advances using viral vectors for plant genome engineering, the current limitations and future directions.	[Zaidi, Syed Shan-e-Ali; Mansoor, Shahid] Natl Inst Biotechnol & Genet Engn, Mol Virol & Gene Silencing Lab, Agr Biotechnol Div, Faisalabad, Pakistan	Zaidi, SSEA; Mansoor, S (reprint author), Natl Inst Biotechnol & Genet Engn, Mol Virol & Gene Silencing Lab, Agr Biotechnol Div, Faisalabad, Pakistan.	shan.e.ali@outlook.com; shahidmansoor7@gmail.com		Zaidi, Syed Shan e Ali/0000-0002-2976-4624			Ali Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep26912; Ali Z, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1044191; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Briddon RW, 2006, VIROLOGY, V344, P198, DOI 10.1016/j.virol.2005.09.042; Briddon R. W., 2015, ELS, DOI [10.1002/9780470015902.a0000750.pub3, DOI 10.1002/9780470015902.A0000750.PUB3]; Butler NM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01045; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Chaparro-Garcia A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0829-4; Choi IR, 2000, PLANT J, V23, P547, DOI 10.1046/j.1365-313x.2000.00820.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Hanley-Bowdoin L., 2013, MICROBIOLOGY, V11, P777, DOI DOI 10.1038/NRMICR03117; Honig A, 2015, MOL PLANT, V8, P1292, DOI 10.1016/j.molp.2015.04.001; Ji X, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.144, 10.1038/nplants.2015.144]; Kharazmi S, 2016, MOL BIOTECHNOL, V58, P362, DOI 10.1007/s12033-016-9935-0; Lee WS, 2012, PLANT PHYSIOL, V160, P582, DOI 10.1104/pp.112.203489; Lozano G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00162; Lozano-Duran R, 2016, NEW PHYTOL, V210, P58, DOI 10.1111/nph.13564; Marton I, 2010, PLANT PHYSIOL, V154, P1079, DOI 10.1104/pp.110.164806; Nawaz-Ul-Rehman MS, 2009, FEBS LETT, V583, P1825, DOI 10.1016/j.febslet.2009.05.045; Noman A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01740; Pyott DE, 2016, MOL PLANT PATHOL, V17, P1276, DOI 10.1111/mpp.12417; Qi YP, 2016, MUTAT RES-FUND MOL M, V783, P9, DOI 10.1016/j.mrfmmm.2015.12.002; Rey MEC, 2012, VIRUSES-BASEL, V4, P1753, DOI 10.3390/v4091753; Richter KS, 2016, VIROLOGY, V493, P113, DOI 10.1016/j.virol.2016.03.014; Rybicki ER, 2009, DRUG DISCOV TODAY, V14, P16, DOI 10.1016/j.drudis.2008.10.002; Schaeffer SM, 2016, PLANT CELL REP, V35, P1451, DOI 10.1007/s00299-016-1987-x; Senthil-Kumar M, 2014, NAT PROTOC, V9, P1549, DOI 10.1038/nprot.2014.092; Songstad DD, 2017, CRIT REV PLANT SCI, V36, P1, DOI 10.1080/07352689.2017.1281663; Voytas DF, 2013, PLANT BIOLOGY, V64, P327, DOI DOI 10.1146/ANNUREV-ARPLANT-042811-105552; Wang MG, 2017, MOL PLANT, V10, P1007, DOI 10.1016/j.molp.2017.03.002; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Zaidi SSEA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01673; Zaidi SSEA, 2016, TRENDS PLANT SCI, V21, P279, DOI 10.1016/j.tplants.2016.01.023; Zhou XP, 2013, ANNU REV PHYTOPATHOL, V51, P357, DOI 10.1146/annurev-phyto-082712-102234; Zlotorynski E, 2015, NAT REV MOL CELL BIO, V16, DOI 10.1038/nrm4079	42	1	1	23	42	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	APR 11	2017	8								539	10.3389/fpls.2017.00539				6	Plant Sciences	Plant Sciences	ER7JY	WOS:000398990300001	28443125	gold			2018-01-05	
J	So, D; Kleiderman, E; Toure, SB; Joly, Y				So, Derek; Kleiderman, Erika; Toure, Seydina B.; Joly, Yann			Disease Resistance and the Definition of Genetic Enhancement	FRONTIERS IN GENETICS			English	Article						enhancement; gene editing; gene therapy; CRISPR/Cas9; CCR5; HIV; disease resistance	GENOME; CCR5; CRISPR/CAS; ISSUES; HIV	Recent gene editing experiments carried out in human embryos have raised the question of whether interventions like the introduction of a CCR5-Delta 32 deletion, which could provide heritable resistance to HIV infection, ought to be considered enhancements. Many authors have used the term "enhancement" in different ways, some based on patients' biomedical outcomes and others on their social context. These classifications are often considered overly imprecise. Nevertheless, the concept of "enhancement" could affect the ways in which these applications are regulated in different jurisdictions, the availability of coverage by insurers or public health care, and the force of public opinion in shaping future policy on gene editing. In order to ethically situate resistance to communicable disease with reference to other techniques, this article provides an overview of its similarities and differences with disease gene therapy in embryos, gene therapy in consenting adults, and vaccination. In discussing key ethical features of CCR5-Delta 32 deletion (including its frequency in various populations, biological mechanism, benefits for individuals, and use in previous clinical trials) we offer some potential guideposts for the continuing discussion on how to classify "enhancements" in the age of CRISPR gene editing.	[So, Derek; Kleiderman, Erika; Toure, Seydina B.; Joly, Yann] McGill Univ, Dept Human Genet, Ctr Genom & Policy, Montreal, PQ, Canada	So, D; Joly, Y (reprint author), McGill Univ, Dept Human Genet, Ctr Genom & Policy, Montreal, PQ, Canada.	derek.so@mail.mcgill.ca; yann.joly@mcgill.ca			Canadian Institutes of Health Research (CIHR) [146265]	DS would like to thank the Canadian Institutes of Health Research (CIHR) for their funding through the Doctoral Research Award titled "Developing a Novel Bioethics Framework for Genomic Engineering in Human Disease" (reference number 146265).	Abou-El-Enein M, 2016, CELL STEM CELL, V19, P293, DOI 10.1016/j.stem.2016.08.012; ACMG Board of Directors, 2017, GENET MED, DOI [10.1038/gim.2016.195, DOI 10.1038/GIM.2016.195]; Agar N., 2004, LIBERAL EUGENICS DEF, DOI [10.1002/9780470775004, DOI 10.1002/9780470775004]; Anderson JA, 2015, CLIN GENET, V87, P301, DOI 10.1111/cge.12460; Annas GJ, 2002, AM J LAW MED, V28, P151; Araki M, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-108; Baltimore D, 2016, ISSUES SCI TECHNOL, V32, P55; Blendon RJ, 2016, NEW ENGL J MED, V374, P1406, DOI 10.1056/NEJMp1602010; Bostrom N., 2007, NEW WAVES APPL ETHIC, P120; Buchanan A., 2000, CHANCE CHOICE GENETI, DOI [10.1017/CBO9780511806940, DOI 10.1017/CBO9780511806940]; Caplan AL, 2015, EMBO REP, V16, P1421, DOI 10.15252/embr.201541337; Chambers GM, 2013, FERTIL STERIL, V100, P319, DOI 10.1016/j.fertnstert.2013.06.017; Cohen I. Glenn, 2014, TULSA LAW REV, V49, P645; Committee on Human Gene Editing and National Academies of Sciences Engineering and Medicine, 2017, HUM GEN ED SCI ETH G; Council of Europe, 1997, CONV PROT HUM RIGHTS; Daniels N, 2000, CAMB Q HEALTHC ETHIC, V9, P309; Daniels N., 1985, JUST HLTH CARE, DOI [10.1017/CBO9780511624971, DOI 10.1017/CBO9780511624971]; de Melo-Martin I, 2010, J MED ETHICS, V36, P483, DOI 10.1136/jme.2010.036095; Douglas T., 2013, ENHANCEMENT BIOMEDIC; Elhauge E, 2014, TULSA LAW REV, V49, P607; Feinberg J, 1980, WHOSE CHILD CHILDREN, P124; Fox D, 2007, RATIO, V20, P1, DOI 10.1111/j.1467-9329.2007.00343.x                                                ; Funk C., 2016, US PUBLIC OPINION FU; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Greely Henry T., 2008, U KAN L REV, V56, P1139; Gyngell C, 2017, J APPL PHILOS, V34, P498, DOI 10.1111/japp.12249; HABERMAS J, 2003, FUTURE HUMAN NATURE; Harris J, 2007, ENHANCING EVOLUTION: THE ETHICAL CASE FOR MAKING BETTER PEOPLE, P1; Hotze TD, 2011, AM J BIOETHICS, V11, P3, DOI 10.1080/15265161.2011.534957; Indian Council of Medical Research, 2000, ETH GUID BIOM RES IN; Interdisciplinary Study Group, 2008, GEN THER GERM INT SU; Isasi R, 2016, SCIENCE, V351, P337, DOI 10.1126/science.aad6778; Isasi R, 2015, NAT BIOTECHNOL, V33, P454, DOI 10.1038/nbt.3231; Ishii T, 2015, TRENDS MOL MED, V21, P473, DOI 10.1016/j.molmed.2015.05.006; Joly Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-25; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Knoppers BM, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0007-2; Knowles L. P., 2007, REPROGENETICS LAW PO; Lander ES, 2015, NEW ENGL J MED, V373, P5, DOI 10.1056/NEJMp1506446; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Lopalco L, 2010, VIRUSES-BASEL, V2, P574, DOI 10.3390/v2020574; McCaughey T, 2016, CELL STEM CELL, V18, P569, DOI 10.1016/j.stem.2016.04.011; Mehlman M., 1998, ACCESS GENOME CHALLE; Mehlman M J, 1999, Wake Forest Law Rev, V34, P671; Moodley K., 2015, INT SUMM GEN ED NAT; Parens E., 1998, ENHANCING HUMAN TRAI, P1; Quigley M, 2010, PHILOS MED, V104, P123, DOI 10.1007/978-90-481-2477-0_7; Resnik D. B., 1999, NAT MED, V5, P245; Roberts J. T. F., 2014, KRITERION, V28, P1; Robertson JA, 2003, HUM REPROD, V18, P465, DOI 10.1093/humrep/deg100; Rodriguez E., 2016, J CLIN RES BIOETH, V7, P266, DOI [10.4172/2155-9627.1000266, DOI 10.4172/2155-9627.1000266]; Sandel Michael, 2004, ATLANTIC MONTHLY, V293, P51; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Walters L., 1997, ETHICS HUMAN GENE TH; Werner-Felmayer G, 2015, AM J BIOETHICS, V15, P49, DOI 10.1080/15265161.2015.1103810; ZIMMERMAN BK, 1991, J MED PHILOS, V16, P593, DOI 10.1093/jmp/16.6.593                                                            	57	0	0	8	8	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-8021			FRONT GENET	Front. Genet.	APR 10	2017	8								40	10.3389/fgene.2017.00040				6	Genetics & Heredity	Genetics & Heredity	EW7WB	WOS:000402727000001	28443132	gold			2018-01-05	
J	Das, J; Dey, P; Banerjee, P				Das, Jayashree; Dey, Pritha; Banerjee, Pradipta			Redesigning nature: to be or not to be?	CURRENT SCIENCE			English	Article						Designer babies; genome editing; patent rights; redesigning nature	CRISPR-CAS9; ENDONUCLEASE; MUTATIONS; SYSTEM; CELLS; CAS9	The concept of designer babies' is indeed intriguing, wherein offspring characteristics can be modified in the embryonic stage by gene editing. Genome editing has got an immense boost with the advent of the Cas/CRISPR technology that utilizes proteins from a bacterial immune system to remove defective genes and replaces them with a rectified edition. The technique is proving to be successful in fighting a host of genetic diseases, including cancer and has even made headway with HIV. The technology has sparked a revolution in genomics with a storm brewing over its patent rights.	[Das, Jayashree; Dey, Pritha] Dayananda Sagar Univ, Dayananda Sagar Inst, Sch Biol Sci, Dept Biochem, Shavige Malleshwara Hills, Bengaluru 560078, India; [Banerjee, Pradipta] Dayananda Sagar Univ, Sch Basic & Appl Sci, Shavige Malleshwara Hills, Bengaluru 560078, India	Das, J (reprint author), Dayananda Sagar Univ, Dayananda Sagar Inst, Sch Biol Sci, Dept Biochem, Shavige Malleshwara Hills, Bengaluru 560078, India.	jayashreedas26@gmail.com			Dayananda Sagar University, Bengaluru	We thank Dayananda Sagar University, Bengaluru for support.	Adhikari K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10815; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; DiCarlo J. E., 2013, NUCLEIC ACIDS RES, P1; Evans M, 2001, N Z Bioeth J, V2, P17; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Regalado A., 2015, MIT TECHNOL REV; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sterckx S, 2013, GENET MED, V15, P923, DOI 10.1038/gim.2013.164; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Wang X., 2016, SCI REP, V6; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042	21	0	0	91	95	INDIAN ACAD SCIENCES	BANGALORE	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA	0011-3891			CURR SCI INDIA	Curr. Sci.	APR 10	2017	112	7					1346	1350		10.18520/cs/v112/i07/1346-1350				5	Multidisciplinary Sciences	Science & Technology - Other Topics	ET6HY	WOS:000400393300013		gold			2018-01-05	
J	Lin, L; Petersen, TS; Jensen, KT; Bolund, L; Kuhn, R; Luo, YL				Lin, Lin; Petersen, Trine Skov; Jensen, Kristopher Torp; Bolund, Lars; Kuehn, Ralf; Luo, Yonglun			Fusion,of SpCas9 to E-coli Rec A protein enhances CRISPR-Cas9 mediated gene knockout in mammalian cells	JOURNAL OF BIOTECHNOLOGY			English	Article						CRISPR; SpCas9; Rec A; SpCas9(1.1); DSB; SSA	HOMOLOGOUS RECOMBINATION; DNA; REPAIR; ENDONUCLEASE; EFFICIENCY; BREAKS; CAS9; EUKARYOTES; NUCLEASES; MECHANISM	Mammalian cells repair double-strand DNA breaks (DSB) by a range of different pathways following DSB induction by the engineered clustered regularly interspaced short palindromic repeats (CRISPR)associated protein Cas9. While CRISPR-Cas9 thus enables predesigned modifications of the genome, applications of CRISPR-Cas9-mediated genome-editing are frequently hampered by the unpredictable and varying pathways for DSB repair in mammalian cells. Here we present a strategy of fusing Cas9 to recombinant proteins for fine-tuning of the DSB repair preferences in mammalian cells. By fusing Streptococcus Pyogenes Cas9 (SpCas9) to the recombinant protein A (Rec A, NP_417179.1) from Escherichia coli, we create a recombinant Cas9 protein (rSpCas9) which enhances the generation of indel mutations at DSB sites in mammalian cells, increases the frequency of DSB repair by homology-directed single-strand annealing (SSA), and represses homology-directed gene conversion by approximately 33%. Our study thus proves for the first time that fusing SpCas9 to recombinant proteins can influence the balance between DSB repair pathways in mammalian cells. This approach may form the basis for further investigations of the applications of recombinant Cas9 proteins to fine-tuning DSB repair pathways in eukaryotic cells.(C) 2017 Elsevier B.V. All rights reserved.	[Lin, Lin; Petersen, Trine Skov; Jensen, Kristopher Torp; Bolund, Lars; Luo, Yonglun] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Jensen, Kristopher Torp] Univ Cambridge, Cambridge, England; [Kuehn, Ralf] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Kuehn, Ralf] Berlin Inst Hlth, D-10117 Berlin, Germany	Luo, YL (reprint author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	alun@biomed.au.dk	Luo, Yonglun/C-4708-2013; Kuhn, Ralf/U-1278-2017	Luo, Yonglun/0000-0002-0007-7759; Kuhn, Ralf/0000-0003-1694-9803	Danish Research Council for Independent Research [DFF-1337-00128]; Sapere Aude Young Research Talent Prize [DFF-1335-00763]; Innovation Fund Denmark (Brain-Stem); Lundbeck Foundation [R173-2014-1105, R151-2013-14439]; German Ministry of Education and Research within the VIP program [TAL-CUT 03V0261]	We thank Andrew Bassett (Head of Genome Engineering Oxford University of Oxford) for critical comments and suggestions to the study, the FACS Core Facility of Aarhus University for technical help with all FCM analyses. This work was funded by grants from the Danish Research Council for Independent Research (DFF-1337-00128, to Y.L.), the Sapere Aude Young Research Talent Prize (DFF-1335-00763, to Y.L.), the Innovation Fund Denmark (Brain-Stem, to Y.L.), the Lundbeck Foundation (R173-2014-1105, to Y.L.; R151-2013-14439, to L.B.), and the German Ministry of Education and Research within the VIP program (TAL-CUT 03V0261, to R.K.).	Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Caner M.C., 2015, NATURE, V527, P192; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500                                          ; Kuhar R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt872; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Luo YL, 2011, TRANSGENIC RES, V20, P975, DOI 10.1007/s11248-010-9472-8; Mali P., 2013, SCIENCE; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Richardson CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12463; Shcherbakova OG, 2000, MUTAT RES-DNA REPAIR, V459, P65, DOI 10.1016/S0921-8777(99)00059-2; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Yasuda H, 2016, J GENET GENOMICS, V43, P705, DOI 10.1016/j.jgg.2016.10.006; Zhou Y, 2016, CELL MOL LIFE SCI, V73, P2543, DOI 10.1007/s00018-015-2128-3	26	0	0	10	40	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1656	1873-4863		J BIOTECHNOL	J. Biotechnol.	APR 10	2017	247						42	49		10.1016/j.jbiotec.2017.02.024				8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ET5II	WOS:000400317000008	28259533				2018-01-05	
J	Wan, XH; Koster, K; Qian, LS; Desmond, E; Brostrom, R; Hou, SB; Douglas, JT				Wan, Xuehua; Koster, Kent; Qian, Lishi; Desmond, Edward; Brostrom, Richard; Hou, Shaobin; Douglas, James T.			Genomic analyses of the ancestral Manila family of Mycobacterium tuberculosis	PLOS ONE			English	Article							SER/THR PROTEIN-KINASE; ABC TRANSPORTER; PHOSPHORYLATION; IDENTIFICATION; ALIGNMENTS; RESISTANCE; SELECTION; VIRUSES; DISEASE; RV1747	With its airborne transmission and prolonged latency period, Mycobacterium tuberculosis spreads worldwide as one of the most successful bacterial pathogens and continues to kill millions of people every year. M. tuberculosis lineage 1 is inferred to originate ancestrally based on the presence of the 52-bp TbD1 sequence and analysis of single nucleotide polymorphisms. Previously, we briefly reported the complete genome sequencing of M. tuberculosis strains 96121 and 96075, which belong to the ancient Manila family and modern Beijing family respectively. Here we present the comprehensive genomic analyses of the Manila family in lineage 1 compared to complete genomes in lineages 2-4. Principal component analysis of the presence and absence of CRISPR spacers suggests that Manila isolate 96121 is distinctly distant from lineages 2-4. We further identify a truncated whiB5 gene and a putative operon consisting of genes encoding a putative serine/threonine kinase PknH and a putative ABC transporter, which are only found in the genomes of Manila family isolates. Six single nucleotide polymorphisms are uniquely conserved in 38 Manila strains. Moreover, when compared to M. tuberculosis H37Rv, 59 proteins are under positive selection in Manila family isolate 96121 but not in Beijing family isolate 96075. The unique features further serve as biomarkers for Manila strains and may shed light on the limited transmission of this ancestral lineage outside of its Filipino host population.	[Wan, Xuehua; Hou, Shaobin] Univ Hawaii, Adv Studies Genom Prote & Bioinformat, Honolulu, HI USA; [Koster, Kent; Qian, Lishi; Douglas, James T.] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; [Desmond, Edward] Calif Dept Publ Hlth, Microbial Dis Lab, Richmond, CA USA; [Brostrom, Richard] Hawaii State Dept Hlth, TB Control Program, Honolulu, HI USA	Douglas, JT (reprint author), Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA.	jtd379@gmail.com		Wan, Xuehua/0000-0002-6367-848X	University of Hawai'i Office of Research Services; Leahi Trust of the Hawai'i Community Foundation, Honolulu, Hawaii; College of Natural Sciences; University of Hawaii; Leahi Trust of the Hawaii Community Foundation	This research was supported by the University of Hawai'i Office of Research Services and the Leahi Trust of the Hawai'i Community Foundation, Honolulu, Hawaii. Partial funding for the work described here was provided by the Dean of the College of Natural Sciences, Dr. William Ditto, to JTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Shuli Kang for advice regarding Roary pipeline, and acknowledge the support of The Leahi Trust of the Hawaii Community Foundation and The University of Hawaii.	Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Aronesty E., 2011, EA UTILS COMMAND LIN; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Burge SW, 2012, RFAM 11 0 10 YEARS R; Casonato S, 2012, INFECT IMMUN, V80, P3132, DOI 10.1128/IAI.06328-11; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Douglas JT, 2003, J CLIN MICROBIOL, V41, P2723, DOI 10.1128/JCM.41.6.2723-2726.2003; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Gardner S.N., 2013, PLOS ONE, V8; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P3795, DOI 10.1128/JCM.01726-14; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12                                                         ; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Oksanen JFG, 2015, VEGAN COMMUNITY ECOL; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schwalb B, 2015, LSD LOTS SUPERIOR DE; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Spivey VL, 2011, J BIOL CHEM, V286, P26198, DOI 10.1074/jbc.M111.246132; VANDONGEN S, 2000, INSR0010 NAT RES I M; Wan X, 2014, GENOME ANNOUNC, V2; World Health Organization, 2014, GLOB TUB REP; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zhang Y, 2011, COMPUT BIOL CHEM, V35, P319, DOI 10.1016/j.compbiolchem.2011.08.001; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhang Z, 2012, BIOCHEM BIOPH RES CO, V419, P779, DOI 10.1016/j.bbrc.2012.02.101; [Anonymous], 2015, GLOB TUB REP	45	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175330	10.1371/journal.pone.0175330				15	Multidisciplinary Sciences	Science & Technology - Other Topics	ET0LV	WOS:000399954800029	28394899	gold			2018-01-05	
J	Yan, Y; Zhao, WK; Huang, YK; Tong, H; Xia, Y; Jiang, Q; Qin, JZ				Yan, Yun; Zhao, Wukui; Huang, Yikai; Tong, Huan; Xia, Yin; Jiang, Qing; Qin, Jinzhong			Loss of Polycomb Group Protein Pcgf1 Severely Compromises Proper Differentiation of Embryonic Stem Cells	SCIENTIFIC REPORTS			English	Article							HISTONE H2A UBIQUITINATION; RNA-SEQ DATA; PRC1 COMPLEX; CPG ISLANDS; GENE; UBIQUITYLATION; REGULATOR; COREPRESSOR; METHYLATION; RECRUITMENT	The Polycomb repressive complex 1 (PRC1) is essential for fate decisions of embryonic stem (ES) cells. Emerging evidence suggests that six major variants of PRC1 complex, defined by the mutually exclusive presence of Pcgf subunit, regulate distinct biological processes, yet very little is known about the mechanism by which each version of PRC1 instructs and maintains cell fate. Here, we disrupted the Pcgf1, also known as Nspc1 and one of six Pcgf paralogs, in mouse ES cells by the CRISPR/Cas9 technology. We showed that although these mutant cells were viable and retained normal self-renewal, they displayed severe defects in differentiation in vitro. To gain a better understanding of the role of Pcgf1 in transcriptional control of differentiation, we analysed mRNA profiles from Pcgf1 deficient cells using RNA-seq. Interestingly, we found that Pcgf1 positively regulated expression of essential transcription factors involved in ectoderm and mesoderm differentiation, revealing an unexpected function of Pcgf1 in gene activation during ES cell lineage specification. Chromatin immunoprecipitation experiments demonstrated that Pcgf1 deletion caused a decrease in Ring1B and its associated H2AK119ub1 mark binding to target genes. Altogether, our results suggested an unexpected function of Pcgf1 in gene activation during ES cell maintenance.	[Yan, Yun; Zhao, Wukui; Huang, Yikai; Tong, Huan; Qin, Jinzhong] Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Jiang, Qing] Nanjing Univ, Dept Sports Med & Adult Reconstruct Surg, Nanjing Drum Tower Hosp, Med Sch, Nanjing, Jiangsu, Peoples R China	Qin, JZ (reprint author), Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China.	qinjz@nicemice.cn			National Natural Science Foundation of China [31471387, 31671532]; Shuangchuang Program of Jiangsu Province	We are indebted to Drs Zan Huang and Xiang Gao for providing lenti-virus expression vector and technical advice. This project was supported by grants from the National Natural Science Foundation of China (31471387 and 31671532) and the 2015 Shuangchuang Program of Jiangsu Province to J.Q.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Boles NC, 2014, CELL REP, V6, P724, DOI 10.1016/j.celrep.2014.01.026; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005                                                    ; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dupret B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158700; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Gong YH, 2006, NUCLEIC ACIDS RES, V34, P6158, DOI 10.1093/nar/gkl834; Gong YH, 2005, FEBS LETT, V579, P115, DOI 10.1016/j.febslet.2004.11.056; Hattori A, 2016, ADV EXP MED BIOL, V907, P153, DOI 10.1007/978-3-319-29073-7_7; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; KANNO M, 1995, EMBO J, V14, P5672; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Nunes M, 2001, MECH DEVELOP, V102, P219, DOI 10.1016/S0925-4773(01)00288-X; Oliviero G, 2015, SCI REP-UK, V5, DOI 10.1038/srep18388; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schwab MH, 2000, J NEUROSCI, V20, P3714; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Taherbhoy AM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8621; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu XD, 2008, NUCLEIC ACIDS RES, V36, P3590, DOI 10.1093/nar/gkn243; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zage PE, 2012, PEDIATR BLOOD CANCER, V58, P682, DOI 10.1002/pbc.23202; Zhao W., 2017, J BIOL CHEM	49	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 10	2017	7								46276	10.1038/srep46276				11	Multidisciplinary Sciences	Science & Technology - Other Topics	ER7GQ	WOS:000398978800001	28393894	gold			2018-01-05	
J	Nejedla, M; Li, ZL; Masser, AE; Biancospino, M; Spiess, M; Mackowiak, SD; Friedlander, MR; Karlsson, R				Nejedla, Michaela; Li, Zhilun; Masser, Anna E.; Biancospino, Matteo; Spiess, Matthias; Mackowiak, Sebastian D.; Friedlander, Marc R.; Karlsson, Roger			A Fluorophore Fusion Construct of Human Profilin I with Non-Compromised Poly(L-Proline) Binding Capacity Suitable for Imaging	JOURNAL OF MOLECULAR BIOLOGY			English	Article							ACTIN POLYMERIZATION; FLUORESCENT PROTEIN; CELL-MIGRATION; LEADING-EDGE; F-ACTIN; MOTILITY; COMPLEX; SITE; END	Profilin is vital for actin organisation in eukaryotic cells. It controls actin filament formation by binding monomeric actin and numerous proteins involved in polarised actin assembly. Important for the latter is the interaction surface formed by the N- and C-terminal helices, which pack close to each other on one side of the molecule at a distance from the actin site and mediate binding to poly-proline sequences present in many of the targeted proteins. Via these interactions, profilin contributes to the spatiotemporal control of actin filament growth. Studies of profilin dynamics in living cells by imaging techniques have been hampered by problems to generate fusion constructs with fluorophore proteins without negatively impacting on its poly-proline binding. With the object to circumvent this problem, we have generated an internal fusion of profilin with the green fluorescent variant citrine, here referred to as citrine profilin. The characterisation of citrine profilin (CIT-Pfn) demonstrates that it has full capacity to interact with poly-proline and also binds phosphatidylinositol lipids and actin, albeit with 10 times reduced affinity for the latter. Imaging of living cells expressing CIT-Pfn showed a distribution of the fusion protein similar to endogenous profilin. Furthermore, CIT-Pfn rescued the phenotypes observed after the Crispr/Cas9 knockout of the profilin 1 gene, including the lost migratory capacity characterising the knockout cells. Based on this, we conclude that the CIT-Pfn construct will be useful as a tool for displaying profilin localisation in living cells and obtaining information on its dynamic organisation under different conditions and activations of the actin microfilament and microtubule systems. (C) 2017 Elsevier Ltd. All rights reserved.	[Nejedla, Michaela; Li, Zhilun; Masser, Anna E.; Karlsson, Roger] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden; [Biancospino, Matteo] Fdn Ist FIRC Oncol Mol IFOM, IT-20139 Milan, Italy; [Spiess, Matthias] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden; [Mackowiak, Sebastian D.; Friedlander, Marc R.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Sci Life Lab, SE-10691 Stockholm, Sweden	Karlsson, R (reprint author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden.	roger.karlsson@su.se	Mackowiak, Sebastian/S-3266-2017		Carl Tryggers Stiftelse; Stiftelsen Olle Engkvist Byggmastare; Swedish Research Council; Strategic Research Area Program of the Swedish Research Council through Stockholm University	Microscopy was performed using instruments provided by IFSU, the Imaging Facility at Stockholm University. Financial support to R.K. from Carl Tryggers Stiftelse and Stiftelsen Olle Engkvist Byggmastare is kindly acknowledged. S.D.M. and M.R.F. acknowledge funding from the Swedish Research Council and the Strategic Research Area Program of the Swedish Research Council through Stockholm University.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; BJORKEGREN C, 1993, FEBS LETT, V333, P123, DOI 10.1016/0014-5793(93)80388-B; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461                                                          ; Ding ZJ, 2012, CELL ADHES MIGR, V6, P442, DOI [10.4161/cam.21832, 10.4161/cam.21831]; Grenklo S, 2004, EUR J CELL BIOL, V83, P413, DOI 10.1078/0171-9335-00400; Grenklo S, 2003, EMBO REP, V4, P523, DOI 10.1038/sj.embor.embor823; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Henty-Ridilla JL, 2015, DEV CELL, V32, P5, DOI 10.1016/j.devcel.2014.12.022; Holmberg MA, 2014, PROTEIN EXPRES PURIF, V98, P38, DOI 10.1016/j.pep.2014.03.002; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Kaiser DA, 1999, J CELL SCI, V112, P3779; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; Karlsson R, 2007, MOL BIOL INTELL UNIT, P29, DOI 10.1007/978-0-387-46407-7_3; Korenbaum E, 1998, BIOCHEMISTRY-US, V37, P9274, DOI 10.1021/bi9803675; Kullmann JA, 2015, CELL ADHES MIGR, V9, P247, DOI 10.4161/19336918.2014.983804; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Leyman S, 2009, MOL BIOL CELL, V20, P4509, DOI 10.1091/mbc.E09-02-0121; Li Y, 2008, EUR J CELL BIOL, V87, P893, DOI 10.1016/j.ejcb.2008.06.003; Lindberg U, 2008, SEMIN CANCER BIOL, V18, P2, DOI 10.1016/j.semcancer.2007.10.002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953                                                             ; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Nejedla M, 2016, MOL BIOL CELL, V27, P2381, DOI 10.1091/mbc.E15-11-0799; Nyman T, 2002, J BIOL CHEM, V277, P15828, DOI 10.1074/jbc.M112195200; Palacios-Moreno J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004130; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Pernier J, 2016, DEV CELL, V36, P201, DOI 10.1016/j.devcel.2015.12.024; Schuler H., 2006, CELL BIOL LAB HDB, V2, P165; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shekhar S, 2016, J CELL SCI, V129, P1085, DOI 10.1242/jcs.179994; Sheridan DL, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-17; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; Suarez C, 2015, DEV CELL, V32, P43, DOI 10.1016/j.devcel.2014.10.027; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Wittenmayer N, 2000, EUR J BIOCHEM, V267, P5247, DOI 10.1046/j.1432-1327.2000.01600.x	43	0	0	1	3	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2836	1089-8638		J MOL BIOL	J. Mol. Biol.	APR 7	2017	429	7					964	976		10.1016/j.jmb.2017.01.004				13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ES1DK	WOS:000399267900004	28077285				2018-01-05	
J	Hahn, F; Schmalen, A; Setz, C; Friedrich, M; Schlosser, S; Kolle, J; Sprenger, R; Rauch, P; Fraedrichl, K; Reif, T; Karius-Fischer, J; Balasubramanyam, A; Henklein, P; Fossen, T; Schubert, U				Hahn, Friedrich; Schmalen, Adrian; Setz, Christian; Friedrich, Melanie; Schloesser, Stefan; Koelle, Julia; Sprenger, Robert; Rauch, Pia; Fraedrichl, Kirsten; Reif, Tatjana; Karius-Fischer, Julia; Balasubramanyam, Ashok; Henklein, Petra; Fossen, Torgils; Schubert, Ulrich			Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AMYLOID BETA-PROTEIN; I ANTIGEN PRESENTATION; TYPE-1 P6; MOLECULAR CHARACTERIZATION; MEMBRANE ASSOCIATION; MUTATIONAL ANALYSIS; ESCRT PATHWAY; VPU-PROTEIN; P9 PROTEIN	There is a significantly higher risk for type II diabetes in HIV-1 carriers, albeit the molecular mechanism for this HIV-related pathology remains enigmatic. The 52 amino acid HIV-1 p6 Gag protein is synthesized as the C-terminal part of the Gag polyprotein Pr55. In this context, p6 promotes virus release by its two late (L-) domains, and facilitates the incorporation of the viral accessory protein Vpr. However, the function of p6 in its mature form, after proteolytic release from Gag, has not been investigated yet. We found that the mature p6 represents the first known viral substrate of the ubiquitously expressed cytosolic metalloendopeptidase insulin-degrading enzyme (IDE). IDE is sufficient and required for degradation of p6, and p6 is approximately 100-fold more efficiently degraded by IDE than its eponymous substrate insulin. This observation appears to be specific for HIV-1, as p6 proteins from HIV-2 and simian immunodeficiency virus, as well as the 51 amino acid p9 from equine infectious anaemia virus were insensitive to IDE degradation. The amount of virus-associated p6, as well as the efficiency of release and maturation of progeny viruses does not depend on the presence of IDE in the host cells, as it was shown by CRISPR/Cas9 edited IDE KO cells. However, HIV-1 mutants harboring IDE-insensitive p6 variants exhibit reduced virus replication capacity, a phenomenon that seems to depend on the presence of an X4-tropic Env. Furthermore, competing for IDE by exogenous insulin or inhibiting IDE by the highly specific inhibitor 6bK, also reduced virus replication. This effect could be specifically attributed to IDE since replication of HIV-1 variants coding for an IDE-insensitive p6 were inert towards IDE-inhibition. Our cumulative data support a model in which removal of p6 during viral entry is important for virus replication, at least in the case of X4 tropic HIV-1.	[Hahn, Friedrich; Schmalen, Adrian; Setz, Christian; Friedrich, Melanie; Schloesser, Stefan; Koelle, Julia; Sprenger, Robert; Rauch, Pia; Fraedrichl, Kirsten; Reif, Tatjana; Karius-Fischer, Julia; Schubert, Ulrich] Friedrich Alexander Univ Erlangen Nurnberg, Inst Virol, Erlangen, Germany; [Balasubramanyam, Ashok] Baylor Coll Med, Diabet Res Ctr, Translat Metab Unit, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Henklein, Petra] Charite, Inst Biochem, Berlin, Germany; [Fossen, Torgils] Univ Bergen, Dept Chem, Bergen, Norway; [Fossen, Torgils] Univ Bergen, Ctr Pharm, Bergen, Norway	Schubert, U (reprint author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Virol, Erlangen, Germany.	Orich.Schubert@viro.med.uni-erlangen.de			Deutsche Forschungsgemeinschaft [SFB643A1, GRK 1071]; Interdisziplinaere Zentrum fuer Klinische Forschung(IZKF) [A70]; NIH [RO1DK81553]	US received funding from "Deutsche Forschungsgemeinschaft", grant number SFB643A1, URL: http://gepris.dfg.de/gepris/projekt/5486111. US received funding from"Deutsche Forschungsgemeinschaft", graduate program GRK 1071, URL: http://gepris.dfg.de/gepris/projekt/440477. US received funding from "Interdisziplinaere Zentrum fuer Klinische Forschung(IZKF)", IZKF grant A70, URL: http:// www.izkf.uk-erlangen.de/. US received funding from the NIH, grant RO1DK81553, URL: https:// grants.nih.gov/grants/funding/r01.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284; Andras IE, 2013, IUBMB LIFE, V65, P43, DOI 10.1002/iub.1106; Andreoni M, 1997, AIDS RES HUM RETROV, V13, P555, DOI 10.1089/aid.1997.13.555; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Bour S, 1996, J VIROL, V70, P820; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Bruns K, 2003, J BIOL CHEM, V278, P43188, DOI 10.1074/jbc.M305413200; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; CHESNEAU V, 1994, J BIOL CHEM, V269, P2056; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3                                                   ; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Flys T, 2005, AIDS RES HUM RETROV, V21, P739, DOI 10.1089/aid.2005.21.739; Fossen T, 2005, J BIOL CHEM, V280, P42515, DOI 10.1074/jbc.M507375200; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Friedrich M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040117; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2                                                   ; GERMINARIO RJ, 1995, AIDS RES HUM RETROV, V11, P555, DOI 10.1089/aid.1995.11.555; Goldwich A, 2008, J IMMUNOL, V180, P372, DOI 10.4049/jimmunol.180.1.372                                                      ; Gottwein E, 2005, J VIROL, V79, P9134, DOI 10.1128/JVI.79.14.9134-9144.2005; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Gurer C, 2005, J VIROL, V79, P910, DOI 10.1128/JVI.79.2.910-917.2005; Gutierrez AD, 2012, ENDOCRINE, V41, P1, DOI 10.1007/s12020-011-9565-z; Hahn F, 2014, VIRUSES-BASEL, V6, P3738, DOI 10.3390/v6103738; Hahn S, 2011, J IMMUNOL, V186, P5706, DOI 10.4049/jimmunol.1003764; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hierholzer J, 2002, AIDS RES HUM RETROV, V18, P1339, DOI 10.1089/088922202320935410; HUANG MJ, 1995, J VIROL, V69, P6810; Hulse RE, 2009, VITAM HORM, V80, P635, DOI 10.1016/S0083-6729(08)00622-5; Kohler G, 1981, CHARACTERIZATION MON; Kondo E, 1996, J VIROL, V70, P159; KONDO E, 1995, J VIROL, V69, P2759; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI YX, 1991, J VIROL, V65, P3973; LIU HM, 1995, J VIROL, V69, P7630; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Marlowe N, 2004, AIDS RES HUM RETROV, V20, P1119, DOI 10.1089/aid.2004.20.1119; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313                                                             ; Martins AN, 2016, J VIROL, V90, P768, DOI 10.1128/JVI.01640-15; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Mo XY, 1999, J IMMUNOL, V163, P5851; Muller B, 2002, J VIROL, V76, P1015, DOI 10.1128/JVI.76.3.1015-1024.2002; Mwaengo DM, 1998, J VIROL, V72, P8976; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Ott DE, 1998, J VIROL, V72, P2962; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; PAN LZ, 1993, J CLIN MICROBIOL, V31, P283; Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; PAXTON W, 1993, J VIROL, V67, P7229; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peters S, 2001, J VIROL, V75, P9644, DOI 10.1128/JVI.75.20.9644-9653.2001                                                ; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Puffer BA, 1997, J VIROL, V71, P6541; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Radestock B, 2013, J VIROL, V87, P724, DOI 10.1128/JVI.02162-12; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0                                                                ; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI 10.1093/nar/gkr987; Reche P, 2015, SEQUENCE IDENTITY SI; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; SCHMIDT M, 1994, FEBS LETT, V356, P238, DOI 10.1016/0014-5793(94)01277-6; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47                                                             ; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; SCHUBERT U, 1995, J VIROL, V69, P7699; Schubert U, 1999, J VIROL, V73, P887; Sharma A, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-74; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SHENG NJ, 1994, J VIROL, V68, P6207; Solbak SMO, 2013, BBA-BIOMEMBRANES, V1828, P816, DOI 10.1016/j.bbamem.2012.11.010; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tamiya S, 2004, J VIROL, V78, P12030, DOI 10.1128/JVI.78.21.12030-12040.2004; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Votteler J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-11; WILLEY RL, 1988, J VIROL, V62, P139; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Yu XG, 2002, AIDS, V16, P321, DOI 10.1097/00002030-200202150-00002	93	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174254	10.1371/journal.pone.0174254				29	Multidisciplinary Sciences	Science & Technology - Other Topics	ES2RO	WOS:000399375800003	28388673	gold			2018-01-05	
J	Liu, YY; Han, X; Yuan, JT; Geng, TY; Chen, SH; Hu, XM; Cui, IH; Cui, HM				Liu, Yangyang; Han, Xiao; Yuan, Junting; Geng, Tuoyu; Chen, Shihao; Hu, Xuming; Cui, Isabelle H.; Cui, Hengmi			Biallelic insertion of a transcriptional terminator via the CRISPR/Cas9 system efficiently silences expression of protein-coding and non-coding RNA genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; gene knockout; gene silencing; long non-coding RNA (long ncRNA; lncRNA); polyadenylation	HUMAN GENOME; LOCUS; LNCRNA; CELLS; MICE; CAS9; DNA	The type II bacterial CRISPR/Cas9 system is a simple, convenient, and powerful tool for targeted gene editing. Here, we describe a CRISPR/Cas9-based approach for inserting a poly(A) transcriptional terminator into both alleles of a targeted gene to silence protein-coding and non-protein-coding genes, which often play key roles in gene regulation but are difficult to silence via insertion or deletion of short DNA fragments. The integration of 225 bp of bovine growth hormone poly(A) signals into either the first intron or the first exon or behind the promoter of target genes caused efficient termination of expression of PPP1R12C, NSUN2 (protein-coding genes), and MALAT1 (non-protein-coding gene). Both NeoR and PuroR were used as markers in the selection of clonal cell lines with biallelic integration of a poly(A) signal. Genotyping analysis indicated that the cell lines displayed the desired biallelic silencing after a brief selection period. These combined results indicate that this CRISPR/Cas9-based approach offers an easy, convenient, and efficient novel technique for gene silencing in cell lines, especially for those in which gene integration is difficult because of a low efficiency of homology-directed repair.	[Liu, Yangyang; Han, Xiao; Yuan, Junting; Geng, Tuoyu; Chen, Shihao; Hu, Xuming; Cui, Hengmi] Yangzhou Univ, Inst Epigenet & Epigen, 48 East Wenhui Rd, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Yangyang; Han, Xiao; Geng, Tuoyu; Chen, Shihao; Hu, Xuming; Cui, Hengmi] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Yuan, Junting] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou 225009, Jiangsu, Peoples R China; [Cui, Hengmi] Yangzhou Univ, Inst Comparat Med, Yangzhou 225009, Jiangsu, Peoples R China; [Cui, Hengmi] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Cui, Isabelle H.] New York Presbyterian Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA	Cui, HM (reprint author), Yangzhou Univ, Inst Epigenet & Epigen, 48 East Wenhui Rd, Yangzhou 225009, Jiangsu, Peoples R China.	hmcui@yzu.edu.cn			National Key Research and Development Program in China [2016YFC1303604]; National Natural Science Foundation of China [81171965, 81372237, 91540117]; Priority Academic Program Development of Jiangsu Higher Education Institutions (Animal Science and Veterinary Medicine)	This work was supported by National Key Research and Development Program in China Grant 2016YFC1303604, National Natural Science Foundation of China Grants 81171965, 81372237, and 91540117, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Animal Science and Veterinary Medicine). The authors declare that they have no conflicts of interest with the contents of this article.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BATT DB, 1994, NUCLEIC ACIDS RES, V22, P2811, DOI 10.1093/nar/22.14.2811; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Han JX, 2014, RNA BIOL, V11, P829, DOI 10.4161/rna.29624; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Jiang Q, 2014, RNA BIOL, V11, P1243, DOI 10.1080/15476286.2014.996067; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Ling H, 2015, ONCOGENE, V34, P5003, DOI 10.1038/onc.2014.456; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhuang CL, 2015, ONCOTARGET, V6, P41194, DOI 10.18632/oncotarget.5880	21	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5624	5633		10.1074/jbc.M116.769034				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ER5AI	WOS:000398813200001	28196870	gold			2018-01-05	
J	Wang, B; Wang, YJ; Frabutt, DA; Zhang, XH; Yao, XY; Hu, D; Zhang, Z; Liu, CN; Zheng, SM; Xiang, SH; Zheng, YH				Wang, Bin; Wang, Yujie; Frabutt, Dylan A.; Zhang, Xihe; Yao, Xiaoyu; Hu, Dan; Zhang, Zhuo; Liu, Chaonan; Zheng, Shimin; Xiang, Shi-Hua; Zheng, Yong-Hui			Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; Ebola virus; glycoprotein; glycosylation; virus entry; calnexin	SIMIAN IMMUNODEFICIENCY VIRUS; PROTEIN-DEGRADATION PATHWAY; ENDOPLASMIC-RETICULUM; VIRION GLYCOPROTEINS; LINKED GLYCANS; ANTIBODY; IDENTIFICATION; TRANSMISSION; INFECTIVITY; CEM.NKR	The Ebola virus (EBOV) trimeric envelope glycoprotein (GP) precursors are cleaved into the receptor-binding GP(1) and the fusion-mediating GP(2) subunits and incorporated into virions to initiate infection. GP(1) and GP(2) form heterodimers that have 15 or two N-glycosylation sites (NGSs), respectively. Here we investigated the mechanism of how N-glycosylation contributes to GP expression, maturation, and function. As reported before, we found that, although GP(1) NGSs are not critical, the two GP(2) NGSs, Asn(563) and Asn(618), are essential for GP function. Further analysis uncovered that Asn(563) and Asn(618) regulate GP processing, demannosylation, oligomerization, and conformation. Consequently, these two NGSs are required for GP incorporation into EBOV-like particles and HIV type 1 (HIV-1) pseudovirions and determine viral transduction efficiency. Using CRISPR/Cas9 technology, we knocked out the two classical endoplasmic reticulum chaperones calnexin (CNX) and/or calreticulin (CRT) and found that both CNX and CRT increase GP expression. Nevertheless, NGSs are not required for the GP interaction with CNX or CRT. Together, we conclude that, although Asn(563) and Asn(618) are not required for EBOV GP expression, they synergistically regulate its maturation, which determines its functionality.	[Wang, Bin; Wang, Yujie; Yao, Xiaoyu; Hu, Dan; Zhang, Zhuo; Zheng, Yong-Hui] Chinese Acad Agr Sci, Harbin Vet Res Inst, CAAS Michigan State Univ Joint Lab Innate Immun, State Key Lab Vet Biotechnol, Harbin 150059, Peoples R China; [Liu, Chaonan; Zheng, Shimin] Northeast Agr Univ, Coll Vet Med, Harbin 150030, Peoples R China; [Xiang, Shi-Hua] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Xiang, Shi-Hua] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, 2215 BPS,567 Wilson Rd, E Lansing, MI 48824 USA	Zheng, YH (reprint author), Michigan State Univ, Dept Microbiol & Mol Genet, 2215 BPS,567 Wilson Rd, E Lansing, MI 48824 USA.	zhengyo@msu.edu			National Natural Science Foundation of China [31502089]; Harbin Veterinary Research Institute Grant [SKLVBP2015012]; NIAID, National Institutes of Health [AI120189, AI106477, AI122863]	Supported by National Natural Science Foundation of China Grant 31502089 and Harbin Veterinary Research Institute Grant SKLVBP2015012. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NIAID, National Institutes of Health Grants AI120189, AI106477, and AI122863. To whom correspondence should be addressed: Dept. of Microbiology and Molecular Genetics, Michigan State University, 2215 BPS, 567 Wilson Rd., East Lansing, MI 48824. Tel.: 517-884-5314; Fax: 517-353-8957; E-mail: zhengyo@msu.edu.	Cook JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003258; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Gaskill PJ, 2008, J VIROL, V82, P1615, DOI 10.1128/JVI.01757-07; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Karsten CB, 2015, J VIROL, V89, P11727, DOI 10.1128/JVI.01358-15; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lennemann NJ, 2015, J INFECT DIS, V212, pS204, DOI 10.1093/infdis/jiv201; Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Maruyama T, 1999, J VIROL, V73, P6024; Mohan GS, 2015, J VIROL, V89, P1205, DOI 10.1128/JVI.01810-14; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Sanchez A, 1998, J VIROL, V72, P6442; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Shen RZ, 2014, J VIROL, V88, P14258, DOI 10.1128/JVI.02164-14; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762                                                         ; Vygen S, 2016, AM J TROP MED HYG, V95, P897, DOI 10.4269/ajtmh.16-0295; WILLEY RL, 1992, J VIROL, V66, P7193; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wojczyk BS, 2005, GLYCOBIOLOGY, V15, P655, DOI 10.1093/glycob/cwi046; Wojczyk BS, 1998, GLYCOBIOLOGY, V8, P121, DOI 10.1093/glycob/8.2.121; Wool-Lewis RJ, 1998, J VIROL, V72, P3155; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yang ZY, 2000, NAT MED, V6, P886; Zhou T, 2015, J BIOL CHEM, V290, P22184, DOI 10.1074/jbc.M115.675207; Zhou T, 2014, J VIROL, V88, P3474, DOI 10.1128/JVI.03286-13; Zhou T, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-93; Zhou T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-31	37	3	3	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					5860	5870		10.1074/jbc.M116.768168				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ER5AI	WOS:000398813200021	28196864				2018-01-05	
J	Jackson, SA; McKenzie, RE; Fagerlund, RD; Kieper, SN; Fineran, PC; Brouns, SJJ				Jackson, Simon A.; McKenzie, Rebecca E.; Fagerlund, Robert D.; Kieper, Sebastian N.; Fineran, Peter C.; Brouns, Stan J. J.			CRISPR-Cas: Adapting to change	SCIENCE			English	Review							QUORUM SENSING CONTROLS; SPACER ACQUISITION; ESCHERICHIA-COLI; IMMUNE-SYSTEM; FOREIGN DNA; STREPTOCOCCUS-THERMOPHILUS; HALOARCULA-HISPANICA; BACTERIAL IMMUNITY; PROTEIN COMPLEX; HOST FACTOR	Bacteria and archaea are engaged in a constant arms race to defend against the ever-present threats of viruses and invasion by mobile genetic elements. The most flexible weapons in the prokaryotic defense arsenal are the CRISPR-Cas adaptive immune systems. These systems are capable of selective identification and neutralization of foreign DNA and/or RNA. CRISPR-Cas systems rely on stored genetic memories to facilitate target recognition. Thus, to keep pace with a changing pool of hostile invaders, the CRISPR memory banks must be regularly updated with new information through a process termed CRISPR adaptation. In this Review, we outline the recent advances in our understanding of the molecular mechanisms governing CRISPR adaptation. Specifically, the conserved protein machinery Cas1-Cas2 is the cornerstone of adaptive immunity in a range of diverse CRISPR-Cas systems.	[Jackson, Simon A.; Fagerlund, Robert D.; Fineran, Peter C.] Univ Otago, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand; [McKenzie, Rebecca E.; Kieper, Sebastian N.; Brouns, Stan J. J.] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Maasweg 9, NL-2629 HZ Delft, Netherlands; [Fineran, Peter C.] Univ Otago, Bioprotect Res Ctr, POB 56, Dunedin 9054, New Zealand; [Brouns, Stan J. J.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands	Fineran, PC (reprint author), Univ Otago, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand.; Brouns, SJJ (reprint author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Maasweg 9, NL-2629 HZ Delft, Netherlands.; Fineran, PC (reprint author), Univ Otago, Bioprotect Res Ctr, POB 56, Dunedin 9054, New Zealand.; Brouns, SJJ (reprint author), Wageningen Univ, Microbiol Lab, Wageningen, Netherlands.	peter.fineran@otago.ac.nz; stanbrouns@gmail.com		Jackson, Simon/0000-0002-4512-3093; Fineran, Peter/0000-0002-4639-6704	Rutherford Discovery Fellowship from the Royal Society of New Zealand (RSNZ); Marsden Fund of the RSNZ; University of Otago; Bio-Protection Research Centre (Tertiary Education Commission); European Research Council [639707]; Netherlands Organisation for Scientific Research (NWO) Vidi grant [864.11.005]; Foundation for Fundamental Research on Matter (FOM) projectruimte grant [15PR3188]	Work in the Fineran laboratory on CRISPR-Cas is supported by a Rutherford Discovery Fellowship (to P.C.F.) from the Royal Society of New Zealand (RSNZ), the Marsden Fund of the RSNZ, the University of Otago, and the Bio-Protection Research Centre (Tertiary Education Commission). The Brouns laboratory is funded by a European Research Council starting grant (639707), a Netherlands Organisation for Scientific Research (NWO) Vidi grant (864.11.005), and a Foundation for Fundamental Research on Matter (FOM) projectruimte grant (15PR3188). We thank members of the Fineran and Brouns groups for useful feedback on the manuscript.	Almendros C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.81, 10.1038/nmicrobiol.2016.81]; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Arslan Z, 2013, NUCLEIC ACIDS RES, V41, P6347, DOI 10.1093/nar/gkt315; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beguin P, 2016, NUCLEIC ACIDS RES, V44, P10367, DOI 10.1093/nar/gkw821; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Dy RL, 2014, ANNU REV VIROL, V1, P307, DOI 10.1146/annurev-virology-031413-085500; Elmore J, 2015, NUCLEIC ACIDS RES, V43, P10353, DOI 10.1093/nar/gkv1140; Erdmann S, 2012, MOL MICROBIOL, V85, P1044, DOI 10.1111/j.1365-2958.2012.08171.x; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Goren MG, 2016, CELL REP, V16, P2811, DOI 10.1016/j.celrep.2016.08.043; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Heussler GE, 2016, J BACTERIOL, V198, P3080, DOI 10.1128/JB.00458-16; Hickman AB, 2015, NUCLEIC ACIDS RES, V43, P10576, DOI 10.1093/nar/gkv1180; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Ka D, 2016, STRUCTURE, V24, P70, DOI 10.1016/j.str.2015.10.019; Koonin EV, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600186; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Krupovic M, 2016, GENOME BIOL EVOL, V8, P375, DOI 10.1093/gbe/evw006; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Lee KH, 2012, PROTEINS, V80, P2573, DOI 10.1002/prot.24138; Leenay RT, 2017, J MOL BIOL, V429, P177, DOI 10.1016/j.jmb.2016.11.024; Lemak S, 2013, J AM CHEM SOC, V135, P17476, DOI 10.1021/ja408729b; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Li RP, 2016, CELL RES, V26, P1273, DOI 10.1038/cr.2016.135; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-7; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Patterson AG, 2016, MOL CELL, V64, P1102, DOI 10.1016/j.molcel.2016.11.012; Patterson AG, 2015, NUCLEIC ACIDS RES, V43, P6038, DOI 10.1093/nar/gkv517; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rao CT, 2016, CELL MICROBIOL, V18, P1319, DOI 10.1111/cmi.12586; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Richter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049549; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Severinov K., 2016, FRONT MOL BIOSCI, V3, P45, DOI 10.3389/fmolb.2016.00045; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Sun CL, 2016, ISME J, V10, P858, DOI 10.1038/ismej.2015.162; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Vorontsova D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1261; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2013, RNA BIOL, V10, P749, DOI 10.4161/rna.24202; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xue CY, 2016, MOL CELL, V64, P826, DOI 10.1016/j.molcel.2016.09.033; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030621	108	17	17	54	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2017	356	6333					40	+		10.1126/science.aal5056				10	Multidisciplinary Sciences	Science & Technology - Other Topics	ER3IA	WOS:000398689100029					2018-01-05	
J	Rupp, LJ; Schumann, K; Roybal, KT; Gate, RE; Ye, CJ; Lim, WA; Marson, A				Rupp, Levi J.; Schumann, Kathrin; Roybal, Kole T.; Gate, Rachel E.; Ye, Chun J.; Lim, Wendell A.; Marson, Alexander			CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells	SCIENTIFIC REPORTS			English	Article							TUMOR MICROENVIRONMENT; ANTI-PD-1 ANTIBODY; CANCER; IMMUNOTHERAPY; NUCLEASES; CAS9; EXPRESSION; GENERATION; SAFETY; GENES	Immunotherapies with chimeric antigen receptor (CAR) T cells and checkpoint inhibitors (including antibodies that antagonize programmed cell death protein 1 [PD-1]) have both opened new avenues for cancer treatment, but the clinical potential of combined disruption of inhibitory checkpoints and CAR T cell therapy remains incompletely explored. Here we show that programmed death ligand 1 (PD-L1) expression on tumor cells can render human CAR T cells (anti-CD19 4-1BB.) hypo-functional, resulting in impaired tumor clearance in a sub-cutaneous xenograft model. To overcome this suppressed antitumor response, we developed a protocol for combined Cas9 ribonucleoprotein (Cas9 RNP)-mediated gene editing and lentiviral transduction to generate PD-1 deficient anti-CD19 CAR T cells. Pdcd1 (PD-1) disruption augmented CAR T cell mediated killing of tumor cells in vitro and enhanced clearance of PDL1+ tumor xenografts in vivo. This study demonstrates improved therapeutic efficacy of Cas9-edited CAR T cells and highlights the potential of precision genome engineering to enhance next-generation cell therapies.	[Rupp, Levi J.; Roybal, Kole T.; Lim, Wendell A.] Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Rupp, Levi J.; Roybal, Kole T.; Lim, Wendell A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Rupp, Levi J.; Roybal, Kole T.; Lim, Wendell A.; Marson, Alexander] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Rupp, Levi J.; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Schumann, Kathrin; Marson, Alexander] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Schumann, Kathrin; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Gate, Rachel E.; Ye, Chun J.] Univ Calif San Francisco, Inst Human Genet, Dept Epidemiol & Biostat, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Gate, Rachel E.] Univ Calif San Francisco, Biol & Med Informat Grad Program, San Francisco, CA 94158 USA; [Marson, Alexander] Univ Calif San Francisco, Dept Med, Div Infect Dis & Rheumatol, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA	Lim, WA (reprint author), Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Lim, WA (reprint author), Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA.; Lim, WA (reprint author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.; Lim, WA (reprint author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	Wendell.lim@ucsf.edu			NIH [F32 AI120352, PN2 EY016546, P50FM081879, R01 GM055040, R01 CA196277]; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft [SCHU 3020/2-1]; UCSF Sandler Fellowship; Innovative Genomics Initiative [IGI]; Burroughs Wellcome Fund	We thank Donghui Wang, Fernando Salangsang, and the UCSF Preclinical Therapeutics Core (PTC) for help with animal studies, Whitney Walker and Krista McNally for cell culture and technical support, and Jon Woo and Eric Boyer for sequencing PD-1 edited cells. This research was supported by NIH grants F32 AI120352 (L.J.R.), PN2 EY016546, P50FM081879, R01 GM055040, R01 CA196277, and the Howard Hughes Medical Institute (W.A.L); a fellowship of the Deutsche Forschungsgemeinschaft (SCHU 3020/2-1, K.S.); the UCSF Sandler Fellowship (A.M.); a gift from Jake Aronov (A.M.); and the Innovative Genomics Initiative [IGI] (A.M.). A.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and is a Chan Zuckerberg Biohub Investigator.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Anders C, 2014, METHOD ENZYMOL, V546, P1, DOI 10.1016/B978-0-12-801185-0.00001-5; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berdien B, 2014, GENE THER, V21, P539, DOI 10.1038/gt.2014.26; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bryan LJ, 2015, ONCOLOGY-NY, V29, P431; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Guedan S, 2014, BLOOD, V124, P1070, DOI 10.1182/blood-2013-10-535245; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Singh N, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5222; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Wu CY, 2015, CURR OPIN IMMUNOL, V35, P123, DOI 10.1016/j.coi.2015.06.015; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	37	5	5	19	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 7	2017	7								737	10.1038/s41598-017-00462-8				10	Multidisciplinary Sciences	Science & Technology - Other Topics	ER1KB	WOS:000398548100019	28389661	gold			2018-01-05	
J	Chen, FQ; Ding, X; Feng, YM; Seebeck, T; Jiang, YF; Davis, GD				Chen, Fuqiang; Ding, Xiao; Feng, Yongmei; Seebeck, Timothy; Jiang, Yanfang; Davis, Gregory D.			Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting	NATURE COMMUNICATIONS			English	Article							NUCLEASE SPECIFICITY; HUMAN-CELLS; DNA; ENDONUCLEASE; IMMUNITY; BINDING; PROTEIN	Bacterial CRISPR-Cas systems comprise diverse effector endonucleases with different targeting ranges, specificities and enzymatic properties, but many of them are inactive in mammalian cells and are thus precluded from genome-editing applications. Here we show that the type II-B FnCas9 from Francisella novicida possesses novel properties, but its nuclease function is frequently inhibited at many genomic loci in living human cells. Moreover, we develop a proximal CRISPR (termed proxy-CRISPR) targeting method that restores FnCas9 nuclease activity in a target-specific manner. We further demonstrate that this proxy-CRISPR strategy is applicable to diverse CRISPR-Cas systems, including type II-C Cas9 and type V Cpf1 systems, and can facilitate precise gene editing even between identical genomic sites within the same genome. Our findings provide a novel strategy to enable use of diverse otherwise inactive CRISPR-Cas systems for genome-editing applications and a potential path to modulate the impact of chromatin microenvironments on genome modification.	[Chen, Fuqiang; Ding, Xiao; Feng, Yongmei; Seebeck, Timothy; Jiang, Yanfang; Davis, Gregory D.] MilliporeSigma, 2909 Laclede Ave, St Louis, MO 63103 USA; [Chen, Fuqiang; Ding, Xiao; Feng, Yongmei; Seebeck, Timothy; Jiang, Yanfang; Davis, Gregory D.] Business Merck KGaA, D-64293 Darmstadt, Germany	Chen, FQ (reprint author), MilliporeSigma, 2909 Laclede Ave, St Louis, MO 63103 USA.; Chen, FQ (reprint author), Business Merck KGaA, D-64293 Darmstadt, Germany.	fuqiang.chen@sial.com					Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chereji RV, 2015, BRIEF FUNCT GENOMICS, V14, P50, DOI 10.1093/bfgp/elu038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kuzminov A, 2014, J BACTERIOL, V196, P1793, DOI 10.1128/JB.00022-14; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Raz M. H., 2016, J AM CHEM SOC, V138, P13842; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	42	4	4	10	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR 7	2017	8								14958	10.1038/ncomms14958				12	Multidisciplinary Sciences	Science & Technology - Other Topics	ER0CZ	WOS:000398455600001	28387220	gold			2018-01-05	
J	Suspene, R; Mussil, B; Laude, H; Caval, V; Berry, N; Bouzidi, MS; Thiers, V; Wain-Hobson, S; Vartanian, JP				Suspene, Rodolphe; Mussil, Bianka; Laude, Helene; Caval, Vincent; Berry, Noemie; Bouzidi, Mohamed S.; Thiers, Valerie; Wain-Hobson, Simon; Vartanian, Jean-Pierre			Self-cytoplasmic DNA upregulates the mutator enzyme APOBEC3A leading to chromosomal DNA damage	NUCLEIC ACIDS RESEARCH			English	Article							RNA-POLYMERASE-III; BREAST-CANCER; MUTATIONAL PROCESSES; I INTERFERON; CYTIDINE DEAMINASES; MITOCHONDRIAL-DNA; EDITING ENZYMES; MOLECULAR-BASIS; FOREIGN DNA; NUCLEAR-DNA	Foreign and self-cytoplasmic DNA are recognized by numerous DNA sensor molecules leading to the production of type I interferons. Such DNA agonists should be degraded otherwise cells would be chronically stressed. Most human APOBEC3 cytidine deaminases can initiate catabolism of cytoplasmic mitochondrial DNA. Using the human myeloid cell line THP-1 with an interferon inducible APOBEC3A gene, we show that cytoplasmic DNA triggers interferon alpha and beta production through the RNA polymerase III transcription/RIG-I pathway leading to massive upregulation of APOBEC3A. By catalyzing C -> U editing in single stranded DNA fragments, the enzyme prevents them from re-annealing so attenuating the danger signal. The price to pay is chromosomal DNA damage in the form of CG. TA mutations and double stranded DNA breaks which, in the context of chronic inflammation, could drive cells down the path toward cancer.	[Suspene, Rodolphe; Mussil, Bianka; Laude, Helene; Caval, Vincent; Berry, Noemie; Bouzidi, Mohamed S.; Thiers, Valerie; Wain-Hobson, Simon; Vartanian, Jean-Pierre] Inst Pasteur, Mol Retrovirol Unit, 28 Rue Dr Roux, F-75724 Paris 15, France; [Mussil, Bianka] German Primate Ctr, Unit Infect Models, Kellnerweg 4, D-37077 Gottingen, Germany	Vartanian, JP (reprint author), Inst Pasteur, Mol Retrovirol Unit, 28 Rue Dr Roux, F-75724 Paris 15, France.	jean-pierre.vartanian@pasteur.fr			Institut Pasteur, Centre National de Recherche Scientifique (CNRS); Institut National du Cancer [S-CR14106]; OSEO [FUI AAP12]; Ligue Nationale contre le Cancer [GB/MA/CD-11283]; Institut Pasteur	Institut Pasteur, Centre National de Recherche Scientifique (CNRS); Institut National du Cancer [S-CR14106 to B.M.]; OSEO [FUI AAP12 to V.C.]; Ligue Nationale contre le Cancer [GB/MA/CD-11283 to M.S.B.]. Funding for open access charge: Institut Pasteur.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0                                                   ; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Caval V, 2015, NUCLEIC ACIDS RES, V43, P9340, DOI 10.1093/nar/gkv935; Caval V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6129; Caval V, 2014, MOL BIOL EVOL, V31, P330, DOI 10.1093/molbev/mst195; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Denissenko MF, 1997, P NATL ACAD SCI USA, V94, P3893, DOI 10.1073/pnas.94.8.3893; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hemmi H, 2000, NATURE, V408, P740; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Komatsu A, 2008, INT J ONCOL, V33, P261, DOI 10.3892/ijo_00000005; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsuda K, 2015, HUM MOL GENET, V24, P1177, DOI 10.1093/hmg/ddu512; Mussil B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073641; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seplyarskiy VB, 2016, GENOME RES, V26, P174, DOI 10.1101/gr.197046.115; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063461; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554                                                      ; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	55	1	1	2	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	APR 7	2017	45	6					3231	3241		10.1093/nar/gkx001				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EQ9AI	WOS:000398376200033	28100701	gold			2018-01-05	
J	Musharova, O; Klimuk, E; Datsenko, KA; Metlitskaya, A; Logacheva, M; Semenova, E; Severinov, K; Savitskaya, E				Musharova, Olga; Klimuk, Evgeny; Datsenko, Kirill A.; Metlitskaya, Anastasia; Logacheva, Maria; Semenova, Ekaterina; Severinov, Konstantin; Savitskaya, Ekaterina			Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation	NUCLEIC ACIDS RESEARCH			English	Article							ADAPTIVE BACTERIAL IMMUNITY; IN-VITRO RECONSTITUTION; ESCHERICHIA-COLI; STREPTOCOCCUS-THERMOPHILUS; FOREIGN DNA; SYSTEM; ACQUISITION; RNA; INTERFERENCE; CASCADE	During primed CRISPR adaptation spacers are preferentially selected from DNA recognized by CRISPR interference machinery, which in the case of Type I CRISPR-Cas systems consists of CRISPR RNA (crRNA) bound effector Cascade complex that locates complementary targets, and Cas3 executor nuclease/helicase. A complex of Cas1 and Cas2 proteins is capable of inserting new spacers in the CRISPR array. Here, we show that in Escherichia coli cells undergoing primed adaptation, spacersized fragments of foreign DNA are associated with Cas1. Based on sensitivity to digestion with nucleases, the associated DNA is not in a standard double-stranded state. Spacer-sized fragments are cut from one strand of foreign DNA in Cas1-and Cas3-dependent manner. These fragments are generated from much longer S1-nuclease sensitive fragments of foreign DNA that require Cas3 for their production. We propose that in the course of CRISPR interference Cas3 generates fragments of foreign DNA that are recognized by the Cas1-Cas2 adaptation complex, which excises spacer-sized fragments and channels them for insertion into CRISPR array.	[Musharova, Olga; Klimuk, Evgeny; Severinov, Konstantin; Savitskaya, Ekaterina] Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia; [Musharova, Olga; Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Musharova, Olga; Klimuk, Evgeny; Metlitskaya, Anastasia; Severinov, Konstantin; Savitskaya, Ekaterina] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Datsenko, Kirill A.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Logacheva, Maria] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119234, Russia; [Semenova, Ekaterina; Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	Severinov, K (reprint author), Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia.; Severinov, K (reprint author), Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia.; Severinov, K (reprint author), Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia.; Severinov, K (reprint author), Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Klimuk, Evgeny/E-5920-2017	Klimuk, Evgeny/0000-0001-5314-038X	National Institutes of Health [NIGMS RO1 10407]; Russian Science Foundation [14-14-00988]; Russian Foundation for Basic Research [16-04-00767]; Skolkovo Institute of Science and Technology	National Institutes of Health [NIGMS RO1 10407] and Russian Science Foundation [14-14-00988] to K.S. and Russian Foundation for Basic Research grant 16-04-00767 to E.S. Funding for open access charge: Skolkovo Institute of Science and Technology.	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Semenova E, 2015, NUCLEIC ACIDS RES, V43, P6049, DOI 10.1093/nar/gkv546; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	52	2	2	4	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	APR 7	2017	45	6					3297	3307		10.1093/nar/gkx097				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EQ9AI	WOS:000398376200038	28204574	gold			2018-01-05	
J	Pirnie, SP; Osman, A; Zhu, YZ; Carmichael, GG				Pirnie, Stephan P.; Osman, Ahmad; Zhu, Yinzhou; Carmichael, Gordon G.			An Ultraconserved Element (UCE) controls homeostatic splicing of ARGLU1 mRNA	NUCLEIC ACIDS RESEARCH			English	Article							NONSENSE-MEDIATED DECAY; PROTEIN-PROTEIN INTERACTIONS; INTRON RETENTION; SR PROTEIN; GENE-EXPRESSION; REGULATORY NETWORK; NEGATIVE CONTROL; HUMAN GENOME; BINDING; IDENTIFICATION	Arginine and Glutamate-Rich protein 1 (ARGLU1) is a protein whose function is poorly understood, but may act in both transcription and pre-mRNA splicing. We demonstrate that the ARGLU1 gene expresses at least three distinct RNA splice isoforms -a fully spliced isoform coding for the protein, an isoform containing a retained intron that is detained in the nucleus, and an isoform containing an alternative exon that targets the transcript for nonsense mediated decay. Furthermore, ARGLU1 contains a long, highly evolutionarily conserved sequence known as an Ultraconserved Element (UCE) that is within the retained intron and overlaps the alternative exon. Manipulation of the UCE, in a reporter minigene or via random mutations in the genomic context using CRISPR/Cas9, changed the splicing pattern. Further, overexpression of the ARGLU1 protein shifted the splicing of endogenous ARGLU1 mRNA, resulting in an increase in the retained intron isoform and nonsense mediated decay susceptible isoform and a decrease in the fully spliced isoform. Taken together with data showing that functional protein knockout shifts splicing toward the fully spliced isoform, our data are consistent with a model in which unproductive splicing complexes assembled at the alternative exon lead to inefficient splicing and intron retention.	[Pirnie, Stephan P.; Osman, Ahmad; Zhu, Yinzhou; Carmichael, Gordon G.] UCONN Hlth Ctr, Dept Genet & Genome Sci, 400 Farmington Ave, Farmington, CT 06030 USA	Carmichael, GG (reprint author), UCONN Hlth Ctr, Dept Genet & Genome Sci, 400 Farmington Ave, Farmington, CT 06030 USA.	carmichael@uchc.edu		Zhu, Yinzhou/0000-0003-0043-1321	National Institute of General Medical Sciences (NIGMS) [R01 HD072418]; NIH [HD072418]	National Institute of General Medical Sciences (NIGMS) [R01 HD072418]. Funding for open access charge: NIH [HD072418].	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Anko ML, 2010, NAT STRUCT MOL BIOL, V17, P962, DOI 10.1038/nsmb.1862; AMREIN H, 1994, CELL, V76, P735, DOI 10.1016/0092-8674(94)90512-6; Aubol BE, 2013, J MOL BIOL, V425, P2894, DOI 10.1016/j.jmb.2013.05.013; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Blencowe BJ, 2000, RNA, V6, P111, DOI 10.1017/S1355838200991982; Boutz PL, 2015, GENE DEV, V29, P63, DOI 10.1101/gad.247361.114; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Bresson SM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005610; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Cho V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r26; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Dimitrieva S, 2013, NUCLEIC ACIDS RES, V41, pD101, DOI 10.1093/nar/gks1092; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725                                                          ; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077                                                        ; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Kuhn AN, 2009, RNA, V15, P153, DOI 10.1261/rna.1332609; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lejeune F, 2001, J BIOL CHEM, V276, P7850, DOI 10.1074/jbc.M009510200; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Liao W, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1708-9; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Minton JAL, 2011, METHODS MOL BIOL, V688, P143, DOI 10.1007/978-1-60761-947-5_10; Munding EM, 2010, GENE DEV, V24, P2693, DOI 10.1101/gad.1977410; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099                                                                   ; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Parenteau J, 2011, CELL, V147, P320, DOI 10.1016/j.cell.2011.08.044; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pimentel H, 2016, NUCLEIC ACIDS RES, V44, P838, DOI 10.1093/nar/gkv1168; Tejedor JR, 2015, MOL CELL, V57, P23, DOI 10.1016/j.molcel.2014.10.029; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Retelska D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-398; SPRITZ RA, 1987, NUCLEIC ACIDS RES, V15, P10373, DOI 10.1093/nar/15.24.10373                                                         ; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; THEISSEN H, 1986, EMBO J, V5, P3209; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095                                                         ; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418                                                        ; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhang DX, 2011, J BIOL CHEM, V286, P17746, DOI 10.1074/jbc.M110.206029; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109	67	3	3	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	APR 7	2017	45	6					3473	3486		10.1093/nar/gkw1140				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EQ9AI	WOS:000398376200051	27899669	gold			2018-01-05	
J	Gurung, I; Berry, JL; Hall, AMJ; Pelicic, V				Gurung, Ishwori; Berry, Jamie-Lee; Hall, Alexander M. J.; Pelicic, Vladimir			Cloning-independent markerless gene editing in Streptococcus sanguinis: novel insights in type IV pilus biology	NUCLEIC ACIDS RESEARCH			English	Article							GRAM-POSITIVE BACTERIA; PREPILIN PEPTIDASES; TWITCHING MOTILITY; BIOGENESIS; IDENTIFICATION; COMPETENCE; PROTEINS; PILIN; ENDOCARDITIS; MUTAGENESIS	Streptococcus sanguinis, a naturally competent opportunistic human pathogen, is a Gram-positive workhorse for genomics. It has recently emerged as a model for the study of type IV pili (Tfp)-exceptionally widespread and important prokaryotic filaments. To enhance genetic manipulation of Streptococcus sanguinis, we have developed a cloning-independent methodology, which uses a counterselectable marker and allows sophisticated markerless gene editing in situ. We illustrate the utility of this methodology by answering several questions regarding Tfp biology by (i) deleting single or mutiple genes, (ii) altering specific bases in genes of interest, and (iii) engineering genes to encode proteins with appended affinity tags. We show that (i) the last six genes in the pil locus harbouring all the genes dedicated to Tfp biology play no role in piliation or Tfp-mediated motility, (ii) two highly conserved Asp residues are crucial for enzymatic activity of the prepilin peptidase PilD and (iii) that pilin subunits with a C-terminally appended hexa-histidine (6His) tag are still assembled into functional Tfp. The methodology for genetic manipulation we describe here should be broadly applicable.	[Gurung, Ishwori; Berry, Jamie-Lee; Hall, Alexander M. J.; Pelicic, Vladimir] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, London, England	Pelicic, V (reprint author), Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, London, England.	v.pelicic@imperial.ac.uk	Pelicic, Vladimir/N-3755-2017	Pelicic, Vladimir/0000-0002-9456-4995	MRC [MR/J006874/1B]	MRC (MR/J006874/1B). Funding for open access charge: MRC.	Akahane K, 2005, MOL GENET GENOMICS, V273, P350, DOI 10.1007/s00438-005-1143-8; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Caufield PW, 2000, INFECT IMMUN, V68, P4018, DOI 10.1128/IAI.68.7.4018-4023.2000; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Bentzmann S, 2006, J BACTERIOL, V188, P4851, DOI 10.1128/JB.00345-06; GAUSTAD P, 1979, ACTA PATH MICRO IM B, V87, P123; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Gurung I, 2016, MOL MICROBIOL, V99, P380, DOI 10.1111/mmi.13237; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997                                                ; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0                                                    ; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Merz AJ, 2000, NATURE, V407, P98; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871                                                     ; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; Rodriguez AM, 2011, MOL ORAL MICROBIOL, V26, P99, DOI 10.1111/j.2041-1014.2011.00606.x; Szabo Z, 2006, J BACTERIOL, V188, P1437, DOI 10.1128/JB.188.4.1437-1443.2006; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tomich M, 2006, J BACTERIOL, V188, P6899, DOI 10.1128/JB.00690-06; TRIEUCUOT P, 1983, GENE, V23, P331, DOI 10.1016/0378-1119(83)90022-7                                                    ; Varga JJ, 2006, MOL MICROBIOL, V62, P680, DOI 10.1111/j.1365-2958.2006.05414.x; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408                                                        ; Wolfgang M, 1998, P NATL ACAD SCI USA, V95, P14973, DOI 10.1073/pnas.95.25.14973                                                        ; Xie ZJ, 2011, APPL ENVIRON MICROB, V77, P8025, DOI 10.1128/AEM.06362-11; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125	39	1	1	5	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	APR 7	2017	45	6							e40	10.1093/nar/gkw1177				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EQ9AI	WOS:000398376200005	27903891	gold			2018-01-05	
J	Ho, YK; Zhou, LH; Tam, KC; Too, HP				Ho, Yoon Khei; Zhou, Li Han; Tam, Kam C.; Too, Heng Phon			Enhanced non-viral gene delivery by coordinated endosomal release and inhibition of beta-tubulin deactylase	NUCLEIC ACIDS RESEARCH			English	Article							MESENCHYMAL STEM-CELLS; INTRACELLULAR TRAFFICKING; DOPAMINERGIC-NEURONS; IN-VITRO; TRANSFECTION; POLYPLEXES; PH; EXPRESSION; AGENTS; EFFICIENCY	Efficient non-viral gene delivery is highly desirable but often unattainable with some cell-types. We report here that non-viral DNA polyplexes can efficiently transfect differentiated neuronal and stem cells. Polyplex transfection centrifugation protocols was enhanced by including a simultaneous treatment with a DOPE/CHEMS lipid suspension and a microtubule inhibitor, Tubastatin A. Lipoplex transfection protocols were not improved by this treatment. This mechanism of action was unravelled by systematically identifying and rationally mitigating barriers limiting high transfection efficiency, allowing unexpected improvements in the transfection of-mesenchymal stem cells (MSC), primary neuron and several hard-to-transfect cell types beyond what are currently achievable using cationic polymers. The optimized formulation and method achieved high transfection efficiency with no adverse effects on cell viability, cell proliferation or differentiation. High efficiency modification of MSC for cytokine overexpression, efficient generation of dopaminergic neuron using neural stem cells and enhanced genome editing with CRISPR-Cas9 were demonstrated. In summary, this study described a cost-effective method for efficient, rapid and scalable workflow for ex vivo gene delivery using a myriad of nucleic acids including plasmid DNA, mRNA, siRNA and shRNA.	[Ho, Yoon Khei; Too, Heng Phon] Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore 138668, Singapore; [Zhou, Li Han] MiRXES, 10 Biopolis Rd,Chromos 03-01, Singapore 138670, Singapore; [Tam, Kam C.] Univ Waterloo, Dept Chem Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada; [Too, Heng Phon] Natl Univ Singapore, Dept Biochem, Singapore 119260, Singapore	Too, HP (reprint author), Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore 138668, Singapore.; Too, HP (reprint author), Natl Univ Singapore, Dept Biochem, Singapore 119260, Singapore.	heng-phon_too@nuhs.edu.sg	Tam, Michael/G-4813-2010	Tam, Michael/0000-0002-7603-5635	Exploit Technologies, Agency for Science, Technology and Research [ETPL/15-R15GAP-007]	Exploit Technologies, Agency for Science, Technology and Research [ETPL/15-R15GAP-007]. Funding for open access charge: Exploit Technologies, Agency for Science, Technology and Research [ETPL/15-R15GAP-007].	Abdul Halim Nur Shuhaidatul Sarmiza, 2014, Int J Mol Sci, V15, P15044, DOI 10.3390/ijms150915044; Baek K., 2016, CURR STEM CELL REP, V2, P52; Barua S, 2010, BIOMATERIALS, V31, P5894, DOI 10.1016/j.biomaterials.2010.04.007; Borestrom C, 2014, STEM CELL TRANSL MED, V3, P433, DOI 10.5966/sctm.2013-0138; Boussif O, 1996, GENE THER, V3, P1074; Brunner S, 2000, GENE THER, V7, P401, DOI 10.1038/sj.gt.3301102; Buckland KF, 2014, ADV DRUG DELIVER REV, V73, P162, DOI 10.1016/j.addr.2014.02.010; Chen W, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00068; Cho YW, 2003, J PHARM PHARMACOL, V55, P721, DOI 10.1211/0022357021206; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; CHU CJ, 1990, PHARMACEUT RES, V7, P824, DOI 10.1023/A:1015908831507                                                         ; Ciftci K, 2001, INT J PHARM, V218, P81, DOI 10.1016/S0378-5173(01)00623-8; Coppola S, 2013, THER DELIV, V4, P191, DOI [10.4155/TDE.12.151, 10.4155/tde.12.151]; de Bruin KG, 2008, J CONTROL RELEASE, V130, P175, DOI 10.1016/j.jconrel.2008.06.001; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Draffehn S, 2016, MOL PHARMACEUT, V13, P1608, DOI [10.1021/acs.molpharmaceut.5b00064, 10.1021/acs.molpharmaceut.6b00064]; El-Guendy N, 2008, MOL CELL BIOCHEM, V312, P147, DOI 10.1007/s11010-008-9730-8; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Gillard M., 2015, BMC P, V9, pP69; Guo WJ, 2000, BIOSCIENCE REP, V20, P419, DOI 10.1023/A:1010338219401; Haider HK, 2008, MOL MED, V14, P79, DOI 10.2119/2007-00092.Haider; Haleem-Smith H, 2005, MOL BIOTECHNOL, V30, P9, DOI 10.1385/MB:30:1:009; Han MR, 2007, J MICROENCAPSUL, V24, P787, DOI 10.1080/02652040701657820; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; HARA K, 1988, EXP HEMATOL, V16, P256; High K, 2014, NAT MED, V20, P476, DOI 10.1038/nm.3566; Hunter MG, 2003, AM J HEMATOL, V74, P149, DOI 10.1002/ajh.10434; Jang YH, 2015, GROWTH FACTORS, V33, P319, DOI 10.3109/08977194.2015.1080695; Karra D, 2010, J NEUROSCI, V30, P6171, DOI 10.1523/JNEUROSCI.0183-10.2010; Ko YT, 2011, OLIGONUCLEOTIDES, V21, P109, DOI 10.1089/oli.2010.0271; Kulkarni RP, 2006, BIOPHYS J, V90, pL42, DOI 10.1529/biophysj.105.077941; Levy O, 2013, BLOOD, V122, pE23, DOI 10.1182/blood-2013-04-495119; Luo CH, 2016, ACS APPL MATER INTER, V8, P8367, DOI 10.1021/acsami.6b00353; Morris VB, 2015, BIOMATERIALS, V60, P151, DOI 10.1016/j.biomaterials.2015.04.052; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Neuhaus B, 2016, RSC ADV, V6, P18102, DOI 10.1039/c5ra25333k; Oliveira C, 2016, J BIOMED NANOTECHNOL, V12, P841, DOI 10.1166/jbn.2016.2245; Ramamoorth Murali, 2015, J Clin Diagn Res, V9, pGE01, DOI 10.7860/JCDR/2015/10443.5394; Ritter SC, 2011, BIOMED OPT EXPRESS, V2, P2012, DOI 10.1364/BOE.2.002012; Sanchez-Danes A, 2012, HUM GENE THER, V23, P56, DOI 10.1089/hum.2011.054; Sharei A, 2013, P NATL ACAD SCI USA, V110, P2082, DOI 10.1073/pnas.1218705110; Simoes S, 2004, ADV DRUG DELIVER REV, V56, P947, DOI 10.1016/j.addr.2003.10.038; Suh J, 2003, P NATL ACAD SCI USA, V100, P3878, DOI 10.1073/pnas.0636277100; Suk JS, 2007, EXP BIOL MED, V232, P461; Suk JS, 2006, BIOMATERIALS, V27, P5143, DOI 10.1016/j.biomaterials.2006.05.013; Tapia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012908; ur Rehman Zia, 2013, ACS Nano, V7, P3767, DOI 10.1021/nn3049494; Vaughan EE, 2006, MOL THER, V13, P422, DOI 10.1016/j.ymthe.2005.10.004; Vink T, 2014, METHODS, V65, P5, DOI 10.1016/j.ymeth.2013.07.018; Wang L, 2004, MOL THER, V9, P729, DOI 10.1016/j.ymthe.2004.02.009; Yoshihara C, 2010, BIOPHYS J, V98, P1257, DOI 10.1016/j.bpj.2009.11.047; Yu-Wai-Man P, 2016, BRIT J OPHTHALMOL, V100, P1322, DOI 10.1136/bjophthalmol-2015-308329; Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19; Zhu K., 2016, STEM CELLS INT, V2016	56	0	0	4	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	APR 7	2017	45	6							e38	10.1093/nar/gkw1143				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EQ9AI	WOS:000398376200003	27899629	gold			2018-01-05	
J	King, JJ; Larijani, M				King, Justin J.; Larijani, Mani			A novel Regulator of Activation-induced Cytidine Deaminase/APOBeCs in immunity and Cancer: Schrodinger's CATalytic Pocket	FRONTIERS IN IMMUNOLOGY			English	Review						lymphoma; antibodies; DNA mutations; leukocytes; enzymes and coenzymes; HIV infections	SINGLE-STRANDED-DNA; CLASS-SWITCH RECOMBINATION; INDUCED DEOXYCYTIDINE DEAMINASE; RNA-EDITING ENZYME; VIF-BINDING DOMAIN; CRYSTAL-STRUCTURE; SOMATIC HYPERMUTATION; HIV-1 VIF; C-TERMINUS; B-CELLS	Activation-induced cytidine deaminase (AID) and its relative APOBEC3 cytidine deam-inases boost immune response by mutating immune or viral genes. Because of their genome-mutating activities, AID/APOBECs are also drivers of tumorigenesis. Due to highly charged surfaces, extensive non-specific protein-protein/nucleic acid interactions, formation of polydisperse oligomers, and general insolubility, structure elucidation of these proteins by X-ray crystallography and NMR has been challenging. Hence, almost all available AID/APOBEC structures are of mutated and/or truncated versions. In 2015, we reported a functional structure for AID using a combined computational-biochemical approach. In so doing, we described a new regulatory mechanism that is a first for human DNA/RNA-editing enzymes. This mechanism involves dynamic closure of the catalytic pocket. Subsequent X-ray and NMR studies confirmed our discovery by showing that other APOBEC3s also close their catalytic pockets. Here, we highlight catalytic pocket closure as an emerging and important regulatory mechanism of AID/APOBEC3s. We focus on three sub-topics: first, we propose that variable pocket closure rates across AID/APOBEC3s underlie differential activity in immunity and cancer and review supporting evidence. Second, we discuss dynamic pocket closure as an ever-present internal regulator, in contrast to other proposed regulatory mechanisms that involve extrinsic binding partners. Third, we compare the merits of classical approaches of X-ray and NMR, with that of emerging computational-biochemical approaches, for structural elucidation specifically for AID/APOBEC3s.	[King, Justin J.; Larijani, Mani] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Program, St John, NF, Canada	Larijani, M (reprint author), Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Program, St John, NF, Canada.	mlarijani@mun.ca			Canadian Cancer Society Research Institute (CCSRI); Canadian Institutes of Health Research (CIHR) [MOP111132]; CIHR Frederick Banting; Charles Best Canada Doctoral Scholarship	The highlighted work was supported by a Canadian Cancer Society Research Institute (CCSRI) Innovation operating grant and Canadian Institutes of Health Research (CIHR) operating grant (MOP111132) to ML. JK is supported by a CIHR Frederick Banting and Charles Best Canada Doctoral Scholarship.	Abdouni H, 2013, NUCLEIC ACIDS RES, V41, P5457, DOI 10.1093/nar/gkt212; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alinikula J, 2014, CELL, V159, P1490, DOI 10.1016/j.cell.2014.12.007; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Barreto VM, 2011, DEV COMP IMMUNOL, V35, P991, DOI 10.1016/j.dci.2011.02.005; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Belanger K, 2015, VIROLOGY, V483, P141, DOI 10.1016/j.virol.2015.04.019; Bohn MF, 2015, STRUCTURE, V23, P903, DOI 10.1016/j.str.2015.03.016; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100; Burns MB, 2015, BIOMED J, V38, P102, DOI 10.4103/2319-4170.148904; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2016, BIOCHEMISTRY-US, V55, P2944, DOI 10.1021/acs.biochem.6b00382; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2011, METHODS MOL BIOL, V718, P185, DOI 10.1007/978-1-61779-018-8_12; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Coker HA, 2006, METHOD ENZYMOL, V408, P156, DOI 10.1016/S0076-6879(06)08010-4; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Dancyger AM, 2012, FASEB J, V26, P1517, DOI 10.1096/fj.11-198135; Delker RK, 2013, P NATL ACAD SCI USA, V110, P1029, DOI 10.1073/pnas.1214538110; Demorest ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011660; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Faltas BM, 2016, NAT GENET, V48, P1490, DOI 10.1038/ng.3692; Fu Y, 2015, BIOCHEM J, V471, P25, DOI 10.1042/BJ20150382; Furukawa Ayako, 2009, Nucleic Acids Symp Ser (Oxf), P87, DOI 10.1093/nass/nrp044; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Garbuzynskiy SO, 2005, PROTEINS, V60, P139, DOI 10.1002/prot.20491; Goncalves Joao, 2004, Retrovirology, V1, P28, DOI 10.1186/1742-4690-1-28; Hasler J, 2011, P NATL ACAD SCI USA, V108, P18366, DOI 10.1073/pnas.1106729108; Han L, 2010, J IMMUNOL, V185, P1379, DOI 10.4049/jimmunol.1001643; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris R, 2008, NAT BIOTECHNOL, V26, P1089, DOI 10.1038/nbt1008-1089; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Hu WJ, 2015, P NATL ACAD SCI USA, V112, P5791, DOI 10.1073/pnas.1506167112; Jeevan-Raj BP, 2011, J EXP MED, V208, P1649, DOI 10.1084/jem.20110118; Kanehiro Y, 2012, P NATL ACAD SCI USA, V109, P1216, DOI 10.1073/pnas.1120368109; King JJ, 2015, STRUCTURE, V23, P615, DOI 10.1016/j.str.2015.01.016; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Klemm L, 2009, CANCER CELL, V16, P232, DOI 10.1016/j.ccr.2009.07.030; Knisbacher BA, 2016, TRENDS GENET, V32, P16, DOI 10.1016/j.tig.2015.10.005; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kouno T, 2015, NAT STRUCT MOL BIOL, V22, P485, DOI 10.1038/nsmb.3033; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kracker S, 2015, J ALLERGY CLIN IMMUN, V135, P998, DOI 10.1016/j.jaci.2014.08.030; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Krzysiak TC, 2012, BIOCHEMISTRY-US, V51, P2008, DOI 10.1021/bi300021s; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Larijani M, 2007, MOL CELL BIOL, V27, P20, DOI 10.1128/MCB.00824-06; Larijani M, 2012, SEMIN IMMUNOL, V24, P255, DOI 10.1016/j.smim.2012.05.003; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu Q, 2008, BIOCHEMISTRY-US, V47, P13966, DOI 10.1021/bi801642q; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; Lu XX, 2015, J BIOL CHEM, V290, P4010, DOI 10.1074/jbc.M114.624262; MacDuff DA, 2006, MOL IMMUNOL, V43, P1099, DOI 10.1016/j.molimm.2005.07.024; Maeda K, 2013, J IMMUNOL, V191, P6030, DOI 10.4049/jimmunol.1302057; Mak CH, 2013, J BIOL CHEM, V288, P29786, DOI 10.1074/jbc.M113.506550; Malinen AM, 2012, NUCLEIC ACIDS RES, V40, P7442, DOI 10.1093/nar/gks383; Martin A, 2002, NATURE, V415, P802; Marx A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18191; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Monajemi M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-35; Munoz DP, 2013, P NATL ACAD SCI USA, V110, pE2977, DOI 10.1073/pnas.1301021110; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470                                                        ; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakashima M, 2016, J VIROL, V90, P1034, DOI 10.1128/JVI.02369-15; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okazaki I, 2011, P NATL ACAD SCI USA, V108, P7920, DOI 10.1073/pnas.1104423108; Orthwein A, 2012, EMBO J, V31, P679, DOI 10.1038/emboj.2011.417; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Parsa JY, 2007, MOL IMMUNOL, V44, P567, DOI 10.1016/j.molimm.2006.02.003; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Pham P, 2016, DNA REPAIR, V43, P48, DOI 10.1016/j.dnarep.2016.05.029; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramiro Almudena, 2007, Adv Immunol, V94, P75, DOI 10.1016/S0065-2776(06)94003-6; Ranjit S, 2011, J IMMUNOL, V187, P2464, DOI 10.4049/jimmunol.1101406; Rebhandl Stefan, 2015, Oncoscience, V2, P320; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9                                                   ; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2014, BIOESSAYS, V36, P382, DOI 10.1002/bies.201300140; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Santa-Marta M, 2005, J BIOL CHEM, V280, P8765, DOI 10.1074/jbc.M409309200; Santa-Marta M, 2007, MOL IMMUNOL, V44, P583, DOI 10.1016/j.molimm.2006.02.005; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Shaban NM, 2016, J MOL BIOL, V428, P2307, DOI 10.1016/j.jmb.2016.04.026; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Shi K, 2015, J BIOL CHEM, V290, P28120, DOI 10.1074/jbc.M115.679951; Shlyakhtenko LS, 2013, J STRUCT BIOL, V184, P217, DOI 10.1016/j.jsb.2013.09.008; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Starrett GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12918; Stavrou S, 2015, J IMMUNOL, V195, P4565, DOI 10.4049/jimmunol.1501504; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uchimura Y, 2011, J EXP MED, V208, P2385, DOI 10.1084/jem.20110856; Valera MS, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0181-5; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; Wang XX, 2012, J VIROL, V86, P3777, DOI 10.1128/JVI.06594-11; Wichroski MJ, 2006, PLOS PATHOG, V2, P374, DOI 10.1371/journal.ppat.0020041; Willmann KL, 2012, J EXP MED, V209, P2099, DOI 10.1084/jem.20112145; Wittkopp CJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005865; Xiao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12193; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	132	2	2	5	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	APR 6	2017	8								351	10.3389/fimmu.2017.00351				11	Immunology	Immunology	EQ9OX	WOS:000398414900001	28439266	gold			2018-01-05	
J	O'Neil, RT; Wang, XJ; Morabito, MV; Emeson, RB				O'Neil, Richard T.; Wang, Xiaojing; Morabito, Michael V.; Emeson, Ronald B.			Comparative analysis of A-to-I editing in human and non-human primate brains reveals conserved patterns and context-dependent regulation of RNA editing	MOLECULAR BRAIN			English	Article							GLUTAMATE RECEPTORS; ADENOSINE-DEAMINASE; ENZYME ADAR2; GENE; DISORDERS; CHANNELS; MICE	A-to-I RNA editing is an important process for generating molecular diversity in the brain through modification of transcripts encoding several proteins important for neuronal signaling. We investigated the relationships between the extent of editing at multiple substrate transcripts (5HT2C, MGLUR4, CADPS, GLUR2, GLUR4, and GABRA3) in brain tissue obtained from adult humans and rhesus macaques. Several patterns emerged from these studies revealing conservation of editing across primate species. Additionally, variability in the human population allows us to make novel inferences about the co-regulation of editing at different editing sites and even across different brain regions.	[O'Neil, Richard T.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA; [O'Neil, Richard T.] Vanderbilt Univ, Sch Med, Div Nephrol, Nashville, TN 37212 USA; [Wang, Xiaojing] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Morabito, Michael V.; Emeson, Ronald B.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Emeson, Ronald B.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Emeson, Ronald B.] Vanderbilt Univ, Vanderbilt Brain Inst, 221 Kirkland Hall, Nashville, TN 37235 USA	O'Neil, RT (reprint author), Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA.; O'Neil, RT (reprint author), Vanderbilt Univ, Sch Med, Div Nephrol, Nashville, TN 37212 USA.	richard.t.oneil@vanderbilt.edu		Emeson, Ronald/0000-0002-4585-1648	NIH [P50 MH096972 05]	This work was funded by NIH grant P50 MH096972 05 awarded to RE. The funders had no part in the study design, data collection, or analysis.	Berg KA, 2001, BRIT J PHARMACOL, V134, P386, DOI 10.1038/sj.bjp.0704255; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Carmel L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002663; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Higuchi M, 2000, NATURE, V406, P78; Hood JL, 2014, MOL CELL NEUROSCI, V61, P97, DOI 10.1016/j.mcn.2014.06.001; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; Jepson JEC, 2011, J BIOL CHEM, V286, P8325, DOI 10.1074/jbc.M110.186817; Kubota-Sakashita M, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-5; Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419                                                          ; Mallela A, 2012, CRIT REV BIOCHEM MOL, V47, P493, DOI 10.3109/10409238.2012.714350; Mitchell AC, 2012, GENOMICS, V99, P144, DOI 10.1016/j.ygeno.2011.12.006; Mittaz L, 1997, GENOMICS, V41, P210, DOI 10.1006/geno.1997.4655; Morabito MV, 2010, MOL PHARMACOL, V77, P895, DOI 10.1124/mol.109.061903; O'Neil RT, 2012, NEUROBIOL DIS, V45, P8, DOI 10.1016/j.nbd.2011.08.026; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	24	0	0	2	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-6606			MOL BRAIN	Mol. Brain	APR 6	2017	10								11	10.1186/s13041-017-0291-1				9	Neurosciences	Neurosciences & Neurology	ER0YI	WOS:000398514700001	28385157	gold			2018-01-05	
J	Slobodin, B; Han, RQ; Calderone, V; Vrielink, JAFO; Loayza-Puch, F; Elkon, R; Agami, R				Slobodin, Boris; Han, Ruiqi; Calderone, Vittorio; Vrielink, Joachim A. F. Oude; Loayza-Puch, Fabricio; Elkon, Ran; Agami, Reuven			Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation	CELL			English	Article							POLYMERASE-II; EARLY PROMOTER; IN-VITRO; POL II; ELONGATION; N-6-METHYLADENOSINE; INITIATION; ENHANCER; PROTEIN; YEAST	Transcription and translation are two main pillars of gene expression. Due to the different timings, spots of action, and mechanisms of regulation, these processes are mainly regarded as distinct and generally uncoupled, despite serving a common purpose. Here, we sought for a possible connection between transcription and translation. Employing an unbiased screen of multiple human promoters, we identified a positive effect of TATA box on translation and a general coupling between mRNA expression and translational efficiency. Using a CRISPR-Cas9-mediated approach, genome-wide analyses, and in vitro experiments, we show that the rate of transcription regulates the efficiency of translation. Furthermore, we demonstrate that m(6)A modification of mRNAs is co-transcriptional and depends upon the dynamics of the transcribing RNAPII. Suboptimal transcription rates lead to elevated m(6)A content, which may result in reduced translation. This study uncovers a general and widespread link between transcription and translation that is governed by epigenetic modification of mRNAs.	[Slobodin, Boris; Han, Ruiqi; Calderone, Vittorio; Vrielink, Joachim A. F. Oude; Loayza-Puch, Fabricio; Agami, Reuven] Netherlands Canc Inst, Div Oncogen, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Agami, Reuven] Erasmus Univ, Med Ctr, Dept Genet, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Elkon, Ran] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Slobodin, B; Agami, R (reprint author), Netherlands Canc Inst, Div Oncogen, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Agami, R (reprint author), Erasmus Univ, Med Ctr, Dept Genet, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.; Elkon, R (reprint author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	boris.slobodin@gmail.com; ranel@tauex.tau.ac.il; r.agami@nki.nl			enhReg ERC-AdV (ERC-AdG) program [322493]; NWO program [NGI 93512001/2012]	We thank Pieter van Breugel, Alejandro Pineiro Ugalde, Behzad Moumbeini, and Nicolas Leveille for the technical assistance and fruitful discussions and greatly appreciate the help of Ron Kerkhoven and the Netherlands Cancer Institute (NKI-AVL) genomics core facility in sequencing. We thank David Bentley for kindly providing us the cell lines expressing alpha-amanitin-resistant versions of RNAPII. R.E. is a Faculty Fellow of the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. This work was supported by funds from the enhReg ERC-AdV (ERC-2012-AdG; grant agreement no. 322493) and NWO (NGI 93512001/2012) programs to R.A.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BYRNE BJ, 1983, P NATL ACAD SCI-BIOL, V80, P721; Choi J, 2016, NAT STRUCT MOL BIOL, V23, P110, DOI 10.1038/nsmb.3148; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dori-Bachash M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r114; Dujardin G, 2014, MOL CELL, V54, P683, DOI 10.1016/j.molcel.2014.03.044; Fong N, 2014, GENE DEV, V28, P2663, DOI 10.1101/gad.252106.114; Haimovich G, 2013, BBA-GENE REGUL MECH, V1829, P643, DOI 10.1016/j.bbagrm.2013.01.004; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hoernes TP, 2016, NUCLEIC ACIDS RES, V44, P852, DOI 10.1093/nar/gkv1182; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; Loayza-Puch F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r32; Marbach-Bar N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3118; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Oktaba K, 2015, MOL CELL, V57, P341, DOI 10.1016/j.molcel.2014.11.024; Qi ST, 2016, J BIOL CHEM, V291, P23020, DOI 10.1074/jbc.M116.748889; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Richter JD, 2015, CELL, V163, P292, DOI 10.1016/j.cell.2015.09.041; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Schwanhausser B., 2011, NATURE, V473, P337, DOI DOI 10.1038/NATURE10098; SHIMBA S, 1995, NUCLEIC ACIDS RES, V23, P2421, DOI 10.1093/nar/23.13.2421                                                          ; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tamarkin-Ben-Harush A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-688; Tamarkin-Ben-Harush A, 2017, ELIFE, V6; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; WILDEMAN AG, 1984, EMBO J, V3, P3129; XIAO H, 1995, MOL CELL BIOL, V15, P5757; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zid BM, 2014, NATURE, V514, P117, DOI 10.1038/nature13578	44	11	11	11	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2017	169	2					326	337		10.1016/j.cell.2017.03.031				12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EQ8QB	WOS:000398349500016	28388414	gold			2018-01-05	
J	Ta-Shma, A; Khan, TN; Vivante, A; Willer, JR; Matak, P; Jalas, C; Pode-Shakked, B; Salem, Y; Anikster, Y; Hildebrandt, F; Katsanis, N; Elpeleg, O; Davis, EE				Ta-Shma, Asaf; Khan, Tahir N.; Vivante, Asaf; Willer, Jason R.; Matak, Pavle; Jalas, Chaim; Pode-Shakked, Ben; Salem, Yishay; Anikster, Yair; Hildebrandt, Friedhelm; Katsanis, Nicholas; Elpeleg, Orly; Davis, Erica E.			Mutations in TMEM260 Cause a Pediatric Neurodevelopmental, Cardiac, and Renal Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CILIARY TRANSITION ZONE; INTELLECTUAL DISABILITY; MENDELIAN DISORDERS; IDENTIFICATION; CILIOPATHY; PROTEOME; JOUBERT; PATHWAY; DISEASE; MECKEL	Despite the accelerated discovery of genes associated with syndromic traits, the majority of families affected by such conditions remain undiagnosed. Here, we employed whole-exome sequencing in two unrelated consanguineous kindreds with central nervous system (CNS), cardiac, renal, and digit abnormalities. We identified homozygous truncating mutations in TMEM260, a locus predicted to encode numerous splice isoforms. Systematic expression analyses across tissues and developmental stages validated two such isoforms, which differ in the utilization of an internal exon. The mutations in both families map uniquely to the long isoform, raising the possibility of an isoform-specific disorder. Consistent with this notion, RT-PCR of lymphocyte cell lines from one of the kindreds showed reduced levels of only the long isoform, which could be ameliorated by emetine, suggesting that the mutation induces nonsense-mediated decay. Subsequent in vivo testing supported this hypothesis. First, either transient suppression or CRISPR/Cas9 genome editing of zebrafish tmem260 recapitulated key neurological phenotypes. Second, co-injection of morphants with the long human TMEM260 mRNA rescued CNS pathology, whereas the short isoform was significantly less efficient. Finally, immunocytochemical and biochemical studies showed preferential enrichment of the long TMEM260 isoform to the plasma membrane. Together, our data suggest that there is overall reduced, but not ablated, functionality of TMEM260 and that attenuation of the membrane-associated functions of this protein is a principal driver of pathology. These observations contribute to an appreciation of the roles of splice isoforms in genetic disorders and suggest that dissection of the functions of these transcripts will most likely inform pathomechanism.	[Ta-Shma, Asaf] Hadassah Med Ctr, Dept Pediat Cardiol, IL-91120 Jerusalem, Israel; [Khan, Tahir N.; Willer, Jason R.; Matak, Pavle; Katsanis, Nicholas; Davis, Erica E.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Vivante, Asaf; Hildebrandt, Friedhelm] Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Vivante, Asaf; Hildebrandt, Friedhelm] Harvard Med Sch, Boston, MA 02115 USA; [Vivante, Asaf; Pode-Shakked, Ben] Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Ramat Gan, Israel; [Jalas, Chaim] Bonei Olam, Ctr Rare Jewish Genet Disorders, Brooklyn, NY 11204 USA; [Pode-Shakked, Ben; Salem, Yishay; Anikster, Yair] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, IL-52621 Ramat Gan, Israel; [Pode-Shakked, Ben; Salem, Yishay; Anikster, Yair] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Elpeleg, Orly] Hadassah Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel	Katsanis, N (reprint author), Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA.; Elpeleg, O (reprint author), Hadassah Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel.	katsanis@cellbio.duke.edu; elpeleg@hadassah.org.il			US NIH [DK075972, HD042601, DK096415, DK072301, DK096493, MH106826, DK068306]; Trudy Mandel Louis Charitable Trust; Manton Center Fellowship program; Boston Children's Hospital; Mallinckrodt Research Fellowship Award	We thank Dr. Jeffrey Jacobson from Edmond and Lily Safra Children's Hospital (Israel) for his technical assistance. This work was funded by US NIH grants DK075972, HD042601, and DK096415 (N.K.), DK072301 and DK096493 (N.K. and E.E.D.), MH106826 (E.E.D.), and DK068306 (F.H.) and the Trudy Mandel Louis Charitable Trust (O.E.). N.K. is a distinguished Jean and George Brumley Professor. F.H. is the William E. Harmon Professor. A.V. is supported by grants from the Manton Center Fellowship program, Boston Children's Hospital, and the Mallinckrodt Research Fellowship Award.	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bogershausen N, 2015, J CLIN INVEST, V125, P3585, DOI 10.1172/JCI80102; Bolar NA, 2016, AM J HUM GENET, V99, P174, DOI 10.1016/j.ajhg.2016.05.028; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Deng HX, 2016, NAT GENET, V48, P733, DOI 10.1038/ng.3589; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961                                                              ; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Isrie M, 2015, AM J HUM GENET, V97, P790, DOI 10.1016/j.ajhg.2015.10.014; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lee JH, 2012, SCIENCE, V335, P966, DOI 10.1126/science.1213506; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Magini P, 2014, HUM MOL GENET, V23, P3607, DOI 10.1093/hmg/ddu070; Matak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059538; Merner ND, 2008, AM J HUM GENET, V82, P809, DOI 10.1016/j.ajhg.2008.01.010; Muller A, 2002, GENOME RES, V12, P1625, DOI 10.1101/gr.221202; Niceta M, 2015, AM J HUM GENET, V96, P816, DOI 10.1016/j.ajhg.2015.03.001; Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338; Perles Z, 2015, J MED GENET, V52, P840, DOI 10.1136/jmedgenet-2015-103336; Roberson EC, 2015, J CELL BIOL, V209, P129, DOI 10.1083/jcb.201411087; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Schueler M, 2015, AM J HUM GENET, V96, P81, DOI 10.1016/j.ajhg.2014.12.002; Schulte EC, 2014, AM J HUM GENET, V95, P85, DOI 10.1016/j.ajhg.2014.06.005; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Van der Auwera G.A., 2013, CURR PROTOC BIOINFOR, V43, P1, DOI DOI 10.1002/0471250953.BI1110S43; Vivante A, 2015, AM J HUM GENET, V97, P291, DOI 10.1016/j.ajhg.2015.07.001; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Wortmann SB, 2015, AM J HUM GENET, V96, P245, DOI 10.1016/j.ajhg.2014.12.013; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	36	1	1	4	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2017	100	4					666	675		10.1016/j.ajhg.2017.02.007				10	Genetics & Heredity	Genetics & Heredity	EQ9FK	WOS:000398389600009	28318500	green_published			2018-01-05	
J	Pashos, EE; Park, Y; Wang, X; Raghavan, A; Yang, WL; Abbey, D; Peters, DT; Arbelaez, J; Hernandez, M; Kuperwasser, N; Li, WJ; Lian, ZR; Liu, Y; Lv, WJ; Lytle-Gabbin, SL; Marchadier, DH; Rogov, P; Shi, JT; Slovik, KJ; Stylianou, IM; Wang, L; Yan, RL; Zhang, XL; Kathiresan, S; Duncan, SA; Mikkelsen, TS; Morrisey, EE; Rader, DJ; Brown, CD; Musunuru, K				Pashos, Evanthia E.; Park, Yoson; Wang, Xiao; Raghavan, Avanthi; Yang, Wenli; Abbey, Deepti; Peters, Derek T.; Arbelaez, Juan; Hernandez, Mayda; Kuperwasser, Nicolas; Li, Wenjun; Lian, Zhaorui; Liu, Ying; Lv, Wenjian; Lytle-Gabbin, Stacey L.; Marchadier, Dawn H.; Rogov, Peter; Shi, Jianting; Slovik, Katherine J.; Stylianou, Ioannis M.; Wang, Li; Yan, Ruilan; Zhang, Xiaolan; Kathiresan, Sekar; Duncan, Stephen A.; Mikkelsen, Tarjei S.; Morrisey, Edward E.; Rader, Daniel J.; Brown, Christopher D.; Musunuru, Kiran			Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; RNA-SEQ DATA; REPORTER ASSAY; DISSECTION; EXPRESSION; DISEASE; GENOME; ENHANCERS; DISCOVERY; CRISPR	Genome-wide association studies have struggled to identify functional genes and variants underlying complex phenotypes. We recruited a multi-ethnic cohort of healthy volunteers (n = 91) and used their tissue to generate induced pluripotent stem cells (iPSCs) and hepatocyte-like cells (HLCs) for genome-wide mapping of expression quantitative trait loci (eQTLs) and allele-specific expression (ASE). We identified many eQTL genes (eGenes) not observed in the comparably sized Genotype-Tissue Expression project's human liver cohort (n = 96). Focusing on blood lipid-associated loci, we performed massively parallel reporter assays to screen candidate functional variants and used genome-edited stem cells, CRISPR interference, and mouse modeling to establish rs2277862CPNE1, rs10889356-DOCK7, rs10889356-ANGPTL3, and rs10872142-FRK as functional SNP-gene sets. We demonstrated HLC eGenes CPNE1, VKORC1, UBE2L3, and ANGPTL3 and HLC ASE gene ACAA2 to be lipid-functional genes in mouse models. These findings endorse an iPSC-based experimental framework to discover functional variants and genes contributing to complex human traits.	[Pashos, Evanthia E.; Park, Yoson; Abbey, Deepti; Hernandez, Mayda; Lytle-Gabbin, Stacey L.; Marchadier, Dawn H.; Stylianou, Ioannis M.; Rader, Daniel J.; Brown, Christopher D.; Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Pashos, Evanthia E.; Abbey, Deepti; Hernandez, Mayda; Lytle-Gabbin, Stacey L.; Marchadier, Dawn H.; Stylianou, Ioannis M.; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Park, Yoson; Brown, Christopher D.] Univ Penn, Perelman Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA; [Wang, Xiao; Li, Wenjun; Lv, Wenjian; Morrisey, Edward E.; Rader, Daniel J.; Musunuru, Kiran] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Raghavan, Avanthi; Peters, Derek T.; Kuperwasser, Nicolas; Kathiresan, Sekar] Harvard Med Sch, Boston, MA 02115 USA; [Yang, Wenli; Arbelaez, Juan; Lian, Zhaorui; Liu, Ying; Shi, Jianting; Slovik, Katherine J.; Yan, Ruilan; Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rogov, Peter; Wang, Li; Zhang, Xiaolan; Kathiresan, Sekar; Mikkelsen, Tarjei S.] Broad Inst, Cambridge, MA 02142 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Duncan, Stephen A.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA	Rader, DJ; Brown, CD; Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.; Rader, DJ (reprint author), Univ Penn, Perelman Sch Med, Dept Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA.; Brown, CD (reprint author), Univ Penn, Perelman Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA.; Rader, DJ; Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.; Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu; chrbro@mail.med.upenn.edu; kiranmusunuru@gmail.com		Duncan, Stephen/0000-0002-2507-7827	Howard Hughes Medical Institute Medical Research Fellows Program; NIH [R01-GM104464, R01-HL118744, R01-DK099571, U01-HG006398, RC2-HL101864, R01-MH101822]; Harvard Stem Cell Institute; NIH/NCATS [UL1-TR000003]	We are grateful to the participants of the study, the staff of the University of Pennsylvania Clinical Translational Research Center, and the staff of the iPSC Core Facility of the Institute for Regenerative Medicine at the University of Pennsylvania. This work was supported in part by the Howard Hughes Medical Institute Medical Research Fellows Program (A.R.), grant R01-GM104464 from the NIH (K.M. and T.S.M.), grants R01-HL118744 and R01-DK099571 from the NIH (K.M.), the Harvard Stem Cell Institute (K.M.), grant U01-HG006398 from the NIH (D.J.R., E.E.M., and S.A.D.), RC2-HL101864 from the NIH (D.J.R.), grant UL1-TR000003 from the NIH/NCATS (D.J.R.), and R01-MH101822 from the NIH (C.D.B.). E.E.P. is now an employee of Pfizer, P.R. is now an employee of Neon Therapeutics, I.M.S. is now an employee of Xenon Therapeutics, and T.S.M. is now an employee of 10X Genomics.	Aguet F, 2016, BIORXIV; Andrews S., 2010, FASTQC QUALITY CONTR; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bass A, 2015, QVALUE Q VALUE ESTIM; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JC144213; Cai J., 2012, STEMBOOK; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Han B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002555; Harvey CT, 2015, BIOINFORMATICS, V31, P1235, DOI 10.1093/bioinformatics/btu802; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Krueger F, 2012, TRIM GALORE; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang W, 2012, STEMBOOK; Zhu H, 2011, NAT REV GENET, V12, P266, DOI 10.1038/nrg2951	44	6	6	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2017	20	4					558	+		10.1016/j.stem.2017.03.017				23	Cell & Tissue Engineering; Cell Biology	Cell Biology	EQ8QO	WOS:000398350800018	28388432				2018-01-05	
J	Modell, JW; Jiang, WY; Marraffini, LA				Modell, Joshua W.; Jiang, Wenyan; Marraffini, Luciano A.			CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity	NATURE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; ALLELIC REPLACEMENT; NUCLEOTIDE-SEQUENCE; BACTERIAL IMMUNITY; PHAGE LAMBDA; DEFENSE; RNA; BACTERIOPHAGE; PROKARYOTES	Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems provide protection against viral(1) and plasmid(2) infection by capturing short DNA sequences from these invaders and integrating them into the CRISPR locus of the prokaryotic host(1). These sequences, known as spacers, are transcribed into short CRISPR RNA guides(3-5) that specify the cleavage site of Cas nucleases in the genome of the invader(6-8). It is not known when spacer sequences are acquired during viral infection. Here, to investigate this, we tracked spacer acquisition in Staphylococcus aureus cells harbouring a type II CRISPR-Cas9 system after infection with the staphylococcal bacteriophage f12. We found that new spacers were acquired immediately after infection preferentially from the cos site, the viral free DNA end that is first injected into the cell. Analysis of spacer acquisition after infection with mutant phages demonstrated that most spacers are acquired during DNA injection, but not during other stages of the viral cycle that produce free DNA ends, such as DNA replication or packaging. Finally, we showed that spacers acquired from early-injected genomic regions, which direct Cas9 cleavage of the viral DNA immediately after infection, provide better immunity than spacers acquired from late-injected regions. Our results reveal that CRISPR-Cas systems exploit the phage life cycle to generate a pattern of spacer acquisition that ensures a successful CRISPR immune response.	[Modell, Joshua W.; Jiang, Wenyan; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA	Marraffini, LA (reprint author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA.	marraffini@rockefeller.edu			Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; Burroughs Wellcome Fund PATH award; NIH Director's New Innovator Award [1DP2AI104556-01]; HHMI-Simons Faculty Scholar Award	We thank R. Heler for plasmid pRH163; J. McGinn for plasmid pJM62; J. Penades for providing phi 12 as well as assistance in working with it; B. Dujon for permission to use the I-SceI endonuclease; and The Rockefeller University Genomics Resource Center core facility for performing next-generation sequencing. J.W.M. is a Fellow of The Jane Coffin Childs Memorial Fund for Medical Research. L.A.M. is supported by the Rita Allen Scholars Program, an Irma T. Hirschl Award, a Sinsheimer Foundation Award, a Burroughs Wellcome Fund PATH award, an NIH Director's New Innovator Award (1DP2AI104556-01) and an HHMI-Simons Faculty Scholar Award.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bobay LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003825; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Halpern D, 2007, PLOS GENET, V3, P1614, DOI 10.1371/journal.pgen.0030153; Heler R, 2017, MOL CELL, V65, P168, DOI 10.1016/j.molcel.2016.11.031; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; HERSHEY AD, 1963, P NATL ACAD SCI USA, V49, P748, DOI 10.1073/pnas.49.5.748; HORINOUCHI S, 1982, J BACTERIOL, V150, P804; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; KHAN SA, 1983, PLASMID, V10, P251, DOI 10.1016/0147-619X(83)90039-2                                                    ; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0                                                                ; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Louwen R, 2013, EUR J CLIN MICROBIOL, V32, P207, DOI 10.1007/s10096-012-1733-4; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martel B, 2014, NUCLEIC ACIDS RES, V42, P9504, DOI 10.1093/nar/gku628; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Quiles-Puchalt N, 2014, P NATL ACAD SCI USA, V111, P6016, DOI 10.1073/pnas.1320538111; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; Ubeda C, 2009, MOL MICROBIOL, V72, P98, DOI 10.1111/j.1365-2958.2009.06634.x; Van Valen D, 2012, CURR BIOL, V22, P1339, DOI 10.1016/j.cub.2012.05.023; Wegrzyn G, 2012, ADV VIRUS RES, V82, P155, DOI 10.1016/B978-0-12-394621-8.00016-9; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917	43	5	5	11	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					101	+		10.1038/nature21719				18	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ8GQ	WOS:000398323300041	28355179	green_accepted			2018-01-05	
J	Aktas, T; Ilik, IA; Maticzka, D; Bhardwaj, V; Rodrigues, CP; Mittler, G; Manke, T; Backofen, R; Akhtar, A				Aktas, Tugce; Ilik, Ibrahim Avsar; Maticzka, Daniel; Bhardwaj, Vivek; Rodrigues, Cecilia Pessoa; Mittler, Gerhard; Manke, Thomas; Backofen, Rolf; Akhtar, Asifa			DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome	NATURE			English	Article							IN-VIVO; DOSAGE COMPENSATION; REPETITIVE ELEMENTS; SEQUENCING DATA; CROSS-LINKING; CIRCULAR RNAS; WEB SERVER; COMPLEX; CELLS; IDENTIFICATION	Transposable elements are viewed as 'selfish genetic elements', yet they contribute to gene regulation and genome evolution in diverse ways(1). More than half of the human genome consists of transposable elements(2). Alu elements belong to the short interspersed nuclear element (SINE) family of repetitive elements, and with over 1 million insertions they make up more than 10% of the human genome(2). Despite their abundance and the potential evolutionary advantages they confer, Alu elements can be mutagenic to the host as they can act as splice acceptors, inhibit translation of mRNAs and cause genomic instability(3). Alu elements are the main targets of the RNA-editing enzyme ADAR(4) and the formation of Alu exons is suppressed by the nuclear ribonucleoprotein HNRNPC5, but the broad effect of massive secondary structures formed by inverted-repeat Alu elements on RNA processing in the nucleus remains unknown. Here we show that DHX9, an abundant(6) nuclear RNA helicase(7), binds specifically to inverted-repeat Alu elements that are transcribed as parts of genes. Loss of DHX9 leads to an increase in the number of circular-RNA-producing genes and amount of circular RNAs, translational repression of reporters containing inverted-repeat Alu elements, and transcriptional rewiring (the creation of mostly nonsensical novel connections between exons) of susceptible loci. Biochemical purifications of DHX9 identify the interferon-inducible isoform of ADAR (p150), but not the constitutively expressed ADAR isoform (p110), as an RNA-independent interaction partner. Co-depletion of ADAR and DHX9 augments the double-stranded RNA accumulation defects, leading to increased circular RNA production, revealing a functional link between these two enzymes. Our work uncovers an evolutionarily conserved function of DHX9. We propose that it acts as a nuclear RNA resolvase that neutralizes the immediate threat posed by transposon insertions and allows these elements to evolve as tools for the post-transcriptional regulation of gene expression.	[Aktas, Tugce; Ilik, Ibrahim Avsar; Bhardwaj, Vivek; Rodrigues, Cecilia Pessoa; Mittler, Gerhard; Manke, Thomas; Akhtar, Asifa] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Maticzka, Daniel; Backofen, Rolf] Albert Ludwigs Univ, Inst Informat, Freiburg, Germany; [Bhardwaj, Vivek; Rodrigues, Cecilia Pessoa] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	Akhtar, A (reprint author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	akhtar@ie-freiburg.mpg.de		Bhardwaj, Vivek/0000-0002-5570-9338	 [CRC 992/2 2016];  [CRC 746];  [CRC 1140];  [BA2168/11-1];  [SPP 1738];  [CRC TRR 167]	We thank members of the Akhtar laboratory especially B. Sheikh, C. Keller and K. Lam for critical reading of the manuscript and helpful discussions. We also thank N. Iovino and R. Sawarkar for critical reading of the manuscript. We also thank the members of the Deep Sequencing, Imaging, FACS and the Proteomics Facilities for their support. We acknowledge the support of the Freiburg Galaxy Team: B. Gruning and T. Houwaart, Bioinformatics, University of Freiburg. This work was supported by CRC 992/2 2016 awarded to A.A., T.M. and R.B., and CRC 746 and CRC 1140 awarded to A.A. R.B. is also funded by BA2168/11-1, SPP 1738 and CRC TRR 167.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Chelmicki T, 2014, ELIFE, V3, DOI 10.7554/eLife.02024; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Elbarbary RA, 2016, SCIENCE, V351, DOI 10.1126/science.aac7247; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Holmqvist E, 2016, EMBO J, V35, P991, DOI 10.15252/embj.201593360; Ibrahim MM, 2015, BIOINFORMATICS, V31, P48, DOI 10.1093/bioinformatics/btu568; Ilik IA, 2013, MOL CELL, V51, P156, DOI 10.1016/j.molcel.2013.07.001; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670                                                         ; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Koh HR, 2014, NUCLEIC ACIDS RES, V42, P8556, DOI 10.1093/nar/gku523; Ule J, 2011, JOVE-J VIS EXP, V50, P2638; Kramerov DA, 2011, HEREDITY, V107, P487, DOI 10.1038/hdy.2011.43; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; Lee CG, 1998, P NATL ACAD SCI USA, V95, P13709, DOI 10.1073/pnas.95.23.13709                                                        ; Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Oshiumi H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00200; Picardi E, 2017, NUCLEIC ACIDS RES, V45, pD750, DOI 10.1093/nar/gkw767; Quinn JJ, 2014, NAT BIOTECHNOL, V32, P933, DOI 10.1038/nbt.2943; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ricci EP, 2014, NAT STRUCT MOL BIOL, V21, P26, DOI 10.1038/nsmb.2739; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shin YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14269; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Svensson Marcus, 2006, Expert Rev Clin Immunol, V2, P759, DOI 10.1586/1744666X.2.5.759; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001	51	11	11	6	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					115	+		10.1038/nature21715				27	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ8GQ	WOS:000398323300044	28355180				2018-01-05	
J	MacLeod, DT; Antony, J; Martin, AJ; Moser, RJ; Hekele, A; Wetzel, KJ; Brown, AE; Triggiano, MA; Hux, JA; Pham, CD; Bartsevich, VV; Turner, CA; Lape, J; Kirkland, S; Beard, CW; Smith, J; Hirsch, ML; Nicholson, MG; Jantz, D; McCreedy, B				MacLeod, Daniel T.; Antony, Jeyaraj; Martin, Aaron J.; Moser, Rachel J.; Hekele, Armin; Wetzel, Keith J.; Brown, Audrey E.; Triggiano, Melissa A.; Hux, Jo Ann; Pham, Christina D.; Bartsevich, Victor V.; Turner, Caitlin A.; Lape, Janel; Kirkland, Samantha; Beard, Clayton W.; Smith, Jeff; Hirsch, Matthew L.; Nicholson, Michael G.; Jantz, Derek; McCreedy, Bruce			Integration of a CD19 CAR into the. TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells	MOLECULAR THERAPY			English	Article							CHIMERIC-ANTIGEN-RECEPTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; ADENOASSOCIATED VIRUS; HOMING ENDONUCLEASE; MESSENGER-RNA; THERAPY; IMMUNOTHERAPY; FOUNDATION; GENERATION; EXPRESSION	Adoptive cellular therapy using chimeric antigen receptor (CAR) T cell therapies have produced significant objective responses in patients with CD19(+) hematological malignancies, including durable complete responses. Although the majority of clinical trials to date have used autologous patient cells as the starting material to generate CART cells, this strategy poses significant manufacturing challenges and, for some patients, may not be feasible because of their advanced disease state or difficulty with manufacturing suitable numbers of CAR T cells. Alternatively, T cells from a healthy donor can be used to produce an allogeneic CAR T therapy, provided the cells are rendered incapable of eliciting graft versus host disease (GvHD). One approach to the production of these cells is gene editing to eliminate expression of the endogenous T cell receptor (TCR). Here we report a streamlined strategy for generating allogeneic CAR T cells by targeting the insertion of a CAR transgene directly into the native TCR locus using an engineered homing endonuclease and an AAV donor template. We demonstrate that anti-CD19 CAR T cells produced in this manner do not express the endogenous TCR, exhibit potent effector functions in vitro, and mediate clearance of CD19(+) tumors in an in vivo mouse model.	[MacLeod, Daniel T.; Antony, Jeyaraj; Martin, Aaron J.; Hekele, Armin; Wetzel, Keith J.; Brown, Audrey E.; Triggiano, Melissa A.; Hux, Jo Ann; Pham, Christina D.; Bartsevich, Victor V.; Turner, Caitlin A.; Lape, Janel; Kirkland, Samantha; Beard, Clayton W.; Smith, Jeff; Nicholson, Michael G.; Jantz, Derek; McCreedy, Bruce] Precis BioSci, 302 East Pettigrew St,Dibrell Bldg,Suite A-100, Durham, NC 27701 USA; [Moser, Rachel J.; Hirsch, Matthew L.] Univ North Carolina Chapel Hill, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Moser, Rachel J.; Hirsch, Matthew L.] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC 27599 USA	MacLeod, DT; McCreedy, B (reprint author), Precis BioSci, 302 East Pettigrew St,Dibrell Bldg,Suite A-100, Durham, NC 27701 USA.	dan.macleod@precisionbiosciences.com; bruce.mccreedy@precisionbiosciences.com			Research to Prevent Blindness;  [RO1A1072176-06A1];  [RO1AR064369-01A1]	All authors, with the exception of R.J.M. and M.L.H., receive compensation as employees of Precision BioSciences, Inc. R.J.M. and M.L.H. are supported by RO1A1072176-06A1, RO1AR064369-01A1, and Research to Prevent Blindness. The authors would like to thank all members of the Precision BioSciences Core Technology-team for their efforts on the production of the engineered nuclease used in this manuscript.	Abou-El-Enein M, 2016, CYTOTHERAPY, V18, P1056, DOI 10.1016/j.jcyt.2016.05.005; Afzali B, 2007, TISSUE ANTIGENS, V69, P545, DOI 10.1111/j.1399-0039.2007.00834.x; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Braun C.J., 2014, SCI TRANS MED, V6, DOI DOI 10.1126/SCITRANSLMED.3007280; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Djukanovic V, 2013, PLANT J, V76, P888, DOI 10.1111/tpj.12335; Dykes JH, 2007, TRANSFUSION, V47, P2134, DOI 10.1111/j.1537-2995.2007.01438.x; Ellis J, 2005, GENE THER, V16, P1241; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Hastie E, 2015, HUM GENE THER, V26, P257, DOI 10.1089/hum.2015.025; Hirsch ML, 2014, METHODS MOL BIOL, V1114, P291, DOI 10.1007/978-1-62703-761-7_19; Hoyos V, 2010, LEUKEMIA, V24, P1160, DOI 10.1038/leu.2010.75; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Kebriaei P, 2016, J CLIN INVEST, V126, P3363, DOI 10.1172/JCI86721; Lorentzen CL, 2015, SCAND J IMMUNOL, V82, P307, DOI 10.1111/sji.12331; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; Miller DG, 2003, MOL CELL BIOL, V23, P3550, DOI 10.1128/MCB.23.10.3550-3557.2003; Moser RJ, 2016, CURR GENE THER, V16, P207, DOI 10.2174/1566523216666160602213738; Osborn MJ, 2016, MOL THER, V24, P570, DOI 10.1038/mt.2015.197; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Qasim W, 2014, BRIT J HAEMATOL, V166, P818, DOI 10.1111/bjh.12981; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Schumm M, 2013, CYTOTHERAPY, V15, P1253, DOI 10.1016/j.jcyt.2013.05.014; Seligman LM, 2002, NUCLEIC ACIDS RES, V30, P3870, DOI 10.1093/nar/gkf495; Si WD, 2010, GENETICS, V185, P443, DOI 10.1534/genetics.110.115196; Stoddard BL, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-7; Torikai H, 2016, MOL THER, V24, P1178, DOI 10.1038/mt.2016.106; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Valton J, 2015, MOL THER, V23, P1507, DOI 10.1038/mt.2015.104; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang XY, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.15	42	5	5	6	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	APR 5	2017	25	4					949	961		10.1016/j.ymthe.2017.02.005				13	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	ER5YC	WOS:000398879500014	28237835	gold			2018-01-05	
J	Quinn, PM; Pellissier, LP; Wijnholds, J				Quinn, Peter M.; Pellissier, Lucie P.; Wijnholds, Jan			The CRB1 Complex: Following the Trail of Crumbs to a Feasible Gene Therapy Strategy	FRONTIERS IN NEUROSCIENCE			English	Review						crumbs complex; retinopathies; gene therapy; CRISPR; human iPSC; retinal organoids	LEBER CONGENITAL AMAUROSIS; EPITHELIAL-CELL POLARITY; MULLER GLIAL-CELLS; INHERITED RETINAL DYSTROPHIES; PLURIPOTENT STEM-CELLS; RETINITIS-PIGMENTOSA; PHOTORECEPTOR PRECURSORS; MOUSE MODEL; MESENCHYMAL TRANSITION; HOST PHOTORECEPTORS	Once considered science fiction, gene therapy is rapidly becoming scientific reality, targeting a growing number of the approximately 250 genes linked to hereditary retinal disorders such as retinitis pigmentosa and Leber's congenital amaurosis. Powerful new technologies have emerged, leading to the development of humanized models for testing and screening these therapies, bringing us closer to the goal of personalized medicine. These tools include the ability to differentiate human induced pluripotent stem cells (iPSCs) to create a "retina-in-a-dish" model and the self-formed ectodermal autonomous multi-zone, which can mimic whole eye development. In addition, highly specific gene-editing tools are now available, including the CRISPR/Cas9 system and the recently developed homology-independent targeted integration approach, which allows gene editing in non-dividing cells. Variants in the CRB1 gene have long been associated with retinopathies, and more recently the CRB2 gene has also been shown to have possible clinical relevance with respect to retinopathies. In this review, we discuss the role of the CRB protein complex in patients with retinopathy. In addition, we discuss new opportunities provided by stem cells and gene-editing tools, and we provide insight into how the retinal therapeutic pipeline can be improved. Finally, we discuss the current state of adeno-associated virus-mediated gene therapy and how it can be applied to treat retinopathies associated with mutations in CRB1.	[Quinn, Peter M.; Wijnholds, Jan] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands; [Pellissier, Lucie P.] Univ Tours, Inst Francais Cheval & Equitat, CNRS, Unite Physiol Reprod & Comportements,INRA,UMR85,U, Nouzilly, France; [Wijnholds, Jan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	Wijnholds, J (reprint author), Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands.; Wijnholds, J (reprint author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.	J.Wijnholds@lumc.nl		Quinn, Peter/0000-0001-9940-4264	Foundation Fighting Blindness [TA-GT0811-0590-NIN, TA-GT-0313-0607-NIN]; Netherlands Organization for Health Research and Development (ZonMw) [43200004]; Curing Retinal Blindness Foundation (CRBF); Stichting Retina Nederland Fonds; Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Rotterdamse Stichting Blindenbelangen (RSB); Stichting Blindenhulp; Stichting Blinden-Penning; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB); Gelderse Blinden Stichting (GBS); MaculaFonds	The Wijnholds Laboratory would like to thank our supporters, which include the Foundation Fighting Blindness (TA-GT0811-0590-NIN and TA-GT-0313-0607-NIN), the Netherlands Organization for Health Research and Development (ZonMw grant 43200004), the Curing Retinal Blindness Foundation (CRBF), Stichting Retina Nederland Fonds, Landelijke Stichting voor Blinden en Slechtzienden (LSBS), Rotterdamse Stichting Blindenbelangen (RSB), Stichting Blindenhulp, Stichting Blinden-Penning, Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB), Gelderse Blinden Stichting (GBS), and MaculaFonds.	Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Alves CH, 2014, HUM MOL GENET, V23, P3384, DOI 10.1093/hmg/ddu048; Alves CH, 2014, PROG RETIN EYE RES, V40, P35, DOI 10.1016/j.preteyeres.2014.01.001; Alves CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082532; Alves CH, 2013, HUM MOL GENET, V22, P35, DOI 10.1093/hmg/dds398; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a                                                                 ; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Bui DA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaa9227; Bujakowska K, 2012, HUM MUTAT, V33, P306, DOI 10.1002/humu.21653; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Capowski EE, 2016, STEM CELLS, V34, P2625, DOI 10.1002/stem.2414; Cepko CL, 2013, HUM GENE THER, V24, P242, DOI 10.1089/hum.2013.050; Christensen AK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-3; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cordovez JA, 2015, OPHTHALMIC GENET, V36, P257, DOI 10.3109/13816810.2014.881505; Corton M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-20; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 1999, NAT GENET, V23, P217; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Ebarasi L, 2015, AM J HUM GENET, V96, P153, DOI 10.1016/j.ajhg.2014.11.014; Edwards TL, 2016, NEW ENGL J MED, V374, P1996, DOI 10.1056/NEJMc1509501; Fan SL, 2007, J CELL BIOL, V178, P387, DOI 10.1083/jcb.200609096; Fischer M. D., 2016, INVEST OPHTH VIS SCI, V57, P5207; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gamblin CL, 2014, J CELL BIOL, V204, P487, DOI 10.1083/jcb.201308032; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Gosens I, 2007, EXP CELL RES, V313, P3959, DOI 10.1016/j.yexcr.2007.08.025; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Hayashi R, 2016, NATURE, V531, P376, DOI 10.1038/nature17000; HECKENLIVELY JR, 1982, BRIT J OPHTHALMOL, V66, P26, DOI 10.1136/bjo.66.1.26; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hsu YC, 2006, DEVELOPMENT, V133, P4849, DOI 10.1242/dev.02685; Hsu YC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-60; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Hurley JB, 2015, J CLIN INVEST, V125, P3424, DOI 10.1172/JCI83194; Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Jaron R, 2016, CLIN GENET, V90, P540, DOI 10.1111/cge.12764; Jayaram H, 2014, STEM CELL TRANSL MED, V3, P323, DOI 10.5966/sctm.2013-0112; Kaewkhaw R., 2016, INVEST OPHTH VIS SCI, V57, DOI DOI 10.1167/IOVS.15-17639; Kantardzhieva A, 2005, INVEST OPHTH VIS SCI, V46, P2192, DOI 10.1167/iovs.04-1417; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Koch SF, 2015, J CLIN INVEST, V125, P3704, DOI 10.1172/JCI82462; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lamont RE, 2016, EUR J HUM GENET, V24, P1436, DOI 10.1038/ejhg.2016.24; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.00885; Lemmers C., 2004, CELL, V15, P1324, DOI [10.1091/mbc.E03-04-0235, DOI 10.1091/MBC.E03-04-0235]; Li YJ, 2014, P NATL ACAD SCI USA, V111, P17444, DOI 10.1073/pnas.1416515111; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lotery A J, 2001, Ophthalmic Genet, V22, P163, DOI 10.1076/opge.22.3.163.2222; Maggio I, 2016, NUCLEIC ACIDS RES, V44, P1449, DOI 10.1093/nar/gkv1540; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McKay GJ, 2005, INVEST OPHTH VIS SCI, V46, P322, DOI 10.1167/iovs.04-0734; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Morarji J, 2016, ACTA OPHTHALMOL, V94, pE513, DOI 10.1111/aos.12997; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Park R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10329; Pearson RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13029; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Pellissier LP, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.9; Pellissier LP, 2015, HUM MOL GENET, V24, P3104, DOI 10.1093/hmg/ddv062; Pellissier LP, 2014, HUM MOL GENET, V23, P3759, DOI 10.1093/hmg/ddu089; Pellissier LP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003976; Pocha SM, 2011, J CELL BIOL, V195, P827, DOI 10.1083/jcb.201105144; Quinn P. M., METHODS MOL IN PRESS; Rainkumar N, 2016, NAT CELL BIOL, V18, P1281, DOI 10.1038/ncb3442; Ramkumar N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005551; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Santos-Ferreira T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13028; Shirai H., 2015, P NATL ACAD SCI USA, V113, pE81, DOI 10.1073/pnas.1512590113; Singh MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13537; Slavotinek A, 2015, AM J HUM GENET, V96, P162, DOI 10.1016/j.ajhg.2014.11.013; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Talib M., OPHTHALMOLO IN PRESS, DOI [10.1016/j.ophtha.2017.01.047, DOI 10.1016/J.OPHTHA.2017.01.047]; Tsang SH, 2014, OPHTHALMOLOGY, V121, P1773, DOI 10.1016/j.ophtha.2014.03.010; Valamehr B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00213; Vallespin E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/iovs.07-0007; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van de Pavert SA, 2007, GLIA, V55, P1486, DOI 10.1002/glia.20561; van de Pavert SA, 2007, J NEUROSCI, V27, P564, DOI 10.1523/JNEUROSCI.3496-06.2007; van den Hurk JAJM, 2005, MOL VIS, V11, P263; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vincent A, 2016, INVEST OPHTH VIS SCI, V57, P2637, DOI 10.1167/iovs.15-18281; Volkner M, 2016, STEM CELL REP, V6, P525, DOI 10.1016/j.stemcr.2016.03.001; Wei ZY, 2015, J BIOL CHEM, V290, P11384, DOI 10.1074/jbc.M115.643791; Wiley LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30742; Xiao ZJ, 2011, DEV DYNAM, V240, P2646, DOI 10.1002/dvdy.22778; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Zacharias DG, 2011, MAYO CLIN PROC, V86, P634, DOI 10.4065/mcp.2011.0054; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhao M, 2015, J NEUROSCI, V35, P6093, DOI 10.1523/JNEUROSCI.3412-14.2015; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115; Zou J, 2012, DEV CELL, V22, P1261, DOI 10.1016/j.devcel.2012.03.007	102	0	0	7	11	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	APR 5	2017	11								175	10.3389/fnins.2017.00175				15	Neurosciences	Neurosciences & Neurology	ER0DZ	WOS:000398458500001	28424578	gold			2018-01-05	
J	Davies, FCJ; Hope, JE; McLachlan, F; Nunez, F; Doig, J; Bengani, H; Smith, C; Abbott, CM				Davies, Faith C. J.; Hope, Jilly E.; McLachlan, Fiona; Nunez, Francis; Doig, Jennifer; Bengani, Hemant; Smith, Colin; Abbott, Catherine M.			Biallelic mutations in the gene encoding eEF1A2 cause seizures and sudden death in F0 mice	SCIENTIFIC REPORTS			English	Article							TRANSFER-RNA SYNTHETASE; ONE-STEP GENERATION; EPILEPTIC ENCEPHALOPATHY; INTELLECTUAL DISABILITY; HUMAN-DISEASE; WASTED MICE; PROTEIN; EXPRESSION; REVEALS; NEURODEGENERATION	De novo heterozygous missense mutations in the gene encoding translation elongation factor eEF1A2 have recently been found to give rise to neurodevelopmental disorders. Children with mutations in this gene have developmental delay, epilepsy, intellectual disability and often autism; the most frequently occurring mutation is G70S. It has been known for many years that complete loss of eEF1A2 in mice causes motor neuron degeneration and early death; on the other hand heterozygous null mice are apparently normal. We have used CRISPR/ Cas9 gene editing in the mouse to mutate the gene encoding eEF1A2, obtaining a high frequency of biallelic mutations. Whilst many of the resulting founder (F0) mice developed motor neuron degeneration, others displayed phenotypes consistent with a severe neurodevelopmental disorder, including sudden unexplained deaths and audiogenic seizures. The presence of G70S protein was not sufficient to protect mice from neurodegeneration in G70S/-mice, showing that the mutant protein is essentially non-functional.	[Davies, Faith C. J.; McLachlan, Fiona; Nunez, Francis; Doig, Jennifer; Abbott, Catherine M.] Univ Edinburgh, Western Gen Hosp, MRC, Ctr Genom & Expt Med,Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Hope, Jilly E.; Abbott, Catherine M.] Univ Edinburgh, Muir Maxwell Epilepsy Ctr, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland; [Bengani, Hemant] Univ Edinburgh, Western Gen Hosp, MRC, Inst Genet & Mol Med,Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland; [Smith, Colin] Acad Dept Neuropathol, Ctr Clin Brain Sci, Chancellors Bldg, Edinburgh EH16 4SB, Midlothian, Scotland	Abbott, CM (reprint author), Univ Edinburgh, Western Gen Hosp, MRC, Ctr Genom & Expt Med,Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.; Abbott, CM (reprint author), Univ Edinburgh, Muir Maxwell Epilepsy Ctr, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland.	C.Abbott@ed.ac.uk		Abbott, Catherine/0000-0001-8794-7173	Medical Research Council; EastBio BBSRC studentship	We are very grateful to the staff of the IGMM transgenic facility, particularly Emma Allan for her excellent skills with microinjection, John Tomlins, Robert Flockhart and Janice Young for their expert care of the mice, and to Simon Cumming and Liz Hurd for their support and advice. We thank David Fitzpatrick and Nick Hastie for their review of the manuscript. F. D. and F. M. are supported by studentships from the Medical Research Council and J. H. by an EastBio BBSRC studentship.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bayes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046683; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Doig J, 2013, FEBS J, V280, P6528, DOI 10.1111/febs.12554; Fujii W, 2014, J REPROD DEVELOP, V60, P324, DOI 10.1262/jrd.2013-139                                                            ; Griffiths LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041917; Inui T, 2016, BRAIN DEV-JPN, V38, P520, DOI 10.1016/j.braindev.2015.11.003; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Kang JQ, 2015, NAT NEUROSCI, V18, P988, DOI 10.1038/nn.4024; Khalyfa A, 2001, J BIOL CHEM, V276, P22915, DOI 10.1074/jbc.M101011200; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; Lam WWK, 2016, MOL GENET GENOM MED, V4, P465, DOI 10.1002/mgg3.219; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; LEE S, 1992, J BIOL CHEM, V267, P24064; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x                                              ; Nakajima J, 2015, CLIN GENET, V87, P356, DOI 10.1111/cge.12394; Nakajima K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34703; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Newbery HJ, 2005, J NEUROPATH EXP NEUR, V64, P295, DOI 10.1093/jnen/64.4.295                                                           ; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; SANDBAKEN MG, 1988, GENETICS, V120, P923; Simons C, 2015, AM J HUM GENET, V96, P675, DOI 10.1016/j.ajhg.2015.02.012; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Wagnon JL, 2015, HUM MOL GENET, V24, P506, DOI 10.1093/hmg/ddu470; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yasue A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05705; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	31	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 5	2017	7								46019	10.1038/srep46019				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ9HI	WOS:000398395100001	28378778	gold			2018-01-05	
J	Van Orden, MJ; Klein, P; Babu, K; Najar, FZ; Rajan, R				Van Orden, Mason J.; Klein, Peter; Babu, Kesavan; Najar, Fares Z.; Rajan, Rakhi			Conserved DNA motifs in the type II-A CRISPR leader region	PEERJ			English	Article						CRISPR-Cas systems; Type II-A CRISPR; Leader-repeat; Adaptation	ADAPTIVE IMMUNE-SYSTEMS; ESCHERICHIA-COLI; STREPTOCOCCUS-THERMOPHILUS; CAS SYSTEMS; HALOARCULA-HISPANICA; SPACER ACQUISITION; DUAL-RNA; ADAPTATION; PROKARYOTES; INTERFERENCE	The Clustered Regularly Interspaced Short Palindromic Repeats associated (CRISPR-Cas) systems consist of RNA-protein complexes that provide bacteria and archaea with sequence-specific immunity against bacteriophages, plasmids, and other mobile genetic elements. Bacteria and archaea become immune to phage or plasmid infections by inserting short pieces of the intruder DNA (spacer) site-specifically into the leader-repeat junction in a process called adaptation, Previous studies have shown that parts of the leader region, especially the 3' end of the leader, fare indispensable for adaptation. However, a comprehensive analysis of leader ends remains absent. Here, we have analyzed the leader, repeat, and Cas proteins from 167 type II-A CRISPR loci. Our results indicate two distinct conserved DNA motifs at the 3' leader end: ATTTGAG (noted previously in the CRISPR1 locus of Streptococcus thermophilus DGCC7710) and a newly defined CTRCGAG, associated with the CRISPR3 locus of S. thermophilus DGCC7710. A third group with a very short CG DNA conservation at the 3' leader end is observed mostly in lactobacilli. Analysis of the repeats land Cas proteins revealed clustering of these CRISPR components that mirrors the leader motif clustering, agreement with the coevolution of CRISPR-Cas components. Based on our analysis of the type II-A CRISPRI loci, we implicate leader end sequences that could confer site-specificity for the adaptation-machinery in the different subsets of type II-A CRISPR loci.	[Van Orden, Mason J.; Klein, Peter; Babu, Kesavan; Najar, Fares Z.; Rajan, Rakhi] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	Rajan, R (reprint author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	r-rajan@ou.edu			Institutional Development Award (IDeA) from National Institute of General Medical Sciences of the National Institutes of Health [P20GM103640]	The research reported in this paper was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under the grant number P20GM103640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Alkhnbashi OS, 2016, BIOINFORMATICS, V32, P576, DOI 10.1093/bioinformatics/btw454; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bernick DL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00251; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2014, MOL MICROBIOL, V93, P98, DOI 10.1111/mmi.12644; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erdmann S, 2014, MOL MICROBIOL, V91, P900, DOI 10.1111/mmi.12503; Erdmann S, 2012, MOL MICROBIOL, V85, P1044, DOI 10.1111/j.1365-2958.2012.08171.x; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jansen Rund, 2002, OMICS A Journal of Integrative Biology, V6, P23, DOI 10.1089/15362310252780816; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Lier C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00214; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2009, STRUCTURE, V17, P786, DOI 10.1016/j.str.2009.05.002; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Okonechnikov K, 2012, BIOINFORMATICS, V8; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; Sanozky-Dawes R, 2015, MICROBIOL-SGM, V161, P1752, DOI 10.1099/mic.0.000129; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sontheimer EJ, 2015, HUM GENE THER, V26, P413, DOI 10.1089/hum.2015.091; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	71	0	0	5	5	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	APR 4	2017	5								e3161	10.7717/peerj.3161				22	Multidisciplinary Sciences	Science & Technology - Other Topics	ER2YW	WOS:000398662200002	28392985	gold			2018-01-05	
J	Puigbo, P; Makarova, KS; Kristensen, DM; Wolf, YI; Koonin, EV				Puigbo, Pere; Makarova, Kira S.; Kristensen, David M.; Wolf, Yuri I.; Koonin, Eugene V.			Reconstruction of the evolution of microbial defense systems	BMC EVOLUTIONARY BIOLOGY			English	Article							CRISPR-CAS SYSTEMS; RESTRICTION-MODIFICATION SYSTEMS; HORIZONTAL GENE-TRANSFER; TOXIN-ANTITOXIN SYSTEMS; GENOME EVOLUTION; PHYLOGENETIC TREES; ORTHOLOGOUS GENES; ADAPTIVE IMMUNITY; PROKARYOTES; DNA	Background: Evolution of bacterial and archaeal genomes is a highly dynamic process that involves intensive loss of genes as well as gene gain via horizontal transfer, with a lesser contribution from gene duplication. The rates of these processes can be estimated by comparing genomes that are linked by an evolutionary tree. These estimated rates of genome dynamics events substantially differ for different functional classes of genes. The genes involved in defense against viruses and other invading DNA are among those that are gained and lost at the highest rates. Results: We employed a stochastic birth- and- death model to obtain maximum likelihood estimates of the rates of gain and loss of defense genes in 35 groups of closely related bacterial genomes and one group of archaeal genomes. We find that on average, the defense genes experience 1.4 fold higher flux than the rest of microbial genes. This excessive flux of defense genes over the genomic mean is consistent across diverse microbial groups. The few exceptions include intracellular parasites with small, degraded genomes that possess few defense systems which are more stable than in other microbes. Generally, defense genes follow the previously established pattern of genome dynamics, with gene family loss being about 3 times more common than gain and an order of magnitude more common than expansion or contraction of gene families. Case by case analysis of the evolutionary dynamics of defense genes indicates frequent multiple events in the same locus and widespread involvement of mobile elements in the gain and loss of defense genes. Conclusions: Evolution of microbial defense systems is highly dynamic but, notwithstanding the host- parasite arms race, generally follows the same trends that have been established for the rest of the genes. Apart from the paucity and the low flux of defense genes in parasitic bacteria with deteriorating genomes, there is no clear connection between the evolutionary regime of defense systems and microbial life style.	[Puigbo, Pere; Makarova, Kira S.; Kristensen, David M.; Wolf, Yuri I.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Puigbo, Pere] Univ Turku, Dept Biol, Div Genet & Physiol, Turku, Finland; [Kristensen, David M.] Univ Iowa, Dept Biomed Engn, Iowa City, IA USA	Koonin, EV (reprint author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov			US Department of Health and Human Services	This work was supported by intramural funds of the US Department of Health and Human Services (to the National Library of Medicine).	Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0                                                   ; Buckling A, 2012, ADV EXP MED BIOL, V751, P347, DOI 10.1007/978-1-4614-3567-9_16; Comeau AM, 2005, CURR OPIN MICROBIOL, V8, P488, DOI 10.1016/j.mib.2005.06.004; Csuros M, 2010, BIOINFORMATICS, V26, P1910, DOI 10.1093/bioinformatics/btq315; Cyranoski D, 2016, NATURE, V536, P136, DOI 10.1038/536136a; Darling AE, 2011, BIOINFORMATICS, V27, P2756, DOI 10.1093/bioinformatics/btr451; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Doolittle WF, 1999, TRENDS CELL BIOL, V9, pM5, DOI 10.1016/S0962-8924(99)01664-5                                                   ; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Forterre P, 2013, CURR OPIN VIROL, V3, P558, DOI 10.1016/j.coviro.2013.06.013; Forterre P, 2009, ANN NY ACAD SCI, V1178, P65, DOI 10.1111/j.1749-6632.2009.04993.x; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Hur JK, 2014, TRENDS BIOCHEM SCI, V39, P257, DOI 10.1016/j.tibs.2014.04.006; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-8; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Komor A. C., 2016, CELL; Koonin EV, 2015, MOL BIOSYST, V11, P20, DOI 10.1039/c4mb00438h; Koonin EV, 2013, CURR OPIN VIROL, V3, P546, DOI 10.1016/j.coviro.2013.06.008; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072; Kristensen DM, 2016, NUCL ACIDS IN PRESS; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2                                                           ; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; Novichkov PS, 2009, NUCLEIC ACIDS RES, V37, pD448, DOI 10.1093/nar/gkn684; Pingoud A, 2016, NUCLEIC ACIDS RES, V42, P7489; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puigbo P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0066-4; Ran FA, 2016, ANAL BIOCH; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Rogers JS, 2001, SYST BIOL, V50, P713, DOI 10.1080/106351501753328839; Sela I, 2016, P NATL ACAD SCI USA, V113, P11399, DOI 10.1073/pnas.1614083113; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501                                                               ; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Surtees JA, 2003, CURR TOP DEV BIOL, V56, P145, DOI 10.1016/S0070-2153(03)01010-X; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Takeuchi N, 2012, J BACTERIOL, V194, P1216, DOI 10.1128/JB.06521-11; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Vale PF, 2015, P ROY SOC B-BIOL SCI, V282, P41, DOI 10.1098/rspb.2015.1270; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Wolf YI, 1999, GENOME RES, V9, P689; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Wolf YI, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-46; Wu HW, 2008, COMPUT BIOL CHEM, V32, P176, DOI 10.1016/j.compbiolchem.2008.02.007	55	3	3	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2148			BMC EVOL BIOL	BMC Evol. Biol.	APR 4	2017	17								94	10.1186/s12862-017-0942-y				13	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	EQ6XS	WOS:000398227700001	28376755	gold			2018-01-05	
J	Basu, S; Adams, L; Guhathakurta, S; Kim, YS				Basu, Sambuddha; Adams, Levi; Guhathakurta, Subhrangshu; Kim, Yoon-Seong			A novel tool for monitoring endogenous alpha-synuclein transcription by NanoLuciferase tag insertion at the 3' end using CRISPR-Cas9 genome editing technique	SCIENTIFIC REPORTS			English	Article							HISTONE DEACETYLASE INHIBITORS; FAMILIAL PARKINSONS-DISEASE; LUCIFERASE REPORTER; DNA METHYLATION; MOLECULAR-MECHANISMS; DOPAMINERGIC-NEURONS; GENE; EXPRESSION; 5-AZA-2'-DEOXYCYTIDINE; DUPLICATION	alpha-synuclein (alpha-SYN) is a major pathologic contributor to Parkinson's disease (PD). Multiplication of alpha-SYN encoding gene (SNCA) is correlated with early onset of the disease underlining the significance of its transcriptional regulation. Thus, monitoring endogenous transcription of SNCA is of utmost importance to understand PD pathology. We developed a stable cell line expressing alpha-SYN endogenously tagged with NanoLuc luciferase reporter using CRISPR/Cas9-mediated genome editing. This allows efficient measurement of transcriptional activity of alpha-SYN in its native epigenetic landscape which is not achievable using exogenous transfection-based luciferase reporter assays. The NanoLuc activity faithfully monitored the transcriptional regulation of SNCA following treatment with different drugs known to regulate alpha-SYN expression; while exogenous promoter-reporter assays failed to reproduce the similar outcomes. To our knowledge, this is the first report showing endogenous monitoring of alpha-SYN transcription, thus making it an efficient drug screening tool that can be used for therapeutic intervention in PD.	[Basu, Sambuddha; Adams, Levi; Guhathakurta, Subhrangshu; Kim, Yoon-Seong] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Div Neurosci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA; [Kim, Yoon-Seong] Kyunghee Univ Med Coll, Seoul, South Korea	Guhathakurta, S (reprint author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Div Neurosci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	Subhrangshu.Guhathakurta@ucf.edu			National Institute of Health [5R21NS088923-02]; University of Central Florida's Graduate Dean's Dissertation Completion Fellowship; University of Central Florida's Trustees Doctoral Fellowship	The study is supported by the financial support from National Institute of Health vide grant number 5R21NS088923-02 awarded to Y.S.K. S.B. is supported from University of Central Florida's Graduate Dean's Dissertation Completion Fellowship. L.A. is recipient of University of Central Florida's Trustees Doctoral Fellowship. All the financial supports are gratefully acknowledged.	Basu S, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.54; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1                                                   ; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Clough RL, 2007, FASEB J, V21, P596, DOI 10.1096/fj.06-7111com; Clough RL, 2011, J NEUROCHEM, V117, P275, DOI 10.1111/j.1471-4159.2011.07199.x; Clough RL, 2009, J NEUROCHEM, V110, P1479, DOI 10.1111/j.1471-4159.2009.06250.x; Consortium EP, 2004, SCIENCE, V306, P636, DOI DOI 10.1126/SCIENCE.1105136; Davie JR, 2003, J NUTR, V133, p2485S; de Boni L, 2011, NEUROMOL MED, V13, P310, DOI 10.1007/s12017-011-8163-9; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Matsumoto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015522; MICHEL PP, 1990, J NEUROSCI RES, V26, P428, DOI 10.1002/jnr.490260405                                                           ; Norisada J, 2014, BIOCHEM BIOPH RES CO, V449, P483, DOI 10.1016/j.bbrc.2014.05.031; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Sharma S., 2015, PARKINSONS DIS, V2015, DOI DOI 10.1155/2015/303294; Shifera AS, 2010, ANAL BIOCHEM, V396, P167, DOI 10.1016/j.ab.2009.09.043; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278                                                         ; Solberg Nina, 2013, Methods Mol Biol, V977, P65, DOI 10.1007/978-1-62703-284-1_6; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Walsh PS, 1992, GENOME RES, V1, P241, DOI DOI 10.1101/GR.1.4.241; Wang Y, 2013, CNS NEUROSCI THER, V19, P183, DOI 10.1111/cns.12059; WILLIAMS TM, 1989, ANAL BIOCHEM, V176, P28, DOI 10.1016/0003-2697(89)90267-4                                                    ; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	38	1	1	3	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 4	2017	7								45883	10.1038/srep45883				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ7BG	WOS:000398236900001		gold			2018-01-05	
J	Kelton, W; Waindok, AC; Pesch, T; Pogson, M; Ford, K; Parola, C; Reddy, ST				Kelton, William; Waindok, Ann Cathrin; Pesch, Theresa; Pogson, Mark; Ford, Kyle; Parola, Cristina; Reddy, Sai T.			Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchange	SCIENTIFIC REPORTS			English	Article							STEM-CELL TRANSPLANTATION; CAS9 RIBONUCLEOPROTEINS; KNOCK-IN; T-CELLS; GENE; NUCLEASES; SYSTEM; EXPRESSION; GENERATION; FIDELITY	The development of programmable nucleases has enabled the application of new genome engineering strategies for cellular immunotherapy. While targeted nucleases have mostly been used to knockout or knock-in genes in immune cells, the scarless exchange of entire immunogenomic alleles would be of great interest. In particular, reprogramming the polymorphic MHC locus could enable the creation of matched donors for allogeneic cellular transplantation. Here we show a proof-of-concept for reprogramming MHC-specificity by performing CRISPR-Cas9-assisted cassette exchange. Using murine antigen presenting cell lines (RAW264.7 macrophages), we demonstrate that the generation of Cas9-induced double-stranded breaks flanking the native MHC-I H2-Kd locus led to exchange of an orthogonal H2-Kb allele. MHC surface expression allowed for easy selection of reprogrammed cells by flow cytometry, thus obviating the need for additional selection markers. MHC-reprogrammed cells were fully functional as they could present H2-Kd-restricted peptide and activate cognate T cells. Finally, we investigated the role of various donor template formats on exchange efficiency, discovering that templates that underwent in situ linearization resulted in the highest MHC-reprogramming efficiency. These findings highlight a potential new approach for the correcting of MHC mismatches in cellular transplantation.	[Kelton, William; Waindok, Ann Cathrin; Pesch, Theresa; Pogson, Mark; Ford, Kyle; Parola, Cristina; Reddy, Sai T.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland	Reddy, ST (reprint author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	sai.reddy@ethz.ch			ETH Zurich Postdoctoral Fellowship; Swiss National Science Foundation; National Center of Competence in Research (NCCR) Molecular Systems Engineering; endowment from the S. Leslie Misrock Foundation	We thank Brian Lang and Simon Friedensohn for their aid with statistical analysis. This work was supported by the ETH Zurich Postdoctoral Fellowship (to M.P.); Swiss National Science Foundation (to S.T.R.); The National Center of Competence in Research (NCCR) Molecular Systems Engineering (to S.T.R.). The professorship of S.T.R. is supported by an endowment from the S. Leslie Misrock Foundation.	Brodin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070388; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Fijalkowska IJ, 2012, FEMS MICROBIOL REV, V36, P1105, DOI 10.1111/j.1574-6976.2012.00338.x; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Furst D, 2013, BLOOD, V122, P3220, DOI 10.1182/blood-2013-02-482547; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Ayala Garcia M. A., 2012, J TRANSPLANTATION, V2012; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Horan J, 2012, BLOOD, V120, P2918, DOI 10.1182/blood-2012-03-417758; Hsu CYM, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-23; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020                                                         ; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kekre N., 2014, BLOOD; Khan TA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501371; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Madeja Z, 2011, P NATL ACAD SCI USA, V108, P4012, DOI 10.1073/pnas.1005342108; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; McInerney P, 2014, MOL BIOL INT, V2014, P8, DOI DOI 10.1155/2014/287430; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Pogson M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12535; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1                                                   ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Remy S, 2014, GENOME RES, V24, P1371, DOI 10.1101/gr.171538.113; Riolobos L, 2013, MOL THER, V21, P1232, DOI 10.1038/mt.2013.59; Saini SK, 2015, P NATL ACAD SCI USA, V112, P202, DOI 10.1073/pnas.1418690112; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Wirth Dagmar, 2007, Curr Opin Biotechnol, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zheng Q., 2014, FEBS J, V57, P115	46	0	0	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 4	2017	7								45775	10.1038/srep45775				12	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ5UY	WOS:000398149500001	28374766	gold			2018-01-05	
J	Mou, HW; Moore, J; Malonia, SK; Li, YX; Ozata, DM; Hough, S; Song, CQ; Smith, JL; Fischer, A; Weng, ZP; Green, MR; Xue, W				Mou, Haiwei; Moore, Jill; Malonia, Sunil K.; Li, Yingxiang; Ozata, Deniz M.; Hough, Soren; Song, Chun-Qing; Smith, Jordan L.; Fischer, Andrew; Weng, Zhiping; Green, Michael R.; Xue, Wen			Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						Kras; lung cancer; Fas; apoptosis	TUMOR-SUPPRESSOR GENES; K-RAS; MOUSE MODELS; EXPRESSION; TARGET; INHIBITORS; CRISPR-CAS9; PROGRESSION; ADDICTION; PROTEINS	Genetic lesions that activate KRAS account for similar to 30% of the 1.6 million annual cases of lung cancer. Despite clinical need, KRAS is still undruggable using traditional small-molecule drugs/inhibitors. When oncogenic Kras is suppressed by RNA interference, tumors initially regress but eventually recur and proliferate despite suppression of Kras. Here, we show that tumor cells can survive knockout of oncogenic Kras, indicating the existence of Kras-independent survival pathways. Thus, even if clinical KRAS inhibitors were available, resistance would remain an obstacle to treatment. Kras-independent cancer cells exhibit decreased colony formation in vitro but retain the ability to form tumors in mice. Comparing the transcriptomes of oncogenic Kras cells and Kras knockout cells, we identified 603 genes that were specifically up-regulated in Kras knockout cells, including the Fas gene, which encodes a cell surface death receptor involved in physiological regulation of apoptosis. Antibodies recognizing Fas receptor efficiently induced apoptosis of Kras knockout cells but not oncogenic Kras-expressing cells. Increased Fas expression in Kras knockout cells was attributed to decreased association of repressive epigenetic marks at the Fas promoter. Concordant with this observation, treating oncogenic Kras cells with histone deacetylase inhibitor and Fas-activating antibody efficiently induced apoptosis, thus bypassing the need to inhibit Kras. Our results suggest that activation of Fas could be exploited as an Achilles' heel in tumors initiated by oncogenic Kras.	[Mou, Haiwei; Ozata, Deniz M.; Hough, Soren; Song, Chun-Qing; Smith, Jordan L.; Xue, Wen] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Moore, Jill; Li, Yingxiang; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Malonia, Sunil K.; Green, Michael R.; Xue, Wen] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Li, Yingxiang] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Fischer, Andrew] Univ Massachusetts, Sch Med, Mem Med Ctr, Dept Pathol, Worcester, MA 01605 USA; [Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01604 USA; [Xue, Wen] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Xue, W (reprint author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA.; Green, MR; Xue, W (reprint author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.; Green, MR (reprint author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01604 USA.; Xue, W (reprint author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	michael.green@umassmed.edu; wen.xue@umassmed.edu		Hough, Soren/0000-0002-1628-2554	NIH [R00CA169512, DP2HL137167]; Worcester Foundation; American Cancer Society [129056-RSG-16-093]; Lung Cancer Research Foundation; China Scholarship Council [201506260151]; Thousand Talent Plan funding from the Chinese government	We thank T. Jacks, P. Zamore, W. Hahn, E. Sontheimer, V. Ambros, N. Wajapeyee, P. Sharp, M. Moore, M. Muzumdar, H. Yin, D. Anderson, and C. Mello for their insightful comments. We thank D. Conte and S. Deibler for critically editing this manuscript. We thank Y. Liu and E. Kittler at the University of Massachusetts core facilities for histology and deep-sequencing support. This work was supported by grants from NIH (R00CA169512 and DP2HL137167), the Worcester Foundation, the American Cancer Society (129056-RSG-16-093), and the Lung Cancer Research Foundation (to W.X.). Y.L. was supported by the China Scholarship Council (Grant 201506260151) and the Thousand Talent Plan funding (to Z.W.) from the Chinese government. M.R.G. is an investigator of the Howard Hughes Medical Institute.	Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Cai J, 2015, BRIT J CANCER, V113, P1720, DOI 10.1038/bjc.2015.367; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fenton RG, 1998, CANCER RES, V58, P3391; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Heist R. S., 2012, CANCER CELL, V21, p[448, e2], DOI DOI 10.1016/J.CCR.2012.03.007; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Li YX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0680-7; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Maecker HL, 2002, CANCER CELL, V2, P139, DOI 10.1016/S1535-6108(02)00095-8; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; McCormick F, 2015, EXPERT OPIN THER TAR, V19, P451, DOI 10.1517/14728222.2014.1000304; Mou HW, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0178-7; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X                                                   ; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Peli J, 1999, EMBO J, V18, P1824, DOI 10.1093/emboj/18.7.1824; Peter ME, 2015, CELL DEATH DIFFER, V22, P885, DOI 10.1038/cdd.2015.25; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarkar S, 2011, ANTICANCER RES, V31, P2723; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203                                                         ; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; Wajapeyee N, 2013, GENE DEV, V27, P2221, DOI 10.1101/gad.227413.113; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Xue W, 2014, P NATL ACAD SCI USA, V111, pE3553, DOI 10.1073/pnas.1412686111; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	46	2	2	1	7	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	APR 4	2017	114	14					3648	3653		10.1073/pnas.1620861114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ5YM	WOS:000398159000046	28320962	green_published			2018-01-05	
J	Vanoli, F; Tomishima, M; Feng, WR; Lamribet, K; Babin, L; Brunet, E; Jasin, M				Vanoli, Fabio; Tomishima, Mark; Feng, Weiran; Lamribet, Khadija; Babin, Loelia; Brunet, Erika; Jasin, Maria			CRISPR-Cas9-guided oncogenic chromosomal translocations with conditional fusion protein expression in human mesenchymal cells	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR-Cas9; chromosomal translocation; homology-directed repair; EWSR1-WT1; DSRCT	DOUBLE-STRAND BREAKS; EWS-WT1 GENE FUSION; IN-VIVO; HOMOLOGOUS RECOMBINATION; CANCER TRANSLOCATIONS; MAMMALIAN-CELLS; TALE NUCLEASES; PAIRED NICKS; ZINC-FINGER; STEM-CELLS	Gene editing techniques have been extensively used to attempt to model recurrent genomic rearrangements found in tumor cells. These methods involve the induction of double-strand breaks at endogenous loci followed by the identification of breakpoint junctions within a population, which typically arise by nonhomologous end joining. The low frequency of these events, however, has hindered the cloning of cells with the desired rearrangement before oncogenic transformation. Here we present a strategy combining CRISPR-Cas9 technology and homology-directed repair to allow for the selection of human mesenchymal stem cells harboring the oncogenic translocation EWSR1-WT1 found in the aggressive desmoplastic small round cell tumor. The expression of the fusion transcript is under the control of the endogenous EWSR1 promoter and, importantly, can be conditionally expressed using Cre recombinase. This method is easily adapted to generate any cancer-relevant rearrangement.	[Vanoli, Fabio; Tomishima, Mark; Feng, Weiran; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Feng, Weiran; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Lamribet, Khadija; Babin, Loelia; Brunet, Erika] INSERM, Imagine Inst, UMR 1163, Genome Dynam Immune Syst, Paris, France	Jasin, M (reprint author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA.; Jasin, M (reprint author), Mem Sloan Kettering Canc Ctr, Jr Grad Sch Biomed Sci, New York, NY 10065 USA.	m-jasin@ski.mskcc.org	BRUNET, ERIKA/H-9297-2017; BRUNET, ERIKA/K-7154-2016	BRUNET, ERIKA/0000-0002-1726-4673; BRUNET, ERIKA/0000-0002-1726-4673	NIH/National Cancer Center [P30 CA008748]; Alex's Lemonade Stand Innovation Award [NIH R01CA185660, R35GM118175]	We thank William Gerald, who first described DSRCT, and Beth Elliott for early interest and efforts on the project; Marc Ladanyi and Lee Spraggon for initial discussions on translocation approaches and materials; Lu Wang, Elodie Pronier, and Enrico Velardi for technical assistance and reagents; and Travis White for careful reading of the manuscript. Memorial Sloan Kettering research is supported by NIH/National Cancer Center Support Grant P30 CA008748. This work was supported in part by an Alex's Lemonade Stand Innovation Award, NIH R01CA185660 and R35GM118175 (to M.J.).	Allen C, 2002, P NATL ACAD SCI USA, V99, P3758, DOI 10.1073/pnas.052545899; Bandopadhayay P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-585; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505                                                            ; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GERALD W L, 1989, Pediatric Pathology, V9, P177; Gerald William L., 1993, Zentralblatt fuer Pathologie, V139, P141; Gerald WL, 2005, SEMIN CANCER BIOL, V15, P197, DOI 10.1016/j.semcancer.2005.01.005; GERALD WL, 1991, AM J SURG PATHOL, V15, P499, DOI 10.1097/00000478-199106000-00001; GERALD WL, 1995, P NATL ACAD SCI USA, V92, P1028, DOI 10.1073/pnas.92.4.1028; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lee SB, 1997, NAT GENET, V17, P309, DOI 10.1038/ng1197-309                                                              ; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Lieber MR, 2016, NAT REV CANCER, V16, P387, DOI 10.1038/nrc.2016.40; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renouf B, 2014, METHOD ENZYMOL, V546, P251, DOI 10.1016/B978-0-12-801185-0.00012-X; Richardson C, 2000, NATURE, V405, P697; Sasai K, 2011, CANCER RES, V71, P2541, DOI 10.1158/0008-5472.CAN-10-2221; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Spraggon L, 2017, J PATHOL, V242, P102, DOI 10.1002/path.4883; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vriend LEM, 2016, NUCLEIC ACIDS RES, V44, P5204, DOI 10.1093/nar/gkw179; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Werner H, 2007, CANCER LETT, V247, P84, DOI 10.1016/j.canlet.2006.03.027; Zhang Y, 2014, METHODS, V69, P171, DOI 10.1016/j.ymeth.2014.05.003	40	3	3	3	9	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	APR 4	2017	114	14					3696	3701		10.1073/pnas.1700622114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ5YM	WOS:000398159000054	28325870	green_published			2018-01-05	
J	Ramlee, MK; Wang, J; Cheung, AMS; Li, S				Ramlee, Muhammad Khairul; Wang, Jing; Cheung, Alice M. S.; Li, Shang			Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Genetics; Issue 122; Genome editing; knockout; insertion/deletion mutation; high-throughput screening; direct lysis; multiplexable	ZINC-FINGER NUCLEASES; HUMAN-CELLS; GENOME	The development of programmable genome-editing tools has facilitated the use of reverse genetics to understand the roles specific genomic sequences play in the functioning of cells and whole organisms. This cause has been tremendously aided by the recent introduction of the CRISPR/Cas9 system-a versatile tool that allows researchers to manipulate the genome and transcriptome in order to, among other things, knock out, knock down, or knock in genes in a targeted manner. For the purpose of knocking out a gene, CRISPR/ Cas9-mediated double-strand breaks recruit the non-homologous end-joining DNA repair pathway to introduce the frameshift-causing insertion or deletion of nucleotides at the break site. However, an individual guide RNA may cause undesirable off-target effects, and to rule these out, the use of multiple guide RNAs is necessary. This multiplicity of targets also means that a high-volume screening of clones is required, which in turn begs the use of an efficient high-throughput technique to genotype the knockout clones. Current genotyping techniques either suffer from inherent limitations or incur high cost, hence rendering them unsuitable for high-throughput purposes. Here, we detail the protocol for using fluorescent PCR, which uses genomic DNA from crude cell lysate as a template, and then resolving the PCR fragments via capillary gel electrophoresis. This technique is accurate enough to differentiate one base-pair difference between fragments and hence is adequate in indicating the presence or absence of a frameshift in the coding sequence of the targeted gene. This precise knowledge effectively precludes the need for a confirmatory sequencing step and allows users to save time and cost in the process. Moreover, this technique has proven to be versatile in genotyping various mammalian cells of various tissue origins targeted by guide RNAs against numerous genes, as shown here and elsewhere.	[Ramlee, Muhammad Khairul; Wang, Jing; Cheung, Alice M. S.; Li, Shang] Duke NUS Med Sch, Canc & Stem Cell Biol Programme, Singapore, Singapore	Li, S (reprint author), Duke NUS Med Sch, Canc & Stem Cell Biol Programme, Singapore, Singapore.	shang.li@duke-nus.edu.sg			NMRC/IRG [NMRC/1314/2011]; MOE AcRF [MOE2011-T2-1-051]	The authors would like to thank Ms. Tan Shi Min, Ms. Helen Ong, and Dr. Zhao Yi for helping with the capillary gel electrophoresis experiments. This work was supported by NMRC/IRG grant NMRC/1314/2011 and MOE AcRF Tier 2 Fund grant MOE2011-T2-1-051.	Chang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22312; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Liu CC, 2016, STEM CELLS, V34, P2471, DOI 10.1002/stem.2431; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ramlee MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	21	0	0	2	2	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2017		122							e55586	10.3791/55586				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FN1KO	WOS:000415747500009					2018-01-05	
J	Strigel, RM; Rollenhagen, J; Burnside, ES; Elezaby, M; Fowler, AM; Kelcz, F; Salkowski, L; DeMartini, WB				Strigel, Roberta M.; Rollenhagen, Jennifer; Burnside, Elizabeth S.; Elezaby, Mai; Fowler, Amy M.; Kelcz, Frederick; Salkowski, Lonie; DeMartini, Wendy B.			Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks	ACADEMIC RADIOLOGY			English	Article						Screening breast MRI; outcomes; benchmarks	INTERPRETIVE PERFORMANCE CRITERIA; PROSPECTIVE MULTICENTER COHORT; HIGH FAMILIAL RISK; IMAGING RECOMMENDATIONS; PERSONAL HISTORY; CANCER; MAMMOGRAPHY; WOMEN; SURVEILLANCE; ULTRASOUND	Rationale and Objectives: The BI-RADS Atlas 5th Edition includes screening breast magnetic resonance imaging (MRI) outcome benchmarks. However, the metrics are from expert practices and clinical trials of women with hereditary breast cancer predispositions, and it is unknown if they are appropriate for routine practice. We evaluated screening breast MRI audit outcomes in routine practice across a spectrum of elevated risk patients. Materials and Methods: This Institutional Review Board-approved, Health Insurance Portability and Accountability Act-compliant retrospective study included all consecutive screening breast MRI examinations from July 1, 2010 to June 30, 2013. Examination indications were categorized as gene mutation carrier (GMC), personal history (PH) breast cancer, family history (FH) breast cancer, chest radiation, and atypia/lobular carcinoma in situ (LCIS). Outcomes were determined by pathology and/or =12 months clinical and/or imaging follow-up. We calculated abnormal interpretation rate (AIR), cancer detection rate (CDR), positive predictive value of recommendation for tissue diagnosis (PPV2) and biopsy performed (PPV3), and median size and percentage of node-negative invasive cancers. Results: Eight hundred and sixty examinations were performed in 566 patients with a mean age of 47 years. Indications were 367 of 860 (42.7%) FH, 365 of 860 (42.4%) PH, 106 of 860 (12.3%) GMC, 14 of 860 (1.6%) chest radiation, and 8 of 22 (0.9%) atypia/LCIS. The AIR was 134 of 860 (15.6%). Nineteen cancers were identified (13 invasive, 4 DCIS, two lymph nodes), resulting in CDR of 19 of 860 (22.1 per 1000), PPV2 of 19 of 88 (21.6%), and PPV3 of 19 of 80 (23.8%). Of 13 invasive breast cancers, median size was 10?mm, and 8 of 13 were node negative (61.5%). Conclusions: Performance outcomes of screening breast MRI in routine clinical practice across a spectrum of elevated risk patients met the American College of Radiology Breast Imaging Reporting and Data System benchmarks, supporting broad application of these metrics. The indication of a personal history of treated breast cancer accounted for a large proportion (42%) of our screening examinations, with breast MRI performance in this population at least comparable to that of other screening indications.	[Strigel, Roberta M.; Rollenhagen, Jennifer; Burnside, Elizabeth S.; Elezaby, Mai; Fowler, Amy M.; Kelcz, Frederick; Salkowski, Lonie; DeMartini, Wendy B.] Univ Wisconsin, Dept Radiol, 600 Highland Ave, Madison, WI 53792 USA; [Strigel, Roberta M.; Fowler, Amy M.] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Strigel, Roberta M.; Burnside, Elizabeth S.; Fowler, Amy M.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA; [Rollenhagen, Jennifer] Kent Radiol, Grand Rapids, MI USA; [DeMartini, Wendy B.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA	Strigel, RM (reprint author), Univ Wisconsin, Dept Radiol, 600 Highland Ave, Madison, WI 53792 USA.; Strigel, RM (reprint author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA.; Strigel, RM (reprint author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA.	rstrigel@uwhealth.org			Center for Predictive Computational Phenotyping (CPCP); National Institutes of Health Big Data to Knowledge (BD2K) Initiative [U54AI117924]; Radiological Society of North America; Wisconsin Women's Health Foundation	We would like to thank Kristie Guite, MD, for her assistance with data acquisition. The authors also acknowledge the support of the Center for Predictive Computational Phenotyping (CPCP), supported by the National Institutes of Health Big Data to Knowledge (BD2K) Initiative, U54AI117924, the Radiological Society of North America, and the Wisconsin Women's Health Foundation.	American College of Radiology, 2015, BREAST MAGN RES IM M; Berg WA, 2009, AM J ROENTGENOL, V192, P390, DOI 10.2214/AJR.08.1706; Brennan S, 2010, AM J ROENTGENOL, V195, P510, DOI 10.2214/AJR.09.3573; Carney PA, 2013, RADIOLOGY, V267, P359, DOI 10.1148/radiol.12121216; Carney PA, 2010, RADIOLOGY, V255, P354, DOI 10.1148/radiol.10091636; DeMartini Wendy, 2008, Top Magn Reson Imaging, V19, P143, DOI 10.1097/RMR.0b013e31818a40a5; DeMartini WB, 2010, J AM COLL RADIOL, V7, P878, DOI 10.1016/j.jacr.2010.06.019; D'Orsi CJSE, 2013, ACR BI RADS ATLAS BR; Ehsani S, 2015, BREAST J, V21, P246, DOI 10.1111/tbj.12396; Elmore L, 2010, ANN SURG ONCOL, V17, pS263, DOI 10.1245/s10434-010-1236-4; Ikeda DM., 2003, BREAST IMAGING REPOR; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl C, 2007, RADIOLOGY, V244, P356, DOI 10.1148/radiol.2442051620; Kuhl C, 2010, J CLIN ONCOL, V28, P1450, DOI 10.1200/JCO.2009.23.0839; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Lee CI, 2014, ACAD RADIOL, V21, P1370, DOI 10.1016/j.acra.2014.06.003; Lehman CD, 2005, CANCER, V103, P1898, DOI 10.1002/cncr.20971; Lehman CD, 2016, J NATL CANC I, V108; Lehman CD, 2007, RADIOLOGY, V244, P381, DOI 10.1148/radiol.2442060461; Morris EA, 2013, ACR BI RADS ATLAS BR; National Comprehensive Cancer Network<SUP>&REG;</SUP>, 2015, BREAST CANC SCREEN D; National Comprehensive Cancer Network, 2016, BREAST CANC VERS 2; National Comprehensive Cancer Network, 2016, GEN FAM HIGH RISK AS; Niel BL, 2014, J AM COLL RADIOL, V11, P883, DOI 10.1016/j.jacr.2014.02.003; Passaperuma K, 2012, BRIT J CANCER, V107, P24, DOI 10.1038/bjc.2012.204; Rijnsburger AJ, 2010, J CLIN ONCOL, V28, P5265, DOI 10.1200/JCO.2009.27.2294; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75                                                        ; Schacht DV, 2014, AM J ROENTGENOL, V202, P289, DOI 10.2214/AJR.13.11553; Sickles EA, 2013, ACR BI RADS ATLAS BR, P27; Sickles EA, 2013, ACR BI RADS ATLAS BR; Stout NK, 2011, J WOMENS HEALTH, V20, P631, DOI 10.1089/jwh.2010.2159; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317	36	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	APR	2017	24	4					411	417		10.1016/j.acra.2016.10.014				7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	FI4BZ	WOS:000411916000005	27986508				2018-01-05	
J	Teichert, I; Dahlmann, TA; Kuck, U; Nowrousian, M				Teichert, Ines; Dahlmann, Tim A.; Kueck, Ulrich; Nowrousian, Minou			RNA Editing During Sexual Development Occurs in Distantly Related Filamentous Ascomycetes	GENOME BIOLOGY AND EVOLUTION			English	Article						A-to-I RNA editing; Sordaria macrospora; Pyronema confluens; fruiting body; protoperithecia; sexual development.	FUNGUS SORDARIA-MACROSPORA; FRUITING BODY DEVELOPMENT; GENE ONTOLOGY; EVOLUTION; ORIGIN; TOOL	RNA editing is a post-transcriptional process that modifies RNA molecules leading to transcript sequences that differ from their template DNA. A-to-I editing was found to be widely distributed in nuclear transcripts of metazoa, but was detected in fungi only recently in a study of the filamentous ascomycete Fusarium graminearum that revealed extensive A-to-I editing of mRNAs in sexual structures (fruiting bodies). Here, we searched for putative RNA editing events in RNA-seq data from Sordaria macrospora and Pyronema confluens, two distantly related filamentous ascomycetes, and in data from the Taphrinomycete Schizosaccharomyces pombe. Like F. graminearum, S. macrospora is a member of the Sordariomycetes, whereas P. confluens belongs to the early-diverging group of Pezizomycetes. We found extensive A-to-I editing in RNA-seq data from sexual mycelium from both filamentous ascomycetes, but not in vegetative structures. A-to-I editing was not detected in different stages of meiosis of S. pombe. A comparison of A-to-I editing in S. macrospora with F. graminearum and P. confluens, respectively, revealed little conservation of individual editing sites. An analysis of RNA-seq data from two sterile developmental mutants of S. macrospora showed that A-to-I editing is strongly reduced in these strains. Sequencing of cDNA fragments containing more than one editing site from P. confluens showed that at the beginning of sexual development, transcripts were incompletely edited or unedited, whereas in later stages transcripts were more extensively edited. Taken together, these data suggest that A-to-I RNA editing is an evolutionary conserved feature during fruiting body development in filamentous ascomycetes.	[Teichert, Ines; Dahlmann, Tim A.; Kueck, Ulrich; Nowrousian, Minou] Ruhr Univ Bochum, Lehrstuhl Allgemeine & Mol Bot, Bochum, Germany	Nowrousian, M (reprint author), Ruhr Univ Bochum, Lehrstuhl Allgemeine & Mol Bot, Bochum, Germany.	minou.nowrousian@rub.de		Nowrousian, Minou/0000-0003-0075-6695	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) [KU517/11-2, KU517/16-1, NO407/5-1]; Ruhr-Universitat Bochum	We would like to thank Swenja Ellssel, Ingeborg Godehardt, Regina Krampe, and Silke Nimtz for excellent technical assistance, and the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) for funding (grants KU517/11-2, KU517/16-1, NO407/5-1, and the Open Access Publication Funds of the Ruhr-Universitat Bochum).	Alon S, 2015, ELIFE, V4, DOI 10.7554/eLife.05198; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Dirschnabel DE, 2014, GENETICS, V196, P729, DOI 10.1534/genetics.113.159368; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Gommans WM, 2009, BIOESSAYS, V31, P1137, DOI 10.1002/bies.200900045; Gott JM, 2003, CR BIOL, V326, P901, DOI 10.1016/j.crvi.2003.09.004; Gray MW, 2012, BIOCHEMISTRY-US, V51, P5235, DOI 10.1021/bi300419r; Grice LF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0279-3; Gwynne-Vaughan HCI, 1931, ANN BOT-LONDON, V45, P355, DOI 10.1093/oxfordjournals.aob.a090280                                              ; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Jin YF, 2009, IUBMB LIFE, V61, P572, DOI 10.1002/iub.207; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li QY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5943; Liu HQ, 2016, GENOME RES, V26, P499, DOI 10.1101/gr.199877.115; Masloff S, 1999, GENETICS, V152, P191; Nowrousian M, 2006, FEMS MICROBIOL LETT, V257, P328, DOI 10.1111/j.1574-6968.2006.00192.x; Nowrousian M, 2005, MOL GENET GENOMICS, V273, P137, DOI 10.1007/s00438-005-1118-9; Nowrousian M, 1999, MOL CELL BIOL, V19, P450; Nowrousian M, 2012, G3-GENES GENOM GENET, V2, P261, DOI 10.1534/g3.111.001479; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Priebe S, 2015, BIOINFORMATICS, V31, P445, DOI 10.1093/bioinformatics/btu627; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; Rosenthal JJC, 2015, J EXP BIOL, V218, P1812, DOI 10.1242/jeb.119065; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Teichert I, 2014, ADV GENET, V87, P199, DOI 10.1016/B978-0-12-800149-3.00004-4; Teichert I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-511; Traeger S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003820; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Zhu YJ, 2014, GENETICS, V196, P1047, DOI 10.1534/genetics.114.161414	38	2	2	8	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1759-6653			GENOME BIOL EVOL	Genome Biol. Evol.	APR	2017	9	4					855	868		10.1093/gbe/evx052				14	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	FC3RC	WOS:000406755800004	28338982	gold			2018-01-05	
J	Soutourina, O				Soutourina, Olga			RNA-based control mechanisms of Clostridium difficile	CURRENT OPINION IN MICROBIOLOGY			English	Review							GRAM-POSITIVE BACTERIA; CYCLIC DI-GMP; BINDING PROTEIN HFQ; LISTERIA-MONOCYTOGENES; REGULATORY RNAS; ESCHERICHIA-COLI; TOXIN PRODUCTION; ANTISENSE RNA; SOLUBLE-RNAS; ACETOBUTYLICUM	Clostridium difficile (CD)-associated diarrhoea is currently the most prevalent nosocomial diarrhoea worldwide. Many characteristics of CD pathogenicity remain poorly understood. Recent data strongly indicate the importance of an RNA network for the control of gene expression in CD. More than 200 regulatory RNAs have been identified by deep sequencing and targeted approaches, including Hfq-dependent trans riboregulators, cis-antisense RNAs, CRISPR RNAs, and c-di-GMP-responsive riboswitches. These regulatory RNAs are involved in the control of major processes in the CD infection cycle, for example motility, biofilm formation, adhesion, sporulation, stress response, and defence against bacteriophages. We will discuss recent advances in elucidation of the original features of RNA-based mechanisms in this important enteropathogen. This knowledge may pave the way for further discoveries in this emergent field.	[Soutourina, Olga] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, 25 Rue Dr Roux, F-75724 Paris 15, France; [Soutourina, Olga] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, 25 Rue Dr Roux, F-75724 Paris 15, France; [Soutourina, Olga] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, F-91198 Gif Sur Yvette, France	Soutourina, O (reprint author), Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, 25 Rue Dr Roux, F-75724 Paris 15, France.; Soutourina, O (reprint author), Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, 25 Rue Dr Roux, F-75724 Paris 15, France.; Soutourina, O (reprint author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, F-91198 Gif Sur Yvette, France.	olgasoutourina@i2bc.paris-saclay.fr	Soutourina, Olga/F-2042-2015		Institut Pasteur; University Paris Diderot; Agence Nationale de la Recherche ('CloSTARn') [ANR-13-JSV3-0005-01]; Institut Universitaire de France; Pasteur-Weizmann Council; University Paris-Sud; I2BC	This work was supported by grants from the Institut Pasteur, the University Paris Diderot, Agence Nationale de la Recherche ('CloSTARn', ANR-13-JSV3-0005-01), Institut Universitaire de France, the Pasteur-Weizmann Council, University Paris-Sud, and I2BC. We thank E. Semenova for help with preparation of this review.	Andersen JM, 2016, GENOME BIOL EVOL, V8, P2841, DOI 10.1093/gbe/evw203; Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Bordeleau E, 2015, J BACTERIOL, V197, P819, DOI 10.1128/JB.02340-14; Bordeleau E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002039; Boudry P, 2014, J BACTERIOL, V196, P3234, DOI 10.1128/JB.01923-14; Boudry P., 2015, MBIO, V6; Bouloc P, 2016, CURR OPIN MICROBIOL, V30, P30, DOI 10.1016/j.mib.2015.12.008; Brantl S, 2014, RNA BIOL, V11, P443, DOI 10.4161/rna.28036; Brantl S, 2012, FUTURE MICROBIOL, V7, P853, DOI [10.2217/FMB.12.59, 10.2217/fmb.12.59]; Caillet J, 2014, RNA, V20, P1567, DOI 10.1261/rna.043372.113; Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824; Cavanagh AT, 2014, ANNU REV MICROBIOL, V68, P45, DOI 10.1146/annurev-micro-092611-150135; Chen AGY, 2011, RNA, V17, P1967, DOI 10.1261/rna.2757311; Chen YL, 2011, MBIO, V2, DOI 10.1128/mBio.00340-10; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.113355-3362.2004; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Durand S, 2015, FEMS MICROBIOL REV, V39, P316, DOI 10.1093/femsre/fuv007; El Meouche I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083748; FIERROMONTI IP, 1992, J BACTERIOL, V174, P7642; Frohlich KS, 2016, MOL MICROBIOL, V101, P701, DOI 10.1111/mmi.13428; Hargreaves KR, 2014, MBIO, V5, DOI 10.1128/mBio.01045-13; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Janoir C, 2016, ANAEROBE, V37, P13, DOI 10.1016/j.anaerobe.2015.10.009; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Khorkova O, 2014, HUM MOL GENET, V23, pR54, DOI 10.1093/hmg/ddu207; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; McKee RW, 2013, J BACTERIOL, V195, P5174, DOI 10.1128/JB.00501-13; Nielsen JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019019; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Ohtani K, 2016, TOXINS BASEL, V8; Oliva G, 2015, FEMS MICROBIOL REV, V39, P331, DOI 10.1093/femsre/fuv022; Panja S, 2013, NUCLEIC ACIDS RES, V41, P7536, DOI 10.1093/nar/gkt521; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Peltier J, 2015, J BIOL CHEM, V290, P24453, DOI 10.1074/jbc.M115.665091; Purcell EB, 2016, J BACTERIOL, V198, P565, DOI 10.1128/JB.00816-15; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Romling U, 2012, ENVIRON MICROBIOL, V14, P1817, DOI 10.1111/j.1462-2920.2011.02617.x; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Saad NY, 2013, P NATL ACAD SCI USA, V110, P12756, DOI 10.1073/pnas.1304307110; Saad NY, 2012, J BIOL CHEM, V287, P20382, DOI 10.1074/jbc.M111.332304; Salim NN, 2012, NUCLEIC ACIDS RES, V40, P8021, DOI 10.1093/nar/gks392; Scaria J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078489; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Seekatz AM, 2014, J CLIN INVEST, V124, P4182, DOI 10.1172/JCI72336; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Sobrero P, 2012, CRIT REV MICROBIOL, V38, P276, DOI 10.3109/1040841X.2012.664540; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Updegrove TB, 2016, CURR OPIN MICROBIOL, V30, P133, DOI 10.1016/j.mib.2016.02.003; Vedantam Gayatri, 2012, Gut Microbes, V3, P121, DOI 10.4161/gmic.19399; Venkataramanan KP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-849; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wagner EGH, 2015, ADV GENET, V90, P133, DOI 10.1016/bs.adgen.2015.05.001; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X                                                   ; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Zheng A, 2016, J MOL BIOL, V428, P2259, DOI 10.1016/j.jmb.2016.03.027	63	0	0	2	2	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	APR	2017	36						62	68		10.1016/j.mib.2017.01.004				7	Microbiology	Microbiology	FC3HQ	WOS:000406730100010	28214735				2018-01-05	
J	Jiang, T; Ge, H; Sun, J; Li, R; Han, R; Liu, JW				Jiang, Ting; Ge, Hua; Sun, Jian; Li, Rong; Han, Rui; Liu, Jiwen			Relationship between Occupational Stress, 5-HT2A Receptor Polymorphisms and Mental Health in Petroleum Workers in the Xinjiang Arid Desert: A Cross-Sectional Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						5-HT2RA; mental health; occupational stress; petroleum workers	MAJOR DEPRESSIVE DISORDER; HTR2A T102C; JOB STRAIN; ASSOCIATION; GENE; METAANALYSIS; SUSCEPTIBILITY; POPULATION; RS6311; COHORT	At present, there is growing interest in research examining the relationship between occupational stress and mental health. Owing to the socioeconomic impact of occupational stress and the unique environment of petroleum workers in Xinjiang, a cross-sectional study was carried out between April and December 2015 to investigate the relationship between occupational stress, 5-hydroxytryptamine receptor (5-HTR2A) genotype, and mental health. A total of 1485 workers were selected. The Symptom Checklist 90 was used to assess nine classes of psychological symptoms. Work-related stressors were evaluated using the Occupational Stress Inventory-Revised Edition. Levels of 5-HTR2A (the Tl02C and A-1438G single nucleotide polymorphism in the 5-HTR2A gene) were measured by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). The findings of the present study revealed a high prevalence rate of mental health problems (40.29%) in petroleum workers stationed in the arid desert, and suggested a strong correlation between occupational stress and mental health. The TC and CC genotype of Tl02C were found to be protective factors against mental health problems (odds ratio (OR) = 0.455, 95% confidence interval (CI): = 0.269-0.771, odds ratio (OR) = 0.340, 95% confidence interval (CI): 0.162-0.716). AG and GG genotype of A-1438G [ odds ratio (OR) 1 = 2.729, 95% confidence interval (CI): 1.433-5.195; odds ratio (OR) 2 = 2.480, 95% confidence interval (CI): 1.221-5.037] were revealed as risk factors. These data provide evidence that occupational stress and 5-HTR2A gene polymorphism contributes to the incidence of mental health problems.	[Jiang, Ting; Ge, Hua; Li, Rong; Liu, Jiwen] Xinjiang Med Univ, Dept Publ Hlth, Urumqi 830011, Peoples R China; [Sun, Jian] Xinjiang Med Univ, Affiliated Hosp 6, Urumqi 830011, Peoples R China; [Han, Rui] Shihezi Univ, Sch Med, Affiliated Hosp 1, Shihezi 832008, Peoples R China	Liu, JW (reprint author), Xinjiang Med Univ, Dept Publ Hlth, Urumqi 830011, Peoples R China.	jt5583@126.com; gehua2710@sina.com; sjt3997@163.com; lurong_128@126.com; shihaohua789@163.com; liujiwen@xjmu.edu.cn			National Nature Science Foundation of China [81460489]	This study was funded by the National Nature Science Foundation of China (Grant No.: 81460489).	An SJ, 2015, ANN OCCUP ENVIRON ME, V27, DOI 10.1186/s40557-014-0044-x; Arnett MG, 2016, NEUROPSYCHOPHARMACOL, V41, P245, DOI 10.1038/npp.2015.215; Bejean S., 2015, EUR J HEALTH ECON, V6, P16; [陈翠 Chen Cui], 2011, [中华神经医学杂志, Chinese Journal of Neuromedicine], V10, P1119; [陈树林 Chen Shulin], 2003, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V29, P323; Cho Ho-Sung, 2013, Ann Occup Environ Med, V25, P12, DOI 10.1186/2052-4374-25-12; Choi MJ, 2004, NEUROPSYCHOBIOLOGY, V49, P38, DOI 10.1159/000075337; Cuijpers P, 2004, ACTA PSYCHIAT SCAND, V109, P325, DOI 10.1111/j.1600-0447.2004.00301.x; de Lange Annet H, 2003, J Occup Health Psychol, V8, P282, DOI 10.1037/1076-8998.8.4.282; Ding N, 2015, SOC SCI MED, V128, P246, DOI 10.1016/j.socscimed.2015.01.022; Dupere V, 2007, AM J COMMUN PSYCHOL, V39, P107, DOI 10.1007/s10464-007-9099-y; Guo HR, 2014, CLIN PHYSIOL FUNCT I, V34, P277, DOI 10.1111/cpf.12094; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Inoue M, 2011, J OCCUP HEALTH, V53, P93, DOI 10.1539/joh.L10098; Jiang Y, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121258; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kelly BD, 2010, SCHIZOPHR RES, V116, P75, DOI 10.1016/j.schres.2009.10.015; Kim JM, 2012, J AFFECT DISORDERS, V136, P1; Klein JP, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00077; Kuepper Y., 2015, INT ENCY SOCIAL BEHA, P476; Lacey KK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012870; Li J, 2001, CHIN J IND HYG OCCUP, V19, P190; Lian YL, 2016, J OCCUP ENVIRON MED, V58, pE256, DOI 10.1097/JOM.0000000000000777; Lin CX, 2015, INT J CLIN EXP MED, V8, P20897; Liu X. D., 2011, HOSP ADM J CHINESE P, V19, P124; Ljosa CH, 2013, IND HEALTH, V51, P145; Marchand A, 2005, SOCIOL HEALTH ILL, V27, P602, DOI 10.1111/j.1467-9566.2005.00458.x                                                ; Martinez MC, 2015, AM J IND MED, V58, P795, DOI 10.1002/ajim.22476; Norton N, 2005, ANN MED, V37, P121, DOI 10.1080/07853890510037347; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; Petit AC, 2014, PROG NEURO-PSYCHOPH, V54, P76, DOI 10.1016/j.pnpbp.2014.04.013; Rao Jakkula V, 2012, Indian J Occup Environ Med, V16, P22, DOI 10.4103/0019-5278.99686; Rugulies R, 2006, AM J EPIDEMIOL, V163, P877, DOI 10.1093/aje/kwj119; Serretti A, 2007, PROG NEURO-PSYCHOPH, V31, P1275, DOI 10.1016/j.pnpbp.2007.05.008; Shan MH, 1998, CHIN MENTAL HLTH J, V12, P81; Strazdins L, 2011, J EPIDEMIOL COMMUN H, V65, P529, DOI 10.1136/jech.2009.093732; Sultan-Taieb H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-748; Tencomnao T, 2010, GENET MOL RES, V9, P1171, DOI 10.4238/vol9-2gmr823; Van Praag H. M., 2002, Neurotox Res, V4, P531, DOI 10.1080/1029842021000022115; Wang LJ, 2011, IND HEALTH, V49, P173, DOI 10.2486/indhealth.MS1209                                                        ; Wang X.D., 1993, MENTAL HLTH RATING S, P31; Weinberg A, 2000, LANCET, V355, P533, DOI 10.1016/S0140-6736(99)07366-3; Wu H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-786; Wu H, 2010, INT ARCH OCC ENV HEA, V83, P155, DOI 10.1007/s00420-009-0456-z; Wu Y, 2013, MOL BIOL REP, V40, P6223, DOI 10.1007/s11033-013-2734-9; Yambo T, 2014, J AM PSYCHIAT NURSES, V20, P31, DOI 10.1177/1078390313516998; Yang X, 2011, PUBLIC HEALTH, V125, P106, DOI 10.1016/j.puhe.2010.10.012; Yildiz SH, 2013, ACTA NEUROPSYCHIATR, V25, P342, DOI 10.1017/neu.2013.22; Yoon H.K., 2009, BIOL PSYCHIAT, V33, P403; Zablotsky B, 2013, J AUTISM DEV DISORD, V43, P1380, DOI 10.1007/s10803-012-1693-7; [张婧 Zhang Jing], 2011, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V37, P210; [张琼 Zhang Qiong], 2014, [护理学杂志, Journal of Nursing Science], V29, P39; Zhao X, 2014, NEUROL SCI, V35, P1857, DOI 10.1007/s10072-014-1970-7	53	0	0	6	6	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2017	14	4							402	10.3390/ijerph14040402				11	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	EY6PG	WOS:000404105100066					2018-01-05	
J	Jain, S; Panda, A; Colson, P; Raoult, D; Pontarotti, P				Jain, Sourabh; Panda, Arup; Colson, Philippe; Raoult, Didier; Pontarotti, Pierre			MimiLook: A Phylogenetic Workflow for Detection of Gene Acquisition in Major Orthologous Groups of Megavirales	VIRUSES-BASEL			English	Article						megavirales; giant viruses; HGT; gene acquisition; T-REX; workflow; orthologous groups	LARGE DNA VIRUSES; GIANT VIRUSES; EUKARYOTIC GENOMES; TRANSFER EVENTS; EVOLUTION; MIMIVIRUS; AMEBAS; RECONSTRUCTION; SEQUENCE; IDENTIFICATION	With the inclusion of new members, understanding about evolutionary mechanisms and processes by which members of the proposed order, Megavirales, have evolved has become a key area of interest. The central role of gene acquisition has been shown in previous studies. However, the major drawback in gene acquisition studies is the focus on few MV families or putative families with large variation in their genetic structure. Thus, here we have tried to develop a methodology by which we can detect horizontal gene transfers (HGTs), taking into consideration orthologous groups of distantly related Megavirale families. Here, we report an automated workflow MimiLook, prepared as a Perl command line program, that deduces orthologous groups (OGs) from ORFomes of Megavirales and constructs phylogenetic trees by performing alignment generation, alignment editing and protein-protein BLAST (BLASTP) searching across the National Center for Biotechnology Information (NCBI) non-redundant (nr) protein sequence database. Finally, this tool detects statistically validated events of gene acquisitions with the help of the T-REX algorithm by comparing individual gene tree with NCBI species tree. In between the steps, the workflow decides about handling paralogs, filtering outputs, identifying Megavirale specific OGs, detection of HGTs, along with retrieval of information about those OGs that are monophyletic with organisms from cellular domains of life. By implementing MimiLook, we noticed that nine percent of Megavirale gene families (i. e., OGs) have been acquired by HGT, 80% OGs were Megaviralespecific and eight percent were found to be sharing common ancestry with members of cellular domains (Eukaryote, Bacteria, Archaea, Phages or other viruses) and three percent were ambivalent. The results are briefly discussed to emphasize methodology. Also, MimiLook is relevant for detecting evolutionary scenarios in other targeted phyla with user defined modifications. It can be accessed at following link 10.6084/m9.figshare.4653622	[Jain, Sourabh; Panda, Arup; Pontarotti, Pierre] Aix Marseille Univ, Ecole Cent Marseille, UMR I2M 7373, CNRS Equipe Evolut Biol & Modelisat, F-13284 Marseille, France; [Jain, Sourabh; Panda, Arup; Colson, Philippe; Raoult, Didier] Aix Marseille Univ, URMITE, CNRS INSERM UM63 U1095IRD 7278 198, Fac Med, F-13284 Marseille, France; [Colson, Philippe; Raoult, Didier] CHU Timone, AP HM, IHU Mediterranee Infect, Pole Malad Infect & Trop Clin & Biol,Federat Bact, F-13385 Marseille, France	Jain, S; Pontarotti, P (reprint author), Aix Marseille Univ, Ecole Cent Marseille, UMR I2M 7373, CNRS Equipe Evolut Biol & Modelisat, F-13284 Marseille, France.; Jain, S (reprint author), Aix Marseille Univ, URMITE, CNRS INSERM UM63 U1095IRD 7278 198, Fac Med, F-13284 Marseille, France.	sourabh.jain@etu.univ-amu.fr; stararup@gmail.com; philippe.colson@univ-amu.fr; didier.raoult@gmail.com; pierre.pontarotti@univ-amu.fr		Pierre, Pontarotti/0000-0001-7202-3648	INFECTIOPOLE-SUD grant	This study was supported by INFECTIOPOLE-SUD grant to S.J.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Beiko RG, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-15; Boc Alix, 2012, Nucleic Acids Res, V40, pW573, DOI 10.1093/nar/gks485; Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334                                           ; Claverie JM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-110; Colson P., 2012, VIRUSES ESSENTIAL AG, P217; Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6; Colson P, 2013, INTERVIROLOGY, V56, P376, DOI 10.1159/000354558; Criscuolo A, 2006, SYSTEMATIC BIOL, V55, P740, DOI 10.1080/10635150600969872; Deschavanne P, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P161, DOI 10.1109/BIBE.2000.889603; Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V19, P164; Filee J, 2008, RES MICROBIOL, V159, P325, DOI 10.1016/j.resmic.2008.04.012; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Filee J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00593; Filee J, 2014, VIROLOGY, V466, P53, DOI 10.1016/j.virol.2014.06.004; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Forterre P, 2010, INTERVIROLOGY, V53, P362, DOI 10.1159/000312921; Hallett M., 2001, P 5 ANN INT C COMP B, P149, DOI DOI 10.1145/369133.369188; Hooper SD, 2002, J MOL EVOL, V54, P365, DOI 10.1007/s00239-001-0051-8; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001                                              ; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Krupovic M, 2015, NAT REV MICROBIOL, V13, P105, DOI 10.1038/nrmicro3389; La Scola B, 2003, SCIENCE, V299, P2033; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112; Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu K., 2011, PLOS ONE, V16; MacLeod D, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-27; Maumus F., 2014, NAT COMMUN, V5, P42; Moreira D, 2005, SCIENCE, V308, DOI 10.1126/science.1110820; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Mueller L, 2013, INTERVIROLOGY, V56, P430, DOI 10.1159/000354565; Pagnier I, 2013, INTERVIROLOGY, V56, P354, DOI 10.1159/000354556; Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ragan MA, 2001, FEMS MICROBIOL LETT, V201, P187, DOI 10.1016/S0378-1097(01)00262-2; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608; Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501                                                               ; Suhre K, 2005, J VIROL, V79, P14095, DOI 10.1128/JVI.79.22.14095-14101.2005; Than C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-322; van Dongen S, 2000, THESIS; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851                                           ; Yutin N, 2014, VIROLOGY, V466, P38, DOI 10.1016/j.virol.2014.06.032; Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-106; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	57	1	1	3	3	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	APR	2017	9	4							72	10.3390/v9040072				15	Virology	Virology	EY8DJ	WOS:000404224400011		gold			2018-01-05	
J	Nishimasu, H; Nureki, O				Nishimasu, Hiroshi; Nureki, Osamu			Structures and mechanisms of CRISPR RNA-guided effector nucleases	CURRENT OPINION IN STRUCTURAL BIOLOGY			English	Article							TARGET DNA RECOGNITION; STAPHYLOCOCCUS-AUREUS CAS9; BACTERIAL IMMUNE-SYSTEM; CRYSTAL-STRUCTURE; SURVEILLANCE COMPLEX; THERMUS-THERMOPHILUS; SILENCING COMPLEX; DUAL-RNA; CLEAVAGE; INTERFERENCE	In the prokaryotic CRISPR-Cas adaptive immune systems, a CRISPR RNA (crRNA) assembles with multiple or single Cas proteins to form crRNA ribonucleoprotein (crRNP) effector complexes, responsible for the destruction of invading genetic elements. Although the mechanisms of target recognition and cleavage by the crRNP effectors are quite diverse among the different types of CRISPR-Cas systems, the basic action principles of these crRNA-guided effector nucleases are highly conserved. In all of the crRNP effectors, the repeat-derived invariant and spacer-derived variable segments of the crRNA are recognized by the Cas protein(s) in sequence-dependent and sequence-independent manners, respectively, with the spacer-derived guide segment available for base pairing with target nucleic acids. Over the past few years, intensive studies have provided an atomic view of the crRNA-guided target interference mechanisms in different types of CRISPR-Cas systems. Here, we review the recent progress toward structural and mechanistic understanding of the diverse crRNP effector nucleases.	[Nishimasu, Hiroshi; Nureki, Osamu] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Nishimasu, Hiroshi] JST, PRESTO, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan	Nishimasu, H; Nureki, O (reprint author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.; Nishimasu, H (reprint author), JST, PRESTO, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	nisimasu@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp			JST, PRESTO; JSPS KAKENHI [26291010, 15H01463]; Japan Agency for Medical Research and Development, AMED	We thank Dr. Eugene V. Koonin, Takashi Yamano and Hisato Hirano for critical comments on the manuscript. H.N. is supported by JST, PRESTO, JSPS KAKENHI Grant Numbers 26291010 and 15H01463. O.N. is supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine, from the Japan Agency for Medical Research and Development, AMED.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Benda C, 2014, MOL CELL, V56, P43, DOI 10.1016/j.molcel.2014.09.002; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Gong B, 2014, P NATL ACAD SCI USA, V111, P16359, DOI 10.1073/pnas.1410806111; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Ramia NF, 2014, CELL REP, V9, P1610, DOI 10.1016/j.celrep.2014.11.007; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Tsui TKM, 2015, ANNU REV BIOPHYS, V44, P229, DOI 10.1146/annurev-biophys-060414-033939; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733; Zhu X, 2015, NUCLEIC ACIDS RES, V43, P1257, DOI 10.1093/nar/gku1355	65	9	9	4	4	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-440X	1879-033X		CURR OPIN STRUC BIOL	Curr. Opin. Struct. Biol.	APR	2017	43						68	78		10.1016/j.sbi.2016.11.013				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EX7WQ	WOS:000403460500011	27912110	gold			2018-01-05	
J	Barker, MJ; Lettner, AF				Barker, Matthew J.; Lettner, Alana Friend			Environmentally Virtuous Agriculture: How and When External Goods and Humility Ethically Constrain (or Favour) Technology Use	JOURNAL OF AGRICULTURAL & ENVIRONMENTAL ETHICS			English	Article						Virtue; External goods; Humility; Hubris argument; Agricultural technology	RISK-ASSESSMENT	This paper concerns virtue-based ethical principles that bear upon agricultural uses of technologies, such as GM crops and CRISPR crops. It does three things. First, it argues for a new type of virtue ethics approach to such cases. Typical virtue ethics principles are vague and unspecific. These are sometimes useful, but we show how to supplement them with more specific virtue ethics principles that are useful to people working in specific applied domains, where morally relevant domain-specific conditions recur. We do this while still fulfilling the need for principles and associated practical reasoning to flexibly respect variation between cases. Second, with our more detailed approach we criticize and improve upon a commonly discussed principle about ecosystemic external goods that are crucial for human flourishing. We show this principle is far more conservative than appreciated, as it would prohibit many technology uses that are uncontroversially acceptable. We then replace this principle with two more specific ones. One identifies specific conditions in which ecosystem considerations are against a technology use, the other identifies favorable conditions. Third, we uncover a humility-based principle that operates within an influential "hubris argument" against uses of several biotechnologies in agriculture. These arguments lack a substantive theory of the nature of humility. We clarify such a theory, and then use it to replace the uncovered humility-based principle with our own more specific one that shifts focus from past moral failings, to current epistemic limits when deciding whether to support new technologies.	[Barker, Matthew J.; Lettner, Alana Friend] Concordia Univ, 1455 Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada	Barker, MJ (reprint author), Concordia Univ, 1455 Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	matthew.barker@concordia.ca					Alfred R., 2008, WIRED; Barker M., 2017, ANN M PAC DIV AM PHI; Barker M., NEW DIRECTIONS CANAD; Brodwin E., 2016, BUSINESS INSIDER; Button M, 2005, POLIT THEORY, V33, P840, DOI 10.1177/0090591705280525; Cafaro P, 2005, ENV VIRTUE ETHICS, P135; Carson R., 1962, SILENT SPRING; Chappell T., 2014, HDB VIRTUE ETHICS, P76; DAVIS DE, 2010, THE JOURNAL OF POSIT, V5, P243, DOI DOI 10.1080/17439761003791672; Dimick D., 2014, NATL GEOGRAPHIC NEWS; Exline JJ, 2004, SELF IDENTITY, V3, P95, DOI 10.1080/13576500342000077; Foot Philippa, 2001, NATURAL GOODNESS; Garcia JLA, 2006, PHILOSOPHIA, V34, P417, DOI 10.1007/s11406-006-9032-x; Giesy JP, 2000, REV ENVIRON CONTAM T, V167, P35; Hamblin J. D., 2013, NATURE BIRTH CATASTR; HERBERT LTVA, 2014, THE JOURNAL OF EXPER, V217, P3457, DOI DOI 10.1242/JEB.109520; Hill S., 2013, TECHRADAR       0923; Hornbeck R, 2014, AM ECON J-APPL ECON, V6, P190, DOI 10.1257/app.6.1.190; Hursthouse R, 1999, VIRTUE ETHICS; Institute of Medicine and the National Research Council of the National Academies, 2004, SAF GEN ENG FOODS AP; Kahneman D., 1982, JUDGMENT UNCERTAINTY; Kahneman D., 2013, THINKING FAST SLOW; Katz E., 2009, ENV ETHICS ANTHOLOGY, P390; Kehlenbeck H., 2016, JULIUS KUHN ARCH, V452, P279; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Konikow LF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048604; LABOUFF JP, 2012, THE JOURNAL OF POSIT, V7, P16, DOI DOI 10.1080/17439760.2011.626787; Luther M., 1948, M LUTHERS CHRISTMAS; McKibben B., 2006, END NATURE; Moula P, 2015, J AGR ENVIRON ETHIC, V28, P161, DOI 10.1007/s10806-014-9526-7; OECD, 1999, 21 CENT TECHN PROM P; Parson E. A., 2003, PROTECTING OZONE LAY; Peterson C., 2004, CHARACTER STRENGTHS; Peterson RKD, 2004, WEED SCI, V52, P834, DOI 10.1614/WS-03-149R; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Plumwood V., 2002, ENV CULTURE ECOLOGIC, V7, P2; Raffensperger C., 2002, ENG FARM ETHICAL SOC, P125; Samuelson PL, 2015, J POSIT PSYCHOL, V10, P389, DOI 10.1080/17439760.2014.967802; Sandler R, 2003, ENVIRON ETHICS, V25, P279, DOI 10.5840/enviroethics200325319                                                   ; Sandler R., 2005, ENV VIRTUE ETHICS, P215; Sandler R., 2007, CHARACTER ENV VIRTUE; Schmitz P. M., 2015, IMPORTANCE CONSERVAT; Schwieger D. S., 2011, ENCY GREAT PLAINS; Sinha GA, 2012, AUSTRALAS J PHILOS, V90, P259, DOI 10.1080/00048402.2011.584542; Song GY, 2016, CROP J, V4, P75, DOI 10.1016/j.cj.2015.12.002; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175                                                         ; Swanton Christine, 2003, VIRTUE ETHICS PLURAL; Szalavitz M, 2012, TIME; Tangney JP, 2000, J SOC CLIN PSYCHOL, V19, P70, DOI 10.1521/jscp.2000.19.1.70                                                       ; Temple J., 2017, MIT TECHNOLOGY REV; van Wensveen L, 2001, ENVIRON ETHICS, V23, P227, DOI 10.5840/enviroethics200123313                                                   ; Videotape Format War, 2016, WIKIPEDIA FREE E; Weare B. C., 1995, California Agriculture, V49, P24; Williams Bernard, 1981, MORAL LUCK	54	0	0	16	16	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1187-7863	1573-322X		J AGR ENVIRON ETHIC	J. Agric. Environ. Ethics	APR	2017	30	2					287	309		10.1007/s10806-017-9669-4				23	Agriculture, Multidisciplinary; Ethics; Environmental Sciences; History & Philosophy Of Science	Agriculture; Social Sciences - Other Topics; Environmental Sciences & Ecology; History & Philosophy of Science	EX2EB	WOS:000403037200009					2018-01-05	
J	Somarelli, JA; Ware, KE; Kostadinov, R; Robinson, JM; Amri, H; Abu-Asab, M; Fourie, N; Diogo, R; Swofford, D; Townsend, JP				Somarelli, Jason A.; Ware, Kathryn E.; Kostadinov, Rumen; Robinson, Jeffrey M.; Amri, Hakima; Abu-Asab, Mones; Fourie, Nicolaas; Diogo, Rui; Swofford, David; Townsend, Jeffrey P.			PhyloOncology: Understanding cancer through phylogenetic analysis	BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER			English	Article						Tumor heterogeneity; Cancer stratification; Clonal evolution; Tumor trees; Cancer types	CIRCULATING TUMOR-CELLS; NEXT-GENERATION; INTRATUMOR HETEROGENEITY; CLONAL EVOLUTION; GENE-EXPRESSION; BREAST-CANCER; NUCLEOTIDE-SEQUENCES; SOMATIC MUTATIONS; DNA METHYLATION; ALLELIC LOSSES	Despite decades of research and an enormity of resultant data, cancer remains a significant public health problem. New tools and fresh perspectives are needed to obtain fundamental insights, to develop better prognostic and predictive tools, and to identify improved therapeutic interventions. With increasingly common genomescale data, one suite of algorithms and concepts with potential to shed light on cancer biology is phylogenetics, a scientific discipline used in diverse fields. From grouping subsets of cancer samples to tracing subclonal evolution during cancer progression and metastasis, the use of phylogenetics is a powerful systems biology approach. Well-developed phylogenetic applications provide fast, robust approaches to analyze high-dimensional, heterogeneous cancer data sets. This article is part of a Special Issue entitled: Evolutionary principles - heterogeneity in cancer?, edited by Dr. Robert A. Gatenby. (c) 2016 Elsevier B.V. All rights reserved.	[Somarelli, Jason A.; Ware, Kathryn E.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA; [Somarelli, Jason A.; Ware, Kathryn E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kostadinov, Rumen] Johns Hopkins Univ, Sch Med, Pediat Oncol, Baltimore, MD 21218 USA; [Robinson, Jeffrey M.; Diogo, Rui] Howard Univ, Anat Dept, Coll Med, Washington, DC 20059 USA; [Robinson, Jeffrey M.; Fourie, Nicolaas] NINR, Digest Disorders Unit, NIH, Bethesda, MD 20892 USA; [Amri, Hakima] Georgetown Univ, Med Ctr, Dept Biochem & Cellular & Mol Biol, Washington, DC 20007 USA; [Abu-Asab, Mones] NEI, Sect Ultrastruct Biol, NIH, Bethesda, MD 20892 USA; [Swofford, David] Duke Univ, Dept Biol, Trinity Coll Arts & Sci, Durham, NC 27710 USA; [Townsend, Jeffrey P.] Yale Univ, Dept Biostat, New Haven, CT 06520 USA; [Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Townsend, Jeffrey P.] Yale Univ, Dept Program Computat Biol & Bioinformat, New Haven, CT 06520 USA	Somarelli, JA (reprint author), Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA.; Somarelli, JA (reprint author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Townsend, JP (reprint author), Yale Univ, Dept Biostat, New Haven, CT 06520 USA.	jason.somarelli@duke.edu; Jeffrey.Townsend@Yale.edu		Townsend, Jeffrey/0000-0002-9890-3907; Abu-Asab, Mones/0000-0002-4047-1232	Duke Cancer Institute, The Duke University Genitourinary Oncology Laboratory; Duke University Department of Orthopaedics; Gilead Sciences; Notsew Orm Sands Foundation; National Evolutionary Synthesis Center (NESCent) [EF-0905606]; Triangle Center for Evolutionary Medicine (TriCEM)	JAS acknowledges support from the Duke Cancer Institute, The Duke University Genitourinary Oncology Laboratory, and the Duke University Department of Orthopaedics. JPT acknowledges support from Gilead Sciences and from Notsew Orm Sands Foundation. The authors would like to thank Dr. Shyamal Pedadda (National Institute of Environmental Health and Safety) for his helpful discussions. The conception of this manuscript was the result of a meeting of the PhyloOncology Working Group, which was sponsored by the National Evolutionary Synthesis Center (NESCent, NSF #EF-0905606) and the Triangle Center for Evolutionary Medicine (TriCEM).	Abu-Asab MS, 2013, CYTOGENET GENOME RES, V139, P206, DOI 10.1159/000348433; Abu-Asab M, 2008, PROTEOM CLIN APPL, V2, P122, DOI 10.1002/prca.200780047; Abu-Asab MS, 2008, OMICS, V12, P183, DOI 10.1089/omi.2008.0010; Abu-Asab MS, 2011, OMICS, V15, P105, DOI 10.1089/omi.2010.0023; Abu-Asab M.S., 2010, ADV BIOINFORMATICS, V2010; Aktipis CA, 2015, PHILOS T R SOC LON B, V370, DOI DOI 10.1098/RSTB.2014.0219; AlGeddawy T, 2014, PROCEDIA CIRP, V21, P87, DOI DOI 10.1016/J.PR0CIR.2014.03.122; Alonso C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00004; Alonso-Alconada L, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-223; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Barret D., 2006, ASTROPH0610190 ARXIV; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Boyd ZS, 2009, J MOL DIAGN, V11, P290, DOI 10.2353/jmoldx.2009.080124; Brosnan JA, 2012, SEMIN CELL DEV BIOL, V23, P237, DOI 10.1016/j.semcdb.2011.12.008; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X                                                   ; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cho WJ, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0829-5; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Consortium M, 2006, NAT BIOTECHNOL, V24, P1151, DOI DOI 10.1038/NBT1239; De Luca F., 2016, ONCOTARGET; De Marchi T., 2016, PROTEOMICS; Desper R, 2000, J COMPUT BIOL, V7, P789, DOI 10.1089/10665270050514936; Desper R, 2004, J THEOR BIOL, V228, P477, DOI 10.1016/j.jtbi.2004.02.021; Echeverry A, 2012, PALAEOGEOGR PALAEOCL, V353, P87, DOI 10.1016/j.palaeo.2012.07.007; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575                                           ; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferreira MM, 2016, MOL ONCOL, V10, P374, DOI 10.1016/j.molonc.2016.01.007; Fraix-Burnet D, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201218769; Fraix-Bumet D., ARXIV2015150806756; Fraix-Burnet D., 2015, ARXIV150806756; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999                                           ; Graham T.A., 2011, GASTROENTEROLOGY, V140; Gupta S., 2016, CLIN CANC RES; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9                                                   ; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong WS, 2015, CANCER RES, V75, P4021, DOI 10.1158/0008-5472.CAN-15-1889; Jensen DH, 2015, J PATHOL, V236, P505, DOI 10.1002/path.4550; Jhunjhunwala S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0436-9; Jiang YC, 2016, P NATL ACAD SCI USA, V113, pE5528, DOI 10.1073/pnas.1522203113; JTaC C.R., 1969, EVOLUTION PROTEIN MO; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581                                                              ; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kogita A, 2015, BIOCHEM BIOPH RES CO, V458, P52, DOI 10.1016/j.bbrc.2015.01.064; Kostadinov R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004413; Kostadinov RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003553; Lee JY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1077-4; Li XH, 2014, CANCER PREV RES, V7, P114, DOI 10.1158/1940-6207.CAPR-13-0289; Longobardi G, 2015, AM J PHYS ANTHROPOL, V157, P630, DOI 10.1002/ajpa.22758; Louhelainen J, 2000, EUR J CANCER, V36, P1441, DOI 10.1016/S0959-8049(00)00127-1; Louhelainen J, 2000, INT J CANCER, V87, P522; Markou A, 2016, CLIN CHEM, V62, P1002, DOI 10.1373/clinchem.2015.253716; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nicolas P, 2007, PLOS COMPUT BIOL, V3, P364, DOI 10.1371/journal.pcbi.0030028; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; PLATNICK NI, 1977, SYST ZOOL, V26, P380, DOI 10.2307/2412794; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; Qiao Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0443-x; Riester M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000777; Scholch S., 2016, ONCOTARGET; Schwartz R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-42; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Simon R, 2000, GENE CHROMOSOME CANC, V28, P106, DOI 10.1002/(SICI)1098-2264(200005)28:1<106::AID-GCC13>3.3.CO;2-J; Skinner MK, 2014, GENOME BIOL EVOL, V6, P1972, DOI 10.1093/gbe/evu158; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Strino F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt641; Szalat R, 2015, CURR OPIN GENET DEV, V30, P56, DOI 10.1016/j.gde.2015.03.008; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Thomas F, 2013, EVOL APPL, V6, P1, DOI 10.1111/eva.12021; Walker BA, 2012, BLOOD, V120, P1077, DOI 10.1182/blood-2012-03-412981; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Wei QX, 2015, ONCOTARGET, V6, P40283, DOI 10.18632/oncotarget.5375; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; YOUNG GC, 1995, J SOUTHE ASIAN EARTH, V11, P167, DOI 10.1016/0743-9547(95)00011-G                                                    ; Zhang XY, 2016, CANCER RES, V76, P1305, DOI 10.1158/0008-5472.CAN-15-1907; Zhao ZM, 2016, P NATL ACAD SCI USA, V113, P2140, DOI 10.1073/pnas.1525677113	82	0	0	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-419X	0006-3002		BBA-REV CANCER	Biochim. Biophys. Acta-Rev. Cancer	APR	2017	1867	2					101	108		10.1016/j.bbcan.2016.10.006				8	Biochemistry & Molecular Biology; Biophysics; Oncology	Biochemistry & Molecular Biology; Biophysics; Oncology	EX0XL	WOS:000402944000005	27810337				2018-01-05	
J	Scott, J; Marusyk, A				Scott, Jacob; Marusyk, Andriy			Somatic clonal evolution: A selection-centric perspective	BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER			English	Article						Cancer; Initiation; Progression; Natural selection; Selective pressures; Driver	DRUG-RESISTANCE; CHROMOSOMAL INSTABILITY; TUMOR HETEROGENEITY; CANCER EVOLUTION; INTRATUMOR HETEROGENEITY; COMBINATION THERAPY; GENETIC INSTABILITY; DARWINIAN DYNAMICS; TARGETED THERAPY; BREAST-CANCER	It is generally accepted that the initiation and progression of cancers is the result of somatic clonal evolution. Despite many peculiarities, evolution within populations of somatic cells should obey the same Darwinian principles as evolution within natural populations, i.e. variability of heritable phenotypes provides the substrate for context-specific selection forces leading to increased population frequencies of phenotypes, which are better adapted to their environment. Yet, within cancer biology, the more prevalent way to view evolution is as being entirely driven by the accumulation of "driver" mutations. Context-specific selection forces are either ignored, or viewed as constraints from which tumor cells liberate themselves during the course of malignant progression. In this review, we will argue that explicitly focusing on selection forces acting on the populations of neoplastic cells as the driving force of somatic clonal evolution might provide for a more accurate conceptual framework compared to the mutation-centric driver gene paradigm. Whereas little can be done to counteract the "bad luck" of stochastic occurrences of cancer-related mutations, changes in selective pressures and the phenotypic adaptations they induce can, in principle, be exploited to limit the incidence of cancers and to increase the efficiency of existing and future therapies. This article is part of a Special Issue entitled: Evolutionary principles - heterogeneity in cancer?, edited by Dr. Robert A. Gatenby. (C) 2017 Elsevier B.V. All rights reserved.	[Scott, Jacob] Cleveland Clin, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA; [Marusyk, Andriy] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Imaging & Metab, Tampa, FL USA	Marusyk, A (reprint author), Dept Imaging & Metab, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Andriy.Marusyk@moffitt.org		Marusyk, Andriy/0000-0002-0087-9575	Shula Breast Cancer Award	These studies were supported by funding from Shula Breast Cancer Award. We thank Andrii Rozhok for his critical comments and suggestions. We thank Dania Miroshnychenko for help with preparing illustrations.	Aktipis CA, 2013, NAT REV CANCER, V13, P883, DOI 10.1038/nrc3606; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Basanta D, 2012, MOL PHARMACEUT, V9, P914, DOI 10.1021/mp200458e; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Blagosklonny MV, 2002, NAT REV CANCER, V2, P221, DOI 10.1038/nrc743; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Bozic I, 2014, P NATL ACAD SCI USA, V111, P15964, DOI 10.1073/pnas.1412075111; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Bussard KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049221; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X                                                   ; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0                                                                ; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Chandhok NS, 2009, CURR OPIN GENET DEV, V19, P74, DOI 10.1016/j.gde.2008.12.004; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Cichon MA, 2010, J MAMMARY GLAND BIOL, V15, P389, DOI 10.1007/s10911-010-9195-8; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DeGregori J, 2013, ONCOGENE, V32, P1869, DOI 10.1038/onc.2012.281; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; DOBZHANSKY T, 1964, AM ZOOL, V4, P443; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4                                                   ; Duesberg P, 2005, CELL ONCOL, V27, P293; Enriquez-Navas PM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7842; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Frank SA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001296; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2011, NAT REV CANCER, V11, P237, DOI 10.1038/nrc3036; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Goldman A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7139; Greaves M., 2001, CANC EVOLUTIONARY LE; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9                                                   ; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Heng HH, 2013, CANCER METAST REV, V32, P325, DOI 10.1007/s10555-013-9427-7; Henry CJ, 2010, P NATL ACAD SCI USA, V107, P21713, DOI 10.1073/pnas.1005486107; Horsthemke B, 2006, CURR TOP MICROBIOL, V310, P45; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kleer CG, 2008, CLIN CANCER RES, V14, P5357, DOI 10.1158/1078-0432.CCR-08-0732; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Korolev KS, 2014, NAT REV CANCER, V14, P371, DOI 10.1038/nrc3712; Kostadinov RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003553; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee CL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9477; Li Q, 2013, NATURE, V504, P143, DOI 10.1038/nature12830; Lipinski Kamil A, 2016, Trends Cancer, V2, P49; Lloyd MC, 2016, CANCER RES, V76, P3136, DOI 10.1158/0008-5472.CAN-15-2962; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Marusyk A, 2016, CANC RES; Marusyk A., 2017, ECOLOGY EVOLUTION CA; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Marusyk A, 2009, CANCER RES, V69, P7262, DOI 10.1158/0008-5472.CAN-09-0604; Marusyk A, 2008, BBA-REV CANCER, V1785, P1, DOI 10.1016/j.bbcan.2007.09.001; MAYR E, 1961, SCIENCE, V134, P1501, DOI 10.1126/science.134.3489.1501; Mayr Ernst, 1982, GROWTH BIOL THOUGHT; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michor F, 2005, SEMIN CANCER BIOL, V15, P43, DOI 10.1016/j.semcancer.2004.09.007; Natrajan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001961; Nesse RM, 2005, Q REV BIOL, V80, P62, DOI 10.1086/431026                                                                  ; Nichol D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004493; Noble R., 2015, PHILOS T R SOC LON B, V370; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Pepper JW, 2007, PLOS COMPUT BIOL, V3, P2532, DOI 10.1371/journal.pcbi.0030250; PETO R, 1975, BRIT J CANCER, V32, P411, DOI 10.1038/bjc.1975.242; Pienta KJ, 2008, TRANSL ONCOL, V1, P158, DOI 10.1593/tlo.08178; Pilon-Thomas S, 2016, CANCER RES, V76, P1381, DOI 10.1158/0008-5472.CAN-15-1743; Pisco AO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3467; Provenzano PP, 2013, BRIT J CANCER, V108, P1, DOI 10.1038/bjc.2012.569; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Robertson-Tessi M, 2015, CANCER RES, V75, P1567, DOI 10.1158/0008-5472.CAN-14-1428; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Rozhok Andrii I, 2016, Trends Cancer, V2, P552, DOI 10.1016/j.trecan.2016.09.004; Rozhok AI, 2015, P NATL ACAD SCI USA, V112, P8914, DOI 10.1073/pnas.1501713112; Rozhok AI, 2014, AGING-US, V6, P1033, DOI 10.18632/aging.100707                                                           ; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Scott JG, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004712; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sieber OM, 2005, NAT REV CANCER, V5, P649, DOI 10.1038/nrc1674; Silva AS, 2012, CANCER RES, V72, P6362, DOI 10.1158/0008-5472.CAN-12-2235; Silva AS, 2009, CANCER RES, V69, P2677, DOI 10.1158/0008-5472.CAN-08-2394; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Sprouffske K, 2012, CURR BIOL, V22, pR762, DOI 10.1016/j.cub.2012.06.065; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Verduzco D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120958; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weinberg RA, 2013, BIOL CANC; Wong PP, 2015, CANCER CELL, V27, P123, DOI 10.1016/j.ccell.2014.10.015; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113	119	3	3	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-419X	0006-3002		BBA-REV CANCER	Biochim. Biophys. Acta-Rev. Cancer	APR	2017	1867	2					139	150		10.1016/j.bbcan.2017.01.006				12	Biochemistry & Molecular Biology; Biophysics; Oncology	Biochemistry & Molecular Biology; Biophysics; Oncology	EX0XL	WOS:000402944000008	28161395				2018-01-05	
J	Wooten, DJ; Quaranta, V				Wooten, David J.; Quaranta, Vito			Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!	BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER			English	Article						Epigenetics; Attractors; Reprogramming; Transcription factors; Gene regulatory network; Mathematical modeling	WADDINGTONS EPIGENETIC LANDSCAPE; GENE-EXPRESSION SIGNATURES; POTENTIAL LANDSCAPE; CLONAL EVOLUTION; FEEDBACK LOOPS; SOMATIC-CELLS; STEM-CELLS; DIFFERENTIATION; PLURIPOTENCY; NETWORK	A cell's phenotype is the observable actualization of complex interactions between its genome, epigenome, and local environment. While traditional views in cancer have held that cellular and tumor phenotypes are largely functions of genomic instability, increasing attention has recently been given to epigenetic and microenvironmental influences. Such non-genetic factors allow cancer cells to experience intrinsic diversity and plasticity, and at the tumor level can result in phenotypic heterogeneity and treatment evasion. In 2006, Takahashi and Yamanaka exploited the epigenome's plasticity by "reprogramming" differentiated cells into a pluripotent state by inducing expression of a cocktail of four transcription factors. Recent advances in cancer biology have shown not only that cellular reprogramming is possible for malignant cells, but it may provide a foundation for future therapies. Nevertheless, cell reprogramming experiments are frequently plagued by low efficiency, activation of aberrant transcriptional programs, instability, and often rely on expertise gathered from systems which may not translate directly to cancer. Here, we review a theoretical framework tracing back to Waddington's epigenetic landscape which may be used to derive quantitative and qualitative understanding of cellular reprogramming. Implications for tumor heterogeneity, evolution and adaptation are discussed in the context of designing new treatments to re-sensitize recalcitrant tumors. This article is part of a Special Issue entitled: Evolutionary principles heterogeneity in cancer?, edited by Dr. Robert A. Gatenby.	[Wooten, David J.; Quaranta, Vito] Vanderbilt Univ, Sch Med, 2220 Pierce Ave,446B, Nashville, TN 37232 USA	Quaranta, V (reprint author), Vanderbilt Univ, Sch Med, 2220 Pierce Ave,446B, Nashville, TN 37232 USA.	aquastarr@me.com			NIH/NCI [U54 CA113007-09]; Integrative Cancer Biology Program (ICBP); NIH [T32 CA009592]; Vanderbilt-Ingram Cancer Center [P30 CA68485]	This work was supported by NIH/NCI U54 CA113007-09, Integrative Cancer Biology Program (ICBP, V. Quaranta), NIH T32 CA009592 (J. Chen), and the Vanderbilt-Ingram Cancer Center P30 CA68485 (J. Pietenpol).	Almendro V, 2014, CANCER RES, V74, P1338, DOI 10.1158/0008-5472.CAN-13-2357-T; Alon U., 2006, INTRO SYSTEMS BIOL D; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Artyomov MN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000785; Ballestar E, 2008, ADV GENET, V61, P247, DOI 10.1016/S0065-2660(07)00009-0; Banerji CRS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03039; Bhagwat Anand S, 2015, Trends Cancer, V1, P53; Bhattacharya S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-85; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Choi M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003363; Crespo I, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-140; Crespo I, 2013, STEM CELLS, V31, P2127, DOI 10.1002/stem.1473; Dai XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep14499; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Duan QN, 2014, NUCLEIC ACIDS RES, V42, pW449, DOI 10.1093/nar/gku476; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Foster DV, 2009, J THEOR BIOL, V260, P589, DOI 10.1016/j.jtbi.2009.07.005; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gilbert SF, 2016, CURR TOP DEV BIOL, V116, P415, DOI 10.1016/bs.ctdb.2015.12.006; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gros C, 2008, COMPLEX ADAPTIVE DYN; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hayes DF, 2013, J INTERN MED, V274, P137, DOI 10.1111/joim.12047; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang Sui, 2002, P181; Huang S, 2012, BIOESSAYS, V34, P149, DOI 10.1002/bies.201100031; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kaneko K., 2006, LIFE INTRO COMPLEX S; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; KAUFFMAN S, 1971, J THEOR BIOL, V31, P429, DOI 10.1016/0022-5193(71)90020-8; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kim KY, 2007, PLOS COMPUT BIOL, V3, P565, DOI 10.1371/journal.pcbi.0030060; Koga C, 2014, ANN SURG ONCOL, V21, pS591, DOI 10.1245/s10434-014-3705-7; Kottke T, 2013, NAT MED, V19, P1625, DOI 10.1038/nm.3397; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lang AH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003734; Li CH, 2014, P NATL ACAD SCI USA, V111, P14130, DOI 10.1073/pnas.1408628111; Li CH, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0787; Li CH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003165; Li S, 2015, ONCOTARGET, V6, P13607, DOI 10.18632/oncotarget.3633                                                        ; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; McHale PT, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003802; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ogawa H., 2015, 19326203 PLOS ONE, V10; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parker NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22477; Rackham O.J., 2016, NAT GENET; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Strogatz S. H., 2014, NONLINEAR DYNAMICS C; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Szedlak A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105842; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; THOMAS R, 1978, J THEOR BIOL, V73, P631, DOI 10.1016/0022-5193(78)90127-3; Tsuno S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03852; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Udyavar A.R., 2017, CANC RES IN PRESS; Vencio EF, 2012, PROSTATE, V72, P1453, DOI 10.1002/pros.22497; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Waddington CH, 2014, STRATEGY GENES, V20; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; WOODCOCK AER, 1978, BEHAV SCI, V23, P390, DOI 10.1002/bs.3830230410; Zhang X, 2013, ONCOGENE, V32, P2249, DOI 10.1038/onc.2012.237; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002; Zhou JX, 2013, SYNTHETIC BIOLOGY: TOOLS AND APPLICATIONS, P81, DOI 10.1016/B978-0-12-394430-6.00005-4; Zhou JX, 2012, J R SOC INTERFACE, V9, P3539, DOI 10.1098/rsif.2012.0434; Zhou JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014752	89	2	2	11	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-419X	0006-3002		BBA-REV CANCER	Biochim. Biophys. Acta-Rev. Cancer	APR	2017	1867	2					167	175		10.1016/j.bbcan.2017.04.001				9	Biochemistry & Molecular Biology; Biophysics; Oncology	Biochemistry & Molecular Biology; Biophysics; Oncology	EX0XL	WOS:000402944000011	28396217				2018-01-05	
J	Vockley, CM; Barrera, A; Reddy, TE				Vockley, Christopher M.; Barrera, Alejandro; Reddy, Timothy E.			Decoding the role of regulatory element polymorphisms in complex disease	CURRENT OPINION IN GENETICS & DEVELOPMENT			English	Review							TRANSCRIPTION FACTOR OCCUPANCY; HUMAN GENOME; HUMAN-CELLS; GENETIC-VARIATION; FUNCTIONAL DISSECTION; ENHANCER ELEMENTS; REPORTER ASSAY; IN-VIVO; EXPRESSION; VARIANTS	Genetic variation in gene regulatory elements contributes to diverse human diseases, ranging from rare and severe developmental defects to common and complex diseases such as obesity and diabetes. Early examples of regulatory mechanisms of human diseases involve large chromosomal rearrangements that change the regulatory connections within the genome. Single nucleotide variants in regulatory elements can also contribute to disease, potentially via demonstrated associations with changes in transcription factor binding, enhancer activity, post-translational histone modifications, long-range enhancer-promoter interactions, or RNA polymerase recruitment. Establishing causality between non-coding genetic variants, gene regulation, and disease has recently become more feasible with advances in genome-editing and epigenome-editing technologies. As establishing causal regulatory mechanisms of diseases becomes routine, functional annotation of target genes is likely to emerge as a major bottleneck for translation into patient benefits. In this review, we discuss the history and recent advances in understanding the regulatory mechanisms of human disease, and new challenges likely to be encountered once establishing those mechanisms becomes rote.	[Vockley, Christopher M.] Duke Univ, Dept Cell Biol, Med Ctr, Durham, NC 27710 USA; [Vockley, Christopher M.; Barrera, Alejandro; Reddy, Timothy E.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Vockley, Christopher M.; Barrera, Alejandro; Reddy, Timothy E.] Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC 27710 USA	Reddy, TE (reprint author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA.; Reddy, TE (reprint author), Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC 27710 USA.	tim.reddy@duke.edu			National Institutes of Health [U01 HG007900, F31 HL129743]	All authors were supported by National Institutes of Health Grant Number U01 HG007900 (to T.E.R.). C.M.V. was also supported by National Institutes of Health Grant Number F31 HL129743.	Adoue V, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145114; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Birnbaum RY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004592; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carr MS, 2007, GENOMICS, V89, P280, DOI 10.1016/j.ygeno.2006.10.005; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Consortium GT, 2015, SCIENCE, V348, P648, DOI DOI 10.1126/SCIENCE.1262110; Corradin O, 2016, NAT GENET, V48, P1313, DOI 10.1038/ng.3674; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cox JJ, 2011, NEW ENGL J MED, V364, P91, DOI 10.1056/NEJMc1010311; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; Fogarty MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004633; Frank CL, 2015, NAT NEUROSCI, V18, P647, DOI 10.1038/nn.3995; Fulco CP, 2016, SCIENCE; Gao X, 2015, J CELL BIOL, V211, P669, DOI 10.1083/jcb.201506014; Gao X, 2013, P NATL ACAD SCI USA, V110, P9356, DOI 10.1073/pnas.1307589110; Gene OC, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI [10.1093/nar/gku1179, DOI 10.1093/NAR/GKU1179]; Guo C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7069; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; He HL, 2015, P NATL ACAD SCI USA, V112, P6128, DOI 10.1073/pnas.1506255112; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kumasaka N, 2016, NAT GENET, V48, P206, DOI 10.1038/ng.3467; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Ni YY, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-46; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Kundaje A, 2015, NATURE, V518, P317, DOI DOI 10.1038/NATURE14248; Rosenberg AB, 2015, CELL, V163, P698, DOI 10.1016/j.cell.2015.09.054; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh P, 2011, MOL CELL BIOL, V31, P1757, DOI 10.1128/MCB.00961-10; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Vockley CM, 2015, GENOME RES, V25, P1206, DOI 10.1101/gr.190090.115; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	64	1	1	4	4	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-437X	1879-0380		CURR OPIN GENET DEV	Curr. Opin. Genet. Dev.	APR	2017	43						38	45		10.1016/j.gde.2016.10.007				8	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	EW8IU	WOS:000402763200007	27984826				2018-01-05	
J	Cho, CJ; Myung, SJ; Chang, S				Cho, Charles J.; Myung, Seung-Jae; Chang, Suhwan			ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Review						ADAR (Adenosine deaminase; RNA specific); UTR (untranslated region); NGS (Next Generation Sequencing)	EDITING ENZYME ADAR1; ADENOSINE-DEAMINASE; HUMAN TRANSCRIPTOME; BINDING DOMAIN; HUMAN-CELLS; RNA; GENE; DSRNA; MICE; BIOGENESIS	The evolution of cancer cells is believed to be dependent on genetic or epigenetic alterations. However, this concept has recently been challenged by another mode of nucleotide alteration, RNA editing, which is frequently up-regulated in cancer. RNA editing is a biochemical process in which either Adenosine or Cytosine is deaminated by a group of RNA editing enzymes including ADAR (Adenosine deaminase; RNA specific) or APOBEC3B (Apolipoprotein B mRNA Editing Enzyme Catalytic Subunit 3B). The result of RNA editing is usually adenosine to inosine (A-to-I) or cytidine to uridine (C-to-U) transition, which can affect protein coding, RNA stability, splicing and microRNA-target interactions. The functional impact of these alterations is largely unclear and is a subject of extensive research. In the present review, we will specifically focus on the influence of ADARs on carcinogenesis via the regulation of microRNA processing and functioning. This follows a brief review of the current knowledge of properties of ADAR enzyme, RNA editing, and microRNA processing.	[Cho, Charles J.; Chang, Suhwan] Univ Ulsan, Coll Med, Dept Biomed Sci, Asan Med Ctr, Seoul 05505, South Korea; [Myung, Seung-Jae] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Convergence Med, Seoul 05505, South Korea	Chang, S (reprint author), Univ Ulsan, Coll Med, Dept Biomed Sci, Asan Med Ctr, Seoul 05505, South Korea.	formidable1981@gmail.com; sjmyung@amc.seoul.kr; suhwan.chang@amc.seoul.kr			SK Chemical Research Fund of The Korean Society of Gastroenterology; Basic Science Research Program of the National Research Foundation Korea(NRF) - Ministry of Education [2017R1A2B2004922]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute(KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C3078]	This research was supported by SK Chemical Research Fund of The Korean Society of Gastroenterology and by the Basic Science Research Program of the National Research Foundation Korea(NRF), funded by the Ministry of Education (grant number: 2017R1A2B2004922) and by Korea Health Technology R&D Project through the Korea Health Industry Development Institute(KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea. (No. HI15C3078).	AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Baltimore D, 2001, NATURE, V409, P814, DOI 10.1038/35057267                                                                ; Chan THM, 2016, GASTROENTEROLOGY, V151, P637, DOI 10.1053/j.gastro.2016.06.043; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170                                                       ; Cho C. J., 2017, ROLE ADAR1 GAS UNPUB; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Fritz J, 2009, MOL CELL BIOL, V29, P1487, DOI 10.1128/MCB.01519-08; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grosshans H., 2010, REGULATION MICRORNAS; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Heale BSE, 2009, EMBO J, V28, P3145, DOI [10.1038/sj.emboj.2009.244, 10.1038/emboj.2009.244]; Higuchi M, 2000, NATURE, V406, P78; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584                                                                ; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li ZQ, 2010, VIROLOGY, V396, P316, DOI 10.1016/j.virol.2009.10.026; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Maas S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004225; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795                                                        ; Mittaz L, 1997, HUM GENET, V100, P398, DOI 10.1007/s004390050523; Mittaz L, 1997, GENOMICS, V41, P210, DOI 10.1006/geno.1997.4655; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Nakano M, 2016, J BIOL CHEM, V291, P894, DOI 10.1074/jbc.M115.699363; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; NISHIKURA K, 1991, EMBO J, V10, P3523; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; PATTERSON JB, 1995, VIROLOGY, V210, P508, DOI 10.1006/viro.1995.1370; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Ramaswami G, 2013, NUCL ACIDS RES; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Singh M, 2011, GENES BRAIN BEHAV, V10, P637, DOI 10.1111/j.1601-183X.2011.00701.x; Singh M, 2009, PHYSIOL BEHAV, V97, P446, DOI 10.1016/j.physbeh.2009.03.029; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Tsuruoka N, 2013, J BIOL CHEM, V288, P826, DOI 10.1074/jbc.M112.365718; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113	55	2	2	2	2	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	APR	2017	18	4							799	10.3390/ijms18040799				10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	EW6SA	WOS:000402639400123		gold			2018-01-05	
J	Kolli, N; Lu, M; Maiti, P; Rossignol, J; Dunbar, GL				Kolli, Nivya; Lu, Ming; Maiti, Panchanan; Rossignol, Julien; Dunbar, Gary L.			CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						Huntington's disease; CAG repeat; mutant huntingtin; gene editing; CRISPR-Cas9 system; pattern of NHEJ; YAC128; Kozak sequence	PLURIPOTENT STEM-CELLS; RNA INTERFERENCE; EUKARYOTIC RIBOSOMES; EXPRESSION; TRANSLATION; INACTIVATION; SEQUENCE; THERAPY; HOMOLOG; REPEAT	Huntington's disease (HD) is a fatal neurodegenerative genetic disease characterized by a loss of neurons in the striatum. It is caused by a mutation in the Huntingtin gene (HTT) that codes for the protein huntingtin (HTT). The mutant Huntingtin gene (mHTT) contains extra poly-glutamine (CAG) repeats from which the translated mutant huntingtin proteins (mHTT) undergo inappropriate post-translational modifications, conferring a toxic gain of function, in addition to its non-functional property. In order to curb the production of the mHTT, we have constructed two CRISPR (clustered regularly interspaced short palindromic repeat)-Cas9 (CRISPR associate protein) plasmids, among which one nicks the DNA at untranslated region upstream to the open reading frame (uORF), and the other nicks the DNA at exon1-intron boundary. The primary goal of this study was to apply this plasmid into mesenchymal stem cells (MSCs) extracted from the bone-marrow of YAC128 mice, which carries the transgene for HD. Our results suggest that the disruption of uORF through CRISPR-Cas9 influences the translation of mHTT negatively and, to a lesser extent, disrupts the exon1-intron boundary, which affects the translation of the mHTT. These findings also revealed the pattern of the nucleotide addition or deletion at the site of the DNA-nick in this model.	[Kolli, Nivya; Lu, Ming; Maiti, Panchanan; Rossignol, Julien; Dunbar, Gary L.] Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA; [Kolli, Nivya; Lu, Ming; Maiti, Panchanan; Rossignol, Julien; Dunbar, Gary L.] Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA; [Maiti, Panchanan; Dunbar, Gary L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA; [Maiti, Panchanan; Dunbar, Gary L.] St Marys Michigan, Field Neurosci Inst, Saginaw, MI 48604 USA; [Maiti, Panchanan] Saginaw Valley State Univ, Dept Biol, Saginaw, MI 48604 USA; [Rossignol, Julien] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA	Dunbar, GL (reprint author), Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA.; Dunbar, GL (reprint author), Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA.; Dunbar, GL (reprint author), Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA.; Dunbar, GL (reprint author), St Marys Michigan, Field Neurosci Inst, Saginaw, MI 48604 USA.	kolli1n@cmich.edu; lu1m@cmich.edu; maiti1p@cmich.edu; rossi1j@cmich.edu; dunba1g@cmich.edu		Rossignol, Julien/0000-0002-8662-0547	Field Neurosciences Institute; Office of Research and Sponsored Programs; College of Medicine; Program in Neuroscience, College of Humanities and Social & Behavioral Sciences at Central Michigan University; John G. Kulhavi Professorship in Neuroscience at CMU	Support for this study was provided by the Field Neurosciences Institute and from the Office of Research and Sponsored Programs, the College of Medicine, the Program in Neuroscience, the College of Humanities and Social & Behavioral Sciences at Central Michigan University, and the John G. Kulhavi Professorship in Neuroscience at CMU.	AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Capetian P, 2011, SEMIN IMMUNOPATHOL, V33, P619, DOI 10.1007/s00281-011-0272-x; Cattaneo E, 2003, NEWS PHYSIOL SCI, V18, P34, DOI 10.1152/nips.01410.2002; Chen ZYJ, 2005, BIOCHEM BIOPH RES CO, V329, P646, DOI 10.1016/j.bbrc.2005.02.024; Clelland CD, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E8; Davidson BL, 2004, LANCET NEUROL, V3, P145, DOI 10.1016/S1474-4422(04)00678-7                                                   ; De Angioletti M, 2004, BRIT J HAEMATOL, V124, P224, DOI 10.1046/j.1365-2141.2003.04754.x; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geballe A., 2000, TRANSLATIONAL CONTRO, P595; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438                                                           ; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Lee J, 2002, NUCLEIC ACIDS RES, V30, P5110, DOI 10.1093/nar/gkf664; Li HY, 2015, J MOD OPTIC, V62, P143, DOI 10.1080/09500340.2014.960020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E                                                    ; Mestre TA, 2012, PARKINSONISM RELAT D, V18, P316, DOI 10.1016/j.parkreldis.2011.10.021; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nethercott HE, 2011, METHODS MOL BIOL, V767, P67, DOI 10.1007/978-1-61779-201-4_6; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Paulsen JS, 2005, J NEUROPSYCH CLIN N, V17, P496, DOI 10.1176/appi.neuropsych.17.4.496; Persichetti F, 1996, NEUROBIOL DIS, V3, P183, DOI 10.1006/nbdi.1996.0018; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shin J. W., 2016, HUM MOL GENET; Stanek LM, 2014, HUM GENE THER, V25, P461, DOI 10.1089/hum.2013.200; Strauss A, 2013, MOL PLANT, V6, P1384, DOI 10.1093/mp/sst075; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Xu XH, 2017, STEM CELL REP, V8, P619, DOI 10.1016/j.stemcr.2017.01.022; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155                                                              ; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	44	3	3	15	16	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	APR	2017	18	4							754	10.3390/ijms18040754				14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	EW6SA	WOS:000402639400079		gold			2018-01-05	
J	Davis, SR; Spelman, RJ; Littlejohn, MD				Davis, S. R.; Spelman, R. J.; Littlejohn, M. D.			BREEDING AND GENETICS SYMPOSIUM: Breeding heat tolerant dairy cattle: the case for introgression of the "slick" prolactin receptor variant into Bos taurus dairy breeds	JOURNAL OF ANIMAL SCIENCE			English	Article						dairy; prolactin; prolactin receptor; Senepol; slick; tropical	LACTATING HOLSTEIN COWS; INFECTED TALL FESCUE; COAT-COLOR DILUTION; PHYSIOLOGICAL-RESPONSES; BODY-TEMPERATURE; HAIR COAT; TROPICAL ENVIRONMENT; DOMESTIC RUMINANTS; ANIMAL PRODUCTION; SWEATING RATES	Increasing environmental temperatures are a threat to the sustainability of livestock production and, because of the high metabolic demands of lactation, to dairy production in particular. Summer heat waves in temperate climates reduce feed intake, milk production, and cow comfort. In extreme heat events, there is an increase in cow mortality. In tropical climates, dairy cattle are mostly Bos indicus (zebu) type or zebu crossbred with temperate dairy breeds. Crossbreeding is undertaken to combine the heat tolerance and tick resistance of zebu with the productivity of temperate dairy breeds. In the absence of improved heat tolerance, milk production and fertility of temperate cattle is severely impaired. We have recently identified a key role for the prolactin pathway in regulating heat tolerance. A de novo mutation in prolactin that impairs prolactin activity was discovered in hairy and heat intolerant, New Zealand dairy cattle. The phenotypes produced were remarkably similar to those seen in fescue toxicosis, a syndrome seen in grazing cattle in the U.S. where ingestion of ergovaline, a fungal toxin from infected pasture, inhibits prolactin secretion. Recognition of the role of prolactin in hairy cattle led us to identify a deletion in exon 10 of the long-form of the prolactin receptor in Senepol cattle that causes truncation of the protein and determines the slick coat and heat tolerance traits found in this Bos taurus, beef breed. The short form of the prolactin receptor is predicted to be unaffected by the deletion. Knowledge of this dominant mutation has provided the impetus to begin a crossbreeding program to investigate performance and heat tolerance of temperate dairy cattle carrying the slick, prolactin receptor variant. The perceived opportunity is to intro-gress this variant into temperate dairy cattle to enable performance and welfare improvement in hot climates. Heat tolerance of cattle with slick coats appears to be mostly associated with coat type although sweating ability may also be enhanced. Further investigation is required of performance traits in cows homozygous for the slick variant because the published data are almost exclusively from heterozygous animals. Combination of the slick mutation with other favorable genes for heat tolerance, especially those for coat color, will be particularly enabled by gene editing technologies, offering opportunities for further improvement in bovine thermotolerance.	[Davis, S. R.; Spelman, R. J.; Littlejohn, M. D.] Livestock Improvement Corp, Private Bag 3016, Hamilton 3240, New Zealand	Davis, SR (reprint author), Livestock Improvement Corp, Private Bag 3016, Hamilton 3240, New Zealand.	steve.davis@lic.co.nz			Journal of Animal Science; American Society of Animal Science	Based on a presentation at the Breeding and Genetics Symposium titled "Resilience of Livestock to Changing Environments" held at the Joint Annual Meeting, July 19-23, 2016, Salt Lake City, UT, with publication sponsored by the Journal of Animal Science and the American Society of Animal Science.	Alamer M, 2011, ASIAN J ANIM VET ADV, V6, P1153, DOI 10.3923/ajava.2011.1153.1169; ALDRICH CG, 1993, J ANIM SCI, V71, P158, DOI 10.2527/1993.711158x                                                            ; Allen T. E., 1962, CROP PASTURE SCI, V13, P165, DOI [10.1071/AR9620165, DOI 10.1071/AR9620165]; BECERRIL CM, 1993, J DAIRY SCI, V76, P2286, DOI 10.3168/jds.S0022-0302(93)77565-7; Bennett J. W., 1964, P AUSTR SOC ANIMAL P, V5, P160; Berman A, 2005, J ANIM SCI, V83, P1377; BERMAN A, 1961, AUST J AGR RES, V12, P528, DOI 10.1071/AR9610528; Berman A, 2011, J DAIRY SCI, V94, P2147, DOI 10.3168/jds.2010-3962; Bertipaglia E. C. A., 2005, Animal Reproduction, V2, P187; BIANCA W, 1965, J DAIRY RES, V32, P291, DOI 10.1017/S0022029900018665                                                       ; Bishop-Williams KE, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0607-2; BLACKSHAW JK, 1994, AUST J EXP AGR, V34, P285, DOI 10.1071/EA9940285                                                               ; BLAKE MJ, 1995, J BIOL CHEM, V270, P29614, DOI 10.1074/jbc.270.49.29614                                                        ; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/er.19.3.225; BOLING JA, 1989, J ANIM SCI, V67, P2377; Brenig B, 2013, ANIM GENET, V44, P450, DOI 10.1111/age.12029; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; CENA K, 1975, PROC R SOC SER B-BIO, V188, P377, DOI 10.1098/rspb.1975.0026; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; Collier R.J., 2015, ANNU REV ANIM BIOSCI, V3, P101, DOI DOI 10.1146/ANNUREV-ANIMAL-022114-110659; Contreras-Correa Z., 2016, J ANIM SCI E S1, V94, P507, DOI [10.2527/jam2016-1078, DOI 10.2527/JAM2016-1078]; CROSS DL, 1995, J ANIM SCI, V73, P899; Das R, 2016, VET WORLD, V9, P260, DOI 10.14202/vetworld.2016.260-268; Dikmen S, 2008, J DAIRY SCI, V91, P3395, DOI 10.3168/jds.2008-1072; Dikmen S, 2015, J ANIM BREED GENET, V132, P409, DOI 10.1111/jbg.12176; Dikmen S, 2014, J DAIRY SCI, V97, P5508, DOI 10.3168/jds.2014-8087; Dorshorst B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128969; DOWLING D. F., 1959, AUSTRALIAN JOUR AGRIC RES, V10, P736, DOI 10.1071/AR9590736; DOWLING D. F., 1958, PROC AUSTRALIAN SOC ANIMAL PROD, V2, P69; DOWLING D. F., 1955, AUSTRALIAN JOUR AGRIC RES, V6, P776, DOI 10.1071/AR9550776; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; FAICHNEY GJ, 1986, AUST J BIOL SCI, V39, P85; FAOSTAT, 2013, FAOSTAT DOM PROD LIV; FINCH VA, 1986, J ANIM SCI, V62, P531; FINCH VA, 1982, J AGR SCI, V99, P479, DOI 10.1017/S0021859600031130                                                       ; Flori L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036133; Fontanesi L, 2010, ANIM GENET, V41, P295, DOI 10.1111/j.1365-2052.2009.02007.x; Galukande E, 2013, ANIMAL GENETIC RESOU, V52, P111, DOI DOI 10.1017/S2078633612000471; Gebremedhin KG, 2011, APPL ENG AGRIC, V27, P999; Gebremedhin KG, 2008, T ASABE, V51, P2167; Gray KA, 2011, LIVEST SCI, V140, P68, DOI 10.1016/j.livsci.2011.02.009; Gutierrez-Gil B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-56; Hammond AC, 1996, J ANIM SCI, V74, P295; HANSEN PJ, 1990, VET REC, V127, P333; Hansen PJ, 2004, ANIM REPROD SCI, V82-3, P349, DOI 10.1016/j.anireprosci.2004.04.011; Harris B. L., 2001, Journal of Dairy Science, V84, pE56; Herrero M, 2016, NAT CLIM CHANGE, V6, P452, DOI [10.1038/NCLIMATE2925, 10.1038/nclimate2925]; Hue T, 2014, TROP ANIM HEALTH PRO, V46, P447, DOI 10.1007/s11250-013-0512-2; Huson HJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00101; Ibelli AMG, 2012, VET PARASITOL, V186, P425, DOI 10.1016/j.vetpar.2011.11.019; Jabbour HN, 1996, MOL CELL ENDOCRINOL, V123, P17, DOI 10.1016/0303-7207(96)03892-0; Jian W, 2015, ASIAN AUSTRAL J ANIM, V28, P1558, DOI 10.5713/ajas.14.0526; Jian W, 2014, INT J BIOMETEOROL, V58, P1087, DOI 10.1007/s00484-013-0700-9; Jimenez-Caban E., 2015, Journal of Agriculture of the University of Puerto Rico, V99, P13; JOHNSON KG, 1983, J THERM BIOL, V8, P273, DOI 10.1016/0306-4565(83)90008-6; JOHNSTON JE, 1958, J ANIM SCI, V17, P473; Jolly RD, 2008, NEW ZEAL VET J, V56, P74, DOI 10.1080/00480169.2008.36812; Kadzere CT, 2002, LIVEST PROD SCI, V77, P59, DOI 10.1016/S0301-6226(01)00330-X; Kline JB, 1999, J BIOL CHEM, V274, P35461, DOI 10.1074/jbc.274.50.35461                                                        ; Klotz JL, 2016, ANIM PROD SCI, V56, P1761, DOI 10.1071/AN14962; Klotz JL, 2015, TOXINS, V7, P2801, DOI 10.3390/toxins7082801; Knaust J, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0199-8; Kolver E. S., 2002, Proceedings of the New Zealand Society of Animal Production, V62, P246; Kuhn C, 2007, ANIM GENET, V38, P109, DOI 10.1111/j.1365-2052.2007.01569.x; Lacasse R, 2015, J DAIRY SCI, V98, P7856, DOI 10.3168/jds.2015-9865; Landaeta-Hernandez A, 2011, TROP ANIM HEALTH PRO, V43, P657, DOI 10.1007/s11250-010-9749-1; Littlejohn MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6861; Madalena F. E., 1998, P 6 WORLD C GEN APPL, V27, P199; Mader TL, 2002, J ANIM SCI, V80, P2373; Maia A. S. C., 2005, Brazilian Journal of Veterinary Research and Animal Science, V42, P180; Maia ASC, 2005, INT J BIOMETEOROL, V50, P17, DOI 10.1007/s00484-005-0267-1; Mariasegaram M, 2007, ANIM GENET, V38, P54, DOI 10.1111/j.1365-2052.2007.01560.x; McClanahan L. K., 2008, Professional Animal Scientist, V24, P269; Mejia R. M., 2010, J ANIM SCI S2, V88, P643; Moran J, 2005, TROPICAL DAIRY FARMI; Nardone A, 2010, LIVEST SCI, V130, P57, DOI 10.1016/j.livsci.2010.02.011; Nay T., 1956, CROP PASTURE SCI, V7, P482, DOI [10.1071/AR9560482, DOI 10.1071/AR9560482]; Nicol AM, 2016, ANIM PROD SCI, V56, P1775, DOI 10.1071/AN14963; Nixon AJ, 2002, J ENDOCRINOL, V172, P605, DOI 10.1677/joe.0.1720605; Olson T, 1999, GENETICS OF CATTLE, P33; Olson T. A., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P16; Olson TA, 2003, J ANIM SCI, V81, P80; PAN YS, 1964, AUST J AGR RES, V15, P346, DOI 10.1071/AR9640346                                                               ; PAN YS, 1969, AUST J AGR RES, V20, P395, DOI 10.1071/AR9690395; Pangestu M., 2000, J ANIM SCI, V13, P505; Perotti C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2193; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Rewe T. O., 2015, LIVEST RES RURAL DEV, V27, P150; RHODES MT, 1991, J ANIM SCI, V69, P2033; SALAH MS, 1995, ANIM SCI, V60, P87, DOI 10.1017/S1357729800008171                                                       ; Schalles RR, 1999, J ANIM SCI, V77, P1144; Scharf B, 2010, J ANIM SCI, V88, P2321, DOI 10.2527/jas.2009-2551; SCHLEGER AV, 1965, AUST J AGR RES, V16, P92, DOI 10.1071/AR9650092; SCHLEGER AV, 1971, AUST J BIOL SCI, V24, P1291, DOI 10.1071/BI9711291                                                               ; Schleger A. V., 1960, CROP PASTURE SCI, V11, P875, DOI [10.1071/AR9600875, DOI 10.1071/AR9600875]; Schmutz SM, 2013, ANIM GENET, V44, P9, DOI 10.1111/j.1365-2052.2012.02361.x; Schmutz S. M., 2012, BOVINE GENOMICS, P20, DOI 10.1002/9781118301739.ch3; SERGENT D, 1988, J THERM BIOL, V13, P53, DOI 10.1016/0306-4565(88)90012-5; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; SMITH VG, 1977, J ANIM SCI, V44, P645; Sonstegard T. S., 2014, J ANIM SCI S2, V92, P86; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5                                               ; Steelman CD, 1997, MED VET ENTOMOL, V11, P257, DOI 10.1111/j.1365-2915.1997.tb00404.x; Strickland J. R., 2009, FORAGE GRAZINGLANDS, V7, DOI [10.1094/FG-2009-1104-01-RS, DOI 10.1094/FG-2009-1104-01-RS]; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; TUCKER HA, 1982, THERIOGENOLOGY, V17, P53; TURNER H. G., 1960, AUSTRALIAN JOUR AGRIC RES, V11, P645, DOI 10.1071/AR9600645; TURNER HG, 1962, AUST J AGR RES, V13, P180, DOI 10.1071/AR9620180; TURNER HG, 1970, AUST J BIOL SCI, V23, P201; USMAN T, 2013, ADV ENVIRON BIOL, V7, P366; Venhoranta H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075659; Verissimo C. J., 2002, Archivos de Zootecnia, V51, P389; Vitali A, 2009, J DAIRY SCI, V92, P3781, DOI 10.3168/jds.2009-2127; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; Worstell D. M., 1953, MISSOURI AGR EXP STN, V515, P1; YEATES N. T. M., 1955, AUSTRALIAN JOUR AGRIC RES, V6, P891, DOI 10.1071/AR9550891	117	0	0	6	6	AMER SOC ANIMAL SCIENCE	CHAMPAIGN	PO BOX 7410, CHAMPAIGN, IL 61826-7410 USA	0021-8812	1525-3163		J ANIM SCI	J. Anim. Sci.	APR	2017	95	4					1788	1800		10.2527/jas2016.0956				13	Agriculture, Dairy & Animal Science	Agriculture	EW2GK	WOS:000402314400037	28464106				2018-01-05	
J	Mendoza-Garcia, P; Hugosson, F; Fallah, M; Higgins, ML; Iwasaki, Y; Pfeifer, K; Wolfstetter, G; Varshney, G; Popichenko, D; Gergen, JP; Hens, K; Deplancke, B; Palmer, RH				Mendoza-Garcia, Patricia; Hugosson, Fredrik; Fallah, Mahsa; Higgins, Michael L.; Iwasaki, Yasuno; Pfeifer, Kathrin; Wolfstetter, Georg; Varshney, Gaurav; Popichenko, Dmitry; Gergen, J. Peter; Hens, Korneel; Deplancke, Bart; Palmer, Ruth H.			The Zic family homologue Odd-paired regulates Alk expression in Drosophila	PLOS GENETICS			English	Article							RECEPTOR TYROSINE KINASE; TRANSCRIPTION FACTOR HAND; VISCERAL MESODERM; MIDGUT MORPHOGENESIS; MYOBLAST FUSION; EMBRYONIC GUT; CELL FATES; GENE; MELANOGASTER; MUSCLE	The Anaplastic Lymphoma Kinase (Alk) receptor tyrosine kinase (RTK) plays a critical role in the specification of founder cells (FCs) in the Drosophila visceral mesoderm (VM) during embryogenesis. Reporter gene and CRISPR/Cas9 deletion analysis reveals enhancer regions in and upstream of the Alk locus that influence tissue-specific expression in the amnioserosa (AS), the VM and the epidermis. By performing high throughput yeast one-hybrid screens (Y1H) with a library of Drosophila transcription factors (TFs) we identify Odd-paired (Opa), the Drosophila homologue of the vertebrate Zic family of TFs, as a novel regulator of embryonic Alk expression. Further characterization identifies evolutionarily conserved Opa-binding cis-regulatory motifs in one of the Alk associated enhancer elements. Employing Alk reporter lines as well as CRISPR/Cas9-mediated removal of regulatory elements in the Alk locus, we show modulation of Alk expression by Opa in the embryonic AS, epidermis and VM. In addition, we identify enhancer elements that integrate input from additional TFs, such as Binou (Bin) and Bagpipe (Bap), to regulate VM expression of Alk in a combinatorial manner. Taken together, our data show that the Opa zinc finger TF is a novel regulator of embryonic Alk expression.	[Mendoza-Garcia, Patricia; Hugosson, Fredrik; Pfeifer, Kathrin; Wolfstetter, Georg; Palmer, Ruth H.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Mendoza-Garcia, Patricia; Fallah, Mahsa; Varshney, Gaurav; Popichenko, Dmitry] Umea Univ, Dept Mol Biol, Umea, Sweden; [Higgins, Michael L.; Iwasaki, Yasuno; Gergen, J. Peter] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Hens, Korneel] Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England; [Deplancke, Bart] Lab Syst Biol & Genet, Lausanne, Switzerland	Palmer, RH (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	ruth.palmer@gu.se		Hens, Korneel/0000-0002-0362-7007; Deplancke, Bart/0000-0001-9935-843X; Hugosson, Fredrik/0000-0002-8332-7011; Varshney, Gaurav K./0000-0002-0429-1904; Pfeifer, Kathrin/0000-0002-2680-8425	Cancerfonden (SE) [RHP 15-0391]; Barncancerfonden (SE) [RHP 15/0096, NC2014-0045]; Vetenskapsradet [RHP 2015-04466]; Swedish Foundation for Strategic Research [RB13-0204]; Goran Gustafsson Foundation [RHP2016]; Carl Tryggers Stiftelse for Vetenskaplig Forskning [CTS KF15:15]; SystemsX.ch [RTD 2013/153]	This work was supported by grants from: Cancerfonden (SE) www.cancerfonden.se (RHP 15-0391); Barncancerfonden (SE) www.bamcancerfonden se (RHP 15/0096; NC2014-0045, Vetenskapsradet www.vrse (RHP 2015-04466), Swedish Foundation for Strategic Research www.stratresearch.se (RB13-0204) and the Goran Gustafsson Foundation www.gustafssonsstiftelse.se (RHP2016), Carl Tryggers Stiftelse for Vetenskaplig Forskning www. carltryggerssfittelse.se (CTS KF15:15), SystemsX.ch www.systemsx.ch (RTD 2013/153 to BD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183                                                          ; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; BODMER R, 1993, DEVELOPMENT, V118, P719; Bour BA, 2000, GENE DEV, V14, P1498; Cannavo E, 2016, CURR BIOL, V26, P38, DOI 10.1016/j.cub.2015.11.034; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; CIMBORA DM, 1995, DEV BIOL, V169, P580, DOI 10.1006/dbio.1995.1171; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Eriksson T, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-86; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gouzi JY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002281; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hens K, 2011, NAT METHODS, V8, P1065, DOI [10.1038/nmeth.1763, 10.1038/NMETH.1763]; Hoskins RA, 2015, GENOME RES, V25, P445, DOI 10.1101/gr.185579.114; Jin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003195; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jurgens G, 1984, Wilehm Roux Arch Dev Biol, V193, P283, DOI 10.1007/BF00848157; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Kim SY, 2006, GENE EXPR PATTERNS, V6, P504, DOI 10.1016/j.modgep.2005.10.009; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Kpebe A, 2008, GENESIS, V46, P132, DOI 10.1002/dvg.20374; Kremnev Dmitry, 2014, Front Plant Sci, V5, P385, DOI 10.3389/fpls.2014.00385; Lasek AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022636; Lee H, 2007, DEVELOPMENT, V134, P1301, DOI 10.1242/dev.02807; Lee HH, 2005, DEVELOPMENT, V132, P1429, DOI 10.1242/dev.01687; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; Liberman LM, 2009, DEV BIOL, V327, P578, DOI 10.1016/j.ydbio.2008.12.020; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520                                                         ; Okamoto N, SIGNALING GLIA CHOLI; Okamoto N, 2015, DEV CELL, V35, P295, DOI 10.1016/j.devcel.2015.10.003; Pfeifer K, 2012, DEV GENES EVOL, V222, P165, DOI 10.1007/s00427-012-0402-z; Popichenko D, 2013, DEVELOPMENT, V140, P3156, DOI 10.1242/dev.094466; Prazak L, 2010, DEV BIOL, V344, P1048, DOI 10.1016/j.ydbio.2010.04.026; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Riechmann V, 1997, DEVELOPMENT, V124, P2915; Rohrbough J, 2010, DEVELOPMENT, V137, P3523, DOI 10.1242/dev.047878; Schaub C, 2013, DEV BIOL, V376, P245, DOI 10.1016/j.ydbio.2013.01.022; Schaub C, 2012, DEVELOPMENT, V139, P1001, DOI 10.1242/dev.073890; Sellin J, 2006, GENE EXPR PATTERNS, V6, P360, DOI 10.1016/j.modgep.2005.09.012; Sen A, 2010, DEV BIOL, V343, P167, DOI 10.1016/j.ydbio.2010.04.003; Shirinian M, 2007, DIFFERENTIATION, V75, P418, DOI 10.1111/j.1432-0436.2006.00148.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472                                                        ; Stute C, 2004, DEVELOPMENT, V131, P743, DOI 10.1242/dev.00972; Swantek D, 2004, DEVELOPMENT, V131, P2281, DOI 10.1242/dev.01109; Varshney GK, 2006, BIOCHEM BIOPH RES CO, V351, P839, DOI 10.1016/j.bbrc.2006.10.117; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Zaffran S, 2001, GENE DEV, V15, P2900; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	57	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	APR	2017	13	4							e1006617	10.1371/journal.pgen.1006617				27	Genetics & Heredity	Genetics & Heredity	EW5MC	WOS:000402549200004		gold			2018-01-05	
J	Kaya, H; Ishibashi, K; Toki, S				Kaya, Hidetaka; Ishibashi, Kazuhiro; Toki, Seiichi			A Split Staphylococcus aureus Cas9 as a Compact Genome-Editing Tool in Plants	PLANT AND CELL PHYSIOLOGY			English	Article						CRISPR/Cas9; Split-SaCas9; Staphylococcus aureus; Tomato mosaic virus	ROS-PRODUCING ACTIVITY; NADPH OXIDASE ATRBOHF; TARGETED MUTAGENESIS; CRISPR/CAS9 SYSTEM; CRYSTAL-STRUCTURE; COAT PROTEIN; GUIDE RNA; IN-VIVO; VIRUS; GENE	Split-protein methods-where a protein is split into two inactive fragments that must re-assemble to form an active protein-can be used to regulate the activity of a given protein and reduce the size of gene transcription units. Here, we show that a Staphylococcus aureus Cas9 (SaCas9) can be split, and that split-SaCas9 expressed from Agrobacterium can induce targeted mutagenesis in Nicotiana benthamiana. Since SaCas9 is smaller than the more commonly used Cas9 derived from Streptococcus pyogenes, the split-SaCas9 provides the smallest tool yet for clustered regularly interspaced short pal-indromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) plant genome editing. Both sets of split-SaCas9 (_430N/431C and _739N/740C) exhibited genome-editing activity, and the activity of split-SaCas9_739N/740C was almost the same as that of full-length SaCas9. This result indicates that split-SaCas9_739N/740C is suitable for use in targeted mutagenesis. We also show that the split-SaCas9 fragment expressed from Tomato mosaic virus could induce targeted mutagenesis together with another fragment expressed from Agrobacterium, suggesting that a split-SaCas9 system using a plant virus vector is a promising tool for integration-free plant genome editing. Split-SaCas9 has the potential to regulate CRISPR/Cas9-mediated genome editing activity in plant cells both temporally and spatially.	[Kaya, Hidetaka; Toki, Seiichi] Natl Agr & Food Res Org, Inst Agrobiol Sci, Plant Genome Engn Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Ishibashi, Kazuhiro] Natl Agr & Food Res Org, Inst Agrobiol Sci, Plant & Microbial Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan	Toki, S (reprint author), Natl Agr & Food Res Org, Inst Agrobiol Sci, Plant Genome Engn Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.; Toki, S (reprint author), Yokohama City Univ, Grad Sch Nanobiosci, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan.; Toki, S (reprint author), Yokohama City Univ, Kihara Inst Biol Res, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan.	stoki@affrc.go.jp		Ishibashi, Kazuhiro/0000-0002-9349-3603	Cabinet Office, Government of Japan [Cross-ministerial Strategic Innovation Promotion Program (SIP)]	This work was supported by the Cabinet Office, Government of Japan [the Cross-ministerial Strategic Innovation Promotion Program (SIP) for S.T. and K.I.].	Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Avesani L, 2007, TRANSGENIC RES, V16, P587, DOI 10.1007/s11248-006-9051-1; Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gao JP, 2015, PLANT MOL BIOL, V87, P99, DOI 10.1007/s11103-014-0263-0; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3                                                   ; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kawarazaki T, 2013, BBA-MOL CELL RES, V1833, P2775, DOI 10.1016/j.bbamcr.2013.06.024; Kaya H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26871; Kaya H, 2014, PLANT CELL, V26, P1069, DOI 10.1105/tpc.113.120642; Kimura S, 2013, J BIOCHEM, V153, P191, DOI 10.1093/jb/mvs132; Kubota K, 2003, J VIROL, V77, P11016, DOI 10.1128/JVI.77.20.11016-11026.2003; Li X, 2007, J INTEGR PLANT BIOL, V49, P222, DOI 10.1111/j.1672-9072.2007.00393.x; Nguyen DP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12009; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; OHNO T, 1984, J BIOCHEM-TOKYO, V96, P1915, DOI 10.1093/oxfordjournals.jbchem.a135026                                           ; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; Qiu WP, 2002, MOL PLANT MICROBE IN, V15, P269, DOI 10.1094/MPMI.2002.15.3.269; Qu F, 2002, MOL PLANT MICROBE IN, V15, P193, DOI 10.1094/MPMI.2002.15.3.193; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Schaeffer SM, 2015, PLANT SCI, V240, P130, DOI 10.1016/j.plantsci.2015.09.011; Scholthof HB, 1996, ANNU REV PHYTOPATHOL, V34, P299, DOI 10.1146/annurev.phyto.34.1.299; SHERWOOD JL, 1982, VIROLOGY, V119, P150, DOI 10.1016/0042-6822(82)90072-1                                                    ; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Taoka K, 1999, PLANT J, V18, P611, DOI 10.1046/j.1365-313x.1999.00486.x; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Yee JK, 2016, FEBS J, V283, P3239, DOI 10.1111/febs.13760; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	39	3	3	8	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	APR	2017	58	4					643	649		10.1093/pcp/pcx034				7	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	EV8ZO	WOS:000402074100001	28371831	gold			2018-01-05	
J	Du, L; Zhang, J; Qu, SF; Zhao, YY; Su, BD; Lv, XQ; Li, RL; Wan, YL; Xiao, JW				Du, Liang; Zhang, Jian; Qu, Shaofeng; Zhao, Yuanyuan; Su, Bodan; Lv, Xueqin; Li, Ruili; Wan, Yinglang; Xiao, Jianwei			The Pentratricopeptide Repeat Protein Pigment-Defective Mutant2 is Involved in the Regulation of Chloroplast Development and Chloroplast Gene Expression in Arabidopsis	PLANT AND CELL PHYSIOLOGY			English	Article						Arabidopsis; Chloroplast; Development; Pentatricopeptide repeat protein; Pigment-Defective Mutant2	ENCODED RNA-POLYMERASE; RIBOSOME-DEFICIENT PLASTIDS; PRE-MESSENGER-RNA; EDITING SITES; PPR PROTEIN; MITOCHONDRIAL TRANSCRIPT; BIOGENESIS; THALIANA; PLANTS; REVEALS	The development of functional chloroplasts, which is assisted by a series of nuclear-encoded auxiliary protein factors, is essential for plant autotrophic growth and development. To understand the molecular mechanisms underlying chloroplast development, we isolated and characterized a pigment-defective mutant, pdm2, and its corresponding variegated RNA interference (RNAi) lines in Arabidopsis. Sequence analysis revealed that PDM2 encodes a pentatricopeptide repeat protein that belongs to the P subgroup. Confocal microscopic analysis and immunoblotting of the chloroplast protein fraction showed that PDM2 was located in the stroma. In RNAi plants, protein-related photosynthesis was severely compromised. Furthermore, analysis of the transcript profile of chloroplast genes revealed that plastid-encoded polymerase-dependent transcript levels were markedly reduced, while nuclear-encoded polymerase-dependent transcript levels were increased, in RNAi plants. In addition, PDM2 affects plastid RNA editing efficiency in most editing sites, apparently by directly interacting with multiple organellar RNA editing factor 2 (MORF2) and MORF9. Thus, our results demonstrate that PDM2 is probably involved in the regulation of plastid gene expression required for normal chloroplast development.	[Du, Liang; Zhang, Jian; Qu, Shaofeng; Zhao, Yuanyuan; Su, Bodan; Lv, Xueqin; Li, Ruili; Wan, Yinglang; Xiao, Jianwei] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing 100083, Peoples R China	Xiao, JW (reprint author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing 100083, Peoples R China.	xiaojianwei@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [BLX201301]; Beijing Advanced Innovation Center for Tree Breeding by Molecular Design; National Natural Science Foundation of China [31400210, 31501168]	This project was supported by the Fundamental Research Funds for the Central Universities [BLX201301]; the Beijing Advanced Innovation Center for Tree Breeding by Molecular Design; and the National Natural Science Foundation of China [31400210 and 31501168].	Apuya NR, 2001, PLANT PHYSIOL, V126, P717, DOI 10.1104/pp.126.2.717; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Boudreau E, 2000, EMBO J, V19, P3366, DOI 10.1093/emboj/19.13.3366                                                        ; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Chateigner-Boutin AL, 2002, MOL CELL BIOL, V22, P8448, DOI 10.1128/MCB.22.24.8448-8456.2002; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Chi W, 2010, PLANT J, V64, P14, DOI 10.1111/j.1365-313X.2010.04304.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; Gao ZP, 2012, PLANT SIGNAL BEHAV, V7, P1354, DOI [10.1104/pp.111.184762;PMID:22010110, 10.4161/psb.21618]; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hedtke B, 1997, SCIENCE, V277, P809, DOI 10.1126/science.277.5327.809; Hess WR, 1999, INT REV CYTOL, V190, P1, DOI 10.1016/S0074-7696(08)62145-2                                                   ; HESS WR, 1993, EMBO J, V12, P563; Huang XZ, 2009, CELL RES, V19, P1205, DOI 10.1038/cr.2009.84; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Karcher D, 2002, CURR GENET, V41, P48, DOI 10.1007/s00294-002-0278-y; Keegstra K., 1998, METHOD ENZYMOL, V118, P316; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Kobayashi K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00272; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393; Lopez-Juez E, 2007, J EXP BOT, V58, P11, DOI 10.1093/jxb/erl196; Loschelder H, 2006, PLANT PHYSIOL, V142, P642, DOI 10.1104/pp.106.085787; LU BW, 1992, NUCLEIC ACIDS RES, V20, P5699, DOI 10.1093/nar/20.21.5699                                                          ; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Moschopoulos A, 2012, J EXP BOT, V63, P5233, DOI 10.1093/jxb/ers184; Muralla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028398; Myouga F, 2010, PLANT J, V61, P529, DOI 10.1111/j.1365-313X.2009.04074.x; Ohtani S, 2010, PLANT CELL PHYSIOL, V51, P1942, DOI 10.1093/pcp/pcq142; Okuda K, 2012, NUCLEIC ACIDS RES, V40, P5052, DOI 10.1093/nar/gks164; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Peeters NM, 2002, RNA, V8, P497, DOI 10.1017/S1355838202029424; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Pogson BJ, 2015, BBA-BIOENERGETICS, V1847, P1017, DOI 10.1016/j.bbabio.2015.02.003; Pyo YJ, 2013, PLANT PHYSIOL, V163, P1844, DOI 10.1104/pp.113.227199; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Romani I, 2012, PLANT J, V72, P922, DOI 10.1111/tpj.12000; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Schweer J, 2006, FEBS LETT, V580, P6617, DOI 10.1016/j.febslet.2006.11.010; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Steiner S, 2011, PLANT PHYSIOL, V157, P1043, DOI 10.1104/pp.111.184515; Summer H, 2000, CURR GENET, V37, P45, DOI 10.1007/s002940050007; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; VANDERKROL AR, 1988, NATURE, V333, P866, DOI 10.1038/333866a0                                                                ; Wang YQ, 1996, J PLANT PHYSIOL, V147, P521, DOI 10.1016/S0176-1617(96)80041-1                                                   ; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Wu H, 2010, CHINESE SCI BULL, V55, P3485, DOI 10.1007/s11434-010-4040-4; Xiao JW, 2012, PLANT PHYSIOL, V160, P1911, DOI 10.1104/pp.112.204891; Yin QQ, 2012, CHINESE SCI BULL, V57, P3452, DOI 10.1007/s11434-012-5278-9; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Zhang HD, 2015, PHOTOSYNTH RES, V126, P311, DOI 10.1007/s11120-015-0171-4; Zhelyazkova P, 2012, PLANT CELL, V24, P123, DOI 10.1105/tpc.111.089441; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x; Zhu Q, 2012, PLANT J, V71, P836, DOI 10.1111/j.1365-313X.2012.05036.x; Zubko MK, 2002, MOL GENET GENOMICS, V267, P27, DOI 10.1007/s00438-001-0627-4	70	1	1	7	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	APR	2017	58	4					747	759		10.1093/pcp/pcx004				13	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	EV8ZO	WOS:000402074100010	28158776				2018-01-05	
J	Bradde, S; Vucelja, M; Tesileanu, T; Balasubramanian, V				Bradde, Serena; Vucelja, Marija; Tesileanu, Tiberiu; Balasubramanian, Vijay			Dynamics of adaptive immunity against phage in bacterial populations	PLOS COMPUTATIONAL BIOLOGY			English	Article							HORIZONTAL GENE-TRANSFER; CRISPR-CAS; ACQUIRED-RESISTANCE; SYSTEMS; INTERFERENCE; ACQUISITION; ADAPTATION; MECHANISMS; MEMORY; DNA	The CRISPR (clustered regularly interspaced short palindromic repeats) mechanism allows bacteria to adaptively defend against phages by acquiring short genomic sequences (spacers) that target specific sequences in the viral genome. We propose a population dynamical model where immunity can be both acquired and lost. The model predicts regimes where bacterial and phage populations can co-exist, others where the populations exhibit damped oscillations, and still others where one population is driven to extinction. Our model considers two key parameters: (1) ease of acquisition and (2) spacer effectiveness in conferring immunity. Analytical calculations and numerical simulations show that if spacers differ mainly in ease of acquisition, or if the probability of acquiring them is sufficiently high, bacteria develop a diverse population of spacers. On the other hand, if spacers differ mainly in their effectiveness, their final distribution will be highly peaked, akin to a "winner-take-all" scenario, leading to a specialized spacer distribution. Bacteria can interpolate between these limiting behaviors by actively tuning their overall acquisition probability.	[Bradde, Serena; Tesileanu, Tiberiu; Balasubramanian, Vijay] CUNY, Grad Ctr, Initiat Theoret Sci, New York, NY 10017 USA; [Bradde, Serena; Tesileanu, Tiberiu; Balasubramanian, Vijay] Univ Penn, David Rittenhouse Labs, Philadelphia, PA 19104 USA; [Vucelja, Marija] Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA; [Vucelja, Marija] Univ Virginia, Dept Phys, Charlottesville, VA 22901 USA	Balasubramanian, V (reprint author), CUNY, Grad Ctr, Initiat Theoret Sci, New York, NY 10017 USA.; Balasubramanian, V (reprint author), Univ Penn, David Rittenhouse Labs, Philadelphia, PA 19104 USA.	vijay@physics.upenn.edu		Tesileanu, Tiberiu/0000-0003-3107-3088	NSF at the KITP, Santa Barbara [PHY11-25915]; NSF at the Aspen Center for Physics [PHY-1066293]; Swartz Foundation; NSF Physics of Living Systems grant [PHY-1058202]; Simons Foundation [400425]	During this work VB, SB, TT and MV were supported by NSF (https://www.nsf.gov/) Grant PHY11-25915 at the KITP, Santa Barbara. VB and MV were also supported by NSF grant PHY-1066293 at the Aspen Center for Physics. SB and TT were also supported by the Swartz Foundation (http://www.theswartzfoundation.org/) and VB was also supported by NSF Physics of Living Systems grant PHY-1058202. VB also received support from the Simons Foundation (https://www.simonsfoundation.org/) under grant number 400425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bikard D, 2012, CURR OPIN IMMUNOL, V24, P15, DOI 10.1016/j.coi.2011.10.005; Bonachela JA, 2014, J THEOR BIOL, V345, P32, DOI 10.1016/j.jtbi.2013.12.006; Brodt A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-65; Childs LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101710; Childs LM, 2012, EVOLUTION, V66, P2015, DOI 10.1111/j.1558-5646.2012.01595.x; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Garrett RA, 2011, BIOCHEM SOC T, V39, P51, DOI 10.1042/BST0390051; Haerter JO, 2011, J VIROL, V85, P10554, DOI 10.1128/JVI.05222-11; Han P, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/025004; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128102; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Iranzo J, 2013, J BACTERIOL, V195, P3834, DOI 10.1128/JB.00412-13; Jiang W, 2013, PLOS GENETICS, V9; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Renshaw E, 1991, MODELING BIOL POPULA; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Weinberger AD, 2012, PLOS COMPUTATIONAL B, V8; Weld RJ, 2004, J THEOR BIOL, V227, P1, DOI 10.1016/S0022-5193(03)00262-5; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	36	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	APR	2017	13	4							e1005486	10.1371/journal.pcbi.1005486				16	Biochemical Research Methods; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Mathematical & Computational Biology	EW5JV	WOS:000402542900028	28414716	gold			2018-01-05	
J	Rampasso, AS; Vilela, CR				Rampasso, Augusto Santos; Vilela, Carlos Ribeiro			A spontaneous body color mutation in Drosophila nappae (Diptera, Drosophilidae)	REVISTA BRASILEIRA DE ENTOMOLOGIA			English	Article						Recessive; sao Paulo; Tripunctata group; X-linked; Yellow	MEDIOPUNCTATA; MELANOGASTER; PATTERN; GENE	A yellow-bodied male appeared spontaneously in an isofemale line of Drosophila nappae established from a wild-caught female collected at the Forest Reserve of the Instituto de Biociencias da Universidade de Sao Paulo, Cidade Universitaria "Armando de Salles Oliveira", Sao Paulo city, state of Sao Paulo, Brazil. This is the first mutation found in D. nappae, a species belonging to the tripunctata group. The yellow male was isolated and individually crossed to two wild-type (brown-colored) virgin females from the same generation, yielding numerous offspring. All F-1 individuals were wild-type, but the phenotypes yielded in the F-2 generation were wild-type females, and both wild-type and yellow-bodied males. The latter yellow male mutants backcrossed with virgin wild-type F-1 females yielded four phenotypes (brown-colored and yellow-colored flies of both sexes), indicating an inheritance pattern of X-linked recessive. Chi-square goodness of fit tests (alpha= 5%) detected no significant differences among the number of flies per phenotype. The new mutation is hereby named yellow, due to its probable homology to a similar mutation with an identical inheritance pattern found in Drosophila melanogaster. (C) 2017 Sociedade Brasileira de Entomologia. Published by Elsevier Editora Ltda.	[Rampasso, Augusto Santos; Vilela, Carlos Ribeiro] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil	Vilela, CR (reprint author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil.	crvilela@ib.usp.br	IB/USP, Genetica e Biologia/G-1755-2017				ARAUJO A M D, 1981, Ciencia e Cultura (Sao Paulo), V33, P1485; Bachli G., 2016, TAXODROS DATABASE TA; Bachli Gerhard, 2000, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V73, P67; BASTOCK M, 1956, EVOLUTION, V10, P421, DOI 10.1111/j.1558-5646.1956.tb02868.x                                              ; BATISTA MRD, 2014, DROS INFORM SERV, V97, P177; BURNET B, 1980, GENET RES, V36, P235, DOI 10.1017/S0016672300019868                                                       ; Coni B., 2016, ZOOLOGIA, V33, P13; de Toni Daniela Cristina, 1995, Revista Brasileira de Biologia, V55, P347; Duda O., 1925, Ann Mus Nat Hungarici Budapest, V22, P149; FRANCK G, 1985, Revista Brasileira de Biologia, V45, P133; FRANCK G, 1984, REV BRAS GENET, V7, P241; FROTA-PESSOA O., 1954, ARQ MUS PARANAENSE, V10, P253; Klaczko LB, 2006, GENETICA, V126, P43, DOI 10.1007/s10709-005-1431-6; Marques H.V.S., 1989, CIENCIA CULTURA, V41, P740; Marques H.V.S., 1991, DROS INF SERV, V70, P280; SAAVEDRA CCR, 1995, J ZOOL SYST EVOL RES, V33, P62; Tidon R., 1994, BRAZIL REV BRAS ENTO, V38, P627; Val F.C., 1988, P189; VALENTE V L, 1991, Revista Brasileira de Entomologia, V35, P237; VILELA C R, 1992, Revista Brasileira de Entomologia, V36, P197; VILELA C R, 1990, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V63, P1; Vilela Carlos R., 2004, Rev. Bras. entomol., V48, P233, DOI 10.1590/S0085-56262004000200012; Wheeler M. R., 1963, Bulletin of the Brooklyn Entomological Society, V58, P51; WILSON R, 1976, GENET RES, V28, P75, DOI 10.1017/S0016672300016748                                                       ; Zar J.H., 1996, BIOSTATISTICAL ANAL	25	0	0	12	12	SOC BRASILEIRA ENTOMOLOGIA	CURITIBA	CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL	0085-5626	1806-9665		REV BRAS ENTOMOL	Rev. Bras. Entomol.	APR-JUN	2017	61	2					111	113		10.1016/j.rbe.2017.01.001				3	Entomology	Entomology	EW7LW	WOS:000402692600003		gold			2018-01-05	
J	Noble, C; Olejarz, J; Esvelt, KM; Church, GM; Nowak, MA				Noble, Charleston; Olejarz, Jason; Esvelt, Kevin M.; Church, George M.; Nowak, Martin A.			Evolutionary dynamics of CRISPR gene drives	SCIENCE ADVANCES			English	Article							DROSOPHILA-MELANOGASTER; GENOME; POPULATIONS; SYSTEMS; CAS9; DNA	The alteration of wild populations has been discussed as a solution to a number of humanity's most pressing ecological and public health concerns. Enabled by the recent revolution in genome editing, clustered regularly interspaced short palindromic repeats (CRISPR) gene drives-selfish genetic elements that can spread through populations even if they confer no advantage to their host organism-are rapidly emerging as the most promising approach. However, before real-world applications are considered, it is imperative to develop a clear understanding of the outcomes of drive release in nature. Toward this aim, we mathematically study the evolutionary dynamics of CRISPR gene drives. We demonstrate that the emergence of drive-resistant alleles presents a major challenge to previously reported constructs, and we show that an alternative design that selects against resistant alleles could greatly improve evolutionary stability. We discuss all results in the context of CRISPR technology and provide insights that inform the engineering of practical gene drive systems.	[Noble, Charleston; Olejarz, Jason; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Noble, Charleston; Esvelt, Kevin M.; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Noble, Charleston; Church, George M.] Harvard Med Sch, Dept Genet, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Esvelt, KM; Nowak, MA (reprint author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	esvelt@mit.edu; martin_nowak@harvard.edu		Esvelt, Kevin/0000-0001-8797-3945; Olejarz, Jason/0000-0003-3571-7709; church, george/0000-0001-6232-9969	NSF Graduate Research Fellowship Program [DGE1144152]; Lynch Foundation; Massachusetts Institute of Technology Media Lab	C.N. received support from the NSF Graduate Research Fellowship Program under grant no. DGE1144152 and from the Lynch Foundation. K.M.E. received support from the Massachusetts Institute of Technology Media Lab.	Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Akbari OS, 2014, ACS SYNTH BIOL, V3, P915, DOI 10.1021/sb300079h; Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059; Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; BULL JJ, 2017, EVOL MED PUBLIC HLTH, V2017, P1, DOI DOI 10.1093/EMPH/E0W030; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; CHARLESWORTH B, 1978, GENETICS, V89, P171; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343                                             ; Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455                                             ; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269                                                         ; Noble C, 2016, BIORXIV; Nowak Martin A., 2006, EVOLUTIONARY DYNAMIC; Ostrov N, 2016, SCIENCE, V353, P819, DOI 10.1126/science.aaf3639; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Rasgon JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005833; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285; Wang KH, 2016, NATURE, V539, P59, DOI 10.1038/nature20124; Ward CM, 2011, EVOLUTION, V65, P1149, DOI 10.1111/j.1558-5646.2010.01186.x; Windbichler N, 2007, NUCLEIC ACIDS RES, V35, P5922, DOI 10.1093/nar/gkm632; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	39	10	10	13	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	APR	2017	3	4							e1601964	10.1126/sciadv.1601964				7	Multidisciplinary Sciences	Science & Technology - Other Topics	EV7KR	WOS:000401954800017	28435878	gold			2018-01-05	
J	Zhang, Y; Long, CZ; Li, H; McAnally, JR; Baskin, KK; Shelton, JM; Bassel-Duby, R; Olson, EN				Zhang, Yu; Long, Chengzu; Li, Hui; McAnally, John R.; Baskin, Kedryn K.; Shelton, John M.; Bassel-Duby, Rhonda; Olson, Eric N.			CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice	SCIENCE ADVANCES			English	Article							MOUSE MODEL; MUSCLE; CELLS; DNA; ENDONUCLEASE; GENERATION; CPF1	Duchenne muscular dystrophy (DMD), caused by mutations in the X-linked dystrophin gene (DMD), is characterized by fatal degeneration of striated muscles. Dilated cardiomyopathy is one of the most common lethal features of the disease. We deployed Cpf1, a unique class 2 CRISPR (clustered regularly interspaced short palindromic repeats) effector, to correct DMD mutations in patient-derived induced pluripotent stem cells (iPSCs) and mdx mice, an animal model of DMD. Cpf1-mediated genomic editing of human iPSCs, either by skipping of an out-of-frame DMD exon or by correcting a nonsense mutation, restored dystrophin expression after differentiation to cardiomyocytes and enhanced contractile function. Similarly, pathophysiological hallmarks of muscular dystrophy were corrected in mdx mice following Cpf1-mediated germline editing. These findings are the first to show the efficiency of Cpf1-mediated correction of genetic mutations in human cells and an animal disease model and represent a significant step toward therapeutic translation of gene editing for correction of DMD.	[Zhang, Yu; Long, Chengzu; Li, Hui; McAnally, John R.; Baskin, Kedryn K.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Zhang, Yu; Long, Chengzu; Li, Hui; McAnally, John R.; Baskin, Kedryn K.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Senator Paul D Wellstone Muscular Dystrophy Coope, Dallas, TX 75390 USA; [Zhang, Yu; Long, Chengzu; Li, Hui; McAnally, John R.; Baskin, Kedryn K.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Long, Chengzu] NYU, Sch Med, Div Cardiol, New York, NY 10016 USA	Long, CZ; Olson, EN (reprint author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Chengzu.Long@nyumc.org; Eric.Olson@UTSouthwestern.edu			NIH [HL130253, HL-077439, DK-099653, AR-067294]; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [U54 HD 087351]; Robert A. Welch Foundation [1-0025]	This work was supported by grants from the NIH (HL130253, HL-077439, DK-099653, and AR-067294), a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (U54 HD 087351), and the Robert A. Welch Foundation ( grant 1-0025 to E.N.O.).	Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Baskin KK, 2014, EMBO MOL MED, V6, P1610, DOI 10.15252/emmm.201404218; Bostick B, 2011, MOL THER, V19, P1826, DOI 10.1038/mt.2011.154; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Hollinger K, 2015, CURR OPIN NEUROL, V28, P522, DOI 10.1097/WCO.0000000000000241; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D., 2016, NAT BIOTECHNOL, V34, P876; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Le Rhun A., 2016, NATURE, V532, P517; Long CZ, 2016, JAMA NEUROL, V73, P1349, DOI 10.1001/jamaneurol.2016.3388; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Padgett RA, 2012, TRENDS GENET, V28, P147, DOI 10.1016/j.tig.2012.01.001; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P2471; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Toth E, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0147-0; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	32	5	5	11	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	APR	2017	3	4							e1602814	10.1126/sciadv.1602814				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EV7KR	WOS:000401954800052					2018-01-05	
J	Shen, JT; Lv, L; Wang, XD; Xiu, ZL; Chen, GQ				Shen, Juntao; Lv, Li; Wang, Xudong; Xiu, Zhilong; Chen, Guoqiang			Comparative analysis of CRISPR-Cas systems in Klebsiella genomes	JOURNAL OF BASIC MICROBIOLOGY			English	Article						CRISPR-Cas; Klebsiella; MLST; mobile elements; self-target	SHORT PALINDROMIC REPEATS; YERSINIA-PESTIS; H-NS; PNEUMONIAE; COLI; EVOLUTIONARY; RESISTANCE; IMMUNITY; IDENTIFICATION; INTERFERENCE	Prokaryotic CRISPR-Cas system provides adaptive immunity against invasive genetic elements. Bacteria of the genus Klebsiella are important nosocomial opportunistic pathogens. However, information of CRISPR-Cas system in Klebsiella remains largely unknown. Here, we analyzed the CRISPR-Cas systems of 68 complete genomes of Klebsiella representing four species. All the elements for CRISPR-Cas system (cas genes, repeats, leader sequences, and PAMs) were characterized. Besides the typical Type I-E and I-F CRISPR-Cas systems, a new Subtype I system located in the ABC transport system-glyoxalase region was found. The conservation of the new subtype CRISPR system between different species showed new evidence for CRISPR horizontal transfer. CRISPR polymorphism was strongly correlated both with species and multilocus sequence types. Some results indicated the function of adaptive immunity: most spacers (112 of 124) matched to prophages and plasmids and no matching housekeeping genes; new spacer acquisition was observed within the same sequence type (ST) and same clonal complex; the identical spacers were observed only in the ancient position (far from the leader) between different STs and clonal complexes. Interestingly, a high ratio of self-targeting spacers (7.5%, 31 of 416) was found in CRISPR-bearing Klebsiella pneumoniae (61%, 11 of 18). In some strains, there even were multiple full matching self-targeting spacers. Some self-targeting spacers were conserved even between different STs. These results indicated that some unknown mechanisms existed to compromise the function of self-targets of CRISPR-Cas systems in K. pneumoniae.	[Shen, Juntao; Wang, Xudong; Xiu, Zhilong] Dalian Univ Technol, Sch Life Sci & Biotechnol, 2 Linggong Rd, Dalian 116024, Peoples R China; [Lv, Li; Chen, Guoqiang] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China	Xiu, ZL (reprint author), Dalian Univ Technol, Sch Life Sci & Biotechnol, 2 Linggong Rd, Dalian 116024, Peoples R China.	zhlxiu@dlut.edu.cn					Almendros C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050797; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Bialek-Davenet S, 2014, EMERG INFECT DIS, V20, P1812, DOI 10.3201/eid2011.140206; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Brisse S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P159, DOI 10.1007/0-387-30746-x_8; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Diez-Villasenor C, 2010, MICROBIOL-SGM, V156, P1351, DOI 10.1099/mic.0.036046-0; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Heussler GE, 2016, J BACTERIOL, V198, P1481, DOI 10.1128/JB.00086-16; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koskela KA, 2015, ENVIRON MICROBIOL, V17, P4306, DOI 10.1111/1462-2920.12816; Lin TL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31644; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Nozawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019543; Ostria-Hernandez Martha Lorena, 2015, BMC Res Notes, V8, P332, DOI 10.1186/s13104-015-1285-7; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Shariat N, 2015, MICROBIOL-SGM, V161, P374, DOI 10.1099/mic.0.000005; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Veesenmeyer JL, 2014, MOL MICROBIOL, V93, P1026, DOI 10.1111/mmi.12715; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Yang CJ, 2015, RNA BIOL, V12, P1109, DOI 10.1080/15476286.2015.1085150; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	42	0	0	5	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0233-111X	1521-4028		J BASIC MICROB	J. Basic Microbiol.	APR	2017	57	4					325	336		10.1002/jobm.201600589				12	Microbiology	Microbiology	EW2ER	WOS:000402309800005	28156004	gold			2018-01-05	
J	Tangprasittipap, A; Jittorntrum, B; Wongkummool, W; Kitiyanant, N; Tubsuwan, A				Tangprasittipap, Amornrat; Jittorntrum, Bunyada; Wongkummool, Wasinee; Kitiyanant, Narisorn; Tubsuwan, Alisa			Generation of induced pluripotent stem cells from peripheral blood CD34+hematopoietic progenitors of a 31 year old healthy woman	STEM CELL RESEARCH			English	Article								The MUi019- A human induced pluripotent stem cell line was generated from peripheral blood CD34+ hematopoietic progenitors of a healthy woman using a non-integrative reprogramming method. Episomal vectors carrying reprogramming factors OCT4, SOX2, KLF4, L-MYC, LIN28, and shRNA of TP53 and EBNA-1 were delivered using electroporation. The iPSC line can be used as a control in studying disease mechanisms. Furthermore, gene editing approaches can be used to introduce specific mutations into the MUi019- A to model disease while the cell type affected by the disease is inaccessible. (C) 2017 The Authors. Published by Elsevier B.V.	[Tangprasittipap, Amornrat; Jittorntrum, Bunyada] Mahidol Univ, Off Res Acad Affairs & Innovat, Fac Med, Ramathibodi Hosp, Bangkok 10400, Thailand; [Wongkummool, Wasinee] Mahidol Univ, Inst Mol Biosci, Thalassemia Res Ctr, Nakhon Pathom 73170, Thailand; [Wongkummool, Wasinee] Mahidol Univ, Fac Med, Dept Biochem, Siriraj Hosp, Bangkok 10700, Thailand; [Kitiyanant, Narisorn; Tubsuwan, Alisa] Mahidol Univ, Inst Mol Biosci, Stem Cell Res Grp, Nakhon Pathom 73170, Thailand	Tubsuwan, A (reprint author), Mahidol Univ, Inst Mol Biosci, Stem Cell Res Grp, Nakhon Pathom 73170, Thailand.	alisa.tub@mahidol.ac.th			Thailand Research Fund [MRG-5980187]; National Research Council of Thailand (NRCT) [DPAR/2559-158]; Office of the Higher Education Commission and Mahidol University under the National Research University Initiative; National Science and Technology Development Agency [NSTDA-P-11-00435]; Mahidol University; European Union Seventh Framework Programme [PIAPP-GA-2012-324451-STEMMAD]; Thailand Graduate Institute of Science and Technology (TGIST) scholarship, NSTDA [TG-22-14-57-036D]	We would like to thank Dr. Keisuke Okita and Prof. Shinya Yamanaka for providing the plasmids. Furthermore, we would like to thank Prof. Duncan R. Smith for proof reading the article. This work was supported by the Thailand Research Fund (MRG-5980187), National Research Council of Thailand (NRCT; DPAR/2559-158), the Office of the Higher Education Commission and Mahidol University under the National Research University Initiative, a Research Chair Grant from the National Science and Technology Development Agency (NSTDA-P-11-00435) and Mahidol University, and European Union Seventh Framework Programme(PIAPP-GA-2012-324451-STEMMAD). Wasinee Wongkummool is supported by the Thailand Graduate Institute of Science and Technology (TGIST; TG-22-14-57-036D to WW) scholarship, NSTDA.	Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Tangprasittipap A, 2015, STEM CELL RES, V15, P506, DOI 10.1016/j.scr.2015.09.003; Tubsuwan A, 2016, STEM CELL RES, V16, P110, DOI 10.1016/j.scr.2015.12.015	4	0	0	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	APR	2017	20						91	93		10.1016/j.scr.2017.02.013				3	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	EW4MD	WOS:000402474700018	28395748	gold			2018-01-05	
J	Hackett, JB; Shi, XW; Kobylarz, AT; Lucas, MK; Wessendorf, RL; Hines, KM; Bentolila, S; Hanson, MR; Lu, Y				Hackett, Justin B.; Shi, Xiaowen; Kobylarz, Amy T.; Lucas, Meriah K.; Wessendorf, Ryan L.; Hines, Kevin M.; Bentolila, Stephane; Hanson, Maureen R.; Lu, Yan			An Organelle RNA Recognition Motif Protein Is Required for Photosystem II Subunit psbF Transcript Editing	PLANT PHYSIOLOGY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; ARABIDOPSIS-THALIANA; PLASTID RNA; CHLOROPLAST; PLANTS; MITOCHONDRIA; SITE; EXPRESSION; MUTANTS; FAMILY	Loss-of-function mutations in ORGANELLE RNA RECOGNITION MOTIF PROTEIN6 (ORRM6) result in the near absence of RNA editing of psbF-C77 and the reduction in accD-C794 editing in Arabidopsis (Arabidopsis thaliana). The orrm6 mutants have decreased levels of photosystem II (PSII) proteins, especially PsbF, lower PSII activity, pale green pigmentation, smaller leaf and plant sizes, and retarded growth. Stable expression of ORRM6 rescues the orrm6 editing defects and mutant phenotype. Unlike ORRM1, the other known ORRM plastid editing factor, ORRM6, does not contain RNA editing interacting protein/multiple organellar RNA editing factor (RIP/MORF) boxes, which are required for ORRM1 to interact with site-specific pentatricopeptide repeat protein editing factors. ORRM6 interacts with RIP1/MORF8, RIP2/MORF2, and RIP9/MORF9, known components of RNA editosomes. While some plastid RRM proteins are involved in other forms of RNA processing and translation, the primary function of ORRM6 is evidently to mediate psbF-C77 editing, like the essential site-specific pentatricopeptide repeat protein LOW PSII ACCUMULATION66. Stable expression in the orrm6 mutants of a nucleus-encoded, plastid-targeted PsbF protein from a psbF gene carrying a T at nucleotide 77 significantly increases leaf and plant sizes, chlorophyll content, and PSII activity. These transformants demonstrate that plastid RNA editing can be bypassed through the expression of nucleus-encoded, edited forms of plastid genes.	[Hackett, Justin B.; Kobylarz, Amy T.; Lucas, Meriah K.; Wessendorf, Ryan L.; Lu, Yan] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Shi, Xiaowen; Hines, Kevin M.; Bentolila, Stephane; Hanson, Maureen R.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Hackett, Justin B.] Wayne State Univ, Detroit, MI 48201 USA; [Shi, Xiaowen] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	Lu, Y (reprint author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.	yan.1.lu@wmich.edu			U.S. National Science Foundation [MCB-1244008, MCB-1330294, MCB-1615393]; Western Michigan University (Faculty Research and Creative Activities Award)	This work was supported by the U.S. National Science Foundation (grant nos. MCB-1244008, MCB-1330294, and MCB-1615393) and Western Michigan University (Faculty Research and Creative Activities Award).	Ajjawi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025368; Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bock R, 2000, BIOCHIMIE, V82, P549, DOI 10.1016/S0300-9084(00)00610-6                                                   ; BOCK R, 1994, EMBO J, V13, P4623; Bock R, 1998, METHODS, V15, P75, DOI 10.1006/meth.1998.0607; Bock R, 1997, EMBO J, V16, P3282, DOI 10.1093/emboj/16.11.3282; Borner T, 2014, ADVAN PL BIO, V5, P3, DOI 10.1007/978-1-4939-1136-3_1; Bondarava N, 2003, J BIOL CHEM, V278, P13554, DOI 10.1074/jbc.M212842200; Bonen L, 2011, ADVAN PL BIO, V1, P131; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; Chateigner-Boutin AL, 2011, WIRES RNA, V2, P493, DOI 10.1002/wrna.72; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343                                                           ; Chaudhuri S, 1996, EMBO J, V15, P5958; Cheng CL, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/1851829; Clark TJ, 2015, PLANT PHYSIOL, V168, P1512, DOI 10.1104/pp.15.00364; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dalby SJ, 2013, MITOCHONDRION, V13, P647, DOI 10.1016/j.mito.2013.09.001; des Francs-Small CC, 2014, BIOCHIMIE, V100, P234, DOI 10.1016/j.biochi.2013.08.019; Fang SC, 2002, PLANT PHYSIOL, V130, P78, DOI 10.1104/pp.004721; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Germain A, 2013, WIRES RNA, V4, P295, DOI 10.1002/wrna.1161; Hartel B, 2013, PLANT MOL BIOL, V81, P337, DOI 10.1007/s11103-012-0003-2; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Karamoko M, 2011, PLANT CELL, V23, P4462, DOI 10.1105/tpc.111.089680; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Levey T, 2014, PLANT J, V80, P292, DOI 10.1111/tpj.12632; Li-Pook-Than J, 2007, PHYSIOL PLANTARUM, V129, P23, DOI [10.1111/ j. 1399- 3054.2006.00770. x, DOI 10.1111/J.1399-3054.2006.00770.X]; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lu Y, 2008, PLANT PHYSIOL, V146, P1482, DOI 10.1104/pp.107.115220; Lu Y, 2006, PLANT PHYSIOL, V142, P878, DOI 10.1104/pp.106.086850; Lu Y, 2016, FRONT PLANT SCI, V7, DOI [10.3389/dpls.2016.00168, 10.3389/fpls.2016.00168]; Lu Y, 2011, PLANT SIGNAL BEHAV, V6, P1881, DOI 10.4161/psb.6.12.18022; Lu Y, 2011, PLANT CELL, V23, P1861, DOI 10.1105/tpc.111.085456; Lu Y, 2011, PLANT PHYSIOL, V155, P1589, DOI 10.1104/pp.110.170118; Lutz KA, 2001, CURR GENET, V40, P214, DOI 10.1007/s002940100242; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nath K, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1282023; Nath K, 2016, PLANT PHYSIOL, V172, P2459, DOI 10.1104/pp.16.01564; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Roberson LM, 2006, RNA, V12, P1907, DOI 10.1261/rna.166906; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Ruwe H, 2011, J PLANT PHYSIOL, V168, P1361, DOI 10.1016/j.jplph.2011.01.012; Sakamoto Wataru, 2008, Arabidopsis Book, V6, pe0110, DOI 10.1199/tab.0110; Schallenberg-Rudinger M, 2013, PLANT J, V76, P420, DOI 10.1111/tpj.12304; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber Christian, 2007, V19, P213, DOI 10.1007/4735_2007_0233; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shi XW, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1167299; Shi XW, 2016, PLANT PHYSIOL, V170, P294, DOI 10.1104/pp.15.01280; Shi XW, 2015, NUCLEIC ACIDS RES, V43, P3814, DOI 10.1093/nar/gkv245; Shikanai T, 2015, BBA-BIOENERGETICS, V1847, P779, DOI 10.1016/j.bbabio.2014.12.010; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tillich M, 2005, PLANT J, V43, P708, DOI 10.1111/j.1365-313X.2005.02484.x; Wang WQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140285; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2                                                   ; Withers J, 2012, P NATL ACAD SCI USA, V109, P20148, DOI 10.1073/pnas.1210054109; Woody ST, 2007, J PLANT RES, V120, P157, DOI 10.1007/s10265-006-0048-x; Yang Y, 2011, P NATL ACAD SCI USA, V108, P18530, DOI 10.1073/pnas.1106706108; Yohn CB, 1998, P NATL ACAD SCI USA, V95, P2238, DOI 10.1073/pnas.95.5.2238                                                          ; Zoschke R, 2011, ADVAN PL BIO, V1, P177	72	3	3	1	1	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	APR	2017	173	4					2278	2293		10.1104/pp.16.01623				16	Plant Sciences	Plant Sciences	EV8SS	WOS:000402054300025	28213559	gold			2018-01-05	
J	Larsen, J; Andersen, PS; Winstel, V; Peschel, A				Larsen, Jesper; Andersen, Paal S.; Winstel, Volker; Peschel, Andreas			Staphylococcus aureus CC395 harbours a novel composite staphylococcal cassette chromosome mec element	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							SEQUENCE; ST398; TOOL	Background: CoNS species are likely reservoirs of the staphylococcal cassette chromosome mec (SCCmec) in Staphylococcus aureus. S. aureus CC395 is unique as it is capable of exchanging DNA with CoNS via bacteriophages, which are also known to mediate transfer of SCCmec. Objectives: To analyse the structure and putative origin of the SCCmec element in S. aureus CC395. Methods: The only MRSA CC395 strain described in the literature, JS395, was subjected to WGS, and its SCCmec element was compared with those found in CoNS species and other S. aureus strains. Results: JS395 was found to carry an unusually large 88 kb composite SCCmec element. The 33 kb region downstream of orfX harboured a type V SCCmec element and a CRISPR locus, which was most similar to those found in the CoNS species Staphylococcus capitis and Staphylococcus schleiferi. A 55 kb SCC element was identified downstream of the type V SCCmec element and contained a mercury resistance region found in the composite SCC element of some Staphylococcus epidermidis and S. aureus strains, an integrated S. aureus plasmid containing genes for the detoxification of cadmium and arsenic, and a stretch of genes that was partially similar to the type IVg SCCmec element found in a bovine S. aureus strain. Conclusions: The size and complexity of the SCCmec element support the idea that CC395 is highly prone to DNA uptake from CoNS. Thus CC395 may serve as an entry point for SCCmec and SCC structures into S. aureus.	[Larsen, Jesper; Andersen, Paal S.] Statens Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark; [Winstel, Volker; Peschel, Andreas] Univ Tubingen, Infect Biol, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Winstel, Volker; Peschel, Andreas] Partner Site Tubingen, German Ctr Infect Res DZIF, Tubingen, Germany; [Winstel, Volker] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	Larsen, J (reprint author), Statens Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark.	jrl@ssi.dk			German Research Council [Transregio 34 (TRR34)]; German Center for Infection Research [Thematic Translation Unit (TTU) Healthcare-Associated and Antibiotic-Resistant Bacterial Infections (HAARBI)]	This work was supported by the German Research Council [Transregio 34 (TRR34)] and the German Center for Infection Research [Thematic Translation Unit (TTU) Healthcare-Associated and Antibiotic-Resistant Bacterial Infections (HAARBI)] to A. P.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chlebowicz MA, 2014, INT J MED MICROBIOL, V304, P764, DOI 10.1016/j.ijmm.2014.05.010; Francois P, 2008, EMERG INFECT DIS, V14, P304, DOI 10.3201/eid1402.070229; Francois P, 2007, J CLIN MICROBIOL, V45, P2011, DOI 10.1128/JCM.00232-07; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Golding GR, 2012, J BACTERIOL, V194, P6627, DOI 10.1128/JB.01680-12; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Kinnevey PM, 2013, ANTIMICROB AGENTS CH, V57, P524, DOI 10.1128/AAC.01689-12; Kwon NH, 2005, J ANTIMICROB CHEMOTH, V56, P624, DOI 10.1093/jac/dki306; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mongkolrattanothai K, 2004, ANTIMICROB AGENTS CH, V48, P1823, DOI 10.1128/AAC.48.5.1823-1836.2004; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Sasaki T., 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.01268-15, DOI 10.1128/GENOMEA.01268-15]; Scharn CR, 2013, ANTIMICROB AGENTS CH, V57, P5233, DOI 10.1128/AAC.01058-13; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Simoes PM, 2013, ANTIMICROB AGENTS CH, V57, P6354, DOI 10.1128/AAC.01576-13; Singh M, 2015, GENOME ANNOUNC, V3; Swift SM, 2014, GENOME ANNOUNC, V2, DOI DOI 10.1128/GENOMEA.00209-14; Winstel V, 2014, MBIO, V5, DOI 10.1128/mBio.00869-14; Winstel V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3345	23	1	1	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	APR	2017	72	4					1002	1005		10.1093/jac/dkw544				4	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	EV8YM	WOS:000402070800008	28088766	gold			2018-01-05	
J	Li, MW; Xin, DW; Gao, YS; Li, KP; Fan, KJ; Munoz, NB; Yung, WS; Lam, HM				Li, Man-Wah; Xin, Dawei; Gao, Yishu; Li, Kwan-Pok; Fan, Kejing; Munoz, Nacira Belen; Yung, Wai-Shing; Lam, Hon-Ming			Using genomic information to improve soybean adaptability to climate change	JOURNAL OF EXPERIMENTAL BOTANY			English	Review						Climate change; epigenomics; genome; genome editing; genome-wide selection; nutrient stress; proteomics; soybean; temperature stress; transcriptomics; water stress; whole-genome sequencing	SPECTROMETRY-BASED PROTEOMICS; STRESS TRANSCRIPTION FACTOR; QUANTITATIVE TRAIT LOCI; INDICATE SEVERE DAMAGES; HEAT-SHOCK-PROTEINS; US CROP YIELDS; GLYCINE-MAX L.; WIDE ANALYSIS; MASS-SPECTROMETRY; TARGET GENES	Climate change has brought severe challenges to agriculture. It is anticipated that there will be a drop in crop yield including that of soybean - due to climatic stress factors that include drastic fluctuations in temperature, drought, flooding and high salinity. Genomic information on soybean has been accumulating rapidly since initial publication of its reference genome, providing a valuable tool for the improvement of cultivated soybean. Not only are many molecular markers that are associated with important quantitative trait loci now identified, but we also have a more detailed picture of the genomic variations among soybean germplasms, enabling us to utilize these as tools to assist crop breeding. In this review, we will summarize and discuss the currently available soybean genomic approaches, including whole-genome sequencing, sequencing-based genotyping, functional genomics, proteomics, and epigenomics. The information uncovered through these techniques will help further pinpoint important gene candidates and genomic loci associated with adaptive traits, as well as achieving a better understanding of how soybeans cope with the changing climate.	[Li, Man-Wah; Xin, Dawei; Gao, Yishu; Li, Kwan-Pok; Fan, Kejing; Munoz, Nacira Belen; Yung, Wai-Shing; Lam, Hon-Ming] Chinese Univ Hong Kong, Ctr Soybean Res, Partner State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Li, Man-Wah; Xin, Dawei; Gao, Yishu; Li, Kwan-Pok; Fan, Kejing; Munoz, Nacira Belen; Yung, Wai-Shing; Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Xin, Dawei] Norytheast Agr Univ, Coll Sci, Chinese Agr Minist, Key Lab Soybean Biol,Chinese Minist Educ,Key Lab, Harbin, Heilongjiang Pr, Peoples R China; [Munoz, Nacira Belen] Ctr Invest Agr INTA, Inst Fisiol & Recursos Genet Vegetales, Cordoba, Argentina; [Munoz, Nacira Belen] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Catedra Fisiol Vegetal, Cordoba, Argentina	Lam, HM (reprint author), Chinese Univ Hong Kong, Ctr Soybean Res, Partner State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China.; Lam, HM (reprint author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk			Hong Kong Research Grants Council [14108014]	This work was supported by grants from the Hong Kong Research Grants Council (General Research Fund: 14108014) to HML. Ms Jee-Yan Chu copyedited the manuscript. We also thank Miss Fuk-Ling Wong and Mr Ming-Sin Ng for proofreading the manuscript.	Abdel-Haleem H, 2012, THEOR APPL GENET, V125, P837, DOI 10.1007/s00122-012-1876-9; Abdel-Haleem H, 2011, THEOR APPL GENET, V122, P935, DOI 10.1007/s00122-010-1500-9; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aghamirzaie D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2108-x; Ainsworth EA, 2006, PLANT PHYSIOL, V142, P135, DOI 10.1104/pp.106.086256; Arikit S, 2014, PLANT CELL, V26, P4584, DOI 10.1105/tpc.114.131847; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Bao Y, 2014, PLANT GENOME, V7, DOI [10.3835/plantgenome2013.3811.0039, DOI 10.3835/PLANTGENOME2013.3811.0039]; Bastien M, 2014, PLANT GENOME, V7, DOI [10.3835/plantgenome2013.3810.0030, DOI 10.3835/PLANTGENOME2013.3810.0030]; Borges F, 2015, NAT REV MOL CELL BIO, V16, P727, DOI 10.1038/nrm4085; Brazelton VA, 2015, QUICK GUIDE CRISPR S, V6, P266, DOI DOI 10.1080/21645698; Brevik E. C., 2013, Agriculture, V3, P398, DOI 10.3390/agriculture3030398; Burton AL, 2016, THEOR APPL GENET, V129, P1113, DOI 10.1007/s00122-016-2687-1; Cai YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136064; Chen KL, 2014, PLANT CELL REP, V33, P575, DOI 10.1007/s00299-013-1539-6; Chung WH, 2014, DNA RES, V21, P153, DOI 10.1093/dnares/dst047; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Dasgupta S, 2015, AMBIO, V44, P815, DOI 10.1007/s13280-015-0681-5; Dentener F, 2005, ATMOS CHEM PHYS, V5, P1731, DOI 10.5194/acp-5-1731-2005                                                         ; Donat MG, 2016, NAT CLIM CHANGE, V6, P508, DOI [10.1038/nclimate2941, 10.1038/NCLIMATE2941]; Dreger M, 2003, EUR J BIOCHEM, V270, P569, DOI 10.1046/j.1432-1033.2003.03439.x; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; Fragkostefanakis S, 2015, PLANT CELL ENVIRON, V38, P1881, DOI 10.1111/pce.12396; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Galant A, 2012, NEW PHYTOL, V194, P220, DOI 10.1111/j.1469-8137.2011.04037.x; Go YM, 2013, J BIOL CHEM, V288, P26512, DOI 10.1074/jbc.R113.464131; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guan RX, 2014, PLANT J, V80, P937, DOI 10.1111/tpj.12695; Guleria Praveen, 2011, Genomics, Proteomics & Bioinformatics, V9, P183, DOI 10.1016/S1672-0229(11)60022-3; Ha BK, 2013, EUPHYTICA, V193, P79, DOI 10.1007/s10681-013-0944-9; Havlik P, 2015, POLICY RES WORKING P, V1; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jarquin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-740; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Kim KD, 2015, PLANT PHYSIOL, V168, P1433, DOI 10.1104/pp.15.00408; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kinoshita T, 2014, PLANT CELL PHYSIOL, V55, P1859, DOI 10.1093/pcp/pcu125; Komatsu S, 2009, J PROTEOME RES, V8, P4487, DOI 10.1021/pr9002883; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larance M, 2015, NAT REV MOL CELL BIO, V16, P269, DOI 10.1038/nrm3970; Leakey ADB, 2009, P NATL ACAD SCI USA, V106, P3597, DOI 10.1073/pnas.0810955106; Leff B., 2004, GLOBAL BIOGEOCHEMICA, V18; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1009; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; Li YH, 2014, G3-GENES GENOM GENET, V4, P553, DOI 10.1534/g3.113.009589; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lin BL, 2001, CELL STRESS CHAPERON, V6, P201, DOI 10.1379/1466-1268(2001)006<0201:GAOTHS>2.0.CO;2; Long SP, 2010, CURR OPIN PLANT BIOL, V13, P241, DOI 10.1016/j.pbi.2010.04.008; Lopes-Caitar VS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-577; Luo QY, 2011, CLIMATIC CHANGE, V109, P583, DOI 10.1007/s10584-011-0028-6; LYNCH DH, 1993, PHYSIOL PLANTARUM, V88, P212, DOI 10.1034/j.1399-3054.1993.880202.x; Mall RK, 2004, AGR FOREST METEOROL, V121, P113, DOI 10.1016/S0168-1923(03)00157-6; Meerburg BG, 2009, P NATL ACAD SCI USA, V106, pE120, DOI 10.1073/pnas.0910618106; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mesquita RO, 2012, GENET MOL BIOL, V35, P353, DOI 10.1590/S1415-47572012000200017; Michno JM, 2015, GM CROPS FOOD, V6, P243, DOI 10.1080/21645698.2015.1106063; Mourtzinis S, 2015, NAT PLANTS, V1, P1, DOI [10.1038/nplants.2014.26, 10.1038/NPLANTS.2014.26]; Muis S, 2015, SCI TOTAL ENVIRON, V538, P445, DOI [10.1016/j.scitotenv.2015.08.068, 10.1016/j.scitonv.2015.08.068]; Mustafa G, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00627; Nakaya A, 2012, ANN BOT-LONDON, V110, P1303, DOI 10.1093/aob/mcs109; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Nouri MZ, 2010, PROTEOMICS, V10, P1930, DOI 10.1002/pmic.200900632; Ohnishi S, 2011, THEOR APPL GENET, V122, P633, DOI 10.1007/s00122-010-1475-6; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Osakabe Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26685; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Patil G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19199; Pi EX, 2016, MOL CELL PROTEOMICS, V15, P266, DOI 10.1074/mcp.M115.051961; Qi XP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5340; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Qiu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108479; Rahmani H, 2009, WORLD J MICROB BIOT, V25, P591, DOI 10.1007/s11274-008-9927-8; Reyes-Fox M, 2014, NATURE, V510, P259, DOI 10.1038/nature13207; Rodrigues EP, 2012, GENET MOL BIOL, V35, P348, DOI 10.1590/S1415-47572012000200016; Sarkar NK, 2013, CELL STRESS CHAPERON, V18, P427, DOI 10.1007/s12192-012-0395-6; Sarkar NK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-393; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Shimomura M., 2015, INT J GENOMICS, V2015; Shu YJ, 2013, GENET MOL RES, V12, P2178, DOI 10.4238/2013.July.3.2; Song QJ, 2015, G3-GENES GENOM GENET, V5, P1999, DOI 10.1534/g3.115.019000; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Song QX, 2013, MOL PLANT, V6, P1961, DOI 10.1093/mp/sst123; Song XF, 2015, G3-GENES GENOM GENET, V5, P2793, DOI 10.1534/g3.115.022780; Song YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041274; Stepinski D, 2012, PLANT PHYSIOL BIOCH, V61, P9, DOI 10.1016/j.plaphy.2012.09.001; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Sun ZX, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01273; Thibaud-Nissen F.S.A., 2013, NCBI HDB; Tricker PJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00699; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; TYAGI SK, 1983, PLANT SOIL, V74, P273, DOI 10.1007/BF02143617                                                              ; Vadivel AKA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00369; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Waters ER, 2008, CELL STRESS CHAPERON, V13, P127, DOI 10.1007/s12192-008-0023-7; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069810; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110; Xu YG, 2014, DATABASE-OXFORD, DOI [10.1093/database/bau1019, DOI 10.1093/DATABASE/BAU1019]; Xu YG, 2014, BIOINFORMATICS, V30, P94, DOI 10.1093/bioinformatics/btt605; Zaffagnini M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00450; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhang D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00372; Zhang J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-532; Zhang L, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.00773, 10.3339/fpls.2015.00773]; Zhang SL, 2014, INT J MOL SCI, V15, P13596, DOI 10.3390/ijms150813596; Zhang WB, 2012, CAN J PLANT SCI, V92, P1381, DOI 10.4141/CJPS2011-098; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	123	1	1	22	22	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	APR 1	2017	68	8			SI		1823	1834		10.1093/jxb/erw348				12	Plant Sciences	Plant Sciences	EV8UG	WOS:000402059000003	27660480	gold			2018-01-05	
J	Chen, KY; Srinivasan, T; Tung, KL; Belmonte, JM; Wang, LH; Murthy, PKL; Choi, J; Rakhilin, N; King, S; Varanko, AK; Witherspoon, M; Nishimura, N; Glazier, JA; Lipkin, SM; Bu, PC; Shen, XL				Chen, Kai-Yuan; Srinivasan, Tara; Tung, Kuei-Ling; Belmonte, Julio M.; Wang, Lihua; Murthy, Preetish Kadur Lakshminarasimha; Choi, Jiahn; Rakhilin, Nikolai; King, Sarah; Varanko, Anastasia Kristine; Witherspoon, Mavee; Nishimura, Nozomi; Glazier, James A.; Lipkin, Steven M.; Bu, Pengcheng; Shen, Xiling			A Notch positive feedback in the intestinal stem cell niche is essential for stem cell self-renewal	MOLECULAR SYSTEMS BIOLOGY			English	Article						gene editing; intestine stem cell; Notch signaling; organoid; positive feedback	LINEAGE COMMITMENT; LATERAL INHIBITION; PROGENITOR CELLS; IN-VITRO; DIFFERENTIATION; ROBUSTNESS; ACTIVATION; CRYPT; LGR5; INTERCONVERSION	The intestinal epithelium is the fastest regenerative tissue in the body, fueled by fast-cycling stem cells. The number and identity of these dividing and migrating stem cells are maintained by a mosaic pattern at the base of the crypt. How the underlying regulatory scheme manages this dynamic stem cell niche is not entirely clear. We stimulated intestinal organoids with Notch ligands and inhibitors and discovered that intestinal stem cells employ a positive feedback mechanism via direct Notch binding to the second intron of the Notch1 gene. Inactivation of the positive feedback by CRISPR/Cas9 mutation of the binding sequence alters the mosaic stem cell niche pattern and hinders regeneration in organoids. Dynamical system analysis and agent-based multiscale stochastic modeling suggest that the positive feedback enhances the robustness of Notch-mediated niche patterning. This study highlights the importance of feedback mechanisms in spatiotemporal control of the stem cell niche.	[Chen, Kai-Yuan; Rakhilin, Nikolai; Shen, Xiling] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA; [Chen, Kai-Yuan; Wang, Lihua; Choi, Jiahn; Rakhilin, Nikolai; Bu, Pengcheng; Shen, Xiling] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Srinivasan, Tara; King, Sarah; Nishimura, Nozomi; Shen, Xiling] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Tung, Kuei-Ling; Wang, Lihua; Varanko, Anastasia Kristine] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Belmonte, Julio M.; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN USA; [Belmonte, Julio M.; Glazier, James A.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Murthy, Preetish Kadur Lakshminarasimha; Witherspoon, Mavee] Cornell Univ, Sch Mech Aerosp Engn, Ithaca, NY USA; [Lipkin, Steven M.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Lipkin, Steven M.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Lipkin, Steven M.] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Bu, Pengcheng] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Key Lab Prot & Peptide Pharmaceut, Beijing, Peoples R China	Shen, XL (reprint author), Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA.; Bu, PC; Shen, XL (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.; Shen, XL (reprint author), Cornell Univ, Dept Biomed Engn, Ithaca, NY USA.; Bu, PC (reprint author), Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Key Lab Prot & Peptide Pharmaceut, Beijing, Peoples R China.	bupc@ibp.ac.cn; xs37@duke.edu		Belmonte, Julio/0000-0002-4315-9631; Chen, Kai-Yuan/0000-0002-9247-8428	DOD (DARPA) [HR0011-16-C-0138]; NIH [R01GM95990, R01GM114254]; NSF [1350659, 1137269]; NYSTEM [C029543]; CAS Pioneer Hundred Talents Program; Thousand Young Talents Program of China	We thank Dr. Spyros Artavanis-Tsakonas for providing the Notch transgenic mice and the Cornell imaging facility. This work was supported by DOD (DARPA): HR0011-16-C-0138, NIH R01GM95990, NIH R01GM114254, NSF 1350659 career award, NSF 1137269, NYSTEM C029543, and CAS Pioneer Hundred Talents Program, the Thousand Young Talents Program of China.	Alon U, 1999, NATURE, V397, P168; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199                                                                   ; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025785; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lander AD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-19; Lefort N, 2006, EXP HEMATOL, V34, P1720, DOI 10.1016/j.exphem.2006.08.007; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Mahapatro M, 2016, CELL REP, V15, P1743, DOI 10.1016/j.celrep.2016.04.049; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Oh P, 2013, CELL STEM CELL, V13, P190, DOI 10.1016/j.stem.2013.05.015; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000                                                 ; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sato T, 2011, YGAST, V141, P1762, DOI DOI 10.1053/J.GASTR0.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0                                                                ; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shen XL, 2008, P NATL ACAD SCI USA, V105, P11340, DOI 10.1073/pnas.0805258105; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sprinzak D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002069; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Srinivasan T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26069; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xu DH, 2012, BIOCHEM BIOPH RES CO, V428, P518, DOI 10.1016/j.bbrc.2012.10.071; Yamamura H, 2014, AM J PHYSIOL-CELL PH, V306, pC871, DOI 10.1152/ajpcell.00221.2013; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	56	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-4292			MOL SYST BIOL	Mol. Syst. Biol.	APR	2017	13	4							927	10.15252/msb.20167324				16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EV7KN	WOS:000401954400003	28455349				2018-01-05	
J	Goncalves, IR; Dantas, RCC; Ferreira, ML; Batistao, DWD; Gontijo, PP; Ribas, RM				Goncalves, Iara Rossi; Caualcanti Dantas, Raquel Cristina; Ferreira, Melina Lorraine; da Fonseca Batistao, Deivid William; Gontijo-Filho, Paulo Pinto; Ribas, Rosineide Marques			Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Pseudomonas aeruginosa; Resistance; Metallo-beta-lactamases; Virulence; Biofilm	METALLO-BETA-LACTAMASE; ANTIMICROBIAL THERAPY; CYSTIC-FIBROSIS; RISK-FACTORS; MORTALITY; IMPACT; BACTEREMIA; INFECTION; DISSEMINATION; SURVEILLANCE	Pseudomonas aeruginosa is an opportunistic pathogen that causes frequently nosocomial infections, currently becoming more difficult to treat due to the various resistance mechanisms and different virulence factors. The purpose of this study was to determine the risk factors independently associated with the development of bacteremia by carbapenem-resistant P. aeruginosa, the frequency of virulence genes in metallo-beta-lactamases producers and to evaluate their ability to produce biofilm. We conducted a case-control study in the Uberlandia Federal University- Hospital Clinic, Brazil. Polymerase Chain Reaction was performed for metallo-beta-lactamases and virulence genes. Adhesion and biofilm assays were done by quantitative tests. Among the 157 strains analyzed, 73.9% were multidrug-resistant, 43.9% were resistant to carbapenems, 16.1% were phenotypically positive for metallo-beta-lactamases, and of these, 10.7% were positive for blaspM gene and 5.3% positive for blavim. The multivariable analysis showed that mechanical ventilation, enteral/nasogastric tubes, primary bacteremia with unknown focus, and inappropriate therapy were independent risk factors associated with bacteremia. All tested strains were characterized as strongly biofilm producers. A higher mortality was found among patients with bacteremia by carbapenem-resistant P. aeruginosa strains, associated independently with extrinsic risk factors, however it was not evident the association with the presence of virulence and metallo-beta-lactamases genes. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Goncalves, Iara Rossi; Caualcanti Dantas, Raquel Cristina; Ferreira, Melina Lorraine; da Fonseca Batistao, Deivid William; Gontijo-Filho, Paulo Pinto; Ribas, Rosineide Marques] Univ Fed Uberlandia, Inst Ciencias Biomed, Lab Microbiol, Uberlandia, MG, Brazil	Goncalves, IR (reprint author), Univ Fed Uberlandia, Para Ave,1720 Umuarama, Uberlandia, MG, Brazil.	iara_rossi@hotmail.com			FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)	The autors would like to thank the financial support by FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais).	Ahmed Shaaban H, 2009, BMC Res Notes, V2, P76, DOI 10.1186/1756-0500-2-76; Arakawa Y, 2000, J CLIN MICROBIOL, V38, P40; Cassat James E, 2014, Methods Mol Biol, V1085, P195, DOI 10.1007/978-1-62703-664-1_12; Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P1; Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007; Clinical and Laboratory Standard Institute, 2009, M100S19 CLIN LAB STA; Clinical and Laboratory Standard Institute, 2010, M100S20 CLIN LAB STA; Clinical and Laboratory Standard Institute, 2011, M100S21 CLIN LAB STA; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318                                                   ; Cavalcanti FLD, 2012, MEM I OSWALDO CRUZ, V107, P420, DOI 10.1590/S0074-02762012000300019; El Salabi A, 2012, ANTIMICROB AGENTS CH, V56, P2241, DOI 10.1128/AAC.05640-11; Fernandes TA, 2010, REV SOC BRAS MED TRO, V43, P372, DOI 10.1590/S0037-86822010000400007; Gales AC, 2003, J ANTIMICROB CHEMOTH, V52, P699, DOI 10.1093/jac/dkg416; Gilbert DN, 2007, SANFORD GUIDE ANTIMI; Franco MRG, 2010, CLINICS, V65, P825, DOI 10.1590/S1807-59322010000900002; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI 10.1586/ERP.10.49; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924; Jamal MA, 2014, ANTIMICROB AGENTS CH; Joo EJ, 2011, INFECTION, V39, P309, DOI 10.1007/s15010-011-0124-6; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; Baumgart AMK, 2010, BRAZ J INFECT DIS, V14, P433, DOI 10.1590/S1413-86702010000500002; Kiffer Carlos, 2005, Braz J Infect Dis, V9, P216, DOI 10.1590/S1413-86702005000300004; Kim YJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-161; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Lanotte P, 2004, J MED MICROBIOL, V53, P73, DOI 10.1099/jmm.0.05324-0; Lee K, 2001, CLIN MICROBIOL INFEC, V7, P88, DOI 10.1046/j.1469-0691.2001.00204.x                                                ; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Manoharan A, 2010, INDIAN J MED MICROBI, V28, P241, DOI 10.4103/0255-0857.66486; Mendes RE, 2006, ARCH PATHOL LAB MED, V42, P103; Morales E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-122; Morata L, 2012, ANTIMICROB AGENTS CH, V56, P4833, DOI 10.1128/AAC.00750-12; Moreira MR, 2013, REV SOC BRAS MED TRO, V46, P39, DOI 10.1590/0037-868216722013; Perez LRR, 2012, EUR J CLIN MICROBIOL, V31, P711, DOI 10.1007/s10096-011-1363-2; Poirel L, 2009, ANTIMICROB AGENTS CH, V53, P2492, DOI 10.1128/AAC.00033-09; Porto JP, 2013, REV SOC BRAS MED TRO, V46, P713, DOI 10.1590/0037-8682-0199-2013; Rodrigues E, 2008, IRAS INFECCAO RELACI; Sader HS, 2005, INT J ANTIMICROB AG, V25, P57, DOI 10.1016/j.ijantimicag.2004.08.013; Sekiguchi J, 2008, ANTIMICROB AGENTS CH, V52, P4194, DOI 10.1128/AAC.01337-07; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Antunes ALS, 2011, MEM I OSWALDO CRUZ, V106, P51, DOI 10.1590/S0074-02762011000100008; Todar K., 2004, PSEUDOMONAS AERUGINO; Woodford N, 2010, METHODS MOL BIOL, V642, P181, DOI 10.1007/978-1-60327-279-7_14; Xavier DE, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-217; Yong D, 2007, 47 ANN INT C ANT AG; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zavascki AP, 2005, J ANTIMICROB CHEMOTH, V56, P1148, DOI 10.1093/jac/dki390	48	1	1	10	10	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	APR-JUN	2017	48	2					211	217		10.1016/j.bjm.2016.11.004				7	Microbiology	Microbiology	EV0TC	WOS:000401456800008	28034598	gold			2018-01-05	
J	Yuan, XY; Yan, JJ; Yang, YC; Wu, CM; Hu, Y; Geng, JL				Yuan, Xiao-yan; Yan, Jin-Jun; Yang, Ya-chao; Wu, Chun-mei; Hu, Yan; Geng, Jian-li			Helicobacter pylori with East Asian-type cagPAI genes is more virulent than strains with Western-type in some cagPAI genes	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Helicobacter pylori; cagPAI; Virulence; IL-8	PATHOGENICITY ISLAND; GASTRIC-CANCER; IV SECRETION; CAGA; EXPRESSION; SEQUENCE; REGION; SYSTEM; RISK	The severity of Helicobacter pylori-related disease is correlated with the presence and integrity of a cag pathogenicity island (cagPAI). cagPAI genotype may have a modifying effect on the pathogenic potential of the infecting strain. After analyzing the sequences of cagPAI genes, some strains with the East Asian-type cagPAI genes were selected for further analysis to examine the association between the diversity of the cagPAI genes and the virulence of H. pylori. The results showed that gastric mucosal inflammatory cell infiltration was significantly higher in patients with East Asian-type cagPAI genes H. pylori strain compared with mosaicism cagPAI genes H. pylori strain (p < 0.05). H. pylon strains with the East Asian-type cagPAI genes were closely associated with IL-8 secretion in vitro and in vivo compared with H. pylori strains with the mosaicism cagPAI genes (p <0.01). H. pylori strains with East Asian type cagPAI genes are able to strongly translocate CagA to host cells. These results suggest that H. pylori strains with East Asian-type cagPAI genes are more virulent than the strains of cagPAI gene/genes that are Western type. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Yuan, Xiao-yan; Yan, Jin-Jun; Yang, Ya-chao; Wu, Chun-mei; Hu, Yan; Geng, Jian-li] Dalian Med Univ, Dept Clin Lab, Weihai Municipal Hosp, Weihai, Shandong, Peoples R China	Geng, JL (reprint author), Dalian Med Univ, Dept Clin Lab, Weihai Municipal Hosp, Weihai, Shandong, Peoples R China.	gengjianli1962@outlook.com			Shandong Provincial Natural Science Foundation, China [ZR2015HM072]; Jiangsu Key Laboratory of Medical Science and Laboratory Medicine [JSKLM-2014-014]	This work was supported by Shandong Provincial Natural Science Foundation, China (No. ZR2015HM072) and Jiangsu Key Laboratory of Medical Science and Laboratory Medicine (No. JSKLM-2014-014).	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Bustamante-Rengifo JA, 2013, WORLD J GASTROENTERO, V19, P6044, DOI 10.3748/wjg.v19.i36.6044; Sanchez-Zauco NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064623; Azuma T, 2004, J CLIN MICROBIOL, V42, P2508, DOI 10.1128/JCM.42.6.2508-2517.2004; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; [高孝忠 GAO Xiao-zhong], 2009, [中华消化杂志, Chinese Journal of Digestion], V29, P289; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Krebes J, 2014, INT J MED MICROBIOL, V304, P1135, DOI 10.1016/j.ijmm.2014.08.007; Kumar S, 2009, BIOCHEM BIOPH RES CO, V387, P456, DOI 10.1016/j.bbrc.2009.07.033; Matos JI, 2013, EUR J GASTROEN HEPAT, V25, P1431, DOI 10.1097/MEG.0b013e328364b53e; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Nguyen LT, 2010, EUR J CLIN MICROBIOL, V29, P651, DOI 10.1007/s10096-010-0909-z; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Vannini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098416; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang MY, 2015, J CARDIOVASC MED, V16, pS138, DOI 10.2459/JCM.0b013e328356a471; Wang MY, 2013, MICROB PATHOGENESIS, V59-60, P13, DOI 10.1016/j.micpath.2013.04.001; XIANG ZY, 1995, INFECT IMMUN, V63, P94	24	0	1	2	2	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	APR-JUN	2017	48	2					218	224		10.1016/j.bjm.2016.12.004				7	Microbiology	Microbiology	EV0TC	WOS:000401456800009	28130020	gold			2018-01-05	
J	Yu, Y; Chang, D; Xu, HW; Zhang, XL; Pan, L; Xu, C; Huang, B; Zhou, H; Li, J; Guo, J; Liu, CT				Yu, Yi; Chang, De; Xu, Huiwen; Zhang, Xuelin; Pan, Lei; Xu, Chou; Huang, Bing; Zhou, Hong; Li, Jia; Guo, Jun; Liu, Changting			The virulence of Streptococcus pneumoniae partially depends on dprA	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Streptococcus pneumoniae; DprA; Transformation; Virulence	PNEUMOCOCCAL SURFACE PROTEIN; ESCHERICHIA-COLI; GENE-EXPRESSION; TRANSFORMATION; COMPETENCE; RECA; BINDING; RECOMBINATION; PROTECTION; INDUCTION	Streptococcus pneumoniae is one of the most frequent opportunistic pathogens worldwide. DNA processing protein A (DprA) is an important factor involved in bacterial uptake and DNA integration into bacterial genome, but its role in S. pneumoniae virulence remains unclear. The aim of this study was to characterize the effects of the pneumococcal dprA gene on the pathogenesis of S. pneumoniae. To construct a dprA-deficient pneumococcal strain, the dprA gene of the S. pneumoniae strain D39 was inactivated. The virulence of this dprA-deficient strain, designated AD39, was compared with that of the wild-type strain by evaluating their respective capabilities to adhere to human pulmonary epithelial cells (PEC-A549) and by analyzing their choline-binding protein expression levels. In addition, the expression profiles of genes associated with virulence and host survival assays were also conducted with the mutant and the wild-type strain. Our results indicate that the capability of AD39 to adhere to the PEC-A549 airway cells was significantly lower (p < 0.01) compared with D39. Additionally, the 100-KD choline-binding protein was not detected in AD39. The addition of competence-stimulating peptide (CSP) lead to a significantly reduction of psaA mRNA expression in the dprA-deficient mutant and an increased level of psaA transcripts in the wild-type strain (p < 0.01). The median survival time of mice intraperitoneally infected with AD39 was significantly higher (p < 0.01) than that of mice infected with D39. The results of this study suggest that DprA has a significant effect on virulence characteristics of S. pneumoniae by influencing the expression of choline-binding protein and PsaA. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Yu, Yi; Chang, De; Zhang, Xuelin; Pan, Lei; Xu, Chou; Huang, Bing; Zhou, Hong; Li, Jia; Guo, Jun; Liu, Changting] Chinese Peoples Liberat Army Gen Hosp, Nanlou Resp Dis Dept, 28 Fuxing Rd, Beijing 100853, Peoples R China; [Chang, De] Gen Hosp Chinese Peoples Armed Police Forces, Dept Resp Med, Beijing, Peoples R China; [Xu, Huiwen] Natl Inst Food & Drug Control, Inst Med Device Standardizat Adm, Beijing, Peoples R China	Liu, CT (reprint author), Chinese Peoples Liberat Army Gen Hosp, Nanlou Resp Dis Dept, 28 Fuxing Rd, Beijing 100853, Peoples R China.	liuchangt@foxmail.com			National Basic Research Program of China (973 Program) [2014CB744400]; National Major Scientific and Technological Special Project for "Significant New Drugs Development" [2015ZX09J15102-003]; National Natural Science Foundation of China [81402471]; Basic Research Program of General Hospital of Chinese People's Armed Police Forces [WZ2014026]	This work was supported by the National Basic Research Program of China (973 Program, No. 2014CB744400), National Major Scientific and Technological Special Project for "Significant New Drugs Development" (grant no. 2015ZX09J15102-003), National Natural Science Foundation of China (grant no. 81402471) and Basic Research Program of General Hospital of Chinese People's Armed Police Forces (grant no. WZ2014026).	Arunasri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057860; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x; Berge M, 2003, MOL MICROBIOL, V50, P527, DOI 10.1046/j.1365-2958.2003.03702.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Engelmoer DJP, 2011, EVOLUTION, V65, P3475, DOI 10.1111/j.1558-5646.2011.01402.x; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x                                              ; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Holmes A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00286; Kausmally L, 2005, J BACTERIOL, V187, P4338, DOI 10.1128/JB.187.13.4338-4345.2005; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin JJ, 2016, CURR GENET, V62, P97, DOI 10.1007/s00294-015-0520-z; Lisboa J, 2014, NUCLEIC ACIDS RES, V42, P7395, DOI 10.1093/nar/gku349; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michod RE, 2008, INFECT GENET EVOL, V8, P267, DOI 10.1016/j.meegid.2008.01.002; Mortier-Barriere I, 1998, MOL MICROBIOL, V27, P159, DOI 10.1046/j.1365-2958.1998.00668.x                                                ; Polissi A, 1998, INFECT IMMUN, V66, P5620; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Siemieniuk RAC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-314; Weng LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064197; Yadav T, 2014, J BIOL CHEM, V289, P27640, DOI 10.1074/jbc.M114.577924; Zhang XM, 2005, J MICROBIOL, V43, P337; Zhu LC, 2013, EXPERT REV ANTI-INFE, V11, P227, DOI [10.1586/ERI.13.10, 10.1586/eri.13.10]	25	0	0	2	2	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	APR-JUN	2017	48	2					225	231		10.1016/j.bjm.2016.10.019				7	Microbiology	Microbiology	EV0TC	WOS:000401456800010	28011228	gold			2018-01-05	
J	Zuma, AVP; Lima, DF; Assef, APDC; Marques, EA; Leao, RS				Pedinotti Zuma, Alexandra Vidal; Lima, Danielle Ferreira; D'Alincourt Carualho Assef, Ana Paula; Marques, Elizabeth Andrade; Leao, Robson Souza			Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from blood in Rio de Janeiro displaying susceptibility profiles to non-beta-lactam antibiotics	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						MRSA; MLST; USA800; USA400; USA1100	PANTON-VALENTINE LEUKOCIDIN; SCCMEC TYPES-I; TRIMETHOPRIM-SULFAMETHOXAZOLE; GENE CARRIAGE; 1ST REPORT; CA-MRSA; BRAZIL; INFECTIONS; LEUCOCIDIN; BACTEREMIA	The distinction between healthcare-associated MRSA (HA-MRSA) and community associated MRSA (CA-MRSA) infections has become increasingly blurred. We assessed the molecular characterization and antimicrobial resistance profile for MRSA isolates from blood. Most of all (81.9%) isolates are related to known HA-MRSA and CA-MRSA epidemic lineages, such as, USA300, USA400, USA600, USA800 and USA1100. This is the first multicenter study in Rio de Janeiro. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Pedinotti Zuma, Alexandra Vidal; Lima, Danielle Ferreira; Marques, Elizabeth Andrade; Leao, Robson Souza] Univ Estado Rio de Janeiro, Dept Microbiol Imunol & Parasitol, Rio De Janeiro, RJ, Brazil; [D'Alincourt Carualho Assef, Ana Paula] Inst Oswaldo Cruz, Lab Pesquisa Infeccao Hosp LAPIH, Rio De Janeiro, RJ, Brazil	Leao, RS (reprint author), Univ Estado Rio de Janeiro, Fac Ciencias Med, Disciplina Microbiol & Imunol, Ave 28 Setembro,87-3 Andar, BR-20551030 Rio De Janeiro, RJ, Brazil.	robson.leao@uerj.br		Leao, Robson/0000-0003-0636-1520	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	We thank the personnel at the microbiology laboratories of the participant hospitals for their generous collaboration in sending us the MRSA blood isolates. This work was supported by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro.	Al-Talib H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-113; Andrade-Figueiredo M, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0733-4; Becker AP, 2012, EPIDEMIOL INFECT, V140, P1372, DOI 10.1017/S095026881100210X; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Brauner J, 2013, EUR J CLIN MICROBIOL, V46, P344; Caiaffa HH, 2013, DIAGN MICR INFEC DIS, V76, P518, DOI 10.1016/j.diagmicrobio.2013.04.024; Cavalcante FS, 2014, BMC RES NOTES, V25, P759; Clinical and Laboratory Standards Institute, 2015, M100S25 CLIN LAB STA; Damasco PV, 2013, INFECTION, V41, P851, DOI 10.1007/s15010-013-0430-2; Demir T, 2012, J ANTIMICROB CHEMOTH, V67, P837, DOI 10.1093/jac/dkr568; Dhand A, 2012, F1000 MED REP, V4, P1; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008; Evangelista Síntia de Souza, 2015, Rev. Bras. Enferm., V68, P136, DOI 10.1590/0034-7167.2015680119p; Caboclo RMF, 2013, AM J INFECT CONTROL, V41, pE21, DOI 10.1016/j.ajic.2012.08.008; Filleron A, 2011, J CYST FIBROS, V10, P377, DOI 10.1016/j.jcf.2011.05.001; Frei CR, 2010, J AM BOARD FAM MED, V23, P714, DOI 10.3122/jabfm.2010.06.090270; Gelatti LC, 2013, REV SOC BRAS MED TRO, V46, P34, DOI 10.1590/0037-868213022013; Lima DF, 2014, DIAGN MICR INFEC DIS, V78, P59, DOI 10.1016/j.diagmicrobio.2013.10.004; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Pardo L, 2013, J INFECT DEV COUNTR, V7, P10, DOI 10.3855/jidc.2261; Ramundo MS, 2016, INT J MED MICROBIOL; Ribeiro A, 2007, DIAGN MICR INFEC DIS, V59, P339, DOI 10.1016/j.diagmicrobio.2007.05.007; Rossi F, 2014, NEW ENGL J MED, V370, P1524, DOI 10.1056/NEJMoa1303359; Rozenbaum R, 2006, INFECT CONT HOSP EP, V27, P1041, DOI 10.1086/507921; Rozenbaum R, 2009, BRAZ J MED BIOL RES, V42, P756, DOI 10.1590/S0100-879X2009005000007; Schuenck RP, 2009, DIAGN MICR INFEC DIS, V64, P434, DOI 10.1016/j.diagmicrobio.2009.04.007; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Teixeira MM, 2012, BRAZ J MED BIOL RES, V45, P637, DOI 10.1590/S0100-879X2012007500065; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	30	0	0	0	0	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	APR-JUN	2017	48	2					237	241		10.1016/j.bjm.2016.09.016				5	Microbiology	Microbiology	EV0TC	WOS:000401456800012	28108350	gold			2018-01-05	
J	Eissazadeh, S; Moeini, H; Dezfouli, MG; Heidary, S; Nelofer, R; Abdullah, MP				Eissazadeh, Samira; Moeini, Hassan; Dezfouli, Maryam Ghandizadeh; Heidary, Somayyeh; Nelofer, Rubina; Abdullah, Mohd Puad			Production of recombinant human epidermal growth factor in Pichia pastoris	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Pichia pastoris; Human epidermal growth factor; Artificial neural network	HIGH-LEVEL SECRETION; PROTEIN EXPRESSION; SURFACE-ANTIGEN; YEAST; GENE; HEGF	This study was carried out to express human epidermal growth factor (hEGF) in Pichia pastoris GS115. For this aim, the hEGF gene was cloned into the pPIC9K expression vector, and then integrated into P. pastoris by electroporation. ELISA-based assay showed that the amount of hEGF secreted into the medium can be affected by the fermentation conditions especially by culture medium, pH and temperature. The best medium for the optimal hEGF production was BMMY buffered at a pH range of 6.0 and 7.0. The highest amount of hEGF with an average yield of 2.27iig/mL was obtained through an induction of the culture with 0.5% (v/v) methanol for 60 h. The artificial neural network (ANN) analysis revealed that changes in both pH and temperature significantly affected the hEGF production with the pH change had slightly higher impact on hEGF production than variations in the temperature. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Eissazadeh, Samira; Heidary, Somayyeh; Abdullah, Mohd Puad] Univ Putra Malaysia, Fac Biotechnol & Mol Sci, Dept Cellular & Mol Biol, Serdang, Malaysia; [Moeini, Hassan] Univ Putra Malaysia, Inst Biosci, Serdang 43400, Malaysia; [Dezfouli, Maryam Ghandizadeh] Arak Univ, Fac Sci, Dept Biol, Arak, Markazi Provinc, Iran; [Nelofer, Rubina] Pakistan Council Sci & Ind Res, Labs Complex, Lahore, Pakistan	Moeini, H (reprint author), Univ Putra Malaysia, Inst Biosci, Serdang 43400, Malaysia.	moeini82@yahoo.com			faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Malaysia	This work was supported by the faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Malaysia.	Barr K A, 1992, PHARM ENG, V12, P48; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1016/S0168-6445(99)00029-7; CLARE JJ, 1991, GENE, V105, P205, DOI 10.1016/0378-1119(91)90152-2; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687                                                                 ; Ebisu S, 1996, ANN NY ACAD SCI, V782, P115, DOI 10.1111/j.1749-6632.1996.tb40553.x; ELLIS SB, 1985, MOL CELL BIOL, V5, P1111, DOI 10.1128/MCB.5.5.1111                                                            ; Fullbrook PD, 1996, IND ENZYMOLOGY; Gou XH, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-14; Hong F, 2002, BIOTECHNOL BIOENG, V79, P438, DOI 10.1002/bit.10297; Jahic M, 2003, MICROB CELL FACT, P2; Katakura Y, 1998, J FERMENT BIOENG, V86, P482, DOI 10.1016/S0922-338X(98)80156-6; Linder S, 1996, BIOTECHNIQUES, V20, P980; Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6; Ptitsyn LR, 1999, BIOORG KHIM+, V25, P923; Abdull Razis AF, 2006, ASIA PAC J MOL BIOL, V14, P41; ROMANOS M, 1995, CURR OPIN BIOTECH, V6, P527, DOI 10.1016/0958-1669(95)80087-5; Sarramegna V, 2002, PROTEIN EXPRES PURIF, V24, P212, DOI 10.1006/prep.2001.1564; SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407; Scorer CA, 1994, NAT BIOTECHNOL, V12, P181; Thiruvengadam G, 2011, TROP BIOMED, V28, P506; Topczewska Jolanta, 1993, Acta Biochimica Polonica, V40, P4; TSCHOPP JF, 1987, NUCLEIC ACIDS RES, V15, P3859, DOI 10.1093/nar/15.9.3859                                                           ; Vassileva A, 2001, PROTEIN EXPRES PURIF, V21, P71, DOI 10.1006/prep.2000.1335; VEDVICK T, 1991, J IND MICROBIOL, V7, P197, DOI 10.1007/BF01575883; Wang C, 1972, APPL PHYS LETT, V21, P209; WHITE CE, 1994, STRUCTURE, V2, P1003, DOI 10.1016/S0969-2126(94)00103-0; Yu W, 2006, AFR J BIOTECHNOL, P5; Zhang WC, 2000, PROCEEDINGS OF THE INTERNATIONAL AGRICULTURAL ENGINEERING CONFERENCE, P1	31	1	1	6	10	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	APR-JUN	2017	48	2					286	293		10.1016/j.bjm.2016.10.017				8	Microbiology	Microbiology	EV0TC	WOS:000401456800019	27998673	gold			2018-01-05	
J	Chauhan, A; Guleria, S; Balgir, PP; Walia, A; Mahajan, R; Mehta, P; Shirkot, CK				Chauhan, Anjali; Guleria, Shiwani; Balgir, Praveen P.; Walia, Abhishek; Mahajan, Rishi; Mehta, Preeti; Shirkot, Chand Karan			Tricalcium phosphate solubilization and nitrogen fixation by newly isolated Aneurinibacillus aneurinilyticus CKMV1 from rhizosphere of Valeriana jatamansi and its growth promotional effect	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Valeriana jatamansi; Phosphate solubilization; Nitrogen fixation; Glucose dehydrogenase; Aneurinibacillus aneurinilyticus; PGPR	TRANS HIMALAYAN REGION; PLANT-GROWTH; HIMACHAL-PRADESH; NIFH GENE; BACTERIA; SOIL; RHIZOBACTERIA; DIVERSITY; MICROORGANISMS; ROOTS	Aneurinibacillus aneurinilyticus strain CKMV1 was isolated from rhizosphere of Valeriana jatamansi and possessed multiple plant growth promoting traits like production of phosphate solubilization (260 mg/L), nitrogen fixation (202.91 nmol ethylene mL(-1) h(-1)), indole-3-acetic acid (IAA) (8.1 mu g/mL), siderophores (61.60%), HCN (hydrogen cyanide) production and antifungal activity. We investigated the ability of isolate CKMV1 to solubilize insoluble P via mechanism of organic acid production. High-performance liquid chromatography (HPLC) study showed that isolate CKMV1 produced mainly gluconic (1.34%) and oxalic acids. However, genetic evidences for nitrogen fixation and phosphate solubilization by organic acid production have been reported first time for A. aneurinilyticus strain CKMV1. A unique combination of glucose dehydrogenase (gdh) gene and pyrroloquinoline quinone synthase (pqq) gene, a cofactor of gdh involved in phosphate solubilization has been elucidated. Nitrogenase (nif H) gene for nitrogen fixation was reported from A. aneurinilyticus. It was notable that isolate CKMV1 exhibited highest antifungal against Sclerotium rolfsii (93.58%) followed by Fusarium oxysporum (64.3%), Dematophora necatrix (52.71%), Rhizoctonia solani (91.58%), Alternaria sp. (71.08%) and Phytophthora sp. (71.37%). Remarkable increase was observed in seed germination (27.07%), shoot length (42.33%), root length (52.6%), shoot dry weight (62.01%) and root dry weight (45.7%) along with NPK (0.74, 0.36, 1.82%) content of tomato under net house condition. Isolate CKMV1 possessed traits related to plant growth promotion, therefore, could be a potential candidate for the development of biofertiliser or biocontrol agent and this is the first study to include the Aneurinibacillus as PGPR. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Chauhan, Anjali] Dr Yashwant Singh Parmar Univ Hort & Forestry, Dept Basic Sci, Microbiol Sect, Nauni, Solan, India; [Guleria, Shiwani] Lovely Profess Univ, Dept Microbiol, Jalandhar, Punjab, India; [Balgir, Praveen P.] Punjabi Univ Patiala, Dept Biotechnol, Patiala, Punjab, India; [Walia, Abhishek] DAV Univ, Dept Microbiol, Jalandhar, Punjab, India; [Mahajan, Rishi] Jaypee Univ Informat Technol, Waknaghat, Himachal Prades, India; [Mehta, Preeti] DBT IOC Ctr Bioenergy Res, Indian Oil R&D Ctr, Faridabad, Haryana, India; [Shirkot, Chand Karan] Dr Yashwant Singh Parmar Univ Hort & Forestry, Dept Basic Sci, Nauni, Solan, India	Shirkot, CK (reprint author), Dr Yashwant Singh Parmar Univ Hort & Forestry, Dept Basic Sci, Nauni, Solan, India.	profckshirkot@gmail.com		Mahajan, Rishi/0000-0001-7885-9497	All India Network Project on Soil Biodiversity and Biofertilizer (ICAR)	We thank the All India Network Project on Soil Biodiversity and Biofertilizer (ICAR) for providing necessary funds to carry out this research work.	Ahemad M., 2011, INSIGHT MICROBIOL, V1, P39, DOI DOI 10.5567/IMICR0-IK.2011.39.54; Ahmed N, 2009, INTERNET J MICROBIOL, V9, P1; Alam S., 2002, INT J AGRIC BIOL, V4, P454; Antoun H., 2001, ENCY GENETICS, P1477; Babi AA, 1973, CROP SCI, V13, P630; BAKKER AW, 1987, SOIL BIOL BIOCHEM, V19, P451, DOI 10.1016/0038-0717(87)90037-X; Boiero L, 2007, APPL MICROBIOL BIOT, V74, P874, DOI 10.1007/s00253-006-0731-9; Chen YP, 2006, APPL SOIL ECOL, V34, P33, DOI 10.1016/j.apsoil.2005.12.002; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Chowdhury SP, 2009, EUR J SOIL BIOL, V45, P114, DOI 10.1016/j.ejsobi.2008.06.005; Dean D. R., 1992, BIOL NITROGEN FIXATI, P763; Ding Y, 2005, J APPL MICROBIOL, V99, P1271, DOI 10.1111/j.1365-2672.2005.02738.x; Donate-Correa J, 2004, PLANT SOIL, V266, P261; DWORKIN M, 1958, J BACTERIOL, V75, P592; Ehrlich H. L, 1990, GEOMICROBIOLOGY; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015                                                                 ; HARDY RWF, 1968, PLANT PHYSIOL, V43, P1185, DOI 10.1104/pp.43.8.1185; Holt JG, 1994, BERGEYS MANUAL DETER; James EK, 2000, FIELD CROP RES, V65, P197, DOI 10.1016/S0378-4290(99)00087-8; Jeon JS, 2003, J MICROBIOL, V41, P271; Kim KY, 1997, FEMS MICROBIOL LETT, V153, P273, DOI 10.1016/S0378-1097(97)00246-2; Koo SY, 2010, J MICROBIOL BIOTECHN, V20, P587, DOI 10.4014/jmb.0907.07017; Kumar A, 2015, ACTA PHYS PLANTARUM, V37, P1; Mehta P, 2013, ANN APPL BIOL, V163, P430, DOI 10.1111/aab.12077; Mehta P, 2015, BIOL AGRIC HORTIC, V31, P265, DOI 10.1080/01448765.2015.1014420; Mehta P, 2014, ACTA PHYSIOL PLANT, V36, P2033, DOI 10.1007/s11738-014-1581-1; Pandey A, 1998, SOIL BIOL BIOCHEM, V30, P379, DOI 10.1016/S0038-0717(97)00121-1                                                   ; Perez E, 2007, SOIL BIOL BIOCHEM, V39, P2905, DOI 10.1016/j.soilbio.2007.06.017; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Raj A, 2007, WORLD J MICROB BIOT, V23, P793, DOI 10.1007/s11274-006-9299-x; Ramos-Solano B, 2010, PLANT SOIL, V334, P189, DOI 10.1007/s11104-010-0371-9; RAO W. V. B. SUNDARA, 1963, INDIAN J AGRIC SCI, V33, P272; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Sambrook J, 1989, MOL CLONING LAB MANU; Sashidhar B, 2010, J Appl Microbiol, V109, P1, DOI 10.1111/j.1365-2672.2009.04654.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sharma R, 2016, P NAT AC SCI IND B; Swain Manas R., 2007, Polish Journal of Microbiology, V56, P103; Tate RL, 2000, SOIL MICROBIOLOGY, P149; UEDA T, 1995, J BACTERIOL, V177, P1414, DOI 10.1128/jb.177.5.1414-1417.1995                                                 ; VINCENT JM, 1947, NATURE, V159, P850, DOI 10.1038/159850b0                                                                ; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Young JPW, 1996, NEW PHYTOL, V133, P87; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522	44	0	0	9	14	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	APR-JUN	2017	48	2					294	304		10.1016/j.bjm.2016.12.001				11	Microbiology	Microbiology	EV0TC	WOS:000401456800020	28063921	gold			2018-01-05	
J	Tian, MY; Du, DY; Zhou, W; Zeng, XB; Cheng, GJ				Tian, Mengyang; Du, Dongyun; Zhou, Wei; Zeng, Xiaobo; Cheng, Guojun			Phenol degradation and genotypic analysis of dioxygenase genes in bacteria isolated from sediments	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Isolation and identification; Gram-negative bacteria; Substrate utilization; Dioxygenase genes; Phenol biodegradation	BETA-KETOADIPATE PATHWAY; PSEUDOMONAS-PSEUDOMALLEI; HORIZONTAL TRANSFER; STRAIN; BIODEGRADATION; BATCH; SOIL; 2,3-DIOXYGENASE; 1,2-DIOXYGENASE; GENETICS	The aerobic degradation of aromatic compounds by bacteria is performed by dioxygenases. To show some characteristic patterns of the dioxygenase genotype and its degradation specificities, twenty-nine gram-negative bacterial cultures were obtained from sediment contaminated with phenolic compounds in Wuhan, China. The isolates were phylogenetically diverse and belonged to 10 genera. All 29 gram-negative bacteria were able to utilize phenol, m-dihydroxybenzene and 2-hydroxybenzoic acid as the sole carbon sources, and members of the three primary genera Pseudomonas, Acinetobacter and Alcaligenes were able to grow in the presence of multiple monoaromatic compounds. PCR and DNA sequence analysis were used to detect dioxygenase genes coding for catechol 1,2-dioxygenase, catechol 2,3-dioxygenase and protocatechuate 3,4-dioxygenase. The results showed that there are 4 genotypes; most strains are either PNP (catechol 1,2-dioxygenase gene is positive, catechol 2,3-dioxygenase gene is negative, protocatechuate 3,4-dioxygenase gene is positive) or PNN (catechol 1,2-dioxygenase gene is positive, catechol 2,3-dioxygenase gene is negative, protocatechuate 3,4-dioxygenase gene is negative). The strains with two dioxygenase genes can usually grow on many more aromatic compounds than strains with one dioxygenase gene. Degradation experiments using a mixed culture representing four bacterial genotypes resulted in the rapid degradation of phenol. Determinations of substrate utilization and phenol degradation revealed their affiliations through dioxygenase genotype data. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Tian, Mengyang; Zhou, Wei; Zeng, Xiaobo; Cheng, Guojun] South Cent Univ Nationalities, Coll Life Sci, Wuhan 430074, Peoples R China; [Du, Dongyun] South Cent Univ Nationalities, Coll Chem & Mat, Wuhan, Peoples R China	Cheng, GJ (reprint author), South Cent Univ Nationalities, Coll Life Sci, Wuhan 430074, Peoples R China.	chengguojun@mail.scuec.edu.cn			Natural Science Foundation of Hubei Province [2014CFB914]; Fundamental Research Funds for the Central Universities, South-Central University for Nationalities [CZW14001, CZW15023]	This work was supported by the Natural Science Foundation of Hubei Province (2014CFB914), and the Fundamental Research Funds for the Central Universities, South-Central University for Nationalities (CZW14001 and CZW15023).	Afzal M, 2007, J HAZARD MATER, V149, P60, DOI 10.1016/j.jhazmat.2007.03.046; Ahamad PYA, 2011, BIODEGRADATION, V22, P253, DOI 10.1007/s10532-010-9392-6; Alquati C, 2005, ANN MICROBIOL, V55, P237; Arutchelvan V, 2006, J HAZARD MATER, V129, P216, DOI 10.1016/j.jhazmat.2005.08.040; Barriault D, 1999, APPL MICROBIOL BIOT, V51, P592, DOI 10.1007/s002530051437                                                           ; Carol FF, 1969, J BACTERIOL, V100, P869; Cheng GJ, 2006, FEMS MICROBIOL LETT, V257, P152, DOI 10.1111/j.1574-6968.2006.00158.x; Fujieda N, 2010, DALTON T, V39, P3083, DOI 10.1039/c000760a; Garcia MT, 2005, FEMS MICROBIOL ECOL, V54, P97, DOI 10.1016/j.femsec.2005.03.009; Gerginova M, 2013, Z NATURFORSCH C, V68, P384; Guzik U., 2009, BRAZ J MICROBIOL, V40, P285; Habe H, 2003, BIOSCI BIOTECH BIOCH, V67, P225, DOI 10.1271/bbb.67.225                                                              ; Haroune N, 2002, APPL ENVIRON MICROB, V68, P6114, DOI 10.1128/AEM.68.12.6114-6120.2002; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553                                                  ; Herrick JB, 1997, APPL ENVIRON MICROB, V63, P2330; Hinteregger C, 1997, BIOTECHNOL LETT, V19, P1099, DOI 10.1023/A:1018488410102; Hupert-Kocurek K, 2012, ACTA BIOCHIM POL, V59, P345; Romero-Silva MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056038; Khan M. A. I., 2011, J SCI RES, V3, P367; Leonard D, 1999, BIOTECHNOL BIOENG, V65, P407; Marta I, 2006, PREVENTION TODAY, V2, P35; MARTIN RW, 1949, ANAL CHEM, V21, P1419, DOI 10.1021/ac60035a038                                                             ; Neumann G, 2004, APPL ENVIRON MICROB, V70, P1907, DOI 10.1128/AEM.70.4.1907-1912.2004; Omokoko B, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-197; Putrins M, 2007, MICROBIOL-SGM, V153, P1860, DOI 10.1099/mic.0.2006/003681-0; Rehfuss M, 2005, SYST APPL MICROBIOL, V28, P421, DOI 10.1016/j.syapm.2005.03.003; Rehman A, 2007, J ENVIRON SCI HEAL A, V42, P1147, DOI 10.1080/1093452071418656; Sainsbury PD, 2015, BIOORG CHEM, V60, P102, DOI 10.1016/j.bioorg.2015.05.002; Shen FT, 2009, SYST APPL MICROBIOL, V32, P291, DOI 10.1016/j.syapm.2009.04.002; Singh S, 2009, POL J MICROBIOL, V58, P319; Suenaga H, 2009, ISME J, V3, P1335, DOI 10.1038/ismej.2009.76; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao XQ, 2007, PROCESS BIOCHEM, V42, P401, DOI 10.1016/j.procbio.2006.09.018; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; Wang Y, 2007, J ENVIRON SCI-CHINA, V19, P222, DOI 10.1016/S1001-0742(07)60036-9; Wei GH, 2008, J HAZARD MATER, V151, P111, DOI 10.1016/j.jhazmat.2007.05.058; Wilson MS, 2003, APPL ENVIRON MICROB, V69, P2172, DOI 10.1128/AEM.69.4.2172-2181.2003; WINKER S, 1991, SYST APPL MICROBIOL, V14, P305, DOI 10.1016/S0723-2020(11)80303-6                                                   ; Yamanashi T, 2015, BIOSCI BIOTECH BIOCH, V79, P830, DOI 10.1080/09168451.2014.993915; Yoon JH, 2006, INT J SYST EVOL MICR, V56, P2165, DOI 10.1099/ijs.0.64114-0; Zhao HP, 2008, J HAZARD MATER, V152, P1293, DOI 10.1016/j.jhazmat.2007.08.008	41	1	1	8	10	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	APR-JUN	2017	48	2					305	313		10.1016/j.bjm.2016.12.002				9	Microbiology	Microbiology	EV0TC	WOS:000401456800021	28065387	gold			2018-01-05	
J	Liu, TX; Li, HR; Ding, YT; Qi, YC; Gao, YQ; Song, AD; Shen, JW; Qiu, LY				Liu, Tianxiang; Li, Huiru; Ding, Yatong; Qi, Yuancheng; Gao, Yuqian; Song, Andong; Shen, Jinwen; Qiu, Liyou			Genome-wide gene expression patterns in dikaryon of the basidiomycete fungus Pleurotus ostreatus	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Differential gene expression; Monoallelic expression; Monokaryon; RNA editing; RNA-Seq	DIFFERENT CELL-TYPES; SCHIZOPHYLLUM-COMMUNE; RNA-SEQ; MONOALLELIC EXPRESSION; SEXUAL MORPHOGENESIS; ISOZYME PATTERNS; MUSHROOM; TRANSCRIPTOME; HETEROSIS; SEQUENCES	Dikarya is a subkingdom of fungi that includes Ascomycota and Basidiomycota. The gene expression patterns of dikaryon are poorly understood. In this study, we bred a dikaryon DK13 x 3 by mating monokaryons MK13 and MK3, which were from the basidiospores of Pleurotus ostreatus TD300. Using RNA-Seq, we obtained the transcriptomes of the three strains. We found that the total transcript numbers in the transcriptomes of the three strains were all more than ten thousand, and the expression profile in DK13 x 3 was more similar to MK13 than MK3. However, the genes involved in macromolecule utilization, cellular material synthesis, stress-resistance and signal transduction were much more up-regulated in the dikaryon than its constituent monokaryons. All possible modes of differential gene expression, when compared to constituent monokaryons, including the presence/absence variation, and additivity/nonadditivity gene expression in the dikaryon may contribute to heterosis. By sequencing the urease gene poure sequences and mRNA sequences, we identified the monoallelic expression of the poure gene in the dikaryon, and its transcript was from the parental monokaryon MK13. Furthermore, we discovered RNA editing in the poure gene mRNA of the three strains. These results suggest that the gene expression patterns in dikaryons should be similar to that of diploids during vegetative growth. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Liu, Tianxiang; Li, Huiru; Ding, Yatong; Qi, Yuancheng; Gao, Yuqian; Song, Andong; Shen, Jinwen; Qiu, Liyou] Henan Agr Univ, Coll Life Sci, Key Lab Enzyme Engn Agr Microbiol, Zhengzhou, Peoples R China	Qiu, LY (reprint author), Henan Agr Univ, Coll Life Sci, Key Lab Enzyme Engn Agr Microbiol, Zhengzhou, Peoples R China.	qliyou@henau.edu.cn			Natural Science Foundation of Henan Province [112300410115]; Innovative Research Team (in Science and Technology) in University of Henan Province [15IRTSTHN014]	This work was funded by a grant from the Natural Science Foundation of Henan Province (112300410115) and the program for Innovative Research Team (in Science and Technology) in University of Henan Province (15IRTSTHN014).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986                                                             ; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Castanera R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073282; Chai R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061693; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Chess A, 2013, NEUROPSYCHOPHARMACOL, V38, P55, DOI 10.1038/npp.2012.85; Clark TA, 2004, GENETICS, V167, P1663, DOI 10.1534/genetics.104.027235; Crockatt ME, 2008, FUNGAL ECOL, V1, P40, DOI 10.1016/j.funeco.2008.01.001; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DEVRIES OMH, 1980, DEV BIOL, V74, P22, DOI 10.1016/0012-1606(80)90050-0; Dong XY, 2012, INT J MED MUSHROOMS, V14, P21, DOI 10.1615/IntJMedMushr.v14.i1.20                                                  ; EVERS DC, 1983, EXP MYCOL, V7, P9, DOI 10.1016/0147-5975(83)90070-1                                                    ; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; GARDES M, 1990, SYMBIOSIS, V8, P233; Gibson G, 2004, DROSOPHILA MELANOGAS, V167, P1791; Goodenough U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016154; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAY MW, 1993, FASEB J, V7, P64; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Hiscox J, 2010, FUNGAL ECOL, V3, P347, DOI 10.1016/j.funeco.2010.02.003; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Izumitsu K, 2012, MYCOSCIENCE, V53, P396, DOI 10.1007/s10267-012-0182-3; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Klimek-Tomczak K, 2006, BRIT J CANCER, V94, P586, DOI 10.1038/sj.bjc.6602938; LaFave MC, 2014, GENETICS, V196, P107, DOI 10.1534/genetics.113.158618; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Matsumoto T, 1996, CURR GENET, V30, P549, DOI 10.1007/s002940050168; Meyer RC, 2012, PLANT J, V71, P669, DOI 10.1111/j.1365-313X.2012.05021.x; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451; MOORE D, 1981, NEW PHYTOL, V87, P101, DOI 10.1111/j.1469-8137.1981.tb01694.x                                              ; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolas FE, 2013, PLOSPA PATHOG, V9; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Qiu LY, 2009, CHIN J CEL BIOL, V31, P212; Ross IK, 1973, COPRINUS J BACT, V114, P1083; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Stajich JE, 2009, CURR BIOL, V19, pR840, DOI 10.1016/j.cub.2009.07.004; Stepanova VV, 2014, MOL BIOL+, V48, P11, DOI 10.1134/S0026893314010154; TAKISHIMA K, 1988, EUR J BIOCHEM, V175, P151, DOI 10.1111/j.1432-1033.1988.tb14177.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; ULLRICH RC, 1977, MOL GEN GENET, V156, P157; Villegas J, 2002, NUCLEIC ACIDS RES, V30, P1895, DOI 10.1093/nar/30.9.1895                                                           ; WANG CS, 1969, J BACTERIOL, V99, P291; WANG CS, 1970, P NATL ACAD SCI USA, V66, P882, DOI 10.1073/pnas.66.3.882; Wang LQ, 2011, HORTTECHNOLOGY, V21, P82; ZANTINGE B, 1979, EUR J BIOCHEM, V101, P251, DOI 10.1111/j.1432-1033.1979.tb04238.x; ZANTINGE B, 1981, EUR J BIOCHEM, V113, P381, DOI 10.1111/j.1432-1033.1981.tb05077.x                                              ; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	50	0	0	8	9	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	APR-JUN	2017	48	2					380	390		10.1016/j.bjm.2016.12.005				11	Microbiology	Microbiology	EV0TC	WOS:000401456800030	28089161	gold			2018-01-05	
J	Sun, P; Guo, J; Winnenburg, R; Baumbach, J				Sun, Peng; Guo, Jiong; Winnenburg, Rainer; Baumbach, Jan			Drug repurposing by integrated literature mining and drug-gene-disease triangulation	DRUG DISCOVERY TODAY			English	Review							PHENOME-WIDE ASSOCIATION; THERAPEUTIC TARGETS; TUBERCULOSIS; OPPORTUNITIES; ROPINIROLE; LEADS	Drug design is expensive, time-consuming and becoming increasingly complicated. Computational approaches for inferring potentially new purposes of existing drugs, referred to as drug repositioning, play an increasingly important part in current pharmaceutical studies. Here, we first summarize recent developments in computational drug repositioning and introduce the utilized data sources. Afterwards, we introduce a new data fusion model based on n-cluster editing as a novel multi-source triangulation strategy, which was further combined with semantic literature mining. Our evaluation suggests that utilizing drug-gene-disease triangulation coupled to sophisticated text analysis is a robust approach for identifying new drug candidates for repurposing.	[Sun, Peng; Baumbach, Jan] Max Planck Inst Informat, Saarbrucken, Germany; [Sun, Peng] Saarland Univ, Cluster Excellence Multimodal Comp & Interact, Saarbrucken, Germany; [Guo, Jiong] Shandong Univ, Sch Comp Sci & Technol, Qingdao, Peoples R China; [Winnenburg, Rainer] Stanford Univ, Stanford Ctr Biomed Res, Stanford, CA 94305 USA; [Baumbach, Jan] Univ Southern Denmark, Inst Math & Comp Sci, Odense, Denmark	Baumbach, J (reprint author), Max Planck Inst Informat, Saarbrucken, Germany.; Baumbach, J (reprint author), Univ Southern Denmark, Inst Math & Comp Sci, Odense, Denmark.	jan.baumbach@imada.sdu.dk					Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Chan CM, 2012, CLIN CANCER RES, V18, P3580, DOI 10.1158/1078-0432.CCR-11-3359; Chan D, 2012, ONCOL LETT, V3, P807, DOI 10.3892/ol.2012.579; Chiang AP, 2009, CLIN PHARMACOL THER, V86, P507, DOI 10.1038/clpt.2009.103; CROWLE AJ, 1992, CHEMOTHERAPY, V38, P410, DOI 10.1159/000239036                                                               ; Daminelli S, 2012, INTEGR BIOL-UK, V4, P778, DOI 10.1039/c2ib00154c; Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Dudley JT, 2011, SCI TRANSL MED, V3, P96, DOI DOI 10.1126/SCITRANSLMED.3002648; Elvidge S., 2010, LIFE SCI LEADER; Fu LM, 2002, INT J TUBERC LUNG D, V6, P569; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Ha S, 2008, BIOINFORMATICS, V24, P1413, DOI 10.1093/bioinformatics/btn138; Hebbring SJ, 2014, IMMUNOLOGY, V141, P157, DOI 10.1111/imm.12195; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kuhn M., 2015, NUCL ACIDS RES; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265; Iorio F., 2010, P NATL ACAD SCI USA, V107, P14621, DOI DOI 10.1073/PNAS.1000138107; Mullard A, 2016, NAT REV DRUG DISCOV, V15, P73, DOI 10.1038/nrd.2016.15; Mullen J, 2016, PEERJ, V4, DOI 10.7717/peerj.1558; Novick PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079568; Ondo W, 1999, MOVEMENT DISORD, V14, P138, DOI 10.1002/1531-8257(199901)14:1<138::AID-MDS1023>3.3.CO;2-1; Oroszlan Gyorgy, 1992, Orvosi Hetilap, V133, P2835; Plenge RM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2608; Rastegar-Mojarad M, 2015, NAT BIOTECHNOL, V33, DOI 10.1038/nbt.3183; Rich RM, 2006, RETINA-J RET VIT DIS, V26, P495, DOI 10.1097/01.iae.0000225766.75009.3a; Shi XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132072; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Swamidass SJ, 2011, BRIEF BIOINFORM, V12, P327, DOI 10.1093/bib/bbr028; Tan FJ, 2014, MOL BIOSYST, V10, P1126, DOI 10.1039/c3mb70554d; von Eichborn J, 2011, NUCLEIC ACIDS RES, V39, pD1060, DOI 10.1093/nar/gkq1037; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078518; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Worthington JJ, 2002, INT CLIN PSYCHOPHARM, V17, P307, DOI 10.1097/00004850-200211000-00006                                                ; Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028025; Ye H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087864; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3                                                   	42	1	1	3	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-6446	1878-5832		DRUG DISCOV TODAY	Drug Discov. Today	APR	2017	22	4					615	619						5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EV2PG	WOS:000401597000002	27780789				2018-01-05	
J	Panda, SK; Boddul, SV; Jimenez-Andrade, GY; Jiang, L; Kasza, Z; Fernandez-Ricaud, L; Wermeling, F				Panda, Sudeepta Kumar; Boddul, Sanjay V.; Jimenez-Andrade, Guillermina Yanek; Jiang, Long; Kasza, Zsolt; Fernandez-Ricaud, Luciano; Wermeling, Fredrik			Green listed-a CRISPR screen tool	BIOINFORMATICS			English	Article							HUMAN GENOME; ACTIVATION; IMMUNITY	Motivation: Genome editing using versions of the bacterial CRISPR/Cas9 system can be used to probe the function of selected genes in any organism.Green Listed is a web-based tool that rapidly designs custom CRISPR screens targeting sets of genes defined by the user. It could thus be used to design screens targeting for example all genes differentially expressed during a specific stimuli or all genes related to a specific pathway or function, as well as to generate targeted secondary screens following a large-scale screen.	[Panda, Sudeepta Kumar; Boddul, Sanjay V.; Jimenez-Andrade, Guillermina Yanek; Jiang, Long; Kasza, Zsolt; Wermeling, Fredrik] Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden; [Panda, Sudeepta Kumar; Boddul, Sanjay V.; Jimenez-Andrade, Guillermina Yanek; Jiang, Long; Kasza, Zsolt; Wermeling, Fredrik] Karolinska Univ Hosp, SE-17176 Stockholm, Sweden; [Fernandez-Ricaud, Luciano] Univ Gothenburg, Dept Marine Sci, Lundberg Lab, SE-41390 Gothenburg, Sweden	Wermeling, F (reprint author), Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden.; Wermeling, F (reprint author), Karolinska Univ Hosp, SE-17176 Stockholm, Sweden.	fredrik.wermeling@ki.se			Swedish Research Council; Swedish Foundation for Strategic Research; Wenner-Gren Foundations; Jeansson Foundations; Karolinska Institutet; BILS (National Bioinformatics Infrastructure for Life Sciences)	This project was financially supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, the Wenner-Gren Foundations, the Jeansson Foundations, the Karolinska Institutet and BILS (National Bioinformatics Infrastructure for Life Sciences).	Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.12; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041	13	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	APR 1	2017	33	7					1099	1100		10.1093/bioinformatics/btw739				2	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	EU4FH	WOS:000400984700023	28414855				2018-01-05	
J	Puchta, H				Puchta, Holger			Applying CRISPR/Cas for genome engineering in plants: the best is yet to come	CURRENT OPINION IN PLANT BIOLOGY			English	Review							DOUBLE-STRAND BREAKS; SEQUENCE-SPECIFIC NUCLEASES; RNA-GUIDED ENDONUCLEASE; TARGETED MUTAGENESIS; HOMOLOGOUS RECOMBINATION; TRANSCRIPTIONAL REGULATION; CRISPR-CAS9 NUCLEASES; MEIOTIC RECOMBINATION; ARABIDOPSIS-THALIANA; REGULATORY ELEMENTS	Less than 5 years ago the CRISPR/Cas nuclease was first introduced into eukaryotes, shortly becoming the most efficient and widely used tool for genome engineering. For plants, efforts were centred on obtaining heritable changes in most transformable crop species by inducing mutations into open reading frames of interest, via non-homologous end joining. Now it is important to take the next steps and further develop the technology to reach its full potential. For breeding, besides using DNA-free editing and avoiding off target effects, it will be desirable to apply the system for the mutation of regulatory elements and for more complex genome rearrangements. Targeting enzymatic activities, like transcriptional regulators or DNA modifying enzymes, will be important for plant biology in the future.	[Puchta, Holger] Karlsruhe Inst Technol, Bot Inst, Mol Biol & Biochem, Kaiserstr 12, D-76131 Karlsruhe, Germany	Puchta, H (reprint author), Karlsruhe Inst Technol, Bot Inst, Mol Biol & Biochem, Kaiserstr 12, D-76131 Karlsruhe, Germany.	holger.puchta@kit.edu		Puchta, Holger/0000-0003-1073-8546	European Research Council (ERC)	My excuses to all those colleagues I was not able to cite with their exciting work. Due to space limitations, I could only discuss a fraction of the work relevant to the topic. I want to thank my group for sharing the enthusiasm on the CRISPR/Cas system, Manfred Focke, Simon Schiml, Amy Whitbread and Felix Wolter for critical reading of the manuscript and the European Research Council (ERC) for generously funding my research on genome engineering.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chandrasegaran S, 2016, J MOL BIOL, V428, P963, DOI 10.1016/j.jmb.2015.10.014; Choi K, 2015, PLANT J, V83, P52, DOI 10.1111/tpj.12870; Choudhury SR, 2016, ONCOTARGET; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kaya H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26871; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kirik A, 2000, EMBO J, V19, P5562, DOI 10.1093/emboj/19.20.5562; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Knoll A, 2014, CHROMOSOME RES, V22, P191, DOI 10.1007/s10577-014-9415-y; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Liu DG, 2016, CURR OPIN PLANT BIOL, V30, P70, DOI 10.1016/j.pbi.2016.01.007; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Luo M, 2016, PLANT CELL REP, V35, P1439, DOI 10.1007/s00299-016-1989-8; Luo S, 2015, MOL PLANT, V8, P1425, DOI 10.1016/j.molp.2015.05.012; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Marton I, 2010, PLANT PHYSIOL, V154, P1079, DOI 10.1104/pp.110.164806; Mikami M, 2016, PLANT CELL PHYSIOL, V57, P1058, DOI 10.1093/pcp/pcw049; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Nishizawa-Yokoi A, 2016, PLANT PHYSIOL, V170, P653, DOI 10.1104/pp.15.01542; Ordon J, 2016, PLANT J CELL MOL BIO; Pacher M, 2007, GENETICS, V175, P21, DOI 10.1534/genetics.106.065185; Park CY, 2016, TRENDS BIOTECHNOL, V34, P548, DOI 10.1016/j.tibtech.2016.02.011; Pecina A, 2002, CELL, V111, P173, DOI 10.1016/S0092-8674(02)01002-4; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Gutierrez C, 2015, PLANT J, V83, P1, DOI [10.1111/tpj.12909, 10.1111/tpj.13100]; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Qi YP, 2013, G3-GENES GENOM GENET, V3, P1707, DOI 10.1534/g3.113.006270; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sadhu MJ, 2016, SCIENCE, V352, P1113, DOI 10.1126/science.aaf5124; Salomon S, 1998, EMBO J, V17, P6086, DOI 10.1093/emboj/17.20.6086                                                        ; Sauer NJ, 2016, PLANT PHYSIOL, V170, P1917, DOI 10.1104/pp.15.01696; Schiml S, 2016, P NATL ACAD SCI USA, V113, P7266, DOI 10.1073/pnas.1603823113; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Siebert R, 2002, PLANT CELL, V14, P1121, DOI 10.1105/tpc.001727; Sprink T, 2016, PLANT CELL REP, V35, P1493, DOI 10.1007/s00299-016-1990-2; Steinert J, 2016, PLANT CELL REP; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Stoddard TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154634; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Swinnen G, 2016, TRENDS PLANT SCI, V21, P506, DOI 10.1016/j.tplants.2016.01.014; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Yan WH, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0125-7; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang DD, 2016, J GENET GENOMICS, V43, P251, DOI 10.1016/j.jgg.2016.03.001; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	79	24	24	103	119	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	APR	2017	36						1	8		10.1016/j.pbi.2016.11.011				8	Plant Sciences	Plant Sciences	EV2PO	WOS:000401597800002	27914284				2018-01-05	
J	Uauy, C				Uauy, Cristobal			Wheat genomics comes of age	CURRENT OPINION IN PLANT BIOLOGY			English	Review							HEXAPLOID WHEAT; BREAD WHEAT; POLYPLOID WHEAT; COPY NUMBER; SEQUENCE CAPTURE; RUST RESISTANCE; POWDERY MILDEW; GRAIN LENGTH; RICE; RNA	Advances in wheat genomics have lagged behind other major cereals (e.g., rice and maize) due to its highly repetitive and large polyploid genome. Recent technological developments in sequencing and assembly methods, however, have largely overcome these barriers. The community now moves to an era centred on functional characterisation of the genome. This includes understanding sequence and structural variation as well as how information is integrated across multiple homoeologous genomes. This understanding promises to uncover variation previously hidden from natural and human selection due to the often observed functional redundancy between homoeologs. Key functional genomic resources will enable this, including sequenced mutant populations and gene editing technologies which are now available in wheat. Training. the next-generation of genomics-enabled researchers will be essential to ensure these advances are quickly translated into farmers' fields.	[Uauy, Cristobal] John Innes Ctr, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	Uauy, C (reprint author), John Innes Ctr, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	Cristobal.uauy@jic.ac.uk			UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004588/1, BB/J003557/1, BBS/E/J/000CA444]; International Wheat Yield Partnership (IWYP) [IWYP76FP]	My excuses to all those colleagues whose work I was not able to cite due to space limitations. This work was supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) [grants BB/J004588/1, BB/J003557/1 and BBS/E/J/000CA444] and the International Wheat Yield Partnership (IWYP) [grant IWYP76FP]. I thank Nikolai Adamski, Jemima Brinton, Sophie Harrington, Clemence Marchal, and Oluwaseyi Shorinola for critical reading of the manuscript.	Acevedo-Garcia J, 2017, PLANT BIOTECHNOL J, V15, P367, DOI 10.1111/pbi.12631; Bassi FM, 2016, PLANT BIOTECHNOL J, V14, P1716, DOI 10.1111/pbi.12532; Baulcombe D., 2009, REAP BEN SCI SUST IN; Baulcombe D, 2010, SCIENCE, V327, P761, DOI 10.1126/science.1186705; Bolser DM, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu183; Borrill P, 2016, PLANT PHYSIOL, V170, P2172, DOI 10.1104/pp.15.01667; Borrill P, 2015, NEW PHYTOL, V208, P1008, DOI 10.1111/nph.13533; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Clavijo BJ, 2016, IMPROVED ASSEMBLY AN; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Gao XY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0515-4; Gardiner LJ, 2016, PLANT J, V87, P403, DOI 10.1111/tpj.13204; Gardiner LJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0838-3; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; King R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137549; Knox AK, 2010, THEOR APPL GENET, V121, P21, DOI 10.1007/s00122-010-1288-7; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Liu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36398; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0692-1; Pfeifer M, 2014, SCIENCE, P345; Pozniak C, 2016, PLANT ANIMAL GENOME; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Ramirez-Gonzalez RH, 2015, BIOINFORMATICS, V31, P2038, DOI 10.1093/bioinformatics/btv069; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Rodgers-Melnick E, 2016, P NATL ACAD SCI USA, V113, pE3177, DOI 10.1073/pnas.1525244113; Sanchez-Martin J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1082-1; Schneeberger K, 2014, NAT REV GENET, V15, P662, DOI 10.1038/nrg3745; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Simmonds J, 2016, THEOR APPL GENET, V129, P1099, DOI 10.1007/s00122-016-2686-2; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Steuernage B, 2016, NAT BIOTECHNOL, V34, P652, DOI 10.1038/nbt.3543; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang TL, 2012, PLANT BIOTECHNOL J, V10, P761, DOI 10.1111/j.1467-7652.2012.00708.x; Wang W, 2016, OPTIMIZING MULTIPLEX; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wilkinson PA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1139-x; Wingen LU, 2014, THEOR APPL GENET, V127, P1831, DOI 10.1007/s00122-014-2344-5; Wurschum T, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0258-0; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890; Zhu J, 2014, THEOR APPL GENET, V127, P1183, DOI 10.1007/s00122-014-2290-2; Zikhali M, 2016, J EXP BOT, V67, P287, DOI 10.1093/jxb/erv458; Zuo JR, 2014, ANNU REV GENET, V48, P99, DOI 10.1146/annurev-genet-120213-092138	57	3	3	39	43	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	APR	2017	36						142	148		10.1016/j.pbi.2017.01.007				7	Plant Sciences	Plant Sciences	EV2PO	WOS:000401597800020	28346895	gold			2018-01-05	
J	Qi, WW; Tian, ZR; Lu, L; Chen, XZ; Chen, XZ; Zhang, W; Song, RT				Qi, Weiwei; Tian, Zhongrui; Lu, Lei; Chen, Xiuzu; Chen, Xinze; Zhang, Wei; Song, Rentao			Editing of Mitochondrial Transcripts nad3 and cox2 by Dek10 Is Essential for Mitochondrial Function and Maize Plant Development	GENETICS			English	Article						Zea mays; dek10; pentatricopeptide repeat protein; mitochondrion; RNA editing; seed development	PENTATRICOPEPTIDE REPEAT PROTEIN; ARABIDOPSIS-THALIANA; ELECTRON-TRANSPORT; TRANSFER CELLS; ENDOSPERM DEVELOPMENT; ALTERNATIVE OXIDASE; SEED DEVELOPMENT; GENE-EXPRESSION; PPR PROTEIN; RNA	Respiration, the core of mitochondrial metabolism, depends on the function of five respiratory complexes. Many respiratory chain-related proteins are encoded by the mitochondrial genome and their RNAs undergo post-transcriptional modifications by nuclear genome-expressed factors, including pentatricopeptide repeat (PPR) proteins. Maize defective kernel 10 (dek10) is a classic mutant with small kernels and delayed development. Through positional cloning, we found that Dek10 encodes an E-subgroup PPR protein localized in mitochondria. Sequencing analysis indicated that Dek10 is responsible for the C-to-U editing at nad3-61, nad3-62, and cox2-550 sites, which are specific editing sites in monocots. The defects of these editing sites result in significant reduction of Nad3 and the loss of Cox2. Interestingly, the assembly of complex I was not reduced, but its NADH dehydrogenase activity was greatly decreased. The assembly of complex IV was significantly reduced. Transcriptome and transmission electron microscopy (TEM) analysis revealed that proper editing of nad3 and cox2 is critical for mitochondrial functions, biogenesis, and morphology. These results indicate that the E-subgroup PPR protein Dek10 is responsible for multiple editing sites in nad3 and cox2, which are essential for mitochondrial functions and plant development in maize.	[Qi, Weiwei; Tian, Zhongrui; Lu, Lei; Chen, Xiuzu; Chen, Xinze; Zhang, Wei; Song, Rentao] Shanghai Univ, Shanghai Key Lab Bioenergy Crops, Sch Life Sci, 333 Nanchen Rd, Shanghai 200444, Peoples R China; [Song, Rentao] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100193, Peoples R China	Song, RT (reprint author), Shanghai Univ, Shanghai Key Lab Bioenergy Crops, Sch Life Sci, 333 Nanchen Rd, Shanghai 200444, Peoples R China.	rentaosong@staff.shu.edu.cn	Song, Rentao/A-6544-2012	Song, Rentao/0000-0003-1810-9875	National Key Research and Development Program of China [2016YFD0101003]; National Natural Sciences Foundation of China [91635303, 31425019]; Fundamental Research Funds for the Central Universities [2016QC077]	This work was supported by the National Key Research and Development Program of China (2016YFD0101003), the National Natural Sciences Foundation of China (91635303 and 31425019), and the Fundamental Research Funds for the Central Universities (2016QC077). The authors declare no conflicts of interest.	Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Becraft PW, 2002, DEVELOPMENT, V129, P5217; BRINK RA, 1947, GENETICS, V32, P350; CHARLTON WL, 1995, DEVELOPMENT, V121, P3089; Colcombet J, 2013, RNA BIOL, V10, P1557, DOI 10.4161/rna.26128; Dahan J, 2014, PLANT PHYSIOL, V166, P1788, DOI 10.1104/pp.114.248526; de Longevialle AF, 2008, PLANT J, V56, P157, DOI 10.1111/j.1365-313X.2008.03581.x; des Francs-Small CC, 2014, BIOCHIMIE, V100, P234, DOI 10.1016/j.biochi.2013.08.019; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; Dudkina NV, 2006, TRENDS PLANT SCI, V11, P232, DOI 10.1016/j.tplants.2006.03.007; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Gal C, 2015, CELL CYCLE, V14, P123, DOI 10.4161/15384101.2014.967123; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; Haili N, 2016, PLANT PHYSIOL, V170, P354, DOI 10.1104/pp.15.01591; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; Hammani K, 2014, TRENDS PLANT SCI, V19, P380, DOI 10.1016/j.tplants.2013.12.008; Holding DR, 2006, MAYDICA, V51, P243; Keren I, 2012, PLANT J, V71, P413, DOI 10.1111/j.1365-313X.2012.04998.x; Kim SR, 2009, PLANT J, V59, P738, DOI 10.1111/j.1365-313X.2009.03909.x; Knoop V, 2013, J SYST EVOL, V51, P1, DOI 10.1111/j.1759-6831.2012.00228.x; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; LENDING CR, 1992, PROTOPLASMA, V171, P123, DOI 10.1007/BF01403727; Li XJ, 2014, PLANT J, V79, P797, DOI 10.1111/tpj.12584; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu S, 2013, RNA BIOL, V10, P1501, DOI 10.4161/rna.26172; Liu YJ, 2013, PLANT CELL, V25, P868, DOI 10.1105/tpc.112.106781; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan DC, 2006, J EXP BOT, V57, P1225, DOI 10.1093/jxb/erj151; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Murayama M, 2012, J EXP BOT, V63, P5301, DOI 10.1093/jxb/ers188; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; NEUFFER MG, 1980, GENETICS, V95, P929; Offler CE, 2003, ANNU REV PLANT BIOL, V54, P431, DOI 10.1146/annurev.arplant.54.031902.134812; Ohtani S, 2010, PLANT CELL PHYSIOL, V51, P1942, DOI 10.1093/pcp/pcq142; PATE JS, 1972, ANN REV PLANT PHYSIO, V23, P173, DOI 10.1146/annurev.pp.23.060172.001133; Qi WW, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0289-2; Qi WW, 2016, PLANT PHYSIOL, V170, P971, DOI 10.1104/pp.15.01722; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; SIEDOW JN, 2000, BIOCH MOL BIOL PLANT, P676; Sosso D, 2012, PLANT CELL, V24, P676, DOI 10.1105/tpc.111.091074; Sun F, 2015, PLANT J, V84, P283, DOI 10.1111/tpj.12993; Sweetlove LJ, 2007, CRIT REV PLANT SCI, V26, P17, DOI 10.1080/07352680601147919; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Thompson RD, 2001, PLANT SCI, V160, P775, DOI 10.1016/S0168-9452(01)00345-4; Toda T, 2012, PLANT J, V72, P450, DOI 10.1111/j.1365-313X.2012.05091.x; VANLERBERGHE GC, 1994, PLANT PHYSIOL, V105, P867, DOI 10.1104/pp.105.3.867; Vanlerberghe GC, 2002, ADV PHOTO RESPIRAT, V12, P173; Wang G, 2011, GENETICS, V189, P1281, DOI 10.1534/genetics.111.133967; Wang G, 2014, PLANT PHYSIOL, V165, P582, DOI 10.1104/pp.114.238030; Xiu ZH, 2016, PLANT J, V85, P507, DOI 10.1111/tpj.13122; Yuan H, 2012, PLANT J, V70, P432, DOI 10.1111/j.1365-313X.2011.04883.x; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhang HD, 2015, PHOTOSYNTH RES, V126, P311, DOI 10.1007/s11120-015-0171-4; Zhu Q, 2012, PLANT J, V71, P836, DOI 10.1111/j.1365-313X.2012.05036.x; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260	58	2	2	11	19	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2017	205	4					1489	1501		10.1534/genetics.116.199331				13	Genetics & Heredity	Genetics & Heredity	EU6EK	WOS:000401126600010	28213476				2018-01-05	
J	Zhang, LL; Martin, A; Perry, MW; van der Burg, KRL; Matsuoka, Y; Monteiro, A; Reed, RD				Zhang, Linlin; Martin, Arnaud; Perry, Michael W.; van der Burg, Karin R. L.; Matsuoka, Yuji; Monteiro, Antonia; Reed, Robert D.			Genetic Basis of Melanin Pigmentation in Butterfly Wings	GENETICS			English	Article						butterfly wing; pigmentation; melanin; CRISPR/Cas9 genome editing; RNA-seq; evo-devo	BOMBYX-MORI; DROSOPHILA-MELANOGASTER; DOPA-DECARBOXYLASE; HELICONIUS BUTTERFLIES; TYROSINE-HYDROXYLASE; PATTERNS; YELLOW; EVOLUTION; EXPRESSION; SILKWORM	Despite the variety, prominence, and adaptive significance of butterfly wing patterns, surprisingly little is known about the genetic basis of wing color diversity. Even though there is intense interest in wing pattern evolution and development, the technical challenge of genetically manipulating butterflies has slowed efforts to functionally characterize color pattern development genes. To identify candidate wing pigmentation genes, we used RNA sequencing to characterize transcription across multiple stages of butterfly wing development, and between different color pattern elements, in the painted lady butterfly Vanessa cardui. This allowed us to pinpoint genes specifically associated with red and black pigment patterns. To test the functions of a subset of genes associated with presumptive melanin pigmentation, we used clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing in four different butterfly genera. pale, Ddc, and yellow knockouts displayed reduction of melanin pigmentation, consistent with previous findings in other insects. Interestingly, however, yellow-d, ebony, and black knockouts revealed that these genes have localized effects on tuning the color of red, brown, and ochre pattern elements. These results point to previously undescribed mechanisms for modulating the color of specific wing pattern elements in butterflies, and provide an expanded portrait of the insect melanin pathway.	[Zhang, Linlin; van der Burg, Karin R. L.; Reed, Robert D.] Cornell Univ, Dept Ecol & Evolutionary Biol, 215 Tower Rd, Ithaca, NY 14853 USA; [Martin, Arnaud] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Perry, Michael W.] NYU, Dept Biol, New York, NY 10003 USA; [Matsuoka, Yuji; Monteiro, Antonia] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore	Zhang, LL; Reed, RD (reprint author), Cornell Univ, Dept Ecol & Evolutionary Biol, 215 Tower Rd, Ithaca, NY 14853 USA.; Monteiro, A (reprint author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Monteiro, A (reprint author), Yale NUS Coll, 6 Coll Ave East, Singapore 138614, Singapore.	lz355@cornell.edu; antonia.monteiro@nus.edu.sg; robertreed@cornell.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Zhang, Linlin/0000-0003-0247-7710; Martin, Arnaud/0000-0002-5980-2249; Perry, Michael/0000-0002-5977-8031	National Science Foundation [IOS-1354318, IOS-1557443]; Ministry of Singapore grant [MOE2015-T2-2-159]	We thank Joseph Fetcho and Joe DiPietro at Cornell University for assistance with microinjection, Kyle DeMarr and Benjamin John Brack for help raising butterflies, and Ellis Loew for help with microspectrophotometry. Finally, we are indebted to members of the Reed and Monteiro Labs, as well as to Nipam Patel and his team for experimental assistance and discussions. This work was supported by National Science Foundation grants IOS-1354318 and IOS-1557443 to R.D.R. and Ministry of Singapore grant MOE2015-T2-2-159 to A. Monteiro.	Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Arakane Y, 2010, INSECT BIOCHEM MOLEC, V40, P259, DOI 10.1016/j.ibmb.2010.01.012; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Beldade P, 2017, CURR OPIN INSECT SCI, V19, P22, DOI 10.1016/j.cois.2016.10.006; BIESSMANN H, 1985, P NATL ACAD SCI USA, V82, P7369, DOI 10.1073/pnas.82.21.7369; Chen SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015633; Connahs H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2586-5; Daniels EV, 2014, MOL ECOL, V23, P6123, DOI 10.1111/mec.12988; Ferguson LC, 2011, DEV GENES EVOL, V221, P297, DOI 10.1007/s00427-011-0380-6; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-46; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Giraldo MA, 2016, J COMP PHYSIOL A, V202, P381, DOI 10.1007/s00359-016-1084-1; Gorman MJ, 2007, INSECT BIOCHEM MOLEC, V37, P1327, DOI 10.1016/j.ibmb.2007.08.006; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hines HM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-288; HIRUMA K, 1984, J COMP PHYSIOL, V154, P13, DOI 10.1007/BF00683211                                                              ; HORI M, 1984, INSECT BIOCHEM, V14, P267, DOI 10.1016/0020-1790(84)90059-3; Ito K, 2012, GENOME, V55, P493, DOI [10.1139/G2012-033, 10.1139/g2012-033]; Koch PB, 1998, DEVELOPMENT, V125, P2303; Kronforst MR, 2015, GENETICS, V200, P1, DOI 10.1534/genetics.114.172387; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; Li XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9212; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Liu J, 2016, GENETICS, V203, P403, DOI 10.1534/genetics.115.186684; Martin A, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-7; Monteiro A, 2015, ANNU REV ENTOMOL, V60, P253, DOI 10.1146/annurev-ento-010814-020942; Morgan T. H., 1916, SEX LINKED INHERITAN; Nijhout H. F., 1991, Journal of Research on the Lepidoptera, V30, P1; Nijhout H F, 1991, SMITHSONIAN SERIES C; Osanai-Futahashi M, 2012, J BIOL CHEM, V287, P17706, DOI 10.1074/jbc.M111.321331; Perez MM, 2010, J INSECT PHYSIOL, V56, P8, DOI 10.1016/j.jinsphys.2009.08.018; Perry M, 2016, NATURE, V535, P280, DOI 10.1038/nature18616; Reed RD, 2005, EVOL DEV, V7, P301, DOI 10.1111/j.1525-142X.2005.05036.x; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROSELAND CR, 1987, INSECT BIOCHEM, V17, P21, DOI 10.1016/0020-1790(87)90139-9; True JR, 1999, CURR BIOL, V9, P1382, DOI 10.1016/S0960-9822(00)80083-4                                                   ; Wallbank RWR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002353; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; WRIGHT TRF, 1976, GENETICS, V84, P287; WRIGHT TRF, 1976, GENETICS, V84, P267; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/S0065-2660(08)60008-5; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Zhang LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11769; Zhao YP, 2012, J INSECT PHYSIOL, V58, P1397, DOI 10.1016/j.jinsphys.2012.08.002	53	4	4	16	23	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2017	205	4					1537	1550		10.1534/genetics.116.196451				14	Genetics & Heredity	Genetics & Heredity	EU6EK	WOS:000401126600014	28193726				2018-01-05	
J	Beaghton, A; Hammond, A; Nolan, T; Crisanti, A; Godfray, HCJ; Burt, A				Beaghton, Andrea; Hammond, Andrew; Nolan, Tony; Crisanti, Andrea; Godfray, H. Charles J.; Burt, Austin			Requirements for Driving Antipathogen Effector Genes into Populations of Disease Vectors by Homing	GENETICS			English	Article						gene drive; population genetic engineering; pest control; homing; malaria	MALARIA TRANSMISSION; ANOPHELES-STEPHENSI; ENDONUCLEASE GENES; ELIMINATION; CRISPR/CAS9; EVOLUTION; DYNAMICS; REPAIR; MODEL; DNA	There is a need for new interventions against the ongoing burden of vector-borne diseases such as malaria and dengue. One suggestion has been to develop genes encoding effector molecules that block parasite development within the vector, and then use the nuclease-based homing reaction as a form of gene drive to spread those genes through target populations. If the effector gene reduces the fitness of the mosquito and does not contribute to the drive, then loss-of-function mutations in the effector will eventually replace functional copies, but protection may nonetheless persist sufficiently long to provide a public health benefit. Here, we present a quantitative model allowing one to predict the duration of protection as a function of the probabilities of different molecular processes during the homing reaction, various fitness effects, and the efficacy of the effector in blocking transmission. Factors that increase the duration of protection include reducing the frequency of pre-existing resistant alleles, the probability of nonrecombinational DNA repair, the probability of homing-associated loss of the effector, the fitness costs of the nuclease and effector, and the completeness of parasite blocking. For target species that extend over an area much larger than the typical dispersal distance, the duration of protection is expected to be highest at the release site, and decrease away from there, eventually falling to zero, as effector-less drive constructs replace effector-containing ones. We also model an alternative strategy of using the nuclease to target an essential gene, and then linking the effector to a sequence that restores the essential function and is resistant to the nuclease. Depending upon parameter values, this approach can prolong the duration of protection. Our models highlight the key design criteria needed to achieve a desired level of public health benefit.	[Beaghton, Andrea; Burt, Austin] Imperial Coll, Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England; [Hammond, Andrew; Nolan, Tony; Crisanti, Andrea] Imperial Coll, Life Sci, London SW7 2AZ, England; [Godfray, H. Charles J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Beaghton, A (reprint author), Imperial Coll, Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	a.beaghton@imperial.ac.uk	Nolan, Tony/I-4925-2012	Nolan, Tony/0000-0002-2982-8333; Hammond, Andrew/0000-0002-1757-5009	Bill & Melinda Gates Foundation	This work was funded by a grant from the Bill & Melinda Gates Foundation.	Adelman ZN, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P277; Beaghton A, 2016, THEOR POPUL BIOL, V108, P51, DOI 10.1016/j.tpb.2015.11.005; BULL JJ, 2017, EVOL MED PUBLIC HLTH, V2017, P1, DOI DOI 10.1093/EMPH/E0W030; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A, 2006, GENES CONFLICT BIOL; Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074254; Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054130; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; Eckhoff PA, 2017, P NATL ACAD SCI USA, V114, pE255, DOI 10.1073/pnas.1611064114; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x                                              ; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; Marshall JM, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P169; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819; North A, 2013, J APPL ECOL, V50, P1216, DOI 10.1111/1365-2664.12133; Rodgers K, 2016, J CELL PHYSIOL, V231, P15, DOI 10.1002/jcp.25053; Shigesada N., 1997, BIOL INVASIONS THEOR; Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285; Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001; Wolfram Research Inc., 2017, WOLFR CDF PLAYER; Wolfram Research Inc., 2015, MATH 10 2; Wu B, 2016, NAT BIOTECHNOL, V34, P137, DOI 10.1038/nbt.3444	35	4	4	20	22	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2017	205	4					1587	1596		10.1534/genetics.116.197632				10	Genetics & Heredity	Genetics & Heredity	EU6EK	WOS:000401126600017	28159753	gold			2018-01-05	
J	Moreno, RL; Josey, M; Ribera, AB				Moreno, Rosa L.; Josey, Megan; Ribera, Angeles B.			Zebrafish In Situ Spinal Cord Preparation for Electrophysiological Recordings from Spinal Sensory and Motor Neurons	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience Issue 122; zebrafish; spinal neurons; motor neurons; sensory neurons; Rohon-Beard cell; CaP; electrophysiology; whole cell; patch clamp	LARVAL ZEBRAFISH; BRACHYDANIO-RERIO; RECRUITMENT ORDER; LOCOMOTOR NETWORK; AXONAL OUTGROWTH; INTERNEURONS; EXPRESSION; CIRCUITS; EMBRYOS; GENOME	Zebrafish, first introduced as a developmental model, have gained popularity in many other fields. The ease of rearing large numbers of rapidly developing organisms, combined with the embryonic optical clarity, served as initial compelling attributes of this model. Over the past two decades, the success of this model has been further propelled by its amenability to large-scale mutagenesis screens and by the ease of transgenesis. More recently, gene-editing approaches have extended the power of the model. For neurodevelopmental studies, the zebrafish embryo and larva provide a model to which multiple methods can be applied. Here, we focus on methods that allow the study of an essential property of neurons, electrical excitability. Our preparation for the electrophysiological study of zebrafish spinal neurons involves the use of veterinarian suture glue to secure the preparation to a recording chamber. Alternative methods for recording from zebrafish embryos and larvae involve the attachment of the preparation to the chamber using a fine tungsten pin(1,2,3,4,5).A tungsten pin is most often used to mount the preparation in a lateral orientation, although it has been used to mount larvae dorsal-side up(4). The suture glue has been used to mount embryos and larvae in both orientations. Using the glue, a minimal dissection can be performed, allowing access to spinal neurons without the use of an enzymatic treatment, thereby avoiding any resultant damage. However, for larvae, it is necessary to apply a brief enzyme treatment to remove the muscle tissue surrounding the spinal cord. The methods described here have been used to study the intrinsic electrical properties of motor neurons, interneurons, and sensory neurons at several developmental stages(6,7,8,9).	[Moreno, Rosa L.; Ribera, Angeles B.] Univ Colorado, Dept Physiol & Biophys, Anschutz Med Campus UCAMC, Boulder, CO 80309 USA; [Josey, Megan; Ribera, Angeles B.] Univ Colorado, Neurosci Grad Program, Anschutz Med Campus UCAMC, Boulder, CO 80309 USA	Moreno, RL (reprint author), Univ Colorado, Dept Physiol & Biophys, Anschutz Med Campus UCAMC, Boulder, CO 80309 USA.	Rosa.Moreno@ucdenver.edu			NIH [F32 NS059120, R01NS25217, P30NS048154]	This work was supported by grants from the NIH (F32 NS059120 to RLM and R01NS25217 and P30NS048154 to ABR).	Ampatzis K, 2014, NEURON, V83, P934, DOI 10.1016/j.neuron.2014.07.018; Arkhipova V, 2012, DEV BIOL, V365, P290, DOI 10.1016/j.ydbio.2012.03.001; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Carmean V, 2015, J NEUROPHYSIOL, V114, P1146, DOI 10.1152/jn.00355.2015; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Del Barrio MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077928; Drapeau P, 2002, PROG NEUROBIOL, V68, P85, DOI 10.1016/S0301-0082(02)00075-8                                                   ; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4                                                   ; Driever W, 1996, DEVELOPMENT, V123, P37; Fetcho JR, 2010, ANN NY ACAD SCI, V1198, P94, DOI 10.1111/j.1749-6632.2010.05539.x; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Haffter P, 1996, DEVELOPMENT, V123, P1; Higashijima S, 2000, J NEUROSCI, V20, P206; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hubbard JM, 2016, CURR BIOL, V26, P2841, DOI 10.1016/j.cub.2016.08.026; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; KIMMEL CB, 1990, NEUROSCI IN, P561; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lambert AM, 2012, J NEUROSCI, V32, P13488, DOI 10.1523/JNEUROSCI.1638-12.2012; LAMBORGHINI JE, 1980, J COMP NEUROL, V189, P323, DOI 10.1002/cne.901890208; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Levin ED, 2009, FRONT NEUROSCI, P293; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ljunggren EE, 2014, J NEUROSCI, V34, P134, DOI 10.1523/JNEUROSCI.4087-13.2014; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; McKeown KA, 2012, DEV BIOL, V362, P162, DOI 10.1016/j.ydbio.2011.11.001; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Menelaou E, 2014, J COMP NEUROL, V522, P1232, DOI 10.1002/cne.23465; Menelaou E, 2012, J NEUROSCI, V32, P10925, DOI 10.1523/JNEUROSCI.1809-12.2012; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; METCALFE WK, 1990, DEVELOPMENT, V110, P491; Moreno RL, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-19; Moreno RL, 2009, J NEUROPHYSIOL, V102, P2477, DOI 10.1152/jn.00446.2009; Mushtaq MY, 2013, BIOTECHNOL GENET ENG, V29, P187, DOI 10.1080/02648725.2013.801238; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Oesterle A., 2015, PIPETTE COOKBOOK 201; Palanca AMS, 2013, DEV NEUROBIOL, V73, P152, DOI 10.1002/dneu.22049; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Phillips JB, 2014, DIS MODEL MECH, V7, P739, DOI 10.1242/dmm.015545; Pineda RH, 2005, J NEUROPHYSIOL, V93, P3582, DOI 10.1152/jn.01070.2004; Reimer MM, 2013, DEV CELL, V25, P478, DOI 10.1016/j.devcel.2013.04.012; Ribera AB, 1998, J NEUROSCI, V18, P9181; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Rossi CC, 2009, DEV DYNAM, V238, P931, DOI 10.1002/dvdy.21915; Saint-Amant Louis, 2003, Methods in Cell Science, V25, P59, DOI 10.1023/B:MICS.0000006896.02938.49; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Satou C, 2013, DEVELOPMENT, V140, P3927, DOI 10.1242/dev.099531; Song JR, 2016, NATURE, V529, P399, DOI 10.1038/nature16497; SPITZER NC, 1976, J PHYSIOL-LONDON, V255, P105, DOI 10.1113/jphysiol.1976.sp011272                                                  ; Stewart A, 2012, NEUROPHARMACOLOGY, V62, P135, DOI 10.1016/j.neuropharm.2011.07.037; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vogel G, 2000, SCIENCE, V290, P1671; WEIS JS, 1968, J EMBRYOL EXP MORPH, V19, P109; Wen H, 2005, J NEUROSCI, V25, P8104, DOI 10.1523/JNEUROSCI.2611-05.2005; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	65	1	1	1	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2017		122							e55507	10.3791/55507				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EU5NC	WOS:000401077600062					2018-01-05	
J	Callif, BL; Maunze, B; Krueger, NL; Simpson, MT; Blackmore, MG				Callif, Ben L.; Maunze, Brian; Krueger, Nick L.; Simpson, Matthew T.; Blackmore, Murray G.			The application of CRISPR technology to high content screening in primary neurons	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						High content screening; CRISPR; Cortical neuron; PTEN	CENTRAL-NERVOUS-SYSTEM; LENTIVIRAL RNAI LIBRARY; SPINAL-CORD-INJURY; AXON REGENERATION; CORTICOSPINAL TRACT; INTERFERON RESPONSE; MAMMALIAN-CELLS; PTEN INHIBITION; GROWTH; GENE	Axon growth is coordinated by multiple interacting proteins that remain incompletely characterized. High content screening (HCS), in which manipulation of candidate genes is combined with rapid image analysis of phenotypic effects, has emerged as a powerful technique to identify key regulators of axon outgrowth. Here we explore the utility of a genome editing approach referred to as CRISPR (Clustered Regularly Interspersed Palindromic Repeats) for knockout screening in primary neurons. In the CRISPR approach a DNA-cleaving Cas enzyme is guided to genomic target sequences by user-created guide RNA (sgRNA), where it initiates a double-stranded break that ultimately results in frameshift mutation and loss of protein production. Using electroporation of plasmid DNA that co-expresses Cas9 enzyme and sgRNA, we first verified the ability of CRISPR targeting to achieve protein level knockdown in cultured postnatal cortical neurons. Targeted proteins included NeuN (RbFox3) and PTEN, a well-studied regulator of axon growth. Effective knockdown lagged at least four days behind transfection, but targeted proteins were eventually undetectable by immunohistochemistry in > 80% of transfected cells. Consistent with this, anti-PTEN sgRNA produced no changes in neurite outgrowth when assessed three days post-transfection. When week-long cultures were replated, however, PTEN knockdown consistently increased neurite lengths. These CRISPR-mediated PTEN effects were achieved using multi-well transfection and automated phenotypic analysis, indicating the suitability of PTEN as a positive control for future CRISPR-based screening efforts. Combined, these data establish an example of CRISPR-mediated protein knockdown in primary cortical neurons and its compatibility with HCS workflows. (C) 2017 Elsevier Inc. All rights reserved.	[Callif, Ben L.; Maunze, Brian; Krueger, Nick L.; Simpson, Matthew T.; Blackmore, Murray G.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53201 USA	Blackmore, MG (reprint author), Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53201 USA.	murray.blackmore@marquette.edu			NIH [R21NS093278]; Bryon Riesch Paralysis Foundation	This work was supported by NIH R21NS093278 and the Bryon Riesch Paralysis Foundation.	An M.C., 2014, PLOS CURR, V6; Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Belin S, 2015, NEURON, V86, P1000, DOI 10.1016/j.neuron.2015.03.060; Blackmore MG, 2012, INT REV NEUROBIOL, V105, P39, DOI 10.1016/B978-0-12-398309-1.00004-4; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Blackmore MG, 2010, MOL CELL NEUROSCI, V44, P43, DOI 10.1016/j.mcn.2010.02.002; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Buchser WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038101; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cullen BR, 2006, GENE THER, V13, P503, DOI 10.1038/sj.gt.3302656; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hutson TH, 2012, J GENE MED, V14, P299, DOI 10.1002/jgm.2626; Incontro S, 2014, NEURON, V83, P1051, DOI 10.1016/j.neuron.2014.07.043; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lerch JK, 2014, MOL CELL NEUROSCI, V59, P97, DOI 10.1016/j.mcn.2014.02.002; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nieland TJF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091744; Ohtake Y, 2015, NEURAL REGEN RES, V10, P1363, DOI 10.4103/1673-5374.165496; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Sharma K, 2013, CELL REP, V5, P1330, DOI 10.1016/j.celrep.2013.11.008; Simpson MT, 2015, MOL CELL NEUROSCI, V68, P272, DOI 10.1016/j.mcn.2015.08.008; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Straub C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105584; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Telese F, 2015, NEURON, V86, P696, DOI 10.1016/j.neuron.2015.03.033; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang ZM, 2015, J NEUROSCI, V35, P3139, DOI 10.1523/JNEUROSCI.2832-14.2015; Welsbie DS, 2013, P NATL ACAD SCI USA, V110, P4045, DOI 10.1073/pnas.1211284110; Wu Xuebing, 2014, Quant Biol, V2, P59; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yungher BJ, 2015, GENE THER, V22, P811, DOI 10.1038/gt.2015.51; Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009; Zou YX, 2015, J NEUROSCI, V35, P10429, DOI 10.1523/JNEUROSCI.1718-15.2015; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	59	1	1	14	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	APR	2017	80						170	179		10.1016/j.mcn.2017.01.003				10	Neurosciences	Neurosciences & Neurology	EU8RS	WOS:000401306800017	28110021				2018-01-05	
J	O'Duibhir, E; Carragher, NO; Pollard, SM				O'Duibhir, Eoghan; Carragher, Neil O.; Pollard, Steven M.			Accelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screening	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Neural stem cell; Glioblastoma stem cell; CRISPR/Cas9; Genome editing; Phenotypic screening; HCS	NEURAL STEM-CELLS; SMALL-MOLECULE LIBRARIES; TUMOR-INITIATING CELLS; HUMAN BRAIN; RADIAL GLIA; SUBVENTRICULAR ZONE; HUMAN NEOCORTEX; CANCER-CELLS; GLIOMA; IDENTIFICATION	Patients diagnosed with glioblastoma (GBM) continue to face a bleak prognosis. It is critical that new effective therapeutic strategies are developed. GBM stem cells have molecular hallmarks of neural stem and progenitor cells and it is possible to propagate both non-transformed normal neural stem cells and GBM stem cells, in defined, feeder-free, adherent culture. These primary stem cell lines provide an experimental model that is ideally suited to cell-based drug discovery or genetic screens in order to identify tumour-specific vulnerabilities. For many solid tumours, including GBM, the genetic disruptions that drive tumour initiation and growth have now been catalogued. CRISPR/Cas-based genome editing technologies have recently emerged, transforming our ability to functionally annotate the human genome. Genome editing opens prospects for engineering precise genetic changes in normal and GBM-derived neural stem cells, which will provide more defined and reliable genetic models, with critical matched pairs of isogenic cell lines. Generation of more complex alleles such as knock in tags or fluorescent reporters is also now possible. These new cellular models can be deployed in cell-based phenotypic drug discovery (POD). Here we discuss the convergence of these advanced technologies (iPS cells, neural stem cell culture, genome editing and high content phenotypic screening) and how they herald a new era in human cellular genetics that should have a major impact in accelerating glioblastoma drug discovery. (C) 2016 The Authors. Published by Elsevier Inc.	[O'Duibhir, Eoghan; Pollard, Steven M.] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [O'Duibhir, Eoghan; Carragher, Neil O.; Pollard, Steven M.] Univ Edinburgh, CRUK Edinburgh Ctr, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	Carragher, NO; Pollard, SM (reprint author), Univ Edinburgh, CRUK Edinburgh Ctr, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.	n.carragher@ed.ac.uk; steven.pollard@ed.ac.uk		Pollard, Steven/0000-0001-6428-0492	Cancer Research UK Senior Research Fellowship [A19778]	SMP is supported by a Cancer Research UK Senior Research Fellowship (A19778). We thank Faye Robertson, Gillian Morrison and Paul Brennan for helpful comments on the manuscript.	Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007; Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brown PJ, 2015, FUTURE MED CHEM, V7, P1901, DOI 10.4155/fmc.15.127; Caie PD, 2010, MOL CANCER THER, V9, P1913, DOI 10.1158/1535-7163.MCT-09-1148; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carragher NO, 2009, CLIN EXP METASTAS, V26, P381, DOI 10.1007/s10585-008-9222-y; Danovi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077053; Danovi D, 2010, BIOCHEM SOC T, V38, P1067, DOI 10.1042/BST0381067; Dawson JC, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00118; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Drewry DH, 2014, CURR TOP MED CHEM, V14, P340, DOI 10.2174/1568026613666131127160819; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gallo M, 2013, CANCER RES, V73, P417, DOI 10.1158/0008-5472.CAN-12-1881; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Isherwood Beverley, 2011, Pharmaceutics, V3, P141, DOI 10.3390/pharmaceutics3020141; Johannessen CM, 2015, TRENDS GENET, V31, P16, DOI 10.1016/j.tig.2014.11.002; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Kitambi SS, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.021; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee JA, 2013, J BIOMOL SCREEN, V18, P1143, DOI 10.1177/1087057113506118; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499                                                           ; Ljosa V, 2013, J BIOMOL SCREEN, V18, P1321, DOI 10.1177/1087057113503553; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Moisan A, 2015, NAT CELL BIOL, V17, P57, DOI 10.1038/ncb3075; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Paul S. M., 2010, NAT REV DRUG DISCOV, P1; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; PIERCE GB, 1988, CANCER RES, V48, P1996; Pilz GA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3125; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Pourquie O, 2015, DEVELOPMENT, V142, P1, DOI 10.1242/dev.119727; Reaume AG, 2012, DRUG DISCOV TODAY, V8, P85, DOI DOI 10.1016/J.DDSTR.2011.09.007; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sancho-Martinez I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10743; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith K, 2014, J BIOMOL SCREEN, V19, P685, DOI 10.1177/1087057114527313; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598                                                          ; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Stransky N., 2015, NATURE, P1; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Tanikawa T, 2009, J AM CHEM SOC, V131, P5075, DOI 10.1021/ja806583y; Taylor DL, 2001, CURR OPIN BIOTECH, V12, P75, DOI 10.1016/S0958-1669(00)00180-4; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Verginelli F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3956; Wagner BK, 2009, CURR OPIN CHEM BIOL, V13, P539, DOI 10.1016/j.cbpa.2009.09.018; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI [10.1073/pnas.1410933111/-/DCSupplemental, 10.1073/pnas.1410933111]; Wenzel C, 2014, EXP CELL RES, V323, P131, DOI 10.1016/j.yexcr.2014.01.017; Wurdak H, 2010, CELL STEM CELL, V6, P37, DOI 10.1016/j.stem.2009.11.002; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Yarrow JC, 2003, COMB CHEM HIGH T SCR, V6, P279; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	82	3	3	2	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	APR	2017	80						198	207		10.1016/j.mcn.2016.11.001				10	Neurosciences	Neurosciences & Neurology	EU8RS	WOS:000401306800020	27825983	gold			2018-01-05	
J	Peng, N; Han, WY; Li, YJ; Liang, YX; She, QX				Peng, Nan; Han, Wenyuan; Li, Yingjun; Liang, Yunxiang; She, Qunxin			Genetic technologies for extremely thermophilic microorganisms of Sulfolobus, the only genetically tractable genus of crenarchaea	SCIENCE CHINA-LIFE SCIENCES			English	Review						Sulfolobus; genetic manipulation; shuttle vector; gene knockout; selection and counter-selection; CRISPR-based gene editing	ARCHAEAL DNA-REPLICATION; MEDIATED VIRUS DEFENSE; HYPERTHERMOPHILIC ARCHAEON; THERMOCOCCUS-KODAKARAENSIS; MERCURY RESISTANCE; SHUTTLE VECTORS; ELEMENT PSSVX; INTRAGENIC RECOMBINATION; HOMOLOGOUS RECOMBINATION; SIMVASTATIN SELECTION	Archaea represents the third domain of life, with the information-processing machineries more closely resembling those of eukaryotes than the machineries of the bacterial counterparts but sharing metabolic pathways with organisms of Bacteria, the sister prokaryotic phylum. Archaeal organisms also possess unique features as revealed by genomics and genome comparisons and by biochemical characterization of prominent enzymes. Nevertheless, diverse genetic tools are required for in vivo experiments to verify these interesting discoveries. Considerable efforts have been devoted to the development of genetic tools for archaea ever since their discovery, and great progress has been made in the creation of archaeal genetic tools in the past decade. Versatile genetic toolboxes are now available for several archaeal models, among which Sulfolobus microorganisms are the only genus representing Crenarchaeota because all the remaining genera are from Euryarchaeota. Nevertheless, genetic tools developed for Sulfolobus are probably the most versatile among all archaeal models, and these include viral and plasmid shuttle vectors, conventional and novel genetic manipulation methods, CRISPR-based gene deletion and mutagenesis, and gene silencing, among which CRISPR tools have been reported only for Sulfolobus thus far. In this review, we summarize recent developments in all these useful genetic tools and discuss their possible application to research into archaeal biology by means of Sulfolobus models.	[Peng, Nan; Li, Yingjun; Liang, Yunxiang; She, Qunxin] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Han, Wenyuan; Li, Yingjun; She, Qunxin] Univ Copenhagen, Dept Biol, Archaeal Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark	She, QX (reprint author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.; She, QX (reprint author), Univ Copenhagen, Dept Biol, Archaeal Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	qunxin@bio.ku.dk	She, Qunxin/E-4311-2012	She, Qunxin/0000-0002-4448-6669	Danish Council of Independent Research [DFF-0602-02196, DFF-4181-00274, DFF-1323-00330]; Fundamental Research Funds for the Central Universities [2662015PX199]	This work was supported by the Danish Council of Independent Research (DFF-0602-02196, DFF-4181-00274, DFF-1323-00330), and the Fundamental Research Funds for the Central Universities (2662015PX199).	Aagaard C, 1996, FEMS MICROBIOL REV, V18, P93; Albers SV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00023; Albers Sonja-Verena, 2008, Archaea, V2, P145, DOI 10.1155/2008/948014; Albers SV, 2006, APPL ENVIRON MICROB, V72, P102, DOI 10.1128/AEM.72.1.102-111.2006; Aravalli RN, 1997, EXTREMOPHILES, V1, P183, DOI 10.1007/s007920050032; Arnold HP, 1999, MOL MICROBIOL, V34, P217, DOI 10.1046/j.1365-2958.1999.01573.x                                                ; Aucelli T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl615; Bell SD, 1998, TRENDS MICROBIOL, V6, P222, DOI 10.1016/S0966-842X(98)01281-5; Berkner S, 2008, ARCH MICROBIOL, V190, P217, DOI 10.1007/s00203-008-0392-4; Berkner S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm449; Berkner S, 2014, MICROBIOLOGYOPEN, V3, P688, DOI 10.1002/mbo3.198; Berkner S, 2010, EXTREMOPHILES, V14, P249, DOI 10.1007/s00792-010-0304-9; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Brugger K, 2002, FEMS MICROBIOL LETT, V206, P131, DOI 10.1016/S0378-1097(01)00504-3; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; CAMMARANO P, 1985, EMBO J, V4, P811; Cannio R, 1998, J BACTERIOL, V180, P3237; Chaban B, 2006, CAN J MICROBIOL, V52, P73, DOI 10.1139/WDS-147; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; Contursi P, 2007, J BACTERIOL, V189, P6339, DOI 10.1128/JB.00638-07; Contursi P, 2014, NUCLEIC ACIDS RES, V42, P5993, DOI 10.1093/nar/gku215; Contursi P, 2014, EXTREMOPHILES, V18, P473, DOI 10.1007/s00792-014-0634-0; Contursi P, 2011, BIOCHEM J, V435, P157, DOI 10.1042/BJ20101334; Contursi P, 2010, EXTREMOPHILES, V14, P453, DOI 10.1007/s00792-010-0325-4; D'Auria S, 1998, BIOCHIMIE, V80, P949, DOI 10.1016/S0300-9084(00)88892-6; Dai X, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01902; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deng L, 2012, NUCLEIC ACIDS RES, V40, P2470, DOI 10.1093/nar/gkr1111; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Dore AS, 2006, NUCLEIC ACIDS RES, V34, P4515, DOI 10.1093/nar/gkl623; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Erauso G, 2006, MICROBIOL-SGM, V152, P1951, DOI 10.1099/mic0.28861-0; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Garrett Roger A., 2015, Life-Basel, V5, P783, DOI 10.3390/life5010783; Garrett RA, 2011, BIOCHEM SOC T, V39, P51, DOI 10.1042/BST0390051; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Greve Bo, 2005, Archaea, V1, P319, DOI 10.1155/2005/159218; Greve Bo, 2004, Archaea, V1, P231, DOI 10.1155/2004/151926; Grogan DW, 2003, J BACTERIOL, V185, P4657, DOI 10.1128/JB.185.15.4657-4661.2003; Grogan DW, 2001, P NATL ACAD SCI USA, V98, P7928, DOI 10.1073/pnas.141113098                                                          ; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; Hansen JE, 2005, J BACTERIOL, V187, P805, DOI 10.1128/JB.187.2.805-809.2005; Hileman TH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00195; Hjort K, 2001, MOL MICROBIOL, V40, P225, DOI 10.1046/j.1365-2958.2001.02377.x; Hong Y, 2012, DNA REPAIR, V11, P102, DOI 10.1016/j.dnarep.2011.10.009; Huang QH, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0030-z; Huang QH, 2015, EXTREMOPHILES, V19, P505, DOI 10.1007/s00792-015-0734-5; Hwang S, 2015, J MICROBIOL BIOTECHN, V25, P196, DOI 10.4014/jmb.1407.07043; Ishino Y, 2015, CURR OPIN MICROBIOL, V25, P103, DOI 10.1016/j.mib.2015.05.010; Jaubert C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130010; Jonuscheit M, 2003, MOL MICROBIOL, V48, P1241, DOI 10.1046/j.1365-2958.2003.03509.x; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; Keeling PJ, 1998, EXTREMOPHILES, V2, P391, DOI 10.1007/s007920050083; Keeling PJ, 1996, PLASMID, V35, P141, DOI 10.1006/plas.1996.0016; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Kletzin A, 1999, GENETICS, V152, P1307; Leigh JA, 2011, FEMS MICROBIOL REV, V35, P577, DOI 10.1111/j.1574-6976.2011.00265.x; Li XY, 2011, J GENET GENOMICS, V38, P253, DOI 10.1016/j.jgg.2011.05.001; Li YJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1044; Liang PJ, 2013, J GENET GENOMICS, V40, P533, DOI 10.1016/j.jgg.2013.05.004; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Lipps G, 2009, BIOCHEM SOC T, V37, P42, DOI 10.1042/BST0370042; Liu GN, 2016, NUCLEIC ACIDS RES, V44, P4233, DOI 10.1093/nar/gkw286; Liu HL, 2011, J GENET GENOMICS, V38, P261, DOI 10.1016/j.jgg.2011.05.003; Liu T, 2015, NUCLEIC ACIDS RES, V43, P1044, DOI 10.1093/nar/gku1383; Ma XQ, 2011, EXTREMOPHILES, V15, P67, DOI 10.1007/s00792-010-0338-z; Maezato Y, 2011, RNA, V17, P1381, DOI 10.1261/rna.2679911; Manica A, 2013, NUCLEIC ACIDS RES, V41, P10509, DOI 10.1093/nar/gkt767; Manica A, 2013, RNA BIOL, V10, P671, DOI 10.4161/rna.24154; Manica A, 2011, MOL MICROBIOL, V80, P481, DOI 10.1111/j.1365-2958.2011.07586.x; Mao D, 2012, ISME J, V6, P1613, DOI 10.1038/ismej.2012.20; MARTIN A, 1984, EMBO J, V3, P2165; Martusewitsch E, 2000, J BACTERIOL, V182, P2574, DOI 10.1128/JB.182.9.2574-2581.2000                                                 ; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; McCarthy S, 2015, GENOME ANNOUNC, V3, DOI DOI 10.1128/GENOMEA.00549-15; Mei YX, 2012, APPL MICROBIOL BIOT, V93, P1965, DOI 10.1007/s00253-011-3504-z; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Peng N, 2012, APPL ENVIRON MICROB, V78, P5630, DOI 10.1128/AEM.00855-12; Peng N, 2011, BIOCHEM SOC T, V39, P99, DOI 10.1042/BST0390099; Peng N, 2009, MOL MICROBIOL, V74, P928, DOI 10.1111/j.1365-2958.2009.06908.x; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Peng WF, 2013, RNA BIOL, V10, P738, DOI 10.4161/rna.23798; Peng X, 2000, J MOL BIOL, V303, P449, DOI 10.1006/jmbi.2000.4160; Peng X, 2012, SCI CHINA LIFE SCI, V55, P422, DOI 10.1007/s11427-012-4325-8; Petitjean C, 2015, GENOME BIOL EVOL, V7, P191, DOI 10.1093/gbe/evu274; Prato S, 2006, PLASMID, V56, P35, DOI 10.1016/j.plasmid.2006.02.002; Purschke WG, 2001, FEMS MICROBIOL LETT, V200, P97, DOI 10.1016/S0378-1097(01)00204-X; Redder P, 2006, J BACTERIOL, V188, P4198, DOI 10.1128/JB.00061-06; Reilly MS, 2001, J BACTERIOL, V183, P2943, DOI 10.1128/JB.183.9.2943-2946.2001; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Richards JD, 2008, J MOL BIOL, V376, P634, DOI 10.1016/j.jmb.2007.12.019; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Roberts JA, 2003, MOL MICROBIOL, V48, P361, DOI 10.1046/j.1365-2958.2003.03444.x                                                ; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Ruggero D, 1996, J BACTERIOL, V178, P3396, DOI 10.1128/jb.178.11.3396-3398.1996                                                ; Samson RY, 2013, CELL REP, V3, P485, DOI 10.1016/j.celrep.2013.01.002; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; Schelert J, 2006, J BACTERIOL, V188, P7141, DOI 10.1128/JB.00558-06; Schelert J, 2013, MICROBIOL-SGM, V159, P1198, DOI 10.1099/mic.0.065854-0; SCHLEPER C, 1995, J BACTERIOL, V177, P4417, DOI 10.1128/jb.177.15.4417-4426.1995                                                ; SCHLEPER C, 1992, P NATL ACAD SCI USA, V89, P7645, DOI 10.1073/pnas.89.16.7645; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; She Q., 2008, MICROBES ENV PERSPEC, P151; She QX, 2009, BIOCHEM SOC T, V37, P92, DOI 10.1042/BST0370092; She QX, 1998, EXTREMOPHILES, V2, P417, DOI 10.1007/s007920050087                                                           ; Song XG, 2016, J GENET GENOMICS, V43, P405, DOI 10.1016/j.jgg.2016.03.003; Song XG, 2016, EXTREMOPHILES, V20, P537, DOI 10.1007/s00792-016-0847-5; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Stedman KM, 1999, GENETICS, V152, P1397; Stedman KM, 2003, RES MICROBIOL, V154, P295, DOI 10.1016/S0923-2508(03)00074-3; Stedman KM, 2000, J BACTERIOL, V182, P7014, DOI 10.1128/JB.182.24.7014-7020.2000; Suzuki S, 2016, EXTREMOPHILES, V20, P139, DOI 10.1007/s00792-016-0807-0; Szabo Z, 2007, J BACTERIOL, V189, P4305, DOI 10.1128/JB.00042-07; van Wolferen M, 2016, P NATL ACAD SCI USA, V113, P2496, DOI 10.1073/pnas.1513740113; van Wolferen M, 2015, J BACTERIOL, V197, P2941, DOI 10.1128/JB.00344-15; van Wolferen M, 2013, MICROBIOLOGYOPEN, V2, P928, DOI 10.1002/mbo3.128; Villafane A, 2011, MICROBIOL-SGM, V157, P2808, DOI 10.1099/mic.0.051862-0; Waege I, 2010, APPL ENVIRON MICROB, V76, P3308, DOI 10.1128/AEM.01951-09; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Wang HN, 2015, MICROBIOL MOL BIOL R, V79, P117, DOI 10.1128/MMBR.00042-14; Wang L, 2012, SCI CHINA LIFE SCI, V55, P261, DOI 10.1007/s11427-012-4292-0; Wang Y, 2007, VIROLOGY, V363, P124, DOI 10.1016/j.virol.2007.01.035; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wong JHY, 2010, EMBO J, V29, P2059, DOI 10.1038/emboj.2010.101; Worthington P, 2003, J BACTERIOL, V185, P482, DOI 10.1128/JB.185.2.482-488.2003; Xiang Xiaoyu, 2015, Life-Basel, V5, P506, DOI 10.3390/life5010506; Yan Z, 2016, EXTREMOPHILES, V20, P785, DOI 10.1007/s00792-016-0867-1; Zebec Z, 2016, G3-GENES GENOM GENET, V6, P3161, DOI 10.1534/g3.116.032482; Zebec Z, 2014, NUCLEIC ACIDS RES, V42, P5280, DOI 10.1093/nar/gku161; Zhang CY, 2016, APPL ENVIRON MICROB, V82, P3070, DOI 10.1128/AEM.00455-16; Zhang CY, 2013, APPL ENVIRON MICROB, V79, P5539, DOI 10.1128/AEM.01608-13; Zhang CY, 2013, BIOCHEM SOC T, V41, P405, DOI 10.1042/BST20120285; Zhang CY, 2013, BIOCHEM SOC T, V41, P458, DOI 10.1042/BST20120338; Zhang CY, 2012, MICROBIOL-SGM, V158, P1513, DOI 10.1099/mic.0.058289-0; Zhang CY, 2010, MICROBIOL-SGM, V156, P3386, DOI 10.1099/mic.0.042523-0; Zheng T, 2012, APPL ENVIRON MICROB, V78, P568, DOI 10.1128/AEM.06095-11; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609; Zillig W, 1998, EXTREMOPHILES, V2, P131, DOI 10.1007/s007920050052                                                           ; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886                                                              ; Zolghadr B, 2007, MOL MICROBIOL, V64, P795, DOI 10.1111/j.1365-2958.2007.05697.x	149	7	7	7	12	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7305	1869-1889		SCI CHINA LIFE SCI	Sci. China-Life Sci.	APR	2017	60	4					370	385		10.1007/s11427-016-0355-8				16	Biology	Life Sciences & Biomedicine - Other Topics	EU5JV	WOS:000401068300005	28251462				2018-01-05	
J	Shiromani, PJ; Peever, JH				Shiromani, Priyattam J.; Peever, John H.			New Neuroscience Tools That Are Identifying the Sleep-Wake Circuit	SLEEP			English	Review						Cellular and molecular biology; chemogenetics; narcolepsy; optogenetics; REM sleep; sleep	MELANIN-CONCENTRATING HORMONE; OREXIN-KNOCKOUT MICE; EYE-MOVEMENT SLEEP; SLOW-WAVE SLEEP; LOCUS-COERULEUS NEURONS; REM-SLEEP; WAKING CYCLE; BASAL FOREBRAIN; PHASE SYNDROME; GENE-TRANSFER	The complexity of the brain is yielding to technology. In the area of sleep neurobiology, conventional neuroscience tools such as lesions, cell recordings, c-Fos, and axon-tracing methodologies have been instrumental in identifying the complex and intermingled populations of sleep-and arousal-promoting neurons that orchestrate and generate wakefulness, NREM, and REM sleep. In the last decade, new technologies such as optogenetics, chemogenetics, and the CRISPR-Cas system have begun to transform how biologists understand the finer details associated with sleep-wake regulation. These additions to the neuroscience toolkit are helping to identify how discrete populations of brain cells function to trigger and shape the timing and transition into and out of different sleep-wake states, and how glia partner with neurons to regulate sleep. Here, we detail how some of the newest technologies are being applied to understand the neural circuits underlying sleep and wake.	[Shiromani, Priyattam J.] Ralph H Johnson Vet Adm Med Ctr, Res Serv, Charleston, SC USA; [Peever, John H.] Univ Toronto, Ctr Biol Timing & Cognit, Dept Cell & Syst Biol & Physiol, Toronto, ON, Canada	Shiromani, PJ (reprint author), Ralph H Johnson Res Serv 151, 109 Bee St, Charleston, SC 29401 USA.; Peever, JH (reprint author), Univ Toronto, Dept Cell & Syst Biol & Physiol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	shiroman@musc.edu; John.peever@utoronto.ca			Department of Veterans Affairs, Veterans Health Administration, Office of Research Development (BLR D) [BX000798]; NIH [NS052287, NS084477, NS098541, NS079940]; CIHR; NSERC	PJS was supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research Development (BLR& D) (grant BX000798), and NIH grants NS052287, NS084477, NS098541, and NS079940. JHP was supported by grants from CIHR and NSERC.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Alam MN, 2009, BRAIN RES, V1304, P96, DOI 10.1016/j.brainres.2009.09.066; Alam MN, 2005, J PHYSIOL-LONDON, V563, P569, DOI 10.1113/jphysiol.2004.076927; Anaclet C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9744; Anaclet C, 2014, NAT NEUROSCI, V17, P1217, DOI 10.1038/nn.3789; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Bellesi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0176-7; Benedetto L, 2013, PEPTIDES, V39, P11, DOI 10.1016/j.peptides.2012.10.005; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bjorness TE, 2016, J NEUROSCI, V36, P3709, DOI 10.1523/JNEUROSCI.3906-15.2016; Blanco-Centurion C, 2007, J NEUROSCI, V27, P14041, DOI 10.1523/JNEUROSCI.3217-07.2007; Blanco-Centurion C, 2006, J NEUROSCI, V26, P8092, DOI 10.1523/JNEUROSCI.2181-06.2006; Blanco-Centurion C, 2016, EUR J NEUROSCI, V44, P2846, DOI 10.1111/ejn.13410; Blanco-Centurion C, 2013, SLEEP, V36, P31, DOI 10.5665/sleep.2296; Blanco-Centurion CA, 2006, EUR J NEUROSCI, V24, P2084, DOI 10.1111/j.1460-9568.2006.05074.x; Blouin AM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2461; Boucetta S, 2014, J NEUROSCI, V34, P4708, DOI 10.1523/JNEUROSCI.2617-13.2014; Broberger C, 1999, BRAIN RES, V848, P101, DOI 10.1016/S0006-8993(99)01977-0                                                   ; Brooks PL, 2012, J NEUROSCI, V32, P9785, DOI 10.1523/JNEUROSCI.0482-12.2012; Burgess CR, 2013, CURR BIOL, V23, P1719, DOI 10.1016/j.cub.2013.07.014; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/NMETH.2481, 10.1038/nmeth.2481]; Cox J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10763; Cvetkovic V, 2004, J NEUROCHEM, V91, P911, DOI 10.1111/j.1471-4159.2004.02776.x; Dissel S., 2015, CURRENT SLEEP MED RE, V1, P47, DOI 10.1007/s40675-014-0006-4; Elias CF, 2008, J CHEM NEUROANAT, V35, P188, DOI 10.1016/j.jchemneu.2007.10.002; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Feuchtinger A, 2016, HISTOCHEM CELL BIOL, V146, P781, DOI 10.1007/s00418-016-1495-7; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; Garcia-Marin Virginia, 2007, Trends Neurosci, V30, P479, DOI 10.1016/j.tins.2007.06.008; GEORGE R, 1964, INT J NEUROPHARMACOL, V3, P541; Gerashchenko D, 2001, J NEUROSCI, V21, P7273; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; GRACE AA, 1986, J PHARMACOL EXP THER, V238, P1092; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Guo F, 2016, NATURE, V536, P292, DOI 10.1038/nature19097; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Han X, 2012, ACS CHEM NEUROSCI, V3, P577, DOI 10.1021/cn300065j; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hasegawa E, 2014, J CLIN INVEST, V124, P604, DOI 10.1172/JCI71017; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; HENLEY K, 1974, ACTA NEUROBIOL EXP, V34, P215; Herrera CG, 2016, NAT NEUROSCI, V19, P290, DOI 10.1038/nn.4209; Hirashima N, 2011, SLEEP, V34, P31, DOI 10.1093/sleep/34.1.31                                                           ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Irmak SO, 2014, SLEEP, V37, P1941, DOI 10.5665/sleep.4246; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; John J, 2004, NEURON, V42, P619, DOI 10.1016/S0896-6273(04)00247-8; Jones CR, 1999, NAT MED, V5, P1062; JOUVET M, 1962, Arch Ital Biol, V100, P125; JOUVET M, 1972, ERG PHYSIOL BIOL CH, V64, P166; Kantor S, 2013, SLEEP, V36, P1129, DOI 10.5665/sleep.2870; Konadhode RR, 2016, SLEEP, V39, P491, DOI 10.5665/sleep.5508; Konadhode RR, 2013, J NEUROSCI, V33, P10257, DOI 10.1523/JNEUROSCI.1225-13.2013; Krueger JM, 2011, CURR TOP MED CHEM, V11, P2390; Lagos P, 2011, BRAIN RES, V1369, P112, DOI 10.1016/j.brainres.2010.11.027; Lee E, 2016, SCI REP-UK, V6, DOI 10.1038/srep18631; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0                                                   ; Liu M, 2008, EUR J NEUROSCI, V28, P1382, DOI 10.1111/j.1460-9568.2008.06446.x; Liu M, 2016, EUR J NEUROSCI, V43, P681, DOI 10.1111/ejn.13158; Liu M, 2011, J NEUROSCI, V31, P6028, DOI 10.1523/JNEUROSCI.6069-10.2011; Lundgaard I, 2017, J CEREBR BLOOD F MET, V37, P2112, DOI 10.1177/0271678X16661202; LYDIC R, 1991, AM J PHYSIOL, V261, pR766; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Mochizuki T, 2011, P NATL ACAD SCI USA, V108, P4471, DOI 10.1073/pnas.1012456108; MORUZZI G, 1972, ERG PHYSIOL BIOL CH, V64, P1; Muramatsu S, 2010, MOL THER, V18, P1731, DOI 10.1038/mt.2010.135; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Peever J, 2016, CURR BIOL, V26, pR34, DOI 10.1016/j.cub.2015.11.011; Peever J, 2014, TRENDS NEUROSCI, V37, P279, DOI 10.1016/j.tins.2014.02.009; Pelluru D, 2016, EUR J NEUROSCI, V43, P1298, DOI 10.1111/ejn.13074; Pelluru D, 2013, SLEEP, V36, P1779, DOI 10.5665/sleep.3196; Peyron C, 2000, NAT MED, V6, P991; Pimentel D, 2016, NATURE, V536, P333, DOI 10.1038/nature19055; Poskanzer KE, 2016, P NATL ACAD SCI USA, V113, pE2675, DOI 10.1073/pnas.1520759113; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reid KJ, 2001, ARCH NEUROL-CHICAGO, V58, P1089, DOI 10.1001/archneur.58.7.1089; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Rye DB, 2015, SLEEP MED CLIN, V10, P227, DOI 10.1016/j.jsmc.2015.05.015; Rye DB, 2015, SLEEP MED CLIN, V10, pxii; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6                                                   ; Sasaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020360; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SCHENCK CH, 1988, AM J PSYCHIAT, V145, P652; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216                                                    ; SHIROMANI PJ, 1987, ANNU REV PHARMACOL, V27, P137; SHIROMANI PJ, 1992, BRAIN RES, V580, P351, DOI 10.1016/0006-8993(92)90968-F                                                    ; SIEGEL JM, 1979, BRAIN RES REV, V1, P69, DOI 10.1016/0165-0173(79)90017-1; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sunagawa GA, 2016, CELL REP, V14, P662, DOI 10.1016/j.celrep.2015.12.052; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Szymusiak R, 2007, SLEEP MED, V8, P291, DOI 10.1016/j.sleep.2007.03.013; Tabuchi S, 2014, J NEUROSCI, V34, P6495, DOI 10.1523/JNEUROSCI.0073-14.2014; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1                                                   ; Tian Lin, 2012, Cold Spring Harb Protoc, V2012, P647, DOI 10.1101/pdb.top069609; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499                                                         ; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Torterolo P, 2009, BRAIN RES, V1268, P76, DOI 10.1016/j.brainres.2009.02.055; Trojanowski NF, 2016, TRENDS NEUROSCI, V39, P54, DOI 10.1016/j.tins.2015.12.005; Tsunematsu T, 2014, J NEUROSCI, V34, P6896, DOI 10.1523/JNEUROSCI.5344-13.2014; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; van den Pol AN, 2009, J COMP NEUROL, V516, P456, DOI 10.1002/cne.22131; Van Dort CJ, 2015, P NATL ACAD SCI USA, V112, P584, DOI 10.1073/pnas.1423136112; Varin C, 2016, BEHAV BRAIN RES, V298, P100, DOI 10.1016/j.bbr.2015.10.051; Venner A, 2016, CURR BIOL, V26, P2137, DOI 10.1016/j.cub.2016.05.078; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Watakabe A, 2015, NEUROSCI RES, V93, P144, DOI 10.1016/j.neures.2014.09.002; Weber F, 2016, NATURE, V538, P51, DOI 10.1038/nature19773; Weber F, 2015, NATURE, V526, P435, DOI 10.1038/nature14979; WEBSTER HH, 1988, BRAIN RES, V458, P285, DOI 10.1016/0006-8993(88)90471-4; Willie JT, 2008, NEUROSCIENCE, V156, P819, DOI 10.1016/j.neuroscience.2008.08.048; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xu M, 2015, NAT NEUROSCI, V18, P1641, DOI 10.1038/nn.4143; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yang HH, 2016, J NEUROSCI, V36, P9977, DOI 10.1523/JNEUROSCI.1095-16.2016; Yang L, 2015, CELL REP, V11, P798, DOI 10.1016/j.celrep.2015.04.002; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	137	2	2	8	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	APR 1	2017	40	4								10.1093/sleep/zsx032				14	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EU2MJ	WOS:000400863200003					2018-01-05	
J	Rock, JM; Hopkins, FF; Chavez, A; Diallo, M; Chase, MR; Gerrick, ER; Pritchard, JR; Church, GM; Rubin, EJ; Sassetti, CM; Schnappinger, D; Fortune, SM				Rock, Jeremy M.; Hopkins, Forrest F.; Chavez, Alejandro; Diallo, Marieme; Chase, Michael R.; Gerrick, Elias R.; Pritchard, Justin R.; Church, George M.; Rubin, Eric J.; Sassetti, Christopher M.; Schnappinger, Dirk; Fortune, Sarah M.			Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform	NATURE MICROBIOLOGY			English	Article							SEQUENCE-SPECIFIC CONTROL; GENE-EXPRESSION; CAS SYSTEMS; STREPTOCOCCUS-THERMOPHILUS; AMINOSALICYLIC ACID; DNA CLEAVAGE; DUAL-RNA; TUBERCULOSIS; RESISTANCE; HOST	The development of new drug regimens that allow rapid, sterilizing treatment of tuberculosis has been limited by the complexity and time required for genetic manipulations in Mycobacterium tuberculosis. CRISPR interference (CRISPRi) promises to be a robust, easily engineered and scalable platform for regulated gene silencing. However, in M. tuberculosis, the existing Streptococcus pyogenes Cas9-based CRISPRi system is of limited utility because of relatively poor knockdown efficiency and proteotoxicity. To address these limitations, we screened eleven diverse Cas9 orthologues and identified four that are broadly functional for targeted gene knockdown in mycobacteria. The most efficacious of these proteins, the CRISPR1 Cas9 from Streptococcus thermophilus (dCas9(Sth1)), typically achieves 20- to 100-fold knockdown of endogenous gene expression with minimal proteotoxicity. In contrast to other CRISPRi systems, dCas9(Sth1)-mediated gene knockdown is robust when targeted far from the transcriptional start site, thereby allowing high-resolution dissection of gene function in the context of bacterial operons. We demonstrate the utility of this system by addressing persistent controversies regarding drug synergies in the mycobacterial folate biosynthesis pathway. We anticipate that the dCas9(Sth1) CRISPRi system will have broad utility for functional genomics, genetic interaction mapping and drug-target profiling in M. tuberculosis.	[Rock, Jeremy M.; Hopkins, Forrest F.; Diallo, Marieme; Chase, Michael R.; Gerrick, Elias R.; Pritchard, Justin R.; Rubin, Eric J.; Fortune, Sarah M.] Harvard T H Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Hopkins, Forrest F.; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Chavez, Alejandro] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Chavez, Alejandro; Church, George M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Schnappinger, Dirk] Weill Cornell Med Coll, Dept Immunol & Microbiol, New York, NY 10065 USA; [Fortune, Sarah M.] Harvard & MIT, Ragon Inst MGH, Cambridge, MA 02139 USA	Fortune, SM (reprint author), Harvard T H Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Fortune, SM (reprint author), Harvard & MIT, Ragon Inst MGH, Cambridge, MA 02139 USA.	sfortune@hsph.harvard.edu		church, george/0000-0001-6232-9969	Helen Hay Whitney fellowship; NIH Director's New Innovator Award [1DP20D001378]; NIAID [U19 AI107774]; Doris Duke Charitable Foundation [2010054]; National Cancer Institute [5T32CA009216-34]; US National Institutes of Health National Human Genome Research Institute [P50 HG005550]; Wyss Institute for Biologically Inspired Engineering	The authors thank L. Gilbert for advice. This work was supported by a Helen Hay Whitney fellowship to J. M. R., an NIH Director's New Innovator Award 1DP20D001378, subcontracts from NIAID U19 AI107774 and a Doris Duke Charitable Foundation Grant 2010054 to S. M. F. A. C. was funded by the National Cancer Institute grant no. 5T32CA009216-34. G. M. C. acknowledges support from the US National Institutes of Health National Human Genome Research Institute grant no. P50 HG005550 and the Wyss Institute for Biologically Inspired Engineering.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barker LP, 1999, FEMS MICROBIOL LETT, V175, P79, DOI 10.1016/S0378-1097(99)00169-X; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; BUSHBY SRM, 1973, J INFECT DIS, V128, pS442, DOI 10.1093/infdis/128.Supplement_3.S442                                            ; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI 10.1093/nar/gkm900; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fivian-Hughes AS, 2012, MICROBIOL-SGM, V158, P308, DOI 10.1099/mic.0.053983-0; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kim JH, 2011, NUCLEIC ACIDS RES, V39, P2210, DOI 10.1093/nar/gkq1149; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Leblanc C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003097; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Lin K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005675; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Minato Y, 2015, ANTIMICROB AGENTS CH, V59, P5097, DOI 10.1128/AAC.00647-15; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; Nielsen AA, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145735; Ong W, 2010, ANTIMICROB AGENTS CH, V54, P2748, DOI 10.1128/AAC.00029-10; Park SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002264; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Reddy BKK, 2014, ANTIMICROB AGENTS CH, V58, P3312, DOI 10.1128/AAC.00140-14; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rock JM, 2015, NAT GENET, V47, P677, DOI 10.1038/ng.3269; Singh Atul K, 2016, Nucleic Acids Res, V44, pe143; Vilcheze C, 2012, ANTIMICROB AGENTS CH, V56, P5142, DOI 10.1128/AAC.00832-12; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; White EL, 2004, FEMS MICROBIOL LETT, V232, P101, DOI 10.1016/S0378-1097(04)00038-2; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946	52	3	3	10	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2058-5276			NAT MICROBIOL	NAT. MICROBIOL	APR	2017	2	4							16274	10.1038/nmicrobiol.2016.274				9	Microbiology	Microbiology	EQ6FS	WOS:000398177800014	28165460	green_accepted			2018-01-05	
J	Van Eenennaam, AL				Van Eenennaam, Alison Louise			Genetic modification of food animals	CURRENT OPINION IN BIOTECHNOLOGY			English	Review							ZINC-FINGER NUCLEASES; FARM-ANIMALS; PIGS; LIVESTOCK; CATTLE; GENERATION; TRANSGENESIS; AGRICULTURE; CRISPR/CAS9; MUTATIONS	Animal breeders have used a variety of methods in selective breeding programs to genetically improve food animal species. Recently this has included the use of both genetic engineering and genome editing, particularly for targeting improvement in traits for which there is no within-species or within-breed genetic variation. Both intraspecies and interspecies allele substitutions and gene knock-ins have been accomplished with genome editing tools, targeting a number of important traits. The regulatory status of such animals is unclear as the definition of a regulated article is not consistent among different regulatory agencies and organizations. In the absence of a harmonized global regulatory approach to the genetic improvement of animals, it will be difficult for breeders to effectively achieve sustainable breeding objectives.	[Van Eenennaam, Alison Louise] Univ Calif Davis, Dept Anim Sci, One Shields Ave, Davis, CA 95616 USA	Van Eenennaam, AL (reprint author), Univ Calif Davis, Dept Anim Sci, One Shields Ave, Davis, CA 95616 USA.	alvaneenennaam@ucdavis.edu			Biotechnology Risk Assessment Grant Program Competitive Grant from the National Institute of Food and Agriculture/U.S. Department of Agriculture [2015-33522-24106]; Agriculture and Food Research Initiative Competitive Grant from the National Institute of Food and Agriculture/U.S. Department of Agriculture [2015-67015-23316]	This work was supported by Biotechnology Risk Assessment Grant Program Competitive Grant no. 2015-33522-24106 and Agriculture and Food Research Initiative Competitive Grant no. 2015-67015-23316 from the National Institute of Food and Agriculture/U.S. Department of Agriculture. Special thanks to Amy E. Young for assistance in preparation of the figures.	Agapito-Tenfen SZ, 2015, 0215 GENOK BIOS; Bosch P, 2015, CELL MOL LIFE SCI, V72, P1907, DOI 10.1007/s00018-015-1842-1; Bruce A, 2013, TRANSGENIC RES, V22, P681, DOI 10.1007/s11248-013-9724-5; Camachol A, 2014, NAT BIOTECHNOL, V32, P1087, DOI 10.1038/nbt.3057; Capper JL, 2009, J ANIM SCI, V87, P2160, DOI 10.2527/jas.2009-1781; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Carroll D, 2016, NAT BIOTECHNOL, V34, P477, DOI 10.1038/nbt.3566; Conko G, 2016, NAT BIOTECHNOL, V34, P493, DOI 10.1038/nbt.3568; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Du S. J., 1992, NAT BIOTECHNOL, V10, P176; FAO/World Health Organization, 2008, 682008 FAO WHO CACGL, P1; Frewer LJ, 2013, TRENDS FOOD SCI TECH, V30, P142, DOI 10.1016/j.tifs.2013.01.003; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Gholap PN, 2014, RES J ANIM VET FISH, V2, P24; Gill M, 2010, ANIMAL, V4, P323, DOI 10.1017/S1751731109004662; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Han HB, 2014, FRONT AGRIC SCI ENG, V1, P2, DOI 10.15302/J-FASE-2014007; Hickey JM, 2013, J ANIM BREED GENET, P130; Jenko J, 2015, GENET SEL EVOL, V47, P1; Kasinathan P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08674; Keefer CL, 2015, P NATL ACAD SCI USA, V112, P8874, DOI 10.1073/pnas.1501718112; Koo T, 2015, MOL CELLS, V38, P475, DOI 10.14348/molcells.2015.0103; Laible G, 2015, BIOTECHNOL J, V10, P109, DOI 10.1002/biot.201400193; Li P, 2015, XENOTRANSPLANTATION, V22, P20, DOI 10.1111/xen.12131; Lievens A, 2015, TRENDS FOOD SCI TECH, V44, P159, DOI 10.1016/j.tifs.2015.05.001; Lillico SG, 2013, SCI RES, P3; Lillico SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21645; Liu X, 2013, NAT COMMUN, P4; Liu XJ, 2014, ADV INTEL SYS RES, V113, P281; Luo JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095225; Murray JD, 2016, P NATL ACAD SCI USA, V113, P3410, DOI 10.1073/pnas.1602474113; Murray JD, 2016, TRANSGENIC RES, V25, P321, DOI 10.1007/s11248-016-9927-7; NAS [National Academies of Sciences Engineering and Medicine], 2016, GEN ENG CROPS EXP PR, DOI 10.17226/; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; O'Geen H, 2015, CURR OPIN CHEM BIOL, V29, P72, DOI 10.1016/j.cbpa.2015.10.001; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Peng J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16705; Petersen B, 2015, TRANSGENIC RES, V24, P381, DOI 10.1007/s11248-015-9862-z; Proudfoot C, 2015, TRANSGENIC RES, P24; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Reyes LM, 2014, J IMMUNOL, V193, P5751, DOI 10.4049/jimmunol.1402059; Scott SE, 2016, PERSPECT PSYCHOL SCI, V11, P315, DOI 10.1177/1745691615621275; Tan W, 2016, TRANSGENIC RES; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Van Eenennaam AL, 2014, ANNU REV ANIM BIOSCI, V2, P105, DOI 10.1146/annurev-animal-022513-114119; Van Eenennaam AL, 2011, NAT BIOTECHNOL, V29, P706, DOI 10.1038/nbt.1938; Van Eenennaam AL, 2015, AGR FOOD SECUR, V4, P1; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Wang SH, 2016, FRONT AGRIC SCI ENG, V3, P1, DOI 10.15302/J-FASE-2016085; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153	54	6	6	23	28	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0958-1669	1879-0429		CURR OPIN BIOTECH	Curr. Opin. Biotechnol.	APR	2017	44						27	34		10.1016/j.copbio.2016.10.007				8	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	ET8ER	WOS:000400532100006	27835795				2018-01-05	
J	Francis, D; Finer, JJ; Grotewold, E				Francis, David; Finer, John J.; Grotewold, Erich			Challenges and opportunities for improving food quality and nutrition through plant biotechnology	CURRENT OPINION IN BIOTECHNOLOGY			English	Review							CROPS; TOMATO; CRISPR/CAS9; ANTHOCYANINS; FRUIT	Plant biotechnology has been around since the advent of humankind, resulting in tremendous improvements in plant cultivation through crop domestication, breeding and selection. The emergence of transgenic approaches involving the introduction of defined DNA sequences into plants by humans has rapidly changed the surface of our planet by further expanding the gene pool used by plant breeders for plant improvement. Transgenic approaches in food plants have raised concerns on the merits, social implications, ecological risks and true benefits of plant biotechnology. The recently acquired ability to precisely edit plant genomes by modifying native genes without introducing new genetic material offers new opportunities to rapidly exploit natural variation, create new variation and incorporate changes with the goal to generate more productive and nutritious plants.	[Francis, David; Finer, John J.; Grotewold, Erich] Ohio State Univ, Dept Hort & Crop Sci, Wooster, OH 44961 USA; [Francis, David; Finer, John J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Wooster, OH 44961 USA; [Grotewold, Erich] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Grotewold, Erich] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA	Grotewold, E (reprint author), Ohio State Univ, Dept Hort & Crop Sci, Wooster, OH 44961 USA.; Grotewold, E (reprint author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.; Grotewold, E (reprint author), Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA.	grotewold.1@osu.edu		Grotewold, Erich/0000-0002-4720-7290; Finer, John/0000-0001-8004-5468	Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture [2015-67013-22810]; State and Federal Funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University	The EG lab acknowledges the Agriculture and Food Research Initiative competitive grant 2015-67013-22810 of the USDA National Institute of Food and Agriculture for research on crop improvement. Salaries and research support were provided in part by State and Federal Funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University. Mention of trademark or proprietary products does not constitute a guarantee or warranty of the product by OSU/OARDC and also does not imply approval to the exclusion of other products that may also be suitable. We apologize to the many authors whose papers we could not cite here due to space limitations.	Abberton M, 2016, PLANT BIOTECHNOL J, V14, P1095, DOI 10.1111/pbi.12467; ALEXANDER LJ, 1963, PHYTOPATHOLOGY, V53, P869; Araki M, 2015, TRENDS PLANT SCI, V20, P145, DOI 10.1016/j.tplants.2015.01.010; Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Calafiore R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00397; Caro M, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0329-y; Cases MI, 2014, FRONT PLANT SCI, V5, P440; Castaneda-Alvarez NP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.22, 10.1038/nplants.2016.22]; Cheng F, 2016, NAT GENET; Crow JF, 1998, GENETICS, V148, P923; Fernandez-Cornejo J., 2014, GENETICALLY ENG CROP; Finn S, 2014, SCIENCE, V346, P1247; Fridman E, 2015, PLANT SCI, V232, P35, DOI 10.1016/j.plantsci.2014.11.014; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Gilligan DO, 2012, CESIFO ECON STUD, V58, P405, DOI 10.1093/cesifo/ifs020; Gray DJ, 2014, PLANT SCI, V228, P3, DOI 10.1016/j.plantsci.2014.03.023; Gruber K, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.48, 10.1038/nplants.2016.48]; Gupta PK, 2015, NAT BIOTECHNOL, V33, P904, DOI 10.1038/nbt.3331; Hall SS, 2016, SCI AM, V314, P56, DOI 10.1038/scientificamerican0316-56                                               ; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Hautea DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157498; Hefferon KL, 2015, INT J MOL SCI, V16, P3895, DOI 10.3390/ijms16023895; Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; Huang JK, 2002, NATURE, V418, P678, DOI 10.1038/nature01015; Jones CM, 2003, J HERED, V94, P449, DOI 10.1093/jhered/esg093; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Malyska A, 2016, TRENDS BIOTECHNOL, V34, P530, DOI 10.1016/j.tibtech.2016.03.005; Mayes S, 2012, J EXP BOT, V63, P1075, DOI 10.1093/jxb/err396; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Mondal S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00991; Perveen R, 2015, CRIT REV FOOD SCI, V55, P919, DOI 10.1080/10408398.2012.657809; Philipson TJ, 2014, SCIENCE, V346, P1247; Prigge Vanessa, 2012, Methods Mol Biol, V877, P161, DOI 10.1007/978-1-61779-818-4_13; Stone GD, 2016, AGR HUM VALUES, P1; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Wolt JD, 2016, IN VITRO CELL DEV, P1; Wolt JD, 2016, PLANT BIOTECHNOL J, V14, P510, DOI 10.1111/pbi.12444; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zhang Y, 2013, CURR BIOL, V23, P1094, DOI 10.1016/j.cub.2013.04.072	44	1	1	29	40	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0958-1669	1879-0429		CURR OPIN BIOTECH	Curr. Opin. Biotechnol.	APR	2017	44						124	129		10.1016/j.copbio.2016.11.009				6	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	ET8ER	WOS:000400532100019	28088010				2018-01-05	
J	Saraggi, D; Fassan, M; Mescoli, C; Scarpa, M; Valeri, N; Michielan, A; D'Inca, R; Rugge, M				Saraggi, Deborah; Fassan, Matteo; Mescoli, Claudia; Scarpa, Marco; Valeri, Nicola; Michielan, Andrea; D'Inca, Renata; Rugge, Massimo			The molecular landscape of colitis-associated carcinogenesis	DIGESTIVE AND LIVER DISEASE			English	Article						Biomarkers; Colitis; Dysplasia; IBD; Molecular pathology	INFLAMMATORY-BOWEL-DISEASE; CHRONIC ULCERATIVE-COLITIS; RAS GENE-MUTATIONS; COLORECTAL-CANCER; COLON-CANCER; MICROSATELLITE INSTABILITY; PRECANCEROUS LESIONS; CROHNS-DISEASE; COLECTOMY SPECIMENS; EPITHELIAL-CELLS	In spite of the well-established histopathological phenotyping of IBD-associated preneoplastic and neoplastic lesions, their molecular landscape remains to be fully elucidated. Several studies have pinpointed the initiating role of longstanding/relapsing inflammatory insult on the intestinal mucosa, with the activation of different pro-inflammatory cytokines (TNF-alpha, IL-6, IL-10, IFN-gamma), chemokines and metabolites of arachidonic acid resulting in the activation of key transcription factors such as NF-kappa B. Longstanding inflammation may also modify the intestinal microbiota, prompting the overgrowth of genotoxic microorganisms, which may act as further cancer promoters. Most of the molecular dysregulation occurring in sporadic colorectal carcinogenesis is documented in colitis-associated adenocarcinoma too, but marked differences have been established in both their timing and prevalence. Unlike sporadic cancers, TP53 alterations occur early in IBD-related carcinogenesis, while APC dysregulation emerges mainly in the most advanced stages of the oncogenic cascade. From the therapeutic standpoint, colitis-associated cancers are associated with a lower prevalence of KRAS mutations than the sporadic variant. Epigenetic changes, including DNA methylation, histone modifications, chromatin remodeling, and non-coding RNAs, are significantly involved in colitis-associated cancer development and progression. The focus now is on identifying diagnostic and prognostic biomarkers, with a view to ultimately designing patient-tailored therapies. (C) 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Saraggi, Deborah; Fassan, Matteo; Rugge, Massimo] Univ Padua, Dept Med DIMED, Surg Pathol & Cytopathol Unit, Padua, Italy; [Scarpa, Marco] IRCCS, IOV, Surg Oncol Unit, Padua, Italy; [Valeri, Nicola] Inst Canc Res, Dept Mol Pathol, London, England; [Valeri, Nicola] Royal Marsden NHS Trust, Dept Med, London, England; [Mescoli, Claudia; Michielan, Andrea; D'Inca, Renata] Univ Padua, Gastroenterol Unit, Dept Surg Oncol & Gastroenterol DiSCOG, Padua, Italy	Rugge, M (reprint author), Univ Padua, Dept Med DIMED, Via Gabelli 61, I-35121 Padua, Italy.	massimo.rugge@unipd.it	Saraggi, Deborah/T-1957-2017	Saraggi, Deborah/0000-0002-0942-2707; Fassan, Matteo/0000-0001-6515-5482	Italian Association for Cancer Research (AIRC) [6421]	This work was partly supported by a grant from the Italian Association for Cancer Research (AIRC Regional grant 2008 N. 6421).	Agoff SN, 2000, AM J PATHOL, V157, P737, DOI 10.1016/S0002-9440(10)64587-7; Allende D, 2014, COLORECTAL DIS, V16, P710, DOI 10.1111/codi.12667; Askling J, 2001, GASTROENTEROLOGY, V120, P1356, DOI 10.1053/gast.2001.24052; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2005, CELL CYCLE, V4, P217; BELL SM, 1991, BRIT J CANCER, V64, P174, DOI 10.1038/bjc.1991.264; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bernstein CN, 2001, CANCER, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z                    ; Boyapati RK, 2016, AM J GASTROENTEROL, V111, P1682, DOI 10.1038/ajg.2016.441; Brackmann S, 2009, SCAND J GASTROENTERO, V44, P46, DOI 10.1080/00365520801977568; Bressenot A, 2014, WORLD J GASTROENTERO, V20, P3164, DOI 10.3748/wjg.v20.i12.3164; BURMER GC, 1992, GASTROENTEROLOGY, V103, P1602, DOI 10.1016/0016-5085(92)91184-6                                                    ; BURMER GC, 1990, GASTROENTEROLOGY, V99, P416, DOI 10.1016/0016-5085(90)91024-Z                                                    ; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; CHAUBERT P, 1994, AM J PATHOL, V144, P767; Collins PD, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000279.pub3; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Cornaggia M, 2011, DIGEST LIVER DIS, V43, pS293, DOI 10.1016/S1590-8658(11)60585-9; D'Angelo E, 2015, CURR DRUG TARGETS, V16, P383, DOI 10.2174/1389450116666141210091454                                               ; Delaunoit T, 2006, CLIN GASTROENTEROL H, V4, P335, DOI 10.1016/j.cgh.2005.12.035; Eaden J, 2003, ALIMENT PHARM THERAP, V18, P15, DOI 10.1046/j.1365-2036.18.s2.3.x; EADEN J, 2001, THE JOURNAL OF PATHO, V194, P152; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Engelsgjerd M, 1999, GASTROENTEROLOGY, V117, P1288, DOI 10.1016/S0016-5085(99)70278-7; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI 10.1053/j.gastro.2009.12.035; Fassan M, 2013, BEST PRACT RES CL GA, V27, P159, DOI 10.1016/j.bpg.2013.03.009; Fassan M, 2013, CURR OPIN GENET DEV, V23, P75, DOI 10.1016/j.gde.2013.02.009; Fassan M, 2011, WORLD J GASTROENTERO, V17, P5231, DOI 10.3748/wjg.v17.i48.5231; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Fisher K, 2015, WORLD J GASTROENTERO, V21, P12274, DOI 10.3748/wjg.v21.i43.12274; Fleisher AS, 2000, CANCER RES, V60, P4864; Fogt F, 1998, HUM PATHOL, V29, P131, DOI 10.1016/S0046-8177(98)90222-2; Fujiwara I, 2008, DIS COLON RECTUM, V51, P1387, DOI 10.1007/s10350-008-9212-9; GILLEN CD, 1994, GUT, V35, P1590, DOI 10.1136/gut.35.11.1590; GREENWALD BD, 1992, CANCER RES, V52, P741; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; HARPAZ N, 1994, HUM PATHOL, V25, P1069, DOI 10.1016/0046-8177(94)90067-1; Harpaz N, 2013, BEST PRACT RES CL GA, V27, P257, DOI 10.1016/j.bpg.2013.03.014; Holzmann K, 1998, INT J CANCER, V76, P1; Hsieh CJ, 1998, CANCER RES, V58, P3942; Hussain SP, 2000, CANCER RES, V60, P3333; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jess T, 2012, GASTROENTEROLOGY, V143, pe1, DOI DOI 10.1053/J.GASTRO.2012.04.016; Jess T, 2012, GASTROENTEROLOGY, V143, P375, DOI 10.1053/j.gastro.2012.04.016; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Kado S, 2001, CANCER RES, V61, P2395; Katsurano M, 2012, ONCOGENE, V31, P342, DOI 10.1038/onc.2011.241; Kiran RP, 2014, ANN SURG, V259, P302, DOI 10.1097/SLA.0b013e31828e7417; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Langner C, 2014, VIRCHOWS ARCH, V464, P511, DOI 10.1007/s00428-014-1543-4; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Ludwig K, 2013, VIRCHOWS ARCH, V462, P57, DOI 10.1007/s00428-012-1345-5; Magro F, 2013, J CROHNS COLITIS, V7, P827, DOI 10.1016/j.crohns.2013.06.001; Mangerich A, 2012, P NATL ACAD SCI USA, V109, pE1820, DOI 10.1073/pnas.1207829109; Manuc TEM, 2016, CLIN EXP GASTROENTER, V9, P59, DOI 10.2147/CEG.S53381; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Matsumura S, 2003, VIRCHOWS ARCH, V443, P518, DOI 10.1007/s00428-003-0877-0; Matula S, 2005, CLIN GASTROENTEROL H, V3, P1015, DOI 10.1053/S1542-3565(05)00738-X; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Mescoli C, 2013, DIGEST LIVER DIS, V45, P186, DOI 10.1016/j.dld.2012.07.013; Mitsuyama K, 2006, GUT, V55, P1263, DOI 10.1136/gut.2005.079343; Nieminen U, 2014, INT J CANCER, V134, P189, DOI 10.1002/ijc.28346; Nuako KW, 1998, GASTROENTEROLOGY, V115, P1079, DOI 10.1016/S0016-5085(98)70077-0; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; PARENTI AR, 1995, THE AMERICAN JOURNAL, V19, P1418; REDSTON MS, 1995, GASTROENTEROLOGY, V108, P383, DOI 10.1016/0016-5085(95)90064-0; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Robles AI, 2016, GASTROENTEROLOGY, V150, P931, DOI 10.1053/j.gastro.2015.12.036; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rutter MD, 2006, GASTROENTEROLOGY, V130, P1030, DOI 10.1053/j.gastro.2005.12.035; Sanchez JA, 2011, INFLAMM BOWEL DIS, V17, P1966, DOI 10.1002/ibd.21526; SCHOTTELIUS AJ, 1999, THE JOURNAL OF BIOLO, V274, P31868; Soderlund S, 2009, GASTROENTEROLOGY, V137, P1858, DOI 10.1053/j.gastro.2009.09.042; Soderlund S, 2009, GASTROENTEROLOGY, V136, P1561, DOI 10.1053/j.gastro.2009.01.064; SUZUKI H, 1994, CANCER RES, V54, P4841; TARMIN L, 1995, CANCER RES, V55, P2035; Tsaitas Christos, 2014, World J Hepatol, V6, P178, DOI 10.4254/wjh.v6.i4.178; Ullman T, 2009, INFLAMM BOWEL DIS, V15, P630, DOI 10.1002/ibd.20766; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Umetani N, 1999, JPN J CANCER RES, V90, P1081, DOI 10.1111/j.1349-7006.1999.tb00681.x                                              ; Valeri N, 2014, CANCER CELL, V25, P469, DOI 10.1016/j.ccr.2014.03.006; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378                                                              ; Yang GY, 2009, METHODS MOL BIOL, V512, P119, DOI 10.1007/978-1-60327-530-9_8; YIN J, 1993, GASTROENTEROLOGY, V104, P1633, DOI 10.1016/0016-5085(93)90639-T                                                    ; Zisman TL, 2008, WORLD J GASTROENTERO, V14, P2662, DOI 10.3748/wjg.14.2662	91	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	APR	2017	49	4					326	330		10.1016/j.dld.2016.12.011				5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	ET6TB	WOS:000400424200002	28089111				2018-01-05	
J	Beres, NJ; Kiss, Z; Sztupinszki, Z; Lendvai, G; Arato, A; Sziksz, E; Vannay, A; Szabo, AJ; Muller, KE; Cseh, A; Boros, K; Veres, G				Beres, Nra Judit; Kiss, Zoltan; Sztupinszki, Zsofia; Lendvai, Gabor; Arato, Andras; Sziksz, Erna; Vannay, Adam; Szabo, Attila J.; Muller, Katalin Eszter; Cseh, Aron; Boros, Kriszta; Veres, Gabor			Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease	DIGESTIVE AND LIVER DISEASE			English	Article						Inflammatory bowel disease; MicroRNA; Mucosal; Pediatric	CROHNS-DISEASE; ULCERATIVE-COLITIS; ADOLESCENT PATIENTS; COLONIC-MUCOSA; CANCER CELLS; EUROKIDS REGISTRY; 5-YEAR ANALYSES; CHILDREN; GENE; PATHOGENESIS	Introduction: MicroRNAs (miRs) came recently into focus as promising novel research targets offering new insights into the pathogenesis of inflammatory bowel diseases (IBD). Aims: The aim of our study was to identify a pediatric IBD (pIBD) characteristic miR profile serving as potential Crohn's disease (CD) and ulcerative colitis (UC) specific diagnostic pattern and to further analyze the related target genes. Methods: Small RNA sequencing was performed on inflamed and intact colonic biopsies of CD, and control patients. Selected miRs were further investigated by RT-PCR, complemented with an UC group, in order to address the differential diagnostic potential of miRs in the two IBD subtypes. To analyze network connection of differentially expressed miRs and their target genes MiRTarBase database and previous transcriptome sequencing data from pediatric patient groups were used. Results: Sequencing analysis identified 170 miRs with altered expression. RT-PCR analysis revealed altered expression of miR-31, -125a, -142-3p, and -146a discriminating between the inflamed mucosa of CD and UC. In the intact mucosa of CD patients the expression of miR-18a, -20a, -21, -31, -99a, -99b, -100, -125a, -126, -142-5p, -146a, -185, -204, -221, and -223 was elevated compared to the controls. The expression of miR-20a, -204 and -221 was elevated exclusively in the intact region of CD patients compared to the controls. Enrichment analysis identified main IBD-related functional groups. Conclusions: We demonstrated a characteristic colonic miR pattern in pIBD that could facilitate deeper understanding of the pathomechanism of IBD and may serve as a diagnostic tool. (C) 2016 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.	[Beres, Nra Judit; Kiss, Zoltan; Sztupinszki, Zsofia; Arato, Andras; Sziksz, Erna; Vannay, Adam; Szabo, Attila J.; Muller, Katalin Eszter; Cseh, Aron; Boros, Kriszta; Veres, Gabor] Semmelweis Univ, Dept Pediat 1, Bokay Janos Str 53-54, H-1083 Budapest, Hungary; [Lendvai, Gabor] MTA SE Tumor Progress Res Grp, Budapest, Hungary; [Sziksz, Erna; Vannay, Adam; Szabo, Attila J.; Veres, Gabor] MTA SE Pediat & Nephrol Res Grp, Budapest, Hungary	Veres, G (reprint author), Semmelweis Univ, Dept Pediat 1, Bokay Janos Str 53-54, H-1083 Budapest, Hungary.	veres.gabor@med.semmelweis-univ.hu	Arato, Andras/N-9802-2017	Arato, Andras/0000-0002-7980-6327; Muller, Katalin Eszter/0000-0001-5355-4224	Hungarian Scientific Research Fund [OTKA-K105530, OTKA-K108688, OTKA-K116928, OTKA-PD105361, LP008/2016]	This work was supported by Hungarian Scientific Research Fund grants OTKA-K105530, -K108688, -K116928, -PD105361, LP008/2016.	Baldassano RN, 1999, GASTROENTEROL CLIN N, V28, P445, DOI 10.1016/S0889-8553(05)70064-9                                                   ; Beres NJ, 2016, INFLAMM BOWEL DIS, V22, P327, DOI 10.1097/MIB.0000000000000687; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; Chen Wei-Xu, 2014, World J Gastrointest Pathophysiol, V5, P63, DOI 10.4291/wjgp.v5.i2.63; Consortium T.G.O. ; Gene Ontology Consortium, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI DOI 10.1093/NAR/GKU1179; Coskun M, 2013, WORLD J GASTROENTERO, V19, P4289, DOI 10.3748/wjg.v19.i27.4289; Coskun M, 2012, WORLD J GASTROENTERO, V18, P4629, DOI 10.3748/wjg.v18.i34.4629; Cromer WE, 2011, WORLD J GASTROENTERO, V17, P578, DOI 10.3748/wjg.v17.i5.578; de Bie CI, 2013, INFLAMM BOWEL DIS, V19, P378, DOI 10.1002/ibd.23008; de Mesquita MB, 2008, DIGEST LIVER DIS, V40, P3, DOI 10.1016/j.dld.2007.07.165; Deuring JJ, 2011, BIOCHEM SOC T, V39, P1107, DOI 10.1042/BST0391107; Di Nardo G, 2011, DIGEST LIVER DIS, V43, P220, DOI 10.1016/j.dld.2010.10.004; Dickover M, 2014, DEV BIOL, V389, P182, DOI 10.1016/j.ydbio.2014.02.014; Eder P, 2014, PRZ GASTROENTEROL, V9, P275, DOI 10.5114/pg.2014.46162; Englund G, 2007, INFLAMM BOWEL DIS, V13, P291, DOI 10.1002/ibd.20030; Fasseu M., 2010, PLOS ONE, V5; Fujioka S, 2014, J GASTROEN HEPATOL, V29, P1207, DOI 10.1111/jgh.12523; Giatromanolaki A, 2003, J CLIN PATHOL, V56, P209, DOI 10.1136/jcp.56.3.209; Gillberg L, 2012, SCAND J GASTROENTERO, V47, P1283, DOI 10.3109/00365521.2012.706830; Grover Z, 2014, J GASTROENTEROL, V49, P638, DOI 10.1007/s00535-013-0815-0; Haberman Y, 2015, J CLIN INVEST, V125, P1363, DOI 10.1172/JCI79657; Hall DP, 2014, CANCER CELL, V26, P738, DOI 10.1016/j.ccell.2014.09.015; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Z, 2014, GUT, V63, P1247, DOI 10.1136/gutjnl-2012-304213; Iborra M, 2013, CLIN EXP IMMUNOL, V173, P250, DOI 10.1111/cei.12104; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Jensen MD, 2015, EUR J GASTROEN HEPAT, V27, P1038, DOI 10.1097/MEG.0000000000000430; Jiao XY, 2013, BREAST CANCER RES TR, V139, P717, DOI 10.1007/s10549-013-2607-x; Kalla R, 2015, GUT, V64, P504, DOI 10.1136/gutjnl-2014-307891; Kim SC, 2004, GASTROENTEROLOGY, V126, P1550, DOI 10.1053/j.gastro.2004.03.022; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lemberg DA, 2005, J GASTROEN HEPATOL, V20, P1696, DOI 10.1111/j.1440-1746.2005.03954.x; Levine A, 2013, J PEDIAT GASTROENTER, V58, P795; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Levine A, 2013, INFLAMM BOWEL DIS, V19, P370, DOI 10.1002/ibd.23013; Lord JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136485; Lovasz BD, 2014, DIGEST LIVER DIS, V46, P405, DOI 10.1016/j.dld.2013.12.013; Mei ZF, 2014, FEBS LETT, V588, P3055, DOI 10.1016/j.febslet.2014.06.020; Meinzer U, 2005, INFLAMM BOWEL DIS, V11, P639, DOI 10.1097/01.MIB.0000165114.10687.bf                                              ; Molnar K, 2012, WORLD J GASTROENTERO, V18, P3254, DOI 10.3748/wjg.v18.i25.3254; Muller KE, 2016, J PEDIATR GASTR NUTR, V62, P50, DOI 10.1097/MPG.0000000000000885; Muller KE, 2013, J PEDIATR GASTR NUTR, V57, P576, DOI 10.1097/MPG.0b013e31829f7d8c; Muller KE, 2013, ORVOSI HETILAP, V154, P1702, DOI 10.1556/OH.2013.29725; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nieuwenhuis EES, 2008, DIGEST LIVER DIS, V40, P12, DOI 10.1016/j.dld.2007.07.166; Palmieri O, 2015, INFLAMM BOWEL DIS, V21, P1260, DOI 10.1097/MIB.0000000000000370; Perrin JM, 2008, J PEDIATR GASTR NUTR, V46, P164, DOI 10.1097/MPG.0b013e31812f7f4e; Rao E, 2012, LEUKEMIA, V26, P1064, DOI 10.1038/leu.2011.305; Rigoli L, 2014, WORLD J GASTROENTERO, V20, P10262, DOI 10.3748/wjg.v20.i30.10262; Schaefer JS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0069-0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen WW, 2013, J MOL MED, V91, P989, DOI 10.1007/s00109-013-1037-x; Sipos F, 2014, WORLD J GASTROENTERO, V20, P12713, DOI 10.3748/wjg.v20.i36.12713; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Sumbul AT, 2014, TUMOR BIOL, V35, P12713, DOI 10.1007/s13277-014-2596-3; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI DOI 10.1155/2015/764641; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Veres G, 2007, DRUGS, V67, P1703, DOI 10.2165/00003495-200767120-00005; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Wen YA, 2015, BBA-MOL BASIS DIS, V1852, P2013, DOI 10.1016/j.bbadis.2015.07.012; Yang T, 2013, EXP BIOL MED, V238, P1024, DOI 10.1177/1535370213497321	65	0	0	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	APR	2017	49	4					378	387		10.1016/j.dld.2016.12.022				10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	ET6TB	WOS:000400424200007	28077249				2018-01-05	
J	Sciarra, A; Pintea, B; Nahm, JH; Donadon, M; Morenghi, E; Maggioni, M; Blanc, JF; Torzilli, G; Yeh, M; Bioulac-Sage, P; Park, YN; Roncalli, M; Di Tommaso, L				Sciarra, Amedeo; Pintea, Bogdan; Nahm, Ji Hae; Donadon, Matteo; Morenghi, Emanuela; Maggioni, Marco; Blanc, Jean Frederic; Torzilli, Guido; Yeh, Matthew; Bioulac-Sage, Paulette; Park, Young Nyun; Roncalli, Massimo; Di Tommaso, Luca			CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation study	DIGESTIVE AND LIVER DISEASE			English	Article						CYP1A2; HCC; Immunocytochemistry; Liver biopsy; Outcome; Translational biomarkers	HEPATOCELLULAR-CARCINOMA; RISK-FACTORS; INTRAHEPATIC RECURRENCE; GENE-EXPRESSION; RESECTION; HEPATECTOMY; PROGNOSIS; CIRRHOSIS	Background: Although hepatic resection is a potentially curative treatment for hepatocellular carcinoma (HCC), post-operative prognosis remains unsatisfactory due to the high incidence of recurrence. Several clinicopathological markers have been associated with HCC recurrence, but none has been validated. Extratumoral expression of cytochrome P4501A2 (CYP1A2) was recently proposed as predictor of HCC recurrence. Aims: To validate extratumoral CYP1A2 as predictor of HCC recurrence and to determine its applicability to pretreatment liver biopsy. Methods: Surgically resected HCC (n.180) with clinicopathological data and follow up were retrospectively studied (HCV n.54; HBV n.91; NAFLD/NASH n.35). CYP1A2 expression was evaluated using an immunohistochemical assay and semiquantitative analysis. Results: Etiology-stratified analysis showed that low CYP1A2 expression was independently associated with recurrence-free survival in HCV patients (HR 2.814, 95% CI 1.300-6.093, p = 0.009); this association was lost in the whole cohort. Pretreatment liver biopsy and paired surgical specimens showed concordant CYP1A2 expression in the vast majority of cases (87%), with NPV of 100%, PPV of 81.25%, and a Cohen kappa of 0.72 (substantial agreement). Conclusion: We validated the extratumoral expression of CYP1A2 as a biomarker of HCC recurrence in HCV patients. CYP1A2 analysis in pretreatment liver biopsy can be of help to stratify HCC patients for personalized treatment. (C) 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Sciarra, Amedeo] Univ Milan, Sch Med, Milan, Italy; [Pintea, Bogdan] Univ Med & Pharm Iuliu Hatieganu, Cluj Napoca, Romania; [Nahm, Ji Hae; Park, Young Nyun] Yonsei Univ, Coll Med, Pathol, Seoul, South Korea; [Donadon, Matteo; Torzilli, Guido] Humanitas Clin & Res Ctr, Hepatobiliary & Gen Surg, Milan, Italy; [Morenghi, Emanuela] Humanitas Clin & Res Ctr, Biostat Unit, Milan, Italy; [Maggioni, Marco] Fdn IRCCS Ca Granda Osped Policlin, Pathol, Milan, Italy; [Blanc, Jean Frederic] CHU Bordeaux, St Andre Hosp, Hepatogastroenterol & Digest Oncol, Bordeaux, France; [Blanc, Jean Frederic; Bioulac-Sage, Paulette] Bordeaux Univ, INSERM, UMR 1053, Bordeaux, France; [Yeh, Matthew] Univ Washington, Sch Med, Pathol, Seattle, WA USA; [Bioulac-Sage, Paulette] Pellegrin Hosp, CHU Bordeaux, Pathol, Bordeaux, France; [Roncalli, Massimo; Di Tommaso, Luca] Humanitas Clin & Res Ctr, Pathol Unit, Milan, Italy; [Roncalli, Massimo; Di Tommaso, Luca] Humanitas Univ, Dept Biomed Sci, Milan, Italy	Roncalli, M (reprint author), Humanitas Clin & Res Ctr, Pathol Unit, Milan, Italy.; Roncalli, M (reprint author), Humanitas Univ, Dept Biomed Sci, Milan, Italy.; Di Tommaso, L (reprint author), Humanitas Clin & Esearch Ctr, Pathol, Via Manzoni 56, I-20089 Milan, Italy.; Di Tommaso, L (reprint author), Humanitas Univ, Via Manzoni 56, I-20089 Milan, Italy.	massimo.roncalli@hunimed.eu; luca.ditommaso@hunimed.eu		Sciarra, Amedeo/0000-0002-7550-0312; Roncalli, Massimo/0000-0002-7901-8910	AIRC (Associazione Italiana Ricerca Cancro) [15437]; National Research Foundation of Korea (NRF) - Korean government (MSIP) [2013R1A2A2A05005990]	This work was partly supported by AIRC (Associazione Italiana Ricerca Cancro) grant no. 15437 to Massimo Roncalli (2014) and the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2013R1A2A2A05005990) to Young Nyun Park.	Akoad ME, 2015, CLIN LIVER DIS, V19, P381, DOI 10.1016/j.cld.2015.01.007; Bonilla GR, 2005, J HEPATOL, V42, P760, DOI DOI 10.1016/J.JHEP.2005.02.005; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Fisher CD, 2009, DRUG METAB DISPOS, V37, P2087, DOI 10.1124/dmd.109.027466; Forner A, 2012, J HEPATOL, V56, P984, DOI 10.1016/j.jhep.2011.08.017; Fung J, 2009, CLIN MICROBIOL INFEC, V15, P964, DOI 10.1111/j.1469-0691.2009.03035.x; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2013, GASTROENTEROLOGY, V144, P1024, DOI 10.1053/j.gastro.2013.01.021; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kim SU, 2014, LIVER INT, V34, P1008, DOI 10.1111/liv.12475; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Liver E.A.F.T.S.O.T., 2012, J HEPATOL, V56, P908; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122                                                          ; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; Nakai K, 2008, DRUG METAB DISPOS, V36, P1786, DOI 10.1124/dmd.107.020073; Perkins James D, 2007, Liver Transpl, V13, P1603, DOI 10.1002/lt.21315; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Reddy SK, 2012, HEPATOLOGY, V55, P1809, DOI 10.1002/hep.25536; Shah SA, 2007, SURGERY, V141, P330, DOI 10.1016/j.surg.2006.06.028; SHIRABE K, 1991, HEPATOLOGY, V14, P802, DOI 10.1002/hep.1840140510; Tanaka S, 2011, HEPATOLOGY, V54, P1273, DOI 10.1002/hep.24536; Villa E, 2016, GUT, V65, P861, DOI 10.1136/gutjnl-2014-308483; Wakai T, 2011, J GASTROINTEST SURG, V15, P1450, DOI 10.1007/s11605-011-1540-8; Zhou J, 2016, ONCOTARGET	25	0	0	5	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	APR	2017	49	4					434	439		10.1016/j.dld.2016.12.002				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	ET6TB	WOS:000400424200014	28040498				2018-01-05	
J	Weber, P; Konneh, M; Jeffrey, P; Overington, J				Weber, P.; Konneh, M.; Jeffrey, P.; Overington, J.			Gene Therapy: Right Here, Right Now. Highlights from the Society for Medicines Research Meeting	DRUGS OF THE FUTURE			English	Article						Gene therapy; Monogenic blood diseases; Hemophilia B; Cystic fibrosis; Short activating RNA		The concept, application and enormous potential of gene therapy to repair the direct cause of monogenic, genetically driven diseases 'at source' has tantalized and fascinated the scientific community for many years; the development of suitable treatments using this technology has encountered many challenges and disappointments. Only few gene therapy trials reported clear clinical benefits and in some, severe adverse events including treatment-related lethality were observed. Overall, concern and scepticism rose over the further deployment of these strategies. However, these attitudes are changing with the introduction of new more targeted and specific delivery approaches and gene engineering and improved adenoviral and retroviral delivery vector technologies. Several trials in inherited genetic diseases, as well as cancers, have now clearly demonstrated evidence of efficacy and safety for gene therapy medicines. Additional precision gene editing technologies, in particular CRISPR/Cas9, are now nearing the clinic, further increasing the possibilities of specifically altering the human genome to treat serious diseases. Practical gene therapy challenges many ingrained standard approaches to medicines discovery, not least in the safety, production and regulatory stages. This meeting brought together experts from academia and industry to discuss the promise, challenges and reality of gene therapy as a therapeutic approach.	[Weber, P.] Immunocore Ltd, Abingdon, Oxon, England; [Konneh, M.] Biotrial Int Ltd, London, England; [Jeffrey, P.] Pfizer Ltd, Rare Dis Res Unit, Cambridge, England; [Overington, J.] Med Discovery Catapult, Alderley Edge, Cheshire, England	Weber, P (reprint author), Immunocore Ltd, Abingdon, Oxon, England.	secretariat@smr.org.uk						0	0	0	3	3	PROUS SCIENCE, SAU-THOMSON REUTERS	BARCELONA	398 PROVENCA, 08025 BARCELONA, SPAIN	0377-8282	2013-0368		DRUG FUTURE	Drug Future	APR	2017	42	4					251	256		10.1358/dof.2017.042.04.2636488				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EU3BB	WOS:000400902500007					2018-01-05	
J	Bence, M; Jankovics, F; Lukacsovich, T; Erdelyi, M				Bence, Melinda; Jankovics, Ferenc; Lukacsovich, Tamas; Erdelyi, Miklos			Combining the auxin-inducible degradation system with CRISPR/Cas9-based genome editing for the conditional depletion of endogenous Drosophila melanogaster proteins	FEBS JOURNAL			English	Article						auxin-inducible degradation; CRISPR/Cas9; Drosophila melanogaster; induced protein depletion; Vasa	MATERNAL-EFFECT MUTATIONS; FEMALE STERILE MUTATIONS; BOX HELICASE VASA; ANTERIOR-POSTERIOR; 2ND CHROMOSOME; DEGRON SYSTEM; LOCALIZATION; GURKEN; POLARITY; OOGENESIS	Inducible protein degradation techniques have considerable advantages over classical genetic approaches, which generate loss-of-function phenotypes at the gene or mRNA level. The plant-derived auxin-inducible degradation system (AID) is a promising technique which enables the degradation of target proteins tagged with the AID motif in nonplant cells. Here, we present a detailed characterization of this method employed during the adult oogenesis of Drosophila. Furthermore, with the help of CRISPR/Cas9-based genome editing, we improve the utility of the AID system in the conditional elimination of endogenously expressed proteins. We demonstrate that the AID system induces efficient and reversible protein depletion of maternally provided proteins both in the ovary and the early embryo. Moreover, the AID system provides a fine spatiotemporal control of protein degradation and allows for the generation of different levels of protein knockdown in a well-regulated manner. These features of the AID system enable the unraveling of the discrete phenotypes of genes with highly complex functions. We utilized this system to generate a conditional loss-of-function allele which allows for the specific degradation of the Vasa protein without affecting its alternative splice variant (solo) and the vasa intronic gene (vig). With the help of this special allele, we demonstrate that dramatic decrease of Vasa protein in the vitellarium does not influence the completion of oogenesis as well as the establishment of proper anteroposterior and dorsoventral polarity in the developing oocyte. Our study suggests that both the localization and the translation of gurken mRNA in the vitellarium is independent from Vasa.	[Bence, Melinda; Jankovics, Ferenc; Erdelyi, Miklos] Hungarian Acad Sci, Inst Genet, Biol Res Ctr, Temesvari Krt 62, H-6726 Szeged, Hungary; [Lukacsovich, Tamas] Univ Zurich, Inst Brain Res, CH-8006 Zurich, Switzerland	Bence, M (reprint author), Hungarian Acad Sci, Inst Genet, Biol Res Ctr, Temesvari Krt 62, H-6726 Szeged, Hungary.	bence.melinda@brc.mta.hu			National Research, Development and Innovation Office [K-117010, GINOP-2.3.2-15-2016-00001, GINOP-2.3.2-15-2016-00032]; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences	We are thankful to Helle D. Ulrich and Beat Suter for providing plasmids. We acknowledge Peter Vilmos and Laszlo Henn for helpful discussions and Gabriella Tick for close reading of the manuscript. We also thank Margit Ugraine Szathmari and Ildiko Velkeyne Krausz for valuable technical assistance. This work was supported by grant from the National Research, Development and Innovation Office (K-117010; GINOP-2.3.2-15-2016-00001; GINOP-2.3.2-15-2016-00032). FJ is supported by the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences.	Ashburner M, 1999, GENETICS, V153, P179; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Dehghani M, 2015, BIOL OPEN, V4, P450, DOI 10.1242/bio.201410579; Deng WM, 1998, INT J DEV BIOL, V42, P541; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ejsmont RK, 2011, METHODS MOL BIOL, V772, P445, DOI 10.1007/978-1-61779-228-1_26; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2015, CURRENT PROTOCOLS MO, V111, P31, DOI [10.1002/0471142727.mb3102s111, DOI 10.1002/0471142727.MB3102S111]; Harder B, 2008, BIOTECHNIQUES, V44, P765, DOI 10.2144/000112884; HAY B, 1990, DEVELOPMENT, V109, P425; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; King RC, 1970, OVARIAN DEV DROSOPHI; Koch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004552; Lasko P, 2013, BBA-GENE REGUL MECH, V1829, P810, DOI 10.1016/j.bbagrm.2013.04.005; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905                                                             ; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0                                                    ; SCHUPBACH T, 1986, ROUX ARCH DEV BIOL, V195, P302, DOI 10.1007/BF00376063; SCHUPBACH T, 1989, GENETICS, V121, P101; SCHUPBACH T, 1991, GENETICS, V129, P1119; Staller MV, 2013, GENETICS, V193, P51, DOI 10.1534/genetics.112.144915; Styhler S, 1998, DEVELOPMENT, V125, P1569; Teale WD, 2006, MOL CELL BIOL, V7, P847, DOI DOI 10.1038/NRM2020; Tinker R, 1998, DEV BIOL, V199, P1, DOI 10.1006/dbio.1998.8941; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Trost M, 2016, FLY, V10, P35, DOI 10.1080/19336934.2016.1168552; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Yan RH, 2010, J CELL BIOL, V188, P335, DOI 10.1083/jcb.200904040; Yatsu J, 2008, INT J DEV BIOL, V52, P913, DOI 10.1387/ijdb.082576jy; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635	37	3	3	6	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	APR	2017	284	7					1056	1069		10.1111/febs.14042				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ET5WB	WOS:000400358600005	28207183	gold			2018-01-05	
J	Cozza, G; Salvi, M; Tagliabracci, VS; Pinna, LA				Cozza, Giorgio; Salvi, Mauro; Tagliabracci, Vincent S.; Pinna, Lorenzo A.			Fam20C is under the control of sphingolipid signaling in human cell lines	FEBS JOURNAL			English	Article						biomineralization; Fam20C; fingolimod; hypophosphatemia; sphingolipid signaling	SERINE PALMITOYLTRANSFERASE INHIBITOR; CASEIN KINASE; MAMMARY-GLAND; SPHINGOSINE; BIOMINERALIZATION; PHOSPHORYLATION; PROTEINS; MYRIOCIN; GROWTH; LIVER	Fam20C, also termed DMP-4 (dentin matrix protein 4) and G-CK (Golgi casein kinase) is an atypical protein kinase committed with the phosphorylation of casein and a plethora of other secreted proteins. Fam20C has been implicated in a number of human pathologies related to biomineralization, phosphate homeostasis, and neoplasia. The mode of regulation of Fam20C is still a matter of conjecture. In in vitro, Fam20C activity is stimulated several fold by sphingosine. To gain in vivo information about the physiological relevance of this observation, three cell lines expressing endogenous Fam20C, and one in which Fam20C has been knocked out with CRISPR/Cas9 technology have been examined for Fam20C activity under basal conditions and where sphingosine has been depleted by treatment with myriocin. In lysates and conditioned medium of the three wild-type cells, Fam20C activity was similar and comparably responsive to sphingosine and a panel of sphingosine analogs, while in knockout cells, Fam20C activity was undetectable either with or without sphingosine addition. Upon depletion of endogenous sphingosine by myriocin treatment, Fam20C activity drops to negligible values both in the lysate and in the conditioned medium; however, it can be partially restored if during myriocin treatment cells are supplemented with either exogenous sphingosine or ceramide, a sphingosine precursor. Alterations of Fam20C activity, promoted by myriocin and sphingolipids, are not accompanied by any significant change in Fam20C protein. These data provide the proof of concept that Fam20C activity is under the control of sphingolipid signaling.	[Cozza, Giorgio; Salvi, Mauro; Pinna, Lorenzo A.] Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58B, I-35131 Padua, Italy; [Cozza, Giorgio; Salvi, Mauro; Pinna, Lorenzo A.] Univ Padua, Inst Neurosci, CNR, Via Ugo Bassi 58B, I-35131 Padua, Italy; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Cozza, Giorgio] Univ Padua, Dept Mol Med, Via Ugo Bassi 58B, I-35131 Padua, Italy	Pinna, LA (reprint author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58B, I-35131 Padua, Italy.; Pinna, LA (reprint author), Univ Padua, Inst Neurosci, CNR, Via Ugo Bassi 58B, I-35131 Padua, Italy.; Cozza, G (reprint author), Univ Padua, Dept Mol Med, Via Ugo Bassi 58B, I-35131 Padua, Italy.	giorgio.cozza@unipd.it; lorenzo.pinna@unipd.it			Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 14180]; University of Padova; Welch Foundation [I-1911]; NIH [R00DK099254]	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC, grant IG 14180) to LAP, by the University of Padova (Progetto Giovani Ricercatori) to GC and Welch Foundation (Grant No I-1911) and NIH (grant R00DK099254) to VST. We thank Prof. Oriano Marin (CRIBI Peptide Facility, University of Padova) for providing the peptides used in this work. We thank Prof. Alfred H. Merrill for helpful suggestions.	Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cozza G, 2015, BBA-PROTEINS PROTEOM, V1854, P1718, DOI 10.1016/j.bbapap.2015.04.023; Cui JX, 2015, ELIFE, V4, DOI 10.7554/eLife.06120; Hammarsten O., 1883, Z PHYSL CHEM, V7, P227; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010                                                             ; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Lasa M, 1997, EUR J BIOCHEM, V243, P719, DOI 10.1111/j.1432-1033.1997.00719.x; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; Lee YS, 2011, CELL PROLIFERAT, V44, P320, DOI 10.1111/j.1365-2184.2011.00761.x; Lee YS, 2012, CANCER BIOL THER, V13, P92, DOI 10.4161/cbt.13.2.18870; Lolli G, 2012, BIOCHEMISTRY-US, V51, P6097, DOI 10.1021/bi300531c; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marycz K, 2016, J BIOMATER TISS ENG, V6, P85, DOI 10.1166/jbt.2016.1423; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827                                                          ; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; OKABE K, 1968, BIOCHEM BIOPH RES CO, V31, P137, DOI 10.1016/0006-291X(68)90043-0; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Salvi M, 2010, J PROTEOME RES, V9, P3335, DOI 10.1021/pr100058r; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Valentijn-Benz M, 2015, CARIES RES, V49, P9, DOI 10.1159/000362096; Vogel P, 2012, VET PATHOL, V49, P998, DOI 10.1177/0300985812453177; Wang SK, 2014, J DENT RES, V93, P42, DOI 10.1177/0022034513512653; White KE, 2014, CURR OSTEOPOROS REP, V12, P252, DOI 10.1007/s11914-014-0223-2	32	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	APR	2017	284	8					1246	1257		10.1111/febs.14052				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ET5WE	WOS:000400358900010	28236661				2018-01-05	
J	Sharma, S; Wang, JM; Gomez, EC; Taggart, RT; Baysal, BE				Sharma, Shraddha; Wang, Jianming; Gomez, Eduardo Cortes; Taggart, Robert T.; Baysal, Bora E.			Mitochondrial complex II regulates a distinct oxygen sensing mechanism in monocytes	HUMAN MOLECULAR GENETICS			English	Article							SUCCINATE-UBIQUINONE OXIDOREDUCTASE; HYPOXIA-INDUCIBLE FACTORS; FAMILIAL PHEOCHROMOCYTOMA; HEREDITARY PARAGANGLIOMA; PROLYL HYDROXYLASE; GENE-EXPRESSION; RNA-SEQ; SDHB; MUTATIONS; MACROPHAGES	Mutations in mitochondrial complex II (succinate dehydrogenase; SDH) genes predispose to paraganglioma tumors that show constitutive activation of hypoxia responses. We recently showed that SDHB mRNAs in hypoxic monocytes gain a stop codon mutation by APOBEC3A-mediated C-to-U RNA editing. Here, we test the hypothesis that inhibition of complex II facilitates hypoxic gene expression in monocytes using an integrative experimental approach. By RNA sequencing, we show that specific inhibition of complex II by atpenin A5 in normoxic conditions mimics hypoxia and induces hypoxic transcripts as well as APOBEC3A-mediated RNA editing in human monocytes. Myxothiazol, a complex III inhibitor, has similar effects in normoxic monocytes. Atpenin A5 partially inhibits oxygen consumption, and neither hypoxia nor atpenin A5 in normoxia robustly stabilizes hypoxia-inducible factor (HIF)-1 alpha in primary monocytes. Several earlier studies in transformed cell lines suggested that normoxic stabilization of HIF-1 alpha explains the persistent expression of hypoxic genes upon complex II inactivation. On the contrary, we find that atpenin A5 antagonizes the stabilization of HIF-1 alpha and reduces hypoxic gene expression in transformed cell lines. Accordingly, compound germline heterozygosity of mouse Sdhb/Sdhc/Sdhd null alleles blunts chronic hypoxia-induced increases in hemoglobin levels, an adaptive response mainly regulated by HIF-2 alpha. In contrast, atpenin A5 or myxothiazol does not reduce hypoxia-induced gene expression or RNA editing in monocytes. These results reveal a novel role for mitochondrial respiratory inhibition in induction of the hypoxic transcriptome in monocytes and suggest that inhibition of complex II activates a distinct hypoxia signaling pathway in a cell-type specific manner.	[Sharma, Shraddha; Taggart, Robert T.; Baysal, Bora E.] Roswell Pk Canc Inst, Dept Pathol, Elm & Carlton St, Buffalo, NY 14263 USA; [Wang, Jianming; Gomez, Eduardo Cortes] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Elm & Carlton St, Buffalo, NY 14263 USA	Baysal, BE (reprint author), Roswell Pk Canc Inst, Dept Pathol, Elm & Carlton St, Buffalo, NY 14263 USA.	bora.baysal@roswellpark.org			National Cancer Institute (NCI) [P30CA016056]	National Cancer Institute (NCI) (P30CA016056) involving the use of Roswell Park Cancer Institute (RPCI)' s Laboratory Animal Shared Resources, Genomics Shared Resources, Bioinformatic Shared Resources, Flow Cytometry and Imaging Facilities.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angelova PR, 2015, J NEUROSCI, V35, P10460, DOI 10.1523/JNEUROSCI.0045-15.2015; Aspuria PJP, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-21; Astrom K, 2003, HUM GENET, V113, P228, DOI 10.1007/s00439-003-0969-6; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bayley JP, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-39; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2013, PEERJ, V1, DOI 10.7717/peerj.152; Bosco MC, 2006, J IMMUNOL, V177, P1941, DOI 10.4049/jimmunol.177.3.1941                                                     ; Brown ST, 2008, AM J PHYSIOL-CELL PH, V294, pC1305, DOI 10.1152/ajpcell.00007.2008; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Buckler KJ, 2013, J PHYSIOL-LONDON, V591, P3549, DOI 10.1113/jphysiol.2013.257741; Fernandez-Aguera MC, 2015, CELL METAB, V22, P825, DOI 10.1016/j.cmet.2015.09.004; Castro-Vega LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7044; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cerecer-Gil NY, 2010, CLIN CANCER RES, V16, P4148, DOI 10.1158/1078-0432.CCR-10-0637; Cervera AM, 2008, CANCER RES, V68, P4058, DOI 10.1158/0008-5472.CAN-07-5580; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Diaz-Castro B, 2012, MOL CELL BIOL, V32, P3347, DOI 10.1128/MCB.00128-12; Elbarghati L, 2008, IMMUNOBIOLOGY, V213, P899, DOI 10.1016/j.imbio.2008.07.016; Fangradt M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4011; Fisher R. A., 1925, STAT METHODS RES WOR; Franke K, 2013, BLOOD, V122, P1122, DOI 10.1182/blood-2013-01-478065; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805                                                         ; Her YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127471; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Jones R, 2016, BLOOD, V127, P2641, DOI 10.1182/blood-2016-02-696922; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lin X, 2008, P NATL ACAD SCI USA, V105, P174, DOI 10.1073/pnas.0706585104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Barneo J, 2016, AM J PHYSIOL-CELL PH, V310, pC629, DOI 10.1152/ajpcell.00265.2015; Lopez-Jimenez E, 2010, MOL ENDOCRINOL, V24, P2382, DOI 10.1210/me.2010-0256; Maher L. J., 2011, PHEOCHROMOCYTOMA NEW; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; MENTZER SJ, 1986, CELL IMMUNOL, V101, P312, DOI 10.1016/0008-8749(86)90144-9                                                    ; Michelakis EV, 2004, J MOL CELL CARDIOL, V37, P1119, DOI 10.1016/j.yjmcc.2004.09.007; Millan-Ucles A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085528; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Niemann S, 2000, NAT GENET, V26, P268; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Opotowsky AR, 2015, J CLIN ENDOCR METAB, V100, P1325, DOI 10.1210/jc.2014-3863; Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; SALDANA MJ, 1973, HUM PATHOL, V4, P251, DOI 10.1016/S0046-8177(73)80012-7; Salter JD, 2016, TRENDS BIOCHEM SCI, V41, P578, DOI 10.1016/j.tibs.2016.05.001; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sharma S., 2016, RNA BIOL, V5, P1; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Strehl C, 2014, J LEUKOCYTE BIOL, V95, P233, DOI 10.1189/jlb.1212627; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Waypa GB, 2016, MOL ASPECTS MED, V47-48, P76, DOI 10.1016/j.mam.2016.01.002; Willems L, 2015, VIRUSES-BASEL, V7, P2999, DOI 10.3390/v7062757; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	68	1	1	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	APR 1	2017	26	7					1328	1339		10.1093/hmg/ddx041				12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	EU3EL	WOS:000400911300010	28204537				2018-01-05	
J	Muller, B; Wagner, F; Lorenz, B; Stieger, K				Mueller, Brigitte; Wagner, Franziska; Lorenz, Birgit; Stieger, Knut			Organotypic Cultures of Adult Mouse Retina: Morphologic Changes and Gene Expression	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						retinal explant; animal models; photoreceptors; apoptosis	ORGAN-CULTURE; MAMMALIAN RETINA; IN-VITRO; PORCINE NEURORETINA; MULLER CELLS; DIFFERENTIATION; EXPLANTS; DEGENERATION; MODEL; IMMUNOREACTIVITY	PURPOSE. The purpose of this study was characterization of adult murine neuroretina in organ culture to investigate its suitability for use in preclinical therapeutic applications. In retinal disorders, neurodegeneration of mature retinal cells takes place. Therefore, neonatal retina cultures are not adequate for therapeutic applications, such as genome editing, as the retina is still developing with cells dividing and differentiating into highly specialized cell types such as photoreceptors. METHODS. Retinal explants were prepared from 3-month-old wild-type C57Bl6 mice and evaluated after 1 to 10 days in culture by immunohistochemistry or quantitative (q)PCR. Histologic modifications of the neuroretina were evaluated with TUNEL assay and immunohistochemical markers for neurons, glia cells, and apoptosis. RESULTS. During the first week, disruption and truncation of outer segments were detectable. Unspecific Muller cell reaction was detected from 4 days in culture. Sprouting of individual rod bipolar cell dendrites into the outer nuclear layer (ONL) was visible during all explant stages. During the second week in culture, cell death in the ONL became more prominent. CONCLUSIONS. Adult organotypic retinal culture was successful for at least 10 days with characteristic alterations of the morphology during this period. This characterization forms the basis to establish retinal explants for gene therapeutic applications as an intermediate step between cell culture and experiments on adult animals, thus reducing the load of animal experimentation.	[Mueller, Brigitte; Wagner, Franziska; Lorenz, Birgit; Stieger, Knut] Justus Liebig Univ Giessen, Dept Ophthalmol, Giessen, Germany	Muller, B (reprint author), Justus Liebig Univ Giessen, Fac Med, Dept Ophthalmol, Friedrichstr 18, D-35392 Giessen, Germany.	Brigitte.Mueller@augen.med.uni-giessen.de			European Research Council (ERC) [311244]	Supported by European Research Council (ERC) Starting Grant 311244.	Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; BLANKS JC, 1993, EXP EYE RES, V57, P265, DOI 10.1006/exer.1993.1124; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; CAFFE AR, 1993, CURR EYE RES, V12, P719, DOI 10.3109/02713689308995767; CAFFE AR, 1989, CURR EYE RES, V8, P1083, DOI 10.3109/02713688908997401; Caffe AR, 2001, INVEST OPHTH VIS SCI, V42, P275; CALEY DW, 1972, AM J ANAT, V133, P179, DOI 10.1002/aja.1001330205; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589                                                           ; Cuenca N, 2005, EUR J NEUROSCI, V22, P1057, DOI 10.1111/j.1460-9568.2005.04300.x; ERICKSON PA, 1990, EXP EYE RES, V51, P153, DOI 10.1016/0014-4835(90)90067-5; FEIGENSPAN A, 1993, VISUAL NEUROSCI, V10, P203, DOI 10.1017/S0952523800003618                                                       ; Fernandez-Bueno I, 2013, MOL VIS, V19, P894; Fernandez-Bueno I, 2012, EXP EYE RES, V104, P26, DOI 10.1016/j.exer.2012.08.012; Fernandez-Bueno I, 2008, MOL VIS, V14, P2148; Fisher SK, 1995, ORG RETINA VISUAL SY; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Germer A, 1997, NEUROREPORT, V8, P3067, DOI 10.1097/00001756-199709290-00012; GOLD R, 1994, LAB INVEST, V71, P219; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Hatakeyama J, 2002, METHODS, V28, P387, DOI 10.1016/S1046-2023(02)00257-8                                                   ; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Krantic S, 2007, PROG NEUROBIOL, V81, P179, DOI 10.1016/j.pneurobio.2006.12.002; Kuhrt H, 2004, GRAEF ARCH CLIN EXP, V242, P512, DOI 10.1007/s00417-004-0882-2; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moritoh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012917; Ogilvie JM, 1999, J NEUROSCI METH, V87, P57; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Pang J, 2004, EXP EYE RES, V79, P189, DOI 10.1016/j.exer.2004.03.010; Pang JJ, 2008, VISION RES, V48, P377, DOI 10.1016/j.visres.2007.08.009; Pang JJ, 2008, GENE THER, V17, P815; Paquet-Durand F, 2010, J NEUROCHEM, V115, P930, DOI 10.1111/j.1471-4159.2010.06983.x; Perera A, 2015, CELL REP, V11, P283, DOI 10.1016/j.celrep.2015.03.020; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sato K, 2012, MOL VIS, V18, P1516; Seigel G, 1999, MOL VIS, V5; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004                                                      ; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; Valdes J, 2016, ALTEX; Wang SW, 2002, METHODS, V28, P448, DOI 10.1016/S1046-2023(02)00264-5; Winkler BS, 2000, INVEST OPHTH VIS SCI, V41, P3183	44	0	0	2	3	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	APR	2017	58	4					1930	1940		10.1167/iovs.16-20718				11	Ophthalmology	Ophthalmology	ET9SY	WOS:000400649600002	28384714	gold			2018-01-05	
J	Bhattacharya, S; Yin, JG; Winborn, CS; Zhang, QH; Yue, JM; Chaum, E				Bhattacharya, Sujoy; Yin, Jinggang; Winborn, Christina S.; Zhang, Qiuhua; Yue, Junming; Chaum, Edward			Prominin-1 Is a Novel Regulator of Autophagy in the Human Retinal Pigment Epithelium	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						CD133; Atg5; Atg7; LC3-II; Akt; p62; mTORC1; mTORC2; autophagy flux; Nutlin-3	PROGENITOR CELLS; PLASMA-MEMBRANE; PHOTORECEPTOR DEGENERATION; NEURODEGENERATIVE DISEASE; RETINITIS-PIGMENTOSA; HEMATOPOIETIC STEM; OXIDATIVE STRESS; CANCER; CD133; PROMOTES	PURPOSE. Prominin-1 (Prom1) is a transmembrane glycoprotein, which is expressed in stem cell lineages, and has recently been implicated in cancer stem cell survival. Mutations in the Prom1 gene have been shown to disrupt photoreceptor disk morphogenesis and cause an autosomal dominant form of Stargardt-like macular dystrophy (STGD4). Despite the apparent structural role of Prom1 in photoreceptors, its role in other cells of the retina is unknown. The purpose of this study is to investigate the role of Prom1 in the highly metabolically active cells of the retinal pigment epithelium (RPE). METHODS. Lentiviral siRNA and the genome editing CRISPR/Cas9 system were used to knockout Prom1 in primary RPE and ARPE-19 cells, respectively. Western blotting, confocal microscopy, and flow sight imaging cytometry assays were used to quantify autophagy flux. Immunoprecipitation was used to detect Prom1 interacting proteins. RESULTS. Our studies demonstrate that Prom1 is primarily a cytosolic protein in the RPE. Stress signals and physiological aging robustly increase autophagy with concomitant upregulation of Prom1 expression. Knockout of Prom1 increased mTORC1 and mTORC2 signaling, decreased autophagosome trafficking to the lysosome, increased p62 accumulation, and inhibited autophagic puncta induced by activators of autophagy. Conversely, ectopic overexpression of Prom1 inhibited mTORC1 and mTORC2 activities, and potentiated autophagy flux. Through interactions with p62 and HDAC6, Prom1 regulates autophagosome maturation and trafficking, suggesting a new cytoplasmic role of Prom1 in RPE function. CONCLUSIONS. Our results demonstrate that Prom1 plays a key role in the regulation of autophagy via upstream suppression of mTOR signaling and also acting as a component of a macromolecular scaffold involving p62 and HDAC6.	[Bhattacharya, Sujoy; Yin, Jinggang; Winborn, Christina S.; Zhang, Qiuhua; Chaum, Edward] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA; [Chaum, Edward] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA	Chaum, E (reprint author), UTHSC Hamilton Eye Inst, Retinal Dis, 930 Madison Ave, Memphis, TN 38163 USA.	echaum@uthsc.edu			Shulsky Foundation; Research to Prevent Blindness (New York, NY, USA); Plough Foundation (Memphis, TN, USA); Lions of Arkansas; NEI [PHS 3P30 EY013080]	Supported by a Shulsky Foundation research grant, an unrestricted departmental grant from Research to Prevent Blindness (New York, NY, USA), the Plough Foundation (Memphis, TN, USA), the Lions of Arkansas, and the NEI vision core Grant PHS 3P30 EY013080. The authors alone are responsible for the content and writing of the paper.	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Bhattacharya S, 2012, INVEST OPHTH VIS SCI, V53, P8350, DOI 10.1167/iovs.12-10495; Bhattacharya S, 2011, INVEST OPHTH VIS SCI, V52, P3368, DOI 10.1167/iovs.10-6991; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BOK D, 1993, J CELL SCI, P189; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Castino R, 2008, J NEUROCHEM, V106, P1426, DOI 10.1111/j.1471-4159.2008.05488.x; Chaum E, 2009, J CELL BIOCHEM, V108, P1280, DOI 10.1002/jcb.22358; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053878; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x                                               ; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fang YY, 2015, CELL BIOL INT, V39, P891, DOI 10.1002/cbin.10463; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2006, FUTURE LIPIDOL, V1, P213, DOI 10.2217/17460875.1.2.213; Fargeas CA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00091; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Forooghian F, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.123125; Frost LS, 2014, EXP EYE RES, V124, P56, DOI 10.1016/j.exer.2014.04.010; Harris JR, 2009, STEM CELLS, V27, P457, DOI 10.1634/stemcells.2008-0836; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Huang M, 2015, DIS MARKERS, V2015, DOI DOI 10.1155/2015/986095256918074323063; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jaszai J, 2007, EXP EYE RES, V85, P585, DOI 10.1016/j.exer.2006.03.022; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269                                                               ; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Karbanova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098927; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Loos B, 2014, AUTOPHAGY, V10, P2087, DOI 10.4161/15548627.2014.973338; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Marzesco AM, 2013, ADV EXP MED BIOL, V777, P41, DOI 10.1007/978-1-4614-5894-4_3; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Meyuhas O, 2015, INT REV CEL MOL BIO, V320, P41, DOI 10.1016/bs.ircmb.2015.07.006; Michaelides M, 2003, INVEST OPHTH VIS SCI, V44, P1657, DOI 10.1167/iovs.02-0941; Mintun MA, 2001, P NATL ACAD SCI USA, V98, P6859, DOI 10.1073/pnas.111164398; Miraglia S, 1997, BLOOD, V90, P5013; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nunukova A, 2015, INT J MOL MED, V36, P65, DOI 10.3892/ijmm.2015.2210; Ojha R, 2015, BIORESEARCH OPEN ACC, V4, P97, DOI 10.1089/biores.2014.0035; Permanyer J, 2010, INVEST OPHTH VIS SCI, V51, P2656, DOI 10.1167/iovs.09-4857; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Roper K, 2000, NAT CELL BIOL, V2, P582; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seo SJ, 2012, EXP EYE RES, V101, P60, DOI 10.1016/j.exer.2012.05.013; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993                                                         ; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toops KA, 2015, MOL BIOL CELL, V26, P1, DOI 10.1091/mbc.E14-05-1028; Vadlapatla RK, 2014, EYE, V28, P93, DOI 10.1038/eye.2013.240; Wang AL, 2009, AUTOPHAGY, V5, P1190, DOI 10.4161/auto.5.8.10087                                                          ; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Wei MF, 2014, AUTOPHAGY, V10, P1179, DOI 10.4161/auto.28679; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Williamson WR, 2010, J CELL BIOL, V189, P885, DOI 10.1083/jcb.201003062; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33                                                               ; Yang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028405; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yin AH, 1997, BLOOD, V90, P5002; Yue JM, 2010, BIOCHEM BIOPH RES CO, V394, P667, DOI 10.1016/j.bbrc.2010.03.047; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhang QJ, 2007, HUM GENET, V122, P293, DOI 10.1007/s00439-007-0395-2; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zhu DH, 2011, INVEST OPHTH VIS SCI, V52, P1573, DOI 10.1167/iovs.10-6413	74	0	0	2	2	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	APR	2017	58	4					2366	2387		10.1167/iovs.16-21162				22	Ophthalmology	Ophthalmology	ET9SY	WOS:000400649600050	28437526	gold			2018-01-05	
J	Taning, CNT; Van Eynde, B; Yu, N; Ma, SY; Smagghe, G				Taning, Clauvis Nji Tizi; Van Eynde, Benigna; Yu, Na; Ma, Sanyuan; Smagghe, Guy			CRISPR/Cas9 in insects: Applications, best practices and biosafety concerns	JOURNAL OF INSECT PHYSIOLOGY			English	Review						CRISPR/Cas9; Insect; Application; Best practice; Biosafety	HOMING ENDONUCLEASE GENES; TAL EFFECTOR NUCLEASES; MOSQUITO AEDES-AEGYPTI; ZINC-FINGER NUCLEASES; BOMBYX-MORI; HOMOLOGOUS RECOMBINATION; DROSOPHILA-MELANOGASTER; BIOLOGICAL-CONTROL; TARGETED MUTAGENESIS; GENOME MODIFICATIONS	Discovered as a bacterial adaptive immune system, CRISPR/Cas9 (clustered, regularly interspaced, short palindromic repeat/CRISPR associated) is being developed as an attractive tool in genome editing. Due to its high specificity and applicability, CRISPR/Cas9-mediated gene editing has been employed in a multitude of organisms and cells, including insects, for not only fundamental research such as gene function studies, but also applied research such as modification of organisms of economic importance. Despite the rapid increase in the use of CRISPR in insect genome editing, results still differ from each study, principally due to existing differences in experimental parameters, such as the Cas9 and guide RNA form, the delivery method, the target gene and off-target effects. Here, we review current reports on the successes of CRISPR/Cas9 applications in diverse insects and insect cells. We furthermore summarize several best practices to give a useful checklist of CRISPR/Cas9 experimental setup in insects for beginners. Lastly, we discuss the biosafety concerns related to the release of CRISPR/Cas9-edited insects into the environment. (C) 2017 Elsevier Ltd. All rights reserved.	[Taning, Clauvis Nji Tizi; Van Eynde, Benigna; Yu, Na; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium; [Ma, Sanyuan] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Yu, Na] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China	Taning, CNT; Smagghe, G (reprint author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium.	tiziclauvis.taningnji@ugent.be; guy.smagghe@ugent.be			Special Research Fund (BOF) of Ghent University - Belgium; Fund for Scientific Research - Belgium, Flanders (FWO Vlaanderen)	This research was supported by the Special Research Fund (BOF) of Ghent University - Belgium and the Fund for Scientific Research - Belgium, Flanders (FWO Vlaanderen).	Alphey L, 2016, NAT BIOTECHNOL, V34, P149, DOI 10.1038/nbt.3473; Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Awata H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15885; Bae S., 2014, BIOINFORMATICS; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P657, DOI 10.1534/g3.112.005439; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bi HL, 2016, INSECT SCI, V23, P469, DOI 10.1111/1744-7917.12341; Bottcher R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku289; Briese DT, 2004, AUST J ENTOMOL, V43, P304, DOI 10.1111/j.1326-6756.2004.00442.x; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432; Caplan AL, 2015, EMBO REP, V16, P1421, DOI 10.15252/embr.201541337; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Cotter J., 2016, URGENT NEED REGULATI; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Daimon T, 2014, DEV GROWTH DIFFER, V56, P14, DOI 10.1111/dgd.12096; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353; Dong ZQ, 2016, ANTIVIR RES, V130, P50, DOI 10.1016/j.antiviral.2016.03.009; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gabrieli P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0535-7; Galizi R., 2016, SCI REP, V6; Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gao JL, 2015, GENE DEV, V29, P760, DOI 10.1101/gad.258863.115; Ghosh S., 2016, NUCLEIC ACIDS RES; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; Gilles AF, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-43; Gokcezade J, 2014, G3-GENES GENOM GENET, V4, P2279, DOI 10.1534/g3.114.014126; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Gui T., 2013, CRISPR CAS9 MEDIATED, pG3; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Hashimoto M., 2015, SCI REP, V5; Hodgins KA, 2009, EVOL APPL, V2, P555, DOI 10.1111/j.1752-4571.2009.00102.x; Holdren JP, 2015, IMPROVING TRANSPAREN; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413                                             ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509                                                      ; Huang Y., 2016, MOL BIOL, V75, P98, DOI [10.1016/j.ibmb.2016.06.004, DOI 10.1016/J.IBMB.2016.06.004]; Itokawa K., 2016, SCI REP, V6; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kleinstiver BP, 2016, NATURE; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Royer C., 2016, SCI REP, V6; Li F, 2016, BIOCHEM BIOPH RES CO, V469, P911, DOI 10.1016/j.bbrc.2015.12.081; Li XM, 2015, IET COMMUN, V9, P10, DOI 10.1049/iet-com.2014.0460; Li Y, 2016, INSECT BIOCHEM MOLEC, V79, P27, DOI 10.1016/j.ibmb.2016.10.003; Lin SL, 2015, GENETICS, V201, P433, DOI 10.1534/genetics.115.181065; Ling L, 2015, RNA BIOL, V12, P742, DOI 10.1080/15476286.2015.1048957; Liu YY, 2014, INSECT BIOCHEM MOLEC, V49, P35, DOI 10.1016/j.ibmb.2014.03.010; Louda SM, 2003, ANNU REV ENTOMOL, V48, P365, DOI 10.1146/annurev.ento.48.060402.102800; Ma SY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04489; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Mabashi-Asazuma H, 2015, ACS CHEM BIOL, V10, P2199, DOI 10.1021/acschembio.5b00340; Markert MJ, 2016, G3-GENES GENOM GENET, V6, P905, DOI 10.1534/g3.116.027029; Marshall JM, 2012, J THEOR BIOL, V294, P153, DOI 10.1016/j.jtbi.2011.10.032; Martin A, 2016, CURR BIOL, V26, P14, DOI 10.1016/j.cub.2015.11.021; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakanishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098363; NEWTON ME, 1976, GENETICA, V46, P297, DOI 10.1007/BF00055473; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Ochiai H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv624; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Port F., 2015, G3, P1493; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Prykhozhij S. V., 2015, PLOS ONE, V10; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reid W, 2016, CURR OPIN INSECT SCI, V13, P43, DOI 10.1016/j.cois.2015.11.001; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rouget M, 2015, S AFR J BOT, V101, P24, DOI 10.1016/j.sajb.2015.04.009; Sajwan S, 2013, INSECT BIOCHEM MOLEC, V43, P17, DOI 10.1016/j.ibmb.2012.10.011; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sebo ZL, 2014, FLY, V8, P52, DOI 10.4161/fly.26828; Sheppard A., 2004, 11 INT S BIOL CONTR, P353; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Somers J, 2015, INSECT BIOCHEM MOLEC, V64, P116, DOI 10.1016/j.ibmb.2015.01.018; Takahashi G, 2015, SCI REP, V5; Tanaka R., 2016, INSECT BIOCH MOL BIO; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wang J, 2016, INSECT BIOCHEM MOLEC, V76, P11, DOI 10.1016/j.ibmb.2016.06.008; Wang Y., 2016, ACS SYNTH BIOL; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Watanabe T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2020; Webber BL, 2015, P NATL ACAD SCI USA, V112, P10565, DOI 10.1073/pnas.1514258112; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101210; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Windbichler N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000291; WOOD RJ, 1991, AM NAT, V137, P379, DOI 10.1086/285171; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Xin HH, 2015, ARCH INSECT BIOCHEM, V90, P59, DOI 10.1002/arch.21244; Xue ZY, 2014, G3-GENES GENOM GENET, V4, P2167, DOI 10.1534/g3.114.014159; Xue ZY, 2014, G3-GENES GENOM GENET, V4, P925, DOI 10.1534/g3.114.010496; Yu Z., 2014, BIOL OPEN; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Yuasa M, 2016, INSECT BIOCHEM MOLEC, V68, P33, DOI 10.1016/j.ibmb.2015.10.016; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2; Zeng BS, 2016, INSECT BIOCHEM MOLEC, V72, P31, DOI 10.1016/j.ibmb.2016.03.006; ZHANG LL, 2016, NAT COMMUN, V7; Zhang X, 2014, G3-GENES GENOM GENET, V4, P2409, DOI 10.1534/g3.114.013979; Zhang ZJ, 2015, J INSECT PHYSIOL, V79, P73, DOI 10.1016/j.jinsphys.2015.06.004; Zhu GH, 2016, INSECT BIOCHEM MOLEC, V75, P1, DOI 10.1016/j.ibmb.2016.05.006; ZHU LY, 2015, SCI REP, V5; Zimmer CT, 2016, INSECT BIOCHEM MOLEC, V73, P62, DOI 10.1016/j.ibmb.2016.04.007	131	7	7	35	46	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	APR	2017	98						245	257		10.1016/j.jinsphys.2017.01.007				13	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	EU0QC	WOS:000400715400032	28108316				2018-01-05	
J	Johnson, GS; Li, J; Beaver, LM; Dashwood, WM; Sun, D; Rajendran, P; Williams, DE; Ho, E; Dashwood, RH				Johnson, Gavin S.; Li, Jia; Beaver, Laura M.; Dashwood, W. Mohaiza; Sun, Deqiang; Rajendran, Praveen; Williams, David E.; Ho, Emily; Dashwood, Roderick H.			A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells	MOLECULAR NUTRITION & FOOD RESEARCH			English	Article						Colorectal cancer; CRISPR/Cas9; Loc344887; noncoding RNA	LONG NONCODING RNAS; SPRAGUE-DAWLEY RATS; ABERRANT CRYPT FOCI; COLORECTAL-CANCER; HISTONE DEACETYLASE; EPIGENETIC REGULATION; HEME OXYGENASE-1; DRUG-RESISTANCE; RECEPTOR-ALPHA; CHEMOPREVENTION	Scope: The anticancer agent sulforaphane (SFN) acts via multiple mechanisms to modulate gene expression, including the induction of nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-dependent signaling and the inhibition of histone deacetylase activity. Transcriptomics studies were performed in SFN-treated human colon cancer cells and in nontransformed colonic epithelial cells in order to pursue new mechanistic leads. Methods and results: RNA-sequencing corroborated the expected changes in cancer-related pathways after SFN treatment. In addition to NAD(P)H quinone dehydrogenase 1 (NQO1) and other well-known Nrf2-dependent targets, SFN strongly induced the expression of Loc344887. This noncoding RNA was confirmed as a novel functional pseudogene for NmrA-like redox sensor 1, and was given the name NmrA-like redox sensor 2 pseudogene (NMRAL2P). Chromatin immunoprecipitation experiments corroborated the presence of Nrf2 interactions on the NMRAL2P genomic region, and interestingly, NMRAL2P also served as a coregulator of NQO1 in human colon cancer cells. Silencing of NMRAL2P via CRISPR/Cas9 genome-editing protected against SFN-mediated inhibition of cancer cell growth, colony formation, and migration. Conclusion: NMRAL2P is the first functional pseudogene to be identified both as a direct transcriptional target of Nrf2, and as a downstream regulator of Nrf2-dependent NQO1 induction. Further studies are warranted on NMRAL2P-Nrf2 crosstalk and the associated mechanisms of gene regulation.	[Johnson, Gavin S.; Li, Jia; Dashwood, W. Mohaiza; Sun, Deqiang; Rajendran, Praveen; Dashwood, Roderick H.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Epigenet & Dis Prevent, Houston, TX 77030 USA; [Beaver, Laura M.; Williams, David E.; Ho, Emily] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Beaver, Laura M.; Ho, Emily] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Williams, David E.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Dashwood, Roderick H.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Dashwood, Roderick H.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA; [Dashwood, Roderick H.] Texas A&M Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Dashwood, RH (reprint author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Epigenet & Dis Prevent, Houston, TX 77030 USA.; Dashwood, RH (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA.; Dashwood, RH (reprint author), Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA.; Dashwood, RH (reprint author), Texas A&M Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	rdashwood@ibt.tamhsc.edu			NIH [CA090890, CA122959, ES00210, ES023512]; John S. Dunn Foundation; Chancellor's Research Initiative	This research was supported in part by NIH grants CA090890, CA122959, ES00210, and ES023512, as well as the John S. Dunn Foundation, and a Chancellor's Research Initiative.	Amjad Ali I, 2015, Curr Pharmacol Rep, V1, P382; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Appari M, 2014, INT J ONCOL, V45, P1391, DOI 10.3892/ijo.2014.2539; Atwell Lauren L, 2015, Curr Pharmacol Rep, V1, P102; Atwell LL, 2015, MOL NUTR FOOD RES, V59, P424, DOI 10.1002/mnfr.201400674; Beaver LM, 2014, MOL NUTR FOOD RES, V58, P2001, DOI 10.1002/mnfr.201400269; Begleiter A, 2003, CANCER EPIDEM BIOMAR, V12, P566; Begleiter A, 2009, ONCOL REP, V21, P1559, DOI 10.3892/or_00000388; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; Clarke JD, 2011, MOL NUTR FOOD RES, V55, P999, DOI 10.1002/mnfr.201000547; Deng H, 2016, TUMOR BIOL, V37, P11623, DOI 10.1007/s13277-016-5125-8; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esposito F, 2014, ONCOTARGET, V5, P8341, DOI 10.18632/oncotarget.2202                                                        ; Fuentes Francisco, 2015, Curr Pharmacol Rep, V1, P179; Gao YF, 2015, CURR MED CHEM, V22, P2051, DOI 10.2174/0929867322666150420102641                                               ; Han D, 2015, CANCER LETT, V361, P13, DOI 10.1016/j.canlet.2015.03.002; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Ho E, 2011, ADV NUTR, V2, P497, DOI 10.3945/an.111.001032; Ho E, 2009, J NUTR, V139, P2393, DOI 10.3945/jn.109.113332; Hsu A, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-3; Hu R, 2006, CARCINOGENESIS, V27, P2038, DOI 10.1093/carcin/bgl049; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Huang XY, 2016, ONCOTARGET, V7, P57379, DOI 10.18632/oncotarget.10545; Iskander K, 2008, CANCER RES, V68, P7915, DOI 10.1158/0008-5472.CAN-08-0766; Kang KA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.149; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Khanduja JS, 2016, MOL CELL, V63, P7, DOI 10.1016/j.molcel.2016.06.011; Kim E, 2016, CURR TOP MED CHEM, V16, P714, DOI 10.2174/1568026615666150825125857; Lan FM, 2015, J NEUROCHEM, V134, P811, DOI 10.1111/jnc.13174; Liu X, 2016, BBA-MOL CELL RES, V1863, P2093, DOI 10.1016/j.bbamcr.2016.05.009; Lo R, 2013, TOXICOL APPL PHARM, V270, P139, DOI 10.1016/j.taap.2013.03.029; Majidinia M, 2016, DNA REPAIR, V45, P25, DOI 10.1016/j.dnarep.2016.06.003; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2006, CANCER LETT, V233, P208, DOI 10.1016/j.canlet.2005.02.033; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Parasramka MA, 2012, MOL CARCINOGEN, V51, P213, DOI 10.1002/mc.20822; Qin S, 2016, MOL NUTR FOOD RES, V60, P1731, DOI 10.1002/mnfr.201501017; Rajendran P, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0132-y; Rajendran P, 2013, EPIGENETICS-US, V8, P612, DOI 10.4161/epi.24710; Rajendran P, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-68; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rigoutsos Isidore, 2010, Nature, V465, P1016, DOI 10.1038/4651016a; Serghiou S, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0535-1; Shan YJ, 2013, J NUTR BIOCHEM, V24, P1062, DOI 10.1016/j.jnutbio.2012.08.004; Slaby O, 2013, NUTR CANCER, V65, P247, DOI 10.1080/01635581.2013.756530; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Tortorella SM, 2015, ANTIOXID REDOX SIGN, V22, P1382, DOI 10.1089/ars.2014.6097; Wagner AE, 2012, J CELL MOL MED, V16, P836, DOI 10.1111/j.1582-4934.2011.01367.x; Xie X, 2016, ONCOTARGET, V7, P5226, DOI 10.18632/oncotarget.6446; Xin Y, 2016, CELL PROLIFERAT, V49, P255, DOI 10.1111/cpr.12252; Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497; Xu MD, 2014, MODERN PATHOL, V27, P1310, DOI 10.1038/modpathol.2014.33; Xue MZ, 2015, ANTIOXID REDOX SIGN, V23, P613, DOI 10.1089/ars.2014.5962; Yang L, 2016, SEMIN ONCOL, V43, P146, DOI 10.1053/j.seminoncol.2015.09.013; Yi YW, 2015, GENES GENOM, V37, P97, DOI 10.1007/s13258-014-0253-2; Yu EJ, 2016, ONCOGENE, V35, P3410, DOI 10.1038/onc.2015.401; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhang YS, 2014, J BIOL CHEM, V289, P31310, DOI 10.1074/jbc.M114.604868; Zheng BA, 2014, ARCH MED SCI, V10, P651, DOI 10.5114/aoms.2014.44856	66	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1613-4125	1613-4133		MOL NUTR FOOD RES	Mol. Nutr. Food Res.	APR	2017	61	4							UNSP 1600769	10.1002/mnfr.201600769				11	Food Science & Technology	Food Science & Technology	ET8SR	WOS:000400571900017		gold			2018-01-05	
J	Yamauchi, T; Yoshioka, M; Fukazawa, A; Mori, H; Nishizawa, NK; Tsutsumi, N; Yoshioka, H; Nakazono, M				Yamauchi, Takaki; Yoshioka, Miki; Fukazawa, Aya; Mori, Hitoshi; Nishizawa, Naoko K.; Tsutsumi, Nobuhiro; Yoshioka, Hirofumi; Nakazono, Mikio			An NADPH Oxidase RBOH Functions in Rice Roots during Lysigenous Aerenchyma Formation under Oxygen-Deficient Conditions	PLANT CELL			English	Article							DEPENDENT PROTEIN-KINASE; PROGRAMMED CELL-DEATH; POSITIVE FEEDBACK-REGULATION; ORYZA-SATIVA-L; ETHYLENE BIOSYNTHESIS; SUBCELLULAR-LOCALIZATION; NICOTIANA-BENTHAMIANA; ARABIDOPSIS-THALIANA; FLOODING TOLERANCE; ADVENTITIOUS ROOTS	Reactive oxygen species (ROS) produced by the NADPH oxidase, respiratory burst oxidase homolog (RBOH), trigger signal transduction in diverse biological processes in plants. However, the functions of RBOH homologs in rice (Oryza sativa) and other gramineous plants are poorly understood. Ethylene induces the formation of lysigenous aerenchyma, which consists of internal gas spaces created by programmed cell death of cortical cells, in roots of gramineous plants under oxygen-deficient conditions. Here, we report that, in rice, one RBOH isoform (RBOHH) has a role in ethylene-induced aerenchyma formation in roots. Induction of RBOHH expression under oxygen-deficient conditions was greater in cortical cells than in cells of other root tissues. In addition, genes encoding group I calcium-dependent protein kinases (CDPK5 and CDPK13) were strongly expressed in root cortical cells. Coexpression of RBOHH with CDPK5 or CDPK13 induced ROS production in Nicotiana benthamiana leaves. Inhibitors of RBOH activity or cytosolic calcium influx suppressed ethylene-induced aerenchyma formation. Moreover, knockout of RBOHH by CRISPR/Cas9 reduced ROS accumulation and inducible aerenchyma formation in rice roots. These results suggest that RBOHH-mediated ROS production, which is stimulated by CDPK5 and/or CDPK13, is essential for ethylene-induced aerenchyma formation in rice roots under oxygen-deficient conditions.	[Yamauchi, Takaki; Yoshioka, Miki; Fukazawa, Aya; Mori, Hitoshi; Yoshioka, Hirofumi; Nakazono, Mikio] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Nishizawa, Naoko K.; Tsutsumi, Nobuhiro] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Nakazono, Mikio] Univ Western Australia, Fac Sci, UWA Sch Agr & Environm, Crawley, WA 6009, Australia	Nakazono, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.; Nakazono, M (reprint author), Univ Western Australia, Fac Sci, UWA Sch Agr & Environm, Crawley, WA 6009, Australia.	nakazono@agr.nagoya-u.ac.jp		, Takaki/0000-0002-6772-6506	Bio-oriented Technology Research Advancement Institution (Promotion of Basic Research Activities for Innovative Biosciences); MEXT of Japan [15H01398]; Scientific Research from the Japan Society of the Promotion of Science [26292023]; Japan Society for the Promotion of Science	We thank Yoshiaki Nagamura for providing information on gene expression profiles in the rice roots; Masaki Endo and Masafumi Mikami for the universal binary vector (CRISPR/Cas9); Kiyoaki Kato and Itsuro Takamure for seeds of rice (cv Shiokari); Motoyuki Ashikari for the protocol of the ethylene collection apparatus; Phil Mullineaux and Roger Hellens for pGreen vector; Andrew O. Jackson for pGD binary vector; Rohm and Haas Japan and AgroFresh for 1-MCP; and the Leaf Tobacco Research Center, Japan, for N. benthamiana seeds. We also thank Timothy D. Colmer, Ole Pedersen, and Al Imran Malik for critical suggestions, as well as Katsuhiro Shiono, Hirokazu Takahashi, Kazuyuki Kuchitsu, Takamitsu Kurusu, Kenji Hashimoto, Atsushi Oyanagi, Kentaro Kawaguchi, Fumitaka Abe, Yoshiro Mano, Mitsuhiro Obara, Tomomi Abiko, Shunsaku Nishiuchi, and Kohtaro Watanabe for stimulating discussion. This work was partly supported by a grant from the Bio-oriented Technology Research Advancement Institution (Promotion of Basic Research Activities for Innovative Biosciences) to M.N. H.Y. was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" (15H01398) from MEXT of Japan and Scientific Research (26292023) from the Japan Society of the Promotion of Science. T.Y. was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science.	Adachi H, 2015, PLANT CELL, V27, P2645, DOI 10.1105/tpc.15.00213; Adachi H, 2015, BRIEF FUNCT GENOMICS, V14, P253, DOI 10.1093/bfgp/elv004; Armstrong W, 2014, PLANT CELL MONOGR, V21, P267, DOI 10.1007/978-3-7091-1254-0_14; Armstrong W., 1979, Advances in Botanical Research, V7, P225; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asai S, 2013, J BIOL CHEM, V288, P14332, DOI 10.1074/jbc.M112.448910; Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Baxter-Burrell A, 2002, SCIENCE, V296, P2026, DOI 10.1126/science.1071505; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Branco-Price C, 2005, ANN BOT-LONDON, V96, P647, DOI 10.1093/aob/mci217; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Colmer TD, 2008, NEW PHYTOL, V178, P326, DOI 10.1111/j.1469-8137.2007.02364.x; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Colmer TD, 2006, NEW PHYTOL, V170, P767, DOI 10.1111/j.1469-8137.2006.01725.x; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; Desikan R, 1998, J EXP BOT, V49, P1767; Drew MC, 2000, TRENDS PLANT SCI, V5, P123, DOI 10.1016/S1360-1385(00)01570-3; Dubiella U, 2013, P NATL ACAD SCI USA, V110, P8744, DOI 10.1073/pnas.1221294110; Evans DE, 2004, NEW PHYTOL, V161, P35, DOI 10.1046/j.1469-8137.2003.00907.x; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Gonzali S, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.151, 10.1038/NPLANTS.2015.151]; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031                                                             ; He CJ, 1996, PLANT PHYSIOL, V112, P463, DOI 10.1104/pp.112.2.463                                                            ; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.127.3.817; Iwai T, 2006, PLANT PHYSIOL, V142, P1202, DOI 10.1104/pp.106.085258; JACKSON MB, 1985, J EXP BOT, V36, P1566, DOI 10.1093/jxb/36.10.1566; Jackson MB, 1999, PLANT BIOLOGY, V1, P274, DOI 10.1111/j.1438-8677.1999.tb00253.x; JUSTIN SHFW, 1991, NEW PHYTOL, V118, P49, DOI 10.1111/j.1469-8137.1991.tb00564.x; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; KAPILOFF MS, 1991, P NATL ACAD SCI USA, V88, P3710, DOI 10.1073/pnas.88.9.3710; Kawai M, 1998, PLANTA, V204, P277, DOI 10.1007/s004250050257; Kimura S, 2012, BBA-MOL CELL RES, V1823, P398, DOI 10.1016/j.bbamcr.2011.09.011; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kobayashi M, 2012, NEW PHYTOL, V196, P223, DOI 10.1111/j.1469-8137.2012.04226.x; Kurusu T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00427; Latz A, 2013, MOL PLANT, V6, P1274, DOI 10.1093/mp/sss158; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; Matsuura A, 2016, PLANT PROD SCI, V19, P348, DOI 10.1080/1343943X.2016.1146907; McDonald MP, 2002, PLANT CELL ENVIRON, V25, P441, DOI 10.1046/j.0016-8025.2001.00817.x; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mira MM, 2016, PLANT PHYSIOL, V172, P2044, DOI 10.1104/pp.16.01150; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Muller K, 2009, NEW PHYTOL, V184, P885, DOI 10.1111/j.1469-8137.2009.03005.x; Nagano M, 2016, PLANT CELL, V28, P1966, DOI 10.1105/tpc.16.00201; Nestler J, 2014, PLANT J, V79, P729, DOI 10.1111/tpj.12578; Parlanti S, 2011, ANN BOT-LONDON, V107, P1335, DOI 10.1093/aob/mcr086; Pucciariello C, 2017, PLANT CELL ENVIRON, V40, P473, DOI 10.1111/pce.12715; Pucciariello C, 2012, PLANT PHYSIOL, V159, P184, DOI 10.1104/pp.111.191122; Rajhi I, 2011, NEW PHYTOL, V190, P351, DOI 10.1111/j.1469-8137.2010.03535.x; Sasidharan R, 2015, PLANT PHYSIOL, V169, P3, DOI 10.1104/pp.15.00387; Sauter M, 2013, CURR OPIN PLANT BIOL, V16, P282, DOI 10.1016/j.pbi.2013.03.013; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shiono K, 2011, ANN BOT-LONDON, V107, P89, DOI 10.1093/aob/mcq221; Simeunovic A, 2016, J EXP BOT, V67, P3855, DOI 10.1093/jxb/erw157; Steffens B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00179; Steffens B, 2011, NEW PHYTOL, V190, P369, DOI 10.1111/j.1469-8137.2010.03496.x; SUBBAIAH CC, 1994, PLANT PHYSIOL, V105, P369, DOI 10.1104/pp.105.1.369                                                            ; Subbaiah CC, 1998, PLANT PHYSIOL, V118, P759, DOI 10.1104/pp.118.3.759                                                            ; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Takahashi H, 2010, J PLANT RES, V123, P807, DOI 10.1007/s10265-010-0319-4; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Van Hautegem T, 2015, TRENDS PLANT SCI, V20, P102, DOI 10.1016/j.tplants.2014.10.003; Visser EJW, 2006, NEW PHYTOL, V171, P305, DOI 10.1111/j.1469-8137.2006.01764.x; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Wiengweera A, 1997, ANN BOT-LONDON, V80, P115, DOI 10.1006/anbo.1996.0405; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Xie HT, 2014, PLANT CELL, V26, P2007, DOI 10.1105/tpc.114.125427; Yamauchi Takaki, 2016, Plant Cell Environ, V39, P2145, DOI 10.1111/pce.12766; Yamauchi T, 2015, PLANT PHYSIOL, V169, P180, DOI 10.1104/pp.15.00106; Yamauchi T, 2014, J EXP BOT, V65, P261, DOI 10.1093/jxb/ert371; Yamauchi T, 2011, PLANT SIGNAL BEHAV, V6, P759, DOI 10.4161/psb.6.5.15417; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yasuno N, 2009, NEW PHYTOL, V182, P91, DOI 10.1111/j.1469-8137.2008.02724.x; Yoshie Y, 2005, PLANT BIOTECHNOL, V22, P127; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992	86	2	2	14	23	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	1040-4651	1532-298X		PLANT CELL	Plant Cell	APR	2017	29	4					775	790		10.1105/tpc.16.00976				16	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	EU1BF	WOS:000400746600018	28351990				2018-01-05	
J	Budhathold-Uprety, J; Langenbacher, RE; Jena, PV; Roxbury, D; Heller, DA				Budhathold-Uprety, Januka; Langenbacher, Rachel E.; Jena, Prakrit V.; Roxbury, Daniel; Heller, Daniel A.			A Carbon Nanotube Optical Sensor Reports Nuclear Entry via a Noncanonical Pathway	ACS NANO			English	Article						helical polymer; hyperspectral imaging; cervical cancer; near-infrared sensor; biosensor; polycation; nuclear pore complex	DNA CONFORMATIONAL POLYMORPHISM; IMPORTIN-BETA; PORE COMPLEX; TRANSPORT; CELL; FLUORESCENCE; INHIBITOR; DELIVERY; MICROSCOPY; THERAPY	Single-walled carbon nanotubes are of interest in biomedicine for imaging and molecular sensing applications and as shuttles for various cargos such as chemotherapeutic drugs, peptides, proteins, and oligonucleotides. Carbon nanotube surface chemistry can be modulated for subcellular targeting while preserving photoluminescence for label-free visualization in complex biological environments, making them attractive materials for such studies. The cell nucleus is a potential target for many pathologies including cancer and infectious diseases. Understanding mechanisms of nanomaterial delivery to the nucleus may facilitate diagnostics, drug development, and gene-editing tools. Currently, there are no systematic studies to understand how these nanomaterials gain access to the nucleus. Herein, we developed a carbon nanotube based hybrid material that elucidate a distinct mechanism of nuclear translocation of a nanomaterial in cultured cells. We developed a nuclear-targeted probe via cloaking photoluminescent single-walled carbon nanotubes in a guanidinium-functionalized helical polycarbodiimide. We found that the nuclear entry of the nanotubes was mediated by the import receptor importin beta without the aid of importin alpha and not by the more common importin alpha/beta pathway. Additionally, the nanotube photoluminescence exhibited distinct red-shifting upon entry to the nucleus, potentially functioning as a reporter of the importin beta-mediated nuclear transport process. This work delineates a noncanonical mechanism for nanomaterial delivery to the nucleus and provides a reporter for the study of nucleus-related pathologies.	[Budhathold-Uprety, Januka; Langenbacher, Rachel E.; Jena, Prakrit V.; Heller, Daniel A.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Langenbacher, Rachel E.; Heller, Daniel A.] Weill Cornell Med Coll, New York, NY 10065 USA; [Roxbury, Daniel] Univ Rhode Isl, Dept Chem Engn, Kingston, RI 02881 USA	Heller, DA (reprint author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.; Heller, DA (reprint author), Weill Cornell Med Coll, New York, NY 10065 USA.	hellerd@mskcc.org		Heller, Daniel/0000-0002-6866-0000; Jena, Prakrit/0000-0001-5493-3058	NIH [DP2-HD075698]; Cancer Center Support Grant [P30 CA008748]; Anna Fuller Fund; Louis V. Gerstner Jr. Young Investigator's Fund; Frank A. Howard Scholars Program; Honorable Tina Brozman Foundation for Ovarian Cancer Research, Cycle for Survival; Alan and Sandra Gerry Metastasis Research Initiative; Mr. William H. Goodwin and Mrs. Alice Goodwin; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center; Imaging & Radiation Sciences Program; Center for Molecular Imaging and Nanotechnology of Memorial Sloan Kettering Cancer; Tow Foundation Postdoctoral Fellowship, Center for Molecular Imaging and Nanotechnology, at MSKCC; NIH National Cancer Institute [2T32CA062948-21]; American Cancer Society; Rhode Island Foundation; National Institute of General Medical Sciences of the NIH [P20GM103430]	This work was supported in part by the NIH New Innovator Award (DP2-HD075698), the Cancer Center Support Grant (P30 CA008748), the Anna Fuller Fund, the Louis V. Gerstner Jr. Young Investigator's Fund, the Frank A. Howard Scholars Program, the Honorable Tina Brozman Foundation for Ovarian Cancer Research, Cycle for Survival, the Alan and Sandra Gerry Metastasis Research Initiative, Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center, the Imaging & Radiation Sciences Program, and the Center for Molecular Imaging and Nanotechnology of Memorial Sloan Kettering Cancer. J.B.-U. was supported by the Tow Foundation Postdoctoral Fellowship, Center for Molecular Imaging and Nanotechnology, at MSKCC. P.V.J. was supported by a an NIH National Cancer Institute T32 Training Grant (2T32CA062948-21). D.R. was supported by an American Cancer Society 2013 Roaring Fork Valley Research Fellowship, the Rhode Island Foundation, and Grant # P20GM103430 from the National Institute of General Medical Sciences of the NIH. We thank V. Boyko for his help in image processing and acknowledge the core facilities at Memorial Sloan Kettering Cancer Center: the Molecular Cytology Core Facility for AFM imaging, the Antibody and Bioresource Core Facility, and the Analytical Core Facility for nuclear magnetic resonance, FTIR, and high-resolution mass spectroscopies.	Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276; Boyer PD, 2016, ACS APPL MATER INTER, V8, P3524, DOI 10.1021/acsami.5b12602; Budhathoki-Uprety J, 2014, J AM CHEM SOC, V136, P15545, DOI 10.1021/ja505529n; Budhathoki-Uprety J, 2011, MACROMOLECULES, V44, P5947, DOI 10.1021/ma200960e; Chahine MN, 2009, PHARMACOL REV, V61, P358, DOI 10.1124/pr.108.000620; Choi JH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2745228; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; Cohen S, 2011, BBA-MOL CELL RES, V1813, P1634, DOI 10.1016/j.bbamcr.2010.12.009; El-Sayed A, 2008, J BIOL CHEM, V283, P23450, DOI 10.1074/jbc.M709387200; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Gillard M, 2014, BIOMACROMOLECULES, V15, P3569, DOI 10.1021/bm5008376; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Heller DA, 2006, SCIENCE, V311, P508, DOI 10.1126/science.1120792; Heller DA, 2009, NAT NANOTECHNOL, V4, P114, DOI [10.1038/nnano.2008.369, 10.1038/NNANO.2008.369]; Hernandez-Rivera M, 2016, BIOMATERIALS, V101, P229, DOI 10.1016/j.biomaterials.2016.05.045; Hill R., 2010, ONCOTARGET, V1, P11; Hong GS, 2015, CHEM REV, V115, P10816, DOI 10.1021/acs.chemrev.5b00008; Jin H, 2007, MACROMOLECULES, V40, P6731, DOI 10.1021/ma070608t; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kim TI, 2010, BIOMATERIALS, V31, P1798, DOI 10.1016/j.biomaterials.2009.10.034; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Ma XW, 2016, BIOMATERIALS, V97, P10, DOI 10.1016/j.biomaterials.2016.04.026; McKinlay CJ, 2016, J AM CHEM SOC, V138, P3510, DOI 10.1021/jacs.5b13452; Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.mythe.2005.02.010; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; Mu QX, 2009, NANO LETT, V9, P4370, DOI 10.1021/nl902647x; Nagy V., 2006, NAT METHODS, V3, px; Nitin N, 2009, ANN BIOMED ENG, V37, P2018, DOI 10.1007/s10439-009-9768-0; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc01-06-0308; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Roxbury D, 2016, ACS NANO, V10, P499, DOI 10.1021/acsnano.5b05438; Roxbury D, 2015, SCI REP-UK, V5, DOI 10.1038/srep14167; Sakiyama Y, 2016, NAT NANOTECHNOL, V11, P719, DOI [10.1038/nnano.2016.62, 10.1038/NNANO.2016.62]; Schroder T, 2008, J MED CHEM, V51, P376, DOI 10.1021/jm070603m; Serpell CJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13118; Serpell CJ, 2016, ACS CENTRAL SCI, V2, P190, DOI 10.1021/acscentsci.6b00005; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; van der Watt PJ, 2016, MOL CANCER THER, V15, P560, DOI 10.1158/1535-7163.MCT-15-0052; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150	45	9	9	20	31	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	APR	2017	11	4					3875	3882		10.1021/acsnano.7b00176				8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	ET4EX	WOS:000400233200046	28398031				2018-01-05	
J	Liu, ZH; Liang, YY; Ang, EL; Zhao, HM				Liu, Zihe; Liang, Youyun; Ang, Ee Lui; Zhao, Huimin			A New Era of Genome Integration-Simply Cut and Paste!	ACS SYNTHETIC BIOLOGY			English	Review						genome integration; programmable nucleases; synthetic biology; metabolic engineering	DOUBLE-STRAND BREAKS; METABOLIC ENGINEERING APPLICATIONS; MEDIATED TARGETED INTEGRATION; CRISPR-CAS SYSTEMS; END-JOINING REPAIR; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; ESCHERICHIA-COLI; MAMMALIAN-CELLS; KNOCK-IN	Genome integration is a powerful tool in both basic and applied biological research. However, traditional genome integration, which is typically mediated by homologous recombination, has been constrained by low efficiencies and limited host range. In recent years, the emergence of homing endonucleases and programmable nucleases has greatly enhanced integration efficiencies and allowed alternative integration mechanisms such as nonhomologous end joining and microhomology-mediated end joining, enabling integration in hosts deficient in homologous recombination. In this review, we will highlight recent advances and breakthroughs in genome integration methods made possible by programmable nucleases, and their new applications in synthetic biology and metabolic engineering.	[Liu, Zihe; Liang, Youyun; Ang, Ee Lui; Zhao, Huimin] Agcy Sci Technol & Res, Sci & Engn Inst, Metabol Engn Res Lab, Singapore, Singapore; [Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA	Ang, EL; Zhao, HM (reprint author), Agcy Sci Technol & Res, Sci & Engn Inst, Metabol Engn Res Lab, Singapore, Singapore.; Zhao, HM (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	angel@merl.a-star.edu.sg; zhao5@illinois.edu		Zhao, Huimin/0000-0002-9069-6739	Agency for Science, Technology and Research (A*STAR), Singapore; National Institutes of Health [1U54DK107965]; Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea [20153030091450]	We thank Agency for Science, Technology and Research (A*STAR), Singapore for supporting various research projects in the Metabolic Engineering Research Laboratory (MERL) through the Visiting Investigator Programme to H.Z. We also gratefully acknowledge financial support from the National Institutes of Health (1U54DK107965) (H.Z.) and the Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP), granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (20153030091450) (H.Z.).	Argyros DA, 2011, APPL ENVIRON MICROB, V77, P8288, DOI 10.1128/AEM.00646-11; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bao ZH, 2016, WIRES SYST BIOL MED, V8, P5, DOI 10.1002/wsbm.1319; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Begemann MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076594; Betermier M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004086; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Brown A, 2016, ACS SYNTH BIOL, V5, P582, DOI 10.1021/acssynbio.6b00056; Callaway E, 2015, NATURE, V521, P18, DOI 10.1038/nature.2015.17462; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chaikind B., 2016, NUCLEIC ACIDS RES; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; Decottignies Anabelle, 2013, Frontiers in Genetics, V4, P48, DOI 10.3389/fgene.2013.00048; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Endo M, 2006, EMBO J, V25, P5579, DOI 10.1038/sj.emboj.7601434; Fang F, 2011, YEAST, V28, P123, DOI 10.1002/yea.1824; Flagfeldt DB, 2009, YEAST, V26, P545, DOI 10.1002/yea.1705; Geisinger JM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1542; Gerami-Nejad M, 2013, MICROBIOL-SGM, V159, P565, DOI 10.1099/mic.0.064097-0; Ha SJ, 2013, BIORESOURCE TECHNOL, V149, P525, DOI 10.1016/j.biortech.2013.09.082; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; He MD, 2015, MUTAT RES-FUND MOL M, V780, P86, DOI 10.1016/j.mrfmmm.2015.08.004; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; He Z., 2016, SPRINGERPLUS, V5, P1; Hendriks WT, 2016, CELL STEM CELL, V18, P53, DOI 10.1016/j.stem.2015.12.002; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Ishii A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108236; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jakociunas T, 2015, ACS SYNTH BIOL, V4, P1226, DOI 10.1021/acssynbio.5b00007; Jayathilaka K, 2008, P NATL ACAD SCI USA, V105, P15848, DOI 10.1073/pnas.0808046105; Jensen NM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-; Jessop-Fabre MM, 2016, BIOTECHNOL J, V11, P1110, DOI 10.1002/biot.201600147; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Joshi R, 2011, J MOL BIOL, V405, P185, DOI 10.1016/j.jmb.2010.10.029; Kamisugi Y, 2006, NUCLEIC ACIDS RES, V34, P6205, DOI 10.1093/nar/gkl832; Karim AS, 2013, FEMS YEAST RES, V13, P107, DOI 10.1111/1567-1364.12016; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Kostyrko K, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1349; Kuhlman T. E., 2010, BIOENG BUGS, V1, P298; Lai Tingfeng, 2013, Pharmaceuticals (Basel), V6, P579, DOI 10.3390/ph6050579; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Lian JZ, 2016, BIOTECHNOL BIOENG, V113, P2462, DOI 10.1002/bit.26004; Liu JG, 2012, J GENET GENOMICS, V39, P489, DOI 10.1016/j.jgg.2012.07.009; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Meyer M, 2012, P NATL ACAD SCI USA, V109, P9354, DOI 10.1073/pnas.1121203109; Mikkelsen MD, 2012, METAB ENG, V14, P104, DOI 10.1016/j.ymben.2012.01.006; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Poncet S, 1997, APPL ENVIRON MICROB, V63, P4413; Prax M, 2013, MICROBIOL-SGM, V159, P421, DOI 10.1099/mic.0.061705-0; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Redder P, 2012, APPL ENVIRON MICROB, V78, P3846, DOI 10.1128/AEM.00202-12; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; RIKKERINK EHA, 1994, CURR GENET, V25, P202, DOI 10.1007/BF00357163; Ronda C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0288-3; Russell WM, 2001, APPL ENVIRON MICROB, V67, P4361, DOI 10.1128/AEM.67.9.4361-4364.2001; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sakuma T, 2015, INT J MOL SCI, V16, P23849, DOI 10.3390/ijms161023849; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Saraya R, 2012, FEMS YEAST RES, V12, P271, DOI 10.1111/j.1567-1364.2011.00772.x; Schaeffer SM, 2015, PLANT SCI, V240, P130, DOI 10.1016/j.plantsci.2015.09.011; Shao XJ, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0514-1; Shao ZY, 2012, METHOD ENZYMOL, V517, P203, DOI 10.1016/B978-0-12-404634-4.00010-3; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Shen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077696; Shi SB, 2016, METAB ENG, V33, P19, DOI 10.1016/j.ymben.2015.10.011; Shi SB, 2014, BIOTECHNOL BIOENG, V111, P1740, DOI 10.1002/bit.25234; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Sirk SJ, 2014, NUCLEIC ACIDS RES, V42, P4755, DOI 10.1093/nar/gkt1389; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; STEINER S, 1995, GENETICS, V140, P973; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Stovicek Vratislav, 2015, Metabolic Engineering Communications, V2, P13, DOI 10.1016/j.meteno.2015.03.001; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tas H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136963; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Valton J, 2014, METHODS, V69, P151, DOI 10.1016/j.ymeth.2014.06.013; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Verbeke J, 2013, BIOTECHNOL LETT, V35, P571, DOI 10.1007/s10529-012-1107-0; Voit RA, 2013, MOL THER, V21, P786, DOI 10.1038/mt.2012.284; Wagner JM, 2016, FUNGAL GENET BIOL, V89, P126, DOI [10.1010/j.fgb.2015.12.001, 10.1016/j.fgb.2015.12.001]; Wang SH, 2014, WORLD J MICROB BIOT, V30, P1369, DOI 10.1007/s11274-013-1561-4; Wang Z, 2008, OLIGONUCLEOTIDES, V18, P21, DOI 10.1089/oli.2007.0093; Wingler LM, 2011, P NATL ACAD SCI USA, V108, P15135, DOI 10.1073/pnas.1100507108; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt.1211; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Xu ZY, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0241-5; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Yuan JF, 2015, ACS SYNTH BIOL, V4, P23, DOI 10.1021/sb500079f; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; Zhang WW, 2015, MBIO, V6, DOI 10.1128/mBio.00861-15; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	121	2	2	9	25	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	APR	2017	6	4					601	609		10.1021/acssynbio.6b00331				9	Biochemical Research Methods	Biochemistry & Molecular Biology	ET2TH	WOS:000400126500001	28073246				2018-01-05	
J	Bao, ZH; Jain, S; Jaroenpuntaruk, V; Zhao, HM				Bao, Zehua; Jain, Surbhi; Jaroenpuntaruk, Valerie; Zhao, Huimin			Orthogonal Genetic Regulation in Human Cells Using Chemically Induced CRISPR/Cas9 Activators	ACS SYNTHETIC BIOLOGY			English	Article						CRISPR/Cas9; synthetic transcription factor; chemically induced dimerization; genetic regulation; orthogonality	TRANSCRIPTION FACTORS; STEM-CELLS; CRISPR-CAS9; COMPLEX; SYSTEM; CAS9; MODULATION; PROTEINS	The concerted action of multiple genes in a time-dependent manner controls complex cellular phenotypes, yet the temporal regulation of gene expressions is restricted on a single-gene level, which limits our ability to control higher-order gene networks and understand the consequences of multiplex genetic perturbations. Here we developed a system for temporal regulation of multiple genes. This system combines the simplicity of CRISPR/Cas9 activators for orthogonal targeting of multiple genes and the orthogonality of chemically induced dimerizing (CID) proteins for temporal control of CRISPR/Cas9 activator function. In human cells, these transcription activators exerted simultaneous activation of multiple genes and orthogonal regulation of different genes in a ligand-dependent manner with minimal background. We envision that our system will enable the perturbation of higher-order gene networks with high temporal resolution and accelerate our understanding of gene gene interactions in a complex biological setting.	[Bao, Zehua; Jain, Surbhi; Jaroenpuntaruk, Valerie; Zhao, Huimin] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem, Urbana, IL 61801 USA; [Zhao, Huimin] Univ Illinois, Carl R Woese Inst Genom Biol, Dept Bioengn, Urbana, IL 61801 USA	Zhao, HM (reprint author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem, Urbana, IL 61801 USA.; Zhao, HM (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Dept Bioengn, Urbana, IL 61801 USA.	zhao5@illinois.edu		Bao, Zehua/0000-0002-5519-4864; Zhao, Huimin/0000-0002-9069-6739	Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign	The authors thank Dr. Charles A. Gersbach (Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA) for sharing plasmid pGL3-Basic-9 X Seq2-hCMVmp-eGFP, Dr. Takanari Inoue (Department of Cell Biology, Center for Cell Dynamics, School of Medicine, Johns Hopkins University, Baltimore, Maryland) for sharing plasmids CFP-GAI(1-92) and YFP-GID1, Dr. Tasuku Ueno (Laboratory of Chemistry and Biology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan) for providing ligand GA<INF>3</INF>-AM. This work was supported by the Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign.	Auslander S, 2013, TRENDS BIOTECHNOL, V31, P155, DOI 10.1016/j.tibtech.2012.11.006; Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Bao ZH, 2016, WIRES SYST BIOL MED, V8, P5, DOI 10.1002/wsbm.1319; Bartsevich VV, 2003, STEM CELLS, V21, P632, DOI 10.1634/stemcells.21-6-632                                                      ; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lienert F, 2013, NUCLEIC ACIDS RES, V41, P9967, DOI 10.1093/nar/gkt758; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Miyamoto T, 2012, NAT CHEM BIOL, V8, P465, DOI [10.1038/NCHEMBIO.922, 10.1038/nchembio.922]; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Polstein LR, 2012, J AM CHEM SOC, V134, P16480, DOI 10.1021/ja3065667; Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795; Rivera V. M., 2012, COLD SPRING HARB PRO, V2012; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	29	1	1	3	7	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	APR	2017	6	4					686	693		10.1021/acssynbio.6b00313				8	Biochemical Research Methods	Biochemistry & Molecular Biology	ET2TH	WOS:000400126500010	28054767				2018-01-05	
J	Mout, R; Ray, M; Lee, YW; Scaletti, F; Rotello, VM				Mout, Rubul; Ray, Moumita; Lee, Yi-Wei; Scaletti, Federica; Rotello, Vincent M.			In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges	BIOCONJUGATE CHEMISTRY			English	Review							MUSCULAR-DYSTROPHY; MEDIATED DELIVERY; MOUSE MODEL; HUMAN-CELLS; GENOME; CAS9; RNA; CRISPR-CAS9; NUCLEASES; ENDONUCLEASE	The successful use of clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-based gene editing for therapeutics requires efficient in vivo delivery of the CRISPR components. There are, however, major challenges on the delivery front. In this Topical Review, we will highlight recent developments in CRISPR delivery, and we will present hurdles that still need to be overcome to achieve effective in vivo editing.	[Mout, Rubul; Ray, Moumita; Lee, Yi-Wei; Scaletti, Federica; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA	Rotello, VM (reprint author), Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA.	rotello@chem.umass.edu		Mout, Rubul/0000-0001-6125-5873	University of Massachusetts Presidents' Science and Technology Fund; NIH [GM077173]	We acknowledge the University of Massachusetts Presidents' Science and Technology Fund as well as the NIH (GM077173).	Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Dong BA, 2010, MOL THER, V18, P87, DOI 10.1038/mt.2009.258; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Latella MC, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2016.92; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mout R., 2017, ACS NANO, DOI [10.1021/acsnano.6b07600, DOI 10.1021/ACSNAN0.6B07600]; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Wang AY, 2004, HUM GENE THER, V15, P405, DOI 10.1089/104303404322959551; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	39	4	4	26	39	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	APR	2017	28	4					880	884		10.1021/acs.bioconjchem.7b00057				5	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	ET0PL	WOS:000399965800003	28263568				2018-01-05	
J	Kang, YK; Kwon, K; Ryu, JS; Lee, HN; Park, C; Chung, HJ				Kang, Yoo Kyung; Kwon, Kyu; Ryu, Jea Sung; Lee, Ha Neul; Park, Chankyu; Chung, Hyun Jung			Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance	BIOCONJUGATE CHEMISTRY			English	Article							VIVO GENE DELIVERY; IN-VIVO; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN-RESISTANT; EFFICIENT DELIVERY; VIRAL VECTORS; THERAPY; POLYETHYLENIMINE; NANOPARTICLES; RNA	The overuse of antibiotics plays a major role in the emergence and spread of multidrug-resistant bacteria. A molecularly targeted, specific treatment method for bacterial pathogens can prevent this problem by reducing the selective pressure during microbial growth. Herein, we introduce a nonviral treatment strategy delivering genome editing material for targeting antibacterial resistance. We apply the CRISPR-Cas9 system, which has been recognized as an innovative tool for highly specific and efficient genome engineering in different organisms, as the delivery cargo. We utilize polymer-derivatized Cas9, by direct covalent modification of the protein with cationic polymer, for subsequent complexation with single-guide RNA targeting antibiotic resistance. We show that nanosized CRISPR complexes (= Cr-Nanocomplex) were successfully formed, while maintaining the functional activity of Cas9 endonuclease to induce double-strand DNA cleavage. We also demonstrate that the Cr-Nanocomplex designed to target mecA-the major gene involved in methicillin resistance-can be efficiently delivered into Methicillin-resistant Staphylococcus aureus (MRSA), and allow the editing of the bacterial genome with much higher efficiency compared to using native Cas9 complexes or conventional lipid-based formulations. The present study shows for the first time that a covalently modified CRISPR system allows nonviral, therapeutic genome editing, and can be potentially applied as a target specific antimicrobial.	[Kang, Yoo Kyung; Ryu, Jea Sung; Lee, Ha Neul; Chung, Hyun Jung] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon 305701, South Korea; [Kwon, Kyu; Park, Chankyu] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 305701, South Korea	Chung, HJ (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon 305701, South Korea.	hyunjc@kaist.ac.kr	Chung, Hyun Jung/J-3205-2014		Ministry of Health and Welfare of Korea [HI14C2270, HI15C1948]; National Research Foundation of Korea [2015R1C1A1A02036647, 2014M3A9D9069603, 2015R1A2A2A01006348]	The study was supported by grants from the Ministry of Health and Welfare of Korea (HI14C2270 and HI15C1948 to H.J.C.) and the National Research Foundation of Korea (2015R1C1A1A02036647 to H.J.C.; 2014M3A9D9069603 and 2015R1A2A2A01006348 to C.P.). We also acknowledge Kka bi Son (KAIST), Hyunjun Kim (KAIST), Hae-Soo Kim (Yonsei University), and Sung-MM Nam (KAIST) for their help with preparation of SpCas9, bioconjugation, and image analysis, respectively.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; BERGOGNEBEREZIN E, 1993, J ANTIMICROB CHEMOTH, V32, P39, DOI 10.1093/jac/32.suppl_A.39                                                       ; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bobbin ML, 2016, ANNU REV PHARMACOL, V56, P103, DOI 10.1146/annurev-pharmtox-010715-103633; Bouard D, 2009, BRIT J PHARMACOL, V157, P153, DOI 10.1038/bjp.2008.349; Bozzuto G, 2015, INT J NANOMED, V10, P975, DOI 10.2147/IJN.S68861; Brave A, 2007, MOL PHARMACEUT, V4, P18, DOI 10.1021/mp060098+; Chung HJ, 2011, BIOCONJUGATE CHEM, V22, P299, DOI 10.1021/bc100438m; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Drucker E, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-7; Dzidic S, 2003, ACTA PHARMACOL SIN, V24, P519; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jin L, 2014, THERANOSTICS, V4, P240, DOI 10.7150/thno.6914; Joseph R., 2009, J COSMOL, V1, P100; Kawahara A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050727; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lin GM, 2015, MOL PHARMACEUT, V12, P314, DOI 10.1021/mp500656v; Lu WP, 1999, BIOCHEMISTRY-US, V38, P6537, DOI 10.1021/bi990025e; Lucas GM, 1998, CLIN INFECT DIS, V26, P1127, DOI 10.1086/520311                                                                  ; Mady M.M., 2011, ROM J BIOPHYS, V21, P151; Marraffini L. A., 2016, STREPTOCOCCUS PYOGEN; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Park CY, 2016, TRENDS BIOTECHNOL, V34, P548, DOI 10.1016/j.tibtech.2016.02.011; Patnaik S, 2013, EXPERT OPIN DRUG DEL, V10, P215, DOI 10.1517/17425247.2013.744964; Postupalenko V, 2014, J CONTROL RELEASE, V178, P86, DOI 10.1016/j.jconrel.2014.01.017; Ren XL, 2016, BIOCONJUGATE CHEM, V27, P66, DOI 10.1021/acs.bioconjchem.5b00650; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanvicens N, 2008, TRENDS BIOTECHNOL, V26, P425, DOI 10.1016/j.tibtech.2008.04.005; Shim MS, 2009, BIOCONJUGATE CHEM, V20, P488, DOI 10.1021/bc800436v; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI.25424; Suarez C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-272; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Taranejoo S, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42096; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Ventola C Lee, 2015, P T, V40, P277; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Whitener CJ, 2004, CLIN INFECT DIS, V38, P1049, DOI 10.1086/382357                                                                  ; Wright GD, 2007, TRENDS MOL MED, V13, P260, DOI 10.1016/j.molmed.2007.04.004; Wright GD, 2016, TRENDS MICROBIOL, V24, P862, DOI 10.1016/j.tim.2016.06.009; Wright GD, 2014, CAN J MICROBIOL, V60, P147, DOI 10.1139/cjm-2014-0063; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Zuris J. A., 2014, NAT BIOTECHNOL, V33	52	2	2	16	21	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	APR	2017	28	4					957	967		10.1021/acs.bioconjchem.6b00676				11	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	ET0PL	WOS:000399965800014	28215090				2018-01-05	
J	Khodadadi, E; Mehrabi, AA; Najafi, A; Rastad, S; Masoudi-Nejad, A				Khodadadi, Ehsan; Mehrabi, Ali Ashraf; Najafi, Ali; Rastad, Saber; Masoudi-Nejad, Ali			Systems biology study of transcriptional and post-transcriptional co-regulatory network sheds light on key regulators involved in important biological processes in Citrus sinensis	PHYSIOLOGY AND MOLECULAR BIOLOGY OF PLANTS			English	Article						Citrus sinensis; miRNA; Transcriptional regulator; Coregulatory network; Co-expression networks	COEXPRESSION NETWORKS; FRUIT-DEVELOPMENT; STRESS RESPONSES; PLANT MICRORNAS; BIG PLAYERS; WEB SERVER; SMALL RNAS; WILD-TYPE; GENE; IDENTIFICATION	Transcriptional and post-transcriptional regulators including transcription regulator, transcription factor and miRNA are the main endogenous molecular elements which control complex cellular mechanisms such as development, growth and response to biotic and abiotic stresses in a coordinated manner in plants. Utilizing the most recent information on such relationships in a plant species, obtained from high-throughput experimental technologies and advanced computational tools, we can reconstruct its co-regulatory network which consequently sheds light on key regulators involved in its important biological processes. In this article, combined systems biology approaches such as mining the literatures, various databases and network reconstruction, analysis, and visualization tools were employed to infer and visualize the coregulatory relationships between miRNAs and transcriptional regulators in Citrus sinensis. Using computationally and experimentally verified miRNA-target interactions and constructed co-expression networks on array-based data, 10 coregulatory networks and 10 corresponding subgraphs include FFL motifs were obtained for 10 distinct tissues/conditions. Then PPI subnetworks were extracted for transcripts/genes included in mentioned subgraphs in order to the functional analysis of extracted coregulatory circuits. These proposed coregulatory connections shed light on precisely identifying C. sinensis metabolic pathways key switches, which are demanded for ultimate goals such as genome editing.	[Khodadadi, Ehsan; Mehrabi, Ali Ashraf] Univ Ilam, Dept Agron & Plant Breeding, Fac Agr, Ilam, Iran; [Najafi, Ali] Med Univ Baqiyatalah, Dept Mol Biol, Tehran, Iran; [Khodadadi, Ehsan; Rastad, Saber; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran	Mehrabi, AA (reprint author), Univ Ilam, Dept Agron & Plant Breeding, Fac Agr, Ilam, Iran.; Masoudi-Nejad, A (reprint author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	a.mehrabi@ilam.ac.ir; amasoudin@ibb.ut.ac.ir		Najafi, Ali/0000-0002-2540-4955			Afshar AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100806; Leyva-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048138; Aruoma OI, 2012, PREV MED, V54, pS12, DOI 10.1016/j.ypmed.2012.02.012; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Ayadi M, 2016, APPL BIOCHEM BIOTECH, V180, P516, DOI 10.1007/s12010-016-2114-8; Berri S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-120; Bonnet E, 2010, BIOINFORMATICS, V26, P1566, DOI 10.1093/bioinformatics/btq233; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cantini L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17386; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; CHIEN CH, 2015, DATABASE OXFORD 0513, DOI DOI 10.1093/DATABASE/BAV042; Chiou TJ, 2007, PLANT CELL ENVIRON, V30, P323, DOI 10.1111/j.1365-3040.2007.01643.x; Da Graca JV, 2004, DIS FRUITS VEGETABLE, VI, P229; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Das A. K., 2003, Journal of Applied Horticulture (Lucknow), V5, P52; Ding YD, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0213-7; Du DL, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.26; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Georgakilas G, 2016, NUCLEIC ACIDS RES, V44, pD190, DOI 10.1093/nar/gkv1254; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Guzzi PH, 2015, EURASIP J BIOINFORM, DOI 10.1186/s13637-015-0023-8; Hamed M, 2015, NUCLEIC ACIDS RES, V43, pW283, DOI 10.1093/nar/gkv418; Hsieh WT, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S1-S5; Hwang E.W., 2011, KOREAN SOC APPL BIOL, V54, P317; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1                                                   ; Kalim B, 2015, MERIT RES J AGR SCI, V3, P106; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Liu J, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S2-S11; Liu XY, 2015, J AGR FOOD CHEM, V63, P2618, DOI 10.1021/jf505843n; Liu X, 2016, MOL BIOL REP, V43, P1059, DOI 10.1007/s11033-016-4048-1; Lu Y, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0009-z; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Megraw M, 2016, PLANT CELL, V28, P286, DOI 10.1105/tpc.15.00852; Mendoza-Soto AB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00105; Naeem H, 2012, THESIS; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Ou J, 2016, GENENETWORKBUILDER B; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125156; Song CJ, 2010, J ARID ENVIRON, V2010, P1, DOI DOI 10.1109/ICBBE.2010.5516254; Srivastava PK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-348; Sun LM, 2014, SCI HORTIC-AMSTERDAM, V178, P95, DOI 10.1016/j.scienta.2014.08.015; Sun XL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-174; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tam W-L, 2009, SYST BIOMED CONCEPTS, V5, P109, DOI [10.1016/B978-0-12-372550-9.00005-5, DOI 10.1016/B978-0-12-372550-9.00005-5]; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Le TD, 2015, BRIEF BIOINFORM, V16, P475, DOI 10.1093/bib/bbu023; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang J, 2014, PLOS ONE, DOI [10.1371/journal.pone.0087723, DOI 10.1371/JOURNAL.PONE.0087723]; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wong DCJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-186; Wu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-953; Wu JX, 2014, J EXP BOT, V65, P1651, DOI 10.1093/jxb/eru044; Wu XY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0755-y; Wu XM, 2015, PLANT BIOTECHNOL J, V13, P383, DOI 10.1111/pbi.12317; Xu MY, 2014, J EXP BOT, V65, P89, DOI 10.1093/jxb/ert353; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Zhang HM, 2015, BRIEF BIOINFORM, V16, P45, DOI 10.1093/bib/bbt085; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhang Z, 2009, NUCLEIC ACIDS RES, DOI 10.1093/nar/gkp818; Zhao H, 2016, BIOCHIM BIOPHYS ACTA, V7, P1475; Zheng Y, 2014, PLANT AN GEN 22 C; Zhou X, 2007, PLOS COMPUT BIOL, V3, P3	72	0	0	5	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0971-5894	0974-0430		PHYSIOL MOL BIOL PLA	Physiol. Mol. Biol. Plants	APR	2017	23	2					331	342		10.1007/s12298-017-0416-0				12	Plant Sciences	Plant Sciences	ES6VI	WOS:000399687900008	28461722				2018-01-05	
J	Salsman, J; Dellaire, G				Salsman, Jayme; Dellaire, Graham			Precision genome editing in the CRISPR era	BIOCHEMISTRY AND CELL BIOLOGY			English	Review						CRISPR; Cas9; genome editing; DNA repair; gene therapy	DOUBLE-STRAND-BREAK; PLURIPOTENT STEM-CELLS; CLASS-SWITCH RECOMBINATION; HOMOLOGY-DIRECTED REPAIR; INDEPENDENT DNA-REPAIR; END-JOINING PATHWAY; LIVING HUMAN-CELLS; MAMMALIAN-CELLS; KNOCK-IN; CHROMOSOMAL REARRANGEMENTS	With the introduction of precision genome editing using CRISPR-Cas9 technology, we have entered a new era of genetic engineering and gene therapy. With RNA-guided endonucleases, such as Cas9, it is possible to engineer DNA double strand breaks (DSB) at specific genomic loci. DSB repair by the error-prone non-homologous end-joining (NHEJ) pathway can disrupt a target gene by generating insertions and deletions. Alternatively, Cas9-mediated DSBs can be repaired by homologydirected repair (HDR) using an homologous DNA repair template, thus allowing precise gene editing by incorporating genetic changes into the repair template. HDR can introduce gene sequences for protein epitope tags, delete genes, make point mutations, or alter enhancer and promoter activities. In anticipation of adapting this technology for gene therapy in human somatic cells, much focus has been placed on increasing the fidelity of CRISPR-Cas9 and increasing HDR efficiency to improve precision genome editing. In this review, we will discuss applications of CRISPR technology for gene inactivation and genome editing with a focus on approaches to enhancing CRISPR-Cas9-mediated HDR for the generation of cell and animal models, and conclude with a discussion of recent advances and challenges towards the application of this technology for gene therapy in humans.	[Salsman, Jayme; Dellaire, Graham] Dalhousie Univ, Dept Pathol, Halifax, NS B3H 4R2, Canada; [Dellaire, Graham] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Dellaire, Graham] Beatrice Hunter Canc Res Inst, Halifax, NS B3H 4R2, Canada	Dellaire, G (reprint author), Dalhousie Univ, Dept Pathol, Halifax, NS B3H 4R2, Canada.; Dellaire, G (reprint author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.; Dellaire, G (reprint author), Beatrice Hunter Canc Res Inst, Halifax, NS B3H 4R2, Canada.	dellaire@dal.ca		Dellaire, Graham/0000-0002-3466-6316	Canadian Institutes of Health Research (CIHR) [MOP-84260]; BHCRI postdoctoral fellowship by the Harvey Graham Cancer Research Fund as part of the Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	This research was funded by operating grants from the Canadian Institutes of Health Research (CIHR) to G.D. (MOP-84260); G.D. is a Senior Scientist of the Beatrice Hunter Cancer Research Institute (BHCRI); J.S. was a recipient of a BHCRI postdoctoral fellowship made possible by the Harvey Graham Cancer Research Fund as part of the Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Castano J., 2016, ONCOTARGET, DOI 10.18632/oncotarget.8938; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chapman JR, 2012, J CELL SCI, V125, P3529, DOI 10.1242/jcs.105353; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Cheng CY, 2011, J VIROL, V85, P765, DOI 10.1128/JVI.01890-10; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Cyranoski D, 2016, NATURE, V540, P20, DOI 10.1038/nature.2016.21023; Dalvai M, 2015, CELL REP, V13, P621, DOI 10.1016/j.celrep.2015.09.009; Dambournet D, 2014, METHOD ENZYMOL, V546, P139, DOI 10.1016/B978-0-12-801185-0.00007-6; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dever SM, 2011, AGING-US, V3, P515, DOI 10.18632/aging.100325                                                           ; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Forrester NA, 2011, J VIROL, V85, P2201, DOI 10.1128/JVI.01748-10; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Gao YZ, 2016, MOL THER, V24, P1378, DOI 10.1038/mt.2016.97; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; Graham DB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0823-x; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586                                                          ; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; He ZY, 2015, BIOTECHNOL BIOENG, V112, P1060, DOI 10.1002/bit.25490; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jayathilaka K, 2008, P NATL ACAD SCI USA, V105, P15848, DOI 10.1073/pnas.0808046105; Jiang WX, 2015, MOL CELL, V58, P172, DOI 10.1016/j.molcel.2015.02.024; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kamens J, 2015, NUCLEIC ACIDS RES, V43, pD1152, DOI 10.1093/nar/gku893; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9                                                   ; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; KOTIN RM, 1992, EMBO J, V11, P5071; KTISTAKIS NT, 1992, NATURE, V356, P344, DOI 10.1038/356344a0; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lagutina IV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004951; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee JS, 2016, BIOTECHNOL BIOENG, V113, P2518, DOI 10.1002/bit.26002; Lee-Theilen M, 2011, NAT STRUCT MOL BIOL, V18, P75, DOI 10.1038/nsmb.1942; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Menon Vijay, 2014, Subcell Biochem, V85, P321, DOI 10.1007/978-94-017-9211-0_17; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mladenov E, 2016, SEMIN CANCER BIOL, V37-38, P51, DOI 10.1016/j.semcancer.2016.03.003; Munck JM, 2012, MOL CANCER THER, V11, P1789, DOI 10.1158/1535-7163.MCT-11-0535; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Niu XH, 2016, J BIOL CHEM, V291, P16576, DOI 10.1074/jbc.M116.719237; Oceguera-Yanez F, 2016, METHODS, V101, P43, DOI 10.1016/j.ymeth.2015.12.012; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Papapetrou EP, 2016, MOL THER, V24, P678, DOI 10.1038/mt.2016.38; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Park JH, 2016, BLOOD, V127, P3312, DOI 10.1182/blood-2016-02-629063; Parmee ER, 1998, BIOORG MED CHEM LETT, V8, P1107, DOI 10.1016/S0960-894X(98)00170-X; Pilato B, 2012, MOL BIOTECHNOL, V52, P8, DOI 10.1007/s12033-011-9468-5; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Renouf B, 2014, METHOD ENZYMOL, V546, P251, DOI 10.1016/B978-0-12-801185-0.00012-X; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Robert F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0215-6; ROTH DB, 1995, CURR BIOL, V5, P496, DOI 10.1016/S0960-9822(95)00101-1; Roth D. B, 2014, MICROBIOL SPECTR, V2, P2, DOI DOI 10.1128/MICR0BI0LSPEC.MDNA3-0041-2014; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138                                                         ; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Savage KI, 2015, FEBS J, V282, P630, DOI 10.1111/febs.13150; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Schwartz RA, 2008, J VIROL, V82, P9043, DOI 10.1128/JVI.00925-08; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; SHULMAN MJ, 1990, MOL CELL BIOL, V10, P4466, DOI 10.1128/MCB.10.9.4466                                                           ; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Sirbu BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023053; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0                                                                ; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Speidel D, 2015, ARCH TOXICOL, V89, P501, DOI 10.1007/s00204-015-1459-z; Stavnezer J, 2014, J IMMUNOL, V193, P5370, DOI 10.4049/jimmunol.1401849; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Tham KC, 2016, DNA REPAIR, V38, P75, DOI 10.1016/j.dnarep.2015.11.010; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Uddin B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2284-8; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vogel G, 2007, SCIENCE, V318, P178, DOI 10.1126/science.318.5848.178                                                    ; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang QH, 2014, EMBO J, V33, P862, DOI 10.1002/embj.201386064; Willers H, 2000, INT J RADIAT BIOL, V76, P1055; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yang YY, 2016, STEM CELL TRANSL MED, V5, P8, DOI 10.5966/sctm.2015-0157; Yoshimatsu K, 1997, CANCER RES, V57, P3208; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098282; Yu SL, 2011, J BIOTECHNOL, V154, P21, DOI 10.1016/j.jbiotec.2011.03.023; Yuan JS, 2010, J BIOL CHEM, V285, P1097, DOI 10.1074/jbc.M109.078436; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940; Zhou Y, 2013, J BIOL CHEM, V288, P37112, DOI 10.1074/jbc.M113.514398; Zhu ZR, 2014, METHOD ENZYMOL, V546, P215, DOI 10.1016/B978-0-12-801185-0.00011-8	170	2	2	22	42	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0829-8211	1208-6002		BIOCHEM CELL BIOL	Biochem. Cell Biol.	APR	2017	95	2			SI		187	201		10.1139/bcb-2016-0137				15	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	ER9RZ	WOS:000399165600028	28177771				2018-01-05	
J	Lau, V; Davie, JR				Lau, Veronica; Davie, James R.			The discovery and development of the CRISPR system in applications in genome manipulation	BIOCHEMISTRY AND CELL BIOLOGY			English	Review						CRISPR-Cas9; genome editing	MUSCULAR-DYSTROPHY; GENE-EXPRESSION; CAS SYSTEMS; MOUSE MODEL; HUMAN-CELLS; STEM-CELLS; RNA; EFFICIENT; REPEATS; DNA	The clustered regularly interspaced short palindromic repeat (CRISPR) associated 9 (Cas9) system is a microbial adaptive immune system that has been recently developed for genomic engineering. From the moment the CRISPR system was discovered in Escherichia coli, the drive to understand the mechanism prevailed, leading to rapid advancement in the knowledge and applications of the CRISPR system. With the ability to characterize and understand the function of the Cas9 endonuclease came the ability to adapt the CRISPR-Cas9 system for use in a variety of applications and disciplines ranging from agriculture to biomedicine. This review will provide a brief overview of the discovery and development of the CRISPR-Cas9 system in applications such as genome regulation and epigenome engineering, as well as the challenges faced.	[Lau, Veronica; Davie, James R.] Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB R3E 3P4, Canada	Davie, JR (reprint author), Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB R3E 3P4, Canada.	jim.davie@umanitoba.ca			Research Manitoba Studentship; CancerCare Manitoba Foundation; Canada Research Chair	This work was supported by a Research Manitoba Studentship in partnership with CancerCare Manitoba Foundation to V.H. and a Canada Research Chair to J.R.D. The authors acknowledge the strong support of the Children's Hospital Research Institute of Manitoba and CancerCare Manitoba Foundation. The authors declare that there are no conflicts of interest associated with this study.	Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Callaway E, 2016, NATURE, V530, P18, DOI 10.1038/nature.2016.19270; Calos MP, 2016, NEW ENGL J MED, V374, P1684, DOI 10.1056/NEJMcibr1601383; Caplan AL, 2015, EMBO REP, V16, P1421, DOI 10.15252/embr.201541337; Chen H, 2014, NUCLEIC ACIDS RES, V42, P1563, DOI 10.1093/nar/gkt1019; Chen Y, 2016, J INTERN MED, V280, P246, DOI 10.1111/joim.12469; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Grandin T, 2009, ANIMALS MAKE US HUMA; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hayashi M, 2016, J CELL BIOCHEM, V117, P780, DOI 10.1002/jcb.25368; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huisman C, 2015, EPIGENETICS-US, V10, P384, DOI 10.1080/15592294.2015.1034415; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lander ES, 2015, NEW ENGL J MED, V373, P5, DOI 10.1056/NEJMp1506446; Laufer BI, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0023-7; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Millman ST, 2000, POULTRY SCI, V79, P1233, DOI 10.1093/ps/79.9.1233                                                            ; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramalingam S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-107; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; van Erp PBG, 2015, CURR OPIN VIROL, V12, P85, DOI 10.1016/j.coviro.2015.03.011; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Webber BL, 2015, P NATL ACAD SCI USA, V112, P10565, DOI 10.1073/pnas.1514258112; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Yang WL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00030; Yuan M, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.35; Zhai XM, 2016, DEV WORLD BIOETH, V16, P116, DOI 10.1111/dewb.12108; Zhang F, 2015, HUM GENE THER, V26, P409, DOI 10.1089/hum.2015.29002.fzh	54	1	1	17	23	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0829-8211	1208-6002		BIOCHEM CELL BIOL	Biochem. Cell Biol.	APR	2017	95	2			SI		203	210		10.1139/bcb-2016-0159				8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	ER9RZ	WOS:000399165600029	28103055				2018-01-05	
J	Lo, CA; Greben, AW; Chen, BE				Lo, Chiu-An; Greben, Alexander W.; Chen, Brian Edwin			Generating stable cell lines with quantifiable protein production using CRISPR/Cas9-mediated knock-in	BIOTECHNIQUES			English	Article						protein quantitation reporter (PQR); CRISPR/Cas9; protein production; recombinant protein; stable cell line	POSITION; QUANTIFICATION; SYSTEM; GENES; ASSAY	Cell lines expressing foreign genes have been widely used to produce a variety of recombinant proteins. However, generating recombinant protein- expressing cell lines is usually a lengthy process and the resulting protein expression levels are often inconsistent. Here, we describe an efficient method for making stable cell lines expressing any recombinant protein of interest in a controllable and quantifiable manner. We integrate transgenes into specific genomic loci using CRISPR/Cas9 such that transgene expression is driven by endogenous promoters to ensure consistent and predictable expression of the recombinant protein. Expression levels can be predetermined by selecting promoters from genes with the desired level of expression. To quantify recombinant protein expression, a protein quantitation reporter (PQR) is incorporated between the endogenous and foreign genes. The PQR allows equimolar production of the endogenous protein, the recombinant protein, and a fluorescent reporter. As a result, expression levels of both the endogenous and recombinant proteins can be continuously monitored using fluorescence.	[Lo, Chiu-An; Greben, Alexander W.; Chen, Brian Edwin] McGill Univ, Hlth Ctr, Res Inst, Ctr Res Neurosci, Montreal, PQ, Canada; [Lo, Chiu-An; Greben, Alexander W.; Chen, Brian Edwin] McGill Univ, Dept Med Neurol, Montreal, PQ, Canada; [Lo, Chiu-An; Greben, Alexander W.; Chen, Brian Edwin] McGill Univ, Dept Neurosurg, Montreal, PQ, Canada	Chen, BE (reprint author), McGill Univ, Res Inst, Hlth Ctr, Montreal Gen Hosp, 1650 Cedar Ave,Bur L7 224,Pavilion Livingston, Montreal, PQ H3G 1A4, Canada.	brian.chen@mcgill.ca					Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Chen M, 2013, CELL REP, V3, P128, DOI 10.1016/j.celrep.2012.12.003; Dobzhansky T, 1936, BIOL REV CAMB PHILOS, V11, P364, DOI 10.1111/j.1469-185X.1936.tb00911.x; Hu Jenny, 2014, Cells, V3, P79, DOI 10.3390/cells3010079; Lai CF, 2006, ASSAY DRUG DEV TECHN, V4, P307, DOI 10.1089/adt.2006.4.307; Lanza AM, 2013, BIOTECHNOL J, V8, P811, DOI 10.1002/biot.201200364; Lemaire G, 2004, BIOCHEM PHARMACOL, V68, P2347, DOI 10.1016/j.bcp.2004.07.041; Li F, 2010, MABS-AUSTIN, V2, P466, DOI 10.4161/mabs.2.5.12720; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Lo CA, 2015, CELL REP, V13, P2634, DOI 10.1016/j.celrep.2015.11.048; Mane Viraj P, 2008, J Biomol Tech, V19, P342; Oliva-Trastoy M, 2005, MUTAGENESIS, V20, P467, DOI 10.1093/mutage/gei072; Ragni E, 2013, J CELL MOL MED, V17, P168, DOI 10.1111/j.1582-4934.2012.01660.x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rangasamy D, 2008, NAT PROTOC, V3, P79, DOI 10.1038/nprot.2007.456; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Xia W, 2006, PROTEIN EXPRES PURIF, V45, P115, DOI 10.1016/j.pep.2005.07.008; Xu ZL, 2004, ACTA PHARMACOL SIN, V25, P1165	19	0	0	0	0	BIOTECHNIQUES OFFICE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0736-6205	1940-9818		BIOTECHNIQUES	Biotechniques	APR	2017	62	4					165	172		10.2144/000114534				8	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	ES4ZL	WOS:000399545300004	28403807	gold			2018-01-05	
J	Park, HR; Babcock, B				Park, Hyeongsu Rick; Babcock, Brenton			The Legal Battle Around CRISPR Gene-Editing Technology and Its Implications	BIOTECHNOLOGY LAW REPORT			English	Article						CRISPR; gene editing; USPTO; PTAB; DNA; patents; intellectual property			[Park, Hyeongsu Rick] Knobbe Martens, San Diego, CA 92130 USA; [Babcock, Brenton] Knobbe Martens, Irvine, CA USA	Park, HR (reprint author), Knobbe Martens, San Diego, CA 92130 USA.	lgard@zumado.com					Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen, 2002, MOL BIOL, V43, P1565; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mojica, 2000, MOL BIOL, V36, P244	8	0	0	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0730-031X	1557-8704		BIOTECHNOL LAW REP	Biotechnol. Law Rep.	APR	2017	36	2					39	42		10.1089/blr.2017.29007.hrp				4	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ES5NV	WOS:000399588200007					2018-01-05	
J	Aguilar, R; Ogburn, MB; Driskell, AC; Weigt, LA; Groves, MC; Hines, AH				Aguilar, Robert; Ogburn, Matthew B.; Driskell, Amy C.; Weigt, Lee A.; Groves, Mary C.; Hines, Anson H.			Gutsy genetics: identification of digested piscine prey items in the stomach contents of sympatric native and introduced warmwater catfishes via DNA barcoding	ENVIRONMENTAL BIOLOGY OF FISHES			English	Article; Proceedings Paper	Conference on Gutshop - New Perspectives on the Feeding Ecology and Trophic Dynamics of Freshwater and Marine Fishes held at the 145th Annual Meeting of the American-Fisheries-Society	AUG, 2015	Portland, OR	Amer Fisheries Soc		Blue catfish; Ictalurus furcatus; Predation; Clupeidae; Chesapeake Bay; Genetic analysis	FRESH-WATER FISHES; BLUE CATFISH; DIETARY ANALYSIS; REEF FISH; DIVERSITY; ECOLOGY; SAMPLES; INFORMATION; MANAGEMENT; LARVAL	A major focus of ecology is understanding trophic relationships and energy flows in natural systems, associated food web dynamics and changes in food webs due to introduced species. Predator-prey interactions are often assessed by examining stomach contents. However, partially digested remains may be difficult to accurately identify by traditional visual analysis. Here we evaluate the effectiveness of DNA barcoding to identify digested piscine prey remains in invasive Blue Catfish Ictalurus furcatus, non-native, but established Channel Catfish Ictalurus punctatus and native White Catfish Ameiurus catus from Chesapeake Bay, USA. Stomach contents were examined and piscine prey items were scored as lightly digested, moderately digested or severely digested. A 652 base pair region of the cytochrome c oxidase subunit I (COI-5P) mitochondrial DNA gene was sequenced for each prey item. Edited barcode sequences were compared to locally-caught and validated reference sequences in BOLD (Barcode of Life Database). A large majority of prey items were sufficiently digested to limit morphological identification (9.4 % to species and an additional 12.1 % to family). However, overall barcoding success was high (90.3 %) with little difference among the digestion classifications. Combining morphological and genetic identifications, we classified 91.6 % of fish prey items to species. Twenty-three fish species were identified, including species undergoing active restoration efforts (e.g., Alosa spp.) and commercially important species, e.g., Striped Bass Morone saxatilis, White Perch Morone americana, American Eel Anguilla rostrata and Menhaden Brevoortia tyrannus. We found DNA barcoding highly successful at identifying all but the most heavily degraded prey items and to be an efficient and effective method for obtaining diet information to strengthen the resolution of trophic analyses including diet comparisons among sympatric native and non-native predators.	[Aguilar, Robert; Ogburn, Matthew B.; Hines, Anson H.] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA; [Driskell, Amy C.; Weigt, Lee A.] Smithsonian Inst, Labs Analyt Biol, Natl Museum Nat Hist, 10th & Constitut Ave, Washington, DC USA; [Groves, Mary C.] Maryland Dept Nat Resources, Inland Fisheries, Cedarville Fish Hatchery, Route 4,Box 106E, Brandywine, MD 20613 USA	Aguilar, R (reprint author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	aguilarr@si.edu			NOAA's Chesapeake Bay Office [NA11NMF4570231]; Smithsonian Institution; Laboratories of Analytical Biology of the National Museum of Natural History; Smithsonian Environmental Research Center (SERC) postdoctoral fellowship	This project was conducted with funding support from NOAA's Chesapeake Bay Office award #NA11NMF4570231, the Smithsonian Institution administered by the Secretariat Office of the Consortium for the Barcode of Life, and the Laboratories of Analytical Biology of the National Museum of Natural History. We gratefully acknowledge Miranda Marvel, Brooke Weigel, Paige Roberts, Angela Owens, Keira Heggie, Mike Goodison, Kim Richie and Midge Kramer for assistance with SERC field collections and sample processing and Timothy Groves, Branson Williams and Ross Williams for MD DNR field collections and sample processing. We would also like to thank Dr. Paul J. Smith (University of Maryland) for his statistical guidance. Internships provided to MM, BW and AO were also funded by NOAA's Chesapeake Bay Office award #NA11NMF4570231 and MO was partially funded by a Smithsonian Environmental Research Center (SERC) postdoctoral fellowship. This project was reviewed by SERC's Institutional Animal Care and Use Committee (IACUC) and all applicable international, national, and/or institutional guidelines for humane animal care and use were followed. The manuscript was strengthened by comments from 3 anonymous peer reviewers.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baeza JA, 2013, ZOOL J LINN SOC-LOND, V168, P699, DOI 10.1111/zoj.12044; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Arroyave J, 2014, ECOL EVOL, V4, P4534, DOI 10.1002/ece3.1321; Baldwin CC, 2009, ZOOTAXA, P1; Bariche M, 2015, J BIOGEOGR, V42, P2363, DOI 10.1111/jbi.12595; Barnett A, 2010, J EXP MAR BIOL ECOL, V393, P188, DOI 10.1016/j.jembe.2010.07.022; Beauchamp David A., 2007, P765; Berry O, 2015, MAR ECOL PROG SER, V540, P167, DOI 10.3354/meps11524; Broughton R. E., 2013, PLOS CURRENTS TREE L, DOI [10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288, DOI 10.1371/CURRENTS.TOL.53BA26640DF0CCAEE75BB165C8C26288]; Boileau N, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0521; Braid HE, 2012, MAR BIOL, V159, P25, DOI 10.1007/s00227-011-1786-4; Budarf AC, 2011, J FISH BIOL, V79, P112, DOI 10.1111/j.1095-8649.2011.02999.x; Carreon-Martinez L, 2011, J FISH BIOL, V78, P1170, DOI 10.1111/j.1095-8649.2011.02925.x; Chandler L, 1998, THESIS; Charles Heather, 2007, V193, P217; Conway KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097664; Cote IM, 2013, MAR ECOL PROG SER, V472, P249, DOI 10.3354/meps09992; Dalton DL, 2011, FORENSIC SCI INT, V207, pE51, DOI 10.1016/j.forsciint.2010.12.017; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Derr RE, 2011, P 25 ANN SAS US GROU; Dunn MR, 2010, DEEP-SEA RES PT I, V57, P923, DOI 10.1016/j.dsr.2010.02.006; Eggleton MA, 2004, ENVIRON BIOL FISH, V70, P107, DOI 10.1023/B:EBFI.0000029341.45030.94                                              ; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113                                                ; Goncalves PFM, 2015, J HERED, V106, P560, DOI 10.1093/jhered/esv035; Graham K, 1999, AM FISH S S, V24, P37; Greenlee RS, 2011, AM FISH S S, V77, P349; Handy SM, 2011, J AOAC INT, V94, P201; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x                                              ; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jenkins R. E., 1993, FRESHWATER FISHES VI; Jo H, 2014, ECOL EVOL, V4, P219, DOI 10.1002/ece3.921; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Legler ND, 2010, T AM FISH SOC, V139, P868, DOI 10.1577/T09-212.1; Leray M, 2015, PEERJ, V3, DOI 10.7717/peerj.1047; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; MacAvoy SE, 2000, OECOLOGIA, V122, P568, DOI 10.1007/s004420050980; MacAvoy SE, 2009, FISH B-NOAA, V107, P165; Meheust E, 2015, MAR BIOL RES, V11, P385, DOI 10.1080/17451000.2014.943240; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Moran Z, 2016, ENVIRON BIOL FISH, V99, P161, DOI 10.1007/s10641-015-0448-7; Murdy EO, 1997, FISHES CHESAPEAKE BA; Nagy ZT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034506; Paquin MM, 2014, DEEP-SEA RES PT I, V85, P110, DOI 10.1016/j.dsr.2013.12.002; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2006.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rocha LA, 2015, CORAL REEFS, V34, P803, DOI 10.1007/s00338-015-1293-z; Ross S. T., 2001, INLAND FISHES MISSIS; Schloesser RW, 2011, AM FISH S S, V77, P369; Schooley JD, 2008, T AM FISH SOC, V137, P1044, DOI 10.1577/T07-169.1; Tuckey TD, 2010, ANN REPORT VIRGINIA; Valdez-Moreno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036636; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weigt LA, 2012, DNA BARCODES METHODS, P109; Weigt LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041059; Wirta HK, 2014, P NATL ACAD SCI USA, V111, P1885, DOI 10.1073/pnas.1316990111; Worth S, 1893, REP US COMMISSIONER, V1893, P78	66	3	3	27	39	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0378-1909	1573-5133		ENVIRON BIOL FISH	Environ. Biol. Fishes	APR	2017	100	4			SI		325	336		10.1007/s10641-016-0523-8				12	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	ES6XL	WOS:000399693900004					2018-01-05	
J	Potaczek, DP; Harb, H; Michel, S; Alhamwe, BA; Renz, H; Tost, J				Potaczek, Daniel P.; Harb, Hani; Michel, Sven; Alhamwe, Bilal Alashkar; Renz, Harald; Tost, Jorg			Epigenetics and allergy: from basic mechanisms to clinical applications	EPIGENOMICS			English	Review						allergy; asthma; cell-free DNA; DNA methylation; environment; epigenetic editing; EWAS; exposure; food allergy; FOXP3; immunotherapy; Th cell lineages	EPIGENOME-WIDE ASSOCIATION; REGULATORY T-CELLS; PEANUT ORAL IMMUNOTHERAPY; LOCUS-CONTROL REGION; SCHOOL-AGE-CHILDREN; COWS MILK ALLERGY; POLYCYCLIC AROMATIC-HYDROCARBONS; GENE-ENVIRONMENT INTERACTIONS; DIFFERENTIAL DNA METHYLATION; ENCODING INTERFERON-GAMMA	Allergic diseases are on the rise in the Western world and well-known allergy-protecting and driving factors such as microbial and dietary exposure, pollution and smoking mediate their influence through alterations of the epigenetic landscape. Here, we review key facts on the involvement of epigenetic modifications in allergic diseases and summarize and critically evaluate the lessons learned from epigenome-wide association studies. We show the potential of epigenetic changes for various clinical applications: as diagnostic tools, to assess tolerance following immunotherapy or possibly predict the success of therapy at an early time point. Furthermore, new technological advances such as epigenome editing and DNAzymes will allow targeted alterations of the epigenome in the future and provide novel therapeutic tools.	[Potaczek, Daniel P.; Harb, Hani; Alhamwe, Bilal Alashkar; Renz, Harald] Philipps Univ Marburg, Inst Lab Med & Pathobiochem, Mol Diagnost, Marburg, Germany; [Potaczek, Daniel P.; Harb, Hani; Renz, Harald] Worldwide Univ Network, Int Inflammat In FLAME Network, Marburg, Germany; [Potaczek, Daniel P.; Harb, Hani; Renz, Harald] German Ctr Lung Res DZL, Giessen, Germany; [Potaczek, Daniel P.] John Paul 2 Hosp, Krakow, Poland; [Michel, Sven] Secarna Pharmaceut GmbH & Co KG, Planegg, Germany; [Tost, Jorg] CEA, Ctr Natl Genotypage, Lab Epigenet & Environm, Inst Genom, Evry, France	Tost, J (reprint author), CEA, Ctr Natl Genotypage, Lab Epigenet & Environm, Inst Genom, Evry, France.	tost@cng.fr			German Centre for Lung Research [82DZL00502]; Universities Giessen and Marburg Lung Centre (UGMLC); Von Behring-Rontgen-Foundation (Von Behring-Rontgen-Stiftung); ANR [ANR-13-EPIG-0003-05, ANR-13-CESA-0011-05]; Aviesan/INSERM [EPIG2014-01, EPIG2014-18]; INCa [PRT-K14-049]; Sirius research award (UCB Pharma S.A.); Passerelle research award (Pfizer); iCARE (MSD Avenir); institutional budget of the CNG; DBV Technologies	This work was supported by funds from the German Centre for Lung Research (DZL; 82DZL00502/A2; DP Potaczek, H Harb, H Renz), the Universities Giessen and Marburg Lung Centre (UGMLC; H Renz) and the Von Behring-Rontgen-Foundation (Von Behring-Rontgen-Stiftung; H Harb, H Renz). H Harb, DP Potaczek and H Renz are the members of the International Inflammation (in-FLAME) Network, Worldwide Universities Network (WUN) and DZL. B Alashkar Alhamwe is a German Academic Exchange Service (DAAD) fellow (personal reference number: 91559386). Work in the laboratory of J Tost is supported by grants from the ANR (ANR-13-EPIG-0003-05 and ANR-13-CESA-0011-05), Aviesan/INSERM (EPIG2014-01 and EPIG2014-18) and INCa (PRT-K14-049), a Sirius research award (UCB Pharma S.A.), a Passerelle research award (Pfizer), iCARE (MSD Avenir) and the institutional budget of the CNG. Work on food allergy in the laboratory of J Tost is partly funded by DBV Technologies and J Tost had travel fees refunded by DBV technologies. S Michel is an employee of Secarna Pharmaceuticals. Funding organizations as well as the management of Secarna had no influence on the content of the manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Acevedo N, 2015, HUM MOL GENET, V24, P875, DOI 10.1093/hmg/ddu479; Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Akhabir L, 2011, RESPIROLOGY, V16, P396, DOI 10.1111/j.1440-1843.2011.01939.x; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Alduraywish SA, PEDIAT ALLERGY IMMUN, V28, P30; Alipoor SD, 2016, MED, V2016; Alipoor S. D., 2016, MEDIAT INFLAMM, V2016, DOI [10.1155/2016/5628404, DOI 10.1155/2016/5628404]; Alipoor SD, 2016, EUR J PHARMACOL, V791, P395, DOI 10.1016/j.ejphar.2016.09.015; Amarasekera M, 2014, EPIGENETICS-US, V9, P1570, DOI 10.4161/15592294.2014.983366; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Ashley S, 2015, CURR OPIN ALLERGY CL, V15, P237, DOI 10.1097/ACI.0000000000000159; Aslibekyan S, 2014, J NUTR, V144, P425, DOI 10.3945/jn.113.187203; Athie-Morales V, 2004, J IMMUNOL, V172, P61, DOI 10.4049/jimmunol.172.1.61                                                       ; Aune TM, 2009, IMMUNOLOGY, V126, P299, DOI 10.1111/j.1365-2567.2008.03026.x; Bager P, 2003, J ALLERGY CLIN IMMUN, V111, P51, DOI 10.1067/mai.2003.34; Bantz SK, 2014, J CLIN CELL IMMUNOL, V5, P202, DOI DOI 10.4172/2155-9899.1000202; Bardana EJ, 2004, ALLERGY, V59, P25, DOI 10.1111/j.1398-9995.2004.00565.x                                                ; Barnes PJ, 2009, CLIN EXP ALLERGY, V39, P1145, DOI 10.1111/j.1365-2222.2009.03298.x; Bauer T, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156520; Bending D, J IMMUNOL, V186; Berni CR, 2015, CLIN EPIGENETICS, V7, P38, DOI DOI 10.1186/S13148-015-0070-8; Bertelsen RJ, 2014, J ALLERGY CLIN IMMUN, V133, P165, DOI 10.1016/j.jaci.2013.07.032; Bieber T, 2012, ALLERGY, V67, P1475, DOI 10.1111/all.12049; Bin LH, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0158-5; Binia A, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13612; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brand S, 2012, J ALLERGY CLIN IMMUN, V129, P1602, DOI 10.1016/j.jaci.2011.12.963; Brand S, 2011, J ALLERGY CLIN IMMUN, V128, P618, DOI 10.1016/j.jaci.2011.04.035; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Breton CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099716; Breton CV, 2012, ENVIRON HEALTH PERSP, V120, P1320, DOI 10.1289/ehp.1104439; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Brick T, 2016, J ALLERGY CLIN IMMUN, V137, P1699, DOI 10.1016/j.jaci.2015.10.042; Brook PO, 2015, EPIGENOMICS-UK, V7, P1017, DOI 10.2217/epi.15.53; Brunst KJ, 2013, J ALLERGY CLIN IMMUN, V131, P592, DOI 10.1016/j.jaci.2012.10.042; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Caubet JC, 2017, PEDIAT ALLERG IMM-UK, V28, P6, DOI 10.1111/pai.12659; Chan RWY, 2014, P NATL ACAD SCI USA, V111, pE5302, DOI 10.1073/pnas.1421126111; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; Chen W, 2013, AM J RESP CRIT CARE, V187, P584, DOI 10.1164/rccm.201210-1789OC; Chhabra D, 2014, EPIGENETICS-US, V9, P1473, DOI 10.4161/15592294.2014.971593; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Cicchini L, 2016, MBIO, V7, DOI 10.1128/mBio.00270-16; Clausen ML, 2015, CURR TREAT OPTIONS A, V2, P218; Clifford RL, 2017, J ALLERGY CLIN IMMUN, V139, P112, DOI 10.1016/j.jaci.2016.03.046; Cohen CJ, 2011, J IMMUNOL, V187, P5615, DOI 10.4049/jimmunol.1101058; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Cook DG, 1997, THORAX, V52, P1081, DOI 10.1136/thx.52.12.1081                                                          ; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Curtin JA, 2013, CLIN EXP ALLERGY, V43, P304, DOI 10.1111/cea.12046; Dave ND, 2011, IMMUNOL ALLERGY CLIN, V31, P55, DOI 10.1016/j.iac.2010.09.009; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Devaud C, 2014, CANCER IMMUNOL IMMUN, V63, P869, DOI 10.1007/s00262-014-1581-4; DeVries A, 2015, CURR OPIN PEDIATR, V27, P719, DOI 10.1097/MOP.0000000000000285; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diller ML, 2016, MEDIAT INFLAMM, DOI 10.1155/2016/6309219; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Eddleston J, 2011, AM J RESP CELL MOL, V44, P118, DOI 10.1165/rcmb.2009-0266OC; Ege MJ, 2012, ALLERGY, V67, P1565, DOI 10.1111/all.12028; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Eulalio A, 2015, J BIOMOL SCREEN, V20, P1003, DOI 10.1177/1087057115578837; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Figueiredo AS, 2016, IMMUNOLOGY, V148, P13, DOI 10.1111/imm.12595; Flanagan JM, 2015, METHODS MOL BIOL, V1238, P51, DOI 10.1007/978-1-4939-1804-1_3; Fofanova TY, 2016, J PEDIATR GASTR NUTR, V62, P208, DOI 10.1097/MPG.0000000000000950; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Frazier AL, 2014, JAMA PEDIATR, V168, P156, DOI 10.1001/jamapediatrics.2013.4139; Fu A, 2012, CLIN EXP ALLERGY, V42, P1575, DOI 10.1111/j.1365-2222.2012.04055.x; Fuchs O, 2017, LANCET RESP MED, V5, P224, DOI 10.1016/S2213-2600(16)30187-4; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaffin JM, 2014, CLIN EXP ALLERGY, V44, P681, DOI 10.1111/cea.12219; Galgani M, 2016, J IMMUNOL, V197, P2567, DOI 10.4049/jimmunol.1600242; Gandhi NA, 2016, NAT REV DRUG DISCOV, V15, P35, DOI 10.1038/nrd4624; Geginat J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00630; Gervin K, 2016, EPIGENETICS-US, V11, P690, DOI 10.1080/15592294.2016.1214782; Godderis L, 2015, BIOMED RES INT, DOI 10.1155/2015/845041; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hagner S, 2013, ALLERGY, V68, P322, DOI 10.1111/all.12094; Harb H, 2016, CURR OPIN PEDIATR, V28, P754, DOI 10.1097/MOP.0000000000000424; Harb H, 2015, INT ARCH ALLERGY IMM, V168, P173, DOI 10.1159/000442158; Harb H, 2015, J ALLERGY CLIN IMMUN, V136, P200, DOI 10.1016/j.jaci.2015.01.027; Harb H, 2015, J ALLERGY CLIN IMMUN, V135, P15, DOI 10.1016/j.jaci.2014.11.009; Hardy T, 2016, GUT, DOI [10.1136/gutjnl-2016-311526, DOI 10.1136/GUTJNL-2016-311526(2016]; Heijmans BT, 2012, INT J EPIDEMIOL, V41, P74, DOI 10.1093/ije/dyr225; Heiss JA, 2017, EPIGENOMICS-UK, V9, P13, DOI 10.2217/epi-2016-0091; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Hew KM, 2015, CLIN EXP ALLERGY, V45, P238, DOI 10.1111/cea.12377; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hinz D, 2012, ALLERGY, V67, P380, DOI 10.1111/j.1398-9995.2011.02767.x; Hirahara K, 2016, INT IMMUNOL, V28, P163, DOI 10.1093/intimm/dxw006; Hirahara K, 2011, IMMUNOLOGY, V134, P235, DOI 10.1111/j.1365-2567.2011.03483.x; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Holt PG, 2011, CHEST, V139, P1165, DOI 10.1378/chest.10-2397; Homburg U, 2015, J ALLERGY CLIN IMMUN, V136, P797, DOI 10.1016/j.jaci.2015.02.018; Hong XM, 2016, J ALLERGY CLIN IMMUN, V138, P908, DOI 10.1016/j.jaci.2016.01.056; Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304; Houseman EA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1140-4; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; How Kit Alexandre, 2012, Biochimie, V94, P2314, DOI 10.1016/j.biochi.2012.07.014; Hudy MH, 2014, AM J RESP CELL MOL, V50, P571, DOI 10.1165/rcmb.2013-0129OC; Huvenne W, 2013, INT ARCH ALLERGY IMM, V161, P304, DOI 10.1159/000350329; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Jartti T, 2011, CURR RESPIR MED REV, V7, P160, DOI 10.2174/157339811795589423; Jensen-Jarolim E, 2008, ALLERGY, V63, P610, DOI 10.1111/j.1398-9995.2008.01645.x; Jiang RW, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0071-3; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Joerink M, 2010, ALLERGY, V65, P1282, DOI 10.1111/j.1398-9995.2010.02328.x; Jones SM, 2014, J ALLERGY CLIN IMMUN, V133, P318, DOI 10.1016/j.jaci.2013.12.1040; Joubert BR, 2016, AM J HUM GENET, V98, P680, DOI 10.1016/j.ajhg.2016.02.019; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Jurkowska RZ, 2016, ADV EXP MED BIOL, V945, P1, DOI 10.1007/978-3-319-43624-1_1; Kabesch M, 2010, EUR RESPIR J, V36, P950, DOI 10.1183/09031936.00019310; Kabesch Michael, 2016, Mol Cell Pediatr, V3, P31, DOI 10.1186/s40348-016-0056-4; Kala Rishabh, 2013, J Clin Bioinforma, V3, P6, DOI 10.1186/2043-9113-3-6; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Khan TK, 2015, CURR OPIN ALLERGY CL, V15, P402, DOI 10.1097/ACI.0000000000000209; Kim YJ, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-39; Kleen TO, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0087-8; Klemens CM, 2011, BJOG-INT J OBSTET GY, V118, P916, DOI 10.1111/j.1471-0528.2010.02846.x; Koestler DC, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0943-7; Kotz D, 2011, J ALLERGY CLIN IMMUN, V127, P623, DOI 10.1016/j.jaci.2010.11.021; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kramer U, 2015, CLIN EXP ALLERGY, V45, P94, DOI 10.1111/cea.12458; Kramer U, 2010, CLIN EXP ALLERGY, V40, P289, DOI 10.1111/j.1365-2222.2009.03435.x; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Kwon NH, 2008, J CLIN IMMUNOL, V28, P139, DOI 10.1007/s10875-007-9148-1; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259                                                      ; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Langie SA, 2016, BASIC CLIN PHARMACOL, DOI [10.1111/bcpt.12721, DOI 10.1111/BCPT.12721(2016)(EPUBAHEADOFPRINT]; Langie SAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151109; Leachman SA, 2010, MOL THER, V18, P442, DOI 10.1038/mt.2009.273; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1                                                   ; Lee HS, 2013, AM J CLIN NUTR, V98, P480, DOI 10.3945/ajcn.112.052241; Lehmann-Werman R, 2016, P NATL ACAD SCI USA, V113, pE1826, DOI 10.1073/pnas.1519286113; Liang LM, 2015, NATURE, V520, P670, DOI 10.1038/nature14125; Liang Y, 2012, ALLERGY, V67, P424, DOI 10.1111/j.1398-9995.2011.02760.x; Liang YS, 2016, CLIN REV ALLERG IMMU, V51, P315, DOI 10.1007/s12016-015-8508-5; Limmroth V, 2014, NEUROLOGY, V83, P1780, DOI 10.1212/WNL.0000000000000926; Ling MF, 2016, ANN AM THORAC SOC, V13, pS25, DOI 10.1513/AnnalsATS.201507-431MG; Liu J, 2008, TOXICOL SCI, V102, P76, DOI 10.1093/toxsci/kfm290; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133, P551, DOI 10.1016/j.jaci.2013.06.034; Lockett GA, 2016, ALLERGY, V71, P1314, DOI 10.1111/all.12882; Lopez-Exposito I, 2009, J ALLERGY CLIN IMMUN, V124, P1039, DOI 10.1016/j.jaci.2009.08.024; Luo Y, 2014, CLIN EXP DERMATOL, V39, P48, DOI 10.1111/ced.12206; Maitra A, 2004, CLIN EXP ALLERGY, V34, P1349, DOI 10.1111/j.1365-2222.2004.02048.x; March ME, 2011, DISCOV MED, V11, P35; Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892; Martino D, 2015, J ALLERGY CLIN IMMUN, V135, P1319, DOI 10.1016/j.jaci.2014.12.1933; Martino D, 2014, J REPROD IMMUNOL, V104, P43, DOI 10.1016/j.jri.2014.05.003; Martino D, 2014, EPIGENETICS-US, V9, P998, DOI 10.4161/epi.28945; Matricardi PM, 2010, CLIN EXP IMMUNOL, V160, P98, DOI 10.1111/j.1365-2249.2010.04130.x; McDade TW, 2012, P NATL ACAD SCI USA, V109, P17281, DOI 10.1073/pnas.1202244109; Michel S, 2013, ALLERGY, V68, P355, DOI 10.1111/all.12097; Miller JA, 2009, CBE-LIFE SCI EDUC, V8, P316, DOI 10.1187/cbe.09-02-0012; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Moheimani F, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0434-4; Moingeon P, 2013, J ALLER CL IMM-PRACT, V1, P228, DOI 10.1016/j.jaip.2013.03.013; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mondoulet L, 2015, J ALLERGY CLIN IMMUN, V135, P1546, DOI 10.1016/j.jaci.2014.11.028; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Morales E, 2012, AM J RESP CRIT CARE, V185, P937, DOI [10.1164/rccm.201105-0870OC, 10.1164/rccm.201105.0870OC]; Moran S, 2016, LANCET ONCOL, V17, P1386, DOI 10.1016/S1470-2045(16)30297-2; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Naumova AK, 2013, HUM GENET, V132, P811, DOI 10.1007/s00439-013-1298-z; Nermes M, 2013, CURR ALLERGY ASTHM R, V13, P622, DOI 10.1007/s11882-013-0381-9; Nestor CE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004059; Nielsen H.M., 2013, BIOCHEM, V61, P455, DOI DOI 10.1007/978-94-007-4525-4_; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Odegard JM, 2015, CLIN IMMUNOL, V161, P44, DOI 10.1016/j.clim.2015.05.023; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Ong PY, 2016, CLIN REV ALLERG IMMU, V51, P329, DOI 10.1007/s12016-016-8548-5; Pajno GB, 2015, EXPERT REV CLIN IMMU, V11, P141, DOI 10.1586/1744666X.2015.977260; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Pan H, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1161-z; Paparo L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0252-z; Pattarayan D., 2016, CLIN REV ALLERG IMMU, DOI [10.1007/s12016-016-8589-9, DOI 10.1007/S12016-016-8589-9]; Perry MM, 2015, CURR OPIN ALLERGY CL, V15, P156, DOI 10.1097/ACI.0000000000000147; Perumal NB, 2011, TRENDS IMMUNOL, V32, P146, DOI 10.1016/j.it.2011.01.006; Pesek RD, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0610-0; Petrus NCM, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0105-z; Pfefferle PI, 2014, ALLERGOL INT, V63, P3, DOI 10.2332/allergolint.13-RAI-0671; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Piletic K, 2016, ARCH TOXICOL, V90, P2405, DOI 10.1007/s00204-016-1815-7; Pistiner M, 2008, J ALLERGY CLIN IMMUN, V122, P274, DOI 10.1016/j.jaci.2008.05.007; Placek K, 2009, IMMUNOLOGY, V127, P155, DOI 10.1111/j.1365-2567.2009.03059.x; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Potaczek DP, 2012, CLIN EXP ALLERGY, V42, P852, DOI 10.1111/j.1365-2222.2011.03953.x; Potaczek DP, 2016, J ALLERGY CLIN IMMUN, V137, P1334, DOI 10.1016/j.jaci.2015.12.1344; Potaczek DP, 2014, INT J CARDIOL, V170, P278, DOI 10.1016/j.ijcard.2013.11.029; Potaczek DP, 2013, PEDIAT ALLERG IMM-UK, V24, P441, DOI 10.1111/pai.12083; Potaczek DP, 2009, IMMUNOL RES, V45, P75, DOI 10.1007/s12026-008-8042-0; Prescott SL, 2007, J ALLERGY CLIN IMMUN, V120, P200, DOI 10.1016/j.jaci.2007.03.045; Rachid R, 2016, CURR OPIN PEDIATR, V28, P748, DOI 10.1097/MOP.0000000000000427; Rahmani E, 2016, NAT METHODS, V13, P443, DOI [10.1038/NMETH.3809, 10.1038/nmeth.3809]; Ramming A, 2012, BLOOD, V119, P4665, DOI 10.1182/blood-2011-11-392589; Rastogi Deepa, 2013, Sci Rep, V3, P2164, DOI 10.1038/srep02164; Rebane A, 2015, ADV EXP MED BIOL, V888, P331, DOI 10.1007/978-3-319-22671-2_17; Rehan VK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-129; Reinartz MT, 2016, ALLERGY, V71, P1223, DOI 10.1111/all.12918; Reinius LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053877; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Renz H, 2011, ALLERGY, V66, P10, DOI 10.1111/j.1398-9995.2011.02622.x; Renz H, 2011, J ALLERGY CLIN IMMUN, V128, pS27, DOI 10.1016/j.jaci.2011.09.039; Renz-Polster H, 2005, CLIN EXP ALLERGY, V35, P1466, DOI 10.1111/j.1365-2222.2005.02356.x; Richmond RC, 2015, HUM MOL GENET, V24, P2201, DOI 10.1093/hmg/ddu739; Rivas MN, 2016, CURR OPIN PEDIATR, V28, P764, DOI 10.1097/MOP.0000000000000419; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Robinson D, 2017, CLIN EXP ALLERGY, V47, P161, DOI 10.1111/cea.12880; Rodriguez E, 2014, J INVEST DERMATOL, V134, P1873, DOI 10.1038/jid.2014.87; Rodriguez RM, 2015, INT J BIOCHEM CELL B, V67, P75, DOI 10.1016/j.biocel.2015.04.020; Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975; Rossnerova A, 2013, MUTAT RES-FUND MOL M, V741, P18, DOI 10.1016/j.mrfmmm.2013.02.003; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Royce SG, 2014, CURR OPIN ALLERGY CL, V14, P44, DOI 10.1097/ACI.0000000000000029; Saetrom P, 2007, PEDIATR RES, V61, p17R, DOI 10.1203/pdr.0b013e318045760e; Santangelo S, 2009, CHROMOSOME RES, V17, P485, DOI 10.1007/s10577-009-9040-3; Sarnowski C, 2016, J ALLERGY CLIN IMMUN, V138, P748, DOI 10.1016/j.jaci.2015.12.1341; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Savage J, 2016, J ALLER CL IMM-PRACT, V4, P196, DOI 10.1016/j.jaip.2015.11.024; Schaub B, J ALLERGY CLIN IMMUN, V123, p[774, e775]; Schieck M, 2014, ALLERGY, V69, P1171, DOI 10.1111/all.12450; Schieck M, 2016, J ALLERGY CLIN IMMUN, V138, P421, DOI 10.1016/j.jaci.2015.12.1305; Schmid P, 2001, ALLERGY, V56, P841, DOI 10.1034/j.1398-9995.2001.00144.x; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Sel S, 2008, J ALLERGY CLIN IMMUN, V121, P910, DOI 10.1016/j.jaci.2007.12.1175; Shaker M, 2014, CURR OPIN PEDIATR, V26, P516, DOI 10.1097/MOP.0000000000000120; Sharma V, 2014, ALLERGY, V69, P1077, DOI 10.1111/all.12431; Slaats GGG, 2012, ALLERGY, V67, P895, DOI 10.1111/j.1398-9995.2012.02831.x; Sly PD, 2010, J ALLERGY CLIN IMMUN, V125, P1202, DOI 10.1016/j.jaci.2010.01.024; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Somineni HK, 2016, J ALLERGY CLIN IMMUN, V137, P797, DOI 10.1016/j.jaci.2015.10.021; Song Y, 2014, J ALLERGY CLIN IMMUN, V134, P1339, DOI 10.1016/j.jaci.2014.08.034; Song YC, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0279-9; Sorensen M, 2016, PEDIAT ALLERG IMM-UK, V27, P728, DOI 10.1111/pai.12595; Sorkness CA, 2013, J ALLER CL IMM-PRACT, V1, P163, DOI 10.1016/j.jaip.2013.01.011; Stefanowicz D, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0254-y; Stefanowicz D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044213; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Suarez-Alvarez B, 2012, TRENDS GENET, V28, P506, DOI 10.1016/j.tig.2012.06.005; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Sun K, 2015, P NATL ACAD SCI USA, V112, pE5503, DOI 10.1073/pnas.1508736112; Sussman J, 2012, ANN NY ACAD SCI, V1275, P13, DOI 10.1111/j.1749-6632.2012.06825.x; Swamy RS, 2012, J ALLERGY CLIN IMMUN, V130, P215, DOI 10.1016/j.jaci.2012.04.021; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tamari M, 2014, J DERMATOL, V41, P213, DOI 10.1111/1346-8138.12321; Tamari M, 2013, ALLERGOL INT, V62, P21, DOI 10.2332/allergolint.13-RAI-0539; Tanaka K, 2016, NICOTINE TOB RES; Tang MLK, 2015, J ALLERGY CLIN IMMUN, V135, P737, DOI 10.1016/j.jaci.2014.11.034; Tang WY, 2012, ENVIRON HEALTH PERSP, V120, P1195, DOI 10.1289/ehp.1103744; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Thomas RM, 2012, J BIOL CHEM, V287, P22900, DOI 10.1074/jbc.M111.312785; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Toncheva AA, 2015, ALLERGY, V70, P1288, DOI 10.1111/all.12652; Tost J, 2016, EPIGENOMICS-UK, V8, P1169, DOI 10.2217/epi-2016-0080; Tost J, 2016, EPIGENOMICS-UK, V8, P153, DOI 10.2217/epi.15.112; Tost J, 2010, MOL BIOTECHNOL, V44, P71, DOI 10.1007/s12033-009-9216-2; Tost J, 2016, ADV EXP MED BIOL, V945, P343, DOI 10.1007/978-3-319-43624-1_15; Tripathi SK, IMMUNOL REV; Turowska A, 2013, TOXICOL APPL PHARM, V272, P365, DOI 10.1016/j.taap.2013.06.020; Vadlamudi A, 2015, CURR OPIN PEDIATR, V27, P649, DOI 10.1097/MOP.0000000000000267; Valenta R, 2015, GASTROENTEROLOGY, V148, P1120, DOI 10.1053/j.gastro.2015.02.006; Vardavas CI, 2016, EUR RESPIR J, V48, P115, DOI 10.1183/13993003.01016-2015; Vercelli D, 2016, ALLERGOL INT, V65, P123, DOI 10.1016/j.alit.2015.12.001; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; von Mutius E, 2000, J ALLERGY CLIN IMMUN, V105, P9, DOI 10.1016/S0091-6749(00)90171-4; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; von Mutius E, 2008, IMMUNOL ALLERGY CLIN, V28, P631, DOI 10.1016/j.iac.2008.03.010; von Mutius E, 2012, CURR OPIN GASTROEN, V28, P570, DOI 10.1097/MOG.0b013e32835955d3; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang IJ, 2013, CLIN EXP ALLERGY, V43, P535, DOI 10.1111/cea.12108; Wang IJ, 2008, PEDIAT ALLERG IMM-UK, V19, P580, DOI 10.1111/j.1399-3038.2008.00759.x; Wapenaar H, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0225-2; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wu CJ, 2013, INT ARCH ALLERGY IMM, V160, P356, DOI 10.1159/000343030; Xiao C, 2015, J ALLERGY CLIN IMMUN, V136, P923, DOI 10.1016/j.jaci.2015.01.045; Yang IV, 2015, J ALLERGY CLIN IMMUN, V136, P69, DOI 10.1016/j.jaci.2015.01.025; Yi X, 2015, AM J TRANSL RES, V7, P2159; Youn CK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111931; Yousefi P, 2015, ENVIRON MOL MUTAGEN, V56, P751, DOI 10.1002/em.21966; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zou J, 2014, NAT METHODS, V11, P309, DOI [10.1038/NMETH.2815, 10.1038/nmeth.2815]	312	3	3	12	15	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1750-1911	1750-192X		EPIGENOMICS-UK	Epigenomics	APR	2017	9	4					539	571		10.2217/epi-2016-0162				33	Genetics & Heredity	Genetics & Heredity	ES2GJ	WOS:000399344700015	28322581	gold			2018-01-05	
J	Wang, Y; Naturale, VF; Adler, PN				Wang, Ying; Naturale, Victor F.; Adler, Paul N.			Planar Cell Polarity Effector Fritz Interacts with Dishevelled and Has Multiple Functions in Regulating PCP	G3-GENES GENOMES GENETICS			English	Article						Drosophila; Planar Polarity Effector; Planar Cell Polarity; fritz; inturned	TISSUE POLARITY; DROSOPHILA-MELANOGASTER; WING CELLS; PROTEIN; PRICKLE; GENE; ESTABLISHMENT; LOCALIZATION; STRABISMUS; EXTENSION	The Planar cell Polarity Effector (PPE) genes inturned, fuzzy, and fritz are downstream components in the frizzled/starry night signaling pathway, and their function is instructed by upstream Planar Cell Polarity (PCP) core genes such as frizzled and dishevelled. PPE proteins accumulate asymmetrically in wing cells and function in a protein complex mediated by direct interactions between In and Frtz and In and Fy. How the PCP proteins instruct the accumulation of PPE protein is unknown. We found a likely direct interaction between Dishevelled and Fritz and Dishevelled and Fuzzy that could play a role in this. We previously found that mild overexpression of frtz rescued a weak in allele. To determine if this was due to extra Frtz stabilizing mutant In or due to Frtz being able to bypass the need for In we generate a precise deletion of the inturned gene (in(PD)). We found that mild overexpression of Fritz partially rescued in(PD), indicating that fritz has In independent activity in PCP. Previous studies of PPE proteins used fixed tissues, and did not provide any insights into the dynamic properties of PPE proteins. We used CRISPR/Cas9 genome editing technology to edit the fritz gene to add a green fluorescent protein tag. fritz(mNeonGreen) provides complete rescue activity and works well for in vivo imaging. Our data showed that Fritz is very dynamic in epidermal cells and preferentially distributed to discrete membrane subdomains (puncta). Surprisingly, we found it in stripes in developing bristles.	[Wang, Ying; Naturale, Victor F.; Adler, Paul N.] Univ Virginia, Dept Biol, Gilmer Hall, Charlottesville, VA 22903 USA; [Wang, Ying; Naturale, Victor F.; Adler, Paul N.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA	Adler, PN (reprint author), Univ Virginia, Dept Biol, Gilmer Hall, Charlottesville, VA 22903 USA.	pna@virginia.edu		Adler, Paul/0000-0002-8547-8040	National Institutes of Health [GM037163]	We thank FlyBase and the stock centers at Indiana University and the VDRC and Addgene where we obtained many stocks and plasmids used in the paper. We also thank G. Guild, J. Axelrod, D. Strutt, and M. Mlodzik for reagents. We also acknowledge the Keck Imaging Center where the confocal microscopy was done. This research was supported by a grant from the National Institutes of Health (GM037163).	Adler PN, 2012, CURR TOP DEV BIOL, V101, P1, DOI 10.1016/B978-0-12-394592-1.00001-6; Adler PN, 2004, CURR BIOL, V14, P2046, DOI 10.1016/j.cub.2004.11.007; ADLER PN, 1994, GENETICS, V137, P829; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Axelrod JD, 2001, GENE DEV, V15, P1182; Babayeva S, 2013, J BIOL CHEM, V288, P24035, DOI 10.1074/jbc.M113.452904; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; BRAND AH, 1993, DEVELOPMENT, V118, P401; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Cho B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005259; Collier S, 2005, GENETICS, V169, P2035, DOI 10.1534/genetics.104.033381; Cui C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001720; Dabdoub A, 2005, J NEUROBIOL, V64, P446, DOI 10.1002/neu.20171; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Donoughe S, 2011, DEVELOPMENT, V138, P2751, DOI 10.1242/dev.063024; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Goggolidou P, 2014, ORGANOGENESIS, V10, P86, DOI 10.4161/org.26766; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; He Biao, 2002, BMC Dev Biol, V2, P7, DOI 10.1186/1471-213X-2-7; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Jenny A, 2006, MT SINAI J MED, V73, P738; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626                                                          ; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Sharp KA, 2016, BIOL OPEN, V5, P229, DOI 10.1242/bio.016162; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Strutt D, 2008, DEVELOPMENT, V135, P3103, DOI 10.1242/dev.025205; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Strutt H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003654; Strutt H, 2011, DEV CELL, V20, P511, DOI 10.1016/j.devcel.2011.03.018; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8                                                   ; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1                                                   ; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077                                                                ; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880                                                          ; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pD339, DOI 10.1093/nar/gku1023; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang Y, 2014, DEV BIOL, V394, P156, DOI 10.1016/j.ydbio.2014.07.013; Wolff T, 1998, DEVELOPMENT, V125, P1149; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Wu J, 2008, DEV CELL, V15, P462, DOI 10.1016/j.devcel.2008.08.004; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043005; Yan J., 2008, THESIS; ZHENG L, 1995, DEVELOPMENT, V121, P3045; Zilber Y, 2013, MOL BIOL CELL, V24, P555, DOI 10.1091/mbc.E12-06-0437	56	0	0	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	APR	2017	7	4					1323	1337		10.1534/g3.116.038695				15	Genetics & Heredity	Genetics & Heredity	ER5KN	WOS:000398840700025	28258110	gold			2018-01-05	
J	Rogers, WA; Goyal, Y; Yamaya, K; Shvartsman, SY; Levine, MS				Rogers, William A.; Goyal, Yogesh; Yamaya, Kei; Shvartsman, Stanislav Y.; Levine, Michael S.			Uncoupling neurogenic gene networks in the Drosophila embryo	GENES & DEVELOPMENT			English	Article						Drosophila embryo; EGFR regulatory networks; rhomboid; intermediate neuroblasts defective; central nervous system	SINGLE-MINDED GENE; CNS MIDLINE CELLS; DORSAL-VENTRAL AXIS; EGF RECEPTOR; SIGNALING PATHWAYS; NERVOUS-SYSTEM; EXPRESSION; ECTODERM; NEUROECTODERM; EVOLUTION	The EGF signaling pathway specifies neuronal identities in the Drosophila embryo by regulating developmental patterning genes such as intermediate neuroblasts defective (ind). EGFR is activated in the ventral midline and neurogenic ectoderm by the Spitz ligand, which is processed by the Rhomboid protease. CRISPR/Cas9 was used to delete defined rhomboid enhancers mediating expression at each site of Spitz processing. Surprisingly, the neurogenic ectoderm, not the ventral midline, was found to be the dominant source of EGF patterning activity. We suggest that Drosophila is undergoing an evolutionary transition in central nervous system (CNS)-organizing activity from the ventral midline to the neurogenic ectoderm.	[Rogers, William A.; Yamaya, Kei; Levine, Michael S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Dept Mol Biol, Princeton, NJ 08544 USA; [Goyal, Yogesh; Shvartsman, Stanislav Y.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Dept Chem & Biol Engn, Princeton, NJ 08544 USA	Levine, MS (reprint author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Dept Mol Biol, Princeton, NJ 08544 USA.; Shvartsman, SY (reprint author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	stas@princeton.edu; msl2@princeton.edu			National Institutes of Health (NIH) [R35 GM118147]; NIH [R01 GM086537]	We thank members of the Levine and Shvartsman laboratories for their invaluable comments and advice. We also thank Hongtao Chen and Thomas Gregor for providing many of the CRISPR/Cas9 plasmids used in our experiments, and Gary Laevsky and Evangelos G. Gatzogiannis for their expert help with imaging. W.A.R. was supported by a National Institutes of Health (NIH) grant to M.S.L. (R35 GM118147). Y.G. and K.Y. were supported by an NIH grant to S.Y.S. (R01 GM086537). W.A.R., Y.G., S.Y.S., and M.S.L. conceived and designed the project; W.A.R. designed the CRISPR/Cas9 mutant flies; Y.G., W.A.R., and K.Y. performed the imaging experiments; W.A.R. and Y.G. analyzed the results; and W.A.R., Y.G., S.Y.S., and M.S.L. wrote the manuscript.	Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Chang J, 2001, INT J DEV BIOL, V45, P715; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; Crocker J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1102; Golembo M, 1996, DEVELOPMENT, V122, P3363; GONZALEZCRESPO S, 1993, GENE DEV, V7, P1703, DOI 10.1101/gad.7.9.1703; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hong JW, 2013, DEV BIOL, V380, P335, DOI 10.1016/j.ydbio.2013.05.015; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Housden BE, 2014, TRENDS BIOCHEM SCI, V39, P457, DOI 10.1016/j.tibs.2014.07.008; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KASAI Y, 1992, P NATL ACAD SCI USA, V89, P3414, DOI 10.1073/pnas.89.8.3414                                                          ; Kearney JB, 2004, DEV BIOL, V275, P473, DOI 10.1016/j.ydbio.2004.08.047; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Lim B, 2015, CURR BIOL, V25, P1784, DOI 10.1016/j.cub.2015.05.039; Lim B, 2013, P NATL ACAD SCI USA, V110, P10330, DOI 10.1073/pnas.1303635110; Lynch JA, 2011, GENE DEV, V25, P107, DOI 10.1101/gad.2010711; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Markstein M, 2004, DEVELOPMENT, V131, P2387, DOI 10.1242/dev.01124; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; Pearson JC, 2014, DEV BIOL, V392, P466, DOI 10.1016/j.ydbio.2014.05.011; RAZ E, 1993, GENE DEV, V7, P1937, DOI 10.1101/gad.7.10.1937; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Rousso T, 2010, DEVELOPMENT, V137, P3427, DOI 10.1242/dev.049858; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518                                                           ; Skeath JB, 1998, DEVELOPMENT, V125, P3301; Stathopoulos A, 2005, DEV BIOL, V280, P482, DOI 10.1016/j.ydbio.2005.02.003; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5                                                    ; Vargas-Vila MA, 2010, DEVELOPMENT, V137, P3469, DOI 10.1242/dev.055160; Von Ohlen T, 2000, DEV BIOL, V224, P362, DOI 10.1006/dbio.2000.9789; Von Ohlen TL, 2007, MECH DEVELOP, V124, P230, DOI 10.1016/j.mod.2006.11.003; Zinzen RP, 2006, DEV CELL, V11, P895, DOI 10.1016/j.devcel.2006.10.012	40	0	0	2	3	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	APR 1	2017	31	7					634	638		10.1101/gad.297150.117				5	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	ET1ZU	WOS:000400068800003	28428262	gold			2018-01-05	
J	Valdmanis, PN; Kay, MA				Valdmanis, Paul N.; Kay, Mark A.			Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond	HUMAN GENE THERAPY			English	Review						AAV vectors; genome editing; non-coding RNA; miRNA; RNAi	AMYOTROPHIC-LATERAL-SCLEROSIS; ADENOASSOCIATED VIRUS VECTORS; CENTRAL-NERVOUS-SYSTEM; ZINC-FINGER NUCLEASES; SHORT HAIRPIN RNAS; IN-VIVO; MOUSE MODEL; MUSCULAR-DYSTROPHY; VIRAL VECTORS; HUMAN-CELLS	The use of recombinant adeno-associated viruses (rAAVs) ushered in a new millennium of gene transfer for therapeutic treatment of a number of conditions, including congenital blindness, hemophilia, and spinal muscular atrophy. rAAV vectors have remarkable staying power from a therapeutic standpoint, withstanding several ebbs and flows. As new technologies such as clustered regularly interspaced short palindromic repeat genome editing emerge, it is now the delivery tool-the AAV vector-that is the stalwart. The long-standing safety of this vector in a multitude of clinical settings makes rAAV a selling point in the advancement of approaches for gene replacement, gene knockdown, gene editing, and genome modification/engineering. The research community is building on these advances to develop more tailored delivery approaches and to tweak the genome in new and unique ways. Intertwining these approaches with newly engineered rAAV vectors is greatly expanding the available tools to manipulate gene expression with a therapeutic intent.	[Kay, Mark A.] Stanford Univ, Dept Pediat, 269 Campus Dr,CCSR 2105, Stanford, CA 94305 USA; [Kay, Mark A.] Stanford Univ, Dept Genet, 269 Campus Dr,CCSR 2105, Stanford, CA 94305 USA	Kay, MA (reprint author), Stanford Univ, Dept Pediat, 269 Campus Dr,CCSR 2105, Stanford, CA 94305 USA.; Kay, MA (reprint author), Stanford Univ, Dept Genet, 269 Campus Dr,CCSR 2105, Stanford, CA 94305 USA.	Markay@stanford.edu		Valdmanis, Paul/0000-0001-8840-6969	NIH [1R01 DK 078424, 1R01 AI11698, R01 HL064274]	We are grateful to members of the Kay lab for their critiques and suggestions. This work was supported by grants NIH 1R01 DK 078424, 1R01 AI11698, R01 HL064274 (M.A.K.).	Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Bibikova M, 2002, GENETICS, V161, P1169; Borner K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt836; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bortolanza S, 2011, MOL THER, V19, P2055, DOI 10.1038/mt.2011.153; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999                                                         ; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chamberlain JR, 2004, SCIENCE, V303, P1198, DOI 10.1126/science.1088757; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choudhury SR, 2016, MOL THER, V24, P1247, DOI 10.1038/mt.2016.84; Choudhury SR, 2016, MOL THER, V24, P726, DOI 10.1038/mt.2015.231; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cruz PE, 2007, LAB INVEST, V87, P893, DOI 10.1038/labinvest.3700629; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foust KD, 2013, MOL THER, V21, P2148, DOI 10.1038/mt.2013.211; Fujita T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30485; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057                                                        ; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Haussecker D, 2015, SCIENCE, V347, P1069, DOI 10.1126/science.1252967; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hickey RD, 2011, HEPATOLOGY, V54, P1351, DOI 10.1002/hep.24490; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Khodr CE, 2011, BRAIN RES, V1395, P94, DOI 10.1016/j.brainres.2011.04.036; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu YP, 2013, NUCLEIC ACIDS RES, V41, P3723, DOI 10.1093/nar/gkt036; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.080177S105; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Melo SP, 2014, MOL THER, V22, P725, DOI 10.1038/mt.2013.290; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Miller DG, 2006, NAT BIOTECHNOL, V24, P1022, DOI 10.1038/nbt1231; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Miyazaki Y, 2012, NAT MED, V18, P1136, DOI 10.1038/nm.2791; Mockenhaupt S, 2015, P NATL ACAD SCI USA, V112, pE4007, DOI 10.1073/pnas.1510476112; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Mueller C, 2012, MOL THER, V20, P590, DOI 10.1038/mt.2011.292; Munch RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7246; Murlidharan G, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.49; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nygaard S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8166; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; O'Reilly M, 2007, AM J HUM GENET, V81, P127, DOI 10.1086/519025; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002                                                              ; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0                                                                ; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325                                                              ; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Shin J. W., 2016, HUM MOL GENET; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Snyder RO, 1997, NAT GENET, V16, P270, DOI 10.1038/ng0797-270; Song S, 1998, P NATL ACAD SCI USA, V95, P14384, DOI 10.1073/pnas.95.24.14384; Suhy DA, 2012, MOL THER, V20, P1737, DOI 10.1038/mt.2012.119; Summerford C, 1998, J VIROL, V72, P1438; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tam LCS, 2008, HUM MOL GENET, V17, P2084, DOI 10.1093/hmg/ddn107; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Thomsen GM, 2014, J NEUROSCI, V34, P15587, DOI 10.1523/JNEUROSCI.2037-14.2014; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Valdmanis PN, 2016, NAT MED, V22, P557, DOI 10.1038/nm.4079; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; Wallace LM, 2011, MOL THER, V19, P2048, DOI 10.1038/mt.2011.118; Wang HY, 2014, HUM MOL GENET, V23, P668, DOI 10.1093/hmg/ddt454; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang LL, 2012, HUM GENE THER, V23, P533, DOI 10.1089/hum.2011.183; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xie C, 2016, CELL RES, V26, P1099, DOI 10.1038/cr.2016.101; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5                                                   ; Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79	123	3	3	11	21	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	APR	2017	28	4					361	372		10.1089/hum.2016.171				12	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	ES5VV	WOS:000399615100008	28073291				2018-01-05	
J	Chen, SQ; Hou, CX; Bi, HL; Wang, YQ; Xu, J; Li, MW; James, AA; Huang, YP; Tan, AJ				Chen, Shuqing; Hou, Chengxiang; Bi, Honglun; Wang, Yueqiang; Xu, Jun; Li, Muwang; James, Anthony A.; Huang, Yongping; Tan, Anjiang			Transgenic Clustered Regularly Interspaced Short Palindromic Repeat/Cas9-Mediated Viral Gene Targeting for Antiviral Therapy of Bombyx mori Nucleopolyhedrovirus	JOURNAL OF VIROLOGY			English	Article						Bombyx mori nucleopolyhedrovirus; CRISPR/Cas9; transgenic silkworm; antiviral therapy	CRISPR/CAS9 SYSTEM; HUMAN-CELLS; GENOME; SILKWORM; RNA; SPECIFICITY; BACULOVIRUS; RESISTANCE; VIRUS; TECHNOLOGY	We developed a novel antiviral strategy by combining transposonbased transgenesis and the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) system for the direct cleavage of Bombyx mori nucleopolyhedrovirus (BmNPV) genome DNA to promote virus clearance in silkworms. We demonstrate that transgenic silkworms constitutively expressing Cas9 and guide RNAs targeting the BmNPV immediate early-1 (ie-1) and me53 genes effectively induce target-specific cleavage and subsequent mutagenesis, especially large (similar to 7-kbp) segment deletions in BmNPV genomes, and thus exhibit robust suppression of BmNPV proliferation. Transgenic animals exhibited higher and inheritable resistance to BmNPV infection than wild-type animals. Our approach will not only contribute to modern sericulture but also shed light on future antiviral therapy. IMPORTANCE Pathogen genome targeting has shown its potential in antiviral research. However, transgenic CRISPR/Cas9 system-mediated viral genome targeting has not been reported as an antiviral strategy in a natural animal host of a virus. Our data provide an effective approach against BmNPV infection in a real-world biological system and demonstrate the potential of transgenic CRISPR/Cas9 systems in antiviral research in other species.	[Chen, Shuqing; Bi, Honglun; Wang, Yueqiang; Xu, Jun; Huang, Yongping; Tan, Anjiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China; [Chen, Shuqing; Xu, Jun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hou, Chengxiang; Li, Muwang] Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	Huang, YP; Tan, AJ (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China.	ajtan01@sibs.ac.cn; ajtan01@sibs.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11010600]; National Basic Research Program of China [2015CB755703]; National Science Foundation of China [31420103918, 31530072]; Chinese Academy of Sciences [KJZD-EW-L12-02]	This work, including the efforts of Shuqing Chen, Honglun Bi, Yueqiang Wang, Jun Xu, Yongping Huang, and Anjiang Tan, was funded by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB11010600), the National Basic Research Program of China (2015CB755703), the National Science Foundation of China (31420103918 and 31530072), and the Chinese Academy of Sciences (KJZD-EW-L12-02). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Das S, 2013, APPL MICROBIOL BIOT, V97, P6019, DOI 10.1007/s00253-013-4868-z; de Jong J, 2011, J VIROL, V85, P9696, DOI 10.1128/JVI.00833-11; de Jong J, 2009, J VIROL, V83, P7440, DOI 10.1128/JVI.02390-08; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323                                                     ; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isobe R, 2004, ARCH VIROL, V149, P1931, DOI 10.1007/s00705-004-0349-0; Jiang L, 2014, INSECT BIOCHEM MOLEC, V48, P1, DOI 10.1016/j.ibmb.2014.02.003; Jiang L, 2013, ANTIVIR RES, V97, P255, DOI 10.1016/j.antiviral.2012.12.020; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041838; Jiang L, 2012, ARCH VIROL, V157, P1323, DOI 10.1007/s00705-012-1309-8; Kamita SG, 2005, P NATL ACAD SCI USA, V102, P2584, DOI 10.1073/pnas.0409457102; Kanginakudru S, 2007, INSECT MOL BIOL, V16, P635, DOI 10.1111/j.1365-2583.2007.00753.x                                                ; Kennedy EM, 2015, VIROLOGY, V479, P213, DOI 10.1016/j.virol.2015.02.024; Khurad AM, 2004, J INVERTEBR PATHOL, V87, P8, DOI 10.1016/j.jip.2004.05.008; KNEBELMORSDORF D, 1993, J VIROL, V67, P753; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Li ZQ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0513; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; Subbaiah EV, 2013, GENETICS, V193, P63, DOI 10.1534/genetics.112.144402; Tamura T, 2000, NAT BIOTECHNOL, V18, P81; Tan AJ, 2013, P NATL ACAD SCI USA, V110, P6766, DOI 10.1073/pnas.1221700110; Tanaka H, 2009, MOL BIOTECHNOL, V41, P173, DOI 10.1007/s12033-008-9108-x; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xu KZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118222; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zhang P, 2014, GENE THER, V21, P81, DOI 10.1038/gt.2013.60	45	1	1	7	10	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	APR	2017	91	8							UNSP e02465	10.1128/JVI.02465-16				13	Virology	Virology	ES4AU	WOS:000399472200038		gold			2018-01-05	
J	Morley, D; Broniewski, JM; Westra, ER; Buckling, A; van Houte, S				Morley, Daniel; Broniewski, Jenny M.; Westra, Edze R.; Buckling, Angus; van Houte, Stineke			Host diversity limits the evolution of parasite local adaptation	MOLECULAR ECOLOGY			English	Article						adaptive immunity; bacteria; CRISPR/Cas; host-parasite co-evolution; local adaptation; phage; specificity	GENE-FOR-GENE; CRISPR-CAS; ACQUIRED-RESISTANCE; IMMUNITY SYSTEM; DYNAMICS; METAPOPULATION; INTERFERENCE; COEVOLUTION; INFECTIONS; DISPERSAL	Specificity in the interactions between hosts and their parasites can lead to local adaptation. However, the degree of local adaptation is predicted to depend upon the diversity of resistance alleles within the host population; increasing host diversity should decrease mean parasite infectivity and hence reduce local adaptation. In this study, we empirically test this prediction using the highly specific interactions between bacteria with clustered regularly interspaced short palindromic repeats/CRISPR-associated (CRISPR/Cas) immunity and their bacteriophage. Bacteria acquire immunity to phage by incorporating a phage-derived spacer sequence into CRISPR loci on the host genome, and phage can escape the CRISPR-mediated immunity of a specific clone by mutating the targeted sequence. We found that high levels of CRISPR allele diversity that naturally evolve in host populations exposed to phage (because each bacterial clone captures a unique phage-derived sequence) prevents phage from becoming locally adapted. By manipulating the number of CRISPR alleles in the host population, we show that phage can become locally adapted to their bacterial hosts but only when CRISPR allele diversity is low.	[Morley, Daniel; Broniewski, Jenny M.; Westra, Edze R.; Buckling, Angus; van Houte, Stineke] Univ Exeter, Environm & Sustainabil Inst, Ctr Ecol & Conservat, Biosci, Penryn, Cornwall, England	van Houte, S (reprint author), Univ Exeter, Environm & Sustainabil Inst, Ctr Ecol & Conservat, Biosci, Penryn, Cornwall, England.	vanhoute.stineke@gmail.com			European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [660039]; NERC; BBSRC; Wellcome Trust; Royal Society; AXA Research Fund	The authors would like to thank two anonymous reviewers for their helpful and insightful comments on the manuscript. SvH received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 660039. We also acknowledge NERC, BBSRC, Wellcome Trust, the Royal Society and the AXA Research Fund for funding.	Agrawal A, 2002, EVOL ECOL RES, V4, P79; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Chabas H, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0721; Childs LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101710; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Emerson JB, 2013, ARCHAEA, V2013; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Gandon S, 2009, EVOLUTION, V63, P826, DOI 10.1111/j.1558-5646.2009.00609.x; Gandon S, 2009, AM NAT, V173, P212, DOI 10.1086/593706; Gomez P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2297; Gorter FA, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0879; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Iranzo J, 2013, J BACTERIOL, V195, P3834, DOI 10.1128/JB.00412-13; Kaltz O, 1998, HEREDITY, V81, P361; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Laine AL, 2008, ECOL LETT, V11, P327, DOI 10.1111/j.1461-0248.2007.01146.x; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210                                                                  ; Miller MEB, 2012, ENVIRON MICROBIOL, V14, P207, DOI 10.1111/j.1462-2920.2011.02593.x; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Orsini L, 2013, MOL ECOL, V22, P5983, DOI 10.1111/mec.12561; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Pascua LL, 2012, J EVOLUTION BIOL, V25, P187, DOI 10.1111/j.1420-9101.2011.02416.x; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sorokin VA, 2010, APPL ENVIRON MICROB, V76, P2136, DOI 10.1128/AEM.01985-09; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Thompson JN, 2005, CURR BIOL, V15, pR992, DOI 10.1016/j.cub.2005.11.046; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Thompson J. N., 1994, COEVOLUTIONARY PROCE; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; vansHoute S, 2016, NATURE, V532, P385; vansHoute S, 2016, MICROBIOL MOL BIOL R, V80, P745; Westra ER, 2015, CURR BIOL, V25, P1043, DOI 10.1016/j.cub.2015.01.065	43	3	3	8	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	APR	2017	26	7			SI		1756	1763		10.1111/mec.13917				8	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	ES6EM	WOS:000399639200006	27862566				2018-01-05	
J	Savitskaya, E; Lopatina, A; Medvedeva, S; Kapustin, M; Shmakov, S; Tikhonov, A; Artamonova, II; Logacheva, M; Severinov, K				Savitskaya, Ekaterina; Lopatina, Anna; Medvedeva, Sofia; Kapustin, Mikhail; Shmakov, Sergey; Tikhonov, Alexey; Artamonova, Irena I.; Logacheva, Maria; Severinov, Konstantin			Dynamics of Escherichia coli type I-E CRISPR spacers over 42 000 years	MOLECULAR ECOLOGY			English	Article						Escherichia coli; CRISPR spacers; CRISPR arrays; palaeo DNA	STREPTOCOCCUS-THERMOPHILUS; DNA; ELEMENTS; RESISTANCE; IMMUNITY; REPEATS; EVOLUTIONARY; PROKARYOTES; ADAPTATION; DIVERSITY	CRISPR-Cas are nucleic acid-based prokaryotic immune systems. CRISPR arrays accumulate spacers from foreign DNA and provide resistance to mobile genetic elements containing identical or similar sequences. Thus, the set of spacers present in a given bacterium can be regarded as a record of encounters of its ancestors with genetic invaders. Such records should be specific for different lineages and change with time, as earlier acquired spacers get obsolete and are lost. Here, we studied type I-E CRISPR spacers of Escherichia coli from extinct pachyderm. We find that many spacers recovered from intestines of a 42000-year-old mammoth match spacers of present-day E.coli. Present-day CRISPR arrays can be reconstructed from palaeo sequences, indicating that the order of spacers has also been preserved. The results suggest that E.coli CRISPR arrays were not subject to intensive change through adaptive acquisition during this time.	[Savitskaya, Ekaterina; Medvedeva, Sofia; Kapustin, Mikhail; Shmakov, Sergey; Severinov, Konstantin] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Savitskaya, Ekaterina; Lopatina, Anna; Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Lopatina, Anna; Medvedeva, Sofia; Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Tikhonov, Alexey] Russian Acad Sci, Inst Zool, St Petersburg, Russia; [Tikhonov, Alexey] North Eastern Fed Univ, Inst Appl Ecol North, Yakutsk, Russia; [Artamonova, Irena I.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia; [Artamonova, Irena I.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Logacheva, Maria] Moscow MV Lomonosov State Univ, Moscow, Russia; [Severinov, Konstantin] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ USA	Severinov, K (reprint author), Skolkovo Inst Sci & Technol, Skolkovo, Russia.; Severinov, K (reprint author), Russian Acad Sci, Inst Mol Genet, Moscow, Russia.; Severinov, K (reprint author), Russian Acad Sci, Inst Gene Biol, Moscow, Russia.; Severinov, K (reprint author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ USA.	severik@waksman.rutgers.edu	Artamonova, Irena/D-3874-2013	Artamonova, Irena/0000-0001-6626-2079	Russian Science Foundation [14-14-00988]; NIH RO1 grant [GM10407]; Russian Foundation for Basic Research [16-04-00767, 17-04-02144]	We thank Dr. Jaroslav Ispolatov for advice. This work was supported by grants from Russian Science Foundation [14-14-00988 to KS], NIH RO1 grant GM10407 to KS and Russian Foundation for Basic Research [16-04-00767 to E.S and 17-04-02144 to IIA].	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2010, MICROBIOL-SGM, V156, P1351, DOI 10.1099/mic.0.036046-0; Erdmann S, 2012, MOL MICROBIOL, V85, P1044, DOI 10.1111/j.1365-2958.2012.08171.x; Fisher D, 2009, J VERTEBR PALEONTOL, V29, p96A; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hofreiter M, 2015, BIOESSAYS, V37, P284, DOI 10.1002/bies.201400160; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Kupczok A, 2015, GENOME BIOL EVOL, V7, P1925, DOI 10.1093/gbe/evv113; Lopatina A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00398; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402                                                    ; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Sheludchenko MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124090; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Sun CL, 2016, ISME J, V10, P858, DOI 10.1038/ismej.2015.162; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	35	3	3	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	APR	2017	26	7			SI		2019	2026		10.1111/mec.13961				8	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	ES6EM	WOS:000399639200025	27997045	gold			2018-01-05	
J	Glaser, AP; Fantini, D; Shilatifard, A; Schaeffer, EM; Meeks, JJ				Glaser, Alexander P.; Fantini, Damiano; Shilatifard, Ali; Schaeffer, Edward M.; Meeks, Joshua J.			The evolving genomic landscape of urothelial carcinoma	NATURE REVIEWS UROLOGY			English	Review							INVASIVE BLADDER-CANCER; TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; DNA METHYLATION; PROGNOSTIC-FACTORS; PHASE-I; FGFR3 MUTATIONS; TP53 MUTATIONS; GENE FUSIONS; SOLID TUMORS	Survival of patients with urothelial carcinoma (including bladder cancer and upper tract urothelial carcinoma) is limited by our current approaches to staging, surgery and chemotherapy. Large-scale, next-generation sequencing collaborations, such as The Cancer Genome Atlas, have already identified drivers and vulnerabilities of urothelial carcinoma. This disease has a high degree of mutational heterogeneity and a high frequency of somatic mutations compared with other solid tumours, potentially resulting in an increased neoantigen burden. Mutational heterogeneity is mediated by multiple factors including the apolipoprotein B mRNA editing enzyme catalytic polypeptide family of enzymes, smoking exposure, viral integrations, and intragene and intergene fusion proteins. The mutational landscape of urothelial carcinoma, including specific mutations in pathways and driver genes, such as FGFR3, ERBB2, PIK3CA, TP53, and STAG2, affects tumour aggressiveness and response to therapy. The next generation of therapies for urothelial carcinoma will be based on patient-specific targetable mutations found in individual tumours. This personalized-medicine approach to urothelial carcinoma has already resulted in unique clinicaltrial design and has the potential to improve patient outcomes and survival.	[Glaser, Alexander P.; Fantini, Damiano; Shilatifard, Ali; Schaeffer, Edward M.; Meeks, Joshua J.] Northwestern Univ, Dept Urol, 303 E Chicago Ave,Tarry 16-703, Chicago, IL 60611 USA	Meeks, JJ (reprint author), Northwestern Univ, Dept Urol, 303 E Chicago Ave,Tarry 16-703, Chicago, IL 60611 USA.	joshua.meeks@northwestern.edu	Fantini, Damiano/M-7185-2017	Glaser, Alexander/0000-0003-1781-9023	Veterans Health Administration Merit grant [BX0033692-01]	The results shown here are in part based upon data generated by the TCGA Research Network: https://cancergenome.nih.gov/. J.J.M. is funded by a Veterans Health Administration Merit grant BX0033692-01	Abdollah F, 2013, CANCER EPIDEMIOL, V37, P219, DOI 10.1016/j.canep.2013.02.002; Acquaviva J, 2014, MOL CANCER RES, V12, P1042, DOI 10.1158/1541-7786.MCR-14-0004; Aine M, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0144-4; Al-Ahmadie H, 2014, CANCER DISCOV, V4, P1014, DOI 10.1158/2159-8290.CD-14-0380; Al-Ahmadie HA, 2016, NAT GENET, V48, P356, DOI 10.1038/ng.3503; Alexander RE, 2016, HISTOL HISTOPATHOL, V31, P595, DOI 10.14670/HH-11-715; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Bagrodia A, 2016, J UROLOGY, V195, P1684, DOI 10.1016/j.juro.2016.01.006; Bakkar A. A., 2003, CANCER RES, V63, P7657; Balbas-Martinez C, 2013, NAT GENET, V45, P1464, DOI 10.1038/ng.2799; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bellmunt J, 2015, CANCER MED-US, V4, P844, DOI 10.1002/cam4.432; Besaratinia A, 2013, EPIGENETICS-US, V8, P1013, DOI 10.4161/epi.25927; Besingi W, 2014, HUM MOL GENET, V23, P2290, DOI 10.1093/hmg/ddt621; Bhattacharya A, 2015, ONCOTARGET, V6, P836, DOI 10.18632/oncotarget.2722                                                        ; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Brait M, 2013, CELL CYCLE, V12, P1058, DOI 10.4161/cc.24050; Broad Institute, MUT AN MUTSIG 2CV V3; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cancer Research UK Clinical Trials Unit Glasgow, 2016, ATLANTIS AD MULT PHA; Weinstein J.N., 2013, NAT GENET, V45, P1113, DOI DOI 10.1038/NG.2764; Cancer Genome Atlas Research Network, 2014, NATURE, V507, P315, DOI DOI 10.1038/NATURE12965; Cerbone L, 2016, ONCOLOGY-BASEL, V90, P21, DOI 10.1159/000440959; Chen PCH, 2013, J CLIN PATHOL, V66, P113, DOI 10.1136/jclinpath-2012-200944; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Crivelli JJ, 2014, EUR UROL, V65, P742, DOI 10.1016/j.eururo.2013.06.010; de Martino M, 2014, CANCER BIOL THER, V15, P1239, DOI 10.4161/cbt.29687; Deng QF, 2016, ONCOL REP, V35, P2665, DOI 10.3892/or.2016.4623; Di Martino E, 2012, ADV UROL, V2012, DOI DOI 10.1155/2012/429213; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; ECOG-ACRIN Cancer Research Group, 2016, EX SUMM INT AN NCI M; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feng ZH, 2002, CARCINOGENESIS, V23, P1721, DOI 10.1093/carcin/23.10.1721; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Ferris J, 2013, ACTAS UROL ESP, V37, P513, DOI 10.1016/j.acuro.2013.01.001; Figueroa JD, 2014, CARCINOGENESIS, V35, P1737, DOI 10.1093/carcin/bgu064; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Galsky MD, 2012, INVEST NEW DRUG, V30, P695, DOI 10.1007/s10637-010-9541-0; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao X, 2016, ONCOTARGET, V7, P46878, DOI 10.18632/oncotarget.9795; Geng H, 2017, ONCOL LETT, V13, P469, DOI 10.3892/ol.2016.5407; Ghosh M, 2014, CURR OPIN ONCOL, V26, P305, DOI 10.1097/CCO.0000000000000064; Gontero P, 2015, EUR UROL, V67, P74, DOI 10.1016/j.eururo.2014.06.040; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guida F, 2015, HUM MOL GENET, V24, P2349, DOI 10.1093/hmg/ddu751; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Harlid S, 2014, ENVIRON HEALTH PERSP, V122, P673, DOI 10.1289/ehp.1307480; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; He E, 2015, CANCER RES, V75, P2017; Hedegaard J, 2016, CANCER CELL, V30, P27, DOI 10.1016/j.ccell.2016.05.004; Hernandez S, 2005, CLIN CANCER RES, V11, P5444, DOI 10.1158/1078-0432.CCR-05-0122                                                   ; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Hussain MHA, 2007, J CLIN ONCOL, V25, P2218, DOI 10.1200/JCO.2006.08.0994; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kardos J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85902; Katoh M, 2016, INT J MOL MED, V38, P3, DOI 10.3892/ijmm.2016.2620; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kawanishi H, 2007, BRIT J CANCER, V97, P260, DOI 10.1038/sj.bjc.6603860; Kawanishi H, 2006, CANCER SCI, V97, P746, DOI 10.1111/j.1349-7006.2006.00259.x; Kellen E, 2007, CANCER LETT, V245, P51, DOI 10.1016/j.canlet.2005.12.025; Kim J, 2015, CLIN CANCER RES, V21, P4514, DOI 10.1158/1078-0432.CCR-14-1215; Kurtoglu M, 2015, CLIN GENITOURIN CANC, V13, P410, DOI 10.1016/j.clgc.2015.02.009; Lamy A, 2006, J UROLOGY, V176, P2686, DOI 10.1016/j.juro.2006.07.132; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee HW, 2014, ONCOTARGET, V5, P3526, DOI 10.18632/oncotarget.1954                                                        ; Lerner SP, 2007, J UROLOGY, V177, P1727, DOI 10.1016/j.juro.2007.01.031; Letasiova S, 2012, ENV HLTH, V11, P11; Letouze E, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r76; Li X, 2015, GENET MOL RES, V14, P2638, DOI 10.4238/2015.March.30.24; Liu X, 2014, GENET MOL RES, V13, P1109, DOI 10.4238/2014.February.20.12; Lopez JS, 2017, NAT REV CLIN ONCOL, V14, P57, DOI 10.1038/nrclinonc.2016.96; Lopez-Beltran A, 2004, EUR UROL, V45, P606, DOI 10.1016/j.eururo.2003.11.011; LoRusso PM, 2008, J CLIN ONCOL, V26, P3051, DOI 10.1200/JCO.2007.14.9633; Lyer G, 2012, SCIENCE, V338, P221; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Maruyama R, 2001, CANCER RES, V61, P8659; McHugh LA, 2007, UROLOGY, V69, P390, DOI 10.1016/j.urology.2006.12.003; Mitra AP, 2013, CANCER-AM CANCER SOC, V119, P756, DOI 10.1002/cncr.27763; Mullane SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27702; Narayan V, 2016, CANCER RES TREAT, V48, P1084, DOI 10.4143/crt.2015.405; Nelson K. N., 2016, MOL CANC RES; Palma N, 2015, EUR UROL, V68, P168, DOI 10.1016/j.eururo.2015.02.023; Petljak M, 2016, CARCINOGENESIS, V37, P531, DOI 10.1093/carcin/bgw055; Pichler R, 2015, WORLD J UROL, V33, P2145, DOI 10.1007/s00345-015-1539-y; Plimack ER, 2015, EUR UROL, V68, P959, DOI 10.1016/j.eururo.2015.07.009; Pottner S., 2012, J TOXICOL ENV HEAL A, V75, P1194; Pouessel D, 2016, ANN ONCOL, V27, P1311, DOI 10.1093/annonc/mdw170; Powels T., 2015, J CLIN ONCOL S, V33, P4505; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rose TL, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0512-2; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Ross JS, 2016, CANCER-AM CANCER SOC, V122, P702, DOI 10.1002/cncr.29826; Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468; Segal R, 2012, BJU INT, V109, P1026, DOI 10.1111/j.1464-410X.2011.10462.x; Sethakorn N, 2016, BJU INT, V118, P680, DOI 10.1111/bju.13552; Sfakianos JP, 2015, EUR UROL, V68, P970, DOI 10.1016/j.eururo.2015.07.039; Shigehara K, 2014, J INFECT CHEMOTHER, V20, P741, DOI 10.1016/j.jiac.2014.08.033; Siegel-Lakhai WS, 2007, CLIN CANCER RES, V13, P4495, DOI 10.1158/1078-0432.CCR-07-0004; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Sun YV, 2013, HUM GENET, V132, P1027, DOI 10.1007/s00439-013-1311-6; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Teschendorff AE, 2013, HUM MOL GENET, V22, pR7, DOI 10.1093/hmg/ddt375; U.S. Cancer Statistics Working Group, 2015, US CANC STAT 1999 20; Van Allen EM, 2014, CANCER DISCOV, V4, P1140, DOI 10.1158/2159-8290.CD-14-0623; van Dongen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11115; Van M., 2015, CANCER METAST REV, V34, P157; van Rhijn BSW, 2004, CANCER RES, V64, P1911, DOI 10.1158/0008-5472.CAN-03-2421                                                   ; van Tilborg AAG, 2000, HUM MOL GENET, V9, P2973, DOI 10.1093/hmg/9.20.2973; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068                                                     ; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wang HT, 2016, ONCOTARGET, V7, P80450, DOI 10.18632/oncotarget.12608; Wang LC, 2014, UROL ONCOL-SEMIN ORI, V32, P433, DOI 10.1016/j.urolonc.2013.10.015; Wang ML, 2014, INT J CANCER, V135, P2653, DOI 10.1002/ijc.28898; World Health Organization International Clinical Trials Registry Platform, 2016, AD MULT PHAS 2 TRIAL; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Wulfing C, 2009, CANCER-AM CANCER SOC, V115, P2881, DOI 10.1002/cncr.24337; Yap KL, 2014, CLIN CANCER RES, V20, P6605, DOI 10.1158/1078-0432.CCR-14-0257; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zeegers MPA, 2004, WORLD J UROL, V21, P392, DOI 10.1007/s00345-003-0382-8	132	2	2	11	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4812	1759-4820		NAT REV UROL	Nat. Rev. Urol.	APR	2017	14	4					215	229		10.1038/nrurol.2017.11				15	Urology & Nephrology	Urology & Nephrology	ES1CH	WOS:000399265000017	28169993				2018-01-05	
J	Ozbey, G; Celikel, FC; Cumurcu, BE; Kan, D; Yucel, B; Hasbek, E; Percin, F; Guzey, IC; Uluoglu, C				Ozbey, Gul; Celikel, Feryal Cam; Cumurcu, Birgul Elbozan; Kan, Derya; Yucel, Berna; Hasbek, Ekrem; Percin, Ferda; Guzey, Ismail Cuneyt; Uluoglu, Canan			Influence of ABCB1 polymorphisms and serum concentrations on venlafaxine response in patients with major depressive disorder	NORDIC JOURNAL OF PSYCHIATRY			English	Article						ABCB1 polymorphism; akathisia; serum concentration; venlafaxine; response	MULTIDRUG-RESISTANCE GENE; ANTIDEPRESSANT TREATMENT RESPONSE; SEROTONIN REUPTAKE INHIBITORS; P-GLYCOPROTEIN; CLINICAL-RESPONSE; MDR1 GENE; EXTRAPYRAMIDAL SYMPTOMS; O-DESMETHYLVENLAFAXINE; C3435T POLYMORPHISM; TURKISH POPULATION	Background: The pharmacokinetics and the pharmacodynamics of antidepressants show large inter-individual variations which result in unpredictable clinical responses.Aim: The aim of the study was to examine the effect of ABCB1 polymorphisms and the serum concentrations on the efficacy and tolerability of venlafaxine in patients with major depressive disorder (MDD).Methods: Fifty-two outpatients who met the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria for MDD were recruited for the study. The severity of depression was assessed using the 17-item Hamilton Rating Scale for Depression scale (HDRS17) and tolerability was assessed based on a query regarding side-effects for 6 weeks. The ABCB1 C3435T/A and G2677T/A polymorphisms were genotyped by PCR/RFLP and steady-state serum venlafaxine concentrations were measured by high-performance liquid chromatography.Results: Patients with the TT genotype for the C3435T and the TT/TA genotype for the G2677T/A polymorphism showed significantly higher frequencies in venlafaxine-induced akathisia. This relationship was not observed for efficacy. As regards serum venlafaxine concentrations, patient groups showed no significant differences in efficacy and tolerability.Conclusion: The results suggest that individuals with the TT-TT/TA genotypes for the C3435T-G2677T/A polymorphisms of ABCB1 may be pre-disposed to a risk of akathisia.	[Ozbey, Gul] Akdeniz Univ, Dept Pharmacol, Fac Med, TR-07070 Antalya, Turkey; [Celikel, Feryal Cam] Isk Univ, Dept Psychol, Istanbul, Turkey; [Cumurcu, Birgul Elbozan] Inonu Univ, Dept Psychiat, Fac Med, Malataya, Turkey; [Kan, Derya; Percin, Ferda] Gazi Univ, Dept Genet, Fac Med, Ankara, Turkey; [Yucel, Berna] Izmir State Author, Izmir, Turkey; [Hasbek, Ekrem] Sivas State Hosp, Dept Psychiat, Sivas, Turkey; [Guzey, Ismail Cuneyt] St Olavs Univ Hosp, Div Psychiat, Dept Res & Dev, Trondheim, Norway; [Guzey, Ismail Cuneyt] Norwegian Univ Sci & Technol, Dept Neurosci, Fac Med, Trondheim, Norway; [Uluoglu, Canan] Gazi Univ, Dept Pharmacol, Fac Med, Ankara, Turkey	Ozbey, G (reprint author), Akdeniz Univ, Dept Pharmacol, Fac Med, TR-07070 Antalya, Turkey.	gulozbey@akdeniz.edu.tr			Scientific Research Projects of Gaziosmanpasa University, Turkey [2007/36]	This study was supported by grants from the Scientific Research Projects of Gaziosmanpasa University (Project No: 2007/36), Turkey.	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bet PM, 2016, PHARMACOGENOMICS J, V16, P202, DOI 10.1038/tpj.2015.38; Breitenstein B, 2016, J PSYCHIATR RES, V73, P86, DOI 10.1016/j.jpsychires.2015.11.010; CALLEN DF, 1987, HUM GENET, V77, P142, DOI 10.1007/BF00272381; Chang HH, 2015, CLIN PSYCHOPHARM NEU, V13, P250, DOI 10.9758/cpn.2015.13.3.250; Charlier C, 2002, J PSYCHOPHARMACOL, V16, P369, DOI 10.1177/026988110201600413                                                      ; Charlier C, 2000, HUM PSYCHOPHARM CLIN, V15, P453, DOI 10.1002/1099-1077(200008)15:6<453::AID-HUP228>3.0.CO;2-F; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; de Klerk OL, 2013, PHARMACOGENOMICS J, V13, P349, DOI 10.1038/tpj.2012.16; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Doran A, 2005, DRUG METAB DISPOS, V33, P165, DOI 10.1124/dmd.104.001230; Duverneuil C, 2003, THER DRUG MONIT, V25, P565, DOI 10.1097/00007691-200310000-00005; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Fujii T, 2012, J PSYCHIATR RES, V46, P555, DOI 10.1016/j.jpsychires.2012.01.012; George M, 2012, J NEUROPSYCH CLIN N, V24, pE3, DOI 10.1176/appi.neuropsych.11060144; Gex-Fabry M, 2004, EUR J CLIN PHARMACOL, V59, P883, DOI 10.1007/s00228-003-0710-3; Haddad PM, 2008, HUM PSYCHOPHARM CLIN, V23, P1, DOI 10.1002/hup.919; Hedenmalm K, 2006, J CLIN PSYCHOPHARM, V26, P192, DOI 10.1097/01.jcp.0000203200.96205.34; Hermann M, 2008, EUR J CLIN PHARMACOL, V64, P483, DOI 10.1007/s00228-007-0453-7; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Hiemke C, 2008, EUR ARCH PSY CLIN N, V258, P21, DOI 10.1007/s00406-007-1005-y; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; HOLLIDAY SM, 1995, DRUGS, V49, P280, DOI 10.2165/00003495-199549020-00010; Huang XY, 2013, PHARMACOGENOMICS, V14, P1723, DOI 10.2217/pgs.13.151; Jeannesson E, 2007, FUND CLIN PHARMACOL, V21, P411, DOI 10.1111/j.1472-8206.2007.00507.x; Jelen AM, 2015, INT J MED SCI, V12, P974, DOI 10.7150/ijms.13119; Karlsson L, 2010, EUR NEUROPSYCHOPHARM, V20, P632, DOI 10.1016/j.euroneuro.2010.04.004; Kastelic M, 2010, PROG NEURO-PSYCHOPH, V34, P387, DOI 10.1016/j.pnpbp.2010.01.005; Kato M, 2008, PROG NEURO-PSYCHOPH, V32, P398, DOI 10.1016/j.pnpbp.2007.09.003; Kaya P, 2005, AM J HEMATOL, V80, P26, DOI 10.1002/ajh.20427; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lai CH, 2013, PSYCHIAT CLIN NEUROS, V67, P127, DOI 10.1111/pcn.12017; Lanni C, 2013, CELL MOL LIFE SCI, V70, P3327, DOI 10.1007/s00018-012-1237-5; Lin KM, 2011, PHARMACOGENET GENOM, V21, P163, DOI 10.1097/FPC.0b013e32833db216; Madhusoodanan S, 2010, ANN CLIN PSYCHIATRY, V22, P148; Mihaljevic PA, 2008, PROG NEUROPSYCHOPHAR, V32, P1439; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ng J, 2009, GEN HOSP PSYCHIAT, V31, P388, DOI 10.1016/j.genhosppsych.2008.10.001; Niitsu T, 2013, PROG NEURO-PSYCHOPH, V45, P183, DOI 10.1016/j.pnpbp.2013.05.011; O'Brien FE, 2012, BRIT J PHARMACOL, V165, P289, DOI 10.1111/j.1476-5381.2011.01557.x; Ozbey G, 2014, PHARMACOL REP, V66, P235, DOI 10.1016/j.pharep.2013.09.004; Pariante CM, 2004, STRESS, V7, P209, DOI 10.1080/10253890500069650; Parksepp M, 2016, NORD J PSYCHIAT, V70, P498, DOI 10.3109/08039488.2016.1164245; Perroud N, 2011, PHARMACOGENOMICS, V12, P365, DOI [10.2217/PGS.10.189, 10.2217/pgs.10.189]; Preskorn SH, 2014, J PSYCHIATR PRACT, V20, P133, DOI 10.1097/01.pra.0000445247.54048.68; Ray A, 2015, PHARMACOGENOMICS J, V15, P332, DOI 10.1038/tpj.2014.72; Reis M, 2002, THER DRUG MONIT, V24, P545, DOI 10.1097/00007691-200208000-00014                                                ; Reis M, 2009, THER DRUG MONIT, V31, P42, DOI 10.1097/FTD.0b013e31819114ea; Roberts R. L., 2002, Pharmacogenomics Journal, V2, P191, DOI 10.1038/sj.tpj.6500099; Sarginson JE, 2010, PHARMACOGENET GENOM, V20, P467, DOI 10.1097/FPC.0b013e32833b593a; Schatzberg AF, 2015, AM J PSYCHIAT, V172, P751, DOI 10.1176/appi.ajp.2015.14050680; Singh AB, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.115; Stamm TJ, 2014, PHARMACOPSYCHIATRY, V47, P174, DOI 10.1055/s-0034-1383565; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Trivedi MH, 2006, J CLIN PSYCHIAT, V67, P27; Uhr M, 2003, BIOL PSYCHIAT, V54, P840, DOI 10.1016/S0006-3223(03)00074-X; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Unterecker S, 2012, PHARMACOPSYCHIATRY, V45, P229, DOI 10.1055/s-0031-1301366; Unterecker S, 2014, THER DRUG MONIT, V36, P269, DOI 10.1097/FTD.0000000000000008; Veefkind AH, 2000, THER DRUG MONIT, V22, P202, DOI 10.1097/00007691-200004000-00011; Waade RB, 2014, EUR J CLIN PHARMACOL, V70, P933, DOI 10.1007/s00228-014-1696-8; Wolf SJ, 2011, PHARMACOGENOMICS J, V11, P315, DOI 10.1038/tpj.2011.16; Xie WW, 2015, NEUROPSYCH DIS TREAT, V11, P1967, DOI 10.2147/NDT.S87175	63	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0803-9488	1502-4725		NORD J PSYCHIAT	Nord. J. Psychiatr.	APR	2017	71	3					230	237		10.1080/08039488.2016.1268203				8	Psychiatry	Psychiatry	ES4JT	WOS:000399501200010	28079463				2018-01-05	
J	Srivastava, V; Underwood, JL; Zhao, S				Srivastava, Vibha; Underwood, Jamie L.; Zhao, Shan			Dual-targeting by CRISPR/Cas9 for precise excision of transgenes from rice genome	PLANT CELL TISSUE AND ORGAN CULTURE			English	Article						CRISPR/Cas9; gRNA; Multiplex gene editing; Marker excision; Rice transformation	HOMOLOGOUS RECOMBINATION; GENE INTEGRATION; PLANT GENOME; SYSTEM; ARABIDOPSIS; MULTIPLEX; RNA; TRANSFORMATION; GENERATION; ENDONUCLEASE	The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 nuclease (Cas9) system has emerged as the robust gene editing tool that functions through the double-stranded break repair process leading to targeted mutagenesis in higher genomes. CRISPR/Cas9 has been simplified to a two component system consisting of a single guide RNA (gRNA) that binds Cas9 to target genomic sites in sequence-dependent manner. This RNA-guided nuclease system has mostly been applied for inducing point mutations or short insertion-deletions at one or multiple loci. The present study addressed the utility of this system for excising marker genes from plant genomes, an application highly relevant for developing marker-free transgenic plants. A transgenic rice line expressing beta-glucuronidase (GUS) gene was transformed by Agrobacterium or gene gun with a construct expressing Cas9 and two gRNAs to target each end of 1.6 kb GUS gene. Molecular analysis of the transformed lines detected excision at low frequency in the callus lines, but at significantly higher frequency in plant lines, indicating robust efficiency of Cas9: gRNA in regenerated plants. Bi-allelic excisions were observed in plants derived from three independent events, allowing recovery of homozygous excision lines in the first generation (T-0). Notably, the excision in different plant lines was formed by precise cut and ligation of the two blunt ends without mutation at or around the excision site. Since the goal of marker-removal technologies is to precisely excise a defined piece of DNA without introducing mutations in the adjacent sequences, Cas9: gRNA system could be an effective tool for producing marker-free plants.	[Srivastava, Vibha; Underwood, Jamie L.; Zhao, Shan] Univ Arkansas, Dept Crop Soil & Environm Sci, 115 Plant Sci Bldg, Fayetteville, AR 72701 USA; [Srivastava, Vibha; Underwood, Jamie L.; Zhao, Shan] Univ Arkansas, Dept Hort, 115 Plant Sci Bldg, Fayetteville, AR 72701 USA	Srivastava, V (reprint author), Univ Arkansas, Dept Crop Soil & Environm Sci, 115 Plant Sci Bldg, Fayetteville, AR 72701 USA.; Srivastava, V (reprint author), Univ Arkansas, Dept Hort, 115 Plant Sci Bldg, Fayetteville, AR 72701 USA.	vibhas@uark.edu		Srivastava, Vibha/0000-0002-3031-6984	Arkansas Division of Agriculture	The vectors pRGEB32, pRGE32 and pGTR were donated by Yinong Yang and obtained from Addgene.com. This project is supported by the Arkansas Division of Agriculture.	Antunes MS, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-86; Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Chen KL, 2014, PLANT CELL REP, V33, P575, DOI 10.1007/s00299-013-1539-6; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Gao XH, 2016, PLANT PHYSIOL, V171, P1794, DOI 10.1104/pp.16.00663; Gidoni D, 2008, IN VITRO CELL DEV-PL, V44, P457, DOI 10.1007/s11627-008-9140-3; Gilbertson L, 2003, TRENDS BIOTECHNOL, V21, P550, DOI 10.1016/j.tibtech.2003.09.011; JEFFERSON RA, 1987, PLANT MOL BIOL REP, V5, P387; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khattri A, 2011, J BIOSCIENCES, V36, P37, DOI 10.1007/s12038-011-9010-8; Lemaux PG, 2008, ANNU REV PLANT BIOL, V59, P771, DOI 10.1146/annurev.arplant.58.032806.103840; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Luo KM, 2007, PLANT BIOTECHNOL J, V5, P263, DOI 10.1111/j.1467-7652.2006.00237.x; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nandy S, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0212-2; Nandy S, 2012, PLANT BIOTECHNOL J, V10, P904, DOI 10.1111/j.1467-7652.2012.00715.x; Nishimura A, 2006, NAT PROTOC, V1, P2796, DOI 10.1038/nprot.2006.469; Ordon J, 2017, PLANT J, V89, P155, DOI 10.1111/tpj.13319; Ow DW, 2002, PLANT MOL BIOL, V48, P183, DOI 10.1023/A:1013718106742; Petolino JF, 2010, PLANT MOL BIOL, V73, P617, DOI 10.1007/s11103-010-9641-4; Siebert R, 2002, PLANT CELL, V14, P1121, DOI 10.1105/tpc.001727; Srivastava V, 2011, HIST TECHNOLOGY DEV, P108, DOI DOI 10.2174/97816080524861110101; Srivastava V, 2016, PLANT BIOTECHNOL J, V14, P471, DOI 10.1111/pbi.12459; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Wang YJ, 2011, PLANT CELL REP, V30, P267, DOI 10.1007/s00299-010-0938-1; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Yau YY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-36; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	36	2	2	16	35	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6857	1573-5044		PLANT CELL TISS ORG	Plant Cell Tissue Organ Cult.	APR	2017	129	1					153	160		10.1007/s11240-016-1166-3				8	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	ES0YU	WOS:000399255900013					2018-01-05	
J	Blower, TR; Chai, R; Przybilski, R; Chindhy, S; Fang, XZ; Kidman, SE; Tan, H; Luisi, BF; Fineran, PC; Salmond, GPC				Blower, Tim R.; Chai, Ray; Przybilski, Rita; Chindhy, Shahzad; Fang, Xinzhe; Kidman, Samuel E.; Tan, Hui; Luisi, Ben F.; Fineran, Peter C.; Salmond, George P. C.			Evolution of Pectobacterium Bacteriophage Phi M1 To Escape Two Bifunctional Type III Toxin-Antitoxin and Abortive Infection Systems through Mutations in a Single Viral Gene	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article						type III toxin-antitoxin; Phi M1; Pectobacterium atrosepticum; abortive infection; bacteriophage-bacterium interaction	CAROTOVORA SUBSP ATROSEPTICA; ESCHERICHIA-COLI; CELL-DEATH; PSEUDOMONAS-AERUGINOSA; LACTOCOCCUS-LACTIS; PHAGE; MECHANISM; SEQUENCE; GENOME; DNA	Some bacteria, when infected by their viral parasites (bacteriophages), undergo a suicidal response that also terminates productive viral replication (abortive infection [Abi]). This response can be viewed as an altruistic act protecting the uninfected bacterial clonal population. Abortive infection can occur through the action of type III protein-RNA toxin-antitoxin (TA) systems, such as ToxIN(Pa) from the phytopathogen Pectobacterium atrosepticum. Rare spontaneous mutants evolved in the generalized transducing phage Phi M1, which escaped ToxIN(Pa)-mediated abortive infection in P. atrosepticum. Phi M1 is a member of the Podoviridae and a member of the "KMV-like" viruses, a subset of the T7 supergroup. Genomic sequencing of Phi M1 escape mutants revealed single-base changes which clustered in a single open reading frame. The "escape" gene product, M1-23, was highly toxic to the host bacterium when overexpressed, but mutations in M1-23 that enabled an escape phenotype caused M1-23 to be less toxic. M1-23 is encoded within the DNA metabolism modular section of the phage genome, and when it was overexpressed, it copurified with the host nucleotide excision repair protein UvrA. While the M1-23 protein interacted with UvrA in coimmunoprecipitation assays, a UvrA mutant strain still aborted Phi M1, suggesting that the interaction is not critical for the type III TA Abi activity. Additionally, Phi M1 escaped a heterologous type III TA system (TenpIN(Pl)) from Photorhabdus luminescens (reconstituted in P. atrosepticum) through mutations in the same protein, M1-23. The mechanistic action of M1-23 is currently unknown, but further analysis of this protein may provide insights into the mode of activation of both systems. IMPORTANCE Bacteriophages, the viral predators of bacteria, are the most abundant biological entities and are important factors in driving bacterial evolution. In order to survive infection by these viruses, bacteria have evolved numerous antiphage mechanisms. Many of the studies involved in understanding these interactions have led to the discovery of biotechnological and gene-editing tools, most notably restriction enzymes and more recently the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems. Abortive infection is another such antiphage mechanism that warrants further investigation. It is unique in that activation of the system leads to the premature death of the infected cells. As bacteria infected with the virus are destined to die, undergoing precocious suicide prevents the release of progeny phage and protects the rest of the bacterial population. This altruistic suicide can be caused by type III toxin-antitoxin systems, and understanding the activation mechanisms involved will provide deeper insight into the abortive infection process.	[Blower, Tim R.; Chai, Ray; Chindhy, Shahzad; Fang, Xinzhe; Kidman, Samuel E.; Tan, Hui; Luisi, Ben F.; Salmond, George P. C.] Univ Cambridge, Dept Biochem, Cambridge, England; [Przybilski, Rita; Fineran, Peter C.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Blower, Tim R.] Univ Durham, Dept Biosci, Durham, England	Salmond, GPC (reprint author), Univ Cambridge, Dept Biochem, Cambridge, England.	gpcs2@cam.ac.uk			Biotechnology and Biological Sciences Research Council, United Kingdom; Marsden Fund, Royal Society of New Zealand (RSNZ); Rutherford Discovery Fellowship (RSNZ); Wellcome Trust, United Kingdom	This research was funded by support from the Biotechnology and Biological Sciences Research Council, United Kingdom, to G.P.C.S., by a Marsden Fund, Royal Society of New Zealand (RSNZ) award to P.C.F. and G.P.C.S., and by a Rutherford Discovery Fellowship (RSNZ) to P.C.F. B.F.L. was supported by the Wellcome Trust, United Kingdom. Work carried out with P. atrosepticum was under DEFRA license no. 50864/197900/3.	Adriaenssens EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033227; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525; Bastias R, 2010, ENVIRON MICROBIOL, V12, P990, DOI [10.1111/j.1462-2920.2009.02143.x, 10.1111/j.1462-2920.2010.02143.x]; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Blower TR, 2009, J BACTERIOL, V191, P6029, DOI 10.1128/JB.00720-09; Blower TR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003023; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Brantl S, 2015, FEMS MICROBIOL REV, V39, P413, DOI 10.1093/femsre/fuv003; Cavanagh D, 2015, FOOD MICROBIOL, V47, P45, DOI 10.1016/j.fm.2014.11.001; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; CHANG ACY, 1978, J BACTERIOL, V134, P1141; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Chopin MC, 2005, CURR OPIN MICROBIOL, V8, P473, DOI 10.1016/j.mib.2005.06.006; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dy RL, 2014, ANNU REV VIROL, V1, P307, DOI 10.1146/annurev-virology-031413-085500; Dy RL, 2014, NUCLEIC ACIDS RES, V42, P4590, DOI 10.1093/nar/gkt1419; Fineran PC, 2005, MICROBIOL-SGM, V151, P3833, DOI 10.1099/mic.0.28251-0; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Georgiou T, 1998, P NATL ACAD SCI USA, V95, P2891, DOI 10.1073/pnas.95.6.2891                                                          ; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995                                                ; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hirata H., 2016, GENOME ANNOUNC, V4; Kalischuk M., 2015, GENOME ANNOUNC, V3; Lavigne R, 2003, VIROLOGY, V312, P49, DOI 10.1016/S0042-6822(03)00123-5; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Otsuka Y, 2012, MOL MICROBIOL, V83, P669, DOI 10.1111/j.1365-2958.2012.07975.x; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; PARMA DH, 1992, GENE DEV, V6, P497, DOI 10.1101/gad.6.3.497; Pecota DC, 1996, J BACTERIOL, V178, P2044, DOI 10.1128/jb.178.7.2044-2050.1996                                                 ; PENNER M, 1995, J MOL BIOL, V249, P857, DOI 10.1006/jmbi.1995.0343                                                          ; Petty NK, 2006, MICROBIOL-SGM, V152, P1701, DOI 10.1099/mic.028712-0; Poulter S., 2011, THESIS; Przybilski R, 2011, RNA BIOL, V8, P517, DOI 10.4161/rna.8.3.15190; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Ramsay JP, 2011, P NATL ACAD SCI USA, V108, P14932, DOI 10.1073/pnas.1109169108; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; Samson JE, 2013, J BACTERIOL, V195, P3947, DOI 10.1128/JB.00296-13; Samson JE, 2013, MOL MICROBIOL, V87, P756, DOI 10.1111/mmi.12129; Sberro H, 2013, MOL CELL, V50, P136, DOI 10.1016/j.molcel.2013.02.002; Short FL, 2013, P NATL ACAD SCI USA, V110, pE241, DOI 10.1073/pnas.1216039110; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Toth IK, 1997, MICROBIOL-UK, V143, P2433, DOI 10.1099/00221287-143-7-2433                                                     ; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Wagner EGH, 2012, RNA BIOL, V9, P1513, DOI 10.4161/rna.22578; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412	60	1	1	7	10	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2017	83	8							UNSP e03229	10.1128/AEM.03229-16				17	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	ER4LM	WOS:000398771200012		gold			2018-01-05	
J	Li, R; Gu, J; Heymach, JV; Shu, X; Zhao, LN; Han, BH; Ye, YQ; Roth, J; Wu, XF				Li, Rong; Gu, Jiang; Heymach, John V.; Shu, Xiang; Zhao, Lina; Han, Baohui; Ye, Yuanqing; Roth, Jack; Wu, Xifeng			Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy	CARCINOGENESIS			English	Article							FORTHCOMING 7TH EDITION; TNM CLASSIFICATION; STAGING PROJECT; REPAIR; POLYMORPHISMS; ASSOCIATIONS; PROPOSALS; REVISION; OXYGEN; TUMORS	Hypoxia is a hallmark of solid tumors and has been implicated in the development of advanced disease and poor clinical outcome. In this multi-stage study, we aimed to assess whether genetic variations in hypoxia pathway genes might affect overall survival (OS) in patients with advanced-stage non-small cell lung cancer (NSCLC). We genotyped 598 potentially functional and tagging single nucleotide polymorphisms (SNPs) in 42 genes of the hypoxia pathway in 602 advanced stage NSCLC patients who received platinum-based chemotherapy or chemoradiation (discovery phase). Significant SNPs were validated in an additional 278 advanced stage patients (validation phase). Cox proportional hazard regression analysis was used to evaluate the association of each SNP with OS. Results showed in chemotherapy only group the median survival time (MST) of NSCLC patients with RPA1: rs2270412 AA+GA genotype versus GG genotype was 10.5 versus 12.7 month [P = 0.004, hazard ratio (HR) = 1.42, 95% CI: 1.16-1.74, combined set]. The MST of patients with EXO1: rs9350 GA+AA genotype versus GG genotypes was 13.2 months versus 11.5 months (P = 0.009, HR = 0.70, 95% CI: 0.56-0.87, combined set). Patients harboring two unfavorable genotypes had a 2.02-fold increased risk of death (P = 3.16E-6) and chemoradiation would improve survival for them (HR = 0.75, 95% CI: 0.51-1.10, P = 0.27, combined set). The MST for patients with 0, 1, and 2 unfavorable genotypes was 13.2, 12.7 and 8.9 months, respectively (P = 0.0002, combined set). In summary, two variants in RPA1 and EXO1 were associated with poor survival in NSCLC patients treated by platinum-based chemotherapy. Adding radiotherapy could improve survival in patients harboring these risk genotypes.	[Li, Rong; Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai 200030, Peoples R China; [Li, Rong; Gu, Jiang; Shu, Xiang; Zhao, Lina; Ye, Yuanqing; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Zhao, Lina] Fourth Mil Med Univ, Xian 710032, Peoples R China; [Roth, Jack] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA	Wu, XF (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org			Cancer Prevention and Research Institute of Texas [RP1300502]; National Cancer Institute [P50 CA070907, R01 CA176568]; MD Anderson institutional support for the Center for Translational and Public Health Genomics, Duncan Family Institute for Cancer Prevention and Risk Assessment	This work was supported in part by grants from the Cancer Prevention and Research Institute of Texas (RP1300502) and National Cancer Institute (P50 CA070907 and R01 CA176568). Additional funding was provided by MD Anderson institutional support for the Center for Translational and Public Health Genomics, Duncan Family Institute for Cancer Prevention and Risk Assessment.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Athey VL, 2012, THORAX, V67, P412, DOI 10.1136/thoraxjnl-2011-200714; Desai A, 2014, STEM CELLS, V32, P582, DOI 10.1002/stem.1596; Dong XQ, 2009, J CLIN ONCOL, V27, P1592, DOI 10.1200/JCO.2008.20.1111; Ettinger DS, 2014, J NATL COMPR CANC NE, V12, P1738, DOI 10.6004/jnccn.2014.0176                                                         ; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hoxha M, 2014, GENE CHROMOSOME CANC, V53, P612, DOI 10.1002/gcc.22171; Kaustov L, 2006, CELL CYCLE, V5, P489, DOI 10.4161/cc.5.5.2489; Koi M, 2011, J OBSTET GYNAECOL RE, V37, P85, DOI 10.1111/j.1447-0756.2010.01377.x; Levidou G, 2011, BJU INT, V108, pE59, DOI 10.1111/j.1464-410X.2010.09828.x; Madan E, 2012, BIOCHEM J, V443, P811, DOI 10.1042/BJ20111627; Nalejska E, 2014, MOL DIAGN THER, V18, P273, DOI 10.1007/s40291-013-0077-9; Ortmann B, 2014, CELL MOL LIFE SCI, V71, P3569, DOI 10.1007/s00018-014-1645-9; Polo V, 2014, ANN ONCOL, V25, P1283, DOI 10.1093/annonc/mdt529; Rami-Porta R, 2007, J THORAC ONCOL, V2, P593, DOI 10.1097/JTO.0b013e31807a2f81                                                    ; Schaetzlein S, 2013, P NATL ACAD SCI USA, V110, pE2470, DOI 10.1073/pnas.1308512110; Nogueira GAS, 2015, INT J CANCER, V137, P810, DOI 10.1002/ijc.29435; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; VAUPEL P, 1989, CANCER RES, V49, P6449; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yu DH, 2013, CELL BIOCHEM BIOPHYS, V67, P175, DOI 10.1007/s12013-013-9530-y	26	2	2	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334	1460-2180		CARCINOGENESIS	Carcinogenesis	APR	2017	38	4					419	424		10.1093/carcin/bgx014				6	Oncology	Oncology	ER5KO	WOS:000398840800008	28186269				2018-01-05	
J	Oulhen, N; Swartz, SZ; Laird, J; Mascaro, A; Wessel, GM				Oulhen, Nathalie; Swartz, S. Zachary; Laird, Jessica; Mascaro, Alexandra; Wessel, Gary M.			Transient translational quiescence in primordial germ cells	DEVELOPMENT			English	Article						Metabolism; Primordial germ cells; Sea urchin; Translation	HUNCHBACK MESSENGER-RNA; SMALL MICROMERE LINEAGE; SEA-URCHIN EMBRYO; DROSOPHILA EMBRYOS; STEM-CELLS; PROTEIN EXPRESSION; SKELETAL-MUSCLE; NANOS FUNCTIONS; PUMILIO; FERTILIZATION	Stem cells in animals often exhibit a slow cell cycle and/or low transcriptional activity referred to as quiescence. Here, we report that the translational activity in the primordial germ cells (PGCs) of the sea urchin embryo (Strongylocentrotus purpuratus) is quiescent. We measured new protein synthesis with O-propargyl-puromycin and Lhomopropargylglycine Click-iT technologies, and determined that these cells synthesize protein at only 6% the level of their adjacent somatic cells. Knockdown of translation of the RNA-binding protein Nanos2 by morpholino antisense oligonucleotides, or knockout of the Nanos2 gene by CRISPR/Cas9 resulted in a significant, but partial, increase (47%) in general translation specifically in the PGCs. We found that the mRNA of the translation factor eEF1A is excluded from the PGCs in a Nanos2-dependent manner, a consequence of a Nanos/Pumilio response element (PRE) in its 3 ' UTR. In addition to eEF1A, the cytoplasmic pH of the PGCs appears to repress translation and simply increasing the pH also significantly restores translation selectively in the PGCs. We conclude that the PGCs of this sea urchin institute parallel pathways to quiesce translation thoroughly but transiently.	[Oulhen, Nathalie; Swartz, S. Zachary; Laird, Jessica; Mascaro, Alexandra; Wessel, Gary M.] Brown Univ, Dept Mol & Cell Biol & Biochem, 185 Meeting St, Providence, RI 02912 USA; [Swartz, S. Zachary] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Wessel, GM (reprint author), Brown Univ, Dept Mol & Cell Biol & Biochem, 185 Meeting St, Providence, RI 02912 USA.	gary_wessel@brown.edu		wessel, gary/0000-0002-1210-9279	National Institutes of Health [R01HD028152]	We gratefully acknowledge the National Institutes of Health (R01HD028152 to G.M.W.). Deposited in PMC for release after 12 months.	AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431; Boonsanay V, 2016, CELL STEM CELL, V18, P229, DOI 10.1016/j.stem.2015.11.002; BRANDHORST BP, 1976, DEV BIOL, V52, P310, DOI 10.1016/0012-1606(76)90248-7; Cheers MS, 2004, METHOD CELL BIOL, V74, P287; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cho PF, 2006, CURR BIOL, V16, P2035, DOI 10.1016/j.cub.2006.08.093; Cormier P, 2001, DEV BIOL, V232, P275, DOI 10.1006/dbio.2001.0206; DALBY B, 1993, EMBO J, V12, P1219; Davidson EH, 1976, GENE ACTIVITY EARLY; de-Leon SB, 2013, DEV BIOL, V374, P245, DOI 10.1016/j.ydbio.2012.11.013; EPEL D, 1967, P NATL ACAD SCI USA, V57, P899, DOI 10.1073/pnas.57.4.899                                                           ; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Goldstein J, 2012, CELL MOL LIFE SCI, V69, P2573, DOI 10.1007/s00018-012-0943-3; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.040147101; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0                                                                ; Juliano CE, 2006, DEV BIOL, V300, P406, DOI 10.1016/j.ydbio.2006.07.035; Juliano CE, 2010, DEV BIOL, V337, P220, DOI 10.1016/j.ydbio.2009.10.030; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; KARP GC, 1975, J EXP ZOOL, V194, P535, DOI 10.1002/jez.1401940310; Lai FF, 2012, DEVELOPMENT, V139, P1476, DOI 10.1242/dev.079608; Lai FF, 2011, MECH DEVELOP, V128, P153, DOI 10.1016/j.mod.2010.12.001; Lopez-Iglesias P, 2015, ANTIOXID REDOX SIGN, V22, P205, DOI 10.1089/ars.2014.5871; Merrick W. C. A. N. J., 2000, PROTEIN BIOSYNTHESIS; Morales J, 2006, DEV BIOL, V300, P293, DOI 10.1016/j.ydbio.2006.07.036; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4                                                    ; Nakamura-Ishizu A, 2014, DEVELOPMENT, V141, P4656, DOI 10.1242/dev.106575; Oulhen N, 2016, MOL REPROD DEV, V83, P1046, DOI 10.1002/mrd.22757; Oulhen N, 2013, DEV BIOL, V377, P275, DOI 10.1016/j.ydbio.2013.01.019; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Rezza A, 2014, CURR TOP DEV BIOL, V107, P333, DOI 10.1016/B978-0-12-416022-4.00012-3; Richmond CA, 2015, CELL REP, V13, P2403, DOI 10.1016/j.celrep.2015.11.035; Sato K, 2007, P NATL ACAD SCI USA, V104, P7455, DOI 10.1073/pnas.0610052104; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704                                                          ; Starck SR, 2004, CHEM BIOL, V11, P999, DOI 10.1016/j.chembiol.2004.05.011; Swartz SZ, 2014, DEVELOPMENT, V141, P3134, DOI 10.1242/dev.110395; TANAKA S, 1990, DEV GROWTH DIFFER, V32, P145; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039; Webb AE, 2013, CELL REP, V4, P477, DOI 10.1016/j.celrep.2013.06.035; Wessel GM, 2014, MOL REPROD DEV, V81, P679, DOI 10.1002/mrd.22223; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Williamson A, 1996, ANNU REV CELL DEV BI, V12, P365, DOI 10.1146/annurev.cellbio.12.1.365; Wreden C, 1997, DEVELOPMENT, V124, P3015; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297                                                                   	47	4	4	2	8	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	APR 1	2017	144	7					1201	1210		10.1242/dev.144170				10	Developmental Biology	Developmental Biology	EP8NJ	WOS:000397631800007	28235822	gold			2018-01-05	
J	Baud, A; Flint, J				Baud, Amelie; Flint, Jonathan			Identifying genes for neurobehavioural traits in rodents: progress and pitfalls	DISEASE MODELS & MECHANISMS			English	Review						Genetics of behaviour; Quantitative trait loci; Rodent resources	GENOME-WIDE ASSOCIATION; RECOMBINANT INBRED STRAINS; ADVANCED INTERCROSS LINES; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPONTANEOUSLY HYPERTENSIVE-RAT; COLLABORATIVE CROSS MICE; OUTBRED MOUSE-POPULATION; HETEROGENEOUS STOCK MICE; COMPLEX TRAITS; QUANTITATIVE TRAITS	Identifying genes and pathways that contribute to differences in neurobehavioural traits is a key goal in psychiatric research. Despite considerable success in identifying quantitative trait loci (QTLs) associated with behaviour in laboratory rodents, pinpointing the causal variants and genes is more challenging. For a long time, the main obstacle was the size of QTLs, which could encompass tens if not hundreds of genes. However, recent studies have exploited mouse and rat resources that allow mapping of phenotypes to narrow intervals, encompassing only a few genes. Here, we review these studies, showcase the rodent resources they have used and highlight the insights into neurobehavioural traits provided to date. We discuss what we see as the biggest challenge in the field-translating QTLs into biological knowledge by experimentally validating and functionally characterizing candidate genes-and propose that the CRISPR/Cas genome-editing system holds the key to overcoming this obstacle. Finally, we challenge traditional views on inbred versus outbred resources in the light of recent resource and technology developments.	[Baud, Amelie] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA	Baud, A (reprint author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England.; Flint, J (reprint author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA.	abaud@ebi.ac.uk; JFlint@mednet.ucla.edu		Flint, Jonathan/0000-0002-9427-4429; Baud, Amelie/0000-0003-2448-0283	Sir Henry Wellcome Fellowship from Wellcome Trust [105941/Z/14/Z]	A.B. is supported by a Sir Henry Wellcome Fellowship (105941/Z/14/Z) from The Wellcome Trust.	Allardyce J, 2007, SCHIZOPHRENIA BULL, V33, P863, DOI 10.1093/schbul/sbm051; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Barrangou R, 2014, SCIENCE, V344, P707, DOI 10.1126/science.1252964; Baud A., 2014, J NEUROSCI, V04, P216, DOI DOI 10.4236/WJNS.2014.43025; Baud A, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.11; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Becanovic K, 2006, J IMMUNOL, V176, P6055, DOI 10.4049/jimmunol.176.10.6055                                                    ; Bennett B, 2015, ALCOHOL CLIN EXP RES, V39, P611, DOI 10.1111/acer.12678; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Bielavska E, 2002, BEHAV GENET, V32, P51, DOI 10.1023/A:1014407928865; Bult CJ, 2016, NUCLEIC ACIDS RES, V44, pD840, DOI 10.1093/nar/gkv1211; Carhuatanta KAK, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00341; Casey BJ, 2013, NAT REV NEUROSCI, V14, P810, DOI 10.1038/nrn3621; Cheng RY, 2010, GENETICS, V185, P1033, DOI 10.1534/genetics.110.116863; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Chesler EJ, 2014, MAMM GENOME, V25, P3, DOI 10.1007/s00335-013-9492-9; Chitsazan A, 2016, PIGM CELL MELANOMA R, V29, P459, DOI 10.1111/pcmr.12487; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Conti LH, 2004, BEHAV GENET, V34, P93, DOI 10.1023/B:BEGE.0000009479.02183.1f; Cook MN, 2015, PHYSIOL GENOMICS, V47, P308, DOI 10.1152/physiolgenomics.00114.2014; Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013, NAT GENET, V45, P984, DOI DOI 10.1038/NG.2711; Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013, LANCET, V381, P1371, DOI DOI 10.1016/S0140-6736(12)62129-1; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; DARVASI A, 1995, GENETICS, V141, P1199; Davies RW, 2016, NAT GENET, V48, P965, DOI 10.1038/ng.3594; Demarest K, 2001, BEHAV GENET, V31, P79, DOI 10.1023/A:1010261909853; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581; Dickson PE, 2016, PSYCHOPHARMACOLOGY, V233, P701, DOI 10.1007/s00213-015-4147-z; Distler MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051235; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Dupuis J, 1999, GENETICS, V151, P373; Durrant C, 2011, GENOME RES, V21, P1239, DOI 10.1101/gr.118786.110; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Flint J, 2014, NEURON, V81, P484, DOI 10.1016/j.neuron.2014.01.027; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Flint J, 2011, METHODS, V53, P163, DOI 10.1016/j.ymeth.2010.07.007; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Flint J, 2008, NATURE, V456, P724, DOI 10.1038/nature07630; Foroud T, 2000, BEHAV GENET, V30, P131, DOI 10.1023/A:1001955205117; French JE, 2015, ENVIRON HEALTH PERSP, V123, P237, DOI 10.1289/ehp.1408202; Furlotte NA, 2012, GENETICS, V191, P959, DOI 10.1534/genetics.112.140277; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gatti DM, 2014, G3-GENES GENOM GENET, V4, P1623, DOI 10.1534/g3.114.013748; Gonzales NM, 2014, MAMM GENOME, V25, P271, DOI 10.1007/s00335-014-9523-1; Goodson M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002970; Graham JB, 2015, MBIO, V6, DOI 10.1128/mBio.00493-15; HANSEN C, 1984, ALCOHOL CLIN EXP RES, V8, P477, DOI 10.1111/j.1530-0277.1984.tb05706.x                                              ; Harenza JL, 2014, GENES BRAIN BEHAV, V13, P213, DOI 10.1111/gbb.12113; Hayman GT, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw034; Hermsen R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1594-1; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hitzemann R, 2009, PSYCHOPHARMACOLOGY, V203, P713, DOI 10.1007/s00213-008-1418-y; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-183X.2003.00050.x; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Iancu OD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-585; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jagodic M, 2004, J IMMUNOL, V173, P1366, DOI 10.4049/jimmunol.173.2.1366                                                     ; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Khisti RT, 2006, ALCOHOL, V40, P119, DOI 10.1016/j.alcohol.2006.12.003; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kirkpatrick SL, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00450; Krohn J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096450; Kumar V, 2013, SCIENCE, V342, P1508, DOI 10.1126/science.1245503; Legare ME, 2000, GENOME RES, V10, P42; Lencz T, 2014, MOL PSYCHIATR, V19, P168, DOI 10.1038/mp.2013.166; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lo CL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006178; Logan RW, 2013, GENES BRAIN BEHAV, V12, P424, DOI 10.1111/gbb.12029; Mao JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16247; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; MCCLEARN G. E., 1970, Contributions to behavior-genetic analysis., P3; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Moreno-Moral A, 2016, DIS MODEL MECH, V9, P1097, DOI 10.1242/dmm.026104; Morgan AP, 2015, MAMM GENOME, V26, P521, DOI 10.1007/s00335-015-9581-z; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mott R, 2013, ANNU REV GENOM HUM G, V14, P421, DOI 10.1146/annurev-genom-091212-153419; Mulligan MK, 2008, GENES BRAIN BEHAV, V7, P677, DOI 10.1111/j.1601-183X.2008.00405.x; Nicod J, 2016, NAT GENET, V48, P912, DOI 10.1038/ng.3595; Nivard MG, 2014, GENES BRAIN BEHAV, V13, P195, DOI 10.1111/gbb.12095; Noben-Trauth K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011459; Owen MJ, 2014, NEURON, V84, P564, DOI 10.1016/j.neuron.2014.10.028; Pandey AK, 2014, INT REV NEUROBIOL, V116, P195, DOI 10.1016/B978-0-12-801105-8.00008-4; Parker CC, 2012, GENES BRAIN BEHAV, V11, P52, DOI 10.1111/j.1601-183X.2011.00747.x; Parker CC, 2016, NAT GENET, V48, P919, DOI 10.1038/ng.3609; Parker Clarissa C., 2011, Frontiers in Genetics, V2, P32, DOI 10.3389/fgene.2011.00032; Parsons MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-476; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7                                                           ; Peirce JL, 1998, MAMM GENOME, V9, P942, DOI 10.1007/s003359900904; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Philip VM, 2011, GENOME RES, V21, P1223, DOI 10.1101/gr.113886.110; Pravenec M, 2004, PHYSIOL RES, V53, pS15; Printz MP, 2003, J APPL PHYSIOL, V94, P2510, DOI 10.1152/japplphysiol.00064.2003; Psychiatric GWAS Consortium Bipolar Disorder Working Group, 2011, NAT GENET, V43, P977, DOI DOI 10.1038/NG.943; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Putman AH, 2016, GENES BRAIN BEHAV, V15, P367, DOI 10.1111/gbb.12289; Rask-Andersen M, 2015, HUM GENET, V134, P1183, DOI 10.1007/s00439-015-1599-5; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Reddy SY, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0061-1; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schadt EE, 2003, NATURE, V422, P297, DOI [10.1038/nature01434, 10.1038/nature01482]; Sheng JR, 2005, GENETICS, V170, P283, DOI 10.1534/genetics.104.035261; Shimoyama M, 2015, NUCLEIC ACIDS RES, V43, pD743, DOI 10.1093/nar/gku1026; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Sittig LJ, 2016, NEURON, V91, P1253, DOI 10.1016/j.neuron.2016.08.013; Stuchlik A, 2012, EUR PSYCHIAT, V27; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Tabakoff B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-70; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Threadgill DW, 2011, ILAR J, V52, P24, DOI 10.1093/ilar.52.1.24                                                            ; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Vanderlinden LA, 2014, ALCOHOL CLIN EXP RES, V38, P2148, DOI 10.1111/acer.12471; Voigt B, 2008, PHYSIOL GENOMICS, V32, P335, DOI 10.1152/physiolgenomics.00158.2007; Organization WH, 2004, INT STAT CLASS DIS R; Williams EG, 2015, CELL, V162, P23, DOI 10.1016/j.cell.2015.06.024; Williams R., 2016, METHODS MOL BIOL, V1488; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yalcin B, 2012, MAMM GENOME, V23, P719, DOI 10.1007/s00335-012-9409-z; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085; Ye R, 2014, GENES BRAIN BEHAV, V13, P247, DOI 10.1111/gbb.12092; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Young EE, 2016, GENES BRAIN BEHAV, V15, P604, DOI 10.1111/gbb.12302; Zhang-James Y, 2013, PHYSIOL GENOMICS, V45, P528, DOI 10.1152/physiolgenomics.00002.2013	135	0	0	3	5	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	APR 1	2017	10	4					373	383		10.1242/dmm.027789				11	Cell Biology; Pathology	Cell Biology; Pathology	ER6FA	WOS:000398899500004	28381599	gold			2018-01-05	
J	Turgeon, MO; Silander, TL; Doycheva, D; Liao, XH; Rigden, M; Ongaro, L; Zhou, X; Joustra, SD; Wit, JM; Wade, MG; Heuer, H; Refetoff, S; Bernard, DJ				Turgeon, Marc-Olivier; Silander, Tanya L.; Doycheva, Denica; Liao, Xiao-Hui; Rigden, Marc; Ongaro, Luisina; Zhou, Xiang; Joustra, Sjoerd D.; Wit, Jan M.; Wade, Mike G.; Heuer, Heike; Refetoff, Samuel; Bernard, Daniel J.			TRH Action Is Impaired in Pituitaries of Male IGSF1-Deficient Mice	ENDOCRINOLOGY			English	Article							THYROTROPIN-RELEASING-HORMONE; CONGENITAL CENTRAL HYPOTHYROIDISM; RECEPTOR 1-DEFICIENT MICE; OF-FUNCTION MUTATIONS; THYROID-HORMONE; MESSENGER-RNA; PARAVENTRICULAR NUCLEUS; DEFICIENCY SYNDROME; MEMBER 1; IN-VIVO	Loss-of-function mutations in the X-linked immunoglobulin superfamily, member 1 (IGSF1) gene cause central hypothyroidism. IGSF1 is a transmembrane glycoprotein of unknown function expressed in thyrotropin (TSH)-producing thyrotrope cells of the anterior pituitary gland. The protein is cotranslationally cleaved, with only its C-terminal domain (CTD) being trafficked to the plasma membrane. Most intragenic IGSF1 mutations in humans map to the CTD. In this study, we used CRISPR-Cas9 to introduce a loss-of-function mutation into the IGSF1-CTD in mice. The modified allele encodes a truncated protein that fails to traffic to the plasma membrane. Under standard laboratory conditions, Igsf1-deficient males exhibit normal serum TSH levels as well as normal numbers of TSH-expressing thyrotropes. However, pituitary expression of the TSH subunit genes and TSH protein content are reduced, as is expression of the receptor for thyrotropin-releasing hormone (TRH). When challenged with exogenous TRH, Igsf1-deficient males release TSH, but to a significantly lesser extent than do their wild-type littermates. The mice show similarly attenuated TSH secretion when rendered profoundly hypothyroid with a low iodine diet supplemented with propylthiouracil. Collectively, these results indicate that impairments in pituitary TRH receptor expression and/or downstream signaling underlie central hypothyroidism in IGSF1 deficiency syndrome.	[Turgeon, Marc-Olivier; Bernard, Daniel J.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Turgeon, Marc-Olivier; Silander, Tanya L.; Ongaro, Luisina; Zhou, Xiang; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, McIntyre Med Bldg, Montreal, PQ H3G 1Y6, Canada; [Silander, Tanya L.; Bernard, Daniel J.] McGill Univ, Integrated Program Neurosci, Montreal, PQ H3A 2B4, Canada; [Doycheva, Denica; Heuer, Heike] Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany; [Doycheva, Denica] Leiden Inst, Aging Fritz Lipmann Inst, D-07745 Jena, Germany; [Liao, Xiao-Hui; Refetoff, Samuel] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Refetoff, Samuel] Univ Chicago, Dept Pediat & Comm Genet, Chicago, IL 60637 USA; [Rigden, Marc; Wade, Mike G.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0K9, Canada; [Joustra, Sjoerd D.] Leiden Univ, Med Ctr, Dept Pediat, NL-2300 RC Leiden, Netherlands	Bernard, DJ (reprint author), McGill Univ, Dept Pharmacol & Therapeut, McIntyre Med Bldg, Montreal, PQ H3G 1Y6, Canada.; Bernard, DJ (reprint author), McGill Univ, Integrated Program Neurosci, Montreal, PQ H3A 2B4, Canada.	daniel.bernard@mcgill.ca			National Institutes of Health Grant [R37DK15070]; Canadian Institutes for Health Research Grant [MOP-133557]; Natural Sciences and Engineering Research Council Grants [2015-05178]; Canada Graduate Scholarships-Master's Program Natural Sciences and Engineering Research Council training grant; Reseau Quebecois en reproduction FONCER grant; Deutsche Forschungsgemeinschaft Grant [SPP1629/HE3418/8-1]	This work was supported by National Institutes of Health Grant R37DK15070 (to S.R.), Canadian Institutes for Health Research Grant MOP-133557 and Natural Sciences and Engineering Research Council Grants 2015-05178 (to D.J.B.), as well as by a Canada Graduate Scholarships-Master's Program Natural Sciences and Engineering Research Council training grant and Reseau Quebecois en reproduction FONCER grant (to M.O.T.). H.H. and D.D. were supported by Deutsche Forschungsgemeinschaft Grant SPP1629/HE3418/8-1.	Alatzoglou KS, 2009, EARLY HUM DEV, V85, P705, DOI 10.1016/j.earlhumdev.2009.08.057; Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Bernard DJ, 2003, MOL CELL BIOL, V23, P4882, DOI 10.1128/MCB.23.14.4882-4891.2003; Bochukova E, 2012, NEW ENGL J MED, V366, P243, DOI 10.1056/NEJMoa1110296; Castinetti F, 2016, EUR J ENDOCRINOL, V174, pR239, DOI 10.1530/EJE-15-1095; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COOKE PS, 1991, ENDOCRINOLOGY, V129, P237, DOI 10.1210/endo-129-1-237                                                          ; DEFRANCA LR, 1995, ANAT REC, V242, P57, DOI 10.1002/ar.1092420108                                                           ; Dzidic A, 2004, CROAT MED J, V45, P130; Fang Q, 2016, CLIN ENDOCRINOL, V85, P408, DOI 10.1111/cen.13067; Ferrara AM, 2013, ENDOCRINOLOGY, V154, P2533, DOI 10.1210/en.2012-2031; Frattini A, 1998, GENE, V214, P1, DOI 10.1016/S0378-1119(98)00253-4; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2015, NAT BIOTECHNOL, V33, P150, DOI 10.1038/nbt.3142; Galton VA, 2014, ENDOCRINOLOGY, V155, P4081, DOI 10.1210/en.2014-1184; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Gershengorn MC, 1996, PHYSIOL REV, V76, P175; Heinen CA, 2016, J CLIN ENDOCR METAB, V101, P4564, DOI 10.1210/jc.2016-2531; Heuer H, 2000, J COMP NEUROL, V428, P319; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Holsberger DR, 2005, BIOL REPROD, V73, P396, DOI 10.1095/biolreprod.105.041426; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hughes JN, 2016, CLIN ENDOCRINOL, V85, P609, DOI 10.1111/cen.13094; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joseph-Bravo P, 2015, J ENDOCRINOL, V227, pX3, DOI 10.1530/JOE-15-0124e; Joustra SD, 2016, J CLIN ENDOCR METAB, V101, P1627, DOI 10.1210/jc.2015-3880; Joustra SD, 2013, J CLIN ENDOCR METAB, V98, P4942, DOI 10.1210/jc.2013-2743; Joustra SD, 2015, J ENDOCRINOL, V226, P181, DOI 10.1530/JOE-15-0204; Joustra SD, 2015, EUR J PEDIATR, V174, P687, DOI 10.1007/s00431-014-2445-9; Joustra SD, 2013, RARE DIS, V1, DOI 10.4161/rdis.24883; Lania A, 2008, PITUITARY, V11, P181, DOI 10.1007/s11102-008-0122-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzarella R, 1998, GENOMICS, V48, P157, DOI 10.1006/geno.1997.5156                                                          ; Nakamura A, 2013, J CLIN ENDOCR METAB, V98, pE1682, DOI 10.1210/jc.2013-1224; Nishigaki S, 2016, THYROID, V26, P1701, DOI 10.1089/thy.2016.0005; O'Geen H, 2015, CURR OPIN CHEM BIOL, V29, P72, DOI 10.1016/j.cbpa.2015.10.001; ORON Y, 1987, SCIENCE, V238, P1406, DOI 10.1126/science.2825350; Persani L, 2012, J CLIN ENDOCR METAB, V97, P3068, DOI 10.1210/jc.2012-1616; Pohlenz J, 1999, THYROID, V9, P1265, DOI 10.1089/thy.1999.9.1265                                                         ; Rabeler R, 2004, MOL ENDOCRINOL, V18, P1450, DOI 10.1210/me.2004-0017; Rakover YT, 2016, THYROID, V26, P1693; Robakis T, 2008, J BIOL CHEM, V283, P36369, DOI 10.1074/jbc.M807527200; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Sotelo-Rivera I, 2014, J NEUROENDOCRINOL, V26, P861, DOI 10.1111/jne.12224; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun Y, 2012, NAT GENET, V44, P1375, DOI 10.1038/ng.2453; Tajima T, 2013, ENDOCR J, V60, P245, DOI 10.1507/endocrj.EJ13-0009                                                       ; Tenenbaum-Rakover Y, 2009, J CLIN ENDOCR METAB, V94, P1706, DOI 10.1210/jc.2008-1938; Van Hulle S, 2016, J CLIN RES PEDIATR E, V8, P86, DOI 10.4274/jcrpe.2512; Vella KR, 2014, MOL CELL BIOL, V34, P1564, DOI 10.1128/MCB.00129-14; YAMADA M, 1992, BIOCHEM BIOPH RES CO, V184, P367, DOI 10.1016/0006-291X(92)91202-2; Yamada M, 2008, NAT CLIN PRACT ENDOC, V4, P683, DOI 10.1038/ncpendmet0995; Zeng H, 2007, MOL ENDOCRINOL, V21, P2795, DOI 10.1210/me.2007-0048; ZOELLER RT, 1990, ENDOCRINOLOGY, V127, P2955, DOI 10.1210/endo-127-6-2955                                                         	57	3	3	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	APR	2017	158	4					815	830		10.1210/en.2016-1788				16	Endocrinology & Metabolism	Endocrinology & Metabolism	ER3SK	WOS:000398718200014	28324000	gold			2018-01-05	
J	Wenderoth, M; Pinecker, C; Voss, B; Fischer, R				Wenderoth, Maximilian; Pinecker, Christoph; Voss, Benjamin; Fischer, Reinhard			Establishment of CRISPR/Cas9 in Alternaria alternata	FUNGAL GENETICS AND BIOLOGY			English	Article						Alternaria; Knock-out; CRISPR; Uracil	GREEN FLUORESCENT PROTEIN; ASPERGILLUS-FUMIGATUS; MYCOTOXIN PRODUCTION; GENE-CLUSTER; FUNGAL; BIOLOGY; EXPRESSION; SYSTEM; TOXINS; CELLS	The filamentous fungus Alternaria alternata is a potent producer of many secondary metabolites, some of which like alternariol or alternariol-methyl ether are toxic and/or cancerogenic. Many Alternaria species do not only cause post-harvest losses of food and feed, but are aggressive plant pathogens. Despite the great economic importance and the large number of research groups working with the fungus, the molecular toolbox is rather underdeveloped. Gene deletions often result in heterokaryotic strains and therefore, gene-function analyses are rather tedious. In addition, A. alternata lacks a sexual cycle and classical genetic approaches cannot be combined with molecular biological methods. Here, we show that CRISPR/Cas9 can be efficiently used for gene inactivation. Two genes of the melanin biosynthesis pathway, pksA and brm2, were chosen as targets. Several white mutants were obtained after several rounds of strain purification through protoplast regeneration or spore inoculation. Mutation of the genes was due to deletions from 1 bp to 1.5 kbp. The CRISPR/Cas9 system was also used to inactivate the orotidine-5-phosphate decarboxylase gene pyrG to create a uracil-auxotrophic strain. The strain was counter-selected with fluor-orotic acid and could be re-transformed with pyrG from Aspergillus fumigates and pyr-4 from Neurospora crassa. In order to test the functioning of GFP, the fluorescent protein was fused to a nuclear localization signal derived from the StuA transcription factor of Aspergillus nidulans. After transformation bright nuclei were visible. (C) 2017 Elsevier Inc. All rights reserved.	[Wenderoth, Maximilian; Pinecker, Christoph; Voss, Benjamin; Fischer, Reinhard] Karlsruhe Inst Technol KIT South Campus, Inst Appl Biosci, Dept Microbiol, Fritz Haber Weg 4, D-76131 Karlsruhe, Germany	Fischer, R (reprint author), Karlsruhe Inst Technol KIT South Campus, Inst Appl Biosci, Dept Microbiol, Fritz Haber Weg 4, D-76131 Karlsruhe, Germany.	reinhard.fischer@KIT.edu			BMBF NANOKAT II [031A613B]	We thank Uffe Mortensen (DTU, Lyngby, Denmark) for providing us plasmids pFC332 and pFC334. This work was supported by BMBF NANOKAT II (No. 031A613B). We would like to thank Christopher Lawrence (Virginia Tech, Blacksburg, VA, USA) for access to the A. alternata sequence database.	Brase S, 2009, CHEM REV, V109, P3903, DOI 10.1021/cr050001f; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cho Y, 2015, EUKARYOT CELL, V14, P335, DOI 10.1128/EC.00226-14; Dang HX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1430-7; Estiarte N, 2016, INT J FOOD MICROBIOL, V238, P153, DOI 10.1016/j.ijfoodmicro.2016.09.003; Fetzner R, 2014, MICROBIOL-SGM, V160, P1845, DOI 10.1099/mic.0.079046-0; Fleck SC, 2016, MUTAT RES-GEN TOX EN, V798, P27, DOI 10.1016/j.mrgentox.2016.02.001; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kabak B, 2006, CRIT REV FOOD SCI, V46, P593, DOI 10.1080/10408390500436185; KIMURA N, 1993, J BACTERIOL, V175, P4427; Kitamoto N, 1998, APPL MICROBIOL BIOT, V50, P85, DOI 10.1007/s002530051260; Krappmann S, 2017, MED MYCOL, V55, P16, DOI 10.1093/mmy/myw097; Kuivanen J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0613-5; Lee HB, 2015, MYCOBIOLOGY, V43, P93, DOI 10.5941/MYCO.2015.43.2.93; Liu Q, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0693-9; Logrieco A, 2009, WORLD MYCOTOXIN J, V2, P129, DOI 10.3920/WMJ2009.1145; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Moretti A, 2017, METHODS MOL BIOL, V1542, P3, DOI 10.1007/978-1-4939-6707-0_1; Nielsen ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169712; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Pruss S, 2014, APPL ENVIRON MICROB, V80, P2582, DOI 10.1128/AEM.00327-14; Rodriguez-Carrasco Y., 2016, TOXINS, V8, pE328; Russel D. W., 1999, MOL CLONING LAB MANU; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; SHIOTANI H, 1995, MOL GEN GENET, V248, P142, DOI 10.1007/BF02190795; Suelmann R, 1997, MOL MICROBIOL, V25, P757, DOI 10.1046/j.1365-2958.1997.5131873.x; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Vejdovszky K, 2017, TOXICOL LETT, V267, P45, DOI 10.1016/j.toxlet.2016.12.011; Weber J, 2017, ACS SYNTH BIOL, V6, P62, DOI 10.1021/acssynbio.6b00203; Yamagishi D, 2006, MOL PLANT MICROBE IN, V19, P1280, DOI 10.1094/MPMI-19-1280; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007	34	3	4	22	33	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	APR	2017	101						55	60		10.1016/j.fgb.2017.03.001				6	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	ER4GJ	WOS:000398756800007	28286319				2018-01-05	
J	Ma, SY; Liu, Y; Liu, YY; Chang, JS; Zhang, T; Wang, XG; Shi, R; Lu, W; Xia, XJ; Zhao, P; Xia, QY				Ma, Sanyuan; Liu, Yue; Liu, Yuanyuan; Chang, Jiasong; Zhang, Tong; Wang, Xiaogang; Shi, Run; Lu, Wei; Xia, Xiaojuan; Zhao, Ping; Xia, Qingyou			An integrated CRISPR Bombyx mori genome editing system with improved efficiency and expanded target sites	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Genome editing; Cas9; Cpfl; Bombyx mori; Target site; Editing efficiency	WIDE SPECIFICITIES; HUMAN-CELLS; SILKWORM; CAS9; DNA; MUTAGENESIS; NUCLEASES; TALENS; CPF1; ENDONUCLEASE	Genome editing enabled unprecedented new opportunities for targeted genomic engineering of a wide variety of organisms ranging from microbes, plants, animals and even human embryos. The serial establishing and rapid applications of genome editing tools significantly accelerated Bombyx mori (B. mori) research during the past years. However, the only CRISPR system in B. mori was the commonly used SpCas9, which only recognize target sites containing NGG PAM sequence. In the present study, we first improve the efficiency of our previous established SpCas9 system by 3.5 folds. The improved high efficiency was also observed at several loci in both BmNs cells and B. mori embryos. Then to expand the target sites, we showed that two newly discovered CRISPR system, SaCas9 and AsCpf1, could also induce highly efficient site-specific genome editing in BmNs cells, and constructed an integrated CRISPR system. Genome-wide analysis of targetable sites was further conducted and showed that the integrated system cover 69,144,399 sites in B. mod genome, and one site could be found in every 6.5 bp. The efficiency and resolution of this CRISPR platform will probably accelerate both fundamental researches and applicable studies in B. mori, and perhaps other insects. (C) 2017 Elsevier Ltd. All rights reserved.	[Ma, Sanyuan; Liu, Yue; Liu, Yuanyuan; Chang, Jiasong; Zhang, Tong; Wang, Xiaogang; Shi, Run; Lu, Wei; Xia, Xiaojuan; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Ma, Sanyuan; Zhao, Ping; Xia, Qingyou] Southwest Univ, Chongqing Engn & Technol Res Ctr Novel Silk Mat, 2,Tiansheng Rd, Chongqing 400716, Peoples R China	Xia, QY (reprint author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.	xiaqy@swu.edu.cn		Xia, Qingyou/0000-0002-9263-2886	National Natural Science Foundation of China [31530071]; Chongqing Postdoctoral Science Foundation [Xm2015024]	This work was supported by grants from the National Natural Science Foundation of China (No. 31530071), and the Chongqing Postdoctoral Science Foundation (Xm2015024).	Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Chen L, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-24; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daimon T, 2015, P NATL ACAD SCI USA, V112, pE4226, DOI 10.1073/pnas.1506645112; Daimon T, 2014, DEV GROWTH DIFFER, V56, P14, DOI 10.1111/dgd.12096; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim H.K., 2016, NAT METHODS; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Liu YY, 2014, INSECT BIOCHEM MOLEC, V49, P35, DOI 10.1016/j.ibmb.2014.03.010; Ma SY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06867; Ma SY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04489; Ma SY, 2013, INSECT BIOCHEM MOLEC, V43, P1079, DOI 10.1016/j.ibmb.2013.08.009; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Onaga L, 2010, J HIST BIOL, V43, P215, DOI 10.1007/s10739-010-9222-z; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Radzisheuskaya Aliaksandra, 2016, Nucleic Acids Res, V44, pe141; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Takasu Y, 2016, INSECT BIOCHEM MOLEC, V78, P29, DOI 10.1016/j.ibmb.2016.08.006; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Wang YQ, 2014, INSECT BIOCHEM MOLEC, V55, P26, DOI 10.1016/j.ibmb.2014.10.003; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zeng BS, 2016, INSECT BIOCHEM MOLEC, V72, P31, DOI 10.1016/j.ibmb.2016.03.006; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep18103	35	0	0	8	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	APR	2017	83						13	20		10.1016/j.ibmb.2017.02.003				8	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	ES1AD	WOS:000399259400002	28189747				2018-01-05	
J	Katoh, Y; Michisaka, S; Nozaki, S; Funabashi, T; Hirano, T; Takei, R; Nakayama, K				Katoh, Yohei; Michisaka, Saki; Nozaki, Shohei; Funabashi, Teruki; Hirano, Tomoaki; Takei, Ryota; Nakayama, Kazuhisa			Practical method for targeted disruption of cilia-related genes by using CRISPR/Cas9-mediated, homology-independent knock-in system	MOLECULAR BIOLOGY OF THE CELL			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; STRAND-BREAK REPAIR; DNA-REPAIR; KIDNEY-DISEASE; HUMAN-CELLS; COMPLEX; CRISPR-CAS9; VIVO; INTEGRATION; TRAFFICKING	The CRISPR/Cas9 system has revolutionized genome editing in virtually all organisms. Although the CRISPR/Cas9 system enables the targeted cleavage of genomic DNA, its use for gene knock-in remains challenging because levels of homologous recombination activity vary among various cells. In contrast, the efficiency of homology-independent DNA repair is relatively high in most cell types. Therefore the use of a homology-independent repair mechanism is a possible alternative for efficient genome editing. Here we constructed a donor knock-in vector optimized for the CRISPR/Cas9 system and developed a practical system that enables efficient disruption of target genes by exploiting homology-independent repair. Using this practical knock-in system, we successfully disrupted genes encoding proteins involved in ciliary protein trafficking, including IFT88 and IFT20, in hTERT-RPE1 cells, which have low homologous recombination activity. The most critical concern using the CRISPR/Cas9 system is off-target cleavage. To reduce the off-target cleavage frequency and increase the versatility of our knock-in system, we constructed a universal donor vector and an expression vector containing Cas9 with enhanced specificity and tandem sgRNA expression cassettes. We demonstrated that the second version of our system has improved usability.	[Katoh, Yohei; Michisaka, Saki; Nozaki, Shohei; Funabashi, Teruki; Hirano, Tomoaki; Takei, Ryota; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Katoh, Y; Nakayama, K (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	ykatoh@pharm.kyoto-u.ac.jp; kazunaka@pharm.kyoto-u.ac.jp		Katoh, Yohei/0000-0003-1649-4917	Ministry of Education, Culture, Sports, Science and Technology, Japan [25113514, 15H01211]; Japan Society for the Promotion of Science [22390013, 15H04370, 25860044, 15K07929]; Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; JSPS Research Fellowship for Young Scientists	We thank Feng Zhang for providing pSpCas9(BB)-2A-Puro (PX459) and eSpCas9(1.1) and Helena Akiko Popiel for critical reading of the manuscript. This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas "Cilia and Centrosome" from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grants 25113514 and 15H01211 to K.N.); the Japan Society for the Promotion of Science (Grants 22390013 and 15H04370 to K.N. and 25860044 and 15K07929 to Y.K.); and grants from the Uehara Memorial Foundation and from the Astellas Foundation for Research on Metabolic Disorders to K.N. and from the Takeda Science Foundation to Y.K. S.N. was supported by the JSPS Research Fellowship for Young Scientists.	Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Dehairs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28973; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Funabashi T, 2017, MOL BIOL CELL, V28, P624, DOI 10.1091/mbc.E16-09-0648; Geisinger JM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1542; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Hirano T, 2017, MOL BIOL CELL, V28, P429, DOI 10.1091/mbc.E16-11-0813; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Katic I, 2015, G3-GENES GENOM GENET, V5, P1649, DOI 10.1534/g3.115.019273; Katoh Y, 2016, J BIOL CHEM, V291, P10962, DOI 10.1074/jbc.M116.713883; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lackner DH, 2015, NAT COMMUN, V6; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Madhivanan K, 2014, TRAFFIC, V15, P1031, DOI 10.1111/tra.12195; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Miyamoto T, 2015, CELL REP, V10, P664, DOI 10.1016/j.celrep.2015.01.003; Mladenov E, 2016, SEMIN CANCER BIOL, V37-38, P51, DOI 10.1016/j.semcancer.2016.03.003; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Motohashi K, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0162-8; Mourao A, 2016, CURR OPIN STRUC BIOL, V41, P98, DOI 10.1016/j.sbi.2016.06.009; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709                                                           ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakuma T., 2015, NAT PROTOC, V11, P118; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tanaka Y, 2016, MOL BIOL CELL, V27, P3883, DOI 10.1091/mbc.E16-08-0586; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589                                                            	41	4	4	1	5	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	APR 1	2017	28	7					898	906		10.1091/mbc.E17-01-0051				9	Cell Biology	Cell Biology	ER4WV	WOS:000398803600008	28179459	gold			2018-01-05	
J	Shakyawar, DK; Dayma, K; Ramadhas, A; Varalakshmi, C; Radha, V				Shakyawar, Dhruv Kumar; Dayma, Kunal; Ramadhas, Anesh; Varalakshmi, Chavvakula; Radha, Vegesna			C3G shows regulated nucleocytoplasmic exchange and represses histone modifications associated with euchromatin	MOLECULAR BIOLOGY OF THE CELL			English	Article							NUCLEOTIDE-RELEASING FACTOR; NUCLEAR EXPORT SIGNALS; CELL-CELL CONTACTS; ACTIN CYTOSKELETON; EPIGENETIC CHANGES; GENE-EXPRESSION; LEPTOMYCIN B; R-RAS; PROTEIN; DOMAIN	C3G (RapGEF1) is a ubiquitously expressed guanine nucleotide exchange factor that functions in signaling pathways regulating cell proliferation, apoptosis, and actin reorganization. It is essential for differentiation and early embryonic development in mice. Overexpressed C3G shows predominant cytoplasmic localization, but endogenous C3G is a component of nuclear fractions in a variety of cell types. Coexpression of importin-a and inhibition of nuclear export by leptomycin B resulted in predominant nuclear localization of C3G. Functional NLSs, NES, and GSK3-beta-dependent phosphorylation regulate its dynamic nuclear localization. C3G translocates to the nucleus in response to myogenic differentiation and sublethal dose of cisplatin. C3G is associated with chromatin and nuclear matrix fractions. Cells with C3G localized in the nucleus showed peripheralization of heterochromatin and reduced histone modifications associated with euchromatin. Short hairpin RNA-mediated depletion of C3G in epithelial cells resulted in reduced expression of CDK inhibitors and the histone demethylase KDM5A. Myoblast clones with CRISPR/Cas9-mediated knockout of C3G failed to show repression of histone marks and did not show up-regulation of myosin heavy chain and myotube formation when grown in differentiation medium. Our results document regulated nucleocytoplasmic exchange of C3G in response to physiological stimuli and provide insights into nuclear functions for C3G.	[Shakyawar, Dhruv Kumar; Dayma, Kunal; Ramadhas, Anesh; Varalakshmi, Chavvakula; Radha, Vegesna] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Radha, V (reprint author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	vradha@ccmb.res.in			Council of Scientific and Industrial Research, Government of India; Council of Scientific and Industrial Research, Government of India [BSC 0115, BSC 0108, BSC 0111]; Department of Science and Technology [SR/SO/BB/087/2012]; Department of Biotechnology, Government of India [BT/PR11759/BRB/10/1301/2014]	We thank S. Tanaka, M. Matsuda, P. J. S. Stork, Beric R. Henderson, Bert Vogelstein, and G. Swarup for gifts of valuable plasmids. D.K.S. acknowledges a fellowship from the Council of Scientific and Industrial Research, Government of India. This work was supported by funds from the Council of Scientific and Industrial Research, Government of India (BSC 0115, BSC 0108, and BSC 0111). Support was also received from the Department of Science and Technology (SR/SO/BB/087/2012) and the Department of Biotechnology, Government of India (BT/PR11759/BRB/10/1301/2014).	Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Banerjee R, 1999, J MED CHEM, V42, P4292, DOI 10.1021/jm9806446; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Dayma Kunal, 2012, Genes Cancer, V3, P564, DOI 10.1177/1947601912471189; Dayma K, 2011, BBA-MOL CELL RES, V1813, P456, DOI 10.1016/j.bbamcr.2011.01.004; Duque-Afonso J, 2011, ONCOGENE, V30, P3062, DOI 10.1038/onc.2011.32; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fernandez V, 2008, HAEMATOL-HEMATOL J, V93, P132, DOI 10.3324/haematol.11694; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5                                                   ; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Guerrero C, 1998, ONCOGENE, V16, P613, DOI 10.1038/sj.onc.1201569; Hahn M, 2010, J APPL PHYSIOL, V109, P232, DOI 10.1152/japplphysiol.00053.2010; Hall MN, 2011, CURR TOP DEV BIOL, V96, P273, DOI 10.1016/B978-0-12-385940-2.00010-3; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825                                                          ; Hirata T, 2004, J HUM GENET, V49, P290, DOI 10.1007/s10038-004-0148-1; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Horton P, 1997, Proc Int Conf Intell Syst Mol Biol, V5, P147; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376                                                        ; Jamieson C, 2011, TRAFFIC, V12, P983, DOI 10.1111/j.1600-0854.2011.01207.x; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Knight JD, 2011, SKELET MUSCLE, V1, P1; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kumar KS, 2015, BBA-MOL CELL RES, V1853, P2629, DOI 10.1016/j.bbamcr.2015.06.015; KURET J, 1986, FEBS LETT, V203, P197, DOI 10.1016/0014-5793(86)80741-4; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Londhe P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004633; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Martin-Encabo S, 2007, EXP CELL RES, V313, P3881, DOI 10.1016/j.yexcr.2007.07.036; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; McEwen Abbye E, 2012, Subcell Biochem, V60, P171, DOI 10.1007/978-94-007-4186-7_8; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Mitra A, 2010, ONCOGENE, V29, P4528, DOI 10.1038/onc.2010.113; Mitra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023681; Mochizuki N, 2000, J BIOL CHEM, V275, P12667, DOI 10.1074/jbc.275.17.12667; Moen PT, 2004, MOL BIOL CELL, V15, P197; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Okino K, 2006, INT J GYNECOL CANCER, V16, P763, DOI 10.1111/j.1525-1438.2006.00352.x; Otto AM, 1996, J CANCER RES CLIN, V122, P603, DOI 10.1007/BF01221192                                                              ; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Radha V, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-31; RADHA V, 1994, BIOCHEM J, V299, P41, DOI 10.1042/bj2990041                                                               ; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Radha V, 2011, BIOSCIENCE REP, V31, P231, DOI 10.1042/BSR20100094; Radha V, 2008, J NEUROCHEM, V107, P1424, DOI 10.1111/j.1471-4159.2008.05710.x; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Shivakrupa R, 2003, J BIOL CHEM, V278, P52188, DOI 10.1074/jbc.M310656200; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2                                                   ; Suarez-Sanchez R, 2014, BBA-MOL CELL RES, V1843, P985, DOI 10.1016/j.bbamcr.2014.01.027; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Utreras E, 2013, NEUROCHEM INT, V62, P848, DOI 10.1016/j.neuint.2013.02.011; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wend P, 2013, EMBO J, V32, P1977, DOI 10.1038/emboj.2013.127; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X                                                   ; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Zhu JH, 2001, ONCOGENE, V20, P4050, DOI 10.1038/sj.onc.1204516	68	0	0	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	APR 1	2017	28	7					984	995		10.1091/mbc.E16-09-0660				12	Cell Biology	Cell Biology	ER4WV	WOS:000398803600015	28148649	gold			2018-01-05	
J	Li, X; Gao, M; Choi, JM; Kim, BJ; Zhou, MT; Chen, Z; Jain, AN; Jung, SY; Yuan, JS; Wang, WQ; Wang, Y; Chen, JJ				Li, Xu; Gao, Min; Choi, Jong Min; Kim, Beom-Jun; Zhou, Mao-Tian; Chen, Zhen; Jain, Antrix N.; Jung, Sung Yun; Yuan, Jingsong; Wang, Wenqi; Wang, Yi; Chen, Junjie			Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-coupled Affinity Purification/Mass Spectrometry Analysis Revealed a Novel Role of Neurofibromin in mTOR Signaling	MOLECULAR & CELLULAR PROTEOMICS			English	Article							PROTEIN-INTERACTION NETWORK; MASS-SPECTROMETRY; HUMAN-CELLS; TUMOR-SUPPRESSOR; QUANTITATIVE PROTEOMICS; CAS9 RIBONUCLEOPROTEINS; HIPPO PATHWAY; NF1 GENE; COMPLEXES; IDENTIFICATION	Neurofibromin (NF1) is a well known tumor suppressor that is commonly mutated in cancer patients. It physically interacts with RAS and negatively regulates RAS GTPase activity. Despite the importance of NF1 in cancer, a high quality endogenous NF1 interactome has yet to be established. In this study, we combined clustered, regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated gene knock-out technology with affinity purification using antibodies against endogenous proteins, followed by mass spectrometry analysis, to sensitively and accurately detect NF1 protein-protein interactions in unaltered in vivo settings. Using this system, we analyzed endogenous NF1-associated protein complexes and identified 49 high-confidence candidate interaction proteins, including RAS and other functionally relevant proteins. Through functional validation, we found that NF1 negatively regulates mechanistic target of rapamycin signaling (mTOR) in a LAMTOR1-dependent manner. In addition, the cell growth and survival of NF1-deficient cells have become dependent on hyperactivation of the mTOR pathway, and the tumorigenic properties of these cells have become dependent on LAMTOR1. Taken together, our findings may provide novel insights into therapeutic approaches targeting NF1-deficient tumors.	[Li, Xu; Gao, Min; Zhou, Mao-Tian; Chen, Zhen; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Choi, Jong Min; Kim, Beom-Jun; Jain, Antrix N.; Jung, Sung Yun; Wang, Yi] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yuan, Jingsong] Columbia Univ, Dept Radiat Oncol, Ctr Radiol Res, New York, NY 10032 USA; [Wang, Wenqi] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	Chen, JJ (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.; Wang, Y (reprint author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Wang, WQ (reprint author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.	wenqiw6@uci.edu; yiw@bcm.edu; jchen8@mdanderson.org		Wang, Wenqi/0000-0003-4053-5088; Jung, Sung Yun/0000-0003-1521-7977	National Institutes of Health [CA016672]	We thank the Chen, Wang, and Qin laboratories for their advice and technical assistance and Markeda Wade and Ann Sutton for editing the manuscript. The University of Texas MD Anderson Cancer Center is supported by National Institutes of Health Core Grant CA016672.	Abbatiello SE, 2015, MOL CELL PROTEOMICS, V14, P2357, DOI 10.1074/mcp.M114.047050; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Braun P, 2006, NAT METHODS, V3, P975, DOI 10.1038/nmeth1206-975                                                           ; Brown KA, 2008, J CELL BIOCHEM, V105, P596, DOI 10.1002/jcb.21860; Cancer Genome Atlas Research Network, 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385; Cancer Genome Atlas Research Network, 2011, NATURE, V474, P609, DOI DOI 10.1038/NATURE10166; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conrotto P, 2007, J PROTEOME RES, V6, P287, DOI 10.1021/pr060427q; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dalvai M, 2015, CELL REP, V13, P621, DOI 10.1016/j.celrep.2015.09.009; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Farid M, 2014, ONCOLOGIST, V19, P193, DOI 10.1634/theoncologist.2013-0328; Feng LP, 2004, FEBS LETT, V557, P275, DOI 10.1016/S0014-5793(03)01507-2; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Glatter T, 2015, J PROTEOME RES, V14, P4472, DOI 10.1021/acs.jproteome.5b00654; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hauri S, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304750; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Keilhauer EC, 2015, MOL CELL PROTEOMICS, V14, P120, DOI 10.1074/mcp.M114.041012; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li X, 2015, MOL SYST BIOL, V11; Liu J, 2015, NAT PROTOC, V10, P1842, DOI 10.1038/nprot.2015.117; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Luo QL, 2006, MOL CELL PROTEOMICS, V5, P1245, DOI 10.1074/mcp.M600065-MCP200; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Matthiesen R, 2011, PROTEOMICS, V11, P604, DOI 10.1002/pmic.201000404; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291                                                           ; Nada S, 2014, METHOD ENZYMOL, V535, P249, DOI 10.1016/B978-0-12-397925-4.00015-8; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33; Ratner N, 2015, NAT REV CANCER, V15, P290, DOI 10.1038/nrc3911; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732                                                                   ; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Selbach M, 2006, NAT METHODS, V3, P981, DOI 10.1038/nmeth972; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soma-Nagae T, 2013, J CELL SCI, V126, P3575, DOI 10.1242/jcs.121913; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Yap YS, 2014, ONCOTARGET, V5, P5873, DOI 10.18632/oncotarget.2194                                                        ; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753                                                         	86	1	1	7	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	1535-9476	1535-9484		MOL CELL PROTEOMICS	Mol. Cell. Proteomics	APR	2017	16	4					594	607		10.1074/mcp.M116.064543				14	Biochemical Research Methods	Biochemistry & Molecular Biology	ER4ZU	WOS:000398811800007	28174230				2018-01-05	
J	Heidari, R; Shaw, DM; Elger, BS				Heidari, Raheleh; Shaw, David Martin; Elger, Bernice Simone			CRISPR and the Rebirth of Synthetic Biology	SCIENCE AND ENGINEERING ETHICS			English	Article						CRISPR; Synthetic biology; Genome engineering; Gene therapy; Bioethics; Society	IN-VIVO; GENE	Emergence of novel genome engineering technologies such as clustered regularly interspaced short palindromic repeat (CRISPR) has refocused attention on unresolved ethical complications of synthetic biology. Biosecurity concerns, deontological issues and human right aspects of genome editing have been the subject of in-depth debate; however, a lack of transparent regulatory guidelines, outdated governance codes, inefficient time-consuming clinical trial pathways and frequent misunderstanding of the scientific potential of cutting-edge technologies have created substantial obstacles to translational research in this area. While a precautionary principle should be applied at all stages of genome engineering research, the stigma of germline editing, synthesis of new life forms and unrealistic presentation of current technologies should not arrest the transition of new therapeutic, diagnostic or preventive tools from research to clinic. We provide a brief review on the present regulation of CRISPR and discuss the translational aspect of genome engineering research and patient autonomy with respect to the "right to try" potential novel non-germline gene therapies.	[Heidari, Raheleh; Shaw, David Martin; Elger, Bernice Simone] Univ Basel, Inst Biomed Eth, Bernoullistr 28, CH-4056 Basel, Switzerland	Elger, BS (reprint author), Univ Basel, Inst Biomed Eth, Bernoullistr 28, CH-4056 Basel, Switzerland.	raheleh.heidari@unibas.ch; david.shaw@unibas.ch; b.elger@unibas.ch	Elger, Bernice/V-7265-2017	Elger, Bernice/0000-0002-4249-7399	University of Basel; Swiss National Science Foundation [PDFMP3_137194/1]	This research project was funded by the University of Basel and the 'Swiss National Science Foundation' under project Grant No. PDFMP3_137194/1.	Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Collins F. S, 2015, COMMUNICATION; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dana GV, 2012, NATURE, V483, P29, DOI 10.1038/483029a; Department of health and human services NIH, 2013, REV NIH GUID RES INV; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; European Commission, 2015, SYNTH BIOL; European Commission, 2014, OP SYNTH BIOL; European Council, 1997, CONV PROT HUM RIGHTS; European Council, 2009, CONT US GEN MOD MICR; European Medicines Agency, 2006, CONC PAP DEV CHMP GU; Food and drug administration center for biologics evaluation and research, 1998, GUID IND GUID HUM SO; Folcher M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6392; Greely H., 2015, LAW BIOSCIENCES BLOG; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; International bioethics committee of UNESCO, 2015, REP IBC UPD ITS REFL; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; LoRusso PM, 2009, J CLIN ONCOL, V27, P2586, DOI 10.1200/JCO.2008.21.5798; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meissner TB, 2014, METHOD ENZYMOL, V546, P273, DOI 10.1016/B978-0-12-801185-0.00013-1; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Reardon S., 2015, LEUKAEMIA SUCCESS HE; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Sarewitz D, 2015, NATURE, V522, P412, DOI 10.1038/522413a; Shaw D, 2014, J ROY SOC MED, V107, P304, DOI 10.1177/0141076814538013; Shino Y., 1987, J BACTERIOL, V169, P5429; United Nations Educational Scientifi c and Cultural Organization (UNESCO), 1997, UN DECL HUM GEN HUM; US FDA, 2006, GUID IND INV REV EXP; Ye HF, 2014, FEBS LETT, V588, P2537, DOI 10.1016/j.febslet.2014.05.003	34	1	1	6	17	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1353-3452	1471-5546		SCI ENG ETHICS	Sci. Eng. Ethics	APR	2017	23	2					351	363		10.1007/s11948-016-9768-z				13	Ethics; Engineering, Multidisciplinary; History & Philosophy Of Science; Multidisciplinary Sciences; Philosophy	Social Sciences - Other Topics; Engineering; History & Philosophy of Science; Science & Technology - Other Topics; Philosophy	ER5OU	WOS:000398852200002	27325413				2018-01-05	
J	Kim, SJ; Kim, CH; An, B; Ha, KS; Hong, SH; Kim, KS				Kim, Su-Jin; Kim, Chang-Hoon; An, Borim; Ha, Kwon-Soo; Hong, Seok-Ho; Kim, Kye-Seong			Effects of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) protein 9 system-Based Deletion of miR-451 in Mouse Embryonic Stem Cells on Their Self-Renewal and Hematopoietic Differentiation	TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						CRISPR/Cas9; Pluripotent stem cells; MicroRNA; Hematopoiesis	ERYTHROID-DIFFERENTIATION; CRISPR/CAS9 SYSTEM; EXPRESSION; MICE; ERYTHROPOIESIS; RECOMBINATION; CRISPR-CAS9; 14-3-3-ZETA; GENERATION; MIRNAS	Pluripotent stem cells (PSCs) are a useful source of cells for exploring the role of genes related with early developmental processes and specific diseases due to their ability to differentiate into all somatic cell types. Recently, the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) protein 9 system has proven to be a robust tool for targeted genetic modification. Here, we generated miR-451-deficient PSCs using the CRISPR/Cas9 system with PCR-based homologous recombination donor and investigated the impact of its deletion on self-renewal and hematopoietic development. CRISPR/Cas9-mediated miR-451 knockout did not alter the gene expressions of pluripotency, cellular morphology, and cell cycle, but led to impaired erythrocyte development. These findings propose that a combination of PSCs and CRISPR/Cas9 system could be useful to promote biomedical applications of PSCs by elucidating the function and manipulating of specific miRNAs during lineage specification and commitment.	[Kim, Su-Jin; Kim, Chang-Hoon; Kim, Kye-Seong] Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Biomed Sci, 222 Wangsimni Ro, Seoul 04763, South Korea; [Kim, Kye-Seong] Hanyang Univ, Coll Med, Seoul, South Korea; [An, Borim; Hong, Seok-Ho] Kangwon Natl Univ, Sch Med, Dept Internal Med, Kangwondaehakgil 1, Chunchon 24341, Gangwon Do, South Korea; [Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, South Korea; [Hong, Seok-Ho] Kangwon Natl Univ, Stem Cell Inst, Chunchon 24341, South Korea	Kim, KS (reprint author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Biomed Sci, 222 Wangsimni Ro, Seoul 04763, South Korea.; Kim, KS (reprint author), Hanyang Univ, Coll Med, Seoul, South Korea.; Hong, SH (reprint author), Kangwon Natl Univ, Sch Med, Dept Internal Med, Kangwondaehakgil 1, Chunchon 24341, Gangwon Do, South Korea.; Hong, SH (reprint author), Kangwon Natl Univ, Stem Cell Inst, Chunchon 24341, South Korea.	shhong@kangwon.ac.kr; ks66kim@hanyang.ac.kr			Medical Research Center [2008-0062287]; Basic Research Lab Program - NRF of the Ministry of Science, ICT & Future Planning, Republic of Korea [2015R1A4A1038666]	This study was supported by a grant from the Medical Research Center (2008-0062287) and the Basic Research Lab Program (2015R1A4A1038666) funded by the NRF of the Ministry of Science, ICT & Future Planning, Republic of Korea.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Bhin J, 2015, MOL CELLS, V38, P895, DOI 10.14348/molcells.2015.0146; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Fennell M, 2014, J BIOMOL SCREEN, V19, P1327, DOI 10.1177/1087057114548414; Ghatak Souvik, 2013, J Biomol Tech, V24, P224, DOI 10.7171/jbt.13-2404-001; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Heo YT, 2015, STEM CELLS DEV, V24, P393, DOI 10.1089/scd.2014.0278; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang Ke, 2015, Cell Regen (Lond), V4, P4, DOI 10.1186/s13619-015-0018-7; Ireland RG, 2015, STEM CELLS, V33, P3187, DOI 10.1002/stem.2105; Jin HL, 2012, MOL CELLS, V34, P177, DOI 10.1007/s10059-012-0090-6; Kouhkan F, 2013, IRAN J BASIC MED SCI, V16, P756; Lee Young Jin, 2016, Cell Regen (Lond), V5, P2, DOI 10.1186/s13619-016-0028-0; Lesinski DA, 2012, STEM CELL TRANSL MED, V1, P581, DOI 10.5966/sctm.2012-0020; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Ma YN, 2015, EMBO J, V34, P361, DOI 10.15252/embj.201489957; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Renneville A, 2015, BLOOD, V126, P1930, DOI 10.1182/blood-2015-06-649087; Romito A, 2016, STEM CELLS INT, DOI 10.1155/2016/9451492; Ru Renli, 2013, Cell Regen (Lond), V2, P5, DOI 10.1186/2045-9769-2-5; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Tan EP, 2015, GENESIS, V53, P225, DOI 10.1002/dvg.22835; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yan Quanmei, 2014, Cell Regen (Lond), V3, P12, DOI 10.1186/2045-9769-3-12; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; Zhou HY, 2014, GENE DEV, V28, P2699, DOI 10.1101/gad.248526.114; Zhu SY, 2015, STEM CELLS DEV, V24, P1147, DOI 10.1089/scd.2014.0507	36	0	0	6	8	KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC	JONGRO-GU	199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA	1738-2696			TISSUE ENG REGEN MED	Tissue Eng. Regen. Med.	APR	2017	14	2					179	185		10.1007/s13770-017-0031-8				7	Cell & Tissue Engineering; Engineering, Biomedical	Cell Biology; Engineering	ER9QL	WOS:000399161300011					2018-01-05	
J	Serif, M; Lepetit, B; Weissert, K; Kroth, PG; Bartulos, CR				Serif, M.; Lepetit, B.; Weissert, K.; Kroth, P. G.; Bartulos, C. Rio			A fast and reliable strategy to generate TALEN-mediated gene knockouts in the diatom Phaeodactylum tricornutum	ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS			English	Article						Phaeodactylum tricornutum; TALEN; PtAUREO1a knockout; Blue light-dependent transcription factor	DOUBLE-STRAND BREAKS; DNA-CLEAVAGE; HOMOLOGOUS RECOMBINATION; NUCLEAR TRANSFORMATION; EFFECTOR NUCLEASES; HUMAN-CELLS; REVEALS; LIGHT; ELECTROPORATION; SPECIFICITY	Reverse genetics techniques are powerful tools for studying gene functions. In the model diatom Phaeodactylum tricornutum, RNAi-mediated knockdown of genes still is the most commonly used reverse genetics technique. Due to the diploidic life cycle missing reproduction in lab cultures, many commonly used techniques to create knockout instead of knockdown lines are not applicable in P. tricornutum. These limitations can be overcome by using genome editing approaches like TALEN (Transcription activator-like effector nucleases), and/or CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats), allowing the introduction of targeted mutagenesis events. Both techniques have recently been adapted exemplarily for diatoms, however, no concise guidelines exist yet for routine utilization of these tools and the subsequent characterization of the mutants. We therefore have adapted a cost-effective TALEN generation system previously established for mammalian cells for the use in P. tricornutum, allowing the assembly of TALENs in about twoweeks. We further provide protocols for: a) choosing a TALEN target site in order to avoid potentially ineffective and/ or off-target prone TALEN constructs, b) efficient transformation of P. tricornutum with both TALEN constructs, utilizing two antibiotics resistance markers, c) effective screening of the transformants. In order to test our system we chose the blue-light dependent transcription factor Aureochrome1a (PtAureo1a) as a target gene due to the known phenotype of previously characterized P. tricornutum RNAi knockdown strains. Our TALEN approach appears to be highly efficient: targeted mutation events were detected in 50% of all transformants obtained, whereas 21% of the transformants were found to be bi-allelic knockout lines. Furthermore, most TALEN transformed cell lines were found to be genetically homogeneous without the need for re-plating, which greatly facilitates the screening process. (C) 2017 Elsevier B. V. All rights reserved.	[Serif, M.; Lepetit, B.; Weissert, K.; Kroth, P. G.; Bartulos, C. Rio] Univ Konstanz, Fachbereich Biol, Plant Ecophysiol, D-78457 Constance, Germany	Bartulos, CR (reprint author), Univ Konstanz, Fachbereich Biol, Plant Ecophysiol, D-78457 Constance, Germany.	riobartulos@gmail.com			University of Konstanz; Graduate School Biological Sciences (GBS); EU FP7 Marie Curie Zukunftskolleg Incoming fellowship [291784]; Gordon and Betty Moore Foundation GBMF [4966]; DFG [KR 1661/8-2, LE 3358/3-1]	The authors are grateful to Doris Ballert for the help with the cultivation and transformation of P. tricornutum, Dr. Daniela Ewe for cloning of pPha-NR-Nat, as well as Simon Kienle and Florian Weeber for help in mutant screening. This work was supported by the University of Konstanz, the Graduate School Biological Sciences (GBS), the EU FP7 Marie Curie Zukunftskolleg Incoming fellowship (grant no. 291784, to BL), the Gordon and Betty Moore Foundation GBMF 4966 (grant DiaEdit to PGK) and the DFG (grants KR 1661/8-2 to PGK, LE 3358/3-1 to BL).	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Chu LL, 2016, PEERJ, V4, DOI 10.7717/peerj.2344; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; Schellenberger B. Costa, 2013, PLOS ONE; Daboussi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4831; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jakob T, 1999, PLANT BIOLOGY, V1, P76, DOI 10.1111/j.1438-8677.1999.tb00711.x; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191; Karas BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7925; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kroth Peter G., 2007, V390, P257; Krysiak C, 1999, PLANT CELL TISS ORG, V58, P163, DOI 10.1023/A:1006303331181; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavaud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036806; Lepetit B., 2016, NEW PHYTOL; Levitan O, 2015, P NATL ACAD SCI USA, V112, P412, DOI 10.1073/pnas.1419818112; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin YN, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1363; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Miyahara M, 2013, BIOSCI BIOTECH BIOCH, V77, P874, DOI 10.1271/bbb.120936; Moscou MJ, 2009, CHINESE J BIOCH MOL, V326, P1501, DOI DOI 10.1126/SCIENCE.1178817; Niu Y. F., 2012, BIOTECHNIQUES, V52, P1, DOI [10.2144/000113881, DOI 10.2144/000113881]; Nymark M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24951; OHSE M, 1995, BIOSCI BIOTECH BIOCH, V59, P1433, DOI 10.1271/bbb.59.1433                                                             ; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ragni M, 2004, J PLANKTON RES, V26, P433, DOI 10.1093/plankt/fbh044; Roesle P, 2014, ANGEW CHEM INT EDIT, V53, P6800, DOI 10.1002/anie.201403991; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Rottberger Julia, 2013, Algological Studies, V141, P37, DOI 10.1127/1864-1318/2013/0105; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Stella S., 2016, INSIDE CELL, V1, P7; Stork S, 2012, EUKARYOT CELL, V11, P1472, DOI 10.1128/EC.00183-12; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Weyman PD, 2015, PLANT BIOTECHNOL J, V13, P460, DOI 10.1111/pbi.12254; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yool A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002018; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; Zhang CY, 2014, MAR GENOM, V16, P63, DOI 10.1016/j.margen.2013.10.003; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	62	4	4	12	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2211-9264			ALGAL RES	Algal Res.	APR	2017	23						186	195		10.1016/j.algal.2017.02.005				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EP6BJ	WOS:000397462700021					2018-01-05	
J	Martinez-Montes, AM; Fernandez, A; Perez-Montarelo, D; Alves, E; Benitez, RM; Nunez, Y; Ovilo, C; Ibanez-Escriche, N; Folch, JM; Fernandez, AI				Martinez-Montes, A. M.; Fernandez, A.; Perez-Montarelo, D.; Alves, E.; Benitez, R. M.; Nunez, Y.; Ovilo, C.; Ibanez-Escriche, N.; Folch, J. M.; Fernandez, A. I.			Using RNA-Seq SNP data to reveal potential causal mutations related to pig production traits and RNA editing	ANIMAL GENETICS			English	Article						association; fatness; Iberian pig; premium cut yield; transcriptom	INSULIN-RESISTANCE; BODY-COMPOSITION; LANDRACE CROSS; MEAT QUALITY; GROWTH; CELL; IDENTIFICATION; FATNESS; GENES; FAT	RNA-Seq technology is widely used in quantitative gene expression studies and identification of non-annotated transcripts. However this technology also can be used for polymorphism detection and RNA editing in transcribed regions in an efficient and costeffective way. This study used SNP data from an RNA-Seq assay to identify genes and mutations underlying production trait variations in an experimental pig population. The hypothalamic and hepatic transcriptomes of nine extreme animals for growth and fatness from an (Iberian x Landrace) x Landrace backcross were analyzed by RNA-Seq methodology, and SNP calling was conducted. More than 125 000 single nucleotide variants (SNVs) were identified in each tissue, and 78% were considered to be potential SNPs, those SNVs segregating in the context of this study. Potential informative SNPs were detected by considering those showing a homozygous or heterozygous genotype in one extreme group and the alternative genotype in the other group. In this way, 4396 and 1862 informative SNPs were detected in hypothalamus and liver respectively. Out of the 32 SNPs selected for validation, 25 (80%) were confirmed as actual SNPs. Association analyses for growth, fatness and premium cut yields with 19 selected SNPs were carried out, and four potential causal genes (RETSAT, COPA, RNMT and PALMD) were identified. Interestingly, new RNA editing modifications were detected and validated for the NR3C1: g. 102797 (ss1985401074) and ACSM2B: g. 13374 (ss1985401075) positions and for the COG3: g3.4525 (ss1985401087) modification previously identified across vertebrates, which could lead to phenotypic variation and should be further investigated.	[Martinez-Montes, A. M.; Fernandez, A.; Perez-Montarelo, D.; Alves, E.; Benitez, R. M.; Nunez, Y.; Ovilo, C.; Fernandez, A. I.] Inst Nacl Tecnol Agr & Alimentaria, Mejora Genet Anim, Ctra Coruna Km 7-5, Madrid 28040, Spain; [Ibanez-Escriche, N.] Inst Recerca & Tecnol Agroalimentaries, Genet & Millora Anim, Lleida 25198, Spain; [Folch, J. M.] Ctr Recerca Agrigen CRAG, Genet Anim, Campus UAB, Bellaterra 08193, Spain; [Folch, J. M.] Univ Autonoma Barcelona, Ciencia Anim & Dels Aliments, Bellaterra 08193, Spain	Fernandez, AI (reprint author), Inst Nacl Tecnol Agr & Alimentaria, Mejora Genet Anim, Ctra Coruna Km 7-5, Madrid 28040, Spain.	avila@inia.es	Folch, Josep/I-4738-2015; Ibanez, Noelia/H-2988-2014	Folch, Josep/0000-0003-3689-1303; Ibanez, Noelia/0000-0002-6221-3576; Martinez Montes, Angel Mario/0000-0003-1461-4516	Ministerio de Ciencia e Innovacion (MICINN) [AGL2011-29821-C02]; Spanish Ministerio de Ciencia e Innovacion	This work was funded by Ministerio de Ciencia e Innovacion (MICINN) project AGL2011-29821-C02. AngelMartinez-Montes was funded by a (FPI) PhD grant from the Spanish Ministerio de Ciencia e Innovacion. We wish to thank Fabian Garcia and Anna Castello for technical assistance, Luis Silio for manuscript corrections and Beatriz Villanueva for comments, suggestions and English style corrections.	Altshuler D, 2000, NATURE, V407, P513; Aregger M, 2013, BIOCHEM J, V455, P67, DOI 10.1042/BJ20130378; Bai YS, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-8; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Casey JP, 2012, MOL GENET METAB, V106, P351, DOI 10.1016/j.ymgme.2012.04.017; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Dashzeveg N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.176; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Dirksen WP, 2003, J BIOL CHEM, V278, P9722, DOI 10.1074/jbc.M207969200; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Estelle J, 2006, ANIM GENET, V37, P589, DOI 10.1111/j.1365-2052.2006.01535.x; Fernandez A.I., 2014, 34 INT SOC AN GEN C; Fernandez AI, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-41; Ferraz ALJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-173; Fresard L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126776; Fujita H, 2015, EMBO J, V34, P1042, DOI 10.15252/embj.201489897; Galve A, 2012, LIVEST SCI, V145, P145, DOI 10.1016/j.livsci.2012.01.010; GREEVE J, 1993, J LIPID RES, V34, P1367; Harrington M, 2007, OBESITY, V15, P563, DOI 10.1038/oby.2007.562                                                            ; Holmes AP, 2013, BIOGERONTOLOGY, V14, P395, DOI 10.1007/s10522-013-9433-8; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Khan IM, 2015, INT J OBESITY, V39, P1607, DOI 10.1038/ijo.2015.104; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Koltes JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1635-9; Liu XF, 2003, J VIROL, V77, P2105, DOI 10.1128/JVI.77.3.2105-2115.2003; MAEKAWA T, 1989, J BIOL CHEM, V264, P2826; Marklund L, 1999, HEREDITY, V82, P134, DOI 10.1038/sj.hdy.6884630; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mercade A, 2005, MAMM GENOME, V16, P374, DOI 10.1007/s00335-004-2447-4; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Moise AR, 2010, FASEB J, V24, P1261, DOI 10.1096/fj.09-147207; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ovilo C, 2000, MAMM GENOME, V11, P344, DOI 10.1007/s003350010065; Ovilo C, 2002, GENET SEL EVOL, V34, P465, DOI 10.1051/gse:2002018; Ovilo C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-413; Ovilo C, 2010, MAMM GENOME, V21, P583, DOI 10.1007/s00335-010-9307-1; Pascall JC, 2004, BIOCHEM BIOPH RES CO, V317, P244, DOI 10.1016/j.bbrc.2004.03.039; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Perez-Montarelo D, 2015, J APPL GENET, V56, P525, DOI 10.1007/s13353-015-0284-7; Perez-Montarelo D, 2014, PHYSIOL GENOMICS, V46, P195, DOI 10.1152/physiolgenomics.00151.2013; Qiu HF, 2010, MOL BIOL REP, V37, P629, DOI 10.1007/s11033-009-9882-y; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Recalcati S, 2003, HEPATOLOGY, V38, P1159, DOI 10.1053/jhep.2003.50417; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Schattner P, 2006, NUCLEIC ACIDS RES, V34, P1700, DOI 10.1093/nar/gkl095; Schupp M, 2009, P NATL ACAD SCI USA, V106, P1105, DOI 10.1073/pnas.0812065106; Serra X, 1998, LIVEST PROD SCI, V56, P215, DOI 10.1016/S0301-6226(98)00151-1                                                   ; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Silva KM, 2011, ANIM GENET, V42, P280, DOI 10.1111/j.1365-2052.2010.02145.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swaab DF, 2001, HORM BEHAV, V40, P93, DOI 10.1006/hbeh.2001.1682; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; Tang ZL, 2014, INT J BIOL SCI, V10, P377, DOI 10.7150/ijbs.8015; Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Upasna Sharma, 2012, International Journal of Animal and Veterinary Advances, V4, P272; Varona L, 2002, GENET RES, V80, P145, DOI 10.1017/S0016672302005803; Veno MT, 2012, RNA BIOL, V9, P1054, DOI 10.4161/rna.21082; Wang ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141138; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weisz F, 2012, ANIM GENET, V43, P614, DOI 10.1111/j.1365-2052.2011.02295.x; Zhang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139514	70	2	2	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	APR	2017	48	2					151	165		10.1111/age.12507				15	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	EN5KZ	WOS:000396045600003	27642173				2018-01-05	
J	Niu, Y; Jin, M; Li, Y; Li, P; Zhou, J; Wang, X; Petersen, B; Huang, X; Kou, Q; Chen, Y				Niu, Y.; Jin, M.; Li, Y.; Li, P.; Zhou, J.; Wang, X.; Petersen, B.; Huang, X.; Kou, Q.; Chen, Y.			Biallelic beta-carotene oxygenase 2 knockout results in yellow fat in sheep via CRISPR/Cas9	ANIMAL GENETICS			English	Article						genetic engineering; genome editing; Ovis aries; phenotype; beta-carotene oxygenase 2	ADIPOSE-TISSUE; BCO2 GENE; METABOLISM; MUTATION; COLOR; MILK	The recently emerged CRISPR/Cas9 approach represents an efficient and versatile genome editing tool for producing genetically modified animals. B-carotene oxygenase 2 (BCO2) is a key enzyme in the progress of beta-carotene metabolism and is associated with yellow adipose tissue color in sheep. We have recently demonstrated targeted multiplex mutagenesis in sheep and have generated a group of BCO2-disrupted sheep by zygote injection of the CRISPR/Cas9 components. Here, we show that biallelic modification of BCO2 resulted in yellow fat, compared with the fat color in monoallelic individuals and wild types (snowflower white). We subsequently characterized the effects of gene modifications at genetic levels employing sequencing and Western blotting, highlighting the importance of the BCO2 gene for the determination of fat color in sheep. These results indicate that genetic modification via CRISPR/Cas9 holds great potential for validating gene functions as well as for generating desirable phenotypes for economically important traits in livestock.	[Niu, Y.; Jin, M.; Li, Y.; Li, P.; Wang, X.; Chen, Y.] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Zhou, J.; Huang, X.] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Petersen, B.] Friedrich Loeffler Inst, Inst Farm Anim Genet, D-31535 Neustadt, Germany; [Kou, Q.] Ningxia Tianyuan Sheep Farm, Hongsibu 751999, Peoples R China	Chen, Y (reprint author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.; Kou, Q (reprint author), Ningxia Tianyuan Sheep Farm, Hongsibu 751999, Peoples R China.	13995004618@163.com; chenyulin@nwafu.edu.cn			Tianyuan Tan Sheep Farm [TYRP201501]; National Natural Science Foundation of China [31372279, 31171377]; China Agriculture Research System [CARS-40-13]	This work is supported by the Tianyuan Tan Sheep Farm (TYRP201501), the National Natural Science Foundation of China (31372279, 31171377), as well as by China Agriculture Research System (CARS-40-13).	BAKER RL, 1985, ACTA AGR SCAND, V35, P389; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; CRANE B, 1975, NEW ZEAL J AGR RES, V18, P273, DOI 10.1080/00288233.1975.10423644                                                  ; Kirton A.H., 2012, NZ J AGR RES, V18, P267; Shete V, 2013, NUTRIENTS, V5, P4849, DOI 10.3390/nu5124849; Strychalski J, 2015, J APPL GENET, V56, P535, DOI 10.1007/s13353-015-0290-9; Tian R, 2010, ANIM GENET, V41, P253, DOI 10.1111/j.1365-2052.2009.01990.x; Vage DI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-10; von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32271	11	2	2	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	APR	2017	48	2					242	244		10.1111/age.12515				3	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	EN5KZ	WOS:000396045600015	27862083	gold			2018-01-05	
J	Yi, X; Tao, Y; Lin, X; Dai, Y; Yang, TL; Yue, XJ; Jiang, XJ; Li, XY; Jiang, DS; Andrade, KC; Chang, J				Yi, Xin; Tao, Ye; Lin, Xi; Dai, Yuan; Yang, Tingli; Yue, Xiaojing; Jiang, Xuejun; Li, Xiaoyan; Jiang, Ding-Sheng; Andrade, Kelsey C.; Chang, Jiang			Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Setd2; H3K36me3; C2C12 myoblasts; Proliferation and differentiation; Epigenetics	SERUM RESPONSE FACTOR; HOMOLOGOUS RECOMBINATION; H3K36 TRIMETHYLATION; BRANCHED EVOLUTION; MYOGENIC CELLS; GENE FAMILY; MUTATIONS; CHROMATIN; MUSCLE; CANCER	Skeletal muscle cell proliferation and differentiation are tightly regulated. Epigenetic regulation is a major component of the regulatory mechanism governing these processes. Histone modification is part of the epigenetic code used for transcriptional regulation of chromatin through the establishment of an active or repressive state for genes involved in myogenesis in a temporal manner. Here, we uncovered the function of SET domain containing 2 (Setd2), an essential histone 3 lysine 36 trimethyltransferase, in regulating the proliferation and differentiation of myoblasts. Setd2 was silenced in the skeletal muscle myoblast cell line, C2C12, using the CRISPR/CAS9 system. The mutant cells exhibited defect in myotube formation. The myotube formation marker, myosin heavy chain (MHC), was downregulated earlier in Setd2 silenced cells compared to wild-type myoblasts during differentiation. The deficiency in Setd2 also resulted in repression of Myogenin (MyoG) expression, a key myogenic regulator during differentiation. In addition to the myoblast differentiation defect, decreased proliferation rate with significantly reduced levels of histone 3 phosphorylation, indicative of cell proliferation defect, were observed in the Setd2 silenced cells; suggesting an impaired proliferation phenotype. Furthermore, compromised Gl/S- and G2/M-phase transition and decreased expression levels of major regulators of cell cycle Gl/S checkpoints, cyclin D1, CDK4, CDK6, and cyclin E2 were detected in Setd2 silenced cells. Consistent with the cell cycle arrested phenotype, cyclin-dependent kinase inhibitor p21 was upregulated in Setd2 silenced cells. Together, this study demonstrates an essential role of Setd2 in myoblast proliferation and differentiation, and uncovers Setd2-mediated molecular mechanism through regulating MyoG and p21. (C) 2017 Elsevier B.V. All rights reserved.	[Yi, Xin; Lin, Xi; Jiang, Xuejun; Li, Xiaoyan] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Hunan, Peoples R China; [Yi, Xin; Tao, Ye; Dai, Yuan; Yang, Tingli; Andrade, Kelsey C.; Chang, Jiang] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Yue, Xiaojing] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou 510515, Peoples R China; [Jiang, Ding-Sheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiothorac & Vasc Surg, Wuhan 430030, Peoples R China	Chang, J (reprint author), Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	jchang@ibt.tamhsc.edu			Fundamental Research Funds for the Central Universities [2042016kf0074]; National Natural Science Foundation of China [81601317]; Chinese Postdoctoral Fellowship [2015M580726]; American Heart Association Predoctoral Fellowship from Harry S. Moss Heart Trust [16PRE27260028]; American Heart Association [0855030F]; NIH-NHLBI [R01HL102314, R01HL123953]	This work is supported by the Fundamental Research Funds for the Central Universities 2042016kf0074 (X.Yi.), the National Natural Science Foundation of China 81601317, the Chinese Postdoctoral Fellowship 2015M580726 (X. Yue), American Heart Association Predoctoral Fellowship from Harry S. Moss Heart Trust 16PRE27260028 (T.Y.), American Heart Association Grant-in-Aid 0855030F, the NIH-NHLBI R01HL102314, and the NIH-NHLBI R01HL123953 (J.C.).	Ahn JW, 2014, GENOME MED, V6, DOI 10.1186/gm535; ALLIS CD, 1981, BIOCHEMISTRY-US, V20, P3828, DOI 10.1021/bi00516a025; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; BOOTSMA D, 1964, EXP CELL RES, V33, P301, DOI 10.1016/S0014-4827(64)81035-1                                                   ; BRAUN T, 1990, EMBO J, V9, P821; BRAUN T, 1989, EMBO J, V8, P701; Bueno R., 2016, NAT GENET; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Chang J, 2000, AM J PHYSIOL-REG I, V278, pR209; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Griffin M.J., 1976, IN VITRO, V12, P393; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Joseph CG, 2014, GENE CHROMOSOME CANC, V53, P15, DOI 10.1002/gcc.22114; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kovac M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7336; Langan TJ, 2011, METHODS MOL BIOL, V761, P75, DOI 10.1007/978-1-61779-182-6_5; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477                                                          ; Lee JJ, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0091-3; Li Q, 2010, AM J PHYSIOL-HEART C, V298, pH1340, DOI 10.1152/ajpheart.00592.2009; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lin X, 2012, MOL CELL BIOL, V32, P297, DOI 10.1128/MCB.05484-11; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753                                                            ; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Moreira AL, 2015, J THORAC ONCOL, V10, P373, DOI 10.1097/JTO.0000000000000397; Moresi V, 2015, WORLD J STEM CELLS, V7, P945, DOI 10.4252/wjsc.v7.i6.945; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050                                                          ; Sanidas I, 2014, MOL CELL, V53, P577, DOI 10.1016/j.molcel.2013.12.018; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Tan J, 2015, NAT GENET, V47, P1341, DOI 10.1038/ng.3409; THOMAS DB, 1975, CELL, V5, P37, DOI 10.1016/0092-8674(75)90089-6; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xie P, 2008, CELL SIGNAL, V20, P1671, DOI 10.1016/j.cellsig.2008.05.012; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; [Anonymous], 2013, NATURE, V499, P43	49	1	1	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	APR	2017	1864	4					697	707		10.1016/j.bbamcr.2017.01.012                                                    				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EP4PN	WOS:000397362500009	28130125				2018-01-05	
J	Buchko, GW; Clifton, MC; Wallace, EG; Atkins, KA; Myler, PJ				Buchko, Garry W.; Clifton, Matthew C.; Wallace, Ellen G.; Atkins, Kateri A.; Myler, Peter J.			Backbone chemical shift assignments and secondary structure analysis of the U1 protein from the Bas-Congo virus	BIOMOLECULAR NMR ASSIGNMENTS			English	Article						Viral hemorrhagic fever; Rhabdovirus; Drug design; Chemical shift index	NMR; SERVER	The Bas-Congo virus (BASV) is the first rhabdovirus associated with a human outbreak of acute hemorrhagic fever. The single-stranded, negative-sense RNA genome of BASV contains the five core genes present in all rhabdoviral genomes plus an additional three genes, annotated U1, U2, and U3, with weak (< 21%) sequence similarity only to a handful of genes observed in a few other rhabdoviral genomes. The function of the rhabdoviral U proteins is unknown, but, they are hypothesized to play a role in viral infection or replication. To better understand this unique family of proteins, a construct containing residues 27-203 of the 216-residue U1 protein (BASV-U1*) was prepared. By collecting data in 0.5 M urea it was possible to eliminate transient association enough to enable the assignment of most of the observable H-1(N), H-1 alpha, N-15, C-13 alpha, C-13 beta, and (13)CA ' chemical shifts for BASV-U1* that will provide a foundation to study its solution properties. The analyses of these chemical shifts along with N-15-edited NOESY data enabled the identification of the elements of secondary structure present in BASV-U1*.	[Buchko, Garry W.; Clifton, Matthew C.; Wallace, Ellen G.; Atkins, Kateri A.; Myler, Peter J.] Seattle Struct Genom Ctr Infect Dis, Seattle, WA USA; [Buchko, Garry W.] Pacific Northwest Natl Lab, Earth & Biol Sci Directorate, Richland, WA 99352 USA; [Clifton, Matthew C.; Wallace, Ellen G.; Atkins, Kateri A.] Beryllium, Bainbridge Isl, OR 97331 USA; [Myler, Peter J.] Ctr Infect Dis Res, 307 Westlake Ave N, Seattle, WA 98109 USA; [Myler, Peter J.] Univ Washington, Dept Global Hlth, Seattle, WA 98165 USA; [Myler, Peter J.] Univ Washington, Dept Biomed Informat & Hlth Educ, Seattle, WA 98195 USA; [Clifton, Matthew C.] Nurix Inc, San Francisco, CA 94158 USA	Buchko, GW (reprint author), Seattle Struct Genom Ctr Infect Dis, Seattle, WA USA.; Buchko, GW (reprint author), Pacific Northwest Natl Lab, Earth & Biol Sci Directorate, Richland, WA 99352 USA.	garry.buchko@pnnl.gov		Buchko, Garry/0000-0002-3639-1061	National Institute of Allergy and Infectious Diseases [HHSN2722001200025C]; U.S. Department of Energy's Office of Biological and Environmental Research (BER) program	This research was supported by the National Institute of Allergy and Infectious Diseases under Federal Contract No. HHSN2722001200025C. The SSGCID internal ID for the BASV-U1* protein construct is RhbaA.18619.a.D16, a community request from Dr. Charles Y. Chiu at the University of California in San Francisco. A large part of this research was performed at the W. R. Wiley Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility located at Pacific Northwest National Laboratory (PNNL) and sponsored by U.S. Department of Energy's Office of Biological and Environmental Research (BER) program. Battelle operates PNNL for the U.S. Department of Energy.	Borio L, 2002, JAMA-J AM MED ASSOC, V297, P2391; Buchko GW, 2016, BIOMOL NMR ASSIGN, V10, P57, DOI 10.1007/s12104-015-9637-8; Buchko GW, 2015, BIOMOL NMR ASSIGN, V9, P381, DOI 10.1007/s12104-015-9614-2; Chae YK, 2004, PROTEIN EXPRES PURIF, V34, P280, DOI 10.1016/j.pep.2003.11.007; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806                                                               ; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Gubala A, 2011, J GEN VIROL, V92, P2160, DOI 10.1099/vir.0.026120-0; Hafsa NE, 2015, NUCLEIC ACIDS RES, V43, pW370, DOI 10.1093/nar/gkv494; Kumin IV, 2009, INFECT GENET EVOL, V9, P541, DOI 10.1016/j.meegid.2009.02.005; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041; Stremlau MH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003631; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599	14	0	0	0	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1874-2718	1874-270X		BIOMOL NMR ASSIGN	Biomol. NMR Assign.	APR	2017	11	1					51	56		10.1007/s12104-016-9719-2				6	Biophysics; Spectroscopy	Biophysics; Spectroscopy	EN6SN	WOS:000396133800011	27981424				2018-01-05	
J	Croessmann, S; Wong, HY; Zabransky, DJ; Chu, D; Rosen, DM; Cidado, J; Cochran, RL; Dalton, WB; Erlanger, B; Cravero, K; Button, B; Kyker-Snowman, K; Hurley, PJ; Lauring, J; Park, BH				Croessmann, Sarah; Wong, Hong Yuen; Zabransky, Daniel J.; Chu, David; Rosen, D. Marc; Cidado, Justin; Cochran, Rory L.; Dalton, W. Brian; Erlanger, Bracha; Cravero, Karen; Button, Berry; Kyker-Snowman, Kelly; Hurley, Paula J.; Lauring, Josh; Park, Ben Ho			PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity	BREAST CANCER RESEARCH AND TREATMENT			English	Article						Breast cancer; TP53; PIK3CA; Tumor heterogeneity	INTRATUMOR HETEROGENEITY; CHROMOSOMAL INSTABILITY; EPITHELIAL-CELLS; BREAST-CANCER; P53; PATHWAYS; PROLIFERATION; ACTIVATION; EVOLUTION; SCREEN	The combined contributions of oncogenes and tumor suppressor genes toward carcinogenesis remain poorly understood. Elucidation of cancer gene cooperativity can provide new insights leading to more effective use of therapies. We used somatic cell genome editing to introduce singly and in combination PIK3CA mutations (E545K or H1047R) with TP53 alterations (R248W or knockout), to assess any enhanced cancerous phenotypes. The non-tumorigenic human breast epithelial cell line, MCF10A, was used as the parental cell line, and resultant cells were assessed via various in vitro assays, growth as xenografts, and drug sensitivity assays using targeted agents and chemotherapies. Compared to single-gene-targeted cells and parental controls, cells with both a PIK3CA mutation and TP53 alteration had increased cancerous phenotypes including cell proliferation, soft agar colony formation, aberrant morphology in acinar formation assays, and genomic heterogeneity. Cells also displayed varying sensitivities to anti-neoplastic drugs, although all cells with PIK3CA mutations showed a relative increased sensitivity to paclitaxel. All cell lines remained non-tumorigenic. This cell line panel provides a resource for further elucidating cooperative genetic mediators of carcinogenesis and response to therapies.	[Croessmann, Sarah; Wong, Hong Yuen; Zabransky, Daniel J.; Chu, David; Rosen, D. Marc; Cidado, Justin; Cochran, Rory L.; Dalton, W. Brian; Erlanger, Bracha; Cravero, Karen; Button, Berry; Kyker-Snowman, Kelly; Hurley, Paula J.; Lauring, Josh; Park, Ben Ho] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, 1650 Orleans St,Room 151, Baltimore, MD 21287 USA; [Park, Ben Ho] Johns Hopkins Univ, Whiting Sch Engn, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Cidado, Justin] AstraZeneca, Oncol iMED, 35 Gatehouse Dr, Waltham, MA 02451 USA	Park, BH (reprint author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, 1650 Orleans St,Room 151, Baltimore, MD 21287 USA.; Park, BH (reprint author), Johns Hopkins Univ, Whiting Sch Engn, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	bpark2@jhmi.edu			Avon Foundation; NIH [CA009071, GM007309, CA168180, CA167939, P30 CA006973]; Sandy Garcia Charitable Foundation; Commonwealth Foundation; Walsh Foundation; Santa Fe Foundation; Breast Cancer Research Foundation; Health Network Foundation; ME Foundation; Augustine Fellowship; Robin Page/Lebor Foundation	This work was supported by: The Avon Foundation (B.H.P., J.L.), and NIH CA009071 (K.C., B.H.P.), GM007309 (D.J.Z.), CA168180 (R.L.C.), CA167939 (S.C.). We would also like to thank and acknowledge the support of NIH P30 CA006973, the Sandy Garcia Charitable Foundation, the Commonwealth Foundation, The Walsh Foundation, the Santa Fe Foundation, the Breast Cancer Research Foundation, the Health Network Foundation, the ME Foundation, the Augustine Fellowship (W.B.D.), and The Robin Page/Lebor Foundation. None of the funding sources influenced the design, interpretation, or submission of this manuscript.	Abukhdeir AM, 2008, P NATL ACAD SCI USA, V105, P288, DOI 10.1073/pnas.0710887105; Beaver JA, 2013, CLIN CANCER RES, V19, P5413, DOI 10.1158/1078-0432.CCR-13-0884; Blair BG, 2015, PROTEOMICS, V15, P318, DOI 10.1002/pmic.201400342; Boyault S, 2012, BREAST CANCER RES TR, V132, P29, DOI 10.1007/s10549-011-1518-y; Bunz F, 2002, CANCER RES, V62, P1129; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122                                                             ; Cidado J, 2016, ONCOTARGET, V7, P6281, DOI 10.18632/oncotarget.7057; Cochran RL, 2015, ONCOTARGET, V6, P25240, DOI 10.18632/oncotarget.4595; Croessmann S, 2015, P NATL ACAD SCI USA, V112, P11583, DOI 10.1073/pnas.1503683112; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Hao YJ, 2013, CANCER CELL, V23, P583, DOI 10.1016/j.ccr.2013.03.021; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Konishi H, 2007, NAT PROTOC, V2, P2865, DOI 10.1038/nprot.2007.409; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Mohseni M, 2014, P NATL ACAD SCI USA, V111, P17606, DOI 10.1073/pnas.1408650111; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; SOULE HD, 1990, CANCER RES, V50, P6075; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang GM, 2013, CANCER RES, V73, P3248, DOI 10.1158/0008-5472.CAN-12-1578; Weiss MB, 2010, ONCOGENE, V29, P4715, DOI 10.1038/onc.2010.220; Wu XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5961; Zabransky DJ, 2015, P NATL ACAD SCI USA, V112, pE6205, DOI 10.1073/pnas.1516853112	26	0	0	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	APR	2017	162	3					451	464		10.1007/s10549-017-4147-2				14	Oncology	Oncology	EN2VD	WOS:000395867500006	28190247				2018-01-05	
J	Attie, AD; Churchill, GA; Nadeau, JH				Attie, Alan D.; Churchill, Gary A.; Nadeau, Joseph H.			How mice are indispensable for understanding obesity and diabetes genetics	CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY			English	Review						diabetes; metabolic disease; mouse genetics; obesity; systems biology	NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; GUT MICROBIOTA COMPOSITION; DIET-INDUCED OBESITY; COMPLEX TRAITS; INSULIN-RESISTANCE; METABOLIC SYNDROME; SYSTEMS GENETICS; GLUCOSE-INTOLERANCE; COLLABORATIVE CROSS; FOOD-INTAKE	Purpose of review The task of cataloging human genetic variation and its relation to disease is rapidly approaching completion. The new challenge is to discover the function of disease-associated genes and to understand the pathways that lead to human disease. We propose that achieving this new level of understanding will increasingly rely on the use of model organisms. We discuss the advantages of the mouse as a model organism to our understanding of human disease. Recent findings The collection of available mouse strains represents as much genetic and phenotypic variation as is found in the human population. However, unlike humans, mice can be subjected to experimental breeding protocols and the availability of tissues allows for a far greater and deeper level of phenotyping. New methods for gene editing make it relatively easy to create mouse models of known human mutations. The distinction between genetic and epigenetic inheritance can be studied in great detail. Various experimental protocols enable the exploration of the role of the microbiome in physiology and disease. Summary We propose that there will be an interdependence between human and model organism research. Technological advances and new genetic screening platforms in the mouse have greatly improved the path to gene discovery and mechanistic studies of gene function.	[Attie, Alan D.] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA; [Churchill, Gary A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Nadeau, Joseph H.] Pacific Northwest Res Inst, Seattle, WA USA	Attie, AD (reprint author), Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA.	adattie@wisc.edu			NIH [DK108259, DK101573, DK102948];  [RR12305]	Research in the Attie lab is supported by NIH grants DK108259, DK101573, and DK102948 and in the Nadeau lab by RR12305.	Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Argmann CA, 2016, CELL METAB, V23, P13, DOI 10.1016/j.cmet.2015.11.012; Atamni HJA, 2016, MAMM GENOME, V27, P565, DOI 10.1007/s00335-016-9658-3; Atamni HJ Abu-Toamih, 2016, MAMM GENOME; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Barbosa TD, 2016, MOL METAB, V5, P184, DOI 10.1016/j.molmet.2015.12.002; Bennett BJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005711; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Botzman M, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00048; Buchner DA, 2015, GENOME RES, V25, P775, DOI 10.1101/gr.187450.114; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chesler EJ, 2016, G3-GENES GENOM GENET, V6, P3893, DOI 10.1534/g3.116.035527; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; COLEMAN DL, 1974, DIABETOLOGIA, V10, P607, DOI 10.1007/BF01221993; Cropley JE, 2016, MOL METAB, V5, P699, DOI 10.1016/j.molmet.2016.06.008; Darvasi A, 1997, MAMM GENOME, V8, P163, DOI 10.1007/s003359900382; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; El Ouaamari A, 2016, CELL METAB, V23, P194, DOI 10.1016/j.cmet.2015.12.001; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Fujisaka S, 2016, J CLIN INVEST, V126, P4430, DOI 10.1172/JCI86674; Garcia-Gonzalez MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33087; Grandjean V, 2015, SCI REP-UK, V5, DOI 10.1038/srep18193; Harms DW, 2014, CURR PROTOC HUM GENE, V83, P11; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hidaka S, 2002, FASEB J, V16, P509, DOI 10.1096/fj.01-0164com; Hui ST, 2015, ELIFE, V4, DOI 10.7554/eLife.05607; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Huypens P, 2016, NAT GENET, V48, P497, DOI 10.1038/ng.3527; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073                                           ; INTERNATIONAL HAPMAP C, 2010, NATURE, V467, P52, DOI DOI 10.1038/NATURE09298; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kebede MA, 2014, J CLIN INVEST, V124, P4240, DOI 10.1172/JCI74072; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kluth O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005506; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lusis AJ, 2016, J LIPID RES, V57, P925, DOI 10.1194/jlr.R066944; McKnite AM, 2012, PLOS ONE, V7; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nadeau JH, 2011, SCIENCE, V331, P1015, DOI 10.1126/science.1203869; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Paigen K, 2003, GENETICS, V163, P1227; Parks BW, 2015, CELL METAB, V21, P334, DOI 10.1016/j.cmet.2015.01.002; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Rando OJ, 2016, COLD SPRING HARB PER, V6, P6; Schaefer S, 2015, Q REV BIOL, V90, P381, DOI 10.1086/683699                                                                  ; Scherneck S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000541; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Sinasac DS, 2016, INT J OBESITY, V40, P346, DOI 10.1038/ijo.2015.184; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5                                                    ; Ussar S, 2016, MOL METAB, V5, P795, DOI 10.1016/j.molmet.2016.07.004; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Visscher PM, 2016, GENETICS, V202, P377, DOI 10.1534/genetics.115.180513; Wang XS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10464; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Williams EG, 2016, SCIENCE, V352, DOI 10.1126/science.aad0189; Williams EG, 2015, CELL, V162, P23, DOI 10.1016/j.cell.2015.06.024; Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yazbek SN, 2010, HUM MOL GENET, V19, P4134, DOI 10.1093/hmg/ddq332; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	79	1	1	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1752-296X	1752-2978		CURR OPIN ENDOCRINOL	Curr. Opin. Endocrinol. Diabetes Obes.	APR	2017	24	2					83	91		10.1097/MED.0000000000000321				9	Endocrinology & Metabolism	Endocrinology & Metabolism	EN2KG	WOS:000395837800002	28107248				2018-01-05	
J	Veys, KR; Elmonem, MA; Arcolino, FO; van den Heuvel, L; Levtchenko, E				Veys, Koenraad R.; Elmonem, Mohamed A.; Arcolino, Fanny O.; van den Heuvel, Lambertus; Levtchenko, Elena			Nephropathic cystinosis: an update	CURRENT OPINION IN PEDIATRICS			English	Review						clinical presentation; cystinosis; gene therapy; pathogenesis	BONE-MARROW ASPIRATE; CYSTEAMINE THERAPY; INFANTILE CYSTINOSIS; LYSOSOMAL STORAGE; SWALLOWING DYSFUNCTION; RENAL-TRANSPLANTATION; HEREDITARY CYSTINOSIS; COGNITIVE PERFORMANCE; CONFOCAL MICROSCOPY; INCREASED APOPTOSIS	Purpose of review Over the past few decades, cystinosis, a rare lysosomal storage disorder, has evolved into a treatable metabolic disease. The increasing understanding of its pathophysiology has made cystinosis a prototype disease, delivering new insights into several fundamental biochemical and cellular processes. Recent findings In this review, we aim to provide an overview of the latest advances in the pathogenetic, clinical, and therapeutic aspects of cystinosis. Summary The development of alternative therapeutic monitoring strategies and new systemic and ocular cysteamine formulations might improve outcome of cystinosis patients in the near future. With the dawn of stem cell based therapy and new emerging gene-editing technologies, novel tools have become available in the search for a cure for cystinosis.	[Veys, Koenraad R.; Levtchenko, Elena] Univ Hosp Leuven, Dept Pediat Nephrol, Herestr 49, B-3000 Leuven, Belgium; [Veys, Koenraad R.; Elmonem, Mohamed A.; Arcolino, Fanny O.; van den Heuvel, Lambertus; Levtchenko, Elena] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Elmonem, Mohamed A.] Cairo Univ, Fac Med, Dept Clin & Chem Pathol, Cairo, Egypt; [van den Heuvel, Lambertus] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Nephrol, Nijmegen, Netherlands	Levtchenko, E (reprint author), Univ Hosp Leuven, Dept Pediat Nephrol, Herestr 49, B-3000 Leuven, Belgium.	elena.levtchenko@uzleuven.be		Elmonem, Mohamed/0000-0002-3154-1948	ERA-Net E-Rare2 project [JTC2014]; Research Foundation - Flanders (F.W.O. Vlaanderen) [1801110N, 11Y5216N, 12Q9917N]; Cystinosis Research Network	M.A.E. is supported by ERA-Net E-Rare2 project JTC2014: Novel therapies for cystinosis.; E.L. is supported by the Research Foundation - Flanders (F.W.O. Vlaanderen), grant 1801110N and the Cystinosis Research Network.; K.R.V. and F.O.A. are supported by the Research Foundation - Flanders (F.W.O. Vlaanderen), grant 11Y5216N and 12Q9917N, respectively.	Abderhalden E, 1903, Z PHYSL CHEM, V38, P557; Abdulsalam AH, 2013, AM J HEMATOL, V88, P151, DOI 10.1002/ajh.23316; Ahlenstiel-Grunow T, 2017, PEDIATR NEPHROL, V32, P91, DOI 10.1007/s00467-016-3438-x; Andrzejewska Z, 2015, TRAFFIC, V16, P712, DOI 10.1111/tra.12277; Anikster Y, 2001, CHEST, V119, P394, DOI 10.1378/chest.119.2.394; Ariceta G, 2016, NEFROLOGIA, V36, P616, DOI 10.1016/j.nefro.2016.05.012; Bacchetta J, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.55; Ballantyne AO, 2013, COGN BEHAV NEUROL, V26, P14, DOI 10.1097/WNN.0b013e31828b9f11; Bava S, 2010, CORTEX, V46, P206, DOI 10.1016/j.cortex.2009.03.008; Berryhill A, 2016, PEDIATR TRANSPLANT, V20, P141, DOI 10.1111/petr.12617; Besouw MTP, 2013, J PEDIATR-US, V163, P754, DOI 10.1016/j.jpeds.2013.03.078; Besouw MTP, 2012, PEDIATR NEPHROL, V27, P2123, DOI 10.1007/s00467-012-2213-x; Besouw MTP, 2011, J PEDIATR-US, V159, P1004, DOI 10.1016/j.jpeds.2011.05.057; Besouw MTP, 2010, FERTIL STERIL, V93, P1880, DOI 10.1016/j.fertnstert.2008.12.113; Brodin-Sartorius A, 2012, KIDNEY INT, V81, P179, DOI 10.1038/ki.2011.277; BROYER M, 1987, PEDIATR NEPHROL, V1, P519, DOI 10.1007/BF00849263                                                              ; Broyer M, 1981, Adv Nephrol Necker Hosp, V10, P137; Broyer M, 1996, J INHERIT METAB DIS, V19, P65, DOI 10.1007/BF01799350; Broyer M, 2000, NEPHROLOGIE, V21, P13; Buntinx L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35395; Chabli A, 2007, CLIN BIOCHEM, V40, P692, DOI 10.1016/j.clinbiochem.2007.02.005; CHAN AM, 1970, AM J MED, V48, P678, DOI 10.1016/S0002-9343(70)80002-X                                                   ; Cherqui S, 2001, J BIOL CHEM, V276, P13314, DOI 10.1074/jbc.M010562200; Chevronnay HPG, 2016, ENDOCRINOLOGY, V157, P1363, DOI 10.1210/en.2015-1762; Chevronnay HPG, 2015, ENDOCRINOLOGY, V156, P2349, DOI 10.1210/en.2014-1672; Chiaverini C, 2013, J AM ACAD DERMATOL, V68, pE111, DOI 10.1016/j.jaad.2011.08.010; CHIK CL, 1993, ANN INTERN MED, V119, P568, DOI 10.7326/0003-4819-119-7_Part_1-199310010-00004; Conforti A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0494-0; COOR C, 1991, J CLIN INVEST, V87, P955, DOI 10.1172/JCI115103                                                               ; Cornelis T, 2008, J GASTROEN HEPATOL, V23, pE428, DOI 10.1111/j.1440-1746.2008.05312.x; de Graaf-Hess A, 1999, CLIN CHEM, V45, P2224; Delgado G, 2005, DEV MED CHILD NEUROL, V47, P403, DOI 10.1017/S0012162205000782; Devuyst O, 2014, LANCET, V383, P1844, DOI 10.1016/S0140-6736(14)60659-0; Drogulu CF, 2004, J PEDIAT, V145, P673; Elmonem MA, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0426-y; Elmonem MA, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0155-z; Ercin C, 2015, APPL IMMUNOHISTO M M, V23, P740, DOI 10.1097/PAI.0000000000000037; FIVUSH B, 1988, J PEDIATR-US, V112, P49, DOI 10.1016/S0022-3476(88)80119-7; FIVUSH B, 1987, AM J DIS CHILD, V141, P1087, DOI 10.1001/archpedi.1987.04460100065027                                            ; GAHL WA, 1984, J PEDIATR-US, V104, P904, DOI 10.1016/S0022-3476(84)80494-1; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552                                                            ; GAHL WA, 1988, NEW ENGL J MED, V319, P1461, DOI 10.1056/NEJM198812013192206                                                     ; Galarreta CI, 2015, AM J PHYSIOL-RENAL, V308, pF1155, DOI 10.1152/ajprenal.00591.2014; Gertsman I, 2016, CLIN CHEM, V62, P766, DOI 10.1373/clinchem.2015.252494; Guillet G, 1998, LANCET, V352, P1444, DOI 10.1016/S0140-6736(05)61267-6; Harrison F, 2013, MOL THER, V21, P433, DOI 10.1038/mt.2012.214; Hippert C, 2008, MOL THER, V16, P1372, DOI 10.1038/mt.2008.126; Iglesias DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042840; Ivanova EA, 2016, J INHERIT METAB DIS, V39, P457, DOI 10.1007/s10545-016-9919-z; Ivanova EA, 2016, KIDNEY INT, V89, P1037, DOI 10.1016/j.kint.2016.01.013; Ivanova EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120998; KAISERKUPFER MI, 1986, ARCH OPHTHALMOL-CHIC, V104, P706; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Kiehntopf M, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9063; KIMONIS VE, 1995, J CLIN ENDOCR METAB, V80, P3257, DOI 10.1210/jc.80.11.3257                                                           ; KLENN PJ, 1994, MODERN PATHOL, V7, P879; Klusmann M, 2014, SKELETAL RADIOL, V43, P387, DOI 10.1007/s00256-013-1735-z; Labbe A, 2014, MOL GENET METAB, V111, P314, DOI 10.1016/j.ymgme.2013.12.298; Labbe A, 2009, OPHTHALMOLOGY, V116, P870, DOI 10.1016/j.ophtha.2008.11.021; Langman CB, 2016, KIDNEY INT, V89, P1192, DOI 10.1016/j.kint.2016.01.033; Laube GF, 2006, PEDIATR NEPHROL, V21, P503, DOI 10.1007/s00467-006-0005-x; Levtchenko E, 2005, NEPHROL DIAL TRANSPL, V20, P1828, DOI 10.1093/ndt/gfh932; Levtchenko E, 2003, CLIN NEPHROL, V60, P386; Lyou Yung, 2015, J Med Case Rep, V9, P205, DOI 10.1186/s13256-015-0691-8; Mannucci L, 2006, PEDIATR RES, V59, P332, DOI 10.1203/pdr.0000196370.57200.da; Marcano DC, 2016, MOL PHARMACEUT, V13, P3468, DOI 10.1021/acs.molpharmaceut.6b00488; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; McKenzie B, 2016, INT J PHARMACEUT, V515, P575, DOI 10.1016/j.ijpharm.2016.10.044; Monier L, 2015, BLOOD, V126, P1515, DOI 10.1182/blood-2015-07-656298; Naphade S, 2015, STEM CELLS, V33, P301, DOI 10.1002/stem.1835; Napolitano G, 2015, EMBO MOL MED, V7, P158, DOI 10.15252/emmm.201404223; Nesterova G, 1993, GENEREVIEWS R; Nesterova G, 2008, PEDIATR NEPHROL, V23, P863, DOI 10.1007/s00467-007-0650-8; NICHOLS SL, 1990, PEDIATR NEUROL, V6, P379, DOI 10.1016/0887-8994(90)90004-K                                                    ; Park MA, 2006, J AM SOC NEPHROL, V17, P3167, DOI 10.1681/ASN.2006050474; Patel R, 2010, J AM ACAD DERMATOL, V62, pAB26; Prencipe G, 2014, J AM SOC NEPHROL, V25, P1163, DOI 10.1681/ASN.2013060653; Raggi C, 2014, HUM MOL GENET, V23, P2266, DOI 10.1093/hmg/ddt617; Rao KI, 2015, J PEDIATR-US, V167, P1126, DOI 10.1016/j.jpeds.2015.07.038; Rega LR, 2016, KIDNEY INT, V89, P862, DOI 10.1016/j.kint.2015.12.045; Sansanwal P, 2010, J AM SOC NEPHROL, V21, P272, DOI 10.1681/ASN.2009040383; SCHNEIDE.JA, 1967, SCIENCE, V157, P1321, DOI 10.1126/science.157.3794.1321; Servais A, 2008, CLIN J AM SOC NEPHRO, V3, P27, DOI 10.2215/CJN.01740407; Shotelersuk V, 1998, AM J HUM GENET, V63, P1352, DOI 10.1086/302118; Sirrs S, 2014, JIMD REP, V13, P27, DOI 10.1007/8904_2013_256; Sonies BC, 2005, MEDICINE, V84, P137, DOI 10.1097/01.md.0000164204.00159.d4; SONIES BC, 1990, NEW ENGL J MED, V323, P565, DOI 10.1056/NEJM199008303230903                                                     ; STEINHERZ R, 1982, P NATL ACAD SCI-BIOL, V79, P4446, DOI 10.1073/pnas.79.14.4446; Stevens MS, 2016, JAMA DERMATOL, V152, P108, DOI 10.1001/jamadermatol.2015.2660; Syres K, 2009, BLOOD, V114, P2542, DOI 10.1182/blood-2009-03-213934; Taranta A, 2010, PEDIATR NEPHROL, V25, P1263, DOI 10.1007/s00467-010-1502-5; Thomas K, 2014, NAT REV UROL, V11, P270, DOI 10.1038/nrurol.2014.51; Touzot F, 2014, EXPERT OPIN BIOL TH, V14, P789, DOI 10.1517/14712598.2014.895811; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Trauner DA, 2001, PEDIATR NEUROL, V24, P365, DOI 10.1016/S0887-8994(01)00268-5                                                   ; Trauner DA, 2007, J PEDIATR-US, V151, P192, DOI 10.1016/j.jpeds.2007.02.062; Trauner DA, 2010, PEDIATR NEPHROL, V25, P2061, DOI 10.1007/s00467-010-1589-8; Tsilou ET, 2006, OPHTHALMOLOGY, V113, P1002, DOI 10.1016/j.ophtha.2005.12.026; Tsilou ET, 2002, CORNEA, V21, P173, DOI 10.1097/00003226-200203000-00009; Van Stralen KJ, 2011, CLIN J AM SOC NEPHRO, V6, P2485, DOI 10.2215/CJN.02000311; Vicari P, 2015, NEW ENGL J MED, V373, pE27, DOI 10.1056/NEJMicm1415736; Viltz L, 2013, J PEDIATR-US, V163, P489, DOI 10.1016/j.jpeds.2013.01.027; VOGEL DG, 1990, J NEUROPATH EXP NEUR, V49, P591, DOI 10.1097/00005072-199011000-00005; Wilmer MJ, 2008, AM J KIDNEY DIS, V51, P893, DOI 10.1053/j.ajkd.2008.03.010; Wilmer MJ, 2011, BBA-MOL BASIS DIS, V1812, P643, DOI 10.1016/j.bbadis.2011.02.010; Wilmer MJ, 2011, PEDIATR NEPHROL, V26, P205, DOI 10.1007/s00467-010-1627-6; Wilmer MJ, 2010, AM J PHYSIOL-RENAL, V299, pF905, DOI 10.1152/ajprenal.00318.2010; WINKLER L, 1993, EUR J PEDIATR, V152, P244, DOI 10.1007/BF01956154; Wollaston WH, 1810, PHILOS T ROY SOC LON, V100, P223; Zimakas PJA, 2003, PEDIATR NEPHROL, V18, P384, DOI 10.1007/s00467-003-1093-5	110	0	1	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-8703	1531-698X		CURR OPIN PEDIATR	CURR. OPIN. PEDIATR.	APR	2017	29	2					168	178		10.1097/MOP.0000000000000462				11	Pediatrics	Pediatrics	EN7YT	WOS:000396218800008	28107209				2018-01-05	
J	Demain, AL; Martens, E				Demain, Arnold L.; Martens, Evan			Production of valuable compounds by molds and yeasts	JOURNAL OF ANTIBIOTICS			English	Review							YARROWIA-LIPOLYTICA YEAST; SOLUBLE RED PIGMENTS; COENZYME-A REDUCTASE; CORN STEEP LIQUOR; SACCHAROMYCES-CEREVISIAE; ACID PRODUCTION; NATURAL-PRODUCTS; ETHANOL-PRODUCTION; ENDOPHYTIC FUNGUS; SECONDARY METABOLITES	We are pleased to dedicate this paper to Dr Julian E Davies. Julian is a giant among microbial biochemists. He began his professional career as an organic chemistry PhD student at Nottingham University, moved on to a postdoctoral fellowship at Columbia University, then became a lecturer at the University of Manchester, followed by a fellowship in microbial biochemistry at Harvard Medical School. In 1965, he studied genetics at the Pasteur Institute, and 2 years later joined the University of Wisconsin in the Department of Biochemistry. He later became part of Biogen as Research Director and then President. After Biogen, Julian became Chair of the Department of Microbiology at the University of British Columbia in Vancouver, Canada, where he has contributed in a major way to the reputation of this department for many years. He also served as an Adjunct Professor at the University of Geneva. Among Julian's areas of study and accomplishment are fungal toxins including a-sarcin, chemical synthesis of triterpenes, mode of action of streptomycin and other aminoglycoside antibiotics, biochemical mechanisms of antibiotic resistance in clinical isolates of bacteria harboring resistance plasmids, their origins and evolution, secondary metabolism of microorganisms, structure and function of bacterial ribosomes, antibiotic resistance mutations in yeast ribosomes, cloning of resistance genes from an antibiotic-producing microbe, gene cloning for industrial purposes, engineering of herbicide resistance in useful crops, bleomycin-resistance gene in clinical isolates of Staphylococcus aureus and many other topics. He has been an excellent teacher, lecturing in both English and French around the world, and has organized international courses. Julian has also served on the NIH study sections, as Editor for several international journals, and was one of the founders of the journal Plasmid. We expect the impact of Julian's accomplishments to continue into the future.	[Demain, Arnold L.] Drew Univ, Res Inst Scientists Emeriti RISE, 36 Madison Ave, Madison, NJ 07940 USA; [Martens, Evan] Cempra, Chapel Hill, NC USA	Demain, AL (reprint author), Drew Univ, Res Inst Scientists Emeriti RISE, 36 Madison Ave, Madison, NJ 07940 USA.	ademain@drew.edu					Adrio JL, 2003, INT MICROBIOL, V6, P191, DOI 10.1007/s10123-003-0133-0; Agbogbo FK, 2008, BIOTECHNOL LETT, V30, P1515, DOI 10.1007/s10529-008-9728-z; Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Alarcon J, 2003, Z NATURFORSCH C, V58, P62; ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Alsberg CL, 1913, USDA BUR PLANT IND B, V270; Amna T, 2006, CAN J MICROBIOL, V52, P189, DOI 10.1139/W05-122; Andersen MR, 2013, P NATL ACAD SCI USA, V110, pE99, DOI 10.1073/pnas.1205532110; ANDREWES AG, 1976, PHYTOCHEMISTRY, V15, P1003, DOI 10.1016/S0031-9422(00)84390-3                                                   ; Arnold DE, 2010, MOL CELL BIOCHEM, V345, P1, DOI 10.1007/s11010-010-0553-z; Bader T, 2008, AM J GASTROENTEROL, V103, P1383, DOI 10.1111/j.1572-0241.2008.01876.x; Balkovec JM, 2014, NAT PROD REP, V31, P15, DOI 10.1039/c3np70070d; Bentley R, 1997, PERSPECT BIOL MED, V40, P364; Bentley R, 2001, ADV APPL MICROBIOL, V48, P229, DOI 10.1016/S0065-2164(01)48005-1; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1                                                               ; Berdy J., 1995, P 9 INT S BIOL ACT 1; Berlec A, 2013, J IND MICROBIOL BIOT, V40, P257, DOI 10.1007/s10295-013-1235-0; Bernardes Nuno, 2010, Bioeng Bugs, V1, P178, DOI 10.4161/bbug.1.3.10903; BIRKINSHAW JH, 1952, BIOCHEM J, V50, P630, DOI 10.1042/bj0500630                                                               ; Blazeck J, 2013, J BIOTECHNOL, V165, P184, DOI 10.1016/j.jbiotec.2013.04.003; Borel JF, 2002, WIEN KLIN WOCHENSCHR, V114, P433; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; BROWN AG, 1976, J CHEM SOC PERK T 1, P1165, DOI 10.1039/p19760001165; Brown KS, 1996, SCIENTIST, V10, P8; Brown SH, 2013, APPL MICROBIOL BIOT, V97, P8903, DOI 10.1007/s00253-013-5132-2; Cardenas ME, 1998, TRENDS BIOTECHNOL, V16, P427, DOI 10.1016/S0167-7799(98)01239-6; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; Caspeta L, 2013, BIOTECHNOL J, V8, P534, DOI 10.1002/biot.201200345; Chen Y, 2015, ADV BIOCHEM ENG BIOT, V148, P143, DOI 10.1007/10_2014_284; Chong CR, 2006, J MED CHEM, V49, P2677, DOI 10.1021/jm051225t; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Colwell RR, 2002, BIOTECHNOL ADV, V20, P215, DOI 10.1016/S0734-9750(02)00011-3; de Albuquerque TL, 2014, PROCESS BIOCHEM, V49, P1779, DOI 10.1016/j.procbio.2014.07.010; de Wilde AH, 2011, J GEN VIROL, V92, P2542, DOI 10.1099/vir.0.034983-0; Demain A. L., 2004, HDB IND MYCOLOGY, P1; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Du Toit A, 2014, NAT REV MICROBIOL, V12, DOI 10.1038/nrmicro3314; [段丽丽 Duan Lili], 2008, [中国抗生素杂志, Chinese Journal of Antibiotics], V33, P650; ENDO A, 1979, J ANTIBIOT, V32, P852, DOI 10.7164/antibiotics.32.852                                                      ; ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346                                                     ; Endo A, 2010, P JPN ACAD B-PHYS, V86, P484, DOI 10.2183/pjab.86.484; Engel CAR, 2008, APPL MICROBIOL BIOT, V78, P379, DOI 10.1007/s00253-007-1341-x; Faus I, 2000, APPL MICROBIOL BIOT, V53, P145, DOI 10.1007/s002530050001; Feng YL, 2012, APPL MICROBIOL BIOT, V96, P1421, DOI 10.1007/s00253-012-4504-3; Fleck W., 1972, J BASIC MICROBIOLOGY, P244; Flores-Bustamante ZR, 2010, J ANTIBIOT, V63, P460, DOI 10.1038/ja.2010.83; Fonseca ACRG, 2009, J ALZHEIMERS DIS, V17, P503, DOI 10.3233/JAD-2009-1067; Fotie J., 2012, BIOACTIVE NATURAL PR, P223; Gangadevi V., 2008, MYCOL BALC, V5, P1; Gaudilliere B, 2001, ANNU REP MED CHEM, V36, P293, DOI 10.1016/S0065-7743(01)36068-2; George KW, 2015, ADV BIOCHEM ENG BIOT, V148, P355, DOI 10.1007/10_2014_288; Gorsich SW, 2006, APPL MICROBIOL BIOT, V71, P339, DOI 10.1007/s00253-005-0142-3; HALLBORN J, 1991, BIO-TECHNOL, V9, P1090, DOI 10.1038/nbt1191-1090; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hasslacher M, 1997, PROTEIN EXPRES PURIF, V11, P61, DOI 10.1006/prep.1997.0765; Hasunuma T, 2014, J BIOSCI BIOENG, V117, P165, DOI 10.1016/j.jbiosc.2013.07.007; Heider SAE, 2014, APPL MICROBIOL BIOT, V98, P4355, DOI 10.1007/s00253-014-5693-8; Hellmuth K., 2013, MICROBIAL PRODUCTION, P262; Hevekerl A, 2014, APPL MICROBIOL BIOT, V98, P10005, DOI 10.1007/s00253-014-6047-2; Hidy P H, 1977, Adv Appl Microbiol, V22, P59, DOI 10.1016/S0065-2164(08)70160-6; Holker U, 2004, APPL MICROBIOL BIOT, V64, P175, DOI 10.1007/s00253-003-1504-3; Jacobson G., 1999, Patent, Patent No. [6,015,684, 6015684]; Jefferys EG, 1970, ADVANCES APPLIED MIC, V13, P283, DOI DOI 10.1016/S0065-2164(08)70407-6; Jeong BY, 2015, J BIOSCI BIOENG, V119, P101, DOI 10.1016/j.jbiosc.2014.06.014; JOHNSON EA, 1980, AQUACULTURE, V20, P123, DOI 10.1016/0044-8486(80)90041-1; Johnson EA, 2013, APPL MICROBIOL BIOT, V97, P7563, DOI 10.1007/s00253-013-5046-z; Juzlova P, 1996, J IND MICROBIOL, V16, P163, DOI 10.1007/BF01569999; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kamzolova SV, 2013, APPL MICROBIOL BIOT, V97, P9133, DOI 10.1007/s00253-013-5182-5; Karaffa L, 2015, APPL MICROBIOL BIOT, V99, P7937, DOI 10.1007/s00253-015-6735-6; Keswani C, 2014, APPL MICROBIOL BIOT, V98, P533, DOI 10.1007/s00253-013-5344-5; Khan I, 2014, APPL MICROBIOL BIOT, V98, P1539, DOI 10.1007/s00253-013-5326-7; Kierek-Pearscon K, 2005, ADV APPL MICROBIOL, V57, P79, DOI 10.1016/S0065-2164(05)57003-5; Kim SJ, 2013, BIORESOURCE TECHNOL, V146, P274, DOI 10.1016/j.biortech.2013.07.081; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; Koivistoinen OM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-82; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kumaran RS, 2008, J BIOSCI BIOENG, V106, P103, DOI 10.1263/jbb.106.103; Kumaran RS, 2011, ENG LIFE SCI, V11, P264, DOI 10.1002/elsc.201000119; Kumaran RS, 2010, J BIOSCI BIOENG, V110, P541, DOI 10.1016/j.jbiosc.2010.06.007; Kumaran R.S., 2012, AFR J BIOTECHNOL, V11, P950; Lam FH, 2014, SCIENCE, V346, P71, DOI 10.1126/science.1257859; Ledesma-Amaro R., 2013, MICROBIAL PRODUCTION, P571; Lee BH, 2012, APPL MICROBIOL BIOT, V94, P1151, DOI 10.1007/s00253-012-4076-2; LEE WA, 1990, PHARMACEUT RES, V7, P161, DOI 10.1023/A:1015828802490; Li JY, 1996, MICROBIOL-UK, V142, P2223, DOI 10.1099/13500872-142-8-2223                                                     ; Li LL, 2013, BIOTECHNOL LETT, V35, P471, DOI 10.1007/s10529-012-1104-3; Li SB, 2016, CRIT REV BIOTECHNOL, V36, P1, DOI 10.3109/07388551.2013.811636; Lin H, 2013, BIOENGINEERED, V4, P292, DOI 10.4161/bioe.23114; LIN TF, 1994, ARCH MICROBIOL, V162, P114, DOI 10.1007/s002030050111; LIN TF, 1991, APPL MICROBIOL BIOT, V36, P70, DOI 10.1007/BF00164701; LIN TF, 1993, J IND MICROBIOL, V12, P361, DOI 10.1007/BF01569666; LIN TF, 1995, APPL MICROBIOL BIOT, V43, P701, DOI 10.1007/s002530050473; Liu KH, 2009, J IND MICROBIOL BIOT, V36, P1171, DOI 10.1007/s10295-009-0598-8; Liu LQ, 2013, CURR OPIN BIOTECH, V24, P1023, DOI 10.1016/j.copbio.2013.03.005; Liu L, 2013, BIOENGINEERED, V4, P212, DOI 10.4161/bioe.24761; Liu ZQ, 2011, MOL CELL BIOCHEM, V354, P77, DOI 10.1007/s11010-011-0807-4; Livermore DM, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1465-0691.2004.1004.x                                                 ; Lorence A, 2004, PHYTOCHEMISTRY, V65, P2735, DOI 10.1016/j.phytochem.2004.09.001; de la Fuente JL, 2010, J BIOTECHNOL, V148, P144, DOI 10.1016/j.jbiotec.2010.05.004; Ma JY, 2000, J AGR FOOD CHEM, V48, P5220, DOI 10.1021/jf000338c; Madzak C, 2015, APPL MICROBIOL BIOT, V99, P4559, DOI 10.1007/s00253-015-6624-z; Makris GC, 2010, EXPERT OPIN INV DRUG, V19, P809, DOI 10.1517/13543784.2010.490830; Martin J, 2012, FUNGAL GENET BIOL, V49, P1004, DOI 10.1016/j.fgb.2012.10.001; Masurekar P., 2008, PROG DRUG RES, V65, P292; Matsushika A, 2015, J IND MICROBIOL BIOT, V42, P1623, DOI 10.1007/s10295-015-1695-5; McLean KJ, 2015, P NATL ACAD SCI USA, V112, P2847, DOI 10.1073/pnas.1419028112; Menge T, 2005, NAT REV NEUROSCI, V6, P325, DOI 10.1038/nrn1652; Meziane-Cherif D, 2014, NATURE, V510, P477, DOI 10.1038/510477a; Mironczuk AM, 2014, J IND MICROBIOL BIOT, V41, P57, DOI 10.1007/s10295-013-1380-5; Misra S, 2012, BIOTECHNOL PROGR, V28, P1457, DOI 10.1002/btpr.1630; Moralejo FJ, 1999, APPL ENVIRON MICROB, V65, P1168; Morgunov IG, 2013, APPL MICROBIOL BIOT, V97, P7387, DOI 10.1007/s00253-013-5054-z; Ndikubwimana JD, 2014, BIOTECHNOL LETT, V36, P1917, DOI 10.1007/s10529-014-1587-1; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499                                                          ; Nielsen J, 2013, BIOENGINEERED, V4, P207, DOI 10.4161/bioe.22856; Panesar PS, 2013, CRIT REV BIOTECHNOL, V33, P345, DOI 10.3109/07388551.2012.709482; PAREKH SR, 1988, APPL BIOCHEM BIOTECH, V18, P325, DOI 10.1007/BF02930836                                                              ; Paterson RRM, 2008, CURR ENZYME INHIB, V4, P46; Peng Y, 1998, J IND MICROBIOL BIOT, V20, P373, DOI 10.1038/sj.jim.2900539                                                          ; Pu X, 2013, APPL MICROBIOL BIOT, V97, P9365, DOI 10.1007/s00253-013-5163-8; Purane N. K., 2012, Journal of Microbial and Biochemical Technology, V4, P92; Puttananjaiah MKH, 2011, APPL BIOCHEM BIOTECH, V163, P215, DOI 10.1007/s12010-010-9031-z; Qi XH, 2015, J IND MICROBIOL BIOT, V42, P807, DOI 10.1007/s10295-015-1603-z; Ratledge C, 2013, MICROBIAL PRODUCTION, P531; Reyes LH, 2014, METAB ENG, V21, P26, DOI 10.1016/j.ymben.2013.11.002; Rodriguez-Saiz M, 2010, APPL MICROBIOL BIOT, V88, P645, DOI 10.1007/s00253-010-2814-x; Roukas T, 2016, CRIT REV BIOTECHNOL, V36, P424, DOI 10.3109/07388551.2014.989424; Sabater-Jara AB, 2010, PHYTOCHEM REV, V9, P343, DOI 10.1007/s11101-010-9167-z; Sanchez S., 2013, MICROBIAL PRODUCTION, P194; Sandstrom AG, 2014, APPL MICROBIOL BIOT, V98, P7299, DOI 10.1007/s00253-014-5866-5; Sankpal NV, 2002, PROCESS BIOCHEM, V37, P1343, DOI 10.1016/S0032-9592(01)00335-1; Sasano Y, 2012, J BIOSCI BIOENG, V113, P451, DOI 10.1016/j.jbiosc.2011.11.017; Scheffler RJ, 2013, APPL MICROBIOL BIOT, V97, P969, DOI 10.1007/s00253-012-4609-8; Schwechheimer SK, 2016, APPL MICROBIOL BIOT, V100, P2107, DOI 10.1007/s00253-015-7256-z; Sebastian L, 2011, CHEMOTHERAPY, V57, P56, DOI 10.1159/000321483; SERIZAWA N, 1991, BIOCHIM BIOPHYS ACTA, V1084, P35, DOI 10.1016/0005-2760(91)90052-J; Shang SB, 2011, ANTIMICROB AGENTS CH, V55, P124, DOI 10.1128/AAC.00978-10; Sharma N, 2013, CARBOHYD POLYM, V93, P95, DOI 10.1016/j.carbpol.2012.06.059; Sirisansaneeyakul S, 2013, J CHEM TECHNOL BIOT, V88, P1121, DOI 10.1002/jctb.3949; Sitepu IR, 2014, APPL MICROBIOL BIOT, V98, P7645, DOI 10.1007/s00253-014-5944-8; Slininger PJ, 2006, APPL MICROBIOL BIOT, V72, P1285, DOI 10.1007/s00253-006-0435-1; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strohl W.R., 1997, BIOTECHNOLOGY ANTIBI, P1; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Tang L, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0327-0; Tani S, 2014, APPL MICROBIOL BIOT, V98, P4829, DOI 10.1007/s00253-014-5707-6; Thakker C, 2015, J IND MICROBIOL BIOT, V42, P403, DOI 10.1007/s10295-014-1560-y; Tudzynski B, 1999, APPL MICROBIOL BIOT, V52, P298, DOI 10.1007/s002530051524; VANCE D, 1972, BIOCHEM BIOPH RES CO, V48, P649, DOI 10.1016/0006-291X(72)90397-X; Venditto VJ, 2010, MOL PHARMACEUT, V7, P307, DOI 10.1021/mp900243b; Verdine GL, 1996, NATURE, V384, P11; Vining L. C., 1979, SECONDARY PRODUCTS M, P389; Wall ME, 1996, J ETHNOPHARMACOL, V51, P239, DOI 10.1016/0378-8741(95)01367-9; Walsh G, 2013, BIOPHARM INT, V26, P54; Wang JF, 2000, FEMS MICROBIOL LETT, V193, P249, DOI 10.1016/S0378-1097(00)00491-2; Wei YaMin, 2012, African Journal of Biotechnology, V11, P9094; Wiemann P, 2014, J IND MICROBIOL BIOT, V41, P301, DOI 10.1007/s10295-013-1366-3; Wynn JP, 2013, NAT BIOTECHNOL, V31, P716, DOI 10.1038/nbt.2656; Xie XK, 2007, APPL ENVIRON MICROB, V73, P2054, DOI 10.1128/AEM.02820-06; Xu F, 2006, BIOCHEM ENG J, V31, P67, DOI 10.1016/j.bej.2006.05.024; Xue ZX, 2013, NAT BIOTECHNOL, V31, P734, DOI 10.1038/nbt.2622; Yang SX, 2014, BIOTECHNOL PROGR, V30, P19, DOI 10.1002/btpr.1817; Yang YM, 2012, J BIOTECHNOL, V161, P250, DOI 10.1016/j.jbiotec.2012.07.007; Yatsyshyn VY, 2014, J IND MICROBIOL BIOT, V41, P823, DOI 10.1007/s10295-014-1422-7; Yovkova V, 2014, APPL MICROBIOL BIOT, V98, P2003, DOI 10.1007/s00253-013-5369-9; Zhang JM, 2012, BIORESOURCE TECHNOL, V105, P134, DOI 10.1016/j.biortech.2011.11.119; Zhang P, 2009, CURR MICROBIOL, V59, P227, DOI 10.1007/s00284-008-9270-1; Zhao K, 2004, NAT SCI, V2, P52; Zhou XW, 2010, APPL MICROBIOL BIOT, V86, P1707, DOI 10.1007/s00253-010-2546-y; Ling L.B., 1989, United States patents US, Patent No. 4877731	174	2	2	13	23	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	APR	2017	70	4					347	360		10.1038/ja.2016.121				14	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	EP7HD	WOS:000397547900003	27731337	gold			2018-01-05	
J	Wang, Z; Pradhan-Bhatt, S; Farach-Carson, MC; Passineau, MJ				Wang, Z.; Pradhan-Bhatt, S.; Farach-Carson, M. C.; Passineau, M. J.			Artificial Induction of Native Aquaporin-1 Expression in Human Salivary Cells	JOURNAL OF DENTAL RESEARCH			English	Article						epigenetic repression; genetic therapy; genetic vectors; salivary glands; xerostomia; progenitor cells	ADENOID CYSTIC CARCINOMA; GENE-TRANSFER; GLAND; METHYLATION; PROMOTER; DEMETHYLATION; HYPOFUNCTION; RESPONSES; CANCER	Gene therapy for dry mouth disorders has transitioned in recent years from theoretical to clinical proof of principle with the publication of a first-in-man phase I/II dose escalation clinical trial in patients with radiation-induced xerostomia. This trial used a prototype adenoviral vector to express aquaporin-1 (AQP1), presumably in the ductal cell layer and/ or in surviving acinar cells, to drive transcellular flux of interstitial fluid into the labyrinth of the salivary duct. As the development of this promising gene therapy continues, safety considerations are a high priority, particularly those that remove nonhuman agents (i. e., viral vectors and genetic sequences of bacterial origin). In this study, we applied 2 emerging technologies, artificial transcriptional complexes and epigenetic editing, to explore whether AQP1 expression could be achieved by activating the native gene locus in a human salivary ductal cell line and primary salivary human stem/progenitor cells (hS/PCs), as opposed to the conventional approach of cytomegalovirus promoter-driven expression from an episomal vector. In our first study, we used a cotransfection strategy to express the components of the dCas9-SAM system to create an artificial transcriptional complex at the AQP1 locus in A253 and hS/PCs. We found that AQP1 expression was induced at a magnitude comparable to adenoviral infection, suggesting that AQP1 is primarily silenced through pretranscriptional mechanisms. Because earlier literature suggested that pretranscriptional silencing of AQP1 in salivary glands is mediated by methylation of the promoter, in our second study, we performed global, chemical demethylation of A253 cells and found that demethylation alone induced robust AQP1 expression. These results suggest the potential for success by inducing AQP1 expression in human salivary ductal cells through epigenetic editing of the native promoter.	[Wang, Z.; Passineau, M. J.] Allegheny Hlth Network, Gene Therapy Program, Room 841,South Tower,320 East North Ave, Pittsburgh, PA 15212 USA; [Pradhan-Bhatt, S.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Pradhan-Bhatt, S.] Helen F Graham Canc Ctr Res Inst, Ctr Translat Canc Res, Newark, DE USA; [Passineau, M. J.] Univ Texas Hlth Sci Ctr Houston, Houston Sch Dent, Houston, TX 77030 USA	Passineau, MJ (reprint author), Allegheny Hlth Network, Gene Therapy Program, Room 841,South Tower,320 East North Ave, Pittsburgh, PA 15212 USA.	mpassine@wpahs.org			National Institutes of Health [DE022973, DE022969]	The authors thank Dr. Ravi Starzl for help with next-generation sequencing results presented in the Appendix. This work was supported by National Institutes of Health grants DE022973 (to M.J.P) and DE022969 (to M.C. F.- C.). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; Baum BJ, 2010, ORAL ONCOL, V46, P4, DOI 10.1016/j.oraloncology.2009.09.004; Chen H, 2014, NUCLEIC ACIDS RES, V42, P1563, DOI 10.1093/nar/gkt1019; Geguchadze R, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.7; Huisman C, 2016, MOL THER, V24, P536, DOI 10.1038/mt.2015.226; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427                                               ; MASTRANGELI A, 1994, AM J PHYSIOL, V266, pG1146; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Pradhan-Bhatt S, 2014, LARYNGOSCOPE, V124, P456, DOI 10.1002/lary.24297; Pradhan-Bhatt S, 2013, TISSUE ENG PT A, V19, P1610, DOI [10.1089/ten.TEA.2012.0301, 10.1089/ten.tea.2012.0301]; Shao CB, 2011, CLIN CANCER RES, V17, P4320, DOI 10.1158/1078-0432.CCR-10-2992; Srinivasan PP, 2017, STEM CELL TRANSL MED, V6, P110, DOI 10.5966/sctm.2016-0083; Tan M, 2014, OTOLARYNG HEAD NECK, V150, P801, DOI 10.1177/0194599814521569; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang Z, 2015, ADV MATER SCI ENG, DOI 10.1155/2015/165631; Zheng C, 2015, GENE THER, V22, P758, DOI 10.1038/gt.2015.55	19	1	1	3	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	APR	2017	96	4					444	449		10.1177/0022034516685045				6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	EQ5ZP	WOS:000398161900012	28072927				2018-01-05	
J	Di Ceglie, I; van den Akker, GGH; Ascone, G; ten Harkel, B; Hacker, H; van de Loo, FAJ; Koenders, MI; van der Kraan, PM; de Vries, TJ; Vogl, T; Roth, J; van Lent, PLEM				Di Ceglie, Irene; van den Akker, Guus G. H.; Ascone, Giuliana; ten Harkel, Bas; Hacker, Hans; van de Loo, Fons A. J.; Koenders, Marije I.; van der Kraan, Peter M.; de Vries, Teun J.; Vogl, Thomas; Roth, Johannes; van Lent, Peter L. E. M.			Genetic modification of ER-Hoxb8 osteoclast precursors using CRISPR/Cas9 as a novel way to allow studies on osteoclast biology	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						cell line; osteoclast differentiation; bone	LARGE T-ANTIGEN; CELL-LINES; DIFFERENTIATION; ESTABLISHMENT; GENERATION; HOXB8; MOUSE	Osteoclasts are cells specialized in bone resorption. Currently, studies on murine osteoclasts are primarily performed on bonemarrow-derived cells with the use of many animals and limited cells available. ER-Hoxb8 cells are conditionally immortalized monocyte/macrophage murine progenitor cells, recently described to be able to differentiate toward functional osteoclasts. Here, we produced an ER-Hoxb8 clonal cell line from C57BL/6 bone marrow cells that strongly resembles phenotype and function of the conventional bone marrow-derived osteoclasts. We then used CRISPR/Cas9 technology to specifically inactivate genes by biallelic mutation. The CRISPR/Cas9 system is an adaptive immune system in Bacteria and Archaea and uses small RNAs and Cas nucleases to degrade foreign nucleic acids. Through specific-guide RNAs, the nuclease Cas9 can be redirected toward any genomic location to genetically modify eukaryotic cells. We genetically modified ER-Hoxb8 cells with success, generating NFATc(-/-) and DC-STAMP(-/-) ER-Hoxb8 cells that lack the ability to differentiate into osteoclasts or to fuse into multinucleated osteoclasts, respectively. In conclusion, this method represents a markedly easy highly specific and efficient system for generating potentially unlimited numbers of genetically modified osteoclast precursors.	[Di Ceglie, Irene; van den Akker, Guus G. H.; Ascone, Giuliana; van de Loo, Fons A. J.; Koenders, Marije I.; van der Kraan, Peter M.; van Lent, Peter L. E. M.] Radboud Univ Nijmegen, Med Ctr, Dept Expt Rheumatol, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands; [ten Harkel, Bas] Vrije Univ Amsterdam, Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [de Vries, Teun J.] Vrije Univ Amsterdam, Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol, Amsterdam, Netherlands; Res Inst MOVE, Amsterdam, Netherlands; [Hacker, Hans] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogl, Thomas; Roth, Johannes] Univ Munster, Inst Immunol, Munster, Germany	van Lent, PLEM (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Expt Rheumatol, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	peter.vanlent@radboudumc.nl		de Vries, Teun/0000-0001-6464-5172	7th Framework Programme of the European Union, project Osteoimmune [289150]; Dutch Arthritis Foundation (Reumafonds) [RF 11-1-305]; American Lebanese Syrian Associated Charities (ALSAC)	We gratefully acknowledge the financial support from 7th Framework Programme of the European Union, project Osteoimmune (Grant 289150), Dutch Arthritis Foundation (Reumafonds) (RF 11-1-305), and the American Lebanese Syrian Associated Charities (ALSAC).	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Barrangou R, 2014, SCIENCE, V344, P707, DOI 10.1126/science.1252964; Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Broeren MGA, 2016, HUM GENE THER, V27, P244, DOI 10.1089/hum.2015.127; CHAMBERS TJ, 1993, P NATL ACAD SCI USA, V90, P5578, DOI 10.1073/pnas.90.12.5578; Chen W, 1998, J BONE MINER RES, V13, P1112, DOI 10.1359/jbmr.1998.13.7.1112; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; Hentunen TA, 1999, ENDOCRINOLOGY, V140, P2954, DOI 10.1210/endo.140.7.6867; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim Jung Ha, 2014, J Bone Metab, V21, P233, DOI 10.11005/jbm.2014.21.4.233; Knoepfler PS, 2001, ONCOGENE, V20, P5440, DOI 10.1038/sj.onc.1204710; Miyamoto A, 1998, BIOCHEM BIOPH RES CO, V242, P703, DOI 10.1006/bbrc.1997.8046; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; PERKINS A, 1990, P NATL ACAD SCI USA, V87, P8398, DOI 10.1073/pnas.87.21.8398                                                         ; Sakiyama H, 2001, J BONE MINER METAB, V19, P220, DOI 10.1007/s007740170024                                                           ; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SHIN JH, 1995, ENDOCRINOLOGY, V136, P4285, DOI 10.1210/en.136.10.4285; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; ten Harkel B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139564; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615; Zach F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142211	25	0	0	4	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	APR	2017	101	4					957	966		10.1189/jlb.1AB0416-180RR				10	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	ER0UG	WOS:000398503100015	27920208				2018-01-05	
J	Weyda, I; Yang, L; Vang, J; Ahring, BK; Lubeck, M; Lubeck, PS				Weyda, Istvan; Yang, Lei; Vang, Jesper; Ahring, Birgitte K.; Lubeck, Mette; Lubeck, Peter S.			A comparison of Agrobacterium-mediated transformation and protoplast-mediated transformation with CRISPR-Cas9 and bipartite gene targeting substrates, as effective gene targeting tools for Aspergillus carbonarius	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						Protoplast; Agrobacterium; CRISPR-Cas9; Transformation; Homologous recombination; Fungi	FUNCTIONAL GENOMICS; FILAMENTOUS FUNGI; SYSTEM; NIDULANS; STRAINS; DNA; EFFICIENCY; PLASMID; MARKER; GUIDE	In recent years, versatile genetic tools have been developed and applied to a number of filamentous fungi of industrial importance. However, the existing techniques have limitations when it comes to achieve the desired genetic modifications, especially for efficient gene targeting. In this study, we used Aspergillus carbonarius as a host strain due to its potential as a cell factory, and compared three gene targeting techniques by disrupting the aygl gene involved in the biosynthesis of conidial pigment in A. carbonarius. The absence of the aygl gene leads to phenotypic change in conidia color, which facilitated the analysis on the gene targeting frequency. The examined transformation techniques included Agrobacterium-mediated transformation (AMT) and protoplast-mediated transformation (PMT). Furthermore, the PMT for the disruption of the aygl gene was carried out with bipartite gene targeting fragments and the recently adapted CRISPR-Cas9 system. All three techniques were successful in generating Delta aygl mutants, but showed different efficiencies. The most efficient method for gene targeting was AMT, but further it was shown to be dependent on the choice of Agrobacterium strain. However, there are different advantages and disadvantages of all three gene targeting methods which are discussed, in order to facilitate future approaches for fungal strain improvements. (C) 2017 Elsevier B.V. All rights reserved.	[Weyda, Istvan; Yang, Lei; Vang, Jesper; Ahring, Birgitte K.; Lubeck, Mette; Lubeck, Peter S.] Aalborg Univ, Sect Sustainable Biotechnol, AC Meyers Vaenge 15, DK-2450 Copenhagen SV, Denmark; [Weyda, Istvan; Ahring, Birgitte K.] Washington State Univ Tricities, BSEL, 2710 Crimson Way, Richland, WA 99354 USA	Lubeck, PS (reprint author), Aalborg Univ, Sect Sustainable Biotechnol, AC Meyers Vaenge 15, DK-2450 Copenhagen SV, Denmark.	psl@bio.aau.dk		Yang, Lei/0000-0003-4851-8872	Danish strategic Research Council [13G 5604 2032]	We thank the Danish strategic Research Council for support under the program MycoFuelChem grant # 13G 5604 2032. We thank Rasmus John Normand Frandsen (Technical University of Denmark, Denmark) for valuable discussions on AMT and providing the binary vectors.	Abarca ML, 2004, ANTON LEEUW INT J G, V86, P33, DOI 10.1023/B:ANTO.0000024907.85688.05; Aleksenko A, 1997, FUNGAL GENET BIOL, V21, P373, DOI 10.1006/fgbi.1997.0980                                                          ; Bakhsh A, 2014, EMIR J FOOD AGR, V26, P259, DOI 10.9755/ejfa.v26i3.16437; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Diez R. B., 2002, J APPL MICROBIOL, V92, P189; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; FINCHAM JRS, 1989, MICROBIOL REV, V53, P148; Fleck O, 2004, J CELL SCI, V117, P515, DOI 10.1242/jcs.00952; Frandsen RJN, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-70; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Hansen NB, 2014, J MICROBIOL METH, V96, P42, DOI 10.1016/j.mimet.2013.10.018; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Institute of Sciences of Food Production, 2009, AGR FOOD TOX FUNG CU; Jager S, 2001, WORLD J MICROB BIOT, V17, P455, DOI 10.1023/A:1011948405581; Jones HD, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-5; Karagiosis S. A., 2012, Food and industrial bioproducts and bioprocessing, P205; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lee SB, 1988, FUNGAL GENET NEWSL, V35, P23; Liu R, 2015, CELL DISCOVERY, V1, P1, DOI DOI 10.1038/CELLDISC.2015.7; Meyer V, 2008, BIOTECHNOL ADV, V26, P177, DOI 10.1016/j.biotechadv.2007.12.001; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; Michielse CB, 2005, FUNGAL GENET BIOL, V42, P9, DOI 10.1016/j.fgb.2004.06.009; Mora-Lugo R, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0247-x; Morioka LRI, 2006, CURR MICROBIOL, V52, P469, DOI 10.1007/s00284-005-0402-6; Nielsen JB, 2008, FUNGAL GENET BIOL, V45, P165, DOI 10.1016/j.fgb.2007.07.003; Nielsen ML, 2007, APPL ENVIRON MICROB, V73, P7240, DOI 10.1128/AEM.01839-07; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Park J., 2015, BIOINFORMATICS; Sambrook J, 2001, MOL CLONING LAB MANU; Samson RA, 2004, INTRO FOOD AIRBORNE; Sinha M, 2015, FUNGAL BIOL-UK, V119, P274, DOI 10.1016/j.funbio.2015.01.001; Sorensen LQ, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-15; Stovicek Vratislav, 2015, Metabolic Engineering Communications, V2, P13, DOI 10.1016/j.meteno.2015.03.001; Weld RJ, 2006, CELL RES, V16, P31, DOI 10.1038/sj.cr.7310006; YADAV NS, 1982, P NATL ACAD SCI-BIOL, V79, P6322, DOI 10.1073/pnas.79.20.6322; Yang L, 2015, J IND MICROBIOL BIOT, V42, P1533, DOI 10.1007/s10295-015-1688-4; Yang L.X., 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1186/S13568-014-0054-7; YUILL EDWARD, 1950, TRANS BRIT MYCOL SOC, V33, P324; Zhou M., 2013, FUNGAL GROWTH ASPERG	44	3	3	15	47	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	APR	2017	135						26	34		10.1016/j.mimet.2017.01.015				9	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	EP7HA	WOS:000397547600006	28159628				2018-01-05	
J	Pandey, PR; Chatterjee, B; Olanich, ME; Khan, J; Miettinen, MM; Hewitt, SM; Barr, FG				Pandey, Puspa R.; Chatterjee, Bishwanath; Olanich, Mary E.; Khan, Javed; Miettinen, Markku M.; Hewitt, Stephen M.; Barr, Frederic G.			PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma	JOURNAL OF PATHOLOGY			English	Article						rhabdomyosarcoma; PAX3-FOXO1; myoblast; differentiation; recurrence	PAX3-FKHR FUSION PROTEIN; GROWTH SUPPRESSIVE ACTIVITIES; ALVEOLAR RHABDOMYOSARCOMA; GENE FUSIONS; MAMMARY TUMORIGENESIS; DRUG-RESISTANCE; IN-VIVO; MYC; CANCER; ONCOPROTEIN	The PAX3-FOXO1 fusion gene is generated by a 2;13 chromosomal translocation and is a characteristic feature of an aggressive subset of rhabdomyosarcoma (RMS). To dissect the mechanism of oncogene action during RMS tumourigenesis and progression, doxycycline-inducible PAX3-FOXO1 and constitutive MYCN expression constructs were introduced into immortalized human myoblasts. Although myoblasts expressing PAX3-FOXO1 or MYCN alone were not transformed in focus formation assays, combined PAX3-FOXO1 and MYCN expression resulted in transformation. Following intramuscular injection into immunodeficient mice, myoblasts expressing PAX3-FOXO1 and MYCN formed rapidly growing RMS tumours, whereas myoblasts expressing only PAX3-FOXO1 formed tumours after a longer latency period. Doxycycline withdrawal in myoblasts expressing inducible PAX3-FOXO1 and constitutive MYCN following tumour formation in vivo or focus formation in vitro resulted in tumour regression or smaller foci associated with myogenic differentiation and cell death. Following regression, most tumours recurred in the absence of doxycycline. Analysis of recurrent tumours revealed a subset without PAX3-FOXO1 expression, and cell lines derived from these recurrent tumours showed transformation in the absence of doxycycline. The doxycycline-independent oncogenicity in these recurrent tumour-derived lines persisted even after PAX3-FOXO1 was inactivated with a CRISPR/Cas9 editing strategy. Whereas cell lines derived from primary tumours were dependent on PAX3-FOXO1 and differentiated following doxycycline withdrawal, recurrent tumour-derived cells without PAX3-FOXO1 expression did not differentiate under these conditions. These findings indicate that PAX3-FOXO1 collaborates with MYCN during early RMS tumourigenesis to dysregulate proliferation and inhibit myogenic differentiation and cell death. Although most cells in the primary tumours are dependent on PAX3-FOXO1, recurrent tumours can develop by a PAX3-FOXO1-independent mechanism, in which rare cells are postulated to acquire secondary transforming events that were activated or selected by initial PAX3-FOXO1 expression. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.	[Pandey, Puspa R.; Chatterjee, Bishwanath; Olanich, Mary E.; Miettinen, Markku M.; Hewitt, Stephen M.; Barr, Frederic G.] NCI, Pathol Lab, Ctr Canc Res, NIH, 10 Ctr Dr,Room 2S235D,MSC1500, Bethesda, MD 20892 USA; [Khan, Javed] NCI, Genet Branch, Ctr Canc Res, NIH, 10 Ctr Dr,Room 2S235D,MSC1500, Bethesda, MD 20892 USA	Barr, FG (reprint author), NCI, Pathol Lab, Ctr Canc Res, 10 Ctr Dr,Room 2S235D,MSC1500, Bethesda, MD 20892 USA.	barrfg@mail.nih.gov	Khan, Javed/P-9157-2014	Khan, Javed/0000-0002-5858-0488	National Cancer Institute; Joanna McAfee Childhood Cancer Foundation	This research was supported by the Intramural Research Program of the National Cancer Institute and by the Joanna McAfee Childhood Cancer Foundation. We thank Dr Zengfeng Wang, Kristofferson Ylaya and Julia Hisey for their technical assistance, and Dr Ji Luo for providing lentiviral constructs.	Ayyanathan K, 2000, CANCER RES, V60, P5803; Barr FG, 2002, CANCER RES, V62, P4704; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Cheong TC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10934; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Davis RJ, 1997, P NATL ACAD SCI USA, V94, P8047, DOI 10.1073/pnas.94.15.8047                                                         ; Ebauer M, 2007, ONCOGENE, V26, P7267, DOI 10.1038/sj.onc.1210525; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940                                                          ; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Jang JW, 2006, MOL CELL BIOL, V26, P8109, DOI 10.1128/MCB.00404-06; Kikuchi K, 2008, BIOCHEM BIOPH RES CO, V365, P568, DOI 10.1016/j.bbrc.2007.11.017; Lam PYP, 1999, MOL CELL BIOL, V19, P594; Linardic CM, 2005, CANCER RES, V65, P4490, DOI 10.1158/0008-5472.CAN-04-3194; Linardic CM, 2007, CANCER RES, V67, P6691, DOI 10.1158/0008-5472.CAN-06-3210; Miettinen M, 2011, AM J SURG PATHOL, V35, P432, DOI 10.1097/PAS.0b013e318206b67b; Naini S, 2008, CANCER RES, V68, P9583, DOI 10.1158/0008-5472.CAN-07-6178; Olanich ME, 2015, CLIN CANCER RES, V21, P4947, DOI 10.1158/1078-0432.CCR-14-2955; Olanich ME, 2013, EXPERT OPIN THER TAR, V17, P607, DOI 10.1517/14728222.2013.772136; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scheidler S, 1996, P NATL ACAD SCI USA, V93, P9805, DOI 10.1073/pnas.93.18.9805                                                         ; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Tonelli R, 2012, CLIN CANCER RES, V18, P796, DOI 10.1158/1078-0432.CCR-11-1981; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Xia SJ, 2007, LAB INVEST, V87, P318, DOI 10.1038/labinvest.3700521; Xia SJ, 2009, AM J PATHOL, V175, P2600, DOI 10.2353/ajpath.2009.090192; Xia SJJ, 2004, ONCOGENE, V23, P6864, DOI 10.1038/sj.onc.1207850; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028	33	1	1	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3417	1096-9896		J PATHOL	J. Pathol.	APR	2017	241	5					626	637		10.1002/path.4867				12	Oncology; Pathology	Oncology; Pathology	EP6CS	WOS:000397466300007	28138962				2018-01-05	
J	Perez, AR; Pritykin, Y; Vidigal, JA; Chhangawala, S; Zamparo, L; Leslie, CS; Ventura, A				Perez, Alexendar R.; Pritykin, Yuri; Vidigal, Joana A.; Chhangawala, Sagar; Zamparo, Lee; Leslie, Christina S.; Ventura, Andrea			GuideScan software for improved single and paired CRISPR guide RNA design	NATURE BIOTECHNOLOGY			English	Article							GENETIC SCREENS; HUMAN-CELLS; IN-VIVO; GENOME; SPECIFICITY; NUCLEASES; SYSTEM; DNA	We present GuideScan software for the design of CRISPR guide RNA libraries that can be used to edit coding and noncoding genomic regions. GuideScan produces high-density sets of guide RNAs (gRNAs) for single- and paired-gRNA genome-wide screens. We also show that the trie data structure of GuideScan enables the design of gRNAs that are more specific than those designed by existing tools.	[Perez, Alexendar R.; Pritykin, Yuri; Chhangawala, Sagar; Zamparo, Lee; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA; [Perez, Alexendar R.; Vidigal, Joana A.; Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Perez, Alexendar R.; Chhangawala, Sagar] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA	Leslie, CS (reprint author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA.; Vidigal, JA; Ventura, A (reprint author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	decampoj@mskcc.org; cleslie@cbio.mskcc.org; venturaa@mskcc.org		A. Vidigal, Joana/0000-0003-2765-6985; Chhangawala, Sagar/0000-0001-9626-1034	NIH [P30-CA008748, U01-HG007033, U01-HG007893]; Geoffrey Beene Cancer Research Foundation; Uniting Against Lung Cancer Foundation; Cycle for Survival Foundation; Pershing Square Sohn Cancer Research Alliance; Lung Cancer Research Foundation	We thank members of the Ventura and the Leslie laboratories for comments and suggestions. We thank L. Fairchild and R. Pelossof for providing source code for the SplashRNA web server to serve as the backbone for the GuideScan website. This work was supported in part by NIH: grants P30-CA008748 (MSK Core), U01-HG007033 (C.S.L.), U01-HG007893 (C.S.L.), and by grants from the Geoffrey Beene Cancer Research Foundation (A.V.), the Uniting Against Lung Cancer Foundation (A.V.), the Cycle for Survival Foundation (A.V.), the Pershing Square Sohn Cancer Research Alliance (A.V.), and the Lung Cancer Research Foundation (J.A.V.). The GuideScan source code and all associated documentation are deposited at guidescan.com.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Pliatsika V, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0035-z; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	25	4	4	5	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2017	35	4					347	+		10.1038/nbt.3804				5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ER4OT	WOS:000398780600025	28263296	green_accepted			2018-01-05	
J	Kim, YB; Komor, AC; Levy, JM; Packer, MS; Zhao, KT; Liu, DR				Kim, Y. Bill; Komor, Alexis C.; Levy, Jonathan M.; Packer, Michael S.; Zhao, Kevin T.; Liu, David R.			Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions	NATURE BIOTECHNOLOGY			English	Article							STAPHYLOCOCCUS-AUREUS CAS9; DNA CLEAVAGE; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; CRISPR-CAS9; APOBEC3G; DOMAIN	Base editing induces single-nucleotide changes in the DNA of living cells using a fusion protein containing a catalytically defective Streptococcus pyogenes Cas9, a cytidine deaminase, and an inhibitor of base excision repair1. This genome editing approach has the advantage that it does not require formation of double-stranded DNA breaks or provision of a donor DNA template. Here we report the development of five C to T (or G to A) base editors that use natural and engineered Cas9 variants with different protospacer-adjacent motif (PAM) specificities to expand the number of sites that can be targeted by base editing 2.5-fold. Additionally, we engineered base editors containing mutated cytidine deaminase domains that narrow the width of the editing window from similar to 5 nucleotides to as little as 1-2 nucleotides. We thereby enabled discrimination of neighboring C nucleotides, which would otherwise be edited with similar efficiency, and doubled the number of disease-associated target Cs able to be corrected preferentially over nearby non-target Cs.	[Kim, Y. Bill; Komor, Alexis C.; Levy, Jonathan M.; Packer, Michael S.; Zhao, Kevin T.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kim, Y. Bill; Komor, Alexis C.; Levy, Jonathan M.; Packer, Michael S.; Zhao, Kevin T.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Liu, David R.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Liu, DR (reprint author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, DR (reprint author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; Liu, DR (reprint author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	drliu@fas.harvard.edu		Komor, Alexis/0000-0001-5043-0998	US National Institutes of Health (NIH) [R01 EB022376]; NIH [R35GM118062]; F-Prime Biomedical Research Initiative [A28161]; Howard Hughes Medical Institute; Ruth L. Kirchstein National Research Service Awards [F32 GM 112366-2]; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (NSERC PGS-D); Harvard Biophysics NIH training grant [T32 GM008313]	This work was supported by US National Institutes of Health (NIH) R01 EB022376 (formerly R01 GM065400), NIH R35GM118062, F-Prime Biomedical Research Initiative (A28161), and the Howard Hughes Medical Institute. A.C.K. is a Ruth L. Kirchstein National Research Service Awards Postdoctoral Fellow (F32 GM 112366-2). Y.B.K. held a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (NSERC PGS-D). M.S.P. is an NSF Graduate Research Fellow and was supported by the Harvard Biophysics NIH training grant T32 GM008313.	Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Li J, 2016, MOL PLANT; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405	19	21	21	22	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2017	35	4					371	+		10.1038/nbt.3803				7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	ER4OT	WOS:000398780600029	28191901	green_accepted			2018-01-05	
J	Cornu, TI; Mussolino, C; Cathomen, T				Cornu, Tatjana I.; Mussolino, Claudio; Cathomen, Toni			Refining strategies to translate genome editing to the clinic	NATURE MEDICINE			English	Review							ZINC-FINGER NUCLEASES; HEMATOPOIETIC STEM/PROGENITOR CELLS; DUCHENNE MUSCULAR-DYSTROPHY; HOMOLOGY-DIRECTED REPAIR; IN-VIVO; GENE-THERAPY; STEM-CELLS; DNA-CLEAVAGE; MAMMALIAN-CELLS; MOUSE MODEL	Recent progress in developing programmable nucleases, such as zinc-finger nucleases, transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeat (CRISPR)-Cas nucleases, have paved the way for gene editing to enter clinical practice. This translation is a result of combining high nuclease activity with high specificity and successfully applying this technology in various preclinical disease models, including infectious disease, primary immunodeficiencies, hemoglobinopathies, hemophilia and muscular dystrophy. Several clinical gene-editing trials, both ex vivo and in vivo, have been initiated in the past 2 years, including studies that aim to knockout genes as well as to add therapeutic transgenes. Here we discuss the advances made in the gene-editing field in recent years, and specify priorities that need to be addressed to expand therapeutic genome editing to further disease entities.	[Cornu, Tatjana I.; Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Med Ctr, Inst Cell & Gene Therapy, Freiburg, Germany; [Cornu, Tatjana I.; Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Cathomen, Toni] Univ Freiburg, Fac Med, Freiburg, Germany	Cathomen, T (reprint author), Univ Freiburg, Med Ctr, Inst Cell & Gene Therapy, Freiburg, Germany.; Cathomen, T (reprint author), Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany.; Cathomen, T (reprint author), Univ Freiburg, Fac Med, Freiburg, Germany.	toni.cathomen@uniklinik-freiburg.de		Cathomen, Toni/0000-0002-7757-4630	Federal Ministry of Education and Research [IFB01EO0803, iMACnet-01EK1602B, HBV-TALE-01DG15005]; German Research Foundation [SFB1160-TP17]; European Commission's Horizon 2020 Program [SCIDNET-666908, CARAT-667980]; Casebia Therapeutics [CAU-950-20140702]; German Academic Exchange Service	We thank all members of the laboratories for helpful discussion. Current research in our labs is funded by the Federal Ministry of Education and Research (IFB01EO0803; iMACnet-01EK1602B; HBV-TALE-01DG15005), the German Research Foundation (SFB1160-TP17), the European Commission's Horizon 2020 Program (SCIDNET-666908; CARAT-667980), Casebia Therapeutics (CAU-950-20140702) and the German Academic Exchange Service.	Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Solinis MA, 2015, EUR J PHARM BIOPHARM, V95, P331, DOI 10.1016/j.ejpb.2014.12.022; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Ding WC, 2014, CLIN CANCER RES, V20, P6495, DOI 10.1158/1078-0432.CCR-14-0250; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hu JH, 2016, CELL CHEM BIOL, V23, P57, DOI 10.1016/j.chembiol.2015.12.009; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Juillerat A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08150; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Luo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20657; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marketsandmarkets.com, 2016, GEN ED GEN ENG MARK; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2015, NAT METHODS, V12, P465, DOI 10.1038/nmeth.3330; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Pankowicz FP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12642; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; de Garibay APR, 2012, DRUG DES DEV THER, V6, P303, DOI 10.2147/DDDT.S36131; Pike-Overzet K, 2014, J ALLERGY CLIN IMMUN, V134, P242, DOI 10.1016/j.jaci.2014.04.033; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2015, MOL THER, V23, P1507, DOI 10.1038/mt.2015.104; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Williams DA, 2014, STEM CELL TRANSL MED, V3, P636, DOI 10.5966/sctm.2013-0206; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yu KR, 2016, HUM GENE THER, V27, P729, DOI 10.1089/hum.2016.107; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	99	12	12	14	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					415	423		10.1038/nm.4313				9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	WOS:000398768100009	28388605				2018-01-05	
J	Xiao, J; Li, X; Chen, L; Han, X; Zhao, W; Li, LL; Chen, JG				Xiao, Jian; Li, Xue; Chen, Lan; Han, Xin; Zhao, Wei; Li, Lianlian; Chen, Jie-Guang			Apobec1 Promotes Neurotoxicity-Induced Dedifferentiation of Muller Glial Cells	NEUROCHEMICAL RESEARCH			English	Article						Muller glial cells; Proliferation; Dedifferentiation; Apobec1; Nestin	NEURAL STEM-CELLS; DNA DEMETHYLATION; GROWTH-FACTORS; RAT RETINA; GENE-EXPRESSION; EMBRYONIC STEM; ACIDIC PROTEIN; MOUSE RETINA; CYCLIN D1; NESTIN	Retinal Muller glial cells in mammals acquire stem and progenitor cell properties after neurotoxic treatment. However, the molecular mechanisms underlying proliferation and dedifferentiation of adult Muller cells in the mammalian retina were unclear. In this study, treatments with N-methyl-d-aspartate ( NMDA) plus epidermal growth factor(EGF) led to the proliferation of Muller cells and expression of stem cell markers including Nanog and Nestin in the retina. The increased mRNA for Nanog and Nestin were coincident with reduced methylation of a Nanog promoter and a Nestin enhancer specific in the neural stem cells, respectively. We found that Apolipoprotein B mRNA editing catalytic subunit 1 ( Apobec1) was upregulated early in the retina treated with NMDA and EGF. Moreover, overexpression of Apobec1 in primary Muller cells increased expression of Nestin and reduced methylation of the Nestin enhancer. The data suggest that neurotoxicity- induced Apobec1 may promote expression of Nestin and help cell cycle reentry of retinal Muller cells via DNA demethylation. This study provides novel insights into the molecular mechanisms underlying dedifferentiation and proliferation of Muller cells in the mammalian retina.	[Xiao, Jian; Li, Xue; Chen, Lan; Han, Xin; Zhao, Wei; Chen, Jie-Guang] Wenzhou Med Univ, Sch Ophthalmol, Wenzhou 325000, Zhejiang, Peoples R China; [Xiao, Jian; Li, Xue; Chen, Lan; Han, Xin; Zhao, Wei; Chen, Jie-Guang] Wenzhou Med Univ, Optometry & Eye Hosp, China State Key Lab Cultivat Base, Wenzhou 325000, Zhejiang, Peoples R China; [Xiao, Jian; Li, Xue; Chen, Lan; Han, Xin; Zhao, Wei; Chen, Jie-Guang] Wenzhou Med Univ, Key Lab Vis Sci, Natl Minist Hlth China, Wenzhou 325000, Zhejiang, Peoples R China; [Xiao, Jian; Li, Xue; Chen, Lan; Han, Xin; Zhao, Wei; Chen, Jie-Guang] Wenzhou Med Univ, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou 325000, Zhejiang, Peoples R China; [Li, Lianlian] Shengli Oilfield Cent Hosp, Dongying 257034, Shandong, Peoples R China; [Chen, Jie-Guang] Wenzhou Med Univ, Key Lab Visual Sci, Natl Minist Hlth, 270 Xueyuan Rd, Wenzhou 325027, Zhejiang, Peoples R China; [Chen, Jie-Guang] Wenzhou Med Univ, Sch Optometry & Ophthalmol, 270 Xueyuan Rd, Wenzhou 325027, Zhejiang, Peoples R China	Chen, JG (reprint author), Wenzhou Med Univ, Sch Ophthalmol, Wenzhou 325000, Zhejiang, Peoples R China.; Chen, JG (reprint author), Wenzhou Med Univ, Optometry & Eye Hosp, China State Key Lab Cultivat Base, Wenzhou 325000, Zhejiang, Peoples R China.; Chen, JG (reprint author), Wenzhou Med Univ, Key Lab Vis Sci, Natl Minist Hlth China, Wenzhou 325000, Zhejiang, Peoples R China.; Chen, JG (reprint author), Wenzhou Med Univ, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou 325000, Zhejiang, Peoples R China.; Chen, JG (reprint author), Wenzhou Med Univ, Key Lab Visual Sci, Natl Minist Hlth, 270 Xueyuan Rd, Wenzhou 325027, Zhejiang, Peoples R China.; Chen, JG (reprint author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, 270 Xueyuan Rd, Wenzhou 325027, Zhejiang, Peoples R China.	jgchen@mail.eye.ac.cn			Natural Science Foundation of Zhejiang Province of China [LQ15H120004]; Scientific Research Fund of the Affiliated Eye Hospital of Wenzhou Medical University [Y20140356]; Scientific Research Startup fund of Wenzhou Medical University [QTJ08007]	The work was supported by Natural Science Foundation of Zhejiang Province of China grant LQ15H120004 (J. Xiao), Scientific Research Fund of the Affiliated Eye Hospital of Wenzhou Medical University Y20140356 (J. Xiao) and Scientific Research Startup fund of Wenzhou Medical University QTJ08007 (J. G. Chen).	Agarwal S, 2010, CELL RES, V20, P253, DOI 10.1038/cr.2010.30; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bramanti V, 2015, J NEUROSCI RES, V93, P521, DOI 10.1002/jnr.23506; Bramanti V, 2016, J NEUROSCI RES, V94, P90, DOI 10.1002/jnr.23678; Bramanti V, 2015, J NEUROSCI RES, V93, P1378, DOI 10.1002/jnr.23606; Bronzi D, 2010, NEUROCHEM RES, V35, P2154, DOI 10.1007/s11064-010-0283-3; Close JL, 2006, GLIA, V54, P94, DOI 10.1002/glia.20361; Facchini LM, 1998, FASEB J, V12, P633; Fischer AJ, 2005, J COMP NEUROL, V484, P1, DOI 10.1002/cne.20406; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kohno H, 2006, OPHTHALMOLOGY, V244, P90; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127671; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Luna G, 2010, MOL VIS, V16, P2511; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842                                                         ; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3                                                   ; Moon JH, 2011, CELL RES, V21, P1305, DOI 10.1038/cr.2011.107; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Pollak J, 2013, DEVELOPMENT, V140, P2619, DOI 10.1242/dev.091355; Powell C, 2013, P NATL ACAD SCI USA, V110, P19814, DOI 10.1073/pnas.1312009110; Powell C, 2012, J NEUROSCI, V32, P1096, DOI 10.1523/JNEUROSCI.5603-11.2012; Qu CS, 2013, GENE EXPR PATTERNS, V13, P51, DOI 10.1016/j.gep.2012.11.003; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Reyes-Aguirre LI, 2013, NEUROSCIENCE, V254, P347, DOI 10.1016/j.neuroscience.2013.09.048; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666                                                       ; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Suga A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094556; Surzenko N, 2013, DEVELOPMENT, V140, P1445, DOI 10.1242/dev.071878; Takeda M, 2008, INVEST OPHTH VIS SCI, V49, P1142, DOI 10.1167/iovs.07-0434; Ueki Y, 2012, GLIA, V60, P1579, DOI 10.1002/glia.22377; Xu Y, 2013, J MOL NEUROSCI, V51, P37, DOI 10.1007/s12031-012-9941-z; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	41	0	0	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	APR	2017	42	4					1151	1164		10.1007/s11064-016-2151-2				14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	EQ8QH	WOS:000398350100022	28150227				2018-01-05	
J	Cai, HJ; Xie, XM; Ji, L; Ruan, XJ; Zheng, ZH				Cai, Huajie; Xie, Xuemeng; Ji, Ling; Ruan, Xiaojiao; Zheng, Zhihai			Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma	ONCOLOGY LETTERS			English	Article						hepatocellular carcinoma; sphingosine kinase 1; prognosis biomarker; synergistic activation mediator	CANCER; 1-PHOSPHATE	Sphingosine kinase 1 (Sphk1) is an oncogenic kinase that is responsible for the phosphorylation of sphingosine to sphingosine-1-phosphate (S1P). Mounting evidence suggests that Sphk1 serves a crucial role in the proliferation and development of a variety of human cancer cells. However, the role of Sphk1 in hepatocellular carcinoma (HCC) has not been fully elucidated. Therefore, the expression of Sphk1 was examined in 127 formalin-fixed, paraffin-embedded HCC tissues using immunohistochemistry, and its clinical implications and prognostic significance were analyzed. As a result, the expression of Sphk1 in HCC tissue was revealed to be significantly higher than in normal tissue (P<0.01). In addition, Sphk1 expression was significantly associated with tumor size, tumor stage and histological differentiation (all P<0.05). The patients with low Sphk1 expression had higher overall survival and recurrence-free survival rates compared with patients with high Sphk1 expression. Furthermore, Sphk1-specific shRNA was used to downregulate the expression of Sphk1 in HCC cell lines, including hepatoblastoma G2 and HCC-9724. The CRISPR/Cas9 based transcription activation system was used to upregulate Sphk1 expression in the normal live cell, L02. Cell proliferation, mRNA expression and protein expression were measured using Cell Counting Kit-8, reverse transcription polymerase chain reaction and western blot analysis in the transfected cells. To the best of our knowledge, the present study provides the first evidence that Sphk1 promotes HCC cell proliferation and is involved in tumor progression. Notably, the data presented suggest that Sphk1 may be a potential independent prognosis biomarker for the treatment of HCC.	[Cai, Huajie; Xie, Xuemeng; Ji, Ling; Ruan, Xiaojiao; Zheng, Zhihai] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gen Surg, 1 Jiedaoqianan Rd, Wenzhou 325000, Zhejiang, Peoples R China	Ji, L (reprint author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gen Surg, 1 Jiedaoqianan Rd, Wenzhou 325000, Zhejiang, Peoples R China.	Dr.jiling@foxmail.com					Bayo J, 2014, BIOMED RES INT, DOI 10.1155/2014/837420; Chessum Nicola, 2015, Prog Med Chem, V54, P1, DOI 10.1016/bs.pmch.2014.11.002; Facchinetti MM, 2010, CELLS TISSUES ORGANS, V192, P314, DOI 10.1159/000318173; Gault CR, 2011, CRIT REV BIOCHEM MOL, V46, P342, DOI 10.3109/10409238.2011.597737; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li W, 2009, CLIN CANCER RES, V15, P1393, DOI 10.1158/1078-0432.CCR-08-1158; Liu SQ, 2012, INT J COLORECTAL DIS, V27, P1569, DOI 10.1007/s00384-012-1510-y; McGlynn KA, 2015, CLIN LIVER DIS, V19, P223, DOI 10.1016/j.cld.2015.01.001; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Wu LH, 2016, MOL MED REP, V14, P1923, DOI 10.3892/mmr.2016.5474; Zhao YJ, 2013, MOL CLIN ONCOL, V1, P593, DOI [10.3892/mco.2013.119, DOI 10.3892/MCO.2013.119]	17	2	2	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2017	13	4					2316	2322		10.3892/ol.2017.5732				7	Oncology	Oncology	ER0YF	WOS:000398514200043	28454397	gold			2018-01-05	
J	Jungbluth, H; Ochala, J; Trevese, S; Gautel, M				Jungbluth, Heinz; Ochala, Julien; Trevese, Susan; Gautel, Mathias			Current and future therapeutic approaches to the congenital myopathies	SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY			English	Review						Neuromuscular disorders; Congenital myopathies; Genetics; Therapy	FIBER-TYPE DISPROPORTION; LINKED MYOTUBULAR MYOPATHY; MULTI-MINICORE DISEASE; CENTRAL CORE DISEASE; DNM2-RELATED CENTRONUCLEAR MYOPATHY; GENOTYPE-PHENOTYPE CORRELATIONS; CALCIUM-RELEASE CHANNEL; DOMINANT ACTA1 DISEASE; SELENOPROTEIN-N GENE; NEMALINE MYOPATHY	The congenital myopathies - including Central Core Disease (CCD), Multi-minicore Disease (MmD), Centronuclear Myopathy (CNM), Nemaline Myopathy (NM) and Congenital Fibre Type Disproportion (CFTD) - are a genetically heterogeneous group of early-onset neuromuscular conditions characterized by distinct histopathological features, and associated with a substantial individual and societal disease burden. Appropriate supportive management has substantially improved patient morbidity and mortality but there is currently no cure. Recent years have seen an exponential increase in the genetic and molecular understanding of these conditions, leading to the identification of underlying defects in proteins involved in calcium homeostasis and excitation-contraction coupling, thick/thin filament assembly and function, redox regulation, membrane trafficking and/or autophagic pathways. Based on these findings, specific therapies are currently being developed, or are already approaching the clinical trial stage. Despite undeniable progress, therapy development faces considerable challenges, considering the rarity and diversity of specific conditions, and the size and complexity of some of the genes and proteins involved. The present review will summarize the key genetic, histopathological and clinical features of specific congenital myopathies, and outline therapies already available or currently being developed in the context of known pathogenic mechanisms. The relevance of newly discovered molecular mechanisms and novel gene editing strategies for future therapy development will be discussed. (C) 2016 Elsevier Ltd. All rights reserved.	[Jungbluth, Heinz] Guys & St Thomas Hosp NHS Fdn Trust, Evelinas Children Hosp, Dept Paediat Neurol, Neuromuscular Serv, London, England; [Jungbluth, Heinz; Gautel, Mathias] Kings Coll London, BHF Ctr Res Excellence, Muscle Signalling Sect Biophys, Randall Div Cell & Mol Biophys, London, England; [Jungbluth, Heinz; Gautel, Mathias] Kings Coll London, BHF Ctr Res Excellence, Cardiovasc Div, London, England; [Jungbluth, Heinz] Kings Coll London, IoPPN, Dept Basic & Clin Neurosci, London, England; [Ochala, Julien] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England; [Trevese, Susan] Basel Univ Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Trevese, Susan] Basel Univ Hosp, Dept Anaesthesia, CH-4031 Basel, Switzerland	Jungbluth, H (reprint author), St Thomas Hosp, Childrens Neurosci Ctr, F01 Staircase D South Wing,Westminster Bridge Rd, London SE1 7EH, England.	heinz.jungbluth@gstt.nhs.uk		Ochala, Julien/0000-0002-6358-2920	Myotubular Trust, Great Britain [12KCL01]; Medical Research Council NI Research Grant [MR/N002768/1]; Swiss National Science Foundation (SNF) [31003A-146198]; OPO Stiftung [2013/14-0036]; Telethon Italy [GGP14003]; Department of Anaesthesia Basel University Hospital; Leducq Foundation; MRC	HJ acknowledges support from the Myotubular Trust, Great Britain (Grant reference number 12KCL01). JO was supported by a project grant from the Medical Research Council NI Research Grant (MR/N002768/1). ST was supported by a grant from the Swiss National Science Foundation (SNF No 31003A-146198), a grant from the OPO Stiftung (Grant reference number 2013/14-0036), a grant from the Myotubular Trust, Great Britain (Grant reference number 12KCL01) and a grant to Telethon Italy (Grant No GGP14003). The support of the Department of Anaesthesia Basel University Hospital is gratefully acknowledged. MG holds the BHF Chair of Molecular Cardiology and is supported by the Leducq Foundation and the MRC.	Agrawal PB, 2014, AM J HUM GENET, V95, P218, DOI 10.1016/j.ajhg.2014.07.004; Agrelo R, 2015, EPIGENETICS-US, V10, P329, DOI 10.1080/15592294.2015.1027853; Amburgey K, 2011, ANN NEUROL, V70, P662, DOI 10.1002/ana.22510; Amthor H, 2012, CURR GENE THER, V12, P245, DOI 10.2174/156652312800840577                                                      ; Andersson Daniel C, 2010, Drug Discov Today Dis Mech, V7, pe151, DOI 10.1016/j.ddmec.2010.09.009; Arbogast S, 2009, ANN NEUROL, V65, P677, DOI 10.1002/ana.21644; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Beggs AH, 2010, P NATL ACAD SCI USA, V107, P14697, DOI 10.1073/pnas.1003677107; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bohm J, 2014, BRAIN, V137, P3160, DOI 10.1093/brain/awu272; Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Cathomen T, 2014, NEW ENGL J MED, V370, P2342, DOI 10.1056/NEJMcibr1403629; Ceyhan-Birsoy O, 2013, NEUROLOGY, V81, P1205, DOI 10.1212/WNL.0b013e3182a6ca62; Chauveau C, 2014, HUM MUTAT, V35, P1046, DOI 10.1002/humu.22611; Chauveau C, 2014, HUM MOL GENET, V23, P980, DOI 10.1093/hmg/ddt494; Childers MK, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007523; Clarke NF, 2006, ANN NEUROL, V59, P546, DOI 10.1002/ana.20761; Clarke NF, 2008, ANN NEUROL, V63, P329, DOI 10.1002/ana.21308; Clarke NF, 2007, ANN NEUROL, V61, P552, DOI 10.1002/ana.21112; Clarke NF, 2011, SEMIN PEDIATR NEUROL, V18, P264, DOI 10.1016/j.spen.2011.10.008; Clarke NF, 2010, HUM MUTAT, V31, pE1544, DOI 10.1002/humu.21278; Cowling BS, 2014, J CLIN INVEST, V124, P1350, DOI 10.1172/JCI71206; Cowling BS, 2012, PLOS GENET, V8, P31, DOI 10.1371/journal.pgen.1002595; Cullup T, 2012, NEUROMUSCULAR DISORD, V22, P1096, DOI 10.1016/j.nmd.2012.06.007; De Cid R, 2015, NEUROLOGY, V85, P2126, DOI 10.1212/WNL.0000000000002200; de Winter JM, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0037-7; de Winter JM, 2013, J MED GENET, V50, P383, DOI 10.1136/jmedgenet-2012-101470; Deniziak M, 2007, EXP CELL RES, V313, P156, DOI 10.1016/j.yexcr.2006.10.005; Dlamini N, 2013, NEUROMUSCULAR DISORD, V23, P540, DOI 10.1016/j.nmd.2013.03.008; Dowling JJ, 2012, DIS MODEL MECH, V5, P852, DOI 10.1242/dmm.009746; Dowling JJ, 2012, BRAIN, V135, P1115, DOI 10.1093/brain/aws036; Ducreux S, 2006, BIOCHEM J, V395, P259, DOI 10.1042/BJ20051282; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Feng JJ, 2009, NEUROMUSCULAR DISORD, V19, P6, DOI 10.1016/j.nmd.2008.09.005; Ferreiro A, 2004, ANN NEUROL, V55, P676, DOI 10.1002/ana.20077; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Ghassemi F, 2009, CELL CALCIUM, V45, P192, DOI 10.1016/j.ceca.2008.10.001; Gibbs EM, 2013, J MOL MED, V91, P727, DOI 10.1007/s00109-013-0994-4; Gordon AM, 2000, PHYSIOL REV, V80, P853; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Herman GE, 1999, J PEDIATR-US, V134, P206, DOI 10.1016/S0022-3476(99)70417-8; Joya JE, 2004, HUM MOL GENET, V13, P2633, DOI 10.1093/hmg/ddh285; Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2; Jungbluth H., 2014, FRONT AGING NEUROSCI, V6, P339; Jungbluth H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-25; Jungbluth Heinz, 2012, Neuromuscul Disord, V22, P453, DOI 10.1016/j.nmd.2011.12.003; Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005; Jungbluth H, 2010, NEUROMUSCULAR DISORD, V20, P49, DOI 10.1016/j.nmd.2009.10.005; Jungbluth H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-31; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Jurynec MJ, 2008, P NATL ACAD SCI USA, V105, P12485, DOI 10.1073/pnas.0806015105; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; Kusaczuk M, 2015, CURR PHARM DESIGN, V21, P2147, DOI 10.2174/1381612821666150105160059                                               ; Laing NG, 2004, ANN NEUROL, V56, P689, DOI 10.1002/ana.20260; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lawlor MW, 2013, HUM MOL GENET, V22, P1525, DOI 10.1093/hmg/ddt003; Lawlor MW, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-23; Lawlor MW, 2011, AM J PATHOL, V178, P784, DOI 10.1016/j.ajpath.2010.10.035; Lindqvist J, 2013, J NEUROPATH EXP NEUR, V72, P472, DOI 10.1097/NEN.0b013e318293b1cc; Loseth S, 2013, J NEUROL, V260, P1504, DOI 10.1007/s00415-012-6817-7; MacArthur DG, 2012, TRENDS GENET, V28, P303, DOI 10.1016/j.tig.2012.05.001; Maggi L, 2013, NEUROMUSCULAR DISORD, V23, P195, DOI 10.1016/j.nmd.2013.01.004; Majczenko K, 2012, AM J HUM GENET, V91, P365, DOI 10.1016/j.ajhg.2012.06.012; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Marttila M, 2014, HUM MUTAT, V35, P779, DOI 10.1002/humu.22554; Messina S, 2004, NEUROPEDIATRICS, V35, P262, DOI 10.1055/s-2004-821173; Michalek-Sauberer A, 1998, ANESTH ANALG, V86, P915, DOI 10.1097/00000539-199804000-00047                                                ; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713                                                                   ; Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; Natera-de Benito D, 2016, J NEUROL, V263, P517, DOI 10.1007/s00415-015-8015-x; Nguyen MAT, 2011, BRAIN, V134, P3513, DOI 10.1093/brain/awr274; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; North KN, 2014, NEUROMUSCULAR DISORD, V24, P97, DOI 10.1016/j.nmd.2013.11.003; Nowak KJ, 1999, NAT GENET, V23, P208; Nowak KJ, 2007, ANN NEUROL, V61, P175, DOI 10.1002/ana.21035; Nowak KJ, 2013, ACTA NEUROPATHOL, V125, P19, DOI 10.1007/s00401-012-1019-z; Nowak KJ, 2009, J CELL BIOL, V185, P903, DOI 10.1083/jcb.200812132; Ochala J., 2016, PLOS ONE, V7; Ochala J, 2012, HUM MOL GENET, V21, P4473, DOI 10.1093/hmg/dds289; Ochala J, 2011, FASEB J, V25, P1903, DOI 10.1096/fj.10-176727; Ochala J, 2010, P NATL ACAD SCI USA, V107, P9807, DOI 10.1073/pnas.1001733107; Ochala J, 2008, J MOL MED-JMM, V86, P1197, DOI 10.1007/s00109-008-0380-9; Ortolano S, 2011, NEUROMUSCULAR DISORD, V21, P254, DOI 10.1016/j.nmd.2010.12.011; Ottenheijm CAC, 2013, BRAIN, V136, P1718, DOI 10.1093/brain/awt113; Ottenheijm CAC, 2011, HUM MOL GENET, V20, P2015, DOI 10.1093/hmg/ddr084; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928                                                       ; Ravenscroft G, 2013, HUM MOL GENET, V22, P3987, DOI 10.1093/hmg/ddt252; Ravenscroft G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028699; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Rendu J, 2013, HUM GENE THER, V24, P702, DOI 10.1089/hum.2013.052; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; Robb SA, 2011, NEUROMUSCULAR DISORD, V21, P379, DOI 10.1016/j.nmd.2011.02.012; Rokach O, 2015, HUM MOL GENET, V24, P4636, DOI 10.1093/hmg/ddv195; Romero NB, 2013, CURR OPIN NEUROL, V26, P519, DOI 10.1097/WCO.0b013e328364d681; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Russell AJ, 2012, NAT MED, V18, P452, DOI 10.1038/nm.2618; Ryan MM, 2001, ANN NEUROL, V50, P312, DOI 10.1002/ana.1080; Ryan MM, 2008, J CHILD NEUROL, V23, P609, DOI 10.1177/0883073807309794; Sanoudou D, 2006, HUM MOL GENET, V15, P2603, DOI 10.1093/hmg/ddl186; Schessl J, 2007, NEUROMUSCULAR DISORD, V17, P28, DOI 10.1016/j.nmd.2006.09.013; Schreuder LTW, 2010, J INHERIT METAB DIS, V33, pS205, DOI 10.1007/s10545-010-9085-7; Shoseyov D., 2016, EXPERT REV RESP MED, V24, P1; Thada V, 2016, J CELL MOL MED, V20, P381, DOI 10.1111/jcmm.12744; Timmins MA, 2015, ANESTHESIOLOGY, V123, P548, DOI 10.1097/ALN.0000000000000732; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; Treves S., 2017, CELL DEV BIOL, V64, P201; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; Wang CH, 2012, J CHILD NEUROL, V27, P363, DOI 10.1177/0883073812436605; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; Winter L, 2014, J CLIN INVEST, V124, P1144, DOI 10.1172/JCI71919; Witting N, 2016, MUSCLE NERVE, V53, P388, DOI 10.1002/mus.24765; Xie M, 2014, CIRCULATION, V129, P1139, DOI 10.1161/CIRCULATIONAHA.113.002416; Young LM, 2016, METHODS, V95, P62, DOI 10.1016/j.ymeth.2015.05.017; Yuen M, 2015, HUM MOL GENET, V24, P6278, DOI 10.1093/hmg/ddv334; Yuen M, 2015, J CLIN INVEST, V125, P456, DOI 10.1172/JCI80057; Zhou HY, 2006, HUM MOL GENET, V15, P2791, DOI 10.1093/hmg/ddl221	126	5	5	3	6	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1084-9521			SEMIN CELL DEV BIOL	Semin. Cell Dev. Biol.	APR	2017	64						191	200		10.1016/j.semcdb.2016.08.004				10	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	ER2GR	WOS:000398612700023	27515125				2018-01-05	
J	Sontag, S; Forster, M; Qin, J; Wanek, P; Mitzka, S; Schuler, HM; Koschmieder, S; Rose-John, S; Sere, K; Zenke, M				Sontag, Stephanie; Foerster, Malrun; Qin, Jie; Wanek, Paul; Mitzka, Saskia; Schueler, Herdit M.; Koschmieder, Steffen; Rose-John, Stefan; Sere, Kristin; Zenke, Martin			Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells	STEM CELLS			English	Article						Induced pluripotent stem cell; Embryonic stem cell; CRISPR/Cas; Hematopoiesis; Interferon regulatory factor 8; Dendritic cell	PLURIPOTENT STEM-CELLS; REGULATORY FACTOR-8; STEADY-STATE; NETWORK; MOUSE; GENERATION; IMMUNODEFICIENCY; DIFFERENTIATION; SPECIFICATION; PROGENITORS	Human induced pluripotent stem (iPS) cells can differentiate into cells of all three germ layers, including hematopoietic stem cells and their progeny. Interferon regulatory factor 8 (IRF8) is a transcription factor, which acts in hematopoiesis as lineage determining factor for myeloid cells, including dendritic cells (DC). Autosomal recessive or dominant IRF8 mutations occurring in patients cause severe monocytic and DC immunodeficiency. To study IRF8 in human hematopoiesis we generated human IRF8-/-iPS cells and IRF8-/-embryonic stem (ES) cells using RNA guided CRISPR/ Cas9n genome editing. Upon induction of hematopoietic differentiation, we demonstrate that IRF8 is dispensable for iPS cell and ES cell differentiation into hemogenic endothelium and for endothelial-to-hematopoietic transition, and thus development of hematopoietic progenitors. We differentiated iPS cell and ES cell derived progenitors into CD141+ cross-presenting cDC1 and CD1c+ classical cDC2 and CD303+ plasmacytoid DC (pDC). We found that IRF8 deficiency compromised cDC1 and pDC development, while cDC2 development was largely unaffected. Additionally, in an unrestricted differentiation regimen, IRF8-/-iPS cells and ES cells exhibited a clear bias toward granulocytes at the expense of monocytes. IRF8-/-DC showed reduced MHC class II expression and were impaired in cytokine responses, migration, and antigen presentation. Taken together, we engineered a human IRF8 knockout model that allows studying molecular mechanisms of human immunodeficiencies in vitro, including the pathophysiology of IRF8 deficient DC.	[Sontag, Stephanie; Foerster, Malrun; Qin, Jie; Wanek, Paul; Mitzka, Saskia; Sere, Kristin; Zenke, Martin] Inst Biomed Engn, Dept Cell Biol, Hyderabad, Andhra Pradesh, India; [Schueler, Herdit M.] Rhein Westfal TH Aachen, Sch Med, Dept Human Genet, Aachen, Germany; [Koschmieder, Steffen] Rhein Westfal TH Aachen, Sch Med, Dept Hematol Oncol Hemostaseol & Stem Cell, Aachen, Germany; [Sontag, Stephanie; Foerster, Malrun; Qin, Jie; Wanek, Paul; Sere, Kristin; Zenke, Martin] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Aachen, Germany; [Rose-John, Stefan] Univ Kiel, Inst Biochem, Fac Med, Kiel, Germany	Zenke, M (reprint author), Inst Biomed Engn, Dept Cell Biol, Hyderabad, Andhra Pradesh, India.; Zenke, M (reprint author), Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Aachen, Germany.	martin.zenke@rwth-aachen.de			Ministry for Innovation, Science and Research of German Federal State of North Rhine-Westphalia, Duesseldorf, Germany; Interdisciplinary Center for Clinical Research (IZKF) Aachen, Germany	We thank Gulcan Aydin for cell sorting and overall technical assistance, Carmen Schalla for expert advice on molecular cloning and Western blotting, Ulla Gollan for sample preparation for cytogenetic analysis, Stefan Frank and Boris Greber for vectors, Gordon Keller and Marion Kennedy for advice on the derivation of hematopoietic cells from pluripotent stem cells and Eveline Mierau and Renate Sous for excellent secretary assistance. This work was supported in part by the Ministry for Innovation, Science and Research of German Federal State of North Rhine-Westphalia, Duesseldorf, Germany (S. S. and M. Z.) and by a research grant of the Interdisciplinary Center for Clinical Research (IZKF) Aachen, Germany (K. S., S. K. and M. Z.).	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Choi KD, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.184; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Felker P, 2010, J IMMUNOL, V185, P5326, DOI 10.4049/jimmunol.0903950; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gottgens B, 2015, BLOOD, V125, P2614, DOI 10.1182/blood-2014-08-570226; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Ju XS, 2007, EUR J IMMUNOL, V37, P1174, DOI 10.1002/eji.200636504; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Lenz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08973; Li Yan, 2014, World J Stem Cells, V6, P1, DOI 10.4252/wjsc.v6.i1.1; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Lundberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052875; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Parekh C, 2013, J CLIN IMMUNOL, V33, P711, DOI 10.1007/s10875-012-9844-3; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rossi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052232; Salem S, 2013, ADV EXP MED BIOL, V783, P45, DOI 10.1007/978-1-4614-6111-1_3; Salem S, 2014, BLOOD, V124, P1894, DOI 10.1182/blood-2014-04570879; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Senju S, 2011, GENE THER, V18, P874, DOI 10.1038/gt.2011.22; Senju S, 2007, STEM CELLS, V25, P2720, DOI 10.1634/stemcells.2007-0321; Sere K, 2012, IMMUNITY, V37, P905, DOI 10.1016/j.immuni.2012.07.019; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Silk KM, 2012, GENE THER, V19, P1035, DOI 10.1038/gt.2011.177; Slukvin II, 2013, BLOOD, V122, P4035, DOI 10.1182/blood-2013-07-474825; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573                                                     ; Tamura T, 2015, INT J HEMATOL, V101, P342, DOI 10.1007/s12185-015-1761-9; Tseng SY, 2009, REGEN MED, V4, P513, DOI 10.2217/RME.09.25; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131                                                     ; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007; Zhang M, 2014, P NATL ACAD SCI USA, V111, pE5383, DOI 10.1073/pnas.1419553111; Ziegler E, 2006, J AM SOC NEPHROL, V17, P2521, DOI 10.1681/ASN.2005070782	54	2	2	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	APR	2017	35	4					898	908		10.1002/stem.2565				11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	EQ5DM	WOS:000398102000006	28090699	gold			2018-01-05	
J	Phanthong, P; Borwornpinyo, S; Kitiyanant, N; Jearawiriyapaisarn, N; Nuntakarn, L; Saetan, J; Nualkaew, T; Sa-Ngiamsuntorn, K; Anurathapan, U; Dinnyes, A; Kitiyanant, Y; Hongeng, S				Phanthong, Phetcharat; Borwornpinyo, Suparerk; Kitiyanant, Narisorn; Jearawiriyapaisarn, Natee; Nuntakarn, Lalana; Saetan, Jirawat; Nualkaew, Tiwaporn; Sa-Ngiamsuntorn, Khanit; Anurathapan, Usanarat; Dinnyes, Andras; Kitiyanant, Yindee; Hongeng, Suradej			Enhancement of beta-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Induced pluripotent stem cell; beta-Thalassemia; U7 snRNA; Induced pluripotent stem cell-derived erythroblast	PRE-MESSENGER-RNA; SMALL NUCLEAR RNAS; IPS CELLS; ANTISENSE OLIGONUCLEOTIDES; POINT MUTATION; IN-VITRO; HEMOGLOBIN; PATIENT; DIFFERENTIATION; RESTORATION	The therapeutic use of patient-specific induced pluripotent stem cells (iPSCs) is emerging as a potential treatment of -thalassemia. Ideally, patient-specific iPSCs would be genetically corrected by various approaches to treat beta-thalassemia including lentiviral gene transfer, lentivirus-delivered shRNA, and gene editing. These corrected iPSCs would be subsequently differentiated into hematopoietic stem cells and transplanted back into the same patient. In this article, we present a proof of principle study for disease modeling and screening using iPSCs to test the potential use of the modified U7 small nuclear (sn) RNA to correct a splice defect in IVS2-654 beta-thalassemia. In this case, the aberration results from a mutation in the human beta-globin intron 2 causing an aberrant splicing of beta-globin pre-mRNA and preventing synthesis of functional beta-globin protein. The iPSCs (derived from mesenchymal stromal cells from a patient with IVS2-654 beta-thalassemia/hemoglobin (Hb) E) were transduced with a lentivirus carrying a modified U7 snRNA targeting an IVS2-654 beta-globin pre-mRNA in order to restore the correct splicing. Erythroblasts differentiated from the transduced iPSCs expressed high level of correctly spliced beta-globin mRNA suggesting that the modified U7 snRNA was expressed and mediated splicing correction of IVS2-654 beta-globin pre-mRNA in these cells. Moreover, a less active apoptosis cascade process was observed in the corrected cells at transcription level. This study demonstrated the potential use of a genetically modified U7 snRNA with patient-specific iPSCs for the partial restoration of the aberrant splicing process of beta-thalassemia.	[Phanthong, Phetcharat; Kitiyanant, Yindee] Mahidol Univ, Fac Sci, Dept Anat, Bangkok, Thailand; [Borwornpinyo, Suparerk] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand; [Borwornpinyo, Suparerk] Mahidol Univ, Fac Sci, Excellent Ctr Drug Discovery, Bangkok, Thailand; [Phanthong, Phetcharat; Kitiyanant, Narisorn; Kitiyanant, Yindee] Mahidol Univ, Stem Cell Res Grp, Phuttamonthon, Nakhon Pathom, Thailand; [Jearawiriyapaisarn, Natee; Nualkaew, Tiwaporn] Mahidol Univ, Thalassemia Res Ctr, Phuttamonthon, Nakhon Pathom, Thailand; [Kitiyanant, Yindee] Mahidol Univ, Inst Mol Biosci, Reproduct Biol Res Grp, Phuttamonthon, Nakhon Pathom, Thailand; [Nuntakarn, Lalana] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Obstet & Gynecol, Bangkok, Thailand; [Anurathapan, Usanarat; Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok, Thailand; [Saetan, Jirawat] Prince Songkla Univ, Fac Sci, Dept Anat, Hat Yai, Thailand; [Sa-Ngiamsuntorn, Khanit] Mahidol Univ, Fac Pharm, Dept Biochem, Bangkok, Thailand; [Dinnyes, Andras] Biotalentum Ltd, Godollo, Hungary; [Dinnyes, Andras] Szent Istvan Univ, Mol Anim Biotechnol Lab, Godollo, Hungary	Borwornpinyo, S (reprint author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand.; Borwornpinyo, S (reprint author), Mahidol Univ, Fac Sci, Excellent Ctr Drug Discovery, Bangkok, Thailand.; Hongeng, S (reprint author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok, Thailand.	suparerk.bor@mahidol.ac.th; suradej.hon@mahidol.ac.th			National Science and Technology Development Agency (NSTDA); Mahidol University Research Fund; Office of the Higher Education Commission; Mahidol University under the National Research University Initiative; Thailand Research Fund; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7-2012-PEOPLE- IAPP under REA grant (STEMMAD) [324451]; program Strategic Scholarships for Frontier Research Network; Office of the Higher Education Commission, Ministry of Education	This work was supported by Research Chair Grant from the National Science and Technology Development Agency (NSTDA), Mahidol University Research Fund, the Office of the Higher Education Commission and Mahidol University under the National Research University Initiative, Thailand Research Fund, and the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7-2012-PEOPLE- IAPP under REA grant agreement 324451 (STEMMAD). P.P. was supported by the program Strategic Scholarships for Frontier Research Network, the Joint PhD Program Thai Doctoral Degree from the Office of the Higher Education Commission, Ministry of Education. We would like to thank Jim Vadolas for providing pLL3.7 lentiviral vector and Christopher Baum and Axel Schambach for providing reprogramming vector. We thank Pirut Thong-ngam and Yongyut Pewklaing for qPCR analysis.	Bauman J, 2009, OLIGONUCLEOTIDES, V19, P1, DOI 10.1089/oli.2008.0161; Cao A, 2010, GENET MED, V12, P61, DOI 10.1097/GIM.0b013e3181cd68ed; Cavazzana M, 2014, BLOOD, V124; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Centis F, 2000, BLOOD, V96, P3624; Chang CJ, 2012, BLOOD, V120, P3906, DOI 10.1182/blood-2012-03-420703; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Chang KH, 2011, STEM CELLS INT, V2011; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]; CHENG TC, 1984, P NATL ACAD SCI-BIOL, V81, P2821, DOI 10.1073/pnas.81.9.2821; DesAngelis FG, 2002, P NATL ACAD SCI USA, V99, P9456; Dias J, 2011, STEM CELLS DEV, V20, P1639, DOI 10.1089/scd.2011.0078; Eckenfelder A, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.24; Fan Y, 2012, J REPROD DEVELOP, V58, P404, DOI 10.1262/jrd.2011-046; Fitzhugh DJ, 2000, J IMMUNOL, V165, P6677, DOI 10.4049/jimmunol.165.12.6677                                                    ; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; FUCHAROEN S, 1987, HEMOGLOBIN, V11, P65, DOI 10.3109/03630268709036587                                                       ; Fucharoen S, 2012, COLD SPRING HARB PER, V2; Fucharoen Suthat, 2011, Indian J Med Res, V134, P498; Geib T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008204; Gorman L, 1998, P NATL ACAD SCI USA, V95, P4929, DOI 10.1073/pnas.95.9.4929; Gorman L, 2000, J BIOL CHEM, V275, P35914, DOI 10.1074/jbc.M006259200; Goyenvalle A, 2009, MOL THER, V17, P1234, DOI 10.1038/mt.2009.113; GRIMM C, 1993, EMBO J, V12, P1229; Ho YT, 2009, ANTICANCER RES, V29, P4063; HUANG SZ, 1994, BRIT J HAEMATOL, V88, P541, DOI 10.1111/j.1365-2141.1994.tb05071.x                                              ; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lacerra G, 2000, P NATL ACAD SCI USA, V97, P9591, DOI 10.1073/pnas.97.17.9591; Lee YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068307; Lewis J, 1998, BLOOD, V91, P2152; Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; Mettananda S, 2015, BLOOD, V125, P3694, DOI 10.1182/blood-2015-03-633594; Mikkola M, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0365; MOWRY KL, 1987, SCIENCE, V238, P1682, DOI 10.1126/science.2825355; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Ponnikorn S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-96; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sa-ngiamsuntorn K, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-89; Shirohzu H, 2000, INT J HEMATOL, V72, P28; Smith BW, 2013, BLOOD, V122, P376, DOI 10.1182/blood-2012-11-466722; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; SPYCHER C, 1994, NUCLEIC ACIDS RES, V22, P4023, DOI 10.1093/nar/22.20.4023                                                          ; Suwanmanee T, 2002, MOL THER, V6, P718, DOI 10.1006/mthe.2002.0805; Suwanmanee T, 2002, MOL PHARMACOL, V62, P545, DOI 10.1124/mol.62.3.545; Svasti S, 2009, P NATL ACAD SCI USA, V106, P1205, DOI 10.1073/pnas.0812436106; Thein SL, 2008, BRIT J HAEMATOL, V141, P357, DOI 10.1111/j.1365-2141.2008.07084.x; Thompson AA, 2014, BLOOD, V124; Tisdale J, 2001, SEMIN HEMATOL, V38, P382, DOI 10.1053/shem.2001.27571; Tubsuwan A, 2011, BRIT J HAEMATOL, V154, P635, DOI 10.1111/j.1365-2141.2011.08770.x; Vacek MM, 2003, BLOOD, V101, P104, DOI 10.1182/blood-2002-06-1869; Vichinsky E, 2007, HEMATOL-AM SOC HEMAT, V2007, P79, DOI DOI 10.1182/ASHEDUCATI0N-2007.1.79; Wang YX, 2012, CELL RES, V22, P637, DOI 10.1038/cr.2012.23; Wang YX, 2009, CELL RES, V19, P1120, DOI 10.1038/cr.2009.100; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Wein N, 2010, HUM MUTAT, V31, P136, DOI 10.1002/humu.21160; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; ZHANG JZ, 1988, HUM GENET, V78, P37, DOI 10.1007/BF00291231; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554	66	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	APR	2017	6	4					1059	1069		10.1002/sctm.16-0121				11	Cell & Tissue Engineering	Cell Biology	EQ6QB	WOS:000398206500002	28213976	gold			2018-01-05	
J	Miro, C; Ambrosio, R; De Stefano, MA; Di Girolamo, D; Di Cicco, E; Cicatiello, AG; Mancino, G; Porcelli, T; Raia, M; Del Vecchio, L; Salvatore, D; Dentice, M				Miro, Caterina; Ambrosio, Raffaele; De Stefano, Maria Angela; Di Girolamo, Daniela; Di Cicco, Emery; Cicatiello, Annunziata Gaetana; Mancino, Giuseppina; Porcelli, Tommaso; Raia, Maddalena; Del Vecchio, Luigi; Salvatore, Domenico; Dentice, Monica			The Concerted Action of Type 2 and Type 3 Deiodinases Regulates the Cell Cycle and Survival of Basal Cell Carcinoma Cells	THYROID			English	Article						deiodinases; thyroid hormone metabolism; basal cell carcinoma	THYROID-HORMONE RECEPTOR; AUTOREGULATORY LOOP; XENOGRAFT MODELS; TUMORIGENESIS; EXPRESSION; SKIN; PROLIFERATION; KERATINOCYTES; INACTIVATION; INHIBITION	Background: Thyroid hormones (THs) mediate pleiotropic cellular processes involved in metabolism, cellular proliferation, and differentiation. The intracellular hormonal environment can be tailored by the type 1 and 2 deiodinase enzymes D2 and D3, which catalyze TH activation and inactivation respectively. In many cellular systems, THs exert well-documented stimulatory or inhibitory effects on cell proliferation; however, the molecular mechanisms by which they control rates of cell cycle progression have not yet been entirely clarified. We previously showed that D3 depletion or TH treatment influences the proliferation and survival of basal cell carcinoma (BCC) cells. Surprisingly, we also found that BCC cells express not only sustained levels of D3 but also robust levels of D2. The aim of the present study was to dissect the contribution of D2 to TH metabolism in the BCC context, and to identify the molecular changes associated with cell proliferation and survival induced by TH and mediated by D2 and D3. Methods: We used the CRISPR/Cas9 technology to genetically deplete D2 and D3 in BCC cells and studied the consequences of depletion on cell cycle progression and on cell death. Cell cycle progression was analyzed by fluorescence activated cell sorting analysis of synchronized cells, and the apoptosis rate by annexin V incorporation. Results: Mechanistic investigations revealed that D2 inactivation accelerates cell cycle progression thereby enhancing the proportion of S-phase cells and cyclin D1 expression. Conversely, D3 mutagenesis drastically suppressed cell proliferation and enhanced apoptosis of BCC cells. Furthermore, the basal apoptotic rate was oppositely regulated in D2-and D3-depleted cells. Conclusion: Our results indicate that BCC cells constitute an example in which the TH signal is finely tuned by the concerted expression of opposite-acting deiodinases. The dual regulation of D2 and D3 expression plays a critical role in cell cycle progression and cell death by influencing cyclin D1-mediated entry into the G1-S phase. These findings reinforce the concept that TH is a potential therapeutic target in human BCC.	[Miro, Caterina; De Stefano, Maria Angela; Di Girolamo, Daniela; Di Cicco, Emery; Cicatiello, Annunziata Gaetana; Mancino, Giuseppina; Porcelli, Tommaso; Salvatore, Domenico; Dentice, Monica] Univ Naples Federico II, Dept Clin Med & Surg, Via S Pansini 5, I-80131 Naples, Italy; [Ambrosio, Raffaele] Ist Ricovero & Cura Carattere Sci SDN, Naples, Italy; [Raia, Maddalena; Del Vecchio, Luigi; Salvatore, Domenico; Dentice, Monica] Ctr Ingn Genet Biotecnol Avanzate Sc Arl, Naples, Italy	Dentice, M (reprint author), Univ Naples Federico II, Dept Clin Med & Surg, Via S Pansini 5, I-80131 Naples, Italy.	monica.dentice@unina.it			Associazione Italiana per la Ricerca sul Cancro [IG 13065, IG 11362]	This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro to M.D. (IG 13065) and D.S. (IG 11362). We thank Jean Ann Gilder (Scientific Communication srl., Naples, Italy) for writing assistance.	Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Antonini Dario, 2013, Front Endocrinol (Lausanne), V4, P104, DOI 10.3389/fendo.2013.00104; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Dentice M, 2007, P NATL ACAD SCI USA, V104, P14466, DOI 10.1073/pnas.0706754104; Dentice M, 2013, EXPERT OPIN THER TAR, V17, P1369, DOI 10.1517/14728222.2013.833189; Dentice M, 2011, J ENDOCRINOL, V209, P273, DOI 10.1530/JOE-11-0002; Di Girolamo D, 2016, J CLIN INVEST, V126, P2308, DOI 10.1172/JCI84465; Engelhard A, 2004, EXP DERMATOL, V13, P257, DOI 10.1111/j.0906-6705.2004.00175.x                                                ; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Garcia-Silva S, 2004, MOL CELL BIOL, V24, P7514, DOI 10.1128/MCB.24.17.7514-7523.2004; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Hanley K, 1996, J INVEST DERMATOL, V106, P404, DOI 10.1111/1523-1747.ep12343405                                                    ; Kim WG, 2014, THYROID, V24, P260, DOI 10.1089/thy.2013.0054; Komuves LG, 1998, J INVEST DERMATOL, V111, P429, DOI 10.1046/j.1523-1747.1998.00296.x; Lukas J, 1996, MOL CELL BIOL, V16, P6917; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Park JW, 2017, MOL CARCINOGEN, V56, P489, DOI 10.1002/mc.22511; Park JW, 2013, AM J CANCER RES, V3, P302; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Puzianowska-Kuznicka M, 2006, ACTA BIOCHIM POL, V53, P641; Qi JS, 1999, MOL CELL BIOL, V19, P864; Sheng H, 2002, CANCER RES, V62, P5308; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sirakov M, 2013, BBA-GEN SUBJECTS, V1830, P3917, DOI 10.1016/j.bbagen.2012.07.014; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; TomicCanic M, 1996, J BIOL CHEM, V271, P1416, DOI 10.1074/jbc.271.3.1416                                                          ; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32; Yen GG, 2001, IEEE T SYST MAN CY B, V31, P523, DOI 10.1109/3477.938258	29	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	APR	2017	27	4					567	576		10.1089/thy.2016.0532				10	Endocrinology & Metabolism	Endocrinology & Metabolism	EQ9ZK	WOS:000398444900014	28088877				2018-01-05	
J	Jung, CJ; Zhang, JL; Trenchard, E; Lloyd, KC; West, DB; Rosen, B; de Jong, PJ				Jung, Chris J.; Zhang, Junli; Trenchard, Elizabeth; Lloyd, Kent C.; West, David B.; Rosen, Barry; de Jong, Pieter J.			Efficient gene targeting in mouse zygotes mediated by CRISPR/Cas9-protein	TRANSGENIC RESEARCH			English	Article						CRISPR; Transgenic mouse model; Gene targeting	ZINC-FINGER NUCLEASES; RNA-GUIDED ENDONUCLEASES; DOUBLE-STRAND BREAKS; ONE-STEP GENERATION; CASSETTE KNOCK-IN; CRISPR-CAS; HUMAN-CELLS; BACTERIAL IMMUNITY; MODIFIED MICE; GENOME-WIDE	The CRISPR/Cas9 system has rapidly advanced targeted genome editing technologies. However, its efficiency in targeting with constructs in mouse zygotes via homology directed repair (HDR) remains low. Here, we systematically explored optimal parameters for targeting constructs in mouse zygotes via HDR using mouse embryonic stem cells as a model system. We characterized several parameters, including single guide RNA cleavage activity and the length and symmetry of homology arms in the construct, and we compared the targeting efficiency between Cas9, Cas9nickase, and dCas9-FokI. We then applied the optimized conditions to zygotes, delivering Cas9 as either mRNA or protein. We found that Cas9 nucleo-protein complex promotes highly efficient, multiplexed targeting of circular constructs containing reporter genes and floxed exons. This approach allows for a one-step zygote injection procedure targeting multiple genes to generate conditional alleles via homologous recombination, and simultaneous knockout of corresponding genes in non-targeted alleles via non-homologous end joining.	[Jung, Chris J.; West, David B.; de Jong, Pieter J.] Univ Calif San Francisco, Benioff Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Zhang, Junli] Gladstone Inst, San Francisco, CA 94158 USA; [Trenchard, Elizabeth; Rosen, Barry] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Lloyd, Kent C.] Univ Calif Davis, Mouse Biol Program, Davis, CA 95618 USA	de Jong, PJ (reprint author), Univ Calif San Francisco, Benioff Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA.	pdejong@chori.org			BACPAC Resources Center at the UCSF Benioff Children's Hospital Oakland Research Institute; National Institutes of Health [5U42OD011175, U42OD012210, 5U24DK092993]	We extend our gratitude to Chih Chang at the Gladstone Institutes for performing all of the tail biopsies and maintaining the mice. This work was financially supported in part by the BACPAC Resources Center at the UCSF Benioff Children's Hospital Oakland Research Institute and by funding provided by National Institutes of Health (Grant Nos. 5U42OD011175, U42OD012210, 5U24DK092993).	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gondo Y, 2008, NAT REV GENET, V9, P803, DOI 10.1038/nrg2431; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Lee AYF, 2014, FEBS OPEN BIO, V4, P637, DOI 10.1016/j.fob.2014.06.007; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Menoret S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14410; Ochiai H, 2010, GENES CELLS, V15, P875, DOI 10.1111/j.1365-2443.2010.01425.x; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548                                                                ; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564                                                                ; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	52	3	3	3	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	APR	2017	26	2					263	277		10.1007/s11248-016-9998-5				15	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	EQ6IE	WOS:000398184200008	27905063	gold			2018-01-05	
J	Walter, DM; Venancio, OS; Buza, EL; Tobias, JW; Deshpande, C; Gudiel, AA; Kim-Kiselak, C; Cicchini, M; Yates, TJ; Feldser, DM				Walter, David M.; Venancio, Olivia S.; Buza, Elizabeth L.; Tobias, John W.; Deshpande, Charuhas; Gudiel, A. Andrea; Kim-Kiselak, Caroline; Cicchini, Michelle; Yates, Travis J.; Feldser, David M.			Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma	CANCER RESEARCH			English	Article							REMODELING FACTOR BRG1; K-RAS; H3K36 TRIMETHYLATION; GENOMICS DATA; CANCER; PROGRESSION; CELLS; ORIGIN; STABILITY; PROMOTES	Chromatin-modifying genes are frequently mutated in human lung adenocarcinoma, but the functional impact of these mutations on disease initiation and progression is not well understood. Using a CRISPR-based approach, we systematically inactivated three of the most commonly mutated chromatin regulatory genes in two KrasG12D-driven mouse models of lung adenocarcinoma to characterize the impact of their loss. Targeted inactivation of SWI/SNF nucleosome-remodeling complex members Smarca4 (Brg1) or Arid1a had complex effects on lung adenocarcinoma initiation and progression. Loss of either Brg1 or Arid1a were selected against in early-stage tumors, but Brg1 loss continued to limit disease progression over time, whereas loss of Arid1a eventually promoted development of higher grade lesions. In contrast to these stage-specific effects, loss of the histone methyltransferase Setd2 had robust tumor-promoting consequences. Despite disparate impacts of Setd2 and Arid1a loss on tumor development, each resulted in a gene expression profile with significant overlap. Setd2 inactivation and subsequent loss of H3K36me3 led to the swift expansion and accelerated progression of both early-and late-stage tumors. However, Setd2 loss per se was insufficient to overcome a p53-regulated barrier to malignant progression, nor establish the prometastatic cellular states that stochastically evolve during lung adenocarcinoma progression. Our study uncovers differential and context-dependent effects of SWI/SNF complex member loss, identifies Setd2 as a potent tumor suppressor in lung adenocarcinoma, and establishes model systems to facilitate further study of chromatin deregulation in lung cancer.	[Walter, David M.; Venancio, Olivia S.; Gudiel, A. Andrea; Kim-Kiselak, Caroline; Cicchini, Michelle; Yates, Travis J.; Feldser, David M.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Walter, David M.; Feldser, David M.] Univ Penn, Grad Program Cell & Mol Biol, Philadelphia, PA 19104 USA; [Buza, Elizabeth L.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Tobias, John W.] Univ Penn, Dept Genet & Penn Genom Anal Core, Philadelphia, PA 19104 USA; [Deshpande, Charuhas] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Feldser, David M.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Feldser, DM (reprint author), Perelman Sch Med, Abramson Family Canc Res Inst, 421 Curie Blvd,Rm 751,BRB 2-3, Philadelphia, PA 19104 USA.	dfeldser@upenn.edu			AACR-Bayer HealthCare Basic Cancer Research Fellowship; NIH [R00-CA158581, R01-CA193602, R21-CA205340]; American Lung Association [LCD400095]; Center of Excellence in Environmental Toxicology training grant [T32ES019851]; University of Pennsylvania's Undergraduate Research Mentorship program; American Cancer Society, North Texas Pay If Group Postdoctoral Fellowship [PF-16-22401TBE]; Penn Abramson Cancer Center core grant [P30-CA016520]	This work was supported by an AACR-Bayer HealthCare Basic Cancer Research Fellowship (M. Cicchini), grants from the NIH (R00-CA158581, R01-CA193602, R21-CA205340 to D.M. Feldser), and and from the American Lung Association (LCD400095 to D.M. Feldser), Center of Excellence in Environmental Toxicology training grant (T32ES019851 to M. Cicchini), and in part by the University of Pennsylvania's Undergraduate Research Mentorship program (O.S. Venancio). T.J. Yates is supported by the American Cancer Society, North Texas Pay If Group Postdoctoral Fellowship, PF-16-22401TBE. All authors are supported by the Penn Abramson Cancer Center core grantP30-CA016520.	[Anonymous], 2015, CANC FACTS FIG 2015; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Caswell DR, 2014, CANCER DISCOV, V4, P781, DOI 10.1158/2159-8290.CD-13-0862; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Zhang L, 2013, FRONT ONCOL, V3, DOI [10.3389/fonc.2013.00007, 10.3389/fonc.2013.00098, 10.3389/fenc.2013.00149]; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Izumchenko E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9258; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Li CMC, 2015, GENE DEV, V29, P1850, DOI 10.1101/gad.267393.115; Li J, 2016, ONCOTARGET, V7, P50719, DOI 10.18632/oncotarget.9368; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Pfister SX, 2015, CANCER CELL, V28, P557, DOI 10.1016/j.ccell.2015.09.015; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Rowbotham SP, 2014, P NATL ACAD SCI USA, V111, P4745, DOI 10.1073/pnas.1401955111; Roy N, 2015, GENE DEV, V29, P658, DOI 10.1101/gad.256628.114; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Sveen A, 2016, ONCOGENE, V35, P2413, DOI 10.1038/onc.2015.318; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589	45	3	3	2	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	APR 1	2017	77	7					1719	1729		10.1158/0008-5472.CAN-16-2159				11	Oncology	Oncology	EQ7KH	WOS:000398262400018	28202515				2018-01-05	
J	Zhang, DX; Li, L; Jiang, HM; Knolhoff, BL; Lockhart, AC; Wang-Gillam, A; DeNardo, DG; Ruzinova, MB; Lim, KH				Zhang, Daoxiang; Li, Lin; Jiang, Hongmei; Knolhoff, Brett L.; Lockhart, Albert C.; Wang-Gillam, Andrea; DeNardo, David G.; Ruzinova, Marianna B.; Lim, Kian-Huat			Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma	CLINICAL CANCER RESEARCH			English	Article							NF-KAPPA-B; STELLATE CELLS; KINASE-ACTIVITY; CANCER MICROENVIRONMENT; SIGNALING PATHWAYS; INHIBITION; EXPRESSION; PROMOTES; MACROPHAGES; COMBINATION	Purpose: Aberrant activation of the NF-kB transcription factors underlies the aggressive behavior and poor outcome of pancreatic ductal adenocarcinoma(PDAC). However, clinically effective and safe NF-kB inhibitors are not yet available. Because NF-kB transcription factors can be activated by the interleukin-1 receptorassociated kinases (IRAKs) downstream of the Toll-like receptors (TLRs), but has not been explored in PDAC, we sought to investigate the role of IRAKs in the pathobiology of PDAC. Experimental Design: We examined the phosphorylation status of IRAK4 (p-IRAK4), the master regulator of TLR signaling, in PDAC cell lines, in surgical samples and commercial tissue microarray. We then performed functional studies using smallmolecule IRAK1/4 inhibitor, RNA-interference, and CRISPR/Cas9n techniques to delineate the role of IRAK4 in NF-kB activity, chemoresistance, cytokine production, and growth of PDAC cells in vitro and in vivo. Results: p-IRAK4 staining was detectable in the majority of PDAC lines and about 60% of human PDAC samples. The presence of p-IRAK4 strongly correlated with phospho-NF-kB/p65 staining in PDAC samples and is predictive of postoperative relapse and poor overall survival. Inhibition of IRAK4 potently reduced NF-kB activity, anchorage-independent growth, chemoresistance, and secretion of proinflammatory cytokines from PDAC cells. Both pharmacologic suppression and genetic ablation of IRAK4 greatly abolished PDAC growth in mice and augmented the therapeutic effect of gemcitabine by promoting apoptosis, reducing tumor cell proliferation and tumor fibrosis. Conclusions: Our data established IRAK4 as a novel therapeutic target for PDAC treatment. Development of potent IRAK4 inhibitors is needed for clinical testing.	[Zhang, Daoxiang; Li, Lin; Jiang, Hongmei; Knolhoff, Brett L.; Lockhart, Albert C.; Wang-Gillam, Andrea; DeNardo, David G.; Lim, Kian-Huat] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ruzinova, Marianna B.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Lim, KH (reprint author), Washington Univ, Sch Med, 660 South Euclid Ave, St Louis, MO 63110 USA.	kian-huat.lim@wustl.edu			NCI Cancer Center Support Grant [P30 CA091842]; Washington University Institute of Clinical and Translational Sciences from the NCATS of the NIH [UL1 TR000448]; Elsa Pardee Foundation Award	This study was supported by the NCI Cancer Center Support Grant # P30 CA091842 (K.-H. Lim), Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the NCATS of the NIH (K.-H. Lim), and Elsa Pardee Foundation Award (K.-H. Lim and M.B. Ruzinova).	Adams AK, 2015, ONCOTARGET, V6, P43395, DOI 10.18632/oncotarget.6028; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Baines AT, 2006, METHOD ENZYMOL, V407, P556, DOI 10.1016/S0076-6879(05)07045-X; Bang D, 2013, CANCER DISCOV, V3, P690, DOI 10.1158/2159-8290.CD-12-0541; Bournazou E, 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.23828; Carbone C, 2012, EXPERT OPIN THER TAR, V16, pS1, DOI 10.1517/14728222.2011.645806; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fraczek J, 2008, J BIOL CHEM, V283, P31697, DOI 10.1074/jbc.M804779200; Hayes TK, 2016, CANCER CELL, V29, P75, DOI 10.1016/j.ccell.2015.11.011; Ikebe M, 2009, J SURG ONCOL, V100, P725, DOI 10.1002/jso.21392; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kelly PN, 2015, J EXP MED, V212, P2189, DOI 10.1084/jem.20151074; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Koziczak-Holbro M, 2007, J BIOL CHEM, V282, P13552, DOI 10.1074/jbc.M700548200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li ZY, 2015, J CLIN INVEST, V125, P1081, DOI 10.1172/JCI75821; Lim KH, 2013, COLD SPRING HARB PER, V5; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Melisi D, 2011, J NATL CANCER I, V103, P1190, DOI 10.1093/jnci/djr243; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nywening TM, 2016, LANCET ONCOL, V17, P651, DOI 10.1016/S1470-2045(16)00078-4; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Ochi A, 2012, J CLIN INVEST, V122, P4118, DOI 10.1172/JCI63606; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.0.20; Prabhu L, 2014, ONCOTARGET, V5, P10969, DOI 10.18632/oncotarget.2624                                                        ; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rhyasen GW, 2015, BRIT J CANCER, V112, P232, DOI 10.1038/bjc.2014.513; Rhyasen GW, 2013, CANCER CELL, V24, P90, DOI 10.1016/j.ccr.2013.05.006; Sanford DE, 2013, CLIN CANCER RES, V19, P3404, DOI 10.1158/1078-0432.CCR-13-0525; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Srivastava R, 2012, CANCER RES, V72, P6209, DOI 10.1158/0008-5472.CAN-12-0337; Tjomsland V, 2011, NEOPLASIA, V13, P664, DOI 10.1593/neo.11332; Vonlaufen A, 2008, CANCER RES, V68, P7707, DOI 10.1158/0008-5472.CAN-08-1132; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wee ZN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10054; Weichert W, 2007, BRIT J CANCER, V97, P523, DOI 10.1038/sj.bjc.6603878; Zambirinis CP, 2015, J EXP MED, V212, P2077, DOI 10.1084/jem.20142162	43	0	0	2	3	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	APR 1	2017	23	7					1748	1759		10.1158/1078-0432.CCR-16-1121				12	Oncology	Oncology	EQ7KK	WOS:000398262700015	27702822	gold			2018-01-05	
J	Guo, MZ; Tomoshige, K; Meister, M; Muley, T; Fukazawa, T; Tsuchiya, T; Karns, R; Warth, A; Fink-Baldauf, IM; Nagayasu, T; Naomoto, Y; Xu, Y; Mall, MA; Maeda, Y				Guo, Minzhe; Tomoshige, Koichi; Meister, Michael; Muley, Thomas; Fukazawa, Takuya; Tsuchiya, Tomoshi; Karns, Rebekah; Warth, Arne; Fink-Baldauf, Iris M.; Nagayasu, Takeshi; Naomoto, Yoshio; Xu, Yan; Mall, Marcus A.; Maeda, Yutaka			Gene signature driving invasive mucinous adenocarcinoma of the lung	EMBO MOLECULAR MEDICINE			English	Article						FOXA3; IMA; MUC5AC/5B; SPDEF; VTCN1	ETS TRANSCRIPTION FACTOR; SIZE CHIP-SEQ; BREAST-CANCER; TUMOR-SUPPRESSOR; PDEF EXPRESSION; CELL METAPLASIA; PEAK-MOTIFS; FACTOR-I; PD-L1; ONCOGENE	Though invasive mucinous adenocarcinoma of the lung (IMA) is pathologically distinctive, the molecular mechanism driving IMA is not well understood, which hampers efforts to identify therapeutic targets. Here, by analyzing gene expression profiles of human and mouse IMA, we identified a Mucinous Lung Tumor Signature of 143 genes, which was unexpectedly enriched in mucin-producing gastrointestinal, pancreatic, and breast cancers. The signature genes included transcription factors FOXA3, SPDEF, HNF4A, mucins MUC5AC, MUC5B, MUC3, and an inhibitory immune checkpoint VTCN1/B7-H4 (but not PD-L1/B7-H1). Importantly, induction of FOXA3 or SPDEF along with mutant KRAS in lung epithelium was sufficient to develop benign or malignant mucinous lung tumors, respectively, in transgenic mice. FOXA3 and SPDEF induced MUC5AC and MUC5B, while HNF4A induced MUC3 in human mucinous lung cancer cells harboring a KRAS mutation. ChIP-seq combined with CRISPR/Cas9 determined that upstream enhancer regions of the mucin genes MUC5AC and MUC5B, which were bound by SPDEF, were required for the expression of the mucin genes. Here, we report the molecular signature and gene regulatory network driving mucinous lung tumors.	[Guo, Minzhe; Tomoshige, Koichi; Fink-Baldauf, Iris M.; Xu, Yan; Maeda, Yutaka] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Neonatol, Cincinnati, OH 45229 USA; [Guo, Minzhe; Tomoshige, Koichi; Fink-Baldauf, Iris M.; Xu, Yan; Maeda, Yutaka] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Perinatal & Pulm Biol, Cincinnati, OH 45229 USA; [Guo, Minzhe; Tomoshige, Koichi; Karns, Rebekah; Fink-Baldauf, Iris M.; Xu, Yan; Maeda, Yutaka] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Guo, Minzhe] Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH USA; [Meister, Michael; Muley, Thomas] Univ Heidelberg Hosp, Thoraxklin, Translat Res Unit, Translat Lung Res Ctr Heidelberg TLRC,German Ctr, Heidelberg, Germany; [Fukazawa, Takuya; Naomoto, Yoshio] Kawasaki Med Univ, Dept Gen Surg, Okayama, Japan; [Tsuchiya, Tomoshi; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki, Japan; [Karns, Rebekah] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Warth, Arne] Heidelberg Univ, German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC, Inst Pathol, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC, Dept Translat Pulmonol, Heidelberg, Germany	Maeda, Y (reprint author), Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Neonatol, Cincinnati, OH 45229 USA.; Maeda, Y (reprint author), Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Perinatal & Pulm Biol, Cincinnati, OH 45229 USA.; Maeda, Y (reprint author), Univ Cincinnati, Coll Med, Cincinnati, OH USA.	yutaka.maeda@cchmc.org			American Lung Association [RG309608]; CF-RDP Pilot & Feasibility Grant; Cincinnati Children's Hospital Medical Center; Rotary Foundation Global Grant; Ministry of Education, Science and Culture, Japan	We thank J. Whitsett, F. Sladek, M. Durbin, I. Mitsui, H. Hao, P. Dexheimer, D. Fletcher, K. Dillehay McKillip, M. Fallenbuchel, G. Chen, Y-C. Hu, H. Miyoshi, F. Accornero, T. Suzuki and A. Perl for materials, technical support, and discussions. This work was supported by the American Lung Association (RG309608), Trustee Award Grant, CF-RDP Pilot & Feasibility Grant, Cincinnati Children's Hospital Medical Center (Y.M.), the Rotary Foundation Global Grant (K. T.), and the Ministry of Education, Science and Culture, Japan (T.T., T.N., Y.N., and T.F.).	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Buchwalter G, 2013, CANCER CELL, V23, P753, DOI 10.1016/j.ccr.2013.04.026; Cancer Genome Atlas Research Network, 2014, NATURE, V511, P543, DOI DOI 10.1038/NATURE13385; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chen G, 2014, AM J RESP CRIT CARE, V189, P301, DOI 10.1164/rccm.201306-1181OC; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; Choi YH, 2011, J BIOL CHEM, V286, P34199, DOI 10.1074/jbc.M111.247684; Ding X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095307; Feldman RJ, 2003, CANCER RES, V63, P4626; Fernandez-Cuesta L, 2014, CANCER DISCOV, V4, P415, DOI 10.1158/2159-8290.CD-13-0633; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Ghadersohi A, 2001, CLIN CANCER RES, V7, P2731; Ghadersohi A, 2008, INT J CANCER, V123, P1376, DOI 10.1002/ijc.23667; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Gu XS, 2007, CANCER RES, V67, P4219, DOI 10.1158/0008-5472.CAN-06-3689; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Hata A, 2010, J THORAC ONCOL, V5, P1197, DOI 10.1097/JTO.0b013e3181e2a2bc; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hirsch FR, 2016, LANCET, V388, P1012, DOI 10.1016/S0140-6736(16)31473-8; Jeon YK, 2015, BIOCHEM BIOPH RES CO, V459, P277, DOI 10.1016/j.bbrc.2015.02.098; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Kunii R, 2011, HISTOPATHOLOGY, V58, P467, DOI 10.1111/j.1365-2559.2011.03764.x; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lee YS, 2013, CANCER CELL, V24, P603, DOI 10.1016/j.ccr.2013.10.003; Leong SR, 2015, MOL PHARMACEUT, V12, P1717, DOI 10.1021/mp5007745; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Maeda Y, 2011, AM J RESP CRIT CARE, V184, P421, DOI 10.1164/rccm.201101-0106OC; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Nakaoku T, 2014, CLIN CANCER RES, V20, P3087, DOI 10.1158/1078-0432.CCR-14-0107; Noah TK, 2013, GASTROENTEROLOGY, V144, P1012, DOI 10.1053/j.gastro.2013.01.043; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; Rodabaugh KJ, 2007, INT J GYNECOL PATHOL, V26, P10, DOI 10.1097/01.pgp.0000225386.41244.bd; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Serresi M, 2016, CANCER CELL, V29, P17, DOI 10.1016/j.ccell.2015.12.006; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Skoulidis F, 2015, CANCER DISCOV, V5, P860, DOI 10.1158/2159-8290.CD-14-1236; Smyth MJ, 2016, NAT REV CLIN ONCOL, V13, P143, DOI 10.1038/nrclinonc.2015.209; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Sonora C, 2006, J HISTOCHEM CYTOCHEM, V54, P289, DOI 10.1369/jhc.5A6763.2005; Sood AK, 2007, HUM PATHOL, V38, P1628, DOI 10.1016/j.humpath.2007.03.010; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugano M, 2013, AM J SURG PATHOL, V37, P211, DOI 10.1097/PAS.0b013e31826be303; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Thomas-Chollier M, 2012, NAT PROTOC, V7, P1551, DOI 10.1038/nprot.2012.088; Thomas-Chollier M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1104; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Turner DP, 2008, MOL BIOL CELL, V19, P3745, DOI 10.1091/mbc.E08-02-0154; Valque H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046699; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	65	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-4676	1757-4684		EMBO MOL MED	EMBO Mol. Med.	APR	2017	9	4					462	481		10.15252/emmm.201606711				20	Medicine, Research & Experimental	Research & Experimental Medicine	EQ4HZ	WOS:000398038200008	28255028	gold			2018-01-05	
J	Manier, S; Powers, JT; Sacco, A; Glavey, SV; Huynh, D; Reagan, MR; Salem, KZ; Moschetta, M; Shi, J; Mishima, Y; Roche-Lestienne, C; Leleu, X; Roccaro, AM; Daley, GQ; Ghobrial, IM				Manier, S.; Powers, J. T.; Sacco, A.; Glavey, S. V.; Huynh, D.; Reagan, M. R.; Salem, K. Z.; Moschetta, M.; Shi, J.; Mishima, Y.; Roche-Lestienne, C.; Leleu, X.; Roccaro, A. M.; Daley, G. Q.; Ghobrial, I. M.			The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma	LEUKEMIA			English	Article							EPITHELIAL OVARIAN-CANCER; MICRORNA EXPRESSION; LET-7 MICRORNA; LIVER-CANCER; LUNG-CANCER; STEM-CELLS; LIN28; MYC; FAMILY; GROWTH	MYC is a major oncogenic driver of multiple myeloma (MM) and yet almost no therapeutic agents exist that target MYC in MM. Here we report that the let-7 biogenesis inhibitor LIN28B correlates with MYC expression in MM and is associated with adverse outcome. We also demonstrate that the LIN28B/let-7 axis modulates the expression of MYC, itself a let-7 target. Further, perturbation of the axis regulates the proliferation of MM cells in vivo in a xenograft tumor model. RNA-sequencing and gene set enrichment analyses of CRISPR-engineered cells further suggest that the LIN28/let-7 axis regulates MYC and cell cycle pathways in MM. We provide proof of principle for therapeutic regulation of MYC through let-7 with an LNA-GapmeR (locked nucleic acid-GapmeR) containing a let-7b mimic in vivo, demonstrating that high levels of let-7 expression repress tumor growth by regulating MYC expression. These findings reveal a novel mechanism of therapeutic targeting of MYC through the LIN28B/let-7 axis in MM that may impact other MYC-dependent cancers as well.	[Manier, S.; Sacco, A.; Glavey, S. V.; Huynh, D.; Reagan, M. R.; Salem, K. Z.; Moschetta, M.; Shi, J.; Mishima, Y.; Roccaro, A. M.; Ghobrial, I. M.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, HIM 237,77 Ave Louis Pasteur, Boston, MA 02115 USA; [Manier, S.; Leleu, X.] CHRU Lille, Serv Malad Sang, Lille, France; [Manier, S.; Roche-Lestienne, C.] Univ Lille 2, INSERM U1172, Jean Pierre Aubert Res Ctr, Lille, France; [Powers, J. T.; Daley, G. Q.] Harvard Med Sch, Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA; [Sacco, A.; Roccaro, A. M.] ASST Spedali Civili Dept Med Oncol, CREA Lab, Brescia, BS, Italy	Ghobrial, IM (reprint author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, HIM 237,77 Ave Louis Pasteur, Boston, MA 02115 USA.	irene_ghobrial@dfci.harvard.edu		Reagan, Michaela/0000-0003-2884-6481	ARC Foundation; National Cancer Institute [R01CA154648]	SM was supported by a grant from ARC Foundation. This work was supported by a grant from the National Cancer Institute (R01CA154648). Author Information: RNA-sequencing data have been deposited to the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under accession numbers GSE71100.	Affer M, 2014, LEUKEMIA, V28, P1725, DOI 10.1038/leu.2014.70; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chng WJ, 2011, LEUKEMIA, V25, P1026, DOI 10.1038/leu.2011.53; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Emmrich S, 2014, GENE DEV, V28, P858, DOI 10.1101/gad.233791.113; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Gerrits A, 2012, BLOOD, V119, P377, DOI [10.1182/blood-2011-01-331686, 10.1182/blood-2011-01331686]; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Howlader N, 2012, AM J EPIDEMIOL, V176, P347, DOI 10.1093/aje/kwr512; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Leleu X, 2007, BLOOD, V110, P4417, DOI 10.1182/blood-2007-05-092098; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nguyen LH, 2014, CANCER CELL, V26, P248, DOI 10.1016/j.ccr.2014.06.018; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Segalla S, 2015, NUCLEIC ACIDS RES, V43, P5182, DOI 10.1093/nar/gkv387; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637                                                   ; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tu HC, 2015, GENE DEV, V29, P1074, DOI 10.1101/gad.256693.114; Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Walker BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7997; Wang J, 2012, STEM CELLS DEV, V21, P1524, DOI 10.1089/scd.2011.0350; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	44	4	4	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	APR	2017	31	4					853	860		10.1038/leu.2016.296				8	Oncology; Hematology	Oncology; Hematology	EQ7KB	WOS:000398261800009	27773931	green_accepted			2018-01-05	
J	Song, CQ; Li, YX; Mou, HW; Moore, J; Park, A; Pomyen, Y; Hough, S; Kennedy, Z; Fischer, A; Yin, H; Anderson, DG; Conte, D; Zender, L; Wang, XW; Thorgeirsson, S; Weng, ZP; Xue, W				Song, Chun-Qing; Li, Yingxiang; Mou, Haiwei; Moore, Jill; Park, Angela; Pomyen, Yotsawat; Hough, Soren; Kennedy, Zachary; Fischer, Andrew; Yin, Hao; Anderson, Daniel G.; Conte, Darryl, Jr.; Zender, Lars; Wang, Xin Wei; Thorgeirsson, Snorri; Weng, Zhiping; Xue, Wen			Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice	GASTROENTEROLOGY			English	Article						Liver Cancer; Mouse Model; CRISPR Screen; Tumor Suppressor Genes	HUMAN HEPATOCELLULAR-CARCINOMA; IN-VIVO; MUTAGENESIS SCREEN; MOUSE-LIVER; HUMAN-CELLS; CANCER; GENES; SYSTEM; PATHOGENESIS; PROGRESSION	BACKGROUND & AIMS: It has been a challenge to identify liver tumor suppressors or oncogenes due to the genetic heterogeneity of these tumors. We performed a genome-wide screen to identify suppressors of liver tumor formation in mice, using CRISPR-mediated genome editing. METHODS: We performed a genome-wide CRISPR/Cas9-based knockout screen of P53-null mouse embryonic liver progenitor cells that overexpressed MYC. We infected p53(-/-); Myc; Cas9 hepatocytes with the mGeCKOa lentiviral library of 67,000 single-guide RNAs ( sgRNAs), targeting 20,611 mouse genes, and transplanted the transduced cells subcutaneously into nude mice. Within 1 month, all the mice that received the sgRNA library developed subcutaneous tumors. We performed high-throughput sequencing of tumor DNA and identified sgRNAs increased at least 8-fold compared to the initial cell pool. To validate the top 10 candidate tumor suppressors from this screen, we collected data from patients with hepatocellular carcinoma ( HCC) using the Cancer Genome Atlas and COSMIC databases. We used CRISPR to inactivate candidate tumor suppressor genes in p53(-/-);Myc; Cas9 cells and transplanted them subcutaneously into nude mice; tumor formation was monitored and tumors were analyzed by histology and immunohistochemistry. Mice with liver-specific disruption of p53 were given hydrodynamic tail-vein injections of plasmids encoding Myc and sgRNA/Cas9 designed to disrupt candidate tumor suppressors; growth of tumors and metastases was monitored. We compared gene expression profiles of liver cells with vs without tumor suppressor gene disrupted by sgRNA/Cas9. Genes found to be up-regulated after tumor suppressor loss were examined in liver cancer cell lines; their expression was knocked down using small hairpin RNAs, and tumor growth was examined in nude mice. Effects of the MEK inhibitors AZD6244, U0126, and trametinib, or the multikinase inhibitor sorafenib, were examined in human and mouse HCC cell lines. RESULTS: We identified 4 candidate liver tumor suppressor genes not previously associated with liver cancer ( Nf1, Plxnb1, Flrt2, and B9d1). CRISPR-mediated knockout of Nf1, a negative regulator of RAS, accelerated liver tumor formation in mice. Loss of Nf1 or activation of RAS up-regulated the liver progenitor cell markers HMGA2 and SOX9. RAS pathway inhibitors suppressed the activation of the Hmga2 and Sox9 genes that resulted from loss of Nf1 or oncogenic activation of RAS. Knockdown of HMGA2 delayed formation of xenograft tumors from cells that expressed oncogenic RAS. In human HCCs, low levels of NF1 messenger RNA or high levels of HMGA2 messenger RNA were associated with shorter patient survival time. Liver cancer cells with inactivation of Plxnb1, Flrt2, and B9d1 formed more tumors in mice and had increased levels of mitogen-activated protein kinase phosphorylation. CONCLUSIONS: Using a CRISPR-based strategy, we identified Nf1, Plxnb1, Flrt2, and B9d1 as suppressors of liver tumor formation. We validated the observation that RAS signaling, via mitogen-activated protein kinase, contributes to formation of liver tumors in mice. We associated decreased levels of NF1 and increased levels of its downstream protein HMGA2 with survival times of patients with HCC. Strategies to inhibit or reduce HMGA2 might be developed to treat patients with liver cancer.	[Song, Chun-Qing; Mou, Haiwei; Park, Angela; Hough, Soren; Kennedy, Zachary; Conte, Darryl, Jr.; Xue, Wen] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA; [Li, Yingxiang; Moore, Jill; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, 368 Plantat St, Worcester, MA 01605 USA; [Li, Yingxiang; Weng, Zhiping] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai, Peoples R China; [Pomyen, Yotsawat; Wang, Xin Wei; Thorgeirsson, Snorri] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Bethesda, MD 20892 USA; [Fischer, Andrew] Univ Massachusetts, Sch Med, UMass Mem Med Ctr, Dept Pathol, Worcester, MA USA; [Yin, Hao; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Anderson, Daniel G.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA; [Anderson, Daniel G.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zender, Lars] Univ Hosp Tubingen, Univ Dept Med, Dept Internal Med 8, Tubingen, Germany; [Zender, Lars] Eberhard Karls Univ Tubingen, Inst Physiol, Dept Physiol 1, Tubingen, Germany; [Xue, Wen] Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantat St,AS4-2043, Worcester, MA 01605 USA; [Xue, Wen] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, 368 Plantat St,AS4-2043, Worcester, MA 01605 USA	Weng, ZP (reprint author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, 368 Plantat St, Worcester, MA 01605 USA.; Xue, W (reprint author), Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantat St,AS4-2043, Worcester, MA 01605 USA.; Xue, W (reprint author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, 368 Plantat St,AS4-2043, Worcester, MA 01605 USA.	Zhiping.Weng@umassmed.edu; Wen.Xue@umassmed.edu	Wang, Xin/B-6162-2009	Wang, Xin/0000-0001-9735-606X; Pomyen, Yotsawat/0000-0002-1070-3047; Kennedy, Zachary/0000-0003-2476-1624; Hough, Soren/0000-0002-1628-2554	Skoltech Center; National Cancer Institute in the Massachusetts Institute of Technology-Harvard Center of Cancer Nanotechnology Excellence [5-U54-CA151884-04]; China Scholarship Council [201506260151]; Thousand Talent Plan; National Institutes of Health [R00CA169512, DP2HL137167, P01HL131471]; Worcester Foundation; University of Massachusetts Center for Clinical and Translational Science Pilot Project Program; Lung Cancer Research Foundation; Center for Cancer Research, National Cancer Institute [Z01-BC 010313, Z01-BC 010876]	Hao Yin was supported by the Skoltech Center and the National Cancer Institute in the Massachusetts Institute of Technology-Harvard Center of Cancer Nanotechnology Excellence (5-U54-CA151884-04). Yingxiang Li was supported by the China Scholarship Council (201506260151) and the Thousand Talent Plan funding to Zhiping Weng from the Chinese government. This work was supported by grants from the National Institutes of Health (R00CA169512, DP2HL137167, and P01HL131471), the Worcester Foundation, University of Massachusetts Center for Clinical and Translational Science Pilot Project Program and the Lung Cancer Research Foundation to Wen Xue. Yotsawat Pomyen and Xin Wei Wang were supported by grants (Z01-BC 010313 and Z01-BC 010876) from the intramural research program of the Center for Cancer Research, National Cancer Institute.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bard-Chapeau EA, 2014, NAT GENET, V46, P24, DOI 10.1038/ng.2847; Breunig C, 2014, CLIN CANCER RES, V20, P2410, DOI 10.1158/1078-0432.CCR-13-1635; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Delire B, 2015, EUR J CLIN INVEST, V45, P609, DOI 10.1111/eci.12441; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Forbes S. A., 2014, NUCLEIC ACIDS RES, V43, pD805, DOI DOI 10.1093/NAR/GKU1075; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Roman JJG, 2008, TRANSL RES, V151, P134, DOI 10.1016/j.trsl.2007.12.003; Haines BP, 2006, DEV BIOL, V297, P14, DOI 10.1016/j.ydbio.2006.04.004; Huang CH, 2014, GENE DEV, V28, P1800, DOI 10.1101/gad.244368.114; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Katz SF, 2012, GASTROENTEROLOGY, V142, P1229, DOI 10.1053/j.gastro.2012.02.009; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kodama T, 2016, GASTROENTEROLOGY, V151, P324, DOI 10.1053/j.gastro.2016.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Li C, 2015, ONCOL RES, V22, P203, DOI 10.3727/096504015X14386062091352; Li YX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0680-7; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Marquardt JU, 2015, NAT REV CANCER, V15, P653, DOI 10.1038/nrc4017; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; O'Donnell KA, 2012, P NATL ACAD SCI USA, V109, pE1377, DOI 10.1073/pnas.1115433109; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Ranzani M, 2013, NAT METHODS, V10, P155, DOI [10.1038/NMETH.2331, 10.1038/nmeth.2331]; Ratner N, 2015, NAT REV CANCER, V15, P290, DOI 10.1038/nrc3911; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Saborowski A, 2013, P NATL ACAD SCI USA, V110, P19513, DOI 10.1073/pnas.1311707110; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weber J, 2015, P NATL ACAD SCI USA, V112, P13982, DOI 10.1073/pnas.1512392112; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	57	6	6	10	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	APR	2017	152	5					1161	+		10.1053/j.gastro.2016.12.002				14	Gastroenterology & Hepatology	Gastroenterology & Hepatology	EP3QV	WOS:000397297700042	27956228				2018-01-05	
J	Wang, XY; Liu, DH; He, DJ; Suo, SB; Xia, X; He, XC; Han, JDJ; Zheng, P				Wang, Xinyi; Liu, Denghui; He, Dajian; Suo, Shengbao; Xia, Xian; He, Xiechao; Han, Jing-Dong J.; Zheng, Ping			Transcriptome analyses of rhesus monkey preimplantation embryos reveal a reduced capacity for DNA double-strand break repair in primate oocytes and early embryos	GENOME RESEARCH			English	Article							ZYGOTIC GENOME ACTIVATION; STEM-CELLS; DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; PRIMITIVE ENDODERM; GERM-LINE; MOUSE; PATHWAY; TRANSITION; CANCER	Preimplantation embryogenesis encompasses several critical events including genome reprogramming, zygotic genome activation (ZGA), and cell-fate commitment. The molecular basis of these processes remains obscure in primates in which there is a high rate of embryo wastage. Thus, understanding the factors involved in genome reprogramming and ZGA might help reproductive success during this susceptible period of early development and generate induced pluripotent stem cells with greater efficiency. Moreover, explaining the molecular basis responsible for embryo wastage in primates will greatly expand our knowledge of species evolution. By using RNA-seq in single and pooled oocytes and embryos, we defined the transcriptome throughout preimplantation development in rhesus monkey. In comparison to archival human and mouse data, we found that the transcriptome dynamics of monkey oocytes and embryos were very similar to those of human but very different from those of mouse. We identified several classes of maternal and zygotic genes, whose expression peaks were highly correlated with the time frames of genome reprogramming, ZGA, and cell-fate commitment, respectively. Importantly, comparison of the ZGA-related network modules among the three species revealed less robust surveillance of genomic instability in primate oocytes and embryos than in rodents, particularly in the pathways of DNA damage signaling and homology-directed DNA double-strand break repair. This study highlights the utility of monkey models to better understand the molecular basis for genome reprogramming, ZGA, and genomic stability surveillance in human early embryogenesis and may provide insights for improved homologous recombination-mediated gene editing in monkey.	[Wang, Xinyi; He, Dajian; He, Xiechao; Zheng, Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Wang, Xinyi; He, Dajian; He, Xiechao; Zheng, Ping] Chinese Acad Sci, Kunming Inst Zool, Yunnan Key Lab Anim Reprod, Kunming 650223, Yunnan, Peoples R China; [Wang, Xinyi; Liu, Denghui; He, Dajian; Suo, Shengbao; Xia, Xian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Xinyi; He, Dajian] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650204, Yunnan, Peoples R China; [Liu, Denghui; Suo, Shengbao; Xia, Xian; Han, Jing-Dong J.] Chinese Acad Sci, Key Lab Computat Biol, CAS Ctr Excellence Mol Cell Sci,Shanghai Inst Bio, Collaborat Innovat Ctr Genet & Dev Biol,Max Planc, Shanghai 200031, Peoples R China; [He, Xiechao; Zheng, Ping] Chinese Acad Sci, Kunming Inst Zool, Primate Res Ctr, Kunming 650223, Peoples R China	Zheng, P (reprint author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China.; Zheng, P (reprint author), Chinese Acad Sci, Kunming Inst Zool, Yunnan Key Lab Anim Reprod, Kunming 650223, Yunnan, Peoples R China.; Han, JDJ (reprint author), Chinese Acad Sci, Key Lab Computat Biol, CAS Ctr Excellence Mol Cell Sci,Shanghai Inst Bio, Collaborat Innovat Ctr Genet & Dev Biol,Max Planc, Shanghai 200031, Peoples R China.; Zheng, P (reprint author), Chinese Acad Sci, Kunming Inst Zool, Primate Res Ctr, Kunming 650223, Peoples R China.	jdhan@picb.ac.cn; zhengp@mail.kiz.ac.cn			"Strategic Priority Research Program" of the CAS [XDA01010203, XDB13000000]; CAS [XDA01010303]; China Ministry of Science and Technology [2015CB964803]; National Natural Science Foundation of China [91329302, 31210103916, 91519330]	We thank Prof. Jurrien Dean at the National Institutes of Health for critical comments on the manuscript; and Prof. Ji-rong Long at Vanderbilt University and Dr. Ian Logan for their assistance with editing the paper. This work was supported by the "Strategic Priority Research Program" of the CAS, grant numbers XDA01010203 and XDB13000000 to P.Z., and grants from CAS XDA01010303, China Ministry of Science and Technology 2015CB964803, and National Natural Science Foundation of China 91329302, 31210103916, and 91519330 to J.-D.J.H.	Artus J, 2011, DEV BIOL, V350, P393, DOI 10.1016/j.ydbio.2010.12.007; Bai H, 2011, J REPROD DEVELOP, V57, P518, DOI 10.1262/jrd.10-186K; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Benetatos L, 2014, CELL MOL LIFE SCI, V71, P257, DOI 10.1007/s00018-013-1426-x; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106                                                             ; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X                                                   ; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Do DV, 2013, GENE DEV, V27, P1378, DOI 10.1101/gad.221176.113; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; Dayalan N, 2015, TRENDS PHARMACOL SCI, V36, P6; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Dupont C, 2009, FERTIL STERIL, V91, P1230, DOI 10.1016/j.fertnstert.2008.01.075; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Freaney JE, 2013, CELL REP, V4, P959, DOI 10.1016/j.celrep.2013.07.043; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hanna CB, 2010, BIOL REPROD, V82, P1190, DOI 10.1095/biolreprod.109.081984; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hewitson Laura, 2002, Reprod Biomed Online, V5, P50; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Huang Y, 2015, GENOME RES, V25, P570, DOI 10.1101/gr.181966.114; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886                                                          ; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/nmeth.2967, 10.1038/NMETH.2967]; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu H, 2014, STEM CELLS, V14, P323; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Murray EL, 2008, METHOD ENZYMOL, V448, P483, DOI 10.1016/S0076-6879(08)02624-4; Nagy Z, 2009, TRENDS CELL BIOL, V19, P617, DOI 10.1016/j.tcb.2009.08.010; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Perry JRB, 2013, HUM MOL GENET, V22, P1465, DOI 10.1093/hmg/dds551; Petropoulos S, 2016, CELL, V165, P1012, DOI 10.1016/j.cell.2016.03.023; Rai Rekha, 2007, Cancer Genomics & Proteomics, V4, P99; Rankin TL, 2001, DEVELOPMENT, V128, P1119; Roberts VH, 2012, RESTRICTION PLACENTA; Roukos V, 2014, NAT CELL BIOL, V16, P293, DOI 10.1038/ncb2941; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Schramm RD, 1999, BIOL REPROD, V60, P721, DOI 10.1095/biolreprod60.3.721                                                      ; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Shen L, 2014, CELL STEM CELL, V15, P459, DOI 10.1016/j.stem.2014.09.002; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Stephenson RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008235; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Su YQ, 2004, DEV BIOL, V276, P64, DOI [10.1016/j.ydbio.2004.08.020, 10.1016/j.ydhbio.2004.08.020]; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tirosh I, 2007, CURR OPIN BIOTECH, V18, P371, DOI 10.1016/j.copbio.2007.07.003; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Xia K, 2006, PLOS COMPUT BIOL, V2, P1482, DOI 10.1371/journal.pcbi.0020145; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yu C, 2016, NAT STRUCT MOL BIOL, V23, P387, DOI 10.1038/nsmb.3204; Yu C, 2016, CELL RES, V26, P275, DOI 10.1038/cr.2016.20; Zhang W, 2013, CELL REP, V4, P542, DOI 10.1016/j.celrep.2013.07.010; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20	89	1	1	2	6	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2017	27	4					567	579		10.1101/gr.198044.115				13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	EQ4OX	WOS:000398058600007	28223401	gold			2018-01-05	
J	Hum, JM; O'Bryan, LM; Tatiparthi, AK; Cass, TA; Clinkenbeard, EL; Cramer, MS; Bhaskaran, M; Johnson, RL; Wilson, JM; Smith, RC; White, KE				Hum, Julia M.; O'Bryan, Linda M.; Tatiparthi, Arun K.; Cass, Taryn A.; Clinkenbeard, Erica L.; Cramer, Martin S.; Bhaskaran, Manoj; Johnson, Robert L.; Wilson, Jonathan M.; Smith, Rosamund C.; White, Kenneth E.			Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							FIBROBLAST GROWTH FACTOR-23; CHRONIC-KIDNEY-DISEASE; FAMILIAL TUMORAL CALCINOSIS; STAGE RENAL-DISEASE; HYPOPHOSPHATEMIC RICKETS; DIABETIC-NEPHROPATHY; CARDIOVASCULAR EVENTS; PARATHYROID-HORMONE; MISSENSE MUTATION; PHOSPHATE BINDERS	Klotho (alpha KL) regulates mineral metabolism, and diseases associated with alpha KL deficiency are characterized by hyperphosphatemia and vascular calcification (VC). alpha KL is expressed as a membrane-bound protein (mKL) and recognized as the coreceptor for fibroblast growth factor-23 (FGF23) and a circulating soluble form (cKL) created by endoproteolytic cleavage of mKL. The functions of cKL with regard to phosphate metabolism are unclear. We tested the ability of cKL to regulate pathways and phenotypes associated with hyperphosphatemia in a mouse model of CKD-mineral bone disorder and alpha KL-null mice. Stable delivery of adeno-associated virus (AAV) expressing alpha KL to diabetic endothelial nitric oxide synthase-deficient mice or alpha KL-null mice reduced serum phosphate levels. Acute injection of recombinant cKL downregulated the renal sodium-phosphate cotransporter Npt2a in alpha KL-null mice supporting direct actions of cKL in the absence of mKL. alpha KL-null mice with sustained AAV-cKL expression had a 74%-78% reduction in aorta mineral content and a 72%-77% reduction in mineral volume compared with control-treated counterparts (P<0.01). Treatment of UMR-106 osteoblastic cells with cKL + FGF23 increased the phosphorylation of extracellular signal-regulated kinasp 1/2 and induced Fgf23 expression. CRISPR/Cas9-mediated deletion of fibroblast growth factor receptor 1 (FGFR1) or pretreatment with inhibitors of mitogen-activated kinase kinase 1 or FGFR ablated these responses. In summary, sustained cKL treatment reduced hyperphosphatemia in a mouse model of CKD-mineral bone disorder, and it reduced hyperphosphatemia and prevented VC in mice without endogenous alpha KL. Furthermore, cKL stimulated Fgf23 in an FGFR1-ependent manner in bone cells. Collectively, these findings indicate that cKL has mKL-independent activity and suggest the potential for enhancing cKL activity in diseases of hyperphosphatemia with associated VC.	[Hum, Julia M.; Cass, Taryn A.; Clinkenbeard, Erica L.; White, Kenneth E.] Indiana Univ Sch Med, Div Mol Genet & Gene Therapy, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [O'Bryan, Linda M.; Cramer, Martin S.; Smith, Rosamund C.] Eli Lilly & Co, Lilly Res Labs, Biotechnol Discovery Res, Indianapolis, IN 46285 USA; [Bhaskaran, Manoj; Johnson, Robert L.] Eli Lilly & Co, Invest Pathol, Indianapolis, IN 46285 USA; [Wilson, Jonathan M.] Eli Lilly & Co, Tailored Therapeut, Indianapolis, IN 46285 USA; [Tatiparthi, Arun K.] Covance Inc, Lead Optimizat Toxicol & Pharmacol, Greenfield, IN USA	Smith, RC (reprint author), Eli Lilly & Co, Lilly Corp Ctr, Biotechnol Discovery Res, Indianapolis, IN 46285 USA.; White, KE (reprint author), Indiana Univ Sch Med, Dept Med & Mol Genet, 975 West Walnut St,IB130, Indianapolis, IN 46202 USA.	smith_rosamund_c@lilly.com; kenewhit@iupui.edu			National Institutes of Health [T32-HL007910, F32-AR065389, R01-DK063934, R01-DK95784]; Indiana Genomics Initiative of Indiana University; Showalter Scholar award through Ralph W. and Grace M. Showalter Research Trust Fund	The authors acknowledge support from National Institutes of Health grants T32-HL007910 (to J.M.H.), F32-AR065389 (to E.L.C.), R01-DK063934 (to K.E.W.), and R01-DK95784 (to K.E.W.); the Indiana Genomics Initiative of Indiana University supported in part by the Lilly Endowment, Inc. (K.E.W.); and a Showalter Scholar award (to K.E.W.) supported through the Ralph W. and Grace M. Showalter Research Trust Fund.	Aizawa H, 1998, BIOCHEM BIOPH RES CO, V249, P865, DOI 10.1006/bbrc.1998.9246; Asai O, 2012, KIDNEY INT, V81, P539, DOI 10.1038/ki.2011.423; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bergwitz C, 2009, J CLIN ENDOCR METAB, V94, P4267, DOI 10.1210/jc.2009-0961; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Brownstein CA, 2008, P NATL ACAD SCI USA, V105, P3455, DOI 10.1073/pnas.0712361105; Econs MJ, 1997, J CLIN ENDOCR METAB, V82, P674, DOI 10.1210/jc.82.2.674                                                             ; Fang YF, 2014, KIDNEY INT, V85, P142, DOI 10.1038/ki.2013.271; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Farrow EG, 2009, BONE, V44, P287, DOI 10.1016/j.bone.2008.10.040; Felaco M, 2001, ANN CLIN LAB SCI, V31, P179; Fioretto P, 2007, SEMIN NEPHROL, V27, P195, DOI 10.1016/j.semnephrol.2007.01.012; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Garringer HJ, 2006, J CLIN ENDOCR METAB, V91, P4037, DOI 10.1210/jc.2006-0305; Ghosh B, 2012, Indian J Nephrol, V22, P285, DOI 10.4103/0971-4065.101249; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Harlan SM, 2015, AM J PHYSIOL-REG I, V309, pR467, DOI 10.1152/ajpregu.00106.2015; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Ichikawa S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P318; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Krajisnik T, 2007, J ENDOCRINOL, V195, P125, DOI 10.1677/JOE-07-0267; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2005, J CLIN ENDOCR METAB, V90, P2424, DOI 10.1210/jc.2004-2238; Leibrock CB, 2016, J MOL MED, V94, P95, DOI 10.1007/s00109-015-1331-x; Leibrock CB, 2015, J AM SOC NEPHROL, V26, P2423, DOI 10.1681/ASN.2014030230; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Moe SM, 2011, J BONE MINER RES, V26, P2672, DOI 10.1002/jbmr.485; Mohan S, 2008, LAB INVEST, V88, P515, DOI 10.1038/labinvest.2008.23; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Navaneethan SD, 2009, AM J KIDNEY DIS, V54, P619, DOI 10.1053/j.ajkd.2009.06.004; Olauson H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003975; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; Satoh M, 2012, AM J PHYSIOL-RENAL, V303, pF1641, DOI 10.1152/ajprenal.00460.2012; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198                                                          ; Sigrist MK, 2007, CLIN J AM SOC NEPHRO, V2, P1241, DOI 10.2215/CJN.02190507; Smith RC, 2012, J CLIN INVEST, V122, P4710, DOI 10.1172/JCI64986; Sun HJD, 2007, AM J PHYSIOL-ENDOC M, V292, pE964, DOI 10.1152/ajpendo.00089.2006; Sun NY, 2012, BIOCHEM BIOPH RES CO, V428, P298, DOI 10.1016/j.bbrc.2012.10.051; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Virkki LV, 2003, J BONE MINER RES, V18, P2135, DOI 10.1359/jbmr.2003.18.12.2135                                                    ; Wang YH, 2009, HYPERTENSION, V54, P810, DOI 10.1161/HYPERTENSIONAHA.109.134320; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Wu AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057322; Xiao ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101251; Yokoyama K, 2014, CLIN J AM SOC NEPHRO, V9, P543, DOI 10.2215/CJN.05170513; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	66	4	5	5	10	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	APR	2017	28	4					1162	1174		10.1681/ASN.2015111266				13	Urology & Nephrology	Urology & Nephrology	EQ1LZ	WOS:000397832900019	27837149				2018-01-05	
J	Siddall, NA; Hime, GR				Siddall, N. A.; Hime, G. R.			A Drosophila toolkit for defining gene function in spermatogenesis	REPRODUCTION			English	Review							GERMLINE STEM-CELL; LONG NONCODING RNAS; BAG-OF-MARBLES; SELF-RENEWAL; JAK/STAT PATHWAY; NICHE; TESTIS; PROTEIN; MELANOGASTER; EXPRESSION	Expression profiling and genomic sequencing methods enable the accumulation of vast quantities of data that relate to the expression of genes during the maturation of male germ cells from primordial germ cells to spermatozoa and potential mutations that underlie male infertility. However, the determination of gene function in specific aspects of spermatogenesis or linking abnormal gene function with infertility remain rate limiting, as even in an era of CRISPR analysis of gene function in mammalian models, this still requires considerable resources and time. Comparative developmental biology studies have shown the remarkable conservation of spermatogenic developmental processes from insects to vertebrates and provide an avenue of rapid assessment of gene function to inform the potential roles of specific genes in rodent and human spermatogenesis. The vinegar fly, Drosophila melanogaster, has been used as a model organism for developmental genetic studies for over one hundred years, and research with this organism produced seminal findings such as the association of genes with chromosomes, the chromosomal basis for sexual identity, the mutagenic properties of X-irradiation and the isolation of the first tumour suppressor mutations. Drosophila researchers have developed an impressive array of sophisticated genetic techniques for analysis of gene function and genetic interactions. This review focuses on how these techniques can be utilised to study spermatogenesis in an organism with a generation time of 9 days and the capacity to introduce multiple mutant alleles into an individual organism in a relatively short time frame.	[Siddall, N. A.; Hime, G. R.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic, Australia	Hime, GR (reprint author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic, Australia.	g.hime@unimelb.edu.au		Hime, Gary/0000-0003-4732-3184	National Health and Medical research Council of Australia project grant [APP1048110]	This work was funded by National Health and Medical research Council of Australia project grant APP1048110.	Amoyel M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005815; Amoyel M, 2014, SEMIN CELL DEV BIOL, V28, P96, DOI 10.1016/j.semcdb.2014.03.023; Amoyel M, 2013, DEVELOPMENT, V140, P56, DOI 10.1242/dev.086413; Barreau C, 2008, BIOCHEM SOC T, V36, P540, DOI 10.1042/BST0360540; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Beumer KJ, 2014, METHODS, V68, P29, DOI 10.1016/j.ymeth.2013.12.002; Bhasin S, 2000, BEST PRACT RES CL EN, V14, P363, DOI 10.1053/beem.2000.0085; Bonilla E, 2008, MOL HUM REPROD, V14, P137, DOI 10.1093/molehr/gan002; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Bunt SM, 2012, GENESIS, V50, P914, DOI 10.1002/dvg.22341; Caldwell JC, 2008, FLY, V2, P269, DOI 10.4161/fly.7352                                                                ; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; del Valle Rodriguez A., 2012, NAT METHODS, V9, P47, DOI DOI 10.1038/NMETH.1800; Demarco RS, 2014, METHODS, V68, P218, DOI 10.1016/j.ymeth.2014.04.020; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X                                                   ; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0                                                                ; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Brill JA, 2012, SPERMATOGENESIS, V2, P197, DOI DOI 10.4161/SPMG.21798; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; Fuller Margaret T., 1993, P71; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Giansanti MG, 2012, CYTOSKELETON, V69, P869, DOI 10.1002/cm.21063; Gnerer JP, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv113; GONCZY P, 1992, DEVELOPMENT, V114, P89; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Greenspan LJ, 2015, ANNU REV CELL DEV BI, V31, P291, DOI 10.1146/annurev-cellbio-100913-013344; Griffin R, 2014, P NATL ACAD SCI USA, V111, P4756, DOI 10.1073/pnas.1403218111; Inaba M, 2015, NATURE, V523, P329, DOI 10.1038/nature14602; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707                                                         ; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; LIN HF, 1994, DEVELOPMENT, V120, P947; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Michel M, 2012, DEVELOPMENT, V139, P2663, DOI 10.1242/dev.075242; Michel M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1426; Monk AC, 2010, CELL STEM CELL, V6, P348, DOI 10.1016/j.stem.2010.02.016; Nagarkar-Jaiswal S, 2015, ELIFE, V4, DOI 10.7554/eLife.05338; Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112; Papagiannouli F, 2009, CELL RES, V19, P1139, DOI 10.1038/cr.2009.71; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Potter CJ, 2011, NAT PROTOC, V6, P1105, DOI 10.1038/nprot.2011.347; Schafer M, 1995, DEV BIOL, V172, P344, DOI 10.1006/dbio.1995.8049                                                          ; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Sitaram P, 2014, JOVE-J VIS EXP, V83, DOI [10.3791/51058, DOI 10.3791/51058]; Tanaka SS, 2000, GENE DEV, V14, P841; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Voog J, 2014, CELL REP, V7, P722, DOI 10.1016/j.celrep.2014.04.025; Waclawska A, 2012, SYST BIOL REPROD MED, V58, P229, DOI 10.3109/19396368.2012.693148; Wen KJ, 2016, GENOME RES, V26, P1233, DOI 10.1101/gr.199547.115; White-Cooper H, 2012, SPERMATOGENESIS, V2, P11, DOI DOI 10.4161/SPMG.19088; Wu H, 2016, P NATL ACAD SCI USA, V113, P4134, DOI 10.1073/pnas.1513682113; XU T, 1993, DEVELOPMENT, V117, P1223; Yamamoto-Hino M, 2013, GENES-BASEL, V4, P646, DOI 10.3390/genes4040646; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795                                                         ; Yatsenko AN, 2010, J ANDROL, V31, P34, DOI 10.2164/jandrol.109.008227; Zhang Z, 2013, PROTEIN CELL, V4, P650, DOI 10.1007/s13238-013-3040-y; Zhao SW, 2013, DEV BIOL, V376, P163, DOI 10.1016/j.ydbio.2013.01.023; Zoller R., 2012, SPERMATOGENESIS, V2, P145, DOI DOI 10.4161/SPMG.21380	81	2	2	4	18	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	1470-1626			REPRODUCTION	Reproduction	APR	2017	153	4					R121	R132		10.1530/REP-16-0347				12	Developmental Biology; Reproductive Biology	Developmental Biology; Reproductive Biology	EN2HH	WOS:000395830100001	28073824	gold			2018-01-05	
J	Kretzmann, JA; Ho, DW; Evans, CW; Plani-Lam, JHC; Garcia-Bloj, B; Mohamed, AE; O'Mara, ML; Ford, E; Tan, DEK; Lister, R; Blancafort, P; Norret, M; Iyer, KS				Kretzmann, Jessica A.; Ho, Diwei; Evans, Cameron W.; Plani-Lam, Janice H. C.; Garcia-Bloj, Benjamin; Mohamed, A. Elaaf; O'Mara, Megan L.; Ford, Ethan; Tan, Dennis E. K.; Lister, Ryan; Blancafort, Pilar; Norret, Marck; Iyer, K. Swaminathan			Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA	CHEMICAL SCIENCE			English	Article							GENE DELIVERY; PAMAM DENDRIMERS; CLICK-CHEMISTRY; IN-VIVO; BIOMEDICAL APPLICATIONS; POLYMERS; CELLS; TRANSFECTION; EFFICIENCY; MASPIN	Tools for editing the genome and epigenome have revolutionised the field of molecular biology and represent a new frontier in targeted therapeutic intervention. Although efficiencies and specificities of genome editing technologies have improved with the development of TALEs and CRISPR platforms, intracellular delivery of these larger constructs still remains a challenge using existing delivery agents. Viral vectors, including lentiviruses and adeno-associated viruses, as well as some non-viral strategies, such as cationic polymers and liposomes, are limited by packaging capacity, poor delivery, toxicity, and immunogenicity. We report a highly controlled synthetic strategy to engineer a flexible dendritic polymer using click chemistry to overcome the aforementioned delivery challenges associated with genome engineering technologies. Using a systematic approach, we demonstrate that high transfection efficiencies and packaging capacity can be achieved using this non-viral delivery methodology to deliver zinc fingers, TALEs and CRISPR/dCas9 platforms.	[Kretzmann, Jessica A.; Ho, Diwei; Evans, Cameron W.; Ford, Ethan; Tan, Dennis E. K.; Lister, Ryan; Norret, Marck; Iyer, K. Swaminathan] Univ Western Australia, Sch Mol Sci, 35 Stirling Hwy, Crawley, WA 6009, Australia; [Kretzmann, Jessica A.; Plani-Lam, Janice H. C.; Garcia-Bloj, Benjamin; Ford, Ethan; Tan, Dennis E. K.; Lister, Ryan; Blancafort, Pilar] Harry Perkins Inst Med Res, 6 Verdun St, Nedlands, WA 6009, Australia; [Mohamed, A. Elaaf; O'Mara, Megan L.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Ford, Ethan; Tan, Dennis E. K.; Lister, Ryan] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, 35 Stirling Hwy, Crawley, WA 6009, Australia; [Blancafort, Pilar] Univ Western Australia, Sch Anat Physiol & Human Biol, 35 Stirling Hwy, Crawley, WA 6009, Australia	Norret, M; Iyer, KS (reprint author), Univ Western Australia, Sch Mol Sci, 35 Stirling Hwy, Crawley, WA 6009, Australia.; Blancafort, P (reprint author), Harry Perkins Inst Med Res, 6 Verdun St, Nedlands, WA 6009, Australia.; Blancafort, P (reprint author), Univ Western Australia, Sch Anat Physiol & Human Biol, 35 Stirling Hwy, Crawley, WA 6009, Australia.	pilar.blancafort@uwa.edu.au; marck.norret@uwa.edu.au; swaminatha.iyer@uwa.edu.au		Evans, Cameron/0000-0003-2312-9803	Australian Research Council (ARC); National Health & Medical Research Council (NHMRC) of Australia; University, State and Commonwealth Governments; Cancer Council Western Australia	This work was funded by the Australian Research Council (ARC) and the National Health & Medical Research Council (NHMRC) of Australia. The authors would like to acknowledge the resources provided at the NCI National Facility systems at the Australian National University through the National Computational Merit Allocation Scheme, and the facilities and the technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation & Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments. The authors thank Prof Michelle Coote from the Australian National University for helpful discussions. J. A. Kretzmann would like to acknowledge Cancer Council Western Australia for a PhD Top Up scholarship.	An M, 2014, SOFT MATTER, V10, P590, DOI 10.1039/c3sm52096j; Beltran AS, 2011, EPIGENETICS-US, V6, P224, DOI 10.4161/epi.6.2.13700; Campeau P, 2001, GENE THER, V8, P1387, DOI 10.1038/sj.gt.3301532                                                           ; Choi M, 2016, ADV HEALTHC MATER, V5, P101, DOI 10.1002/adhm.201400834; Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grimmer M. R., 2014, NUCLEIC ACIDS RES; HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Helms B, 2004, J AM CHEM SOC, V126, P15020, DOI 10.1021/ja044744e; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kreiss P, 1999, NUCLEIC ACIDS RES, V27, P3792, DOI 10.1093/nar/27.19.3792; Lachelt U, 2015, CHEM REV, V115, P11043, DOI 10.1021/cr5006793; Lee JW, 2006, MACROMOLECULES, V39, P2418, DOI 10.1021/ma05256f; Liao XH, 2014, CELL SIGNAL, V26, P1335, DOI 10.1016/j.cellsig.2014.03.001; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Pavan GM, 2010, J PHYS CHEM B, V114, P2667, DOI 10.1021/jp100271w; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sevenson S, 2012, ADV DRUG DELIVER REV, V64, P102, DOI 10.1016/j.addr.2012.09.030; Teoh SSY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4164; Wang M, 2017, GENE THER, V24, P144, DOI 10.1038/gt.2016.72; Wang MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4053; Weaver JVM, 2004, MACROMOLECULES, V37, P2395, DOI 10.1021/ma0356358; Wiseman JW, 2003, GENE THER, V10, P1654, DOI 10.1038/sj.gt.3302050; Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang JP, 2015, CHEM REV, V115, P5274, DOI 10.1021/cr500542t; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Zeng HX, 2013, J AM CHEM SOC, V135, P4962, DOI 10.1021/ja400986u; Zhang Y, 2012, POLYM CHEM-UK, V3, P2752, DOI 10.1039/c2py20403g; Zhao P, 2012, POLYMER, V53, P1992, DOI 10.1016/j.polymer.2012.02.055	34	3	3	8	19	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.	APR 1	2017	8	4					2923	2930		10.1039/c7sc00097a				8	Chemistry, Multidisciplinary	Chemistry	EP7LY	WOS:000397560500053	28451358	gold			2018-01-05	
J	Qin, ZW; Munnoch, JT; Devine, R; Holmes, NA; Seipke, RF; Wilkinson, KA; Wilkinson, B; Hutchings, MI				Qin, Zhiwei; Munnoch, John T.; Devine, Rebecca; Holmes, Neil A.; Seipke, Ryan F.; Wilkinson, Karl A.; Wilkinson, Barrie; Hutchings, Matthew I.			Formicamycins, antibacterial polyketides produced by Streptomyces formicae isolated from African Tetraponera plant-ants	CHEMICAL SCIENCE			English	Article							DISCOVERY; FUNGI; SYMBIOSIS; BACTERIA; GENE	We report a new Streptomyces species named S. formicae that was isolated from the African fungus-growing plant-ant Tetraponera penzigi and show that it produces novel pentacyclic polyketides that are active against MRSA and VRE. The chemical scaffold of these compounds, which we have called the formicamycins, is similar to the fasamycins identified from the heterologous expression of clones isolated from environmental DNA, but has significant differences that allow the scaffold to be decorated with up to four halogen atoms. We report the structures and bioactivities of 16 new molecules and show, using CRISPR/Cas9 genome editing, that biosynthesis of these compounds is encoded by a single type 2 polyketide synthase biosynthetic gene cluster in the S. formicae genome. Our work has identified the first antibiotic from the Tetraponera system and highlights the benefits of exploring unusual ecological niches for new actinomycete strains and novel natural products.	[Qin, Zhiwei; Wilkinson, Barrie] John Innes Inst, Dept Mol Microbiol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Munnoch, John T.; Devine, Rebecca; Holmes, Neil A.; Hutchings, Matthew I.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Seipke, Ryan F.] Univ Leeds, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Wilkinson, Karl A.] Univ Cape Town, Sci Res Comp Unit, Dept Chem, ZA-7701 Cape Town, South Africa	Wilkinson, B (reprint author), John Innes Inst, Dept Mol Microbiol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.; Hutchings, MI (reprint author), Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	barrie.wilkinson@jic.ac.uk; m.hutchings@uea.ac.uk		QIN, ZHIWEI/0000-0002-1444-3684; Devine, Rebecca/0000-0003-0008-2184; Wilkinson, Karl/0000-0001-8455-346X	MRC Milstein award [G0801721]; NERC [NE/J01074X/1, NE/M015033/1]; Norwich Research Park (NRP) Translational Award; BBSRC NPRONET [BB/L013754/1]; Norwich Research Park BBSRC Doctoral Training Program Studentship [BB/M011216/1]; BBSRC via Institute Strategic Programme Grant [BB/J004561/1]	This work was supported by the following awards: MRC Milstein award G0801721 (to MIH), NERC research grants NE/J01074X/1 (to MIH) and NE/M015033/1 (to MIH/BW), Norwich Research Park (NRP) Translational Award (to BW/MIH), and a BBSRC NPRONET (BB/L013754/1) Proof of Concept award (to MIH/BW). RD is funded by a Norwich Research Park BBSRC Doctoral Training Program Studentship BB/M011216/1 and ZQ is funded by the BBSRC via Institute Strategic Programme Grant BB/J004561/1 to the John Innes Centre. The authors declare no conflicts of interest. We thank Catherine Tremlett, Andrew Hart and Ashleigh Crane at the Norfolk and Norwich University Hospital for the VRE strain and Justin O'Grady at the UEA Medical School for the MRSA strain. We are also grateful to Dr Jioji Tabudravu, University of Aberdeen, for his kind comments. KAW would like to thank the South African Centre for High Performance Computing for access to computational resources.	Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Bister B, 2003, CHEMBIOCHEM, V4, P658, DOI 10.1002/cbic.200300619; Blatrix R., 2013, PLOS ONE, V7; Blatrix R, 2012, P ROY SOC B-BIOL SCI, V279, P3940, DOI 10.1098/rspb.2012.1403; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Defossez E, 2009, NEW PHYTOL, V182, P942, DOI 10.1111/j.1469-8137.2009.02793.x; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/nchembio.1659, 10.1038/NCHEMBIO.1659]; Feng ZY, 2012, J AM CHEM SOC, V134, P2981, DOI 10.1021/ja207662w; Feng ZY, 2011, P NATL ACAD SCI USA, V108, P12629, DOI 10.1073/pnas.1103921108; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gao P, 2009, APPL ENVIRON MICROB, V75, P4813, DOI 10.1128/AEM.02958-08; Jones AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069319; Ju KS, 2015, P NATL ACAD SCI USA, V112, P12175, DOI 10.1073/pnas.1500873112; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Lackner M, 2014, FUNGAL DIVERS, V67, P1, DOI 10.1007/s13225-014-0295-4; MARCONI P, 1976, ANN SCLAVO, V18, P61; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Moore JM, 2012, METHOD ENZYMOL, V517, P367, DOI 10.1016/B978-0-12-404634-4.00018-8; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396                                                     ; Ruiz-Gonzalez MX, 2011, BIOL LETTERS, V7, P475, DOI 10.1098/rsbl.2010.0920; [Anonymous], 2016, SCHROD REL 2016 3 MA; Seipke RF, 2013, MICROBIOLOGYOPEN, V2, P276, DOI 10.1002/mbo3.73; Seipke RF, 2012, FEMS MICROBIOL REV, V36, P862, DOI 10.1111/j.1574-6976.2011.00313.x; Seipke RF, 2012, ANTON LEEUW INT J G, V101, P443, DOI 10.1007/s10482-011-9621-y; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Wyche TP, 2014, ANGEW CHEM INT EDIT, V53, P11583, DOI 10.1002/anie.201405990; Xu Z, 2007, J AM CHEM SOC, V129, P6022, DOI 10.1021/ja069045b	29	1	1	15	19	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2041-6520	2041-6539		CHEM SCI	Chem. Sci.	APR 1	2017	8	4					3218	3227		10.1039/c6sc04265a				10	Chemistry, Multidisciplinary	Chemistry	EP7LY	WOS:000397560500088	28507698	gold			2018-01-05	
J	Canver, MC; Lessard, S; Pinello, L; Wu, YX; Ilboudo, Y; Stern, EN; Needleman, AJ; Galacteros, F; Brugnara, C; Kutlar, A; McKenzie, C; Reid, M; Chen, DD; Das, PP; Cole, MA; Zeng, J; Kurita, R; Nakamura, Y; Yuan, GC; Lettre, G; Bauer, DE; Orkin, SH				Canver, Matthew C.; Lessard, Samuel; Pinello, Luca; Wu, Yuxuan; Ilboudo, Yann; Stern, Emily N.; Needleman, Austen J.; Galacteros, Frederic; Brugnara, Carlo; Kutlar, Abdullah; McKenzie, Colin; Reid, Marvin; Chen, Diane D.; Das, Partha Pratim; Cole, Mitchel A.; Zeng, Jing; Kurita, Ryo; Nakamura, Yukio; Yuan, Guo-Cheng; Lettre, Guillaume; Bauer, Daniel E.; Orkin, Stuart H.			Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FETAL-HEMOGLOBIN LEVELS; RED-BLOOD-CELL; INTERGENIC VARIANTS; AFRICAN-AMERICANS; GENETIC-VARIATION; CRISPR-CAS9; BCL11A; HBS1L-MYB; DNA	Cas9-mediated, high-throughput, saturating in situ mutagenesis permits fine-mapping of function across genomic segments. Disease-and trait-associated variants identified in genome-wide association studies largely cluster at regulatory loci. Here we demonstrate the use of multiple designer nucleases and variant-aware library design to interrogate trait-associated regulatory DNA at high resolution. We developed a computational tool for the creation of saturating-mutagenesis libraries with single or multiple nucleases with incorporation of variants. We applied this methodology to the HBS1L-MYB intergenic region, which is associated with red-blood-cell traits, including fetal hemoglobin levels. This approach identified putative regulatory elements that control MYB expression. Analysis of genomic copy number highlighted potential false-positive regions, thus emphasizing the importance of off-target analysis in the design of saturating-mutagenesis experiments. Together, these data establish a widely applicable high-throughput and high-resolution methodology to identify minimal functional sequences within large disease-and trait-associated regions.	[Canver, Matthew C.; Wu, Yuxuan; Stern, Emily N.; Needleman, Austen J.; Chen, Diane D.; Das, Partha Pratim; Cole, Mitchel A.; Zeng, Jing; Bauer, Daniel E.; Orkin, Stuart H.] Boston Childrens Hosp, Dana Farber Canc Inst, Harvard Stem Cell Inst, Div Hematol Oncol, Boston, MA 02115 USA; [Canver, Matthew C.; Wu, Yuxuan; Stern, Emily N.; Needleman, Austen J.; Chen, Diane D.; Das, Partha Pratim; Cole, Mitchel A.; Zeng, Jing; Bauer, Daniel E.; Orkin, Stuart H.] Harvard Stem Cell Inst, Harvard Med Sch, Dept Pediat, Boston, MA 02138 USA; [Lessard, Samuel; Ilboudo, Yann; Lettre, Guillaume] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Pinello, Luca] Massachusetts Gen Hosp, Harvard Med Sch, Dept Mol Pathol, Boston, MA USA; [Galacteros, Frederic] AP HP, Hop Henri Mondor, IMRB U955, UPeC,Red Cell Genet Dis Unit, Creteil, France; [Brugnara, Carlo] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Kutlar, Abdullah] Augusta Univ, Sickle Cell Ctr, Dept Med, Augusta, GA USA; [McKenzie, Colin; Reid, Marvin] Univ West Indies, Caribbean Inst Hlth Res, Kingston, Jamaica; [Kurita, Ryo] Japanese Red Cross Soc, Cent Blood Inst, Dept Res & Dev, Tokyo, Japan; [Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Nakamura, Yukio] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA USA; [Yuan, Guo-Cheng] Harvard T H Chan Sch Publ Hlth, Boston, MA USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Bauer, DE; Orkin, SH (reprint author), Boston Childrens Hosp, Dana Farber Canc Inst, Harvard Stem Cell Inst, Div Hematol Oncol, Boston, MA 02115 USA.; Bauer, DE; Orkin, SH (reprint author), Harvard Stem Cell Inst, Harvard Med Sch, Dept Pediat, Boston, MA 02138 USA.; Orkin, SH (reprint author), Howard Hughes Med Inst, Boston, MA 02115 USA.	Daniel.Bauer@childrens.harvard.edu; Stuart_Orkin@dfci.harvard.edu	Nakamura, Yukio/A-5263-2016	Canver, Matthew/0000-0002-8146-3992; Reid, Marvin/0000-0003-4005-9384	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [F30DK103359-01A1]; National Human Genome Research institute (NHGRI) Career Development Award [K99HG008399]; Canadian Institutes of Health Research Banting Doctoral Scholarship; Hematology Opportunities for the Next Generation at Research Scientists (HONORS) Award from the American Society of Hematology; National Heart, Lung, and Blood Institute (NHLBI) [R01HL119099]; Canada Research Program; Montreal Heart Institute Foundation; Canadian Institute of Health Research [MOP123382]; NIDDK [K08DK093705, R03DK109232, P30DK049216]; NHLBI [DP2OD022716, P01HL032262]; Burroughs Wellcome Fund; Doris Duke Charitable Foundation Innovzitions in Clinical Research Award; ASH Scholar Award; Charles H. Hood Foundation Child Health Research Award; Cooley's Anemia Foundation Fellowship	We thank Z.Ilerbert, M. Berkeley, and M. Vangala (Dana -Farber Cancer Institute Molecular Biology Core Facility) for sequencing, F. Lu at the HHMI Sequencing facility, and members at the Hematologic Neoplasia How Cytometry and the Flow Cytometry Core facilities at the Dana -Farber Cancer institute for cell -sorting. We also thank J. Docnch, M. Haeussler, J.-P. Coneordct, R. Barrett, V. Sankaran, and J. Xu for helpful discussions. M.C.C. is supported by a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) award (F30DK103359-01A1). L.P. is supported by a National Human Genome Research institute (NHGRI) Career Development Award (K99HG008399). S.L. is funded by a Canadian Institutes of Health Research Banting Doctoral Scholarship. E.N.S. is supported by a Hematology Opportunities for the Next Generation at Research Scientists (HONORS) Award from the American Society of Hematology. G.C.Y. is supported by awards from the National Heart, Lung, and Blood Institute (NHLBI) (R01HL119099). G.L. is funded by the Canada Research Program, the Montreal Heart Institute Foundation, and the Canadian Institute of Health Research (MOP123382). A portion of the DNA genotyping was performed as part of the Biogen Sickle Cell Disease Consortium. D.E.B. is supported by NIDDK (K08DK093705, R03DK109232), NHLBI (DP2OD022716), the Burroughs Wellcome Fund, a Doris Duke Charitable Foundation Innovzitions in Clinical Research Award, an ASH Scholar Award, a Charles H. Hood Foundation Child Health Research Award, and a Cooley's Anemia Foundation Fellowship. S.H.O. is supported by an award from the NHLBI (P01HL032262) and an award from the NIDDK (P30DK049216, Center of Excellence in Molecular Hematology).	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bae HT, 2012, BLOOD, V120, P1961, DOI 10.1182/blood-2012-06-432849; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Canver MC, 2016, BLOOD, V127, P2536, DOI 10.1182/blood-2016-01-678128; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Menzel S, 2013, BRIT J HAEMATOL, V160, P101, DOI 10.1111/bjh.12084; Mtatiro SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111464; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Pinello L, 2014, P NATL ACAD SCI USA, V111, pE344, DOI 10.1073/pnas.1322570111; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sankaran VG, 2011, P NATL ACAD SCI USA, V108, P1519, DOI 10.1073/pnas.1018384108; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	52	8	8	5	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2017	49	4					625	+		10.1038/ng.3793				13	Genetics & Heredity	Genetics & Heredity	EP8CO	WOS:000397603700028	28218758	green_accepted			2018-01-05	
J	Joung, J; Konermann, S; Gootenberg, JS; Abudayyeh, OO; Platt, RJ; Brigham, MD; Sanjana, NE; Zhang, F				Joung, Julia; Konermann, Silvana; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Platt, Randall J.; Brigham, Mark D.; Sanjana, Neville E.; Zhang, Feng			Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening	NATURE PROTOCOLS			English	Article							LENTIVIRAL RNAI LIBRARY; DOUBLE-STRANDED-RNA; HUMAN-CELLS; ESSENTIAL GENES; FUNCTIONAL GENOMICS; CAS9 NUCLEASE; DNA CLEAVAGE; INTERFERENCE; CRISPR/CAS9; SYSTEM	Forward genetic screens are powerful tools for the unbiased discovery and functional characterization of specific genetic elements associated with a phenotype of interest. Recently, the RNA-guided endonuclease Cas9 from the microbial CRISPR (clustered regularly interspaced short palindromic repeats) immune system has been adapted for genome-scale screening by combining Cas9 with pooled guide RNA libraries. Here we describe a protocol for genome-scale knockout and transcriptional activation screening using the CRISPR-Cas9 system. Custom-or ready-made guide RNA libraries are constructed and packaged into lentiviral vectors for delivery into cells for screening. As each screen is unique, we provide guidelines for determining screening parameters and maintaining sufficient coverage. To validate candidate genes identified by the screen, we further describe strategies for confirming the screening phenotype, as well as genetic perturbation, through analysis of indel rate and transcriptional activation. Beginning with library design, a genome-scale screen can be completed in 9-15 weeks, followed by 4-5 weeks of validation.	[Joung, Julia; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Joung, Julia; Konermann, Silvana; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Platt, Randall J.; Brigham, Mark D.; Sanjana, Neville E.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Joung, Julia; Konermann, Silvana; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Platt, Randall J.; Brigham, Mark D.; Sanjana, Neville E.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Joung, Julia; Konermann, Silvana; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Platt, Randall J.; Brigham, Mark D.; Sanjana, Neville E.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Abudayyeh, Omar O.] MIT, Dept Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Konermann, Silvana] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Platt, Randall J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Zurich, Switzerland; [Sanjana, Neville E.] New York Genome Ctr, New York, NY USA; [Sanjana, Neville E.] NYU, Dept Biol, New York, NY 10003 USA	Zhang, F (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Zhang, F (reprint author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	zhang@broadinstitute.org		Sanjana, Neville/0000-0002-1504-0027	Zhang laboratory; Paul and Daisy Soros Fellowship; Friends of the McGovern Institute Fellowship; Poitras Center for Affective Disorders; DOE Computational Science Graduate Fellowship; NIH through the National Institute of Mental Health (NIMH) [5DP1-MH100706, 1R01-MH110049]; National Science Foundation (NSF); Howard Hughes Medical Institute (HHMI); New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation	We thank O. Shalem, D. A. Scott and P. D. Hsu for helpful discussions and insights; R. Belliveau for overall research support; R. Macrae for critical reading of the manuscript; and the entire Zhang laboratory for support and advice. O. O. A. was supported by a Paul and Daisy Soros Fellowship, a Friends of the McGovern Institute Fellowship, and the Poitras Center for Affective Disorders. J.S.G. was supported by a DOE Computational Science Graduate Fellowship. F. Z. was supported by the NIH through the National Institute of Mental Health (NIMH; grants 5DP1-MH100706 and 1R01-MH110049), the National Science Foundation (NSF), the Howard Hughes Medical Institute (HHMI), the New York Stem Cell Foundation, the Simons Foundation, the Paul G. Allen Family Foundation, and the Vallee Foundation, and James and Patricia Poitras, Robert Metcalfe, and David Cheng. F. Z. is a New York Stem Cell Foundation-Robertson Investigator. Reagents are available through Addgene; support forums and computational tools are available via the Zhang laboratory website (http://www.genome-engineering.org).	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Blondel CJ, 2016, CELL HOST MICROBE, V20, P226, DOI 10.1016/j.chom.2016.06.010; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266                                                         ; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107                                                                ; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	76	10	10	12	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	APR	2017	12	4					828	863		10.1038/nprot.2017.016				36	Biochemical Research Methods	Biochemistry & Molecular Biology	EP3LB	WOS:000397282700011	28333914	green_accepted			2018-01-05	
J	Gibson, GJ; Yang, MZ				Gibson, Gary J.; Yang, Maozhou			What rheumatologists need to know about CRISPR/Cas9	NATURE REVIEWS RHEUMATOLOGY			English	Review							DISTAL REGULATORY ELEMENTS; LARGE ANIMAL-MODELS; HUMAN-CELLS; STEM-CELLS; MOUSE MODEL; GENE DRIVE; MUSCULAR-DYSTROPHY; CRISPR-CAS9 SYSTEM; MAMMALIAN-CELLS; CAS9 NUCLEASES	CRISPR/Cas9 genome editing technology has taken the research world by storm since its use in eukaryotes was first proposed in 2012. Publications describing advances in technology and new applications have continued at an unrelenting pace since that time. In this Review, we discuss the application of CRISPR/Cas9 for creating gene mutations - the application that initiated the current avalanche of interest - and new developments that have largely answered initial concerns about its specificity and ability to introduce new gene sequences. We discuss the new, diverse and rapidly growing adaptations of the CRISPR/Cas9 technique that enable activation, repression, multiplexing and gene screening. These developments have enabled researchers to create sophisticated tools for dissecting the function and inter-relatedness of genes, as well as noncoding regions of the genome, and to identify gene networks and noncoding regions that promote disease or confer disease susceptibility. These approaches are beginning to be used to interrogate complex and multilayered biological systems and to produce complex animal models of disease. CRISPR/Cas9 technology has enabled the application of new therapeutic approaches to treating disease in animal models, some of which are beginning to be seen in the first human clinical trials. We discuss the direct application of these techniques to rheumatic diseases, which are currently limited but are sure to increase rapidly in the near future.	[Gibson, Gary J.; Yang, Maozhou] Henry Ford Hosp, Ctr Bone & Joint, 6135 Woodward Ave, Detroit, MI 48202 USA	Gibson, GJ (reprint author), Henry Ford Hosp, Ctr Bone & Joint, 6135 Woodward Ave, Detroit, MI 48202 USA.	GGIBSON1@bjc.hfh.edu					Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Birney E, 2015, NATURE, V526, P52, DOI 10.1038/526052a; Bono JM, 2015, MOL ECOL, V24, P3810, DOI 10.1111/mec.13252; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Chavez A., 2016, BIORXIV; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cotsapas C, 2013, TRENDS IMMUNOL, V34, P22, DOI 10.1016/j.it.2012.09.001; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dubail J, 2015, MATRIX BIOL, V44-46, P24, DOI 10.1016/j.matbio.2015.03.001; Eberl G, 2010, NATURE, V464, P1285, DOI 10.1038/4641285a; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Henao-Mejia J., 2016, COLD SPRING HARB PRO; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang Y, 2016, MATRIX BIOL, V56, P74, DOI 10.1016/j.matbio.2016.04.002; Hudson DF, 2002, TRENDS CELL BIOL, V12, P281, DOI 10.1016/S0962-8924(02)02281-X; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juliano RL, 2016, NUCLEIC ACIDS RES, V44, P6518, DOI 10.1093/nar/gkw236; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kirino Y, 2015, NAT REV RHEUMATOL, V11, P401, DOI 10.1038/nrrheum.2015.41; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li L, 2015, HUM GENE THER, V26, P452, DOI 10.1089/hum.2015.069; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Meyer MB, 2015, J BIOL CHEM, V290, P11093, DOI 10.1074/jbc.M115.648394; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; National Academies of Sciences Engineering and Medicine (NASEM), 2016, GEN DRIV HOR ADV SCI; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Osborn MJ, 2016, INT J HEMATOL, V104, P18, DOI 10.1007/s12185-016-2017-z; Parikh BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116484; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reardon S, 2016, NATURE; Reardon S, 2016, NATURE, V531, P160, DOI 10.1038/531160a; Reeves WH, 2014, ARTHRITIS RHEUMATOL, V66, P6, DOI 10.1002/art.38224; Ren J., 2015, BLOOD, V126, P4280; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Saavedra PHV, 2015, SEMIN IMMUNOPATHOL, V37, P313, DOI 10.1007/s00281-015-0485-5; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shimizu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075754; Shinkuma S, 2016, P NATL ACAD SCI USA, V113, P5676, DOI 10.1073/pnas.1512028113; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; So A, 2013, NAT REV RHEUMATOL, V9, P391, DOI 10.1038/nrrheum.2013.61; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Suzuki H, 2016, P NATL ACAD SCI USA, V113, P7840, DOI 10.1073/pnas.1522054113; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Tu ZC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0031-x; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang SF, 2015, ARTHRITIS RHEUMATOL, V67, P1, DOI 10.1002/art.38800; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang ZD, 2015, CHROMOSOME RES, V23, P17, DOI 10.1007/s10577-014-9452-6; Whitelaw CBA, 2016, J PATHOL, V238, P247, DOI 10.1002/path.4648; Wu MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24360; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Yan H, 2016, P NATL ACAD SCI USA, V113, pE6199, DOI 10.1073/pnas.1608245113; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yang MZ, 2014, BONE, V69, P118, DOI 10.1016/j.bone.2014.09.005; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yao LJ, 2015, CRIT REV BIOCHEM MOL, V50, P550, DOI 10.3109/10409238.2015.1087961; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	110	2	2	4	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4790	1759-4804		NAT REV RHEUMATOL	Nat. Rev. Rheumatol.	APR	2017	13	4					205	216		10.1038/nrrheum.2017.6				12	Rheumatology	Rheumatology	EP3WM	WOS:000397312400004	28202911				2018-01-05	
J	Snyder, EM; Mccarty, C; Mehalow, A; Svenson, KL; Murray, SA; Korstanje, R; Braun, RE				Snyder, Elizabeth M.; Mccarty, Christopher; Mehalow, Adrienne; Svenson, Karen L.; Murray, Stephen A.; Korstanje, Ron; Braun, Robert E.			APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo	RNA			English	Article						RNA editing; ACF; APOBEC1; APOB; kidney	B MESSENGER-RNA; MOLECULAR-CLONING; GENE; PROTEIN; BINDING; IDENTIFICATION; REVEALS; ENZYME; MICE; EXPRESSION	Editing of the human and murine ApoB mRNA by APOBEC1, the catalytic enzyme of the protein complex that catalyzes C-to-U RNA editing, creates an internal stop codon within the APOB coding sequence, generating two protein isoforms. It has been long held that APOBEC1-mediated editing activity is dependent on the RNA binding protein A1CF. The function of A1CF in adult tissues has not been reported because a previously reported null allele displays embryonic lethality. This work aimed to address the function of A1CF in adult mouse tissues using a conditional A1cf allele. Unexpectedly, A1cf-null mice were viable and fertile with modest defects in hematopoietic, immune, and metabolic parameters. C-to-U RNA editing was quantified for multiple targets, including ApoB, in the small intestine and liver. In all cases, no changes in RNA editing efficiency were observed. Blood plasma analysis demonstrated a male-specific increase in solute concentration and increased cellularity in the glomeruli of male A1cf-null mice. Urine analysis showed a reduction in solute concentration, suggesting abnormal water homeostasis and possible kidney abnormalities exclusive to the male. Computational identification of kidney C-to-U editing sites from polyadenylated RNA-sequencing identified a number of editing sites exclusive to the kidney. However, molecular analysis of kidney C-to-U editing showed no changes in editing efficiency with A1CF loss. Taken together, these observations demonstrate that A1CF does not act as the APOBEC1 complementation factor in vivo under normal physiological conditions and suggests new roles for A1CF, specifically within the male adult kidney.	[Snyder, Elizabeth M.; Mccarty, Christopher; Mehalow, Adrienne; Svenson, Karen L.; Murray, Stephen A.; Korstanje, Ron; Braun, Robert E.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Braun, RE (reprint author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	bob.braun@jax.org		Mehalow, Adrienne/0000-0002-1744-827X	National Human Genome Research Institute (NHGRI) [HG006332]; National Institute of Child Health and Human Development (NICHD) [HD083521]; National Institutes of Health (NIH) [5U51OD020351-02]	The authors thank Dr. Rosalinda Doty, DMV for kidney histological evaluation, Dr. Dayana Krawchuk for figure preparation, and the Clinical Assessment Laboratory of the Jackson Laboratory Histopathology services for technical support. Funding support was provided by National Human Genome Research Institute (NHGRI) grant HG006332, National Institute of Child Health and Human Development (NICHD) grant HD083521, and National Institutes of Health (NIH), Office of the Director, 5U51OD020351-02.	Blanc V, 2005, MOL CELL BIOL, V25, P7260, DOI 10.1128/MCB.25.16.7260-7269.2005; Blanc V, 2003, J BIOL CHEM, V278, P41198, DOI 10.1074/jbc.M302951200; Blanc V, 2010, J BIOL CHEM, V285, P19184, DOI 10.1074/jbc.M110.115147; Carouge D, 2016, P NATL ACAD SCI USA, V113, pE5425, DOI 10.1073/pnas.1604773113; Chester A, 2004, RNA, V10, P1399, DOI 10.1261/rna.7490704; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; DAVIES MS, 1989, J BIOL CHEM, V264, P13395; DRISCOLL DM, 1989, CELL, V58, P519, DOI 10.1016/0092-8674(89)90432-7; DRISCOLL DM, 1990, J BIOL CHEM, V265, P21401; Dur S, 2004, BBA-GENE STRUCT EXPR, V1680, P11, DOI 10.1016/j.bbaexp.2004.07.006; Fossat N, 2014, EMBO REP, V15, P903, DOI 10.15252/embr.201438450; Galloway CA, 2010, BBA-MOL BASIS DIS, V1802, P976, DOI 10.1016/j.bbadis.2010.06.003; Gu TJ, 2016, GENETICS, V202, P787, DOI 10.1534/genetics.115.179481; Gu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033720; Harkins S, 2016, TRANSGENIC RES, V25, P639, DOI 10.1007/s11248-016-9960-6; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Higuchi M, 2000, NATURE, V406, P78; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887                                                         ; Huang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020197; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768                                                        ; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Mehta A, 2002, RNA, V8, P69, DOI 10.1017/S1355838202015649; Mehta A, 1998, MOL CELL BIOL, V18, P4426, DOI 10.1128/MCB.18.8.4426                                                           ; Nakamuta M, 1996, J BIOL CHEM, V271, P25981, DOI 10.1074/jbc.271.42.25981                                                        ; NAKAMUTA M, 1995, J BIOL CHEM, V270, P13042, DOI 10.1074/jbc.270.22.13042                                                        ; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Severi F, 2015, RNA BIOL, V12, P389, DOI 10.1080/15476286.2015.1026033; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; SMITH HC, 1991, P NATL ACAD SCI USA, V88, P1489, DOI 10.1073/pnas.88.4.1489; Sowden MP, 2004, J BIOL CHEM, V279, P197, DOI 10.1074/jbc.M307920200; Sowden MP, 2002, J CELL SCI, V115, P1027; TENG BB, 1990, J BIOL CHEM, V265, P20616; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Underkoffler LA, 2005, GENETICS, V169, P843, DOI 10.1534/genetics.104.032755	39	1	1	1	1	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	APR	2017	23	4					457	465		10.1261/rna.058818.116				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EO6EZ	WOS:000396786100003	28069890	gold			2018-01-05	
J	Yang, Y; Wang, HX; Zhang, XR; Huo, W; Qi, RQ; Gao, YL; Zhang, GF; Song, B; Chen, HD; Gao, XH				Yang, Yang; Wang, Hexiao; Zhang, Xinrui; Huo, Wei; Qi, Ruiqun; Gao, Yali; Zhang, Gaofeng; Song, Bing; Chen, Hongduo; Gao, Xinghua			Heat Increases the Editing Efficiency of Human Papillomavirus E2 Gene by Inducing Upregulation of APOBEC3A and 3G	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							CARCINOMA CELL-LINES; LOCAL HYPERTHERMIA; CERVICAL-CARCINOMA; CONDYLOMA ACUMINATUM; MESSENGER-RNA; GENITAL WARTS; HUMAN CANCERS; IN-VITRO; DNA; EXPRESSION	Apolipoprotein B mRNA-editing catalytic polypeptide (APOBEC) 3 proteins have been identified as potent viral DNA mutators and have broad antiviral activity. In this study, we demonstrated that apolipoprotein B mRNA-editing catalytic polypeptide 3A (A3A) and A3G expression levels were significantly upregulated in human papillomavirus (HPV)-infected cell lines and tissues. Heat treatment resulted in elevated expression of A3A and A3G in a temperature-dependent manner in HPV-infected cells. Correspondingly, HPV-infected cells heattreated at 44 degrees C showed accumulated G-to-A or C-to-T mutation in HPV E2 gene. Knockdown of A3A or A3G could promote cell viability, along with the lower frequency of A/T in HPV E2 gene. In addition, regressing genital viral warts also harbored high G-to-A or C-to-T mutation in HPV E2 gene. Taken together, we demonstrate that apolipoprotein B mRNA-editing catalytic polypeptide 3 expression and editing function was heat sensitive to a certain degree, partly explaining the mechanism of action of local hyperthermia to treat viral warts.	[Yang, Yang; Wang, Hexiao; Zhang, Xinrui; Huo, Wei; Qi, Ruiqun; Gao, Yali; Zhang, Gaofeng; Song, Bing; Chen, Hongduo; Gao, Xinghua] China Med Univ, Hosp 1, Dept Dermatol, Shenyang 110001, Peoples R China; [Zhang, Gaofeng; Song, Bing] Cardiff Univ, Sch Dent, Cardiff Inst Tissue Engn & Repair, Regenerat Med, Cardiff, S Glam, Wales	Gao, XH (reprint author), China Med Univ, Hosp 1, Dept Dermatol, Shenyang 110001, Peoples R China.	gaobarry@hotmail.com			Ministry for Health, China [201202013]	We thank Wenjie Zheng for the excellent technical assistance. This research is supported by grants from the public funding for healthcare, Ministry for Health, China (201202013).	Ahasan MM, 2015, BIOCHEM BIOPH RES CO, V457, P295, DOI 10.1016/j.bbrc.2014.12.103; BAKER CC, 1987, J VIROL, V61, P962; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Choi JW, 2005, BIOSENS BIOELECTRON, V20, P2236, DOI 10.1016/j.bios.2004.11.022; Giannaki M, 2013, PEDIATR DERMATOL, V30, P730, DOI 10.1111/pde.12113; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Huo W, 2014, DERMATOL THER, V27, P109, DOI 10.1111/dth.12066; Huo W, 2013, INT J HYPERTHER, V29, P17, DOI 10.3109/02656736.2012.758874; Huo W, 2010, J INFECT DIS, V201, P1169, DOI 10.1086/651506; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kukimoto I, 2015, J MED VIROL, V87, P1754, DOI 10.1002/jmv.24215; Kukimoto I, 2015, JPN J INFECT DIS, V68, P169, DOI 10.7883/yoken.JJID.2014.584; Li XD, 2009, J DERMATOL SCI, V54, P121, DOI 10.1016/j.jdermsci.2008.12.004; Ma Y, 2012, DERMATOL THER, V25, P386, DOI 10.1111/j.1529-8019.2012.01470.x; McBride AA, 2013, VIROLOGY, V445, P57, DOI [10.1016/j.viro1.2013.06.006, 10.1016/j.virol.2013.06.006]; Mehta HV, 2012, J IMMUNOL, V189, P4088, DOI 10.4049/jimmunol.1200777; Moris A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00534; Ostberg JR, 2003, INT J HYPERTHER, V19, P520, DOI 10.1080/02656730310001607986; Ostrowska KM, 2010, ANALYST, V135, P3087, DOI 10.1039/c0an00571a; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Payne J, 2000, INT J HYPERTHER, V16, P492, DOI 10.1080/02656730050199340                                                       ; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Shterzer N, 2014, VIROLOGY, V468, P647, DOI 10.1016/j.virol.2014.09.015; Sunthamala N, 2014, GENOM DATA, V2, P147, DOI 10.1016/j.gdata.2014.06.013; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vieira VC, 2013, BIOMED RES INT, DOI 10.1155/2013/683095; Wang XQ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-301; Wang XQ, 2009, APOPTOSIS, V14, P721, DOI 10.1007/s10495-009-0344-8; Wang Z, 2014, J VIROL, V88, P1308, DOI 10.1128/JVI.03091-13; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14; Xue Y, 2015, ONCOTARGET, V6, P34979, DOI 10.18632/oncotarget.5512; Yang Y, ONCOL LETT IN PRESS; YEE C, 1985, AM J PATHOL, V119, P361; Zhu LL, 2010, ANTIVIR RES, V88, P187, DOI 10.1016/j.antiviral.2010.08.012	36	1	1	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	APR	2017	137	4					810	818		10.1016/j.jid.2016.06.635				9	Dermatology	Dermatology	EO7QE	WOS:000396884400009	27890786				2018-01-05	
J	Gorski, SA; Vogel, J; Doudna, JA				Gorski, Stanislaw A.; Vogel, Joerg; Doudna, Jennifer A.			RNA-based recognition and targeting: sowing the seeds of specificity	NATURE REVIEWS MOLECULAR CELL BIOLOGY			English	Review							GUIDED SURVEILLANCE COMPLEX; CRISPR-CAS SYSTEMS; ARGONAUTE SILENCING COMPLEX; BACTERIAL SMALL RNA; SM-LIKE PROTEIN; MESSENGER-RNA; ESCHERICHIA-COLI; NONCODING RNA; CRYSTAL-STRUCTURE; IN-VIVO	RNA is involved in the regulation of multiple cellular processes, often by forming sequence-specific base pairs with cellular RNA or DNA targets that must be identified among the large number of nucleic acids in a cell. Several RNA-based regulatory systems in eukaryotes, bacteria and archaea, including microRNAs (mi-RNAs), small interfering RNAs (siRNAs), CRISPR RNAs (crRNAs) and small RNAs (sRNAs) that are dependent on the RNA chaperone protein Hfq, achieve specificity using similar strategies. Central to their function is the presentation of short 'seed sequences' within a ribonucleoprotein complex to facilitate the search for and recognition of targets.	[Gorski, Stanislaw A.; Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, Josef Schneider Str 2,D15, D-97080 Wurzburg, Germany; [Vogel, Joerg] Univ Wurzburg, Helmholtz Inst RNA Based Infect Res HIRI, D-97080 Wurzburg, Germany; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA	Vogel, J (reprint author), Univ Wurzburg, Inst Mol Infect Biol, Josef Schneider Str 2,D15, D-97080 Wurzburg, Germany.; Vogel, J (reprint author), Univ Wurzburg, Helmholtz Inst RNA Based Infect Res HIRI, D-97080 Wurzburg, Germany.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	joerg.vogel@uni-wuerzburg.de; doudna@berkeley.edu	Vogel, Jorg/D-5574-2011	Vogel, Jorg/0000-0003-2220-1404			Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Attaiech L, 2016, P NATL ACAD SCI USA, V113, P8813, DOI 10.1073/pnas.1601626113; Balbontin R, 2010, MOL MICROBIOL, V78, P380, DOI 10.1111/j.1365-2958.2010.07342.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brunel C, 2002, BIOCHIMIE, V84, P925, DOI 10.1016/S0300-9084(02)01401-3; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032; Chao YJ, 2017, MOL CELL, V65, P39, DOI 10.1016/j.molcel.2016.11.002; Chao YJ, 2016, MOL CELL, V61, P352, DOI 10.1016/j.molcel.2015.12.023; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Coornaert A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003156; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dimastrogiovanni D, 2014, ELIFE, V3, DOI 10.7554/eLife.05375; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fei JY, 2015, SCIENCE, V347, P1371, DOI 10.1126/science.1258849; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Franch T, 1999, J MOL BIOL, V294, P1115, DOI 10.1006/jmbi.1999.3306; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frohlich KS, 2013, EMBO J, V32, P2963, DOI 10.1038/emboj.2013.222; Fromm B, 2015, ANNU REV GENET, V49, P213, DOI 10.1146/annurev-genet-120213-092023; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871                                                        ; Holmqvist E, 2016, EMBO J, V35, P991, DOI 10.15252/embj.201593360; Horstmann N, 2012, NUCLEIC ACIDS RES, V40, P11023, DOI 10.1093/nar/gks809; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hui MP, 2014, ANNU REV GENET, V48, P537, DOI 10.1146/annurev-genet-120213-092340; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jo MH, 2015, MOL CELL, V59, P117, DOI 10.1016/j.molcel.2015.04.027; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kuhn CD, 2013, TRENDS BIOCHEM SCI, V38, P263, DOI 10.1016/j.tibs.2013.02.008; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lalaouna D, 2013, BBA-GENE REGUL MECH, V1829, P742, DOI 10.1016/j.bbagrm.2013.02.013; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Melamed S, 2016, MOL CELL, V63, P884, DOI 10.1016/j.molcel.2016.07.026; Miyakoshi M, 2015, CURR OPIN MICROBIOL, V24, P132, DOI 10.1016/j.mib.2015.01.013; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Panja S, 2013, NUCLEIC ACIDS RES, V41, P7536, DOI 10.1093/nar/gkt521; Papenfort K, 2015, P NATL ACAD SCI USA, V112, pE4772, DOI 10.1073/pnas.1507825112; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Papenfort K, 2012, P NATL ACAD SCI USA, V109, pE757, DOI 10.1073/pnas.1119414109; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Papenfort K, 2009, MOL MICROBIOL, V74, P139, DOI 10.1111/j.1365-2958.2009.06857.x; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Peer A, 2014, RNA, V20, P994, DOI 10.1261/rna.043133.113; Peng Y, 2014, P NATL ACAD SCI USA, V111, P17134, DOI 10.1073/pnas.1410114111; QUIGLEY GJ, 1976, SCIENCE, V194, P796, DOI 10.1126/science.790568; Rutherford ST, 2015, P NATL ACAD SCI USA, V112, pE6038, DOI 10.1073/pnas.1518958112; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Sauer E, 2012, P NATL ACAD SCI USA, V109, P9396, DOI 10.1073/pnas.1202521109; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schu DJ, 2015, EMBO J, V34, P2557, DOI 10.15252/embj.201591569; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Smirnov A, 2016, P NATL ACAD SCI USA, V113, P11591, DOI 10.1073/pnas.1609981113; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Tree JJ, 2014, MOL CELL, V55, P199, DOI 10.1016/j.molcel.2014.05.006; Updegrove TB, 2016, CURR OPIN MICROBIOL, V30, P133, DOI 10.1016/j.mib.2016.02.003; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wagner EGH, 2015, ADV GENET, V90, P133, DOI 10.1016/bs.adgen.2015.05.001; Wagner EGH, 2002, ADV GENET, V46, P361; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Westermann AJ, 2016, NATURE, V529, P496, DOI 10.1038/nature16547; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Zeiler B. N., 1998, RNA STRUCTURE FUNCTI, V35, P437; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	118	13	13	19	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-0072	1471-0080		NAT REV MOL CELL BIO	Nat. Rev. Mol. Cell Biol.	APR	2017	18	4					215	228		10.1038/nrm.2016.174				14	Cell Biology	Cell Biology	EO5AP	WOS:000396705700007	28196981				2018-01-05	
J	Beaver, LM; Kuintzle, R; Buchanan, A; Wiley, MW; Glasser, ST; Wong, CP; Johnson, GS; Chang, JH; Lohr, CV; Williams, DE; Dashwood, RH; Hendrix, DA; Ho, E				Beaver, Laura M.; Kuintzle, Rachael; Buchanan, Alex; Wiley, Michelle W.; Glasser, Sarah T.; Wong, Carmen P.; Johnson, Gavin S.; Chang, Jeff H.; Lohr, Christiane V.; Williams, David E.; Dashwood, Roderick H.; Hendrix, David A.; Ho, Emily			Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Chemoprevention; Long noncoding RNA; LINC01116; Prostate cancer; Sulforaphane; Diet-gene interactions	HISTONE DEACETYLASE ACTIVITY; CRUCIFEROUS VEGETABLES; NRF2-REGULATED GENES; CELLS; EXPRESSION; IDENTIFICATION; METHYLATION; PATHWAY; GROWTH; DIET	Long noncoding RNAs (lncRNAs) have emerged as important in cancer development and progression. The impact of diet on IncRNA expression is largely unknown. Sulforaphane (SFN), obtained from vegetables like broccoli, can prevent and suppress cancer formation. Here we tested the hypothesis that SFN attenuates the expression of cancer-associated IncRNAs. We analyzed whole-genome RNA-sequencing data of normal human prostate epithelial cells and prostate cancer cells treated with 15 M SFN or dimethylsulfoxide. SFN significantly altered expression of similar to 100 lncRNAs in each cell type and normalized the expression of some lncRNAs that were differentially expressed in cancer cells. SFN-mediated alterations in IncRNA expression correlated with genes that regulate cell cycle, signal transduction and metabolism. LINC01116 was functionally investigated because it was overexpressed in several cancers, and was transcriptionally repressed after SFN treatment. Knockdown of LINC01116 with siRNA decreased proliferation of prostate cancer cells and significantly up-regulated several genes including GAPDH (regulates glycolysis), MAP1LC3B2 (autophagy) and H2AFY (chromatin structure). A four-fold decrease in the ability of the cancer cells to form colonies was found when the LINC01116 gene was disrupted through a CRISPR/CAS9 method, further supporting an oncogenic function for LINC01116 in PC-3 cells. We identified a novel isoform of LINC01116 and bioinformatically investigated the possibility that LINC01116 could interact with target genes via ssRNA:dsDNA triplexes. Our data reveal that chemicals from the diet can influence the expression of functionally important lncRNAs, and suggest a novel mechanism by which SFN may prevent and suppress prostate cancer. Published by Elsevier Inc.	[Beaver, Laura M.; Buchanan, Alex; Glasser, Sarah T.; Wong, Carmen P.; Ho, Emily] Oregon State Univ, Biol & Populat Hlth Sci, 103 Milam Hall, Corvallis, OR 97331 USA; [Beaver, Laura M.; Wong, Carmen P.; Williams, David E.; Ho, Emily] Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA; [Kuintzle, Rachael; Wiley, Michelle W.; Hendrix, David A.] Oregon State Univ, Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg, Corvallis, OR 97331 USA; [Buchanan, Alex; Chang, Jeff H.] Oregon State Univ, Dept Bot & Plant Pathol, 2082 Cordley Hall, Corvallis, OR 97331 USA; [Johnson, Gavin S.; Dashwood, Roderick H.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Epigenet & Dis Prevent, 2121 W Holcombe Blvd,Mail Stop 1201, Houston, TX 77030 USA; [Chang, Jeff H.; Ho, Emily] Oregon State Univ, Ctr Genome Res & Biocomp, 3021 Agr & Life Sci Bldg, Corvallis, OR 97331 USA; [Lohr, Christiane V.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, 105 Magruder Hall, Corvallis, OR 97331 USA; [Williams, David E.] Oregon State Univ, Environm & Mol Toxicol, 1007 Agr Life & Sci Bldg, Corvallis, OR 97331 USA; [Hendrix, David A.] Oregon State Univ, Sch Elect Engn & Comp Sci, Kelley Engn Ctr 1148, Corvallis, OR 97331 USA; [Ho, Emily] Oregon State Univ, Moore Family Ctr, 103 Milam Hall, Corvallis, OR 97331 USA	Ho, E (reprint author), Oregon State Univ, Sch Biol & Populat Hlth Sci, 103 Milam Hall, Corvallis, OR 97331 USA.	Laura.Beaver@oregonstate.edu; kuintzlr@oregonstate.edu; buchanae@gmail.com; wileym@oregonstate.edu; glasser.sarah@gmail.com; Carmen.Wong@oregonstate.edu; gjohnson@ibt.tamhsc.edu; changj@science.oregonstate.edu; Christiane.Loehr@oregonstate.edu; david.williams@oregonstate.edu; rdashwood@ibt.tamhsc.edu; David.Hendrix@oregonstate.edu; Emily.Ho@oregonstate.edu		Chang, Jeff/0000-0002-1833-0695	National Institutes of Health [CA90890, CA65525, CA122906, CA122959, CA80176, R01GM104977]; National Institute of Environmental Health Sciences Center [P30 ES00210]; Oregon State University general research fund	Work conducted in the authors' laboratory is supported by National Institutes of Health grants CA90890, CA65525, CA122906, CA122959, CA80176 and R01GM104977; National Institute of Environmental Health Sciences Center grant P30 ES00210; and the Oregon State University general research fund.	American Cancer Society, 2012, CANC FACTS FIG 2012; Beaver LM, 2014, MOL NUTR FOOD RES, V58, P2001, DOI 10.1002/mnfr.201400269; Beaver LM, 2012, TOXICOL APPL PHARM, V263, P345, DOI 10.1016/j.taap.2012.07.007; Buske FA, 2012, GENOME RES, V22, P1372, DOI 10.1101/gr.130237.111; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Clarke JD, 2011, PHARM RES-DORDR, V28, P3171, DOI 10.1007/s11095-011-0500-z; Clarke JD, 2011, MOL NUTR FOOD RES, V55, P999, DOI 10.1002/mnfr.201000547; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cumbie JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025279; DEPRISCO R, 1984, BIOCHIM BIOPHYS ACTA, V788, P356, DOI 10.1016/0167-4838(84)90049-9; Escrich E, 2004, MOL CARCINOGEN, V40, P73, DOI 10.1002/mc.20028; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Goff LA, 2015, P NATL ACAD SCI USA, V112, P6855, DOI 10.1073/pnas.1411263112; Gong L, 2010, EPIGENETICS-US, V5, P619, DOI 10.4161/epi.5.7.12882; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hsu A, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-3; International Agency for Research on Cancer, 2010, GLOBOCAN CANC FACT S; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Lin Y, 2012, NUTRITION, V28, P1037, DOI 10.1016/j.nut.2012.01.002; Ling H, 2015, ONCOGENE, V34, P5003, DOI 10.1038/onc.2014.456; Liu B, 2012, INT J UROL, V19, P134, DOI 10.1111/j.1442-2042.2011.02906.x; Liu S, 2014, J BIOL CHEM, V289, P13000, DOI 10.1074/jbc.M114.564658; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mallory AC, 2015, BIOCHIMIE, V117, P3, DOI 10.1016/j.biochi.2015.03.014; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Melchini A, 2009, FOOD CHEM TOXICOL, V47, P1430, DOI 10.1016/j.fct.2009.03.024; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Myzak MC, 2006, CARCINOGENESIS, V27, P811, DOI 10.1093/carcin/bgi265; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Myzak MC, 2007, EXP BIOL MED, V232, P227; Nian H, 2009, ENVIRON MOL MUTAGEN, V50, P213, DOI 10.1002/em.20454; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Postepska-Igielska A, 2015, MOL CELL, V60, P626, DOI 10.1016/j.molcel.2015.10.001; Rajendran P, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-68; Ramalho-Carvalho J, 2016, CANCER METAST REV, V35, P235, DOI 10.1007/s10555-016-9628-y; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Sun AJ, 2016, PROSTATE, V76, P172, DOI 10.1002/pros.23106; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Traka MH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-189; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07146; Watson GW, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.47; Weiss M, 2014, BIOL CHEM, V395, P1275, DOI 10.1515/hsz-2014-0201; Wong CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086787; Xu ZJ, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-2869-9; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zhang XY, 2015, INT J CLIN EXP PATHO, V8, P6981	57	1	1	5	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	APR	2017	42						72	83		10.1016/j.jnutbio.2017.01.001				12	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	EQ3YT	WOS:000398010600009	28131897				2018-01-05	
J	Li, YZ; Banerjee, S; Goldstein, SA; Dong, BH; Gaughan, C; Rath, S; Donovan, J; Korennykh, A; Silverman, RH; Weiss, SR				Li, Yize; Banerjee, Shuvojit; Goldstein, Stephen A.; Dong, Beihua; Gaughan, Christina; Rath, Sneha; Donovan, Jesse; Korennykh, Alexei; Silverman, Robert H.; Weiss, Susan R.			Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line	ELIFE			English	Article							AICARDI-GOUTIERES SYNDROME; ADENOSINE-DEAMINASE; MURINE CORONAVIRUS; VIRUS-REPLICATION; INTERFERON; ACTIVATION; EXPRESSION; INFECTION; PROTEIN; CGAS	ADAR1 isoforms are adenosine deaminases that edit and destabilize double-stranded RNA reducing its immunostimulatory activities. Mutation of ADAR1 leads to a severe neurodevelopmental and inflammatory disease of children, Aicardi-Goutieres syndrome. In mice, Adar1 mutations are embryonic lethal but are rescued by mutation of the Mda5 or Mavs genes, which function in IFN induction. However, the specific IFN regulated proteins responsible for the pathogenic effects of ADAR1 mutation are unknown. We show that the cell-lethal phenotype of ADAR1 deletion in human lung adenocarcinoma A549 cells is rescued by CRISPR/Cas9 mutagenesis of the RNASEL gene or by expression of the RNase L antagonist, murine coronavirus NS2 accessory protein. Our result demonstrate that ablation of RNase L activity promotes survival of ADAR1 deficient cells even in the presence of MDA5 and MAVS, suggesting that the RNase L system is the primary sensor pathway for endogenous dsRNA that leads to cell death.	[Li, Yize; Goldstein, Stephen A.; Weiss, Susan R.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Banerjee, Shuvojit; Dong, Beihua; Gaughan, Christina; Silverman, Robert H.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Rath, Sneha; Donovan, Jesse; Korennykh, Alexei] Princeton Univ, Dept Mol Biol, Princeton, NJ USA	Weiss, SR (reprint author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Silverman, RH (reprint author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA.	silverr@ccf.org; weisssr@upenn.edu		Li, Yize/0000-0003-1721-741X; Weiss, Susan/0000-0002-8155-4528	National Institute of Allergy and Infectious Diseases [R01AI104887, T32AI007324]; National Cancer Institute [R01CA044059]; Burroughs Wellcome Fund Grant [1013579]; Sidney Kimmel Foundation for Cancer Research [AWD1004002]; National Institute of General Medical Sciences [R01GM110161, T32GM007388]; National Institute of Neurological Disorders and Stroke [R01NS080081]; Vallee Foundation [23307-G0002-10009-96]	National Institute of Allergy and Infectious Diseases R01AI104887 Robert H Silverman, Susan R Weiss; National Institute of Neurological Disorders and Stroke R01NS080081 Susan R Weiss; National Cancer Institute R01CA044059 Robert H Silverman; Burroughs Wellcome Fund Grant 1013579 Alexei Korennykh; Sidney Kimmel Foundation for Cancer Research AWD1004002 Alexei Korennykh; National Institute of General Medical Sciences R01GM110161 Alexei Korennykh; Vallee Foundation 23307-G0002-10009-96 Alexei V Korennykh; National Institute of Allergy and Infectious Diseases T32AI007324 Stephen A Goldstein; National Institute of General Medical Sciences T32GM007388 Sneha Rath	Banerjee S, 2015, ONCOTARGET, V6, P44360, DOI 10.18632/oncotarget.6246; Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14; Birdwell LD, 2016, J VIROL, V90, P3160, DOI 10.1128/JVI.03036-15; Chakrabarti A, 2015, CELL HOST MICROBE, V17, P466, DOI 10.1016/j.chom.2015.02.010; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133                                                          ; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; Donovan J, 2016, BIORXIV, DOI [10.1101/087106, DOI 10.1101/087106]; Elbahesh H, 2011, VIROLOGY, V409, P262, DOI 10.1016/j.virol.2010.10.016; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; George CX, 2014, J INTERF CYTOK RES, V34, P437, DOI 10.1089/jir.2014.0001; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Gusho E, 2014, MBIO, V5, DOI 10.1128/mBio.01312-14; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; KNIGHT M, 1980, NATURE, V288, P189, DOI 10.1038/288189a0; Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Matthaei KI, 2011, P NATL ACAD SCI USA, V108, pE43, DOI 10.1073/pnas.1100419108; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rath S, 2015, P NATL ACAD SCI USA, V112, P15916, DOI 10.1073/pnas.1513034112; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; SILVERMAN RH, 1983, J VIROL, V46, P1051; Silverman RH, 2014, J INTERF CYTOK RES, V34, P455, DOI 10.1089/jir.2014.0007; Thakur CS, 2005, METH MOLEC MED, V116, P103; Tomaselli S, 2015, CURR ISSUES MOL BIOL, V17, P37; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Wong SK, 2003, RNA, V9, P586, DOI 10.1261/rna.5160403; Wong SK, 2002, P NATL ACAD SCI USA, V99, P15118, DOI 10.1073/pnas.232416799; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	36	2	2	4	6	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	MAR 31	2017	6								e25687	10.7554/eLife.25687				18	Biology	Life Sciences & Biomedicine - Other Topics	ET1IH	WOS:000400020300001		gold			2018-01-05	
J	Won, MH; Dawid, IB				Won, Minho; Dawid, Igor B.			PCR artifact in testing for homologous recombination in genomic editing in zebrafish	PLOS ONE			English	Article							CRISPR/CAS9 SYSTEM; DNA; EFFICIENT; TALEN; PRECISE; EXPRESSION; IMMUNITY; DESIGN; LIGASE	We report a PCR-induced artifact in testing for homologous recombination in zebrafish. We attempted to replace the Inx2a gene with a donor cassette, mediated by a TALEN induced double stranded cut. The donor construct was flanked with homology arms of about 1 kb at the 5' and 3' ends. Injected embryos (G0) were raised and outcrossed to wild type fish. A fraction of the progeny appeared to have undergone the desired homologous recombination, as tested by PCR using primer pairs extending from genomic DNA outside the homology region to a site within the donor cassette. However, Southern blots revealed that no recombination had taken place. We conclude that recombination happened during PCR in vitro between the donor integrated elsewhere in the genome and the Inx2a locus. We conclude that PCR alone may be insufficient to verify homologous recombination in genome editing experiments in zebrafish.	[Won, Minho; Dawid, Igor B.] NICHHD, Sect Dev Biol, DDB, NIH, Bethesda, MD 20892 USA; [Won, Minho] Chungnam Natl Univ, Dept Pharmacol, Coll Med, Daejeon, South Korea	Dawid, IB (reprint author), NICHHD, Sect Dev Biol, DDB, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov			intramural research program of the Eugene Kennedy Shriver National Institute for Child Health and Human Development [008809]	This work was funded by the intramural research program of the Eugene Kennedy Shriver National Institute for Child Health and Human Development, under program number ZIA HD 008809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, manuscripts emanating from the intramural research program are subject to a clearance procedure, and this manuscript has been cleared.	Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; He F, 2007, CANCER RES, V67, P634, DOI 10.1158/0008-5472.CAN-06-1860; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Horstick EJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv035; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Liu Y, 2014, METHODS, V69, P58, DOI 10.1016/j.ymeth.2014.02.011; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Southern E, 2015, METHODS MOL BIOL, V1312, P1, DOI 10.1007/978-1-4939-2694-7_1; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Truett GE, 2000, BIOTECHNIQUES, V29, P52; Won MH, 2015, P NATL ACAD SCI USA, V112, P12426, DOI 10.1073/pnas.1517033112; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Zhang Y, 2016, METHOD CELL BIOL, V135, P107, DOI 10.1016/bs.mcb.2016.03.005; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	30	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0172802	10.1371/journal.pone.0172802				10	Multidisciplinary Sciences	Science & Technology - Other Topics	ER9VK	WOS:000399175000003	28362803	gold			2018-01-05	
J	Glaser, T; Han, I; Wu, LQ; Zeng, X				Glaser, Talita; Han, Inbo; Wu, Liquan; Zeng, Xiang			Targeted Nanotechnology in Glioblastoma Multiforme	FRONTIERS IN PHARMACOLOGY			English	Review						cancer stem cell; glioma; nanotechnology; targeted therapy; blood-brain barrier; nanomedicine	BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; CANCER STEM-CELLS; PEGYLATED LIPOSOMAL DOXORUBICIN; TUMOR-INITIATING CELLS; PHASE-II TRIAL; POLYMERIC MICELLE FORMULATION; CONVECTION-ENHANCED DELIVERY; RAT GLIOMA MODEL; DRUG-DELIVERY	Gliomas, and in particular glioblastoma multiforme, are aggressive brain tumors characterized by a poor prognosis and high rates of recurrence. Current treatment strategies are based on open surgery, chemotherapy (temozolomide) and radiotherapy. However, none of these treatments, alone or in combination, are considered effective in managing this devastating disease, resulting in a median survival time of less than 15 months. The efficiency of chemotherapy is mainly compromised by the blood-brain barrier (BBB) that selectively inhibits drugs from infiltrating into the tumor mass. Cancer stem cells (CSCs), with their unique biology and their resistance to both radio-and chemotherapy, compound tumor aggressiveness and increase the chances of treatment failure. Therefore, more effective targeted therapeutic regimens are urgently required. In this article, some well-recognized biological features and biomarkers of this specific subgroup of tumor cells are profiled and new strategies and technologies in nanomedicine that explicitly target CSCs, after circumventing the BBB, are detailed. Major achievements in the development of nanotherapies, such as organic poly(propylene glycol) and poly(ethylene glycol) or inorganic (iron and gold) nanoparticles that can be conjugated to metal ions, liposomes, dendrimers and polymeric micelles, form the main scope of this summary. Moreover, novel biological strategies focused on manipulating gene expression (small interfering RNA and clustered regularly interspaced short palindromic repeats [CRISPR]/CRISPR associated protein 9 [Cas 9] technologies) for cancer therapy are also analyzed. The aim of this review is to analyze the gap between CSC biology and the development of targeted therapies. A better understanding of CSC properties could result in the development of precise nanotherapies to fulfill unmet clinical needs.	[Glaser, Talita] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Han, Inbo] CHA Univ, Dept Neurosurg, Spine Ctr, CHA Bundang Med Ctr, Seongnam, South Korea; [Wu, Liquan] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan, Peoples R China; [Zeng, Xiang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China	Wu, LQ (reprint author), Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan, Peoples R China.; Zeng, X (reprint author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China.	wuliquan@whu.edu.cn; zengx33@mail.sysu.edu.cn		Zeng, Xiang/0000-0003-4577-749X	Youth Program of National Natural Science Foundation of China [31600780]; Sao Paulo Research Foundation (FAPESP) Postdoctoral Fellowship [2015/13345-1, 2016/07659-6]; National Research Foundation of Korea (NRF) [NRF-2014R1A1A2059118]	We thank the following funding sources: Youth Program of National Natural Science Foundation of China (31600780) to XZ. Sao Paulo Research Foundation (FAPESP) Postdoctoral Fellowship 2015/13345-1 and 2016/07659-6 to TG. National Research Foundation of Korea (NRF) (NRF-2014R1A1A2059118) to IH.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Albrecht KW, 2001, J NEURO-ONCOL, V53, P267, DOI 10.1023/A:1012287212388; Ananda S, 2011, J CLIN NEUROSCI, V18, P1444, DOI 10.1016/j.jocn.2011.02.026; Anderson HJ, 2016, CELL ONCOL, V39, P229, DOI 10.1007/s13402-016-0267-7; Aryal M, 2015, PHYS MED BIOL, V60, P2511, DOI 10.1088/0031-9155/60/6/2511; Aryal M, 2014, ADV DRUG DELIVER REV, V72, P94, DOI 10.1016/j.addr.2014.01.008; Aryal M, 2013, J CONTROL RELEASE, V169, P103, DOI 10.1016/j.jconrel.2013.04.007; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Beier CP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-308; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Birngruber T, 2014, J PHARM SCI-US, V103, P1945, DOI 10.1002/jps.23994; Black Keith L, 2004, Cancer Control, V11, P165; Bobyk L, 2013, NANOMED-NANOTECHNOL, V9, P1089, DOI 10.1016/j.nano.2013.04.007; Bradshaw A, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00021; Brown DV, 2015, ONCOTARGET, V6, P6267, DOI 10.18632/oncotarget.3365                                                        ; Cardoso ALC, 2007, J GENE MED, V9, P170, DOI 10.1002/jgm.1006; Chacko AM, 2013, EXPERT OPIN DRUG DEL, V10, P907, DOI 10.1517/17425247.2013.808184; Corsini NS, 2010, CELL STEM CELL, V6, P403, DOI 10.1016/j.stem.2010.04.003; Couvreur P, 2002, CRIT REV THER DRUG, V19, P99, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i2.10                                    ; Cruceru ML, 2013, J CELL MOL MED, V17, P1218, DOI 10.1111/jcmm.12122; Dai Z, 2014, BIOENGINEERED, V5, P30, DOI 10.4161/bioe.27339; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Fabel K, 2001, CANCER, V92, P1936, DOI 10.1002/1097-0142(20011001)92:7<1936::AID-CNCR1712>3.0.CO;2-H                   ; Fiandaca MS, 2011, TOXINS, V3, P369, DOI 10.3390/toxins3040369; Fiorillo A, 2004, J NEURO-ONCOL, V66, P179, DOI 10.1023/B:NEON.0000013471.53015.52; Fischhaber PL, 1999, CANCER RES, V59, P4363; FROSS RD, 1991, J NEURO-ONCOL, V11, P185, DOI 10.1007/BF00165526; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Georgieva Julia V, 2014, Pharmaceutics, V6, P557, DOI 10.3390/pharmaceutics6040557; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Haseloff RF, 2015, SEMIN CELL DEV BIOL, V38, P16, DOI 10.1016/j.semcdb.2014.11.004; Hawkins CJ, 2004, VITAM HORM, V67, P427; He J., 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Hirose Y, 2001, CANCER RES, V61, P1957; Hu QY, 2013, BIOMATERIALS, V34, P5640, DOI 10.1016/j.biomaterials.2013.04.025; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Inoue A, 2016, NEUROPATHOLOGY, V36, P168, DOI 10.1111/neup.12244; Jing H, 2016, THERANOSTICS, V6, P862, DOI 10.7150/thno.12890; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5                                                   ; Kanai Y, 2014, J CELL BIOL, V204, P395, DOI 10.1083/jcb.201309066; Kim DW, 2007, ANN ONCOL, V18, P2009, DOI 10.1093/annonc/mdm374; Kimura K, 2016, J PEDIATR SURG, V51, P2068, DOI 10.1016/j.jpedsurg.2016.09.041; KOBAYASHI T, 1991, J NEURO-ONCOL, V10, P153, DOI 10.1007/BF00146877; Krauze MT, 2007, NEURO-ONCOLOGY, V9, P393, DOI 10.1215/15228517-2007-019; Kuittinen Outi, 2013, Duodecim, V129, P1563; Kumar A, 2016, TUMOR BIOL, V37, P11611, DOI 10.1007/s13277-016-5112-0; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lee KS, 2008, BREAST CANCER RES TR, V108, P241, DOI 10.1007/s10549-007-9591-y; Liu LH, 2008, BIOPOLYMERS, V90, P617, DOI 10.1002/bip.20998; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu W, 2006, CANCER RES, V66, P11878, DOI 10.1158/0008-5472.CAN-06-2354; Luo S., 2014, OA CANC, V2, P2; Maier-Hauff K, 2007, J NEURO-ONCOL, V81, P53, DOI 10.1007/s11060-006-9195-0; Maier-Hauff K, 2011, J NEURO-ONCOL, V103, P317, DOI 10.1007/s11060-010-0389-0; Menei P, 2005, NEUROSURGERY, V56, P242, DOI 10.1227/01.neu.0000144982.82068.A2; Misra A, 2003, J PHARM PHARM SCI, V6, P252; Modrek Aram S, 2014, World J Stem Cells, V6, P43, DOI 10.4252/wjsc.v6.i1.43; Morokoff A, 2015, J CLIN NEUROSCI, V22, P1219, DOI 10.1016/j.jocn.2015.02.008; Ningaraj NS, 2003, DRUG NEWS PERSPECT, V16, P291, DOI 10.1358/dnp.2003.16.5.878815; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; O'Reilly MA, 2012, INT J HYPERTHER, V28, P386, DOI 10.3109/02656736.2012.666709; Ochs K, 2000, CANCER RES, V60, P5815; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.NEU.0000297079.43917.79; Ohtsuki S, 2007, PHARM RES, V24, P1745, DOI 10.1007/s11095-007-9374-5; Ozpolat B, 2014, ADV DRUG DELIVER REV, V66, P110, DOI 10.1016/j.addr.2013.12.008; Papademetriou IT, 2015, THER DELIV, V6, P989, DOI [10.4155/tde.15.48, 10.4155/TDE.15.48]; Pardridge WM, 2015, CLIN PHARMACOL THER, V97, P347, DOI 10.1002/cpt.18; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Regina A, 2001, CANCER METAST REV, V20, P13, DOI 10.1023/A:1013104423154                                                         ; Regina A, 2015, MOL CANCER THER, V14, P129, DOI 10.1158/1535-7163.MCT-14-0399; Ren H, 2003, J NEURO-ONCOL, V64, P147, DOI 10.1023/A:1024979103780; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Safa AR, 2015, GENES DIS, V2, P152, DOI 10.1016/j.gendis.2015.02.001; Sanchez-Covarrubias L, 2014, CURR PHARM DESIGN, V20, P1422, DOI 10.2174/13816128113199990463                                                    ; Santos T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00180; Senzer N, 2013, MOL THER, V21, P1096, DOI 10.1038/mt.2013.32; Sharma US, 1997, PHARMACEUT RES, V14, P992, DOI 10.1023/A:1012136925030                                                         ; Shipitsin M, 2008, LAB INVEST, V88, P459, DOI 10.1038/labinvest.2008.14; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330                                                            ; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Su YJ, 2015, ONCOTARGET, V6, P38029, DOI 10.18632/oncotarget.5703; Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102; Sun T, 2015, ONCOL LETT, V10, P3399, DOI 10.3892/ol.2015.3823; Tchoghandjian A, 2010, BRAIN PATHOL, V20, P211, DOI 10.1111/j.1750-3639.2009.00269.x; Thomas FC, 2009, PHARM RES-DORDR, V26, P2486, DOI 10.1007/s11095-009-9964-5; Tzeng SY, 2013, ADV HEALTHC MATER, V2, P468, DOI 10.1002/adhm.201200257; Upadhyay RK, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/869269; van Houdt WJ, 2006, J NEUROSURG, V104, P583, DOI 10.3171/jns.2006.104.4.583; Velpula KK, 2012, CELL SIGNAL, V24, P2076, DOI 10.1016/j.cellsig.2012.07.002; VONHOLST H, 1990, ACTA NEUROCHIR, V104, P13, DOI 10.1007/BF01842886                                                              ; Wakabayashi T, 2008, J GENE MED, V10, P329, DOI 10.1002/jgm.1160; Wang CH, 2011, NANOMED-NANOTECHNOL, V7, P69, DOI 10.1016/j.nano.2010.06.010; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Weyerbrock A, 2003, J NEUROSURG, V99, P728, DOI 10.3171/jns.2003.99.4.0728; Weyerbrock A, 2011, NEURO-ONCOLOGY, V13, P203, DOI 10.1093/neuonc/noq161; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Xu R, 2009, CELL RES, V19, P1031, DOI 10.1038/cr.2009.89; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Ying X, 2010, J CONTROL RELEASE, V141, P183, DOI 10.1016/j.jconrel.2009.09.020; Yoshida J, 2004, HUM GENE THER, V15, P77, DOI 10.1089/10430340460732472; Yu W, 2004, GENE THER, V11, P1434, DOI 10.1038/sj.gt.3302304; Zeng X, 2016, CELL TRANSPLANT, V25, P2099, DOI 10.3727/096368916X691493; Zheng Y, 2008, RADIAT RES, V169, P19, DOI 10.1667/RR1080.1; Zhu XY, 2014, NEOPLASMA, V61, P401, DOI 10.4149/neo_2014_049; Zucchetti M, 1999, CANCER CHEMOTH PHARM, V44, P173, DOI 10.1007/s002800050964                                                           	116	3	3	17	31	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	MAR 31	2017	8								166	10.3389/fphar.2017.00166				14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EQ3MD	WOS:000397975900001	28408882	gold			2018-01-05	
J	Devost, D; Sleno, R; Petrin, D; Zhang, A; Shinjo, Y; Okde, R; Aoki, J; Inoue, A; Hebert, TE				Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Zhang, Alice; Shinjo, Yuji; Okde, Rakan; Aoki, Junken; Inoue, Asuka; Hebert, Terence E.			Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AT(1) RECEPTOR; BIOSENSORS REVEAL; FUNCTIONAL SELECTIVITY; SIGNALING PATHWAYS; ACTIVATION; GPCRS; DETERMINANTS; MODULATION; MECHANISMS; COMPLEX	Here, we report the design and use of G protein-coupled receptor-based biosensors to monitor ligand-mediated conformational changes in receptors in intact cells. These biosensors use bioluminescence resonance energy transfer with Renilla luciferase (RlucII) as an energy donor, placed at the distal end of the receptor C-tail, and the small fluorescent molecule FlAsH as an energy acceptor, its binding site inserted at different positions throughout the intracellular loops and C-terminal tail of the angiotensin II type I receptor. We verified that the modifications did not compromise receptor localization or function before proceeding further. Our biosensors were able to capture effects of both canonical and biased ligands, even to the extent of discriminating between different biased ligands. Using a combination of G protein inhibitors and HEK 293 cell lines that were CRISPR/Cas9-engineered to delete G alpha(q), G alpha(11), G alpha(12), and G alpha(13) or beta-arrestins, we showed that G alpha(q) and G alpha(11) are required for functional responses in conformational sensors in ICL3 but not ICL2. Loss of beta-arrestin did not alter biased ligand effects on ICL2P2. We also demonstrate that such biosensors are portable between different cell types and yield context-dependent read-outs of G protein-coupled receptor conformation. Our study provides mechanistic insights into signaling events that depend on either G proteins or beta-arrestin.	[Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Zhang, Alice; Okde, Rakan; Hebert, Terence E.] McGill Univ, Dept Pharmacol & Therapeut, Rm 1303 McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada; [Shinjo, Yuji; Aoki, Junken; Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Aoki, Junken] Japan Agcy Med Res & Dev Core Res Evolut Sci & Te, Chiyoda Ku, Tokyo 1000004, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Hebert, TE (reprint author), McGill Univ, Dept Pharmacol & Therapeut, Rm 1303 McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	terence.hebert@mcgill.ca			Consortium Quebecois sur la Decouverte du Medicament; Canadian Institutes of Health Research (CIHR) [MOP-130309]; PRESTO, JST; AMED-CREST; McGill-CIHR Drug Development Training Program	This work was supported by a grant from the Consortium Quebecois sur la Decouverte du Medicament and Canadian Institutes of Health Research (CIHR) Grant MOP-130309 (to T. E. H.) as well as grants from PRESTO, JST (to A. I.) and AMED-CREST (to J. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from the McGill-CIHR Drug Development Training Program.	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Balakumar P, 2014, J MOL ENDOCRINOL, V53, pR71, DOI 10.1530/JME-14-0125; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Casiraghi M, 2016, J AM CHEM SOC, V138, P11170, DOI 10.1021/jacs.6b04432; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Devost D, 2016, METHOD CELL BIOL, V132, P319, DOI 10.1016/bs.mcb.2015.11.010; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Domazet I, 2015, MOL PHARMACOL, V87, P982, DOI 10.1124/mol.114.097337; Gidon A, 2014, NAT CHEM BIOL, V10, P707, DOI [10.1038/NCHEMBIO.1589, 10.1038/nchembio.1589]; Goupil E, 2015, J BIOL CHEM, V290, P3137, DOI 10.1074/jbc.M114.631119; Hao Y, 2016, BIOINFORMATICS, V32, P3435, DOI 10.1093/bioinformatics/btw510; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kahsai AW, 2016, NAT CHEM BIOL, V12, P709, DOI 10.1038/nchembio.2126; Kenakin T, 2015, MOL PHARMACOL, V88, P1055, DOI 10.1124/mol.115.099770; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Lamichhane R, 2015, P NATL ACAD SCI USA, V112, P14254, DOI 10.1073/pnas.1519626112; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Maier-Peuschel M, 2010, J BIOL CHEM, V285, P8793, DOI 10.1074/jbc.M109.098517; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Namkung Y, 2016, METHODS, V92, P5, DOI 10.1016/j.ymeth.2015.04.010; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebois RV, 2012, CELL SIGNAL, V24, P2051, DOI 10.1016/j.cellsig.2012.06.011; Robertson DN, 2016, METHODS, V92, P19, DOI 10.1016/j.ymeth.2015.07.011; Ronan T, 2016, J BIOL CHEM, V291, P5528, DOI 10.1074/jbc.M115.710087; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sleno R, 2016, METHODS, V92, P11, DOI 10.1016/j.ymeth.2015.05.003; Spille JH, 2011, BIOPHYS J, V100, P1139, DOI 10.1016/j.bpj.2010.08.080; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Stumpf AD, 2016, BRIT J PHARMACOL, V173, P255, DOI 10.1111/bph.13382; Svensson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038517; Tian H, 2017, CHEM REV, V117, P186, DOI 10.1021/acs.chemrev.6b00084; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vaniotis G, 2011, AM J PHYSIOL-HEART C, V301, pH1754, DOI 10.1152/ajpheart.00657.2011; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye LB, 2016, NATURE, V533, P265, DOI 10.1038/nature17668; Yu B, 2000, J BIOL CHEM, V275, P71, DOI 10.1074/jbc.275.1.71; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	50	6	6	4	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5443	5456		10.1074/jbc.M116.763854				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EQ2CI	WOS:000397875500024	28213525				2018-01-05	
J	Chen, J; Du, YN; He, XY; Huang, XX; Shi, YS				Chen, Jiang; Du, Yinan; He, Xueyan; Huang, Xingxu; Shi, Yun S.			A Convenient Cas9-based Conditional Knockout Strategy for Simultaneously Targeting Multiple Genes in Mouse	SCIENTIFIC REPORTS			English	Article							GENOME-EDITING SPECIFICITY; HUMAN-CELLS; MICE; CAS9; MACROPHAGES; RECOMBINATION; CRISPR-CAS9; GENERATION; PROTEIN; CRE	The most powerful way to probe protein function is to characterize the consequence of its deletion. Compared to conventional gene knockout (KO), conditional knockout (cKO) provides an advanced gene targeting strategy with which gene deletion can be performed in a spatially and temporally restricted manner. However, for most species that are amphiploid, the widely used Cre-flox conditional KO (cKO) system would need targeting loci in both alleles to be loxP flanked, which in practice, requires time and labor consuming breeding. This is considerably significant when one is dealing with multiple genes. CRISPR/Cas9 genome modulation system is advantaged in its capability in targeting multiple sites simultaneously. Here we propose a strategy that could achieve conditional KO of multiple genes in mouse with Cre recombinase dependent Cas9 expression. By transgenic construction of loxPstop- loxP (LSL) controlled Cas9 (LSL-Cas9) together with sgRNAs targeting EGFP, we showed that the fluorescence molecule could be eliminated in a Cre-dependent manner. We further verified the efficacy of this novel strategy to target multiple sites by deleting c-Maf and MafB simultaneously in macrophages specifically. Compared to the traditional Cre-flox cKO strategy, this sgRNAs-LSL-Cas9 cKO system is simpler and faster, and would make conditional manipulation of multiple genes feasible.	[Chen, Jiang; He, Xueyan; Shi, Yun S.] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China; [Chen, Jiang; He, Xueyan; Shi, Yun S.] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Huang, Xingxu] Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd,Pudong New Area, Shanghai 201210, Peoples R China; [Du, Yinan] Anhui Med Univ, Dept Microbiol & Parasitol, Hefei 230032, Peoples R China	Shi, YS (reprint author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China.; Shi, YS (reprint author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China.; Huang, XX (reprint author), Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd,Pudong New Area, Shanghai 201210, Peoples R China.	huangxx@shanghaitech.edu.cn; yunshi@nju.edu.cn			National Basic Research Program of China [2014CB942804, 2015BAI08B02]; National Science Foundation of China [31471400, 31371061, 31571060]; Natural Science Foundation of Jiangsu Province [BK20140018]	This work is supported by grants from the National Basic Research Program of China (2014CB942804, 2015BAI08B02), the National Science Foundation of China (31471400, 31371061, 31571060), and the Natural Science Foundation of Jiangsu Province (BK20140018).	Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Du YN, 2015, CELL RES, V25, P877, DOI 10.1038/cr.2015.70; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ikawa M, 1999, CURR TOP DEV BIOL, V44, P1; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Li XD, 2003, J STEROID BIOCHEM, V86, P469, DOI 10.1016/S0960-0760(03)00376-5; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pluck A, 1996, INT J EXP PATHOL, V77, P269; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schleicher Ulrike, 2009, V531, P203, DOI 10.1007/978-1-59745-396-7_14; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7	25	0	0	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 31	2017	7								517	10.1038/s41598-017-00654-2				7	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ2DZ	WOS:000397879800005	28364122	gold			2018-01-05	
J	Gayle, S; Landrette, S; Beeharry, N; Conrad, C; Hernandez, M; Beckett, P; Ferguson, SM; Mandelkern, T; Zheng, M; Xu, T; Rothberg, J; Lichenstein, H				Gayle, Sophia; Landrette, Sean; Beeharry, Neil; Conrad, Chris; Hernandez, Marylens; Beckett, Paul; Ferguson, Shawn M.; Mandelkern, Talya; Zheng, Meiling; Xu, Tian; Rothberg, Jonathan; Lichenstein, Henri			Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma	BLOOD			English	Article							ORAL INTERLEUKIN-12/23 INHIBITOR; TRANSCRIPTIONAL CONTROL; IL-12/IL-23 INHIBITOR; LYSOSOMAL BIOGENESIS; CROHNS-DISEASE; AUTOPHAGY; TFEB; MATURATION; TRANSPORT; HOMEOSTASIS	Weidentified apilimod as an antiproliferative compound by high-throughput screening of clinical-stage drugs. Apilimod exhibits exquisite specificity for phosphatidylinositol-3phosphate 5-kinase (PIKfyve) lipid kinase and has selective cytotoxic activity in B-cell non-Hodgkin lymphoma (B-NHL) compared with normal cells. Apilimod displays nanomolar activity in vitro, and in vivo studies demonstrate single-agent efficacy as well as synergy with approved B-NHL drugs. Using biochemical and knockdown approaches, and discovery of a kinase domain mutation conferring resistance, we demonstrate that apilimod-mediated cytotoxicity is driven by PIKfyve inhibition. Furthermore, a critical role for lysosome dysfunction as a major factor contributing to apilimod's cytotoxicity is supported by a genome-wide CRISPR screen. In the screen, TFEB (master transcriptional regulator of lysosomal biogenesis) and endosomal/lysosomal genes CLCN7, OSTM1, and SNX10 were identified as important determinants of apilimod sensitivity. These findings thus suggest that disruptionof lysosomalhomeostasis withapilimod represents anovel approach to treatB-NHL.	[Gayle, Sophia; Landrette, Sean; Beeharry, Neil; Conrad, Chris; Hernandez, Marylens; Beckett, Paul; Mandelkern, Talya; Rothberg, Jonathan; Lichenstein, Henri] LAM Therapeut, 530 Whitfield St, Guilford, CT 06437 USA; [Ferguson, Shawn M.] Yale Univ, Sch Med, Dept Cell Biol, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Zheng, Meiling] Crown Biosci Inc, Dept Canc Pharmacol, Beijing, Peoples R China; [Xu, Tian] Howard Hughes Med Inst, New Haven, CT 06510 USA; [Xu, Tian] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Lichenstein, H (reprint author), LAM Therapeut, 530 Whitfield St, Guilford, CT 06437 USA.	hlichens@lamthera.com			LAM Therapeutics	This work was supported by LAM Therapeutics.	Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719; Baird AM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00162; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Burakoff R, 2006, INFLAMM BOWEL DIS, V12, P558, DOI 10.1097/01.ibd.0000225337.14356.31                                              ; Cai XM, 2013, CHEM BIOL, V20, P912, DOI 10.1016/j.chembiol.2013.05.010; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Compton LM, 2016, AM J PHYSIOL-CELL PH, V311, pC366, DOI 10.1152/ajpcell.00104.2016; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dupuis-Coronas S, 2011, J BIOL CHEM, V286, P32105, DOI 10.1074/jbc.M111.227512; Elis A, 2002, AM J HEMATOL, V69, P41, DOI 10.1002/ajh.10017                                                               ; Ferguson SM, 2015, CURR OPIN CELL BIOL, V35, P59, DOI 10.1016/j.ceb.2015.04.014; Gayle S, 2015, STEM CELL REP, V4, P926, DOI 10.1016/j.stemcr.2015.03.001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hayakawa N, 2014, BIOORGAN MED CHEM, V22, P3021, DOI 10.1016/j.bmc.2014.03.036; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200                                                          ; Ikonomov OC, 2002, J BIOL CHEM; Ishida Y, 2013, J GEN PHYSIOL, V141, P705, DOI 10.1085/jgp.201210930; Kim GHE, 2014, TRAFFIC, V15, P1143, DOI 10.1111/tra.12199; Koster H, 2007, ASSAY DRUG DEV TECHN, V5, P381, DOI 10.1089/adt.2006.039; Krausz S, 2012, ARTHRITIS RHEUM-US, V64, P1750, DOI 10.1002/art.34339; Krishna S, 2016, DEV CELL, V38, P536, DOI 10.1016/j.devcel.2016.08.001; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Min SH, 2014, BLOOD, V124; Min SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5691; Oppelt A, 2014, BIOCHEM J, V461, P383, DOI 10.1042/BJ20140132; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Qin BM, 2006, J BIOL CHEM, V281, P36891, DOI 10.1074/jbc.M608884200; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sands BE, 2010, INFLAMM BOWEL DIS, V16, P1209, DOI 10.1002/ibd.21159; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sano O, 2016, FEBS LETT, V590, P1576, DOI 10.1002/1873-3468.12195; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sbrissa D, 2002, J BIOL CHEM, V277, P6073, DOI 10.1074/jbc.M110194200; SEER Program, 2015, SEER STAT FACT SHEET; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shalem O, 2014, SCIENCE; Vicinanza M, 2015, MOL CELL, V57, P219, DOI 10.1016/j.molcel.2014.12.007; Wada Y, 2007, BLOOD, V109, P1156, DOI 10.1182/blood-2006-04-019398; Wada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035069; Wang WY, 2015, P NATL ACAD SCI USA, V112, pE1373, DOI 10.1073/pnas.1419669112; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	53	5	5	4	8	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	MAR 30	2017	129	13					1768	1778		10.1182/blood-2016-09736892				11	Hematology	Hematology	EQ0QX	WOS:000397776800009	28104689				2018-01-05	
J	Alam, S; Anugraham, M; Huang, YL; Kohler, RS; Hettich, T; Winkelbach, K; Grether, Y; Lopez, MN; Khasbiullina, N; Bovin, NV; Schlotterbeck, G; Jacob, F				Alam, Shahidul; Anugraham, Merrina; Huang, Yen-Lin; Kohler, Reto S.; Hettich, Timm; Winkelbach, Katharina; Grether, Yasmin; Lopez, Monica Nunez; Khasbiullina, Nailia; Bovin, Nicolai V.; Schlotterbeck, Goetz; Jacob, Francis			Altered (neo-) lacto series glycolipid biosynthesis impairs alpha 2-6 sialylation on N-glycoproteins in ovarian cancer cells	SCIENTIFIC REPORTS			English	Article							ANTICARBOHYDRATE ANTIBODIES; MONOCLONAL-ANTIBODIES; GANGLIOSIDE SYNTHESIS; EXPRESSION; GLYCOSPHINGOLIPIDS; GM3; GLYCOSYLATION; ANTIGENS; ENZYME; LACTOTRIAOSYLCERAMIDE	The (neo-) lacto series glycosphingolipids (nsGSLs) comprise of glycan epitopes that are present as blood group antigens, act as primary receptors for human pathogens and are also increasingly associated with malignant diseases. Beta-1, 3-N-acetyl-glucosaminyl-transferase 5 (B3GNT5) is suggested as the key glycosyltransferase for the biosynthesis of nsGSLs. In this study, we investigated the impact of CRISPR-Cas9 -mediated gene disruption of B3GNT5 (Delta B3GNT5) on the expression of glycosphingolipids and N-glycoproteins by utilizing immunostaining and glycomics-based PGC-UHPLCESI-QTOF-MS/MS profiling. Delta B3GNT5 cells lost nsGSL expression coinciding with reduction of alpha 2-6 sialylation on N-glycoproteins. In contrast, disruption of B4GALNT1, a glycosyltransferase for ganglio series GSLs did not affect alpha 2-6 sialylation on N-glycoproteins. We further profiled all known alpha 2-6 sialyltransferase-encoding genes and showed that the loss of alpha 2-6 sialylation is due to silencing of ST6GAL1 expression in Delta B3GNT5 cells. These results demonstrate that nsGSLs are part of a complex network affecting N-glycosylation in ovarian cancer cells.	[Alam, Shahidul; Anugraham, Merrina; Huang, Yen-Lin; Kohler, Reto S.; Winkelbach, Katharina; Grether, Yasmin; Lopez, Monica Nunez; Jacob, Francis] Univ Basel, Univ Basel Hosp, Dept Biomed, Ovarian Canc Res, CH-4031 Basel, Switzerland; [Alam, Shahidul; Jacob, Francis] Univ Basel, Univ Basel Hosp, Dept Biomed, Glyco Oncol Ovarian Canc Res, CH-4031 Basel, Switzerland; [Hettich, Timm; Schlotterbeck, Goetz] Univ Appl Sci & Arts Northwestern Switzerland, Sch Life Sci, CH-4132 Muttenz, Switzerland; [Khasbiullina, Nailia; Bovin, Nicolai V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Jacob, F (reprint author), Univ Basel, Univ Basel Hosp, Dept Biomed, Ovarian Canc Res, CH-4031 Basel, Switzerland.; Jacob, F (reprint author), Univ Basel, Univ Basel Hosp, Dept Biomed, Glyco Oncol Ovarian Canc Res, CH-4031 Basel, Switzerland.	francis.jacob@unibas.ch			Novartis Foundation for Biomedical Research [13B093]; Krebsliga beider Basel; Swiss Cancer League [KLS-3841-02-2016]; Department of Biomedicine, University Hospital Basel and University of Basel; Russian Science Foundation [14-50-00131]	We are grateful to the Flow Cytometry Facility (Danny Labes and Emmanuel Traunecker) and Microscopy Facility (Michael Abanto and Beat Erne) for providing all necessary support. We would also like to acknowledge the following people for their various contributions to this publication: Viola Heinzelmann-Schwarz, Christian Berchthold, Andreas Schotzau, and Tatiana Pochechueva. We also thank Jolene Molley for final proofreading the manuscript. This work was supported by Novartis Foundation for Biomedical Research (13B093), Krebsliga beider Basel (14-2015), Swiss Cancer League (KLS-3841-02-2016), and FreeNovation 2016 provided by Novartis all to FJ, and the Department of Biomedicine, University Hospital Basel and University of Basel. Work of NVB was supported by the Russian Science Foundation project no. 14-50-00131.	Alam S, 2015, GLYCOBIOLOGY, V25, P351, DOI 10.1093/glycob/cwu187; Anugraham M, 2015, RAPID COMMUN MASS SP, V29, P545, DOI 10.1002/rcm.7130; Anugraham M, 2014, MOL CELL PROTEOMICS, V13, P2213, DOI 10.1074/mcp.M113.037085; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Bovin N, 2012, BBA-GEN SUBJECTS, V1820, P1373, DOI 10.1016/j.bbagen.2012.02.005; Brank AS, 2002, J MOL BIOL, V323, P53, DOI 10.1016/S0022-2836(02)00918-X; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell MP, 2014, NUCLEIC ACIDS RES, V42, pD215, DOI 10.1093/nar/gkt1128; Cherian RM, 2014, GLYCOBIOLOGY, V24, P26, DOI 10.1093/glycob/cwt086; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; D'Angelo G, 2013, FEBS J, V280, P6338, DOI 10.1111/febs.12559; Damerell David, 2015, Methods Mol Biol, V1273, P3, DOI 10.1007/978-1-4939-2343-4_1; DUNSTAN RA, 1985, AM J CLIN PATHOL, V83, P731; Flesken-Nikitin A, 2013, NATURE, V495, P241, DOI 10.1038/nature11979; Fragaki K, 2013, EUR J HUM GENET, V21, P528, DOI 10.1038/ejhg.2012.202; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Henion TR, 2001, J BIOL CHEM, V276, P30261, DOI 10.1074/jbc.M102979200                                                          ; HOLMES EH, 1987, J BIOL CHEM, V262, P11331; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Jacob F, 2014, BRIT J CANCER, V111, P1634, DOI 10.1038/bjc.2014.455; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jacob F, 2012, INT J CANCER, V130, P138, DOI 10.1002/ijc.26002; Kim SJ, 2013, BIOCHEM J, V449, P241, DOI 10.1042/BJ20120189; Kohler RS, 2016, ONCOTARGET, V7, P51674, DOI 10.18632/oncotarget.10543; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n                                                               ; Magalhaes A, 2015, BBA-MOL BASIS DIS, V1852, P1928, DOI 10.1016/j.bbadis.2015.07.001; Marcos-Silva L, 2015, GLYCOBIOLOGY, V25, P1172, DOI 10.1093/glycob/cwv056; Marcos-Silva L, 2014, J PROTEOME RES, V13, P3349, DOI 10.1021/pr500215g; NAIKI M, 1975, BIOCHEMISTRY-US, V14, P4831, DOI 10.1021/bi00693a009; Nozaki H, 2010, GLYCOBIOLOGY, V20, P1631, DOI 10.1093/glycob/cwq117; Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ricardo S, 2015, MOL ONCOL, V9, P503, DOI 10.1016/j.molonc.2014.10.005; ROGERIEUX F, 1993, ANAL BIOCHEM, V211, P200, DOI 10.1006/abio.1993.1257                                                          ; Shevchuk NA, 2007, BBA-MOL CELL BIOL L, V1771, P1226, DOI 10.1016/j.bbalip.2007.05.008; Sivasubramaniyan K, 2015, GLYCOBIOLOGY, V25, P902, DOI 10.1093/glycob/cwv032; Steentoft C, 2014, GLYCOBIOLOGY, V24, P663, DOI 10.1093/glycob/cwu046; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Thuresson B, 2011, BLOOD, V117, P678, DOI 10.1182/blood-2010-08-301333; Togayachi A, 2001, J BIOL CHEM, V276, P22032, DOI 10.1074/jbc.M011369200; Uphoff Cord C, 2005, Methods Mol Biol, V290, P13; van Oss C. J., 1994, IMMUNOCHEMISTRY; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang Z, 2012, GLYCOBIOLOGY, V22, P930, DOI 10.1093/glycob/cws061; Widmer M, 1999, EUR J CLIN MICROBIOL, V18, P823, DOI 10.1007/s100960050409; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; YOUNG WW, 1981, J BIOL CHEM, V256, P967; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	52	0	0	8	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 30	2017	7								45367	10.1038/srep45367				18	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ1GK	WOS:000397817600001	28358117	gold			2018-01-05	
J	Ueta, R; Abe, C; Watanabe, T; Sugano, SS; Ishihara, R; Ezura, H; Osakabe, Y; Osakabe, K				Ueta, Risa; Abe, Chihiro; Watanabe, Takahito; Sugano, Shigeo S.; Ishihara, Ryosuke; Ezura, Hiroshi; Osakabe, Yuriko; Osakabe, Keishi			Rapid breeding of parthenocarpic tomato plants using CRISPR/Cas9	SCIENTIFIC REPORTS			English	Article							BOX PROTEIN TIR1; FRUIT-DEVELOPMENT; NUCLEASE SPECIFICITY; HORMONAL-REGULATION; AUXIN RECEPTOR; CAS9; RNA; ARABIDOPSIS; SYSTEM; SET	Parthenocarpy in horticultural crop plants is an important trait with agricultural value for various industrial purposes as well as direct eating quality. Here, we demonstrate a breeding strategy to generate parthenocarpic tomato plants using the CRISPR/Cas9 system. We optimized the CRISPR/Cas9 system to introduce somatic mutations effectively into SlIAA9-a key gene controlling parthenocarpy-with mutation rates of up to 100% in the T0 generation. Furthermore, analysis of off-target mutations using deep sequencing indicated that our customized gRNAs induced no additional mutations in the host genome. Regenerated mutants exhibited morphological changes in leaf shape and seedless fruit-a characteristic of parthenocarpic tomato. And the segregated next generation (T1) also showed a severe phenotype associated with the homozygous mutated genome. The system developed here could be applied to produce parthenocarpic tomato in a wide variety of cultivars, as well as other major horticultural crops, using this precise and rapid breeding technique.	[Ueta, Risa; Abe, Chihiro; Ishihara, Ryosuke] Univ Tokushima, Grad Sch Adv Technol & Sci, Tokushima, Japan; [Watanabe, Takahito; Sugano, Shigeo S.] Univ Tokushima, Ctr Collaborat Agr Ind & Commerce, Tokushima, Japan; [Ezura, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Osakabe, Yuriko; Osakabe, Keishi] Univ Tokushima, Fac Biosci & Bioind, Tokushima, Japan	Osakabe, K (reprint author), Univ Tokushima, Fac Biosci & Bioind, Tokushima, Japan.	kosakabe@tokushima-u.ac.jp			JSPS [26430190, 25450002]; Japan Society for the Promotion of Science (JSPS) [15H01245]; Cabinet Office, Government of Japan; Cross-ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next-generation agriculture, forestry and fisheries" (Bio-oriented Technology Research Advancement Institution, NARO)	We thank M. Fukuhara and H. Takahashi for their technical assistance. This work was supported by the Grant-in-Aid for Scientific Research C (26430190 to Y.O. and 25450002 to K.O.) and Grant-in-Aid for Scientific Research on Innovative Areas from JSPS (15H01245 to Y.O.) from the Japan Society for the Promotion of Science (JSPS). This work was supported by Cabinet Office, Government of Japan, Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO).	Ariizumi T, 2013, BREEDING SCI, V63, P3, DOI 10.1270/jsbbs.63.3; Breitel DA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005903; Cai Y., 2015, PLOS ONE, V10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Du LM, 2016, MOL GENET GENOMICS, V291, P93, DOI 10.1007/s00438-015-1088-5; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Gorguet B, 2005, PLANT BIOLOGY, V7, P131, DOI 10.1055/s-2005-837494; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karapanos I. C., 2008, EUR J PL SCI BIOTECH, V2, P88; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Martinelli F, 2009, J EXP BOT, V60, P3873, DOI 10.1093/jxb/erp227; Nishitani C., 2016, SCI REPORTS IN PRESS; Osakabe Y., 2016, SCI REPORTS, V26, P26685; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; Osakabe Y, 2013, PLANT CELL, V25, P609, DOI 10.1105/tpc.112.105700; Pandolfini T, 2009, NUTRIENTS, V1, P168, DOI 10.3390/nu1020168; Parry G, 2006, CURR OPIN CELL BIOL, V18, P152, DOI 10.1016/j.ceb.2006.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Schaart JG, 2016, TRENDS PLANT SCI, V21, P438, DOI 10.1016/j.tplants.2015.11.006; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389	37	5	5	25	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 30	2017	7								507	10.1038/s41598-017-00501-4				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ1EH	WOS:000397811900002	28360425	gold			2018-01-05	
J	Bu, Q; Wang, AX; Hamzah, H; Waldman, A; Jiang, K; Dong, QP; Li, RH; Kim, J; Turner, D; Chang, Q				Bu, Qian; Wang, Anxin; Hamzah, Hamdi; Waldman, Alex; Jiang, Keer; Dong, Qiping; Li, Ronghui; Kim, Jason; Turner, Daniel; Chang, Qiang			CREB Signaling Is Involved in Rett Syndrome Pathogenesis	JOURNAL OF NEUROSCIENCE			English	Article						CREB; hESC; iPSC; MECP2; Rett syndrome; rolipram	OBSTRUCTIVE PULMONARY-DISEASE; PLURIPOTENT STEM-CELLS; CPG-BINDING PROTEIN-2; MECP2 MUTANT MOUSE; PHOSPHODIESTERASE-4 INHIBITOR; MITOCHONDRIAL DYSFUNCTION; DENDRITIC ARBORIZATION; NEURONS; MICE; MODEL	Rett syndrome (RTT) is a debilitating neurodevelopmental disorder caused by mutations in the MECP2 gene. To facilitate the study of cellular mechanisms in human cells, we established several human stem cell lines: human embryonic stem cell (hESC) line carrying the common T158 Mmutation (MECP2(T158M/T158M)), hESCline expressing no MECP2(MECP2-KO), congenic pair of wild-type and mutant RTT patient-specific induced pluripotent stem cell (iPSC) line carrying the V247fs mutation (V247fs-WT and V247fs-MT), and iPSC line in which the V247fs mutation was corrected by CRISPR/Cas9-based genome editing (V247fs-MT-correction). Detailed analyses of forebrain neurons differentiated from these human stem cell lines revealed genotype-dependent quantitative phenotypes in neurite growth, dendritic complexity, and mitochondrial function. At the molecular level, we found a significant reduction in the level of CREB and phosphorylated CREB in forebrain neurons differentiated from MECP2(T158M/T158M), MECP2-KO, and V247fs-MT stem cell lines. Importantly, overexpression of CREB or pharmacological activation of CREB signaling in those forebrain neurons rescued the phenotypes in neurite growth, dendritic complexity, and mitochondrial function. Finally, pharmacological activation of CREB in the female Mecp2 heterozygous mice rescued several behavioral defects. Together, our study establishes a robust in vitro platform for consistent quantitative evaluation of genotype-dependent RTT phenotypes, reveals a previously unappreciated role of CREB signaling in RTT pathogenesis, and identifies a potential therapeutic target for RTT.	[Bu, Qian; Wang, Anxin; Hamzah, Hamdi; Waldman, Alex; Jiang, Keer; Dong, Qiping; Li, Ronghui; Kim, Jason; Turner, Daniel; Chang, Qiang] Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA; [Chang, Qiang] Univ Wisconsin, Dept Med Genet, 1500 Highland Ave, Madison, WI 53705 USA; [Chang, Qiang] Univ Wisconsin, Dept Neurol, 1500 Highland Ave, Madison, WI 53705 USA	Chang, Q (reprint author), Univ Wisconsin, 1500 Highland Ave, Madison, WI 53705 USA.	qchang@waisman.wisc.edu		Li, Ronghui/0000-0001-6329-5895; Chang, Qiang/0000-0002-7625-2170	National Institutes of Health National Institute of Child Health and Human Development [P30HD03352/U54HD090256]	This work was supported in part by National Institutes of Health National Institute of Child Health and Human Development P30HD03352/U54HD090256 to the Waisman Center. We thank Xiaoji Zhang for technical support.	Amir RE, 1999, NAT GENET, V23, P185; Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Balakrishnan S, 2016, FRONT CELL NEUROSCI, V10, DOI [10.3389/fnce1.2016.00015, 10.3389/fncel.2016.00015]; Belichenko NP, 2008, J COMP NEUROL, V508, P184, DOI 10.1002/cne.21673; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Brown K, 2016, HUM MOL GENET, V25, P558, DOI 10.1093/hmg/ddv496; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen YJ, 2015, CELL STEM CELL, V17, P233, DOI 10.1016/j.stem.2015.06.001; Cheng TL, 2014, DEV CELL, V28, P547, DOI 10.1016/j.devcel.2014.01.032; Cheung AY, 2011, HUM MOL GENET, V20, P2013; Choi CH, 2015, J NEUROSCI, V35, P396, DOI 10.1523/JNEUROSCI.1356-12.2015; COKER SB, 1991, J CHILD NEUROL, V6, P164, DOI 10.1177/088307389100600216                                                      ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CORNFORD ME, 1994, J CHILD NEUROL, V9, P424, DOI 10.1177/088307389400900419                                                      ; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; DOTTI MT, 1993, BRAIN DEV-JPN, V15, P103, DOI 10.1016/0387-7604(93)90045-A; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; EEGOLOFSSON O, 1990, J CHILD NEUROL, V5, P210, DOI 10.1177/088307389000500311                                                      ; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Gold WA, 2014, MITOCHONDRION, V15, P10, DOI 10.1016/j.mito.2014.02.012; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Grosser E, 2012, NEUROBIOL DIS, V48, P102, DOI 10.1016/j.nbd.2012.06.007; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899                                                                   ; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x                                              ; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jugloff DGM, 2005, NEUROBIOL DIS, V19, P18, DOI 10.1016/j.nbd.2004.11.002; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Li YF, 2009, NEUROPSYCHOPHARMACOL, V34, P2404, DOI 10.1038/npp.2009.66; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Mironov SL, 2011, NEUROPHARMACOLOGY, V60, P869, DOI 10.1016/j.neuropharm.2011.01.002; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Pitcher MR, 2015, HUM MOL GENET, V24, P2662, DOI 10.1093/hmg/ddv030; Rabe KF, 2011, BRIT J PHARMACOL, V163, P53, DOI 10.1111/j.1476-5381.2011.01218.x; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7                                                   ; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Samaco RC, 2011, J NEUROSCI, V31, P7951, DOI 10.1523/JNEUROSCI.0169-11.2011; Schaevitz LR, 2013, GENES BRAIN BEHAV, V12, P732, DOI 10.1111/gbb.12070; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Vecsey CG, 2009, NATURE, V461, P1122, DOI 10.1038/nature08488; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wegener E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115444; Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008; Zhong XF, 2012, J NEUROSCI, V32, P12841, DOI 10.1523/JNEUROSCI.2784-12.2012	63	1	1	2	2	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 29	2017	37	13					3671	3685		10.1523/JNEUROSCI.3735-16.2017				15	Neurosciences	Neurosciences & Neurology	EQ1IP	WOS:000397823700021	28270572				2018-01-05	
J	Kopischke, S; Schussler, E; Althoff, F; Zachgo, S				Kopischke, Sarah; Schuessler, Esther; Althoff, Felix; Zachgo, Sabine			TALEN-mediated genome-editing approaches in the liverwort Marchantia polymorpha yield high efficiencies for targeted mutagenesis	PLANT METHODS			English	Article						TALEN; Genome editing; Marchantia polymorpha; MpNOP1	HOMOLOGOUS RECOMBINATION; GENE ORGANIZATION; CRISPR/CAS9 SYSTEM; COMPLETE SEQUENCE; ANALYSIS REVEALS; Y-CHROMOSOME; DNA; TRANSFORMATION; ARABIDOPSIS; PLANTS	Background: The liverwort Marchantia polymorpha occupies a crucial position in land plant evolution and provides the opportunity to investigate adaptations to a terrestrial plant life style. Marchantia reverse genetic analyses have thus far been conducted by employing a homologous recombination approach, which yields an efficiency of around 3%. Availability of the characterized and suitable endogenous MpEF1a promoter prompted us to establish the TALEN gene targeting technique for Marchantia. Results: Here, two different TALEN techniques, using custom and self-assembled TALEN constructs, were applied and compared. The MpNOP1 gene was selected as a candidate gene, as the respective knockout mutant has been shown to lack air chamber formation, representing an easily traceable phenotype. We demonstrate that both TALEN approaches are successful in Marchantia yielding high gene targeting efficiencies of over 20%. Investigation of selected G1 up to G4 generations proved the stability of the knockout mutants. In 392 analyzed T1 plants, no additional phenotypes were observed and only one chimeric knockout plant was detected after an extended cultivation period. Interestingly, two out of the 24 sequenced mutants harbored indels causing in-frame mutations and revealed novel Mpnop1-related phenotypes. This demonstrates the potential to detect crucial amino acids and motives of targeted proteins, which is of special interest for essential genes where full knockouts are lethal. The FastTALE(TM) TALEN assembly kit enables the rapid assembly and ligation of the TALEN arms within half a day. For transformations, custom and assembled constructs were subcloned into Marchantia binary vectors possessing the MpEF1a promoter. Conclusion: Considering time, costs and practicability, the assembly TALEN approach represents a rapid and highly efficient gene targeting system to generate Marchantia knockout mutants, which can be further adapted for future advanced genome-editing applications.	[Kopischke, Sarah; Schuessler, Esther; Althoff, Felix; Zachgo, Sabine] Univ Osnabruck, Sch Biol Chem, Dept Bot, Osnabruck, Germany	Zachgo, S (reprint author), Univ Osnabruck, Sch Biol Chem, Dept Bot, Osnabruck, Germany.	zachgo@biologie.uni-osnabrueck.de			German Research Foundation (DFG) [SFB944, ZA256/7-1]	This work was supported by the German Research Foundation (DFG) (Grant Nos. SFB944, ZA256/7-1).	Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Bowman JL, 2016, PLANT CELL PHYSIOL, V57, P205, DOI 10.1093/pcp/pcw023; Brandl C, 2015, FEBS OPEN BIO, V5, P26, DOI 10.1016/j.fob.2014.11.009; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen KL, 2014, METHODS, V69, P2, DOI 10.1016/j.ymeth.2014.02.013; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Eklund DM, 2015, PLANT CELL, V27, P1650, DOI 10.1105/tpc.15.00065; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Forner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121056; Gurushidze M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092046; He ZY, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2536-3; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Ishizaki K, 2016, PLANT CELL PHYSIOL, V57, P262, DOI 10.1093/pcp/pcv097; Ishizaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138876; Ishizaki K, 2013, PLANT CELL, V25, P4075, DOI 10.1105/tpc.113.117051; Ishizaki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01532; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Komatsu A, 2014, PLANT PHYSIOL, V166, P411, DOI 10.1104/pp.114.245100; Kubota A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4668; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.12; Moscou MJ, 2009, CHINESE J BIOCH MOL, V326, P1501, DOI DOI 10.1126/SCIENCE.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R                                                    ; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Okada S, 2001, P NATL ACAD SCI USA, V98, P9454, DOI 10.1073/pnas.171304798; Paul JW, 2016, PLANT CELL REP, V35, P1417, DOI 10.1007/s00299-016-1985-z; Puchta H, 2002, PLANT MOL BIOL, V48, P173, DOI 10.1023/A:1013761821763; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Shimamura M, 2016, PLANT CELL PHYSIOL, V57, P230, DOI 10.1093/pcp/pcv192; Sprink T, 2015, CURR OPIN BIOTECH, V32, P47, DOI 10.1016/j.copbio.2014.11.010; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Tsuboyama S, 2014, PLANT CELL PHYSIOL, V55, P229, DOI 10.1093/pcp/pct168; Tsuboyama-Tanaka S, 2015, J PLANT RES, V128, P337, DOI 10.1007/s10265-014-0695-2; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang C, 2015, J GENET GENOMICS, V42, P703, DOI 10.1016/j.jgg.2015.09.011; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104; Yu ZS, 2014, BIOL OPEN, V3, P271, DOI 10.1242/bio.20147682; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang ZJ, 2016, PLANT CELL REP, V35, P1519, DOI 10.1007/s00299-015-1900-z	54	0	0	8	20	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1746-4811			PLANT METHODS	Plant Methods	MAR 29	2017	13								20	10.1186/s13007-017-0167-5				11	Biochemical Research Methods; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	EP9EQ	WOS:000397677200001	28360929	gold			2018-01-05	
J	Anelli, V; Villefranc, JA; Chhangawala, S; Martinez-McFaline, R; Riva, E; Nguyen, A; Verma, A; Bareja, R; Chen, ZM; Scognamiglio, T; Elemento, O; Houvras, Y				Anelli, Viviana; Villefranc, Jacques A.; Chhangawala, Sagar; Martinez-McFaline, Raul; Riva, Eleonora; Nguyen, Anvy; Verma, Akanksha; Bareja, Rohan; Chen, Zhengming; Scognamiglio, Theresa; Elemento, Olivier; Houvras, Yariv			Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression	ELIFE			English	Article							RNA-SEQ DATA; MESENCHYMAL TRANSITION; CANCER; ZEBRAFISH; MELANOMA; BRAF(V600E); MUTATION; MOUSE; MICROCARCINOMA; PROGRESSION	Thyroid cancer is common, yet the sequence of alterations that promote tumor formation are incompletely understood. Here, we describe a novel model of thyroid carcinoma in zebrafish that reveals temporal changes due to BRAF(V600E). Through the use of real-time in vivo imaging, we observe disruption in thyroid follicle structure that occurs early in thyroid development. Combinatorial treatment using BRAF and MEK inhibitors reversed the developmental effects induced by BRAF(V600E). Adult zebrafish expressing BRAF(V600E) in thyrocytes developed invasive carcinoma. We identified a gene expression signature from zebrafish thyroid cancer that is predictive of disease-free survival in patients with papillary thyroid cancer. Gene expression studies nominated TWIST2 as a key effector downstream of BRAF. Using CRISPR/Cas9 to genetically inactivate a TWIST2 orthologue, we suppressed the effects of BRAF(V600E) and restored thyroid morphology and hormone synthesis. These data suggest that expression of TWIST2 plays a role in an early step of BRAF(V600E)-mediated transformation.	[Anelli, Viviana; Villefranc, Jacques A.; Chhangawala, Sagar; Martinez-McFaline, Raul; Nguyen, Anvy; Houvras, Yariv] New York Presbyterian Hosp, Weil Cornell Med Coll, Dept Surg, New York, NY USA; [Riva, Eleonora] Univ Ferrara, Dept Med Sci, Sect Endocrinol, Ferrara, Italy; [Verma, Akanksha; Bareja, Rohan; Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Verma, Akanksha; Bareja, Rohan; Elemento, Olivier] Weill Cornell Med Coll, Dept Physiol & Biophy, New York, NY USA; [Chen, Zhengming] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Scognamiglio, Theresa] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Houvras, Yariv] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA; [Houvras, Yariv] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Med, New York, NY USA	Houvras, Y (reprint author), New York Presbyterian Hosp, Weil Cornell Med Coll, Dept Surg, New York, NY USA.	yah9014@med.cornell.edu		Riva, Eleonora/0000-0003-3603-5806	National Institutes of Health [R21 CA202540 01, T32GM007739, P50-CA172012]	National Institutes of Health R21 CA202540 01 Yariv Houvras; National Institutes of Health T32GM007739 Raul Martinez-McFaline; National Institutes of Health P50-CA172012 Jacques A Villefranc	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chakravarty D, 2011, J CLIN INVEST, V121, P4700, DOI 10.1172/JCI46382; Charles RP, 2011, CANCER RES, V71, P3863, DOI 10.1158/0008-5472.CAN-10-4463; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; Haser GC, 2016, THYROID, V26, P989, DOI 10.1089/thy.2016.0109; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Kainthla R, 2014, PHARMACOGN PERS MED, V7, P21, DOI 10.2147/PGPM.S37220; Kim DW, 2014, ONCOTARGETS THER, V7, P1631, DOI 10.2147/OTT.S51596; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047                                                   ; Landa I, 2016, J CLIN INVEST, V126, P1052, DOI DOI 10.1172/JCI85271; Li F, 2015, ENDOCR-RELAT CANCER, V22, P159, DOI 10.1530/ERC-14-0531; Lindsay H, 2016, NAT BIOTECHNOL, V34, P701, DOI 10.1038/nbt.3628; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Haser GC, 2016, ENDOCR PRACT, V22, P602, DOI [10.4158/EP151065.RA, DOI 10.4158/3P151065.RA]; McCarty SK, 2014, ENDOCR-RELAT CANCER, V21, P865, DOI 10.1530/ERC-14-0424; McFadden DG, 2014, P NATL ACAD SCI USA, V111, pE1600, DOI 10.1073/pnas.1404357111; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; Opitz R, 2013, EUR THYROID J, V2, P229, DOI 10.1159/000357079; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031                                                       ; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Pritchard AL, 2013, CLIN CANCER RES, V19, P2301, DOI 10.1158/1078-0432.CCR-12-0383; Sanchez-Hernandez I, 2013, CANC LETT, V335, P232, DOI [10.1016/j.canlet.2013.02.033, DOI 10.1016/I.CANIET.2013,02.033]; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Salerno P, 2011, J CLIN ENDOCR METAB, V96, pE772, DOI 10.1210/jc.2010-1182; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Wang N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/589423; Wendl T, 2002, DEVELOPMENT, V129, P3751; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	38	4	4	2	3	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	MAR 28	2017	6								e20728	10.7554/eLife.20728.001				19	Biology	Life Sciences & Biomedicine - Other Topics	ER6GA	WOS:000398902200001					2018-01-05	
J	Halim, D; Wilson, MP; Oliver, D; Brosens, E; Verheij, JBGM; Han, Y; Nanda, V; Lyu, Q; Doukas, M; Stoop, H; Brouwer, RWW; van IJcken, WFJ; Slivano, OJ; Burns, AJ; Christie, CK; Bentley, KLD; Brooks, AS; Tibboel, D; Xu, SW; Jin, ZG; Djuwantono, T; Yan, W; Alves, MM; Hofstra, RMW; Miano, JM				Halim, Danny; Wilson, Michael P.; Oliver, Daniel; Brosens, Erwin; Verheij, Joke B. G. M.; Han, Yu; Nanda, Vivek; Lyu, Qing; Doukas, Michael; Stoop, Hans; Brouwer, Rutger W. W.; van IJcken, Wilfred F. J.; Slivano, Orazio J.; Burns, Alan J.; Christie, Christine K.; Bentley, Karen L. de Mesy; Brooks, Alice S.; Tibboel, Dick; Xu, Suowen; Jin, Zheng Gen; Djuwantono, Tono; Yan, Wei; Alves, Maria M.; Hofstra, Robert M. W.; Miano, Joseph M.			Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR-Cas9; genetics; Leiomodin; myopathy; smooth muscle	LIGHT-CHAIN KINASE; NEMALINE MYOPATHY; MOUSE EMBRYOGENESIS; ACTA2 MUTATION; GENE; EXPRESSION; MYOSIN; TROPOMODULIN; LEIOMODIN; FAMILY	Megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) is a congenital visceral myopathy characterized by severe dilation of the urinary bladder and defective intestinal motility. The genetic basis of MMIHS has been ascribed to spontaneous and autosomal dominant mutations in actin gamma 2 (ACTG2), a smooth muscle contractile gene. However, evidence suggesting a recessive origin of the disease also exists. Using combined homozygosity mapping and whole exome sequencing, a genetically isolated family was found to carry a premature termination codon in Leiomodin1 (LMOD1), a gene preferentially expressed in vascular and visceral smooth muscle cells. Parents heterozygous for the mutation exhibited no abnormalities, but a child homozygous for the premature termination codon displayed symptoms consistent with MMIHS. We used CRISPR-Cas9 (CRISPR-associated protein) genome editing of Lmod1 to generate a similar premature termination codon. Mice homozygous for the mutation showed loss of LMOD1 protein and pathology consistent with MMIHS, including late gestation expansion of the bladder, hydronephrosis, and rapid demise after parturition. Loss of LMOD1 resulted in a reduction of filamentous actin, elongated cytoskeletal dense bodies, and impaired intestinal smooth muscle contractility. These results define LMOD1 as a disease gene for MMIHS and suggest its role in establishing normal smooth muscle cytoskeletal-contractile coupling.	[Halim, Danny; Brosens, Erwin; Burns, Alan J.; Brooks, Alice S.; Alves, Maria M.; Hofstra, Robert M. W.] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 CN Rotterdam, Netherlands; [Wilson, Michael P.; Han, Yu; Nanda, Vivek; Lyu, Qing; Slivano, Orazio J.; Christie, Christine K.; Xu, Suowen; Jin, Zheng Gen; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Oliver, Daniel; Yan, Wei] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Verheij, Joke B. G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Doukas, Michael; Stoop, Hans] Erasmus Univ, Med Ctr, Dept Pathol, NL-3015 CN Rotterdam, Netherlands; [Brouwer, Rutger W. W.; van IJcken, Wilfred F. J.] Erasmus Univ, Med Ctr, Ctr Biom, NL-3015 CN Rotterdam, Netherlands; [Burns, Alan J.; Hofstra, Robert M. W.] Univ London, Inst Child Hlth, Birth Defects Res Ctr, Stem Cells & Regenerat Med, London WC1N 1EH, England; [Bentley, Karen L. de Mesy] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Tibboel, Dick] Erasmus Univ, Med Ctr, Dept Pediat Surg, NL-3015 CN Rotterdam, Netherlands; [Djuwantono, Tono] Padjadjaran State Univ, Fac Med, Dept Obstet & Gynecol, Bandung, Indonesia	Hofstra, RMW (reprint author), Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 CN Rotterdam, Netherlands.; Miano, JM (reprint author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.; Hofstra, RMW (reprint author), Univ London, Inst Child Hlth, Birth Defects Res Ctr, Stem Cells & Regenerat Med, London WC1N 1EH, England.	r.hofstra@erasmusmc.nl; j.m.miano@rochester.edu		Brosens, Erwin/0000-0001-8235-4010	NIH [1P30GM110767, HL-117907, HL-112793]; Vrienden van het Sophia	We thank the family involved in this study. We thank the University of Rochester Mouse Genome Editing Resource for the microinjection experiments involving three-component CRISPR editing of the Lmod1 CArG boxes. We thank Gayle Schneider of the University of Rochester's Electron Microscope Shared Resource Laboratory for thin sectioning of the transmission electron microscopy specimens. The two-component CRISPR knockout of Lmod1 was conducted in the Genome Editing Core of the University of Nevada, Reno School of Medicine, which is supported, in part, by a COBRE grant from the NIH (1P30GM110767). J.M.M. is supported by NIH Grants HL-117907 and HL-112793. R.M.W.H. is supported by a grant from the Vrienden van het Sophia.	Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; BERDON WE, 1976, AM J ROENTGENOL, V126, P957, DOI 10.2214/ajr.126.5.957                                                           ; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x                                               ; Boczkowska M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9314; BOND M, 1982, J CELL BIOL, V95, P403, DOI 10.1083/jcb.95.2.403; Brosens E, 2016, EUR J HUM GENET, V24, P1715, DOI 10.1038/ejhg.2016.86; Brouwer RWW, 2012, BIOINFORMATICS, V28, P284, DOI 10.1093/bioinformatics/btr613; Cenik BK, 2015, J CLIN INVEST, V125, P1569, DOI 10.1172/JCI80115; Chen M, 2013, J BIOL CHEM, V288, P34647, DOI 10.1074/jbc.M113.510362; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; Conley CA, 2001, AM J PHYSIOL-CELL PH, V280, pC1645; Consortium G.T., 2013, NAT GENET, V45, P580, DOI DOI 10.1038/NG.2653; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de Visser KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132549; DONG Q, 1991, J CLIN ENDOCR METAB, V72, P1375, DOI 10.1210/jcem-72-6-1375                                                          ; Fishilevich S, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw030; Gauthier J, 2015, EUR J HUM GENET, V23, P1266, DOI 10.1038/ejhg.2014.256; Guo HQ, 2013, PFLUG ARCH EUR J PHY, V465, P283, DOI 10.1007/s00424-012-1178-8; Halim D, 2016, HUM MOL GENET, V25, P571, DOI 10.1093/hmg/ddv497; Han Y, 2015, ARTERIOSCL THROM VAS, V35, P312, DOI 10.1161/ATVBAHA.114.305017; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kostyukova AS, 2007, ARCH BIOCHEM BIOPHYS, V465, P227, DOI 10.1016/j.abb.2007.05.012; Kunita R, 2002, GENOMICS, V80, P456, DOI 10.1006/geno.2002.6857; Lilly B, 2010, ARTERIOSCL THROM VAS, V30, P694, DOI 10.1161/ATVBAHA.109.200741; Mc Laughlin D, 2013, PEDIATR SURG INT, V29, P947, DOI 10.1007/s00383-013-3357-x; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; Meuwissen MEC, 2013, AM J MED GENET A, V161A, P1376, DOI 10.1002/ajmg.a.35858; Miano JM, 1996, J BIOL CHEM, V271, P7095, DOI 10.1074/jbc.271.12.7095                                                         ; MIANO JM, 1994, CIRC RES, V75, P803; Miano JM, 2016, ARTERIOSCL THROM VAS, V36, P1058, DOI 10.1161/ATVBAHA.116.304790; Milewicz DM, 2010, AM J MED GENET A, V152A, P2437, DOI 10.1002/ajmg.a.33657; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Moreno CA, 2016, AM J MED GENET A, V170, P2965, DOI 10.1002/ajmg.a.37857; Nanda V, 2012, J BIOL CHEM, V287, P2459, DOI 10.1074/jbc.M111.302224; Niessen P, 2005, GASTROENTEROLOGY, V129, P1592, DOI 10.1053/j.gastro.2005.08.018; Oliver D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129457; Pappas CT, 2015, P NATL ACAD SCI USA, V112, P13573, DOI 10.1073/pnas.1508273112; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Rensen SSM, 2002, CARDIOVASC RES, V55, P850, DOI 10.1016/S0008-6363(02)00491-1                                                   ; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; SHAFIQ SA, 1967, BRAIN, V90, P817, DOI 10.1093/brain/90.4.817; SHY GM, 1963, BRAIN, V86, P793, DOI 10.1093/brain/86.4.793                                                          ; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; Thorson W, 2014, HUM GENET, V133, P737, DOI 10.1007/s00439-013-1406-0; Tian L, 2015, DIS MODEL MECH, V8, P635, DOI 10.1242/dmm.019430; Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004; Wangler MF, 1993, ACTG2 RELATED DISORD; Wangler MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004258; Wierenga KJ, 2013, GENET MED, V15, P354, DOI 10.1038/gim.2012.136; Wymer KM, 2016, J PEDIATR SURG, V51, P1565, DOI 10.1016/j.jpedsurg.2016.06.011; Yoshikawa H, 1998, GENES CELLS, V3, P685, DOI 10.1046/j.1365-2443.1998.00214.x; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185                                                                ; Yuen M, 2014, J CLIN INVEST, V124, P4693, DOI 10.1172/JCI75199; Zeegers MPA, 2004, EUR J HUM GENET, V12, P591, DOI 10.1038/sj.ejhg.5201151; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	59	4	4	2	3	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAR 28	2017	114	13					E2739	E2747		10.1073/pnas.1620507114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EP8DY	WOS:000397607300024	28292896	gold			2018-01-05	
J	Guan, J; Liu, H; Shi, XY; Feng, SY; Huang, B				Guan, Juan; Liu, Harrison; Shi, Xiaoyu; Feng, Siyu; Huang, Bo			Tracking Multiple Genomic Elements Using Correlative CRISPR Imaging and Sequential DNA FISH	BIOPHYSICAL JOURNAL			English	Article							CHROMATIN ORGANIZATION; GENE-EXPRESSION; CELLS; LOCI; PROBES; CHROMOSOMES; DYNAMICS; SYSTEM; SEQUENCES; DOMAINS	Live imaging of genome has offered important insights into the dynamics of the genome organization and gene expression. The demand to image simultaneously multiple genomic loci has prompted a flurry of exciting advances in multicolor CRISPR imaging, although color-based multiplexing is limited by the need for spectrally distinct fluorophores. Here we introduce an approach to achieve highly multiplexed live recording via correlative CRISPR imaging and sequential DNA fluorescence in situ hybridization (FISH). This approach first performs one-color live imaging of multiple genomic loci and then uses sequential rounds of DNA FISH to determine the loci identity. We have optimized the FISH protocol so that each round is complete in 1 min, demonstrating the identification of seven genomic elements and the capability to sustain reversible staining and washing for up to 20 rounds. We have also developed a correlation-based algorithm to faithfully register live and FISH images. Our approach keeps the rest of the color palette open to image other cellular phenomena of interest, as demonstrated by our simultaneous live imaging of genomic loci together with a cell cycle reporter. Furthermore, the algorithm to register faithfully between live and fixed imaging is directly transferrable to other systems such as multiplex RNA imaging with RNA-FISH and multiplex protein imaging with antibody-staining.	[Guan, Juan; Liu, Harrison; Shi, Xiaoyu; Feng, Siyu; Huang, Bo] Univ Calif San Francisco, San Francisco, CA 94143 USA	Huang, B (reprint author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	bo.huang@ucsf.edu	Shi, Xiaoyu/D-4682-2017	Shi, Xiaoyu/0000-0002-9634-2659	W.M. Keck Foundation Medical Research; National Institutes of Health [R21EB021453, R33EB019784]; National Science Foundation Graduate Research Fellowship	This work is supported by a W.M. Keck Foundation Medical Research grant, the National Institutes of Health (No. R21EB021453 and the Single Cell Analysis Program No. R33EB019784). H. L. receives the National Science Foundation Graduate Research Fellowship.	Agerholm IE, 2005, HUM REPROD, V20, P1072, DOI 10.1093/humrep/deh735; Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Belmont AS, 2014, CURR OPIN CELL BIOL, V26, P69, DOI 10.1016/j.ceb.2013.10.002; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573                                                            ; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Chen BH, 2016, ANNU REV BIOPHYS, V45, P1, DOI 10.1146/annurev-biophys-062215-010830; Chen BH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1533; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Coskun AF, 2016, NAT METHODS, V13, P657, DOI [10.1038/NMETH.3895, 10.1038/nmeth.3895]; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; Fu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11707; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shachar S, 2015, CELL, V162, P911, DOI 10.1016/j.cell.2015.07.035; Shaffer SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075120; Shao SP, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw066; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Wang QY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10966; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; Wang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26857; Wood AM, 2011, MOL CELL, V44, P29, DOI 10.1016/j.molcel.2011.07.035; Xu QK, 2009, P NATL ACAD SCI USA, V106, P2289, DOI 10.1073/pnas.0812506106	32	2	2	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	MAR 28	2017	112	6					1077	1084		10.1016/j.bpj.2017.01.032				8	Biophysics	Biophysics	EQ3JY	WOS:000397969500006	28355536				2018-01-05	
J	Ha, JS; Lee, JS; Jeong, J; Kim, H; Byun, J; Kim, SA; Lee, HJ; Chung, HS; Lee, JB; Ahn, DR				Ha, Jong Seong; Lee, Jae Sung; Jeong, Jaepil; Kim, Hejin; Byun, Juyoung; Kim, Sang Ah; Lee, Hee Jae; Chung, Hak Suk; Lee, Jong Bum; Ahn, Dae-Ro			Poly-sgRNA/siRNA ribonucleoprotein nanoparticles for targeted gene disruption	JOURNAL OF CONTROLLED RELEASE			English	Article						Poly-ribonucleoprotein; CRISPR/Cas9; Rolling circle amplification; Gene disruption; Gene delivery	SIRNA DELIVERY; RNA INTERFERENCE; GUIDE RNA; DNA; CELLS; CRISPR-CAS9; CRISPR/CAS9; IMMUNITY; VECTORS; COMPLEX	Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein-9 nuclease (Cas9) can be used for the specific disruption of a target gene to permanently suppress the expression of the protein encoded by the target gene. Efficient delivery of the system to an intracellular target site should be achieved to utilize the tremendous potential of the genome-editing tool in biomedical applications such as the knock-out of disease-related genes and the correction of defect genes. Here, we devise polymeric CRISPR/Cas9 system based on poly-ribonucleoprotein (RNP) nanoparticles consisting of polymeric sgRNA, siRNA, and Cas9 endonuclease in order to improve the delivery efficiency. When delivered by cationic lipids, the RNP nanoparticles built with chimeric poly-sgRNA/siRNA sequences generate multiple sgRNA-Cas9 RNP complexes upon the Dicer-mediated digestion of the siRNA parts, leading to more efficient disruption of the target gene in cells and animal models, compared with the monomeric sgRNA-Cas9 RNP complex. (C) 2017 Elsevier B.V. All rights reserved.	[Ha, Jong Seong; Byun, Juyoung; Kim, Sang Ah; Lee, Hee Jae; Chung, Hak Suk; Ahn, Dae-Ro] Korea Inst Sci & Technol, Ctr Theragnosis, Seoul 02792, South Korea; [Lee, Jae Sung; Jeong, Jaepil; Kim, Hejin; Lee, Jong Bum] Univ Seoul, Dept Chem Engn, Seoul 02504, South Korea; [Kim, Sang Ah] Korea Univ, Sch Life Sci & Biotechnol, Seoul 02841, South Korea; [Chung, Hak Suk; Ahn, Dae-Ro] Korea Univ Sci & Technol UST, KIST Sch, Dept Biol Chem, Seoul 02792, South Korea	Ahn, DR (reprint author), Korea Inst Sci & Technol, Ctr Theragnosis, Seoul 02792, South Korea.; Lee, JB (reprint author), Univ Seoul, Dept Chem Engn, Seoul 02504, South Korea.	jblee@uos.ac.kr; drahn@kist.re.kr		Chung, Hak Suk/0000-0003-1166-9909; Ha, Jong seong/0000-0001-5804-2607	intramural research programs of KIST; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2014-R1A2A2A04002526]; Pioneer Research Center Program through NRF - the Ministry of Science, ICT & Future Planning [2014M3C1A3054141]; Bio & Medical Technology Development Programof the National Research Foundation of Korea (NRF) - Korean Government [NRF2016M3A9C6917402]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Government [NRF-2015R1A1A1A05001174]; Global RNAi Carrier Initiative and Convergence Technology Program of KIST	This study was supported by intramural research programs of KIST, Global RNAi Carrier Initiative and Convergence Technology Program of KIST, the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2014-R1A2A2A04002526),the Pioneer Research Center Program through NRF funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3054141), the Bio & Medical Technology Development Programof the National Research Foundation of Korea ( NRF) funded by the Korean Government (NRF2016M3A9C6917402), and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Korean Government (NRF-2015R1A1A1A05001174).	Benjamin D., 2015, NAT MED, V21, P121; DAUBENDIEK SL, 1995, J AM CHEM SOC, V117, P7818, DOI 10.1021/ja00134a032; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Ha JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep22847; Han D, 2014, CHEM COMMUN, V50, P11665, DOI 10.1039/c4cc04969a; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509                                                      ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12737; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Lee JB, 2012, NAT MATER, V11, P316, DOI [10.1038/NMAT3253, 10.1038/nmat3253]; Lee SY, 2010, J CONTROL RELEASE, V141, P339, DOI 10.1016/j.jconrel.2009.10.007; Manoharan M, 2002, ANTISENSE NUCLEIC A, V12, P103, DOI 10.1089/108729002760070849                                                      ; Mok H, 2010, NAT MATER, V9, P272, DOI [10.1038/NMAT2626, 10.1038/nmat2626]; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Park Y, 2016, ACS BIOMATER SCI ENG, V2, P616, DOI 10.1021/acsbiomaterials.5b00554; Pinero J, 1997, APOPTOSIS, V2, P330, DOI 10.1023/A:1026497306006                                                         ; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Scholz C, 2012, J CONTROL RELEASE, V161, P554, DOI 10.1016/j.jconrel.2011.11.014; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Tu ZC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0031-x; Veldhoen S., 2015, INT J MOL SCI, V16, P543; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Xiao W., 1999, J VIROL, V73, P3394; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	30	0	0	11	30	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	MAR 28	2017	250						27	35		10.1016/j.jconrel.2017.02.007				9	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	EP2ZP	WOS:000397252600004	28167287				2018-01-05	
J	Yoshino, H; Yonemori, M; Miyamoto, K; Tatarano, S; Kofuji, S; Nohata, N; Nakagawa, M; Enokida, H				Yoshino, Hirofumi; Yonemori, Masaya; Miyamoto, Kazutaka; Tatarano, Syuichi; Kofuji, Satoshi; Nohata, Nijiro; Nakagawa, Masayuki; Enokida, Hideki			microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma	ONCOTARGET			English	Article						microRNA; miR-210-3p; renal cell carcinoma; CRISPR/Cas9; TWIST1	ABERRANT EXPRESSION; CANCER GENOMICS; IN-VITRO; RNAS; BIOGENESIS; IMMUNITY; GAIN; GENE; VIVO	Previous studies showed that five miRNAs (miR-885-5p, miR-1274, miR-210-3p, miR-224 and miR-1290) were upregulated the most in clear cell renal cell carcinoma (ccRCC). Our focus was to understand from a clinical standpoint the functional consequences of upregulating miR-210-3p. Towards this, we utilized the CRISPR/Cas9 gene editing system to deplete miR-210-3p in RCC cell lines (786-o, A498 and Caki2) and characterized the outcomes. We observed that miR-210-3p depletion dramatically increased tumorigenesis, including altering the morphology of A498 and Caki2 cells in a manner characteristic of epithelial-mesenchymal transition (EMT). These results were corroborated by in vivo xenograft studies, which showed enhanced growth of tumors from miR-210-3p-depleted A498 cells. We identified Twist-related protein 1 (TWIST1) as a key target of miR-210-3p. Analysis of the ccRCC patient data in The Cancer Genome Atlas database showed a negative correlation between miR-210-3p and TWIST1 expression. High TWIST1 and low miR-210-3p expression associated with poorer overall and disease-free survival as compared to low TWIST1 and high miR-210-3p expression. These findings suggest that renal cell carcinoma progression is promoted by TWIST1 suppression mediated by miR-210-3p.	[Yoshino, Hirofumi; Yonemori, Masaya; Miyamoto, Kazutaka; Tatarano, Syuichi; Nakagawa, Masayuki; Enokida, Hideki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 8908520, Japan; [Kofuji, Satoshi] Univ Cincinnati, Vontz Ctr, Dept Internal Med, Cincinnati, OH 45267 USA; [Nohata, Nijiro] Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	Enokida, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 8908520, Japan.	enokida@m.kufm.kagoshima-u.ac.jp			JSPS KAKENHI Grant [16H05464, 16K15691]	We thank Mutsumi Miyazaki and Gretchen Ostendarp for excellent laboratory assistance and critically editing this manuscript. This study was supported by JSPS KAKENHI Grant Numbers 16H05464 and 16K15691.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cancer Genome Atlas N, 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222]; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22312; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fernandez S, 2014, ONCOGENE, V33, P4114, DOI 10.1038/onc.2013.376; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hadoux J, 2010, CLIN MED INSIGHTS-ON, V4, P143, DOI 10.4137/CMO.S4482; Hidaka H, 2012, ONCOTARGET, V3, P44; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu YW, 2016, NEUROSCI LETT, V622, P61, DOI 10.1016/j.neulet.2016.04.034; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jiang Q, 2014, RNA BIOL, V11, P1243, DOI 10.1080/15476286.2014.996067; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khanbabaei H, 2016, TUMOR BIOL, V37, P7007, DOI 10.1007/s13277-016-4960-y; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; McCormick RI, 2013, BRIT J CANCER, V108, P1133, DOI 10.1038/bjc.2013.56; Memmel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087052; Naito S, 2010, JPN J CLIN ONCOL, V40, pi51, DOI 10.1093/jjco/hyq127; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Nohata N, 2013, BRIT J CANCER, V108, P1648, DOI 10.1038/bjc.2013.122; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI 10.4161/rna.7.4.13141; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yoshino H, 2013, CANCER SCI, V104, P1567, DOI 10.1111/cas.12280; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	43	8	8	0	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	MAR 28	2017	8	13					20881	20894		10.18632/oncotarget.14930				14	Oncology; Cell Biology	Oncology; Cell Biology	EP8RL	WOS:000397642400034	28152509	gold			2018-01-05	
J	Nekrasov, V; Wang, CM; Win, J; Lanz, C; Weigel, D; Kamoun, S				Nekrasov, Vladimir; Wang, Congmao; Win, Joe; Lanz, Christa; Weigel, Detlef; Kamoun, Sophien			Rapid generation of a transgene-free powdery mildew resistant tomato by genome deletion	SCIENTIFIC REPORTS			English	Article							EDITED CROPS; GENE; IMMUNITY	Genome editing has emerged as a technology with a potential to revolutionize plant breeding. In this study, we report on generating, in less than ten months, Tomelo, a non- transgenic tomato variety resistant to the powdery mildew fungal pathogen using the CRISPR/ Cas9 technology. We used wholegenome sequencing to show that Tomelo does not carry any foreign DNA sequences but only carries a deletion that is indistinguishable from naturally occurring mutations. We also present evidence for CRISPR/ Cas9 being a highly precise tool, as we did not detect off- target mutations in Tomelo. Using our pipeline, mutations can be readily introduced into elite or locally adapted tomato varieties in less than a year with relatively minimal effort and investment.	[Nekrasov, Vladimir; Win, Joe; Kamoun, Sophien] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Wang, Congmao] Zhejiang Acad Agr Sci, Inst Digital Agr, Hangzhou 310021, Zhejiang, Peoples R China; [Lanz, Christa; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Nekrasov, Vladimir] Rothamsted Res, Harpenden AL5 2JQ, Herts, England	Kamoun, S (reprint author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.; Weigel, D (reprint author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	detlef.weigel@tuebingen.mpg.de; sophien.kamoun@tsl.ac.uk	Nekrasov, Vladimir/N-4428-2017; Kamoun, Sophien/B-3529-2009	Nekrasov, Vladimir/0000-0001-9386-1683; Kamoun, Sophien/0000-0002-0290-0315	Gatsby Charitable Foundation; European Research Council (ERC); Biotechnology and Biological Sciences Research Council (BBSRC)	We thank Levente Kiss for the Oidium neolycopersici isolate, and Matthew Smoker for tomato transformation and technical advice. This work was supported by the Gatsby Charitable Foundation, the European Research Council (ERC), and the Biotechnology and Biological Sciences Research Council (BBSRC).	Acevedo-Garcia J, 2014, NEW PHYTOL, V204, P273, DOI 10.1111/nph.12889; BALINTKURTI PJ, 1995, THEOR APPL GENET, V90, P17, DOI 10.1007/BF00220991; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; Huang SW, 2016, NAT GENET, V48, P109, DOI 10.1038/ng.3484; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Pan C., 2016, NAT SCI REP, V6, P24765, DOI DOI 10.1038/SREP24765; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Petre B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149035; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Waltz E, 2016, NAT BIOTECHNOL, V34, P582, DOI 10.1038/nbt0616-582; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Zheng Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00380	15	7	7	12	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 28	2017	7								482	10.1038/s41598-017-00578-x				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EP6ZY	WOS:000397528600014	28352080	gold			2018-01-05	
J	Nadarajan, S; Lambert, TJ; Altendorfer, E; Gao, JM; Blower, MD; Waters, JC; Colaiacovo, MP				Nadarajan, Saravanapriah; Lambert, Talley J.; Altendorfer, Elisabeth; Gao, Jinmin; Blower, Michael D.; Waters, Jennifer C.; Colaiacovo, Monica P.			Polo-like kinase-dependent phosphorylation of the synaptonemal complex protein SYP-4 regulates double-strand break formation through a negative feedback loop	ELIFE			English	Article							CAENORHABDITIS-ELEGANS MEIOSIS; C-ELEGANS; MEIOTIC RECOMBINATION; CHROMOSOME SYNAPSIS; CROSSING-OVER; INTERHOMOLOG RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CRISPR-CAS9 SYSTEM; CHIASMA FORMATION; PARTNER CHOICE	The synaptonemal complex (SC) is an ultrastructurally conserved proteinaceous structure that holds homologous chromosomes together and is required for the stabilization of pairing interactions and the completion of crossover (CO) formation between homologs during meiosis I. Here, we identify a novel role for a central region component of the SC, SYP-4, in negatively regulating formation of recombination-initiating double-strand breaks (DSBs) via a feedback loop triggered by crossover designation in C. elegans. We found that SYP-4 is phosphorylated dependent on Polo-like kinases PLK-1/2. SYP-4 phosphorylation depends on DSB formation and crossover designation, is required for stabilizing the SC in pachytene by switching the central region of the SC from a more dynamic to a less dynamic state, and negatively regulates DSB formation. We propose a model in which Polo-like kinases recognize crossover designation and phosphorylate SYP-4 thereby stabilizing the SC and making chromosomes less permissive for further DSB formation.	[Nadarajan, Saravanapriah; Altendorfer, Elisabeth; Gao, Jinmin; Blower, Michael D.; Colaiacovo, Monica P.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Lambert, Talley J.; Waters, Jennifer C.] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Blower, Michael D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Colaiacovo, MP (reprint author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	mcolaiacovo@genetics.med.harvard.edu		Lambert, Talley/0000-0002-2409-0181	National Institutes of Health [R01GM072551]; Lalor Foundation	National Institutes of Health R01GM072551 Monica P Colaiacovo; Lalor Foundation Saravanapriah Nadarajan	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Attner MA, 2013, P NATL ACAD SCI USA, V110, P14278, DOI 10.1073/pnas.1311845110; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8                                                   ; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4                                                   ; Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Colaiacovo MP, 2006, CHROMOSOMA, V115, P195, DOI 10.1007/s00412-006-0061-9; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6                                                   ; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukuda T, 2008, NUCLEIC ACIDS RES, V36, P984, DOI 10.1093/nar/gkm1082; Garcia V, 2015, NATURE, V520, P114, DOI 10.1038/nature13993; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devce1.2007.11.016; Govindan JA, 2006, CURR BIOL, V16, P1257, DOI 10.1016/j.cub.2006.05.020; Harper NC, 2011, DEV CELL, V21, P934, DOI [10.1016/j.devce1.2011.09.001, 10.1016/j.devcel.2011.09.001]; Hayashi M, 2010, GENETICS, V186, P45, DOI 10.1534/genetics.110.115501; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Jaramillo-Lambert A, 2007, DEV BIOL, V308, P206, DOI 10.1016/j.ydbio.2007.05.019; Jones G H, 1984, Symp Soc Exp Biol, V38, P293; Jordan PW, 2012, J CELL SCI, V125, P5061, DOI 10.1242/jcs.105015; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keeney S, 2014, ANNU REV GENET, V48, P187, DOI 10.1146/annurev-genet-120213-092304; Kelly KO, 2000, GENETICS, V156, P617; Kelly WG, 2002, DEVELOPMENT, V129, P479; Labella S, 2011, DEV CELL, V21, P948, DOI [10.1016/j.devce1.2011.07.011, 10.1016/j.devcel.2011.07.011]; Lam I, 2015, SCIENCE, V350, P932, DOI 10.1126/science.aad0814; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Latypov V, 2010, MOL CELL BIOL, V30, P1570, DOI 10.1128/MCB.00919-09; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Libuda DE, 2013, NATURE, V502, P703, DOI 10.1038/nature12577; Liu ZX, 2013, BRIEF BIOINFORM, V14, P344, DOI 10.1093/bib/bbs041; LOIDL J, 1994, J CELL BIOL, V125, P1191, DOI 10.1083/jcb.125.6.1191; Machovina TS, 2016, CURR BIOL, V26, P2873, DOI 10.1016/j.cub.2016.09.007; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MaoDraayer Y, 1996, GENETICS, V144, P71; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Nabeshima K, 2005, J CELL BIOL, V168, P683, DOI 10.1083/jcb.200410144; NAG DK, 1995, GENETICS, V141, P75; Nishi Y, 2008, DEVELOPMENT, V135, P687, DOI 10.1242/dev.013425; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605                                                         ; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001                                                              ; Pattabiraman D, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006670; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Rog O, 2017, ELIFE, V6, DOI 10.7554/eLife.21455; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sanchez-Moran E, 2007, GENE DEV, V21, P2220, DOI 10.1101/gad.439007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Smolikov S, 2007, GENETICS, V176, P2015, DOI 10.1534/genetics.107.072413; Smolikov S, 2007, GENETICS, V176, P2027, DOI 10.1534/genetics.107.076968; Smolikov S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000669; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; SULSTON JE, 1974, GENETICS, V77, P95; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tzur YB, 2013, GENETICS, V195, P1181, DOI 10.1534/genetics.113.156075; Voelkel-Meiman K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002993; Woglar A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003335; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000                                                ; WU TC, 1995, GENETICS, V140, P55; XU LH, 1995, EMBO J, V14, P5115; Yokoo R, 2012, CELL, V149, P75, DOI 10.1016/j.cell.2012.01.052; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108	80	4	4	2	4	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	MAR 27	2017	6								e23437	10.7554/eLife.23437				25	Biology	Life Sciences & Biomedicine - Other Topics	EU2AO	WOS:000400828400001		gold			2018-01-05	
J	Mercx, S; Smargiasso, N; Chaumont, F; De Pauw, E; Boutry, M; Navarre, C				Mercx, Sebastien; Smargiasso, Nicolas; Chaumont, Francois; De Pauw, Edwin; Boutry, Marc; Navarre, Catherine			Inactivation of the beta(1,2)-xylosyltransferase and the alpha(1,3)-fucosyltransferase genes in Nicotiana tabacum BY-2 Cells by a Multiplex CRISPR/Cas9 Strategy Results in Glycoproteins without Plant-Specific Glycans	FRONTIERS IN PLANT SCIENCE			English	Article						antibody; plant-specific glycans; humanized N-glycosylation; molecular farming; gene editing; glycoproteins; glyco-engineering; suspension cells	MONOCLONAL-ANTIBODY; SUSPENSION CULTURE; BENTHAMIANA; EXPRESSION; GENERATION; GLYCOEPITOPES; GLYCOSYLATION; OPTIMIZATION; ARABIDOPSIS; RESIDUES	Plants or plant cells can be used to produce pharmacological glycoproteins such as antibodies or vaccines. However these proteins carry N-glycans with plant-typical residues [beta(1,2)-xylose and core alpha(1,3)-fucose], which can greatly impact the immunogenicity, allergenicity, or activity of the protein. Two enzymes are responsible for the addition of plant-specific glycans: beta(1,2)-xylosyltransferase (XylT) and alpha(1,3)fucosyltransferase (FucT). Our aim consisted of knocking-out two XylT genes and four FucT genes (12 alleles altogether) in Nicotiana tabacum BY-2 suspension cells using CRISPR/Cas9. Three XylT and six FucT sgRNAs were designed to target conserved regions. After transformation of N. tabacum BY-2 cells with genes coding for sgRNAs, Cas9, and a selectable marker (bar), transgenic lines were obtained and their extracellular as well as intracellular protein complements were analyzed by Western blotting using antibodies recognizing beta(1,2)-xylose and alpha(1,3)-fucose. Three lines showed a strong reduction of beta(1,2)-xylose and alpha(1,3)-fucose, while two lines were completely devoid of them, indicating complete gene inactivation. The absence of these carbohydrates was confirmed by mass spectrometry analysis of the extracellular proteins. PCR amplification and sequencing of the targeted region indicated small INDEL and/or deletions between the target sites. The KO lines did not show any particular morphology and grew as the wild-type. One KO line was transformed with genes encoding a human IgG2 antibody. The IgG2 expression level was as high as in a control transformant which had not been glycoengineered. The IgG glycosylation profile determined by mass spectrometry confirmed that no beta(1,2)-xylose or alpha(1,3)-fucose were present on the glycosylation moiety and that the dominant glycoform was the GnGn structure. These data represent an important step toward humanizing the glycosylation of pharmacological proteins expressed in N. tabacum BY-2 cells.	[Mercx, Sebastien; Chaumont, Francois; Boutry, Marc; Navarre, Catherine] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium; [Smargiasso, Nicolas; De Pauw, Edwin] Univ Liege, Mol Syst Res Unit, Mass Spectrometry Lab, Liege, Belgium	Boutry, M (reprint author), Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium.	marc.boutry@uclouvain.be		De Pauw, Edwin/0000-0003-3475-1315	Service Public de Wallonie [WBHealth 1318062]; Belgian National Fund for Scientific Research; Interuniversity Poles of Attraction Program (Belgium); Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (Belgium); Walloon Region; European Union	This work was supported in part by grants from the Service Public de Wallonie (WBHealth 1318062), the Belgian National Fund for Scientific Research, and the Interuniversity Poles of Attraction Program (Belgium). SM is a recipient of a fellowship from the Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (Belgium). Mass Spectrometry facility of ULg was funded by the Walloon Region, the Belgian National Fund for Scientific Research and the European Union.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Bosch D, 2013, CURR PHARM DESIGN, V19, P5503, DOI 10.2174/1381612811319310006                                                     ; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Diamos AG, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00200; Grabowski GA, 2014, MOL GENET METAB, V112, P1, DOI 10.1016/j.ymgme.2014.02.011; Hanania U, 2017, PLANT BIOTECHNOL J, V15, P1120, DOI 10.1111/pbi.12702; Huether CM, 2005, PLANT BIOLOGY, V7, P292, DOI 10.1055/s-2005-837653; Kunert R, 2016, APPL MICROBIOL BIOT, V100, P3451, DOI 10.1007/s00253-016-7388-9; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li J, 2016, PLANT BIOTECHNOL J, V14, P533, DOI 10.1111/pbi.12403; Magy B, 2014, PLANT BIOTECHNOL J, V12, P457, DOI 10.1111/pbi.12152; Makhzoum A, 2014, BIODRUGS, V28, P145, DOI 10.1007/s40259-013-0062-1; Mercx S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00040; Misaki R, 2001, BIOSCI BIOTECH BIOCH, V65, P2482, DOI 10.1271/bbb.65.2482; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3                                                   ; Navarre C, 2017, TRANSGENIC RES, V26, P375, DOI 10.1007/s11248-017-0013-6; Puchta H, 2016, CURR OPIN PLANT BIOL, V36, P1, DOI [10.1016/j.pbi.2016.11.011, DOI 10.1016/J.PBI.2016.11.011]; Santos RB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00297; Shin YJ, 2017, PLANT BIOTECHNOL J, V15, P197, DOI 10.1111/pbi.12602; Shin YJ, 2011, PLANT BIOTECHNOL J, V9, P1109, DOI 10.1111/j.1467-7652.2011.00636.x; SIJMONS PC, 1990, BIO-TECHNOL, V8, P217, DOI 10.1038/nbt0390-217; Sourrouille C, 2008, PLANT BIOTECHNOL J, V6, P702, DOI 10.1111/j.1467-7652.2008.00353.x; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; Vasilev N, 2013, PLANT BIOTECHNOL J, V11, P867, DOI 10.1111/pbi.12079; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Ward BJ, 2014, VACCINE, V32, P6098, DOI [10.1016/j.vaccine.2014.08.079, 10.10]; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yao J, 2015, INT J MOL SCI, V16, P28549, DOI 10.3390/ijms161226122; Yin BJ, 2011, PROTEIN CELL, V2, P41, DOI 10.1007/s13238-011-1007-4	35	1	1	24	37	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	MAR 27	2017	8								403	10.3389/fpls.2017.00403				11	Plant Sciences	Plant Sciences	EP5NS	WOS:000397426200001	28396675	gold			2018-01-05	
J	Zhang, BB; Liu, GY; Li, X; Guo, LP; Zhang, XX; Qi, TX; Wang, HL; Tang, HN; Qiao, XQ; Zhang, JF; Xing, CZ; Wu, JY				Zhang, Bingbing; Liu, Guoyuan; Li, Xue; Guo, Liping; Zhang, Xuexian; Qi, Tingxiang; Wang, Hailin; Tang, Huini; Qiao, Xiuqin; Zhang, Jinfa; Xing, Chaozhu; Wu, Jianyong			A genome-wide identification and analysis of the DYW-deaminase genes in the pentatricopeptide repeat gene family in cotton (Gossypium spp.)	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; SINGLE-STRANDED RNA; POLYPLOID GOSSYPIUM; STRUCTURAL BASIS; RESTORER GENE; PPR PROTEINS; MITOCHONDRIAL; DOMAIN; RECOGNITION; SITE	The RNA editing occurring in plant organellar genomes mainly involves the change of cytidine to uridine. This process involves a deamination reaction, with cytidine deaminase as the catalyst. Pentatricopeptide repeat (PPR) proteins with a C-terminal DYW domain are reportedly associated with cytidine deamination, similar to members of the deaminase superfamily. PPR genes are involved in many cellular functions and biological processes including fertility restoration to cytoplasmic male sterility (CMS) in plants. In this study, we identified 227 and 211 DYW deaminase-coding PPR genes for the cultivated tetraploid cotton species G. hirsutum and G. barbadense (2n = 4x = 52), respectively, as well as 126 and 97 DYW deaminase-coding PPR genes in the ancestral diploid species G. raimondii and G. arboreum (2n = 26), respectively. The 227 G. hirsutum PPR genes were predicted to encode 52-2016 amino acids, 203 of which were mapped onto 26 chromosomes. Most DYW deaminase genes lacked introns, and their proteins were predicted to target the mitochondria or chloroplasts. Additionally, the DYW domain differed from the complete DYW deaminase domain, which contained part of the E domain and the entire E+ domain. The types and number of DYW tripeptides may have been influenced by evolutionary processes, with some tripeptides being lost. Furthermore, a gene ontology analysis revealed that DYW deaminase functions were mainly related to binding as well as hydrolase and transferase activities. The G. hirsutum DYW deaminase expression profiles varied among different cotton tissues and developmental stages, and no differentially expressed DYW deaminasecoding PPRs were directly associated with the male sterility and restoration in the CMS-D2 system. Our current study provides an important piece of information regarding the structural and evolutionary characteristics of Gossypium DYW-containing PPR genes coding for deaminases and will be useful for characterizing the DYW deaminase gene family in cotton biology and breeding.	[Zhang, Bingbing; Liu, Guoyuan; Li, Xue; Guo, Liping; Zhang, Xuexian; Qi, Tingxiang; Wang, Hailin; Tang, Huini; Qiao, Xiuqin; Xing, Chaozhu; Wu, Jianyong] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol China, Anyang, Henan, Peoples R China; [Zhang, Jinfa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA	Xing, CZ; Wu, JY (reprint author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol China, Anyang, Henan, Peoples R China.	xingcz@cricaas.com.cn; dr.wujianyong@live.cn			National Key Research and Development program of China [2016YFD0101400]; Cotton Germplasm Innovation; Molecular breeding of High yield varieties in National Natural Science Foundation of China [31621005]	This research was financed by funds from the National Key Research and Development program of China (2016YFD0101400) and Cotton Germplasm Innovation and the Molecular breeding of High yield varieties in National Natural Science Foundation of China (31621005).	Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Chakraborty A, 2015, PLANTA, V241, P1463, DOI 10.1007/s00425-015-2269-5; Dahan J, 2013, RNA BIOL, V10, P1469, DOI 10.4161/rna.25568; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hayes ML, 2015, J BIOL CHEM, V290, P10136, DOI 10.1074/jbc.M114.631630; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Hu GJ, 2010, GENOME, V53, P599, DOI [10.1139/G10-038, 10.1139/g10-038]; Huang WC, 2015, P NATL ACAD SCI USA, V112, P14984, DOI 10.1073/pnas.1511748112; Jordan DR, 2010, THEOR APPL GENET, V120, P1279, DOI 10.1007/s00122-009-1255-3; Kazama T, 2014, RICE, V7, DOI 10.1186/s12284-014-0028-z; Klein RR, 2005, THEOR APPL GENET, V111, P994, DOI 10.1007/s00122-005-2011-y; Knoop V, 2010, FEBS LETT, V584, P4287, DOI 10.1016/j.febslet.2010.09.041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI DOI 10.1093/NAR/GKR691; Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shen CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11285; Shikanai T, 2015, BBA-BIOENERGETICS, V1847, P779, DOI 10.1016/j.bbabio.2014.12.010; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sugita M, 2013, RNA BIOL, V10, P1439, DOI 10.4161/rna.24772; Suzuki H, 2013, PLANT CELL REP, V32, P1531, DOI 10.1007/s00299-013-1465-7; Suzuki H, 2013, MOL GENET GENOMICS, V288, P445, DOI 10.1007/s00438-013-0764-6; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Wang F, 2007, GENOME, V50, P818, DOI 10.1139/G07-061; Wang J, 2009, MITOCHONDRION, V9, P364, DOI 10.1016/j.mito.2009.07.005; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wei L, 2008, ACTA PHYSIOL PLANT, V30, P657, DOI 10.1007/s11738-008-0162-6; Wu JY, 2014, MOL BREEDING, V34, P231, DOI 10.1007/s11032-014-0032-4; Wu JY, 2011, EUPHYTICA, V181, P17, DOI 10.1007/s10681-011-0357-6; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; You Q, 2017, NUCLEIC ACIDS RES, V45, pD1090, DOI 10.1093/nar/gkw910	40	1	1	12	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2017	12	3							e0174201	10.1371/journal.pone.0174201				21	Multidisciplinary Sciences	Science & Technology - Other Topics	ER9AZ	WOS:000399116700021	28339482	gold			2018-01-05	
J	Putman, TE; Lelong, S; Burgstaller-Muehlbacher, S; Waagmeester, A; Diesh, C; Dunn, N; Munoz-Torres, M; Stupp, GS; Wu, CL; Su, AI; Good, BM				Putman, Tim E.; Lelong, Sebastien; Burgstaller-Muehlbacher, Sebastian; Waagmeester, Andra; Diesh, Colin; Dunn, Nathan; Munoz-Torres, Monica; Stupp, Gregory S.; Wu, Chunlei; Su, Andrew I.; Good, Benjamin M.			WikiGenomes: an open web application for community consumption and curation of gene annotation data in Wikidata	DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION			English	Article							LIFE SCIENCES; PLATFORM; JBROWSE	With the advancement of genome-sequencing technologies, new genomes are being sequenced daily. Although these sequences are deposited in publicly available data warehouses, their functional and genomic annotations (beyond genes which are predicted automatically) mostly reside in the text of primary publications. Professional curators are hard at work extracting those annotations from the literature for the most studied organisms and depositing them in structured databases. However, the resources don't exist to fund the comprehensive curation of the thousands of newly sequenced organisms in this manner. Here, we describe WikiGenomes (wikigenomes. org), a web application that facilitates the consumption and curation of genomic data by the entire scientific community. WikiGenomes is based on Wikidata, an openly editable knowledge graph with the goal of aggregating published knowledge into a free and open database. WikiGenomes empowers the individual genomic researcher to contribute their expertise to the curation effort and integrates the knowledge into Wikidata, enabling it to be accessed by anyone without restriction.	[Putman, Tim E.; Lelong, Sebastien; Burgstaller-Muehlbacher, Sebastian; Stupp, Gregory S.; Wu, Chunlei; Su, Andrew I.; Good, Benjamin M.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Waagmeester, Andra] Micelio, Antwerp, Belgium; [Diesh, Colin] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Dunn, Nathan; Munoz-Torres, Monica] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA	Su, AI; Good, BM (reprint author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.	asu@scripps.edu; bgood@scripps.edu		Su, Andrew I./0000-0002-9859-4104; Putman, Timothy/0000-0002-4291-0737	National Institutes of General Medical Sciences [R01GM089820]; National Institutes for Health Common Fund [U54GM114833, U54DA036134]; National Institutes for Health from National Institute of General Medical Sciences [5R01GM080203]; National Human Genome Research Institute [5R01HG004483]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]	This project was supported by the National Institutes of General Medical Sciences (R01GM089820) and National Institutes for Health Common Fund programs for Big Data to Knowledge (U54GM114833) and Extracellular RNA Communication (U54DA036134). Nathan Dunn s and Monica Munoz-Torres s work with Apollo is supported by National Institutes for Health grants 5R01GM080203 from National Institute of General Medical Sciences, and 5R01HG004483 from National Human Genome Research Institute. Nathan Dunn and Monica Munoz-Torres are also supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Bolleman JT, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0067-z; Buels R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0924-1; Bult CJ, 2016, NUCLEIC ACIDS RES, V44, pD840, DOI 10.1093/nar/gkv1211; Burgstaller-Muehlbacher S, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw015; Cheung KH, 2005, BIOINFORMATICS, V21, pI85, DOI 10.1093/bioinformatics/bti1026; Elvira M., P 2015 SWAT4LS INT C; Good BM, 2012, NUCLEIC ACIDS RES, V40, pD1255, DOI 10.1093/nar/gkr925; Himmelstein D., INTEGRATING RESOURCE; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Huss JW, 2008, PLOS BIOL, V6, P1398, DOI 10.1371/journal.pbio.0060175; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Miles A, 2010, J BIOMED INFORM, V43, P752, DOI 10.1016/j.jbi.2010.04.004; Mons B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r89; O'Leary Nuala A, 2016, Nucleic Acids Res, V44, pD733, DOI 10.1093/nar/gkv1189; Okuda S, 2011, NUCLEIC ACIDS RES, V39, pD552, DOI 10.1093/nar/gkq1090; Perez J, 2006, LECT NOTES COMPUT SC, V4273, P30; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; PUTMAN TE, 2016, DATABASE OXFORD 0328, DOI DOI 10.1093/DATABASE/BAW028; Quest DJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S15; Quilitz B., 2008, LECT NOTES COMPUTER, P524; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Vrandecic D, 2014, COMMUN ACM, V57, P78, DOI 10.1145/2629489	26	0	0	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1758-0463			DATABASE-OXFORD	Database	MAR 24	2017									bax025	10.1093/database/bax025				9	Mathematical & Computational Biology	Mathematical & Computational Biology	EP7CC	WOS:000397534300001		gold			2018-01-05	
J	Fondong, VN				Fondong, Vincent N.			The Search for Resistance to Cassava Mosaic Geminiviruses: How Much We Have Accomplished, and What Lies Ahead	FRONTIERS IN PLANT SCIENCE			English	Review						cassava; geminiviruses; natural resistance; artificial miRNA; trans-acting siRNA; CRISPR	BROWN STREAK DISEASE; COAT PROTEIN GENE; SMALL INTERFERING RNAS; TRANS-ACTING SIRNAS; CRISPR-CAS SYSTEMS; AFRICAN-CASSAVA; VIRUS-RESISTANCE; NICOTIANA-BENTHAMIANA; IMMUNE-SYSTEM; PLANT GENOME	The cassava mosaic disease (CMD), which occurs in all cassava growing regions of Africa and the Indian subcontinent, is caused by cassava mosaic geminiviruses (CMGs). CMGs are considered to be the most damaging vector-borne plant pathogens. So far, the most successful approach used to control these viruses has been the transfer of a polygenic recessive resistance locus, designated CMD1, from wild cassava to cassava cultivars. Further progress in harnessing natural resistance to contain CMGs has come from the discovery of the dominant monogenic resistance locus, CMD2, in some West African cassava cultivars. CMD2 has been combined with CMD1 through genetic crosses. Because of the limitations of the cassava breeding approach, especially with regard to time required to produce a variety and the loss of preferred agronomic attributes, efforts have been directed toward the deployment of genetic engineering approaches. Most of these approaches have been centered on RNA silencing strategies, developed mainly in the model plant Nicotiana benthamiana. Early RNA silencing platforms assessed for CMG resistance have been use of viral genes for co-suppression, antisense suppression or for hairpin RNAs-mediated gene silencing. Here, progress and challenges in the deployment of these approaches in the control of CMGs are discussed. Novel functional genomics approaches with potential to overcome some of the drawbacks of the current strategies are also discussed.	[Fondong, Vincent N.] Delaware State Univ, Dept Biol Sci, Dover, DE 19901 USA	Fondong, VN (reprint author), Delaware State Univ, Dept Biol Sci, Dover, DE 19901 USA.	vfondong@desu.edu			National Science Foundation Integrative Organismal Systems (NSF-IOS) grant [NSF-IOS-1212576]	The disease resistance work in my laboratory is supported by the National Science Foundation Integrative Organismal Systems (NSF-IOS) grant NSF-IOS-1212576	Adenle Ademola A, 2011, BMC Res Notes, V4, P388, DOI 10.1186/1756-0500-4-388; Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; Alene AD, 2015, CROP IMPROVEMENT, ADOPTION, AND IMPACT OF IMPROVED VARIETIES IN FOOD CROPS IN SUB-SAHARAN AFRICA, P74, DOI 10.1079/9781780644011.0074; Ali Z, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1044191; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Allen E, 2010, SEMIN CELL DEV BIOL, V21, P798, DOI 10.1016/j.semcdb.2010.03.008; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Ashby MK, 1997, PLANT MOL BIOL, V35, P313, DOI 10.1023/A:1005885200550; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Azzam O., 1996, ANN REP BEAN IMPROV, V39, P276; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Barrangou R, 2015, CURR OPIN IMMUNOL, V32, P36, DOI 10.1016/j.coi.2014.12.008; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; BAULCOMBE DC, 1986, NATURE, V321, P446, DOI 10.1038/321446a0; Bawa AS, 2013, J FOOD SCI TECH MYS, V50, P1035, DOI 10.1007/s13197-012-0899-1; Beck B. D. A., 1982, P WORKSH ROOT CROPS, P13; Bengyella L, 2015, PLANT MOL BIOL, V89, P243, DOI 10.1007/s11103-015-0362-6; Berrie LC, 1998, ARCH VIROL, V143, P2253, DOI 10.1007/s007050050457; Bertsch C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-21; Bertschinger L., 1990, P CONTR VIR VIR LIK, P203; Black R, 2011, J BIOTECHNOL, V156, P370, DOI 10.1016/j.jbiotec.2011.06.036; BOCK KR, 1983, PLANT DIS, V67, P994, DOI 10.1094/PD-67-994; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bull SE, 2006, J GEN VIROL, V87, P3053, DOI 10.1099/vir.0.82013-0; Chabannes M, 2013, CURR OPIN VIROL, V3, P615, DOI 10.1016/j.coviro.2013.08.012; Chellappan P, 2005, PLANT PHYSIOL, V138, P1828, DOI 10.1104/pp.105.066563; Chellappan P, 2004, PLANT MOL BIOL, V56, P601, DOI 10.1007/s11103-004-0147-9; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen LY, 2016, J VIROL METHODS, V228, P16, DOI 10.1016/j.jviromet.2015.11.004; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; da Fonseca GC, 2016, PLANT SCI, V246, P62, DOI 10.1016/j.plantsci.2016.01.011; de la Luz Gutierrez-Nava Maria, 2008, Plant Physiol, V147, P543, DOI 10.1104/pp.108.118307; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Dixon A. G. O., 2010, IMPROVED CASSAVA VAR; Duan YP, 1997, MOL PLANT MICROBE IN, V10, P617, DOI 10.1094/MPMI.1997.10.5.617; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; ETESSAMI P, 1988, NUCLEIC ACIDS RES, V16, P4811, DOI 10.1093/nar/16.11.4811; Fahim M, 2012, PLANT BIOTECHNOL J, V10, P150, DOI 10.1111/j.1467-7652.2011.00647.x; FAO, 2013, CROP PROSP FOOD SIT, P1; FARGETTE D, 1995, PHYTOPATHOLOGY, V85, P370, DOI 10.1094/Phyto-85-370; Fargette D, 1996, EUR J PLANT PATHOL, V102, P645, DOI 10.1007/BF01877245; Fargette D., 1994, Tropical Science, V34, P123; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Felippes FF, 2009, EMBO REP, V10, P264, DOI 10.1038/embor.2008.247; Filloux D., 2015, VIRUS EVOL, V1, P1; Flegel TW, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-32; Fondong V. N., 1998, Plant Disease, V82, P1172, DOI 10.1094/PDIS.1998.82.10.1172B; Fondong VN, 2016, PHYTOPATHOLOGY, V106, P1231, DOI 10.1094/PHYTO-03-16-0145-FI; Fondong VN, 2000, INT J PEST MANAGE, V46, P211, DOI 10.1080/096708700415553; Fondong VN, 2000, J GEN VIROL, V81, P287, DOI 10.1099/0022-1317-81-1-287                                                      ; Fondong V. N., 1999, THESIS, P152; FRAZIER NW, 1965, PHYTOPATHOLOGY, V55, P1203; Frischmuth T, 1998, J GEN VIROL, V79, P1265, DOI 10.1099/0022-1317-79-5-1265                                                     ; Gibson RW, 1997, ANN APPL BIOL, V130, P481, DOI 10.1111/j.1744-7348.1997.tb07676.x; Gibson RW, 1997, ANN APPL BIOL, V131, P259, DOI 10.1111/j.1744-7348.1997.tb05155.x; Gottula J, 2009, ADV VIRUS RES, V75, P161, DOI 10.1016/S0065-3527(09)07505-8; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Harimalala M, 2012, ARCH VIROL, V157, P2027, DOI 10.1007/s00705-012-1399-3; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hokanson KE, 2016, TRANSGENIC RES, V25, P71, DOI 10.1007/s11248-015-9923-3; Hong Y, 1996, VIROLOGY, V220, P119, DOI 10.1006/viro.1996.0292; Hong YG, 1996, MOL PLANT MICROBE IN, V9, P219, DOI 10.1094/MPMI-9-0219; HONG YG, 1993, J GEN VIROL, V74, P2437, DOI 10.1099/0022-1317-74-11-2437; HONG YG, 1995, J GEN VIROL, V76, P2415, DOI 10.1099/0022-1317-76-10-2415; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jennings D. L., 1994, Tropical Science, V34, P110; Jennings D. L., 1976, REP INT WORKSH MUG K, P39; Ji X, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.144, 10.1038/nplants.2015.144]; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; JORGENSEN R, 1990, TRENDS BIOTECHNOL, V8, P340, DOI 10.1016/0167-7799(90)90220-R; Kanchiswamy CN, 2015, TRENDS BIOTECHNOL, V33, P62, DOI 10.1016/j.tibtech.2014.07.003; Khatabi B, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2391-1; Khonje M., 2015, 29 TRIENN C INT ASS; Kis A, 2016, MOL PLANT PATHOL, V17, P427, DOI 10.1111/mpp.12291; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kuria P, 2017, VIRUS RES, V227, P69, DOI 10.1016/j.virusres.2016.09.022; Legg JP, 2015, ADV VIRUS RES, V91, P85, DOI 10.1016/bs.aivir.2014.10.001; Legg JP, 2000, VIRUS RES, V71, P135, DOI 10.1016/S0168-1702(00)00194-5; Li HQ, 1996, NAT BIOTECHNOL, V14, P736, DOI 10.1038/nbt0696-736; Lin SS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000312; Lokko Y., 2001, AFRICAN CROP SCI J, V5, P29; Lokko Y., 2001, P INT SOC TROP ROOT, P438; Lowder L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2076.07683; Mahungu N. M., 1994, African Crop Science Journal, V2, P539; Manyong V. M., 2000, CONTRIBUTION IITA IM; Maruthi MN, 2004, ARCH VIROL, V149, P2365, DOI 10.1007/s00705-004-0380-1; Masinde E. A., 2016, African Journal of Agricultural Research, V11, P2064; Mbewe W, 2015, J PHYTOPATHOL, V163, P433, DOI 10.1111/jph.12339; Mohammed I. U., 2012, THESIS; Morroni M, 2009, J GEN VIROL, V90, P2798, DOI 10.1099/vir.0.013771-0; Muengula-Manyi M., 2012, American Journal of Plant Sciences, V3, P512, DOI 10.4236/ajps.2012.34061; NELSON RS, 1987, VIROLOGY, V158, P126, DOI 10.1016/0042-6822(87)90245-5; Noris E, 1996, VIROLOGY, V224, P130, DOI 10.1006/viro.1996.0514; Ntawuruhunga P, 2013, AJRTC, V10, P41; Ntui VO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120551; Nweke F. I., 2002, CASSAVA TRANSFORMATI; Odipio John, 2014, GM Crops Food, V5, P16, DOI 10.4161/gmcr.26408; Ogwok E, 2012, MOL PLANT PATHOL, V13, P1019, DOI 10.1111/j.1364-3703.2012.00812.x; Okeno JA, 2013, NEW BIOTECHNOL, V30, P124, DOI 10.1016/j.nbt.2012.09.001; Okogbenin E, 2012, CROP SCI, V52, P2576, DOI 10.2135/cropsci2011.11.0586; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Padidam M, 1999, J VIROL, V73, P1609; Pariyo A., 2015, J PLANT BREED CROP S, V7, P66; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Pati BL, 2015, J GEN VIROL, V96, P956, DOI 10.1099/vir.0.000014; Patil BL, 2007, VIRUS RES, V124, P59, DOI 10.1016/j.virusres.2006.10.003; Patil BL, 2016, VIRUS RES, V213, P109, DOI 10.1016/j.virusres.2015.11.011; Patil BL, 2015, VIRUS GENES, V50, P474, DOI 10.1007/s11262-015-1184-y; Patil BL, 2015, MOL PLANT PATHOL, V16, P484, DOI 10.1111/mpp.12205; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/J.1364-3703.2009.00559.X, 10.1111/j.1364-3703.2009.00559.x]; Pita JS, 2001, J GEN VIROL, V82, P655, DOI 10.1099/0022-1317-82-3-655                                                      ; POWELLABEL P, 1986, SCIENCE, V232, P738; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Raja P, 2014, J VIROL, V88, P2611, DOI 10.1128/JVI.02305-13; Ran F. A., 2013, NAT PROTOC, V153, P910; Resmi TR, 2015, VIRUSES-BASEL, V7, P2641, DOI 10.3390/v7052641; Rogans SJ, 2016, VIRUS RES, V225, P10, DOI 10.1016/j.virusres.2016.08.011; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sangare A, 1999, MOL BREEDING, V5, P95, DOI 10.1023/A:1009611403565; Sauer NJ, 2016, PLANT PHYSIOL, V170, P1917, DOI 10.1104/pp.15.01696; Saunders K, 2002, VIROLOGY, V293, P63, DOI 10.1006/viro.2001.1251; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Selth LA, 2004, MOL PLANT MICROBE IN, V17, P27, DOI 10.1094/MPMI.2004.17.1.27; Sera T, 2005, J VIROL, V79, P2614, DOI 10.1128/JVI.79.4.2614-2619.2005; Sinebo W, 2016, GM CROPS FOOD, V7, P1, DOI 10.1080/21645698.2016.1151989; Singh A, 2015, MOL PLANT PATHOL, V16, P724, DOI 10.1111/mpp.12229; Sinisterra XH, 1999, PHYTOPATHOLOGY, V89, P701, DOI 10.1094/PHYTO.1999.89.8.701; Staginnus C, 2006, TRENDS PLANT SCI, V11, P485, DOI 10.1016/j.tplants.2006.08.008; STANLEY J, 1985, NUCLEIC ACIDS RES, V13, P2189, DOI 10.1093/nar/13.7.2189; STANLEY J, 1990, P NATL ACAD SCI USA, V87, P6291, DOI 10.1073/pnas.87.16.6291; STANLEY J, 1983, NATURE, V301, P260, DOI 10.1038/301260a0; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Storey HH, 1938, ANN APPL BIOL, V25, P790, DOI 10.1111/j.1744-7348.1938.tb02354.x; Sunitha S, 2011, VIRUS GENES, V43, P445, DOI 10.1007/s11262-011-0654-0; Swanson M. M., 1994, Tropical Science, V34, P15; Taylor DJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-88; Taylor Nigel J, 2012, GM Crops Food, V3, P93, DOI 10.4161/gmcr.19144; Tepfer M, 2015, NEW PHYTOL, V207, P536, DOI 10.1111/nph.13358; Thresh J. M., 2003, African Crop Science Journal, V11, P199; Thresh J. M., 1994, African Crop Science Journal, V2, P459; Thresh JM, 2005, PLANT PATHOL, V54, P587, DOI 10.1111/j.1365-3059.2005.01282.x; Thresh JM, 1998, PLANT VIRUS DISEASE CONTROL, P670; Tiendrebeogo F, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-67; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; TUMER NE, 1987, EMBO J, V6, P1181; Vanderschuren H, 2007, PLANT BIOTECHNOL J, V5, P207, DOI 10.1111/j.1467-7652.2006.00217.x; Vanderschuren H, 2009, PLANT MOL BIOL, V70, P265, DOI 10.1007/s11103-009-9472-3; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Verdaguer B, 1996, PLANT MOL BIOL, V31, P1129, DOI 10.1007/BF00040830; VONARNIM A, 1992, VIROLOGY, V187, P555, DOI 10.1016/0042-6822(92)90458-2; Wagaba H, 2016, J VIROL METHODS, V231, P38, DOI 10.1016/j.jviromet.2016.02.004; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; WROTH JM, 1992, ANN APPL BIOL, V121, P329, DOI 10.1111/j.1744-7348.1992.tb03446.x; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xie M, 2015, CURR GENOMICS, V16, P23, DOI 10.2174/1389202915666141128002211; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Yadav JS, 2011, MOL PLANT PATHOL, V12, P677, DOI [10.1111/j.1364-3703.2010.00700.x, 10.1111/J.1364-3703.2010.00700.X]; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang P, 2005, PLANT BIOTECHNOL J, V3, P385, DOI 10.1111/j.1467-7652.2005.00132.x; Zhou XP, 1998, J GEN VIROL, V79, P2835, DOI 10.1099/0022-1317-79-11-2835                                                    	170	1	1	8	16	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	MAR 24	2017	8								408	10.3389/fpls.2017.00408				19	Plant Sciences	Plant Sciences	EP3JX	WOS:000397279700001	28392798	gold			2018-01-05	
J	Lopez-Guerrero, AM; Tomas-Martin, P; Pascual-Caro, C; Macartney, T; Rojas-Fernandez, A; Ball, G; Alessi, DR; Pozo-Guisado, E; Martin-Romero, FJ				Lopez-Guerrero, Aida M.; Tomas-Martin, Patricia; Pascual-Caro, Carlos; Macartney, Thomas; Rojas-Fernandez, Alejandro; Ball, Graeme; Alessi, Dario R.; Pozo-Guisado, Eulalia; Javier Martin-Romero, Francisco			Regulation of membrane ruffling by polarized STIM1 and ORAI1 in cortactin-rich domains	SCIENTIFIC REPORTS			English	Article							OPERATED CALCIUM-ENTRY; DEPENDENT PROTEASE CALPAIN; CELL-MIGRATION; CHANNEL FUNCTION; PLASMA-MEMBRANE; STORE; PHOSPHORYLATION; CA2+; DYNAMICS; METASTASIS	Cell motility and migration requires the reorganization of the cortical cytoskeleton at the leading edge of cells and extracellular Ca2+ entry is essential for this reorganization. However the molecular nature of the regulators of this pathway is unknown. This work contributes to understanding the role of STIM1 and ORAI1 in the promotion of membrane ruffling by showing that phospho-STIM1 localizes at the leading edge of cells, and that both phospho-STIM1 and ORAI1 co-localize with cortactin (CTTN), a regulator of the cytoskeleton at membrane ruffling areas. STIM1-KO and ORAI1-KO cell lines were generated by CRISPR/Cas9 genome editing in U2OS cells. In both cases, KO cells presented a notable reduction of store-operated Ca2+ entry (SOCE) that was rescued by expression of STIM1-mCherry and ORAI1-mCherry. These results demonstrated that SOCE regulates membrane ruffling at the leading edge of cells. Moreover, endogenous ORAI1 and overexpressed ORAI1-GFP co-immunoprecipitated with endogenous CTTN. This latter result, in addition to the KO cells' phenotype, the preservation of ORAI1-CTTN co-localization during ruffling, and the inhibition of membrane ruffling by the Ca2+- channel inhibitor SKF96365, further supports a functional link between SOCE and membrane ruffling.	[Lopez-Guerrero, Aida M.; Tomas-Martin, Patricia; Pascual-Caro, Carlos; Javier Martin-Romero, Francisco] Univ Extremadura, Sch Life Sci, Dept Biochem & Mol Biol, Badajoz 06006, Spain; [Macartney, Thomas; Alessi, Dario R.] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Rojas-Fernandez, Alejandro] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee DD1 5EH, Scotland; [Ball, Graeme] Univ Dundee, Sch Life Sci, Dundee Imaging Facil, Dundee DD1 5EH, Scotland; [Rojas-Fernandez, Alejandro] Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile; [Rojas-Fernandez, Alejandro] Univ Austral Chile, Inst Med, Valdivia, Chile; [Pozo-Guisado, Eulalia] Univ Extremadura, Sch Med, Dept Cell Biol, Badajoz 06006, Spain	Martin-Romero, FJ (reprint author), Univ Extremadura, Sch Life Sci, Dept Biochem & Mol Biol, Badajoz 06006, Spain.	fjmartin@unex.es		Martin-Romero, Francisco Javier/0000-0001-6796-7396; PASCUAL-CARO, CARLOS/0000-0002-2345-393X	European Social Fund [BFU2011-22798, BFU2014-52401-P]; Medical Research Council [MC_UU_12016/2]; Spanish Ministerio de Economia y Competitividad [BES-2012-052061]; Gobierno de Extremadura [PD10081]; Ministerio de Educacion, Cultura y Deporte [FPU13/03430]; "Next Generation Optical Microscopy" award from the Medical Research Council [MR/K015869/1]; EMBO [ASTF-311-2014]; short-term fellowship under the "Salvador de Madariaga" Program of the Spanish Ministerio de Educacion, Cultura y Deporte [PRX14/00176]; Spanish Ministerio de Economia y Competitividad	We express our gratitude for the technical support of the MRC-Protein Phosphorylation and Ubiquitylation Unit (PPU) DNA Sequencing Service (coordinated by Nicholas Helps), the MRC-PPU tissue culture team (coordinated by Laura Fin), the PPU Reagents antibody purification teams (coordinated by Hilary McLauchlan and James Hastie) and cloning teams (coordinated by Mark Peggie and Rachel Toth), and Dundee Imaging Facility (coordinated by Sam Swift). We also thank Dr. Gopal Sapkota (University of Dundee) for technical advice. F.J.M.R. thanks the Spanish Ministerio de Economia y Competitividad and European Social Fund (grants BFU2011-22798 and BFU2014-52401-P) for support. DRA thanks the Medical Research Council (MC_UU_12016/2) for support. A. L.-G., P.T.-M., and C.P.-C. were supported by predoctoral fellowships from the Spanish Ministerio de Economia y Competitividad (BES-2012-052061), Gobierno de Extremadura (PD10081), and Ministerio de Educacion, Cultura y Deporte (FPU13/03430), respectively. G.B. was supported by a "Next Generation Optical Microscopy" award from the Medical Research Council (MR/K015869/1). E.P.-G. was awarded with a short-term fellowship from the EMBO (ASTF-311-2014). F.J.M.-R. was awarded with a short-term fellowship under the "Salvador de Madariaga" Program of the Spanish Ministerio de Educacion, Cultura y Deporte (PRX14/00176). This work was supported by grants BFU2011-22798 and BFU2014-52401-P of the Spanish Ministerio de Economia y Competitividad and European Social Fund (to F.J.M.-R.), and MC_UU_12016/2 of the Medical Research Council (to D.R.A.).	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhatt A, 2002, J CELL SCI, V115, P3415; Casas-Rua V, 2015, BBA-MOL CELL RES, V1853, P233, DOI 10.1016/j.bbamcr.2014.10.027; Casas-Rua V, 2013, BIOCHEM PHARMACOL, V86, P1555, DOI 10.1016/j.bcp.2013.09.018; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gomez-Fernandez C, 2009, REPRODUCTION, V138, P211, DOI 10.1530/REP-09-0126; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gutierrez-Martin Y, 2005, BBA-BIOMEMBRANES, V1711, P33, DOI 10.1016/j.bbamem.2005.02.017; Hartzell CA, 2016, ELIFE, V5, DOI 10.7554/eLife.14850; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.E02-11-0753; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Lai YC, 2015, EMBO J, V34, P2840, DOI 10.15252/embj.201591593; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Motiani RK, 2013, PFLUG ARCH EUR J PHY, V465, P1249, DOI 10.1007/s00424-013-1254-8; Munoz IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109752; Pozo-Guisado Eulalia, 2013, Commun Integr Biol, V6, pe26283, DOI 10.4161/cib.26283; Pozo-Guisado E, 2013, J CELL SCI, V126, P3170, DOI 10.1242/jcs.125054; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rojas-Fernandez A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09811; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1093/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Suganuma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045056; Tomas-Martin P, 2015, CELL SIGNAL, V27, P545, DOI 10.1016/j.cellsig.2014.12.017; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 1998, J CELL SCI, V111, P2433; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yoshida J, 2012, BIOCHEM PHARMACOL, V84, P1592, DOI 10.1016/j.bcp.2012.09.021; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	42	2	2	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 24	2017	7								383	10.1038/s41598-017-00331-4				15	Multidisciplinary Sciences	Science & Technology - Other Topics	EP3JN	WOS:000397278700001	28341841	gold			2018-01-05	
J	Lin, A; Giuliano, CJ; Sayles, NM; Sheltzer, JM				Lin, Ann; Giuliano, Christopher J.; Sayles, Nicole M.; Sheltzer, Jason M.			CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials	ELIFE			English	Article							LEUCINE-ZIPPER KINASE; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; CELL LINES; MELK; EXPRESSION; RNAI; INHIBITORS; DISCOVERY; SCREENS	The Maternal Embryonic Leucine Zipper Kinase (MELK) has been reported to be a genetic dependency in several cancer types. MELK RNAi and small-molecule inhibitors of MELK block the proliferation of various cancer cell lines, and MELK knockdown has been described as particularly effective against the highly-aggressive basal/triple-negative subtype of breast cancer. Based on these preclinical results, the MELK inhibitor OTS167 is currently being tested as a novel chemotherapy agent in several clinical trials. Here, we report that mutagenizing MELK with CRISPR/Cas9 has no effect on the fitness of basal breast cancer cell lines or cell lines from six other cancer types. Cells that harbor null mutations in MELK exhibit wild-type doubling times, cytokinesis, and anchorage-independent growth. Furthermore, MELK-knockout lines remain sensitive to OTS167, suggesting that this drug blocks cell division through an off-target mechanism. In total, our results undermine the rationale for a series of current clinical trials and provide an experimental approach for the use of CRISPR/Cas9 in preclinical target validation that can be broadly applied.	[Lin, Ann; Giuliano, Christopher J.; Sayles, Nicole M.; Sheltzer, Jason M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Lin, Ann; Giuliano, Christopher J.] SUNY Stony Brook, Stony Brook, NY USA	Sheltzer, JM (reprint author), Cold Spring Harbor Lab, Cold Spring Harbor, NY USA.	sheltzer@cshl.edu		Lin, Ann/0000-0002-4618-8120; Giuliano, Christopher/0000-0002-0586-6095	National Institutes of Health [1DP50D021385]	National Institutes of Health 1DP50D021385 Jason M Sheltzer	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Alachkar H, 2014, ONCOTARGET, V5, P12371, DOI 10.18632/oncotarget.2642                                                        ; Badouel C, 2010, EXP CELL RES, V316, P2166, DOI 10.1016/j.yexcr.2010.04.019; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Campbell J, 2016, CELL REP, V14, P2490, DOI 10.1016/j.celrep.2016.02.023; Cao LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070031; Cho YS, 2014, BIOCHEM BIOPH RES CO, V447, P7, DOI 10.1016/j.bbrc.2014.03.034; Choi S, 2011, BIOCHEM BIOPH RES CO, V412, P207, DOI 10.1016/j.bbrc.2011.07.060; Chung SY, 2012, ONCOTARGET, V3, P1629; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Du T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-100; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Heyer BS, 1997, MOL REPROD DEV, V47, P148; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Ji WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153518; Johnson CN, 2015, ACS MED CHEM LETT, V6, P31, DOI 10.1021/ml5001273; Johnson CN, 2015, ACS MED CHEM LETT, V6, P25, DOI 10.1021/ml5001245; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kig C, 2013, J BIOL CHEM, V288, P24200, DOI 10.1074/jbc.M113.471433; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kuner R, 2013, J MOL MED, V91, P237, DOI 10.1007/s00109-012-0949-1; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Marie SKN, 2008, INT J CANCER, V122, P807, DOI 10.1002/ijc.23189; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sheltzer JM, 2013, CANCER RES, V73, P6401, DOI 10.1158/0008-5472.CAN-13-0749; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Singh S, 2011, PHARM RES-DORDR, V28, P2996, DOI 10.1007/s11095-011-0608-1; Smale ST., 2010, COLD SPRING HARB PRO, V2010, DOI [10.1101/pdb.prot5372, DOI 10.1101/PDB.PROT5372]; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Speers C, 2016, CLIN CANCER RES, V22, P5864, DOI 10.1158/1078-0432.CCR-15-2711; Toure BB, 2016, J MED CHEM, V59, P4711, DOI 10.1021/acs.jmedchem.6b00052; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200; Wang YB, 2014, ELIFE, V3, DOI 10.7554/eLife.01763; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Xia HP, 2016, CANCER LETT, V383, P85, DOI 10.1016/j.canlet.2016.09.017	58	6	6	5	14	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	MAR 24	2017	6								e24179	10.7554/eLife.24179				17	Biology	Life Sciences & Biomedicine - Other Topics	EP8TQ	WOS:000397648100001		gold			2018-01-05	
J	Altermann, E; Lu, J; McCulloch, A				Altermann, Eric; Lu, Jingli; McCulloch, Alan			GAMOLA2, a Comprehensive Software Package for the Annotation and Curation of Draft and Complete Microbial Genomes	FRONTIERS IN MICROBIOLOGY			English	Article						genome annotation; microbial; sequence analysis; stand-alone software; genome visualization; expert curation; Artemis genome viewer	LACTOBACILLUS-GASSERI; PROKARYOTIC GENOMES; BACTERIAL GENOMES; ORTHOLOGOUS GENES; SIGNAL PEPTIDES; ANALYSIS SYSTEM; COG DATABASE; SEQUENCE; RUMEN; IDENTIFICATION	Expert curated annotation remains one of the critical steps in achieving a reliable biological relevant annotation. Here we announce the release of GAMOLA2, a user friendly and comprehensive software package to process, annotate and curate draft and complete bacterial, archaeal, and viral genomes. GAMOLA2 represents a wrapping tool to combine gene model determination, functional Blast, COG, Pfam, and TIGRfam analyses with structural predictions including detection of tRNAs, rRNA genes, non-coding RNAs, signal protein cleavage sites, transmembrane helices, CRISPR repeats and vector sequence contaminations. GAMOLA2 has already been validated in a wide range of bacterial and archaeal genomes, and its modular concept allows easy addition of further functionality in future releases. A modified and adapted version of the Artemis Genome Viewer (Sanger Institute) has been developed to leverage the additional features and underlying information provided by the GAMOLA2 analysis, and is part of the software distribution. In addition to genome annotations, GAMOLA2 features, among others, supplemental modules that assist in the creation of custom Blast databases, annotation transfers between genome versions, and the preparation of Genbank files for submission via the NCBI Sequin tool. GAMOLA2 is intended to be run under a Linux environment, whereas the subsequent visualization and manual curation in Artemis is mobile and platform independent. The development of GAMOLA2 is ongoing and community driven. New functionality can easily be added upon user requests, ensuring that GAMOLA2 provides information relevant to microbiologists. The software is available free of charge for academic use.	[Altermann, Eric; Lu, Jingli] AgResearch, Grasslands Res Ctr, Palmerston North, New Zealand; [Altermann, Eric] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [McCulloch, Alan] AgResearch, Invermay Agr Ctr, Mosgiel, New Zealand	Altermann, E (reprint author), AgResearch, Grasslands Res Ctr, Palmerston North, New Zealand.; Altermann, E (reprint author), Massey Univ, Riddet Inst, Palmerston North, New Zealand.	eric.altermann@agresearch.co.nz					Altermann Eric, 2003, OMICS A Journal of Integrative Biology, V7, P161, DOI 10.1089/153623103322246557; Altermann E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00048; Altermann E, 2011, GENES NUTR, V6, P319, DOI 10.1007/s12263-010-0191-9; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Attwood GT, 2008, AUST J EXP AGR, V48, P83, DOI 10.1071/EA07269; Azcarate-Peril MA, 2008, APPL ENVIRON MICROB, V74, P4610, DOI 10.1128/AEM.00054-08; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133                                           ; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Cavanagh D, 2015, APPL ENVIRON MICROB, V81, P3961, DOI 10.1128/AEM.04092-14; Ciric M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-356; Cookson AL, 2011, FEMS MICROBIOL LETT, V316, P144, DOI 10.1111/j.1574-6968.2010.02204.x; Crespo MD, 2012, APPL ENVIRON MICROB, V78, P8488, DOI 10.1128/AEM.02258-12; Cruveiller S, 2005, NUCLEIC ACIDS RES, V33, pW471, DOI 10.1093/nar/gki498; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Galens K, 2011, STAND GENOMIC SCI, V4, P244, DOI 10.4056/sigs.1223234; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Goh YJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S22; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hagen KE, 2010, PLASMID, V63, P108, DOI 10.1016/j.plasmid.2009.12.004; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kelly WJ, 2014, STAND GENOMIC SCI, V9, DOI 10.1186/1944-3277-9-15; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kislyuk AO, 2010, BIOINFORMATICS, V26, P1819, DOI 10.1093/bioinformatics/btq284; Kristensen DM, 2013, J BACTERIOL, V195, P941, DOI 10.1128/JB.01801-12; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017469; Lambie SC, 2014, GENOME ANNOUNC, V2, P1, DOI [10.1128/genomeA.00107-14, DOI 10.1128/GENOMEA.00107-14]; Lambie SC, 2015, STAND GENOMIC SCI, V10, DOI [10.1186/s40793-015-0038-5, 10.1186/s40793-015-00380-5]; Leahy SC, 2013, STAND GENOMIC SCI, V8, P215, DOI 10.4056/sigs.3977691; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Liao YC, 2015, J MICROBIOL METH, V113, P72, DOI 10.1016/j.mimet.2015.04.006; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu Z, 2010, APPL ENVIRON MICROB, V76, P1955, DOI 10.1128/AEM.02126-09; Lugli GA, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw049; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Makarova Kira S., 2015, Life-Basel, V5, P818, DOI 10.3390/life5010818; Markowitz VM, 2015, TRENDS MICROBIOL, V23, P730, DOI 10.1016/j.tim.2015.07.012; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Nelson DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010785; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poptsova MS, 2010, MICROBIOL-SGM, V156, P1909, DOI 10.1099/mic.0.033811-0; Ross DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151214; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; Sangwan N, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0154-5; Seemann T., 2014, GENOME ANAL, V30, P2068, DOI [10.1093/bioinformatics/btu153, DOI 10.1093/BI0INF0RMATICS/BTU153]; Sturino J. M., 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00478-14, DOI 10.1128/GENOMEA.00478-14]; Sturino J. M., 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00208-13, DOI 10.1128/GENOMEA.00208-13]; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Ventura M, 2006, APPL ENVIRON MICROB, V72, P3130, DOI 10.1128/AEM.72.5.3130-3146.2006; Weinmaier T, 2016, BIOINFORMATICS, V32, P3327, DOI 10.1093/bioinformatics/btw393; Yeoman CJ, 2011, PLASMID, V66, P67, DOI 10.1016/j.plasmid.2011.05.002	58	1	1	1	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	MAR 23	2017	8								346	10.3389/fmicb.2017.00346				14	Microbiology	Microbiology	EP1PC	WOS:000397155800001	28386247	gold			2018-01-05	
J	Chowdhury, S; Carter, J; Rollins, MF; Golden, SM; Jackson, RN; Hoffmann, C; Nosaka, L; Bondy-Denomy, J; Maxwell, KL; Davidson, AR; Fischer, ER; Lander, GC; Wiedenheft, B				Chowdhury, Saikat; Carter, Joshua; Rollins, MaryClare F.; Golden, Sarah M.; Jackson, Ryan N.; Hoffmann, Connor; Nosaka, Lyn'Al; Bondy-Denomy, Joseph; Maxwell, Karen L.; Davidson, Alan R.; Fischer, Elizabeth R.; Lander, Gabriel C.; Wiedenheft, Blake			Structure Reveals Mechanisms of Viral Suppressors that Intercept a CRISPR RNA-Guided Surveillance Complex	CELL			English	Article							BACTERIAL IMMUNE-SYSTEM; ESCHERICHIA-COLI; CAS SYSTEMS; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; UCSF CHIMERA; CRYO-EM; CASCADE; RECOGNITION	Genetic conflict between viruses and their hosts drives evolution and genetic innovation. Prokaryotes evolved CRISPR-mediated adaptive immune systems for protection from viral infection, and viruses have evolved diverse anti-CRISPR (Acr) proteins that subvert these immune systems. The adaptive immune system in Pseudomonas aeruginosa (type I-F) relies on a 350 kDa CRISPR RNA (crRNA)-guided surveillance complex (Csy complex) to bind foreign DNA and recruit a trans-acting nuclease for target degradation. Here, we report the cryo-electron microscopy (cryo-EM) structure of the Csy complex bound to two different Acr proteins, AcrF1 and AcrF2, at an average resolution of 3.4 angstrom. The structure explains the molecular mechanism for immune system suppression, and structure-guided mutations show that the Acr proteins bind to residues essential for crRNA-mediated detection of DNA. Collectively, these data provide a snapshot of an ongoing molecular arms race between viral suppressors and the immune system they target.	[Chowdhury, Saikat; Nosaka, Lyn'Al; Lander, Gabriel C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Carter, Joshua; Rollins, MaryClare F.; Golden, Sarah M.; Jackson, Ryan N.; Hoffmann, Connor; Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Bondy-Denomy, Joseph] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Maxwell, Karen L.; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Fischer, Elizabeth R.] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Jackson, Ryan N.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Lander, GC (reprint author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wiedenheft, B (reprint author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	glander@scripps.edu; bwiedenheft@gmail.com		Jackson, Ryan/0000-0001-7403-3794; Lander, Gabriel C./0000-0003-4921-1135	National Institutes of Health [GM103310, P20GM103500, P30GM110732-03, R01GM110270, R01GM108888, DP2EB020402]; National Science Foundation EPSCoR [EPS-110134]; M.J. Murdock Charitable Trust; Amgen; Montana State University Agricultural Experimental Station; University of California San Francisco Program for Breakthrough in Biomedical Research; NIH Office of the Director Early Independence Award [DP5-OD021344]; Canadian Institutes of Health Research [MOP-130482, MOP-136845]; NIH intramural research program; Sandler Foundation	We thank Jeff Speir and Anchi Cheng, who aided with early EM data collection and analyses at the National Resource for Automated Molecular Microscopy, which is supported by National Institutes of Health grant (GM103310). We thank Mark A. Herzik, Jr. for advice in model building and C. Martin Lawrence for pointing out the distinct fold of Cas7f. We are grateful to Bill Anderson, TSRI Electron Microscopy facility manager, and Jean-Christophe Ducom at TSRI High Performance Computing for support during EM data collection and processing. Research in the Wiedenheft lab is supported by the National Institutes of Health (P20GM103500, P30GM110732-03, R01GM110270, and R01GM108888), the National Science Foundation EPSCoR (EPS-110134), the M.J. Murdock Charitable Trust, a young investigator award from Amgen, and the Montana State University Agricultural Experimental Station. J.C. is supported by the National Institutes of Health (P20GM103474) through Montana INBRE. R.N.J. is a recipient of the Ruth L. Kirschstein National Research Service Award from the National Institutes of Health (F32 GM108436). G.C.L. is supported as a Searle Scholar, as a Pew Scholar, and by the National Institutes of Health (DP2EB020402). J.B.-D. is supported by the University of California San Francisco Program for Breakthrough in Biomedical Research, funded in part by the Sandler Foundation, and an NIH Office of the Director Early Independence Award (DP5-OD021344). A.R.D. and K.L.M. are supported by the Canadian Institutes of Health Research (MOP-130482 and MOP-136845, respectively). E.R.F. is supported by the NIH intramural research program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Carter J, 2017, CELL, V168, P9, DOI 10.1016/j.cell.2016.12.007; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/NMETH.3286, 10.1038/nmeth.3286]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gleditzsch D, 2016, NUCLEIC ACIDS RES, V44, P5872, DOI 10.1093/nar/gkw469; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jackson RN, 2014, CURR OPIN STRUC BIOL, V24, P106, DOI 10.1016/j.sbi.2014.01.001; Kuznedelov K, 2016, NUCLEIC ACIDS RES, V44, P10849, DOI 10.1093/nar/gkw914; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Maxwell KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13134; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Topuzlu E, 2016, RNA BIOL, V13, P254, DOI 10.1080/15476286.2015.1130209; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; Van Valen L, 1973, EVOL THEORY, V1, P1, DOI DOI 10.1017/CBO9781139173179; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang JY, 2016, CELL RES, V26, P1165, DOI 10.1038/cr.2016.103; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Xue CY, 2016, MOL CELL, V64, P826, DOI 10.1016/j.molcel.2016.09.033; Zhang Y, 2014, SCIENCE, V345, P1452, DOI 10.1126/science.1260026; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	62	13	13	14	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					47	+		10.1016/j.cell.2017.03.012				22	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EP0PU	WOS:000397090000007	28340349				2018-01-05	
J	Li, H; Sheng, CY; Wang, S; Yang, L; Liang, Y; Huang, Y; Liu, HB; Li, P; Yang, CJ; Yang, XX; Jia, LL; Xie, J; Wang, LG; Hao, RZ; Du, XY; Xu, DP; Zhou, JJ; Li, MZ; Sun, YS; Tong, YG; Li, Q; Qiu, SF; Song, HB				Li, Hao; Sheng, Chunyu; Wang, Shan; Yang, Lang; Liang, Yuan; Huang, Yong; Liu, Hongbo; Li, Peng; Yang, Chaojie; Yang, Xiaoxia; Jia, Leili; Xie, Jing; Wang, Ligui; Hao, Rongzhang; Du, Xinying; Xu, Dongping; Zhou, Jianjun; Li, Mingzhen; Sun, Yansong; Tong, Yigang; Li, Qiao; Qiu, Shaofu; Song, Hongbin			Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9	FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY			English	Article						hepatitis B virus; CRISPR-Cas9; integrated HBV DNA; HBV cccDNA; whole genome sequencing	CLOSED CIRCULAR DNA; HBV DRUG-RESISTANCE; HEPATOCELLULAR-CARCINOMA; X-PROTEIN; EFFECTOR NUCLEASES; INFECTED-CELLS; LIVER-TISSUE; VIRAL-DNA; IN-VIVO; REPLICATION	The presence of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and the permanent integration of HBV DNA into the host genome confers the risk of viral reactivation and hepatocellular carcinoma. Nucleoside/nucleotide analogs alone have little or no capacity to eliminate replicative HBV templates consisting of cccDNA or integrated HBV DNA. Recently, CRISPR/Cas9 technology has been widely applied as a promising genome-editing tool, and HBV-specific CRISPR-Cas9 systems were shown to effectively mediate HBV cccDNA disruption. However, the integrated HBV DNA fragments are considered as important pro-oncogenic properties and it serves as an important template for viral replication and expression in stable HBV cell line. In this study, we completely excised a full-length 3,175-bp integrated HBV DNA fragment and disrupted HBV cccDNA in a stable HBV cell line. In HBV-excised cell line, the HBV cccDNA inside cells, supernatant HBV DNA, HBsAg, and HBeAg remained below the negative critical values formore than 10months. Besides, by whole genome sequencing, we analyzed off-target effects and excluded cell contamination. It is the first time that the HBV infection has been fully eradicated in a stable HBV cell line. These findings demonstrate that the CRISPR-Cas9 system is a potentially powerful tool capable of promoting a radical or "sterile" HBV cure.	[Li, Hao; Sheng, Chunyu; Wang, Shan; Yang, Lang; Liang, Yuan; Liu, Hongbo; Li, Peng; Yang, Chaojie; Yang, Xiaoxia; Jia, Leili; Xie, Jing; Wang, Ligui; Hao, Rongzhang; Du, Xinying; Sun, Yansong; Qiu, Shaofu; Song, Hongbin] Acad Mil Med Sci, Inst Dis Control & Prevent, Ctr Infect Dis Control, Beijing, Peoples R China; [Huang, Yong; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Xu, Dongping] Beijing 302nd Hosp, Res Ctr Liver Failure, Beijing, Peoples R China; [Zhou, Jianjun] Tongji Univ, Canc Stem Cell Inst, East Hosp, Sch Med,Res Ctr Translat Med, Shanghai, Peoples R China; [Zhou, Jianjun] Gladcan Consulting Co, Beijing, Peoples R China; [Li, Mingzhen] Beijing Ctr Phys & Chem Anal, Dept Res & Dev, Beijing, Peoples R China; [Li, Qiao] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	Qiu, SF; Song, HB (reprint author), Acad Mil Med Sci, Inst Dis Control & Prevent, Ctr Infect Dis Control, Beijing, Peoples R China.	qiushf0613@hotmail.com; hongbinsong@263.net		Tong, Yigang/0000-0002-8503-8045	National Nature Science Foundation of China [81371854]; Beijing Nature Science Foundation [7162145]; Innovation Foundation of AMMS [2015CXJJ26]	This work was supported by grants from the National Nature Science Foundation of China (81371854), the Beijing Nature Science Foundation (7162145), and the Innovation Foundation of AMMS (2015CXJJ26).	Bang KB, 2014, WORLD J GASTROENTERO, V20, P11641, DOI 10.3748/wjg.v20.i33.11641; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Bonilla GR, 2005, J HEPATOL, V42, P760, DOI DOI 10.1016/J.JHEP.2005.02.005; Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; Cha C, 2005, BEST PRACT RES CL GA, V19, P25, DOI 10.1016/j.bpg.2004.11.005; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Dandri M, 2000, HEPATOLOGY, V32, P139, DOI 10.1053/jhep.2000.8701                                                          ; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Feitelson MA, 2007, CANCER LETT, V252, P157, DOI 10.1016/j.canlet.2006.11.010; Gish RG, 2015, ANTIVIR RES, V121, P47, DOI 10.1016/j.antiviral.2015.06.008; Gounder PP, 2016, ALIMENT PHARM THER, V43, P1197, DOI 10.1111/apt.13621; Guo JT, 2015, ANTIVIR RES, V122, P91, DOI 10.1016/j.antiviral.2015.08.005; Hai H, 2014, WORLD J GASTROENTERO, V20, P6236, DOI 10.3748/wjg.v20.i20.6236; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Jaitovich-Groisman I, 2001, J BIOL CHEM, V276, P14124, DOI 10.1074/jbc.M010852200                                                          ; Jiang SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040363; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8                                                   ; Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Li H, 2016, INT J BIOL SCI, V12, P1104, DOI 10.7150/ijbs.16064; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Liu W, 2016, LIVER INT, V36, P1284, DOI 10.1111/liv.13104; Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MATSUBARA K, 1990, MOL BIOL MED, V7, P243; Moraleda G, 1997, J VIROL, V71, P9392; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Peng C, 2015, VIROL SIN, V30, P317, DOI 10.1007/s12250-015-3660-x; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rakotomalala L, 2008, J BIOL CHEM, V283, P28729, DOI 10.1074/jbc.M802751200; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roberts LR, 2005, SEMIN LIVER DIS, V25, P212, DOI 10.1055/s-2005-871200; Seeger C, 2016, MOL THER, V24, P1258, DOI 10.1038/mt.2016.94; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Seo Y, 2014, WORLD J GASTROENTERO, V20, P13284, DOI 10.3748/wjg.v20.i37.13284; Sharon A, 2008, ANTIVIR RES, V80, P339, DOI 10.1016/j.antiviral.2008.07.010; Shaw T, 2006, J HEPATOL, V44, P593, DOI 10.1016/j.jhep.2006.01.001; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tarocchi M, 2014, WORLD J GASTROENTERO, V20, P11630, DOI 10.3748/wjg.v20.i33.11630; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; van de Klundert MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048940; Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Wei-ming Y, 2014, MED J CHIN PLA, V39, P4; Xu C, 2014, CANCER LETT, V345, P216, DOI 10.1016/j.canlet.2013.08.035; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zhong YW, 2011, CLIN CHIM ACTA, V412, P1905, DOI 10.1016/j.cca.2011.06.031; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063; Zucnan-Rossi J, 2007, PHARMACOGENOMICS, V8, P997, DOI 10.2217/14622416.8.8.997	56	3	3	13	17	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2235-2988			FRONT CELL INFECT MI	Front. Cell. Infect. Microbiol.	MAR 22	2017	7								91	10.3389/fcimb.2017.00091				9	Immunology; Microbiology	Immunology; Microbiology	EO8YU	WOS:000396977200001	28382278	gold			2018-01-05	
J	Zhang, J; Yu, DS; Zhang, Y; Liu, K; Xu, KD; Zhang, FL; Wang, J; Tan, GX; Nie, XH; Ji, QH; Zhao, L; Li, CW				Zhang, Ju; Yu, Deshui; Zhang, Yi; Liu, Kun; Xu, Kedong; Zhang, Fuli; Wang, Jian; Tan, Guangxuan; Nie, Xianhui; Ji, Qiaohua; Zhao, Lu; Li, Chengwei			Vacuum and Co-cultivation Agroinfiltration of (Germinated) Seeds Results in Tobacco Rattle Virus (TRV) Mediated Whole-Plant Virus-Induced Gene Silencing (VIGS) in Wheat and Maize	FRONTIERS IN PLANT SCIENCE			English	Article						TRV-VIGS; vacuum and co-cultivation agroinfiltration; whole-plant level gene silencing; wheat; maize	POWDERY MILDEW RESISTANCE; STRIPE-MOSAIC-VIRUS; CRISPR-CAS SYSTEM; NICOTIANA-BENTHAMIANA; FUNCTIONAL GENOMICS; ARABIDOPSIS-THALIANA; CROP PLANTS; ZEA-MAYS; DISEASE-RESISTANCE; RNA INTERFERENCE	Tobacco rattle virus (TRV)-mediated virus-induced gene silencing (VIGS) has been frequently used in dicots. Here we show that it can also be used in monocots, by presenting a system involving use of a novel infiltration solution (containing acetosyringone, cysteine, and Tween 20) that enables whole-plant level VIGS of (germinated) seeds in wheat and maize. Using the established system, phytoene desaturase (PDS) genes were successfully silenced, resulting in typical photo-bleaching symptoms in the leaves of treated wheat and maize. In addition, three wheat homoeoalleles of MLO, a key gene repressing defense responses to powdery mildew in wheat, were simultaneously silenced in susceptible wheat with this system, resulting in it becoming resistant to powdery mildew. The system has the advantages generally associated with TRV-mediated VIGS systems (e.g., high-efficiency, mild virus infection symptoms, and effectiveness in different organs). However, it also has the following further advantages: (germinated) seed-stage agroinfiltration; greater rapidity and convenience; whole-plant level gene silencing; adequately stable transformation; and suitability for studying functions of genes involved in seed germination and early plant development stages.	[Zhang, Ju; Yu, Deshui; Zhang, Yi; Liu, Kun; Xu, Kedong; Wang, Jian; Tan, Guangxuan; Nie, Xianhui; Ji, Qiaohua; Zhao, Lu; Li, Chengwei] Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China; [Zhang, Ju; Yu, Deshui; Zhang, Yi; Liu, Kun; Xu, Kedong; Wang, Jian; Tan, Guangxuan; Nie, Xianhui; Ji, Qiaohua; Zhao, Lu; Li, Chengwei] Henan Key Lab Crop Mol Breeding & Bioreactor, Zhoukou, Peoples R China; [Zhang, Yi] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China; [Zhang, Fuli; Nie, Xianhui; Ji, Qiaohua; Zhao, Lu] Zhoukou Normal Univ, Coll Life Sci & Agron, Zhoukou, Peoples R China; [Li, Chengwei] Henan Inst Sci & Technol, Coll Life Sci & Technol, Xinxiang, Peoples R China	Li, CW (reprint author), Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China.; Li, CW (reprint author), Henan Key Lab Crop Mol Breeding & Bioreactor, Zhoukou, Peoples R China.; Li, CW (reprint author), Henan Inst Sci & Technol, Coll Life Sci & Technol, Xinxiang, Peoples R China.	lichengweiwau@hotmail.com			National Natural Science Foundation of China [31272168, 31071807]; Science and Technology Open Cooperation Project of Henan Province [132106000077]; Foundation of He'nan Educational Committee [17B180008, 16A180057]; Foundation of He'nan Science and Technology Committee [152300410229, 142102210108, 152102410074, 144300510072]; Startup Fund for Advanced Talents of Zhoukou Normal University [ZKNU2014101]	This research was supported by the National Natural Science Foundation of China (Nos. 31272168, 31071807), Science and Technology Open Cooperation Project of Henan Province (No. 132106000077), Foundation of He'nan Educational Committee (No. 17B180008 and 16A180057), Foundation of He'nan Science and Technology Committee (No. 152300410229, 142102210108, 152102410074, and 144300510072), and Startup Fund for Advanced Talents of Zhoukou Normal University (No. ZKNU2014101).	Acevedo-Garcia J, 2014, NEW PHYTOL, V204, P273, DOI 10.1111/nph.12889; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bai YL, 2008, MOL PLANT MICROBE IN, V21, P30, DOI 10.1094/MPMI-21-1-0030; Becker A, 2010, TRENDS PLANT SCI, V15, P1, DOI 10.1016/j.tplants.2009.09.002; Belfield EJ, 2012, GENOME RES, V22, P1306, DOI 10.1101/gr.131474.111; Brautigam A, 2010, PLANT BIOLOGY, V12, P831, DOI 10.1111/j.1438-8677.2010.00373.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1323, DOI 10.1094/MPMI-20-11-1323; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Chen KM, 2015, J GENET GENOMICS, V42, P21, DOI 10.1016/j.jgg.2014.11.002; Cho MJ, 2014, PLANT CELL REP, V33, P1767, DOI 10.1007/s00299-014-1656-x; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Dhaliwal AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145227; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Ding XS, 2006, MOL PLANT MICROBE IN, V19, P1229, DOI 10.1094/MPMI-19-1229; Feng C, 2016, J GENET GENOMICS, V43, P37, DOI 10.1016/j.jgg.2015.10.002; Fitzgerald TL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-264; George GM, 2015, METHODS MOL BIOL, V1287, P243, DOI 10.1007/978-1-4939-2453-0_18; George GM, 2012, BIOTECHNOL J, V7, P884, DOI 10.1002/biot.201100469; George GM, 2010, PLANT PHYSIOL, V154, P55, DOI 10.1104/pp.110.157776; Hanafy MS, 2014, APPL RADIAT ISOTOPES, V86, P71, DOI 10.1016/j.apradiso.2013.12.033; He HG, 2016, THEOR APPL GENET, V129, P819, DOI 10.1007/s00122-016-2668-4; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Jia J, 2013, AEGILOPS TAUSCHII, V496, P91, DOI DOI 10.1038/NATURE12028; Jiao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126621; King JL, 2015, PLANT CELL REP, V34, P133, DOI 10.1007/s00299-014-1694-4; Kirigia D, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-16; Kodym A, 2003, METH MOL B, V236, P189; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679                                                          ; Kumar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-597; Kumar V, 2015, J EXP BOT, V66, P47, DOI 10.1093/jxb/eru429; Kusaba M, 2004, CURR OPIN BIOTECH, V15, P139, DOI 10.1016/j.copbio.2004.02.004; Li GT, 2016, MOL PLANT, V9, P1078, DOI 10.1016/j.molp.2016.03.009; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu L, 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/251364; Liu N, 2016, PLANT PHYSIOL, V171, P1801, DOI 10.1104/pp.16.00010; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Mahmood-Ur-Rahman, 2008, BIOTECHNOL ADV, V26, P202, DOI 10.1016/j.biotechadv.2007.12.002; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McGinnis K, 2007, PLANT PHYSIOL, V143, P1441, DOI 10.1104/pp.106.094334; Mei Y, 2016, PLANT PHYSIOL, V171, P760, DOI 10.1104/pp.16.00172; Meng Y, 2009, PLANT PHYSIOL, V149, P271, DOI 10.1104/pp.108.129031; Mustafa R, 2016, MOL BIOTECHNOL, V58, P65, DOI 10.1007/s12033-015-9904-z; Nannas NJ, 2015, GENETICS, V199, P655, DOI 10.1534/genetics.114.165183; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Ramegowda V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00323; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Scofield SR, 2009, PLANT PHYSIOL, V149, P152, DOI 10.1104/pp.108.128702; Senthil-Kumar M, 2007, NEW PHYTOL, V176, P782, DOI 10.1111/j.1469-8137.2007.02225.x; Senthil-Kumar M, 2014, NAT PROTOC, V9, P1549, DOI 10.1038/nprot.2014.092; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Serrat X, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-5; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shen ZD, 2015, TREE PHYSIOL, V35, P1016, DOI 10.1093/treephys/tpv064; SMITH DB, 1975, CHROMOSOMA, V50, P223; Tague B. W., 2006, ARABIDOPSIS PROTOCOL, P215; Tian J, 2014, J EXP BOT, V65, P311, DOI 10.1093/jxb/ert381; Unver T, 2009, INT J PLANT GENOMICS, V2009, DOI [10.1155/2009/198680, DOI 10.1155/2009/198680]; Varallyay E, 2012, ARCH VIROL, V157, P1345, DOI 10.1007/s00705-012-1286-y; Wang FT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00108; Wang GF, 2011, NEW PHYTOL, V191, P418, DOI 10.1111/j.1469-8137.2011.03715.x; Wang L, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn715; Wang L, 2013, PLANT BIOTECHNOL J, V11, P997, DOI 10.1111/pbi.12093; Wang R, 2016, PLANT J, V86, P102, DOI 10.1111/tpj.13142; Wang XY, 2016, PLANT PHYSIOL BIOCH, V103, P106, DOI 10.1016/j.plaphy.2016.02.031; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Xu KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083556; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468; Zhang FL, 2014, BIOTECHNOL APPL BIOC, V61, P620, DOI 10.1002/bab.1207; Zhang N, 2016, GENE, V575, P285, DOI 10.1016/j.gene.2015.09.002; Zhang Y, 2015, NEW PHYTOL, V206, P1101, DOI 10.1111/nph.13302; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3; Zhu JJ, 2016, J GENET GENOMICS, V43, P25, DOI 10.1016/j.jgg.2015.10.006	83	0	0	31	61	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	MAR 22	2017	8								393	10.3389/fpls.2017.00393				12	Plant Sciences	Plant Sciences	EP0NX	WOS:000397085100001	28382049	gold			2018-01-05	
J	Miki, D; Zhu, PY; Zhang, WC; Mao, YF; Feng, ZY; Huang, H; Zhang, H; Li, YQ; Liu, RY; Zhang, HM; Qi, YJ; Zhu, JK				Miki, Daisuke; Zhu, Peiying; Zhang, Wencan; Mao, Yanfei; Feng, Zhengyan; Huang, Huan; Zhang, Hui; Li, Yanqiang; Liu, Renyi; Zhang, Huiming; Qi, Yijun; Zhu, Jian-Kang			Efficient Generation of diRNAs Requires Components in the Posttranscriptional Gene Silencing Pathway	SCIENTIFIC REPORTS			English	Article							STRAND BREAK REPAIR; DIRECTED DNA METHYLATION; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; SMALL RNAS; ARABIDOPSIS; PLANTS; TRANSCRIPTION; SYSTEM; GENOME	It has been reported that double-stranded break (DSB)-induced small RNAs (diRNAs) are generated via the RNA-directed DNA methylation pathway and function in DSB repair in Arabidposis. However, important questions remain regarding the biogenesis and function of diRNAs. Here, we used CRISPR/Cas9-or TALEN-triggered DSBs to characterize diRNAs in Arabidopsis and rice. We found that 21-nt diRNAs were generated from a 35S promoter:: GU-US reporter transgene targeted by CRISPR/Cas9. Unexpectedly, Pol II transcription of the transgene was required for efficient diRNA production and the level of diRNA accumulation correlated with the expression level of the transgene. diRNAs were not detected from CRISPR/Cas9-or TALEN-induced DSBs within the examined endogenous genes in Arabidopsis or rice. We also found that DCL4 and RDR6 that are known to be involved in posttranscriptional gene silencing were required to generate diRNAs. Our results suggest that DSBs are necessary but not sufficient for efficient diRNA generation and a high level of diRNAs is not necessary for DSB repair.	[Miki, Daisuke; Zhu, Peiying; Zhang, Wencan; Mao, Yanfei; Feng, Zhengyan; Huang, Huan; Zhang, Hui; Li, Yanqiang; Liu, Renyi; Zhang, Huiming; Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai 210602, Peoples R China; [Qi, Yijun] Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Beijing 100084, Peoples R China; [Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Miki, D (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai 210602, Peoples R China.	miki@sibs.ac.cn			Chinese Academy of Sciences; Sumitomo Foundation	This work was supported by the Chinese Academy of Sciences to J.K.Z., and by Grant for Basic Science Research Projects from The Sumitomo Foundation to D.M. We thank Life Science Editors for editorial assistance.	Ba ZQ, 2013, SCI CHINA LIFE SCI, V56, P933, DOI 10.1007/s11427-013-4552-7; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Carradec Q, 2015, NUCLEIC ACIDS RES, V43, P1818, DOI 10.1093/nar/gku1331; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; de Alba AEM, 2013, BBA-GENE REGUL MECH, V1829, P1300, DOI 10.1016/j.bbagrm.2013.10.005; di Fagagna FD, 2014, TRENDS CELL BIOL, V24, P171, DOI 10.1016/j.tcb.2013.09.008; Eamens A, 2008, PLANT J, V55, P596, DOI 10.1111/j.1365-313X.2008.03525.x; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Filichkin SA, 2007, PLANT BIOTECHNOL J, V5, P615, DOI 10.1111/j.1467-7652.2007.00267.x; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao M, 2014, CELL RES, V24, P532, DOI 10.1038/cr.2014.36; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Koseki M, 2005, PLANT CELL PHYSIOL, V46, P1879, DOI 10.1093/pcp/pci192; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lei MG, 2015, P NATL ACAD SCI USA, V112, P3553, DOI 10.1073/pnas.1502279112; Liang P., 2015, PROTEIN CELL; Mannuss A, 2010, PLANT CELL, V22, P3318, DOI 10.1105/tpc.110.078568; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Matzke MA, 2015, ANNU REV PLANT BIOL, V66, P243, DOI 10.1146/annurev-arplant-043014-114633; Michalik KM, 2012, NUCLEIC ACIDS RES, V40, P9596, DOI 10.1093/nar/gks711; Miki D, 2005, PLANT PHYSIOL, V138, P1903, DOI 10.1104/pp.105.063933; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Orel N, 2003, PLANT J, V35, P604, DOI 10.1046/j.1365-313X.2003.01832.x; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Parent JS, 2015, PLANT J, V81, P223, DOI 10.1111/tpj.12720; Petersen BO, 2005, PLANT MOL BIOL, V58, P575, DOI 10.1007/s11103-005-7307-4; Qian WQ, 2012, SCIENCE, V336, P1445, DOI 10.1126/science.1219416; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Vermeersch L, 2013, PLANT J, V74, P867, DOI 10.1111/tpj.12172; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Yang QY, 2015, GENE DEV, V29, P526, DOI 10.1101/gad.255828.114; Zhang CZ, 2015, MUTAT RES-REV MUTAT, V763, P202, DOI 10.1016/j.mrrev.2014.11.003; Zhang H., 2015, PLANT BIOTECHNOLOGY; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200	44	2	2	5	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 22	2017	7								301	10.1038/s41598-017-00374-7				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EO9BA	WOS:000396983000012	28331197	gold			2018-01-05	
J	Trautman, EP; Healy, AR; Shine, EE; Herzon, SB; Crawford, JM				Trautman, Eric P.; Healy, Alan R.; Shine, Emilee E.; Herzon, Seth B.; Crawford, Jason M.			Domain-Targeted Metabolomics Delineates the Heterocycle Assembly Steps of Colibactin Biosynthesis	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							I POLYKETIDE SYNTHASE; NONRIBOSOMAL PEPTIDES; NATURAL-PRODUCTS; DNA; PRECOLIBACTIN; PATHWAY; CELLS; ACID; IDENTIFICATION; MACHINERY	Modular polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs) comprise giant multidomain enzymes responsible for the "assembly line" biosynthesis of many genetically encoded small molecules. Site-directed mutagenesis, protein biochemical, and structural studies have focused on elucidating the catalytic mechanisms of individual multidomain proteins and protein domains within these megasynthases. However, probing their functions at the cellular level typically has invoked the complete deletion (or overexpression) of multidomain-encoding genes or combinations of genes and comparing those mutants with a control pathway. Here we describe a "domain-targeted" metabolomic strategy that combines genome editing with pathway analysis to probe the functions of individual PKS and NRPS catalytic domains at the cellular metabolic level. We apply the approach to the bacterial colibactin pathway, a genotoxic NRPS PKS hybrid pathway found in certain Escherichia coli. The pathway produces precolibactins, which are converted to colibactins by a dedicated peptidase, ClbP. Domain-targeted metabolomics enabled the characterization of "multidomain signatures", or functional readouts of NRPS-PKS domain contributions to the pathway-dependent metabolome. These multidomain signatures provided experimental support for individual domain contributions to colibactin biosynthesis and delineated the assembly line timing events of colibactin heterocycle formation. The analysis also led to the structural characterization of two- reactive precolibactin metabolites. We demonstrate the fate of these reactive intermediates in the presence and absence of ClbP, which dictates the formation of distinct product groups resulting from alternative cyclization cascades. In the presence of the peptidase, the reactive intermediates are converted to a known genotoxic scaffold, providing metabolic support of our mechanistic model for colibactin-induced genotoxicity. Domain-targeted metabolomics could be more widely used to characterize NRPS PKS pathways with unprecedented genetic and metabolic precision.	[Trautman, Eric P.; Healy, Alan R.; Herzon, Seth B.; Crawford, Jason M.] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA; [Trautman, Eric P.; Healy, Alan R.; Shine, Emilee E.; Crawford, Jason M.] Yale Univ, Inst Chem Biol, West Haven, CT 06516 USA; [Shine, Emilee E.; Crawford, Jason M.] Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Herzon, Seth B.] Yale Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Crawford, JM (reprint author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.; Crawford, JM (reprint author), Yale Univ, Inst Chem Biol, West Haven, CT 06516 USA.; Crawford, JM (reprint author), Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA.	jason.crawford@yale.edu			National Institutes of Health [1DP2-CA186575, R01GM110506]; Damon Runyon Cancer Research Foundation [DRR-39-16]; Searle Scholars Program [13-SSP-210]; Yale University; National Science Foundation Graduate Research Fellowships Program	Financial support from the National Institutes of Health (1DP2-CA186575 to J.M.C. and R01GM110506 to S.B.H.), the Damon Runyon Cancer Research Foundation (DRR-39-16 to J.M.C.), the Searle Scholars Program (13-SSP-210 to J.M.C.), and Yale University is gratefully acknowledged. E.E.S. was supported by the National Science Foundation Graduate Research Fellowships Program. We thank Ryan R. Gallagher, Jaymin R. Patel, and Farren J. Isaacs (Yale University) for providing the EcNR1 variant used in this study and guidance in initiating MAGE technologies in the lab.	ADAMS DO, 1979, P NATL ACAD SCI USA, V76, P170, DOI 10.1073/pnas.76.1.170; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Balskus EP, 2015, NAT PROD REP, V32, P1534, DOI 10.1039/c5np00091b; Bian XY, 2015, CHEM SCI, V6, P3154, DOI 10.1039/c5sc00101c; Bian XY, 2013, CHEMBIOCHEM, V14, P1194, DOI 10.1002/cbic.201300208; Brachmann AO, 2015, CHEM COMMUN, V51, P13138, DOI 10.1039/c5cc02718g; Brotherton CA, 2015, ORG LETT, V17, P1545, DOI 10.1021/acs.orglett.5b00432; Brotherton CA, 2013, J AM CHEM SOC, V135, P3359, DOI 10.1021/ja312154m; Cougnoux A, 2012, J MOL BIOL, V424, P203, DOI 10.1016/j.jmb.2012.09.017; Crawford JM, 2008, BIOORG CHEM, V36, P16, DOI 10.1016/j.bioorg.2007.11.002; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Dalmasso Guillaume, 2014, Gut Microbes, V5, P675, DOI 10.4161/19490976.2014.969989; Dubois D, 2011, J BIOL CHEM, V286, P35562, DOI 10.1074/jbc.M111.221960; Engel P, 2015, APPL ENVIRON MICROB, V81, P1502, DOI 10.1128/AEM.03283-14; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gallagher RR, 2014, NAT PROTOC, V9, P2301, DOI 10.1038/nprot.2014.082; Galm U, 2011, J NAT PROD, V74, P526, DOI 10.1021/np1008152; Healy AR, 2016, J AM CHEM SOC, V138, P15563, DOI 10.1021/jacs.6b10354; Healy AR, 2016, J AM CHEM SOC, V138, P5426, DOI 10.1021/jacs.6b02276; Helfrich EJN, 2016, NAT PROD REP, V33, P231, DOI 10.1039/c5np00125k; Khosla C, 2014, BIOCHEMISTRY-US, V53, P2875, DOI 10.1021/bi500290t; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Li ZR, 2016, NAT CHEM BIOL, V12, P773, DOI 10.1038/nchembio.2157; Li ZR, 2015, CHEMBIOCHEM, V16, P1715, DOI 10.1002/cbic.201500239; Lohman JR, 2015, P NATL ACAD SCI USA, V112, P12693, DOI 10.1073/pnas.1515460112; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Olier Maiwenn, 2012, Gut Microbes, V3, P501, DOI 10.4161/gmic.21737; Park HB, 2015, J NAT PROD, V78, P1437, DOI 10.1021/np500974f; Shen B, 2015, CELL, V163, P1297, DOI 10.1016/j.cell.2015.11.031; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Taieb F., 2016, ECOSAL PLUS, V7, P1, DOI [10.1128/ecosalplus.ESP-0008-2016, DOI 10.1128/ECOSALPLUS.ESP-0008-2016]; Trautman EP, 2016, CURR TOP MED CHEM, V16, P1705, DOI 10.2174/1568026616666151012111046; Vizcaino MI, 2015, NAT CHEM, V7, P411, DOI [10.1038/NCHEM.2221, 10.1038/nchem.2221]; Vizcaino MI, 2014, J AM CHEM SOC, V136, P9244, DOI 10.1021/ja503450q; Walsh CT, 2013, ANGEW CHEM INT EDIT, V52, P7098, DOI 10.1002/anie.201208344; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Zha L, 2016, ACS CHEM BIOL, V11, P1287, DOI 10.1021/acschembio.6b00014	40	7	7	7	20	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	MAR 22	2017	139	11					4195	4201		10.1021/jacs.7b00659				7	Chemistry, Multidisciplinary	Chemistry	EP6GY	WOS:000397477700039	28240912				2018-01-05	
J	Kage, F; Winterhoff, M; Dimchev, V; Mueller, J; Thalheim, T; Freise, A; Bruhmann, S; Kollasser, J; Block, J; Dimchev, G; Geyer, M; Schnittler, HJ; Brakebusch, C; Stradal, TEB; Carlier, MF; Sixt, M; Kas, J; Faix, J; Rottner, K				Kage, Frieda; Winterhoff, Moritz; Dimchev, Vanessa; Mueller, Jan; Thalheim, Tobias; Freise, Anika; Bruehmann, Stefan; Kollasser, Jana; Block, Jennifer; Dimchev, Georgi; Geyer, Matthias; Schnittler, Hans-Joachim; Brakebusch, Cord; Stradal, Theresia E. B.; Carlier, Marie-France; Sixt, Michael; Kaes, Josef; Faix, Jan; Rottner, Klemens			FMNL formins boost lamellipodial force generation	NATURE COMMUNICATIONS			English	Article							ACTIN-FILAMENT ELONGATION; ARP2/3 COMPLEX; CELL-MIGRATION; WAVE-COMPLEX; DIRECTIONAL PERSISTENCE; COLORECTAL-CARCINOMA; FILOPODIA FORMATION; LEADING-EDGE; BARBED END; MOTILITY	Migration frequently involves Rac-mediated protrusion of lamellipodia, formed by Arp2/3 complex-dependent branching thought to be crucial for force generation and stability of these networks. The formins FMNL2 and FMNL3 are Cdc42 effectors targeting to the lamellipodium tip and shown here to nucleate and elongate actin filaments with complementary activities in vitro. In migrating B16-F1 melanoma cells, both formins contribute to the velocity of lamellipodium protrusion. Loss of FMNL2/3 function in melanoma cells and fibroblasts reduces lamellipodial width, actin filament density and -bundling, without changing patterns of Arp2/3 complex incorporation. Strikingly, in melanoma cells, FMNL2/3 gene inactivation almost completely abolishes protrusion forces exerted by lamellipodia and modifies their ultrastructural organization. Consistently, CRISPR/Cas-mediated depletion of FMNL2/3 in fibroblasts reduces both migration and capability of cells to move against viscous media. Together, we conclude that force generation in lamellipodia strongly depends on FMNL formin activity, operating in addition to Arp2/3 complex-dependent filament branching.	[Kage, Frieda; Dimchev, Vanessa; Freise, Anika; Dimchev, Georgi; Rottner, Klemens] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Mol Cell Biol Div, Spielmannstr 7, D-38106 Braunschweig, Germany; [Kage, Frieda; Dimchev, Vanessa; Freise, Anika; Block, Jennifer; Dimchev, Georgi; Rottner, Klemens] Helmholtz Ctr Infect Res, Mol Cell Biol Grp, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Winterhoff, Moritz; Bruehmann, Stefan; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Mueller, Jan; Sixt, Michael] IST Austria, Campus 1, A-3400 Klosterneuburg, Austria; [Thalheim, Tobias; Kaes, Josef] Univ Leipzig, Inst Expt Phys 1, Soft Matter Phys Grp, Linnestr 5, D-04103 Leipzig, Germany; [Kollasser, Jana; Brakebusch, Cord] Univ Copenhagen, Biomed Inst BRIC, DK-2200 Copenhagen, Denmark; [Kollasser, Jana] Helmholtz Ctr Infect Res, Dept Cell Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Geyer, Matthias] Univ Bonn, Inst Innate Immun, Dept Struct Immunol, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Schnittler, Hans-Joachim] Westfal Wilhelms Univ Munster, Inst Anat & Vasc Biol, Vesaliusweg 2-4, D-48149 Munster, Germany; [Carlier, Marie-France] CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, Cytoskeleton Dynam & Motil Grp, F-91198 Gif Sur Yvette, France	Rottner, K (reprint author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Mol Cell Biol Div, Spielmannstr 7, D-38106 Braunschweig, Germany.; Rottner, K (reprint author), Helmholtz Ctr Infect Res, Mol Cell Biol Grp, Inhoffenstr 7, D-38124 Braunschweig, Germany.	k.rottner@tu-braunschweig.de		Rottner, Klemens/0000-0003-4244-4198; Stradal, Theresia/0000-0002-0352-9474	Deutsche Forschungsgemeinschaft (DFG) [RO2414/3-2, RO2414/5-1, FA330/9-1, FA33010/1, GE976/7-2, SCHN430/6-2]; Seventh Framework Programme grant FORCEFULACTIN of the European Research Council	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG), grants RO2414/3-2 and RO2414/5-1 (to K.R.), FA330/9-1 and FA33010/1 (to J.F.), GE976/7-2 (to M.G.), SCHN430/6-2 (to H.-J.S.) as well as the Seventh Framework Programme grant FORCEFULACTIN of the European Research Council (to M.-F.C. and K.R.). M.G. and H.-J.S. are members of DFG Excellence Clusters ImmunoSensation and Cells in Motion, respectively. We would like to thank Laetitia Kurzawa and Laurent Blanchoin for sharing unpublished data, Vic Small and Martin Falcke for advice, Pontus Aspenstrom, Laura Machesky and Roland Wedlich-Soldner for DNA constructs, Markus Sommerfeld for help with AFM measurements, and Gerd Landsberg and Brigitte Denker for excellent technical assistance.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Anderson K. L., 2016, J STRUCT BIOL, VS1047-8477, P30254; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Brunner CA, 2006, EUR BIOPHYS J BIOPHY, V35, P713, DOI 10.1007/s00249-006-0079-1; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Colon-Franco JM, 2011, J CELL SCI, V124, P3118, DOI 10.1242/jcs.083725; Dieterich P, 2000, BIOPHYS J, V79, P1285, DOI 10.1016/S0006-3495(00)76382-X                                                   ; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; Gauvin TJ, 2015, MOL BIOL CELL, V26, P467, DOI 10.1091/mbc.E14-07-1247; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Gurel PS, 2015, J BIOL CHEM, V290, P22494, DOI 10.1074/jbc.M115.670166; Gurniak CB, 2014, EUR J CELL BIOL, V93, P252, DOI 10.1016/j.ejcb.2014.01.007; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Harris ES, 2010, CYTOSKELETON, V67, P755, DOI 10.1002/cm.20485; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Isogai T, 2015, J CELL SCI, V128, P3796, DOI 10.1242/jcs.176768; Koestler SA, 2013, MOL BIOL CELL, V24, P2861, DOI 10.1091/mbc.E12-12-0857; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuhn S., NAT COMMUN, V6, P7088; Kuhn S., 2014, SMALL GTPASES, V5, DOI DOI 10.4161/SGTP.29513; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Leibiger C, 2013, J HISTOCHEM CYTOCHEM, V61, P306, DOI 10.1369/0022155413476868; Leithner A, 2016, NAT CELL BIOL, V18, P1253, DOI 10.1038/ncb3426; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; MALM B, 1984, FEBS LETT, V173, P399, DOI 10.1016/0014-5793(84)80813-3                                                    ; Nicholson-Dykstra SM, 2008, CELL MOTIL CYTOSKEL, V65, P904, DOI 10.1002/cm.20312; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Peckham M, 2001, J CELL SCI, V114, P1367; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ramalingam N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9496; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Steffen A, 2013, J CELL SCI, V126, P4572, DOI 10.1242/jcs.118232; Suraneni P, 2015, MOL BIOL CELL, V26, P901, DOI 10.1091/mbc.E14-07-1250; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Vitriol EA, 2013, MOL BIOL CELL, V24, P2238, DOI 10.1091/mbc.E13-03-0156; Wakayama Y, 2015, DEV CELL, V32, P109, DOI 10.1016/j.devcel.2014.11.024; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470                                                         ; Winkler C, 2012, J STRUCT BIOL, V178, P19, DOI 10.1016/j.jsb.2012.02.011; Winterhoff M, 2014, EUR J CELL BIOL, V93, P212, DOI 10.1016/j.ejcb.2013.11.002; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Young LE, 2015, MOL BIOL CELL, V26, P4646, DOI 10.1091/mbc.E15-09-0626; Zeng YF, 2015, EXP MOL PATHOL, V98, P260, DOI 10.1016/j.yexmp.2015.03.008; Zhu XL, 2011, J PATHOL, V224, P377, DOI 10.1002/path.2871	70	8	8	4	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAR 22	2017	8								14832	10.1038/ncomms14832				16	Multidisciplinary Sciences	Science & Technology - Other Topics	EO9FD	WOS:000396993700001	28327544	gold			2018-01-05	
J	Geue, L; Menge, C; Eichhorn, I; Semmler, T; Wieler, LH; Pickard, D; Berens, C; Barth, SA				Geue, Lutz; Menge, Christian; Eichhorn, Inga; Semmler, Torsten; Wieler, Lothar H.; Pickard, Derek; Berens, Christian; Barth, Stefanie A.			Evidence for Contemporary Switching of the O-Antigen Gene Cluster between Shiga Toxin-Producing Escherichia coli Strains Colonizing Cattle	FRONTIERS IN MICROBIOLOGY			English	Article						E. coli; STEC; O-antigen gene cluster; recombination; genome sequencing	VIBRIO-CHOLERAE; SALMONELLA-ENTERICA; O139 BENGAL; E. COLI; DIVERSITY; LIPOPOLYSACCHARIDE; TRANSFORMATION; SEQUENCE; O157-H7; PLASMID	Shiga toxin-producing Escherichia coli (STEC) comprise a group of zoonotic enteric pathogens with ruminants, especially cattle, as the main reservoir. O-antigens are instrumental for host colonization and bacterial niche adaptation. They are highly immunogenic and, therefore, targeted by the adaptive immune system. The O-antigen is one of the most diverse bacterial cell constituents and variation not only exists between different bacterial species, but also between individual isolates/strains within a single species. We recently identified STEC persistently infecting cattle and belonging to the different serotypes O156:H25 (n = 21) and O182:H25 (n = 15) that were of the MLST sequence types ST300 or ST688. These STs differ by a single nucleotide in purA only. Fitness-, virulence-associated genome regions, and CRISPR/CAS (clustered regularly interspaced short palindromic repeats/CRISPR associated sequence) arrays of these STEC O156:H25 and O182:H25 isolates were highly similar, and identical genomic integration sites for the stx converting bacteriophages and the core LEE, identical Shiga toxin converting bacteriophage genes for stx 1a, identical complete LEE loci, and identical sets of chemotaxis and flagellar genes were identified. In contrast to this genomic similarity, the nucleotide sequences of the O-antigen gene cluster (O-AGC) regions between galF and grid and very few flanking genes differed fundamentally and were specific for the respective serotype. Sporadic aEPEC O156:H8 isolates (n = 5) were isolated in temporal and spatial proximity. While the O-AGC and the corresponding 5' and 3' flanking regions of these aEPEC isolates were identical to the respective region in the STEC O156: H25 isolates, the core genome, the virulence associated genome regions and the CRISPR/CAS elements differed profoundly. Our cumulative epidemiological and molecular data suggests a recent switch of the O-AGC between isolates with O156:H8 strains having served as DNA donors. Such O-antigen switches can affect the evaluation of a strain's pathogenic and virulence potential, suggesting that NGS methods might lead to a more reliable risk assessment.	[Geue, Lutz; Berens, Christian; Barth, Stefanie A.] Inst Mol Pathol, Fed Res Inst Anim Hlth, Friedrich Loeffier Inst, Jena, Germany; [Eichhorn, Inga; Semmler, Torsten; Wieler, Lothar H.] Free Univ Berlin, Inst Microbial & Epizoot, Berlin, Germany; [Semmler, Torsten; Wieler, Lothar H.] Robert Koch Inst, Berlin, Germany; [Pickard, Derek] Welcome Trust Sanger Int, Pathogen Gen, Cambridge, England	Barth, SA (reprint author), Inst Mol Pathol, Fed Res Inst Anim Hlth, Friedrich Loeffier Inst, Jena, Germany.	stefanie.barth@fli.de		Barth, Stefanie/0000-0003-4921-5056	Deutsche Forschungsgemeinschaft (DFG) [GE2509/1-1]	This work, including the efforts of SB, CM, and LG was funded by Deutsche Forschungsgemeinschaft (DFG) (GE2509/1-1).	Amin A, 2009, HISTOL HISTOPATHOL, V24, P559, DOI 10.14670/HH-24.559; Barnett FD, 2013, VIRULENCE, V4, P315, DOI [10.4161/viru.24318, DOI 10.4161/VIRU.24318]; Barth SA, 2016, APPL ENVIRON MICROB, V82, P5455, DOI 10.1128/AEM.00909-16; Baur B, 1996, APPL ENVIRON MICROB, V62, P3673; Bazaka K, 2011, ADV EXP MED BIOL, V715, P213, DOI 10.1007/978-94-007-0940-9_13; BIK EM, 1995, EMBO J, V14, P209; Blokesch M, 2007, PLOS PATHOG, V3, P733, DOI 10.1371/journal.ppat.0030081; Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x                                                ; Brunder W, 1999, MICROBIOL-UK, V145, P1005, DOI 10.1099/13500872-145-5-1005                                                     ; Brunder W, 1996, MICROBIOL-UK, V142, P3305, DOI 10.1099/13500872-142-11-3305                                                    ; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Diez-Villasenor C, 2010, MICROBIOL-SGM, V156, P1351, DOI 10.1099/mic.0.036046-0; Etchuuya R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016355; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Geue L, 2002, EPIDEMIOL INFECT, V129, P173, DOI 10.1017/S0950268802007288; Geue L, 2010, APPL ENVIRON MICROB, V76, P5510, DOI 10.1128/AEM.00743-10; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079                                           ; Guo MY, 2015, J BACTERIOL, V197, P3317, DOI 10.1128/JB.00291-15; Hernandes RT, 2009, FEMS MICROBIOL LETT, V297, P137, DOI 10.1111/j.1574-6968.2009.01664.x; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; Joris MA, 2011, TOXINS, V3, P672, DOI 10.3390/toxins3060672; La Ragione RM, 2009, FEMS MICROBIOL REV, V33, P394, DOI 10.1111/j.1574-6976.2008.00138.x; Lam JS, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00118; Leimbach A, 2013, CURR TOP MICROBIOL, V358, P3, DOI 10.1007/82_2012_303; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Liu B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Marinus Martin G, 2013, F1000Res, V2, P7, DOI 10.12688/f1000research.2-7.v1; MCKEE ML, 1995, INFECT IMMUN, V63, P3739; Mekalanos JJ, 1997, FEMS IMMUNOL MED MIC, V18, P241, DOI 10.1016/S0928-8244(97)00054-0; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142; Niba ETE, 2007, DNA RES, V14, P237, DOI 10.1093/dnares/dsm024; Pacheco AR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0001-2014; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Paton AW, 1998, J CLIN MICROBIOL, V36, P598; Penner JL, 1997, J INFECT DIS, V176, pS135, DOI 10.1086/513778                                                                  ; Ramamurthy T, 2003, MICROBES INFECT, V5, P329, DOI 10.1016/S1286-4579(03)00035-2; REEVES P, 1995, TRENDS MICROBIOL, V3, P381, DOI 10.1016/S0966-842X(00)88983-0; Remuzzi G, 1998, Kidney Int Suppl, V66, pS54; Rodriguez-Beltran J, 2015, MOL BIOL EVOL, V32, P1708, DOI 10.1093/molbev/msv072; Samuel G, 2004, J BACTERIOL, V186, P6536, DOI 10.1128/JB.186.19.6536-6543.2004; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055; Sinha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035620; Sperandio V, 2001, TRENDS MICROBIOL, V9, P159, DOI 10.1016/S0966-842X(01)02023-6; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; Sugiyama T, 1997, GENE, V198, P111, DOI 10.1016/S0378-1119(97)00300-4; Tarr PI, 2000, J BACTERIOL, V182, P6183, DOI 10.1128/JB.182.21.6183-6191.2000; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Tsen SD, 2002, J BIOMED SCI, V9, P246, DOI 10.1159/000059425; WALDOR MK, 1994, P NATL ACAD SCI USA, V91, P11388, DOI 10.1073/pnas.91.24.11388                                                        ; Wang L, 2002, J BACTERIOL, V184, P2620, DOI 10.1128/JB.184.10.2620-2625.2002; Wang L, 2001, INFECT IMMUN, V69, P6923, DOI 10.1128/IAI.69.11.6923-6930.2001; Werber D, 2008, EMERG INFECT DIS, V14, P1803, DOI 10.3201/eid1411.080361; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yin Shuang, 2013, Appl Environ Microbiol, V79, P5710, DOI 10.1128/AEM.00950-13	58	0	0	4	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	MAR 21	2017	8								424	10.3389/fmicb.2017.00424				13	Microbiology	Microbiology	EO7ZD	WOS:000396907700002	28377748	gold			2018-01-05	
J	Leister, D; Wang, LS; Kleine, T				Leister, Dario; Wang, Liangsheng; Kleine, Tatjana			Organellar Gene Expression and Acclimation of Plants to Environmental Stress	FRONTIERS IN PLANT SCIENCE			English	Review						organellar gene expression; plastid; retrograde signaling; Arabidopsis; acclimation	MESSENGER-RNA STABILITY; PLASTID SIGMA-FACTOR; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; CHLOROPLAST TRANSCRIPTION; NUCLEAR GENES; COLD STRESS; RIBOSOME CHLOROPLAST; SIGNAL-TRANSDUCTION; CONTAINING PROTEIN	Organelles produce ATP and a variety of vital metabolites, and are indispensable for plant development. While most of their original gene complements have been transferred to the nucleus in the course of evolution, they retain their own genomes and gene-expression machineries. Hence, organellar function requires tight coordination between organellar gene expression (OGE) and nuclear gene expression (NGE). OGE requires various nucleus-encoded proteins that regulate transcription, splicing, trimming, editing, and translation of organellar RNAs, which necessitates nucleus-to-organelle (anterograde) communication. Conversely, changes in OGE trigger retrograde signaling that modulates NGE in accordance with the current status of the organelle. Changes in OGE occur naturally in response to developmental and environmental changes, and can be artificially induced by inhibitors such as lincomycin or mutations that perturb OGE. Focusing on the model plant Arabidopsis thaliana and its plastids, we review here recent findings which suggest that perturbations of OGE homeostasis regularly result in the activation of acclimation and tolerance responses, presumably via retrograde signaling.	[Leister, Dario; Wang, Liangsheng; Kleine, Tatjana] Ludwig Maximilians Univ Munchen, Dept Biol, Plant Mol Biol, Planegg Martinsried, Germany	Kleine, T (reprint author), Ludwig Maximilians Univ Munchen, Dept Biol, Plant Mol Biol, Planegg Martinsried, Germany.	tatjana.kleine@lmu.de	Kleine, Tatjana/K-3463-2014; Leister, Dario/D-5587-2009	Leister, Dario/0000-0003-1897-8421	Deutsche Forschungsgemeinschaft [TRR175]	This work was supported by the Deutsche Forschungsgemeinschaft (TRR175, project C01 and C05).	Baena-Gonzalez E, 2001, PLANT PHYSIOL, V127, P1044, DOI 10.1104/pp.127.3.1044; Baginsky S, 1999, PLANT MOL BIOL, V39, P1013, DOI 10.1023/A:1006177807844; Barkan A, 2000, BIOCHIMIE, V82, P559, DOI 10.1016/S0300-9084(00)00602-7; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Belbin FE, 2017, NEW PHYTOL, V213, P727, DOI 10.1111/nph.14176; Bobik K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00781; Borner T, 2015, BBA-BIOENERGETICS, V1847, P761, DOI 10.1016/j.bbabio.2015.02.004; Cheng CL, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/1851829; Chi W, 2015, BBA-BIOENERGETICS, V1847, P770, DOI 10.1016/j.bbabio.2015.01.001; Chi W, 2013, ANNU REV PLANT BIOL, V64, P559, DOI 10.1146/annurev-arplant-050312-120147; Chiba Y, 2013, PLANT CELL PHYSIOL, V54, P180, DOI 10.1093/pcp/pcs164; Cho WK, 2009, DNA RES, V16, P31, DOI 10.1093/dnares/dsn031; Coll NS, 2009, PLANT CELL PHYSIOL, V50, P707, DOI 10.1093/pcp/pcp036; Colombo M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01427; Cottage A, 2010, J EXP BOT, V61, P3773, DOI 10.1093/jxb/erq186; del Campo EM, 2009, GENE REGUL SYST BIO, V3, P31; Dietz KJ, 2016, PLANT PHYSIOL, V171, P1541, DOI 10.1104/pp.16.00375; Feng PQ, 2016, P NATL ACAD SCI USA, V113, P10708, DOI 10.1073/pnas.1521599113; Foyer CH, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0226; GILMOUR SJ, 1991, PLANT MOL BIOL, V17, P1233, DOI 10.1007/BF00028738; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Gollan PJ, 2015, CURR OPIN PLANT BIOL, V27, P180, DOI 10.1016/j.pbi.2015.07.006; Gu L, 2015, J PLANT PHYSIOL, V189, P34, DOI 10.1016/j.jplph.2015.10.003; Gu L, 2014, PLANT PHYSIOL BIOCH, V82, P309, DOI 10.1016/j.plaphy.2014.07.006; Hammani K, 2014, BIOCHIMIE, V100, P141, DOI 10.1016/j.biochi.2013.08.031; Hui MP, 2014, ANNU REV GENET, V48, P537, DOI 10.1146/annurev-genet-120213-092340; Isemer R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00283; Isemer R, 2012, FEBS LETT, V586, P85, DOI 10.1016/j.febslet.2011.11.029; Kim M, 2012, PLANT CELL, V24, P3349, DOI 10.1105/tpc.112.101006; KIM MY, 1993, PLANT MOL BIOL, V22, P447, DOI 10.1007/BF00015975; Kindgren P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138010; KLAFF P, 1991, PLANT CELL, V3, P517; Kleine T, 2016, BBA-BIOENERGETICS, V1857, P1313, DOI 10.1016/j.bbabio.2016.03.017; Kleine T, 2015, BBA-BIOENERGETICS, V1847, P786, DOI 10.1016/j.bbabio.2014.12.009; Kleine T, 2009, TRENDS GENET, V25, P185, DOI 10.1016/j.tig.2009.02.004; Koussevitzky S, 2007, PLANT MOL BIOL, V63, P85, DOI 10.1007/s11103-006-9074-2; Kupsch C, 2012, PLANT CELL, V24, P4266, DOI 10.1105/tpc.112.103002; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978                                                         ; Lee K, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-98; Leister D, 2011, PLANT PHYSIOL, V157, P386, DOI 10.1104/pp.111.177691; Leister D, 2008, CELL RES, V18, P1081, DOI 10.1038/cr.2008.297; Leon Patricia, 2012, Front Plant Sci, V3, P304, DOI 10.3389/fpls.2012.00304; Lerbs-Mache S, 2011, PLANT MOL BIOL, V76, P235, DOI 10.1007/s11103-010-9714-4; Marles-Wright J, 2007, CURR OPIN STRUC BIOL, V17, P755, DOI 10.1016/j.sbi.2007.08.004; Martin G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11431; Meskauskiene R, 2009, PLANT J, V60, P399, DOI 10.1111/j.1365-313X.2009.03965.x; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Monde RA, 2000, BIOCHIMIE, V82, P573, DOI 10.1016/S0300-9084(00)00606-4; Nagahatenna DSK, 2015, PLANT BIOTECHNOL J, V13, P447, DOI 10.1111/pbi.12356; Nagashima A, 2004, PLANT CELL PHYSIOL, V45, P357, DOI 10.1093/pcp/pch050; Narsai R, 2007, PLANT CELL, V19, P3418, DOI 10.1105/tpc.107.055046; Noordally ZB, 2013, SCIENCE, V339, P1316, DOI 10.1126/science.1230397; OELMULLER R, 1986, PLANTA, V167, P106, DOI 10.1007/BF00446376; Pfannschmidt T, 1999, IUBMB LIFE, V48, P271, DOI 10.1080/152165499306955; Quesada V, 2011, PLANT J, V68, P738, DOI 10.1111/j.1365-313X.2011.04726.x; Radhakrishnan A, 2016, J MOL BIOL, V428, P3558, DOI 10.1016/j.jmb.2016.05.025; Raven JA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-209; Robles P, 2015, PHYSIOL PLANTARUM, V154, P297, DOI 10.1111/ppl.12307; Robles P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042924; Saini G, 2011, PLANT J, V65, P690, DOI 10.1111/j.1365-313X.2010.04454.x; Schmitz-Linneweber C, 2015, BBA-BIOENERGETICS, V1847, P798, DOI 10.1016/j.bbabio.2015.01.009; Schweer J, 2010, PLANT J, V62, P192, DOI 10.1111/j.1365-313X.2010.04138.x; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Sun AZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00398; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Sun Y, 2015, BBA-BIOENERGETICS, V1847, P809, DOI 10.1016/j.bbabio.2015.05.008; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Suzuki N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147625; Suzuki N, 2013, PLANT CELL, V25, P3553, DOI 10.1105/tpc.113.114595; Tadini L, 2016, PLANT PHYSIOL, V170, P1817, DOI 10.1104/pp.15.02033; Terry MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00014; Tiller N, 2014, MOL PLANT, V7, P1105, DOI 10.1093/mp/ssu022; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Tsunoyama Y, 2002, FEBS LETT, V516, P225, DOI 10.1016/S0014-5793(02)02538-3; Voigt C, 2010, PHYSIOL PLANTARUM, V138, P503, DOI 10.1111/j.1399-3054.2009.01343.x; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Woodson JD, 2016, NEW PHYTOL, V212, P36, DOI 10.1111/nph.14134; Yamaguchi K, 2000, J BIOL CHEM, V275, P28455, DOI 10.1074/jbc.M004350200; Yamaguchi K, 2000, J BIOL CHEM, V275, P28466, DOI 10.1074/jbc.M005012200; Yamburenko MV, 2015, PLANT J, V82, P1030, DOI 10.1111/tpj.12876; Yamburenko MV, 2013, J EXP BOT, V64, P4491, DOI 10.1093/jxb/ert258; Yu HD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002669; Zhang JX, 2016, J EXP BOT, V67, P2731, DOI 10.1093/jxb/erw106	84	1	1	11	20	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	MAR 21	2017	8								387	10.3389/fpls.2017.00387				10	Plant Sciences	Plant Sciences	EO5XV	WOS:000396767200002	28377785	gold			2018-01-05	
J	Park, JY; Moon, BY; Park, JW; Thornton, JA; Park, YH; Seo, KS				Park, Joo Youn; Moon, Bo Youn; Park, Juw Won; Thornton, Justin A.; Park, Yong Ho; Seo, Keun Seok			Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus	SCIENTIFIC REPORTS			English	Article							SEQUENCE-SPECIFIC ANTIMICROBIALS; VIRULENCE GENES; UNITED-STATES; VANCOMYCIN; RESISTANCE; BACTERIA; ISLAND; RNA; INFECTIONS; NUCLEASES	Discovery of clustered, regularly interspaced, short palindromic repeats and the Cas9 RNA-guided nuclease (CRISPR/Cas9) system provides a new opportunity to create programmable gene-specific antimicrobials that are far less likely to drive resistance than conventional antibiotics. However, the practical therapeutic use of CRISPR/Cas9 is still questionable due to current shortcomings in phage-based delivery systems such as inefficient delivery, narrow host range, and potential transfer of virulence genes by generalized transduction. In this study, we demonstrate genetic engineering strategies to overcome these shortcomings by integrating CRISPR/Cas9 system into a temperate phage genome, removing major virulence genes from the host chromosome, and expanding host specificity of the phage by complementing tail fiber protein. This significantly improved the efficacy and safety of CRISPR/Cas9 antimicrobials to therapeutic levels in both in vitro and in vivo assays. The genetic engineering tools and resources established in this study are expected to provide an efficacious and safe CRISPR/Cas9 antimicrobial, broadly applicable to Staphylococcus aureus.	[Park, Joo Youn; Moon, Bo Youn; Seo, Keun Seok] Mississippi State Univ, Dept Basic Sci, Coll Vet Med, Mississippi State, MS 39762 USA; [Moon, Bo Youn; Park, Yong Ho] Seoul Natl Univ, Dept Microbiol, Coll Vet Med, Seoul 151742, South Korea; [Moon, Bo Youn; Park, Yong Ho] Seoul Natl Univ, Program Vet Sci BK21, Seoul 151742, South Korea; [Park, Juw Won] Univ Louisville, KBRIN, Dept Comp Engn & Comp Sci, Louisville, KY 40208 USA; [Thornton, Justin A.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Seo, KS (reprint author), Mississippi State Univ, Dept Basic Sci, Coll Vet Med, Mississippi State, MS 39762 USA.	seo@cvm.msstate.edu			Center for Biomedical Research Excellence in Pathogen-Host interactions; National Institute of General Medical Sciences, NIH [1P20GM103646-01A1]; Animal and Plant Quarantine Agency, South Korea; NIH [P20GM103436]	We thank to Moyim Kim for making the scientific illustration. This work was partially supported by grants from Center for Biomedical Research Excellence in Pathogen-Host interactions, National Institute of General Medical Sciences, NIH (1P20GM103646-01A1) and Animal and Plant Quarantine Agency, South Korea to K.S.S. and NIH (P20GM103436) to J.W.P.	ABREMSKI K, 1982, J BIOL CHEM, V257, P9658; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bakhshinejad B, 2014, EXPERT OPIN DRUG DEL, V11, P1561, DOI 10.1517/17425247.2014.927437; BALL CA, 1991, J BACTERIOL, V173, P4032, DOI 10.1128/jb.173.13.4032-4038.1991                                                ; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bartual SG, 2010, P NATL ACAD SCI USA, V107, P20287, DOI 10.1073/pnas.1011218107; Beisel CL, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0516-x; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Chen J, 2015, MOL CELL, V57, P138, DOI 10.1016/j.molcel.2014.11.011; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Hafer C, 2012, ANTIMICROB AGENTS CH, V56, P5845, DOI 10.1128/AAC.01139-12; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X                                                   ; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763                                                        ; Koc C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27581; Le S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068562; Levine DP, 2008, SOUTH MED J, V101, P284, DOI 10.1097/SMJ.0b013e3181647037; Li XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26455; Loc-Carrillo C., 2011, Bacteriophage, V1, P111; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Moon BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151409; Moon BY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09784; Penades JR, 2015, CURR OPIN MICROBIOL, V23, P171, DOI 10.1016/j.mib.2014.11.019; Perera MN, 2015, FOOD MICROBIOL, V52, P42, DOI 10.1016/j.fm.2015.06.006; Pirnay JP, 2015, PHARM RES-DORDR, V32, P2173, DOI 10.1007/s11095-014-1617-7; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Seo KS, 2007, INFECT IMMUN, V75, P260, DOI 10.1128/IAI.01358-06; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Suaya JA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-296; Ubeda C, 2005, MOL MICROBIOL, V56, P836, DOI 10.1111/j.1365-2958.2005.04584.x; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Winstel V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3345; Yosef I, 2015, P NATL ACAD SCI USA, V112, P7267, DOI 10.1073/pnas.1500107112	39	1	1	12	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 21	2017	7								44929	10.1038/srep44929				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EO7GR	WOS:000396859700003	28322317	gold			2018-01-05	
J	Vo, BT; Li, CL; Morgan, MA; Theurillat, I; Finkelstein, D; Wright, S; Hyle, J; Smith, SMC; Fan, YP; Wang, YD; Wu, G; Orr, BA; Northcott, PA; Shilatifard, A; Sherr, CJ; Roussel, MF				Vo, BaoHan T.; Li, Chunliang; Morgan, Marc A.; Theurillat, Ilan; Finkelstein, David; Wright, Shaela; Hyle, Judith; Smith, Stephanie M. C.; Fan, Yiping; Wang, Yong-Dong; Wu, Gang; Orr, Brent A.; Northcott, Paul A.; Shilatifard, Ali; Sherr, Charles J.; Roussel, Martine F.			Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma	CELL REPORTS			English	Article							ZINC-FINGER PROTEIN; T-CELL LYMPHOMAGENESIS; TRANSCRIPTIONAL REPRESSOR; BINDING-PROTEINS; STEM-CELLS; CANCER; SUBGROUPS; METHYLATION; GENES; DIFFERENTIATION	The most aggressive of four medulloblastoma (MB) subgroups are cMyc-driven group 3 (G3) tumors, some of which overexpress EZH2, the histone H3K27 mono-, di-, and trimethylase of polycombrepressive complex 2. Ezh2 has a context-dependent role in different cancers as an oncogene or tumor suppressor and retards tumor progression in a mouse model of G3 MB. Engineered deletions of Ezh2 in G3 MBs by gene editing nucleases accelerated tumorigenesis, whereas Ezh2 re-expression reversed attendant histone modifications and slowed tumor progression. Candidate oncogenic drivers suppressed by Ezh2 included Gfi1, a proto-oncogene frequently activated in human G3 MBs. Gfi1 disruption antagonized the tumor-promoting effects of Ezh2 loss; conversely, Gfi1 overexpression collaborated with Myc to bypass effects of Trp53 inactivation in driving MB progression in primary cerebellar neuronal progenitors. Although negative regulation of Gfi1 by Ezh2 may restrain MB development, Gfi1 activation can bypass these effects.	[Vo, BaoHan T.; Li, Chunliang; Theurillat, Ilan; Wright, Shaela; Hyle, Judith; Smith, Stephanie M. C.; Orr, Brent A.; Sherr, Charles J.; Roussel, Martine F.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Finkelstein, David; Fan, Yiping; Wang, Yong-Dong; Wu, Gang] St Jude Childrens Res Hosp, Dept Computat Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Wright, Shaela; Hyle, Judith; Sherr, Charles J.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Orr, Brent A.] St Jude Childrens Res Hosp, Dept Pathol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Northcott, Paul A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, 320 East Super St, Chicago, IL 60611 USA; [Theurillat, Ilan] Inst Pasteur, 25-28 Rue Docteur Roux, F-75724 Paris 15, France	Roussel, MF (reprint author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	martine.roussel@stjude.org			NIH [CA-096832, CA-21765]; Sununu Endowed Fellowship	We thank all members of the Roussel/Sherr laboratory for helpful discussions and comments during the course of these experiments. We are indebted to the Core Flow Cytometry and Cell Sorting Shared Resource facility; the Pathology Core; and Melissa Johnson, Shantel Brown, and Allison Weaver from the Small Animal Imaging Core for cranial implants. We thank Jose Grenet for making high-titer retroviruses, and Dana Farmer and Frederique Zindy for tumor cell purification and fixation of cells for ChIP-seq analysis. This work was funded in part by the NIH grants CA-096832 and CA-21765 to M.F.R., Sununu Endowed Fellowship to B.T.V., and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. C.J.S. is an investigator of the Howard Hughes Medical Institute.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ayrault O, 2010, CANCER RES, V70, P5618, DOI 10.1158/0008-5472.CAN-09-3740; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bodey B, 2000, ANTICANCER RES, V20, P1769; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chowdhury AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053666; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Dubuc Adrian M, 2012, Methods Mol Biol, V863, P139, DOI 10.1007/978-1-61779-612-8_8; Dubuc AM, 2013, ACTA NEUROPATHOL, V125, P373, DOI 10.1007/s00401-012-1070-9; Gilbertson R, 2001, BRIT J CANCER, V85, P705, DOI 10.1054/bjoc.2001.1987; Gilbertson RJ, 2005, ONCOLOGIST, V10, P508, DOI 10.1634/theoncologist.10-7-508                                                  ; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Horman SR, 2009, BLOOD, V113, P5466, DOI 10.1182/blood-2008-09-179747; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Koh CM, 2011, ONCOTARGET, V2, P669; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot2006.98; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Q, 2010, ONCOGENE, V29, P2843, DOI 10.1038/onc.2010.48; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morfouace M, 2014, CANCER CELL, V25, P516, DOI 10.1016/j.ccr.2014.02.009; Neri F, 2012, MOL CELL BIOL, V32, P840, DOI 10.1128/MCB.06148-11; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; O'Meara MM, 2012, CHROMOSOMA, V121, P221, DOI 10.1007/s00412-012-0361-1; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Ramaswamy V, 2015, COLD SPRING HARB PER, V6; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; Vo BT, 2016, CANCER CELL, V29, P5, DOI 10.1016/j.ccell.2015.12.003; Zornig M, 1996, ONCOGENE, V12, P1789; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	52	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	MAR 21	2017	18	12					2907	2917		10.1016/j.celrep.2017.02.073				11	Cell Biology	Cell Biology	EP4DG	WOS:000397330200010	28329683	gold			2018-01-05	
J	Zhu, Y; Tong, HL; Li, SF; Yan, YQ				Zhu, Yue; Tong, Hui-Li; Li, Shu-Feng; Yan, Yun-Qin			Effect of TCEA3 on the differentiation of bovine skeletal muscle satellite cells	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						TCEA3; Transcription elongation factor; Muscle-derived satellite cell; Differentiation	TRANSCRIPTION ELONGATION-FACTOR; EMBRYONIC STEM-CELLS; EXPRESSION; TFIIS; MOUSE; ACTIVATION; GENES	Bovine muscle-derived satellite cells (MDSCs) are important for animal growth. In this study, the effect of transcription elongation factor A3 (TCEA3) on bovine MDSC differentiation was investigated. Western blotting, immunofluorescence assays, and cytoplasmic and nuclear protein isolation and purification techniques were used to determine the expression pattern and protein localization of TCEA3 in bovine MDSCs during in vitro differentiation. TCEA3 expression was upregulated using the CRISPR/Cas9 technique to study its effects on MDSC differentiation in vitro. TCEA3 expression gradually increased during the in vitro differentiation of bovine MDSCs and peaked on the 5th day of differentiation. TCEA3 was mainly localized in the cytoplasm of bovine MDSCs, and its expression was not detected in the nucleus. The level of TCEA3 was relatively higher in myotubes at a higher degree of differentiation than during early differentiation. After transfection with a TCEA3-activating plasmid vector (TCEA3 overexpression) for 24 h, the myotube fusion rate, number of myotubes, and expression levels of the muscle differentiation-related loci myogenin (MYOG) and myosin heavy chain 3 (MYH3) increased significantly during the in vitro differentiation of bovine MDSCs. After transfection with a TCEA3-inhibiting plasmid vector for 24 h, the myotube fusion rate, number of myotubes, and expression levels of MYOG and MYH3 decreased significantly. Our results indicated, for the first time, that TCEA3 promotes the differentiation of bovine MDSCs and have implications for meat production and animal rearing. (C) 2017 Elsevier Inc. All rights reserved.	[Zhu, Yue; Tong, Hui-Li; Li, Shu-Feng; Yan, Yun-Qin] Northeast Agr Univ, Lab Cell & Dev, Mucai St 59, Harbin 150030, Heilongjiang, Peoples R China	Yan, YQ (reprint author), Northeast Agr Univ, Lab Cell & Dev, Mucai St 59, Harbin 150030, Heilongjiang, Peoples R China.	yanyunqin@sohu.com			program for new high-quality varieties of genetically modified bovine from the National Major Transgenic Project [2014ZX08007-002]	This work was supported by the breeding program for new high-quality varieties of genetically modified bovine from the National Major Transgenic Project [grant number 2014ZX08007-002].	Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Cha Y, 2013, GENE EXPRESSION, V16, P25, DOI 10.3727/105221613X13776146743343; Cha Y, 2013, CELL SIGNAL, V25, P1245, DOI 10.1016/j.cellsig.2013.01.016; Ito T, 2007, DRUG DISCOV THER, V1, P9; Jia L., 2014, MED SCI MONITOR, V21, P3241; Labhart P, 1998, GENOMICS, V52, P278, DOI 10.1006/geno.1998.5449; Lee S, 2006, FREE RADICAL BIO MED, V41, P1174, DOI 10.1016/j.freebiomed.2006.07.005; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Park KS, 2013, STEM CELLS, V31, P282, DOI 10.1002/stem.1284; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reines D, 1996, TRENDS BIOCHEM SCI, V21, P351, DOI 10.1016/S0968-0004(96)10045-1; Tong HL, 2015, CELL MOL BIOL LETT, V20, P351, DOI 10.1515/cmble-2015-0019; Weaver ZA, 1997, GENOMICS, V46, P516, DOI 10.1006/geno.1997.5073                                                          ; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4                   ; Xu XQ, 2009, STEM CELLS, V27, P2163, DOI 10.1002/stem.166; YOO OJ, 1991, NUCLEIC ACIDS RES, V19, P1073, DOI 10.1093/nar/19.5.1073	16	0	0	6	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAR 18	2017	484	4					827	832		10.1016/j.bbrc.2017.01.182				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EN2PF	WOS:000395851700017	28161635				2018-01-05	
J	Liu, YL; Yang, Y; Kang, XJ; Lin, B; Yu, Q; Song, B; Gao, G; Chen, YY; Sun, XF; Li, XP; Bu, L; Fan, Y				Liu, Yali; Yang, Yi; Kang, Xiangjin; Lin, Bin; Yu, Qian; Song, Bing; Gao, Ge; Chen, Yaoyong; Sun, Xiaofang; Li, Xiaoping; Bu, Lei; Fan, Yong			One-Step Biallelic and Scarless Correction of a beta-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							GENE CORRECTION; CELLS; TRANSPLANTATION; CRISPR/CAS9; TARGET	Monogenic disorders (MGDs), which are caused by single gene mutations, have a serious effect on human health. Among these, beta-thalassemia (beta-thal) represents one of the most common hereditary hematological diseases caused by mutations in the human hemoglobin beta (HBB) gene. The technologies of induced pluripotent stem cells (iPSCs) and genetic correction provide insights into the treatments for MGDs, including b-thal. However, traditional approaches for correcting mutations have a low efficiency and leave a residual footprint, which leads to some safety concerns in clinical applications. As a proof of concept, we utilized single-strand oligodeoxynucleotides (ssODNs), high-fidelity CRISPR/Cas9 nuclease, and small molecules to achieve a seamless correction of the beta-41/42 (TCTT) deletion mutation in b thalassemia patient-specific iPSCs with remarkable efficiency. Additionally, off-target analysis and whole-exome sequencing results revealed that corrected cells exhibited a minimal mutational load and no off-target mutagenesis. When differentiated into hematopoietic progenitor cells (HPCs) and then further to erythroblasts, the genetically corrected cells expressed normal beta-globin transcripts. Our studies provide the most efficient and safe approach for the genetic correction of the beta-41/42 (TCTT) deletion in iPSCs for further potential cell therapy of beta-thal, which represents a potential therapeutic avenue for the gene correction of MGD-associated mutants in patient-specific iPSCs.	[Liu, Yali; Yang, Yi; Kang, Xiangjin; Yu, Qian; Song, Bing; Chen, Yaoyong; Sun, Xiaofang; Fan, Yong] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstetr Dis Guangdong Prov, Key Lab Reprod & Genet Guangdong Higher Educ Inst, Guangzhou 510150, Guangdong, Peoples R China; [Gao, Ge; Li, Xiaoping] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Gao, Ge; Li, Xiaoping] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Lin, Bin; Bu, Lei] NYU, Sch Med, Leon H Charney Div Cardiol, 522 First Ave, New York, NY 10016 USA	Fan, Y (reprint author), Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstetr Dis Guangdong Prov, Key Lab Reprod & Genet Guangdong Higher Educ Inst, Guangzhou 510150, Guangdong, Peoples R China.; Li, XP (reprint author), Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.; Li, XP (reprint author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.; Bu, L (reprint author), NYU, Sch Med, Leon H Charney Div Cardiol, 522 First Ave, New York, NY 10016 USA.	li_xiaoping@gibh.ac.cn; lei.bu@med.nyu.edu; yongfan011@gzhmu.edu.cn			National Natural Science Foundation of China [81370766, 81401254, 81570101, 81671121, 31601187]; Guangdong Province Higher Education Funding [Yq2013135]; Guangdong Province Science and Technology Project [2014TQ01R683, 2014A02011029, 2016A020216023, 2015A030310119]; Bureau of Science and Technology of Guangzhou Municipality [201505011111498]; State 863 Project [2015AA020307]; NYU	This work was supported in part by the National Natural Science Foundation of China (81370766, 81401254, 81570101, 81671121, and 31601187), Guangdong Province Higher Education Funding (Yq2013135), the Guangdong Province Science and Technology Project (2014TQ01R683, 2014A02011029, 2016A020216023, and 2015A030310119), and the Bureau of Science and Technology of Guangzhou Municipality (201505011111498). Y.F. was supported by State 863 Project 2015AA020307. L.B. was supported by NYU startup funding.	Bernardo ME, 2008, BRIT J HAEMATOL, V143, P548, DOI 10.1111/j.1365-2141.2008.07385.x; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Finotti A, 2015, J BLOOD MED, V6, P69, DOI 10.2147/JBM.S46256; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lucarelli G, 2008, BLOOD REV, V22, P53, DOI 10.1016/j.blre.2007.10.001; Ma N, 2015, J BIOL CHEM, V290, P12079, DOI 10.1074/jbc.M114.624999; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Moore JC, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt23; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Qin YR, 2016, STEM CELLS, V34, P44, DOI 10.1002/stem.2112; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436                                                            ; Song J., 2016, NAT COMMUN, V28, P10548; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang YX, 2012, CELL RES, V22, P637, DOI 10.1038/cr.2012.23; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yang Y, 2016, J MOL CELL BIOL, V8, P174, DOI 10.1093/jmcb/mjw008; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhu ZR, 2015, STEM CELL REP, V4, P1103, DOI 10.1016/j.stemcr.2015.04.016	23	0	0	3	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	MAR 17	2017	6						57	67		10.1016/j.omtn.2016.11.010				11	Medicine, Research & Experimental	Research & Experimental Medicine	EP0QP	WOS:000397092100005	28325300	gold			2018-01-05	
J	Perrin, A; Rousseau, J; Tremblay, JP				Perrin, Arnaud; Rousseau, Joel; Tremblay, Jacques P.			Increased Expression of Laminin Subunit Alpha 1 Chain by dCas9-VP160	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MOUSE MODEL; INTEGRIN; ANGIOGENESIS; CRISPR/CAS9; THERAPIES; LIGANDS; CELLS; MICE	Laminin-111 protein complex links the extracellular matrix to integrin alpha 7 beta 1 in sarcolemma, thus replacing in dystrophic muscles links normally insured by the dystrophin complex. Laminin-111 injection in mdx mouse stabilized sarcolemma, restored serum creatine kinase to wild-type levels, and protected muscles from exercised-induced damages. These results suggested that increased laminin-111 is a potential therapy for DMD. Laminin subunit beta 1 and laminin subunit gamma 1 are expressed in adult human muscle, but laminin subunit alpha 1 (LAMA1) gene is expressed only during embryogenesis. We thus developed an alternative method to laminin-111 protein repeated administration by inducing expression of the endogenous mouse Lama1 gene. This was done with the CRSPR/Cas9 system, i.e., by targeting the Lama1 promoter with one or several gRNAs and a dCas9 coupled with the VP160 transcription activation domain. Lama1 mRNA (qRT-PCR) and proteins (immunohistochemistry and western blot) were not detected in the control C2C12 myoblasts and in control muscles. However, significant expression was observed in cells transfected and in mouse muscles electroporated with plasmids coding for dCas9-VP160 and a gRNA. Larger synergic increases were observed by using two or three gRNAs. The increased Lama1 expression did not modify the expression of the alpha 7 and b1 integrins. Increased expression of Lama1 by the CRISPR/Cas9 system will have to be further investigated by systemic delivery of the CRISPR/Cas9 components to verify whether this could be a treatment for several myopathies.	[Perrin, Arnaud; Rousseau, Joel; Tremblay, Jacques P.] Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Unite Genet Humaine,Axe Neurosci, Quebec City, PQ G1V 4G2, Canada; [Perrin, Arnaud; Rousseau, Joel; Tremblay, Jacques P.] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1V 0A6, Canada	Tremblay, JP (reprint author), Univ Laval, CHU Quebec, Unite Neurosci, 2705 Blvd Laurier,Room P09300, Quebec City, PQ G1V 4G2, Canada.	jacques-p.tremblay@crchul.ulaval.ca			Canadian Institute of Health Research (CIHR) [257171]	This work was supported by grant 257171 from the Canadian Institute of Health Research (CIHR).	Aurino S, 2006, Acta Myol, V25, P5; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O                       ; Cao Jian, 2016, Nucleic Acids Res, V44, pe149; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Cossu G, 2007, TRENDS MOL MED, V13, P520, DOI 10.1016/j.molmed.2007.10.003; de Solis CA, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00070; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Ervasti J M, 1993, Mol Cell Biol Hum Dis Ser, V3, P139; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Feng JF, 2016, GENESIS, V54, P490, DOI 10.1002/dvg.22956; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gawlik KI, 2011, AM J PATHOL, V178, P1728, DOI 10.1016/j.ajpath.2010.12.030; Goudenege S, 2010, MOL THER, V18, P2155, DOI 10.1038/mt.2010.165; Guo C, 2006, HUM MOL GENET, V15, P989, DOI 10.1093/hmg/ddl018; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143                                                         ; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iyombe-Engembe JP, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.58; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Long C., 2016, SCIENCE; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Millward-Sadler SJ, 2004, ANN BIOMED ENG, V32, P435, DOI 10.1023/B:ABME.0000017538.72511.48; Nelson C. E., 2016, SCIENCE; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Piccinni SA, 2004, J BIOL CHEM, V279, P9103, DOI 10.1074/jbc.M305804200; Robinson-Hamm JN, 2016, HUM GENET, V135, P1029, DOI 10.1007/s00439-016-1725-z; Rooney JE, 2012, AM J PATHOL, V180, P1593, DOI 10.1016/j.ajpath.2011.12.019; Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106; Rooney JE, 2009, AM J PATHOL, V174, P256, DOI 10.2353/ajpath.2009.080522; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Slaymaker l. M, 2015, SCIENCE; Sussman Michael, 2002, J Am Acad Orthop Surg, V10, P138; Tabebordbar M., 2016, SCIENCE; Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015; Van Ry PM, 2014, HUM MOL GENET, V23, P383, DOI 10.1093/hmg/ddt428; Wagner KR, 2007, BBA-MOL BASIS DIS, V1772, P229, DOI 10.1016/j.bbadis.2006.06.009; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0                                                                ; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wilton S, 2007, NEUROMUSCULAR DISORD, V17, P719, DOI 10.1016/j.nmd.2007.07.001; Wilton SD, 2008, NEUROL INDIA, V56, P254, DOI 10.4103/0028-3886.43443                                                         ; Wu J., 2016, SCI REP, V6, P18759; Yee KL, 2008, IET SYST BIOL, V2, P8, DOI 10.1049/iet-syb:20060058; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104; Zou K, 2014, STEM CELL TRANSL MED, V3, P1013, DOI 10.5966/sctm.2014-0044	52	0	0	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	MAR 17	2017	6						68	79		10.1016/j.omtn.2016.11.004				12	Medicine, Research & Experimental	Research & Experimental Medicine	EP0QP	WOS:000397092100006	28325301	gold			2018-01-05	
J	Brabetz, O; Alla, V; Angenendt, L; Schliemann, C; Berdel, WE; Arteaga, MF; Mikesch, JH				Brabetz, Oliver; Alla, Vijay; Angenendt, Linus; Schliemann, Christoph; Berdel, Wolfgang E.; Arteaga, Maria-Francisca; Mikesch, Jan-Henrik			RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							CRISPR/CAS9; PROGNOSIS; VECTORS; VIVO; IDH2	Current acute myeloid leukemia (AML) disease models face severe limitations because most of them induce un-physiological gene expressions that do not represent conditions in AML patients and/or depend on external promoters for regulation of gene expression/repression. Furthermore, many AML models are based on reciprocal chromosomal translocations that only reflect the minority of AML patients, whereas more than 50% of patients have a normal karyotype. The majority of AML, however, is driven by somatic mutations. Thus, identification as well as a detailed molecular and functional characterization of the role of these driver mutations via improved AML models is required for better approaches toward novel targeted therapies. Using the IDH2 R140Q mutation as a model, we present a new effective methodology here using the RNAguided clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 system to reproduce or remove AML-associated mutations in or from human leukemic cells, respectively, via introduction of a DNA template at the endogenous gene locus via homologous recombination. Our technology represents a precise way for AML modeling to gain insights into AML development and progression and provides a basis for future therapeutic approaches.	[Brabetz, Oliver; Alla, Vijay; Angenendt, Linus; Schliemann, Christoph; Berdel, Wolfgang E.; Arteaga, Maria-Francisca; Mikesch, Jan-Henrik] Univ Munster, Dept Med A, D-48149 Munster, Germany	Arteaga, MF; Mikesch, JH (reprint author), Univ Munster, Dept Med A, Hematol & Oncol, Albert Schweitzer Campus, D-48149 Munster, Germany.	marifrancis.arteaga@uni-muenster.de; jan-henrik.mikesch@ukmuenster.de	Angenendt, Linus/K-2711-2017	Angenendt, Linus/0000-0003-2502-9910	Deutsche Forschungsgemeinschaft [DFG EXC 1003]	We would like to thank T. Cathomen and T. Cornu for providing us with the pLVdLacZGFPiNwpre IDLV plasmid as well as the pMDL. gpD64A and pMDG helper plasmids. We would like to thank D. Schwammbach for help with the experimental work. W.E.B.'s laboratory was supported by Deutsche Forschungsgemeinschaft (grant DFG EXC 1003).	Arteaga MF, 2013, CANCER CELL, V23, P376, DOI 10.1016/j.ccr.2013.02.014; Cornu TI, 2007, MOL THER, V15, P2107, DOI 10.1038/sj.mt.6300345; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Metzeler KH, 2016, BLOOD, V128, P686, DOI 10.1182/blood-2016-01-693879; Pabst C, 2014, NAT METHODS, V11, P436, DOI 10.1038/nmeth.2847; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023	17	1	1	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	MAR 17	2017	6						243	248		10.1016/j.omtn.2016.12.012				6	Medicine, Research & Experimental	Research & Experimental Medicine	EP0QP	WOS:000397092100021	28325290	gold			2018-01-05	
J	Moch, C; Fromant, M; Blanquet, S; Plateau, P				Moch, Clara; Fromant, Michel; Blanquet, Sylvain; Plateau, Pierre			DNA binding specificities of Escherichia coli Cas1-Cas2 integrase drive its recruitment at the CRISPR locus	NUCLEIC ACIDS RESEARCH			English	Article							CAS ADAPTIVE IMMUNITY; SPACER ACQUISITION; MECHANISTIC BASIS; FOREIGN DNA; INVADER DNA; SYSTEMS; PROKARYOTES; ADAPTATION; REPEATS; ELEMENTS	Prokaryotic adaptive immunity relies on the capture of fragments of invader DNA (protospacers) followed by their recombination at a dedicated acceptor DNA locus. This integrative mechanism, called adaptation, needs both Cas1 and Cas2 proteins. Here, we studied in vitro the binding of an Escherichia coli Cas1-Cas2 complex to various protospacer and acceptor DNA molecules. We show that, to form a long-lived ternary complex containing Cas1-Cas2, the acceptor DNA must carry a CRISPR locus, and the protospacer must not contain 3 '-single-stranded overhangs longer than 5 bases. In addition, the acceptor DNA must be supercoiled. Formation of the ternary complex is synergistic, in such that the binding of Cas1-Cas2 to acceptor DNA is reinforced in the presence of a protospacer. Mutagenesis analysis at the CRISPR locus indicates that the presence in the acceptor plasmid of the palindromic motif found in CRISPR repeats drives stable ternary complex formation. Most of the mutations in this motif are deleterious even if they do not prevent cruciform structure formation. The leader sequence of the CRISPR locus is fully dispensable. These DNA binding specificities of the Cas1-Cas2 integrase are likely to play a major role in the recruitment of this enzyme at the CRISPR locus.	[Moch, Clara; Fromant, Michel; Blanquet, Sylvain; Plateau, Pierre] Univ Paris Saclay, CNRS, Ecole polytech, Lab Biochimie, F-91128 Palaiseau, France	Plateau, P (reprint author), Univ Paris Saclay, CNRS, Ecole polytech, Lab Biochimie, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu			Centre National de la Recherche Scientifique (CNRS); Ecole polytechnique	Centre National de la Recherche Scientifique (CNRS); Ecole polytechnique. Funding for open access charge: CNRS; Ecole polytechnique.	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; BENSON FE, 1994, EMBO J, V13, P5764; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; DARDEL F, 1994, COMPUT APPL BIOSCI, V10, P273; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Gasiunas G, 2014, CELL MOL LIFE SCI, V71, P449, DOI 10.1007/s00018-013-1438-6; Goren MG, 2016, CELL REP, V16, P2811, DOI 10.1016/j.celrep.2016.08.043; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	42	1	1	5	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAR 17	2017	45	5					2714	2723		10.1093/nar/gkw1309				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EP3MO	WOS:000397286600045	28034956	gold			2018-01-05	
J	Wettengel, J; Reautschnig, P; Geisler, S; Kahle, PJ; Stafforst, T				Wettengel, Jacqueline; Reautschnig, Philipp; Geisler, Sven; Kahle, Philipp J.; Stafforst, Thorsten			Harnessing human ADAR2 for RNA repair - Recoding a PINK1 mutation rescues mitophagy	NUCLEIC ACIDS RESEARCH			English	Article							EDITING ENZYME ADAR1; ANTISENSE OLIGONUCLEOTIDES; HUMAN-CELLS; IN-VITRO; DEAMINASES; EXPRESSION; ADENOSINE; GENE; INOSINE; DISEASE	Site-directed A-to-I RNA editing is a technology for e-programming genetic information at the RNA-level. we describe here the first design of genetically encodable guideRNAs that enable the re-addressing of human ADAR2 toward specific sites in user-defined RNA targets. Up to 65% editing yield has been achieved in cell culture for the recoding of a remature Stop codon (UAG) into tryptophan (UIG). In the targeted gene, editing was very specific. We applied the technology to recode a recessive loss-of function mutation in PINK1 (W437X) in HeLa cells and showed functional rescue of PINK1/Parkin-mediated mitophagy, which is linked to the etiology of Parkin-son's disease. In contrast to other editing strategies, his approach requires no artificial protein. Our novel GuideRNAs may allow for the development of a platform technology that requires only the administration for expression of a GguideRNA to recode genetic information, with high potential for application in biology and medicine.	[Wettengel, Jacqueline; Reautschnig, Philipp; Stafforst, Thorsten] Univ Tubingen, Interfac Inst Biochem, Auf Morgenstelle 15, D-72076 Tubingen, Germany; [Geisler, Sven; Kahle, Philipp J.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Otfried Muller Str 27, D-72076 Tubingen, Germany; [Geisler, Sven; Kahle, Philipp J.] German Ctr Neurodegenerat Dis, Otfried Muller Str 23, D-72076 Tubingen, Germany	Stafforst, T (reprint author), Univ Tubingen, Interfac Inst Biochem, Auf Morgenstelle 15, D-72076 Tubingen, Germany.	thorsten.stafforst@uni-tuebingen.de			University of Tubingen, the Hertie Foundation; German Center for Neurodegenerative Disease and the Deutsche Forschungsgemeinschaft [STA 1053/3-2, GE 2844/1-1]; European Research Council (ERC) under the European Union's Horizon [647328]; DFG	University of Tubingen, the Hertie Foundation, the German Center for Neurodegenerative Disease and the Deutsche Forschungsgemeinschaft [STA 1053/3-2 to T.S., GE 2844/1-1 to S.G.); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [grant no. 647328]. Funding for open access charge: DFG.	Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Daigle N, 2007, NAT METHODS, V4, P633, DOI 10.1038/NMETH1065; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Gallo A, 2013, NAT MED, V19, P130, DOI 10.1038/nm.3072; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hanswillemenke A, 2015, J AM CHEM SOC, V137, P15875, DOI 10.1021/jacs.5b10216; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Higuchi M, 2000, NATURE, V406, P78; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Keryer-Bibens C, 2008, BIOL CELL, V100, P125, DOI 10.1042/BC20070067; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Maas Stefan, 2006, RNA Biol, V3, P1; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Montiel-Gonzalez MF, 2013, P NATL ACAD SCI USA, V110, P18285, DOI 10.1073/pnas.1306243110; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Paz-Yaacov N., 2015, NUCLEIC ACIDS RES, V13, P267; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Persson T, 2002, CHEMBIOCHEM, V3, P1066, DOI 10.1002/1439-7633(20021104)3:11<1066::AID-CBIC1066>3.0.CO;2-G                   ; Picardi E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14941; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Reautschnig P, 2017, RNA BIOL, V14, P651, DOI 10.1080/15476286.2016.1208323; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; RUETER SM, 1995, SCIENCE, V267, P1491, DOI 10.1126/science.7878468; Schneider MF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku272; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847; Shimokawa T, 2013, RNA BIOL, V10, P321, DOI 10.4161/rna.23343; Silberberg G, 2012, HUM MOL GENET, V21, P311, DOI 10.1093/hmg/ddr461; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Stafforst T, 2012, ANGEW CHEM INT EDIT, V51, P11166, DOI 10.1002/anie.201206489; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Stern M., 2002, GENE THERAPY LUNG DI, V169, P383; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Vogel P, 2014, CHEMMEDCHEM, V9, P2021, DOI 10.1002/cmdc.201402139; Vogel P, 2014, ANGEW CHEM INT EDIT, V53, P6267, DOI 10.1002/anie.201402634; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; World Health Organization, 2006, NEUR DIS PUBL HLTH C; WOOLF TM, 1995, P NATL ACAD SCI USA, V92, P8298, DOI 10.1073/pnas.92.18.8298; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhang XJ, 2004, HUM MUTAT, V23, P629, DOI 10.1002/humu.9246	57	6	6	4	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAR 17	2017	45	5					2797	2808		10.1093/nar/gkw911				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EP3MO	WOS:000397286600052	27907896	gold			2018-01-05	
J	Wang, YB; Wang, YJ; Chang, T; Huang, H; Yee, JK				Wang, Yebo; Wang, Yingjia; Chang, Tammy; Huang, He; Yee, Jiing-Kuan			Integration-defective lentiviral vector mediates efficient gene editing through homology-directed repair in human embryonic stem cells	NUCLEIC ACIDS RESEARCH			English	Article							ZINC-FINGER NUCLEASES; STRAND BREAK REPAIR; DNA-END RESECTION; RECOMBINATION; MUTATIONS; LEDGF/P75; DESIGN; REPLICATION; CRISPR-CAS9; MECHANISM	Human embryonic stem cells (hESCs) are used as platforms for disease study, drug screening and cellbased therapy. To facilitate these applications, it is frequently necessary to genetically manipulate the hESC genome. Gene editing with engineered nucleases enables site- specific geneticmodification of the human genome through homology- directed repair (HDR). However, the frequency of HDR remains low in hESCs. We combined efficient expression of engineered nucleases and integration- defective lentiviral vector (IDLV) transduction for donor template delivery to mediate HDR in hESC line WA09. This strategy led to highly efficient HDR with more than 80% of the selected WA09 clones harboring the transgene inserted at the targeted genomic locus. However, certain portions of the HDR clones contained the concatemeric IDLV genomic structure at the target site, probably resulted from recombination of the IDLV genomic input before HDR with the target. We found that the integrase protein of IDLV mediated the highly efficient HDR through the recruitment of a cellular protein, LEDGF/p75. This study demonstrates that IDLV- mediated HDR is a powerful and broadly applicable technology to carry out site- specific gene modification in hESCs.	[Wang, Yebo; Huang, He] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yebo; Chang, Tammy; Yee, Jiing-Kuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA; [Wang, Yingjia] Hangzhou Normal Univ, Sch Med, Dept Pathol, Hangzhou 310036, Zhejiang, Peoples R China	Huang, H (reprint author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China.; Yee, JK (reprint author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA.	huanghe@zju.edu.cn; jyee@coh.org			National Key Basic Research Program of China [2015CB964900]; Projects of International Cooperation and Exchanges [81520108002]; Zhejiang Provincial Natural Science Foundation of China [LQ14H080001]; Major Program of National Natural Science Foundation of China [81230014]; National Cancer Institute of the National Institutes of Health [P30CA033572]	National Key Basic Research Program of China [2015CB964900, in part]; Projects of International Cooperation and Exchanges [81520108002]; Zhejiang Provincial Natural Science Foundation of China [LQ14H080001]; Major Program of National Natural Science Foundation of China [81230014]; National Cancer Institute of the National Institutes of Health [P30CA033572]. Funding for open access charge: National Key Basic Research Program of China [2015CB964900].	Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X                                                   ; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Coluccio A, 2013, MOL THER, V21, P1695, DOI 10.1038/mt.2013.143; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2007, MOL THER, V15, P2107, DOI 10.1038/sj.mt.6300345; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Forster R, 2014, STEM CELL REP, V2, P838, DOI 10.1016/j.stemcr.2014.05.001; Gupta K, 2010, J BIOL CHEM, V285, P20303, DOI 10.1074/jbc.M110.114413; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Joglekar AV, 2014, HUM GENE THER, V25, P599, DOI 10.1089/hum.2013.211; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mochizuki H, 1998, J VIROL, V72, P8873; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Rahman SH, 2013, HUM GENE THER, V24, P67, DOI 10.1089/hum.2012.168; Saeed MQ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.65; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093575; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	49	2	2	1	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAR 17	2017	45	5							e29	10.1093/nar/gkw1057				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EP3MO	WOS:000397286600004	27899664	gold			2018-01-05	
J	Xu, L; Zhao, LX; Gao, YD; Xu, J; Han, RZ				Xu, Li; Zhao, Lixia; Gao, Yandi; Xu, Jing; Han, Renzhi			Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA	NUCLEIC ACIDS RESEARCH			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SEQUENCE-SPECIFIC CONTROL; POLYMERASE-III; IN-VIVO; GENOMIC LOCI; MOUSE MODEL; CAS SYSTEM; GUIDE RNA; EXPRESSION; TRANSCRIPTION	Clustered regularly interspaced short palindromic repeat/Cas9 (CRISPR/Cas9) system has emerged in recent years as a highly efficient RNA-guided gene manipulation platform. Simultaneous editing or transcriptional activation/suppression of different genes becomes feasible with the co-delivery of multiple guide RNAs (gRNAs). Here, we report that multiple gRNAs linked with self-cleaving ribozymes and/or tRNA could be simultaneously expressed from a single U6 promoter to exert genome editing of dystrophin and myosin binding protein C3 in human and mouse cells. Moreover, this strategy allows the expression of multiple gRNAs for synergistic transcription activation of follistatin when used with catalytically inactive dCas9-VP64 or dCas9-p300core fusions. Finally, the gRNAs linked by the self-cleaving ribozymes and tRNA could be expressed from RNA polymerase type II (pol II) promoters such as generic CMV and muscle/heart-specific MHCK7. This is particularly useful for in vivo applications when the packaging capacity of recombinant adenoassociated virus is limited while tissue-specific delivery of gRNAs and Cas9 is desired. Taken together, this study provides a novel strategy to enable tissuespecific expression of more than one gRNAs for multiplex gene editing from a single pol II promoter.	[Xu, Li; Zhao, Lixia; Gao, Yandi; Xu, Jing; Han, Renzhi] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr,Biophys Grad Program,Biomed Sci Gr, Columbus, OH 43210 USA	Han, RZ (reprint author), Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr,Biophys Grad Program,Biomed Sci Gr, Columbus, OH 43210 USA.	renzhi.han@osumc.edu			U. S. National Institutes of Health [HL116546, AR064241]	U. S. National Institutes of Health [HL116546 and AR064241 to R. H.]. Funding for open access charge: Departmental Fund.	Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Carrier L, 1997, CIRC RES, V80, P427; Carter CW, 2015, P NATL ACAD SCI USA, V112, P7489, DOI 10.1073/pnas.1507569112; Chen BH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1533; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2                                                   ; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iyombe-Engembe JP, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.58; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098                                                          ; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Medina MFC, 1999, CURR OPIN MOL THER, V1, P580; Mefferd AL, 2015, RNA, V21, P1683, DOI 10.1261/rna.051631.115; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283                                                           ; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Port F., 2016, BIOARXIV, DOI [10.1101/046417, DOI 10.1101/046417]; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qi WW, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0289-2; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Scott WG, 1996, SCIENCE, V274, P2065, DOI 10.1126/science.274.5295.2065; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sweeney JA, 2002, VIROLOGY, V295, P284, DOI 10.1006/viro.2002.1406; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu J, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0069-z; Xu L., 2013, MOL THERAPY NUCL ACI, V2, P112; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang W, 2015, MATH PROBL ENG, V2015, P9, DOI DOI 10.1128/MBI0.00861-15; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	59	4	4	15	25	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	MAR 17	2017	45	5							e28	10.1093/nar/gkw1048				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EP3MO	WOS:000397286600003	27799472	gold			2018-01-05	
J	Jarrett, KE; Lee, CM; Yeh, YH; Hsu, RH; Gupta, R; Zhang, M; Rodriguez, PJ; Lee, CS; Gillard, BK; Bissig, KD; Pownall, HJ; Martin, JF; Bao, G; Lagor, WR				Jarrett, Kelsey E.; Lee, Ciaran M.; Yeh, Yi-Hsien; Hsu, Rachel H.; Gupta, Rajat; Zhang, Min; Rodriguez, Perla J.; Lee, Chang Seok; Gillard, Baiba K.; Bissig, Karl-Dimiter; Pownall, Henry J.; Martin, James F.; Bao, Gang; Lagor, William R.			Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease	SCIENTIFIC REPORTS			English	Article							HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; PLASMA-CHOLESTEROL LEVELS; HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-B GENE; IN-VIVO; HEPATIC GENOTOXICITY; CRISPR-CAS9 SYSTEM; KNOCKOUT MICE; MOUSE MODELS; DELIVERY	Germline manipulation using CRISPR/Cas9 genome editing has dramatically accelerated the generation of new mouse models. Nonetheless, many metabolic disease models still depend upon laborious germline targeting, and are further complicated by the need to avoid developmental phenotypes. We sought to address these experimental limitations by generating somatic mutations in the adult liver using CRISPR/Cas9, as a new strategy to model metabolic disorders. As proof-of-principle, we targeted the low-density lipoprotein receptor (Ldlr), which when deleted, leads to severe hypercholesterolemia and atherosclerosis. Here we show that hepatic disruption of Ldlr with AAV-CRISPR results in severe hypercholesterolemia and atherosclerosis. We further demonstrate that co-disruption of Apob, whose germline loss is embryonically lethal, completely prevented disease through compensatory inhibition of hepatic LDL production. This new concept of metabolic disease modeling by somatic genome editing could be applied to many other systemic as well as liver-restricted disorders which are difficult to study by germline manipulation.	[Jarrett, Kelsey E.; Yeh, Yi-Hsien; Hsu, Rachel H.; Gupta, Rajat; Zhang, Min; Lee, Chang Seok; Martin, James F.; Lagor, William R.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Jarrett, Kelsey E.; Rodriguez, Perla J.; Lagor, William R.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Lee, Ciaran M.; Bao, Gang] Rice Univ, Dept Bioengn, Houston, TX 77030 USA; [Rodriguez, Perla J.; Gillard, Baiba K.; Pownall, Henry J.] Houston Methodist Res Inst, Houston, TX 77030 USA; [Gillard, Baiba K.; Pownall, Henry J.] Weill Cornell Med, Houston, TX 77030 USA; [Bissig, Karl-Dimiter] Baylor Coll Med, Ctr Cell & Gene Therapy, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Martin, James F.] Texas Heart Inst, Houston, TX 77030 USA	Lagor, WR (reprint author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.; Lagor, WR (reprint author), Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA.	lagor@bcm.edu		Lee, Ciaran/0000-0002-0789-9149; Gillard, Baiba/0000-0002-2527-5102	NIH through the Texas Digestive Diseases morphology core [NIH P30DK56338, T32 GM08231, T32 HL0767, AR053349, HL134510, HL056865, HL129767, DE023177, HL127717, HL130804, HL118761, PN2EY018244, HL132840]; Vivian L. Smith Foundation; Foundation LeDucq [14CVD01]; Cancer Prevention and Research Institute of Texas [RR140081]; American Heart Association [16BGIA26420102]; Baylor College of Medicine; Rice University Hamill Innovation Award	We thank Jason Burton for the original artwork used in Figure 1 and Fabio Stossi and the Baylor College of Medicine Integrative Microscopy Core for assistance with the images in Figure 4. This research was supported by the NIH through the Texas Digestive Diseases morphology core (NIH P30DK56338), T32 GM08231 (K.E.J. and P.J.R.), T32 HL07676 (K.E.J.), AR053349 (C.S.L., PI: Susan L. Hamilton), HL134510 (K.D.B.), HL056865 (H.J.P.), HL129767 (H.J.P.), DE023177 (J.F.M.), HL127717(J.F.M.), HL130804 (J.F.M.), HL118761 (J.F.M.), PN2EY018244 (G.B.), and HL132840 (W.R.L.). Support was also provided by the Vivian L. Smith Foundation (J.F.M.), Foundation LeDucq 14CVD01(J.F.M.), Cancer Prevention and Research Institute of Texas RR140081 (G.B.), American Heart Association 16BGIA26420102 (W.R.L.), Baylor College of Medicine start up funds (W.R.L.), and the Rice University Hamill Innovation Award (G.B. and W.R.L.). The funding sources had no role in study design, collection, analysis, or publication of the data.	Adams D, 2013, DIS MODEL MECH, V6, P571, DOI 10.1242/dmm.011833; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Bissig-Choisat B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8339; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown RJ, 2004, J BIOL CHEM, V279, P42403, DOI 10.1074/jbc.M407748200; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Chen XY, 2016, NUCLEIC ACIDS RES, V44, P6482, DOI 10.1093/nar/gkw524; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conlon D. M., 2016, J CLIN INVEST; Conlon DM, 2016, J CLIN INVEST, V126, P3852, DOI 10.1172/JCI86028; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Cuchel M, 2014, ATHEROSCLEROSIS SUPP, V15, P33, DOI 10.1016/j.atherosclerosissup.2014.07.005; Deignan JL, 2008, MOL GENET METAB, V93, P7, DOI 10.1016/j.ymgme.2007.08.123; Donsante A, 2001, GENE THER, V8, P1343, DOI 10.1038/sj.gt.3301541; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; FARESE RV, 1995, P NATL ACAD SCI USA, V92, P1774, DOI 10.1073/pnas.92.5.1774; Gil-Farina I, 2016, MOL THER, V24, P1100, DOI 10.1038/mt.2016.52; Gillard BK, 2007, BIOCHEMISTRY-US, V46, P12968, DOI 10.1021/bi701525w; Gouni-Berthold I, 2015, ATHEROSCLEROSIS SUPP, V18, P28, DOI 10.1016/j.atherosclerosissup.2015.02.005; Grimm D, 2006, GENE THER, V13, P563, DOI 10.1038/sj.gt.3302727; Guex JJ, 2010, PHLEBOLOGY, V25, P267, DOI 10.1258/phleb.2010.010e05; Hager EJ, 2007, J INHERIT METAB DIS, V30, P888, DOI 10.1007/s10545-007-0776-7; Hamano M, 2014, J GASTROENTEROL, V49, P305, DOI 10.1007/s00535-013-0780-7; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Inagaki K, 2007, J VIROL, V81, P11304, DOI 10.1128/JVI.01225-07; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kassim SH, 2013, HUM GENE THER, V24, P19, DOI 10.1089/hum.2012.108; Lagor WR, 2014, ATHEROSCLEROSIS, V233, P234, DOI 10.1016/j.atherosclerosis.2013.12.043; Lagor WR, 2013, METHODS MOL BIOL, V1027, P273, DOI 10.1007/978-1-60327-369-5_13; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lee RG, 2013, J CARDIOVASC TRANSL, V6, P969, DOI 10.1007/s12265-013-9495-7; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maczuga P, 2014, GENE THER, V21, P60, DOI 10.1038/gt.2013.58; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miao B, 2004, J LIPID RES, V45, P1410, DOI [10.1194/jlr.M300450-JLR200, 10.1194/jlr.M300450]; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V315, P199, DOI 10.1006/abbi.1994.1490; Pankowicz FP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12642; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; Veedu RN, 2010, CHEM BIODIVERS, V7, P536, DOI 10.1002/cbdv.200900343; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Xiao X, 1998, J VIROL, V72, P2224; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598                                                          ; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; YOUNG SG, 1988, SCIENCE, V241, P591, DOI 10.1126/science.3399894; Young SM, 2001, P NATL ACAD SCI USA, V98, P13525, DOI 10.1073/pnas.241508998	58	6	6	5	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 16	2017	7								44624	10.1038/srep44624				12	Multidisciplinary Sciences	Science & Technology - Other Topics	EO2RS	WOS:000396544200001	28300165	gold			2018-01-05	
J	Das, K; Eisel, D; Lenkl, C; Goyal, A; Diederichs, S; Dickes, E; Osen, W; Eichmueller, SB				Das, Krishna; Eisel, David; Lenkl, Clarissa; Goyal, Ashish; Diederichs, Sven; Dickes, Elke; Osen, Wolfram; Eichmueller, Stefan B.			Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CLASS-I; TRANSGENIC MICE; T-CELLS; ANTIGEN; IDENTIFICATION; SPECIFICITY; NUCLEASES; MELANOMA; CANCER	In this study, the CRISPR/Cas9 technology was used to establish murine tumor cell lines, devoid of MHC I or MHC II surface expression, respectively. The melanoma cell line B16F10 and the murine breast cancer cell line EO-771, the latter stably expressing the tumor antigen NY-BR-1 (EO-NY), were transfected with an expression plasmid encoding a beta(2)m-specific single guide (sg) RNA and Cas9. The resulting MHC I negative cells were sorted by flow cytometry to obtain single cell clones, and loss of susceptibility of peptide pulsed MHC I negative clones to peptide-specific CTL recognition was determined by IFN gamma ELISpot assay. The beta(2)m knockout (KO) clones did not give rise to tumors in syngeneic mice (C57BL/6N), unless NK cells were depleted, suggesting that outgrowth of the beta(2)m KO cell lines was controlled by NK cells. Using sgRNAs targeting the beta-chain encoding locus of the IA(b) molecule we also generated several B16F10 MHC II KO clones. Peptide loaded B16F10 MHC II KO cells were insusceptible to recognition by OT-II cells and tumor growth was unaltered compared to parental B16F10 cells. Thus, in our hands the CRISPR/Cas9 system has proven to be an efficient straight forward strategy for the generation of MHC knockout cell lines. Such cell lines could serve as parental cells for co-transfection of compatible HLA alleles together with human tumor antigens of interest, thereby facilitating the generation of HLA matched transplantable tumor models, e.g. in HLAtg mouse strains of the newer generation, lacking cell surface expression of endogenous H2 molecules. In addition, our tumor cell lines established might offer a useful tool to investigate tumor reactive T cell responses that function independently from MHC molecule surface expression by the tumor.	[Das, Krishna; Eisel, David; Lenkl, Clarissa; Dickes, Elke; Osen, Wolfram; Eichmueller, Stefan B.] German Canc Res Ctr, GMP & T Cell Therapy Unit, Heidelberg, Germany; [Goyal, Ashish; Diederichs, Sven] German Canc Res Ctr, Div RNA Biol & Canc, Heidelberg, Germany; [Diederichs, Sven] Univ Freiburg, Fac Med, Dept Thorac Surg, Med Ctr,Div Canc Res, Freiburg, Germany; [Diederichs, Sven] German Canc Consortium DKTK, Freiburg, Germany	Eichmueller, SB (reprint author), German Canc Res Ctr, GMP & T Cell Therapy Unit, Heidelberg, Germany.	s.eichmueller@dkfz.de	Diederichs, Sven/J-6237-2012; Eichmuller, Stefan/A-5053-2008	Diederichs, Sven/0000-0001-7901-4752; Eichmuller, Stefan/0000-0002-3497-6904			Abrahimi P, 2015, CIRC RES, V117, P121, DOI 10.1161/CIRCRESAHA.117.306290; ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; Bernal M, 2012, IMMUNOTHERAPY, V61, P1359; BIX M, 1992, J EXP MED, V176, P829, DOI 10.1084/jem.176.3.829                                                           ; Bohm W, 1998, J IMMUNOL, V161, P897; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005                                                             ; Clay TM, 2001, CLIN CANCER RES, V7, P1127; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; EVAN GI, 1983, EUR J IMMUNOL, V13, P160, DOI 10.1002/eji.1830130213                                                          ; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gardyan A, 2015, INT J CANCER, V136, P2588, DOI 10.1002/ijc.29322; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; Horii T, 2013, PEERJ, V1, DOI 10.7717/peerj.230; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jager D, 2007, APPL IMMUNOHISTO M M, V15, P77; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lei J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138458; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x                                              ; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025                                                             ; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Osen W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014137; Pajot A, 2004, INT IMMUNOL, V16, P1275, DOI 10.1093/intimm/dxh129; Parkhurst MR, 1998, CANCER RES, V58, P4895; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Pol J, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.974411; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sawada Y, 2014, ONCOL REP, V31, P1051, DOI 10.3892/or.2013.2941; SEGE K, 1981, BIOCHEMISTRY-US, V20, P4523, DOI 10.1021/bi00519a003; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Speidel K, 1997, EUR J IMMUNOL, V27, P2391, DOI 10.1002/eji.1830270938; TADA N, 1980, IMMUNOGENETICS, V11, P441, DOI 10.1007/BF01567813; Tveita A, 2016, ONCOTARGET; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921	43	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174077	10.1371/journal.pone.0174077				19	Multidisciplinary Sciences	Science & Technology - Other Topics	EN9KE	WOS:000396318300123	28301575	gold			2018-01-05	
J	Yamada, M; Watanabe, Y; Gootenberg, JS; Hirano, H; Ran, FA; Nakane, T; Ishitani, R; Zhang, F; Nishimasu, H; Nureki, O				Yamada, Mari; Watanabe, Yuto; Gootenberg, Jonathan S.; Hirano, Hisato; Ran, F. Ann; Nakane, Takanori; Ishitani, Ryuichiro; Zhang, Feng; Nishimasu, Hiroshi; Nureki, Osamu			Crystal Structure of the Minimal Cas9 from Campylobacter jejuni Reveals the Molecular Diversity in the CRISPR-Cas9 Systems	MOLECULAR CELL			English	Article							STAPHYLOCOCCUS-AUREUS CAS9; TARGET DNA RECOGNITION; DUAL-RNA; CLEAVAGE; IMMUNITY; COMPLEX; ENDONUCLEASE	The RNA-guided endonuclease Cas9 generates a double-strand break at DNA target sites complementary to the guide RNA and has been harnessed for the development of a variety of new technologies, such as genome editing. Here, we report the crystal structures of Campylobacter jejuni Cas9 (CjCas9), one of the smallest Cas9 orthologs, in complex with an sgRNA and its target DNA. The structures provided insights into a minimal Cas9 scaffold and revealed the remarkable mechanistic diversity of the CRISPR-Cas9 systems. The CjCas9 guide RNA contains a triple-helix structure, which is distinct from known RNA triple helices, thereby expanding the natural repertoire of RNA triple helices. Furthermore, unlike the other Cas9 orthologs, CjCas9 contacts the nucleotide sequences in both the target and non-target DNA strands and recognizes the 5'-NNNVRYM-3' as the protospacer-adjacent motif. Collectively, these findings improve our mechanistic understanding of the CRISPR-Cas9 systems and may facilitate Cas9 engineering.	[Yamada, Mari; Watanabe, Yuto; Hirano, Hisato; Nakane, Takanori; Ishitani, Ryuichiro; Nishimasu, Hiroshi; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Gootenberg, Jonathan S.; Ran, F. Ann; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gootenberg, Jonathan S.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Zhang, Feng] MIT, Dept Biol Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Ran, F. Ann] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA; [Nishimasu, Hiroshi] JST, PRESTO, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan	Nishimasu, H; Nureki, O (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.; Nishimasu, H (reprint author), JST, PRESTO, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	nisimasu@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp		Gootenberg, Jonathan/0000-0003-2757-2175	U.S. Department of Energy Computational Science Graduate Fellowship [DE-FG02-97ER25308]; NIH through the National Institute of Mental Health (NIMH) [5DP1-MH100706, 1R01-MH110049]; NSF; New York Stem Cell; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; JST, PRESTO; JSPS KAKENHI [26291010, 15H01463]; Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development, AMED; Council for Science, Technology and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP); "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (Bio-Oriented Technology Research Advancement Institution, NARO); Platform for Drug Discovery, Informatics, and Structural Life Science from Ministry of Education, Culture, Sports, Science and Technology	We thank the beamline scientists at PXI at the Swiss Light Source and BL32XU and BL41XU at SPring-8 for assistance with data collection. J.S.G. is supported by a U.S. Department of Energy Computational Science Graduate Fellowship (DE-FG02-97ER25308). F.A.R. is a junior fellow at the Harvard Society of Fellows. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by the NIH through the National Institute of Mental Health (NIMH) (5DP1-MH100706 and 1R01-MH110049), NSF, the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and James and Patricia Poitras, Robert Metcalfe, and David Cheng. H.N. is supported by JST, PRESTO, JSPS KAKENHI grant numbers (26291010 and 15H01463). O.N. is supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development, AMED, and the Council for Science, Technology and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (funding agency: Bio-Oriented Technology Research Advancement Institution, NARO), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Brown JA, 2014, NAT STRUCT MOL BIOL, V21, P633, DOI 10.1038/nsmb.2844; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481                                                              ; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nishimasu H., 2016, CURR OPIN STRUC BIOL, V43, P68; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Waterman D. G., 2013, CCP4 NEWSL PROTEIN C, V49, P16; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020	43	7	7	5	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	MAR 16	2017	65	6					1109	+		10.1016/j.molcel.2017.02.007				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EO1BF	WOS:000396431900016	28306506				2018-01-05	
J	Yoshida, K; Hozumi, A; Treen, N; Sakuma, T; Yamamoto, T; Shirae-Kurabayashi, M; Sasakura, Y				Yoshida, Keita; Hozumi, Akiko; Treen, Nicholas; Sakuma, Tetsushi; Yamamoto, Takashi; Shirae-Kurabayashi, Maki; Sasakura, Yasunori			Germ cell regeneration-mediated, enhanced mutagenesis in the ascidian Ciona intestinalis reveals flexible germ cell formation from different somatic cells	DEVELOPMENTAL BIOLOGY			English	Article						Ciona; Ascidian; Primordial germ cell; Regeneration; TALEN; Mutagenesis	TARGET-SELECTED MUTAGENESIS; ZINC-FINGER NUCLEASES; BOTRYLLUS-PRIMIGENUS; BASAL CHORDATE; GENE-FUNCTION; STEM-CELLS; EXPRESSION; EMBRYOS; GENOME; SPECIFICATION	The ascidian Ciona intestinalis has a high regeneration capacity that enables the regeneration of artificially removed primordial germ cells (PGCs) from somatic cells. We utilized PGC regeneration to establish efficient methods of germ line mutagenesis with transcription activator-like effector nucleases (TALENs). When PGCs were artificially removed from animals in which a TALEN pair was expressed, somatic cells harboring mutations in the target gene were converted into germ cells, this germ cell population exhibited higher mutation rates than animals not subjected to PGC removal. PGC regeneration enables us to use TALEN expression vectors of specific somatic tissues for germ cell mutagenesis. Unexpectedly, cis elements for epidermis, neural tissue and muscle could be used for germ cell mutagenesis, indicating there are multiple sources of regenerated PGCs, suggesting a flexibility of differentiated Ciona somatic cells to regain totipotency. Sperm and eggs of a single hermaphroditic, PGC regenerated animal typically have different mutations, suggesting they arise from different cells. PGCs can be generated from somatic cells even though the maternal PGCs are not removed, suggesting that the PGC regeneration is not solely an artificial event but could have an endogenous function in Ciona. This study provides a technical innovation in the genome-editing methods, including easy establishment of mutant lines. Moreover, this study suggests cellular mechanisms and the potential evolutionary significance of PGC regeneration in Ciona.	[Yoshida, Keita; Hozumi, Akiko; Treen, Nicholas; Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda, Shizuoka 4150025, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan; [Shirae-Kurabayashi, Maki] Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Nagoya, Aichi 4648601, Japan; [Treen, Nicholas] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Sasakura, Y (reprint author), Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda, Shizuoka 4150025, Japan.	asakura@shimoda.tsukuba.ac.jp	Sakuma, Tetsushi/A-7615-2013; Yamamoto, Takashi/U-4790-2017	Yamamoto, Takashi/0000-0002-6516-2903	MEXT [23681039, 15K14520, 16H04815]; National BioResource Project (NBRP); JSPS	We thank Drs. Shigeki Fujiwara, Kunifumi Tagawa, Nobuo Yamaguchi and all members of the Department of Zoology, Kyoto University, the Misaki Marine Biological Station, the University of Tokyo, and the Maizuru Fishery Research Station of Kyoto University for the cultivation and provision of Ciona adults. This study was supported by Grants-in-Aid for the Scientific Research from JSPS and MEXT to YS (23681039, 15K14520, 16H04815). This study was further supported by grants from the National BioResource Project (NBRP).	Akanuma T, 2002, DEV GENES EVOL, V212, P459, DOI 10.1007/s00427-002-0264-x; Auger H, 2010, DEV BIOL, V339, P374, DOI 10.1016/j.ydbio.2009.12.040; Blitz IL, 2016, DEVELOPMENT, V143, P2868, DOI 10.1242/dev.138057; Brown FD, 2007, EVOL DEV, V9, P165, DOI 10.1111/j.1525-142X.2007.00147.x                                                ; Brown FD, 2009, DEVELOPMENT, V136, P3485, DOI 10.1242/dev.037754; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Corbo JC, 1997, DEVELOPMENT, V124, P589; Cuppen E, 2007, GENOME RES, V17, P649, DOI 10.1101/gr.6080607; Dahlberg C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004458; Davidson B, 2003, P NATL ACAD SCI USA, V100, P11469, DOI 10.1073/pnas.1634991100; Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353; Etani K, 2002, DEV GENES EVOL, V212, P447, DOI 10.1007/s00427-002-0260-1; Fujimura M, 2000, DEV GENES EVOL, V210, P64, DOI 10.1007/s004270050012; HIKOSAKA A, 1992, DEV GROWTH DIFFER, V34, P627; Hozumi A, 2010, DEV DYNAM, V239, P1076, DOI 10.1002/dvdy.22254; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Iitsuka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05050; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; Ikuta T, 2010, DEVELOPMENT, V137, P1505, DOI 10.1242/dev.046938; Jeffery WR, 2015, GENESIS, V53, P48, DOI 10.1002/dvg.22799; Joly JS, 2007, DEV DYNAM, V236, P1832, DOI 10.1002/dvdy.21124; Kassmer SH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9565; Kawai N, 2015, DEV BIOL, V403, P43, DOI 10.1016/j.ydbio.2015.03.018; Kawai N, 2012, DEV GROWTH DIFFER, V54, P535, DOI 10.1111/j.1440-169X.2012.01355.x; Kitaura Y., 2007, MEM KONAN U SCI ENG, V54, P75; Kurn U, 2011, BIOL BULL-US, V221, P43, DOI 10.1086/BBLv221n1p43                                                            ; Lemaire P, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150053; Lemaire P, 2009, DEV BIOL, V332, P48, DOI 10.1016/j.ydbio.2009.05.540; Matsuoka T, 2005, GENESIS, V41, P67, DOI 10.1002/gene.20096; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Nakayama S, 2016, CELL TISSUE RES, V365, P65, DOI 10.1007/s00441-016-2360-7; Nakazawa K, 2013, DEV DYNAM, V242, P1172, DOI 10.1002/dvdy.24009; OKA H, 1957, BIOL BULL, V112, P225, DOI 10.2307/1539200; Okada T, 1999, DEV GROWTH DIFFER, V41, P759; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Prodon F, 2007, DEV DYNAM, V236, P1698, DOI 10.1002/dvdy.21109; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Rinkevich Y, 2013, DEV CELL, V24, P76, DOI 10.1016/j.devcel.2012.11.010; Ristoratore F, 1999, DEVELOPMENT, V126, P5149; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Sasaki H, 2014, DEV GROWTH DIFFER, V56, P499, DOI 10.1111/dgd.12149; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Sasakura Y, 2007, DEV DYNAM, V236, P1758, DOI 10.1002/dvdy.21111; Sasakura Y, 2010, MOL GENET GENOMICS, V283, P99, DOI 10.1007/s00438-009-0500-4; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Sehring IM, 2016, CURR OPIN GENET DEV, V40, P48, DOI 10.1016/j.gde.2016.05.011; Shirae-Kurabayashi M, 2006, DEVELOPMENT, V133, P2683, DOI 10.1242/dev.02446; Stolfi A, 2015, GENESIS, V53, P1, DOI 10.1002/dvg.22822; Stolfi A, 2014, DEVELOPMENT, V141, P4115, DOI 10.1242/dev.114488; Sunanaga T, 2006, DEV GROWTH DIFFER, V48, P87, DOI 10.1111/j.1440-169x.2006.00849.x; Sunanaga T, 2010, DEV GROWTH DIFFER, V52, P603, DOI 10.1111/j.1440-169X.2010.01196.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takamura K, 2002, DEV GENES EVOL, V212, P11, DOI 10.1007/s00427-001-0204-1; Treen N, 2014, DEVELOPMENT, V141, P481, DOI 10.1242/dev.099572; Voskoboynik A, 2008, CELL STEM CELL, V3, P456, DOI 10.1016/j.stem.2008.07.023; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Yoshida K, 2014, GENESIS, V52, P431, DOI 10.1002/dvg.22770; Yoshida R, 2012, ZOOL SCI, V29, P11, DOI 10.2108/zsj.29.11; Zeng LY, 2006, INTEGR COMP BIOL, V46, P255, DOI 10.1093/icb/icj035	62	0	0	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	MAR 15	2017	423	2					111	125		10.1016/j.ydbio.2017.01.022				15	Developmental Biology	Developmental Biology	EO8VA	WOS:000396967400003	28161521				2018-01-05	
J	Flanagan, AM; Stavenschi, E; Basavaraju, S; Gaboriau, D; Hoey, DA; Morrison, CG				Flanagan, Anne-Marie; Stavenschi, Elena; Basavaraju, Shivakumar; Gaboriau, David; Hoey, David A.; Morrison, Ciaran G.			Centriole splitting caused by loss of the centrosomal linker protein C-NAP1 reduces centriolar satellite density and impedes centrosome amplification	MOLECULAR BIOLOGY OF THE CELL			English	Article							COILED-COIL PROTEIN; DNA-DAMAGE; CILIARY ROOTLET; HUMAN-CELLS; STEM-CELLS; G2 PHASE; COHESION; DUPLICATION; SEPARATION; CILIOGENESIS	Duplication of the centrosomes is a tightly regulated process. Abnormal centrosome numbers can impair cell division and cause changes in how cells migrate. Duplicated centrosomes are held together by a proteinaceous linker made up of rootletin filaments anchored to the centrioles by C-NAP1. This linker is removed in a NEK2A kinase-dependent manner as mitosis begins. To explore C-NAP1 activities in regulating centrosome activities, we used genome editing to ablate it. C-NAP1-null cells were viable and had an increased frequency of premature centriole separation, accompanied by reduced density of the centriolar satellites, with reexpression of C-NAP1 rescuing both phenotypes. We found that the primary cilium, a signaling structure that arises from the mother centriole docked to the cell membrane, was intact in the absence of C-NAP1, although components of the ciliary rootlet were aberrantly localized away from the base of the cilium. C-NAP1-deficient cells were capable of signaling through the cilium, as determined by gene expression analysis after fluid flow-induced shear stress and the relocalization of components of the Hedgehog pathway. Centrosome amplification induced by DNA damage or by PLK4 or CDK2 overexpression was markedly reduced in the absence of C-NAP1. We conclude that centriole splitting reduces the local density of key centriolar precursors to impede overduplication.	[Flanagan, Anne-Marie; Basavaraju, Shivakumar; Gaboriau, David; Morrison, Ciaran G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Stavenschi, Elena; Hoey, David A.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin 2, Ireland; [Stavenschi, Elena; Hoey, David A.] Trinity Coll Dublin, Dept Mech & Mfg Engn, Sch Engn, Dublin 2, Ireland; [Hoey, David A.] Trinity Coll Dublin, Adv Mat & Bioengn Res Ctr, Dublin 2, Ireland; [Hoey, David A.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Gaboriau, David] Imperial Coll London, Facil Imaging Light Microscopy, London SW7 2AZ, England	Morrison, CG (reprint author), Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland.	Ciaran.Morrison@nuigalway.ie	Morrison, Ciaran/B-6568-2008; Gaboriau, David/O-3197-2017	Morrison, Ciaran/0000-0003-2401-7029; Gaboriau, David/0000-0003-4047-6487; Hoey, David/0000-0001-5898-0409	Irish Government Programme for Research in Third-Level Institutions Cycles 4 and 5; Science Foundation Ireland Principal Investigator Award [10/IN.1/B2972]; European Commission [SEC-2009-4.3-02, 242361 'BOOSTER']; Irish Research Council Postgraduate Scholarship; European Research Council [336882]; SFI ERC Support Grant [SFI 13/ERC/L2864]	We acknowledge the National Biophotonics and Imaging Platform Ireland and the National Centre for Biomedical Engineering Science Flow Cytometry Core Facility, which were supported by Irish Government Programme for Research in Third-Level Institutions Cycles 4 and 5. This work was funded by Science Foundation Ireland Principal Investigator Award 10/IN.1/B2972 and European Commission SEC-2009-4.3-02, Project 242361 'BOOSTER' (to C.G.M.), an Irish Research Council Postgraduate Scholarship (to S.B.), and European Research Council Grant 336882 and SFI ERC Support Grant SFI 13/ERC/L2864 (to D.A.H.).	Agircan FG, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0461; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Barenz F, 2011, EUR J CELL BIOL, V90, P983, DOI 10.1016/j.ejcb.2011.07.007; Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105                                                           ; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Cha B, 2016, GENE DEV, V30, P1454, DOI 10.1101/gad.282400.116; Chen JV, 2015, J CELL BIOL, V211, P435, DOI 10.1083/jcb.201502032; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conroy PC, 2012, CELL CYCLE, V11, P3769, DOI 10.4161/cc.21986; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Douthwright S, 2014, J CELL PHYSIOL, V229, P1427, DOI 10.1002/jcp.24579; Fang GL, 2014, J CELL SCI, V127, P1631, DOI 10.1242/jcs.139451; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Fletcher L, 2004, RADIAT RES, V162, P128, DOI 10.1667/RR3211                                                                  ; Floriot S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7894; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181                                                           ; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; He RS, 2013, CELL REP, V4, P1100, DOI 10.1016/j.celrep.2013.08.005; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Inanc B, 2010, MOL BIOL CELL, V21, P3866, DOI 10.1091/mbc.E10-02-0124; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519; Kushner EJ, 2014, J CELL BIOL, V206, P257, DOI 10.1083/jcb.201311013; Loffler H, 2013, ONCOGENE, V32, P2963, DOI 10.1038/onc.2012.310; Lopes CAM, 2015, DEV CELL, V35, P222, DOI 10.1016/j.devcel.2015.09.020; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mardin BR, 2011, CURR BIOL, V21, P1145, DOI 10.1016/j.cub.2011.05.047; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2                                                   ; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Mazo G, 2016, DEV CELL, V39, P424, DOI [10.1016/j.devcel.2016.10.006, 10.1016/j.devce1.2016.10.006]; Meraldi P, 1999, NAT CELL BIOL, V1, P88; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Pagan JK, 2015, NAT CELL BIOL, V17, P31, DOI 10.1038/ncb3076; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Panic M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005243; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Roosing S, 2015, ELIFE, V4, DOI 10.7554/eLife.06602; Saladino C, 2009, ENVIRON MOL MUTAGEN, V50, P725, DOI 10.1002/em.20477; Styczynska-Soczka Katarzyna, 2015, Cilia, V4, P9, DOI 10.1186/s13630-015-0018-9; Thi MM, 2007, ANN NY ACAD SCI, V1117, P73, DOI 10.1196/annals.1402.020; Tollenaere MAX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10075; Tollenaere MAX, 2015, CELL MOL LIFE SCI, V72, P11, DOI 10.1007/s00018-014-1711-3; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Villumsen BH, 2013, EMBO J, V32, P3029, DOI 10.1038/emboj.2013.223; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Yang J, 2006, MOL BIOL CELL, V17, P1033, DOI 10.1091/mbc.E05-10-0943; Yang J, 2005, MOL CELL BIOL, V25, P4129, DOI 10.1128/MCB.25.10.4129-4137.2005; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111; Zhang W, 2005, J BIOL CHEM, V280, P42994, DOI 10.1074/jbc.M505450200	62	1	1	1	1	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	MAR 15	2017	28	6					736	745		10.1091/mbc.E16-05-0325				10	Cell Biology	Cell Biology	EN8HE	WOS:000396240700005	28100636	gold			2018-01-05	
J	Chechenova, MB; Maes, S; Oas, ST; Nelson, C; Kiani, KG; Bryantsev, AL; Cripps, RM				Chechenova, Maria B.; Maes, Sara; Oas, Sandy T.; Nelson, Cloyce; Kiani, Kaveh G.; Bryantsev, Anton L.; Cripps, Richard M.			Functional redundancy and nonredundancy between two Troponin C isoforms in Drosophila adult muscles	MOLECULAR BIOLOGY OF THE CELL			English	Article							INDIRECT FLIGHT-MUSCLE; MYOSIN HEAVY-CHAINS; GENE-EXPRESSION; WILD-TYPE; MELANOGASTER; TRANSFORMATION; MYOGENESIS; PHENOTYPES; INSECTS; PROTEIN	We investigated the functional overlap of two muscle Troponin C (TpnC) genes that are expressed in the adult fruit fly, Drosophila melanogaster: TpnC4 is predominantly expressed in the indirect flight muscles (IFMs), whereas TpnC41C is the main isoform in the tergal depressor of the trochanter muscle (TDT; jump muscle). Using CRISPR/Cas9, we created a transgenic line with a homozygous deletion of TpnC41C and compared its phenotype to a line lacking functional TpnC4. We found that the removal of either of these genes leads to expression of the other isoform in both muscle types. The switching between isoforms occurs at the transcriptional level and involves minimal enhancers located upstream of the transcription start points of each gene. Functionally, the two TpnC isoforms were not equal. Although ectopic TpnC4 in TDT muscles was able to maintain jumping ability, TpnC41C in IFMs could not effectively support flying. Simultaneous functional disruption of both TpnC genes resulted in jump-defective and flightless phenotypes of the survivors, as well as abnormal sarcomere organization. These results indicated that TpnC is required for myofibril assembly, and that there is functional specialization among TpnC isoforms in Drosophila.	[Chechenova, Maria B.; Maes, Sara; Oas, Sandy T.; Nelson, Cloyce; Bryantsev, Anton L.; Cripps, Richard M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Chechenova, Maria B.; Kiani, Kaveh G.; Bryantsev, Anton L.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA	Cripps, RM (reprint author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rcripps@unm.edu			National Institutes of Health/National Institute of General Medical Sciences [GM061738, T34 GM008751]; Stephanie Ruby Undergraduate Fellowship; College of Science and Mathematics; Office of Vice-President for Research at Kennesaw State University; National Institutes of Health from the Institute Development Award Program of the National Institute of General Medical Sciences [P20 GM103452]	This work was supported by National Institutes of Health/National Institute of General Medical Sciences Grant GM061738 to R.M.C. S.M. was supported by National Institutes of Health/National Institute of General Medical Sciences Grant T34 GM008751 and a Stephanie Ruby Undergraduate Fellowship. A.L.B. acknowledges support from internal grants provided by the College of Science and Mathematics and the Office of Vice-President for Research at Kennesaw State University. We also acknowledge technical support from the Molecular Biology Facility and the Cell Biology Facility at the Department of Biology, University of New Mexico, which is supported by National Institutes of Health Grant P20 GM103452 from the Institute Development Award Program of the National Institute of General Medical Sciences.	Adame V, 2016, BIOCHEM MOL BIOL EDU, V44, P263, DOI 10.1002/bmb.20950; Allen DL, 2001, DEV BIOL, V229, P383, DOI 10.1006/dbio.2000.9974; Benoist P, 1998, J BIOL CHEM, V273, P7538, DOI 10.1074/jbc.273.13.7538                                                         ; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bryantsev AL, 2012, DEV CELL, V23, P664, DOI 10.1016/j.devcel.2012.08.004; Bryantsev AL, 2012, DEV BIOL, V361, P191, DOI 10.1016/j.ydbio.2011.09.031; Chechenova MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144615; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; CRIPPS RM, 1994, J CELL BIOL, V126, P689, DOI 10.1083/jcb.126.3.689; Diss G, 2014, J EXP ZOOL PART B, V322, P488, DOI 10.1002/jez.b.22555; Domingo A, 1998, J MUSCLE RES CELL M, V19, P393, DOI 10.1023/A:1005349704790; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589                                                              ; Eldred CC, 2014, J MUSCLE RES CELL M, V35, P211, DOI 10.1007/s10974-014-9387-8; Elliott CJH, 2007, FLY, V1, P68, DOI 10.4161/fly.3979                                                                ; Firdaus H, 2015, GENETICS, V200, P149, DOI 10.1534/genetics.115.175604; Fyrberg EA, 1998, BIOCHEM GENET, V36, P271, DOI 10.1023/A:1018785127079; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Herranz R, 2005, J MOL EVOL, V60, P31, DOI 10.1007/s00239-004-0031-x; Herranz R, 2004, GENE EXPR PATTERNS, V4, P183, DOI 10.1016/j.modgep.2003.09.008; Huang AM, 2009, COLD SPRING HARB PRO; KATJU V, 2012, INT J EVOL BIOL, DOI DOI 10.1155/2012/341932; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Lieber RL, 2010, SKELETAL MUSCLE STRU; Lovato TL, 2009, GENETICS, V183, P107, DOI 10.1534/genetics.109.105056; Morriss GR, 2012, METHODS MOL BIOL, V798, P127, DOI 10.1007/978-1-61779-343-1_8; Qiu F, 2003, BIOCHEM J, V371, P811, DOI 10.1042/BJ20021814; Roy S, 1997, DEVELOPMENT, V124, P3333; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sartorius CA, 1998, J CELL BIOL, V141, P943, DOI 10.1083/jcb.141.4.943                                                           ; Schonbauer C, 2011, NATURE, V479, P406, DOI 10.1038/nature10559; Singh SH, 2014, J GENET, V93, P379, DOI 10.1007/s12041-014-0386-8                                                       ; Terami H, 1999, J CELL BIOL, V146, P193, DOI 10.1083/jcb.146.1.193; Thummel CS, 1992, DROS INF SERV, V71, P150; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417                                                ; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101; Zumstein N, 2004, J EXP BIOL, V207, P3515, DOI 10.1242/jeb.01181	36	2	2	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	MAR 15	2017	28	6					760	770		10.1091/mbc.E16-07-0498				11	Cell Biology	Cell Biology	EN8HE	WOS:000396240700007	28077621	gold			2018-01-05	
J	Matsui, T; Nieto-Estevez, V; Kyrychenko, S; Schneider, JW; Hsieh, J				Matsui, Takeshi; Nieto-Estevez, Vanesa; Kyrychenko, Sergii; Schneider, Jay W.; Hsieh, Jenny			Retinoblastoma protein controls growth, survival and neuronal migration in human cerebral organoids	DEVELOPMENT			English	Article						Retinoblastoma; Human embryonic stem cells; Organoid; Brain; CRISPR/Cas9; Cell cycle	EMBRYONIC STEM-CELLS; HUMAN BRAIN-DEVELOPMENT; NERVOUS-SYSTEM; ADULT NEUROGENESIS; NEURAL PRECURSORS; CORTICAL-NEURONS; DENTATE GYRUS; RB; DIFFERENTIATION; REQUIREMENT	The tumor suppressor retinoblastoma protein (RB) regulates S-phase cell cycle entry via E2F transcription factors. Knockout (KO) mice have shown that RB plays roles in cell migration, differentiation and apoptosis, in developing and adult brain. In addition, the RB family is required for self-renewal and survival of human embryonic stem cells (hESCs). Since little is known about the role of RB in human brain development, we investigated its function in cerebral organoids differentiated from gene-edited hESCs lacking RB. We show that RB is abundantly expressed in neural stem and progenitor cells in organoids at 15 and 28 days of culture. RB loss promoted S-phase entry in DCX+ cells and increased apoptosis in Sox2(+) neural stem and progenitor cells, and in DCX+ and Tuj1(+) neurons. Associated with these cell cycle and pro-apoptotic effects, we observed increased CCNA2 and BAX gene expression, respectively. Moreover, we observed aberrant Tuj1(+) neuronal migration in RB-KO organoids and upregulation of the gene encoding VLDLR, a receptor important in reelin signaling. Corroborating the results in RB-KO organoids in vitro, we observed ectopically localized Tuj1(+) cells in RB-KO teratomas grown in vivo. Taken together, these results identify crucial functions for RB in the cerebral organoid model of human brain development.	[Matsui, Takeshi; Nieto-Estevez, Vanesa; Hsieh, Jenny] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Reg Sci & Med, Dept Molecular Biol, Dallas, TX 75390 USA; [Kyrychenko, Sergii; Schneider, Jay W.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Reg Sci & Med, Dept Int Med, Dallas, TX 75390 USA	Hsieh, J (reprint author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Reg Sci & Med, Dept Molecular Biol, Dallas, TX 75390 USA.; Schneider, JW (reprint author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Reg Sci & Med, Dept Int Med, Dallas, TX 75390 USA.	jay.schneider@utsouthwestern.edu; jenny.hsieh@utsouthwestern.edu			National Institutes of Health [R01NS093992, R01NS089770, R01NS081203, R21NS090926, K02AG041815, U01HL100401, U54HD087351]; American Heart Association [15GRNT25750034]; U.S. Department of Defense [W81XWH-15-1-0399]; Texas Institute for Brain Injury and Repair, University of Texas Southwestern Medical Center; Cancer Prevention Research Institute of Texas [RP110486]	This work was supported by grants from the National Institutes of Health (R01NS093992, R01NS089770, R01NS081203, R21NS090926 and K02AG041815 to J.H.; U01HL100401 and U54HD087351 to J.W.S.), the American Heart Association (15GRNT25750034 to J.H.), the U.S. Department of Defense (W81XWH-15-1-0399 to J.H.), the Texas Institute for Brain Injury and Repair, University of Texas Southwestern Medical Center (to J.H.) and the Cancer Prevention Research Institute of Texas (RP110486 to J.W.S.). Deposited in PMC for release after 12 months.	Andrusiak MG, 2011, MOL CELL BIOL, V31, P238, DOI 10.1128/MCB.00378-10; Brunne B, 2013, GLIA, V61, P1347, DOI 10.1002/glia.22519; Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Cheng L, 2011, EUR J PAEDIATR NEURO, V15, P361, DOI 10.1016/j.ejpn.2011.03.011; Christie KJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4670; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Conklin JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2254; Drew LJ, 2016, HIPPOCAMPUS, V26, P763, DOI 10.1002/hipo.22557; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Ferguson KL, 2005, EMBO J, V24, P4381, DOI 10.1038/sj.emboj.7600887; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Ghanem N, 2012, J NEUROSCI, V32, P8219, DOI 10.1523/JNEUROSCI.1344-12.2012; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hoerder-Suabedissen A, 2015, NAT REV NEUROSCI, V16, P133, DOI 10.1038/nrn3915; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101                                                           ; Julian LM, 2016, CELL DEATH DIFFER, V23, P565, DOI 10.1038/cdd.2015.36; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Macleod KF, 1996, EMBO J, V15, P6178; MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003; McClellan KA, 2007, MOL CELL BIOL, V27, P4825, DOI 10.1128/MCB.02100-06; McClellan KA, 2006, CELL CYCLE, V5, P1506, DOI 10.4161/cc.5.14.2980                                                            ; Mitter D, 2011, EUR J HUM GENET, V19, P947, DOI 10.1038/ejhg.2011.58; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; Naser R, 2016, SCI REP-UK, V6, DOI 10.1038/srep20230; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodjan F, 2010, AM J NEURORADIOL, V31, P1385, DOI 10.3174/ajnr.A2102; Sosa-Garcia B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013954; Teixeira CM, 2012, J NEUROSCI, V32, P12051, DOI 10.1523/JNEUROSCI.1857-12.2012; Vandenbosch R, 2016, HIPPOCAMPUS, V26, P1379, DOI 10.1002/hipo.22613; Yu Y, 2012, NEUROCHEM RES, V37, P503, DOI 10.1007/s11064-011-0636-6; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19	40	2	2	1	5	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	MAR 15	2017	144	6			SI		1025	1034		10.1242/dev.143636				10	Developmental Biology	Developmental Biology	EN8BC	WOS:000396224900014	28087635				2018-01-05	
J	Jensen, ED; Ferreira, R; Jakociunas, T; Arsovska, D; Zhang, J; Ding, L; Smith, JD; David, F; Nielsen, J; Jensen, MK; Keasling, JD				Jensen, Emil D.; Ferreira, Raphael; Jakociunas, Tadas; Arsovska, Dushica; Zhang, Jie; Ding, Ling; Smith, Justin D.; David, Florian; Nielsen, Jens; Jensen, Michael K.; Keasling, Jay D.			Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies	MICROBIAL CELL FACTORIES			English	Article						dCas9; gRNA; VPR; Mxi1; scRNA; Yeast; Isoprenoids; Triacylglycerols; Transcriptional regulation	SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; ALPHA-SANTALENE; CRISPR; GENOME; METABOLISM; PROMOTERS; CHEMICALS; DYNAMICS; BIOFUELS	Background: Transcriptional reprogramming is a fundamental process of living cells in order to adapt to environmental and endogenous cues. In order to allow flexible and timely control over gene expression without the interference of native gene expression machinery, a large number of studies have focused on developing synthetic biology tools for orthogonal control of transcription. Most recently, the nuclease-deficient Cas9 (dCas9) has emerged as a flexible tool for controlling activation and repression of target genes, by the simple RNA-guided positioning of dCas9 in the vicinity of the target gene transcription start site. Results: In this study we compared two different systems of dCas9-mediated transcriptional reprogramming, and applied them to genes controlling two biosynthetic pathways for biobased production of isoprenoids and triacylglycerols (TAGs) in baker's yeast Saccharomyces cerevisiae. By testing 101 guide-RNA (gRNA) structures on a total of 14 different yeast promoters, we identified the best-performing combinations based on reporter assays. Though a larger number of gRNA-promoter combinations do not perturb gene expression, some gRNAs support expression perturbations up to similar to threefold. The best-performing gRNAs were used for single and multiplex reprogramming strategies for redirecting flux related to isoprenoid production and optimization of TAG profiles. From these studies, we identified both constitutive and inducible multiplex reprogramming strategies enabling significant changes in isoprenoid production and increases in TAG. Conclusion: Taken together, we show similar performance for a constitutive and an inducible dCas9 approach, and identify multiplex gRNA designs that can significantly perturb isoprenoid production and TAG profiles in yeast without editing the genomic context of the target genes. We also identify a large number of gRNA positions in 14 native yeast target pomoters that do not affect expression, suggesting the need for further optimization of gRNA design tools and dCas9 engineering.\	[Jensen, Emil D.; Jakociunas, Tadas; Arsovska, Dushica; Zhang, Jie; Ding, Ling; Nielsen, Jens; Jensen, Michael K.; Keasling, Jay D.] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Ferreira, Raphael; David, Florian; Nielsen, Jens] Chalmers, Novo Nordisk Fdn, Ctr Biosustainabil, Dept Biol & Biol Engn, S-41296 Gothenburg, Sweden; [Smith, Justin D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Smith, Justin D.] Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Keasling, Jay D.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Biomol & Chem Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Jensen, MK (reprint author), Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, DK-2800 Lyngby, Denmark.	mije@biosustain.dtu.dk		Jensen, Michael Krogh/0000-0001-7574-4707; Ferreira, Raphael/0000-0001-9881-6232	Novo Nordisk Foundation	This work was supported by the Novo Nordisk Foundation.	Alonso-Gutierrez J, 2015, METAB ENG, V28, P123, DOI 10.1016/j.ymben.2014.11.011; Amiri P, 2016, BIOTECHNOL LETT, V38, P503, DOI 10.1007/s10529-015-2000-4; Bonke M, 2013, G3-GENES GENOM GENET, V3, P75, DOI 10.1534/g3.112.004283; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Deaner M, 2017, METAB ENG, V40, P14, DOI 10.1016/j.ymben.2017.01.012; Fang ZJ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02319-16; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jakociunas T, 2015, ACS SYNTH BIOL, V4, P1226, DOI 10.1021/acssynbio.5b00007; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Jessop-Fabre MM, 2016, BIOTECHNOL J, V11, P1110, DOI 10.1002/biot.201600147; Jullesson D, 2015, BIOTECHNOL ADV, V33, P1395, DOI 10.1016/j.biotechadv.2015.02.011; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kennedy MA, 2001, BBA-GENE STRUCT EXPR, V1517, P177, DOI 10.1016/S0167-4781(00)00246-3; Khoomrung S, 2013, ANAL CHEM, V85, P4912, DOI 10.1021/ac3032405; Kim SK, 2016, METAB ENG, V38, P228, DOI 10.1016/j.ymben.2016.08.006; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lee ME, 2013, NUCLEIC ACIDS RES, V41, P10668, DOI 10.1093/nar/gkt809; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Maji B, 2016, NAT CHEM BIOL, DOI [10.1038/nchembio.2224, DOI 10.1038/NCHEMBIO.2224]; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nanchen A, 2011, MOL SYST BIOL, V7, P477, DOI DOI 10.1038/MSB.2011.9; Oakes BL, 2016, NAT BIOTECHNOL, DOI [10.1038/nbt.3528.cell.2015.09.038, DOI 10.1038/NBT.3528.CELL.2015.09.038]; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Pajoro A, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r41; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qiao K, 2015, METAB ENG, V29, P56, DOI 10.1016/j.ymben.2015.02.005; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Runguphan W, 2014, METAB ENG, V21, P103, DOI 10.1016/j.ymben.2013.07.003; Scalcinati G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-117; Scalcinati G, 2012, METAB ENG, V14, P91, DOI 10.1016/j.ymben.2012.01.007; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Shi S., 2014, IMPROVING PRODUCTION, V5, P1, DOI DOI 10.1128/MBI0.01130-14; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002                                                   ; Tippmann S, 2013, BIOTECHNOL J, V8, P1435, DOI 10.1002/biot.201300028; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Vanegas KG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0632-x; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Verwaal R, 2007, APPL ENVIRON MICROB, V73, P4342, DOI 10.1128/AEM.02759-06; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	51	6	6	8	31	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2859			MICROB CELL FACT	Microb. Cell. Fact.	MAR 15	2017	16								46	10.1186/s12934-017-0664-2				16	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EQ0BT	WOS:000397737400003	28298224	gold			2018-01-05	
J	Chen, WH; Zhang, YF; Yeo, WS; Bae, T; Ji, QJ				Chen, Weizhong; Zhang, Yifei; Yeo, Won-Sik; Bae, Taeok; Ji, Quanjiang			Rapid and Efficient Genome Editing in Staphylococcus aureus by Using an Engineered CRISPR/Cas9 System	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							GENE-EXPRESSION; DNA RECOGNITION; TARGET DNA; CAS9; RNA; VIRULENCE; ENDONUCLEASE; SPECIFICITY; INFECTIONS; NUCLEASES	Staphylococcus aureus, a major human pathogen, has been the cause of serious infectious diseases with a high mortality rate. Although genetics is a key means to study S. aureus physiology, such as drug resistance and pathogenesis, genetic manipulation in S. aureus is always time-consuming and laborintensive. Here we report a CRISPR/Cas9 system (pCasSA) for rapid and efficient genome editing, including gene deletion, insertion, and single-base substitution mutation in S. aureus. The designed pCasSA system is amenable to the assembly of spacers and repair arms by Golden Gate assembly and Gibson assembly, respectively, enabling rapid construction of the plasmids for editing. We further engineered the pCasSA system to be an efficient transcription inhibition system for gene knockdown and possible genome-wide screening. The development of the CRISPR/Cas9-mediated genome editing and transcription inhibition tools will dramatically accelerate drug-target exploration and drug development.	[Chen, Weizhong; Zhang, Yifei; Ji, Quanjiang] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 201210, Peoples R China; [Yeo, Won-Sik; Bae, Taeok] Indiana Univ, Sch Med Northwest, Dept Microbiol & Immunol, Gary, IN 46408 USA	Ji, QJ (reprint author), ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 201210, Peoples R China.	quanjiangji@shanghaitech.edu.cn		Ji, Quanjiang/0000-0002-2321-8462	ShanghaiTech Startup Funding; "Thousand Plan" Youth Programme; NIH [AI121664]	This work was financially supported by ShanghaiTech Startup Funding and the "Thousand Plan" Youth Programme (to Q.J.) and the NIH (AI121664 to T.B.).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289                                                                  ; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; CHEUNG AL, 1994, J BACTERIOL, V176, P4168; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Foster TJ, 1998, METHOD MICROBIOL, V27, P433; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763                                                        ; KRAEMER GR, 1990, CURR MICROBIOL, V21, P373, DOI 10.1007/BF02199440; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806                                                     ; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McNamara Peter J., 2008, P89; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rice LB, 2006, AM J INFECT CONTROL, V34, pS11, DOI 10.1016/j.ajic.2006.05.220; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schwendener S, 2015, APPL ENVIRON MICROB, V81, P3243, DOI 10.1128/AEM.03803-14; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Steinhuber A, 2003, J BACTERIOL, V185, P6278, DOI 10.1128/JB.185.21.6278-6286.2003; Sun F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015703; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	36	3	3	14	33	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	MAR 15	2017	139	10					3790	3795		10.1021/jacs.6b13317				6	Chemistry, Multidisciplinary	Chemistry	EO6KN	WOS:000396801300033	28218837				2018-01-05	
J	van Tienen, LM; Mieszczanek, J; Fielder, M; Rutherford, TJ; Bienz, M				van Tienen, Laurens M.; Mieszczanek, Juliusz; Fielder, Marc; Rutherford, Trevor J.; Bienz, Mariann			Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9	ELIFE			English	Article							TARGET GENE ACTIVATION; HISTONE H3 TAIL; BETA-CATENIN; IN-VIVO; TRANSCRIPTION FACTOR; COLORECTAL-CANCER; PHD-FINGER; DROSOPHILA; WINGLESS; PROTEIN	Wnt/b-catenin signaling elicits context-dependent transcription switches that determine normal development and oncogenesis.These are mediated by the Wnt enhanceosome, a multiprotein complex binding to the Pygo chromatin read and acting through TCF/LEF responsive enhancers. Pygo renders this complex Wnt-responsive, by capturing beta-catenin via the Legless/BCL9 adaptor. We used CRISPR/Cas9 genome engineering of Drosophila legless (lgs) and human BCL9 and B9L to show that the C-terminus downstream of their adaptor elements is crucial for Wnt responses. BioID proximity labeling revealed that BCL9 and B9L, like PYGO2, are constitutive components of the Wnt enhanceosome. Wnt-dependent docking of beta-catenin to the enhanceosome apparently causes rearrangement that apposes the BCL9/B9L C-terminus to TCF. This C-terminus binds to the Groucho/TLE co-repressor, and also to the Chip/LDB1-SSDP enhanceosome core complex via an evolutionary conserved element. An unexpected link between BCL9/B9L, PYGO2 and nuclear co-receptor complexes suggests that these beta-catenin co-factors may coordinate Wnt and nuclear hormone responses.	[van Tienen, Laurens M.; Mieszczanek, Juliusz; Fielder, Marc; Rutherford, Trevor J.; Bienz, Mariann] MRC, Mol Biol Lab, Cambridge, England	Bienz, M (reprint author), MRC, Mol Biol Lab, Cambridge, England.	mb2@mrc-lmb.cam.ac.uk					Adachi S, 2004, CANCER RES, V64, P8496, DOI 10.1158/0008-5472.CAN-04-2254                                                   ; Al-Jassar C, 2017, STRUCTURE, V25, P146, DOI 10.1016/j.str.2016.11.014; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chodaparambil JV, 2014, EMBO J, V33, P719, DOI 10.1002/embj.201387188; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collins RT, 2000, GENE DEV, V14, P3140, DOI 10.1101/gad.854300                                                              ; de la Roche M, 2007, CURR BIOL, V17, P556, DOI 10.1016/j.cub.2007.01.063; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; de la Roche M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1680; de la Roche M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-199; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Fiedler M, 2015, ELIFE, V4, DOI 10.7554/eLife.09073; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Firat-Karalar EN, 2014, CURR BIOL, V24, P664, DOI 10.1016/j.cub.2014.01.067; Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Gallet A, 1999, EMBO J, V18, P2208, DOI 10.1093/emboj/18.8.2208; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hanson AJ, 2012, MOL CELL, V45, P619, DOI 10.1016/j.molcel.2011.12.032; Holmes KA, 2012, P NATL ACAD SCI USA, V109, P2748, DOI 10.1073/pnas.1018863108; Hoverter NP, 2012, MOL CELL BIOL, V32, P3648, DOI 10.1128/MCB.06769-11; Jennings BH, 2008, EMBO REP, V9, P76, DOI 10.1038/sj.embor.7401122; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kypta RM, 2012, NAT REV UROL, V9, P418, DOI 10.1038/nrurol.2012.116; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Love PE, 2014, TRENDS GENET, V30, P1, DOI 10.1016/j.tig.2013.10.001; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Metcalfe C, 2010, J CELL SCI, V123, P1588, DOI 10.1242/jcs.067546; Mieszczanek J, 2008, P NATL ACAD SCI USA, V105, P19324, DOI 10.1073/pnas.0806098105; Miller TCR, 2013, STRUCTURE, V21, P2208, DOI 10.1016/j.str.2013.09.013; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Parker DS, 2008, MOL CELL BIOL, V28, P1815, DOI 10.1128/MCB.01230-07; Parker DS, 2002, DEVELOPMENT, V129, P2565; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9                                                    ; Peng J, 2011, PROTEINS, V79, P161, DOI 10.1002/prot.23175; Port F, 2015, G3-GENES GENOM GENET, V5, P1493, DOI 10.1534/g3.115.019083; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roux K.J., 2013, CURR PROTOC PROTEIN, V74, P23, DOI DOI 10.1002/0471140864.PS1923S74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saller E, 2002, GENE DEV, V16, P1828, DOI 10.1101/gad230002; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Schneider AJ, 2014, INT J MOL SCI, V15, P17852, DOI 10.3390/ijms151017852; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shoresh M, 1998, GENETICS, V150, P283; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Stadeli R, 2005, MECH DEVELOP, V122, P1171, DOI 10.1016/j.mod.2005.07.004; Theisen H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000142; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Turki-Judeh W, 2012, CURR TOP DEV BIOL, V98, P65, DOI 10.1016/B978-0-12-386499-4.00003-3; van Meyel DJ, 2003, DEVELOPMENT, V130, P1915, DOI 10.1242/dev.00389; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Waltzer L, 1998, NATURE, V395, P521; Waltzer L, 2001, EMBO J, V20, P137, DOI 10.1093/emboj/20.1.137                                                          ; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wernet MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004210; WILDER EL, 1995, DEVELOPMENT, V121, P477	75	1	1	5	7	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	MAR 15	2017	6								e20882	10.7554/eLife.20882.001				23	Biology	Life Sciences & Biomedicine - Other Topics	EP8KO	WOS:000397624500001		gold			2018-01-05	
J	Zhang, XM; Li, WR; Wu, YS; Peng, XR; Lou, B; Wang, LQ; Liu, MJ				Zhang, Xuemei; Li, Wenrong; Wu, Yangsheng; Peng, Xinrong; Lou, Bian; Wang, Liqin; Liu, Mingjun			Disruption of the sheep BMPR-IB gene by CRISPR/Cas9 in in vitro-produced embryos	THERIOGENOLOGY			English	Article						Sheep; BMPR-IB; CRISPR/Cas9; Embryo; Gene editing; Indel	ONE-STEP GENERATION; ZYGOTE INJECTION; SOMATIC-CELLS; SYSTEM; NUCLEASES; PIGS; ENDONUCLEASE; MECHANISM; IMMUNITY; MICE	BMPR-IB (also known as FecB) is a key candidate gene for the genetic control of sheep reproductive performance. Loss-of-function mutations in the sheep BMPR-IB gene lead to an increase in ovulation rate and consequently larger litter size. However, the BMPR-IB gene has been identified in only a few sheep breeds. To improve sheep reproduction through modification of the BMPR-IB gene, we designed an sgRNA to target the sheep BMPR-IB gene by using the CRISPR/Cas9 system. First, we performed gene editing by injecting Cas9/sgRNA into the cytoplasm of one-cell fertilized eggs. A total of 88 embryos were assayed by T7EI digestion and Sanger sequencing. The results reported that the efficiency of gene modification was 37.5% (33/88) and increased with the developmental stage of embryo from the 2-cell stage to the blastocyst stage. Of the 33 gene editing embryos, 12 (36%, 12/33) were homozygous and 21 (64%, 21/33) were heterozygous. Moreover, sequence analysis of the PCR products from the positive embryos revealed that there were more than 10 modification forms that resulted in frame shift and truncated proteins. Further analysis by cloning and sequencing of each individual embryo showed a high level of mosaicism. In addition, off-target event analysis revealed that none of the off target mutations was introduced into the embryos. Our results indicated that the Cas9/sgRNA system is a simple and efficient tool that may potentially be used in the genetic modification of the sheep BMPR-IB gene in vivo. (C) 2016 Elsevier Inc. All rights reserved.	[Zhang, Xuemei; Li, Wenrong; Liu, Mingjun] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Xinjiang, Peoples R China; [Zhang, Xuemei; Li, Wenrong; Wu, Yangsheng; Peng, Xinrong; Lou, Bian; Wang, Liqin; Liu, Mingjun] Minist Agr, Key Lab Anim Biotechnol Xinjiang, Key Lab Genet Breeding & Reprod Grass Feeding Ani, Urumqi, Xinjiang, Peoples R China; [Zhang, Xuemei; Li, Wenrong; Wu, Yangsheng; Peng, Xinrong; Lou, Bian; Wang, Liqin; Liu, Mingjun] Xinjiang Acad Anim Sci, Inst Anim Biotechnol, Urumqi, Xinjiang, Peoples R China	Liu, MJ (reprint author), Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Xinjiang, Peoples R China.; Liu, MJ (reprint author), Minist Agr, Key Lab Anim Biotechnol Xinjiang, Key Lab Genet Breeding & Reprod Grass Feeding Ani, Urumqi, Xinjiang, Peoples R China.; Liu, MJ (reprint author), Xinjiang Acad Anim Sci, Inst Anim Biotechnol, Urumqi, Xinjiang, Peoples R China.	mingjun_l@sina.com			Key Laboratory Research Program of XinJiang Province [2014KL007]; National Major Development Program of Transgenic Breeding [2014ZX08010-004-009]	The Key Laboratory Research Program of XinJiang Province (2014KL007) and the National Major Development Program of Transgenic Breeding (2014ZX08010-004-009) supported this study.	Bevacqua RJ, 2016, THERIOGENOLOGY, V86, P1886, DOI 10.1016/j.theriogenology.2016.06.010; Choi W, 2015, ZYGOTE, V23, P916, DOI 10.1017/S096719941400063X; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Crispo M, 2015, TRANSGENIC RES, V24, P31, DOI 10.1007/s11248-014-9816-x; Fabre S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-20; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Han HB, 2014, FRONT AGRIC SCI ENG, V1, P2, DOI 10.15302/J-FASE-2014007; Heo YT, 2015, STEM CELLS DEV, V24, P393, DOI 10.1089/scd.2014.0278; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Jeong YH, 2015, ZYGOTE, V22, P1; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li P, 2013, XENOTRANSPLANTATION, V20, P370; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Qiu ZW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt258; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	27	3	3	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0093-691X	1879-3231		THERIOGENOLOGY	Theriogenology	MAR 15	2017	91						163	172		10.1016/j.theriogenology.2016.10.025				10	Reproductive Biology; Veterinary Sciences	Reproductive Biology; Veterinary Sciences	EL6LN	WOS:000394734200022	28108032				2018-01-05	
J	Wang, J; Feng, YJ; Wang, CJ; Zheng, F; Hassan, B; Zhi, LM; Li, WJ; Yao, Y; He, E; Jiang, SB; Tang, JQ				Wang, Jing; Feng, Youjun; Wang, Changjun; Zheng, Feng; Hassan, Bachar; Zhi, Liming; Li, Wenjuan; Yao, Yi; He, Elaine; Jiang, Shibo; Tang, Jiaqi			Genome-wide analysis of a avirulent and reveal the strain induces pro-tective immunity against challenge with virulent Streptococcus suis Serotype 2	BMC MICROBIOLOGY			English	Article							SIGNAL-TRANSDUCTION SYSTEM; TOXIC-SHOCK-SYNDROME; PNEUMONIAE; EXPRESSION; INFECTION; PROTEIN; CRISPR; GENE; PIGS; TOOL	Background: It was previously reported in China that two recent large-scale outbreaks of Streptococcus suis serotype 2 (S. suis 2) infections in human were caused by two highly virulent S. suis 2 strains, from which a novel genomic island (GEI), associated with disease onset and progression and designated 89 K, was identified. Here, an avirulent strain, 05HAS68, was isolated from a clinically healthy pig. Results: By comparing the genomes of this avirulent strain with virulent strains, it was found that massive genomic rearrangements occurred, resulting in alterations in gene expression that caused enormous single gene gain and loss. Important virulent genes were lost, such as extracellular protein factor (ef) and suilysin (sly) and larger mutants, such as muramidase-released protein (mrp). Piglets vaccinated with the avirulent strain, 05HAS68, had increased TNF-alpha and IFN-gamma levels in the peripheral blood and were fully protected from challenge infection with the most virulent S. suis 2 strain, 05ZYH33. Transfusion of T cells and plasma from vaccinated pigs resulted in protection of recipient animals against the 05ZYH33 challenge. Conclusion: These results suggest that analysis genome of the avirulent strains are instrumental in the development of vaccines and for the functional characterization of important of genetic determinants.	[Wang, Jing; Zhi, Liming; Li, Wenjuan; Yao, Yi] PLA Hosp 454, Translat Med Ctr, Nanjing 210002, Jiangsu, Peoples R China; [Feng, Youjun] Zhejiang Univ, Dept Med Microbiol & Parasitol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Changjun; Zheng, Feng] Nanjing Mil Command, Med Res Inst, Dept Epidemiol, Nanjing 210002, Jiangsu, Peoples R China; [Hassan, Bachar] Univ N Carolina, Chapel Hill, NC USA; [He, Elaine] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Tang, Jiaqi] Nanjing Gen Hosp, PLA Res Inst Clin Lab Med, Nanjing 210002, Jiangsu, Peoples R China; [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA	Wang, J (reprint author), PLA Hosp 454, Translat Med Ctr, Nanjing 210002, Jiangsu, Peoples R China.; Tang, JQ (reprint author), Nanjing Gen Hosp, PLA Res Inst Clin Lab Med, Nanjing 210002, Jiangsu, Peoples R China.	wj6373@hotmail.com; tjq85@hotmail.com		Wang, Jing/0000-0002-0079-0773	National Natural Science Foundation of China [81171527, 81371768, 81471920, 31170124, 81172794, 31300119]; Key Issue of Medical and Health Foundation of Nanjing Military Command [12Z17, 09Z015]	This work was supported by grants to J.T. from the National Natural Science Foundation of China (#81171527 and 81371768), to C.W. from the National Natural Science Foundation of China (#81471920, 31170124 and 81172794), to Feng Zheng from the National Natural Science Foundation of China (#31300119) and to J.W. from the Key Issue of Medical and Health Foundation of Nanjing Military Command (#12Z17 and 09Z015).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Baums CG, 2007, APPL ENVIRON MICROB, V73, P711, DOI 10.1128/AEM.01800-06; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; BORST P, 1987, SCIENCE, V235, P658, DOI 10.1126/science.3544215; Burrus V, 2000, APPL ENVIRON MICROB, V66, P1749, DOI 10.1128/AEM.66.4.1749-1753.2000; Busque P, 1997, CAN J VET RES, V61, P275; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Derrick EF, 2006, NUCLEIC ACIDS RES, V34, P5839; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12                                                         ; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Levesque CM, 2007, LETT APPL MICROBIOL, V45, P398, DOI 10.1111/j.1472-765X.2007.02203.x; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Li YY, 2006, INFECT IMMUN, V74, P305, DOI 10.1128/IAI.74.1.305-312.2006; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Mitrophanov AY, 2007, J THEOR BIOL, V246, P113, DOI 10.1016/j.jtbi.2006.11.009; Nakamatsu M, 2007, MICROBES INFECT, V9, P364, DOI 10.1016/j.micinf.2006.12.003; Newcombe J, 2004, INFECT IMMUN, V72, P338, DOI 10.1128/IAI.72.1.338-344.2004                                                   ; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Savic DJ, 2003, J BACTERIOL, V185, P1857, DOI 10.1128/JB.185.6.1857-1869.2003; Segura M, 1999, INFECT IMMUN, V67, P4646; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; van Rossum AMC, 2005, INFECT IMMUN, V73, P7718, DOI 10.1128/IAI.73.11.7718-7726.2005; Vernikos GS, 2008, GENOME RES, V18, P331, DOI 10.1101/gr.7004508; Wisselink HJ, 2002, VET MICROBIOL, V84, P155, DOI 10.1016/S0378-1135(01)00452-7; Wisselink HJ, 2001, VET REC, V148, P473, DOI 10.1136/vr.148.15.473                                                           ; Zhang Q, 2008, J INFECT DIS, V197, P1354	38	2	2	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2180			BMC MICROBIOL	BMC Microbiol.	MAR 14	2017	17								67	10.1186/s12866-017-0971-0				14	Microbiology	Microbiology	EO5YW	WOS:000396769900007	28292261	gold			2018-01-05	
J	Hough, SH; Kancleris, K; Brody, L; Humphryes-Kirilov, N; Wolanski, J; Dunaway, K; Ajetunmobi, A; Dillard, V				Hough, Soren H.; Kancleris, Kris; Brody, Leigh; Humphryes-Kirilov, Neil; Wolanski, Joseph; Dunaway, Keith; Ajetunmobi, Ayokunmi; Dillard, Victor			Guide Picker is a comprehensive design tool for visualizing and selecting guides for CRISPR experiments	BMC BIOINFORMATICS			English	Article						CRISPR; sgRNA; RNA guide design software; Cas9; Genome editing; Functional genomics	OFF-TARGET; CAS9; NUCLEASES; SCREENS; SYSTEM; CELLS	Background: Guide Picker ( https://www.deskgen.com/guide-picker/)serves as a meta tool for designing CRISPR experiments by presenting ten different guide RNA scoring functions in one simple graphical interface. It allows investigators to simultaneously visualize and sort through every guide targeting the protein-coding regions of any mouse or human gene. Results: Utilizing a multidimensional graphical display featuring two plots and four axes, Guide Picker can analyze all guides while filtering based on four different criteria at a time. Guide Picker further facilitates the CRISPR design process by using pre-computed scores for all guides, thereby offering rapid guide RNA generation and selection. Conclusions: The ease-of-use of Guide Picker complements CRISPR itself, matching a powerful and modular biological system with a flexible online web tool that can be used in a variety of genome editing experimental contexts.	[Hough, Soren H.; Kancleris, Kris; Brody, Leigh; Humphryes-Kirilov, Neil; Wolanski, Joseph; Dunaway, Keith; Ajetunmobi, Ayokunmi; Dillard, Victor] Desktop Genet Ltd, 28 Hanbury St, London E1 6QR, England	Hough, SH (reprint author), Desktop Genet Ltd, 28 Hanbury St, London E1 6QR, England.	sorenh@desktopgenetics.com		Hough, Soren/0000-0002-1628-2554	Desktop Genetics Ltd	All funding for this project was provided through Desktop Genetics Ltd. No external grants were used for the development of this tool.	Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hough Soren H, 2016, Per Med, V13, P517, DOI 10.2217/pme-2016-0068; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Maruyama T, 2016, NAT BIOTECHNOL, V34, P210, DOI 10.1038/nbt0216-210c; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	16	1	1	1	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	MAR 14	2017	18								167	10.1186/s12859-017-1581-4				10	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	EP6SF	WOS:000397508500001	28288556	gold			2018-01-05	
J	Mitzelfelt, KA; McDermott-Roe, C; Grzybowski, MN; Marquez, M; Kuo, CT; Riedel, M; Lai, SP; Choi, MJ; Kolander, KD; Helbling, D; Dimmock, DP; Battle, MA; Jou, CJ; Tristani-Firouzi, M; Verbsky, JW; Benjamin, IJ; Geurts, AM				Mitzelfelt, Katie A.; McDermott-Roe, Chris; Grzybowski, Michael N.; Marquez, Maribel; Kuo, Chieh-Ti; Riedel, Michael; Lai, Shuping; Choi, Melinda J.; Kolander, Kurt D.; Helbling, Daniel; Dimmock, David P.; Battle, Michele A.; Jou, Chuanchau J.; Tristani-Firouzi, Martin; Verbsky, James W.; Benjamin, Ivor J.; Geurts, Aron M.			Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection	STEM CELL REPORTS			English	Article							PLURIPOTENT STEM-CELLS; CAENORHABDITIS-ELEGANS; CRISPR-CAS9; NUCLEASES; CARDIOMYOCYTES; GENERATION; SYSTEMS; REPAIR	Genome editing in induced pluripotent stem cells is currently hampered by the laborious and expensive nature of identifying homology-directed repair (HDR)-modified cells. We present an approach where isolation of cells bearing a selectable, HDR-mediated editing event at one locus enriches for HDR-mediated edits at additional loci. This strategy, called co-targeting with selection, improves the probability of isolating cells bearing HDR-mediated variants and accelerates the production of disease models.	[Mitzelfelt, Katie A.; Benjamin, Ivor J.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [McDermott-Roe, Chris; Grzybowski, Michael N.; Marquez, Maribel; Kuo, Chieh-Ti; Lai, Shuping; Choi, Melinda J.; Kolander, Kurt D.; Benjamin, Ivor J.; Geurts, Aron M.] Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA; [McDermott-Roe, Chris; Grzybowski, Michael N.; Marquez, Maribel; Geurts, Aron M.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Riedel, Michael] PharmaCell, NL-6229 Maastricht, Netherlands; [Helbling, Daniel; Dimmock, David P.] Med Coll Wisconsin, Human Mol Genet Ctr, Dept Pediat, Div Genet, Milwaukee, WI 53226 USA; [Battle, Michele A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Jou, Chuanchau J.; Tristani-Firouzi, Martin] Univ Utah, Nora Eccles Harrison CVRTI, Sch Med, Salt Lake City, UT 84112 USA; [Jou, Chuanchau J.; Tristani-Firouzi, Martin] Univ Utah, Sch Med, Div Pediat Cardiol, Salt Lake City, UT 83113 USA; [Verbsky, James W.] Med Coll Wisconsin, Sect Quantitat Hlth Sci, Dept Pediat, Milwaukee, WI 53226 USA	McDermott-Roe, C; Geurts, AM (reprint author), Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA.; McDermott-Roe, C; Geurts, AM (reprint author), Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA.	mcdec@mail.med.upenn.edu; ageurts@mcw.edu		Helbling, Daniel/0000-0002-2693-5598; Dimmock, David/0000-0001-6690-2523	NIH New Innovator Award [1DP2OD008396]; NIH Director's Pioneer Award [8DP1HL17650-04]; Steven Cullen Healthy Heart Award; Research and Education Program Fund; Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; W.M.Keck Foundation Medical Research; Ruth L.Kirschstein National Research Service Award F31 Individual Fellowship [1F31AR067618-01A1]	We thank Shirng-Wern Tsaih and Michael Tschannen (Human Molecular Genetics Center, Medical College of Wisconsin) for advice and technical support.This work was supported by NIH New Innovator Award 1DP2OD008396 (A.M.G.) and NIH Director's Pioneer Award Grant 8DP1HL17650-04 (I.J.B.), the Steven Cullen Healthy Heart Award (A.M.G.), made possible by the Research and Education Program Fund, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin, a W.M.Keck Foundation Medical Research Grant (J.W.V.), and a Ruth L.Kirschstein National Research Service Award F31 Individual Fellowship 1F31AR067618-01A1 (K.A.M.).	Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Flemr M, 2015, CELL REP, V12, P709, DOI 10.1016/j.celrep.2015.06.051; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Liao SR, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv675; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mitzelfelt KA, 2016, J BIOL CHEM, V291, P14939, DOI 10.1074/jbc.M116.730481; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Moriarity BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096114; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Riedel M, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.04.017; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Ward JD, 2015, GENETICS, V199, P363, DOI 10.1534/genetics.114.172361; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	33	1	1	4	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	MAR 14	2017	8	3					491	499		10.1016/j.stemcr.2017.01.021				9	Cell & Tissue Engineering; Cell Biology	Cell Biology	EP0VD	WOS:000397103900001	28238794	gold			2018-01-05	
J	Xu, XH; Tay, YL; Sim, B; Yoon, SI; Huang, YH; Ooi, J; Utami, KH; Ziaei, A; Ng, B; Radulescu, C; Low, D; Ng, AYJ; Loh, M; Venkatesh, B; Ginhoux, F; Augustine, GJ; Pouladi, MA				Xu, Xiaohong; Tay, Yilin; Sim, Bernice; Yoon, Su-In; Huang, Yihui; Ooi, Jolene; Utami, Kagistia Hana; Ziaei, Amin; Ng, Bryan; Radulescu, Carola; Low, Donovan; Ng, Alvin Yu Jin; Loh, Marie; Venkatesh, Byrappa; Ginhoux, Florent; Augustine, George J.; Pouladi, Mahmoud A.			Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells	STEM CELL REPORTS			English	Article							STRIATAL PROJECTION NEURONS; TRANSGENIC MICE; DIFFERENTIATION; INHIBITION; MUTATIONS; DEFECTS; MODELS; CAS9	Huntington disease (HD) is a dominant neurodegenerative disorder caused by a CAG repeat expansion in HTT. Here we report correction of HD human induced pluripotent stem cells (hiPSCs) using a CRISPR-Cas9 and piggyBac transposon-based approach. We show that both HDand corrected isogenic hiPSCs can be differentiated into excitable, synaptically active forebrain neurons. We further demonstrate that phenotypic abnormalities in HD hiPSC-derived neural cells, including impaired neural rosette formation, increased susceptibility to growth factor withdrawal, and deficits in mitochondrial respiration, are rescued in isogenic controls. Importantly, using genome-wide expression analysis, we show that a number of apparent gene expression differences detected between HD and non-related healthy control lines are absent betweenHDand corrected lines, suggesting that these differences are likely related to genetic background rather than HD-specific effects. Our study demonstrates correction of HD hiPSCs and associated phenotypic abnormalities, and the importance of isogenic controls for disease modeling using hiPSCs.	[Xu, Xiaohong; Tay, Yilin; Sim, Bernice; Huang, Yihui; Ooi, Jolene; Utami, Kagistia Hana; Ziaei, Amin; Ng, Bryan; Radulescu, Carola; Loh, Marie; Pouladi, Mahmoud A.] ASTAR, TLGM, 8A Biomed Grove,Level 5, Singapore 138648, Singapore; [Yoon, Su-In; Augustine, George J.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637553, Singapore; [Low, Donovan; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Ng, Alvin Yu Jin; Venkatesh, Byrappa] ASTAR, Biopolis, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore 138673, Singapore; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119228, Singapore; [Augustine, George J.] IMCB, Singapore 138673, Singapore; [Pouladi, Mahmoud A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117597, Singapore	Pouladi, MA (reprint author), ASTAR, TLGM, 8A Biomed Grove,Level 5, Singapore 138648, Singapore.; Pouladi, MA (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117597, Singapore.	map@pouladilab.org			Strategic Positioning Fund for Genetic Orphan Diseases [SPF2012/005]; Agency for Science, Technology and Research (Singapore) [1431AFG122]; Tier 1 grant from Ministry of Education (Singapore) [R-172-000-297-112]; Singapore Immunology Network (SIgN) core funding; A*STAR Research Attachment Program (ARAP); A*STAR Singapore International Graduate Award (SINGA)	We thank Qiyu Chen for technical assistance, Sumanty Tohari for whole-exome sequencing, and Kerry McLaughlin for editorial assistance. The work was partly funded by a Strategic Positioning Fund for Genetic Orphan Diseases (SPF2012/005) and a Joint Council Office Project grant (1431AFG122) from the Agency for Science, Technology and Research (Singapore), and a Tier 1 grant R-172-000-297-112 from the Ministry of Education (Singapore) to M.A.P.F.G. and D.L. are supported by the Singapore Immunology Network (SIgN) core funding. C.R. is supported by the A*STAR Research Attachment Program (ARAP) and A.Z. is supported by the A*STAR Singapore International Graduate Award (SINGA). We thank the NINDS iPSC Repository for the HD and control iPSC lines (ND36997 and ND36999).	An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; An M.C., 2014, PLOS CURR, V6; Aras S, 2015, MITOCHONDRION, V20, P43, DOI 10.1016/j.mito.2014.10.003; Arber C, 2015, DEVELOPMENT, V142, P1375, DOI 10.1242/dev.117093; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Block RC, 2010, J CLIN LIPIDOL, V4, P17, DOI 10.1016/j.jacl.2009.11.003; Carri AD, 2013, STEM CELL REV REP, V9, P461, DOI 10.1007/s12015-013-9441-8; Dias JM, 2014, NEURON, V84, P927, DOI 10.1016/j.neuron.2014.10.033; Dickey AS, 2016, NAT MED, V22, P37, DOI 10.1038/nm.4003; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Ichida JK, 2015, EMBO J, V34, P1456, DOI 10.15252/embj.201591267; Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kandasamy M, 2010, J NEUROPATH EXP NEUR, V69, P717, DOI 10.1097/NEN.0b013e3181e4f733; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Lo Sardo V, 2012, NAT NEUROSCI, V15, P713, DOI 10.1038/nn.3080; Ma DL, 2015, NEUROTHERAPEUTICS, V12, P477, DOI 10.1007/s13311-015-0343-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E                                                    ; Macdonald V, 2002, NEUROBIOL DIS, V10, P378, DOI 10.1006/nbdi.2002.0528; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Mattis V. B., 2015, BRAIN RES; Molina-Calavita M, 2014, J NEUROSCI, V34, P10034, DOI 10.1523/JNEUROSCI.0715-14.2014; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Niclis JC, 2009, REPROD BIOMED ONLINE, V19, P106, DOI 10.1016/S1472-6483(10)60053-3                                                   ; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174; Onorati M, 2014, NAT NEUROSCI, V17, P1804, DOI 10.1038/nn.3860; Ooi J, 2015, MOL NEUROBIOL, V52, P1850, DOI 10.1007/s12035-014-8974-4; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733                                                         ; Ring KL, 2015, STEM CELL REP, V5, P1023, DOI [10.1016/j.stemer.2015.11.005, 10.1016/j.stemcr.2015.11.005]; Ruzo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127687; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xu XH, 2013, STEM CELL RES, V10, P213, DOI 10.1016/j.scr.2012.11.005; Yusa K, 2013, NAT PROTOC, V8, P2061, DOI 10.1038/nprot.2013.126; Zhou Z.-D., 2016, MOL NEUROBIOL	45	10	10	7	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	MAR 14	2017	8	3					619	633		10.1016/j.stemcr.2017.01.022				15	Cell & Tissue Engineering; Cell Biology	Cell Biology	EP0VD	WOS:000397103900012	28238795	gold			2018-01-05	
J	Zhang, Y; Schmid, B; Nikolaisen, NK; Rasmussen, MA; Aldana, BI; Agger, M; Calloe, K; Stummann, TC; Larsen, HM; Nielsen, TT; Huang, JR; Xu, FP; Liu, X; Bolund, L; Meyer, M; Bak, LK; Waagepetersen, HS; Luo, YL; Nielsen, JE; Holst, B; Clausen, C; Hyttel, P; Freude, KK				Zhang, Yu; Schmid, Benjamin; Nikolaisen, Nanett K.; Rasmussen, Mikkel A.; Aldana, Blanca I.; Agger, Mikkel; Calloe, Kirstine; Stummann, Tina C.; Larsen, Hjalte M.; Nielsen, Troels T.; Huang, Jinrong; Xu, Fengping; Liu, Xin; Bolund, Lars; Meyer, Morten; Bak, Lasse K.; Waagepetersen, Helle S.; Luo, Yonglun; Nielsen, Jorgen E.; Holst, Bjorn; Clausen, Christian; Hyttel, Poul; Freude, Kristine K.		FReJA Consortium	Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B	STEM CELL REPORTS			English	Article							ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; APOLIPOPROTEIN-E; CELLS; MITOCHONDRIA; EXPRESSION; PATHOLOGY; TOXICITY; PROMOTES; DEFICITS	The truncated mutant form of the charged multivesicular body protein 2B (CHMP2B) is causative for frontotemporal dementia linked to chromosome 3 (FTD3). CHMP2B is a constituent of the endosomal sorting complex required for transport (ESCRT) and, when mutated, disrupts endosome-to-lysosome trafficking and substrate degradation. To understand the underlying molecular pathology, FTD3 patient induced pluripotent stem cells (iPSCs) were differentiated into forebrain-type cortical neurons. FTD3 neurons exhibited abnormal endosomes, as previously shown in patients. Moreover, mitochondria of FTD3 neurons displayed defective cristae formation, accompanied by deficiencies in mitochondrial respiration and increased levels of reactive oxygen. In addition, we provide evidence for perturbed iron homeostasis, presenting an in vitro patient-specific model to study the effects of iron accumulation in neurodegenerative diseases. All phenotypes observed in FTD3 neurons were rescued in CRISPR/Cas9-edited isogenic controls. These findings illustrate the relevance of our patient-specific in vitro models and open up possibilities for drug target development.	[Zhang, Yu; Nikolaisen, Nanett K.; Larsen, Hjalte M.; Hyttel, Poul; Freude, Kristine K.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Stem Cells & Embryol Grp, DK-1870 Frederiksberg C, Denmark; [Schmid, Benjamin; Rasmussen, Mikkel A.; Holst, Bjorn; Clausen, Christian] Bioneer AS, DK-2970 Horsholm, Denmark; [Aldana, Blanca I.; Bak, Lasse K.; Waagepetersen, Helle S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Neurometab Res Unit, DK-2100 Copenhagen, Denmark; [Agger, Mikkel; Meyer, Morten] Univ Southern Denmark, Dept Neurobiol Res, Stem Cell & Dev Neurobiol Grp, DK-5000 Odense C, Denmark; [Calloe, Kirstine] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Physiol Grp, DK-1870 Frederiksberg C, Denmark; [Stummann, Tina C.] H Lundbeck & Co AS, DK-2500 Valby, Denmark; [Nielsen, Troels T.; Nielsen, Jorgen E.] Univ Copenhagen, Rigshosp, Dept Neurol, Neurogenet Clin,Danish Dementia Res Ctr, DK-2100 Copenhagen, Denmark; [Nielsen, Troels T.; Nielsen, Jorgen E.] Univ Copenhagen, Rigshosp, Dept Neurol, Res Lab,Danish Dementia Res Ctr, DK-2100 Copenhagen, Denmark; [Huang, Jinrong; Xu, Fengping; Liu, Xin] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Huang, Jinrong; Xu, Fengping; Liu, Xin] BGI Shenzhen, China Natl GeneBank Shenzhen, Shenzhen 518083, Peoples R China; [Bolund, Lars; Luo, Yonglun] Aarhus Univ, Dept Biomed, Danish Regenerat Engn Alliance Med DREAM, DK-8000 Aarhus C, Denmark	Zhang, Y; Freude, KK (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Stem Cells & Embryol Grp, DK-1870 Frederiksberg C, Denmark.	yu.zhang@sund.ku.dk; kkf@sund.ku.dk	Calloe, Kirstine/H-8643-2016; Luo, Yonglun/C-4708-2013; Zhang, Yu/M-4249-2017	Calloe, Kirstine/0000-0002-1777-7938; Luo, Yonglun/0000-0002-0007-7759; Zhang, Yu/0000-0002-5592-111X; Holst, Bjorn/0000-0002-4517-6881; Liu, Xin/0000-0003-3256-2940; Bak, Lasse K./0000-0003-0784-7864	EU FP7 Marie Curie Industry-Academia Partnerships and Pathways (IAPP) grant (STEMMAD) [PIAPP-GA-2012-324451]; Innovation Fund Denmark (BrainStem) [4108-00008B]; Lundbeck Foundation [R151-201314439]; Danish Research Council for Independent Research [DFF-1337-00128, DFF-1335-00763]; China Scholarship Council; Ministry of Science, Technology and Innovation of Mexico	This work was supported by awards from: EU FP7 Marie Curie Industry-Academia Partnerships and Pathways (IAPP) grant (STEMMAD, PIAPP-GA-2012-324451), Innovation Fund Denmark (BrainStem, 4108-00008B), Lundbeck Foundation (R151-201314439) (L.B.), Danish Research Council for Independent Research (DFF-1337-00128 and DFF-1335-00763) (Y.L.), China Scholarship Council (Y.Z.), and Ministry of Science, Technology and Innovation of Mexico (B.I.A.). We are grateful to the FTD3 family for their support of this work. Finally, we would like to thank Ms. Hanne Holm and Tina Christoffersen from the University of Copenhagen, Ms. Ulla Poulsen from Bioneer A/S, and Mr. Lingfei Ye from BGIShenzhen for expert technical assistance.	Ahmad ST, 2009, P NATL ACAD SCI USA, V106, P12168, DOI 10.1073/pnas.0903134106; Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Cannizzo ES, 2012, CELL REPORTS, V2, P136, DOI 10.1016/j.celrep.2012.06.005; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chassefeyre R, 2015, J NEUROSCI, V35, P3155, DOI 10.1523/JNEUROSCI.0586-14.2015; Cho HJ, 2013, HUM MOL GENET, V22, P608, DOI 10.1093/hmg/dds470; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Ehrlich M, 2015, STEM CELL REP, V5, P83, DOI 10.1016/j.stemcr.2015.06.001; Ghazi-Noori S, 2012, BRAIN, V135, P819, DOI 10.1093/brain/aws006; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Holm IE, 2007, J NEUROPATH EXP NEUR, V66, P884, DOI 10.1097/nen.0b013e3181567f02; Isaacs AM, 2011, CURR ALZHEIMER RES, V8, P246; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Maki RA, 2009, J BIOL CHEM, V284, P3158, DOI 10.1074/jbc.M807731200; Martinez E, 2012, J ALZHEIMERS DIS, V30, P233, DOI 10.3233/JAD-2012-112102; Mwanjewe J, 2004, BIOCHEM J, V378, P975, DOI 10.1042/BJ20031187; Nguyen Ha Nam, 2011, Cell Stem Cell, V8, P267, DOI 10.1016/j.stem.2011.01.013; Nielsen TT, 2012, J GENE MED, V14, P521, DOI 10.1002/jgm.2649; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rasmussen MA, 2014, STEM CELL REP, V3, P404, DOI 10.1016/j.stemcr.2014.07.006; Rawson RL, 2014, CURR BIOL, V24, P760, DOI 10.1016/j.cub.2014.02.025; Rossor MN, 2010, LANCET NEUROL, V9, P793, DOI 10.1016/S1474-4422(10)70159-9; Urwin H, 2010, HUM MOL GENET, V19, P2228, DOI 10.1093/hmg/ddq100; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Xie YX, 2015, NEURON, V87, P355, DOI 10.1016/j.neuron.2015.06.026	27	5	5	6	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	MAR 14	2017	8	3					648	658		10.1016/j.stemcr.2017.01.012				11	Cell & Tissue Engineering; Cell Biology	Cell Biology	EP0VD	WOS:000397103900014	28216144	gold			2018-01-05	
J	Wang, Y; Xu, YQ; Liu, Q; Zhang, YY; Gao, Z; Yin, MZ; Jiang, N; Cao, GS; Yu, BY; Cao, ZY; Kou, JP				Wang, Yan; Xu, Yingqiong; Liu, Qian; Zhang, Yuanyuan; Gao, Zhen; Yin, Mingzhu; Jiang, Nan; Cao, Guosheng; Yu, Boyang; Cao, Zhengyu; Kou, Junping			Myosin IIA-related Actomyosin Contractility Mediates Oxidative Stress-induced Neuronal Apoptosis	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						oxidative stress; neuronal apoptosis; myosin IIA; myosin IIB; actomyosin contractility; positive feedback loop	NEURITE OUTGROWTH; HYDROGEN-PEROXIDE; MLC PHOSPHORYLATION; GROWTH CONES; BLEBBISTATIN INHIBITION; SYNAPTIC PLASTICITY; MICROTUBULE ADVANCE; CASPASE ACTIVATION; ACTIN DYNAMICS; CYTOCHALASIN-D	Oxidative stress-induced neuronal apoptosis plays an important role in the progression of central nervous system (CNS) diseases. In our study, when neuronal cells were exposed to hydrogen peroxide (H2O2), an exogenous oxidant, cell apoptosis was observed with typical morphological changes including membrane blebbing, neurite retraction and cell contraction. The actomyosin system is considered to be responsible for the morphological changes, but how exactly it regulates oxidative stress-induced neuronal apoptosis and the distinctive functions of different myosin II isoforms remain unclear. We demonstrate that myosin IIA was required for neuronal contraction, while myosin IIB was required for neuronal outgrowth in normal conditions. During H2O2-induced neuronal apoptosis, myosin IIA, rather than IIB, interacted with actin filaments to generate contractile forces that lead to morphological changes. Moreover, myosin IIA knockout using clustered regularly interspaced short palindromic repeats/CRISPR-associated protein-9 nuclease (CRISPR/Cas9) reduced H2O2-induced neuronal apoptosis and the associated morphological changes. We further demonstrate that caspase-3/Rho-associated kinase 1 (ROCK1) dependent phosphorylation of myosin light chain (MLC) was required for the formation of the myosin IIA-actin complex. Meanwhile, either inhibition of myosin II ATPase with blebbistatin or knockdown of myosin IIA with siRNA reversely attenuated caspase-3 activation, suggesting a positive feedback loop during oxidative stress-induced apoptosis. Based on our observation, myosin IIA-actin complex contributes to actomyosin contractility and is associated with the positive feedback loop of caspase-3/ROCK1/MLC pathway. This study unravels the biochemical and mechanistic mechanisms during oxidative stress-induced neuronal apoptosis and may be applicable for the development of therapies for CNS diseases.	[Wang, Yan; Xu, Yingqiong; Zhang, Yuanyuan; Jiang, Nan; Cao, Guosheng; Yu, Boyang; Cao, Zhengyu; Kou, Junping] China Pharmaceut Univ, Dept Complex Prescript TCM, Jiangsu Key Lab TCM Evaluat & Translat Res, State Key Lab Nat Prod, Nanjing, Jiangsu, Peoples R China; [Liu, Qian] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Gao, Zhen] Baylor Coll Med, Dept Med Ather & Lipo, Houston, TX 77030 USA; [Yin, Mingzhu] Yale Sch Med, Dept Pathol, New Haven, CT USA	Cao, ZY; Kou, JP (reprint author), China Pharmaceut Univ, Dept Complex Prescript TCM, Jiangsu Key Lab TCM Evaluat & Translat Res, State Key Lab Nat Prod, Nanjing, Jiangsu, Peoples R China.	zycao1999@hotmail.com; junpingkou@cpu.edu.cn			National Natural Science Foundation of China [81274004]; Fundamental Research Funds for the Central Universities [2410724]; Priority Academic Program Development of Jiangsu Higher Education Institution	This work was supported by the National Natural Science Foundation of China (No. 81274004) and the Fundamental Research Funds for the Central Universities (No. 2410724), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution.	Ailenberg M, 2003, BBA-MOL CELL RES, V1593, P249, DOI 10.1016/S0167-4889(02)00395-6; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Bao JJ, 2007, J BIOL CHEM, V282, P22102, DOI 10.1074/jbc.M702731200; Beach JR, 2015, EXP CELL RES, V334, P2, DOI 10.1016/j.yexcr.2015.01.012; Ben Amor N, 2006, CELL SIGNAL, V18, P1252, DOI 10.1016/j.cellsig.2005.10.002; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Cao ZY, 2015, MAR DRUGS, V13, P903, DOI 10.3390/md13020903; Chantler P D, 2003, IEE Proc Nanobiotechnol, V150, P111, DOI 10.1049/ip-nbt:20031076; Cheffings TH, 2016, CURR BIOL, V26, pR719, DOI 10.1016/j.cub.2016.06.071; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; Eitaki M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-469; Even-Faitelson L, 2005, CELL SIGNAL, V17, P1137, DOI 10.1016/j.cellsig.2004.12.015; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fenix AM, 2016, MOL BIOL CELL, V27, P1465, DOI 10.1091/mbc.E15-10-0725; Gordon-Weeks PR, 2014, J NEUROCHEM, V129, P206, DOI 10.1111/jnc.12502; Guo W, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.276; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Hayashi-Takagi A, 2014, P NATL ACAD SCI USA, V111, P6461, DOI 10.1073/pnas.1321109111; Hur EM, 2011, P NATL ACAD SCI USA, V108, P5057, DOI 10.1073/pnas.1011258108; Hyland C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04961; Kamat PK, 2016, MOL NEUROBIOL, V53, P648, DOI 10.1007/s12035-014-9053-6; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245                                                    ; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lai JM, 2003, J CELL SCI, V116, P3491, DOI 10.1242/jcs.00660; Landino J, 2016, CURR BIOL, V26, P698, DOI 10.1016/j.cub.2016.01.018; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Liu JY, 2017, MOL MED REP, V15, P169, DOI 10.3892/mmr.2016.6031; Liu L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.469; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Minambres R, 2006, J CELL SCI, V119, P271, DOI 10.1242/jcs.02723; Nair UB, 2008, J MOL BIOL, V384, P848, DOI 10.1016/j.jmb.2008.09.082; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; Nilius B, 2000, FEBS LETT, V466, P346, DOI 10.1016/S0014-5793(00)01097-8; Ozkan ED, 2015, J NEUROCHEM, V134, P429, DOI 10.1111/jnc.13146; Park JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21857; Pool M, 2011, J NEUROIMMUNOL, V237, P101, DOI 10.1016/j.jneuroim.2011.06.004; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sari-Hassoun M, 2016, BIOCHEM PHARMACOL, V102, P45, DOI 10.1016/j.bcp.2015.12.013; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shelton MA, 2015, BIOL PSYCHIAT, V78, P374, DOI 10.1016/j.biopsych.2014.12.029; Shen K, 2015, REJUV RES, V18, P517, DOI 10.1089/rej.2015.1697; Shen KK, 2015, MOL CANCER THER, V14, P1738, DOI 10.1158/1535-7163.MCT-14-1048; Shi YL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.547; SIMONS M, 1991, CIRC RES, V69, P530; Sohn EJ, 2016, INT J MOL MED, V38, P225, DOI 10.3892/ijmm.2016.2596; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Solinet S, 2008, J CELL SCI, V121, P1681, DOI 10.1242/jcs.022640; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Turney SG, 2016, MOL BIOL CELL, V27, P500, DOI 10.1091/mbc.E15-09-0636; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Volpe M, 2015, EUR HEART J, V36, P1573, DOI 10.1093/eurheartj/ehv175; Walker A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1074; Wang SY, 2017, APOPTOSIS, V22, P449, DOI 10.1007/s10495-016-1329-z; Wang Y, 2016, INT J BIOL SCI, V12, P1341, DOI 10.7150/ijbs.15992; Wickman GR, 2013, CELL DEATH DIFFER, V20, P1293, DOI 10.1038/cdd.2013.69; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Wylie SR, 2001, NAT CELL BIOL, V3, P88; Yu PP, 2012, J NEUROCHEM, V120, P1117, DOI 10.1111/j.1471-4159.2011.07638.x; Zambon P, 2017, CURR BIOL, V27, pR99, DOI 10.1016/j.cub.2016.12.024; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783	72	0	0	2	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	MAR 14	2017	10								75	10.3389/fnmol.2017.00075				20	Neurosciences	Neurosciences & Neurology	EN8UH	WOS:000396274800001	28352215	gold			2018-01-05	
J	Nayak, DD; Metcalf, WW				Nayak, Dipti D.; Metcalf, William W.			Cas9-mediated genome editing in the methanogenic archaeon Methanosarcina acetivorans	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						Cas9; Archaea; methanogens; Methanosarcina; genetics	COENZYME-M REDUCTASE; CRISPR-CAS SYSTEMS; GENE-EXPRESSION; BARKERI FUSARO; HUMAN-CELLS; BACTERIA; DIVERSITY; PROTEINS; REPAIR; RECOMBINATION	Although Cas9-mediated genome editing has proven to be a powerful genetic tool in eukaryotes, its application in Bacteria has been limited because of inefficient targeting or repair; and its application to Archaea has yet to be reported. Here we describe the development of a Cas9-mediated genome-editing tool that allows facile genetic manipulation of the slow-growing methano-genic archaeon Methanosarcina acetivorans. Introduction of both insertions and deletions by homology-directed repair was remarkably efficient and precise, occurring at a frequency of approximately 20% relative to the transformation efficiency, with the desired mutation being found in essentially all transformants examined. Off-target activity was not observed. We also observed that multiple single-guide RNAs could be expressed in the same transcript, reducing the size of mutagenic plasmids and simultaneously simplifying their design. Cas9-mediated genome editing reduces the time needed to construct mutants by more than half (3 vs. 8 wk) and allows simultaneous construction of double mutants with high efficiency, exponentially decreasing the time needed for complex strain constructions. Furthermore, coexpression the non-homologous end-joining (NHEJ) machinery from the closely related archaeon, Methanocella paludicola, allowed efficient Cas9-mediated genome editing without the need for a repair template. The NHEJ-dependent mutations included deletions ranging from 75 to 2.7 kb in length, most of which appear to have occurred at regions of naturally occurring microhomology. The combination of homology-directed repair-dependent and NHEJ-dependent genome-editing tools comprises a powerful genetic system that enables facile insertion and deletion of genes, rational modification of gene expression, and testing of gene essentiality.	[Nayak, Dipti D.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	Metcalf, WW (reprint author), Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA.	metcalf@illinois.edu		Nayak, Dipti/0000-0002-8390-7251; Metcalf, William/0000-0002-0182-0671	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-02ER15296]; Carl R.Woese Institute for Genomic Biology postdoctoral fellowship	We thank Dr.Mary Elizabeth Metcalf for technical assistance. This work was supported in part by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy Grant DE-FG02-02ER15296 (to W.W.M.), and the Carl R. Woese Institute for Genomic Biology postdoctoral fellowship (to D.D.N.). D.D.N. currently a Simons Foundation fellow of the Life Sciences Research Foundation.	Barrangou R, 2016, CURR OPIN BIOTECH, V37, P61, DOI 10.1016/j.copbio.2015.10.003; Barrick JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1039; Bartlett EJ, 2016, NUCLEIC ACIDS RES, V44, P2173, DOI 10.1093/nar/gkv965; Bartlett EJ, 2013, P NATL ACAD SCI USA, V110, pE1984, DOI 10.1073/pnas.1302616110; Boccazzi P, 2000, J BACTERIOL, V182, P2611, DOI 10.1128/JB.182.9.2611-2618.2000; Buan NR, 2010, MOL MICROBIOL, V75, P843, DOI 10.1111/j.1365-2958.2009.06990.x; Costa KC, 2014, CURR OPIN BIOTECH, V29, P70, DOI 10.1016/j.copbio.2014.02.012; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Guss Adam M., 2008, Archaea, V2, P193, DOI 10.1155/2008/534081; Guss AM, 2005, MOL MICROBIOL, V55, P1671, DOI 10.1111/j.1365-2958.2005.04514.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kahnt J, 2007, FEBS J, V274, P4913, DOI 10.1111/j.1742-4658.2007.06016.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim SY, 2012, ANTIMICROB AGENTS CH, V56, P4175, DOI 10.1128/AAC.06478-11; Kohler PRA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00259; Li H, 2016, METAB ENG, V38, P293, DOI 10.1016/j.ymben.2016.09.006; Li YJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1044; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Metcalf WW, 1998, APPL ENVIRON MICROB, V64, P768; Metcalf WW, 1997, P NATL ACAD SCI USA, V94, P2626, DOI 10.1073/pnas.94.6.2626                                                          ; Metcalf WW, 1996, J BACTERIOL, V178, P5797, DOI 10.1128/jb.178.19.5797-5802.1996                                                ; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pritchett MA, 2004, APPL ENVIRON MICROB, V70, P1425, DOI 10.1128/AEM.70.3.1425-1433.2004; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rother M, 2005, J BACTERIOL, V187, P5552, DOI 10.1128/JB.187.16.5552-5559.2005; SOWERS KR, 1993, APPL ENVIRON MICROB, V59, P3832; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213                                                  ; White MF, 2011, BIOCHEM SOC T, V39, P15, DOI 10.1042/BST0390015; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Youngblut ND, 2015, ISME J, V9, P2191, DOI 10.1038/ismej.2015.31	45	4	4	3	19	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAR 14	2017	114	11					2976	2981		10.1073/pnas.1618596114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EN6DH	WOS:000396094200058	28265068	green_published			2018-01-05	
J	Qin, PW; Parlak, M; Kuscu, C; Bandaria, J; Mir, M; Szlachta, K; Singh, R; Darzacq, X; Yildiz, A; Adli, M				Qin, Peiwu; Parlak, Mahmut; Kuscu, Cem; Bandaria, Jigar; Mir, Mustafa; Szlachta, Karol; Singh, Ritambhara; Darzacq, Xavier; Yildiz, Ahmet; Adli, Mazhar			Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9	NATURE COMMUNICATIONS			English	Article							SPATIAL GENOME ORGANIZATION; ONE-STEP GENERATION; CRISPR/CAS SYSTEM; GENE-EXPRESSION; NUCLEAR LAMINA; DNA-SEQUENCES; CAS SYSTEMS; RNA; CHROMATIN; ENDONUCLEASE	Imaging chromatin dynamics is crucial to understand genome organization and its role in transcriptional regulation. Recently, the RNA-guidable feature of CRISPR-Cas9 has been utilized for imaging of chromatin within live cells. However, these methods are mostly applicable to highly repetitive regions, whereas imaging regions with low or no repeats remains as a challenge. To address this challenge, we design single-guide RNAs (sgRNAs) integrated with up to 16 MS2 binding motifs to enable robust fluorescent signal amplification. These engineered sgRNAs enable multicolour labelling of low-repeat-containing regions using a single sgRNA and of non-repetitive regions with as few as four unique sgRNAs. We achieve tracking of native chromatin loci throughout the cell cycle and determine differential positioning of transcriptionally active and inactive regions in the nucleus. These results demonstrate the feasibility of our approach to monitor the position and dynamics of both repetitive and non-repetitive genomic regions in live cells.	[Qin, Peiwu; Bandaria, Jigar; Yildiz, Ahmet] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Parlak, Mahmut; Kuscu, Cem; Szlachta, Karol; Singh, Ritambhara; Adli, Mazhar] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Mir, Mustafa; Darzacq, Xavier; Yildiz, Ahmet] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Singh, Ritambhara] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22904 USA	Yildiz, A (reprint author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Adli, M (reprint author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.; Yildiz, A (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	yildiz@berkeley.edu; adli@virginia.edu		Darzacq, Xavier/0000-0003-2537-8395	V scholar award of V Cancer Research foundation; University of Virginia Cancer Center Pilot award; NIH [GM094522, U54-DK107980, U01-EB021236]; NSF CAREER Award [MCB-1055017]; California Institute for Regenerative Medicine (CIRM) [LA1-08013]	We thank Adli and Yildiz lab members for constructive criticism and discussions and B. Huang for sharing the dCas9-eGFP U2OS cell line. X.D. and M.M. thank A. Tangara for help in the assembly and maintenance of the LLSM. The research was funded by V scholar award of V Cancer Research foundation (M.A.), University of Virginia Cancer Center Pilot award (M.A.), NIH (GM094522 to A.Y.), the NSF CAREER Award (MCB-1055017 to A.Y.), NIH (U54-DK107980 and U01-EB021236 to X.D.), and California Institute for Regenerative Medicine (CIRM, LA1-08013 to X.D.).	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Chen BH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1533; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11707; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jegou T, 2009, MOL BIOL CELL, V20, P2070, DOI 10.1091/mbc.E08-02-0108; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindhout BI, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm618; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Shachar S, 2015, CELL, V162, P911, DOI 10.1016/j.cell.2015.07.035; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao SP, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw066; SUGIYAMA T, 1970, J MOL BIOL, V48, P349, DOI 10.1016/0022-2836(70)90166-X; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/NMETH.1171; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26857; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Williamson I, 2014, GENE DEV, V28, P2778, DOI 10.1101/gad.251694.114; Wu B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03615; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	52	7	7	10	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAR 14	2017	8								14725	10.1038/ncomms14725				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EN6IA	WOS:000396106500001	28290446	gold			2018-01-05	
J	Yu, WH; Mookherjee, S; Chaitankar, V; Hiriyanna, S; Kim, JW; Brooks, M; Ataeijannati, Y; Sun, X; Dong, LJ; Li, TS; Swaroop, A; Wu, ZJ				Yu, Wenhan; Mookherjee, Suddhasil; Chaitankar, Vijender; Hiriyanna, Suja; Kim, Jung-Woong; Brooks, Matthew; Ataeijannati, Yasaman; Sun, Xun; Dong, Lijin; Li, Tiansen; Swaroop, Anand; Wu, Zhijian			Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice	NATURE COMMUNICATIONS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; STAPHYLOCOCCUS-AUREUS CAS9; TRANSCRIPTION FACTOR NRL; CONE VIABILITY FACTOR; IN-VIVO; GENE-THERAPY; ROD PHOTORECEPTORS; MUSCULAR-DYSTROPHY; MOUSE RETINA; RAT MODEL	In retinitis pigmentosa, loss of cone photoreceptors leads to blindness, and preservation of cone function is a major therapeutic goal. However, cone loss is thought to occur as a secondary event resulting from degeneration of rod photoreceptors. Here we report a genome editing approach in which adeno-associated virus (AAV)-mediated CRISPR/Cas9 delivery to postmitotic photoreceptors is used to target the Nrl gene, encoding for Neural retina-specific leucine zipper protein, a rod fate determinant during photoreceptor development. Following Nrl disruption, rods gain partial features of cones and present with improved survival in the presence of mutations in rod-specific genes, consequently preventing secondary cone degeneration. In three different mouse models of retinal degeneration, the treatment substantially improves rod survival and preserves cone function. Our data suggest that CRISPR/Cas9-mediated NRL disruption in rods may be a promising treatment option for patients with retinitis pigmentosa.	[Yu, Wenhan; Mookherjee, Suddhasil; Hiriyanna, Suja; Ataeijannati, Yasaman; Wu, Zhijian] NEI, Ocular Gene Therapy Core, NIH, 6 Ctr Dr,Room 307, Bethesda, MD 20892 USA; [Chaitankar, Vijender; Kim, Jung-Woong; Brooks, Matthew; Sun, Xun; Li, Tiansen; Swaroop, Anand] NEI, Neurobiology Neurodegenerat & Repair Lab, NIH, 6 Ctr Dr,Room 307, Bethesda, MD 20892 USA; [Dong, Lijin] NEI, Genet Engn Core, NIH, 6 Ctr Dr,Room B102, Bethesda, MD 20892 USA	Wu, ZJ (reprint author), NEI, Ocular Gene Therapy Core, NIH, 6 Ctr Dr,Room 307, Bethesda, MD 20892 USA.	wuzh@mail.nih.gov		Li, Tiansen/0000-0002-9537-2573; Yu, Wenhan/0000-0002-0125-4358	National Eye Institute	We thank Wei Li, Jacob Nellissery, Jessica Gumerson, Yide Mi, Megan Kopera and Linn Gieser for their assistance. We also thank the Visual Function Core, Flow Cytometry Core, Histopathology Core and Biological Imaging Core of the National Eye Institute and the NIH Intramural Sequencing Center (NISC) for their assistance. This work was supported by the intramural research program of the National Eye Institute.	Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Bessant DAR, 1999, NAT GENET, V21, P355; Botta S, 2016, ELIFE, V5, DOI [10.7554/eLife/12242, 10.7554/eLife.12242]; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Brooks Matthew J, 2012, Methods Mol Biol, V884, P319, DOI 10.1007/978-1-61779-848-1_23; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; FLETCHER RT, 1986, J NEUROCHEM, V46, P1240, DOI 10.1111/j.1471-4159.1986.tb00644.x; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495                                                      ; Guo XZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9005; Hao H, 2014, HUM MOL GENET, V23, P4260, DOI 10.1093/hmg/ddu143; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P781, DOI 10.1167/iovs.07-0715; Khani SC, 2007, INVEST OPHTH VIS SCI, V48, P3954, DOI 10.1167/iovs.07-0257; Kim JW, 2016, DEV CELL, V37, P520, DOI 10.1016/j.devcel.2016.05.023; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736                                                           ; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176                                                        ; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V57, P224; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Millington-Ward S, 2011, MOL THER, V19, P642, DOI 10.1038/mt.2010.293; Mo A, 2016, ELIFE, V5, DOI 10.7554/eLife.11613; Montana CL, 2013, P NATL ACAD SCI USA, V110, P1732, DOI 10.1073/pnas.1214387110; Montana CL, 2011, J BIOL CHEM, V286, P36921, DOI 10.1074/jbc.M111.279026; Mussolino C, 2011, EMBO MOL MED, V3, P118, DOI 10.1002/emmm.201000119; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishiguchi KM, 2004, P NATL ACAD SCI USA, V101, P17819, DOI 10.1073/pnas.0408183101; Ogilvie JM, 1999, J NEUROSCI METH, V87, P57; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Onishi A, 2010, P NATL ACAD SCI USA, V107, P11579, DOI 10.1073/pnas.1000102107; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roger JE, 2012, J NEUROSCI, V32, P528, DOI 10.1523/JNEUROSCI.3591-11.2012; Ronquillo CC, 2016, FASEB J, V30, P3400, DOI 10.1096/fj.201600511R; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Strettoi E, 2004, J NEUROSCI, V24, P7576, DOI 10.1523/JNEUROSCI.2245-04.2004; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Venkatesh A, 2015, J CLIN INVEST, V125, P1446, DOI 10.1172/JCI79766; Wen R, 2012, PROG RETIN EYE RES, V31, P136, DOI 10.1016/j.preteyeres.2011.11.005; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471	70	12	12	7	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAR 14	2017	8								14716	10.1038/ncomms14716				15	Multidisciplinary Sciences	Science & Technology - Other Topics	EN6HX	WOS:000396106200001	28291770	gold			2018-01-05	
J	Chen, XG; Lu, XK; Shu, N; Wang, S; Wang, JJ; Wang, DL; Guo, LX; Ye, WW				Chen, Xiugui; Lu, Xuke; Shu, Na; Wang, Shuai; Wang, Junjuan; Wang, Delong; Guo, Lixue; Ye, Wuwei			Targeted mutagenesis in cotton (Gossypium hirsutum L.) using the CRISPR/Cas9 system	SCIENTIFIC REPORTS			English	Article							GENE; SPECIFICITY; ARABIDOPSIS; GENERATION; NUCLEASES	The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 system has been widely used for genome editing in various plants because of its simplicity, high efficiency and design flexibility. However, to our knowledge, there is no report on the application of CRISPR/Cas9-mediated targeted mutagenesis in cotton. Here, we report the genome editing and targeted mutagenesis in upland cotton (Gossypium hirsutum L., hereafter cotton) using the CRISPR/Cas9 system. We designed two guide RNAs to target distinct sites of the cotton Cloroplastos alterados 1 (GhCLA1) and vacuolar H+-pyrophosphatase (GhVP) genes. Mutations in these two genes were detected in cotton protoplasts. Most of the mutations were nucleotide substitutions, with one nucleotide insertion and one substitution found in GhCLA1 and one deletion found in GhVP in cotton protoplasts. Subsequently, the two vectors were transformed into cotton shoot apexes through Agrobacterium-mediated transformation, resulting in efficient target gene editing. Most of the mutations were nucleotide deletions, and the mutation efficiencies were 47.6-81.8% in transgenic cotton plants. Evaluation using restriction-enzyme-PCR assay and sequence analysis detected no off-target mutations. Our results indicated that the CRISPR/Cas9 system was an efficient and specific tool for targeted mutagenesis of the cotton genome.	[Chen, Xiugui; Lu, Xuke; Shu, Na; Wang, Shuai; Wang, Junjuan; Wang, Delong; Guo, Lixue; Ye, Wuwei] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China; [Chen, Xiugui] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China	Ye, WW (reprint author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	yew158@163.com			National key research and development program [2016YFD0101006]	This work was supported by grants from National key research and development program (2016YFD0101006).	Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang W., 2014, PLOS ONE; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li F, 2015, NATURE BIOTECHNOLOGY, V33; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; [吕素莲 Lv Sulian], 2004, [高技术通讯, High Technology Letters], V14, P20; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Rinaldo AR, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0210-z; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang B., 2013, TRANSGENIC COTTON BI; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang KW, 2011, EUPHYTICA, V181, P1, DOI 10.1007/s10681-011-0354-9; Zhou XH, 2015, NEW PHYTOL, V208, P298, DOI 10.1111/nph.13470	22	6	6	15	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 13	2017	7								44304	10.1038/srep44304				7	Multidisciplinary Sciences	Science & Technology - Other Topics	EN7UE	WOS:000396206900001	28287154	gold			2018-01-05	
J	Wrona, D; Siler, U; Reichenbach, J				Wrona, Dominik; Siler, Ulrich; Reichenbach, Janine			CRISPR/Cas9-generated p47(phox)-deficient cell line for Chronic Granulomatous Disease gene therapy vector development	SCIENTIFIC REPORTS			English	Article							PLURIPOTENT STEM-CELLS; MATURE NEUTROPHILS; DIFFERENTIATION; GRANULOCYTES; PLB-985; RESCUE; SYSTEM; CGD	Development of gene therapy vectors requires cellular models reflecting the genetic background of a disease thus allowing for robust preclinical vector testing. For human p47(phox)-deficient chronic granulomatous disease (CGD) vector testing we generated a cellular model using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 to introduce a GT-dinucleotide deletion (Delta GT) mutation in p47(phox) encoding NCF1 gene in the human acute myeloid leukemia PLB-985 cell line. CGD is a group of hereditary immunodeficiencies characterized by impaired respiratory burst activity in phagocytes due to a defective phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. In Western countries autosomal-recessive p47(phox)-subunit deficiency represents the second largest CGD patient cohort with unique genetics, as the vast majority of p47(phox) CGD patients carries Delta GT deletion in exon two of the NCF1 gene. The established PLB-985 NCF1 Delta GT cell line reflects the most frequent form of p47(phox)-deficient CGD genetically and functionally. It can be differentiated to granulocytes efficiently, what creates an attractive alternative to currently used iPSC models for rapid testing of novel gene therapy approaches.	[Wrona, Dominik; Siler, Ulrich; Reichenbach, Janine] Univ Childrens Hosp Zurich, Div Immunol, Zurich, Switzerland; [Wrona, Dominik; Siler, Ulrich; Reichenbach, Janine] Childrens Res Ctr, Zurich, Switzerland; [Wrona, Dominik; Siler, Ulrich; Reichenbach, Janine] Univ Zurich, Zurich, Switzerland	Reichenbach, J (reprint author), Univ Childrens Hosp Zurich, Div Immunol, Zurich, Switzerland.; Reichenbach, J (reprint author), Childrens Res Ctr, Zurich, Switzerland.; Reichenbach, J (reprint author), Univ Zurich, Zurich, Switzerland.	janine.reichenbach@kispi.uzh.ch			CGD Society [CGDS16/01]; EU-FP7 CELL-PID [HEALTH-2010-261387]; EU-FP7 NET4CGD; Fondazione Ettore e Valeria Rossi foundation; Gebert Ruf Stiftung, program [GRS-046/10]; Gottfried und Julia Bangerter-Rhyner-Stiftung; Hochspezialisierte Medizin Schwerpunkt Immunologie (HSM-2-Immunologie); ZIHP (Zurich Center for Integrative Human Physiology)	We thank the Functional Genomics Center Zurich for SMRT sequencing, and Giancarlo Russo for SMRT sequencing data analysis. The study was supported by The CGD Society (grant no. CGDS16/01), EU-FP7 CELL-PID HEALTH-2010-261387, EU-FP7 NET4CGD, Fondazione Ettore e Valeria Rossi foundation, Gebert Ruf Stiftung, program "Rare Diseases- New Approaches" (grant no. GRS-046/10), the Gottfried und Julia Bangerter-Rhyner-Stiftung, Hochspezialisierte Medizin Schwerpunkt Immunologie (HSM-2-Immunologie) and by ZIHP (Zurich Center for Integrative Human Physiology),	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Brendel C, 2013, HUM GENE THER METHOD, V24, P151, DOI 10.1089/hgtb.2012.157; COLLINS JM, 1983, J CELL BIOL, V96, P94, DOI 10.1083/jcb.96.1.94                                                             ; CURNUTTE JT, 1994, MOL BASIS BLOOD DISE, P493; Dekker J, 2001, EXP HEMATOL, V29, P1319, DOI 10.1016/S0301-472X(01)00731-7; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Gorlach A, 1997, J CLIN INVEST, V100, P1907, DOI 10.1172/JCI119721; Gungor T, 2014, LANCET, V383, P436, DOI [10.1016/s0140-6736(13)62069-3, 10.1016/S0140-6736(13)62069-3]; Jiang Y, 2012, STEM CELLS, V30, P599, DOI 10.1002/stem.1053; Kaufmann KB, 2014, CURR GENE THER, V14, P447, DOI 10.2174/1566523214666140918113201                                               ; Lachmann N, 2015, STEM CELL REP, V4, P282, DOI 10.1016/j.stemcr.2015.01.005; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roos D, 2003, MICROBES INFECT, V5, P1307, DOI 10.1016/j.micinf.2003.09.009; Seger RA, 2011, CURR OPIN HEMATOL, V18, P36, DOI 10.1097/MOH.0b013e32834115e7; Siler U, 2015, CURR GENE THER, V15, P416, DOI 10.2174/1566523215666150515145255                                               ; Sweeney CL, 2014, METHODS MOL BIOL, V1124, P189, DOI 10.1007/978-1-62703-845-4_12; TUCKER KA, 1987, BLOOD, V70, P372; Vazquez N, 2001, EXP HEMATOL, V29, P234, DOI 10.1016/S0301-472X(00)00646-9                                                   ; Wohlgensinger V, 2010, GENE THER, V17, P1193, DOI 10.1038/gt.2010.73; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	24	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 13	2017	7								44187	10.1038/srep44187				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EO0YD	WOS:000396423600001	28287132	gold			2018-01-05	
J	Kaya, H; Numa, H; Nishizawa-Yokoi, A; Toki, S; Habu, Y				Kaya, Hidetaka; Numa, Hisataka; Nishizawa-Yokoi, Ayako; Toki, Seiichi; Habu, Yoshiki			DNA Methylation Affects the Efficiency of Transcription Activator-Like Effector Nucleases-Mediated Genome Editing in Rice	FRONTIERS IN PLANT SCIENCE			English	Article						DNA methylation; genome editing; methylcytosine-recognition module; rice; TALENs	TARGETED MUTAGENESIS; TALEN; ANIMALS; PLANTS	Genome editing in plants becomes popular since the advent of sequence-specific nucleases (SSNs) that are simple to set up and efficient in various plant species. Although transcription activator-like effector nucleases (TALENs) are one of the most prevalent SSNs and have a potential to provide higher target specificity by their dimeric property, TALENs are sensitive to methylated cytosines that are present not only in transposons but also in active genes in plants. In mammalian cells, the methylation sensitivity of TALENs could be overcome by using a base-recognition module (N*) that has a higher affinity to methylated cytosine. In contrast to mammals, plants carry DNA methylation at all cytosine contexts (CG, CHG, and CHH, where H represents A, C, or T) with various degrees and effectiveness of N* module in genome editing in plants has not been explored. In this study, we designed sets of TALENs with or without N* modules and examined their efficiency in genome editing of methylated regions in rice. Although improvement in genome editing efficiency was observed with N*-TALENs designed to a stably methylated target, another target carrying cytosines with various levels of methylation showed resistance to both normal and N*-TALENs. The results suggest that variability of cytosine methylation in target regions is an additional factor affecting the genome editing efficiency of TALENs.	[Kaya, Hidetaka; Nishizawa-Yokoi, Ayako; Toki, Seiichi; Habu, Yoshiki] Natl Agr & Food Res Org NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Numa, Hisataka] Natl Agr & Food Res Org NARO, Adv Anal Ctr, Tsukuba, Ibaraki, Japan	Habu, Y (reprint author), Natl Agr & Food Res Org NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	habu@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries Japan [PGE1004]; CREST/JST	This work was supported by grants of the Ministry of Agriculture, Forestry and Fisheries Japan (PGE1004) and CREST/JST to YH.	Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nishizawa-Yokoi A, 2016, PLANT PHYSIOL, V170, P653, DOI 10.1104/pp.15.01542; Stroud H, 2013, ELIFE, V2, DOI 10.7554/eLife.00354; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	14	1	1	2	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	MAR 13	2017	8								302	10.3389/fpls.2017.00302				4	Plant Sciences	Plant Sciences	EN5YP	WOS:000396082000001	28348570	gold			2018-01-05	
J	Liu, H; Leslie, EJ; Carlson, JC; Beaty, TH; Marazita, ML; Lidral, AC; Cornell, RA				Liu, Huan; Leslie, Elizabeth J.; Carlson, Jenna C.; Beaty, Terri H.; Marazita, Mary L.; Lidral, Andrew C.; Cornell, Robert A.			Identification of common non-coding variants at 1p22 that are functional for non-syndromic orofacial clefting	NATURE COMMUNICATIONS			English	Article							GENOME-WIDE ASSOCIATION; EPIDERMAL DIFFERENTIATION; CHROMATIN INTERACTIONS; SUSCEPTIBILITY LOCUS; TOPOLOGICAL DOMAINS; STARGARDTS-DISEASE; MAMMALIAN GENOMES; GENE-EXPRESSION; TARGET GENE; PALATE	Genome-wide association studies (GWAS) do not distinguish between single nucleotide polymorphisms (SNPs) that are causal and those that are merely in linkage-disequilibrium with causal mutations. Here we describe a versatile, functional pipeline and apply it to SNPs at 1p22, a locus identified in several GWAS for non-syndromic cleft lip with or without cleft palate (NS CL/P). First we amplified DNA elements containing the ten most-highly risk-associated SNPs and tested their enhancer activity in vitro, identifying three SNPs with allele-dependent effects on such activity. We then used in vivo reporter assays to test the tissue-specificity of these enhancers, chromatin configuration capture to test enhancer-promoter interactions, and genome editing in vitro to show allele-specific effects on ARHGAP29 expression and cell migration. Our results further indicate that two SNPs affect binding of CL/P-associated transcription factors, and one affects chromatin configuration. These results translate risk into potential mechanisms of pathogenesis.	[Liu, Huan; Cornell, Robert A.] Univ Iowa, Dept Anat & Cell Biol, Coll Med, Iowa City, IA 52242 USA; [Liu, Huan] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Hubei, Peoples R China; [Liu, Huan] Wuhan Univ, Sch, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Hubei, Peoples R China; [Liu, Huan] Wuhan Univ, Hosp Stomatol, Wuhan 430079, Hubei, Peoples R China; [Leslie, Elizabeth J.; Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15219 USA; [Carlson, Jenna C.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Marazita, Mary L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15219 USA; [Marazita, Mary L.] Univ Pittsburgh, Clin & Translat Sci Inst, Sch Med, Pittsburgh, PA 15219 USA; [Lidral, Andrew C.] Univ Iowa, Dept Orthodont, Coll Dent, Iowa City, IA 52246 USA	Cornell, RA (reprint author), Univ Iowa, Dept Anat & Cell Biol, Coll Med, Iowa City, IA 52242 USA.	robert-cornell@uiowa.edu		Liu, Huan/0000-0002-9947-6687	National Institute of Health [DE023575, DE025060, DE016148, HG005925, DE014581, DE018993]; National Natural Science Foundation of China [81400477];  [DE08559]	We are grateful for excellent technical assistance and animal husbandry from Greg Bonde. We are grateful to Johann Eberhart from the University of Texas at Austin for helping us interpret zebrafish craniofacial anatomy. We thank Martine Dunnwald for discussion of the in vitro scratch assay, Adam Dupuy for discussion of CRISPR experiment design, and Jeffery Murray, supported by DE08559, for permitting analysis of unpublished targeted resequencing results. We thank Axel Visel and Cailyn Spurrell for preliminary analyses of enhancer activity in mouse embryos of a subset of elements discussed here. Research reported in this publication was supported by the National Institute of Health grants DE023575 (R.A.C.), DE025060 (E.J.L.), DE016148 (M.L.M.), HG005925 (M.L.M.), DE014581 and DE018993 (T.H.B.), and by the National Natural Science Foundation of China 81400477 (H.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Barde I, 2010, CURR PROTOC NEUROSCI, V53, P4211; Beaty TH, 2013, HUM GENET, V132, P771, DOI 10.1007/s00439-013-1283-6; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Biggs LC, 2014, J CELL SCI, V127, P2840, DOI 10.1242/jcs.139246; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Camargo M, 2012, EUR J MED GENET, V55, P510, DOI 10.1016/j.ejmg.2012.06.005; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Finger JH, 2015, GENESIS, V53, P510, DOI 10.1002/dvg.22864; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gilchrist EP, 2000, ORAL SURG ORAL MED O, V90, P340, DOI 10.1067/moe.2000.107360; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hitchler MJ, 2011, METHODS MOL BIOL, V767, P253, DOI 10.1007/978-1-61779-201-4_19; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Knight RD, 2005, DEVELOPMENT, V132, P3127, DOI 10.1242/dev.01879; LaFave MC, 2014, GENETICS, V198, P167, DOI 10.1534/genetics.114.166769; Leslie EJ, 2017, HUM GENET, V136, P275, DOI 10.1007/s00439-016-1754-7; Leslie EJ, 2016, HUM MOL GENET, V25, P2862, DOI 10.1093/hmg/ddw104; Leslie EJ, 2015, AM J HUM GENET, V96, P397, DOI 10.1016/j.ajhg.2015.01.004; Leslie EJ, 2012, BIRTH DEFECTS RES A, V94, P934, DOI 10.1002/bdra.23076; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-553; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu H, 2017, BIRTH DEFECTS RES, V109, P27, DOI 10.1002/bdra.23596; Liu H, 2016, HUM MOL GENET, V25, P766, DOI 10.1093/hmg/ddv614; Lopez-Pajares V, 2015, DEV CELL, V32, P693, DOI 10.1016/j.devcel.2015.01.028; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649                                                           ; Rahimov F, 2012, CLEFT PALATE-CRAN J, V49, P73, DOI 10.1597/10-178; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090                                                                  ; Kundaje A, 2015, NATURE, V518, P317, DOI DOI 10.1038/NATURE14248; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333                                                        ; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Singh HP, 2006, AM J OPHTHALMOL, V141, P906, DOI 10.1016/j.ajo.2005.12.009; Smith EM, 2016, AM J HUM GENET, V98, P185, DOI 10.1016/j.ajhg.2015.12.002; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Sun YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7414; Talbot JC, 2014, ZEBRAFISH, V11, P583, DOI 10.1089/zeb.2014.1047; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Westerfield M., 1993, ZEBRAFISH BOOK; Wolf ZT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005059; YONEDA T, 1981, SCIENCE, V213, P563, DOI 10.1126/science.7017936; Zhang ZG, 2011, EUR J CELL BIOL, V90, P1, DOI 10.1016/j.ejcb.2010.09.005; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	63	3	3	3	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAR 13	2017	8								14759	10.1038/ncomms14759				13	Multidisciplinary Sciences	Science & Technology - Other Topics	EN8DN	WOS:000396231200001	28287101	gold			2018-01-05	
J	Wang, P; Mokhtari, R; Pedrosa, E; Kirschenbaum, M; Bayrak, C; Zheng, DY; Lachman, HM				Wang, Ping; Mokhtari, Ryan; Pedrosa, Erika; Kirschenbaum, Michael; Bayrak, Can; Zheng, Deyou; Lachman, Herbert M.			CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells	MOLECULAR AUTISM			English	Article						DLX6-AS1; Distal-less homeobox; Gabaergic; Cancer; Autism; Schizophrenia; Bipolar disorder; TCF4; HMGA2; ZNF132; Wnt; Beta-catenin	DE-NOVO MUTATIONS; HUMAN CORTICAL DEVELOPMENT; GENOME-WIDE ASSOCIATION; PLURIPOTENT STEM-CELLS; HISTONE H1 RECRUITMENT; LONG NONCODING RNAS; PROTEIN 8 CHD8; SPECTRUM DISORDER; BIPOLAR DISORDER; NEURODEVELOPMENTAL DISORDERS	Background: CHD8(chromodomain helicase DNA-binding protein 8), which codes for a member of the CHD family of ATP-dependent chromatin-remodeling factors, is one of the most commonly mutated genes in autism spectrum disorders (ASD) identified in exome-sequencing studies. Loss of function mutations in the gene have also been found in schizophrenia (SZ) and intellectual disabilities and influence cancer cell proliferation. We previously reported an RNA-seq analysis carried out on neural progenitor cells (NPCs) and monolayer neurons derived from induced pluripotent stem (iPS)cells that were heterozygous for CHD8 knockout (KO) alleles generated using CRISPRCas9 gene editing. A significant number of ASD and SZ candidate genes were among those that were differentially expressed in a comparison of heterozygous KO lines (CHD8+/-) vs isogenic controls (CHD8+/-), including the SZ and bipolar disorder (BD) candidate gene TCF4, which was markedly upregulated in CHD8+/- neuronal cells. Methods: In the current study, RNA-seq was carried out on CHD8+/- and isogenic control (CHD vertical bar (/) (vertical bar)) cerebral organoids, which are 3-dimensional structures derived from iPS cells that model the developing human telencephalon. Results: TCF4 expression was, again, significantly upregulated. Pathway analysis carried out on differentially expressed genes (DEGs) revealed an enrichment of genes involved in neurogenesis, neuronal differentiation, forebrain development, Wnt/beta-catenin signaling, and axonal guidance, similar to our previous study on NPCs and monolayer neurons. There was also significant overlap in our CHD8+/- DEGs with those found in a transcriptome analysis carried out by another group using cerebral organoids derived from a family with idiopathic ASD. Remarkably, the top DEG in our respective studies was the non-coding RNA DLX6-AS1, which was markedly upregulated in both studies; DLX6-AS1 regulates the expression of members of the DLX (distal-less homeobox) gene family. DLX1 was also upregulated in both studies. DLX genes code for transcription factors that play a key role in GABAergic interneuron differentiation. Significant overlap was also found in a transcriptome study carried out by another group using iPS cell-derived neurons from patients with BD, a condition characterized by dysregulated WNT/beta-catenin signaling in a subgroup of affected individuals. Conclusions: Overall, the findings show that distinct ASD, SZ, and BD candidate genes converge on common molecular targets-an important consideration for developing novel therapeutics in genetically heterogeneous complex traits.	[Wang, Ping; Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10467 USA; [Mokhtari, Ryan; Pedrosa, Erika; Kirschenbaum, Michael; Lachman, Herbert M.] Erciyes Univ, Dept Psychiat & Behav Sci, Sch Med, Kayseri, Turkey; [Bayrak, Can] Erciyes Univ, Sch Med, Kayseri, Turkey; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, 1300 Morris Pk Ave, Bronx, NY 10467 USA; [Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10467 USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10467 USA	Zheng, DY; Lachman, HM (reprint author), Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10467 USA.; Lachman, HM (reprint author), Erciyes Univ, Dept Psychiat & Behav Sci, Sch Med, Kayseri, Turkey.; Zheng, DY (reprint author), Albert Einstein Coll Med, Dept Neurol, 1300 Morris Pk Ave, Bronx, NY 10467 USA.; Zheng, DY; Lachman, HM (reprint author), Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10467 USA.; Lachman, HM (reprint author), Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10467 USA.	Deyou.Zheng@einstein.yu.edu; Herb.Lachman@einstein.yu.edu		Zheng, Deyou/0000-0003-4354-5337	National Institute of Mental Health (NIMH) [MH099452, MH099427, MH087840]; New York State Department of Health [C029154]; Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK-IDDRC); National Institute of Child Health & Human Development (NICHD) [1P30HD071593-01]	This work was supported by grants from the National Institute of Mental Health (NIMH); MH099452 to DZ and MH099427 and MH087840 to HML. We are grateful to the New York State Department of Health (NYSTEM Program) for the shared facility grant support (C029154). This work was also supported in part by a grant to The Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK-IDDRC) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) at the NIH (1P30HD071593-01).	Abildgaard MO, 2012, INT J CANCER, V130, P885, DOI 10.1002/ijc.26097; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Alda M, 2015, MOL PSYCHIATR, V20, P661, DOI 10.1038/mp.2015.4; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Barry G, 2014, MOL PSYCHIATR, V19, P486, DOI 10.1038/mp.2013.45; Bayatti N, 2008, EUR J NEUROSCI, V28, P1449, DOI 10.1111/j.1460-9568.2008.06475.x; Benedetti F, 2015, PSYCHOPHARMACOLOGY, V232, P1325, DOI 10.1007/s00213-014-3770-4; Benes FM, 1996, NEUROSCIENCE, V75, P1021, DOI 10.1016/0306-4522(96)00328-4; Berghoff EG, 2013, DEVELOPMENT, V140, P4407, DOI 10.1242/dev.099390; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brzozka MM, 2010, BIOL PSYCHIAT, V68, P33, DOI 10.1016/j.biopsych.2010.03.015; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cajigas I, 2015, DEVELOPMENT, V142, P2641, DOI 10.1242/dev.126318; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Canitano R, 2015, CLIN NEUROPHARMACOL, V38, P177, DOI 10.1097/WNF.0000000000000096; Capasso M, 2013, CARCINOGENESIS, V34, P605, DOI 10.1093/carcin/bgs380; Caronia-Brown G, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0065-y; Cattane N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116686; Chan AS, 2002, ONCOGENE, V21, P3029, DOI 10.1038/sj/onc/1205460; Chen ES, 2014, AM J HUM GENET, V95, P490, DOI 10.1016/j.ajhg.2014.09.013; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124597; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075682; Chung DW, 2016, AM J PSYCHIAT, V173, P60, DOI 10.1176/appi.ajp.2015.15020150; Cicek MS, 2013, HUM MOL GENET, V22, P3038, DOI 10.1093/hmg/ddt160; Citrome L, 2009, EXPERT REV NEUROTHER, V9, P55, DOI 10.1586/14737175.9.1.55; Cole AR, 2013, FEBS J, V280, P5213, DOI 10.1111/febs.12407; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Crawley JN, 2016, TRENDS GENET, V32, P139, DOI 10.1016/j.tig.2016.01.001; Damaschke NA, 2014, NEOPLASIA, V16, P1018, DOI 10.1016/j.neo.2014.10.003; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Denk D, 2012, LEUKEMIA RES, V36, pE178, DOI 10.1016/j.leukres.2012.04.015; Durak O, 2016, NAT NEUROSCI, V19, P1477, DOI 10.1038/nn.4400; Elizalde C, 2011, STEM CELLS, V29, P141, DOI 10.1002/stem.562; Fan YJ, 2016, AM J MED GENET A, V170, P515, DOI 10.1002/ajmg.a.37454; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010; Forrest MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073169; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Garg S, 2015, J AUTISM DEV DISORD, V45, P1649, DOI 10.1007/s10803-014-2321-5; Gigek CO, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.56; Giurgea I, 2008, HUM MUTAT, V29, pE242, DOI 10.1002/humu.20859; Gonzalez-Burgos G, 2015, BIOL PSYCHIAT, V77, P1031, DOI 10.1016/j.biopsych.2015.03.010; Green MJ, 2013, MOL PSYCHIATR, V18, P774, DOI 10.1038/mp.2012.84; Guella I, 2013, J PSYCHIATR RES, V47, P1215, DOI 10.1016/j.jpsychires.2013.05.021; Guo XL, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks967; Habl G, 2012, NEUROPSYCHOBIOLOGY, V66, P57, DOI 10.1159/000337129; Hall J, 2014, BIOL PSYCHIAT; Hall J, 2015, BIOL PSYCHIAT, V77, P52, DOI 10.1016/j.biopsych.2014.07.011; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hashemi E, 2016, CEREB CORTEX; Hatou S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0286; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Iafrati J, 2014, MOL PSYCHIATR, V19, P417, DOI 10.1038/mp.2013.66; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iseki H, 2012, CANCER SCI, V103, P1267, DOI 10.1111/j.1349-7006.2012.02300.x; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lammert DB, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00084; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Leucht S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003834.pub2; Leucht S, 2015, COCHRANE DB SYST REV, V10; Levy AD, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00116; Lin MY, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0366-0; Lin MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094968; Liu L, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-22; Liu Y, 2015, AM J MED GENET A, V167, P1381, DOI 10.1002/ajmg.a.37050; Lopes F, 2016, J MED GENET, V53, P190, DOI 10.1136/jmedgenet-2015-103568; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LU KH, 2013, BMC CANCER, V13; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Miyano M, 2008, J CELL MOL MED, V12, P1188, DOI 10.1111/j.1582-4934.2008.00377.x; Moos WH, 2016, DRUG DEVELOP RES, V77, P53, DOI 10.1002/ddr.21295; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SY, 2013, MOL CELL, V51, P349, DOI 10.1016/j.molcel.2013.07.017; Nicholls C, 2011, PROTEIN CELL, V2, P726, DOI 10.1007/s13238-011-1093-3; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Dushlaine C, 2010, MOL PSYCHIAT; Okerlund ND, 2011, J NEURODEV DISORD, V3, P162, DOI 10.1007/s11689-011-9083-6; Paina S, 2011, J NEUROSCI, V31, P2675, DOI 10.1523/JNEUROSCI.3110-10.2011; Pedrosa E, 2010, J NEUROGENET, V24, P182, DOI 10.3109/01677063.2010.495182; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Plasschaert E, 2015, AM J MED GENET B, V168, P72, DOI 10.1002/ajmg.b.32280; Poitras L, 2010, DEVELOPMENT, V137, P3089, DOI 10.1242/dev.051052; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Ribarska T, 2014, EPIGENETICS-US, V9, P704, DOI 10.4161/epi.28006; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Sawada G, 2013, ONCOL REP, V30, P1137, DOI 10.3892/or.2013.2597; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Serretti A, 2009, CURR MED CHEM, V16, P1917, DOI 10.2174/092986709788186101                                                      ; Siegel M, 2014, J CHILD ADOL PSYCHOP, V24, P399, DOI 10.1089/cap.2014.0019; Spadaro PA, 2015, BIOL PSYCHIAT, V78, P848, DOI 10.1016/j.biopsych.2015.02.004; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Subtil-Rodriguez A, 2014, NUCLEIC ACIDS RES, V42, P2185, DOI 10.1093/nar/gkt1161; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Szafron LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127475; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Tahara T, 2014, GASTROENTEROLOGY, V146, P530, DOI 10.1053/j.gastro.2013.10.060; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Teichroeb JH, 2016, RNA BIOL, V13, P707, DOI 10.1080/15476286.2015.1134413; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; TOMMERUP N, 1995, GENOMICS, V27, P259, DOI 10.1006/geno.1995.1040; Tracy DK, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0559-x; van de Vondervoort IIGM, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00053; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang B, 2013, J COMP NEUROL, V521, P1561, DOI 10.1002/cne.23242; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Wang YL, 2015, CANCER LETT, V367, P122, DOI 10.1016/j.canlet.2015.03.027; Wang ZL, 2014, AM J MED GENET B, V165, P192, DOI 10.1002/ajmg.b.32222; Wen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153329; Wilkinson B, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.62; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Zhang X, 2010, ENDOCRINOLOGY, V151, P939, DOI 10.1210/en.2009-0657; Zhao DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132387; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008; Zhu JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139790	147	6	6	10	19	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2040-2392			MOL AUTISM	Mol. Autism	MAR 11	2017	8								11	10.1186/s13229-017-0124-1				17	Genetics & Heredity; Neurosciences	Genetics & Heredity; Neurosciences & Neurology	EP0SC	WOS:000397096000001	28321286	gold			2018-01-05	
J	Richardson, SM; Mitchell, LA; Stracquadanio, G; Yang, K; Dymond, JS; DiCarlo, JE; Lee, D; Huang, CLV; Chandrasegaran, S; Cai, YZ; Boeke, JD; Bader, JS				Richardson, Sarah M.; Mitchell, Leslie A.; Stracquadanio, Giovanni; Yang, Kun; Dymond, Jessica S.; DiCarlo, James E.; Lee, Dongwon; Huang, Cheng Lai Victor; Chandrasegaran, Srinivasan; Cai, Yizhi; Boeke, Jef D.; Bader, Joel S.			Design of a synthetic yeast genome	SCIENCE			English	Article							AUTOMATED DESIGN; GENES; CHROMOSOME; DNA; MANIPULATION; GENERATION; GENEDESIGN; SEQUENCES; DATABASE; INTRONS	We describe complete design of a synthetic eukaryotic genome, Sc2.0, a highly modified Saccharomyces cerevisiae genome reduced in size by nearly 8%, with 1.1 megabases of the synthetic genome deleted, inserted, or altered. Sc2.0 chromosome designwas implemented with BioStudio, an open-source framework developed for eukaryotic genome design, which coordinates design modifications from nucleotide to genome scales and enforces version control to systematically track edits. To achieve complete Sc2.0 genome synthesis, individual synthetic chromosomes built by Sc2.0 Consortium teams around the world will be consolidated into a single strain by " endoreduplication intercross." Chemically synthesized genomes like Sc2.0 are fully customizable and allow experimentalists to ask otherwise intractable questions about chromosome structure, function, and evolution with a bottom-up design strategy.	[Richardson, Sarah M.; Stracquadanio, Giovanni; Yang, Kun; Lee, Dongwon; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Richardson, Sarah M.; Mitchell, Leslie A.; Stracquadanio, Giovanni; Yang, Kun; Dymond, Jessica S.; DiCarlo, James E.; Huang, Cheng Lai Victor; Cai, Yizhi; Boeke, Jef D.; Bader, Joel S.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Mitchell, Leslie A.; Boeke, Jef D.] NYU, Langone Med Ctr, Inst Syst Genet, 550 1St Ave, New York, NY 10016 USA; [Mitchell, Leslie A.; Boeke, Jef D.] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, 550 1St Ave, New York, NY 10016 USA; [Stracquadanio, Giovanni] Univ Essex, Sch Comp Sci & Elect Engn, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Chandrasegaran, Srinivasan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Cai, Yizhi] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland; [Richardson, Sarah M.] Ignit Genom, Unit 703, 12240 Roundwood Rd, Lutherville Timonium, MD 21093 USA; [Dymond, Jessica S.] Johns Hopkins Univ, Appl Phys Lab, Res & Exploratory Dev Dept, Biol Sci, 11100 Johns Hopkins Rd,Mail Stop 21-N352, Laurel, MD 20723 USA; [DiCarlo, James E.] Columbia Univ, Coll Phys & Surg, Dept Ophthalmol, New York, NY 10032 USA; [Lee, Dongwon] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Bader, JS (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Boeke, JD; Bader, JS (reprint author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.; Boeke, JD (reprint author), NYU, Langone Med Ctr, Inst Syst Genet, 550 1St Ave, New York, NY 10016 USA.; Boeke, JD (reprint author), NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, 550 1St Ave, New York, NY 10016 USA.	jef.boeke@nyumc.org; joel.bader@jhu.edu		Richardson, Sarah/0000-0002-9820-9421; Cai, Yizhi/0000-0003-1663-2865; Stracquadanio, Giovanni/0000-0001-9819-3645	NSF [MCB-0718846, MCB-1026068, MCB-1616111, MCB-0546446, MCB-1445545]; Department of Energy [DE-FG02097ER25308]; NSERC; Microsoft Research	This work was supported in part by funding from NSF (grants MCB-0718846 and MCB-1026068 to J.D.B. and J.S.B., MCB-1616111 to J.D.B., MCB-0546446 and MCB-1445545 to J.S.B.), the Department of Energy (grant number DE-FG02097ER25308 to S.M.R.); NSERC Postdoctoral Fellowship to L.A.M.; and Microsoft Research (to J.S.B.). We thank all Sc2.0 Consortium members and members of the S. cerevisiae community for their helpful comments during the design phase of this project. We thank the leadership and staff of the SGD for helping make this project possible. J.D.B. and J.S.B. are founders and directors of Neochromosome, Inc. J.D.B. serves as a scientific advisor to Recombinetics, Inc., and Sample6, Inc. These arrangements are reviewed and managed by the committees on conflict of interest at NYU Langone Medical Center (J.D.B.) and Johns Hopkins University (J.S.B.). Additional information including design diagrams, PCRTag sequences, feature summary tables, and variants in the physical strains corresponding to Sc2.0 synthetic chromosomes can be accessed on the Sc2.0 website, www.syntheticyeast.org.	Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; BARNETT RW, 1990, NUCLEIC ACIDS RES, V18, P3094, DOI 10.1093/nar/18.10.3094; Berliner B., 1990, Proceedings of the Winter 1990 USENIX Conference, P341; Chacon S., 2014, PROGIT; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; CICCARELLI RB, 1991, NUCLEIC ACIDS RES, V19, P6007, DOI 10.1093/nar/19.21.6007; Dymond J, 2012, BIOENGINEERED, V3, P168, DOI 10.4161/bbug.19543; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546                                                    ; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397                                                            ; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287                                                           ; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; JI H, 1993, CELL, V73, P1007, DOI 10.1016/0092-8674(93)90278-X; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829                                                           ; Mitchell L. A., 2015, JOVE-J VIS EXP, V99; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Muller Heloise, 2012, Methods Mol Biol, V852, P133, DOI 10.1007/978-1-61779-564-0_11; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Parenteau J, 2011, CELL, V147, P320, DOI 10.1016/j.cell.2011.08.044; PlLATO C. M., 2008, VERSION CONTROL SUBV; Reid RJD, 2008, GENETICS, V180, P1799, DOI 10.1534/genetics.108.087999; Richardson SM, 2010, LECT NOTES COMPUT SC, V6068, P280; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Salim HMW, 2008, PROTIST, V159, P283, DOI 10.1016/j.protis.2007.11.003; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Shen Y, 2016, GENOME RES, V26, P36, DOI 10.1101/gr.193433.115; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981	36	25	26	41	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI					10.1126/science.aaf4557				5	Multidisciplinary Sciences	Science & Technology - Other Topics	EN9VY	WOS:000396348900031	28280199	gold			2018-01-05	
J	Pazhakh, V; Clark, S; Keightley, MC; Lieschke, GJ				Pazhakh, Vahid; Clark, Sharon; Keightley, M. Cristina; Lieschke, Graham J.			A GCSFR/CSF3R zebrafish mutant models the persistent basal neutrophil deficiency of severe congenital neutropenia	SCIENTIFIC REPORTS			English	Article							COLONY-STIMULATING FACTOR; CSF3R MUTATIONS; GRANULOCYTE; RECEPTOR; SPECIFICATION; MACROPHAGES; EXPRESSION; MIGRATION; EMBRYOS; ROLES	Granulocyte colony-stimulating factor (GCSF) and its receptor (GCSFR), also known as CSF3 and CSF3R, are required to maintain normal neutrophil numbers during basal and emergency granulopoiesis in humans, mice and zebrafish. Previous studies identified two zebrafish CSF3 ligands and a single CSF3 receptor. Transient antisense morpholino oligonucleotide knockdown of both these ligands and receptor reduces neutrophil numbers in zebrafish embryos, a technique widely used to evaluate neutrophil contributions to models of infection, inflammation and regeneration. We created an allelic series of zebrafish csf3r mutants by CRISPR/Cas9 mutagenesis targeting csf3r exon 2. Biallelic csf3r mutant embryos are viable and have normal early survival, despite a substantial reduction of their neutrophil population size, and normal macrophage abundance. Heterozygotes have a haploinsufficiency phenotype with an intermediate reduction in neutrophil numbers. csf3r mutants are viable as adults, with a 50% reduction in tissue neutrophil density and a substantial reduction in the number of myeloid cells in the kidney marrow. These csf3r mutants are a new animal model of human CSF3R-dependent congenital neutropenia. Furthermore, they will be valuable for studying the impact of neutrophil loss in the context of other zebrafish disease models by providing a genetically stable, persistent, reproducible neutrophil deficiency state throughout life.	[Pazhakh, Vahid; Clark, Sharon; Keightley, M. Cristina; Lieschke, Graham J.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia	Lieschke, GJ (reprint author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia.	Graham.Lieschke@monash.edu		Keightley, Maria-Cristina/0000-0001-8141-4069	Monash International Postgraduate Research Scholarship; Monash Graduate Scholarship; Monash Postgraduate Publication Award; NHMRC [1044754, 1069284, 1070687]; State Government of Victoria; Australian Federal Government	We thank F. Ellett and J. Wittig for early contributions to the project, S. Varma for technical assistance, FishCore staff for excellent animal care, and FlowCore, Monash Micro Imaging and Micromon platform technologies for services and their staff for technical assistance. VP was supported by a Monash International Postgraduate Research Scholarship, a Monash Graduate Scholarship, and a Monash Postgraduate Publication Award. This work was supported by the NHMRC (1044754 [GL], 1069284 [GL], 1070687 [GL, MCK]). The Australian Regenerative Medicine Institute is supported by funds from the State Government of Victoria and the Australian Federal Government.	ANDREWS JP, 1960, AM J MED, V29, P358, DOI 10.1016/0002-9343(60)90031-0; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DEMETRI GD, 1991, BLOOD, V78, P2791; Ellett F, 2012, METHOD ENZYMOL, V506, P425, DOI 10.1016/B978-0-12-391856-7.00046-9; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Galdames JA, 2014, J IMMUNOL, V193, P372, DOI 10.4049/jimmunol.1303220; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; Hogan BM, 2006, CURR BIOL, V16, P506, DOI 10.1016/j.cub.2006.01.047; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Jin H, 2012, BLOOD, V119, P5239, DOI 10.1182/blood-2011-12-398362; Jing CB, 2013, DEV BIOL, V374, P24, DOI 10.1016/j.ydbio.2012.11.032; Keightley MC, 2014, INT J BIOCHEM CELL B, V56, P92, DOI 10.1016/j.biocel.2014.07.010; Keightley MC, 2013, FEBS LETT, V587, P2150, DOI 10.1016/j.febslet.2013.05.030; Keightley MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023845; Klimiankou M, 2015, BLOOD, V126, P1865, DOI 10.1182/blood-2015-07-661264; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Liongue C, 2009, BLOOD, V113, P2535, DOI 10.1182/blood-2008-07-171967; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Okuda KS, 2015, BIOL OPEN, V4, P1270, DOI 10.1242/bio.013540; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Reischauer S, 2016, NATURE, V535, P294, DOI 10.1038/nature18614; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Stachura DL, 2013, BLOOD, V122, P3918, DOI 10.1182/blood-2012-12-475392; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Touw IP, 2015, HEMATOL-AM SOC HEMAT, P1; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Triot A, 2014, BLOOD, V123, P3811, DOI 10.1182/blood-2013-11-535419; Walton EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138949; Zeidler C, 2009, BRIT J HAEMATOL, V144, P459, DOI 10.1111/j.1365-2141.2008.07425.x	38	1	1	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 10	2017	7								44455	10.1038/srep44455				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EO2FY	WOS:000396513200001	28281657	gold			2018-01-05	
J	Wall, AA; Luo, L; Hung, Y; Tong, SJ; Condon, ND; Blumenthal, A; Sweet, MJ; Stow, JL				Wall, Adam A.; Luo, Lin; Hung, Yu; Tong, Samuel J.; Condon, Nicholas D.; Blumenthal, Antje; Sweet, Matthew J.; Stow, Jennifer L.			Small GTPase Rab8a-recruited Phosphatidylinositol 3-Kinase gamma Regulates Signaling and Cytokine Outputs from Endosomal Toll-like Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED MACROPHAGES; GROWTH-FACTOR; PI3K-GAMMA; MTOR; PI3K; INFLAMMATION; DISCOVERY; RUFFLES; PATHWAY; BINDING	LPS-mediated activation of Toll-like receptor 4 (TLR4) in macrophages results in the coordinated release of proinflammatory cytokines, followed by regulatory mediators, to ensure that this potentially destructive pathway is tightly regulated. We showed previously that Rab8a recruits PI3K gamma for Akt-dependent signaling during TLR4 activation to limit the production of the proinflammatory cytokines IL-6 and IL-12p40 while enhancing the release of the regulatory/ anti-inflammatory cytokine IL-10. Here we broaden the array of immune receptors controlled by Rab8a-PI3K gamma and further define the Rab-mediated membrane domains required for signaling. With CRISPR/Cas9mediated gene editing to stably knock out and recover Rab8a in macrophage cell lines, we match Akt signaling profiles with cytokine outputs, confirming that Rab8a is a novel regulator of the Akt/mammalian target of rapamycin (mTOR) pathway downstream of multiple TLRs. Upondeveloping a Rab8a activation assay, weshow that TLR3 and 9 agonists also activate Rab8a. Live-cell imaging reveals that Rab8a is first recruited to the plasma membrane and dorsal ruffles, but it is retained during collapse of ruffles to form macropinosomes enriched for phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5) P3) and phosphatidylinositol 3,4-bisphosphate (PI(3,4) P-2), suggesting that the macropinosome is the location where Rab8a is active. We pinpoint macropinosomes as the sites for Rab8-mediated biasing of inflammatory signaling responses via inducible production of anti-inflammatory cytokines. Thus, Rab8a and PI3K gamma are positioned in multiple TLR pathways, and this signalingaxismayserveasapharmacologicallytractabletargetduring infection and inflammation.	[Wall, Adam A.; Luo, Lin; Hung, Yu; Tong, Samuel J.; Condon, Nicholas D.; Sweet, Matthew J.; Stow, Jennifer L.] Univ Queensland, IMB, Brisbane, Qld 4072, Australia; [Wall, Adam A.; Luo, Lin; Hung, Yu; Tong, Samuel J.; Condon, Nicholas D.; Sweet, Matthew J.; Stow, Jennifer L.] Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld 4072, Australia; [Blumenthal, Antje] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld 4102, Australia	Stow, JL (reprint author), Univ Queensland, IMB, Brisbane, Qld 4072, Australia.; Stow, JL (reprint author), Univ Queensland, IMB Ctr Inflammat & Dis Res, Brisbane, Qld 4072, Australia.	j.stow@imb.uq.edu.au		Blumenthal, Antje/0000-0003-3673-7015	National Health and Medical Research Council of Australia [APP1003021, APP1098710, APP1107914]; Australian Infectious Diseases Research Centre	This work was supported by the National Health and Medical Research Council of Australia (Fellowship APP1003021 to J. L. S., Grant APP1098710 to J. L. S. and A. B., and Senior Research Fellowship APP1107914 to M. J. S.) and was supported by the Australian Infectious Diseases Research Centre. The authors declare that they have no conflicts of interest with the contents of this article.	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ariffin JK, 2016, ANTIMICROB AGENTS CH, V60, P1521, DOI 10.1128/AAC.01876-15; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Cohen HB, 2013, J LEUKOCYTE BIOL, V94, P913, DOI 10.1189/jlb.0413236; Coudriet GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015384; Damilano F, 2010, ANN NY ACAD SCI, V1188, P39, DOI 10.1111/j.1749-6632.2009.05081.x; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Evans CA, 2016, ACS MED CHEM LETT, V7, P862, DOI 10.1021/acsmedchemlett.6b00238; Hagemann Nina, 2012, Small GTPases, V3, P107, DOI 10.4161/sgtp.19380; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; HUME DA, 1982, ADV EXP MED BIOL, V155, P261; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Luo L, 2016, J BIOL CHEM, V291, P9411, DOI 10.1074/jbc.M115.703108; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20                                                ; Ruckle T, 2006, NAT REV DRUG DISCOV, V5, P903, DOI 10.1038/nrd2145; Santos-Sierra Sandra, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Stow JL, 2013, CYTOKINE GROWTH F R, V24, P227, DOI 10.1016/j.cytogfr.2013.04.001; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2                                                    ; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Welliver TP, 2012, BIOL OPEN, V1, P754, DOI 10.1242/bio.20121784; Yeo JC, 2015, MOL BIOL CELL, V26, P952, DOI 10.1091/mbc.E14-10-1457; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207	38	0	0	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4411	4422		10.1074/jbc.M116.766337				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EP7VK	WOS:000397585100003	28130450				2018-01-05	
J	Xu, XJ; Duan, DS; Chen, SJ				Xu, Xiaojun; Duan, Dongsheng; Chen, Shi-Jie			CRISPR-Cas9 cleavage efficiency correlates strongly with target-sgRNA folding stability: from physical mechanism to off-target assessment	SCIENTIFIC REPORTS			English	Article							RNA-GUIDED CAS9; MUSCULAR-DYSTROPHY; ENDONUCLEASE CAS9; DNA; SPECIFICITY; NUCLEASES; BINDING; CRISPR/CAS9; EXPRESSION; ENABLES	The CRISPR/Cas9 complex, a bacterial immune response system, has been widely adopted for RNA-guided genome editing and transcription regulation in applications such as targeted genome modification and site-directed mutagenesis. However, the physical basis for its target specificity is not fully understood. In this study, based on a statistical mechanical analysis for the whole ensemble of sgRNA-target complex conformations, we identify a strong correlation between Cas9 cleavage efficiency and the stability of the DNA-RNA (R-loop) complex structures, with a Pearson correlation coefficient ranging from 0.775 to 0.886 for the tested systems. The finding leads to quantitative insights into important experimental results, such as the greater Cas9 tolerance to single-base mismatches in PAM-distal region than to PAM-proximal region and the high specificity and efficiency for shorter protospacers. Moreover, the results from the genome-wide off-target assessments, compared with other off-target scoring tools, indicate that the statistical mechanics-based approach provides more reliable off-target analyses and sgRNA design. To facilitate the genome engineering applications, a new web-based tool for genome-wide off-target assessment is established.	[Xu, Xiaojun; Chen, Shi-Jie] Univ Missouri, Dept Biochem, Dept Phys, Columbia, MO USA; [Xu, Xiaojun; Chen, Shi-Jie] Univ Missouri, Inst Informat, Columbia, MO USA; [Duan, Dongsheng] Univ Missouri, Sch Med, Dept Neurol, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Duan, Dongsheng] Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO USA; [Duan, Dongsheng] Univ Missouri, Dept Bioengn, Columbia, MO USA	Chen, SJ (reprint author), Univ Missouri, Dept Biochem, Dept Phys, Columbia, MO USA.; Chen, SJ (reprint author), Univ Missouri, Inst Informat, Columbia, MO USA.	chenshi@missouri.edu			NIH [R01-GM063732, R01-AR69085]; Department of Defense [MD150133]	This research was supported by NIH grant R01-GM063732 (SC). DD is supported by NIH R01-AR69085 and Department of Defense MD150133.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Josephs EA, 2015, NUCLEIC ACIDS RES, V43, P8924, DOI 10.1093/nar/gkv892; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Liu Y, 2016, INT J OPHTHALMOL-CHI, V9, P9, DOI 10.18240/ijo.2016.01.02; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; RASTRIGIN LA, 1964, AUTOMAT REM CONTR+, V24, P1337; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19                                                             ; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029                                                             ; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xiong X, 2016, ANNU REV GENOM HUM G, V17, P131, DOI 10.1146/annurev-genom-083115-022258; Xu XJ, 2012, J AM CHEM SOC, V134, P12499, DOI 10.1021/ja3013819; Zhang JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep28566; Zhang WB, 2002, P NATL ACAD SCI USA, V99, P1931, DOI 10.1073/pnas.032443099	36	1	1	7	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 10	2017	7								143	10.1038/s41598-017-00180-1				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EO6UX	WOS:000396829100006	28273945	gold			2018-01-05	
J	Czapinski, J; Kielbus, M; Kalafut, J; Kos, M; Stepulak, A; Rivero-Muller, A				Czapinski, Jakub; Kielbus, Michal; Kalafut, Joanna; Kos, Michal; Stepulak, Andrzej; Rivero-Mueller, Adolfo			ow to Train a Cell-Cutting-Edge Molecular Tools	FRONTIERS IN CHEMISTRY			English	Article						protein interactions; signaling pathways; cell communication; optogenetics; gene editing; synthetic biology; gene expression regulation; controlling behavior	LONG NONCODING RNA; MAMMALIAN GENE-EXPRESSION; SEQUENCE-SPECIFIC CONTROL; BLUE-LIGHT PHOTORECEPTOR; CRISPR-CAS SYSTEMS; OPTOGENETIC CONTROL; MESSENGER-RNA; LIVING CELLS; OPTICAL CONTROL; COAT PROTEIN	In biological systems, the formation of molecular complexes is the currency for all cellular processes. Traditionally, functional experimentation was targeted to single molecular players in order to understand its effects in a cell or animal phenotype. In the last few years, we have been experiencing rapid progress in the development of ground-breaking molecular biology tools that affect the metabolic, structural, morphological, and (epi) genetic instructions of cells by chemical, optical (optogenetic) and mechanical inputs. Such precise dissection of cellular processes is not only essential for a better understanding of biological systems, but will also allow us to better diagnose and fix common dysfunctions. Here, we present several of these emerging and innovative techniques by providing the reader with elegant examples on how these tools have been implemented in cells, and, in some cases, organisms, to unravel molecular processes in minute detail. We also discuss their advantages and disadvantages with particular focus on their translation to multicellular organisms for in vivo spatiotemporal regulation. We envision that further developments of these tools will not only help solve the processes of life, but will give rise to novel clinical and industrial applications.	[Czapinski, Jakub; Kielbus, Michal; Kalafut, Joanna; Kos, Michal; Stepulak, Andrzej; Rivero-Mueller, Adolfo] Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland; [Czapinski, Jakub] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Rivero-Mueller, Adolfo] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Rivero-Mueller, Adolfo] Abo Akad Univ, Turku, Finland; [Rivero-Mueller, Adolfo] Abo Akad Univ, Dept Biosci, Turku, Finland	Rivero-Muller, A (reprint author), Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland.; Rivero-Muller, A (reprint author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.; Rivero-Muller, A (reprint author), Abo Akad Univ, Turku, Finland.; Rivero-Muller, A (reprint author), Abo Akad Univ, Dept Biosci, Turku, Finland.	adolfo.rivero-muller@umlub.pl			Polish National Science Centre [2015/17/B/NZ1/01777]; Medical University of Lublin for Young Scientist [MnMb511]	We are supported by Grants from (1) Polish National Science Centre no. 2015/17/B/NZ1/01777 and (2) Medical University of Lublin for Young Scientist MnMb511.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0                                                                ; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; An WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145783; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Anthony K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095790; Aramaki S, 2006, DEV DYNAM, V235, P2192, DOI 10.1002/dvdy.20826; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bachand M, 2005, J NANOSCI NANOTECHNO, V5, P718, DOI 10.1166/jnn.2005.112; Ballister ER, 2016, METHODS MOL BIOL, V1413, P325, DOI 10.1007/978-1-4939-3542-0_20; Ballister ER, 2014, J CELL BIOL, V204, P901, DOI 10.1083/jcb.201311113; Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X                  ; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barakate A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00765; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3                                                   ; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bikard David, 2013, F1000Prime Rep, V5, P47, DOI 10.12703/P5-47; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buckley CE, 2016, DEV CELL, V36, P117, DOI 10.1016/j.devcel.2015.12.011; Carter CW, 2015, P NATL ACAD SCI USA, V112, P7489, DOI 10.1073/pnas.1507569112; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chattopadhyay S, 1995, P NATL ACAD SCI USA, V92, P12131, DOI 10.1073/pnas.92.26.12131; Chen D, 2013, J CELL BIOL, V201, P631, DOI 10.1083/jcb.201210119; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen X., 2013, CURRENT PROTOCOLS CH, P111, DOI [10.1002/9780470559277.ch120267, DOI 10.1002/9780470559277.CH120267]; Cheng CY, 2016, CHEMPHYSCHEM, V17, P1780, DOI 10.1002/cphc.201501155; Cho HS, 2015, ONCOTARGET, V6, P23837, DOI 10.18632/oncotarget.4340; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Collin JP, 2001, ACCOUNTS CHEM RES, V34, P477, DOI 10.1021/ar0001766; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper C, 2009, NUCLEIC ACIDS RES, V37, P4518, DOI 10.1093/nar/gkp441; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556                                                                ; Crefcoeur RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2800; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Daigle N, 2007, NAT METHODS, V4, P633, DOI 10.1038/NMETH1065; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; DeRose R, 2013, PFLUG ARCH EUR J PHY, V465, P409, DOI 10.1007/s00424-012-1208-6; Di Ventura B, 2016, CURR OPIN CHEM BIOL, V34, P62, DOI 10.1016/j.cbpa.2016.06.009; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Drinnenberg IA, 2011, SCIENCE, V333, P1592, DOI 10.1126/science.1209575; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Espinosa JM, 2016, MOL CELL, V62, P1, DOI 10.1016/j.molcel.2016.03.022; Etoc F, 2013, NAT NANOTECHNOL, V8, P193, DOI [10.1038/nnano.2013.23, 10.1038/NNANO.2013.23]; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fagerlund RD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0824-9; Fallis A., 2009, NAT METHODS, V53, P1689, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feng SX, 2016, CYTOSKELETON, V73, P508, DOI 10.1002/cm.21274; Feringa BL, 2007, J ORG CHEM, V72, P6635, DOI 10.1021/jo070394d; Fischer ES, 2016, CURR OPIN STRUC BIOL, V37, P115, DOI 10.1016/j.sbi.2016.01.004; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Furuta A, 2017, NAT NANOTECHNOL, V12, P233, DOI [10.1038/NNANO.2016.238, 10.1038/nnano.2016.238]; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Gonzalez F., 2014, STEM CELLS, V15, P215, DOI DOI 10.1016/J.STEM.2014.05.018; Gonzalez I, 2015, NAT STRUCT MOL BIOL, V22, P370, DOI 10.1038/nsmb.3005; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guru A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv079; Haugwitz M., 2008, NAT METHODS, V5, DOI [10.1038/nmeth.f.223, DOI 10.1038/NMETH.F.223]; Haurwitz RE, 2012, EMBO J, V31, P2824, DOI 10.1038/emboj.2012.107; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Huang J, 2009, J MOL BIOL, V392, P1221, DOI 10.1016/j.jmb.2009.07.067; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/NMETH.2765, 10.1038/nmeth.2765]; Inobe T, 2015, BIOCHEM BIOPH RES CO, V467, P322, DOI 10.1016/j.bbrc.2015.09.162; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jacques SL, 2013, PHYS MED BIOL, V58, P5007, DOI 10.1088/0031-9155/58/14/5007; Jansen V, 2015, ELIFE, V4, DOI 10.7554/eLife.05161; Jentzsch K, 2009, BIOCHEMISTRY-US, V48, P10321, DOI 10.1021/bi901115z; Jin CL, 2015, EPIGENETICS-US, V10, P1006, DOI 10.1080/15592294.2015.1091145; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Karimova M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30130; Katz ZB, 2012, GENE DEV, V26, P1885, DOI 10.1101/gad.190413.112; Kawano F, 2016, NAT CHEM BIOL, V12, P1059, DOI [10.1038/NCHEMBIO.2205, 10.1038/nchembio.2205]; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kelwick Richard, 2014, Front Bioeng Biotechnol, V2, P60, DOI 10.3389/fbioe.2014.00060; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Keung AJ, 2016, SCIENCE, V351, P661, DOI 10.1126/science.aaf1647; Kim B, 2013, BIOCHEM SOC T, V41, P1183, DOI 10.1042/BST20130150; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim DS, 2005, RNA, V11, P1667, DOI 10.1261/rna.2162205; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kooistra SM, 2012, MOL CELL BIOL, V13, P297, DOI DOI 10.1038/NRM3327; Kopan R, 2002, J CELL SCI, V115, P1095; Kornienko AE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-59; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Laufer BI, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0023-7; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Levy F, 1999, EUR J BIOCHEM, V259, P244, DOI 10.1046/j.1432-1327.1999.00024.x; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Lim F, 2002, NUCLEIC ACIDS RES, V30, P4138, DOI 10.1093/nar/gkf552; Lim F, 2001, J BIOL CHEM, V276, P22507, DOI 10.1074/jbc.M102411200                                                          ; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liu H, 2013, INT J MATER FORM, P1, DOI DOI 10.1371/J0URNAL.P0NE.0055389; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Liu Z, 2016, NAT METHODS, V13, P143, DOI [10.1038/nmeth.3689, 10.1038/NMETH.3689]; Lokhandwala J, 2016, J BIOL CHEM, V291, P14839, DOI 10.1074/jbc.M116.731448; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X                                                   ; Ma YW, 2014, FEBS J, V281, P5186, DOI 10.1111/febs.13110; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Nguyen MK, 2016, NAT CHEM BIOL, V12, P431, DOI [10.1038/NCHEMBIO.2064, 10.1038/nchembio.2064]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; MORAS D, 1995, CURR BIOL, V5, P249, DOI 10.1016/S0960-9822(95)00051-0; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Morsut L., 2016, FRONT CHEM, V164, P780, DOI DOI 10.1016/J.CELL.2016.01.012; Moscou MJ, 2009, CHINESE J BIOCH MOL, V326, P1501, DOI DOI 10.1126/SCIENCE.1178817; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt340; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4                                                    ; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Niopek D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10624; Niopek D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5404; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584; Park SJ, 2016, SCIENCE, V353, P158, DOI 10.1126/science.aaf4292; Potorac I, 2016, J ENDOCRINOL, V231, P197, DOI 10.1530/JOE-16-0384; Prashant E. K. Mali, 2014, NIH PUBLIC ACCESS, V10, P957, DOI [10.1038/nmeth.2649.Cas9, DOI 10.1038/NMETH.2649.CAS9]; Przybilski R, 2011, RNA BIOL, V8, P517, DOI 10.4161/rna.8.3.15190; Putyrski M, 2012, FEBS LETT, V586, P2097, DOI 10.1016/j.febslet.2012.04.061; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qi WW, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0289-2; Qin W, 2015, CELL RES, V25, P1074, DOI 10.1038/cr.2015.95; Quintino L, 2013, MOL THER, V21, P2169, DOI 10.1038/mt.2013.169; Rein ML, 2012, MOL GENET GENOMICS, V287, P95, DOI 10.1007/s00438-011-0663-7; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; ROMANIUK PJ, 1987, BIOCHEMISTRY-US, V26, P1563, DOI 10.1021/bi00380a011; Root CM, 2014, NATURE, V515, P269, DOI 10.1038/nature13897; Rumnieks J, 2014, J MOL BIOL, V426, P1039, DOI 10.1016/j.jmb.2013.08.025; Sachdeva G, 2014, NUCLEIC ACIDS RES, V42, P9493, DOI 10.1093/nar/gku617; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Tai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046269; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Taslimi A, 2016, NAT CHEM BIOL, V12, P425, DOI [10.1038/NCHEMBIO.2063, 10.1038/nchembio.2063]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Thompson Kristin M, 2002, BMC Biotechnol, V2, P21, DOI 10.1186/1472-6750-2-21; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Toth E, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0147-0; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Bergeijk P, 2015, NATURE, V518, P111, DOI 10.1038/nature14128; Van Duyne G. D., 2014, MICROBIOL SPECTR, V2, P1, DOI [10.1128/microbiolspec, DOI 10.1128/MICROBIOLSPEC]; VanGilst MR, 1997, BIOCHEMISTRY-US, V36, P1514, DOI 10.1021/bi961920q                                                               ; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang FY, 2016, TRENDS CELL BIOL, V26, P875, DOI 10.1016/j.tcb.2016.08.004; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang H, 2016, NAT METHODS, V13, P755, DOI [10.1038/NMETH.3926, 10.1038/nmeth.3926]; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Wehler Pierre, 2016, Curr Protoc Chem Biol, V8, P131, DOI 10.1002/cpch.4; Wesley R., 2006, NAT NANOTECHNOL, P25, DOI [10.1038/nnano.2006.45, DOI 10.1038/NNANO.2006.45]; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Wood L, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150230; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu D, 2012, NATURE, V484, P214, DOI 10.1038/nature10931; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu L, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1048; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yang YF, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0050-x; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341; Young DD, 2009, CHEM COMMUN, P568, DOI 10.1039/b819375d; Yumerefendi H, 2016, NAT CHEM BIOL, V12, P399, DOI 10.1038/nchembio.2068; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang K, 2015, TRENDS BIOTECHNOL, V33, P92, DOI 10.1016/j.tibtech.2014.11.007; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002; Zhao YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03943; Zhou XX, 2012, SCIENCE, V338, P810, DOI 10.1126/science.1226854	223	0	0	11	22	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	2296-2646			FRONT CHEM	Front. Chem.	MAR 10	2017	5								12	10.3389/fchem.2017.00012				25	Chemistry, Multidisciplinary	Chemistry	EN2VO	WOS:000395868600001	28344971	gold			2018-01-05	
J	Xie, ZX; Li, BZ; Mitchell, LA; Wu, Y; Qi, X; Jin, Z; Jia, B; Wang, X; Zeng, BX; Liu, HM; Wu, XL; Feng, Q; Zhang, WZ; Liu, W; Ding, MZ; Li, X; Zhao, GR; Qiao, JJ; Cheng, JS; Zhao, M; Kuang, Z; Wang, XY; Martin, JA; Stracquadanio, G; Yang, K; Bai, X; Zhao, J; Hu, ML; Lin, QH; Zhang, WQ; Shen, MH; Chen, S; Su, W; Wang, EX; Guo, R; Zhai, F; Guo, XJ; Du, HX; Zhu, JQ; Song, TQ; Dai, JJ; Li, FF; Jiang, GZ; Han, SL; Liu, SY; Yu, ZC; Yang, XN; Chen, K; Hu, C; Li, DS; Jia, N; Liu, Y; Wang, LT; Wang, S; Wei, XT; Fu, MQ; Qu, LM; Xin, SY; Liu, T; Tian, KR; Li, XN; Zhang, JH; Song, LX; Liu, JG; Lv, JF; Xu, H; Tao, R; Wang, Y; Zhang, TT; Deng, YX; Wang, YR; Li, T; Ye, GX; Xu, XR; Xia, ZB; Zhang, W; Yang, SL; Liu, YL; Ding, WQ; Liu, ZN; Zhu, JQ; Liu, NZ; Walker, R; Luo, YS; Wang, Y; Shen, Y; Yang, HM; Cai, YZ; Ma, PS; Zhang, CT; Bader, JS; Boeke, JD; Yuan, YJ				Xie, Ze-Xiong; Li, Bing-Zhi; Mitchell, Leslie A.; Wu, Yi; Qi, Xin; Jin, Zhu; Jia, Bin; Wang, Xia; Zeng, Bo-Xuan; Liu, Hui-Min; Wu, Xiao-Le; Feng, Qi; Zhang, Wen-Zheng; Liu, Wei; Ding, Ming-Zhu; Li, Xia; Zhao, Guang-Rong; Qiao, Jian-Jun; Cheng, Jing-Sheng; Zhao, Meng; Kuang, Zheng; Wang, Xuya; Martin, J. Andrew; Stracquadanio, Giovanni; Yang, Kun; Bai, Xue; Zhao, Juan; Hu, Meng-Long; Lin, Qiu-Hui; Zhang, Wen-Qian; Shen, Ming-Hua; Chen, Si; Su, Wan; Wang, En-Xu; Guo, Rui; Zhai, Fang; Guo, Xue-Jiao; Du, Hao-Xing; Zhu, Jia-Qing; Song, Tian-Qing; Dai, Jun-Jun; Li, Fei-Fei; Jiang, Guo-Zhen; Han, Shi-Lei; Liu, Shi-Yang; Yu, Zhi-Chao; Yang, Xiao-Na; Chen, Ken; Hu, Cheng; Li, Da-Shuai; Jia, Nan; Liu, Yue; Wang, Lin-Ting; Wang, Su; Wei, Xiao-Tong; Fu, Mei-Qing; Qu, Lan-Meng; Xin, Si-Yu; Liu, Ting; Tian, Kai-Ren; Li, Xue-Nan; Zhang, Jin-Hua; Song, Li-Xiang; Liu, Jin-Gui; Lv, Jia-Fei; Xu, Hang; Tao, Ran; Wang, Yan; Zhang, Ting-Ting; Deng, Ye-Xuan; Wang, Yi-Ran; Li, Ting; Ye, Guang-Xin; Xu, Xiao-Ran; Xia, Zheng-Bao; Zhang, Wei; Yang, Shi-Lan; Liu, Yi-Lin; Ding, Wen-Qi; Liu, Zhen-Ning; Zhu, Jun-Qi; Liu, Ning-Zhi; Walker, Roy; Luo, Yisha; Wang, Yun; Shen, Yue; Yang, Huanming; Cai, Yizhi; Ma, Ping-Sheng; Zhang, Chun-Ting; Bader, Joel S.; Boeke, Jef D.; Yuan, Ying-Jin			"Perfect" designer chromosome V and behavior of a ring derivative	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EUKARYOTIC CHROMOSOME; GENOME; YEAST; GENES	Perfect matching of an assembled physical sequence to a specified designed sequence is crucial to verify design principles in genome synthesis. We designed and de novo synthesized 536,024-base pair chromosome synV in the " Build-A-Genome China" course. We corrected an initial isolate of synV to perfectly match the designed sequence using integrative cotransformation and clustered regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9)-mediated editing in 22 steps; synV strains exhibit high fitness under a variety of culture conditions, compared with that of wild-type V strains. A ring synV derivative was constructed, which is fully functional in Saccharomyces cerevisiae under all conditions tested and exhibits lower spore viability during meiosis. Ring synV chromosome can extends Sc2.0 design principles and provides a model with which to study genomic rearrangement, ring chromosome evolution, and human ring chromosome disorders.	[Xie, Ze-Xiong; Li, Bing-Zhi; Wu, Yi; Qi, Xin; Jin, Zhu; Jia, Bin; Wang, Xia; Zeng, Bo-Xuan; Liu, Hui-Min; Wu, Xiao-Le; Feng, Qi; Zhang, Wen-Zheng; Liu, Wei; Ding, Ming-Zhu; Li, Xia; Zhao, Guang-Rong; Qiao, Jian-Jun; Cheng, Jing-Sheng; Zhao, Meng; Bai, Xue; Zhao, Juan; Hu, Meng-Long; Lin, Qiu-Hui; Zhang, Wen-Qian; Shen, Ming-Hua; Chen, Si; Su, Wan; Wang, En-Xu; Guo, Rui; Zhai, Fang; Guo, Xue-Jiao; Du, Hao-Xing; Zhu, Jia-Qing; Song, Tian-Qing; Dai, Jun-Jun; Li, Fei-Fei; Jiang, Guo-Zhen; Han, Shi-Lei; Liu, Shi-Yang; Yu, Zhi-Chao; Yang, Xiao-Na; Chen, Ken; Hu, Cheng; Li, Da-Shuai; Jia, Nan; Liu, Yue; Wang, Lin-Ting; Wang, Su; Wei, Xiao-Tong; Fu, Mei-Qing; Qu, Lan-Meng; Xin, Si-Yu; Liu, Ting; Tian, Kai-Ren; Li, Xue-Nan; Zhang, Jin-Hua; Song, Li-Xiang; Liu, Jin-Gui; Lv, Jia-Fei; Xu, Hang; Tao, Ran; Wang, Yan; Zhang, Ting-Ting; Deng, Ye-Xuan; Wang, Yi-Ran; Li, Ting; Ye, Guang-Xin; Xu, Xiao-Ran; Xia, Zheng-Bao; Zhang, Wei; Yang, Shi-Lan; Liu, Yi-Lin; Ding, Wen-Qi; Liu, Zhen-Ning; Zhu, Jun-Qi; Liu, Ning-Zhi; Ma, Ping-Sheng; Zhang, Chun-Ting; Yuan, Ying-Jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Xie, Ze-Xiong; Li, Bing-Zhi; Wu, Yi; Qi, Xin; Jin, Zhu; Jia, Bin; Wang, Xia; Zeng, Bo-Xuan; Liu, Hui-Min; Wu, Xiao-Le; Feng, Qi; Zhang, Wen-Zheng; Liu, Wei; Ding, Ming-Zhu; Li, Xia; Zhao, Guang-Rong; Qiao, Jian-Jun; Cheng, Jing-Sheng; Zhao, Meng; Stracquadanio, Giovanni; Bai, Xue; Zhao, Juan; Hu, Meng-Long; Lin, Qiu-Hui; Zhang, Wen-Qian; Shen, Ming-Hua; Chen, Si; Su, Wan; Wang, En-Xu; Guo, Rui; Zhai, Fang; Guo, Xue-Jiao; Du, Hao-Xing; Zhu, Jia-Qing; Song, Tian-Qing; Dai, Jun-Jun; Li, Fei-Fei; Jiang, Guo-Zhen; Han, Shi-Lei; Liu, Shi-Yang; Yu, Zhi-Chao; Yang, Xiao-Na; Chen, Ken; Hu, Cheng; Li, Da-Shuai; Jia, Nan; Liu, Yue; Wang, Lin-Ting; Wang, Su; Wei, Xiao-Tong; Fu, Mei-Qing; Qu, Lan-Meng; Xin, Si-Yu; Liu, Ting; Tian, Kai-Ren; Li, Xue-Nan; Zhang, Jin-Hua; Song, Li-Xiang; Liu, Jin-Gui; Lv, Jia-Fei; Xu, Hang; Tao, Ran; Wang, Yan; Zhang, Ting-Ting; Deng, Ye-Xuan; Wang, Yi-Ran; Li, Ting; Ye, Guang-Xin; Xu, Xiao-Ran; Xia, Zheng-Bao; Zhang, Wei; Yang, Shi-Lan; Liu, Yi-Lin; Ding, Wen-Qi; Liu, Zhen-Ning; Zhu, Jun-Qi; Liu, Ning-Zhi; Yuan, Ying-Jin] Tianjin Univ, SynBio Res Platform, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China; [Mitchell, Leslie A.; Kuang, Zheng; Wang, Xuya; Martin, J. Andrew; Boeke, Jef D.] NYU, Inst Syst Genet, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Mitchell, Leslie A.; Kuang, Zheng; Wang, Xuya; Martin, J. Andrew; Boeke, Jef D.] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Stracquadanio, Giovanni; Yang, Kun; Bader, Joel S.] Johns Hopkins Univ, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Stracquadanio, Giovanni; Yang, Kun; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Stracquadanio, Giovanni] Univ Essex, Sch Comp Sci & Elect Engn, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Walker, Roy; Luo, Yisha; Cai, Yizhi] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland; [Wang, Yun; Shen, Yue; Yang, Huanming] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China	Yuan, YJ (reprint author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.; Yuan, YJ (reprint author), Tianjin Univ, SynBio Res Platform, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	Tao, Rongjia/K-3133-2017	Tao, Rongjia/0000-0001-5058-4401; Cai, Yizhi/0000-0003-1663-2865; Stracquadanio, Giovanni/0000-0001-9819-3645	"863" program [2012AA02A708]; International Cooperative Project [2015DFA00960]; "973" program [2014CB745100]; National Natural Science Foundation of China program [21390203, 21621004]; U.S. NSF [MCB-1026068, MCB-1158201, MCB-1445545]	This work in TJU was funded by the "863" program, 2012AA02A708; the International Cooperative Project, 2015DFA00960; the "973" program, 2014CB745100; and the National Natural Science Foundation of China program, 21390203 and 21621004. Work in the United States was funded by U.S. NSF grants MCB-1026068 and MCB-1158201 to J.D.B. and U.S. NSF grant MCB-1445545 to J.S.B. J.D.B. and J.S.B. are founders and directors of Neochromosome. J.D.B. serves as a scientific advisor to Recombinetics and Sample6. These arrangements are reviewed and managed by the Committees on Conflict of Interest at New York University (NYU) Langone Medical Center (J.D.B.) and Johns Hopkins University (J.S.B.). We thank A. Heguy and her staff at NYU's Genome Technology Center for outstanding deep sequencing services. We thank P. Hare for the help with editing and N. Agmon for assistance with use of CRISPR/Cas9. Additional information [synV design diagram, PCRTag sequences, Feature summary table (wild-type V, designed synV, physical strains; yeast_chr05_9_01 to yeast_chr05_9_22), variants in physical strains (yeast_chr05_9_01 to yeast_chr05_9_22), PCR primers, and a summary of BBs and minichunks] related to synV can be accessed on the Sc2.0 website (www.syntheticyeast.org). All genomic data for this paper are available under the Sc2.0 umbrella BioProject accession no. PRJNA351844. Requests for materials should be addressed to Y.-J.Y. (Email: yjyuan@tju.edu.cn).	Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Ciuladaite Z, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0124-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dietrich FS, 1997, NATURE, V387, P78; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Dymond JS, 2009, GENETICS, V181, P13, DOI 10.1534/genetics.108.096784; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546                                                    ; HABER JE, 1984, GENETICS, V106, P185; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hou LH, 2010, APPL BIOCHEM BIOTECH, V160, P1084, DOI 10.1007/s12010-009-8552-9; Hou LH, 2009, BIOTECHNOL LETT, V31, P671, DOI 10.1007/s10529-009-9916-5; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jovicevic D, 2014, BIOESSAYS, V36, P855, DOI 10.1002/bies.201400086; Kaboli S, 2014, NUCLEIC ACIDS RES, V42, P9838, DOI 10.1093/nar/gku576; Kim T, 2014, NUCLEUS-PHILA, V5, P391, DOI 10.4161/nucl.36300; la Cour Sibbesen Else, 2013, Am J Med Genet A, V161A, P1447, DOI 10.1002/ajmg.a.35901; Lin QH, 2015, ACS SYNTH BIOL, V4, P213, DOI 10.1021/sb500241e; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; OCHMAN H, 1988, GENETICS, V120, P621; Reid RJD, 2008, GENETICS, V180, P1799, DOI 10.1534/genetics.108.087999; Richardson SM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4557; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Severino M, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0121-z; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Sivendran S, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-25; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Specchio N, 2012, EPILEPSY BEHAV, V25, P585, DOI 10.1016/j.yebeh.2012.09.032; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Vaudano AE, 2015, EPILEPSY BEHAV, V45, P155, DOI 10.1016/j.yebeh.2015.02.002; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981	36	17	19	35	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2017	355	6329			SI				eaaf4704	10.1126/science.aaf4704				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EN9VY	WOS:000396348900033		gold			2018-01-05	
J	Pinos, S; Pontarotti, P; Raoult, D; Merhej, V				Pinos, Sandrine; Pontarotti, Pierre; Raoult, Didier; Merhej, Vicky			Identification of constraints influencing the bacterial genomes evolution in the PVC super-phylum	BMC EVOLUTIONARY BIOLOGY			English	Article						Horizontal transfer; Bacteria; Environments; Lifestyle; Genomes; Functions	HORIZONTAL GENE-TRANSFER; LIFE-STYLE; PATHOGENICITY ISLANDS; CRISPR INTERFERENCE; COMMUNITY STRUCTURE; PROTEIN FAMILIES; MARINE SPONGES; REVEALS; CHLAMYDIAE; CELL	Background: Horizontal transfer plays an important role in the evolution of bacterial genomes, yet it obeys several constraints, including the ecological opportunity to meet other organisms, the presence of transfer systems, and the fitness of the transferred genes. Bacteria from the Planctomyctetes, Verrumicrobia, Chlamydiae (PVC) super-phylum have a compartmentalized cell plan delimited by an intracytoplasmic membrane that might constitute an additional constraint with particular impact on bacterial evolution. In this investigation, we studied the evolution of 33 genomes from PVC species and focused on the rate and the nature of horizontally transferred sequences in relation to their habitat and their cell plan. Results: Using a comparative phylogenomic approach, we showed that habitat influences the evolution of the bacterial genome's content and the flux of horizontal transfer of DNA (HT). Thus bacteria from soil, from insects and ubiquitous bacteria presented the highest average of horizontal transfer compared to bacteria living in water, extracellular bacteria in vertebrates, bacteria from amoeba and intracellular bacteria in vertebrates (with a mean of 379 versus 110 events per species, respectively and 7.6% of each genomes due to HT against 4.8%). The partners of these transfers were mainly bacterial organisms (94.9%); they allowed us to differentiate environmental bacteria, which exchanged more with Proteobacteria, and bacteria from vertebrates, which exchanged more with Firmicutes. The functional analysis of the horizontal transfers revealed a convergent evolution, with an over-representation of genes encoding for membrane biogenesis and lipid metabolism, among compartmentalized bacteria in the different habitats. Conclusions: The presence of an intracytoplasmic membrane in PVC species seems to affect the genome's evolution through the selection of transferred DNA, according to their encoded functions.	[Pinos, Sandrine; Pontarotti, Pierre] Aix Marseille Univ, CNRS, Cent Marseille, I2M,UMR 7373,Evolut Biol & Modelisat, 3 Pl Victor Hugo, F-13331 Marseille, France; [Pinos, Sandrine; Raoult, Didier; Merhej, Vicky] Aix Marseille Univ, CNRS, IRD, INSERM,AP HM,URMIIE,IHU Mediterranee Infect, 19-21 Blvd Jean Moulin, F-13005 Marseille, France	Merhej, V (reprint author), Aix Marseille Univ, CNRS, IRD, INSERM,AP HM,URMIIE,IHU Mediterranee Infect, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.	vicky_merhej@hotmail.com			Assistance Publique - Hopitaux de Marseille (Marseille Public University Hospital System); Centre National de la Recherche Scientifique (CNRS)	This work was supported by the Assistance Publique - Hopitaux de Marseille (Marseille Public University Hospital System). VM was supported by a Chairs of Excellence program from the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and interpretation or the decision to submit the work.	Aminov RI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00158; Baquero F, 2009, ENV MICROBIOL REP, V1, P469, DOI 10.1111/j.1758-2229.2009.00053.x; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Besemer K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1760; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Caro-Quintero A, 2015, ISME J, V9, P958, DOI 10.1038/ismej.2014.193; Charlebois RL, 2003, FEMS MICROBIOL LETT, V225, P213, DOI 10.1016/S0378-1097(03)00512-3; Cho JC, 2004, ENVIRON MICROBIOL, V6, P611, DOI 10.1111/j.1462-2920.2004.00614.x; Craigie R, 1989, AM SOC MICROBIOLOGY; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; Dorer MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001026; Michael FA, 1991, COMMUN STAT-THEOR M, V20, P127; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fieseler L, 2004, APPL ENVIRON MICROB, V70, P3724, DOI 10.1128/aem.70.6.3724-3732.2004; Fischer S, 2011, CURR PROTOC BIOINFOR, V35, P1; FUERST JA, 1991, P NATL ACAD SCI USA, V88, P8184, DOI 10.1073/pnas.88.18.8184                                                         ; Fuerst JA, 2013, ANTON LEEUW INT J G, V104, P451, DOI 10.1007/s10482-013-9986-1; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; GEMSKI P, 1980, INFECT IMMUN, V28, P1044; Georgiades K, 2012, CLIN MICROBIOL INFEC, V18, P213, DOI 10.1111/j.1469-0691.2012.03781.x; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581                                                                ; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046                                           ; Gonzalez-Candelas F, 2012, HORIZONTAL GENE TRANSFER IN MICROORGANISMS, P47; Gouret P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-298; Grigoriev IV, 2012, NUCL ACIDS RES D, VD1, pD26; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Gupta RS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00327; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hacker J, 2011, EMBO REP, V21, P376; Hirt RP, 2015, CURR OPIN MICROBIOL, V23, P155, DOI 10.1016/j.mib.2014.11.018; Ilves H, 2001, J BACTERIOL, V183, P5445, DOI 10.1128/JB.183.18.5445-5448.2001; Kamneva OK, 2012, GENOME BIOL EVOL, V4, P1375, DOI 10.1093/gbe/evs113; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583; Lage OM, 2013, ANTON LEEUW INT J G, V104, P467, DOI 10.1007/s10482-013-9969-2; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lee KC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-5; Levene H., 1960, CONTRIBUTIONS PROBAB, V1, P278; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lindsay MR, 1997, MICROBIOL-UK, V143, P739, DOI 10.1099/00221287-143-3-739                                                      ; Maccario L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00413; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mendes LW, 2015, MICROB ECOL, V70, P255, DOI 10.1007/s00248-014-0559-2; Merhej V, 2011, MOL BIOL EVOL, V28, P3213, DOI 10.1093/molbev/msr239; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moliner C, 2010, FEMS MICROBIOL REV, V34, P281, DOI [10.1111/j.1574-6976.2009.00209.x, 10.1111/j.1574-6976.2010.00209.x]; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Moustafa A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002205; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pal C, 2005, BIOINFORMATICS, V21, P222, DOI 10.1093/bioinformatics/bti1136; Paparoditis P, 2014, BBA-BIOMEMBRANES, V1838, P193, DOI 10.1016/j.bbamem.2013.08.007; Le PT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-243; Pinos S, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0144-3; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quaiser A, MOL MICROBIOL; Reddy T. B. K., 2014, NUCLEIC ACIDS RES, V43, pD1099; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; SANKOFF D, 1973, NATURE-NEW BIOL, V245, P232; Santarella-Mellwig R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001565; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159                                                                 ; Stanton TB, 2014, APPL ENVIRON MICROB, V74, P2950; Subtil A, 2014, TRENDS PLANT SCI, V19, P36, DOI 10.1016/j.tplants.2013.10.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tooming-Klunderud A, 2013, APPL ENVIRON MICROB, V79, P6803, DOI 10.1128/AEM.01455-13; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Viswanathan VK, 2012, GUT MICROBES, V3, P399; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444	82	0	0	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2148			BMC EVOL BIOL	BMC Evol. Biol.	MAR 9	2017	17								75	10.1186/s12862-017-0921-3				14	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	EP4FZ	WOS:000397337500004	28274202	gold			2018-01-05	
J	Gerace, D; Martiniello-Wilks, R; Nassif, NT; Lal, S; Steptoe, R; Simpson, AM				Gerace, Dario; Martiniello-Wilks, Rosetta; Nassif, Najah Therese; Lal, Sara; Steptoe, Raymond; Simpson, Ann Margaret			CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?	STEM CELL RESEARCH & THERAPY			English	Review						Mesenchymal stem cells; Type 1 diabetes; Clinical trials; Immunomodulation; Insulin-producing cells	INSULIN-PRODUCING CELLS; BONE-MARROW; IN-VITRO; STROMAL CELLS; UMBILICAL-CORD; GENE-THERAPY; PANCREATIC TRANSDIFFERENTIATION; IMMUNE MODULATION; MICE; REVERSAL	Due to their ease of isolation, differentiation capabilities, and immunomodulatory properties, the therapeutic potential of mesenchymal stem cells (MSCs) has been assessed in numerous pre-clinical and clinical settings. Currently, whole pancreas or islet transplantation is the only cure for people with type 1 diabetes (T1D) and, due to the autoimmune nature of the disease, MSCs have been utilised either natively or transdifferentiated into insulin-producing cells (IPCs) as an alternative treatment. However, the initial success in pre-clinical animal models has not translated into successful clinical outcomes. Thus, this review will summarise the current state of MSC-derived therapies for the treatment of T1D in both the pre-clinical and clinical setting, in particular their use as an immunomodulatory therapy and targets for the generation of IPCs via gene modification. In this review, we highlight the limitations of current clinical trials of MSCs for the treatment of T1D, and suggest the novel clustered regularly interspaced short palindromic repeat (CRISPR) gene-editing technology and improved clinical trial design as strategies to translate pre-clinical success to the clinical setting.	[Gerace, Dario; Martiniello-Wilks, Rosetta; Nassif, Najah Therese; Lal, Sara; Simpson, Ann Margaret] Univ Technol Sydney, Sch Life Sci, Chron Dis Solut Team, POB 123, Broadway, NSW 2007, Australia; [Gerace, Dario; Martiniello-Wilks, Rosetta; Nassif, Najah Therese; Lal, Sara; Simpson, Ann Margaret] Univ Technol Sydney, Ctr Hlth Technol, POB 123, Broadway, NSW 2007, Australia; [Martiniello-Wilks, Rosetta] Univ Technol Sydney, Translat Canc Res Grp, Sydney, NSW, Australia; [Lal, Sara] Univ Technol Sydney, Neurosci Res Unit, Sydney, NSW, Australia; [Steptoe, Raymond] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia	Simpson, AM (reprint author), Univ Technol Sydney, Sch Life Sci, Chron Dis Solut Team, POB 123, Broadway, NSW 2007, Australia.; Simpson, AM (reprint author), Univ Technol Sydney, Ctr Hlth Technol, POB 123, Broadway, NSW 2007, Australia.	Ann.Simpson@uts.edu.au		Gerace, Dario/0000-0001-9154-0624	Australian Postgraduate Award; Arrow Bone Marrow Transplant Foundation; University of Queensland Vice Chancellor's Senior Research Fellowship; National Health & Medical Research Council of Australia [352909, 513100]; Diabetes Australia Research Trust; Rebecca L. Cooper Medical Research Foundation	DG is supported by an Australian Postgraduate Award and a scholarship from the Arrow Bone Marrow Transplant Foundation, and was commissioned by the School of Life Sciences, The University of Technology Sydney, to assist with the production of this review. RS is supported by a University of Queensland Vice Chancellor's Senior Research Fellowship. Research conducted by AMS, NTN, and DG was supported by National Health & Medical Research Council of Australia Project Grants (352909, 513100), project grants from Diabetes Australia Research Trust and Rebecca L. Cooper Medical Research Foundation.	Abouzaripour M, 2016, CELL J, V17, P701; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004; Cai JQ, 2016, DIABETES CARE, V39, P149, DOI 10.2337/dc15-0171; Carlsson PO, 2015, DIABETES, V64, P587, DOI 10.2337/db14-0656; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691; Gerace D, 2013, TRANSPL P, V45, P1869, DOI 10.1016/j.transproceed.2013.01.051; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimenez CA, 2016, GENE THER, V23, P543, DOI 10.1038/gt.2016.28; Heathman TRJ, 2016, BIOCHEM ENG J, V108, P14, DOI 10.1016/j.bej.2015.06.018; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JX, 2013, ENDOCR J, V60, P347; Jusiak B, 2016, TRENDS BIOTECHNOL, V34, P535, DOI 10.1016/j.tibtech.2015.12.014; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kabadi AM, 2014, METHODS, V69, P188, DOI 10.1016/j.ymeth.2014.06.014; Kajiyama H, 2010, INT J DEV BIOL, V54, P699, DOI 10.1387/ijdb.092953hk; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kirk K, 2014, STEM CELL RES, V12, P807, DOI 10.1016/j.scr.2014.03.003; Klinker MW, 2015, WORLD J STEM CELLS, V7, P556, DOI 10.4252/wjsc.v7.i3.556; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li Y, 2007, RECENT PATENTS ENG, V1, P1; Lin GT, 2009, STEM CELLS DEV, V18, P1399, DOI 10.1089/scd.2009.0010; Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z; Meloche RM, 2007, WORLD J GASTROENTERO, V13, P6347, DOI 10.3748/wjg.13.6347; Mesples Alejandro, 2013, Med Sci Monit, V19, P852, DOI 10.12659/MSM.889525; Moll G, 2014, STEM CELLS, V32, P2430, DOI 10.1002/stem.1729; Oh SH, 2004, LAB INVEST, V84, P607, DOI 10.1038/labinvest.3700074; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Ren B, 2007, DIABETOLOGIA, V50, P1910, DOI 10.1007/s00125-007-0722-0; Ren BH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040534; Ren BH, 2013, J GENE MED, V15, P28, DOI 10.1002/jgm.2692; Scuteri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084309; Sohni A, 2013, STEM CELLS INT, V2013, DOI DOI 10.1155/2013/130763; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Tsai PJ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-47; Wang HW, 2011, CHINESE MED J-PEKING, V124, P1534, DOI 10.3760/cma.j.issn.0366-6999.2011.10.018; Wei S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19648; Wu H, 2013, MOL THER, V21, P1778, DOI 10.1038/mt.2013.147; Wu XH, 2007, WORLD J GASTROENTERO, V13, P3342, DOI 10.3748/wjg.v13.i24.3342                                                        ; Xie QP, 2009, DIFFERENTIATION, V77, P483, DOI 10.1016/j.diff.2009.01.001; Xu J, 2007, WORLD J SURG, V31, P1872, DOI 10.1007/s00268-007-9168-2; Zhao Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-160; Zhao Y, 2012, CURR DIABETES REP, V12, P517, DOI 10.1007/s11892-012-0308-1; Zhao Y, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-3; Zhao Y, 2010, AUTOIMMUN REV, V10, P103, DOI 10.1016/j.autrev.2010.08.011	50	3	3	3	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	MAR 9	2017	8								62	10.1186/s13287-017-0511-8				10	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	EO8YZ	WOS:000396977700013	28279194	gold			2018-01-05	
J	Suzuki, HI; Young, RA; Sharp, PA				Suzuki, Hiroshi I.; Young, Richard A.; Sharp, Phillip A.			Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis	CELL			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; IDENTITY GENES; DIFFERENTIATION; DATABASE; GENOME; DROSHA; EVOLUTION; DISEASE	Super-enhancers are an emerging subclass of regulatory regions controlling cell identity and disease genes. However, their biological function and impact on miRNA networks are unclear. Here, we report that super-enhancers drive the biogenesis of master miRNAs crucial for cell identity by enhancing both transcription and Drosha/DGCR8-mediated primary miRNA ( pri-miRNA) processing. Super-enhancers, together with broad H3K4me3 domains, shape a tissue-specific and evolutionarily conserved atlas of miRNAexpression and function. CRISPR/Cas9 genomics revealed that super-enhancer constituents act cooperatively and facilitate Drosha/DGCR8 recruitment and pri-miRNA processing to boost cell-specific miRNA production. The BET-bromodomain inhibitor JQ1 preferentially inhibits super-enhancerdirected cotranscriptional pri-miRNA processing. Furthermore, super-enhancers are characterized by pervasive interaction with DGCR8/Drosha and DGCR8/Drosha-regulated mRNA stability control, suggesting unique RNA regulation at super-enhancers. Finally, super-enhancers mark multiple miRNAsassociated with cancer hallmarks. This study presents principles underlying miRNA biology in health and disease and an unrecognized higher-order property of super-enhancers in RNA processing beyond transcription.	[Suzuki, Hiroshi I.; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Young, Richard A.; Sharp, Phillip A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Sharp, PA (reprint author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sharp, PA (reprint author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu			JSPS Postdoctoral Fellowship for Research Abroad; Uehara Memorial Foundation; United States Public Health Service from the NIH [R01-CA133404]; Koch Institute from the NCI [P30-CA14051]	We thank S. Dubbury, A. Chiu, C.K. JnBaptiste, B.J. Abraham, and members of Sharp laboratories for discussions and assistance and S. Levine and the staff of the BioMicro Center at MIT for sequencing support. H.I.S. is supported by JSPS Postdoctoral Fellowship for Research Abroad and Uehara Memorial Foundation. The results here are in part based upon data generated by the TCGA Research Network: https://cancergenome.nih.gov/. R.A.Y. is a founder and P.A.S. is a board member of Syros Pharmaceuticals, which is developing SE directed agents, none of which were used in the study. This research has been supported by United States Public Health Service grant R01-CA133404 (to P.A.S.) from the NIH and partially by Koch Institute Support (core) grant P30-CA14051 from the NCI.	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gromak N, 2013, CELL REP, V5, P1499, DOI 10.1016/j.celrep.2013.11.032; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Kwon SC, 2016, CELL, V164, P81, DOI 10.1016/j.cell.2015.12.019; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Liu HM, 2016, MOL CELL, V63, P420, DOI 10.1016/j.molcel.2016.06.014; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Young R. A., 2013, CELL, V153, P320; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Macias S, 2015, MOL CELL, V60, P873, DOI 10.1016/j.molcel.2015.11.011; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq.367; Porstner M, 2015, EUR J IMMUNOL, V45, P1206, DOI 10.1002/eji.201444637; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Skene PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09225; Squadrito ML, 2012, CELL REPORTS, V1, P141, DOI 10.1016/j.celrep.2011.12.005; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang DF, 2014, BIOINFORMATICS, V30, P2237, DOI 10.1093/bioinformatics/btu155; Wang HP, 2014, NAT IMMUNOL, V15, P393, DOI 10.1038/ni.2846; Wang WY, 2012, LEARN MEMORY, V19, P359, DOI 10.1101/lm.026492.112; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	58	8	8	14	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2017	168	6					1000	+		10.1016/j.cell.2017.02.015				30	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EN8ZF	WOS:000396287900009	28283057				2018-01-05	
J	Wan, LL; Wen, H; Li, YY; Lyu, J; Xi, YX; Hoshii, T; Joseph, JK; Wang, XL; Loh, YHE; Erb, MA; Souza, AL; Bradner, JE; Shen, L; Li, W; Li, HT; Allis, CD; Armstrong, SA; Shi, XB				Wan, Liling; Wen, Hong; Li, Yuanyuan; Lyu, Jie; Xi, Yuanxin; Hoshii, Takayuki; Joseph, Julia K.; Wang, Xiaolu; Loh, Yong-Hwee E.; Erb, Michael A.; Souza, Amanda L.; Bradner, James E.; Shen, Li; Li, Wei; Li, Haitao; Allis, C. David; Armstrong, Scott A.; Shi, Xiaobing			ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia	NATURE			English	Article							RNA-POLYMERASE-II; MLL-REARRANGED LEUKEMIA; ELONGATION COMPLEX; TRANSCRIPTION ELONGATION; H3K79 METHYLATION; STEM-CELLS; P-TEFB; CHROMATIN; INHIBITION; BROMODOMAINS	Cancer cells are characterized by aberrant epigenetic landscapes and often exploit chromatin machinery to activate oncogenic gene expression programs(1). Recognition of modified histones by 'reader' proteins constitutes a key mechanism underlying these processes; therefore, targeting such pathways holds clinical promise, as exemplified by the development of bromodomain and extra-terminal (BET) inhibitors(2,3). We recently identified the YEATS domain as an acetyl-lysine-binding module(4), but its functional importance in human cancer remains unknown. Here we show that the YEATS domain-containing protein ENL, but not its paralogue AF9, is required for disease maintenance in acute myeloid leukaemia. CRISPR-Cas9-mediated depletion of ENL led to anti-leukaemic effects, including increased terminal myeloid differentiation and suppression of leukaemia growth in vitro and in vivo. Biochemical and crystal structural studies and chromatin-immunoprecipitation followed by sequencing analyses revealed that ENL binds to acetylated histone H3, and co-localizes with H3K27ac and H3K9ac on the promoters of actively transcribed genes that are essential for leukaemia. Disrupting the interaction between the YEATS domain and histone acetylation via structure-based mutagenesis reduced the recruitment of RNA polymerase II to ENL-target genes, leading to the suppression of oncogenic gene expression programs. Notably, disrupting the functionality of ENL further sensitized leukaemia cells to BET inhibitors. Together, our data identify ENL as a histone acetylation reader that regulates oncogenic transcriptional programs in acute myeloid leukaemia, and suggest that displacement of ENL from chromatin may be a promising epigenetic therapy, alone or in combination with BET inhibitors, for aggressive leukaemia.	[Wan, Liling; Joseph, Julia K.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Wan, Liling; Hoshii, Takayuki; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Wan, Liling; Hoshii, Takayuki; Armstrong, Scott A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Wen, Hong; Wang, Xiaolu; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Wen, Hong; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Li, Yuanyuan; Li, Haitao] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Med, Dept Basic Med Sci,MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Li, Yuanyuan; Li, Haitao] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Lyu, Jie; Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Loh, Yong-Hwee E.; Shen, Li] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Loh, Yong-Hwee E.; Shen, Li] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Erb, Michael A.; Souza, Amanda L.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Bradner, James E.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Shi, Xiaobing] Univ Texas Houston, Grad Sch Biomed Sci, Genes & Dev & Epigenet & Mol Carcinogenesis Grad, Houston, TX 77030 USA; [Souza, Amanda L.; Bradner, James E.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Allis, CD (reprint author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.; Armstrong, SA (reprint author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.; Armstrong, SA (reprint author), Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA.; Shi, XB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.; Shi, XB (reprint author), Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA.; Shi, XB (reprint author), Univ Texas Houston, Grad Sch Biomed Sci, Genes & Dev & Epigenet & Mol Carcinogenesis Grad, Houston, TX 77030 USA.	alliscd@rockefeller.edu; scott_armstrong@dfci.harvard.edu; xbshi@mdanderson.org		Erb, Michael/0000-0001-9993-3481; Wen, Hong/0000-0001-8739-4572; Shi, Xiaobing/0000-0001-5242-8189	NIH [1R01CA204639-01, CA66996, CA140575, R01HG007538, R01CA193466]; Leukaemia and Lymphoma Society [LLS-SCOR 7006-13]; Rockefeller University; NIH/NCI [1R01CA204020-01]; Cancer Prevention and Research Institute of Texas [RP160237, RP170285]; Welch Foundation [G1719]; Major State Basic Research Development Program in China [2016YFA0500700, 2015CB910503]; Tsinghua University Initiative Scientific Research Program	We thank H. Li, M. Armstrong, C.-W. Chen, M. Yu, H. Chu, K. Tanaka, D. Peng and T. Scott for discussions and technical supports. We are grateful to The Rockefeller University Genomic Resource Center, Flow Cytometry Resource Center, The MD Anderson Science Park Next-Generation Sequencing Facility (CPRIT RP120348), The Sequencing and Microarray Facility and The Flow Cytometry and Cellular Imaging Core Facility (NIH/NCI P30CA016672), The Shanghai Synchrotron Radiation Facility BL17U beamline, and The China National Center for Protein Sciences Beijing for facility supports. The research was supported by funds from NIH (1R01CA204639-01), the Leukaemia and Lymphoma Society (LLS-SCOR 7006-13), and The Rockefeller University to C.D.A.; NIH grants (CA66996 and CA140575) and the Leukaemia and Lymphoma Society to S.A.A.; grants from NIH/NCI (1R01CA204020-01), Cancer Prevention and Research Institute of Texas (RP160237 and RP170285) and Welch Foundation (G1719) to X.S.; grants from the Major State Basic Research Development Program in China (2016YFA0500700 and 2015CB910503), and the Tsinghua University Initiative Scientific Research Program to H.L.; and grants from NIH (R01HG007538 and R01CA193466) to W.L. X.S. is a recipient of a Leukaemia & Lymphoma Society Career Development Award and an R. Lee Clark Fellow and Faculty Scholar of MD Anderson Cancer Center. L.W. is a fellow of the Jane Coffin Childs Memorial Fund. Y.L. is a Tsinghua Advanced Innovation fellow.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deshpande AJ, 2012, TRENDS IMMUNOL, V33, P563, DOI 10.1016/j.it.2012.06.002; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kawahara M, 2012, CANCER CELL, V22, P194, DOI 10.1016/j.ccr.2012.06.027; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Perlman EJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10013; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Sims Robert J. III, 2004, Genes & Development, V18, P2437, DOI 10.1101/gad.1235904; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	27	5	5	7	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					265	+		10.1038/nature21687				18	Multidisciplinary Sciences	Science & Technology - Other Topics	EN0GQ	WOS:000395688700044	28241141	green_accepted			2018-01-05	
J	Erb, MA; Scott, TG; Li, BE; Xie, HF; Paulk, J; Seo, HS; Souza, A; Roberts, JM; Dastjerdi, S; Buckley, DL; Sanjana, NE; Shalem, O; Nabet, B; Zeid, R; Offei-Addo, NK; Dhe-Paganon, S; Zhang, F; Orkin, SH; Winter, GE; Bradner, JE				Erb, Michael A.; Scott, Thomas G.; Li, Bin E.; Xie, Huafeng; Paulk, Joshiawa; Seo, Hyuk-Soo; Souza, Amanda; Roberts, Justin M.; Dastjerdi, Shiva; Buckley, Dennis L.; Sanjana, Neville E.; Shalem, Ophir; Nabet, Behnam; Zeid, Rhamy; Offei-Addo, Nana K.; Dhe-Paganon, Sirano; Zhang, Feng; Orkin, Stuart H.; Winter, Georg E.; Bradner, James E.			Transcription control by the ENL YEATS domain in acute leukaemia	NATURE			English	Article							BET BROMODOMAIN INHIBITION; MIXED-LINEAGE LEUKEMIA; H3K79 METHYLATION; HISTONE CROTONYLATION; ESSENTIAL GENES; IN-VIVO; C-MYC; CHROMATIN; CELLS; PROTEIN	Recurrent chromosomal translocations producing a chimaeric MLL oncogene give rise to a highly aggressive acute leukaemia associated with poor clinical outcome(1). The preferential involvement of chromatin-associated factors as MLL fusion partners belies a dependency on transcription control(2). Despite recent progress made in targeting chromatin regulators in cancer(3), available therapies for this well-characterized disease remain inadequate, prompting the need to identify new targets for therapeutic intervention. Here, using unbiased CRISPR-Cas9 technology to perform a genome-scale loss-of-function screen in an MLL-AF4-positive acute leukaemia cell line, we identify ENL as an unrecognized gene that is specifically required for proliferation in vitro and in vivo. To explain the mechanistic role of ENL in leukaemia pathogenesis and dynamic transcription control, a chemical genetic strategy was developed to achieve targeted protein degradation. Acute loss of ENL suppressed the initiation and elongation of RNA polymerase II at active genes genome-wide, with pronounced effects at genes featuring a disproportionate ENL load. Notably, an intact YEATS chromatin-reader domain was essential for ENL-dependent leukaemic growth. Overall, these findings identify a dependency factor in acute leukaemia and suggest a mechanistic rationale for disrupting the YEATS domain in disease.	[Erb, Michael A.; Scott, Thomas G.; Paulk, Joshiawa; Souza, Amanda; Roberts, Justin M.; Dastjerdi, Shiva; Buckley, Dennis L.; Nabet, Behnam; Zeid, Rhamy; Winter, Georg E.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Li, Bin E.; Xie, Huafeng; Orkin, Stuart H.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Li, Bin E.; Xie, Huafeng; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Li, Bin E.; Xie, Huafeng; Orkin, Stuart H.] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Seo, Hyuk-Soo; Offei-Addo, Nana K.; Dhe-Paganon, Sirano] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Sanjana, Neville E.; Shalem, Ophir; Zhang, Feng] Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Sanjana, Neville E.; Shalem, Ophir] MIT, McGovern Inst Brain Res, Dept Biol Engn, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Orkin, Stuart H.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bradner, James E.] Harvard Med Sch, Dept Med, Boston, MA USA; [Winter, Georg E.] Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria; [Bradner, James E.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Bradner, JE (reprint author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Bradner, JE (reprint author), Harvard Med Sch, Dept Med, Boston, MA USA.	james.bradner@novartis.com		Nabet, Behnam/0000-0002-6738-4200; Erb, Michael/0000-0001-9993-3481; Roberts, Justin/0000-0001-6112-7476	NIH [R01-CA176745, P01-CA109901]; EMBO long-term fellowship; Pathway to Independence Award from the NHGRI [R00-HG008171]	The authors thank S. A. Armstrong, C. D. Allis, and X. Shi for transparent and supportive dialogue. We also thank J. A. Perry for editing the manuscript and N. S. Gray and C. J. Ott for suggestions. Quantitative proteomics studies were performed by R. Kunz. This research was supported by philanthropic gifts from K. Lubin and E. Woods, as well as NIH grants (R01-CA176745 and P01-CA109901 to J.E.B.). G.E.W. was supported by an EMBO long-term fellowship. D.L.B. is a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2196-14). N. E. S. is supported by a Pathway to Independence Award (R00-HG008171) from the NHGRI.	Andrews FH, 2016, NAT CHEM BIOL, V12, P396, DOI 10.1038/nchembio.2065; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Cai SF, 2015, MOL CELL, V60, P561, DOI 10.1016/j.molcel.2015.10.042; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Levis M, 2002, BLOOD, V99, P3885, DOI 10.1182/blood.V99.11.3885                                                       ; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; RUBNITZ JE, 1994, BLOOD, V84, P1747; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shanle EK, 2015, GENE DEV, V29, P1795, DOI [10.1101/gad.269977, 10.1101/gad.269977.115]; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Slany RK, 2005, HEMATOL ONCOL, V23, P1, DOI 10.1002/hon.739; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wilkinson AC, 2013, CELL REP, V3, P116, DOI 10.1016/j.celrep.2012.12.016; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	31	9	9	8	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					270	+		10.1038/nature21688				14	Multidisciplinary Sciences	Science & Technology - Other Topics	EN0GQ	WOS:000395688700045	28241139	green_accepted			2018-01-05	
J	Beukers, AG; Zaheer, R; Goji, N; Amoako, KK; Chaves, AV; Ward, MP; McAllister, TA				Beukers, Alicia G.; Zaheer, Rahat; Goji, Noriko; Amoako, Kingsley K.; Chaves, Alexandre V.; Ward, Michael P.; McAllister, Tim A.			Comparative genomics of Enterococcus spp. isolated from bovine feces	BMC MICROBIOLOGY			English	Article						Bovine feces; Enterococcus; Comparative genomics	CRISPR-CAS SYSTEMS; ANTIBIOTIC-RESISTANCE GENES; MACROLIDE-LINCOSAMIDE-STREPTOGRAMIN; PHEROMONE RESPONSE PLASMID; SEQUENCE TYPING SCHEME; ANTIMICROBIAL RESISTANCE; VANCOMYCIN-RESISTANT; VIRULENCE FACTORS; CONJUGATIVE ELEMENTS; NUCLEOTIDE-SEQUENCE	Background: Enterococcus is ubiquitous in nature and is a commensal of both the bovine and human gastrointestinal (GI) tract. It is also associated with clinical infections in humans. Subtherapeutic administration of antibiotics to cattle selects for antibiotic resistant enterococci in the bovine GI tract. Antibiotic resistance genes (ARGs) may be present in enterococci following antibiotic use in cattle. If located on mobile genetic elements (MGEs) their dissemination between Enterococcus species and to pathogenic bacteria may be promoted, reducing the efficacy of antibiotics. Results: We present a comparative genomic analysis of twenty-one Enterococcus spp. isolated from bovine feces including Enterococcus hirae (n = 10), Enterococcus faecium (n = 3), Enterococcus villorum (n = 2), Enterococcus casseliflavus (n = 2), Enterococcus faecalis (n = 1), Enterococcus durans (n = 1), Enterococcus gallinarum (n = 1) and Enterococcus thailandicus (n = 1). The analysis revealed E. faecium and E. faecalis from bovine feces share features with human clinical isolates, including virulence factors. The Tn917 transposon conferring macrolide-lincosamidestreptogramin B resistance was identified in both E. faecium and E. hirae, suggesting dissemination of ARGs on MGEs may occur in the bovine GI tract. An E. faecium isolate was also identified with two integrative conjugative elements (ICEs) belonging to the Tn916 family of ICE, Tn916 and Tn5801, both conferring tetracycline resistance. Conclusions: This study confirms the presence of enterococci in the bovine GI tract possessing ARGs on MGEs, but the predominant species in cattle, E. hirae is not commonly associated with infections in humans. Analysis using additional complete genomes of E. faecium from the NCBI database demonstrated differential clustering of commensal and clinical isolates, suggesting that these strains may be specifically adapted to their respective environments.	[Beukers, Alicia G.; Zaheer, Rahat; McAllister, Tim A.] Lethbridge Res Ctr, Agr & Agri Food Canada, Lethbridge, AB, Canada; [Beukers, Alicia G.; Chaves, Alexandre V.; Ward, Michael P.] Univ Sydney, Sch Life & Environm Sci, Fac Vet Sci, Sydney, NSW, Australia; [Goji, Noriko; Amoako, Kingsley K.] Canadian Food Inspect Agcy, Natl Ctr Anim Dis, Lethbridge Lab, Lethbridge, AB, Canada	McAllister, TA (reprint author), Lethbridge Res Ctr, Agr & Agri Food Canada, Lethbridge, AB, Canada.	tim.mcallister@agr.gc.ca	Ward, Michael/C-5758-2009	Ward, Michael/0000-0002-9921-4986	Beef Cattle Research Council (BCRC) Beef Cluster of Agriculture and Agri-Food Canada; GRDI program of the Government of Canada	This study was conducted with funding from Beef Cattle Research Council (BCRC) Beef Cluster of Agriculture and Agri-Food Canada and the GRDI program of the Government of Canada and is gratefully acknowledged. The funders had no role in the design, collection of samples, analysis, interpretation or writing of the manuscript.	Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Anderson JF, 2008, APPL ENVIRON MICROB, V74, P1726, DOI 10.1128/AEM.02164-07; Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Aymerich T, 1996, APPL ENVIRON MICROB, V62, P1676; Bager F, 1997, PREV VET MED, V31, P95, DOI 10.1016/S0167-5877(96)01119-1; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Beukers AG, 2016, GENOME ANNOUNC, V4; Beukers AG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00483; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bi DX, 2012, NUCLEIC ACIDS RES, V40, pD621, DOI 10.1093/nar/gkr846; Borst LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121294; Boyd DA, 2015, J ANTIMICROB CHEMOTH, V70, P2163, DOI 10.1093/jac/dkv057; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x                                                ; Camargo ILBC, 2006, CLIN MICROBIOL INFEC, V12, P1123, DOI 10.1111/j.1469-0691.2006.01496.x; Casaus P, 1997, MICROBIOL-UK, V143, P2287, DOI 10.1099/00221287-143-7-2287                                                     ; Celli J, 1998, MOL MICROBIOL, V28, P103, DOI 10.1046/j.1365-2958.1998.00778.x; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Ciric L, 2013, BACTERIAL INTEGRATIV; Clements MO, 1999, TRENDS MICROBIOL, V7, P458, DOI 10.1016/S0966-842X(99)01607-8; CLEWELL DB, 1993, CELL, V73, P9, DOI 10.1016/0092-8674(93)90153-H                                                    ; Clewell DB, 2007, PLASMID, V58, P205, DOI 10.1016/j.plasmid.2007.05.001; Coburn PS, 2007, MOL MICROBIOL, V63, P530, DOI 10.1111/j.1365-2958.2006.05520.x; COSTA Y, 1993, ANTIMICROB AGENTS CH, V37, P1896, DOI 10.1128/AAC.37.9.1896                                                           ; Da Cunha V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5544; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Vries LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00576; DEIBEL RH, 1963, J BACTERIOL, V86, P1275; del Campo R, 2005, J ANTIMICROB CHEMOTH, V55, P1053, DOI 10.1093/jac/dki138; Del Papa MF, 2008, J BACTERIOL, V190, P7147, DOI 10.1128/JB.00952-08; Derbise A, 1997, ANTIMICROB AGENTS CH, V41, P1024; Devriese LA, 2002, J APPL MICROBIOL, V92, P821, DOI 10.1046/j.1365-2672.2002.01586.x                                                ; DEVRIESE LA, 1993, J APPL BACTERIOL, V75, P399, DOI 10.1111/j.1365-2672.1993.tb02794.x; Duerkop BA, 2014, ENTEROCOCCI COMMENSA; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Eijsink VGH, 2002, ANTON LEEUW INT J G, V81, P639, DOI 10.1023/A:1020582211262; Fard RMN, 2011, LETT APPL MICROBIOL, V52, P559, DOI 10.1111/j.1472-765X.2011.03043.x; Fard RMN, 2010, CURR MICROBIOL, V60, P400, DOI 10.1007/s00284-009-9555-z; FARROW JAE, 1985, INT J SYST BACTERIOL, V35, P73, DOI 10.1099/00207713-35-1-73                                                        ; FLANNAGAN SE, 1994, PLASMID, V32, P350, DOI 10.1006/plas.1994.1077; FORD M, 1994, J CLIN MICROBIOL, V32, P2999; FRANKE AE, 1981, J BACTERIOL, V145, P494; Frankenberg L, 2002, J BACTERIOL, V184, P6351, DOI 10.1128/JB.184.22.6351-6356.2002; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Franz CMAP, 2001, APPL ENVIRON MICROB, V67, P4385, DOI 10.1128/AEM.67.9.4385-4389.2001; Gold HS, 2001, CLIN INFECT DIS, V33, P210, DOI 10.1086/321815; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hancock LE, 2004, J BACTERIOL, V186, P7951, DOI 10.1128/JB.186.23.7951-7958.2004; HANDWERGER S, 1990, ANTIMICROB AGENTS CH, V34, P358, DOI 10.1128/AAC.34.2.358                                                            ; Hegstad K, 2010, CLIN MICROBIOL INFEC, V16, P541, DOI 10.1111/j.1469-0691.2010.03226.x; Higuita N. I. Agudelo, 2014, ENTEROCOCCI COMMENSA; Health Canada, 2002, US ANT FOOD AN CAN I; Holzel CS, 2010, J APPL MICROBIOL, V108, P1642, DOI 10.1111/j.1365-2672.2009.04570.x; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Iweriebor BC, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0468-7; Jimenez E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-288; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; KANAFANI H, 1985, J CLIN MICROBIOL, V21, P607; Katyal I, 2013, MICROB ECOL, V66, P182, DOI 10.1007/s00248-013-0217-0; Klare I, 1995, MICROB DRUG RESIST, V1, P265, DOI 10.1089/mdr.1995.1.265                                                          ; Kristich CJ, 2014, ENTEROCOCCI COMMENSA; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P454, DOI 10.1016/j.mib.2006.07.001; LECLERCQ R, 1992, ANTIMICROB AGENTS CH, V36, P2005, DOI 10.1128/AAC.36.9.2005                                                           ; LOWE AM, 1995, INFECT IMMUN, V63, P703; Magi G, 2003, ANTIMICROB AGENTS CH, V47, P1571, DOI 10.1128/AAC.47.5.1571-1576.2003; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Miller MEB, 2012, ENVIRON MICROBIOL, V14, P207, DOI 10.1111/j.1462-2920.2011.02593.x; Nakayama J, 2006, J BACTERIOL, V188, P8321, DOI 10.1128/JB.00865-06; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; NAVARRO F, 1994, ANTIMICROB AGENTS CH, V38, P1788, DOI 10.1128/AAC.38.8.1788                                                           ; Nes I. F., 2014, ENTEROCOCCI COMMENSA; Nicolas E, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0060-2014; Novais C, 2012, ANTIMICROB AGENTS CH, V56, P6014, DOI 10.1128/AAC.00758-12; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Palmer K. L., 2014, ENTEROCOCCI COMMENSA; Palmieri C, 2012, ANTIMICROB AGENTS CH, V56, P5994, DOI 10.1128/AAC.01487-12; Petkau A., 2016, BIORXIV; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Poeta P, 2006, INT J ANTIMICROB AG, V27, P131, DOI 10.1016/j.ijantimicag.2005.09.018; Poeta P, 2005, J VET MED B, V52, P396, DOI 10.1111/j.1439-0450.2005.00881.x; Poh CH, 2006, J INFECTION, V52, P383, DOI 10.1016/j.jinf.2005.07.011; Portillo A, 2000, ANTIMICROB AGENTS CH, V44, P967, DOI 10.1128/AAC.44.4.967-971.2000; PubMLST, 2016, CLON COMPL DES; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871; Rich RL, 1999, J BIOL CHEM, V274, P26939, DOI 10.1074/jbc.274.38.26939; Roberts AP, 2011, FEMS MICROBIOL REV, V35, P856, DOI 10.1111/j.1574-6976.2011.00283.x; Roberts MC, 2002, MOL BIOTECHNOL, V20, P261, DOI 10.1385/MB:20:3:261; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Ruiz-Garbajosa P, 2006, J CLIN MICROBIOL, V44, P2220, DOI 10.1128/JCM.02596-05; Schouten MA, 1997, LANCET, V349, P1258, DOI 10.1016/S0140-6736(05)62461-0; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Semedo T, 2003, SYST APPL MICROBIOL, V26, P13, DOI 10.1078/0723202022528942; SHAW JH, 1985, J BACTERIOL, V164, P782; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; SU YA, 1991, INFECT IMMUN, V59, P415; Sun JL, 2009, J CLIN MICROBIOL, V47, P2218, DOI 10.1128/JCM.00388-09; Tanasupawat S, 2008, INT J SYST EVOL MICR, V58, P1630, DOI 10.1099/ijs.0.65535-0; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Werner G, 2001, ANTIMICROB AGENTS CH, V45, P3267, DOI 10.1128/AAC.45.11.3267-3269.2001; Werner G, 2013, INT J MED MICROBIOL, V303, P360, DOI 10.1016/j.ijmm.2013.03.001; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204                                                             ; WIRTH R, 1994, EUR J BIOCHEM, V222, P235, DOI 10.1111/j.1432-1033.1994.tb18862.x; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Yamada Y, 2015, P NATL ACAD SCI USA, V112, P857, DOI 10.1073/pnas.1422108112; Yamada Y, 2012, METHOD ENZYMOL, V515, P123, DOI 10.1016/B978-0-12-394290-6.00007-0; Yang SC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00241; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	124	1	1	9	21	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2180			BMC MICROBIOL	BMC Microbiol.	MAR 8	2017	17								52	10.1186/s12866-017-0962-1				18	Microbiology	Microbiology	EO5YC	WOS:000396767900001	28270110	gold			2018-01-05	
J	Gui, HS; Schriemer, D; Cheng, WW; Chauhan, RK; Antinolo, G; Berrios, C; Bleda, M; Brooks, AS; Brouwer, RWW; Burns, AJ; Cherny, SS; Dopazo, J; Eggen, BJL; Griseri, P; Jalloh, B; Le, TL; Lui, VCH; Luzon-Toro, B; Matera, I; Ngan, ESW; Pelet, A; Ruiz-Ferrer, M; Sham, PC; Shepherd, IT; So, MT; Sribudiani, Y; Tang, CSM; van den Hout, MCGN; van der Linde, HC; van Ham, TJ; van IJcken, WFJ; Verheij, JBGM; Amiel, J; Borrego, S; Ceccherini, I; Chakravarti, A; Lyonnet, S; Tam, PKH; Garcia-Barcelo, MM; Hofstra, RMW				Gui, Hongsheng; Schriemer, Duco; Cheng, William W.; Chauhan, Rajendra K.; Antinolo, Guillermo; Berrios, Courtney; Bleda, Marta; Brooks, Alice S.; Brouwer, Rutger W. W.; Burns, Alan J.; Cherny, Stacey S.; Dopazo, Joaquin; Eggen, Bart J. L.; Griseri, Paola; Jalloh, Binta; Thuy-Linh Le; Lui, Vincent C. H.; Luzon-Toro, Berta; Matera, Ivana; Ngan, Elly S. W.; Pelet, Anna; Ruiz-Ferrer, Macarena; Sham, Pak C.; Shepherd, Iain T.; So, Man-Ting; Sribudiani, Yunia; Tang, Clara S. M.; van den Hout, Mirjam C. G. N.; van der Linde, Herma C.; van Ham, Tjakko J.; van IJcken, Wilfred F. J.; Verheij, Joke B. G. M.; Amiel, Jeanne; Borrego, Salud; Ceccherini, Isabella; Chakravarti, Aravinda; Lyonnet, Stanislas; Tam, Paul K. H.; Garcia-Barcelo, Maria-Merce; Hofstra, Robert M. W.			Whole exome sequencing coupled with unbiased functional analysis reveals new Hirschsprung disease genes	GENOME BIOLOGY			English	Article						De novo mutations; Hirschsprung disease; Neural crest; ENS	DE-NOVO MUTATIONS; ENTERIC NERVOUS-SYSTEM; CELL-DIFFERENTIATION; IN-VIVO; ZEBRAFISH; VARIANTS; FRAMEWORK; COMMON; AUTISM; SCHIZOPHRENIA	Background: Hirschsprung disease (HSCR), which is congenital obstruction of the bowel, results from a failure of enteric nervous system (ENS) progenitors to migrate, proliferate, differentiate, or survive within the distal intestine. Previous studies that have searched for genes underlying HSCR have focused on ENS-related pathways and genes not fitting the current knowledge have thus often been ignored. We identify and validate novel HSCR genes using whole exome sequencing (WES), burden tests, in silico prediction, unbiased in vivo analyses of the mutated genes in zebrafish, and expression analyses in zebrafish, mouse, and human. Results: We performed de novo mutation (DNM) screening on 24 HSCR trios. We identify 28 DNMs in 21 different genes. Eight of the DNMs we identified occur in RET, the main HSCR gene, and the remaining 20 DNMs reside in genes not reported in the ENS. Knockdown of all 12 genes with missense or loss-of-function DNMs showed that the orthologs of four genes (DENND3, NCLN, NUP98, and TBATA) are indispensable for ENS development in zebrafish, and these results were confirmed by CRISPR knockout. These genes are also expressed in human and mouse gut and/or ENS progenitors. Importantly, the encoded proteins are linked to neuronal processes shared by the central nervous system and the ENS. Conclusions: Our data open new fields of investigation into HSCR pathology and provide novel insights into the development of the ENS. Moreover, the study demonstrates that functional analyses of genes carrying DNMs are warranted to delineate the full genetic architecture of rare complex diseases.	[Gui, Hongsheng; Cheng, William W.; Lui, Vincent C. H.; Ngan, Elly S. W.; So, Man-Ting; Tang, Clara S. M.; Tam, Paul K. H.; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Gui, Hongsheng; Cherny, Stacey S.; Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Schriemer, Duco] Univ Groningen, Univ Med Ctr Groningen, Sect Med Physiol, Dept Neurosci, Groningen, Netherlands; [Cheng, William W.; Chauhan, Rajendra K.; Brooks, Alice S.; Burns, Alan J.; Sribudiani, Yunia; van der Linde, Herma C.; van Ham, Tjakko J.; Hofstra, Robert M. W.] Erasmus Univ, Med Ctr, Dept Clin Genet, POB 20403000CA, Rotterdam, Netherlands; [Antinolo, Guillermo; Dopazo, Joaquin; Luzon-Toro, Berta; Ruiz-Ferrer, Macarena; Borrego, Salud] Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Seville,Dept Genet Reprod & Fetal Med, Seville, Spain; [Antinolo, Guillermo; Bleda, Marta; Dopazo, Joaquin; Luzon-Toro, Berta; Ruiz-Ferrer, Macarena; Borrego, Salud] CIBERER, Ctr Biomed Network Res Rare Dis, Seville, Spain; [Berrios, Courtney; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Bleda, Marta] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge, England; [Brouwer, Rutger W. W.; van den Hout, Mirjam C. G. N.; van IJcken, Wilfred F. J.] Erasmus MC, Erasmus Ctr Biom, Rotterdam, Netherlands; [Burns, Alan J.; Hofstra, Robert M. W.] UCL Inst Child Hlth, Birth Defects Res Ctr, Stem Cells & Regenerat Med, London, England; [Griseri, Paola; Matera, Ivana; Ceccherini, Isabella] Ist Giannina Gaslini, UOC Genet Med, Genoa, Italy; [Jalloh, Binta; Shepherd, Iain T.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Pelet, Anna; Amiel, Jeanne; Lyonnet, Stanislas] INSERM, Inst Imagine, UMR 1163, Lab Embryol & Genet Human Malformat, Paris, France; [Pelet, Anna; Amiel, Jeanne] Paris Descartes Sorbonne Paris Cite Univ, Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France; [Sribudiani, Yunia] Padjadjaran State Univ, Fac Med, Dept Biochem & Mol Biol, Bandung, Indonesia; [Verheij, Joke B. G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Garcia-Barcelo, MM (reprint author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.; Hofstra, RMW (reprint author), Erasmus Univ, Med Ctr, Dept Clin Genet, POB 20403000CA, Rotterdam, Netherlands.; Hofstra, RMW (reprint author), UCL Inst Child Hlth, Birth Defects Res Ctr, Stem Cells & Regenerat Med, London, England.	mmgarcia@hku.hk; r.hofstra@erasmusmc.nl	Cherny, Stacey/B-3315-2008; amiel, jeanne/H-3501-2017; Lyonnet, Stanislas/H-5483-2017	Cherny, Stacey/0000-0002-0269-3352; amiel, jeanne/0000-0001-5973-4728; Lyonnet, Stanislas/0000-0001-5426-9417; Tang, Clara/0000-0003-0265-2638; PELET, Anastella/0000-0002-8353-1725; Chauhan, Rajendra Kumar/0000-0002-3904-5332; van Ham, Tjakko/0000-0002-2175-8713	ZonMW [40-00812-98-10042]; Maag Lever Darm stichting [WO09-62]; NIH [R37 HD28088]; Health and Medical Research Fund [HMRF 01121326, HMRF 02131866, 01121476]; General Research Fund [HKU 777612]; HKU [201110159001]; Research Grant Council of the Hong Kong Special Administrative Region, China [T12C-714/14R]; Italian Ministry of Health through "Cinque per mille"; Ricerca Corrente; Spanish Ministry of Economy and Competitiveness [PI13/01560, EXP00052887/ITC-20111037]; Regional Ministry of Innovation, Science and Enterprise of the Autonomous Government of Andalusia [CTS-7447]; NINDS [5R21NS082546];  [201309176158]	DS, AB, RC, BE, YS, and RH are supported by research grants from ZonMW (TOP-subsidie 40-00812-98-10042 to BJLE/RMWH) and the Maag Lever Darm stichting (WO09-62 to RMWH); AC is supported by NIH grant R37 HD28088; HG, WC, VL, EN, PS, MS, CT, PT, and MMG-B are supported by Health and Medical Research Fund (HMRF 01121326 to VCHL; HMRF 02131866 to MMGB; and 01121476 to ESWN); General Research Fund (HKU 777612 M to PKT); HKU seed funding for basic research (201110159001 to PKT) and small project funding (201309176158 to CSMT). The work described was also partially supported by a grant from the Research Grant Council of the Hong Kong Special Administrative Region, China, project number T12C-714/14R to PKT; CH and PG are supported by grants from the Italian Ministry of Health through "Cinque per mille" and Ricerca Corrente to the Gaslini Institute; GA, MB, BL-T, MR-F, and SB are supported by the Spanish Ministry of Economy and Competitiveness (Institute of Health Carlos III (ISCIII), PI13/01560 and CDTI, FEDER-Innterconecta EXP00052887/ITC-20111037), and the Regional Ministry of Innovation, Science and Enterprise of the Autonomous Government of Andalusia (CTS-7447); NINDS (5R21NS082546) awarded to ITS.	Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; Alves MM, 2013, DEV BIOL, V382, P320, DOI 10.1016/j.ydbio.2013.05.019; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Churkin A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-221; D'Angelo MA, 2012, DEV CELL, V22, P446, DOI 10.1016/j.devcel.2011.11.021; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Gui HS, 2014, ANN HUM GENET, V78, P381, DOI 10.1111/ahg.12076; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Haffner C, 2004, EMBO J, V23, P3041, DOI 10.1038/sj.emboj.7600307; Harrison C, 2014, GENESIS, V52, P985, DOI 10.1002/dvg.22826; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Irla M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-41; Irla M, 2007, EXP CELL RES, V313, P4107, DOI 10.1016/j.yexcr.2007.09.006; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang Q, 2015, AM J HUM GENET, V96, P581, DOI 10.1016/j.ajhg.2015.02.014; Jiang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021219; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Matsui T, 2014, J BIOL CHEM, V289, P13986, DOI 10.1074/jbc.M113.546689; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Piloto S, 2010, DEVELOPMENT, V137, P1981, DOI 10.1242/dev.048439; Pingault V, 2000, ANN NEUROL, V48, P671, DOI 10.1002/1531-8249(200010)48:4<671::AID-ANA17>3.3.CO;2-#; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shepherd I, 2011, METHOD CELL BIOL, V101, P143, DOI 10.1016/B978-0-12-387036-0.00006-2; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Srinivasan S, 2005, MOL CELL NEUROSCI, V29, P107, DOI 10.1016/j.mcn.2005.02.005; Tang CS, 2010, HUM GENET, V127, P675, DOI 10.1007/s00439-010-0813-8; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Van Ginneken C, 2011, BRAIN RES, V1378, P43, DOI 10.1016/j.brainres.2011.01.030; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wahba G, 2015, NEUROGASTROENT MOTIL, V27, P1156, DOI 10.1111/nmo.12605; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Winge K, 2003, J NEUROL NEUROSUR PS, V74, P13, DOI 10.1136/jnnp.74.1.13                                                            ; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yammine M, 2014, MOL CELL NEUROSCI, V59, P1, DOI 10.1016/j.mcn.2013.12.007	64	1	1	3	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	MAR 8	2017	18								48	10.1186/s13059-017-1174-6				13	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	EP0YP	WOS:000397112900001	28274275	gold			2018-01-05	
J	Miroshnichenko, D; Chaban, I; Chernobrovkina, M; Dolgov, S				Miroshnichenko, Dmitry; Chaban, Inna; Chernobrovkina, Mariya; Dolgov, Sergey			Protocol for efficient regulation of in vitro morphogenesis in einkorn (Triticum monococcum L.), a recalcitrant diploid wheat species	PLOS ONE			English	Article							IMMATURE EMBRYO CULTURES; HORDEUM-VULGARE L.; PLANT-REGENERATION; SOMATIC EMBRYOGENESIS; AESTIVUM L; CALLUS INDUCTION; MATURE EMBRYOS; PARTICLE BOMBARDMENT; DURUM DESF.; BARLEY	Einkorn (Triticum monococcum L.) is A-genome diploid wheat that has a potential to become a useful model for understanding the biology and genomics in Triticeae. Unfortunately, the application of modern technologies such as genetic engineering, RNAi-based gene silencing and genome editing is not available for einkorn as there is no efficient in vitro tissue culture and plant regeneration system. In the present study an efficient and simple protocol for plant regeneration via direct or indirect somatic embryogenesis and organogenesis has been developed. Various auxins used as sole inductors in einkorn displayed low effect for morphogenesis (0-8%) and plant regeneration (1-2 shoots per explant). The addition of Daminozide, the inhibitor of biosynthesis of gibberellins, together with auxin significantly improved the formation of morphogenic structures, especially when Dicamba (51.4%) and Picloram (56.6%) were used for combination; furthermore, the simultaneous addition of cytokinin into induction medium significantly promoted in vitro performance. Among the tested cytokinins, the urea-type substances, such as TDZ and CPPU were more effective than the adenine type ones, BA and Zeatin, for the regulation of morphogenesis; especially, TDZ was more effective than CPPU for shoot formation (11.73 vs. 7.04 per regenerating callus). The highest morphogenic response of 90.2% with the production of more than 10 shoots per initial explant was observed when 3.0 mg/L Dicamba, 50.0 mg/L Daminozide and 0.25 mg/L TDZ were combined together. Along with the identification of appropriate induction medium, the optimal developmental stage for einkorn was found as partially transparent immature embryo in size of around 1.0 mm. Although in the present study the critical balance between plant growth regulators was established for einkorn only, we assume that further the proposed strategy could be successfully applied to other recalcitrant cereal species and genotypes.	[Miroshnichenko, Dmitry] RAS, Inst Basic Biol Problems, Pushchino, Moscow Region, Russia; [Miroshnichenko, Dmitry; Dolgov, Sergey] RAS, Branch Shemyakin & Ovchinnikov Inst Bioorgan Chem, Pushchino, Moscow Region, Russia; [Chaban, Inna; Chernobrovkina, Mariya; Dolgov, Sergey] All Russia Res Inst Agr Biotechnol, Moscow, Russia	Miroshnichenko, D (reprint author), RAS, Inst Basic Biol Problems, Pushchino, Moscow Region, Russia.; Miroshnichenko, D (reprint author), RAS, Branch Shemyakin & Ovchinnikov Inst Bioorgan Chem, Pushchino, Moscow Region, Russia.	miroshnichenko@bibch.ru	Chernobrovkina, Mariya/L-4713-2017; Miroshnichenko, Dmitry/U-7330-2017		Russian Science Foundation [16-14-10155]	This work was supported by the Russian Science Foundation, Grant number: 16-14-10155 (http:rscf.ru/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikina O, 2016, CROP BREED APPL BIOT, V16, P307, DOI 10.1590/1984-70332016v16n4a46; Bakos F, 2009, SEX PLANT REPROD, V22, P15, DOI 10.1007/s00497-008-0087-7; Barro F, 1999, EUPHYTICA, V108, P161, DOI 10.1023/A:1003676830857; Bi RuiMing, 2008, Frontiers of Agriculture in China, V2, P262, DOI 10.1007/s11703-008-0038-y; Biesaga-Koscielniak J, 2010, ACTA PHYSIOL PLANT, V32, P1047, DOI 10.1007/s11738-010-0495-9; Bouamama B, 2011, IN VITRO CELL DEV-PL, V47, P321, DOI 10.1007/s11627-011-9357-4; BROWN C, 1989, J PLANT PHYSIOL, V133, P727, DOI 10.1016/S0176-1617(89)80080-X                                                   ; Brown RGS, 1997, PHYSIOL PLANTARUM, V101, P309, DOI 10.1034/j.1399-3054.1997.1010208.x; CARMAN JG, 1987, PLANT CELL TISS ORG, V10, P115, DOI 10.1007/BF00035909; Chang Y, 2003, PLANT CELL REP, V21, P733, DOI 10.1007/s00299-003-0607-8; Chauhan H, 2007, PLANT CELL TISS ORG, V91, P191, DOI 10.1007/s11240-007-9285-5; Delporte F, 2014, PROTOPLASMA, V251, P1455, DOI 10.1007/s00709-014-0647-7; Delporte F, 2012, PLANT SIGNAL BEHAV, V7, P1608, DOI 10.4161/psb.22424; Elhiti M, 2011, METHODS MOL BIOL, V710, P229, DOI 10.1007/978-1-61737-988-8_17; Eudes F, 2003, PLANT CELL TISS ORG, V73, P147, DOI 10.1023/A:1022800512708; Fernandez S, 1999, PLANT GROWTH REGUL, V28, P147, DOI 10.1023/A:1006142504577; Fu FL, 2011, AFR J BIOTECHNOL, V10, P2618; Ganeshan S, 2006, PLANT CELL TISS ORG, V85, P63, DOI 10.1007/s11240-005-9049-z; Guo B, 2011, AFR J BIOTECHNOL, V10, P8984; GUSSMAN CD, 1993, PLANT GROWTH REGUL, V12, P149, DOI 10.1007/BF00144596; Haliloglu K, 2005, J PLANT BIOCHEM BIOT, V14, P155, DOI 10.1007/BF03263244                                                              ; Harlan JR, 1981, WHEAT SCI TODAY TOMO, P1; HE DG, 1986, PLANT SCI, V45, P119, DOI 10.1016/0168-9452(86)90047-6; He GY, 2001, EUPHYTICA, V119, P369, DOI 10.1023/A:1017587628995; Hess JR, 1998, CROP SCI, V38, P249, DOI 10.2135/cropsci1998.0011183X003800010042x                                       ; Jha AK, 2007, PLANT CELL REP, V26, P285, DOI 10.1007/s00299-006-0252-0; JOHANSSON L, 1986, POTATO RES, V29, P179, DOI 10.1007/BF02357649                                                              ; Konieczny R, 2003, PLANT CELL TISS ORG, V73, P177, DOI 10.1023/A:1022877807237; Kothari SL, 1998, J PLANT BIOCHEM BIOT, V7, P93, DOI 10.1007/BF03263042                                                              ; Kumar S, 2005, BIOL PLANTARUM, V49, P629, DOI 10.1007/s10535-005-0064-z; Leon E, 2006, PLANT BREEDING, V125, P580, DOI 10.1111/j.1439-0523.2006.01262.x                                                ; Li BC, 2003, IN VITRO CELL DEV-PL, V39, P20, DOI 10.1079/IVP2002356; Longin CFH, 2016, TRENDS PLANT SCI, V21, P731, DOI 10.1016/j.tplants.2016.05.005; MESSENS E, 1990, P NATL ACAD SCI USA, V87, P4368, DOI 10.1073/pnas.87.11.4368; Miroshnichenko D., 2009, Australian Journal of Crop Science, V3, P83; Miroshnichenko D. N., 2013, Russian Agricultural Sciences, V39, P24, DOI 10.3103/S1068367413010175; Miroshnichenko D, 2016, PLANT CELL TISS ORG, V125, P495, DOI 10.1007/s11240-016-0965-x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murthy BNS, 1998, IN VITRO CELL DEV-PL, V34, P267; Ozgen M, 2017, PLANT GENET RESOUR-C, V15, P45, DOI 10.1017/S1479262115000350; OZIASAKINS P, 1982, PROTOPLASMA, V110, P95, DOI 10.1007/BF01281535; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Przetakiewicz A, 2003, PLANT CELL TISS ORG, V73, P245, DOI 10.1023/A:1023030511800; Pullman GS, 2005, PLANT CELL REP, V23, P596, DOI 10.1007/s00299-004-0880-1; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Rasco-Gaunt S, 2001, J EXP BOT, V52, P865, DOI 10.1093/jexbot/52.357.865                                                       ; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Schulze J., 2007, FRUIT VEGETABLE CERE, V1, P64; Seldimirova OA, 2016, IN VITRO CELL DEV-PL, V52, P251, DOI 10.1007/s11627-016-9767-4; Shan He, 2014, Journal of Northeast Agricultural University (English Edition), V21, P12; Shan XY, 2000, IN VITRO CELL DEV-PL, V36, P207, DOI 10.1007/s11627-000-0038-y; She MY, 2013, MOL BIOTECHNOL, V54, P451, DOI 10.1007/s12033-012-9583-y; Takumi S, 1997, GENES GENET SYST, V72, P63, DOI 10.1266/ggs.72.63; Viertel K, 1998, J PLANT PHYSIOL, V152, P167, DOI 10.1016/S0176-1617(98)80128-4                                                   ; Ward KA, 2001, IN VITRO CELL DEV-PL, V37, P361; Yang S, 2015, ACTA PHYSIOL PLANT, V37, P1; Yin N, 2012, PLANT MOL BIOL REP, V30, P949, DOI 10.1007/s11105-011-0403-5; Zaharieva M, 2014, GENET RESOUR CROP EV, V61, P677, DOI 10.1007/s10722-014-0084-7; Zale JM, 2004, PLANT CELL TISS ORG, V76, P277, DOI 10.1023/B:TICU.0000009248.32457.4c	59	0	0	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173533	10.1371/journal.pone.0173533				23	Multidisciplinary Sciences	Science & Technology - Other Topics	EN5VL	WOS:000396073700014	28273182	gold			2018-01-05	
J	Shcherbakova, A; Tiemann, B; Buettner, FFR; Bakker, H				Shcherbakova, Aleksandra; Tiemann, Birgit; Buettner, Falk F. R.; Bakker, Hans			Distinct C-mannosylation of netrin receptor thrombospondin type 1 repeats by mammalian DPY19L1 and DPY19L3	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						glycosylation; thrombospondin type 1 repeat; C-mannosylation	RNASE U-S; O-FUCOSYLATION; CRYSTAL-STRUCTURE; LAYERED FOLD; WSXWS MOTIF; F-SPONDIN; I REPEATS; PROTEIN; GLOBOZOOSPERMIA; GLYCOSYLATION	Thrombospondin type 1 repeats (TSRs) occur in diverse proteins involved in adhesion and signaling. The two extracellular TSRs of the netrin receptor UNC5A contain WxxWxxWxxC motifs that can be C-mannosylated on all tryptophans. A single C-mannosyltransferase (dumpy-19, DPY-19), modifying the first two tryptophans, occurs in Caenorhabditis elegans, but four putative enzymes (DPY-19- like 1-4, DPY19L1-4) exist in mammals. Single and triple CRISPR-Cas9 knockouts of the three homologs that are expressed in Chinese hamster ovary cells (DPY19L1, DPY19L3, and DPY19L4) and complementation experiments with mouse homologs showed that DPY19L1 preferentially mannosylates the first two tryptophans and DPY19L3 prefers the third, whereas DPY19L4 has no function in TSR glycosylation. Mannosylation by DPY19L1 but not DPY19L3 is required for transport of UNC5A from the endoplasmic reticulum to the cell surface. In vertebrates, a new C-mannosyltransferase has apparently evolved to increase glycosylation of TSRs, potentially to increase the stability of the structurally essential tryptophan ladder or to provide additional adhesion functions.	[Shcherbakova, Aleksandra; Tiemann, Birgit; Buettner, Falk F. R.; Bakker, Hans] Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany	Bakker, H (reprint author), Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany.	bakker.hans@mh-hannover.de	Bakker, Hans/A-1787-2017	Bakker, Hans/0000-0002-1364-9154	DFG (Deutsche Forschungsgemeinschaft) [BA4091/5-1]; Cluster of Excellence REBIRTH (Regenerative Biology to Reconstructive Therapy) [EXC 62/2]	This work was supported by the DFG (Deutsche Forschungsgemeinschaft), Grant BA4091/5-1, and Cluster of Excellence REBIRTH (Regenerative Biology to Reconstructive Therapy, EXC 62/2).	Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Carson AR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-45; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cova M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0949-z; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; DEBEER T, 1995, BIOCHEMISTRY-US, V34, P11785, DOI 10.1021/bi00037a016                                                             ; Doucey MA, 1999, GLYCOBIOLOGY, V9, P435, DOI 10.1093/glycob/9.5.435; ElInati E, 2012, HUM MOL GENET, V21, P3695, DOI 10.1093/hmg/dds200; Ervin LA, 2005, INVEST OPHTH VIS SCI, V46, P627, DOI 10.1167/iovs.04-0894; Furmanek A, 2003, BIOCHEMISTRY-US, V42, P8452, DOI 10.1021/bi034112p; Hamming OJ, 2012, J BIOL CHEM, V287, P9454, DOI 10.1074/jbc.M111.311084; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Hartmann S, 2000, J BIOL CHEM, V275, P28569, DOI 10.1074/jbc.M001732200                                                          ; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003                                                             ; HOLT GD, 1990, J BIOL CHEM, V265, P2852; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; Klenotic PA, 2013, ARTERIOSCL THROM VAS, V33, P1655, DOI 10.1161/ATVBAHA.113.301523; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Niwa Y, 2016, MOL BIOL CELL, V27, P744, DOI 10.1091/mbc.E15-06-0373; Niwa Y, 2015, FEBS LETT, V589, P3287, DOI 10.1016/j.febslet.2015.09.012; Olsen JG, 2014, CYTOKINE GROWTH F R, V25, P337, DOI 10.1016/j.cytogfr.2014.04.007; Perez-Vilar J, 2004, GLYCOBIOLOGY, V14, P325, DOI 10.1093/glycob/cwh041; Pierre V, 2012, DEVELOPMENT, V139, P2955, DOI 10.1242/dev.077982; PRATER CA, 1991, J CELL BIOL, V112, P1031, DOI 10.1083/jcb.112.5.1031; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Russell S, 2015, FASEB J, V29, P576, DOI 10.1096/fj.14-261636; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tossavainen H, 2006, PROTEIN SCI, V15, P1760, DOI 10.1110/ps.052068506; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Tzarfaty-Majar V, 2001, J BIOL CHEM, V276, P28233, DOI 10.1074/jbc.M102585200; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; van der Burg M, 2011, LEUKEMIA, V25, P1467, DOI 10.1038/leu.2011.118; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059	41	2	2	3	5	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	MAR 7	2017	114	10					2574	2579		10.1073/pnas.1613165114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	EM7SA	WOS:000395511400064	28202721	green_published			2018-01-05	
J	Chen, JL; Jiang, DN; Tan, DJ; Fan, Z; Wei, YY; Li, MH; Wang, DS				Chen, Jinlin; Jiang, Dongneng; Tan, Dejie; Fan, Zheng; Wei, Yingying; Li, Minghui; Wang, Deshou			Heterozygous mutation of eEF1A1b resulted in spermatogenesis arrest and infertility in male tilapia, Oreochromis niloticus	SCIENTIFIC REPORTS			English	Article							ELONGATION-FACTOR 1-ALPHA; NILE TILAPIA; FACTOR 1A; XENOPUS-LAEVIS; DIFFERENTIAL EXPRESSION; ACTIN CYTOSKELETON; RNA LOCALIZATION; FACTOR-1-ALPHA; GENE; TISSUE	Eukaryotic elongation factor 1 alpha (eEF1A) is an essential component of the translational apparatus. In the present study, eEF1A1b was isolated from the Nile tilapia. Real-time PCR and Western blot revealed that eEF1A1b was expressed highly in the testis from 90 dah (days after hatching) onwards. In situ hybridization and immunohistochemistry analyses showed that eEF1A1b was highly expressed in the spermatogonia of the testis. CRISPR/Cas9 mediated mutation of eEF1A1b resulted in spermatogenesis arrest and infertility in the F-0 XY fish. Consistently, heterozygous mutation of eEF1A1b (eEF1A1b(+/-)) resulted in an absence of spermatocytes at 90 dah, very few spermatocytes, spermatids and spermatozoa at 180 dah, and decreased Cyp11b2 and serum 11-ketotestosterone level at both stages. Further examination of the fertilization capacity of the sperm indicated that the eEF1A1b(+/-) XY fish were infertile due to abnormal spermiogenesis. Transcriptomic analyses of the eEF1A1b(+/-) testis from 180 dah XY fish revealed that key elements involved in spermatogenesis, steroidogenesis and sperm motility were significantly down-regulated compared with the control XY. Transgenic overexpression of eEF1A1b rescued the spermatogenesis arrest phenotype of the eEF1A1b(+/-) testis. Taken together, our data suggested that eEF1A1b is crucial for spermatogenesis and male fertility in the Nile tilapia.	[Chen, Jinlin; Jiang, Dongneng; Tan, Dejie; Fan, Zheng; Wei, Yingying; Li, Minghui; Wang, Deshou] Southwest Univ, Sch Life Sci, Key Lab Aquat Sci Chongqing, Key Lab Freshwater Fish Reprod & Dev Minist Edu, Chongqing, Peoples R China	Wang, DS (reprint author), Southwest Univ, Sch Life Sci, Key Lab Aquat Sci Chongqing, Key Lab Freshwater Fish Reprod & Dev Minist Edu, Chongqing, Peoples R China.	wdeshou@swu.edu.cn		Jiang, Dongneng/0000-0003-2465-1775	National Natural Science Foundation of China [91331119, 31630082, 31602134]; National High Technology Research and Development Program (863 program) of China [2011 AA100404]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130182130003]; Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission [cstc2015jcyjB80001, cstc2013kjrc-tdjs80003]; China Postdoctoral Science Foundation [2016T90830, 2015M570765]; Chongqing Postdoctoral Science Foundation [Xm2015028]; Fundamental Research Funds for the Central Universities [XDJK2016C157]	This work was supported by grants 91331119, 31630082 and 31602134 from the National Natural Science Foundation of China; grant 2011 AA100404 from the National High Technology Research and Development Program (863 program) of China; grant 20130182130003 from the Specialized Research Fund for the Doctoral Program of Higher Education of China; grants cstc2015jcyjB80001 and cstc2013kjrc-tdjs80003 from the Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission; grant 2016T90830 and 2015M570765 from China Postdoctoral Science Foundation; grant Xm2015028 from Chongqing Postdoctoral Science Foundation; grant XDJK2016C157 from the Fundamental Research Funds for the Central Universities.	Abbas W, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00075; ABDALLAH B, 1991, P NATL ACAD SCI USA, V88, P9277, DOI 10.1073/pnas.88.20.9277; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; Danforth BN, 1998, MOL BIOL EVOL, V15, P225, DOI 10.1093/oxfordjournals.molbev.a025920                                           ; DESCHAMPS S, 1991, J CELL BIOL, V114, P1109, DOI 10.1083/jcb.114.6.1109; Escott Gustavo M, 2014, Curr Mol Pharmacol, V7, P96; Gao DY, 1997, BBA-GENE STRUCT EXPR, V1350, P1, DOI 10.1016/S0167-4781(96)00179-0; Gao YY, 2016, NAT STRUCT MOL BIOL, V23, P441, DOI 10.1038/nsmb.3206; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; HOVEMANN B, 1988, NUCLEIC ACIDS RES, V16, P3175, DOI 10.1093/nar/16.8.3175; Infante C., 2008, BMC MOL BIOL, V9, P1; Khalyfa A, 2001, J BIOL CHEM, V276, P22915, DOI 10.1074/jbc.M101011200; Kinoshita M, 1999, FISHERIES SCI, V65, P133, DOI 10.2331/fishsci.65.133                                                          ; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; Kobayashi T, 2002, MECH DEVELOP, V111, P167, DOI 10.1016/S0925-4773(01)00613-X; Koji N., 1986, GENE, V45, P265; LEE S, 1995, EXP CELL RES, V219, P589, DOI 10.1006/excr.1995.1268; LEE S, 1992, J BIOL CHEM, V267, P24064; LEE S, 1993, J BIOL CHEM, V268, P24453; Li MH, 2014, GENETICS, V197, P591, DOI 10.1534/genetics.114.163667; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeber J, 2010, FEBS J, V277, P4722, DOI 10.1111/j.1742-4658.2010.07878.x; MANOVA K, 1990, DEVELOPMENT, V110, P1057; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Miura C, 1996, DEV GROWTH DIFFER, V38, P257; Mochida K, 2002, FISHERIES SCI, V68, P830, DOI 10.1046/j.1444-2906.2002.00499.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu WP, 2014, GENE DEV, V28, P2056, DOI 10.1101/gad.246124.114; Munshi R, 2001, GENETICS, V157, P1425; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Nowell MA, 2000, MAR BIOTECHNOL, V2, P173; Ostyn A, 2012, FOOD ANAL METHOD, V5, P173, DOI 10.1007/s12161-011-9244-y; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Qiu YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123900; Rios-Rojas C., 2015, DEV DYNAMICS; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; Sun LN, 2014, ENDOCRINOLOGY, V155, P1476, DOI 10.1210/en.2013-1959; Sun YL, 2014, AQUACULTURE, V433, P19, DOI 10.1016/j.aquaculture.2014.05.035; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Tash JS, 2008, BIOL REPROD, V78, P1139, DOI 10.1095/biolreprod.107.062679; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wang Y., 2015, SCI REPORTS, V5; Wargelius A, 2016, SCI REPORTS, V6; Wosnitzer MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098638; Xie Q, 2015, PLOS ONE, V1; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; Yu XG, 2014, MOL CELL ENDOCRINOL, V392, P152, DOI 10.1016/j.mce.2014.05.013; Zhang X., 2014, BIOL REPROD; Zheng B, 2014, PROTEOMICS, V14, P274, DOI 10.1002/pmic.201300395	55	1	1	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 7	2017	7								43733	10.1038/srep43733				15	Multidisciplinary Sciences	Science & Technology - Other Topics	EM9RG	WOS:000395648200001	28266557	gold			2018-01-05	
J	Hacker, I; Harrell, RA; Eichner, G; Pilitt, KL; O'Brochta, DA; Handler, AM; Schetelig, MF				Haecker, Irina; Harrell, Robert A., II; Eichner, Gerrit; Pilitt, Kristina L.; O'Brochta, David A.; Handler, Alfred M.; Schetelig, Marc F.			Cre/lox-Recombinase-Mediated Cassette Exchange for Reversible Site-Specific Genomic Targeting of the Disease Vector, Aedes aegypti	SCIENTIFIC REPORTS			English	Article							PIGGYBAC TRANSPOSON VECTOR; LINEAR MIXED MODELS; MUTANT LOX SITES; GERMLINE TRANSFORMATION; DROSOPHILA; INTEGRATION; DNA; TRANSGENESIS; NUCLEASES; MOSQUITO	Site-specific genome modification (SSM) is an important tool for mosquito functional genomics and comparative gene expression studies, which contribute to a better understanding of mosquito biology and are thus a key to finding new strategies to eliminate vector-borne diseases. Moreover, it allows for the creation of advanced transgenic strains for vector control programs. SSM circumvents the drawbacks of transposon-mediated transgenesis, where random transgene integration into the host genome results in insertional mutagenesis and variable position effects. We applied the Cre/lox recombinase-mediated cassette exchange (RMCE) system to Aedes aegypti, the vector of dengue, chikungunya, and Zika viruses. In this context we created four target site lines for RMCE and evaluated their fitness costs. Cre-RMCE is functional in a two-step mechanism and with good efficiency in Ae. aegypti. The advantages of Cre-RMCE over existing site-specific modification systems for Ae. aegypti, phiC31-RMCE and CRISPR, originate in the preservation of the recombination sites, which 1) allows successive modifications and rapid expansion or adaptation of existing systems by repeated targeting of the same site; and 2) provides reversibility, thus allowing the excision of undesired sequences. Thereby, Cre-RMCE complements existing genomic modification tools, adding flexibility and versatility to vector genome targeting.	[Haecker, Irina; Schetelig, Marc F.] Justus Liebig Univ Glessen, Inst Insect Biotechnol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany; [Harrell, Robert A., II; Pilitt, Kristina L.; O'Brochta, David A.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20850 USA; [Harrell, Robert A., II] Univ Maryland, Insect Transformat Facil, Rockville, MD 20850 USA; [Eichner, Gerrit] Univ Giessen, Math Inst, Arndtstr 2, D-35392 Giessen, Germany; [O'Brochta, David A.] Univ Maryland, Dept Entomol, Rockville, MD 20850 USA; [Handler, Alfred M.] USDA ARS, Ctr Med Agr & Vet Entomol, 1700 SW 23rd Dr, Gainesville, FL 32608 USA	Hacker, I (reprint author), Justus Liebig Univ Glessen, Inst Insect Biotechnol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	irina.haecker@agrar.uni-giessen.de; marc.schetelig@agrar.uni-giessen.de		Schetelig, Marc F./0000-0002-9217-394X	Emmy Noether program of the German Research Foundation [SCHE 1833/1-1]; Biotechnology Risk Assessment Program from the USDA - National Institute of Food and Agriculture [2015-33522-24094]	We thank Tanja Rehling for excellent technical assistance. The Emmy Noether program of the German Research Foundation (SCHE 1833/1-1; to MFS; http://www.dfg.de/foerderung/programme/einzelfoerderung/emmy_noether/) and the LOEWE Center for Insect Biotechnology and Bioresources (to MFS; https://wissenschaft.hessen.de/loewe), National Institute for Allergy and Infectious Diseases R01AI099060 (to DOB; https://www.niaid.nih.gov), and Biotechnology Risk Assessment Program competitive grant number 2015-33522-24094 from the USDA - National Institute of Food and Agriculture (to AMH; https://nifa.usda.gov/funding-opportunity/biotechnology-risk-assessment-research-grants-program-brag). The funders had no role in study design, data collection, analysis and interpretation, decision to publish, or preparation of the manuscript.	ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x                                              ; Andrews B J, 1986, Basic Life Sci, V40, P407; Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Ashburner M., 1989, DROSOPHILA LAB MANUA, V2; Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bates D, 2015, J STAT SOFTW, V67, P1; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748                                                          ; Fleiss J. L., 2003, STAT METHODS RATES P; Fox J., 2011, R COMPANION APPL REG; Franz AWE, 2011, INSECT MOL BIOL, V20, P587, DOI 10.1111/j.1365-2583.2011.01089.x; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Haghighat-Khah RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121097; Halekoh U, 2014, J STAT SOFTW, V59, P1; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Horn C, 2005, P NATL ACAD SCI USA, V102, P12483, DOI 10.1073/pnas.0504305102; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Horn C, 2002, MOL BIOL, V32, P1221; Horn M., 1995, MULTIPLE TESTS AUSWA; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Labbe GMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000788; Long DP, 2013, INSECT BIOCHEM MOLEC, V43, P997, DOI 10.1016/j.ibmb.2013.08.001; Meredith JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059264; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; R Development Core Team, 2016, R LANG ENV STAT COMP; Scheipl F, 2008, COMPUT STAT DATA AN, V52, P3283, DOI 10.1016/j.csda.2007.10.022; Schetelig MF, 2013, GENETICA, V141, P189, DOI 10.1007/s10709-013-9717-6; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P790, DOI 10.1016/j.ibmb.2012.07.007; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Schetelig M. F., 2013, G3-GENES GENOM GENET, DOI [10.1534/g3.112.005488, DOI 10.1534/G3.112.005488]; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Siegal ML, 1996, GENETICS, V144, P715; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Wimmer EA, 2005, NAT METHODS, V2, P580, DOI 10.1038/nmeth0805-580                                                           ; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; [Anonymous], 2015, PACKAGE SURVIVAL ANA	44	2	2	3	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 7	2017	7								43883	10.1038/srep43883				14	Multidisciplinary Sciences	Science & Technology - Other Topics	EM9TS	WOS:000395654600001	28266580	gold			2018-01-05	
J	Beyene, G; Chauhan, RD; Taylor, NJ				Beyene, Getu; Chauhan, Raj Deepika; Taylor, Nigel J.			A rapid virus- induced gene silencing (VIGS) method for assessing resistance and susceptibility to cassava mosaic disease	VIROLOGY JOURNAL			English	Article						Cassava mosaic disease; VIGS; SPINDLY; Resistance; Susceptible; Geminivirus	GIBBERELLIN SIGNAL-TRANSDUCTION; MANIHOT-ESCULENTA PLANTS; BROWN STREAK DISEASE; ARABIDOPSIS; GEMINIVIRUSES; VALIDATION; CYTOKININ; PROTEIN	Background: Cassava mosaic disease (CMD) is a major constraint to cassava production in sub- Saharan Africa. Under field conditions, evaluation for resistance to CMD takes 12- 18 months, often conducted across multiple years and locations under pressure from whitefly-mediated transmission. Under greenhouse or laboratory settings, evaluation for resistance or susceptibility to CMD involves transmission of the causal viruses from an infected source to healthy plants through grafting, or by using Agrobacterium- mediated or biolistic delivery of infectious clones. Following inoculation, visual assessment for CMD symptom development and recovery requires 12- 22 weeks. Here we report a rapid screening system for determining resistance and susceptibility to CMD based on virus- induced gene silencing (VIGS) of an endogenous cassava gene. Results: A VIGS vector was developed based on an infectious clone of the virulent strain of East African cassava mosaic virus (EACMV- K201). A sequence from the cassava (Manihot esculenta) ortholog of Arabidopsis SPINDLY (SPY) was cloned into the CP position of the DNA- A genomic component and used to inoculate cassava plants by Helios r Gene Gun microparticle bombardment. Silencing of Manihot esculenta SPY (MeSPY) using MeSPY1- VIGS resulted in shoot- tip necrosis followed by death of the whole plant in CMD susceptible cassava plants within 2- 4 weeks. CMD resistant cultivars were not affected and remained healthy after challenge with MeSPY1- VIGS. Significantly higher virus titers were detected in CMD- susceptible cassava lines compared to resistant controls and were correlated with a concomitant reduction in MeSPY expression in susceptible plants. Conclusions: A rapid VIGS- based screening system was developed for assessing resistance and susceptibility to CMD. The method is space and resource efficient, reducing the time required to perform CMD screening to as little as 2- 4 weeks. It can be employed as a high throughput rapid screening system to assess new cassava cultivars and for screening transgenic, gene edited and breeding lines under controlled growth conditions.	[Beyene, Getu; Chauhan, Raj Deepika; Taylor, Nigel J.] Donald Danforth Plant Sci Ctr, 975 North Warson Rd, St Louis, MO 63132 USA	Beyene, G (reprint author), Donald Danforth Plant Sci Ctr, 975 North Warson Rd, St Louis, MO 63132 USA.	gduguma@danforthcenter.org	Taylor, Nigel/M-2851-2013		Bill and Melinda Gates Foundation [OPPGD1485]; United States Agency for International Development from the American people [AID-EDH-A-00-09-00010]; Monsanto Fund	Funding for this research was provided by the Bill and Melinda Gates Foundation (OPPGD1485), the United States Agency for International Development from the American people (USAID Cooperative Agreement No. AID-EDH-A-00-09-00010), and the Monsanto Fund. The funders had no role in the design of the study; collection, analysis, or interpretation of data; nor in the writing of the manuscript.	Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; Beyene G, 2016, MOL PLANT PATHOL, V17, P1095, DOI 10.1111/mpp.12353; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Bull SE, 2006, J GEN VIROL, V87, P3053, DOI 10.1099/vir.0.82013-0; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Chauhan RD, 2015, PLANT CELL TISS ORG, V121, P591, DOI 10.1007/s11240-015-0729-z; Damba Y, 2013, PLANT MAT IJSTR, V2, P282; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; FAO, 2015, FAOSTAT DAT; FAUQUET C, 1990, PLANT DIS, V74, P404, DOI 10.1094/PD-74-0404; Fofana IBF, 2004, PLANT MOL BIOL, V56, P613, DOI 10.1007/s11103-004-0161-y; Hartweck LM, 2006, J EXP BOT, V57, P865, DOI 10.1093/jxb/erj071; Hartweck LM, 2002, GENETICS, V161, P1279; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Kawuki R. S., 2011, Journal of Plant Breeding and Crop Science, V3, P120; Kawuki RS, 2016, BREEDING SCI, V66, P560, DOI 10.1270/jsbbs.16005; Kjemtrup S, 1998, PLANT J, V14, P91, DOI 10.1046/j.1365-313X.1998.00101.x                                                ; Kuria P, 2017, VIRUS RES, V227, P69, DOI 10.1016/j.virusres.2016.09.022; Legg J, 2014, FOOD SECUR, V6, P231, DOI 10.1007/s12571-014-0340-x; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lokko Y, 2005, AFR J BIOTECHNOL, V4, P873; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Monde G., 2012, Archives of Phytopathology and Plant Protection, V45, P2189, DOI 10.1080/03235408.2012.724969; Moreno I, 2011, J VIROL METHODS, V177, P49, DOI 10.1016/j.jviromet.2011.06.013; Mwangangi M., 2014, Journal of Biology, Agriculture and Healthcare, V4, P34; Ntui VO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120551; Ogwok E, 2015, PLANT PATHOL, V64, P1235, DOI 10.1111/ppa.12343; Okogbenin E, 2012, CROP SCI, V52, P2576, DOI 10.2135/cropsci2011.11.0586; Okogbenin E., 2013, TRANSLATIONAL GENOMI, V1, P291; Patil BL, 2015, VIRUS GENES, V50, P474, DOI 10.1007/s11262-015-1184-y; Patil BL, 2010, J GEN VIROL, V91, P1871, DOI 10.1099/vir.0.019513-0; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/J.1364-3703.2009.00559.X, 10.1111/j.1364-3703.2009.00559.x]; Pita JS, 2001, J GEN VIROL, V82, P655, DOI 10.1099/0022-1317-82-3-655                                                      ; Qin F, 2011, PLANT PHYSIOL, V157, P1900, DOI 10.1104/pp.111.187302; Rabbi IY, 2014, VIRUS RES, V186, P87, DOI 10.1016/j.virusres.2013.12.028; Steiner E, 2016, PLANT PHYSIOL, V171, P1485, DOI 10.1104/pp.16.00343; Steiner E, 2012, PLANT CELL, V24, P96, DOI 10.1105/tpc.111.093518; Taylor N, 2012, TROP PLANT BIOL, V5, P127, DOI 10.1007/s12042-012-9099-4; Vanderschuren H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045277; Vanderschuren H, 2009, PLANT MOL BIOL, V70, P265, DOI 10.1007/s11103-009-9472-3; Wagaba Henry, 2013, BMC Res Notes, V6, P516, DOI 10.1186/1756-0500-6-516	43	0	0	5	26	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-422X			VIROL J	Virol. J.	MAR 7	2017	14								6	10.1186/s12985-017-0716-6				11	Virology	Virology	EN4QU	WOS:000395992800001	28270156	gold			2018-01-05	
J	Sun, YW; Jiao, GA; Liu, ZP; Zhang, X; Li, JY; Guo, XP; Du, WM; Du, JL; Francis, F; Zhao, YD; Xia, LQ				Sun, Yongwei; Jiao, Guiai; Liu, Zupei; Zhang, Xin; Li, Jingying; Guo, Xiuping; Du, Wenming; Du, Jinlu; Francis, Frederic; Zhao, Yunde; Xia, Lanqin			Generation of High-Amylose Rice through CRISPR/Cas9-Mediated Targeted Mutagenesis of Starch Branching Enzymes	FRONTIERS IN PLANT SCIENCE			English	Article						amylose content (AC); CRISPR/Cas9; genome editing; resistant starch (RS); rice; starch; starch branching enzyme (SBE)	ORYZA-SATIVA-L; ZEA-MAYS-L; MUTATOR INSERTIONAL MUTANTS; ANTISENSE RNA INHIBITION; RESISTANT-STARCH; IMPROVES INDEXES; MULTIPLE FORMS; POTATO STARCH; CHAIN-LENGTH; MAIZE STARCH	Cereals high in amylose content (AC) and resistant starch (RS) offer potential health benefits. Previous studies using chemical mutagenesis or RNA interference have demonstrated that starch branching enzyme (SBE) plays a major role in determining the fine structure and physical properties of starch. However, it remains a challenge to control starch branching in commercial lines. Here, we use CRISPR/Cas9 technology to generate targeted mutagenesis in SBEI and SBEIIb in rice. The frequencies of obtained homozygous or bi-allelic mutant lines with indels in SBEI and SBEIIb in T-0 generation were from 26.7 to 40%. Mutations in the homozygous T-0 lines stably transmitted to the T-1 generation and those in the bi-allelic lines segregated in a Mendelian fashion. Transgene-free plants carrying only the frame-shifted mutagenesis were recovered in T-1 generation following segregation. Whereas no obvious differences were observed between the sbeI mutants and wild type, sbeII mutants showed higher proportion of long chains presented in debranched amylopectin, significantly increased AC and RS content to as higher as 25.0 and 9.8%, respectively, and thus altered fine structure and nutritional properties of starch. Taken together, our results demonstrated for the first time the feasibility to create high-amylose rice through CRISPR/Cas9-mediated editing of SBEIIb.	[Sun, Yongwei; Liu, Zupei; Zhang, Xin; Li, Jingying; Guo, Xiuping; Du, Wenming; Du, Jinlu; Xia, Lanqin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Jiao, Guiai] China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Francis, Frederic] Univ Liege, Gembloux Agrobio Tech, Funct & Evolutionary Entomol, Gembloux, Belgium; [Zhao, Yunde] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	Xia, LQ (reprint author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.; Zhao, YD (reprint author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	yundezhao@ucsd.edu; xialanqin@caas.cn			Ministry of Science and Technology of China [2016YFD0100500]; Ministry of Agriculture of China [2016ZX08010-003]; GSCAAS-ULg Joint Ph.D. Program	This work is partly funded by the Ministry of Science and Technology of China (grant no. 2016YFD0100500) and the Ministry of Agriculture of China (grant no. 2016ZX08010-003). YS is supported by a GSCAAS-ULg Joint Ph.D. Program.	AACC, 1995, APPR METH AM ASS CER; ASAOKA M, 1986, STARCH-STARKE, V38, P114, DOI 10.1002/star.19860380403; ASP NG, 1992, EUR J CLIN NUTR, V46, pS1; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; BHATTACHARYYA MK, 1990, CELL, V60, P115, DOI 10.1016/0092-8674(90)90721-P; Blauth SL, 2002, PLANT MOL BIOL, V48, P287, DOI 10.1023/A:1013335217744; Blauth SL, 2001, PLANT PHYSIOL, V125, P1396, DOI 10.1104/pp.125.3.1396; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4                                                   ; Butardo Jr V., 2008, P AACC INT ANN M 200, pA15; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; Carciofi M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-223; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dumez S, 2006, PLANT CELL, V18, P2694, DOI 10.1105/tpc.105.037671; Endo M, 2016, PLANT PHYSIOL, V170, P667, DOI 10.1104/pp.15.01663; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Food and Agriculture Organization [FAO], 2004, INT YEAR RIC ONL; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Gao XH, 2016, PLANT PHYSIOL, V171, P1794, DOI 10.1104/pp.16.00663; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; GARWOOD DL, 1976, CEREAL CHEM, V53, P355; Giacco R, 1998, DIABETES NUTR METAB, V11, P330; Hanashiro I, 1996, CARBOHYD RES, V283, P151, DOI 10.1016/0008-6215(95)00408-4; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hoebler C, 1999, EUR J CLIN NUTR, V53, P360, DOI 10.1038/sj.ejcn.1600718; Itoh K, 2003, PLANT CELL PHYSIOL, V44, P473, DOI 10.1093/pcp/pcg068; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; Jiang HX, 2010, J AGR FOOD CHEM, V58, P8043, DOI 10.1021/jf101056y; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jobling SA, 1999, PLANT J, V18, P163, DOI 10.1046/j.1365-313X.1999.00441.x; Jones HD, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.11, 10.1038/nplants.2014.11]; Kim KS, 2005, J AGR FOOD CHEM, V53, P8745, DOI 10.1021/jf051194a; Li C, 2016, PLANTA, V243, P13, DOI 10.1007/s00425-015-2421-2; Li JY, 2017, MOL PLANT, V10, P526, DOI 10.1016/j.molp.2016.12.001; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; McCleary BV, 2002, J AOAC INT, V85, P1103; MIZUNO K, 1993, J BIOL CHEM, V268, P19084; MIZUNO K, 1992, J BIOCHEM-TOKYO, V112, P643, DOI 10.1093/oxfordjournals.jbchem.a123953                                           ; Morell MK, 2005, CURR OPIN PLANT BIOL, V8, P204, DOI 10.1016/j.pbi.2005.01.009; Morell MK, 2004, J AOAC INT, V87, P740; NAKAMURA Y, 1992, PHYSIOL PLANTARUM, V84, P329, DOI 10.1034/j.1399-3054.1992.840302.x; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI 10.1104/pp.127.2.459; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Paul JW, 2016, PLANT CELL REP, V35, P1417, DOI 10.1007/s00299-016-1985-z; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Rahman S, 2007, J CEREAL SCI, V46, P251, DOI 10.1016/j.jcs.2007.05.001; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Regina A, 2004, FUNCT PLANT BIOL, V31, P591, DOI 10.1071/FP03193; Regina A, 2010, J EXP BOT, V61, P1469, DOI 10.1093/jxb/erq011; Regmi PR, 2011, J NUTR, V141, P1273, DOI 10.3945/jn.111.140509; Safford R, 1998, CARBOHYD POLYM, V35, P155, DOI 10.1016/S0144-8617(97)00249-X; Satoh H, 2003, PLANT PHYSIOL, V133, P1111, DOI 10.1104/pp.103.021527; Schwall GP, 2000, NAT BIOTECHNOL, V18, P551, DOI 10.1038/75427; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shi J., 2016, PLANT BIOTECHNOL J, V15, P207, DOI [10.1111/pbi.12603, DOI 10.1111/PBI.12603]; Shu XL, 2006, STARCH-STARKE, V58, P411, DOI 10.1002/star.200600501; STINARD PS, 1993, PLANT CELL, V5, P1555, DOI 10.1105/tpc.5.11.1555; Sun YW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01928; Sun YW, 2016, MOL PLANT, V9, P628, DOI 10.1016/j.molp.2016.01.001; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Syahariza ZA, 2013, FOOD CHEM, V136, P742, DOI 10.1016/j.foodchem.2012.08.053; Thompson DB, 2000, CARBOHYD POLYM, V43, P223, DOI 10.1016/S0144-8617(00)00150-8; Unwin N., 2013, INT DIABETES FEDERAT; Vonk RJ, 2000, AM J CLIN NUTR, V72, P432; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang TL, 1998, J EXP BOT, V49, P481, DOI 10.1093/jexbot/49.320.481; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Wei CX, 2010, J AGR FOOD CHEM, V58, P11097, DOI 10.1021/jf1024533; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; YAMANOUCHI H, 1992, PLANT CELL PHYSIOL, V33, P985; YANO M, 1985, THEOR APPL GENET, V69, P253, DOI 10.1007/BF00662436; Yao Y, 2004, PLANT PHYSIOL, V136, P3515, DOI 10.1104/pp.104.043315; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu LJ, 2012, PLANT BIOTECHNOL J, V10, P353, DOI 10.1111/j.1467-7652.2011.00667.x	81	6	6	9	46	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	MAR 7	2017	8								298	10.3389/fpls.2017.00298				15	Plant Sciences	Plant Sciences	EM7TO	WOS:000395515400001	28326091	gold			2018-01-05	
J	Birling, MC; Schaeffer, L; Andre, P; Lindner, L; Marechal, D; Ayadi, A; Sorg, T; Pavlovic, G; Herault, Y				Birling, Marie-Christine; Schaeffer, Laurence; Andre, Philippe; Lindner, Loic; Marechal, Damien; Ayadi, Abdel; Sorg, Tania; Pavlovic, Guillaume; Herault, Yann			Efficient and rapid generation of large genomic variants in rats and mice using CRISMERE	SCIENTIFIC REPORTS			English	Article							SYNDROMIC INTELLECTUAL DISABILITY; DOWN-SYNDROME; COGNITIVE DEFICITS; MOUSE MODELS; DYRK1A; REGION; INVERSIONS; DUPLICATIONS; PHENOTYPE; HAPLOINSUFFICIENCY	Modelling Down syndrome (DS) in mouse has been crucial for the understanding of the disease and the evaluation of therapeutic targets. Nevertheless, the modelling so far has been limited to the mouse and, even in this model, generating duplication of genomic regions has been labour intensive and time consuming. We developed the CRISpr MEdiated REarrangement (CRISMERE) strategy, which takes advantage of the CRISPR/Cas9 system, to generate most of the desired rearrangements from a single experiment at much lower expenses and in less than 9 months. Deletions, duplications, and inversions of genomic regions as large as 24.4 Mb in rat and mouse founders were observed and germ line transmission was confirmed for fragment as large as 3.6 Mb. Interestingly we have been able to recover duplicated regions from founders in which we only detected deletions. CRISMERE is even more powerful than anticipated it allows the scientific community to manipulate the rodent and probably other genomes in a fast and efficient manner which was not possible before.	[Birling, Marie-Christine; Schaeffer, Laurence; Andre, Philippe; Lindner, Loic; Marechal, Damien; Ayadi, Abdel; Sorg, Tania; Pavlovic, Guillaume; Herault, Yann] Univ Strasbourg, CNRS, PHENOMIN, INSERM,ICS, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France; [Herault, Yann] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Herault, Yann] CNRS, UMR7104, Illkirch Graffenstaden, France; [Herault, Yann] Inst Natl Sante & Rech Med, U964, Illkirch Graffenstaden, France; [Herault, Yann] Univ Strasbourg, Illkirch Graffenstaden, France	Herault, Y (reprint author), Univ Strasbourg, CNRS, PHENOMIN, INSERM,ICS, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.; Herault, Y (reprint author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.; Herault, Y (reprint author), CNRS, UMR7104, Illkirch Graffenstaden, France.; Herault, Y (reprint author), Inst Natl Sante & Rech Med, U964, Illkirch Graffenstaden, France.; Herault, Y (reprint author), Univ Strasbourg, Illkirch Graffenstaden, France.	herault@igbmc.fr	Herault, Yann/B-5500-2012	Herault, Yann/0000-0001-7049-6900; Pavlovic, Guillaume/0000-0001-9122-4592; Birling, Marie-Christine/0000-0002-3372-8108	National Centre for Scientific Research (CNRS); French National Institute of Health and Medical Research (INSERM); University of Strasbourg (UDS); Centre Europeen de Recherche en Biologie et en Medecine; French state funds through the "Agence Nationale de la Recherche" [ANR-10IDEX-0002-02, ANR-10-LABX-0030-INRT, ANR-10-INBS-07 PHENOMIN]; Fondation Jerome Lejeune [1166]; Fondation Bettencourt-Schueller	This work was supported by the National Centre for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM), the University of Strasbourg (UDS), the "Centre Europeen de Recherche en Biologie et en Medecine". This study also received support from French state funds through the "Agence Nationale de la Recherche" under the frame programme Investissements d'Avenir labelled ANR-10IDEX-0002-02, ANR-10-LABX-0030-INRT, ANR-10-INBS-07 PHENOMIN, and the Fondation Jerome Lejeune (grant #1166) and the Fondation Bettencourt-Schueller to Y.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are grateful to G. Prevost for caring our rats, J-V Figerolle and C Kujath for mouse injection, D Ali-Hadji and her team for caring for the animals, and P Reilly for critical reading of the manuscript.	Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Boroviak K, 2016, GENESIS, V54, P78, DOI 10.1002/dvg.22915; Brault V, 2007, Handb Exp Pharmacol, P29; Brault V, 2006, PLOS GENET, V2, P911, DOI 10.1371/journal.pgen.0020086; Brault V, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005062; Bronicki LM, 2015, EUR J HUM GENET, V23, P1482, DOI 10.1038/ejhg.2015.29; Brudno M, 2004, GENOME RES, V14, P685, DOI 10.1101/gr.2067704; Choong XY, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00268, 10.3339/fnbeh.2015.00263]; De la Torre R, 2014, MOL NUTR FOOD RES, V58, P278, DOI 10.1002/mnfr.201300325; Deng T, 2013, MOL CELL BIOL, V33, P3377, DOI 10.1128/MCB.00435-13; Dierssen M, 2009, PHYSIOL REV, V89, P887, DOI 10.1152/physrev.00032.2007; Duchon A, 2008, GENETICS, V180, P51, DOI 10.1534/j.genetics.108.092312; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1097/0735-7044.118.4.815; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Guedj F, 2012, NEUROBIOL DIS, V46, P190, DOI 10.1016/j.nbd.2012.01.007; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Herault Y, 2010, CURR GENOMICS, V11, P470, DOI 10.2174/138920210793176038; Jiang X., 2015, HUM MOL GENET; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Lana-Elola E, 2016, ELIFE, V5, DOI 10.7554/eLife.11614; Lane AA, 2014, NAT GENET, V46, P618, DOI 10.1038/ng.2949; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; Li ZY, 2007, HUM MOL GENET, V16, P1359, DOI 10.1093/hmg/ddm086; Luco SM, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0276-4; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Mullins LJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-221; Nigam R, 2013, PHYSIOL GENOMICS, V45, P809, DOI 10.1152/physiolgenomics.00065.2013; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Pan D, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/545269; Pereira PL, 2009, HUM MOL GENET, V18, P4756, DOI 10.1093/hmg/ddp438; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Tai DJC, 2016, NAT NEUROSCI, V19, P517, DOI 10.1038/nn.4235; van Bon BWM, 2016, MOL PSYCHIATR, V21, P126, DOI 10.1038/mp.2015.5; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585                                                          ; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060; Yu T, 2010, BRAIN RES, V1366, P162, DOI 10.1016/j.brainres.2010.09.107; Zhang L, 2014, HUM MOL GENET, V23, P578, DOI 10.1093/hmg/ddt446; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zhao SY, 2004, GENOME RES, V14, P1851, DOI 10.1101/gr.2663304; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354                                                          	50	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 7	2017	7								43331	10.1038/srep43331				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EM9IC	WOS:000395624100001	28266534	gold			2018-01-05	
J	Ren, JT; Zhang, XH; Liu, XJ; Fang, CY; Jiang, SG; June, CH; Zhao, YB				Ren, Jiangtao; Zhang, Xuhua; Liu, Xiaojun; Fang, Chongyun; Jiang, Shuguang; June, Carl H.; Zhao, Yangbing			A versatile system for rapid multiplex genome-edited CAR T cell generation	ONCOTARGET			English	Article						CRISPR/CAS9; T lymphocytes; chimeric antigen receptors; PD-1; CD95	CHIMERIC-ANTIGEN-RECEPTOR; FAS/FAS LIGAND PATHWAY; ANTITUMOR IMMUNITY; DEATH; FAS; NUCLEASES; CAS9; IMMUNOTHERAPY; CRISPR/CAS9; SPECIFICITY	The therapeutic potential of CRISPR system has already been demonstrated in many instances and begun to overlap with the rapidly expanding field of cancer immunotherapy, especially on the production of genetically modified T cell receptor or chimeric antigen receptor (CAR) T cells. Efficient genomic disruption of multiple gene loci to generate universal donor cells, as well as potent effector T cells resistant to multiple inhibitory pathways such as PD-1 and CTLA4 is an attractive strategy for cell therapy. In this study, we accomplished rapid and efficient multiplex genomic editing, and re-directing T cells with antigen specific CAR via a one-shot CRISPR protocol by incorporation of multiple gRNAs in a CAR lentiviral vector. High efficient double knockout of endogenous TCR and HLA class I could be easily achieved to generate allogeneic universal CAR T cells. We also generated Fas-resistant universal CAR T cells by triple gene disruption. Simultaneous gene editing of four gene loci using the one-shot CRISPR protocol to generate allogeneic universal T cells deficient of both PD1 and CTLA-4 was also attempted.	[Ren, Jiangtao; Zhang, Xuhua; Liu, Xiaojun; Fang, Chongyun; Jiang, Shuguang; June, Carl H.; Zhao, Yangbing] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA; [June, Carl H.; Zhao, Yangbing] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA	Zhao, YB (reprint author), Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA.; Zhao, YB (reprint author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA.	yangbing@upenn.edu	Ren, Jiangtao/J-4985-2017		US National Institutes of Health (NIH) [2R01CA120409]	This work was supported by a US National Institutes of Health (NIH) grant to C.H.J. and Y.Z. (2R01CA120409).	Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chen XL, 1997, J GEN VIROL, V78, P3277, DOI 10.1099/0022-1317-78-12-3277                                                    ; Chevolet I, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.982382; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ewing MM, 2013, INT J CARDIOL, V168, P1965, DOI 10.1016/j.ijcard.2012.12.085; Gorak-Stolinska P, 2001, J LEUKOCYTE BIOL, V70, P756; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Huang RY, 2015, ONCOTARGET, V6, P27359, DOI 10.18632/oncotarget.4751; Ishizaki Y, 2010, HUM GENET, V127, P411, DOI 10.1007/s00439-009-0781-z; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kunkele A, 2015, CANCER IMMUNOL RES, V3, P368, DOI 10.1158/2326-6066.CIR-14-0200; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Maher S, 2002, IMMUNOL CELL BIOL, V80, P131, DOI 10.1046/j.1440-1711.2002.01068.x; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Ngiow SF, 2011, CANCER RES, V71, P6567, DOI 10.1158/0008-5472.CAN-11-1487; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Pignatti P, 2001, CLIN EXP RHEUMATOL, V19, P339; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Ren J, 2016, CLIN CANC RES; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; Sakuishi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23849; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Wang W, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1016/J.GR.2014.02.002; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x	36	10	10	7	12	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	MAR 7	2017	8	10					17002	17011		10.18632/oncotarget.15218				10	Oncology; Cell Biology	Oncology; Cell Biology	EN5DA	WOS:000396024600072	28199983	gold			2018-01-05	
J	Ma, L; Liu, J; Li, MZ; Fu, Y; Zhang, X; Liu, Q				Ma, Lei; Liu, Jing; Li, Muzi; Fu, Yong; Zhang, Xiao; Liu, Qun			Rhoptry protein 5 (ROP5) Is a Key Virulence Factor in Neospora caninum	FRONTIERS IN MICROBIOLOGY			English	Article						Neospora caninum; gene editing; rhoptry protein 5; virulence factor; protozoan parasites	TOXOPLASMA-GONDII; PARASITOPHOROUS VACUOLE; INFECTION; SYSTEM; TRANSMISSION; DIAGNOSIS; KINASES; ISOLATE; CATTLE; GENES	Neospora caninum, of the Apicomplexa phylum, is a common cause of abortions in cattle and nervous system dysfunction in dogs. Rhoptry proteins of Apicomplexa play an important role in virulence. The objectives of this study were to study functions of NcROP5 in N. caninum by deleting the NcROP5 gene from the wild Nc-1 strain. We selected NcROP5 in ToxoDB and successfully constructed an NcROP5 genedeleted vector, pTCR-NcROP5-CD KO. Then we screened the NcROP5 knockout strains (1 NcROP5) at the gene, protein and transcription levels. Plaque assay, host cell invasion assay and intracellular proliferation test showed that the 1 NcROP5 strain had less plaque space, weakened invasion capacity and slower intracellular growth. Animal testing showed significantly lower cerebral load of 1 NcROP5 than the load of the Nc-1 strain, as well as a loss of virulence for the 1 NcROP5 strains. Phenotypic analyses using the label-free LC-MS/MS assay-based proteomic method and KEGG pathway enrichment analysis showed a reduction of NcGRA7 transcription and altered expression of multiple proteins including the apicomplexan family of binding proteins. The present study indicated that ROP5 is a key virulence factor in N. caninum in mice. The proteomic profiling of Nc-1 and 1 NcROP5 provided some data on differential proteins. These data provide a foundation for future research of protein functions in N. caninum.	[Ma, Lei; Liu, Jing; Li, Muzi; Fu, Yong; Zhang, Xiao; Liu, Qun] China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing, Peoples R China	Liu, Q (reprint author), China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing, Peoples R China.	qunliu@cau.edu.cn			National Key Basic Research Program (973 program) of China [2015CB150300]; Beijing Municipal Natural Science Foundation [6131001]; Earmarked fund for Modern Agro-industry Technology Research System [CARS-37]	This study was supported by the National Key Basic Research Program (973 program) of China (Grant No. 2015CB150300), Beijing Municipal Natural Science Foundation (Grant No. 6131001) and Earmarked fund for Modern Agro-industry Technology Research System (CARS-37).	Alaganan A, 2014, P NATL ACAD SCI USA, V111, P1126, DOI 10.1073/pnas.1313501111; Altschul SF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000852; Arranz-Solis D, 2015, VET PARASITOL, V211, P133, DOI 10.1016/j.vetpar.2015.05.021; Behnke MS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005434; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Brydges SD, 2008, BIOL CELL, V100, P253, DOI 10.1042/BC20070076; Cardenas-Mondragon MG, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01872; Caspe SG, 2012, VET PARASITOL, V189, P171, DOI 10.1016/j.vetpar.2012.04.034; Deutsch DR, 2014, J PROTEOME RES, V13, P4363, DOI 10.1021/pr500550t; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; Dubey JP, 1999, VET PARASITOL, V84, P349, DOI 10.1016/S0304-4017(99)00044-8; Dubremetz JF, 2012, MICROBES INFECT, V14, P1403, DOI 10.1016/j.micinf.2012.09.005; Etheridge RD, 2014, CELL HOST MICROBE, V15, P537, DOI 10.1016/j.chom.2014.04.002; Gagnaire A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01987; Gaji RY, 2011, TRAFFIC, V12, P840, DOI 10.1111/j.1600-0854.2011.01192.x; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hajj H.E., 2007, PLOS PATHOG, V3, pe14; Hall CA, 2005, VET PARASITOL, V128, P231, DOI 10.1016/j.vetpar.2004.12.012; Hammoudi PM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005211; Hecker YP, 2015, VET PARASITOL, V214, P247, DOI 10.1016/j.vetpar.2015.10.015; Hermanns T, 2016, CELL MICROBIOL, V18, P244, DOI 10.1111/cmi.12499; Hui W., 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0111993; Lai BS, 2012, P NATL ACAD SCI USA, V109, P14182, DOI 10.1073/pnas.1208775109; Li JH, 2014, VET PARASITOL, V205, P361, DOI 10.1016/j.vetpar.2014.06.036; Li MZ, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01560; Liu GZ, 2013, ACTA BIOCH BIOPH SIN, V45, P607, DOI 10.1093/abbs/gmt036; Lyon C, 2010, TOP COMPANION ANIM M, V25, P170, DOI 10.1053/j.tcam.2010.07.005; Mota CM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01456; Nolan SJ, 2015, EUKARYOT CELL, V14, P454, DOI 10.1128/EC.00262-14; Pan H., 2014, J PARASITOL, V100, P812, DOI [10.1645/14-498.1, DOI 10.1645/14-498.1]; Pastor-Fernandez I, 2016, PARASITOLOGY, V143, P97, DOI 10.1017/S0031182015001511; Payne TM, 2011, MOL MICROBIOL, V82, P1204, DOI 10.1111/j.1365-2958.2011.07879.x; Pereira G. D., 2010, PARASITOLOGY, V137, P1057, DOI [10.1017/S0031182009991855, DOI 10.1017/S0031182009991855]; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Radke JB, 2013, P NATL ACAD SCI USA, V110, P6871, DOI 10.1073/pnas.1300059110; Reese ML, 2011, J BIOL CHEM, V286, P29366, DOI 10.1074/jbc.M111.253435; Regidor-Cerrillo J, 2010, VET RES, V41, DOI 10.1051/vetres/2010024; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Sandberg A., 2012, MOL CELL PROTEOMICS, V7, DOI [10.1074/mcp.M112.016998, DOI 10.1074/MCP.M112.016998]; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Shwab EK, 2016, INT J PARASITOL, V46, P141, DOI 10.1016/j.ijpara.2015.10.005; Sinai AP, 2001, J CELL BIOL, V154, P95, DOI 10.1083/jcb.200101073; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Tao L., 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0099744; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Tilley M, 1997, INFECT IMMUN, V65, P4598; Vemulapalli R, 2007, VET PARASITOL, V148, P219, DOI 10.1016/j.vetpar.2007.06.029; Walker R, 2013, J BIOL CHEM, V288, P31127, DOI 10.1074/jbc.M113.486589; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Walzer KA, 2013, P NATL ACAD SCI USA, V110, P7446, DOI 10.1073/pnas.1304322110; Wang J, 2017, EXP PARASITOL, V175, P21, DOI 10.1016/j.exppara.2017.01.004; Williams MJ, 2015, MBIO, V6, DOI 10.1128/mBio.00845-15; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005	60	1	1	1	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	MAR 7	2017	8								370	10.3389/fmicb.2017.00370				13	Microbiology	Microbiology	EM8OG	WOS:000395570100001	28326073	gold			2018-01-05	
J	Zhou, LZ; Juranic, M; Dresselhaus, T				Zhou, Liang-Zi; Juranic, Martina; Dresselhaus, Thomas			Germline Development and Fertilization Mechanisms in Maize	MOLECULAR PLANT			English	Review						germline; gametophyte; pollen tube; progamic phase; fertilization; maize	POLLEN-TUBE GROWTH; ZEA-MAYS-L; IN-VITRO SYSTEM; FEMALE GAMETOPHYTE; ANTHER DEVELOPMENT; FLOWERING PLANTS; SEX DETERMINATION; CELL-DIVISION; EMBRYO SAC; CYTOLOGICAL EVENTS	Maize is the most important agricultural crop used for food, feed, and biofuel as well as a raw material for industrial products such as packaging material. To increase yield and to overcome hybridization barriers, studies of maize gamete development, the pollen tube journey, and fertilization mechanisms were initiated more than a century ago. In this review, we summarize and discuss our current understanding of theregulatory components for germline development including sporogenesis and gametogenesis, the progamic phase of pollen germination and pollen tube growth and guidance, as well as fertilization mechanisms consisting of pollen tube arrival and reception, sperm cell release, fusion with the female gametes, and egg cell activation. Mechanisms of asexual seed development are not considered here. While only a few molecular players involved in these processes have been described to date and the underlying mechanisms are far from being understood, maize now represents a spearhead of reproductive research for all grass species. Recent development of essentially improved transformation and gene-editing systems may boost research in this area in the near future.	[Zhou, Liang-Zi; Juranic, Martina; Dresselhaus, Thomas] Univ Regensburg, Biochem Zentrum Regensburg, Cell Biol & Plant Biochem, Univ Str 31, D-93053 Regensburg, Germany; [Juranic, Martina] CSIRO Agr & Food, PMB2, Glen Osmond, SA 5064, Australia	Dresselhaus, T (reprint author), Univ Regensburg, Biochem Zentrum Regensburg, Cell Biol & Plant Biochem, Univ Str 31, D-93053 Regensburg, Germany.	thomas.dresselhaus@ur.de		Juranic, Martina/0000-0001-6113-7623; Dresselhaus, Thomas/0000-0001-6442-4302	Alexander von Humboldt Foundation; German Research Council (DFG) vai Collaborative Research Center [SFB924]	Funding by the Alexander von Humboldt Foundation to L.-Z.Z. and the German Research Council (DFG) via Collaborative Research Center SFB924 to T.D.is greatly acknowledged.	Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Antoine AF, 2001, NAT CELL BIOL, V3, P1120, DOI 10.1038/ncb1201-1120; BEDINGER P, 1992, PLANT CELL, V4, P879, DOI 10.1105/tpc.4.8.879                                                             ; Bedinger Patricia A., 2009, P57, DOI 10.1007/978-0-387-79418-1_4; Bhatt AM, 2001, TRENDS PLANT SCI, V6, P114, DOI 10.1016/S1360-1385(00)01861-6; Bonnett OT, 1940, J AGRIC RES, V60, P0025; Buitink J, 2000, PLANT PHYSIOL, V122, P1217, DOI 10.1104/pp.122.4.1217; Calderon-Urrea A, 1999, DEVELOPMENT, V126, P435; CALLIS J, 1994, P NATL ACAD SCI USA, V91, P6074, DOI 10.1073/pnas.91.13.6074; CHANG MT, 1989, GENOME, V32, P232, DOI 10.1139/g89-434                                                                 ; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; Chaubal R, 2000, AM J BOT, V87, P1193, DOI 10.2307/2656657; Chaubal R, 2003, PLANTA, V216, P778, DOI 10.1007/s00425-002-0929-8; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chettoor AM, 2016, GENETICS, V204, P233, DOI 10.1534/genetics.116.191833; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Cigan AM, 2001, SEX PLANT REPROD, V14, P135, DOI 10.1007/s004970100099; Cordts S, 2001, PLANT J, V25, P103, DOI 10.1046/j.0960-7412.2000.00944.x; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; DELLAPORTA SL, 1993, PLANT CELL, V5, P1241; Denninger P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5645; DIBOLL AG, 1966, AM J BOT, V53, P391, DOI 10.2307/2439880; Digonnet C, 1997, DEVELOPMENT, V124, P2867; Dixit R, 2001, PLANT MOL BIOL, V45, P51, DOI 10.1023/A:1006428007826; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Dresselhaus T, 2016, CURR BIOL, V26, pR125, DOI 10.1016/j.cub.2015.12.032; Dresselhaus T, 2013, MOL PLANT, V6, P1018, DOI 10.1093/mp/sst061; Dresselhaus T, 2011, ANN BOT-LONDON, V108, P727, DOI 10.1093/aob/mcr017; DUMAS C, 1993, PLANT CELL, V5, P1337; DUPUIS I, 1987, PLANT PHYSIOL, V85, P876, DOI 10.1104/pp.85.4.876; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Evans MMS, 2007, PLANT CELL, V19, P46, DOI 10.1105/tpc.106.047506; FAURE JE, 1994, SCIENCE, V263, P1598, DOI 10.1126/science.263.5153.1598; Feng XQ, 2007, TRENDS GENET, V23, P503, DOI 10.1016/j.tig.2007.08.005; Field S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146534; Fonseca AE, 2005, FIELD CROP RES, V94, P114, DOI 10.1016/j.fcr.2004.12.001; FUJIOKA S, 1988, P NATL ACAD SCI USA, V85, P9031, DOI 10.1073/pnas.85.23.9031; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Golubovskaya I, 1997, GENETICS, V147, P1339; GOLUBOVSKAYA IN, 1989, ADV GENET, V26, P149, DOI 10.1016/S0065-2660(08)60225-4; Guo FL, 2004, PROTOPLASMA, V223, P111, DOI 10.1007/s00709-004-0045-7; Gutierrez-Marcos JF, 2006, GENETICS, V174, P317, DOI 10.1534/genetics.106.059709; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; HESLOPHARRISON J, 1981, ACTA BOT NEERL, V30, P289, DOI 10.1111/j.1438-8677.1981.tb00410.x                                              ; Huang BQ, 1996, PLANT CELL, V8, P1391; HUANG BQ, 1994, PLANT CELL, V6, P845; Jin LB, 2012, FIELD CROP RES, V134, P30, DOI 10.1016/j.fcr.2012.04.008; Juranic M, 2012, PLANT CELL, V24, P4974, DOI 10.1105/tpc.112.107169; Kelliher T, 2012, SCIENCE, V337, P345, DOI 10.1126/science.1220080; Kelliher T, 2011, DEV BIOL, V350, P32, DOI 10.1016/j.ydbio.2010.11.005; KERMICLE JL, 1969, SCIENCE, V166, P1422, DOI 10.1126/science.166.3911.1422                                                   ; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; KRANZ E, 1995, PLANT J, V8, P9, DOI 10.1046/j.1365-313X.1995.08010009.x; KRANZ E, 1991, SEX PLANT REPROD, V4, P17; Krohn NG, 2012, DEV CELL, V23, P219, DOI 10.1016/j.devcel.2012.05.018; Lausser A, 2010, J EXP BOT, V61, P673, DOI 10.1093/jxb/erp330; LebelHardenack S, 1997, TRENDS PLANT SCI, V2, P130, DOI 10.1016/S1360-1385(97)01012-1; LIN BY, 1978, CAN J GENET CYTOL, V20, P249, DOI 10.1139/g78-028                                                                 ; Lituiev DS, 2013, DEVELOPMENT, V140, P4544, DOI 10.1242/dev.098301; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Marowa P, 2016, PLANT CELL REP, V35, P949, DOI 10.1007/s00299-016-1948-4; Marton ML, 2012, CURR BIOL, V22, P1194, DOI 10.1016/j.cub.2012.04.061; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Miller EC, 1919, J AGRIC RES, V18, P0255; MOL R, 1994, PLANT J, V5, P197, DOI 10.1046/j.1365-313X.1994.05020197.x; Moon J, 2013, PLANT J, V76, P592, DOI 10.1111/tpj.12318; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pawlowski WP, 2009, P NATL ACAD SCI USA, V106, P3603, DOI 10.1073/pnas.0810115106; Peng XB, 2005, CELL RES, V15, P734, DOI 10.1038/sj.cr.7290343                                                           ; RUBINSTEIN AL, 1995, P NATL ACAD SCI USA, V92, P3086, DOI 10.1073/pnas.92.8.3086; Rubinstein AL, 1995, PLANT CELL, V7, P2211; Sheridan WF, 1999, GENETICS, V153, P933; Sheridan WF, 1996, GENETICS, V142, P1009; SHIVANNA KR, 1982, ACTA BOT NEERL, V31, P307, DOI 10.1111/j.1438-8677.1982.tb01637.x                                              ; Spielman M, 2008, SEX PLANT REPROD, V21, P53, DOI 10.1007/s00497-007-0063-7; Sprunck S, 2011, SEX PLANT REPROD, V24, P123, DOI 10.1007/s00497-011-0161-4; Srilunchang KO, 2010, DEVELOPMENT, V137, P333, DOI 10.1242/dev.035964; STAIGER CJ, 1992, DEV BIOL, V154, P226, DOI 10.1016/0012-1606(92)90063-M; STIEGLITZ H, 1977, DEV BIOL, V57, P87, DOI 10.1016/0012-1606(77)90356-6; Suen DF, 2003, J BIOL CHEM, V278, P43672, DOI 10.1074/jbc.M307843200; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Tekleyohans DG, 2017, PLANT PHYSIOL, V173, P122, DOI 10.1104/pp.16.01472; Timofejeva L, 2013, G3-GENES GENOM GENET, V3, P231, DOI 10.1534/g3.112.004465; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Uebler S., 2014, PLANT SIGNAL BEHAV, V8; Uebler S, 2015, PLANT REPROD, V28, P183, DOI 10.1007/s00497-015-0269-z; Valdivia ER, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000154; Valdivia ER, 2009, SEX PLANT REPROD, V22, P141, DOI 10.1007/s00497-009-0099-y; VEIT B, 1993, PLANT CELL, V5, P1205, DOI 10.1105/tpc.5.10.1205; Vernoud V, 2009, PLANT J, V59, P883, DOI 10.1111/j.1365-313X.2009.03916.x; VOLLBRECHT E, 1995, DEV GENET, V16, P44, DOI 10.1002/dvg.1020160109                                                          ; WAGNER VT, 1988, PLANT SCI, V59, P127; Walbot V, 2016, ANNU REV PLANT BIOL, V67, P365, DOI 10.1146/annurev-arplant-043015-111804; Wang CJR, 2012, DEVELOPMENT, V139, P2594, DOI 10.1242/dev.077891; Wang DX, 2013, PLANT REPROD, V26, P329, DOI 10.1007/s00497-013-0230-y; Wang DX, 2010, PLANT J, V63, P939, DOI 10.1111/j.1365-313X.2010.04294.x; Whipple C, 2012, SCIENCE, V337, P301, DOI 10.1126/science.1224362; Woriedh M, 2013, PLANT REPROD, V26, P255, DOI 10.1007/s00497-013-0221-z; Yang F, 2015, PLANT CELL, V27, P121, DOI 10.1105/tpc.114.130393; Zhang W, 2014, MOL GENET GENOMICS, V289, P1061, DOI 10.1007/s00438-014-0867-8	103	0	0	6	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1674-2052	1752-9867		MOL PLANT	Mol. Plant.	MAR 6	2017	10	3					389	401		10.1016/j.molp.2017.01.012				13	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	EO9UH	WOS:000397033100003	28267957	gold			2018-01-05	
J	Chen, XZ; Feng, F; Qi, WW; Xu, LM; Yao, DS; Wang, Q; Song, RT				Chen, Xinze; Feng, Fan; Qi, Weiwei; Xu, Liming; Yao, Dongsheng; Wang, Qun; Song, Rentao			Dek35 Encodes a PPR Protein that Affects cis-Splicing of Mitochondrial nad4 Intron 1 and Seed Development in Maize	MOLECULAR PLANT			English	Article						PPR; splicing; mitochondria; NADH; maize	PENTATRICOPEPTIDE REPEAT PROTEIN; PRE-MESSENGER-RNA; GROUP-II INTRONS; ARABIDOPSIS-THALIANA; COMPLEX-I; PLANT-MITOCHONDRIA; GENE-EXPRESSION; TRANSFER CELLS; EDITING SITE; BIOGENESIS	In higher plants, the splicing of organelle-encoded mRNA involves a complex collaboration with nuclearencoded proteins. Pentatricopeptide repeat (PPR) proteins have been implicated in these RNA-protein interactions. In this study, we performed the cloning and functional characterization of maize Defective kernel 35 ( Dek35). The dek35-ref mutant is a lethal-seed mutant with developmental deficiency. Dek35 was cloned through Mutator tag isolation and further confirmed by four additional independent mutant alleles. Dek35 encodes an P-type PPR protein that targets the mitochondria. The dek35 mutation causes significant reduction in the accumulation of DEK35 proteins and reduced splicing efficiency of mitochondrial nad4 intron 1. Analysis of mitochondrial complex in dek35 immature seeds indicated severe deficiency in the complex I assembly and NADH dehydrogenase activity. Transcriptome analysis of dek35 endosperm revealed enhanced expression of genes involved in the alternative respiratory pathway and extensive differentially expressed genes related to mitochondrial function and activity. Collectively, these results indicate that Dek35 encodes an PPR protein that affects the cis-splicing of mitochondrial nad4 intron 1 and is required for mitochondrial function and seed development.	[Chen, Xinze; Feng, Fan; Qi, Weiwei; Xu, Liming; Yao, Dongsheng; Wang, Qun; Song, Rentao] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai 200444, Peoples R China; [Song, Rentao] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100193, Peoples R China; [Qi, Weiwei; Song, Rentao] Coordinated Crop Biol Res Ctr CBRC, Beijing 100193, Peoples R China	Song, RT (reprint author), Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai 200444, Peoples R China.; Song, RT (reprint author), China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100193, Peoples R China.; Song, RT (reprint author), Coordinated Crop Biol Res Ctr CBRC, Beijing 100193, Peoples R China.	rentaosong@staff.shu.edu.cn	Song, Rentao/A-6544-2012	Song, Rentao/0000-0003-1810-9875	National Natural Sciences Foundation of China [91335208, 31425019]	This work was supported by the National Natural Sciences Foundation of China (91335208 and 31425019).	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Aubourg S, 2000, PLANT MOL BIOL, V42, P603, DOI 10.1023/A:1006352315928; Ban T, 2013, J BIOL CHEM, V288, P31540, DOI 10.1074/jbc.M113.496828; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bentolila S, 2010, PLANT PHYSIOL, V154, P1966, DOI 10.1104/pp.110.165969; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Brangeon J, 2000, PLANT J, V21, P269, DOI 10.1046/j.1365-313x.2000.00679.x; Braun HP, 2014, MITOCHONDRION, V19, P295, DOI 10.1016/j.mito.2014.02.006; Brown GG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00035; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; CHARLTON WL, 1995, DEVELOPMENT, V121, P3089; Chateigner-Boutin AL, 2013, PLANT J, V74, P935, DOI 10.1111/tpj.12180; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Chateigner-Boutin A-L, 2014, RNA BIOL, V7, P213; Chaudhuri S, 1996, EMBO J, V15, P5958; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Choury D, 2005, NUCLEIC ACIDS RES, V33, P7058, DOI 10.1093/nar/gki1017; Choury D, 2006, CURR GENET, V50, P405, DOI 10.1007/s00294-006-0100-3; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Cohen S, 2014, PLANT J, V78, P253, DOI 10.1111/tpj.12466; Cosson P, 1997, CURR OPIN CELL BIOL, V9, P484, DOI 10.1016/S0955-0674(97)80023-3; de Longevialle AF, 2008, PLANT J, V56, P157, DOI 10.1111/j.1365-313X.2008.03581.x; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; des Francs-Small CC, 2014, PLANT PHYSIOL, V165, P1409, DOI 10.1104/pp.114.244616; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Haili N, 2016, PLANT PHYSIOL, V170, P354, DOI 10.1104/pp.15.01591; Haili N, 2013, NUCLEIC ACIDS RES, V41, P6650, DOI 10.1093/nar/gkt337; Holzle A, 2011, PLANT J, V65, P737, DOI 10.1111/j.1365-313X.2010.04460.x; Hsieh WY, 2015, PLANT PHYSIOL, V168, P490, DOI 10.1104/pp.15.00354; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Kusmierczyk AR, 2003, BIOCHEM J, V371, P669, DOI 10.1042/BJ20030230; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Law SR, 2014, MITOCHONDRION, V19, P214, DOI 10.1016/j.mito.2014.04.002; Li XJ, 2014, PLANT J, V79, P797, DOI 10.1111/tpj.12584; Liu YJ, 2013, PLANT CELL, V25, P868, DOI 10.1105/tpc.112.106781; Liu Y, 2010, PLANT J, V63, P749, DOI 10.1111/j.1365-313X.2010.04280.x; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Manavski N, 2012, PLANT CELL, V24, P3087, DOI 10.1105/tpc.112.099051; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Murayama M, 2012, J EXP BOT, V63, P5301, DOI 10.1093/jxb/ers188; Nakagawa N, 2006, PLANT CELL PHYSIOL, V47, P772, DOI 10.1093/pcp/pcj051; Offler CE, 2003, ANNU REV PLANT BIOL, V54, P431, DOI 10.1146/annurev.arplant.54.031902.134812; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730                                        ; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sosso D, 2012, PLANT CELL, V24, P676, DOI 10.1105/tpc.111.091074; Sun F, 2015, PLANT J, V84, P283, DOI 10.1111/tpj.12993; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Thompson RD, 2001, PLANT SCI, V160, P775, DOI 10.1016/S0168-9452(01)00345-4; Tian HL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0335-0; Uyttewaal M, 2008, PLANT CELL, V20, P3331, DOI 10.1105/tpc.107.057208; Wang G, 2011, GENETICS, V189, P1281, DOI 10.1534/genetics.111.133967; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Xiu ZH, 2016, PLANT J, V85, P507, DOI 10.1111/tpj.13122; Yap A, 2015, PLANT J, V81, P661, DOI 10.1111/tpj.12756; Zhang HD, 2015, PHOTOSYNTH RES, V126, P311, DOI 10.1007/s11120-015-0171-4	70	6	6	7	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1674-2052	1752-9867		MOL PLANT	Mol. Plant.	MAR 6	2017	10	3					427	441		10.1016/j.molp.2016.08.008				15	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	EO9UH	WOS:000397033100006	27596292				2018-01-05	
J	Bekpen, C; Kunzel, S; Xie, C; Eaaswarkhanth, M; Lin, YL; Gokcumen, O; Akdis, CA; Tautz, D				Bekpen, Cemalettin; Kuenzel, Sven; Xie, Chen; Eaaswarkhanth, Muthukrishnan; Lin, Yen-Lung; Gokcumen, Omer; Akdis, Cezmi A.; Tautz, Diethard			Segmental duplications and evolutionary acquisition of UV damage response in the SPATA31 gene family of primates and humans	BMC GENOMICS			English	Article						Segmental Duplications; Core duplicons; SPATA31 gene family; Comparative Genomics; Copy number variation; UV response	MULTIPLE SEQUENCE ALIGNMENT; GENOME SEQUENCE; CYTO-TOXICITY; COPY NUMBER; DNA-REPAIR; TBC1D3; CRYPTOCHROME; DIVERSITY; RELEASE; RAS	Background: Segmental duplications are an abundant source for novel gene functions and evolutionary adaptations. This mechanism of generating novelty was very active during the evolution of primates particularly in the human lineage. Here, we characterize the evolution and function of the SPATA31 gene family (former designation FAM75A), which was previously shown to be among the gene families with the strongest signal of positive selection in hominoids. The mouse homologue for this gene family is a single copy gene expressed during spermatogenesis. Results: We show that in primates, the SPATA31 gene duplicated into SPATA31A and SPATA31C types and broadened the expression into many tissues. Each type became further segmentally duplicated in the line towards humans with the largest number of full-length copies found for SPATA31A in humans. Copy number estimates of SPATA31A based on digital PCR show an average of 7.5 with a range of 5-11 copies per diploid genome among human individuals. The primate SPATA31 genes also acquired new protein domains that suggest an involvement in UV response and DNA repair. We generated antibodies and show that the protein is re-localized from the nucleolus to the whole nucleus upon UV-irradiation suggesting a UV damage response. We used CRISPR/Cas mediated mutagenesis to knockout copies of the gene in human primary fibroblast cells. We find that cell lines with reduced functional copies as well as naturally occurring low copy number HFF cells show enhanced sensitivity towards UV-irradiation. Conclusion: The acquisition of new SPATA31 protein functions and its broadening of expression may be related to the evolution of the diurnal life style in primates that required a higher UV tolerance. The increased segmental duplications in hominoids as well as its fast evolution suggest the acquisition of further specific functions particularly in humans.	[Bekpen, Cemalettin; Kuenzel, Sven; Xie, Chen; Tautz, Diethard] Max Planck Inst Evolut Biol, August Thienemann Str 2, D-24306 Plon, Germany; [Eaaswarkhanth, Muthukrishnan; Lin, Yen-Lung; Gokcumen, Omer] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Eaaswarkhanth, Muthukrishnan] Dasman Diabet Inst, Populat Genom & Genet Epidemiol Unit, POB 1180, Dasman 15462, Kuwait; [Akdis, Cezmi A.] Swiss Inst Allergy & Asthma Res SIAF, CH-7270 Davos, Switzerland	Bekpen, C; Tautz, D (reprint author), Max Planck Inst Evolut Biol, August Thienemann Str 2, D-24306 Plon, Germany.	bekpen@evolbio.mpg.de; tautz@evolbio.mpg.de		Eaaswarkhanth, Muthukrishnan/0000-0001-9631-8555; Gokcumen, Omer/0000-0003-4371-679X; Tautz, Diethard/0000-0002-0460-5344	TUBITAK [1001 (112 T421)]; ERC [GA322564]; Max-Planck Society	This work was supported by TUBITAK 1001 (112 T421) granted to C.B., the ERC advanced grant GA322564 - NewGenes to D.T. and institutional funds of the Max-Planck Society to D.T.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Avitabile D, 2014, CELL MOL LIFE SCI, V71, P2547, DOI 10.1007/s00018-013-1503-1; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bekpen C, 2012, GENOME RES, V22, P1050, DOI 10.1101/gr.134098.111; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Giannuzzi G, 2013, GENOME RES, V23, P46, DOI 10.1101/gr.138842.112; Gokcumen O, 2013, P NATL ACAD SCI USA, V110, P15764, DOI 10.1073/pnas.1305904110; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581                                                              ; Konkel MK, 2010, EVOL ANTHROPOL, V19, P236, DOI 10.1002/evan.20283; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Lee JH, 2013, CANCER RES, V73, P785, DOI 10.1158/0008-5472.CAN-12-1994; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marques-Bonet T, 2009, COLD SPRING HARBOR S; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Ohno S., 1970, EVOLUTION GENE DUPLI; Ozkan-Dagliyan I, 2013, J BIOL CHEM, V288, P23244, DOI 10.1074/jbc.M113.493361; Pace JK, 2008, EVOLUTIONARY HIST GE; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sancar A, 2010, FEBS LETT, V584, P2618, DOI 10.1016/j.febslet.2010.03.017; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Soria G, 2008, J CELL SCI, V121, P3271, DOI 10.1242/jcs.027730; Stahl PD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.289pe59; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Whitehurst CB, 2012, J VIROL, V86, P8097, DOI 10.1128/JVI.00588-12; Wu YY, 2015, MOL REPROD DEV, V82, P432, DOI 10.1002/mrd.22491; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262; Zuo Y, 2010, BIOCHEM BIOPH RES CO, V401, P275, DOI 10.1016/j.bbrc.2010.09.049	46	0	0	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAR 6	2017	18								222	10.1186/s12864-017-3595-8				12	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	EM8VT	WOS:000395589900001	28264649	gold			2018-01-05	
J	Sonoiki, E; Ng, CL; Lee, MCS; Guo, DH; Zhang, YK; Zhou, Y; Alley, MRK; Ahyong, V; Sanz, LM; Lafuente-Monasterio, MJ; Dong, C; Schupp, PG; Gut, J; Legac, J; Cooper, RA; Gamo, FJ; DeRisi, J; Freund, YR; Fidock, DA; Rosenthal, PJ				Sonoiki, Ebere; Ng, Caroline L.; Lee, Marcus C. S.; Guo, Denghui; Zhang, Yong-Kang; Zhou, Yasheen; Alley, M. R. K.; Ahyong, Vida; Sanz, Laura M.; Jose Lafuente-Monasterio, Maria; Dong, Chen; Schupp, Patrick G.; Gut, Jiri; Legac, Jenny; Cooper, Roland A.; Gamo, Francisco-Javier; DeRisi, Joseph; Freund, Yvonne R.; Fidock, David A.; Rosenthal, Philip J.			A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue	NATURE COMMUNICATIONS			English	Article							TRANSFER-RNA SYNTHETASE; MALARIA PARASITES; FACTOR CPSF-73; LIFE-CYCLE; DISCOVERY; BORON; RESISTANCE; DRUGS; INHIBITORS; ENDONUCLEASE	Benzoxaboroles are effective against bacterial, fungal and protozoan pathogens. We report potent activity of the benzoxaborole AN3661 against Plasmodium falciparum laboratory-adapted strains (mean IC50 32 nM), Ugandan field isolates (mean ex vivo IC50 64 nM), and murine P. berghei and P. falciparum infections (day 4 ED90 0.34 and 0.57 mg kg(-1), respectively). Multiple P. falciparum lines selected in vitro for resistance to AN3661 harboured point mutations in pfcpsf3, which encodes a homologue of mammalian cleavage and polyadenylation specificity factor subunit 3 (CPSF-73 or CPSF3). CRISPR-Cas9-mediated introduction of pfcpsf3 mutations into parental lines recapitulated AN3661 resistance. PfCPSF3 homology models placed these mutations in the active site, where AN3661 is predicted to bind. Transcripts for three trophozoite-expressed genes were lost in AN3661 treated trophozoites, which was not observed in parasites selected or engineered for AN3661 resistance. Our results identify the pre-mRNA processing factor PfCPSF3 as a promising antimalarial drug target.	[Sonoiki, Ebere; Guo, Denghui; Gut, Jiri; Legac, Jenny; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, Box 0811, San Francisco, CA 94143 USA; [Sonoiki, Ebere] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, 293 Univ Hall,2199 Addison St, Berkeley, CA 94720 USA; [Ng, Caroline L.; Lee, Marcus C. S.; Schupp, Patrick G.; Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, Room 1502 HHSC,701 West 168th St, New York, NY 10032 USA; [Zhang, Yong-Kang; Zhou, Yasheen; Alley, M. R. K.; Dong, Chen; Freund, Yvonne R.] Anacor Pharmaceut Inc, 1020 East Meadow Circle, Palo Alto, CA 94303 USA; [Ahyong, Vida; DeRisi, Joseph] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, Box 2542,1700 4th St, San Francisco, CA 94158 USA; [Jose Lafuente-Monasterio, Maria; Gamo, Francisco-Javier] GlaxoSmithKline, Malaria Discovery Performance Unit, Developing World, Tres Cantos Medicines Dev Campus, Tres Cantos 28760, Spain; [Cooper, Roland A.] Dominican Univ Calif, Dept Nat Sci & Math, 50 Acacia Ave, San Rafael, CA 94901 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA; [Lee, Marcus C. S.] Wellcome Trust Sanger Inst, Malaria Programme, Wellcome Genome Campus, Cambridge CB10 1SA, England	Rosenthal, PJ (reprint author), Univ Calif San Francisco, Dept Med, Box 0811, San Francisco, CA 94143 USA.	Philip.Rosenthal@ucsf.edu		Lee, Marcus/0000-0002-4973-0915; Fidock, David/0000-0001-6753-8938	National Institutes of Health [AI095324, AI103058]; Medicines for Malaria Venture; Howard Hughes Medical Institute	This work was supported by the National Institutes of Health (AI095324 and AI103058) and the Medicines for Malaria Venture. J.D. was funded by the Howard Hughes Medical Institute.	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Baker SJ, 2011, CHEM SOC REV, V40, P4279, DOI 10.1039/c0cs00131g; Baker SJ, 2009, FUTURE MED CHEM, V1, P1275, DOI 10.4155/FMC.09.71; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH, V53, P4533, DOI 10.1128/AAC.00519-09; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755                                                          ; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Freund YR, 2012, FEBS LETT, V586, P3410, DOI 10.1016/j.febslet.2012.07.058; Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375; Gupta AK, 2016, EXPERT OPIN INV DRUG, V25, P297, DOI 10.1517/13543784.2016.1142529; Hernandez V, 2013, ANTIMICROB AGENTS CH, V57, P1394, DOI 10.1128/AAC.02058-12; Hu QH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02475; Jacobs RT, 2011, CURR OPIN INFECT DIS, V24, P586, DOI 10.1097/QCO.0b013e32834c630e; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Nare B, 2010, ANTIMICROB AGENTS CH, V54, P4379, DOI 10.1128/AAC.00498-10; Ng CL, 2016, MOL MICROBIOL, V101, P381, DOI 10.1111/mmi.13397; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Palencia A., 2017, EMBO MOL MED; Palencia A, 2016, ANTIMICROB AGENTS CH, V60, P5817, DOI 10.1128/AAC.00873-16; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Rosenthal PJ, 2013, MOL MICROBIOL, V89, P1025, DOI 10.1111/mmi.12349; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404                                                             ; Sanz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030949; Schonemann L, 2014, GENE DEV, V28, P2381, DOI 10.1101/gad.250985.114; Shenai BR, 2002, BIOL CHEM, V383, P843, DOI 10.1515/BC.2002.089                                                             ; Sonoiki E, 2016, ANTIMICROB AGENTS CH, V60, P4886, DOI 10.1128/AAC.00820-16; Tumwebaze P, 2015, ANTIMICROB AGENTS CH, V59, P3018, DOI 10.1128/AAC.05141-14; Valderramos SG, 2006, TRENDS PHARMACOL SCI, V27, P594, DOI 10.1016/j.tips.2006.09.005; Wells Timothy N. C., 2013, Infectious Disorders - Drug Targets, V13, P292; WHO, 2016, WORLD MAL REP 2016; Xia Y, 2011, BIOORG MED CHEM LETT, V21, P2533, DOI 10.1016/j.bmcl.2011.02.024; Xiang KH, 2014, MOL CELL BIOL, V34, P1894, DOI 10.1128/MCB.00084-14; Zhang YP, 2015, J NUCL ENG RADIAT SC, V1, DOI 10.1115/1.4030364; Zhang YK, 2012, BIOORG MED CHEM LETT, V22, P1299, DOI 10.1016/j.bmcl.2011.12.096; Zhang YK, 2011, BIOORG MED CHEM LETT, V21, P644, DOI 10.1016/j.bmcl.2010.12.034; Zhang YK, 2010, BIOORG MED CHEM LETT, V20, P2270, DOI 10.1016/j.bmcl.2010.02.010	44	3	3	4	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAR 6	2017	8								14574	10.1038/ncomms14574				11	Multidisciplinary Sciences	Science & Technology - Other Topics	EM7OK	WOS:000395501800001	28262680	gold			2018-01-05	
J	Achigar, R; Magadan, AH; Tremblay, DM; Pianzzola, MJ; Moineau, S				Achigar, Rodrigo; Magadan, Alfonso H.; Tremblay, Denise M.; Pianzzola, Maria Julia; Moineau, Sylvain			Phage-host interactions in Streptococcus thermophilus: Genome analysis of phages isolated in Uruguay and ectopic spacer acquisition in CRISPR array	SCIENTIFIC REPORTS			English	Article							BACTERIOPHAGE DT1; CAS SYSTEMS; DIVERSITY; SEQUENCE; ORGANIZATION; RESISTANCE; IMMUNITY; RNA; DNA	Three cos-type virulent Streptococcus thermophilus phages were isolated from failed mozzarella production in Uruguay. Genome analyses showed that these phages are similar to those isolated elsewhere around the world. The CRISPR1 and CRISPR3 arrays of the three S. thermophilus host strains from Uruguay were also characterized and similarities were noted with previously described model strains SMQ-301, LMD-9 and DGCC7710. Spontaneous bacteriophage-insensitive S. thermophilus mutants (BIMs) were obtained after challenging the phage-sensitive wild-type strain Uy02 with the phage 128 and their CRISPR content was analyzed. Analysis of 23 BIMs indicated that all of them had acquired at least one new spacer in their CRISPR1 array. While 14 BIMs had acquired spacer at the 5'-end of the array, 9 other BIMs acquired a spacer within the array. Comparison of the leader sequence in strains Uy02 and DGCC7710 showed a nucleotide deletion at position -1 in Uy02, which may be responsible for the observed ectopic spacer acquisition. Analysis of the spacer sequences upstream the newly acquired ectopic spacer indicated presence of a conserved adenine residue at position -2. This study indicates that natural strains of S. thermophilus can also acquire spacers within a CRISPR array.	[Achigar, Rodrigo; Pianzzola, Maria Julia] Univ Republica, Lab Microbiol Mol, Dept Biociencias, Fac Quim, Montevideo, Uruguay; [Magadan, Alfonso H.; Tremblay, Denise M.; Moineau, Sylvain] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1V 0A6, Canada; [Magadan, Alfonso H.; Tremblay, Denise M.; Moineau, Sylvain] Univ Laval, PROTEO, Fac Sci & Genie, Felix Herelle Reference Ctr Bacterial Viruses, Quebec City, PQ G1V 0A6, Canada; [Magadan, Alfonso H.; Tremblay, Denise M.; Moineau, Sylvain] Univ Laval, GREB, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada; [Magadan, Alfonso H.] Chr Hansen AS, Dept Strains, DK-2970 Horsholm, Denmark	Moineau, S (reprint author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ G1V 0A6, Canada.; Moineau, S (reprint author), Univ Laval, PROTEO, Fac Sci & Genie, Felix Herelle Reference Ctr Bacterial Viruses, Quebec City, PQ G1V 0A6, Canada.; Moineau, S (reprint author), Univ Laval, GREB, Fac Med Dent, Quebec City, PQ G1V 0A6, Canada.	Sylvain.Moineau@bcm.ulaval.ca		Moineau, Sylvain/0000-0002-2832-5101	Uruguayan National Research and Innovation Agency (ANII); ELAP program of the Department of Foreign Affairs and International Trade of Canada; NSERC of Canada (Discovery program)	We thank Dominique Fournier and Lorena Betancor for editorial assistance, Philippe Horvath for access to the DuPont CRISPR tools as well as Christophe Fremaux and Simon Labrie for discussion. R.A. is supported by the Uruguayan National Research and Innovation Agency (ANII). R.A. also was supported by the ELAP program of the Department of Foreign Affairs and International Trade of Canada. S.M. acknowledges funding from NSERC of Canada (Discovery program). S.M. holds a Tier 1 Canada Research Chair in Bacteriophages.	Achigar R., 2014, MEJORAMIENTO RESISTE; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bruttin A, 1997, APPL ENVIRON MICROB, V63, P3144; Carte J, 2014, MOL MICROBIOL, V93, P98, DOI 10.1111/mmi.12644; del Rio B, 2008, APPL ENVIRON MICROB, V74, P4779, DOI 10.1128/AEM.00295-08; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Guglielmotti DM, 2009, INT J FOOD MICROBIOL, V136, P101, DOI 10.1016/j.ijfoodmicro.2009.09.005; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hynes AP, 2016, CURR OPIN CHEM BIOL, V34, P30, DOI 10.1016/j.cbpa.2016.05.021; Hynes AP, 2016, MBIO, V7, DOI 10.1128/mBio.00202-16; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Labrie S. J., 2015, GENOME ANNOUNC, V3; Lamothe GV, 2005, APPL ENVIRON MICROB, V71, P1237, DOI 10.1128/AEM.71.3.1237-1246.2005; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Li W, 2016, CURR MICROBIOL, V73, P393, DOI 10.1007/s00284-016-1076-y; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Mahony J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00007; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; McDonnell B., 2016, APPL ENVIRON MICROB, V82; McGinn J., 2016, MOL CELL, P1; Mills S, 2010, J APPL MICROBIOL, V108, P945, DOI 10.1111/j.1365-2672.2009.04486.x; Moineau S, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P285; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Quiberoni A, 2006, J DAIRY SCI, V89, P3791, DOI 10.3168/jds.S0022-0302(06)72420-1                                               ; Quiberoni A, 2010, INT DAIRY J, V20, P657, DOI 10.1016/j.idairyj.2010.03.012; Sambrook J, 2001, MOL CLONING LAB MANU; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Samson JE, 2013, ANNU REV FOOD SCI T, V4, P347, DOI 10.1146/annurev-food-030212-182541; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sun CL, 2013, ENVIRON MICROBIOL, V15, P463, DOI 10.1111/j.1462-2920.2012.02879.x; Tremblay DM, 1999, VIROLOGY, V255, P63, DOI 10.1006/viro.1998.9525; Vale PF, 2015, P ROY SOC B-BIOL SCI, V282, P41, DOI 10.1098/rspb.2015.1270; Verreault D, 2011, APPL ENVIRON MICROB, V77, P491, DOI 10.1128/AEM.01391-10; Wei Y., 2015, NUCL ACIDS RES, V1407	45	1	1	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 6	2017	7								43438	10.1038/srep43438				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EM6AN	WOS:000395395300001	28262818	gold			2018-01-05	
J	Zhao, J; Zhang, B; Jiang, JP; Liu, NV; Wei, Q; Xi, XG; Fu, J				Zhao, Jing; Zhang, Bo; Jiang, Junpeng; Liu, Nanv; Wei, Qi; Xi, Xuguang; Fu, Jing			AvrXa27 binding influences unwinding of the double-stranded DNA in the UPT box	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						TAL; Binding affinity; Helicase; Transcriptional activation	TAL EFFECTORS; RESISTANCE GENE; DISEASE RESISTANCE; BACTERIAL-BLIGHT; III EFFECTORS; RECOGNITION; PROTEINS; HELICASE; SPECIFICITY; RICE	Transcription-Activator Like (TAL) effectors, delivered by Xanthomonas pathogens bind specifically to UP regulated by TAL effectors (UPT) box of the host gene promoter to arouse disease or trigger defense response. This type of protein-DNA interaction model has been applied in site-directed genome editing. However, the off-target effects of TAL have severely hindered the development of this promising technology. To better exploit the specific interaction and to deeper understand the TAL-induced host transcription rewiring, the binding between the central repeat region (CRR) of the TAL effector AvrXa27 and its UPT box variants was studied by kinetics analysis and TAL-blocked helicase unwinding assay. The results revealed that while AvrXa27 exhibited the highest affinity to the wild type UPT box, it could also bind to mutated UPT box variants, implying the possibility of non-specific interactions. Furthermore, some of these non-specific combinations restricted the helicase-elicited double-stranded DNA (dsDNA) separation to a greater extent. Our findings provide insight into the mechanism of TAL transcriptional activation and are beneficial to TAL-mediated genome modification.(C) 2017 Elsevier Inc. All rights reserved.	[Zhao, Jing; Zhang, Bo; Jiang, Junpeng; Liu, Nanv; Wei, Qi; Xi, Xuguang; Fu, Jing] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Zhang, Bo; Jiang, Junpeng; Liu, Nanv; Wei, Qi; Xi, Xuguang; Fu, Jing] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Zhao, Jing] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Fu, J (reprint author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Fu, J (reprint author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	jingfu@nwsuaf.edu.cn			National Natural Science Foundation of China [31301632]; Fundamental Research Funds for the Central Universities [2452015075, 2452015418]; Doctoral Starting up Foundation of Shaanxi province, China [Z109021115]	This work was supported by the National Natural Science Foundation of China (31301632), the Fundamental Research Funds for the Central Universities (2452015075, 2452015418), and the Doctoral Starting up Foundation of Shaanxi province, China (Z109021115). We thank Prafes-SU Yi Zhongchao (Ternasek Life Sciences Laboratory, Singapore) for providing the vector carrying full-length AvrXa27 cDNA sequence and Dr. Cui Hongchang (Department of Biological Science, Florida State University, USA) for reviewing the manuscript.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hummel AW, 2012, NEW PHYTOL, V195, P883, DOI 10.1111/j.1469-8137.2012.04216.x; Jantz D, 2010, BIOPHYS J, V98, P852, DOI 10.1016/j.bpj.2009.11.021; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Liu NN, 2015, NUCLEIC ACIDS RES, V43, P8942, DOI 10.1093/nar/gkv916; lwahara J., 2006, P NATL ACAD SCI USA, V103, P15062; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nunez N, 2011, J BIOL CHEM, V286, P38190, DOI 10.1074/jbc.M111.301234; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Qin W, 2014, J BACTERIOL, V196, P4216, DOI 10.1128/JB.06367-11; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Saijo Y, 2008, CELL HOST MICROBE, V4, P96, DOI 10.1016/j.chom.2008.07.001; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yuan T, 2011, MOL PLANT, V4, P300, DOI 10.1093/mp/ssq076; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200	37	0	0	4	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAR 4	2017	484	2					390	395		10.1016/j.bbrc.2017.01.130				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EL6LZ	WOS:000394735400027	28132804				2018-01-05	
J	Zhan, MX; Sun, XH; Liu, JX; Li, Y; Li, Y; He, X; Zhou, ZZ; Lu, LG				Zhan, Meixiao; Sun, Xiaohan; Liu, Jinxiao; Li, Yan; Li, Yong; He, Xu; Zhou, Zizhang; Lu, Ligong			Usp7 promotes medulloblastoma cell survival and metastasis by activating Shh pathway	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Usp7; Medulloblastoma; Shh; P53; CRISPR/Cas9	UBIQUITIN; HAUSP; DEUBIQUITINATION; DEGRADATION; PROTEIN; NEUROBLASTOMA; EXPRESSION; APOPTOSIS; INHIBITOR; STABILITY	The ubiquitin-specific protease Usp7 plays roles in multiple cellular processes through deubiquitinating and stabilizing numerous substrates, including P53, Pten and Gli. Aberrant Usp7 activity has been implicated in many disorders and tumorigenesis, making it as a potential target for therapeutic intervention. Although it is clear that Usp7 is involved in many types of cancer, its role in regulating medulloblastoma (MB) is still unknown. In this study, we show that knockdown of Usp7 inhibits the proliferation and migration of MB cells, while Usp7 overexpression exerts an opposite effect. Furthermore, we establish Usp7 knockout MB cell line using the CRISPR/Cas9 system and further confirm that Usp7 knockout also blocks MB cell proliferation and metastasis. In addition, we reveal that knockdown of Usp7 compromises Shh pathway activity and decrease Gli protein levels, while P53 level and P53 target gene expression have no obvious changes. Finally, we find that Usp7 inhibitors apparently inhibit MB cell viability and migration. Taken together, our findings suggest that Usp7 is important for MB cell proliferation and metastasis by activating Shh pathway, and is a putative therapeutic target for MBs. (C) 2017 Elsevier Inc. All rights reserved.	[Zhan, Meixiao; Li, Yong; Lu, Ligong] Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Guangdong Gen Hosp, Dept Intervent Oncol, Guangzhou, Guangdong, Peoples R China; [Sun, Xiaohan; Liu, Jinxiao; Li, Yan; Zhou, Zizhang] Shandong Agr Univ, Coll Life Sci, Tai An, Shangdong, Peoples R China; [Zhan, Meixiao; Li, Yong; He, Xu; Lu, Ligong] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Precis Med Ctr, Zhuhai, Peoples R China	Lu, LG (reprint author), Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Guangdong Gen Hosp, Dept Intervent Oncol, Guangzhou, Guangdong, Peoples R China.; Zhou, ZZ (reprint author), Shandong Agr Univ, Coll Life Sci, Tai An, Shangdong, Peoples R China.	zhouzz@sdau.edu.cn; luligong1969@126.com			National Natural Scientific Foundation of China [81571785]; Science and Technology Foundation of Guangdong Province [2013B021800180]	This study was supported by the National Natural Scientific Foundation of China (No. 81571785), and Science and Technology Foundation of Guangdong Province (No. 2013B021800180).	Altaba ARI, 2002, NAT REV NEUROSCI, V3, P24; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Fan YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.400; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Guessous F, 2008, J CELL PHYSIOL, V217, P577, DOI 10.1002/jcp.21542; He SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027684; Heride C, 2016, J CELL SCI, V129, P4001, DOI 10.1242/jcs.188516; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hochstrasser Mark, 1992, Current Opinion in Cell Biology, V4, P1024, DOI 10.1016/0955-0674(92)90135-Y; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0                                                                ; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737                                                               ; Li S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001239; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Masuya D, 2006, J PATHOL, V208, P724, DOI 10.1002/path.1931; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Samkari A, 2015, EXPERT REV NEUROTHER, V15, P763, DOI 10.1586/14737175.2015.1052796; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Tavana O, 2016, NAT MED, V22, P1180, DOI 10.1038/nm.4180; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Yang Z, 2012, FEBS LETT, V586, P3013, DOI 10.1016/j.febslet.2012.06.025; Zhou ZZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12709; Zhou ZZ, 2015, DEV CELL, V34, P58, DOI 10.1016/j.devcel.2015.05.016; Zhu L, 2015, MOL MED REP, V12, P4652, DOI 10.3892/mmr.2015.3998	27	1	1	1	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAR 4	2017	484	2					429	434		10.1016/j.bbrc.2017.01.144				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	EL6LZ	WOS:000394735400033	28137592				2018-01-05	
J	Li, C; Unver, T; Zhang, BH				Li, Chao; Unver, Turgay; Zhang, Baohong			A high-efficiency CRISPR/Cas9 system for targeted mutagenesis in Cotton (Gossypium hirsutum L.)	SCIENTIFIC REPORTS			English	Article							DOUBLE-STRAND BREAKS; RNA-GUIDED ENDONUCLEASE; FIBER CELL-DEVELOPMENT; VERTICILLIUM-DAHLIAE; HOMOLOGOUS RECOMBINATION; TRANSCRIPTION FACTOR; CAS SYSTEM; CRISPRCAS SYSTEM; MAMMALIAN-CELLS; GENOME SEQUENCE	The complex allotetraploid genome is one of major challenges in cotton for repressing gene expression. Developing site-specific DNA mutation is the long-term dream for cotton breeding scientists. The clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system is emerging as a robust biotechnology for targeted-DNA mutation. In this study, two sgRNAs, GhMYB25-like-sgRNA1 and GhMYB25-like-sgRNA2, were designed in the identical genomic regions of GhMYB25-like A and GhMYB25-like D, which were encoded by cotton A subgenome and the D subgenome, respectively, was assembled to direct Cas9-mediated allotetraploid cotton genome editing. High proportion (14.2-21.4%) CRISPR/Cas9-induced specific truncation events, either from GhMYB25-like A DNA site or from GhMYB25-like D DNA site, were detected in 50% examined transgenic cotton through PCR amplification assay and sequencing analyses. Sequencing results also demonstrated that 100% and 98.8% mutation frequency were occurred on GhMYB25-like-sgRNA1 and GhMYB25-like-sgRNA2 target site respectively. The off-target effect was evaluated by sequencing two putative off-target sites, which have 3 and 1 mismatched nucleotides with GhMYB25-like-sgRNA1 and GhMYB25-like-sgRNA2, respectively; all the examined samples were not detected any off-targetcaused mutation events. Thus, these results demonstrated that CRISPR/Cas9 is qualified for generating DNA level mutations on allotetraploid cotton genome with high-efficiency and high-specificity.	[Li, Chao; Zhang, Baohong] East Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Unver, Turgay] Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst iBG Izmir, TR-35340 Izmir, Turkey; [Unver, Turgay] Egitim Mah,Ekrem Guer Sok 26-3, TR-35340 Izmir, Turkey	Zhang, BH (reprint author), East Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	zhangb@ecu.edu	Unver, Turgay/B-4819-2009	Unver, Turgay/0000-0001-6760-443X	Cotton Incorporated	The CRISPR-Cas9 vectors were kindly provided by Dr. Qi-jun Chen of China Agricultural University. This work is partially supported by the Cotton Incorporated.	Cantos C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00302; Cheng Y, 2016, PLANT PHYSIOL BIOCH, V109, P128, DOI 10.1016/j.plaphy.2016.09.009; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Deng FL, 2012, PLANT PHYSIOL, V158, P890, DOI 10.1104/pp.111.186742; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; FIROOZABADY E, 1987, PLANT MOL BIOL, V10, P105, DOI 10.1007/BF00016148; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Guan XY, 2014, TRENDS PLANT SCI, V19, P516, DOI 10.1016/j.tplants.2014.04.007; Guo WF, 2016, PLANT MOL BIOL, V91, P305, DOI 10.1007/s11103-016-0467-6; Han J, 2014, PLANT BIOTECHNOL J, V12, P861, DOI 10.1111/pbi.12187; Hao J, 2012, J EXP BOT, V63, P6267, DOI 10.1093/jxb/ers278; He X, 2016, PLANT CELL REP, V35, P2167, DOI 10.1007/s00299-016-2027-6; Hermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041796; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099225; Jin S, 2006, BIOL PLANTARUM, V50, P519, DOI 10.1007/s10535-006-0082-5; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Li C, 2016, J CELL PHYSIOL, V231, P303, DOI 10.1002/jcp.25125; Li C, 2014, PLANT PHYSIOL, V166, P2179, DOI 10.1104/pp.114.246694; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li F., 2015, NAT BIOTECHNOL; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li HB, 2007, NEW PHYTOL, V175, P462, DOI 10.1111/j.1469-8137.2007.02120.x; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li Y, 2016, PLANT BIOTECHNOL J, V14, P951, DOI 10.1111/pbi.12450; Li YB, 2016, PLANT PHYSIOL, V170, P2392, DOI 10.1104/pp.15.01930; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lin YF, 1999, MOL CELL BIOL, V19, P8353; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma X.L., 2015, MOL PLANT; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Min L., 2013, PLANT J; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Sander JD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-543; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Tan JF, 2013, PLANT PHYSIOL, V162, P86, DOI 10.1104/pp.112.212142; Tang WX, 2014, NEW PHYTOL, V202, P509, DOI 10.1111/nph.12676; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Tuttle JR, 2008, PLANT PHYSIOL, V148, P41, DOI 10.1104/pp.108.123869; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wan Q, 2016, NEW PHYTOL, V210, P1298, DOI 10.1111/nph.13860; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang L, 2014, PLANT J, V78, P686, DOI 10.1111/tpj.12512; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang YQ, 2016, MOL PLANT, V9, P1436, DOI 10.1016/j.molp.2016.06.013; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu L., 2012, PLANT CELL REP; Xu L, 2011, J PHYTOPATHOL, V159, P606, DOI 10.1111/j.1439-0434.2011.01813.x; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yang XY, 2008, J EXP BOT, V59, P3661, DOI 10.1093/jxb/ern214; Yang ZR, 2014, NEW PHYTOL, V203, P437, DOI 10.1111/nph.12824; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zhang B, 2001, J CHINA AIDS STD PRE, V7, P7; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang T., 2015, NAT BIOTECHNOL; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; ZHOU H, 2014, NUCLEIC ACIDS RES, V42, DOI DOI 10.1093/NAR/GKT1248; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	79	7	7	11	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 3	2017	7								43902	10.1038/srep43902				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EN6VY	WOS:000396142700001	28256588	gold			2018-01-05	
J	Doetschman, T; Georgieva, T				Doetschman, Thomas; Georgieva, Teodora			Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease	CIRCULATION RESEARCH			English	Review						cardiovascular diseases; clustered regularly interspaced short palindromic repeats; gene editing; genetic engineering; muscular dystrophies	PLURIPOTENT STEM-CELLS; DUCHENNE MUSCULAR-DYSTROPHY; ZINC-FINGER NUCLEASES; FIBROBLAST GROWTH FACTOR-2; HUMAN SOMATIC-CELLS; OF-THE-ART; IN-VIVO; KNOCKOUT PIGS; MOUSE MODEL; CRISPR-CAS9 SYSTEM	Genetic engineering of model organisms and cultured cells has for decades provided important insights into the mechanisms underlying cardiovascular development and disease. In the past few years the development of several nuclease systems has broadened the range of model/cell systems that can be engineered. Of these, the CRISPR (clustered regularly interspersed short palindromic repeats)/Cas9 (CRISPR-associated protein 9) system has become the favorite for its ease of application. Here we will review this RNA-guided nuclease system for gene editing with respect to its usefulness for cardiovascular studies and with an eye toward potential therapy. Studies on its off-target activity, along with approaches to minimize this activity will be given. The advantages of gene editing versus gene targeting in embryonic stem cells, including the breadth of species and cell types to which it is applicable, will be discussed. We will also cover its use in iPSC for research and possible therapeutic purposes; and we will review its use in muscular dystrophy studies where considerable progress has been made toward dystrophin correction in mice. The CRISPR/Ca9s system is also being used for high-throughput screening of genes, gene regulatory regions, and long noncoding RNAs. In addition, the CRISPR system is being used for nongene-editing purposes such as activation and inhibition of gene expression, as well as for fluorescence tagging of chromosomal regions and individual mRNAs to track their cellular location. Finally, an approach to circumvent the inability of post-mitotic cells to support homologous recombination-based gene editing will be presented. In conclusion, applications of the CRISPR/Cas system are expanding at a breath-taking pace and are revolutionizing approaches to gain a better understanding of human diseases.	[Doetschman, Thomas; Georgieva, Teodora] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Doetschman, Thomas] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA	Doetschman, T (reprint author), BIO5 Inst, Cellular & Mol Med, 1657 E Helen St, Tucson, AZ 85721 USA.	tdoetsch@u.arizona.edu			University of Arizona for Studies on Human Genetic Disorders; Genetically Engineered Mouse Models Core, BIO5 Institute, University of Arizona	Gift to University of Arizona for Studies on Human Genetic Disorders (T. Doetschman) and Genetically Engineered Mouse Models Core, BIO5 Institute, University of Arizona (T. Doetschman).	Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Azhar M, 2009, DEV DYNAM, V238, P351, DOI 10.1002/dvdy.21835; Bao L, 2014, SCI CHINA LIFE SCI, V57, P263, DOI 10.1007/s11427-013-4601-2; Beaudoin M, 2015, ARTERIOSCL THROM VAS, V35, P1472, DOI 10.1161/ATVBAHA.115.305534; Bertoni C, 2008, FRONT BIOSCI-LANDMRK, V13, P517, DOI 10.2741/2697; Bibikova M, 2002, GENETICS, V161, P1169; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boroviak K, 2016, GENESIS, V54, P78, DOI 10.1002/dvg.22915; Broughton KM, 2016, CIRC RES, V118, P867, DOI 10.1161/CIRCRESAHA.115.305227; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189                                                          ; Cao JL, 2016, DEVELOPMENT, V143, P232, DOI 10.1242/dev.130534; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chapman KM, 2015, CELL REP, V10, P1828, DOI 10.1016/j.celrep.2015.02.040; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen S, 2016, J BIOL CHEM, V291, P14457, DOI 10.1074/jbc.M116.733154; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen Y, 2016, J INTERN MED; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Deptula N, 2016, AM J PHYSIOL-LUNG C, V311, pL412, DOI 10.1152/ajplung.00181.2016; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; DOETSCHMAN T, 1988, DEV BIOL, V127, P224, DOI 10.1016/0012-1606(88)90204-7; Doetschman T, 2012, CIRC RES, V110, P1498, DOI 10.1161/CIRCRESAHA.112.265066; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Feng WY, 2015, INT J MOL SCI, V16, P6545, DOI 10.3390/ijms16036545; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Fishman GI, 1998, CIRC RES, V82, P837; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Garmy-Susini B, 2004, CIRC RES, V94, P1301, DOI 10.1161/01.RES.0000127719.13255.81; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; GRAVES KH, 1993, MOL REPROD DEV, V36, P424, DOI 10.1002/mrd.1080360404; Guan X, 2014, STEM CELL RES, V12, P467, DOI 10.1016/j.scr.2013.12.004; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hockemeyer D., 2010, COLD SPRING HARB SYM, V75, P201, DOI 10.1101/sqb.2010.75.021; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hofsteen P, 2016, P NATL ACAD SCI USA, V113, P1002, DOI 10.1073/pnas.1523930113; Horlbeck M. A., 2016, ELIFE, V5; Hotta A, 2015, ANNU REV GENET, V49, P47, DOI 10.1146/annurev-genet-112414-054926; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hulot JS, 2016, EUR HEART J, V37, P1651, DOI 10.1093/eurheartj/ehw019; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; IANNACCONE PM, 1994, DEV BIOL, V163, P288, DOI 10.1006/dbio.1994.1146; Intawicha P, 2016, THERIOGENOLOGY, V86, P1799, DOI 10.1016/j.theriogenology.2016.05.035; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Iyombe-Engembe JP, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.58; James J, 2016, CIRC RES, V118, P920, DOI 10.1161/CIRCRESAHA.116.308468; James JF, 1998, CIRC RES, V82, P407; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Jeziorowska D, 2015, EXPERT OPIN BIOL TH, V15, P1399, DOI 10.1517/14712598.2015.1064109; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johannesson B, 2014, CELL STEM CELL, V15, P634, DOI 10.1016/j.stem.2014.10.002; Kaneko T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142755; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Knollmann BC, 2013, CIRC RES, V112, P969, DOI 10.1161/CIRCRESAHA.112.300567; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kotani H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128319; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lewandowski J, 2017, J TISSUE ENG REGEN M, V11, P1658, DOI 10.1002/term.2117; Li DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015286; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Li MC, 2015, J PATHOL, V237, P249, DOI 10.1002/path.4565; Limpitikul WB, 2017, CIRC RES, V120, P39, DOI 10.1161/CIRCRESAHA.116.309283; Logan CV, 2015, AM J HUM GENET, V97, P878, DOI 10.1016/j.ajhg.2015.10.017; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lopes R, 2016, NAT REV MOL CELL BIO, V17, P597, DOI 10.1038/nrm.2016.79; Lu QL, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.6; Luo JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095225; Lv QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25029; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martinez-Galvez G, 2016, HUM GENE THER, V27, P419, DOI 10.1089/hum.2016.071; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Meek S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014225; Merkert S, 2016, STEM CELL RES, V16, P377, DOI 10.1016/j.scr.2016.02.027; Mitalipova M, 2001, Cloning, V3, P59, DOI 10.1089/15204550152475563; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Miyagawa S, 2016, CURR GENE THER, V16, P5, DOI 10.2174/1566523216666160119094143; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nguyen DP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12009; Niimi M, 2016, ATHEROSCLEROSIS, V245, P187, DOI 10.1016/j.atherosclerosis.2015.12.002; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Noel ES, 2016, HUM MUTAT, V37, P194, DOI 10.1002/humu.22928; NOTARIANNI E, 1991, J REPROD FERTIL, P255; Novodvorsky P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141611; Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Ousterout DG, 2015, MOL THER, V23, P523, DOI [10.1038/mt.2074.234, 10.1038/mt.2014.234]; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Ousterout DG, 2013, MOL THER, V21, P1718, DOI 10.1038/mt.2013.111; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perles Z, 2015, J MED GENET, V52, P840, DOI 10.1136/jmedgenet-2015-103336; Pioner JM, 2016, STEM CELL REP, V6, P885, DOI 10.1016/j.stemcr.2016.04.006; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Punnoose AR, 2016, PEDIATR CARDIOL, V37, P1290, DOI 10.1007/s00246-016-1432-5; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Ramos J, 2015, EXPERT OPIN ORPHAN D, V3, P1255, DOI 10.1517/21678707.2015.1088780; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; ROBBINS J, 1993, CIRC RES, V73, P3, DOI 10.1161/01.RES.73.1.3                                                           ; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Ross SB, 2016, TRENDS CARDIOVAS MED, V26, P663, DOI 10.1016/j.tcm.2016.05.001; Sakurai T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20011; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Scime A, 2008, MOL DIAGN THER, V12, P99, DOI 10.1007/BF03256275                                                              ; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Spencer HT, 2016, HAEMOPHILIA, V22, P66, DOI 10.1111/hae.13011; Suzuki H, 2016, P NATL ACAD SCI USA, V113, P7840, DOI 10.1073/pnas.1522054113; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan W, 2012, ADV GENET, V80, P37, DOI 10.1016/B978-0-12-404742-6.00002-8; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang YM, 2014, J AM COLL CARDIOL, V64, P451, DOI 10.1016/j.jacc.2014.04.057; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wu M. L, 2016, SCI REP, V6; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yu JY, 2007, SCIENCE, V318, P1917, DOI [10.1126/science.1151526, 10.1126/science.1172482]; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Zacchigna S, 2014, CIRC RES, V114, P1827, DOI 10.1161/CIRCRESAHA.114.302331; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396; Zhong ZM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22953; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu S, 2016, NAT BIOTECHNOL; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23496	179	3	3	15	64	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7330	1524-4571		CIRC RES	Circ.Res.	MAR 3	2017	120	5					876	894		10.1161/CIRCRESAHA.116.309727				19	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	EM8WT	WOS:000395592500025	28254804				2018-01-05	
J	Li, B; Cui, GH; Shen, GA; Zhan, ZL; Huang, LQ; Chen, JC; Qi, XQ				Li, Bin; Cui, Guanghong; Shen, Guoan; Zhan, Zhilai; Huang, Luqi; Chen, Jiachun; Qi, Xiaoquan			Targeted mutagenesis in the medicinal plant Salvia miltiorrhiza	SCIENTIFIC REPORTS			English	Article							AGROBACTERIUM-RHIZOGENES; HAIRY ROOT; BIOSYNTHESIS; TANSHINONES; EXPRESSION; BACTERIA; PLASMID; PATHWAY; ARCHAEA; SYSTEMS	CRISPR/Cas9 is a powerful genome editing tool that has been extensively used in model plants and crops, such as Arabidopsis thaliana, rice, wheat, and soybean. Here, we report the use of CRISPR/ Cas9 to precisely knock out the committed diterpene synthase gene ( SmCPS1) involved in tanshinone biosynthesis in Salvia miltiorrhiza, a traditional Chinese medicinal herb with significant pharmacological activities, such as vasorelaxation, protection against ischemia-reperfusion injury, and antiarrhythmic effects. Three homozygous and eight chimeric mutants were obtained from 26 independent transgenic hairy root lines by Agrobacterium rhizogenes-mediated transformation. The metabolomic analysis based on LC-qTOF-MS and Q-TRAP-LC-MS/MS revealed that tanshinones, especially cryptotanshinone, tanshinone IIA and tanshinone I, are completely missing in homozygous mutants, without influencing other phenolic acid metabolites. By contrast, tanshinones are decreased but still detectable in chimeric mutants, which is similar to a previously-reported an RNAi study of SmCPS1. These results demonstrate that Agrobacterium rhizogenes-mediated transformation using CRISPR/Cas9 is a simple and efficient genome editing tool in S. miltiorrhiza, thus paving the way for large-scale genome editing in S. miltiorrhiza, which is important for pathway elucidation of secondary metabolites, quality improvement, and yield increases for this valuable traditional Chinese medicinal herb.	[Li, Bin; Chen, Jiachun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Hubei Key Lab Nat Med Chem & Resource Evaluat, Wuhan 430030, Peoples R China; [Li, Bin; Shen, Guoan; Qi, Xiaoquan] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China; [Cui, Guanghong; Zhan, Zhilai; Huang, Luqi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing 100700, Peoples R China	Chen, JC (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Hubei Key Lab Nat Med Chem & Resource Evaluat, Wuhan 430030, Peoples R China.; Qi, XQ (reprint author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China.	homespringchen@126.com; xqi@ibcas.ac.cn			Key Project of Chinese National Programs for Fundamental Research and Development [2013CB127000]; Chinese National Programs for High Technology Research and Development [2012AA10A304]	We thank Botao Zhang for providing basic vectors of CRISPR/Cas9, Bin Han for technical assistance with LC-MS analysis. No conflicts of interest declared. This work was partially supported by the Key Project of Chinese National Programs for Fundamental Research and Development (2013CB127000) and by the Chinese National Programs for High Technology Research and Development (2012AA10A304).	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Altvorst AC, 1992, PLANT SCI, V83, P77; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Cheng QQ, 2014, BIOTECHNOL LETT, V36, P363, DOI 10.1007/s10529-013-1358-4; CHILTON MD, 1982, NATURE, V295, P432, DOI 10.1038/295432a0; Cui GH, 2015, PLANT PHYSIOL, V169, P1607, DOI 10.1104/pp.15.00695; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Guo J, 2016, NEW PHYTOL, V210, P525, DOI 10.1111/nph.13790; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Liu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090646; Luo HM, 2014, PHYSIOL PLANTARUM, V152, P241, DOI 10.1111/ppl.12193; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; MOORE L, 1979, PLASMID, V2, P617, DOI 10.1016/0147-619X(79)90059-3                                                    ; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108                                                              ; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Sana Theodore R, 2008, J Biomol Tech, V19, P258; [史金铭 SHI Jin-ming], 2009, [生物学杂志, Journal of Biology], V26, P74; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; WHITE FF, 1980, J BACTERIOL, V141, P1134; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xu HB, 2016, MOL PLANT, V9, P949, DOI 10.1016/j.molp.2016.03.010; Xu P, 2006, PLANT PHYSIOL, V142, P429, DOI 10.1104/pp.106.083295; Xu ZC, 2015, PLANT J, V82, P951, DOI 10.1111/tpj.12865; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; [Anonymous], 1993, BIOTECHNIQUES, V14, P748	31	3	3	10	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 3	2017	7								43320	10.1038/srep43320				9	Multidisciplinary Sciences	Science & Technology - Other Topics	EM4ML	WOS:000395287000001	28256553	gold			2018-01-05	
J	Ferry, QRV; Lyutova, R; Fulga, TA				Ferry, Quentin R. V.; Lyutova, Radostina; Fulga, Tudor A.			Rational design of inducible CRISPR guide RNAs for de novo assembly of transcriptional programs	NATURE COMMUNICATIONS			English	Article							ANTISENSE OLIGONUCLEOTIDES; MAMMALIAN-CELLS; CAS9; DNA; SYSTEM; ENDONUCLEASE; THERAPEUTICS; RECOGNITION; ACTIVATION; EVOLUTION	CRISPR-based transcription regulators (CRISPR-TRs) have transformed the current synthetic biology landscape by allowing specific activation or repression of any target gene. Here we report a modular and versatile framework enabling rapid implementation of inducible CRISPR-TRs in mammalian cells. This strategy relies on the design of a spacer-blocking hairpin (SBH) structure at the 50 end of the single guide RNA (sgRNA), which abrogates the function of CRISPR-transcriptional activators. By replacing the SBH loop with ligand-controlled RNA-cleaving units, we demonstrate conditional activation of quiescent sgRNAs programmed to respond to genetically encoded or externally delivered triggers. We use this system to couple multiple synthetic and endogenous target genes with specific inducers, and assemble gene regulatory modules demonstrating parallel and orthogonal transcriptional programs. We anticipate that this `plug and play' approach will be a valuable addition to the synthetic biology toolkit, facilitating the understanding of natural gene circuits and the design of cell-based therapeutic strategies.	[Ferry, Quentin R. V.; Lyutova, Radostina; Fulga, Tudor A.] Univ Oxford, Radcliffe Dept Med, Weatherall Inst Mol Med, Oxford OX3 9DS, England	Fulga, TA (reprint author), Univ Oxford, Radcliffe Dept Med, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	tudor.fulga@imm.ox.ac.uk		Fulga, Tudor/0000-0002-1056-0082	Wellcome Trust; MRC [G0902418]; BBSRC [BB/N006550/1]; Wellcome Trust ISSF [105605/Z/14/Z]	We thank Kevin Clark and Paul Sopp (WIMM) for help with the flow cytometry experiments, and Toni A. Baeumler, Mike Barnkob, Andrew Bassett, Diana Chin, Yale S. Michaels, Bruno R. Steinkraus, Markus Toegel and Qianxin Wu for providing critical comments on the manuscript. Q.R.V.F. is supported by a Wellcome Trust PhD studentship. R.L. was a visiting student under Erasmus+ program from the University of Wuerzburg. T.A.F. is supported by MRC (G0902418), BBSRC (BB/N006550/1) and Wellcome Trust ISSF (105605/Z/14/Z).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Auslander S, 2010, MOL BIOSYST, V6, P807, DOI 10.1039/b923076a; Auslander S., 2016, COLD SPRING HARB PER; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/nmeth.2926, 10.1038/NMETH.2926]; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Ding Y, 2001, NUCLEIC ACIDS RES, V29, P1034, DOI 10.1093/nar/29.5.1034; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0                                                                ; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jusiak B, 2016, TRENDS BIOTECHNOL, V34, P535, DOI 10.1016/j.tibtech.2015.12.014; Klauser B, 2015, ACS SYNTH BIOL, V4, P516, DOI 10.1021/sb500062p; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Liang XH, 2016, NAT BIOTECHNOL, V34, P875, DOI 10.1038/nbt.3589; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Liu YC, 2016, NAT METHODS, V13, P938, DOI [10.1038/NMETH.3994, 10.1038/nmeth.3994]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Niewoehner O, 2014, NUCLEIC ACIDS RES, V42, P1341, DOI 10.1093/nar/gkt922; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scherr M, 2000, NUCLEIC ACIDS RES, V28, P2455, DOI 10.1093/nar/28.13.2455; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; WALDER RY, 1988, P NATL ACAD SCI USA, V85, P5011, DOI 10.1073/pnas.85.14.5011                                                         ; Wieland M, 2008, ANGEW CHEM INT EDIT, V47, P2604, DOI 10.1002/anie.200703700; Wieland M, 2012, METHODS, V56, P351, DOI 10.1016/j.ymeth.2012.01.005; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	41	2	2	4	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAR 3	2017	8								14633	10.1038/ncomms14633				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EN8UO	WOS:000396275500001	28256578	gold			2018-01-05	
J	Hallmann, AL; Arauzo-Bravo, MJ; Mavrommatis, L; Ehrlich, M; Ropke, A; Brockhaus, J; Missler, M; Sterneckert, J; Scholer, HR; Kuhlmann, T; Zaehres, H; Hargus, G				Hallmann, Anna-Lena; Arauzo-Bravo, Marcos J.; Mavrommatis, Lampros; Ehrlich, Marc; Roepke, Albrecht; Brockhaus, Johannes; Missler, Markus; Sterneckert, Jared; Schoeler, Hans R.; Kuhlmann, Tanja; Zaehres, Holm; Hargus, Gunnar			Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein	SCIENTIFIC REPORTS			English	Article							IN-VITRO; NEURODEGENERATIVE DISEASES; SURVIVAL; MUTATION; BRAIN; EXPRESSION; NEURONS; SYSTEM; ALS	Astroglial pathology is seen in various neurodegenerative diseases including frontotemporal dementia (FTD), which can be caused by mutations in the gene encoding the microtubule-associated protein TAU (MAPT). Here, we applied a stem cell model of FTD to examine if FTD astrocytes carry an intrinsic propensity to degeneration and to determine if they can induce non-cell-autonomous effects in neighboring neurons. We utilized CRISPR/Cas9 genome editing in human induced pluripotent stem (iPS) cell-derived neural progenitor cells (NPCs) to repair the FTD-associated N279K MAPT mutation. While astrocytic differentiation was not impaired in FTD NPCs derived from one patient carrying the N279K MAPT mutation, FTD astrocytes appeared larger, expressed increased levels of 4R-TAU isoforms, demonstrated increased vulnerability to oxidative stress and elevated protein ubiquitination and exhibited disease-associated changes in transcriptome profiles when compared to astrocytes derived from one control individual and to the isogenic control. Interestingly, co-culture experiments with FTD astrocytes revealed increased oxidative stress and robust changes in whole genome expression in previously healthy neurons. Our study highlights the utility of iPS cell-derived NPCs to elucidate the role of astrocytes in the pathogenesis of FTD.	[Hallmann, Anna-Lena; Mavrommatis, Lampros; Ehrlich, Marc; Schoeler, Hans R.; Zaehres, Holm; Hargus, Gunnar] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Hallmann, Anna-Lena; Ehrlich, Marc; Kuhlmann, Tanja; Hargus, Gunnar] Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany; [Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Grp Computat Biol & Syst Biomed, San Sebastian 20014, Spain; [Arauzo-Bravo, Marcos J.] Ikerbasque, Basque Fdn Sci, Bilbao 48011, Spain; [Mavrommatis, Lampros; Zaehres, Holm] Ruhr Univ Bochum, Fac Med, Dept Anat & Mol Embryol, D-44801 Bochum, Germany; [Roepke, Albrecht] Univ Munster, Inst Human Genet, D-48149 Munster, Germany; [Brockhaus, Johannes; Missler, Markus] Univ Munster, Inst Anat & Mol Neurobiol, D-48149 Munster, Germany; [Sterneckert, Jared] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, D-01307 Dresden, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Hargus, Gunnar] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, York, NY 10032 USA	Zaehres, H; Hargus, G (reprint author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.; Hargus, G (reprint author), Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany.; Zaehres, H (reprint author), Ruhr Univ Bochum, Fac Med, Dept Anat & Mol Embryol, D-44801 Bochum, Germany.; Hargus, G (reprint author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, York, NY 10032 USA.	holm.zaehres@mpi-muenster.mpg.de; gh2374@cumc.columbia.edu		Sterneckert, Jared/0000-0002-7688-3124; Scholer, Hans/0000-0003-2643-5136	IMF at University Hospital Munster [I-HA-111219]; Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia [005-1403-0107]; DFG [SFB-TRR128-B7]; Max Planck Society	We would like to thank Ingrid Gelker, Martina Sinn, Martin Stehling, Elke Hoffmann and Claudia Kemming for outstanding technical assistance. We further acknowledge the participation of Jihye Park and Danbi Song, Jeong Beom Kim laboratory, UNIST, Ulsan, South Korea in the course of this project. This study was supported by research funding from the IMF at University Hospital Munster to GH (I-HA-111219), the Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia to HZ (Stem Cell Factory II, 005-1403-0107), from the DFG to TK (SFB-TRR128-B7) and the Max Planck Society to HS.	Angelucci F, 2014, CAN J PHYSIOL PHARM, V92, P621, DOI 10.1139/cjpp-2014-0099; Boxer AL, 2005, ALZ DIS ASSOC DIS, V19, pS3, DOI 10.1097/01.wad.0000183086.99691.91                                              ; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Ehrlich M, 2015, STEM CELL REP, V5, P83, DOI 10.1016/j.stemcr.2015.06.001; Fong H, 2013, STEM CELL REP, V1, P226, DOI 10.1016/j.stemcr.2013.08.001; Fuchs J, 2012, EUR J NEUROSCI, V35, P1837, DOI 10.1111/j.1460-9568.2012.08139.x; Galvin JE, 2006, ACTA NEUROPATHOL, V112, P665, DOI 10.1007/s00401-006-0147-8; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Goedert M, 2011, J MOL NEUROSCI, V45, P425, DOI 10.1007/s12031-011-9593-4; Hargus G, 2014, CELL REP, V8, P1697, DOI 10.1016/j.celrep.2014.08.014; Iovino M, 2015, BRAIN, V138, DOI 10.1093/brain/awv222; Iovino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013947; Jansen AHP, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00073; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kalman M., 2001, Neurobiology (Budapest), V9, P139, DOI 10.1556/Neurob.9.2001.3-4.1; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Lam AGM, 2001, NEUROBIOL AGING, V22, P765, DOI 10.1016/S0197-4580(01)00233-0                                                   ; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo M, 2013, SEMIN THROMB HEMOST, V39, P338, DOI 10.1055/s-0033-1334143; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Noble W, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00083; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Rabinovich-Nikitin I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0587-6; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Slowinski J, 2007, NEUROPATHOLOGY, V27, P73, DOI 10.1111/j.1440-1789.2006.00742.x; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	32	3	3	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 3	2017	7						1	10	42991	10.1038/srep42991				10	Multidisciplinary Sciences	Science & Technology - Other Topics	EM4KC	WOS:000395280900001	28256506	gold			2018-01-05	
J	Xiong, H; Liu, DB; Li, QY; Lei, MY; Xu, LQ; Wu, L; Wang, ZJ; Ren, SC; Li, WS; Xia, M; Lu, LH; Lu, HR; Hou, Y; Zhu, SD; Liu, X; Sun, YH; Wang, J; Yang, HM; Wu, K; Xu, X; Lee, LJ				Xiong, Heng; Liu, Dongbing; Li, Qiye; Lei, Mengyue; Xu, Liqin; Wu, Liang; Wang, Zongji; Ren, Shancheng; Li, Wangsheng; Xia, Min; Lu, Lihua; Lu, Haorong; Hou, Yong; Zhu, Shida; Liu, Xin; Sun, Yinghao; Wang, Jian; Yang, Huanming; Wu, Kui; Xu, Xun; Lee, Leo J.			RED-ML: a novel, effective RNA editing detection method based on machine learning	GIGASCIENCE			English	Article						RNA editing; A-to-I editing; RNA-seq; posttranscriptional modification; machine learning	HUMAN-DISEASE; SEQ DATA; SITES; IDENTIFICATION; ADARS; TRANSCRIPTOME; LANDSCAPE; ALIGNER; CANCER	With the advancement of second generation sequencing techniques, our ability to detect and quantify RNA editing on a global scale has been vastly improved. As a result, RNA editing is now being studied under a growing number of biological conditions so that its biochemical mechanisms and functional roles can be further understood. However, a major barrier that prevents RNA editing from being a routine RNA-seq analysis, similar to gene expression and splicing analysis, for example, is the lack of user-friendly and effective computational tools. Based on years of experience of analyzing RNA editing using diverse RNA-seq datasets, we have developed a software tool, RED-ML: RNA Editing Detection based on Machine learning (pronounced as "red ML"). The input to RED-ML can be as simple as a single BAM file, while it can also take advantage of matched genomic variant information when available. The output not only contains detected RNA editing sites, but also a confidence score to facilitate downstream filtering. We have carefully designed validation experiments and performed extensive comparison and analysis to show the efficiency and effectiveness of RED-ML under different conditions, and it can accurately detect novel RNA editing sites without relying on curated RNA editing databases. We have also made this tool freely available via GitHub <https://github.com/BGIRED/RED-ML>. We have developed a highly accurate, speedy and general-purpose tool for RNA editing detection using RNA-seq data. With the availability of RED-ML, it is now possible to conveniently make RNA editing a routine analysis of RNA-seq. We believe this can greatly benefit the RNA editing research community and has profound impact to accelerate our understanding of this intriguing posttranscriptional modification process.	[Xiong, Heng; Liu, Dongbing; Li, Qiye; Lei, Mengyue; Xu, Liqin; Wu, Liang; Wang, Zongji; Li, Wangsheng; Xia, Min; Lu, Lihua; Lu, Haorong; Hou, Yong; Zhu, Shida; Liu, Xin; Wang, Jian; Yang, Huanming; Wu, Kui; Xu, Xun; Lee, Leo J.] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Xiong, Heng; Liu, Dongbing; Li, Qiye; Lei, Mengyue; Xu, Liqin; Wu, Liang; Wang, Zongji; Li, Wangsheng; Xia, Min; Lu, Lihua; Lu, Haorong; Hou, Yong; Zhu, Shida; Liu, Xin; Wu, Kui; Xu, Xun] BGI Shenzhen, China Natl GeneBank Shenzhen, Shenzhen 518083, Peoples R China; [Ren, Shancheng; Sun, Yinghao] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Hou, Yong; Zhu, Shida; Wu, Kui] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Wang, Jian; Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Lee, Leo J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada	Lee, LJ (reprint author), Univ Toronto, Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada.; Xu, X (reprint author), China Natl GeneBank CNGB, Jinsha Rd, Shenzhen 518120, Peoples R China.	xuxun@genomics.cn; ljlee@psi.toronto.edu		Liu, Xin/0000-0003-3256-2940	Shenzhen Peacock Plan [KQTD20150330171505310]	This project was supported by the Shenzhen Peacock Plan (no. KQTD20150330171505310). We are indebted to colleagues of Beijing Genomics Institute who contributed to this work but were not included in the author list. We also thank Dr. Laurie Goodman and Dr. Scott Edmunds for their valuable suggestions.	Ahn J, 2015, BIOINFORMATICS, V31, P3906, DOI 10.1093/bioinformatics/btv505; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; Bass B, 2012, NAT BIOTECHNOL, V30, P1207, DOI 10.1038/nbt.2452; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Bishop C.M., 2006, PATTERN RECOGNITION; Daniel C, 2015, BIOCHIMIE, V117, P22, DOI 10.1016/j.biochi.2015.05.020; Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Galeano F, 2012, SEMIN CELL DEV BIOL, V23, P244, DOI 10.1016/j.semcdb.2011.09.003; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee JH, 2013, RNA, V19, P725, DOI 10.1261/rna.037903.112; Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539; Li QY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5943; Liu H, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-44; Nigita Giovanni, 2015, Front Bioeng Biotechnol, V3, P37, DOI 10.3389/fbioe.2015.00037; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; Rieder LE, 2012, SEMIN CELL DEV BIOL, V23, P281, DOI 10.1016/j.semcdb.2011.11.004; Sakurai M, 2014, GENOME RES, V24, P522, DOI 10.1101/gr.162537.113; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Tomaselli S, 2014, CELL TISSUE RES, V356, P527, DOI 10.1007/s00441-014-1863-3; Wang ZJ, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0143-4; Xiong H, 2017, GIGASCIENCE DATABASE; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yuan YX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2745-8; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]	34	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-217X			GIGASCIENCE	GigaScience	MAR 2	2017	6	5								10.1093/gigascience/gix012				8	Multidisciplinary Sciences	Science & Technology - Other Topics	EY1JC	WOS:000403721200001		gold			2018-01-05	
J	Kim, E; Hurtz, C; Koehrer, S; Wang, ZQ; Balasubramanian, S; Chang, BY; Muschen, M; Davis, RE; Burger, JA				Kim, Ekaterina; Hurtz, Christian; Koehrer, Stefan; Wang, Zhiqiang; Balasubramanian, Sriram; Chang, Betty Y.; Muschen, Markus; Davis, R. Eric; Burger, Jan A.			Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK	BLOOD			English	Article							BRUTONS TYROSINE KINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; BONE-MARROW; T-LYMPHOCYTES; STROMAL CELLS; RECEPTOR; EXPRESSION; PCI-32765; SURVIVAL; MIGRATION	Targeting B-cell receptor (BCR) signaling is a successful therapeutic strategy in mature B-cell malignancies. Precursor BCR (pre-BCR) signaling, which is critical during normal B lymphopoiesis, also plays an important role in pre-BCR+ B cell acute lymphoblastic leukemia (B-ALL). Here, we investigated the activity and mechanism of action of the BTK inhibitor ibrutinib in preclinical models of B-ALL. Pre-BCR+ ALL cells were exquisitely sensitive to ibrutinib at therapeutically relevant drug concentrations. In pre-BCR+ ALL, ibrutinib thwarted autonomous and induced pre-BCR signaling, resulting in deactivation of PI3K/Akt signaling. Ibrutinib modulated the expression of pre-BCR regulators (PTPN6, CD22, CD72, and PKC beta) and substantially reduced BCL6 levels. Ibrutinib inhibited ALL cell migration toward CXCL12 and beneath marrow stromal cells and reduced CD44 expression. CRISPR-Cas9 gene editing revealed that both BTK and B lymphocyte kinase (BLK) are relevant targets of ibrutinib in pre-BCR+ ALL. Consequently, in mouse xenograft models of pre-BCR+ ALL, ibrutinib treatment significantly prolonged survival. Combination treatment of ibrutinib with dexamethasone or vincristine demonstrated synergistic activity against pre-BCR+ ALL. These data corroborate ibrutinib as a promising targeted agent for pre-BCR+ ALL and highlight the importance of ibrutinib effects on alternative kinase targets. (Blood. 2017; 129(9): 1155-1165)	[Kim, Ekaterina; Koehrer, Stefan; Burger, Jan A.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Unit 428,POB 301402, Houston, TX 77230 USA; [Hurtz, Christian; Muschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Hurtz, Christian] Univ Penn, Dept Med, Div Hematol & Oncol, Philadelphia, PA 19104 USA; [Koehrer, Stefan] Univ Ulm, Med Ctr, Dept Pediat & Adolescent Med, Ulm, Germany; [Wang, Zhiqiang; Davis, R. Eric] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Balasubramanian, Sriram] Janssen Res & Dev LLC, Spring House, PA USA; [Chang, Betty Y.] Pharmacyclics Inc, Sunnyvale, CA USA	Burger, JA (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Unit 428,POB 301402, Houston, TX 77230 USA.	jaburger@mdanderson.org			Leukemia & Lymphoma Society Scholar Award in Clinical Research; Janssen Research Development; Anderson Cancer Center Support Grant [CA016672]; Cancer Center Support Grant; National Institutes of Health National Cancer Institute [CA016672]; National Institutes of Health through Anderson Cancer Center Support Grant [CA016672]	The work was supported by a Leukemia & Lymphoma Society Scholar Award in Clinical Research (J.A.B.), and by Janssen Research & Development. This research is also supported in part by the Anderson Cancer Center Support Grant CA016672. STR DNA fingerprinting was done by the Cancer Center Support Grant-funded Characterized Cell Line core, National Institutes of Health National Cancer Institute CA016672. Cell sorting was performed in the Flow Cytometry & Cellular Imaging Facility, which is supported in part by the National Institutes of Health through Anderson Cancer Center Support Grant CA016672.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Anbazhagan K, 2013, IMMUN INFLAMM DIS, V1, P26, DOI 10.1002/iid3.4; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P4204, DOI 10.1073/pnas.91.10.4204; Bernard S, 2015, INT J CANCER, V136, P2761, DOI 10.1002/ijc.29326; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Buggy JJ, 2012, INT REV IMMUNOL, V31, P119, DOI 10.3109/08830185.2012.664797; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 1999, BLOOD, V94, P3658; Burger JA, 2014, CURR HEMATOL MALIG R, V9, P44, DOI 10.1007/s11899-013-0188-8; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; Chang BY, 2013, BLOOD, V122, P2412, DOI 10.1182/blood-2013-02-482125; Daver N, 2013, CURR HEMATOL MALIG R, V8, P123, DOI 10.1007/s11899-013-0160-7; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Feldhahn N, 2005, P NATL ACAD SCI USA, V102, P13266, DOI 10.1073/pnas.0505196102; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; GENEVIER HC, 1994, EUR J IMMUNOL, V24, P3100, DOI 10.1002/eji.1830241228; Geng HM, 2015, CANCER CELL, V27, P409, DOI 10.1016/j.ccell.2015.02.003; Goodman PA, 2003, LEUKEMIA LYMPHOMA, V44, P1011, DOI 10.1080/1042819031000067576; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Hendriks RW, 2006, SEMIN IMMUNOL, V18, P67, DOI 10.1016/j.smim.2005.10.002; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hunger SP, 1996, BLOOD, V87, P1211; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; KATZ FE, 1994, LEUKEMIA, V8, P574; Klein F, 2006, ONCOGENE, V25, P1118, DOI 10.1038/sj.onc.1209133; Klein F, 2004, J EXP MED, V199, P673, DOI 10.1084/jem.20031637; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Kohrer S, 2016, LEUKEMIA, V30, P1246, DOI 10.1038/leu.2016.9; Lannine BR, 2014, NAT CHEM BIOL, V10, P760, DOI [10.1038/NCHEMBIO.1582, 10.1038/nchembio.1582]; Ma WC, 2010, CANCER EPIDEM BIOMAR, V19, P2445, DOI 10.1158/1055-9965.EPI-10-0565; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nahar R, 2011, BLOOD, V118, P4174, DOI 10.1182/blood-2011-01-331181; Nisitani S, 2000, P NATL ACAD SCI USA, V97, P2737, DOI 10.1073/pnas.050583597; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; Pillinger G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12949; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Rushworth SA, 2015, LANCET HAEMATOL, V2, pE204, DOI 10.1016/S2352-3026(15)00046-0; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1111/j.1600-065X.2000.imr017504.x; Sivina M, 2014, BRIT J HAEMATOL, V166, P177, DOI 10.1111/bjh.12867; SMITH CIE, 1994, J IMMUNOL, V152, P557; Tai YT, 2012, BLOOD, V120, P1877, DOI 10.1182/blood-2011-12-396853; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; van der Veer A, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.5; Young RM, 2013, NAT REV DRUG DISCOV, V12, P229, DOI 10.1038/nrd3937; Zaitseva L, 2014, ONCOTARGET, V5, P9930, DOI 10.18632/oncotarget.2479                                                        ; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhou Y, 2012, HUM PATHOL, V43, P1347, DOI 10.1016/j.humpath.2012.02.004	58	2	2	5	12	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	MAR 2	2017	129	9					1155	1165		10.1182/blood-2016-06-722900				11	Hematology	Hematology	EP1JZ	WOS:000397142500016	28031181				2018-01-05	
J	Lim, JS; Gopalappa, R; Kim, SH; Ramakrishna, S; Lee, M; Kim, WI; Kim, J; Park, SM; Lee, J; Oh, JH; Kim, HD; Park, CH; Lee, JS; Kim, S; Kim, DS; Han, JM; Kang, HC; Kim, HH; Lee, JH				Lim, Jae Seok; Gopalappa, Ramu; Kim, Se Hoon; Ramakrishna, Suresh; Lee, Minji; Kim, Woo-il; Kim, Junho; Park, Sang Min; Lee, Junehawk; Oh, Jung-Hwa; Kim, Heung Dong; Park, Chang-Hwan; Lee, Joon Soo; Kim, Sangwoo; Kim, Dong Seok; Han, Jung Mm; Kang, Hoon-Chul; Kim, Hyongbum (Henry); Lee, Jeong Ho			Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUBEROUS SCLEROSIS COMPLEX; MAMMALIAN TARGET; CELL-GROWTH; IN-VIVO; MTOR; EPILEPSY; BRAIN; MALFORMATIONS; PATHWAY; CRISPR-CAS9	Focal cortical dysplasia (FCD) is a major cause of the sporadic form of intractable focal epilepsies that require surgical treatment. It has recently been reported that brain somatic mutations in MTOR account for 15%-25% of FCD type II (FCDII), characterized by cortical dyslamination and dysmorphic neurons. However, the genetic etiologies of FCDII-affected individuals who lack the MTOR mutation remain unclear. Here, we performed deep hybrid capture and amplicon sequencing (read depth of 100 x-20,012 x) of five important mTOR pathway genes-PIK3CA, PIK3R2, AKT3, TSC1, and TSC2-by using paired brain and saliva samples from 40 FCDII individuals negative for MTOR mutations. We found that 5 of 40 individuals (12.5%) had brain somatic mutations in TSC1 (c.64C>T [p.Arg22Trp] and c.610C>T [p.Arg204Cys]) and TSC2 (c.4639G>A [p.Va11547I1e]), and these results were reproducible on two different sequencing platforms. All identified mutations induced hyperactivation of the mTOR pathway by disrupting the formation or function of the TSC1TSC2 complex. Furthermore, in utero CRISPR-Cas9-mediated genome editing of Tsc1 or Tsc2 induced the development of spontaneous behavioral seizures, as well as cytomegalic neurons and cortical dyslamination. These results show that brain somatic mutations in TSC1 and TSC2 cause FCD and that in utero application of the CRISPR-Cas9 system is useful for generating neurodevelopmental disease models of somatic mutations in the brain.	[Lim, Jae Seok; Kim, Woo-il; Park, Sang Min; Lee, Jeong Ho] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Brain Korea Plus Project 21, Daejeon 34141, South Korea; [Gopalappa, Ramu; Ramakrishna, Suresh; Park, Chang-Hwan] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 04763, South Korea; [Gopalappa, Ramu; Kim, Hyongbum (Henry)] Yonsei Univ, Coll Med, Dept Pharmacol, Brain Korea Plus Project Med Sci 21,Grad Program, Seoul 03722, South Korea; [Kim, Se Hoon] Yonsei Univ, Dept Pathol, Coll Med, Seoul 03722, South Korea; [Lee, Minji; Han, Jung Mm] Yonsei Univ, Dept Integrated OMICS Biomed Sci, Seoul 03722, South Korea; [Han, Jung Mm] Yonsei Univ, Coll Pharm, Seoul 03722, South Korea; [Kim, Junho; Kim, Sangwoo; Kim, Hyongbum (Henry)] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul 03722, South Korea; [Lee, Junehawk] Korea Inst Sci & Technol Informat, Biomed HPC Technol Res Ctr, Daejeon 34141, South Korea; [Oh, Jung-Hwa] Korea Inst Toxicol, Dept Predict Toxicol, Daejeon 34114, South Korea; [Kim, Heung Dong; Lee, Joon Soo; Kang, Hoon-Chul] Yonsei Univ, Coll Med, Div Pediat Neurol,Epilepsy Res Inst, Dept Pediat,Pediat Epilepsy Clin,Severance Childr, Seoul 03722, South Korea; [Kim, Dong Seok] Yonsei Univ, Coll Med, Pediat Neurosurg, Severance Childrens Hosp,Dept Neurosurg, Seoul 03722, South Korea; [Kim, Hyongbum (Henry)] Yonsei Univ, Inst Basic Sci, Ctr Nanomed, Seoul 03722, South Korea	Lee, JH (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Brain Korea Plus Project 21, Daejeon 34141, South Korea.; Kim, HH (reprint author), Yonsei Univ, Coll Med, Dept Pharmacol, Brain Korea Plus Project Med Sci 21,Grad Program, Seoul 03722, South Korea.; Kim, HH (reprint author), Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul 03722, South Korea.; Kim, HH (reprint author), Yonsei Univ, Inst Basic Sci, Ctr Nanomed, Seoul 03722, South Korea.	hkim1@yuhs.ac; jhlee4246@kaist.ac.kr	Lee, Jeong Ho/G-7361-2012	Kim, Sangwoo/0000-0001-5356-0827; Kim, Hyongbum/0000-0002-4693-738X	Korean Health Technology R&D Project of the Korean Ministry of Health Welfare [H15C3143, H16C0415, HI14C1588, HI15C1601, HI14C2019]; Citizens United for Research in Epilepsy; Brain Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2013M3C7A1056564, 2015R1A2A1A15052668]; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT, and Future Planning	We thank Dr. Sun Min Park at the Korea Advanced Institute of Science and Technology (KAIST) for coordinating clinical information. This work was supported by the Korean Health Technology R&D Project of the Korean Ministry of Health & Welfare (grants H15C3143 and H16C0415 to J.H.L., HI14C1588 and HI15C1601 to H.C.K., and HI14C2019 to H.K.); Citizens United for Research in Epilepsy (J.H.L.); the Brain Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning (grants 2013M3C7A1056564 to J.H.L. and 2015R1A2A1A15052668 to H.K.); and the KAIST Future Systems Healthcare Project from the Ministry of Science, ICT, and Future Planning (J.H.L.).	An KS, 2007, GENET MED, V9, P88, DOI 10.1097/GIM.0b013e31803068c7; Aronica E, 2007, ACTA NEUROPATHOL, V114, P287, DOI 10.1007/s00401-007-0225-6; Bast T, 2006, ACTA NEUROL SCAND, V113, P72, DOI 10.1111/j.1600-0404.2005.00555.x; Baulac S, 2015, ANN NEUROL, V77, P675, DOI 10.1002/ana.24368; Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Blumcke I, 2009, EPILEPTIC DISORD, V11, P181, DOI 10.1684/epd.2009.0261; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costa-Mattioli M, 2013, NAT NEUROSCI, V16, P1537, DOI 10.1038/nn.3546; D'Gama AM, 2015, ANN NEUROL, V77, P720, DOI 10.1002/ana.24357; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fauser S, 2006, BRAIN, V129, P1907, DOI 10.1093/brain/awl133; Fauser S, 2004, BRAIN, V127, P2406, DOI 10.1093/brain/awh277; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hoogeveen-Westerveld M, 2012, HUM MUTAT, V33, P476, DOI 10.1002/humu.22007; Hoogeveen-Westerveld M, 2011, HUM MUTAT, V32, P424, DOI 10.1002/humu.21451; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Jansen LA, 2015, BRAIN, V138, P1613, DOI 10.1093/brain/awv045; Kalebic N, 2016, EMBO REP, V17, P338, DOI 10.15252/embr.201541715; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r90; Kim YH, 2011, EPILEPSIA, V52, P722, DOI 10.1111/j.1528-1167.2010.02950.x; Kim YH, 2014, METHODS, V69, P108, DOI 10.1016/j.ymeth.2014.04.012; Kuilman T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0617-1; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.53; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Lim JS, 2015, NAT MED, V21, P395, DOI 10.1038/nm.3824; Lin DC, 2014, NAT GENET, V46, P866, DOI 10.1038/ng.3006; Ljungberg MC, 2006, ANN NEUROL, V60, P420, DOI 10.1002/ana.20949; Lozovaya N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5563; Magri L, 2013, DIS MODEL MECH, V6, P1185, DOI 10.1242/dmm.012096; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Miyata H, 2004, ANN NEUROL, V56, P510, DOI 10.1002/ana.20234; Mozaffari M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-88; Nakashima M, 2015, ANN NEUROL, V78, P375, DOI 10.1002/ana.24444; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Qin W, 2010, HUM GENET, V127, P573, DOI 10.1007/s00439-010-0801-z; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ratan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055089; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Sim JC, 2016, ANN NEUROL, V79, P132, DOI 10.1002/ana.24502; Sisodiya SM, 2000, BRAIN, V123, P1075, DOI 10.1093/brain/123.6.1075                                                        ; Straub C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105584; Tassi L, 2002, BRAIN, V125, P1719, DOI 10.1093/brain/awf175; Tyburczy ME, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005637; Walsh R, 2016, GENET MED; Wong M., 2012, SOURCEJASPERS BASIC; Wong M, 2015, EPILEPSY CURR, V15, P129, DOI 10.5698/1535-7597-15.3.129; Zech R, 2016, J BIOL CHEM, V291, P20008, DOI 10.1074/jbc.M116.732446; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391	70	0	0	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					454	472		10.1016/j.ajhg.2017.01.030				19	Genetics & Heredity	Genetics & Heredity	EN2PH	WOS:000395851900012	28215400				2018-01-05	
J	Kotini, AG; Chang, CJ; Chow, A; Yuan, H; Ho, TC; Wang, TS; Vora, S; Solovyov, A; Husser, C; Olszewska, M; Teruya-Feldstein, J; Perumal, D; Klimek, VM; Spyridonidis, A; Rampal, RK; Silverman, L; Reddy, EP; Papaemmanuil, E; Parekh, S; Greenbaum, BD; Leslie, CS; Kharas, MG; Papapetrou, EP				Kotini, Andriana G.; Chang, Chan-Jung; Chow, Arthur; Yuan, Han; Ho, Tzu-Chieh; Wang, Tiansu; Vora, Shailee; Solovyov, Alexander; Husser, Chrystel; Olszewska, Malgorzata; Teruya-Feldstein, Julie; Perumal, Deepak; Klimek, Virginia M.; Spyridonidis, Alexandros; Rampal, Raajit K.; Silverman, Lewis; Reddy, E. Premkumar; Papaemmanuil, Elli; Parekh, Samir; Greenbaum, Benjamin D.; Leslie, Christina S.; Kharas, Michael G.; Papapetrou, Eirini P.			Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia	CELL STEM CELL			English	Article							MYELODYSPLASTIC SYNDROMES; CLONAL HEMATOPOIESIS; EXPRESSION PROFILES; CANCER PROGRESSION; PROGENITOR CELLS; GENERATION; MUTATIONS; DIFFERENTIATION; CLASSIFICATION; PROGNOSIS	Myeloid malignancy is increasingly viewed as a disease spectrum, comprising hematopoietic disorders that extend across a phenotypic continuum ranging from clonal hematopoiesis to myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this study, we derived a collection of induced pluripotent stem cell (iPSC) lines capturing a range of disease stages encompassing preleukemia, low-risk MDS, high-risk MDS, and secondary AML. Upon their differentiation, we found hematopoietic phenotypes of graded severity and/or stage specificity that together delineate a phenotypic roadmap of disease progression culminating in serially transplantable leukemia. We also show that disease stage transitions, both reversal and progression, can be modeled in this system using genetic correction or introduction of mutations via CRISPR/Cas9 and that this iPSC-based approach can be used to uncover disease-stage-specific responses to drugs. Our study therefore provides insight into the cellular events demarcating the initiation and progression of myeloid transformation and a new platform for testing genetic and pharmacological interventions.	[Kotini, Andriana G.; Chang, Chan-Jung; Wang, Tiansu; Vora, Shailee; Solovyov, Alexander; Husser, Chrystel; Olszewska, Malgorzata; Perumal, Deepak; Parekh, Samir; Greenbaum, Benjamin D.; Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Kotini, Andriana G.; Chang, Chan-Jung; Wang, Tiansu; Vora, Shailee; Solovyov, Alexander; Husser, Chrystel; Olszewska, Malgorzata; Perumal, Deepak; Silverman, Lewis; Reddy, E. Premkumar; Parekh, Samir; Greenbaum, Benjamin D.; Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Kotini, Andriana G.; Chang, Chan-Jung; Wang, Tiansu; Vora, Shailee; Husser, Chrystel; Olszewska, Malgorzata; Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Kotini, Andriana G.; Chang, Chan-Jung; Wang, Tiansu; Vora, Shailee; Solovyov, Alexander; Husser, Chrystel; Olszewska, Malgorzata; Perumal, Deepak; Silverman, Lewis; Reddy, E. Premkumar; Parekh, Samir; Greenbaum, Benjamin D.; Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Chow, Arthur; Ho, Tzu-Chieh; Kharas, Michael G.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY 10065 USA; [Chow, Arthur; Ho, Tzu-Chieh; Kharas, Michael G.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA; [Chow, Arthur; Ho, Tzu-Chieh; Kharas, Michael G.] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA; [Chow, Arthur; Ho, Tzu-Chieh; Kharas, Michael G.] Mem Sloan Kettering Canc Ctr, Ctr Expt Therapeut, New York, NY 10065 USA; [Yuan, Han; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Solovyov, Alexander; Teruya-Feldstein, Julie; Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Klimek, Virginia M.; Rampal, Raajit K.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Spyridonidis, Alexandros] Univ Patras, Sch Med, Patras 26504, Greece; [Papaemmanuil, Elli] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA	Papapetrou, EP (reprint author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Papapetrou, EP (reprint author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Papapetrou, EP (reprint author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.; Papapetrou, EP (reprint author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.; Kharas, MG (reprint author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY 10065 USA.; Kharas, MG (reprint author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA.; Kharas, MG (reprint author), Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA.; Kharas, MG (reprint author), Mem Sloan Kettering Canc Ctr, Ctr Expt Therapeut, New York, NY 10065 USA.	kharasm@mskcc.org; eirini.papapetrou@mssm.edu			NIH [R00DK087923, R01HL121570, R01DK101989, R01CA193842, P30CA008748]; Damon Runyon-Rachleff Innovation Award from the Damon Runyon Cancer Research Foundation [30-14]; Edward P. Evans Foundation; New Scholar in Aging Award from the Ellison Medical Foundation [AGS-NS-0984-13]; Henry and Marilyn Taub Foundation; Babich Family Foundation; Alex's Lemonade Stand Foundation; Kimmel Scholar Award; V-Scholar Award; Tri-Institutional Training Program in Computational Biology and Medicine (NIH) [T32GM083937]	This work was supported by NIH grants R00DK087923 and R01HL121570, Damon Runyon-Rachleff Innovation Award 30-14 from the Damon Runyon Cancer Research Foundation, the Edward P. Evans Foundation, New Scholar in Aging Award AGS-NS-0984-13 from the Ellison Medical Foundation, and research grants from the Henry and Marilyn Taub Foundation, the Babich Family Foundation, and Alex's Lemonade Stand Foundation (to E.P.P.). This work was also supported by NIH grants R01DK101989, R01CA193842, and P30CA008748, a Kimmel Scholar Award, and a V-Scholar Award (to M.G.K.). H.Y. was supported by the Tri-Institutional Training Program in Computational Biology and Medicine (NIH grant T32GM083937).	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Bejar R, 2014, BLOOD, V124, P2793, DOI 10.1182/blood-2014-04-522136; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collin M, 2015, BRIT J HAEMATOL, V169, P173, DOI 10.1111/bjh.13317; de Pater E, 2013, J EXP MED, V210, P2843, DOI 10.1084/jem.20130751; Elias HK, 2014, ONCOGENE, V33, P5139, DOI 10.1038/onc.2013.520; Flores-Figueroa E, 1999, LEUKEMIA RES, V23, P385, DOI 10.1016/S0145-2126(98)00176-3                                                   ; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8                                                   ; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kerbauy DB, 2007, EXP HEMATOL, V35, P1739, DOI 10.1016/j.exphem.2007.09.007; Kim J, 2015, EMBO J, V34, P739, DOI 10.15252/embj.201490736; Kim J, 2013, CELL REP, V3, P2088, DOI 10.1016/j.celrep.2013.05.036; Kotini AG, 2015, NAT BIOTECHNOL, V33, P646, DOI 10.1038/nbt.3178; Link DC, 2016, LEUKEMIA, V30, P1633, DOI 10.1038/leu.2016.130; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Pandolfi A, 2013, STEM CELL TRANSL MED, V2, P143, DOI 10.5966/sctm.2012-0109; Papaemmanuil E., 2013, BLOOD, V122, P3699; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Papapetrou EP, 2016, NAT MED, V22, P1392, DOI 10.1038/nm.4238; Papapetrou EP, 2011, NAT PROTOC, V6, P1251, DOI 10.1038/nprot.2011.374; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sato T, 1998, LEUKEMIA, V12, P1187, DOI 10.1038/sj.leu.2401084; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Sperling AS, 2017, NAT REV CANCER, V17, P5, DOI 10.1038/nrc.2016.112; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Themeli M, 2013, NAT BIOTECHNOL, V31, P928, DOI 10.1038/nbt.2678; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vo LT, 2015, BLOOD, V125, P2641, DOI 10.1182/blood-2014-10-570234; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Wlodarski MW, 2016, BLOOD, V127, P1387, DOI 10.1182/blood-2015-09-669937; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Woolthuis CM, 2016, BLOOD, V127, P1242, DOI 10.1182/blood-2015-07-607945; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733	49	6	6	2	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 2	2017	20	3					315	+		10.1016/j.stem.2017.01.009				21	Cell & Tissue Engineering; Cell Biology	Cell Biology	EO0GC	WOS:000396375300008	28215825				2018-01-05	
J	Eyquem, J; Mansilla-Soto, J; Giavridis, T; van der Stegen, SJC; Hamieh, M; Cunanan, KM; Odak, A; Gonen, M; Sadelain, M				Eyquem, Justin; Mansilla-Soto, Jorge; Giavridis, Theodoros; van der Stegen, Sjoukje J. C.; Hamieh, Mohamad; Cunanan, Kristen M.; Odak, Ashlesha; Goenen, Mithat; Sadelain, Michel			Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection	NATURE			English	Article							CHIMERIC ANTIGEN RECEPTORS; T-CELL EXHAUSTION; LYMPHOCYTES; EXPRESSION; DESIGN; PROLIFERATION; INTEGRATION; THERAPY; CD8(+); SITE	Chimeric antigen receptors (CARs) are synthetic receptors that redirect and reprogram T cells to mediate tumour rejection(1). The most successful CARs used to date are those targeting CD19 (ref. 2), which offer the prospect of complete remission in patients with chemorefractory or relapsed B-cell malignancies(3). CARs are typically transduced into the T cells of a patient using gamma-retroviral(4) vectors or other randomly integrating vectors(5), which may result in clonal expansion, oncogenic transformation, variegated transgene expression and transcriptional silencing(6-8). Recent advances in genome editing enable efficient sequence-specific interventions in human cells(9,10), including targeted gene delivery to the CCR5 and AAVS1 loci(11,12). Here we show that directing a CD19-specific CAR to the T-cell receptor a constant (TRAC) locus not only results in uniform CAR expression in human peripheral blood T cells, but also enhances T-cell potency, with edited cells vastly outperforming conventionally generated CAR T cells in a mouse model of acute lymphoblastic leukaemia. We further demonstrate that targeting the CAR to the TRAC locus averts tonic CAR signalling and establishes effective internalization and re-expression of the CAR following single or repeated exposure to antigen, delaying effector T-cell differentiation and exhaustion. These findings uncover facets of CAR immunobiology and underscore the potential of CRISPR/Cas9 genome editing to advance immunotherapies.	[Eyquem, Justin; Mansilla-Soto, Jorge; Giavridis, Theodoros; van der Stegen, Sjoukje J. C.; Hamieh, Mohamad; Odak, Ashlesha; Sadelain, Michel] Sloan Kettering Inst, Ctr Cell Engn, New York, NY 10065 USA; [Eyquem, Justin; Mansilla-Soto, Jorge; Giavridis, Theodoros; van der Stegen, Sjoukje J. C.; Hamieh, Mohamad; Odak, Ashlesha; Sadelain, Michel] Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA; [Cunanan, Kristen M.; Goenen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA	Sadelain, M (reprint author), Sloan Kettering Inst, Ctr Cell Engn, New York, NY 10065 USA.; Sadelain, M (reprint author), Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA.	m-sadelain@ski.mskcc.org		Giavridis, Theodoros/0000-0002-8716-781X	Lake Road Foundation; Commonwealth Foundation for Cancer Research; Stand Up To Cancer/American Association for Cancer Research; Lymphoma and Leukemia Society; NYSTEM; NYSCF; MSK Cancer Center [P30 CA008748]	We thank I. Riviere (MSKCC) for helpful discussion and for reviewing the manuscript. We thank the SKI Flow Cytometry core facility and animal facility for excellent support. This work was in part supported by the Lake Road Foundation, the Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, Stand Up To Cancer/American Association for Cancer Research (a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research), the Lymphoma and Leukemia Society, NYSTEM, NYSCF and the MSK Cancer Center Support Grant/Core Grant (P30 CA008748).	Allison KA, 2016, ELIFE, V5, DOI 10.7554/eLife.10134; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Corthay A, 2001, J AUTOIMMUN, V16, P423, DOI 10.1006/jaut.2001.0504; de Vree PJP, 2014, NAT BIOTECHNOL, V32, P1019, DOI 10.1038/nbt.2959; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Frigault MJ, 2015, CANCER IMMUNOL RES, V3, P356, DOI 10.1158/2326-6066.CIR-14-0186; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Gallardo HF, 1997, GENE THER, V4, P1115, DOI 10.1038/sj.gt.3300506; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gong Michael C., 1999, Neoplasia (New York), V1, P123, DOI 10.1038/sj.neo.7900018; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Jensen MC, 2015, CURR OPIN IMMUNOL, V33, P9, DOI 10.1016/j.coi.2015.01.002; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70                                                              ; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733                                                         ; Riviere I, 2012, BLOOD, V119, P1107, DOI 10.1182/blood-2011-09-349993; Sadelain M., 1992, 9 INT IMM C BUD, V88, P34; Sadelain M, 2015, J CLIN INVEST, V125, P3392, DOI 10.1172/JCI80010; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schrum AG, 2003, IMMUNOL REV, V196, P7, DOI 10.1046/j.1600-065X.2003.00083.x; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; von Kalle C, 2014, HUM GENE THER, V25, P475, DOI 10.1089/hum.2014.2525; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang XY, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.15; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	34	37	38	83	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2017	543	7643					113	+		10.1038/nature21405				19	Multidisciplinary Sciences	Science & Technology - Other Topics	EN0AA	WOS:000395671500043	28225754	green_accepted			2018-01-05	
J	Hale, M; Lee, B; Honaker, Y; Leung, WH; Grier, AE; Jacobs, HM; Sommer, K; Sahni, J; Jackson, SW; Scharenberg, AM; Astrakhan, A; Rawlings, DJ				Hale, Malika; Lee, Baeckseung; Honaker, Yuchi; Leung, Wai-Hang; Grier, Alexandra E.; Jacobs, Holly M.; Sommer, Karen; Sahni, Jaya; Jackson, Shaun W.; Scharenberg, Andrew M.; Astrakhan, Alexander; Rawlings, David J.			Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells	MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT			English	Article							NF-KAPPA-B; HEMATOPOIETIC STEM; MATURATION ANTIGEN; ANTITUMOR-ACTIVITY; MULTIPLE-MYELOMA; MESSENGER-RNA; IN-VIVO; HIV; EXPRESSION; CCR5	Gene editing by homology-directed recombination (HDR) can be used to couple delivery of a therapeutic gene cassette with targeted genomic modifications to generate engineered human T cells with clinically useful profiles. Here, we explore the functionality of therapeutic cassettes delivered by these means and test the flexibility of this approach to clinically relevant alleles. Because CCR5-negative T cells are resistant to HIV-1 infection, CCR5-negative anti-CD19 chimeric antigen receptor ( CAR) T cells could be used to treat patients with HIV-associated B cell malignancies. We show that targeted delivery of an anti-CD19 CAR cassette to the CCR5 locus using a recombinant AAV homology template and an engineered megaTAL nuclease results in T cells that are functionally equivalent, in both in vitro and in vivo tumor models, to CAR T cells generated by random integration using lentiviral delivery. With the goal of developing off-the-shelf CAR T cell therapies, we next targeted CARs to the T cell receptor alpha constant (TRAC) locus by HDR, producing TCR-negative anti-CD19 CAR and anti-B cell maturation antigen (BCMA) CAR T cells. These novel cell products exhibited in vitro cytolytic activity against both tumor cell lines and primary cell targets. Our combined results indicate that high-efficiency HDR delivery of therapeutic genes may provide a flexible and robust method that can extend the clinical utility of cell therapeutics.	[Hale, Malika; Honaker, Yuchi; Grier, Alexandra E.; Jacobs, Holly M.; Sommer, Karen; Sahni, Jaya; Jackson, Shaun W.; Scharenberg, Andrew M.; Rawlings, David J.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA; [Hale, Malika; Honaker, Yuchi; Sommer, Karen; Sahni, Jaya; Scharenberg, Andrew M.; Rawlings, David J.] Seattle Childrens Res Inst, Program Cell & Gene Therapy, Seattle, WA 98101 USA; [Lee, Baeckseung; Leung, Wai-Hang; Astrakhan, Alexander] Bluebird Bio, 1616 Eastlake Ave E,Suite 208, Seattle, WA 98102 USA; [Jackson, Shaun W.; Scharenberg, Andrew M.; Rawlings, David J.] Univ Washington, Dept Pediat, Seattle, WA 98101 USA; [Grier, Alexandra E.; Scharenberg, Andrew M.; Rawlings, David J.] Univ Washington, Dept Immunol, Seattle, WA 98101 USA	Astrakhan, A (reprint author), Bluebird Bio, 1616 Eastlake Ave E,Suite 208, Seattle, WA 98102 USA.; Astrakhan, A (reprint author), Seattle Childrens Res Inst, 1900 9th Ave,Mail Stop JMB-6, Seattle, WA 98101 USA.	sastrakhan@bluebirdbio.com; drawling@uw.edu		Jacobs, Holly/0000-0003-3250-8258	Seattle Children's Program for Cell and Gene Therapy; Center for Immunity and Immunotherapies and bluebird bio; Children's Guild Association Endowed Chair in Pediatric Immunology	We thank Michael Jensen and Cindy Chang at the Ben Towne Center for Childhood Cancer Research for use of the IVIS instrument. This work was supported by Seattle Children's Program for Cell and Gene Therapy and the Center for Immunity and Immunotherapies and bluebird bio. D.J.R. received support as a recipient of the Children's Guild Association Endowed Chair in Pediatric Immunology.	Ali SA, 2016, BLOOD, V128, P1688, DOI 10.1182/blood-2016-04-711903; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Carpenter RO, 2013, CLIN CANCER RES, V19, P2048, DOI 10.1158/1078-0432.CCR-12-2422; Castillo J, 2008, AM J HEMATOL, V83, P804, DOI 10.1002/ajh.21250; CHALLITA PM, 1995, J VIROL, V69, P748; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Dezube BJ, 2004, AIDS READ, V14, P377; Dezube Bruce J, 2004, AIDS Read, V14, P372; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; Fesnak AD, 2016, NAT REV CANCER, V16, P566, DOI 10.1038/nrc.2016.97; Grier Alexandra E, 2016, Mol Ther Nucleic Acids, V5, pe306, DOI 10.1038/mtna.2016.21; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gunthel CJ, 2016, CANCER-AM CANCER SOC, V122, P2621, DOI 10.1002/cncr.30110; Gwiazda KS, 2016, MOL THER, V24, P1570, DOI 10.1038/mt.2016.105; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoban MD, 2016, BLOOD, V127, P2525, DOI 10.1182/blood-2016-01-678151; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kebriaei P, 2016, J CLIN INVEST, V126, P3363, DOI 10.1172/JCI86721; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Maus MV, 2016, CLIN CANCER RES, V22, P1875, DOI 10.1158/1078-0432.CCR-15-1433; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morgan RA, 2014, CANCER J, V20, P145, DOI 10.1097/PPO.0000000000000033; Osborn MJ, 2016, MOL THER, V24, P570, DOI 10.1038/mt.2015.197; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Porteus MH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0859-y; Qasim W, 2015, BLOOD, V126, P2046; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064138; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Torikai H, 2016, MOL THER, V24, P1178, DOI 10.1038/mt.2016.106; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang XF, 2015, MOL THER, V23, P617, DOI 10.1038/mt.2015.20	43	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2329-0501			MOL THER-METH CLIN D	Mol.Ther.-Methods Clin. Dev.	MAR	2017	4						192	203		10.1016/j.omtm.2016.12.008				12	Medicine, Research & Experimental	Research & Experimental Medicine	EP5YJ	WOS:000397454700018	28345004	gold			2018-01-05	
J	Flavell, RB				Flavell, Richard B.			Innovations continuously enhance crop breeding and demand new strategic planning	GLOBAL FOOD SECURITY-AGRICULTURE POLICY ECONOMICS AND ENVIRONMENT			English	Article						Crop improvement; Genomics; Microbes; Genome editing; Strategic leadership and planning	GENETICALLY-ENGINEERED PLANTS; GENOME-WIDE ASSOCIATION; SCIENTISTS ANALYSIS; GUIDE RNA; WHEAT; AGRICULTURE; ENDOPHYTES; TECHNOLOGIES; MICROBIOME; SCIENCE	Food security relies on continuous supplies of improved products from plant breeding and their assimilation into agriculture. Extraordinary innovations in the life sciences have brought plant breeding into a new phase of opportunity. These include the means to discover, manage and select better versus poorer versions of genes and the ability to change gene sequences in situ by gene editing. Genomics is also revealing the thousands of different microbes in all plants and the roles that their genomes play in determining crop traits that can be further improved by addition of the right microbes. Assimilation of such innovations into breeding strategies can have major impacts on rates of breeding gain but to achieve this will require comprehensive strategic leadership, planning and investments by scientists, leading global agencies and all governments based on appreciation of (i) the continuous streams of innovations underpinning crop improvement and (ii) the necessities for more rapid crop improvements everywhere to help avert otherwise inevitable catastrophes.	[Flavell, Richard B.] Ceres Inc, Thousand Oaks, CA 91320 USA	Flavell, RB (reprint author), Ceres Inc, Thousand Oaks, CA 91320 USA.						BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chassy BM, 2007, CEREAL FOOD WORLD, V52, P169, DOI 10.1094/CFW-52-4-0169; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.1365-313X.2003.01999.x; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Delmer DP, 2005, P NATL ACAD SCI USA, V102, P15739, DOI 10.1073/pnas.0505895102; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eaglesham A., 2014, NABC, V26, P3; Eathington SR, 2007, CROP SCI, V47, pS154, DOI 10.2135/cropsci2007.04.0015IPBS; Fischer R.A., 2009, CAN TECHNOLOGY DELIV; Fisher R.A., 2010, CROP SCI; Flavell R.B., 2016, NAT BIOTECH IN PRESS; Flavell R.B., 2015, ISAAA, V51, P28; FORDE BG, 1981, NUCLEIC ACIDS RES, V9, P6689, DOI 10.1093/nar/9.24.6689; Gaiero JR, 2013, AM J BOT, V100, P1738, DOI 10.3732/ajb.1200572; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869                                                            ; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131                                                                 ; Hartung F., 2014, PLANT J, DOI 10.1111/tpj.12413.; Haslberger AG, 2000, SCIENCE, V287, P431, DOI 10.1126/science.287.5452.431; Henry IM, 2014, PLANT CELL, V26, P1382, DOI 10.1105/tpc.113.121590; Herring RJ, 2008, NAT REV GENET, V9, P458, DOI 10.1038/nrg2338; Heslot N., 2012, CROP SCI; Hoffman N.E., 2013, NABC, V26, P185; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2013, TRENDS GENET, V29, P225, DOI 10.1016/j.tig.2012.12.001; Jaggard K.W., 2010, PHILOS T R SOC B; Jones J.D.G., 2014, PHILOS T R SOC B; Poupin MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069435; Kershon D.L., 2014, NABC REPORT, V26, P159; Kumar K., 2014, J EX BOT; Lemaux PG, 2008, ANNU REV PLANT BIOL, V59, P771, DOI 10.1146/annurev.arplant.58.032806.103840; Lemaux PG, 2009, ANNU REV PLANT BIOL, V60, P511, DOI 10.1146/annurev.arplant.043008.092013; Li H., 2015, BMC GENOM; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Lusser M, 2013, NEW BIOTECHNOL, V30, P437, DOI 10.1016/j.nbt.2013.02.004; Lynas M., 2013, TIME CALL OUT ANTIGM; Mammadov J, 2012, INT J PLANT GENOM; Mayer K.X, 2014, SCIENCE; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; National Academy,, 2016, GEN ENG CROP EXP PRO; Naveed M, 2014, ENVIRON EXP BOT, V97, P30, DOI 10.1016/j.envexpbot.2013.09.014; Paarlberg R, 2010, NEW BIOTECHNOL, V27, P609, DOI 10.1016/j.nbt.2010.07.005; Pieruschka R, 2012, FUNCT PLANT BIOL, V39, P813, DOI 10.1071/FPv39n11_IN; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Ran F.A, 2014, NABC, V26, P69; RIMPAU J, 1978, J MOL BIOL, V123, P327, DOI 10.1016/0022-2836(78)90083-9; Roder MS, 1998, GENETICS, V149, P2007; THE ROYAL SOCIETY, 2016, GM PLANTS QUEST ANSW; Schieman J., 2014, NABC, V26, P201; Scoones I, 2009, J PEASANT STUD, V36, P547, DOI 10.1080/03066150903155008; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shearer H., 2014, NAT BIOTECHNOL, V26, P193; Smith S.M., 1983, NUCLEIC ACIDS RES; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Voytas D., 2013, NABC, V26, P29; Wang, 2014, PLANT BIOTECHNOL, V12, P1787; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Whelan A.I., 2015, GM CROPS FOOD BIOTEC; Zuniga A., 2012, PSJN MOL PLANT MICRO, V26, P546	65	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2211-9124			GLOB FOOD SECUR-AGR	Glob. Food Secur.-Agric.Policy	MAR	2017	12						15	21		10.1016/j.gfs.2016.10.001				7	Food Science & Technology	Food Science & Technology	FE2AR	WOS:000408019200003					2018-01-05	
J	Huo, XY; Du, YT; Lu, J; Guo, M; Li, ZK; Zhang, SY; Li, XH; Chen, ZW; Du, XY				Huo, Xueyun; Du, Yating; Lu, Jing; Guo, Meng; Li, Zhenkun; Zhang, Shuangyue; Li, Xiaohong; Chen, Zhenwen; Du, Xiaoyan			Analysis of microsatellite instability in CRISPR/Cas9 editing mice	MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS			English	Article						CRISPR/Cas9; Microsatellite instability (MSI); C57BL/6J mice	CAS NUCLEASES; HUMAN-CELLS; DNA-REPAIR; STEM-CELLS; GENOME; GENES; ENDONUCLEASE; MUTAGENESIS; MUTATIONS; GENETICS	Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR- associated (Cas) protein 9 system is a novel and powerful tool which is widely used for genome editing. CRISPR/Cas9 is RNA-guided and can lead to desired genomic modifications. However, whether the CRISPR/Cas9-mediated genome editing causes genomic alterations and genomic instability, such as microsatellite instability (MSI), is still unknown. Here we detected MSI in 21 CRISPR/Cas9 mouse strains using a panel of 42 microsatellite loci which were selected from our previous studies. Surprisingly, MSI occurrence was common in CRISPR/Cas9 modified genome, and most of the strains (19/21, 90.5%) examined showed MSI. Of 42 loci examined, 8 loci (8/42, 19.05%) exhibited MSI in the Cas9 editing mice. The Ttll9 (4/42, 9.5%) were the most unstable strains, and D10Mit3 and D10Mit198 (9/21, 42.9%) were considered to be the most "hot" loci in the Cas9 strains we tested. Through analyzing the mutation of microsatellite loci, we provide new insights into the genomic alterations of CRISPR/Cas9 models and it will help us for a better understanding of this powerful technology. (C) 2017 Elsevier B.V. All rights reserved.	[Huo, Xueyun; Du, Yating; Lu, Jing; Guo, Meng; Li, Zhenkun; Zhang, Shuangyue; Li, Xiaohong; Chen, Zhenwen; Du, Xiaoyan] Capital Med Univ, Sch Basic Med Sci, Beijing 100069, Peoples R China; [Guo, Meng; Du, Xiaoyan] Capital Med Univ, Dept Lab Anim, Beijing 100069, Peoples R China	Du, XY (reprint author), Capital Med Univ, Sch Basic Med Sci, Beijing 100069, Peoples R China.; Du, XY (reprint author), Capital Med Univ, Dept Lab Anim, Beijing 100069, Peoples R China.	duduyan@ccmu.edu.cn			Key Projects in the National Science & Technology Pillar Program [2015BAI091301, 2015BAI07B01]; National Science Foundation of China [31372272]; Beijing Natural Science Foundation [7141002]	This study was funded by Key Projects in the National Science & Technology Pillar Program (Nos. 2015BAI091301; 2015BAI07B01), the National Science Foundation of China (No. 31372272) and the Beijing Natural Science Foundation (No. 7141002).	Barnes DE, 2001, CURR BIOL, V11, pR455, DOI 10.1016/S0960-9822(01)00279-2; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Chen XY, 2015, GENETICS, V201, P1295, DOI 10.1534/genetics.115.181883; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Du XY, 2013, MOL GENET GENOMICS, V288, P309, DOI 10.1007/s00438-013-0751-y; Duval A, 2002, CANCER RES, V62, P1609; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Horii T, 2016, ENDOCR J, V63, P213, DOI 10.1507/endocrj.EJ15-0734; Huo XY, 2015, MUTAT RES-FUND MOL M, V771, P21, DOI 10.1016/j.mrfmmm.2014.11.007; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Klapacz J, 2010, MOL CELL, V37, P843, DOI 10.1016/j.molcel.2010.01.038; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Menoyo A, 2001, CANCER RES, V61, P7727; Ottini L, 2006, ANN ONCOL, V17, pVII97, DOI 10.1093/annonc/mdl960; Ottini L., 2013, NAT BIOTECHNOL, V31, P822; Savic N, 2016, TRANSL RES, V168, P15, DOI 10.1016/j.trsl.2015.09.008; Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171; Staebler A, 2000, HUM PATHOL, V31, P354, DOI 10.1016/S0046-8177(00)80250-6; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127                                                          ; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Zuo BF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034555	31	0	0	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0027-5107	1873-135X		MUTAT RES-FUND MOL M	Mutat. Res.-Fundam. Mol. Mech. Mutagen.	MAR-MAY	2017	797						1	6		10.1016/j.mrfmmm.2017.02.003				6	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	EW2SE	WOS:000402345500001	28284774				2018-01-05	
J	Mansouri, M; Ehsaei, Z; Taylor, V; Berger, P				Mansouri, Maysam; Ehsaei, Zahra; Taylor, Verdon; Berger, Philipp			Baculovirus-based genome editing in primary cells	PLASMID			English	Article						Genome editing; CRISPR/Cas9; Baculovirus; Primary cells	CRISPR-CAS9; CRISPR/CAS9; EFFICIENCY; DELIVERY; ZYGOTES; KNOCKIN; SYSTEM	Genome editing in eukaryotes became easier in the last years with the development of nucleases that induce double strand breaks in DNA at user-defined sites. CRISPR/Cas9-based genome editing is currently one of the most powerful strategies. In the easiest case, a nuclease (e.g. Cas9) and a target defining guide RNA (gRNA) are transferred into a target cell. Non-homologous end joining (NHEJ) repair of the DNA break following Cas9 cleavage can lead to inactivation of the target gene. Specific repair or insertion of DNA with Homology Directed Repair (HDR) needs the simultaneous delivery of a repair template. Recombinant Lentivirus or Adenovirus genomes have enough capacity for a nuclease coding sequence and the gRNA but are usually too small to also carry large targeting constructs. We recently showed that a baculovirus-based multigene expression system (MultiPrime) can be used for genome editing in primary cells since it possesses the necessary capacity to carry the nuclease and gRNA expression constructs and the HDR targeting sequences. Here we present new Acceptor plasmids for MultiPrime that allow simplified cloning of baculoviruses for genome editing and we show their functionality in primary cells with limited life span and induced pluripotent stem cells (iPS). (C) 2017 Elsevier Inc. All rights reserved.	[Mansouri, Maysam; Berger, Philipp] Paul Scherrer Inst, Biomol Res, Mol Cell Biol, CH-5232 Villigen, Switzerland; [Mansouri, Maysam] ETH, Dept Biol, CH-8093 Zurich, Switzerland; [Ehsaei, Zahra; Taylor, Verdon] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland	Berger, P (reprint author), Paul Scherrer Inst, Mol Cell Biol, CH-5232 Villigen, Switzerland.	Philipp.Berger@psi.ch			Swiss National Science Foundation [31003A__146975]; Swiss National Science Foundation through SystemX.ch under the RTD project NeuroStemX	This work was supported by the Swiss National Science Foundation (31003A__146975 to PB). We would like to thank Dr. Stefan Jakobs for plasmids. This work was also supported by the Swiss National Science Foundation through SystemX.ch under the RTD project NeuroStemX to VT.	Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Benjamin D., 2015, NAT MED, V21; Chen X, 2016, MOL THER, V24, P447, DOI 10.1038/mt.2015.164; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kennedy MA, 2009, MOL THER, V17, P1664, DOI 10.1038/mt.2009.202; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansouri M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11529; Mansouri M, 2014, PLASMID, V75, P12, DOI 10.1016/j.plasmid.2014.07.001; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; Peng J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16705; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Savic N, 2016, TRANSL RES, V168, P15, DOI 10.1016/j.trsl.2015.09.008; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; van Erp P.B., 2015, HIST MARKET IMPACT C; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339	24	0	0	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-619X	1095-9890		PLASMID	Plasmid	MAR	2017	90						5	9		10.1016/j.plasmid.2017.01.003				5	Genetics & Heredity; Microbiology	Genetics & Heredity; Microbiology	EU5DN	WOS:000401051900002	28119062				2018-01-05	
J	Avgan, N; Sutherland, HG; Spriggens, LK; Yu, C; Ibrahim, O; Bellis, C; Haupt, LM; Shum, DHK; Griffiths, LR				Avgan, Nesli; Sutherland, Heidi G.; Spriggens, Lauren K.; Yu, Chieh; Ibrahim, Omar; Bellis, Claire; Haupt, Larisa M.; Shum, David H. K.; Griffiths, Lyn R.			BDNF Variants May Modulate Long-Term Visual Memory Performance in a Healthy Cohort	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						BDNF; long-term visual memory; human memory; genetics of memory	VAL66MET POLYMORPHISM; EPISODIC MEMORY; SYNAPTIC PLASTICITY; ASSOCIATION; STORAGE; METAANALYSIS; PERSISTENCE; CONSOLIDATION; POPULATION; COGNITION	Brain-derived neurotrophic factor (BDNF) is involved in numerous cognitive functions including learning and memory. BDNF plays an important role in synaptic plasticity in humans and rats with BDNF shown to be essential for the formation of long-term memories. We previously identified a significant association between the BDNF Val66Met polymorphism (rs6265) and long-term visual memory (p-value = 0.003) in a small cohort (n = 181) comprised of healthy individuals who had been phenotyped for various aspects of memory function. In this study, we have extended the cohort to 597 individuals and examined multiple genetic variants across both the BDNF and BDNF-AS genes for association with visual memory performance as assessed by the Wechsler Memory Scale-Fourth Edition subtests Visual Reproduction I and II (VR I and II). VR I assesses immediate visual memory, whereas VR II assesses long-term visual memory. Genetic association analyses were performed for 34 single nucleotide polymorphisms genotyped on Illumina OmniExpress BeadChip arrays with the immediate and long-term visual memory phenotypes. While none of the BDNF and BDNF-AS variants were shown to be significant for immediate visual memory, we found 10 variants (including the Val66Met polymorphism (p-value = 0.006)) that were nominally associated, and three variants (two variants in BDNF and one variant in the BDNF-AS locus) that were significantly associated with long-term visual memory. Our data therefore suggests a potential role for BDNF, and its anti-sense transcript BDNF-AS, in long-term visual memory performance.	[Avgan, Nesli; Sutherland, Heidi G.; Yu, Chieh; Ibrahim, Omar; Bellis, Claire; Haupt, Larisa M.; Griffiths, Lyn R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, Genom Res Ctr,Chron Dis & Ageing, Brisbane, Qld 4059, Australia; [Spriggens, Lauren K.; Shum, David H. K.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast 4222, Australia; [Spriggens, Lauren K.; Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Gold Coast 4222, Australia; [Bellis, Claire] Agcy Sci Technol & Res Singapore, Genome Inst Singapore, Human Genet, Singapore 138672, Singapore	Griffiths, LR (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, Genom Res Ctr,Chron Dis & Ageing, Brisbane, Qld 4059, Australia.	nesli.avgan@qut.edu.au; heidi.sutherland@qut.edu.au; l.spriggens@griffith.edu.au; c22.yu@hdr.qut.edu.au; omarezzedin@gmail.com; bellisc@gis.a-star.edu.sg; larisa.haupt@qut.edu.au; d.shum@griffith.edu.au; lyn.griffiths@qut.edu.au			Australian Research Council grant The Genetic Basis of Human Memory [DP130101921]; Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia-Queensland Node project	This work was supported by an Australian Research Council grant The Genetic Basis of Human Memory (Project ID: DP130101921). This work was also supported by infrastructure purchased with Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia-Queensland Node project. We thank Miles Benton for his contribution in data preparation for targeted analysis.	Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017                                                    ; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Beste C, 2011, NEUROPHARMACOLOGY, V60, P467, DOI 10.1016/j.neuropharm.2010.10.028; Bombardier A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111886; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082707; Cathomas F, 2010, INT J NEUROPSYCHOPH, V13, P975, DOI 10.1017/S1461145710000519; Chen DY, 2012, NAT NEUROSCI, V15, P1707, DOI 10.1038/nn.3266; Correa DD, 2016, NEURO-ONCOLOGY, V18, P1425, DOI 10.1093/neuonc/now057; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X                                                   ; Cunha Carla, 2010, Front Mol Neurosci, V3, P1, DOI 10.3389/neuro.02.001.2010; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Dincheva I, 2012, NEUROSCIENTIST, V18, P439, DOI 10.1177/1073858411431646; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Goldberg TE, 2008, BIOL PSYCHOL, V77, P20, DOI 10.1016/j.biopsycho.2007.08.009; Hariri AR, 2003, J NEUROSCI, V23, P6690; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Harrisberger F, 2015, NEUROSCI BIOBEHAV R, V55, P107, DOI 10.1016/j.neubiorev.2015.04.017; Harrisberger F, 2014, NEUROSCI BIOBEHAV R, V42, P267, DOI 10.1016/j.neubiorev.2014.03.011; Hashimoto T, 2016, CEREB CORTEX, V26, P1795, DOI 10.1093/cercor/bhw020; Healy AF, 1996, ANNU REV PSYCHOL, V47, P143, DOI 10.1146/annurev.psych.47.1.143; Honea RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076001; Jin TB, 2016, J GENE MED, V18, P288, DOI 10.1002/jgm.2927; Kandel Eric, 2006, Newsweek, V147, P47; Kaufman AS, 2001, ASSESSMENT, V8, P267, DOI 10.1177/107319110100800303                                                      ; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Mandelman SD, 2012, GENES BRAIN BEHAV, V11, P127, DOI 10.1111/j.1601-183X.2011.00738.x; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; O'Bryant SE, 2011, DEMENT GERIATR COGN, V31, P31, DOI 10.1159/000321980; Ogmen H, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00830; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2017, R LANG ENV STAT COMP; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Silva AJ, 2003, J NEUROBIOL, V54, P224, DOI 10.1002/neu.10169; Tan YL, 2005, SCHIZOPHR RES, V77, P355, DOI 10.1016/j.schres.2005.03.012; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tulving E., 1972, ORG MEMORY, P423; Wilkosc M, 2016, ACTA NEUROBIOL EXP, V76, P43; Yogeetha BS, 2013, MOL BIOL REP, V40, P5483, DOI 10.1007/s11033-013-2648-6	53	1	1	1	1	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	MAR	2017	18	3							655	10.3390/ijms18030655				14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	EU2WM	WOS:000400890600014		gold			2018-01-05	
J	Stone, JD; Kolouskova, P; Sloan, DB; Storchova, H				Stone, James D.; Kolouskova, Pavla; Sloan, Daniel B.; Storchova, Helena			Non-coding RNA may be associated with cytoplasmic male sterility in Silene vulgaris	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Cytoplasmic male sterility; editing; mitochondrion; non-coding RNA; Silene vulgaris; splicing; transcriptome	MASSIVE MITOCHONDRIAL GENOME; OPEN READING FRAME; GYNODIOECIOUS PLANT; ARABIDOPSIS-THALIANA; MESSENGER-RNAS; EDITING SITES; SEQ DATA; GENES; ANGIOSPERM; RICE	Cytoplasmic male sterility (CMS) is a widespread phenomenon in flowering plants caused by mitochondrial (mt) genes. CMS genes typically encode novel proteins that interfere with mt functions and can be silenced by nuclear fertility-restorer genes. Although the molecular basis of CMS is well established in a number of crop systems, our understanding of it in natural populations is far more limited. To identify CMS genes in a gynodioecious plant, Silene vulgaris, we constructed mt transcriptomes and compared transcript levels and RNA editing patterns in floral bud tissue from female and hermaphrodite full siblings. The transcriptomes from female and hermaphrodite individuals were very similar overall with respect to variation in levels of transcript abundance across the genome, the extent of RNA editing, and the order in which RNA editing and intron splicing events occurred. We found only a single genomic region that was highly overexpressed and differentially edited in females relative to hermaphrodites. This region is not located near any other transcribed elements and lacks an open-reading frame (ORF) of even moderate size. To our knowledge, this transcript would represent the first non-coding mt RNA associated with CMS in plants and is, therefore, an important target for future functional validation studies.	[Stone, James D.; Kolouskova, Pavla; Storchova, Helena] Acad Sci Czech Republ, Inst Expt Bot, Vvi, Rozvojova 263, CR-16502 Prague, Czech Republic; [Stone, James D.] Acad Sci Czech Republ, Inst Bot, Vvi, Pruhonice 25243, Central Bohemia, Czech Republic; [Sloan, Daniel B.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Storchova, H (reprint author), Acad Sci Czech Republ, Inst Expt Bot, Vvi, Rozvojova 263, CR-16502 Prague, Czech Republic.	storchova@ueb.cas.cz		Stone, James/0000-0002-4636-5158	Projects of Large Infrastructure for Research, Development, and Innovations [LM2010005]; Integration of the experimental and population biology using new methods of interdisciplinary issues - the way to excellence with young scientists [CZ.1.07/2.3.00/30.0048]; European Social Fund (ESF); state budget of Czech Republic through the Operational Program Education for Competitiveness (OPEC); Grant Agency of the Czech Republic [16-09220S]; National Science Foundation [MCB-1412260]	We thank Charles Nicolet for helpful advice on Illumina sequencing and Zhiqiang Wu for assistance with RNA editing data from Silene noctiflora. We also thank two anonymous reviewers for comments on an earlier version of this manuscript. Access to computing and storage facilities owned by parties and projects contributing to the National Grid Infrastructure MetaCentrum, provided under the program 'Projects of Large Infrastructure for Research, Development, and Innovations' (LM2010005), is greatly appreciated. JDS was supported by the project 'Integration of the experimental and population biology using new methods of interdisciplinary issues - the way to excellence with young scientists', Reg. No.: CZ.1.07/2.3.00/30.0048, funded by the European Social Fund (ESF) and the state budget of Czech Republic through the Operational Program Education for Competitiveness (OPEC). Financial support through the grants of the Grant Agency of the Czech Republic 16-09220S to HS and National Science Foundation MCB-1412260 to DBS is acknowledged.	Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Arrieta-Montiel MP, 2011, ADVAN PL BIO, V1, P65; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Case AL, 2008, EVOLUTION, V62, P1026, DOI 10.1111/j.1558-5646.2008.00360.x; Case AL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1493; Castandet B, 2010, NUCLEIC ACIDS RES, V38, P7112, DOI 10.1093/nar/gkq591; Chakraborty A, 2015, PLANTA, V241, P1463, DOI 10.1007/s00425-015-2269-5; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Darracq A, 2011, GENOME BIOL EVOL, V3, P723, DOI 10.1093/gbe/evr042; Dietrich A, 2015, BIOCHIMIE, V117, P48, DOI 10.1016/j.biochi.2015.06.027; Duroc Y, 2009, PLANT MOL BIOL, V70, P123, DOI 10.1007/s11103-009-9461-6; Elansary HO, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-11; Farre JC, 1999, PLANT MOL BIOL, V40, P959, DOI 10.1023/A:1006296422485; Farre JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052644; Forner J, 2007, NUCLEIC ACIDS RES, V35, P3676, DOI 10.1093/nar/gkm270; Fujii S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-279; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Gillman JD, 2007, PLANT J, V49, P217, DOI 10.1111/j.1365-313X.2006.02953.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grewe F, 2016, GENOME BIOL EVOL, V8, P3193, DOI 10.1093/gbe/evw233; Grewe F, 2014, MITOCHONDRION, V19, P135, DOI 10.1016/j.mito.2014.05.008; Grimes BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-31; Guo WH, 2017, NEW PHYTOL, V213, P391, DOI 10.1111/nph.14135; Hammani K, 2014, TRENDS PLANT SCI, V19, P380, DOI 10.1016/j.tplants.2013.12.008; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hellens RP, 2016, TRENDS PLANT SCI, V21, P317, DOI 10.1016/j.tplants.2015.11.005; Horn R, 2014, MITOCHONDRION, V19, P198, DOI 10.1016/j.mito.2014.04.004; Houliston GJ, 2006, GENETICS, V174, P1983, DOI 10.1534/genetics.106.060202; Hu J, 2014, MITOCHONDRION, V19, P282, DOI 10.1016/j.mito.2014.02.008; Huang JZ, 2014, RICE, V7, DOI 10.1186/s12284-014-0013-6; Ingvarsson PK, 2002, P NATL ACAD SCI USA, V99, P11265, DOI 10.1073/pnas.172318099; Janska H, 1998, PLANT CELL, V10, P1163; Kazama T, 2008, PLANT J, V55, P619, DOI 10.1111/j.1365-313X.2008.03529.x; Kim DH, 2007, PLANT MOL BIOL, V63, P519, DOI 10.1007/s11103-006-9106-y; Kuhn K, 2005, NUCLEIC ACIDS RES, V33, P337, DOI 10.1093/nar/gki179; Laing WA, 2015, PLANT CELL, V27, P772, DOI 10.1105/tpc.114.133777; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li-Pook-Than J, 2007, PHYSIOL PLANTARUM, V129, P23, DOI [10.1111/ j. 1399- 3054.2006.00770. x, DOI 10.1111/J.1399-3054.2006.00770.X]; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Marker C, 2002, CURR BIOL, V12, P2002, DOI 10.1016/S0960-9822(02)01304-0; McCauley DE, 2008, EVOLUTION, V62, P1013, DOI 10.1111/j.1558-5646.2008.00363.x; Mower JP, 2012, GENOME BIOL EVOL, V4, P670, DOI 10.1093/gbe/evs042; Muller K, 2013, PLANT MOL BIOL, V81, P495, DOI 10.1007/s11103-013-0018-3; Oldenburg DJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00883; Olson MS, 2002, EVOLUTION, V56, P253; Pearl SA, 2009, MOL BIOL EVOL, V26, P537, DOI 10.1093/molbev/msn273; Preuten T, 2010, PLANT J, V64, P948, DOI 10.1111/j.1365-313X.2010.04389.x; Raczynska KD, 2006, FEBS LETT, V580, P5641, DOI 10.1016/j.febslet.2006.09.010; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruwe H, 2012, NUCLEIC ACIDS RES, V40, P3106, DOI 10.1093/nar/gkr1138; Sabar M, 2003, EMBO REP, V4, P381, DOI 10.1038/sj.embor.embor800; Sanderson BJ, 2016, ECOL EVOL, V6, P1411, DOI 10.1002/ece3.1958; Skippington E, 2015, P NATL ACAD SCI USA, V112, pE3515, DOI 10.1073/pnas.1504491112; Sloan DB, 2012, NEW PHYTOL, V196, P1228, DOI 10.1111/j.1469-8137.2012.04340.x; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Sloan DB, 2010, GENETICS, V185, P1369, DOI 10.1534/genetics.110.118000; Stadler T, 2002, P NATL ACAD SCI USA, V99, P11730, DOI 10.1073/pnas.182267799; Stone JD, 2015, MOL GENET GENOMICS, V290, P1, DOI 10.1007/s00438-014-0905-6; Storchova H, 2004, MOL ECOL, V13, P2909, DOI 10.1111/j.1365-294X.2004.02278.x; Storchova H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030401; Touzet P, 2014, MITOCHONDRION, V19, P166, DOI 10.1016/j.mito.2014.04.009; Touzet P, 2009, GENETICS, V181, P631, DOI 10.1534/genetics.108.092411; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang K, 2013, NEW PHYTOL, V198, P408, DOI 10.1111/nph.12180; Woloszynska M, 2006, PLANT MOL BIOL, V61, P1, DOI 10.1007/s11103-005-5773-3; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu ZQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2155-3; Wu ZQ, 2015, P NATL ACAD SCI USA, V112, P10185, DOI 10.1073/pnas.1421397112; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	72	1	1	6	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	MAR	2017	68	7					1599	1612		10.1093/jxb/erx057				14	Plant Sciences	Plant Sciences	ET5RH	WOS:000400341800019	28369520	gold			2018-01-05	
J	Mitchell, JK; Midkiff, BR; Israelow, B; Evans, MJ; Lanford, RE; Walker, CM; Lemon, SM; McGivern, DR				Mitchell, Jonathan K.; Midkiff, Bentley R.; Israelow, Benjamin; Evans, Matthew J.; Lanford, Robert E.; Walker, Christopher M.; Lemon, Stanley M.; McGivern, David R.			Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase	MBIO			English	Article						hepatitis C virus; liver cancer; p53; translation	TUMOR-SUPPRESSOR P53; HEPATOCELLULAR-CARCINOMA; CORE PROTEIN; LIVER-CANCER; HEPATOMA-CELLS; RNA; REPLICATION; INFECTION; PATHWAYS; BINDING	Many DNA tumor viruses promote cellular transformation by inactivating the critically important tumor suppressor protein p53. In contrast, it is not known whether p53 function is disrupted by hepatitis C virus (HCV), a unique, oncogenic RNA virus that is the leading infectious cause of liver cancer in many regions of the world. Here we show that HCV-permissive, liver-derived HepG2 cells engineered to constitutively express microRNA-122 (HepG2/miR-122 cells) have normal p53-mediated responses to DNA damage and that HCV replication in these cells potently suppresses p53 responses to etoposide, an inducer of DNA damage, or nutlin-3, an inhibitor of p53 degradation pathways. Upregulation of p53-dependent targets is consequently repressed within HCV-infected cells, with potential consequences for cell survival. Despite this, p53 function is not disrupted by overexpression of the complete HCV polyprotein, suggesting that altered p53 function may result from the host response to viral RNA replication intermediates. Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-mediated ablation of double-stranded RNA (dsRNA)activated protein kinase R (PKR) restored p53 responses while boosting HCV replication, showing that p53 inhibition results directly from viral activation of PKR. The hepatocellular abundance of phosphorylated PKR is elevated in HCV-infected chimpanzees, suggesting that PKR activation and consequent p53 inhibition accompany HCV infection in vivo. These findings reveal a feature of the host response to HCV infection that may contribute to hepatocellular carcinogenesis. IMPORTANCE Chronic infection with hepatitis C virus (HCV) is the leading cause of liver cancer in most developed nations. However, the mechanisms whereby HCV infection promotes carcinogenesis remain unclear. Here, we demonstrate that HCV infection inhibits the activation of p53 following DNA damage. Contrary to previous reports, HCV protein expression is insufficient to inhibit p53. Rather, p53 inhibition is mediated by cellular protein kinase R (PKR), which is activated by HCV RNA replication and subsequently suppresses global protein synthesis. These results redefine our understanding of how HCV infection influences p53 function. We speculate that persistent disruption of p53-mediated DNA damage responses may contribute to hepatocellular carcinogenesis in chronically infected individuals.	[Mitchell, Jonathan K.; Lemon, Stanley M.; McGivern, David R.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Midkiff, Bentley R.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Israelow, Benjamin; Evans, Matthew J.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Lanford, Robert E.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Walker, Christopher M.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Lemon, Stanley M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lemon, Stanley M.] Univ N Carolina, Div Infect Dis, Dept Med, Chapel Hill, NC 27599 USA	Lemon, SM; McGivern, DR (reprint author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Lemon, SM (reprint author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Lemon, SM (reprint author), Univ N Carolina, Div Infect Dis, Dept Med, Chapel Hill, NC 27599 USA.	smlemon@med.unc.edu; mcgivern@med.unc.edu		McGivern, David/0000-0003-3497-5087	NIH [T32-CA009156, F32-CA192633, T32-AI07647, F30-DK096892, R01-DK095125, R01-CA164029, R01-AI095690, R37-AI047367, R21-AI115207]; University Cancer Research Fund of the University of North Carolina; Cancer Center Core Support Grant [P30 CA016086]; NIH grant from the Office of Research Infrastructure Programs/Office of the Director [P51-OD011133]	This work was supported by research grants from the NIH, T32-CA009156 and F32-CA192633 (J.K.M.), T32-AI07647 and F30-DK096892 (B.I.), R01-DK095125 (M.J.E.), R01-CA164029 and R01-AI095690 (S.M.L.), R37-AI047367 (C.M.W.), and R21-AI115207 (D.R.M.), and the University Cancer Research Fund of the University of North Carolina. The UNC Flow Cytometry, Animal Histopathology, and Translational Pathology Laboratory Core Facilities are supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. Southwest National Primate Research Center resources were supported by NIH grant P51-OD011133 from the Office of Research Infrastructure Programs/Office of the Director.	Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bittar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062581; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Buhler S, 2012, DIGEST DIS, V30, P445, DOI 10.1159/000341688; CALDECOTT K, 1990, CANCER RES, V50, P5778; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Cox AL, 2015, SCIENCE, V349, P790, DOI 10.1126/science.aad1302; Deng L, 2006, J GEN VIROL, V87, P1703, DOI 10.1099/vir.0.81735-0; Dharel N, 2008, HEPATOLOGY, V47, P1136, DOI 10.1002/hep.22176; Dixit U, 2015, J VIROL, V89, P7905, DOI 10.1128/JVI.00729-15; Gale M, 1999, J VIROL, V73, P6506; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Harouaka D, 2016, P NATL ACAD SCI USA, V113, P1375, DOI 10.1073/pnas.1516879113; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Higgs MR, 2014, J GEN VIROL, V95, P991, DOI 10.1099/vir.0.059485-0; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Ishido S, 1998, FEBS LETT, V438, P258, DOI 10.1016/S0014-5793(98)01312-X; Israelow B, 2014, HEPATOLOGY, V60, P1170, DOI 10.1002/hep.27227; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Kao CF, 2004, ONCOGENE, V23, P2472, DOI 10.1038/sj.onc.1207368; KASTAN MB, 1991, CANCER RES, V51, P6304; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kwun HJ, 2001, J GEN VIROL, V82, P2235, DOI 10.1099/0022-1317-82-9-2235                                                     ; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001                                                 ; Marques JT, 2005, J VIROL, V79, P11105, DOI 10.1128/JVI.79.17.11105-11114.2005; Masaki T, 2015, CELL HOST MICROBE, V17, P217, DOI 10.1016/j.chom.2014.12.014; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Milward A, 2010, J GEN VIROL, V91, P373, DOI 10.1099/vir.0.015305-0; Moradpour D, 1998, HEPATOLOGY, V28, P192, DOI 10.1002/hep.510280125; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; National Research Council, 2011, GUIDE CARE USE LAB A; National Institute of Health (NIH), 2002, PUBL HLTH SERV POL H; Otsuka M, 2000, J BIOL CHEM, V275, P34122, DOI 10.1074/jbc.M000578200; Qadri I, 2002, BBA-MOL CELL RES, V1592, P193, DOI 10.1016/S0167-4889(02)00315-4                                                   ; Ray RB, 1998, GENE, V208, P331, DOI 10.1016/S0378-1119(98)00030-4; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato Y, 2013, REV MED VIROL, V23, P213, DOI 10.1002/rmv.1738; Sheahan T, 2014, CELL HOST MICROBE, V15, P190, DOI 10.1016/j.chom.2014.01.007; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; United States Department of Agriculture (USDA), 2013, AN WELF ACT AN WELF; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103	52	1	1	3	5	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	MAR-APR	2017	8	2							e00121-17	10.1128/mBio.00121-17				15	Microbiology	Microbiology	ET8TW	WOS:000400575700043		gold			2018-01-05	
J	Nigro, OD; Jungbluth, SP; Lin, HT; Hsieh, CC; Miranda, JA; Schvarcz, CR; Rappe, MS; Steward, GF				Nigro, Olivia D.; Jungbluth, Sean P.; Huei-Ting Lin; Hsieh, Chih-Chiang; Miranda, Jaclyn A.; Schvarcz, Christopher R.; Rappe, Michael S.; Steward, Grieg F.			Viruses in the Oceanic Basement	MBIO			English	Article							ARCHAEAL VIRUSES; HYPERTHERMOPHILIC ARCHAEA; HYDROTHERMAL VENTS; MICROBIAL LIFE; WATER COLUMN; TRANSFER-RNA; RIDGE FLANK; FRESH-WATER; CRUST; BIOSPHERE	Microbial life has been detected well into the igneous crust of the seafloor (i.e., the oceanic basement), but there have been no reports confirming the presence of viruses in this habitat. To detect and characterize an ocean basement virome, geothermally heated fluid samples (ca. 60 to 65 degrees C) were collected from 117 to 292 m deep into the ocean basement using seafloor observatories installed in two boreholes (Integrated Ocean Drilling Program [IODP] U1362A and U1362B) drilled in the eastern sediment-covered flank of the Juan de Fuca Ridge. Concentrations of virus-like particles in the fluid samples were on the order of 0.2 x 10(5) to 2 x 105 ml(-1) (n = 8), higher than prokaryote-like cells in the same samples by a factor of 9 on average (range, 1.5 to 27). Electron microscopy revealed diverse viral morphotypes similar to those of viruses known to infect bacteria and thermophilic archaea. An analysis of virus-like sequences in basement microbial metagenomes suggests that those from archaeon-infecting viruses were the most common (63 to 80%). Complete genomes of a putative archaeon-infecting virus and a prophage within an archaeal scaffold were identified among the assembled sequences, and sequence analysis suggests that they represent lineages divergent from known thermophilic viruses. Of the clustered regularly interspaced short palindromic repeat (CRISPR)-containing scaffolds in the metagenomes for which a taxonomy could be inferred (163 out of 737), 51 to 55% appeared to be archaeal and 45 to 49% appeared to be bacterial. These results imply that the warmed, highly altered fluids in deeply buried ocean basement harbor a distinct assemblage of novel viruses, including many that infect archaea, and that these viruses are active participants in the ecology of the basement microbiome. IMPORTANCE The hydrothermally active ocean basement is voluminous and likely provided conditions critical to the origins of life, but the microbiology of this vast habitat is not well understood. Viruses in particular, although integral to the origins, evolution, and ecology of all life on earth, have never been documented in basement fluids. This report provides the first estimate of free virus particles (virions) within fluids circulating through the extrusive basalt of the seafloor and describes the morphological and genetic signatures of basement viruses. These data push the known geographical limits of the virosphere deep into the ocean basement and point to a wealth of novel viral diversity, exploration of which could shed light on the early evolution of viruses.	[Nigro, Olivia D.; Jungbluth, Sean P.; Huei-Ting Lin; Hsieh, Chih-Chiang; Miranda, Jaclyn A.; Schvarcz, Christopher R.; Steward, Grieg F.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Jungbluth, Sean P.; Rappe, Michael S.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Jungbluth, Sean P.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Huei-Ting Lin] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Hsieh, Chih-Chiang] Acad Sinica, Res Ctr Environm Changes, Taipei, Taiwan; [Miranda, Jaclyn A.] Thermo Fisher Sci, Carlsbad, CA USA	Nigro, OD; Steward, GF (reprint author), Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA.	onigro@hawaii.edu; grieg@hawaii.edu	Jungbluth, Sean/A-9054-2012	Jungbluth, Sean/0000-0001-9265-8341; LIN, HUEI-TING/0000-0003-3754-6739; Steward, Grieg/0000-0001-5988-0522	National Science Foundation via the Center for Dark Energy Biosphere Investigations (C-DEBI) [OCE-0939564]; Center for Microbial Ecology Research and Education (C-MORE) [EF-0424599]; National Science Foundation [MCB-0604014, OCE-1260723]; C-DEBI [41231607, 59410979]; C-MORE; C-DEBI postdoctoral fellowship [49059511]	The project was supported by funding from the National Science Foundation via the Center for Dark Energy Biosphere Investigations (C-DEBI; OCE-0939564) and the Center for Microbial Ecology Research and Education (C-MORE; EF-0424599). The efforts of M. S. Rappe and S. P. Jungbluth were also supported by National Science Foundation grants MCB-0604014 and OCE-1260723. Research support for G. F. Steward was provided by C-DEBI (subawards 41231607 and 59410979) and C-MORE. O. D. Nigro was supported by a C-DEBI postdoctoral fellowship (subaward 49059511). S. P. Jungbluth was also supported by a C-DEBI graduate student fellowship. J. A. Miranda was supported by C-MORE and C-DEBI. C. R. Schvarcz was supported by C-MORE.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson RE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00219; Anderson RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097506; ARMON R, 1988, CAN J MICROBIOL, V34, P651, DOI 10.1139/m88-107                                                                 ; Biller SJ, 2017, ISME J, V11, P394, DOI 10.1038/ismej.2016.134; Bird DF, 2001, MAR GEOL, V174, P227, DOI 10.1016/S0025-3227(00)00152-3                                                   ; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Brum JR, 2013, ISME J, V7, P1738, DOI 10.1038/ismej.2013.67; Brum JR, 2010, MICROB ECOL, V60, P636, DOI 10.1007/s00248-010-9688-4; Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6; Cowen JP, 2012, DEEP-SEA RES PT I, V61, P43, DOI 10.1016/j.dsr.2011.11.004; Cowen JP, 2003, SCIENCE, V299, P120, DOI 10.1126/science.1075653; Danovaro R, 2008, FRESHWATER BIOL, V53, P1186, DOI 10.1111/j.1365-2427.2008.01961.x; Davis EE, 1992, P OCEAN DRILL PROGRA, V139, P43, DOI DOI 10.2973/ODP.PROC.IR.139.103.1992; DEMING JW, 1993, GEOCHIM COSMOCHIM AC, V57, P3219, DOI 10.1016/0016-7037(93)90535-5; Dick GJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00124; Drummond A.J., 2011, GENEIOUS V5 4; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Edwards KJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00008; Edwards KJ, 2011, NAT REV MICROBIOL, V9, P703, DOI 10.1038/nrmicro2647; Engelhardt T, 2011, ENV MICROBIOL REP, V3, P459, DOI 10.1111/j.1758-2229.2010.00232.x; Fisher AT, 2010, OCEANOGRAPHY, V23, P74, DOI 10.5670/oceanog.2010.63                                                         ; Fisher AT, 2011, P INTEGR OCEAN DRILL, V327, P1, DOI DOI 10.2204/I0DP.PR0C.327.107.2011; Forster JL, 2008, J VIROL METHODS, V149, P190, DOI 10.1016/j.jviromet.2007.12.020; Geslin C, 2003, RES MICROBIOL, V154, P303, DOI 10.1016/S0923-2508(03)00075-5; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holmfeldt K, 2012, APPL ENVIRON MICROB, V78, P892, DOI 10.1128/AEM.06580-11; Huntemann M, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0138-x; Expedition 327 Scientists, 2010, INT OC DRILL PROGR E; Johnson HP, 2003, EARTH PLANET SC LETT, V216, P565, DOI 10.1016/S0012-821X(03)00545-4; Jungbluth SP, 2016, ISME J, V10, P2033, DOI 10.1038/ismej.2015.248; Jungbluth SP, 2013, ISME J, V7, P161, DOI 10.1038/ismej.2012.73; Jungbluth SP, SCI DATA IN PRESS; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimura M, 2008, SOIL SCI PLANT NUTR, V54, P1, DOI 10.1111/j.1747-0765.2007.00197.x; Koonin EV, 2009, ANN NY ACAD SCI, V1178, P47, DOI 10.1111/j.1749-6632.2009.04992.x; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; LAWRENCE J E, 2010, MANUAL AQUATIC VIRAL, V17, P166; Li JT, 2014, MAR ECOL PROG SER, V508, P67, DOI 10.3354/meps10841; Lin HT, 2014, EARTH PLANET SC LETT, V405, P62, DOI 10.1016/j.epsl.2014.07.037; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LYTLE CD, 1995, APPL ENVIRON MICROB, V61, P643; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Middelboe M, 2011, AQUAT MICROB ECOL, V63, P1, DOI 10.3354/ame01485; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Ortmann AC, 2005, DEEP-SEA RES PT I, V52, P1515, DOI 10.1016/j.dsr.2005.04.002; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Peng X, 2001, VIROLOGY, V291, P226, DOI 10.1006/viro.2001.1190; Prangishvili D, 2004, BIOCHEM SOC T, V32, P204, DOI 10.1042/BST0320204; Prangishvili D, 2003, RES MICROBIOL, V154, P289, DOI 10.1016/S0923-2508(03)00073-1; Prangishvili D, 2013, ANNU REV MICROBIOL, V67, P565, DOI 10.1146/annurev-micro-092412-155633; Prangishvill D, 2006, VIRUS RES, V117, P52, DOI 10.1016/j.virusres.2006.01.007; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985; Santelli CM, 2010, GEOMICROBIOL J, V27, P158, DOI 10.1080/01490450903456780; Soler N, 2008, RES MICROBIOL, V159, P390, DOI 10.1016/j.resmic.2008.04.015; Steward GF, 2010, MANUAL AQUATIC VIRAL, P154; Suttle CA, 2010, MANUAL AQUATIC VIRAL, P145, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7; Thorseth IH, 1995, CHEM GEOL, V126, P137, DOI 10.1016/0009-2541(95)00114-8                                                    ; Uhlenhaut C, 2005, J VIROL METHODS, V128, P189, DOI 10.1016/j.jviromet.2005.05.002; Wheat CG, 2013, GEOCHEM GEOPHY GEOSY, V14, P1957, DOI 10.1002/ggge.20131; Wheat CG, 2011, P INT OC DRILL PROGR, V327, P1; Wilhelm SW, 2008, FRESHWATER BIOL, V53, P1076, DOI 10.1111/j.1365-2427.2008.01980.x; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866                                                            ; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73; Williamson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042047; Wommack KE, 2004, DEEP-SEA RES PT I, V51, P1781, DOI 10.1016/j.dsr.2004.05.011; Lader ES, 2001, US patent, Patent No. [6,204,375 B1, 6204375]; [Anonymous], 2011, P INTEGR OCEAN DRILL, V327, P1	70	2	2	8	11	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	MAR-APR	2017	8	2							e02129-16	10.1128/mBio.02129-16				15	Microbiology	Microbiology	ET8TW	WOS:000400575700044		gold			2018-01-05	
J	Straimer, J; Gnadig, NF; Stokes, BH; Ehrenberger, M; Crane, AA; Fidock, DA				Straimer, Judith; Gnadig, Nina F.; Stokes, Barbara H.; Ehrenberger, Michelle; Crane, Audrey A.; Fidock, David A.			Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro	MBIO			English	Article						K13/Kelch13; Plasmodium falciparum; artemisinin; drug resistance; fitness; gene editing; ozonides	DIHYDROARTEMISININ-PIPERAQUINE FAILURE; ARTEMISININ-RESISTANT MALARIA; WESTERN CAMBODIA; SOUTHEAST-ASIA; DELAYED-CLEARANCE; DRUG-RESISTANCE; CLINICAL-TRIAL; ARTEROLANE; MULTICENTER; PHENOTYPE	The emergence and spread in Southeast Asia of Plasmodium falciparum resistance to artemisinin (ART) derivatives, the cornerstone of first-line artemisinin-based combination therapies (ACTs), underscore the urgent need to identify suitable replacement drugs. Discovery and development efforts have identified a series of ozonides with attractive chemical and pharmacological properties that are being touted as suitable replacements. Partial resistance to ART, defined as delayed parasite clearance in malaria patients treated with an ART derivative or an ACT, has been associated with mutations in the P. falciparum K13 gene. In light of reports showing that ART derivatives and ozonides share similar modes of action, we have investigated whether parasites expressing mutant K13 are cross-resistant to the ozonides OZ439 (artefenomel) and OZ227 (arterolane). This work used a panel of culture-adapted clinical isolates from Cambodia that were genetically edited to express variant forms of K13. Phenotypic analyses employed ring-stage survival assays (ring-stage survival assay from 0 to 3 h [RSA(0-3h)]), whose results have earlier been shown to correlate with parasite clearance rates in patients. Our results document cross-resistance between OZ277 and dihydroartemisinin (DHA), a semisynthetic derivative of ART, in parasites carrying the K13 mutations C580Y, R539T, and I543T. For OZ439, we observed cross-resistance only for parasites that carried the rare K13 I543T mutation, with no evidence of cross-resistance afforded by the prevalent C580Y mutation. Mixed-culture competition experiments with isogenic lines carrying modified K13 revealed variable growth deficits depending on the K13 mutation and parasite strain and provide a rationale for the broad dissemination of the fitness-neutral K13 C580Y mutation throughout strains currently circulating in Southeast Asia. IMPORTANCE ACTs have helped halve the malaria disease burden in recent years; however, emerging resistance to ART derivatives threatens to reverse this substantial progress. Resistance is driven primarily by mutations in the P. falciparum K13 gene. These mutations pose a threat to ozonides, touted as promising alternatives to ARTs that share a similar mode of action. We report that DHA was considerably more potent than OZ439 and OZ277 against ART-sensitive asexual blood-stage parasites cultured in vitro. We also document that mutant K13 significantly compromised the activity of the registered drug OZ277. In contrast, OZ439 remained effective against most parasite lines expressing mutant K13, with the exception of I543T that merits further monitoring in field-based OZ439 efficacy studies. K13 mutations differed considerably in their impact on parasite growth rates, in a strain-dependent context, with the most prevalent C580Y mutation being fitness neutral in recently culture-adapted strains from Cambodia, the epicenter of emerging ART resistance.	[Straimer, Judith; Gnadig, Nina F.; Stokes, Barbara H.; Ehrenberger, Michelle; Crane, Audrey A.; Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA	Fidock, DA (reprint author), Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA.; Fidock, DA (reprint author), Columbia Univ Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA.	df2260@cumc.columbia.edu		Fidock, David/0000-0001-6753-8938	National Institutes of Health [NIAID R01 AI109023]; Medicines for Malaria Venture	Partial funding for this work was provided by the National Institutes of Health (NIAID R01 AI109023 to D.A.F.) and the Medicines for Malaria Venture.	Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amaratunga C, 2014, ANTIMICROB AGENTS CH, V58, P4935, DOI 10.1128/AAC.03055-14; Amato R, 2017, LANCET INFECT DIS, V17, P164, DOI [10.1016/s1473-3099(16)30409-1, 10.1016/S1473-3099(16)30409-1]; Anderson TJC, 2017, MOL BIOL EVOL, V34, P131, DOI 10.1093/molbev/msw228; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baumgartner F, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1696-0; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Ekland EH, 2011, FASEB J, V25, P3583, DOI 10.1096/fj.11-187401; Fairhurst RM, 2015, CURR OPIN INFECT DIS, V28, P417, DOI 10.1097/QCO.0000000000000199; Fugi MA, 2010, ANTIMICROB AGENTS CH, V54, P1042, DOI 10.1128/AAC.01305-09; Gabryszewski SJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005976; Gabryszewski SJ, 2016, MOL BIOL EVOL, V33, P1554, DOI 10.1093/molbev/msw037; Gautam A, 2011, J CLIN PHARMACOL, V51, P1519, DOI 10.1177/0091270010385578; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Hott A, 2015, J ANTIMICROB CHEMOTH, V70, P2787, DOI 10.1093/jac/dkv199; Imwong M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17412; Kaiser M, 2007, ANTIMICROB AGENTS CH, V51, P2991; Klonis N, 2013, CURR OPIN MICROBIOL, V16, P722, DOI 10.1016/j.mib.2013.07.005; Laufer MK, 2010, J INFECT DIS, V202, P801, DOI 10.1086/655659; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Leroy D, 2017, EMBO MOL MED, V9, P133, DOI 10.15252/emmm.201607295; MalariaGEN Plasmodium falciparum Community Project, 2016, ELIFE, V5; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Meunier B, 2010, ACCOUNTS CHEM RES, V43, P1444, DOI 10.1021/ar100070k; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mishra N, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1636-4; Moehrle JJ, 2013, BRIT J CLIN PHARMACO, V75, P524, DOI 10.1111/j.1365-2125.2012.04368.x; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Phyo AP, 2016, LANCET INFECT DIS, V16, P61, DOI 10.1016/S1473-3099(15)00320-5; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; Rosenthal PJ, 2013, MOL MICROBIOL, V89, P1025, DOI 10.1111/mmi.12349; Saha N, 2014, J CLIN PHARMACOL, V54, P386, DOI 10.1002/jcph.232; Saunders DL, 2014, NEW ENGL J MED, V371, P484, DOI 10.1056/NEJMc1403007; Siriwardana A, 2016, ANTIMICROB AGENTS CH, V60, P6952, DOI 10.1128/AAC.00857-16; Spring MD, 2015, LANCET INFECT DIS, V15, P683, DOI 10.1016/S1473-3099(15)70049-6; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Talundzic E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004789; Tilley L, 2016, TRENDS PARASITOL, V32, P682, DOI [10.10164/j.pt.2016.05.010, 10.1016/j.pt.2016.05.010]; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Valecha N, 2012, CLIN INFECT DIS, V55, P663, DOI 10.1093/cid/cis475; Valecha N, 2010, CLIN INFECT DIS, V51, P684, DOI 10.1086/655831; Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; World Health Organization, 2016, WHOHTMGMP201611; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI 10.1016/S1473-3099(16)30415-7; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Woodrow CJ, 2017, FEMS MICROBIOL REV, V41, P34, DOI 10.1093/femsre/fuw037; Yang T, 2016, ANTIMICROB AGENTS CH, V60, P4501, DOI 10.1128/AAC.00574-16; Ye R, 2016, SCI REP-UK, V6, DOI 10.1038/srep20100	58	3	3	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	MAR-APR	2017	8	2							e00172-17	10.1128/mBio.00172-17				12	Microbiology	Microbiology	ET8TW	WOS:000400575700058		gold			2018-01-05	
J	Alapati, D; Morrisey, EE				Alapati, Deepthi; Morrisey, Edward E.			Gene Editing and Genetic Lung Disease Basic Research Meets Therapeutic Application	AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY			English	Article						genetic lung disease; CRISPR/Cas9; gene editing; lung progenitor cells	SURFACTANT PROTEIN-B; CONGENITAL ALVEOLAR PROTEINOSIS; DOUBLE-STRAND BREAKS; PHASE 2B TRIAL; CYSTIC-FIBROSIS; IN-VIVO; ALPHA-1-ANTITRYPSIN DEFICIENCY; HOMOLOGOUS RECOMBINATION; PULMONARY SURFACTANT; RESPIRATORY-FAILURE	Although our understanding of the genetics and pathology of congenital lung diseases such as surfactant protein deficiency, cystic fibrosis, and alpha-1 antitrypsin deficiency is extensive, treatment options are lacking. Because the lung is a barrier organ in direct communication with the external environment, targeted delivery of gene corrective technologies to the respiratory system via intratracheal or intranasal routes is an attractive option for therapy. CRISPR/Cas9 gene-editing technology is a promising approach to repairing or inactivating disease- causing mutations. Recent reports have provided proof of concept by using CRISPR/Cas9 to successfully repair or inactivate mutations in animal models of monogenichuman diseases. Potential pulmonary applications of CRISPR/Cas9 gene editing include gene correction of monogenic diseases in pre-or postnatal lungs and ex vivo gene editing of patient-specific airway stem cells followed by autologous cell transplant. Strategies to enhance gene- editing efficiency and eliminate off-target effects by targeting pulmonary stem/progenitor cells and the assessment of short-term and long-term effects of gene editing are important considerations as the field advances. If methods continue to advance rapidly, CRISPR/Cas9-mediated gene editing may provide a novel opportunity to correct monogenic diseases of the respiratory system.	[Alapati, Deepthi] Nemours Alfred I duPont Hosp Children, Dept Pediat, Wilmington, DE USA; [Alapati, Deepthi] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Alapati, Deepthi; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Alapati, Deepthi; Morrisey, Edward E.] Univ Penn, Penn Ctr Pulm Biol, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	Morrisey, EE (reprint author), Univ Penn, Translat Res Ctr, Room 11-124,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu			Nemours Foundation; National Institutes of Health	The authors thank the Nemours Foundation for research support. The Morrisey laboratory is supported by funding from the National Institutes of Health.	Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Boelig MM, 2016, BIOL BLOOD MARROW TR, V22, P991, DOI 10.1016/j.bbmt.2016.01.017; Brantly ML, 2006, HUM GENE THER, V17, P1177, DOI 10.1089/hum.2006.17.1177; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Cameron HS, 2005, J PEDIATR-US, V146, P370, DOI 10.1016/j.jpeds.2004.10.028; Carlon M, 2010, MOL THER, V18, P2130, DOI 10.1038/mt.2010.153; Carlon MS, 2014, HUM GENE THER, V25, P517, DOI 10.1089/hum.2013.196; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cole FS, 2000, PEDIATRICS, V105, P538, DOI 10.1542/peds.105.3.538; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Cystic Fibrosis Foundation, 2014, CYST FIBR FDN PAT RE; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; David AL, 2003, FETAL DIAGN THER, V18, P385, DOI 10.1159/000071984; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Grosse SD, 2006, J PEDIATR-US, V149, P362, DOI 10.1016/j.jpeds.2006.04.059; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Halbert CL, 1998, J VIROL, V72, P9795; Hamvas A, 1997, J PEDIATR-US, V130, P231, DOI 10.1016/S0022-3476(97)70348-2                                                   ; Hamvas A, 2006, SEMIN PERINATOL, V30, P316, DOI 10.1053/j.semperi.2005.11.002; Joyeux L, 2014, HUM GENE THER METHOD, V25, P197, DOI 10.1089/hgtb.2013.143; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; LaBarbera AR, 2016, J ASSIST REPROD GEN, V33, P1123, DOI 10.1007/s10815-016-0753-x; Lee TW, 2016, COCHRANE DB SYST REV, V6; Litao M. K., 2017, PEDIAT PULMONOL, V52, P57, DOI [10.1002/ppul.23493, DOI 10.1002/PPUL.23493]; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679                                                            ; Marshall BC, 2014, BMJ QUAL SAF, V23, P95, DOI 10.1136/bmjqs-2013-002790; Mastorakos P, 2015, P NATL ACAD SCI USA, V112, P8720, DOI 10.1073/pnas.1502281112; Melton KR, 2003, AM J PHYSIOL-LUNG C, V285, pL543, DOI 10.1152/ajplung.00011.2003; Moss RB, 2007, HUM GENE THER, V18, P726, DOI 10.1089/hum.2007.022; Myint M, 2014, HUM GENE THER, V25, P966, DOI 10.1089/hum.2014.002; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nogee LM, 2010, PEDIAT ALLER IMM PUL, V23, P15, DOI 10.1089/ped.2009.0024; Nogee LM, 2004, BIOL NEONATE, V85, P314, DOI 10.1159/000078171; Nogee LM, 2002, CHEST, V121, p20S, DOI 10.1378/chest.121.3_suppl.20S                                                   ; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; Palomar LM, 2006, J PEDIATR-US, V149, P548, DOI 10.1016/j.jpeds.2006.06.004; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184                                                            ; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Song S, 2001, GENE THER, V8, P1299, DOI 10.1038/sj.gt.3301422                                                           ; Spoonhower KA, 2016, CLIN CHEST MED, V37, P1, DOI 10.1016/j.ccm.2015.10.002; Stuhrmann M, 1998, PRENATAL DIAG, V18, P953, DOI 10.1002/(SICI)1097-0223(199809)18:9<953::AID-PD364>3.0.CO;2-J; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tanash HA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-44; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang LQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000155	69	0	0	10	16	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1044-1549	1535-4989		AM J RESP CELL MOL	Am. J. Respir. Cell Mol. Biol.	MAR	2017	56	3					283	290		10.1165/rcmb.2016-0301PS				8	Biochemistry & Molecular Biology; Cell Biology; Respiratory System	Biochemistry & Molecular Biology; Cell Biology; Respiratory System	ER4YL	WOS:000398808300005	27780343				2018-01-05	
J	Mascarenhas, JX; Korokhov, N; Burger, L; Kassim, A; Tuter, J; Miller, D; Borgschulte, T; George, HJ; Chang, A; Pintel, DJ; Onions, D; Kayser, KJ				Mascarenhas, Joaquina X.; Korokhov, Nikolay; Burger, Lisa; Kassim, Ademola; Tuter, Jason; Miller, Daniel; Borgschulte, Trissa; George, Henry J.; Chang, Audrey; Pintel, David J.; Onions, David; Kayser, Kevin J.			Genetic engineering of CHO cells for viral resistance to minute virus of mice	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						Chinese hamster ovary; adventitious contamination; mouse minute virus; cell line engineering; glycoengineering	SIALIC-ACID; DIFFERENTIAL EXPRESSION; MURINE PARVOVIRUS; BINDING-AFFINITY; O-GLYCOPROTEOME; PROTEINS; ALPHA-2,3-SIALYLTRANSFERASE; GLYCOSYLATION; INFECTION; CLONING	Contamination by the parvovirus minute virus of mice (MVM) remains a challenge in Chinese hamster ovary (CHO) biopharmaceutical production processes. Although infrequent, infection of a bioreactor can be catastrophic for a manufacturer, can impact patient drug supply and safety, and can have regulatory implications. We evaluated engineering a CHO parental cell line (CHOZN((R)) GS(-/-)) to create a new host cell line that is resistant to MVM infection by modifying the major receptors used by the virus to enter cells. Attachment to a cell surface receptor is a key first step in the infection cycle for many viruses. While the exact functional receptor for MVM binding to CHO cell surface is unknown, sialic acid on the cell surface has been implicated. In this work, we used the zinc finger nuclease gene editing technology to validate the role of sialic acid on the cell surface in the binding and internalization of the MVM virus. Our approach was to systematically mutate genes involved in cell surface sialylation and then challenge each cell line for their ability to resist viral entry and propagation. To test the importance of sialylation, the following genes were knocked out: the CMP-sialic acid transporter, solute carrier family 35A1 (Slc35a1), the core 1--1,3-galactosyltransferase-1 specific chaperone (Cosmc), and mannosyl (-1,3-)-glycoprotein -1,2-N-acetylglucosaminyltransferase (Mgat1) as well as members of the sialyltransferase family. Slc35a1 is responsible for transporting sialic acid into the Golgi. Knocking out function of this gene in a cell results in asialylated glycan structures, thus eliminating the ability of MVM to bind to and enter the cell. The complete absence of sialic acid on the Slc35a1 knockout cell line led to complete resistance to MVM infection. The Cosmc and Mgat1 knockouts also show significant inhibition of infection likely due to their effect on decreasing cell surface sialic acid. Previously in vitro glycan analysis has been used to elucidate the precise sialic acid structures required for MVM binding and internalization. In this work, we performed the sequential knockout of various sialyltransferases that add terminal sialic acid to glycans with different linkage specificities. Cell lines with modifications of the various genes included in this study resulted in varying effects on MVM infection expanding on the knowledge of MVM receptors. MVM resistant host cell lines were also tested for the production of model recombinant proteins. Our data demonstrate that resistance against the MVM virus can be incorporated into CHO production cell lines, adding another level of defense against the devastating financial consequences of MVM infection without compromising recombinant protein yield or quality. Biotechnol. Bioeng. 2017;114: 576-588. (c) 2016 Wiley Periodicals, Inc.	[Mascarenhas, Joaquina X.; Kassim, Ademola; Tuter, Jason; Miller, Daniel; Borgschulte, Trissa; George, Henry J.; Kayser, Kevin J.] SAFC MilliporeSigma, Cell Sci & Dev, St Louis, MO 63103 USA; [Korokhov, Nikolay; Chang, Audrey; Onions, David] MilliporeSigma, Bioreliance, Rockville, MD USA; [Burger, Lisa; Pintel, David J.] Univ Missouri, Sch Med, Columbia, MO USA	Mascarenhas, JX (reprint author), SAFC MilliporeSigma, Cell Sci & Dev, St Louis, MO 63103 USA.	joaquina.mascarenhas@sial.com			NIAID NIH HHS [R01 AI046458]		Adeyemi RO, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003891; Adeyemi RO, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001141; Agbandje-McKenna M, 1998, STRUCT FOLD DES, V6, P1369, DOI 10.1016/S0969-2126(98)00137-3                                                   ; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Berting A, 2010, BIOTECHNOL BIOENG, V106, P598, DOI 10.1002/bit.22723; Besselsen DG, 2006, J GEN VIROL, V87, P1543, DOI 10.1099/vir.0.81547-0; Chung CY, 2015, BIOCHEM BIOPH RES CO, V463, P211, DOI 10.1016/j.bbrc.2015.05.023; Cohen S, 2011, J VIROL, V85, P4863, DOI 10.1128/JVI.01999-10; Cotmore SF, 2007, ADV VIRUS RES, V70, P183, DOI 10.1016/S0065-3527(07)70005-2; Cotmore SF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012989; Cotmorel SF, 2003, J VIROL, V77, P6245, DOI 10.1128/JVI.77.11.6245-6254.2003; Cotmore SF, 1996, COLD SPRING HARBOR M, V31, P799; European Medicines Agency, 2006, GUID VIR SAF EV BIOT; Farr GA, 2006, J VIROL, V80, P161, DOI 10.1128/JVI.80.1.161-171.2006; Fay N, 2013, VIROLOGY, V444, P181, DOI 10.1016/j.virol.2013.06.009; Fukumoto S, 1999, J BIOL CHEM, V274, P9271, DOI 10.1074/jbc.274.14.9271; Garcin PO, 2015, VIROLOGY, V481, P63, DOI 10.1016/j.virol.2015.02.019; Garnick RL, 1996, DEV BIOL STAND, V88, P49; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Halder S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086909; Harduin-Lepers A, 2010, GLYCOBIOLOGY INSIGHT, V2, P29, DOI DOI 10.4137/GBI.S3123; Haryadi R, 2012, BIOENGINEERED, V4, P1; Hidalgo A, 2006, NEUROPATHOLOGY, V26, P501, DOI 10.1111/j.1440-1789.2006.00718.x; Kiss Robert D, 2011, PDA J Pharm Sci Technol, V65, P715, DOI 10.5731/pdajpst.2011.00852; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Lim SF, 2008, GLYCOBIOLOGY, V18, P851, DOI 10.1093/glycob/cwn080; Lin N, 2015, BIOTECHNOL PROGR, V31, P334, DOI 10.1002/btpr.2038; Liu LM, 2015, J PHARM SCI-US, V104, P1866, DOI 10.1002/jps.24444; Lopez-Bueno A, 2006, J VIROL, V80, P1563, DOI 10.1128/JVI.80.3.1563-1573.2005; Lopez-Bueno A, 2008, J VIROL, V82, P1195, DOI 10.1128/JVI.01692-07; MAXWELL IH, 1995, J VIROL, V69, P5829; Moody Mark, 2011, PDA J Pharm Sci Technol, V65, P580, DOI 10.5731/pdajpst.2011.00824; NAEGER LK, 1990, J VIROL, V64, P6166; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479                                                        ; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Raymond C, 2012, GLYCOSYLATION, P397, DOI 10.5772/51301; SASAKI K, 1993, J BIOL CHEM, V268, P22782; Sealover NR, 2013, J BIOTECHNOL, V167, P24, DOI 10.1016/j.jbiotec.2013.06.006; Services H., 1997, J IMMUNOTHER, V20, P214; Skrine Jim, 2011, PDA J Pharm Sci Technol, V65, P599, DOI 10.5731/pdajpst.2011.00823; Sonntag F, 2006, J VIROL, V80, P11040, DOI 10.1128/JVI.01056-06; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346; TATTERSALL P, 1983, J VIROL, V46, P944; TULLIS GE, 1988, J VIROL, V62, P2736; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Vihinen-Ranta M, 2004, J VIROL, V78, P6709, DOI 10.1128/JVI.78.13.6709-6714.2004; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yang Z, 2014, MOL CELL PROTEOMICS, V13, P3224, DOI 10.1074/mcp.M114.041541	54	0	0	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	MAR	2017	114	3					576	588		10.1002/bit.26186				13	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EL4QN	WOS:000394606000010	27642072	gold			2018-01-05	
J	Chadwick, AC; Musunuru, K				Chadwick, Alexandra C.; Musunuru, Kiran			Genome Editing for the Study of Cardiovascular Diseases	CURRENT CARDIOLOGY REPORTS			English	Review						Genome editing; Cardiovascular disease; ZFN; TALEN; CRISPR/Cas9; iPSC	PLURIPOTENT STEM-CELLS; ZINC-FINGER NUCLEASES; INNATE IMMUNE-RESPONSE; GENE-THERAPY; IN-VIVO; CRISPR-CAS9 NUCLEASES; IMPROVED SPECIFICITY; ADENOVIRAL VECTORS; TARGET SPECIFICITY; CAS9 NUCLEASES	Purpose of Review The opportunities afforded through the recent advent of genome-editing technologies have allowed investigators to more easily study a number of diseases. The advantages and limitations of the most prominent genome-editing technologies are described in this review, along with potential applications specifically focused on cardiovascular diseases. Recent Findings The recent genome-editing tools using programmable nucleases, such as zinc-finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9), have rapidly been adapted to manipulate genes in a variety of cellular and animal models. A number of recent cardiovascular disease-related publications report cases in which specific mutations are introduced into disease models for functional characterization and for testing of therapeutic strategies. Summary Recent advances in genome-editing technologies offer new approaches to understand and treat diseases. Here, we discuss genome editing strategies to easily characterize naturally occurring mutations and offer strategies with potential clinical relevance.	[Chadwick, Alexandra C.; Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.; Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	kiranmusunuru@gmail.com					Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Cao JL, 2016, DEVELOPMENT, V143, P232, DOI 10.1242/dev.130534; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Duff CJ, 2009, BIOCHEM J, V419, P577, DOI 10.1042/BJ20082407; Endres BT, 2014, P NATL ACAD SCI USA, V111, P12817, DOI 10.1073/pnas.1410745111; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Gregory SM, 2011, FUTURE VIROL, V6, P357, DOI 10.2217/FVL.11.6; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Gupta RM, 2016, ARTERIOSCL THROM VAS, V36, P15, DOI 10.1161/ATVBAHA.115.305956; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Ji DN, 2015, TRANSGENIC RES, V24, P227, DOI 10.1007/s11248-014-9834-8; Jiang JM, 2013, SCIENCE, V342, P111, DOI 10.1126/science.1236921; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Karakikes I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7955; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kotani H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128319; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; Li J, 2015, CIRC RES, V116, P1655, DOI 10.1161/CIRCRESAHA.116.306287; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maetzel D, 2014, STEM CELL REP, V2, P866, DOI 10.1016/j.stemcr.2014.03.014; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2015, NAT METHODS, V12, P465, DOI 10.1038/nmeth.3330; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Moreno C, 2011, HYPERTENSION, V57, P614, DOI 10.1161/HYPERTENSIONAHA.110.163840; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Niimi M, 2016, ATHEROSCLEROSIS, V245, P187, DOI 10.1016/j.atherosclerosis.2015.12.002; Novodvorsky P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141611; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Powell SK, 2015, DISCOV MED, V19, P49; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Seidah NG, 2013, CURR PHARM DESIGN, V19, P3161; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Themis M, 2005, MOL THER, V12, P763, DOI 10.1016/j.ymthe.2005.07.358; Theodoris CV, 2015, CELL, V160, P1072, DOI 10.1016/j.cell.2015.02.035; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Umeyama K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24413; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Wang YM, 2014, J AM COLL CARDIOL, V64, P451, DOI 10.1016/j.jacc.2014.04.057; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zhang M, 2014, P NATL ACAD SCI USA, V111, pE5383, DOI 10.1073/pnas.1419553111; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhu XH, 2015, HYPERTENSION, V66, P571, DOI 10.1161/HYPERTENSIONAHA.115.05183; Zou J, 2015, ELIFE, V4, DOI 10.7554/eLife.09406	92	2	2	4	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1523-3782	1534-3170		CURR CARDIOL REP	Curr. Cardiol. Rep.	MAR	2017	19	3							22	10.1007/s11886-017-0830-5				8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	ER6MG	WOS:000398918800004	28220462				2018-01-05	
J	Huang, MNY; Mitchell, AP				Huang, Manning Y.; Mitchell, Aaron P.			Marker Recycling in Candida albicans through CRISPR-Cas9-Induced Marker Excision	MSPHERE			English	Article						CRISPR; biotechnology; genetics	GENE DISRUPTION; SACCHAROMYCES-CEREVISIAE; DNA; SYSTEM; RECOMBINATION; STRAINS; CONSTRUCTION; CELLS	We describe here a new approach to marker recycling, a controlled sequence of steps in which a genetic marker is selected and then lost. Marker recycling is important for genetic manipulation, because it allows a single selection marker to be used repeatedly. Our approach relies upon the ability of the CRISPR-Cas9 system to make a targeted double-strand break in DNA and the expectation that a double-strand break within a selection marker may promote recombination between directly repeated sequences that flank the marker. We call the approach CRISPR-Cas9-induced marker excision (CRIME). We tested the utility of this approach with the fungal pathogen Candida albicans, which is typically diploid. We used two selection markers, modified to include flanking direct repeats. In a proof-of-principle study, we created successive homozygous deletions in three genes through use of the two markers and had one of the markers available in the final strain for further selection and recycling. This strategy will accelerate the creation of multiple-mutant strains in C. albicans. CRISPR-Cas9 systems have been applied to many organisms, so the genetic design principles described here may be broadly applicable. IMPORTANCE It is critical to be able to alter genes in order to elucidate their functions. These alterations often rely upon markers that allow selection for a rare cell in a population that has incorporated a piece of DNA. The number of alterations that can be accomplished is thus limited by the number of selection markers that are available. This limitation is circumvented by marker recycling strategies, in which a marker is eliminated after its initial use. Then, the marker can be used again. In this report, we describe a new marker recycling strategy that is enabled by recently developed CRISPR-Cas9 technology.	[Huang, Manning Y.; Mitchell, Aaron P.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA	Mitchell, AP (reprint author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	apm1@cmu.edu		Huang, Manning/0000-0001-6045-9698; Mitchell, Aaron/0000-0002-0868-4000			ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test                                                   ; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; de Hoogt R, 2000, BIOTECHNIQUES, V28, P1112; FONZI WA, 1993, GENETICS, V134, P717; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones EW, 2008, YEAST, V25, P41, DOI 10.1002/yea.1552; Min K, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00130-16; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Nobile Clarissa J., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020063; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Papon N, 2012, MICROBIOL-SGM, V158, P585, DOI 10.1099/mic.0.055244-0; Reu O, 2004, GENE, V341, P119, DOI DOI 10.1016/J.GENE.2004.06.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SIKORSKI RS, 1989, GENETICS, V122, P19; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563                                                            ; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	26	3	3	2	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5042			MSPHERE	mSphere	MAR-APR	2017	2	2							e00050-17	10.1128/mSphere.00050-17				10	Microbiology	Microbiology	ER9VH	WOS:000399174700007		gold			2018-01-05	
J	Pennington, MR; Van de Walle, GR				Pennington, Matthew R.; Van de Walle, Gerlinde R.			Electric Cell-Substrate Impedance Sensing To Monitor Viral Growth and Study Cellular Responses to Infection with Alphaherpesviruses in Real Time	MSPHERE			English	Article						ECIS; alphaherpesvirus; antiviral agents; genome editing; growth kinetics	IN-VITRO CYTOTOXICITY; FELINE HERPESVIRUS; OCULAR MANIFESTATIONS; CRISPR-CAS9 SYSTEM; MDCK CELLS; VIRUS; PROTEIN; DRUGS; CIDOFOVIR; APOPTOSIS	Electric cell-substrate impedance sensing (ECIS) measures changes in an electrical circuit formed in a culture dish. As cells grow over a gold electrode, they block the flow of electricity and this is read as an increase in electrical impedance in the circuit. ECIS has previously been used in a variety of applications to study cell growth, migration, and behavior in response to stimuli in real time and without the need for cellular labels. Here, we demonstrate that ECIS is also a valuable tool with which to study infection by alphaherpesviruses. To this end, we used ECIS to study the kinetics of cells infected with felid herpesvirus type 1 (FHV-1), a close relative of the human alphaherpesviruses herpes simplex virus 1 (HSV-1) and HSV-2, and compared the results to those obtained with conventional infectivity assays. First, we demonstrated that ECIS can easily distinguish between wells of cells infected with different amounts of FHV-1 and provides information about the cellular response to infection. Second, we found ECIS useful in identifying differences between the replication kinetics of recombinant DsRed Express2-labeled FHV-1, created via CRISPR/Cas9 genome engineering, and wild-type FHV-1. Finally, we demonstrated that ECIS can accurately determine the half-maximal effective concentration of antivirals. Collectively, our data show that ECIS, in conjunction with current methodologies, is a powerful tool that can be used to monitor viral growth and study the cellular response to alphaherpesvirus infection. IMPORTANCE Alphaherpesviruses, including those that commonly infect humans, such as HSV-1 and HSV-2, typically infect and cause cellular damage to epithelial cells at mucosal surfaces, leading to disease. The development of novel technologies to study the cellular responses to infection may allow a more complete understanding of virus replication and the creation of novel antiviral therapies. This study demonstrates the use of ECIS to study various aspects of herpesvirus biology, with a specific focus on changes in cellular morphology as a result of infection. We conclude that ECIS represents a valuable new tool with which to study alphaherpesvirus infections in real time and in an objective and reproducible manner.	[Pennington, Matthew R.; Van de Walle, Gerlinde R.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA	Van de Walle, GR (reprint author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	grv23@cornell.edu			Cornell University Feline Health Center	The Cornell University Feline Health Center supported Gerlinde Van de Walle. The funding agency had no role in study design, data collection and interpretation, manuscript preparation, or the decision to submit the work for publication.	Arii J, 2009, MICROBIOL IMMUNOL, V53, P433, DOI 10.1111/j.1348-0421.2009.00147.x; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984                                                        ; Bennet D, 2013, ANAL CHEM, V85, P4902, DOI 10.1021/ac303068t; Bondu V, 2015, VIRUSES-BASEL, V7, P559, DOI 10.3390/v7020559; Bussche L, 2015, STEM CELL RES THER, V2; Butler J. M., 2001, FORENSIC DNA TYPING; Fontenelle JR, 2008, AM J VET RES, V69, P289, DOI 10.2460/ajvr.69.2.289; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Gaskell R, 2007, VET RES, V38, P337, DOI 10.1051/vetres:2006063; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Gould D, 2011, J FELINE MED SURG, V13, P333, DOI 10.1016/j.jfms.2011.03.010; Grobner S, 2014, MICROBIOL IMMUNOL, V58, P61, DOI 10.1111/1348-0421.12116; Harman RM, 2016, J MAMMARY GLAND BIOL, V21, P51, DOI 10.1007/s10911-016-9350-y; Kilani MM, 2004, CHEST, V126, P186, DOI 10.1378/chest.126.1.186                                                         ; Ledbetter EC, 2013, NEW ZEAL VET J, V61, P193, DOI 10.1080/00480169.2013.768151; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0                                                   ; Lo CM, 1999, EXP CELL RES, V250, P576, DOI 10.1006/excr.1999.4538; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Maes R., 2012, ISRN VET SCI, V2012; Maggs DJ, 2004, AM J VET RES, V65, P399, DOI 10.2460/ajvr.2004.65.399; Mansouri M, 2008, J VIROL, V82, P9615, DOI 10.1128/JVI.02633-07; Marconi P, 2014, METHODS MOL BIOL, V1144, P19, DOI 10.1007/978-1-4939-0428-0_2; McCoy MH, 2005, J VIROL METHODS, V130, P157, DOI 10.1016/j.jviromet.2005.06.023; Motamedifar M, 2008, MICRON, V39, P1331, DOI 10.1016/j.micron.2008.02.007; Murono S, 2001, CANCER RES, V61, P7875; Musee J, 2002, ANTIVIR RES, V56, P143, DOI 10.1016/S0166-3542(02)00106-7; Opp D, 2009, BIOSENS BIOELECTRON, V24, P2625, DOI 10.1016/j.bios.2009.01.015; Pennington MR, 2016, J GEN VIROL, V97, P1414, DOI 10.1099/jgv.0.000451; Pennington MR, 2016, TISSUE ENG PART C-ME, V22, P596, DOI [10.1089/ten.tec.2015.0403, 10.1089/ten.TEC.2015.0403]; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Russell TA, 2015, J VIROL METHODS, V213, P18, DOI 10.1016/j.jviromet.2014.11.009; Stiles J, 2014, VET J, V201, P166, DOI 10.1016/j.tvjl.2013.11.018; Stolwijk JA, 2015, PFLUG ARCH EUR J PHY, V467, P2193, DOI 10.1007/s00424-014-1674-0; Suenaga T, 2014, MICROBIOL IMMUNOL, V58, P513, DOI 10.1111/1348-0421.12180; Szulcek R, 2014, JOVE-J VIS EXP, V85, P51300; Tai SHS, 2016, VIRUS RES, V221, P15, DOI 10.1016/j.virusres.2016.05.001; van der Meulen K, 2006, BMC Vet Res, V2, P13, DOI 10.1186/1746-6148-2-13; Vrzheshch PV, 2000, FEBS LETT, V487, P203, DOI 10.1016/S0014-5793(00)02344-9; Wakisaka N, 2005, INT J CANCER, V116, P640, DOI 10.1002/ijc.21096; WALTON TE, 1970, CORNELL VET, V60, P232; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Xie FB, 2012, ANALYST, V137, P1343, DOI 10.1039/c2an16141a; Xu YC, 2016, BIOSENS BIOELECTRON, V77, P824, DOI 10.1016/j.bios.2015.10.027	44	1	1	0	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5042			MSPHERE	mSphere	MAR-APR	2017	2	2							e00039-17	10.1128/mSphere.00039-17				12	Microbiology	Microbiology	ER9VH	WOS:000399174700004		gold			2018-01-05	
J	Duan, Y; Dou, S; Luo, S; Zhang, H; Lu, J				Duan, Yuange; Dou, Shengqian; Luo, Shiqi; Zhang, Hong; Lu, Jian			Adaptation of A-to-I RNA editing in Drosophila	PLOS GENETICS			English	Article							DNA-SEQUENCE DIFFERENCES; HIGHLY EXPRESSED PROTEINS; MESSENGER-RNA; HUMAN TRANSCRIPTOME; WIDESPREAD RNA; ADENOSINE DEAMINASES; HUMAN BRAIN; HEAT-SHOCK; GLUR-B; EVOLUTION	Adenosine-to-inosine (A-to-I) editing is hypothesized to facilitate adaptive evolution by expanding proteomic diversity through an epigenetic approach. However, it is challenging to provide evidences to support this hypothesis at the whole editome level. In this study, we systematically characterized 2,114 A-to-I RNA editing sites in female and male brains of D. melanogaster, and nearly half of these sites had events evolutionarily conserved across Drosophila species. We detected strong signatures of positive selection on the nonsynonymous editing sites in Drosophila brains, and the beneficial editing sites were significantly enriched in genes related to chemical and electrical neurotransmission. The signal of adaptation was even more pronounced for the editing sites located in X chromosome or for those commonly observed across Drosophila species. We identified a set of gene candidates (termed '' PSEB '' genes) that had nonsynonymous editing events favored by natural selection. We presented evidence that editing preferentially increased mutation sequence space of evolutionarily conserved genes, which supported the adaptive evolution hypothesis of editing. We found prevalent nonsynonymous editing sites that were favored by natural selection in female and male adults from five strains of D. melanogaster. We showed that temperature played a more important role than gender effect in shaping the editing levels, although the effect of temperature is relatively weaker compared to that of species effect. We also explored the relevant factors that shape the selective patterns of the global editomes. Altogether we demonstrated that abundant nonsynonymous editing sites in Drosophila brains were adaptive and maintained by natural selection during evolution. Our results shed new light on the evolutionary principles and functional consequences of RNA editing.	[Duan, Yuange; Dou, Shengqian; Luo, Shiqi; Zhang, Hong; Lu, Jian] Peking Univ, Sch Life Sci Peking Tsinghua Ctr Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Duan, Yuange] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China	Lu, J (reprint author), Peking Univ, Sch Life Sci Peking Tsinghua Ctr Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China.	luj@pku.edu.cn			National Natural Science Foundation of China [91431101, 31571333]; Ministry of Science and Technology of the People's Republic of China [2016YFA0500800]; Peking T singhua Center for Life Science	This work was supported by grants from the National Natural Science Foundation of China (No.91431101 and 31571333), Ministry of Science and Technology of the People's Republic of China (2016YFA0500800) and the Peking T singhua Center for Life Science to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alon S, 2015, ELIFE, V4, DOI 10.7554/eLife.05198; Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bass BL, 1997, RNA, V3, P947; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bhansali P, 2007, J NEUROSCI, V27, P1467, DOI 10.1523/JNEUROSCI.4632-06.2007; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chen JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004274; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Englander MT, 2005, J NEUROSCI, V25, P648, DOI 10.1523/JNEUROSCI.3895-04.2005; Fisher R. A., 1930, GENETICAL THEORY NAT; Flomen R, 2004, NUCLEIC ACIDS RES, V32, P2113, DOI 10.1093/nar/gkh536; Garrett S, 2012, SCIENCE, V335, P848, DOI 10.1126/science.1212795; Gan Z, 2006, J BIOL CHEM, V281, P33386; Gommans WM, 2009, BIOESSAYS, V31, P1137, DOI 10.1002/bies.200900045; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Grenier JK, 2015, G3-GENES GENOM GENET, V5, P593, DOI 10.1534/g3.114.015883; Hannon GJ, 2002, NATURE, P418; Hanrahan CJ, 2000, GENETICS, V155, P1149; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Hedrick PW, 1999, HEREDITY, V82, P126; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Jepson JEC, 2011, J BIOL CHEM, V286, P8325, DOI 10.1074/jbc.M110.186817; Jin YF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-98; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584                                                                ; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kleinberger Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-453; Kleinman CL, 2012, SCIENCE, V335, DOI 10.1126/science.1209658; Klironomos FD, 2013, BIOESSAYS, V35, P571, DOI 10.1002/bies.201200169; Kurmangaliyev YZ, 2016, G3-GENES GENOM GENET, V6, P391, DOI 10.1534/g3.115.024471; Laehnemann D, 2016, BRIEF BIOINFORM, V17, P154, DOI 10.1093/bib/bbv029; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; LI WH, 1985, MOL BIOL EVOL, V2, P150; Liang H, 2007, RNA, V13, P463, DOI 10.1261/rna.296407; Licht K, 2016, J CELL BIOL, V213, P15, DOI 10.1083/jcb.201511041; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu J, 2005, P NATL ACAD SCI USA, V102, P4063, DOI 10.1073/pnas.0500436102; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Maldonado C, 2013, MOL CELL NEUROSCI, V52, P173, DOI 10.1016/j.mcn.2012.10.009; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nevo-Caspi Y, 2011, SHOCK, V35, P585, DOI 10.1097/SHK.0b013e31820fe4b7; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrn2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, P6; Park C, 2013, P NATL ACAD SCI USA, V110, pE678, DOI 10.1073/pnas.1218066110; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Qian WF, 2012, CELL REP, V2, P1399, DOI 10.1016/j.celrep.2012.09.017; Ramaswami G, 2015, NAT COMMUN, P6; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2                                                   ; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rieder LE, 2015, BMC BIOL, V13, DOI 10.1186/s12915-014-0111-3; Rodriguez J, 2012, MOL CELL, V47, P27, DOI 10.1016/j.molcel.2012.05.002; ROSE MR, 1982, HEREDITY, V48, P63, DOI 10.1038/hdy.1982.7                                                              ; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Ryman K, 2007, RNA, V13, P1071, DOI 10.1261/rna.404407; Sakurai M, 2014, GENOME RES, V24, P522, DOI 10.1101/gr.162537.113; Savva YA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4157; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; Savva YA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1789; Schirmer M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0976-y; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12<1057::AID-BIES3>3.3.CO;2-N; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675; Stearns FW, 2010, GENETICS, V186, P767, DOI 10.1534/genetics.110.122549; Stocker J, 2013, KAOHSIUNG J MED SCI, V29, P478, DOI 10.1016/j.kjms.2013.01.001; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; Tian N, 2008, RNA, V14, P211, DOI 10.1261/rna.797108; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; WAHBA AJ, 1962, P NATL ACAD SCI USA, V48, P1683, DOI 10.1073/pnas.48.9.1683; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wall JD, 2014, GENOME RES, V24, P1734, DOI 10.1101/gr.168393.113; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x                                              ; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Xu GX, 2015, MOL BIOL EVOL, V32, P536, DOI 10.1093/molbev/msu314; Xu GX, 2014, P NATL ACAD SCI USA, V111, P3769, DOI 10.1073/pnas.1321745111; Yang JR, 2012, P NATL ACAD SCI USA, V109, pE831, DOI 10.1073/pnas.1117408109; Yang XZ, 2015, MOL BIOL EVOL, V32, P3143, DOI 10.1093/molbev/msv183; Yu Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006191; Zhang JZ, 2015, NAT REV GENET, V16, P409, DOI 10.1038/nrg3950; Zhang R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006563; Zhao HQ, 2015, GENOME RES, V25, P66, DOI 10.1101/gr.176107.114; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310; Zinshteyn B, 2009, WIRES SYST BIOL MED, V1, P202, DOI [10.1002/wsbm.010, 10.1002/wsbm.10]	119	3	3	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	MAR	2017	13	3							e1006648	10.1371/journal.pgen.1006648				46	Genetics & Heredity	Genetics & Heredity	EQ4JO	WOS:000398043000035	28282384	gold			2018-01-05	
J	Dale, J; Paul, JY; Dugdale, B; Harding, R				Dale, James; Paul, Jean-Yves; Dugdale, Benjamin; Harding, Robert			Modifying Bananas: From Transgenics to Organics?	SUSTAINABILITY			English	Review						bananas; disease resistance; biofortification; organic farming; genetic modification	F-SP CUBENSE; BUNCHY-TOP-VIRUS; SUB-SAHARAN AFRICA; TROPICAL RACE 4; FUSARIUM-OXYSPORUM; MUSA SPP.; WILT DISEASE; 1ST REPORT; NEW-GUINEA; RESISTANCE	Bananas are one of the top ten world food crops. Unlike most other major food crops, bananas are difficult to genetically improve. The challenge is that nearly all banana cultivars and landraces are triploids, with high levels of male and female infertility. There are a number of international conventional breeding programs and many of these are developing new cultivars. However, it is virtually impossible to backcross bananas, thus excluding the possibility of introgressing new traits into a current cultivar. The alternative strategy is to "modify" the cultivar itself. We have been developing the capacity to modify Cavendish bananas and other cultivars for both disease resistance and enhanced fruit quality. Initially, we were using transgenes; genes that were derived from species outside of the Musa or banana genus. However, we have recently incorporated two banana genes (cisgenes) into Cavendish; one to enhance the level of pro-vitamin A and the other to increase the resistance to Panama disease. Modified Cavendish with these cisgenes have been employed in a field trial. Almost certainly, the next advance will be to edit the Cavendish genome, to generate the desired traits. As these banana cultivars are essentially sterile, transgene flow and the outcrossing of modified genes into wild Musa species. are highly unlikely and virtually impossible in other triploid cultivars. Therefore, genetic changes in bananas may be compatible with organic farming.	[Dale, James; Paul, Jean-Yves; Dugdale, Benjamin; Harding, Robert] Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld 4000, Australia	Dale, J (reprint author), Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld 4000, Australia.	j.dale@qut.edu.au; jy.paul@qut.edu.au; b.dugdale@qut.edu.au; r.harding@qut.edu.au		Harding, Rob/0000-0002-9600-7287			Adegbola RO, 2013, PLANT DIS, V97, P290, DOI 10.1094/PDIS-08-12-0745-PDN; Alliance for a Green Revolution in Africa (AGRA), 2014, AFR AGR STAT REP 201; Ahmad P, 2012, BIOTECHNOL ADV, V30, P524, DOI 10.1016/j.biotechadv.2011.09.006; Arango Isaza R. E., 2016, PLOS GENET, V12, DOI [10.1371/journal.pgen.1005876 27512984, DOI 10.1371/JOURNAL.PGEN.1005876]; Arias P., 2003, OVERVIEW WORLD BANAN; Arias P, 2003, WORLD BANANA EC 1985; Asif MH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0316-1; Becker DK, 2000, PLANT CELL REP, V19, P229, DOI 10.1007/s002990050004; Blomme G, 2013, ANN APPL BIOL, V162, P4, DOI 10.1111/aab.12002; Buddenhagen I, 2009, ACTA HORTIC, V828, P193; Butler D, 2013, NATURE, V504, P195, DOI 10.1038/504195a; Cardi T, 2016, PLANT CELL REP, V35, P1401, DOI 10.1007/s00299-016-1975-1; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dale J., 2015, DEV BANANAS OPTIMISE, p[106, 113]; DALE JL, 1987, ADV VIRUS RES, V33, P301, DOI 10.1016/S0065-3527(08)60321-8; Damodaran T, 2009, FRUITS, V64, P3, DOI 10.1051/fruits:2008044; Davey MW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-683; Foure E, 2010, FRUITS, V65, P327; Denham T, 2004, ANTIQUITY, V78, P839; Denham TP, 2003, SCIENCE, V301, P189, DOI 10.1126/science.1085255; Eden-Green S., 2004, Infomusa, V13, P38; Elitzur T, 2016, PLANT PHYSIOL, V171, P380, DOI 10.1104/pp.15.01866; Garcia-Bastidas F, 2014, PLANT DIS, V98, P694, DOI 10.1094/PDIS-09-13-0954-PDN; Ghag SB, 2014, PLANT CELL TISS ORG, V119, P247, DOI 10.1007/s11240-014-0529-x; Ghag SB, 2014, PLANT BIOTECHNOL J, V12, P541, DOI 10.1111/pbi.12158; HARDING RM, 1991, J GEN VIROL, V72, P225, DOI 10.1099/0022-1317-72-2-225; HarvestPlus Disseminating, 2012, DISS OR FLESH SWEET; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; Iskra-Caruana ML, 2014, INFECT GENET EVOL, V21, P83, DOI 10.1016/j.meegid.2013.10.013; Khanna H, 2004, MOL BREEDING, V14, P239, DOI 10.1023/B:MOLB.0000047771.34186.e8; Kumar PL, 2011, VIRUS RES, V159, P171, DOI 10.1016/j.virusres.2011.04.021; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; Li WM, 2015, PLANT PATHOL, V64, P1061, DOI 10.1111/ppa.12340; Lisko KA, 2013, IN VITRO CELL DEV-PL, V49, P643, DOI 10.1007/s11627-013-9568-y; Molina A., 2008, P CENT M AM PHYT SOC; Mwari B., 2016, THESIS; Namukwaya B, 2012, TRANSGENIC RES, V21, P855, DOI 10.1007/s11248-011-9574-y; Nowakunda K, 2015, HORTSCIENCE, V50, P621; Ordonez N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005197; ORTIZ R, 1994, THEOR APPL GENET, V89, P146, DOI 10.1007/BF00225134; Ortiz R, 2014, BIOTECHNOL ADV, V32, P158, DOI 10.1016/j.biotechadv.2013.09.010; Paul JY, 2011, PLANT BIOTECHNOL J, V9, P1141, DOI 10.1111/j.1467-7652.2011.00639.x; Paul JW, 2016, PLANT CELL REP, V35, P1417, DOI 10.1007/s00299-016-1985-z; Peraza-Echeverria S, 2009, MOL BREEDING, V23, P431, DOI 10.1007/s11032-008-9247-6; Peraza-Echeverria S, 2007, THESIS; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Ploetz R., 2007, SPECIES PROFILES PAC; Ploetz RC, 2015, PHYTOPATHOLOGY, V105, P1512, DOI 10.1094/PHYTO-04-15-0101-RVW; Ploetz RC, 2015, CROP PROT, V73, P7, DOI 10.1016/j.cropro.2015.01.007; Ploetz R. C., 2015, FUTURE GLOBAL BANANA, V43, P311; Queensland Government Department of Agriculture and Fisheries, 2015, A Z LIST EM PLANT PE; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Shekhawat UKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075506; Shekhawat UKS, 2012, J GEN VIROL, V93, P1804, DOI 10.1099/vir.0.041871-0; Simmonds N. W., 1966, BANANAS; Ssali RT, 2013, EUPHYTICA, V194, P425, DOI 10.1007/s10681-013-0971-6; Stover R. H., 1962, FUSARIAL WILT PANAMA; Syed RN, 2015, J PLANT PATHOL, V97, P213; Tripathi L., 2016, COMMUNICATION; Tripathi L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08127; Tripathi L, 2014, NAT BIOTECHNOL, V32, P868, DOI 10.1038/nbt.3007; Tripathi L, 2010, MOL PLANT PATHOL, V11, P721, DOI 10.1111/j.1364-3703.2010.00639.x; Uganda Bureau of Statistics (UBOS), 2011, UG DEM HLTH SURV 200; UBOS, 2006, UG DEM HLTH SURV 200; Umber M, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0493-8; Food and Agriculture Organization of the United Nations, 2014, BAN MARK REV BAN STA; Wang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-650	67	2	2	19	84	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2071-1050			SUSTAINABILITY-BASEL	Sustainability	MAR	2017	9	3							333	10.3390/su9030333				13	GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Environmental Sciences; Environmental Studies	Science & Technology - Other Topics; Environmental Sciences & Ecology	ER3RA	WOS:000398714100010		gold			2018-01-05	
J	Chen, J; MacCarthy, T				Chen, Jeffrey; MacCarthy, Thomas			The preferred nucleotide contexts of the AID/APOBEC cytidine deaminases have differential effects when mutating retrotransposon and virus sequences compared to host genes	PLOS COMPUTATIONAL BIOLOGY			English	Article							SINGLE-STRANDED-DNA; RNA-EDITING ENZYME; POLYNUCLEOTIDE (DEOXY)CYTIDINE DEAMINASES; INHIBIT LINE-1 RETROTRANSPOSITION; SOMATIC HYPERMUTATION; IN-VIVO; APOBEC3 PROTEINS; HOUSEKEEPING GENES; MURINE APOBEC3; AID	The AID / APOBEC genes are a family of cytidine deaminases that have evolved in vertebrates, and particularly mammals, to mutate RNA and DNA at distinct preferred nucleotide contexts (or "hotspots") on foreign genomes such as viruses and retrotransposons. These enzymes play a pivotal role in intrinsic immunity defense mechanisms, often deleteriously mutating invading retroviruses or retrotransposons and, in the case of AID, changing antibody sequences to drive affinity maturation. We investigate the strength of various hotspots on their known biological targets by evaluating the potential impact of mutations on the DNA coding sequences of these targets, and compare these results to hypothetical hotspots that did not evolve. We find that the existing AID / APOBEC hotspots have a large impact on retrotransposons and non-mammalian viruses while having a much smaller effect on vital mammalian genes, suggesting co-evolution with AID / APOBECs may have had an impact on the genomes of the viruses we analyzed. We determine that GC content appears to be a significant, but not sole, factor in resistance to deaminase activity. We discuss possible mechanisms AID and APOBEC viral targets have adopted to escape the impacts of deamination activity, including changing the GC content of the genome.	[Chen, Jeffrey; MacCarthy, Thomas] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	MacCarthy, T (reprint author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	thomas.maccarthy@stonybrook.edu			National Institutes of Health [1R01GM111741]; Stony Brook Graduate School fellowship	This work was supported by National Institutes of Health 1R01GM111741 to TM and by a Stony Brook Graduate School fellowship to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Armitage AE, 2008, J VIROL, V82, P8743, DOI 10.1128/JVI.00584-08; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100; Brown Jay C, 2007, Open Biochem J, V1, P33, DOI 10.2174/1874091X00701010033; Carmi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1525; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Esnault C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-75; Etard C, 2010, J CELL BIOL, V189, P527, DOI 10.1083/jcb.200912125; Harris R, 2008, NAT BIOTECHNOL, V26, P1089, DOI 10.1038/nbt1008-1089; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Harris RS, 2015, VIROLOGY; Henry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030036; HIGUCHI K, 1992, J LIPID RES, V33, P1753; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Ikeda T, 2011, NUCLEIC ACIDS RES, V39, P5538, DOI 10.1093/nar/gkr124; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; KARLIN S, 1985, P NATL ACAD SCI USA, V82, P5800, DOI 10.1073/pnas.82.17.5800                                                         ; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Knisbacher BA, 2015, TRENDS GENETICS TIG; Knisbacher BA, 2015, MOL BIOL EVOLUTION; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Komeno Y, 2010, LEUKEMIA, V24, P1018, DOI 10.1038/leu.2010.40; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li ZQ, 2006, IMMUNITY, V24, P393, DOI 10.1016/j.immuni.2006.02.011; Li ZQ, 2003, NAT IMMUNOL, V4, P945, DOI 10.1038/ni1003-945; Liang GX, 2013, P NATL ACAD SCI USA, V110, P2246, DOI 10.1073/pnas.1221921110; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Lovsin N, 2009, ANN NY ACAD SCI, V1178, P268, DOI 10.1111/j.1749-6632.2009.05006.x; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; McLaughlin RN, 2016, MOL BIOL EVOL, V33, P1889, DOI 10.1093/molbev/msw070; Minkah N, 2014, VIROLOGY, V454, P215, DOI [10.1016/j.viro1.2014.02.022, 10.1016/j.virol.2014.02.022]; Monajemi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093428; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Orthwein A, 2012, SEMIN IMMUNOL, V24, P246, DOI 10.1016/j.smim.2012.05.001; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peng ZG, 2011, HEPATOLOGY, V53, P1080, DOI 10.1002/hep.24160; Petan T, 2013, RETROVIROLOGY, V10, P156; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Powell C, 2014, J BIOL CHEM, V289, P28924, DOI 10.1074/jbc.M114.603043; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Richardson SR, 2014, APOBEC3A DEAMINATES, V14; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994                                                             ; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Sato K., 2014, WORMBOOK, V2014, P1, DOI DOI 10.1895/W0RMB00K.1.77.2; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Suspene R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063461; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Sweet RA, 2013, J IMMUNOL, V190, P1974, DOI 10.4049/jimmunol.1202816; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tsuge M, 2010, VIRUS RES, V149, P211, DOI 10.1016/j.virusres.2010.01.019; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vonica A, 2011, DEV BIOL, V350, P13, DOI 10.1016/j.ydbio.2010.09.016; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Willems L, 2015, VIRUSES, V7, P2757; Willems L, 2015, VIRUSES-BASEL, V7, P2999, DOI 10.3390/v7062757; Yaari G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00358; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031849	83	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	MAR	2017	13	3							e1005471	10.1371/journal.pcbi.1005471				32	Biochemical Research Methods; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Mathematical & Computational Biology	EQ4FY	WOS:000398031900005	28362825	gold			2018-01-05	
J	Zhang, C; Gao, H; Yang, ZK; Jiang, YY; Li, ZK; Wang, X; Xiao, B; Su, XZ; Cui, HT; Yuan, J				Zhang, Cui; Gao, Han; Yang, Zhenke; Jiang, Yuanyuan; Li, Zhenkui; Wang, Xu; Xiao, Bo; Su, Xin-Zhuan; Cui, Huiting; Yuan, Jing			CRISPR/Cas9 mediated sequential editing of genes critical for ookinete motility in Plasmodium yoelii	MOLECULAR AND BIOCHEMICAL PARASITOLOGY			English	Article						Rodent malaria; Genetic modifications; Cas9; Pyctrp; Pycdpk3; yFCU	MALARIA PARASITES; BLOOD STAGES; FALCIPARUM; BERGHEI; EXPRESSION; MOSQUITO; PROTEIN; TRANSFORMATION; RECOMBINATION; TRANSFECTION	CRISPR/Cas9 has been successfully adapted for gene editing in malaria parasites including Plasmodium falciparum and Plasmodium yoelii. However, the reported methods were limited to editing one gene at a time. In practice, it is often desired to modify multiple genetic loci in a parasite genome. Here we describe a CRISPR/Cas9 mediated genome editing method that allows successive modification of more than one gene in the genome of P. yoelii using an improved single-vector system (pYCm) we developed previously. Drug resistant genes encoding human dihydrofolate reductase (hDHFR) and a yeast bifunctional protein (yFCU), with cytosine deaminase (CD) and uridyl phosphoribosyl transferase (UPRT) activities in the plasmid, allowed sequential positive (pyrimethamine, Pyr) and negative (5-fluorocytosine, 5FC) selections and generation of transgenic parasites free of the episomal plasmid after genetic modification. Using this system, we were able to efficiently tag a gene of interest (Pyp28) and subsequently disrupted two genes (Pyctrp and Pycdpk3) that are individually critical for ookinete motility. Disruption of the genes either eliminated (Pyctrp) or greatly reduced (Pycdpk3) ookinete forward motility in matrigel in vitro and completely blocked oocyst development in mosquito midgut. The method will greatly facilitate studies of parasite gene function, development, and disease pathogenesis. (C) 2016 Elsevier B.V. All rights reserved.	[Zhang, Cui; Gao, Han; Yang, Zhenke; Jiang, Yuanyuan; Li, Zhenkui; Wang, Xu; Xiao, Bo; Su, Xin-Zhuan; Cui, Huiting; Yuan, Jing] Xiamen Univ, Innovat Ctr Cell Signaling Network, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China; [Su, Xin-Zhuan] NIH, Lab Malaria & Vector Res, Natl Inst Allergy & Infect Dis, Bethesda, MD 20892 USA	Cui, HT; Yuan, J (reprint author), Xiamen Univ, Innovat Ctr Cell Signaling Network, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China.	cuihuiting@xmu.edu.cn; yuanjing@xmu.edu.cn		Su, Xinzhuan/0000-0003-3246-3248	"863" National High Technology Research and Development Program of China [2014AA020530]; National Natural Science Foundation of China [81522027, 31401143, 31501912]; China Thousand Youth Talents Plan; "973" National Basic Research Program of China [2014CB744501]; Fundamental Research Funds for the Central Universities of China-Xiamen University [20720160069, 20720150165, 2013121033]; Special Research Fund for the Doctoral Program of Higher Education of China [20130121120023, 20130121120024]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China; "111" Project of the Ministration of Education of China [B06016]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)	We are grateful to Dr. Olivier Silvie for providing plasmid pGOMO. This work was supported by grants from the "863" National High Technology Research and Development Program of China (2014AA020530, Y.J.), the National Natural Science Foundation of China (grant numbers 81522027 (Y.J.), 31401143 (Y.J.), and 31501912 (H.C.)), the China Thousand Youth Talents Plan (Y.J.), the "973" National Basic Research Program of China (2014CB744501, Y.J.), the Fundamental Research Funds for the Central Universities of China-Xiamen University (20720160069 (Y.J.), 20720150165 (Y.J.), and 2013121033 (Y.J.)), the Special Research Fund for the Doctoral Program of Higher Education of China (20130121120023 (Y.J.) and 20130121120024 (H.C.)), the Scientific Research Foundation for Returned Scholars, Ministry of Education of China (H.C), the "111" Project of the Ministration of Education of China (B06016), and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The authors thank Cindy Clark, NIH Library Writing Center, for manuscript editing assistance.	Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; de Koning-Ward TF, 2015, NAT REV MICROBIOL, V13, P373, DOI 10.1038/nrmicro3450; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Guttery DS, 2014, CELL HOST MICROBE, V16, P128, DOI 10.1016/j.chom.2014.05.020; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165                                                          ; Lu JN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1487-4; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Manzoni G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04760; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Ng CL, 2016, MOL MICROBIOL, V101, P381, DOI 10.1111/mmi.13397; Orr RY, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-103; Rodriguez MD, 2000, MOL BIOCHEM PARASIT, V110, P147; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; vanDijk MR, 1997, MOL BIOCHEM PARASIT, V86, P155, DOI 10.1016/S0166-6851(97)02843-0; vanDijk MR, 1996, SCIENCE, V271, P662, DOI 10.1126/science.271.5249.662; Volkman SK, 2012, NAT REV GENET, V13, P315, DOI 10.1038/nrg3187; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096908	30	1	1	3	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-6851	1872-9428		MOL BIOCHEM PARASIT	Mol. Biochem. Parasitol.	MAR	2017	212						1	8		10.1016/j.molbiopara.2016.12.010				8	Biochemistry & Molecular Biology; Parasitology	Biochemistry & Molecular Biology; Parasitology	EP4UF	WOS:000397374700001	28034675				2018-01-05	
J	Burle-Caldas, GA; Grazielle-Silva, V; Soares-Simoes, M; Burkard, GS; Roditi, I; DaRocha, WD; Teixeira, SM				Burle-Caldas, Gabriela Assis; Grazielle-Silva, Viviane; Soares-Simoes, Melissa; Burkard, Gabriela Schumann; Roditi, Isabel; DaRocha, Wanderson Duarte; Teixeira, Santuza M.			Editing the Trypanosoma cruzi genome with zinc finger nucleases	MOLECULAR AND BIOCHEMICAL PARASITOLOGY			English	Article						Trypanosoma cruzi; Genome editing; Gene knockout; gp72; Zinc finger nucleases	AFRICAN TRYPANOSOMES; MUTATIONS; SEQUENCE; DELETION; DISEASE; RNAI	Gene function studies in Trypanosoma cruzi, the protozoan parasite that causes Chagas disease, have been hindered by the lack of efficient genetic manipulation protocols. In most organisms, insertion and deletion of DNA fragments in the genome are dependent on the generation of double-stranded DNA break (DSB) and repair. By inducing a site-specific DSB, zinc finger nucleases (ZFNs) have proven to be useful to enhance gene editing in many cell types. Using a pair of ZFNs targeted to the T. cruzi gp72 gene, we were able to generate gp72 knockout parasites with improved efficiency compared to the conventional gene knockout protocol. We also provide evidence that, in T. cruzi, repair of DSBs generated by ZFNs occurs primarily by the homologous recombination pathway. (C) 2017 Elsevier B.V. All rights reserved.	[Burle-Caldas, Gabriela Assis; Grazielle-Silva, Viviane; Soares-Simoes, Melissa; Teixeira, Santuza M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Av Antoni Carlos 6627, Belo Horizonte, MG, Brazil; [Burkard, Gabriela Schumann; Roditi, Isabel] Univ Bern, Inst Cell Biol, Bern, Switzerland; [DaRocha, Wanderson Duarte] Univ Fed Parana, Dept Bioquim & Biol Mol, Curitiba, Parana, Brazil	Teixeira, SM (reprint author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Av Antoni Carlos 6627, Belo Horizonte, MG, Brazil.	santuzat@ufmg.br			Fundacao de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [590109/2011-1]; Howard Hughes Medical Institute; Velux Foundation; CODEV	This work was supported by Fundacao de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant number 590109/2011-1). IR is Senior International Research Scholar funded by the Howard Hughes Medical Institute, the Velux Foundation and CODEV. We are indebted to Gregory T. Kitten from the Centro de Microscopia at UFMG for helping with microscopy analyses.	Bibikova M, 2002, GENETICS, V161, P1169; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Cai M, 2014, CURR GENE THER, V14, P2, DOI 10.2174/156652321402140318165450; COOPER R, 1993, J CELL BIOL, V122, P149, DOI 10.1083/jcb.122.1.149; DaRocha WD, 2004, PARASITOL RES, V92, P113, DOI 10.1007/s00436-003-1004-5; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Burle-Caldas Gde A., 2015, MOL BIOCHEM PARASIT, V203, P25; Glover L, 2008, NUCLEIC ACIDS RES, V36, P2608, DOI 10.1093/nar/gkn104; Glover L, 2011, NUCLEIC ACIDS RES, V39, P1372, DOI 10.1093/nar/gkq981; Glover L, 2009, MOL BIOCHEM PARASIT, V166, P194, DOI 10.1016/j.molbiopara.2009.03.010; Grazielle-Silva V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003870; Lander N, 2016, J BIOL CHEM, V291, P25505, DOI 10.1074/jbc.M116.749655; Lander N, 2016, J EUKARYOT MICROBIOL, V63, P679, DOI 10.1111/jeu.12338; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Passos-Silva DG, 2010, J NUCL ACIDS, V2010, DOI DOI 10.4061/2010/840768; Peng D, 2015, MBIO, V6, DOI 10.1128/mBio.02097-14; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553	23	0	0	4	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-6851	1872-9428		MOL BIOCHEM PARASIT	Mol. Biochem. Parasitol.	MAR	2017	212						28	32		10.1016/j.molbiopara.2017.01.002				5	Biochemistry & Molecular Biology; Parasitology	Biochemistry & Molecular Biology; Parasitology	EP4UF	WOS:000397374700005	28108186				2018-01-05	
J	Standage-Beier, K; Wang, X				Standage-Beier, Kylie; Wang, Xiao			Genome reprogramming for synthetic biology	FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING			English	Review						CRISPR; genome engineering; synthetic biology; rational design	CRISPR-CAS SYSTEMS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CLOSTRIDIUM-ACETOBUTYLICUM; CHROMOSOMAL INTEGRATION; DIRECTED EVOLUTION; BACTERIAL IMMUNITY; GENETIC CIRCUIT; HUMAN-CELLS; DNA	The ability to go from a digitized DNA sequence to a predictable biological function is central to synthetic biology. Genome engineering tools facilitate rewriting and implementation of engineered DNA sequences. Recent development of new programmable tools to reengineer genomes has spurred myriad advances in synthetic biology. Tools such as clustered regularly interspace short palindromic repeats enable RNA-guided rational redesign of organisms and implementation of synthetic gene systems. New directed evolution methods generate organisms with radically restructured genomes. These restructured organisms have useful new phenotypes for biotechnology, such as bacteriophage resistance and increased genetic stability. Advanced DNA synthesis and assembly methods have also enabled the construction of fully synthetic organisms, such as J. Craig Venter Institute (JCVI)-syn 3.0. Here we summarize the recent advances in programmable genome engineering tools.	[Standage-Beier, Kylie] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Wang, Xiao] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA	Wang, X (reprint author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	xiaowang@asu.edu			National Institutes of Health [GM106081]	Work by the Xiao Wang laboratory has been supported by National Institutes of Health Grant GM106081.	Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/nmeth.2926, 10.1038/NMETH.2926]; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Choi KR, 2016, BIOTECHNOL ADV, V34, P1180, DOI 10.1016/j.biotechadv.2016.08.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001                                                 ; Csorgo B, 2016, CURR OPIN MICROBIOL, V33, P113, DOI 10.1016/j.mib.2016.07.005; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Enyeart PJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.41; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Faucon PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102873; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131                                                                ; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hao HH, 2016, ANAL BIOCHEM, V509, P118, DOI 10.1016/j.ab.2016.07.008; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jakociunas T, 2015, ACS SYNTH BIOL, V4, P1226, DOI 10.1021/acssynbio.5b00007; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang HS, 2016, ACS SYNTH BIOL, V5, P1002, DOI 10.1021/acssynbio.6b00080; Kannan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30714; Karas BJ, 2014, NAT PROTOC, V9, P743, DOI 10.1038/nprot.2014.045; Karpinski J, 2016, NAT BIOTECHNOL, V34, P401, DOI 10.1038/nbt.3467; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/NMETH.2969, 10.1038/nmeth.2969]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Krishnakumar R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku509; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Lajoie MJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks751; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Li Q, 2016, BIOTECHNOL J, V11, P961, DOI 10.1002/biot.201600053; Liao C, 2015, P NATL ACAD SCI USA, V112, P8505, DOI 10.1073/pnas.1423143112; Litcofsky KD, 2012, NAT METHODS, V9, P1077, DOI [10.1038/NMETH.2205, 10.1038/nmeth.2205]; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Pal C, 2014, NAT REV GENET, V15, P504, DOI 10.1038/nrg3746; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Ran FA, 2013, CELL, V155, P479, DOI 10.1016/j.cell.2013.09.040; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Santos CNS, 2014, NAT PROTOC, V9, P1320, DOI 10.1038/nprot.2014.084; Santos CNS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3503; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; St-Pierre F, 2013, ACS SYNTH BIOL, V2, P537, DOI [10.1021/s400021j, 10.1021/sb400021j]; Standage-Beier K, 2015, ACS SYNTH BIOL, V4, P1217, DOI 10.1021/acssynbio.5b00132; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tsarmpopoulos I, 2016, ACS SYNTH BIOL, V5, P104, DOI [10.1021/acssyntio3b00196, 10.1021/acssynbio.5b00196]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang LZ, 2016, INTEGR BIOL-UK, V8, P394, DOI 10.1039/c5ib00252d; Wang Y, 2015, J BIOTECHNOL, V200, P1, DOI 10.1016/j.jbiotec.2015.02.005; Wu FQ, 2014, CHEM BIOL, V21, P1629, DOI 10.1016/j.chembiol.2014.10.008; Wu M, 2013, P NATL ACAD SCI USA; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	77	0	0	6	22	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2095-0179	2095-0187		FRONT CHEM SCI ENG	Front. Chem. Sci. Eng.	MAR	2017	11	1					37	45		10.1007/s11705-017-1618-2				9	Engineering, Chemical	Engineering	ER3UD	WOS:000398723700005					2018-01-05	
J	Rossi, CC; Dias, ID; Muniz, IM; Lilenbaum, W; Giambiagi-deMarval, M				Rossi, Ciro Cesar; Dias, Ingrid da Silva; Muniz, Igor Mansur; Lilenbaum, Walter; Giambiagi-deMarval, Marcia			The oral microbiota of domestic cats harbors a wide variety of Staphylococcus species with zoonotic potential	VETERINARY MICROBIOLOGY			English	Article						Domestic cats; Feline; Staphylococcus; Antimicrobial resistance; CRISPR	COAGULASE-NEGATIVE STAPHYLOCOCCI; DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; MUPIROCIN RESISTANCE; IDENTIFICATION; AUREUS; INFECTION; GENES; MRSA; PCR	This study aimed to characterize the species, antimicrobial resistance and dispersion of CRISPR systems in staphylococci isolated from the oropharynx of domestic cats in Brazil. Staphylococcus strains (n = 75) were identified by MALDI-TOF and sequencing of rpoB and tuf genes. Antimicrobial susceptibility was assessed by disk diffusion method and PCR to investigate the presence of antimicrobial-resistance genes usually present in mobile genetic elements (plasmids), in addition to plasmid extraction. CRISPR genetic arrangements that give the bacteria the ability to resist the entry of exogenous DNA were investigated by the presence of the essential protein Casl gene. A great diversity of Staphylococcus species (n =13) was identified. The presence of understudied species, like S. nepalensis and S. pettenkoferi reveals that more than one identification method may be necessary to achieve conclusive results. At least 56% of the strains contain plamids, being 99% resistant to at least one of the eight tested antimicrobials and 12% multidrug resistant. CRISPR were rare among the studied strains, consistent with their putative role as gene reservoirs. Moreover, herein we describe for the first time their existence in Staphylococcus lentus, to which the system must confer additional adaptive advantage. Prevalence of resistance among staphylococci against antimicrobials used in veterinary and human clinical practice and the zoonotic risk highlight the need of better antimicrobial management practices, as staphylococci may transfer resistance genes among themselves, including to virulent species, like S. aureus. (C) 2017 Elsevier B.V. All rights reserved.	[Rossi, Ciro Cesar; Dias, Ingrid da Silva; Giambiagi-deMarval, Marcia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Ave Carlos Chagas Filho 373,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil; [Muniz, Igor Mansur] Univ Fed Rondonia, Dept Med Vet, Porto Velho, RO, Brazil; [Lilenbaum, Walter] Univ Fed Fluminense, Lab Bacteriol Vet, Niteroi, RJ, Brazil	Giambiagi-deMarval, M (reprint author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Ave Carlos Chagas Filho 373,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.	marciagm@micro.ufrj.br			FAPERJ [E-26/112.649/2012, E-26/202.799/2016]; CNPq [476119/2012-0]; CAPES-Proex [23038.001255/2011-29]	This work was supported by FAPERJ [grant E-26/112.649/2012], CNPq [grant 476119/2012-0] and CAPES-Proex [grant 23038.001255/2011-29]. C.C.R. was recipient of a scholarship from FAPERJ [grant E-26/202.799/2016].	Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Buma Ryoko, 2006, Biocontrol Science, V11, P1; Carpaij N, 2011, EUR J CLIN MICROBIOL, V30, P1169, DOI 10.1007/s10096-011-1204-3; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781; Clinical and Laboratory Standards Institute (CLSI), 2015, PERF STAND ANT DISK; Czekaj T, 2015, MICROBIOL-SGM, V161, P2061, DOI 10.1099/mic.0.000178; da Costa PM, 2013, INT J ENV RES PUB HE, V10, P278, DOI 10.3390/ijerph10010278; Deeny SR, 2015, J ANTIMICROB CHEMOTH, V70, P3366, DOI 10.1093/jac/dkv249; DELVECCHIO VG, 1995, J CLIN MICROBIOL, V33, P2141; Drancourt M, 2002, J CLIN MICROBIOL, V40, P1333, DOI 10.1128/JCM.40.4.1333-1338.2002; Eriksson A, 2013, APMIS, V121, P72, DOI 10.1111/j.1600-0463.2012.02937.x; GIAMBIAGIMARVAL M, 1990, J GEN MICROBIOL, V136, P1591, DOI 10.1099/00221287-136-8-1591                                                     ; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; HASAN A. A., 2014, INT J MED MED SCI, V47, P1491; Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mazal C, 2010, INT J INFECT DIS, V14, pE397, DOI 10.1016/j.ijid.2010.02.502; Muniz IM, 2013, VET REC, V173, P502, DOI 10.1136/vr.101971; Novakova D, 2006, FEMS MICROBIOL LETT, V263, P163, DOI 10.1111/j.1574-6968.2006.00408.x; Nunes ELD, 1999, DIAGN MICR INFEC DIS, V34, P77; Oliveira NE, 2007, J MED MICROBIOL, V56, P937; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Prescott JF, 2014, VET MICROBIOL, V171, P273, DOI 10.1016/j.vetmic.2014.02.035; Rossi CC, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw121; Schiwon K, 2013, MICROB ECOL, V65, P638, DOI 10.1007/s00248-013-0193-4; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Sirmatel F., 2015, CASE STUDY CASE REP, V5, P142; Soldera J, 2013, SAO PAULO MED J, V131, P59, DOI 10.1590/S1516-31802013000100010; Spergser J, 2003, INT J SYST EVOL MICR, V53, P2007, DOI 10.1099/ijs.0.02646-0; Stepanovic S, 2005, INT J STD AIDS, V16, P452, DOI 10.1258/0956462054093999                                                        ; Tomazi T, 2014, J CLIN MICROBIOL, V52, P1658, DOI 10.1128/JCM.03032-13; Trulzsch K, 2002, DIAGN MICR INFEC DIS, V43, P175, DOI 10.1016/S0732-8893(02)00399-1; Vigne JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147295	34	1	1	4	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1135	1873-2542		VET MICROBIOL	Vet. Microbiol.	MAR	2017	201						136	140		10.1016/j.vetmic.2017.01.029				5	Microbiology; Veterinary Sciences	Microbiology; Veterinary Sciences	EP9JL	WOS:000397689800019	28284599				2018-01-05	
J	Mout, R; Ray, M; Tonga, GY; Lee, YW; Tay, T; Sasaki, K; Rotello, VM				Mout, Rubul; Ray, Moumita; Tonga, Gulen Yesilbag; Lee, Yi-Wei; Tay, Tristan; Sasaki, Kanae; Rotello, Vincent M.			Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing	ACS NANO			English	Article						CRISPR/Cas9; gene editing; CRISPR/Cas9 engineering; nanoparticle; CRISPR delivery; genome engineering	CAS9 RIBONUCLEOPROTEINS; HUMAN-CELLS; CRISPR-CAS9; NANOPARTICLES; CRISPR/CAS9; CHALLENGES; ACTIVATION; PROTEINS; SYSTEM; RNA	Genome editing through the delivery of CRISPR/Cas9-ribonucleoprotein (Cas9-RNP) reduces unwanted gene targeting and avoids integrational mutagenesis that can occur through gene delivery strategies. Direct and efficient delivery of Cas9-RNP into the cytosol followed by translocation to the nucleus remains a challenge. Here, we report a remarkably highly efficient (similar to 90%) direct cytoplasmic/nuclear delivery of Cas9 protein complexed with a guide RNA (sgRNA) through the coengineering of Cas9 protein and carrier nanoparticles. This construct provides effective (similar to 30%) gene editing efficiency and opens up opportunities in studying genome dynamics.	[Mout, Rubul; Ray, Moumita; Tonga, Gulen Yesilbag; Lee, Yi-Wei; Tay, Tristan; Sasaki, Kanae; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA	Rotello, VM (reprint author), Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA.	rotello@chem.umass.edu		Mout, Rubul/0000-0001-6125-5873	NIH [GM077173]; NSF [CHE-1307021]; UMass OTCV grant	This research was supported by the NIH (GM077173), NSF (CHE-1307021), and a UMass OTCV grant. We thank James Chambers for help in confocal microscopy.	Blenke EO, 2016, J CONTROL RELEASE, V244, P139, DOI 10.1016/j.jconrel.2016.08.002; Charpentier E., 2012, SCIENCE, V337, P816, DOI [10.1126/science.1225829, DOI 10.1126/SCIENCE.1225829]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Han X, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500454; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang Y, 2015, ANGEW CHEM INT EDIT, V54, P506, DOI 10.1002/anie.201409161; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li L, 2015, HUM GENE THER, V26, P452, DOI 10.1089/hum.2015.069; Liu J, 2015, NAT PROTOC, V10, P1842, DOI 10.1038/nprot.2015.117; Mout R., PROGRAMMED SEL UNPUB; Mout R, 2014, NANOSCALE, V6, P8873, DOI 10.1039/c4nr02097a; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Saha K, 2013, SMALL, V9, P300, DOI 10.1002/smll.201201129; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang XC, 2011, ANGEW CHEM INT EDIT, V50, P477, DOI 10.1002/anie.201005662; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	28	13	13	69	103	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	MAR	2017	11	3					2452	2458		10.1021/acsnano.6b07600				7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	EQ4AK	WOS:000398014900012	28129503				2018-01-05	
J	Silva, AC				Silva, Afonso C.			Anatomical and functional neuroimaging in awake, behaving marmosets	DEVELOPMENTAL NEUROBIOLOGY			English	Review						marmoset; neuroimaging; functional magnetic resonance imaging; two-photon laser scanning microscopy; transgenic marmosets	MANGANESE-ENHANCED MRI; FLUORESCENT CA2+ INDICATOR; RESONANCE-IMAGING MEMRI; COMMON MARMOSET; CALLITHRIX-JACCHUS; VISUAL-CORTEX; IN-VIVO; TRANSGENIC MICE; NEURAL ACTIVITY; SOMATOSENSORY CORTEX	The common marmoset (Callithrix jacchus) is a small New World monkey that has gained significant recent interest in neuroscience research, not only because of its compatibility with gene editing techniques, but also due to its tremendous versatility as an experimental animal model. Neuroimaging modalities, including anatomical (MRI) and functional magnetic resonance imaging (fMRI), complemented by two-photon laser scanning microscopy and electrophysiology, have been at the forefront of unraveling the anatomical and functional organization of the marmoset brain. High-resolution anatomical MRI of the marmoset brain can be obtained with remarkable cytoarchitectonic detail. Functional MRI of the marmoset brain has been used to study various sensory systems, including somatosensory, auditory, and visual pathways, while resting-state fMRI studies have unraveled functional brain networks that bear great correspondence to those previously described in humans. Two-photon laser scanning microscopy of the marmoset brain has enabled the simultaneous recording of neuronal activity from thousands of neurons with single cell spatial resolution. In this article, we aim to review the main results obtained by our group and by our colleagues in applying neuroimaging techniques to study the marmoset brain. (c) 2016 Wiley Periodicals, Inc. Develop Neurobiol 77: 373-389, 2017	[Silva, Afonso C.] NINDS, Cerebral Microcirculat Sect, Lab Funct & Mol Imaging, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Silva, AC (reprint author), NINDS, Cerebral Microcirculat Sect, Lab Funct & Mol Imaging, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	SilvaA@ninds.nih.gov			NIH, NINDS	Contract grant sponsor: NIH, NINDS.	Abbott DH, 2003, COMPARATIVE MED, V53, P339; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; ANGEL A, 1969, J PHYSIOL-LONDON, V205, pP25; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Austin VC, 2005, NEUROIMAGE, V24, P92, DOI 10.1016/j.neuroimage.2004.08.011; Barbier EL, 2002, MAGNET RESON MED, V48, P735, DOI 10.1002/mrm.10255; Barros M, 2000, BEHAV BRAIN RES, V108, P205, DOI 10.1016/S0166-4328(99)00153-9; Belcher AM, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00009; Belcher AM, 2013, J NEUROSCI, V33, P16796, DOI 10.1523/JNEUROSCI.3146-13.2013; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bihel E, 2010, J CEREBR BLOOD F MET, V30, P273, DOI 10.1038/jcbfm.2009.209; Bock NA, 2008, NMR BIOMED, V21, P473, DOI 10.1002/nbm.1211; Bock NA, 2011, ANN NY ACAD SCI, V1225, pE171, DOI 10.1111/j.1749-6632.2011.06000.x; Bock NA, 2009, J NEUROSCI METH, V185, P15, DOI 10.1016/j.jneumeth.2009.08.022; Bock NA, 2009, NMR BIOMED, V22, P730, DOI 10.1002/nbm.1384; Boretius S, 2006, NMR BIOMED, V19, P41, DOI 10.1002/nbm.999; Brevard ME, 2006, MAGN RESON IMAGING, V24, P707, DOI 10.1016/j.mri.2006.03.010; Broussard GJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00097; Bullmore ET, 2012, NEUROIMAGE, V62, P1267, DOI 10.1016/j.neuroimage.2012.01.026; Burman KJ, 2006, J COMP NEUROL, V495, P149, DOI 10.1002/cne.20837; Campbell AW, 1905, HISTOLOGICAL STUDIES, Vxix; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Cheong SK, 2013, J NEUROSCI, V33, P6864, DOI 10.1523/JNEUROSCI.5208-12.2013; CLARK VP, 1992, CEREB CORTEX, V2, P417, DOI 10.1093/cercor/2.5.417; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Einspanier A, 2006, METH MOLEC MED, V121, P111; Ferris CF, 2001, NEUROREPORT, V12, P2231, DOI 10.1097/00001756-200107200-00037; Ferris CF, 2004, J MAGN RESON IMAGING, V19, P168, DOI 10.1002/jmri.10456; Franke SK, 2016, NEURODEGENER DIS; Gaitan MI, 2014, MULT SCLER J, V20, P64, DOI 10.1177/1352458513492244; GASPAR AM, 1992, MEM I OSWALDO CRUZ, V87, P449, DOI 10.1590/S0074-02761992000300020                                                 ; Gennari F., 1782, EXREGIO TYPOGRAPHEO; Gerrits RJ, 2001, BRAIN RES, V907, P20, DOI 10.1016/S0006-8993(01)02298-3; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Groschel S, 2013, NEUROIMAGE, V71, P10, DOI 10.1016/j.neuroimage.2012.12.039; Haig D, 1999, AM J PRIMATOL, V49, P285, DOI 10.1002/(SICI)1098-2345(199912)49:4<285::AID-AJP1>3.3.CO;2-O; Hart BA, 2006, DRUG DISCOV TODAY, V11, P58; Helms G, 2013, J NEUROSCI METH, V215, P121, DOI 10.1016/j.jneumeth.2013.02.011; Hikishima K, 2013, NEUROSCIENCE, V230, P102, DOI 10.1016/j.neuroscience.2012.09.053; Hikishima K, 2011, NEUROIMAGE, V54, P2741, DOI 10.1016/j.neuroimage.2010.10.061; Hikishima K, 2015, RADIOLOGY, V275, P430, DOI 10.1148/radiol.14140601; Huang L, 2016, NEUROSCI BIOBEHAV R, V66, P104, DOI 10.1016/j.neubiorev.2016.04.009; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Hung CC, 2015, NEUROIMAGE, V120, P1, DOI 10.1016/j.neuroimage.2015.06.090; Hung CC, 2015, J NEUROSCI, V35, P1160, DOI 10.1523/JNEUROSCI.2659-14.2015; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kap YS, 2016, DRUG DISCOV TODAY; Kato Y, 2014, BEHAV BRAIN RES, V275, P43, DOI 10.1016/j.bbr.2014.08.047; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; KRUBITZER LA, 1990, J NEUROSCI, V10, P952; KRUBITZER LA, 1992, J COMP NEUROL, V319, P123, DOI 10.1002/cne.903190111; Lafer-Sousa R, 2013, NAT NEUROSCI, V16, P1870, DOI 10.1038/nn.3555; Lake EM, 2016, PHILOS T R SOC LON B, V371; Layne DG, 2003, COMPARATIVE MED, V53, P351; Liu JJV, 2013, NEUROIMAGE, V78, P186, DOI 10.1016/j.neuroimage.2013.03.038; Liu JV, 2011, NEUROIMAGE, V56, P1154, DOI 10.1016/j.neuroimage.2011.02.075; Lui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068276; Maclean CJ, 2000, J NEURAL TRANSM, V107, P799, DOI 10.1007/s007020070060; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Maggi P, 2014, ANN NEUROL, V76, P594, DOI 10.1002/ana.24242; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Marshall JWB, 2003, BRAIN RES BULL, V61, P577, DOI 10.1016/S0361-9230(03)00214-4; McDonald JS, 2014, J NEUROPHYSIOL, V111, P369, DOI 10.1152/jn.00254.2013; Meyer JS, 2006, ANN NY ACAD SCI, V1074, P365, DOI 10.1196/annals.1369.036; Miller CT, 2016, NEURON, V90, P219, DOI 10.1016/j.neuron.2016.03.018; Mitchell JF, 2015, NEUROSCI RES, V93, P20, DOI 10.1016/j.neures.2015.01.008; Mitchell JF, 2014, J NEUROSCI, V34, P1183, DOI 10.1523/JNEUROSCI.3899-13.2014; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Mundinano IC, 2016, NAT PROTOC, V11, P1299, DOI 10.1038/nprot.2016.076; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Newman JD, 2009, BRAIN RES REV, V62, P1, DOI 10.1016/j.brainresrev.2009.09.001; Okano H, 2015, NEUROSCI RES, V93, P3, DOI 10.1016/j.neures.2014.08.014; Okano H, 2015, PHILOS T R SOC B, V370, P33, DOI 10.1098/rstb.2014.0310; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tica.2004.05.009; Papoti D, 2013, NMR BIOMED, V26, P1395, DOI 10.1002/nbm.2965; Park JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep34931; Paxinos G, 2012, MARMOSET BRAIN STERE; Peeters RR, 2001, MAGN RESON IMAGING, V19, P821, DOI 10.1016/S0730-725X(01)00391-5                                                   ; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Poldrack RA, 2015, NATURE, V526, P371, DOI 10.1038/nature15692; Puentes S, 2015, NEUROSCIENCE, V284, P400, DOI 10.1016/j.neuroscience.2014.10.015; Reser DH, 2009, EUR J NEUROSCI, V30, P578, DOI 10.1111/j.1460-9568.2009.06846.x; Rosa MGP, 2005, J COMP NEUROL, V483, P164, DOI 10.1002/cne.20412; Rowe MJ, 1996, CLIN EXP PHARMACOL P, V23, P931, DOI 10.1111/j.1440-1681.1996.tb01145.x; Sadagopan S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10950; Sadakane O, 2015, CELL REP, V13, P1989, DOI 10.1016/j.celrep.2015.10.050; Saito A, 2015, NEUROSCI RES, V93, P99, DOI 10.1016/j.neures.2014.12.011; Santisakultarm TP, 2016, J NEUROSCI METH, V271, P55, DOI 10.1016/j.jneumeth.2016.07.003; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; SHAPIRO HM, 1978, ANESTHESIOLOGY, V48, P97, DOI 10.1097/00000542-197802000-00004; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2008, SCHIZOPHRENIA BULL, V34, P595, DOI 10.1093/schbul/sbn056; Silva AC, 2011, METHODS MOL BIOL, V711, P281, DOI 10.1007/978-1-61737-992-5_14; Smith D, 2001, LAB ANIM-UK, V35, P117, DOI 10.1258/0023677011911444; Smith GE, 1907, J ANAT PHYSIOL, V41, P237; Smith RL, 2000, J VIROL, V74, P11254, DOI 10.1128/JVI.74.23.11254-11261.2000                                              ; Solomon SG, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00096; STEVENSON MF, 1977, LAB ANIM SCI, V27, P895; Tardif SD, 2008, INTERDISC TOPICS GER, V36, P29, DOI 10.1159/000137678; Tenney JR, 2004, EPILEPSIA, V45, P1240, DOI 10.1111/j.0013-9580.2004.21504.x                                                ; Teo L, 2014, BRAIN PATHOL, V24, P459, DOI 10.1111/bpa.12129; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Uccelli A, 2003, Int MS J, V10, P6; Virley D, 2004, J CEREBR BLOOD F MET, V24, P24, DOI 10.1097/01.WCB.0000095801.98378.4A; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Warner CE, 2015, CURR BIOL, V25, P424, DOI 10.1016/j.cub.2014.12.028; Watakabe A, 2014, NEUROSCI RES; Yoshiura T, 2000, RADIOLOGY, V214, P217, DOI 10.1148/radiology.214.1.r00ja17217                                              ; Yu HH, 2014, VISUAL NEUROSCI, V31, P85, DOI 10.1017/S0952523813000448; Yun Jun-Won, 2015, Lab Anim Res, V31, P155, DOI 10.5625/lar.2015.31.4.155; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; ZILLES K, 1989, BRAIN BEHAV EVOLUT, V34, P143, DOI 10.1159/000116500                                                               ; Zuhlke U, 2003, Toxicol Pathol, V31 Suppl, P123, DOI 10.1080/01926230309767	119	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	MAR	2017	77	3					373	389		10.1002/dneu.22456				17	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	EM9PJ	WOS:000395643300010	27706916				2018-01-05	
J	Nie, J; Hashino, E				Nie, Jing; Hashino, Eri			Organoid technologies meet genome engineering	EMBO REPORTS			English	Review						CRISPR; disease modeling; homology-directed repair; organoids; stem cells	PLURIPOTENT STEM-CELLS; HOMOLOGY-DIRECTED REPAIR; IN-VITRO; MAMMALIAN-CELLS; CRISPR-CAS9 NUCLEASES; 3-DIMENSIONAL CULTURE; INTESTINAL ORGANOIDS; MUSCULAR-DYSTROPHY; SELF-ORGANIZATION; KIDNEY ORGANOIDS	Three-dimensional (3D) stem cell differentiation cultures recently emerged as a novel model system for investigating human embryonic development and disease progression in vitro, complementing existing animal and two-dimensional (2D) cell culture models. Organoids, the 3D self-organizing structures derived from pluripotent or somatic stem cells, can recapitulate many aspects of structural organization and functionality of their in vivo organ counterparts, thus holding great promise for biomedical research and translational applications. Importantly, faithful recapitulation of disease and development processes relies on the ability to modify the genomic contents in organoid cells. The revolutionary genome engineering technologies, CRISPR/Cas9 in particular, enable investigators to generate various reporter cell lines for prompt validation of specific cell lineages as well as to introduce disease-associated mutations for disease modeling. In this review, we provide historical overviews, and discuss technical considerations, and potential future applications of genome engineering in 3D organoid models.	[Nie, Jing; Hashino, Eri] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [Hashino, Eri] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Hashino, E (reprint author), Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA.; Hashino, E (reprint author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	ehashino@iupui.edu			Action on Hearing Loss grant; National Institutes of Health grant [R01DC013294]	We would like to thank Rick Nelson and Emma Longworth-Mills for their critical reading of the manuscript. This work was supported by an Action on Hearing Loss grant and a National Institutes of Health grant R01DC013294 (to E.H.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bednarski C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161072; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0                                                                ; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013                                                     ; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Forster R, 2014, STEM CELL REP, V2, P838, DOI 10.1016/j.stemcr.2014.05.001; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao X, 2015, J CELL BIOL, V211, P669, DOI 10.1083/jcb.201506014; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; He ZY, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2536-3; Helms AW, 2000, DEVELOPMENT, V127, P1185; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Howden SE, 2016, STEM CELL REP, V7, P508, DOI 10.1016/j.stemcr.2016.07.001; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Koehler KR, 2014, NAT PROTOC, V9, P1229, DOI 10.1038/nprot.2014.100; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Konishi S, 2016, STEM CELL REP, V6, P18, DOI 10.1016/j.stemcr.2015.11.010; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu XP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11508; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V155, P479, DOI 10.1016/j.cell.2013.09.040; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; RUDIN N, 1989, GENETICS, V122, P519; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0                                                                ; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takata N, 2016, HUM GENE THER, V27, P436, DOI 10.1089/hum.2015.148; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; THOMAS KR, 1986, NATURE, V324, P34, DOI 10.1038/324034a0; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093608; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Woo DH, 2016, CELL STEM CELL, V19, P397, DOI 10.1016/j.stem.2016.05.024; Yan HHN, 2017, GUT, V66, P1645, DOI 10.1136/gutjnl-2016-311849; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081; [Anonymous], 2017, EMBO REPORTS, V18, P367	96	4	4	8	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	MAR	2017	18	3					367	376		10.15252/embr.201643732				10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EM1EN	WOS:000395061000008	28202491				2018-01-05	
J	Arash, EH; Shiban, A; Song, SY; Attisano, L				Arash, Emad Heidary; Shiban, Ahmed; Song, Siyuan; Attisano, Liliana			MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells	EMBO REPORTS			English	Article						breast cancer; Hippo pathway; MARK4; TAZ; YAP	AMPK-MEDIATED REGULATION; PROTEIN-KINASES; PATHWAY REGULATION; TISSUE HOMEOSTASIS; GROWTH-CONTROL; YAP; POLARITY; YAP/TAZ; FAMILY; METABOLISM	The Hippo pathway is a critical regulator of tissue size, and aberrations in pathway regulation lead to cancer. MST1/2 and LATS1/2 kinases comprise the core of the pathway that, in association with adaptor proteins SAV and MOB, functions in a sequential manner to phosphorylate and inhibit the transcription factors YAP and TAZ. Here we identify mammalian MARK family members as activators of YAP/TAZ. We show that depletion of MARK4 in MDA-MB-231 breast cancer cells results in the loss of nuclear YAP/TAZ and decreases the expression of YAP/TAZ targets. We demonstrate that MARK4 can bind to MST and SAV, leading to their phosphorylation, and that MARK4 expression attenuates the formation of a complex between MST/SAV and LATS, which depends on the kinase activity of MARK4. Abrogation of MARK4 expression using siRNAs and CRISPR/Cas9 gene editing attenuates the proliferation and migration of MDA-MB-231 cells. Our results show that MARK4 acts as a negative regulator of the Hippo kinase cassette to promote YAP/TAZ activity and that loss of MARK4 restrains the tumorigenic properties of breast cancer cells.	[Arash, Emad Heidary; Shiban, Ahmed; Song, Siyuan; Attisano, Liliana] Univ Toronto, Donnelly Ctr, Dept Biochem, Toronto, ON, Canada	Attisano, L (reprint author), Univ Toronto, Donnelly Ctr, Dept Biochem, Toronto, ON, Canada.	liliana.attisano@utoronto.ca			Canadian Institute of Health Research [133532, 148455]; Terry Fox Research Institute	We thank Ki Myung Song, Marina Smiley, and Mandeep Gill for preliminary experiments. This work was supported by Grants # 133532 and 148455 from Canadian Institute of Health Research and from the Terry Fox Research Institute to L.A. L.A. is Canada Research Chair.	Arash EH, 2014, EMBO J, V33, P2997; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Bao RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048670; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang HL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001620; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576                                                            ; Irvine KD, 2012, SEMIN CELL DEV BIOL, V23, P812, DOI 10.1016/j.semcdb.2012.04.006; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miller BW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.72; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Naz F, 2013, CELL BIOCHEM BIOPHYS, V67, P485, DOI 10.1007/s12013-013-9550-7; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pardo OE, 2016, EMBO REP, V17, P570, DOI 10.15252/embr.201540970; Park BH, 2011, BMB REP, V44, P584, DOI 10.5483/BMBRep.2011.44.9.584; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Schroeder MC, 2012, SEMIN CELL DEV BIOL, V23, P803, DOI 10.1016/j.semcdb.2012.06.001; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sopko R, 2009, CURR OPIN CELL BIOL, V21, P717, DOI 10.1016/j.ceb.2009.07.001; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wehr MC, 2013, NAT CELL BIOL, V15, P61, DOI 10.1038/ncb2658; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; [Anonymous], 2017, EMBO REPORTS, V18, P420	56	3	4	6	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	MAR	2017	18	3					420	436		10.15252/embr.201642455				17	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	EM1EN	WOS:000395061000012	28183853				2018-01-05	
J	Filipescu, D; Naughtin, M; Podsypanina, K; Lejour, V; Wilson, L; Gurard-Levin, ZA; Orsi, GA; Simeonova, I; Toufektchan, E; Attardi, LD; Toledo, F; Almouzni, G				Filipescu, Dan; Naughtin, Monica; Podsypanina, Katrina; Lejour, Vincent; Wilson, Laurence; Gurard-Levin, Zachary A.; Orsi, Guillermo A.; Simeonova, Iva; Toufektchan, Eleonore; Attardi, Laura D.; Toledo, Franck; Almouzni, Genevieve			Essential role for centromeric factors following p53 loss and oncogenic transformation	GENES & DEVELOPMENT			English	Article						HJURP; CENP-A; p53; oncogenic transformation; centromere	ASSEMBLY FACTOR-I; CENP-A NUCLEOSOMES; CELL-CYCLE; BREAST-CANCER; PROTEIN-A; COPY NUMBER; CHROMOSOME SEGREGATION; GENOMIC INSTABILITY; CHROMATIN REQUIRES; TUMOR SUPPRESSION	In mammals, centromere definition involves the histone variant CENP-A (centromere protein A), deposited by its chaperone, HJURP (Holliday junction recognition protein). Alterations in this process impair chromosome segregation and genome stability, which are also compromised by p53 inactivation in cancer. Here we found that CENP-A and HJURP are transcriptionally up-regulated in p53-null human tumors. Using an established mouse embryonic fibroblast (MEF) model combining p53 inactivation with E1A or HRas-V12 oncogene expression, we reproduced a similar up-regulation of HJURP and CENP-A. We delineate functional CDE/CHR motifs within the Hjurp and Cenpa promoters and demonstrate their roles in p53-mediated repression. To assess the importance of HJURP up-regulation in transformed murine and human cells, we used a CRISPR/Cas9 approach. Remarkably, depletion of HJURP leads to distinct outcomes depending on their p53 status. Functional p53 elicits a cell cycle arrest response, whereas, in p53-null transformed cells, the absence of arrest enables the loss of HJURP to induce severe aneuploidy and, ultimately, apoptotic cell death. We thus tested the impact of HJURP depletion in pre-established allograft tumors in mice and revealed a major block of tumor progression in vivo. We discuss a model in which an "epigenetic addiction" to the HJURP chaperone represents an Achilles' heel in p53-deficient transformed cells.	[Filipescu, Dan; Naughtin, Monica; Podsypanina, Katrina; Wilson, Laurence; Gurard-Levin, Zachary A.; Orsi, Guillermo A.; Simeonova, Iva; Almouzni, Genevieve] Paris Sci & Lettres PSL Res Univ, Inst Curie, UMR3664, Equipe Labellisee Ligue Canc,CNRS, F-75005 Paris, France; [Filipescu, Dan; Naughtin, Monica; Podsypanina, Katrina; Wilson, Laurence; Gurard-Levin, Zachary A.; Orsi, Guillermo A.; Simeonova, Iva; Almouzni, Genevieve] Univ Pierre & Marie Curie UPMC Univ Paris 06, CNRS, UMR3664, Sorbonne Univ, F-75005 Paris, France; [Lejour, Vincent; Toufektchan, Eleonore; Toledo, Franck] PSL Res Univ, Inst Curie, CNRS, UMR3244,Equipe Labellisee Ligue Canc, F-75005 Paris, France; [Lejour, Vincent; Toufektchan, Eleonore; Toledo, Franck] UPMC Univ Paris 06, Sorbonne Univ, CNRS, UMR3244, F-75005 Paris, France; [Attardi, Laura D.] Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Attardi, Laura D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Filipescu, Dan] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Wilson, Laurence] Commonwealth Sci & Ind Res Org, N Ryde, NSW, Australia; [Gurard-Levin, Zachary A.] SAMDI Tech Inc, Chicago, IL 60616 USA	Almouzni, G (reprint author), Paris Sci & Lettres PSL Res Univ, Inst Curie, UMR3664, Equipe Labellisee Ligue Canc,CNRS, F-75005 Paris, France.; Almouzni, G (reprint author), Univ Pierre & Marie Curie UPMC Univ Paris 06, CNRS, UMR3664, Sorbonne Univ, F-75005 Paris, France.	genevieve.almouzni@curie.fr		Filipescu, Dan/0000-0001-6381-2557	la Ligue Nationale contre le Cancer; Paris Sciences et Lettres [ANR-11-LABX-0044_DEEP, ANR-10-IDEX-0001-02]; "CHAPINHIB" [ANR-12-BSV5-0022-02]; "Epicure" [ANR-14-CE16-0009]; "CEL-LECTCHIP" [ANR-14-CE10-0013]; EU from "EPOCH28" [678563]; "ChromADICT" [ERC-2015-ADG-694694]; "CHRODYT" [ANR-16-CE15-0018]; Chaperone-Histone Determinants of Cell Identity, Lineage Fate, and Transitions [ANR-16-CE12-0024]; "REPLICAF" [ANR-16-CE11-0028]; Ministere de l'Enseignement Superieur et de la Recherche	We thank Bruno Amati, Renata Basto, Emily Bernstein, and Moshe Oren for helpful discussions and/or reagents. This work was supported by la Ligue Nationale contre le Cancer. Both the Chromatin Dynamics laboratory (G.A.) and the Genetics of Tumor Suppression laboratory (F.T.) are Equipes Labellisees Ligue. This work was also supported by ANR-11-LABX-0044_DEEP and ANR-10-IDEX-0001-02 from Paris Sciences et Lettres; ANR-12-BSV5-0022-02 from "CHAPINHIB"; ANR-14-CE16-0009 from "Epicure"; ANR-14-CE10-0013 from "CEL-LECTCHIP"; EU project 678563 from "EPOCH28"; ERC-2015-ADG-694694 from "ChromADICT"; ANR-16-CE15-0018 from "CHRODYT"; ANR-16-CE12-0024 from Chaperone-Histone Determinants of Cell Identity, Lineage Fate, and Transitions; and ANR-16-CE11-0028 from "REPLICAF." E.T. was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. D.F. and G.A. conceived the project. L.D.A. provided reagents and expertise for the MEF transformation system. The design of the experiments involved D.F., G.A., M.N., K.P., and F.T. D.F., M.N., and K.P. conducted experiments in MEFs, with assistance from G.A.O. for the CRISPR HJURP knockout experiments. K.P., D.F., and M.N. did the animal experiments. K.P. and M.N. did the experiments in human cells and immunofluorescence analysis in tumors. Z.A.G.-L. and L.W. did bioinformatic analyses of TCGA data and mouse resequencing data, and F.T. performed positional frequency matrix bioinformatics analyses. V.L. performed luciferase assays. I.S. performed qPCR and cell cycle assays. E.T. performed qPCR. M.N., D.F., F.T., and G. A. wrote the manuscript. L.D.A. and K.P. provided critical reading of the manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Athwal RK, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-2; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Benson EK, 2014, ONCOGENE, V33, P3959, DOI 10.1038/onc.2013.378; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Black B E, 2010, Cold Spring Harb Symp Quant Biol, V75, P403, DOI 10.1101/sqb.2010.75.038; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; Boyarchuk E, 2014, J CELL SCI, V127, P3347, DOI 10.1242/jcs.148189; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Carone DM, 2013, SEMIN CANCER BIOL, V23, P99, DOI 10.1016/j.semcancer.2012.06.008; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; de Oca RM, 2015, MOL ONCOL, V9, P657, DOI 10.1016/j.molonc.2014.11.002; de Tayrac M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073332; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Fang D, 2016, SCIENCE, V352, P1344, DOI 10.1126/science.aae0065; Filipescu D, 2014, ANNU REV CELL DEV BI, V30, P615, DOI 10.1146/annurev-cellbio-100913-013311; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P6070, DOI 10.1093/nar/gkw523; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Ghiselli G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-52; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Gu XM, 2014, PATHOL RES PRACT, V210, P228, DOI 10.1016/j.prp.2013.12.007; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; HARVEY M, 1993, ONCOGENE, V8, P2457; Heo JI, 2013, J GERONTOL A-BIOL, V68, P914, DOI 10.1093/gerona/gls257; Hoffmann S, 2016, CELL REP, V17, P2394, DOI 10.1016/j.celrep.2016.10.084; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148                                                          ; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Jaber S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11091; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.20070166; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CANT-07-1307; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kenzelmann BD, 2013, GENE DEV, V27, P1016; Kim EH, 2009, CANCER RES, V69, P9404, DOI 10.1158/0008-5472.CAN-09-1411; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Lambrus BG, 2015, J CELL BIOL, V210, P63, DOI 10.1083/jcb.201502089; Leibiger C, 2013, J HISTOCHEM CYTOCHEM, V61, P306, DOI 10.1369/0022155413476868; Li J, 2009, CELL DEATH DIFFER, V16, P498, DOI 10.1038/cdd.2008.174; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017794; Liu Song-Tao, 2009, P455, DOI 10.1007/978-0-387-69076-6_15; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09; Mahadevan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095184; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Muller S, 2017, NAT REV GENET, V18, P192, DOI 10.1038/nrg.2016.157; Muller S, 2014, CELL REP, V8, P190, DOI 10.1016/j.celrep.2014.06.002; Muller S, 2014, BBA-GENE REGUL MECH, V1839, P241, DOI 10.1016/j.bbagrm.2013.11.008; Murphy KL, 2000, ONCOGENE, V19, P1045, DOI 10.1038/sj.onc.1203274; Ohashi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8668; Pezer Z, 2015, GENOME RES, V25, P1114, DOI 10.1101/gr.187187.114; Polo SE, 2004, CANCER RES, V64, P2371, DOI 10.1158/0008-5472.CAN-03-2893; Polo SE, 2010, HISTOPATHOLOGY, V57, P716, DOI 10.1111/j.1365-2559.2010.03681.x; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Qiu JJ, 2013, TUMOR BIOL, V34, P2971, DOI 10.1007/s13277-013-0860-6; Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Simeonova I, 2013, CELL REP, V3, P2046, DOI 10.1016/j.celrep.2013.05.028; Sokolova M, 2017, CELL CYCLE, V16, P189, DOI 10.1080/15384101.2016.1261765; Stankovic A, 2017, MOL CELL, V65, P231, DOI 10.1016/j.molcel.2016.11.021; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Sun X, 2016, INT J CANCER, V139, P899, DOI 10.1002/ijc.30133; Talbert PB, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-7; Tanaka K, 2009, CANCER SCI, V100, P1158, DOI 10.1111/j.1349-7006.2009.01178.x; Tarailo-Graovac M, 2009, CURR PROTOC BIOINFOR, V4, P4, DOI DOI 10.1002/0471250953.BI0410S25; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tomonaga T, 2003, CANCER RES, V63, P3511; Tomonaga Takeshi, 2009, P433, DOI 10.1007/978-0-387-69076-6_14; Valente V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062200; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang ZB, 2013, MOL CANCER THER, V12, P759, DOI 10.1158/1535-7163.MCT-12-0903; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu Q, 2012, LUNG CANCER, V77, P407, DOI 10.1016/j.lungcan.2012.04.007; Yau C, 2015, BREAST CANCER RES TR, V154, P23, DOI 10.1007/s10549-015-3589-7; Zhang X, 2014, ONCOTARGET, V5, P11365, DOI 10.18632/oncotarget.2497                                                        ; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	94	0	0	0	1	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	MAR 1	2017	31	5					463	480		10.1101/gad.290924.116				18	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	EQ9FI	WOS:000398389400003	28356341	gold			2018-01-05	
J	Le Heron, A; Patterson, S; Yanez-Munoz, RJ; Dickson, G				Le Heron, Anita; Patterson, Steven; Yanez-Munoz, Rafael J.; Dickson, George			Chimeric Trojan Protein Insertion in Lentiviral Membranes Makes Lentiviruses Susceptible to Neutralization by Anti-Tetanus Serum Antibodies	HUMAN GENE THERAPY			English	Article						lentiviral; HIV; neutralization; tetanus; chimeric protein	HIV GENE-THERAPY; ANTIRETROVIRAL THERAPY; PRIMARY INFECTION; TARGET-CELLS; VECTORS; EXPRESSION; VACCINE; CRISPR/CAS9; INDUCE; ACQUISITION	This study describes the initial testing of a novel strategy for neutralization of lentiviruses using the fundamental biology of enveloped viruses' assembly and budding. In the field of gene therapy, viral vector surface proteins have been manipulated in order to redirect host cell specificity by alteration of pseudotypes. This study tested whether known viral pseudo-typing proteins or surface proteins known to be recruited to the human immunodeficiency virus (HIV) envelope could be engineered to carry neutralizing epitopes from another microorganism onto the lentiviral surface. The results identify ICAM1 as a novel vehicle for lentiviral pseudo-typing. Importantly, the study shows that in a model lentiviral system, ICAM1 can be engineered in chimeric form to result in expression of a fragment of the tetanus toxoid on the viral membrane and that these viruses can then be neutralized by human serum antibodies protective against tetanus. This raises the possibility of delivering chimeric antigens as a gene therapy in HIV-infected patients.	[Le Heron, Anita; Yanez-Munoz, Rafael J.; Dickson, George] Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, Egham TW20 0EX, Surrey, England; [Patterson, Steven] Imperial Coll London, Dept Immunol, London, England	Yanez-Munoz, RJ; Dickson, G (reprint author), Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, Egham TW20 0EX, Surrey, England.	rafael.yanez@rhul.ac.uk; g.dickson@rhul.ac.uk			Bill and Melinda Gates Foundation, Seattle, WA [52116]	Thanks to J. Rice and F. Stevenson (Southampton University, United Kingdom) for providing sequence information and plasmids for TetFrC, and to M. Kaikkonen and S. Yla-Herttuala (University of Kuopio, Finland) for providing sequences and plasmids for Strep-VSVg. This work was funded by the Bill and Melinda Gates Foundation, Seattle, WA (grant 52116).	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Beausejour Y, 2004, J VIROL, V78, P11916, DOI 10.1128/JVI.78.21.11916-11925.2004; Bialek JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158294; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brockman MA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00506; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Choudhury SA, 2013, INT J INFECT DIS, V17, pE1249, DOI 10.1016/j.ijid.2013.07.008; Chung J, 2014, MOL THER, V22, P952, DOI 10.1038/mt.2014.32; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Dahabieh MS, 2015, ANNU REV MED, V66, P407, DOI 10.1146/annurev-med-092112-152941; Degar S, 1996, VIROLOGY, V226, P424, DOI 10.1006/viro.1996.0672                                                          ; Didigu C, 2014, VIRUSES-BASEL, V6, P1395, DOI 10.3390/v6031395; Ensoli B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00417; Fauci AS, 2013, NAT IMMUNOL, V14, P1104, DOI 10.1038/ni.2735; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; Garg H, 2016, HUM GENE THER, V27, P400, DOI 10.1089/hum.2015.126; Gaufin T, 2009, BLOOD, V113, P4250, DOI 10.1182/blood-2008-09-177741; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Jalaguier P, 2015, J VIROL, V89, P323, DOI 10.1128/JVI.02701-14; Joseph SB, 2015, J NEUROVIROL, V21, P276, DOI 10.1007/s13365-014-0287-x; Kaikkonen MU, 2009, GENE THER, V16, P894, DOI 10.1038/gt.2009.47; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kasahara TM, 2015, HUM IMMUNOL, V76, P701, DOI 10.1016/j.humimm.2015.09.023; KRAUT JJ, 1962, ANN ALLERGY, V20, P198; Kulpa DA, 2015, J VIRUS ERAD, V1, P59; Kymalainen H, 2014, HUM GENE THER, V25, P428, DOI 10.1089/hum.2013.172; Lee WS, 2016, J VIROL, V90, P2021, DOI 10.1128/JVI.02717-15; Levy C, 2015, CURR OPIN PHARMACOL, V24, P79, DOI 10.1016/j.coph.2015.08.003; Liang C, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0270-0; Liu C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0517-y; Lu-Nguyen NB, 2014, HUM GENE THER, V25, P631, DOI 10.1089/hum.2014.003; Mautino Mario R., 2002, Current Gene Therapy, V2, P23, DOI 10.2174/1566523023348165; Melkova Z, 2016, FOLIA MICROBIOL PRAH; O'Leary VB, 2013, MOL PHARMACEUT, V10, P4195, DOI 10.1021/mp400247t; Park J, 2009, VIRUS RES, V140, P112, DOI 10.1016/j.virusres.2008.11.016; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Rice J, 2002, J IMMUNOL, V169, P3908, DOI 10.4049/jimmunol.169.7.3908                                                     ; Rice J, 2001, J IMMUNOL, V167, P1558, DOI 10.4049/jimmunol.167.3.1558                                                     ; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6                                                   ; Rubens M, 2015, J IMMUNOL RES, DOI 10.1155/2015/560347; Saayman S, 2015, EXPERT OPIN BIOL TH, V15, P819, DOI 10.1517/14712598.2015.1036736; Saayman SM, 2016, MOL THER, V24, P488, DOI 10.1038/mt.2015.202; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; STAUNTON DE, 1992, J IMMUNOL, V148, P3271; Teh BS, 2015, J RADIOL ONCOL, V4, P377, DOI 10.1007/s13566-015-0239-y; Torres RA, 2014, LAB INVEST, V94, P120, DOI 10.1038/labinvest.2013.142; Tremblay MJ, 1998, IMMUNOL TODAY, V19, P346, DOI 10.1016/S0167-5699(98)01286-9; Trundley A, 2007, EUR J IMMUNOL, V37, P780, DOI 10.1002/eji.200636773; Ueda S, 2016, MICROBIOL IMMUNOL, V60, P483, DOI 10.1111/1348-0421.12395; Uhlig KM, 2015, J VIROL, V89, P9044, DOI 10.1128/JVI.00844-15; Unwalla HJ, 2004, NAT BIOTECHNOL, V22, P1573, DOI 10.1038/nbt1040; Vassall A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001567; Vittes GE, 2011, EUR J IMMUNOL, V41, P2447, DOI 10.1002/eji.201141518; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365	55	0	0	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	MAR	2017	28	3					242	254		10.1089/hum.2016.126				13	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	EP7PT	WOS:000397570400004	27889981				2018-01-05	
J	Liu, XY; Chen, M; Li, L; Gong, LY; Zhou, H; Gao, DM				Liu, Xiangyuan; Chen, Min; Li, Long; Gong, Liyan; Zhou, Hu; Gao, Daming			Extracellular Signal-regulated Kinases (ERKs) Phosphorylate Lin28a Protein to Modulate P19 Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; STEM-CELLS; NEURONAL DIFFERENTIATION; SELF-RENEWAL; CYCLIN D1; PLURIPOTENCY; METABOLISM; EXPRESSION; NEUROGENESIS; URIDYLATION	Lin28a, originally discovered in the nematode Caenorhabditis elegans and highly conserved across species, is a well characterized regulator of let-7 microRNA (miRNA) and is implicated in cell proliferation and pluripotency control. However, little is known about how Lin28a function is modulated at the posttranslational level and thereby responds to major signaling pathways. Here we show that Lin28a is directly phosphorylated by ERK1/2 kinases at Ser-200. By editing lin28a gene with the CRISPR/Cas9-based method, we generated P19 mouse embryonic carcinoma stem cells expressing Lin28a-S200A (phosphodeficient) and Lin28a-S200D (phospho-mimetic) mutants, respectively, to study the functional impact of Ser-200 phosphorylation. Lin28a-S200D-expressing cells, but not Lin28a-S200A-expressing or control P19 embryonic carcinoma cells, displayed impaired inhibition of let-7 miRNA and resulted in decreased cyclin D1, whereas Lin28a-S200-A knock-in cells expressed less let-7 miRNA, proliferated faster, and exhibited differentiation defect upon retinoic acid induction. Therefore our results support that ERK kinase-mediated Lin28a phosphorylation may be an important mechanism for pluripotent cells to facilitate the escape from the self-renewal cycle and start the differentiation process.	[Liu, Xiangyuan; Chen, Min; Li, Long; Gong, Liyan; Zhou, Hu; Gao, Daming] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,CAS Key Lab Sys, CAS Ctr Excellence Mol Cell Sci,Innovat Ctr Cell, 320 Yueyang Rd, Shanghai 200031, Peoples R China	Gao, DM (reprint author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,CAS Key Lab Sys, CAS Ctr Excellence Mol Cell Sci,Innovat Ctr Cell, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	dgao@sibcb.ac.cn		Gao, Daming/0000-0003-4374-1055	Ministry of Science and Technology of China [2015CB964502]; National Science Foundation of China Grant [81372602, 81422033]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]	This work was supported by Ministry of Science and Technology of China Grant 2015CB964502, National Science Foundation of China Grants 81372602 and 81422033, and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000) (to D.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8                                                   ; Choudhury NR, 2014, CELL REP, V9, P1265, DOI 10.1016/j.celrep.2014.10.017; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9; Dalton S, 2015, TRENDS CELL BIOL, V25, P592, DOI 10.1016/j.tcb.2015.07.007; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280                                                           ; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Kim SK, 2014, CELL STEM CELL, V15, P735, DOI 10.1016/j.stem.2014.10.016; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Leontieva OV, 2013, CELL DEATH DIFFER, V20, P1241, DOI 10.1038/cdd.2013.86; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8                                                    ; Mayr F, 2013, INT J MOL SCI, V14, P16532, DOI 10.3390/ijms140816532; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Meloche S, 2004, CELL CYCLE, V3, P241; Nowak JS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4687; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Politis PK, 2008, CELL CYCLE, V7, P691, DOI 10.4161/cc.7.6.5550                                                             ; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093                                                          ; Rehfeld F, 2015, CELL TISSUE RES, V359, P145, DOI 10.1007/s00441-014-1872-2; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Tsanov KM, 2017, NAT CELL BIOL, V19, P60, DOI 10.1038/ncb3453; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wainwright LJ, 2001, P NATL ACAD SCI USA, V98, P9396, DOI 10.1073/pnas.161288698; Wong SCC, 2001, J PATHOL, V194, P35, DOI 10.1002/path.838                                                                ; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	42	0	0	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					3970	3976		10.1074/jbc.C117.775122				7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EN2JZ	WOS:000395837100002	28179426				2018-01-05	
J	Srikumar, A; Krishna, PS; Sivaramakrishna, D; Kopfmann, S; Hess, WR; Swamy, MJ; Lin-Chao, S; Prakash, JSS				Srikumar, Afshan; Krishna, Pilla Sankara; Sivaramakrishna, Dokku; Kopfmann, Stefan; Hess, Wolfgang R.; Swamy, Musti J.; Lin-Chao, Sue; Prakash, Jogadhenu S. S.			The Ssl2245-Sll1130 Toxin-Antitoxin System Mediates Heat-induced Programmed Cell Death in Synechocystis sp PCC6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP PCC 6803; ESCHERICHIA-COLI; MARINE CYANOBACTERIUM; BIOFILM FORMATION; MOLTEN GLOBULE; PLASMID; BACTERIA; BINDING; STRESS; GENES	Twoputative heat-responsive genes, ssl2245 and sll1130, constitute an operon that also has characteristics of a toxin-antitoxin system, thus joining several enigmatic features. Closely related orthologs of Ssl2245 and Sll1130 exist in widely different bacteria, which thrive under environments with large fluctuations in temperature and salinity, among which some are thermo-epilithic biofilm-forming cyanobacteria. Transcriptome analyses revealed that the clustered regularly interspaced short palindromic repeats (CRISPR) genes as well as several hypothetical genes were commonly up-regulated in Delta ssl2245 and Delta sll1130 mutants. Genes coding for heat shock proteins and pilins were also induced in Delta sll1130. We observed that the majority of cells in a Delta sll1130 mutant strain remained unicellular and viable after prolonged incubation at high temperature (50 degrees C). In contrast, the wild type formed large cell clumps of dead and live cells, indicating the attempt to form biofilms under harsh conditions. Furthermore, we observed that Sll1130 is a heat-stable ribonuclease whose activity was inhibited by Ssl2245 at optimal temperatures but not at high temperatures. In addition, we demonstrated that Ssl2245 is physically associated with Sll1130 by electrostatic interactions, thereby inhibiting its activity at optimal growth temperature. This association is lost upon exposure to heat, leaving Sll1130 to exhibit its ribonuclease activity. Thus, the activation of Sll1130 leads to the degradation of cellular RNA and thereby heat-induced programmed cell death that in turn supports the formation of a more resistant biofilm for the surviving cells. Wesuggest to designate Ssl2245 and Sll1130 as MazE and MazF, respectively.	[Srikumar, Afshan; Krishna, Pilla Sankara; Prakash, Jogadhenu S. S.] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India; [Sivaramakrishna, Dokku; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India; [Kopfmann, Stefan; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, Genet & Expt Bioinformat, D-79104 Freiburg, Germany; [Lin-Chao, Sue] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Krishna, Pilla Sankara] Uppsala Univ, Dept Chem, Angstrom Lab, Mol Biomimet, S-75236 Uppsala, Sweden	Prakash, JSS (reprint author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India.	syamsunderp@yahoo.com		Hess, Wolfgang/0000-0002-5340-3423; Swamy, Musti/0000-0002-3108-3633	University Grants Commission (India)	We acknowledge the Department of Biotechnology-Centre for Research and Education in Biology and Biotechnology program of the School of Life Sciences, University of Hyderabad for providing genomics facility. We acknowledge Taiwan International Graduate Program, Academia Sinica, Taiwan for the summer internship to A. S. The MicroCal VP-ITC and VP-DSC equipment used in this study were obtained from the funds made available to the University of Hyderabad through the Universities with Potential for Excellence program of the University Grants Commission (India). We acknowledge the University Grants Commission (India) for support through the Centre for Advanced Studies program to the School of Chemistry.	Allocati N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.570; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bar-Zeev E, 2013, ISME J, V7, P2340, DOI 10.1038/ismej.2013.121; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997                                                       ; Chan Wai Ting, 2016, Front Mol Biosci, V3, P9, DOI 10.3389/fmolb.2016.00009; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Claessen D, 2014, NAT REV MICROBIOL, V12, P115, DOI 10.1038/nrmicro3178; de Laureto PP, 2002, PROTEINS, V49, P385, DOI 10.1002/prot.10234; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Foster JS, 2009, ISME J, V3, P573, DOI 10.1038/ismej.2008.129; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hosoya-Matsuda N, 2005, J BIOL CHEM, V280, P840, DOI 10.1074/jbc.M411493200; Hu MX, 2010, INT J MICROBIOL, V2010; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Johnson LR, 2008, J THEOR BIOL, V251, P24, DOI 10.1016/j.jtbi.2007.10.039; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752                                                         ; Kavitha M, 2010, BIOCHIMIE, V92, P58, DOI 10.1016/j.biochi.2009.09.009; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Klemencic M, 2016, CURR GENET, V62, P669, DOI 10.1007/s00294-016-0582-6; Kopf M, 2014, DNA RES, V21, P527, DOI 10.1093/dnares/dsu018; Kopfmann S, 2013, J BIOL CHEM, V288, P7399, DOI 10.1074/jbc.M112.434100; Krishna PS, 2013, BIOCHEM J, V449, P751, DOI 10.1042/BJ20120928; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993                                                ; Narahari A, 2011, J PHYS CHEM B, V115, P4110, DOI 10.1021/jp110468n; Ning DG, 2011, CURR MICROBIOL, V63, P496, DOI 10.1007/s00284-011-0011-5; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pandey V. D., 2013, INT J CURR MICROBIOL, V2, P519; Prakash JSS, 2010, MICROBIOL-SGM, V156, P442, DOI 10.1099/mic.0.031823-0; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Sabart M, 2013, ENV MICROBIOL REP, V5, P747, DOI 10.1111/1758-2229.12077; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Soo VWC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03186; Spungin D, 2016, BIOGEOSCIENCES, V13, P4187, DOI 10.5194/bg-13-4187-2016; Stazic D, 2011, NUCLEIC ACIDS RES, V39, P4890, DOI 10.1093/nar/gkr037; Tanouchi Y, 2013, TRENDS MICROBIOL, V21, P265, DOI 10.1016/j.tim.2013.04.001; Tseng YT, 2015, J BIOL CHEM, V290, P29953, DOI 10.1074/jbc.M115.691881; WALSBY AE, 1983, PROC R SOC SER B-BIO, V217, P417, DOI 10.1098/rspb.1983.0019; Wen YR, 2014, PATHOG DIS, V70, P240, DOI 10.1111/2049-632X.12145; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zorzini V, 2015, NUCLEIC ACIDS RES, V43, P1241, DOI 10.1093/nar/gku1352	53	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4222	4234		10.1074/jbc.M116.748178				13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EN2JZ	WOS:000395837100020	28104802				2018-01-05	
J	Oakes, E; Anderson, A; Cohen-Gadol, A; Hundley, HA				Oakes, Eimile; Anderson, Ashley; Cohen-Gadol, Aaron; Hundley, Heather A.			Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; GLUR-B; Q/R SITE; SELECTIVE ADENOSINE; MAMMALIAN BRAIN; AMPA RECEPTORS; NEURONAL DEATH; DSRNA-BINDING; HUMAN-DISEASE; ENZYME ADAR2	RNA editing is a cellular process that precisely alters nucleotide sequences, thus regulating gene expression and generating protein diversity. Over 60% of human transcripts undergo adenosine to inosine RNA editing, and editing is required for normal development and proper neuronal function of animals. Editing of one adenosine in the transcript encoding the glutamate receptor subunit B, glutamate receptor ionotropic AMPA 2 (GRIA2), modifies a codon, replacing the genomically encoded glutamine (Q) with arginine (R); thus this editing site is referred to as the Q/R site. Editing at the Q/R site of GRIA2 is essential, and reduced editing of GRIA2 transcripts has been observed in patients suffering from glioblastoma. In glioblastoma, incorporation of unedited GRIA2 subunits leads to a calcium-permeable glutamate receptor, which can promote cell migration and tumor invasion. In this study, we identify adenosine deaminase that acts on RNA 3 (ADAR3) as an important regulator of Q/R site editing, investigate its mode of action, and detect elevated ADAR3 expression in glioblastoma tumors compared with adjacent brain tissue. Overexpression of ADAR3 in astrocyte and astrocytoma cell lines inhibits RNA editing at the Q/R site of GRIA2. Furthermore, the double-stranded RNA binding domains of ADAR3 are required for repression of RNA editing. As the Q/R site of GRIA2 is specifically edited by ADAR2, we suggest that ADAR3 directly competes with ADAR2 for binding to GRIA2 transcript, inhibiting RNA editing, as evidenced by the direct binding of ADAR3 to the GRIA2 pre-mRNA. Finally, we provide evidence that both ADAR2 and ADAR3 expression contributes to the relative level of GRIA2 editing in tumors from patients suffering from glioblastoma.	[Oakes, Eimile] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Anderson, Ashley; Hundley, Heather A.] Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA; [Cohen-Gadol, Aaron] Dept Neurol Surg, Goodman Campbell Brain & Spine, Indianapolis, IN 46202 USA	Hundley, HA (reprint author), Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA.	hahundle@indiana.edu			American Cancer Society Institutional Research Grant [IRG-84-002-28]; American Cancer Society Research Scholar Award [RSG-15-051-RMC]	This work was supported by American Cancer Society Institutional Research Grant IRG-84-002-28 (to H.A.H.) and American Cancer Society Research Scholar Award RSG-15-051-RMC (to H.A.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Barbon A, 2011, BIOCHEMISTRY-MOSCOW+, V76, P882, DOI 10.1134/S0006297911080037; Barraud P, 2012, CURR TOP MICROBIOL, V353, P35, DOI 10.1007/82_2011_145; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Behm M, 2016, TRENDS GENET, V32, P165, DOI 10.1016/j.tig.2015.12.005; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170                                                       ; Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371                                                               ; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Ekdahl Y, 2012, GENOME RES, V22, P1477, DOI 10.1101/gr.131912.111; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57; Galeano F, 2013, ONCOGENE, V32, P998, DOI 10.1038/onc.2012.125; Galeano F, 2012, SEMIN CELL DEV BIOL, V23, P244, DOI 10.1016/j.semcdb.2011.09.003; Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208; Gleghorn ML, 2013, NAT STRUCT MOL BIOL, V20, P515, DOI 10.1038/nsmb.2528; Goodman RA, 2012, CURR TOP MICROBIOL, V353, P1, DOI 10.1007/82_2011_144; Higuchi M, 2000, NATURE, V406, P78; Hitti EG, 2004, FEBS LETT, V574, P25, DOI 10.1016/j.febslet.2004.07.080; Hong HQ, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140190; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Kawahara Y, 2003, EUR J NEUROSCI, V18, P23, DOI 10.1046/j.1460-9568.2003.02718.x; Keegan LP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-209; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kwak S, 2005, J MOL MED-JMM, V83, P110, DOI 10.1007/s00109-004-0599-z; Kwak S, 2010, NEUROPATHOLOGY, V30, P182, DOI 10.1111/j.1440-1789.2009.01090.x; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413                                                           ; Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539; Licht K, 2016, NUCLEIC ACIDS RES, V44, P6398, DOI 10.1093/nar/gkw325; Licht K, 2016, J CELL BIOL, V213, P15, DOI 10.1083/jcb.201511041; Liu Y, 1996, J VIROL, V70, P1961; Maas S, 1996, J BIOL CHEM, V271, P12221, DOI 10.1074/jbc.271.21.12221                                                        ; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maas Stefan, 2006, RNA Biol, V3, P1; Maas S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004225; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795                                                        ; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566                                                         ; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; Ohlson J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/bar/gnil169; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pachernegg S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00069; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286                                                           ; Rieder LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3232; Rosenthal JJC, 2015, J EXP BIOL, V218, P1812, DOI 10.1242/jeb.119065; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Ryman K, 2007, RNA, V13, P1071, DOI 10.1261/rna.404407; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Sansam CL, 2003, P NATL ACAD SCI USA, V100, P14018, DOI 10.1073/pnas.2336131100; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; SCHUMACHER JM, 1995, BIOL REPROD, V52, P1274, DOI 10.1095/biolreprod52.6.1274; Shtrichman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041576; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Sonoda Y, 2001, CANCER RES, V61, P4956; Tariq A, 2013, NUCLEIC ACIDS RES, V41, P2581, DOI 10.1093/nar/gks1353; Tariq A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00099; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Vesely C, 2014, NUCLEIC ACIDS RES, V42, P12155, DOI 10.1093/nar/gku844; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Washburn MC, 2016, RNA, V22, P722, DOI 10.1261/rna.055079.115; Washburn MC, 2014, CELL REP, V6, P599, DOI 10.1016/j.celrep.2014.01.011; Whitney NP, 2008, FASEB J, V22, P2888, DOI 10.1096/fj.07-104661; Wright A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00034; Yamashita T, 2012, NEUROSCI RES, V73, P42, DOI 10.1016/j.neures.2012.02.002; Yang JH, 1997, P NATL ACAD SCI USA, V94, P4354, DOI 10.1073/pnas.94.9.4354; Yang Y, 2013, SCI CHINA LIFE SCI, V56, P944, DOI 10.1007/s11427-013-4546-5; Zipeto MA, 2015, TRENDS MOL MED, V21, P549, DOI 10.1016/j.molmed.2015.07.001	82	5	6	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4326	4335		10.1074/jbc.M117.779868				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EN2JZ	WOS:000395837100029	28167531				2018-01-05	
J	Hurwitz, SN; Nkosi, D; Conlon, MM; York, SB; Liu, X; Tremblay, DC; Meckes, DG				Hurwitz, Stephanie N.; Nkosi, Dingani; Conlon, Meghan M.; York, Sara B.; Liu, Xia; Tremblay, Deanna C.; Meckes, David G., Jr.			CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-kappa B Signaling	JOURNAL OF VIROLOGY			English	Article						Epstein-Barr virus; cell signaling; exosomes; extracellular vesicles; human herpesviruses	LATENT MEMBRANE-PROTEIN; NASOPHARYNGEAL CARCINOMA-CELLS; GROWTH-FACTOR-RECEPTOR; EXTRACELLULAR VESICLES; LIPID RAFTS; ACTIVATION; MEMBRANE-PROTEIN-1; LATENT-MEMBRANE-PROTEIN-1; TRANSFORMATION; INFECTION	Latent membrane protein 1 (LMP1) is an Epstein-Barr virus (EBV)-encoded oncoprotein that is packaged into small extracellular vesicles (EVs) called exosomes. Trafficking of LMP1 into multivesicular bodies (MVBs) alters the content and function of exosomes. LMP1-modified exosomes enhance the growth, migration, and invasion of malignant cells, demonstrating the capacity to manipulate the tumor microenvironment and enhance the progression of EBV-associated cancers. Despite the growing evidence surrounding the significance of LMP1-modified exosomes in cancer, very little is understood about the mechanisms that orchestrate LMP1 incorporation into these vesicles. Recently, LMP1 was shown to be copurified with CD63, a conserved tetraspanin protein enriched in late endosomal and lysosomal compartments. Here, we demonstrate the importance of CD63 presence for exosomalpackaging of LMP1. Nanoparticle tracking analysis and gradient purification revealed an increase in extracellular vesicle secretion and exosomal proteins following LMP1 expression. Immunoisolation of CD63-positive exosomes exhibited accumulation of LMP1 in this vesicle population. Functionally, CRISPR/Cas9 knockout of CD63 resulted in a reduction of LMP1-induced particle secretion. Furthermore, LMP1 packaging was severely impaired in CD63 knockout cells, concomitant with a disruption in the perinuclear localization of LMP1. Importantly, LMP1 trafficking to lipid rafts and activation of NF-kappa B and PI3K/Akt pathways remained intact following CD63 knockout, while mitogen- activated protein kinase/ extracellular signal- regulated kinase (MAPK/ERK) and noncanonical NF-kappa B activation were observed to be increased. These results suggest that CD63 is a critical player in LMP1 exosomal trafficking and LMP1mediated enhancement of exosome production and may play further roles in limiting downstream LMP1 signaling. IMPORTANCE EBV is a ubiquitous gamma herpesvirus linked to malignancies such as nasopharyngeal carcinoma, Burkitt's lymphoma, and Hodgkin's lymphoma. In the context of cancer, EBV hijacks the exosomal pathway to modulate cell-to-cell signaling by secreting viral components such as an oncoprotein, LMP1, into host cell membrane-bound EVs. Trafficking of LMP1 into exosomes is associated with increased oncogenicity of these secreted vesicles. However, we have only a limited understanding of the mechanisms surrounding exosomal cargo packaging, including viral proteins. Here, we describe a role of LMP1 in EV production that requires CD63 and provide an extensive demonstration of CD63-mediated exosomal LMP1 release that is distinct from lipid raft trafficking. Finally, we present further evidence of the role of CD63 in limiting LMP1-induced noncanonical NF-kappa B and ERK activation. Our findings have implications for future investigations of physiological and pathological mechanisms of exosome biogenesis, protein trafficking, and signal transduction, especially in viral-associated tumorigenesis.	[Hurwitz, Stephanie N.; Nkosi, Dingani; Conlon, Meghan M.; York, Sara B.; Liu, Xia; Tremblay, Deanna C.; Meckes, David G., Jr.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Meckes, DG (reprint author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	david.meckes@med.fsu.edu			National Institutes of Health [RO1CA204621, R15CA188941]	This study was supported by grants from the National Institutes of Health (RO1CA204621 and R15CA188941) awarded to D.G.M.	Aga M, 2014, ONCOGENE, V33, P4613, DOI 10.1038/onc.2014.66; Alvarez A, 2014, JOVE-J VIS EXP, V2014; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Brady G, 2007, J CLIN PATHOL, V60, P1397, DOI 10.1136/jcp.2007.047977; Ceccarelli S, 2007, INT J CANCER, V121, P1494, DOI 10.1002/ijc.22844; Chu Eugene A, 2008, Medscape J Med, V10, P165; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707                                                     ; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Dirmeier U, 2003, CANCER RES, V63, P2982; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085                                                        ; Eliopoulos AG, 1998, ONCOGENE, V16, P1731, DOI 10.1038/sj.onc.1201694; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Flanagan J, 2003, J GEN VIROL, V84, P1871, DOI 10.1099/vir.0.18944-0; Floettmann JE, 1996, VIROLOGY, V223, P29, DOI 10.1006/viro.1996.0452; Gires O, 1997, EMBO J, V16, P6131, DOI 10.1093/emboj/16.20.6131; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.183143100; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1                                                   ; Gutzeit C, 2014, J IMMUNOL, V192, P5852, DOI 10.4049/jimmunol.1302068; HAMMERSCHMIDT W, 1989, J VIROL, V63, P2469; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929                                                           ; HUEN DS, 1995, ONCOGENE, V10, P549; Hurwitz SN, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31295; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700                                                         ; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Kung CP, 2008, J VIROL, V82, P5486, DOI 10.1128/JVI.00125-08; Kung CP, 2011, J VIROL, V85, P4399, DOI 10.1128/JVI.01703-10; Kung CP, 2010, J VIROL, V84, P6605, DOI 10.1128/JVI.00344-10; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284                                                            ; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Lee DY, 2008, ONCOGENE, V27, P2833, DOI 10.1038/sj.onc.1210946; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lu JJY, 1996, J GEN VIROL, V77, P1883, DOI 10.1099/0022-1317-77-8-1883; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Luftig M, 2003, P NATL ACAD SCI USA, V100, P15595, DOI 10.1073/pnas.2136756100; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; MARTIN J, 1991, J VIROL, V65, P3246; MARTIN J, 1991, CELL GROWTH DIFFER, V2, P653; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Meckes DG, 2015, J VIROL, V89, P5200, DOI 10.1128/JVI.02470-14; Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110; Meckes DG, 2013, J VIROL, V87, P1301, DOI 10.1128/JVI.02519-12; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; MITCHELL T, 1995, J VIROL, V69, P2968; Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13; Nolte-'t Hoen E, 2016, P NATL ACAD SCI USA, V113, P9155, DOI 10.1073/pnas.1605146113; Pallet N, 2013, PROTEOMICS, V13, P1108, DOI 10.1002/pmic.201200531; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Pattle SB, 2006, EXPERT OPIN BIOL TH, V6, P1193, DOI 10.1517/14712598.6.11.1193; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qazi KR, 2009, BLOOD, V113, P2673, DOI 10.1182/blood-2008-04-153536; Rider MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23978; Saito N, 2003, J BIOL CHEM, V278, P46565, DOI 10.1074/jbc.M302549200; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Sandberg M, 1997, J VIROL, V71, P4649; Savina A, 2002, J CELL SCI, V115, P2505; Shair KHY, 2008, CANCER RES, V68, P6997, DOI 10.1158/0008-5472.CAN-08-1178; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Silva J, 2012, GENE CHROMOSOME CANC, V51, P409, DOI 10.1002/gcc.21926; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Vazirabadi G, 2003, J GEN VIROL, V84, P1997, DOI 10.1099/vir.0.19156-0; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Wasil LR, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.31; Wasil LR, 2015, J VIROL, V89, P7612, DOI 10.1128/JVI.00958-15; Yasui T, 2004, P NATL ACAD SCI USA, V101, P278, DOI 10.1073/pnas.2237224100                                                         ; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Zhang XJ, 2002, CELL DEATH DIFFER, V9, P790, DOI 10.1038/sj.cdd.4401034; Zhang X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0181-x	83	5	5	13	14	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAR	2017	91	5							UNSP e02251-16	10.1128/JVI.02251-16				19	Virology	Virology	EL1BV	WOS:000394356400032		gold			2018-01-05	
J	Pan, YJ; Lin, TL; Chen, CC; Tsai, YT; Cheng, YH; Chen, YY; Hsieh, PF; Lin, YT; Wang, JT				Pan, Yi-Jiun; Lin, Tzu-Lung; Chen, Ching-Ching; Tsai, Yun-Ting; Cheng, Yi-Hsiang; Chen, Yi-Yin; Hsieh, Pei-Fang; Lin, Yi-Tsung; Wang, Jin-Town			Klebsiella Phage Phi K64-1 Encodes Multiple Depolymerases for Multiple Host Capsular Types	JOURNAL OF VIROLOGY			English	Article						Klebsiella; bacteriophage; capsular type; capsule depolymerase; multiple host	PYOGENIC LIVER-ABSCESS; PNEUMONIAE STRAINS; ESCHERICHIA-COLI; CRISPR-CAS; BACTERIOPHAGE; POLYSACCHARIDE; GENOME; GENE; K1; SEROEPIDEMIOLOGY	The genome of the multihost bacteriophage alpha K64-1, capable of infecting Klebsiella capsular types K1, K11, K21, K25, K30, K35, K64, and K69, as well as new capsular types KN4 and KN5, was analyzed and revealed that 11 genes (S1-1, S1-2, S1-3, S2-1, S2-2, S2-3, S2-4, S2-5, S2-6, S2-7, and S2-8) encode proteins with amino acid sequence similarity to tail fibers/spikes or lyases. S2-5 previously was shown to encode a K64 capsule depolymerase (K64dep). Specific capsule-degrading activities of an additional eight putative capsule depolymerases (S2-4 against K1, S1-1 against K11, S1-3 against K21, S2-2 against K25, S2-6 against K30/K69, S2-3 against K35, S1-2 against KN4, and S2-1 against KN5) was demonstrated by expression and purification of the recombinant proteins. Consistent with the capsular type-specific depolymerization activity of these gene products, phage mutants of S1-2, S2-2, S2-3, or S2-6 lost infectivity for KN4, K25, K35, or K30/K69, respectively, indicating that capsule depolymerase is crucial for infecting specific hosts. In conclusion, we identified nine functional capsule depolymerase-encoding genes in a bacteriophage and correlated activities of the gene products to all ten hosts of this phage, providing an example of type-specific host infection mechanisms in a multihost bacteriophage. IMPORTANCE We currently identified eight novel capsule depolymerases in a multihost Klebsiella bacteriophage and correlated the activities of the gene products to all hosts of this phage, providing an example of carriage of multiple depolymerases in a phage with a wide capsular type host spectrum. Moreover, we also established a recombineering system for modification of Klebsiella bacteriophage genomes and demonstrated the importance of capsule depolymerase for infecting specific hosts. Based on the powerful tool for modification of phage genome, further studies can be conducted to improve the understanding of mechanistic details of Klebsiella phage infection. Furthermore, the newly identified capsule depolymerases will be of great value for applications in capsular typing.	[Pan, Yi-Jiun] China Med Univ, Sch Med, Dept Microbiol, Taichung, Taiwan; [Lin, Tzu-Lung; Chen, Ching-Ching; Tsai, Yun-Ting; Cheng, Yi-Hsiang; Chen, Yi-Yin; Hsieh, Pei-Fang; Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Div Infect Dis, Dept Med, Taipei, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan	Wang, JT (reprint author), Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei, Taiwan.; Wang, JT (reprint author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.	wangjt@ntu.edu.tw			Ministry of Science and Technology; National Taiwan University; China Medical University; Liver Disease Prevention and Treatment Research Foundation in Taiwan; National Taiwan University Hospital	This study was supported by grants from Ministry of Science and Technology, National Taiwan University, National Taiwan University Hospital, China Medical University, and the Liver Disease Prevention and Treatment Research Foundation in Taiwan.	Abbott S.L., 2003, MANUAL CLIN MICROBIO, P684; ADAMS MH, 1956, VIROLOGY, V2, P719, DOI 10.1016/0042-6822(56)90054-X                                                    ; Beck NK, 2009, J RAPID METH AUT MIC, V17, P455, DOI 10.1111/j.1745-4581.2009.00182.x; Brisse S, 2004, J CLIN MICROBIOL, V42, P3388, DOI 10.1128/JCM.42.8.3388-3398.2004; Brisse S, 2013, J CLIN MICROBIOL, V51, P4073, DOI 10.1128/JCM.01924-13; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; CROSS AS, 1990, CURR TOP MICROBIOL, V150, P87; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Feher T, 2012, MICROB BIOTECHNOL, V5, P466, DOI 10.1111/j.1751-7915.2011.00292.x; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; GASTON MA, 1987, J CLIN MICROBIOL, V25, P1228; HACKLAND PL, 1988, CARBOHYD RES, V172, P209, DOI 10.1016/S0008-6215(00)90855-3; Hsu CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070092; Jenney AW, 2006, J CLIN MICROBIOL, V44, P102, DOI 10.1128/JCM.44.1.102-107.2006; Kaliniene L, 2011, ARCH VIROL, V156, P1913, DOI 10.1007/s00705-011-1084-y; Kiro R, 2014, RNA BIOL, V11, P42, DOI 10.4161/rna.27766; Lin TL, 2014, J INFECT DIS, V210, P1734, DOI 10.1093/infdis/jiu332; LINDBERG B, 1979, CARBOHYD RES, V76, P281, DOI 10.1016/0008-6215(79)80031-2; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marinelli Laura J, 2012, Bacteriophage, V2, P5; Marinelli LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003957; Martel B, 2014, NUCLEIC ACIDS RES, V42, P9504, DOI 10.1093/nar/gku628; Nolan JM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-30; Ohmori S, 2002, HEPATOL RES, V22, P307, DOI 10.1016/S1386-6346(01)00153-X                                                   ; Oppenheim AB, 2004, VIROLOGY, V319, P185, DOI 10.1016/j.virol.2003.11.007; ORSKOV I, 1977, INT J SYST BACTERIOL, V27, P386, DOI 10.1099/00207713-27-4-386                                                       ; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; Pan YJ, 2015, ANTIMICROB AGENTS CH, V59, P1038, DOI 10.1128/AAC.03560-14; Pan YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080670; PIERONI P, 1994, J MED MICROBIOL, V41, P423, DOI 10.1099/00222615-41-6-423                                                       ; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145; Rakieten ML, 1940, J BACTERIOL, V40, P529; RIEGERHUG D, 1981, VIROLOGY, V113, P363, DOI 10.1016/0042-6822(81)90162-8; Roberts I.S., 1995, 1995 FLEMING LECT MI, V141, P2023; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001                                                 ; Simoliunas E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060717; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; THUROW H, 1974, VIROLOGY, V58, P306, DOI 10.1016/0042-6822(74)90166-4; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y	43	3	3	3	6	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAR	2017	91	6							UNSP e02457	10.1128/JVI.02457-16				16	Virology	Virology	EQ5CF	WOS:000398098300039		gold			2018-01-05	
J	Shi, ZD; Soh, CL; Zhu, ZR; Huangfu, D				Shi, Zhong-Dong; Soh, Chew-Li; Zhu, Zengrong; Huangfu, Danwei			Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Genetics; Issue 121; CRISPR/Cas9; iCas9; genome editing; AAVS1; human pluripotent stem cells; pancreatic differentiation; glucoseresponsive beta-like cells; diabetes	PLURIPOTENT STEM-CELLS; IN-VITRO; FUNCTIONAL-ANALYSIS; ICRISPR PLATFORM; NUCLEASES; CRISPR-CAS9; PROGENITORS; GENERATION; IPSCS	Interrogating gene function in self-renewing or differentiating human pluripotent stem cells (hPSCs) offers a valuable platform towards understanding human development and dissecting disease mechanisms in a dish. To capitalize on this potential application requires efficient genome-editing tools to generate hPSC mutants in disease-associated genes, as well as in vitro hPSC differentiation protocols to produce disease-relevant cell types that closely recapitulate their in vivo counterparts. An efficient genome-editing platform for hPSCs named iCRISPR has been developed through the TALEN-mediated targeting of a Cas9 expression cassette in the AAVS1 locus. Here, the protocols for the generation of inducible Cas9 hPSC lines using cells cultured in a chemically defined medium and a feeder-free condition are described. Detailed procedures for using the iCRISPR system for gene knockout or precise genetic alterations in hPSCs, either through non-homologous end joining (NHEJ) or via precise nucleotide alterations using a homology-directed repair (HDR) template, respectively, are included. These technical procedures include descriptions of the design, production, and transfection of CRISPR guide RNAs ( gRNAs); the measurement of the CRISPR mutation rate by T7E1 or RFLP assays; and the establishment and validation of clonal mutant lines. Finally, we chronicle procedures for hPSC differentiation into glucose-responsive pancreatic beta-like cells by mimicking in vivo pancreatic embryonic development. Combining iCRISPR technology with directed hPSC differentiation enables the systematic examination of gene function to further our understanding of pancreatic development and diabetes disease mechanisms.	[Shi, Zhong-Dong; Soh, Chew-Li; Zhu, Zengrong; Huangfu, Danwei] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Zhu, ZR; Huangfu, D (reprint author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	zhuzengrong@gmail.com; huangfud@mskcc.org		Huangfu, Danwei/0000-0002-1145-6199	NIH/NIDDK [R01DK096239]; New York State Stem Cell Science [NYSTEM C029156]; NYSTEM postdoctoral fellowship from the Center for Stem Cell Biology of the Sloan Kettering Institute	This work was funded in part by NIH/NIDDK (R01DK096239) and New York State Stem Cell Science (NYSTEM C029156). Z.Z. was supported by the NYSTEM postdoctoral fellowship from the Center for Stem Cell Biology of the Sloan Kettering Institute.	Braam SR, 2008, NAT METHODS, V5, P389, DOI [10.1038/nmeth.1200, 10.1038/NMETH.1200]; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carlson-Stevermer J, 2016, STEM CELL REP, V6, P109, DOI 10.1016/j.stemcr.2015.11.014; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kotini AG, 2015, NAT BIOTECHNOL, V33, P646, DOI 10.1038/nbt.3178; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; Nostro MC, 2015, STEM CELL REP, V4, P591, DOI 10.1016/j.stemcr.2015.02.017; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Shi Z. D., 2017, CELL STEM C IN PRESS; Soh C. L., 2017, METHOD MOL BIOL, V1498, P22; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhu ZR, 2016, CELL STEM CELL, V18, P755, DOI 10.1016/j.stem.2016.03.015; Zhu ZR, 2015, STEM CELL REP, V4, P1103, DOI 10.1016/j.stemcr.2015.04.016; Zhu ZR, 2014, METHOD ENZYMOL, V546, P215, DOI 10.1016/B978-0-12-801185-0.00011-8; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	31	0	0	0	2	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	MAR	2017		121							e55267	10.3791/55267				14	Multidisciplinary Sciences	Science & Technology - Other Topics	EQ1RW	WOS:000397848300044		gold			2018-01-05	
J	Mueller, SJ; Hoernstein, SNW; Reski, R				Mueller, Stefanie J.; Hoernstein, Sebastian N. W.; Reski, Ralf			The mitochondrial proteome of the moss Physcomitrella patens	MITOCHONDRION			English	Article						Metabolic labelling; Quantitative proteomics; Mitochondria; Bryophyte; Dual targeting; Abiotic stress	END RULE PATHWAY; DESICCATION TOLERANCE; ENDOPLASMIC-RETICULUM; COMPLEX-I; QUANTITATIVE-ANALYSIS; PLANT-MITOCHONDRIA; OXIDATIVE STRESS; ABSCISIC-ACID; GENE FAMILY; ARABIDOPSIS	Extant basal land plants are routinely used to trace plant evolution and to track strategies for high abiotic stress resistance. Whereas the structure of mitochondrial genomes and RNA editing are already well studied, mitochondrial proteome research is restricted to a few data sets. While the mitochondrial proteome of the model moss Physcomitrella patens is covered to an estimated 15-25% by proteomic evidence to date, the available data have already provided insights into the evolution of metabolic compartmentation, dual targeting and mitochondrial heterogeneity. This review summarizes the current knowledge about the mitochondrial proteome of P. patens, and gives a perspective on its use as a mitochondrial model system. Its amenability to gene editing, metabolic labelling as well as fluorescence microscopy provides a unique platform to study open questions in mitochondrial biology, such as regulation of protein stability, responses to stress and connectivity to other organelles. Future challenges will include improving the proteomic resources for P. patens, and to link protein inventories and modifications as well as evolutionary differences to the functional level. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.	[Mueller, Stefanie J.] Univ Bonn, INRES, Chem Signalling, Friedrich Ebert Allee 144, DE-53113 Bonn, Germany; [Hoernstein, Sebastian N. W.; Reski, Ralf] Univ Freiburg, Fac Biol, Plant Biotechnol, Schaenzlestr 1, DE-79104 Freiburg, Germany; [Reski, Ralf] Ctr Biol Signalling Studies, BIOSS, DE-79104 Freiburg, Germany	Reski, R (reprint author), Univ Freiburg, Fac Biol, Plant Biotechnol, Schaenzlestr 1, DE-79104 Freiburg, Germany.	stefanie.mueller@uni-bonn.de; sebastian.hoernstein@biologie.uni-freiburg.de; ralf.reski@biologie.uni-freiburg.de		Reski, Ralf/0000-0002-5496-6711	Excellence Initiative of the German Federal and State Governments [EXC294]	Funding by the Excellence Initiative of the German Federal and State Governments (EXC294 to R. R.) is gratefully acknowledged.	Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Birke H, 2012, PROTOPLASMA, V249, P147, DOI 10.1007/s00709-012-0411-9; Carrie C, 2013, BBA-MOL CELL RES, V1833, P253, DOI 10.1016/j.bbamcr.2012.05.029; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Cui SX, 2012, J EXP BOT, V63, P711, DOI 10.1093/jxb/err296; Cuming AC, 2007, NEW PHYTOL, V176, P275, DOI 10.1111/j.1469-8137.2007.02187.x; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fesenko IA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0468-7; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; Frank W, 2007, PLANT J, V51, P1004, DOI 10.1111/j.1365-313X.2007.03198.x; Furt F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-70; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Heintz D, 2006, J PROTEOME RES, V5, P2283, DOI 10.1021/pr060152e; Hoernstein SNW, 2016, MOL CELL PROTEOMICS, V15, P1808, DOI 10.1074/mcp.M115.057190; Hooper CM, 2014, BIOINFORMATICS, V30, P3356, DOI 10.1093/bioinformatics/btu550; Huang SB, 2014, METHODS MOL BIOL, V1072, P499, DOI 10.1007/978-1-62703-631-3_34; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jaipargas Erica-Ashley, 2015, Front Plant Sci, V6, P783, DOI 10.3389/fpls.2015.00783; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Khandelwal A, 2010, SCIENCE, V327, P546, DOI 10.1126/science.1183672; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Konig AC, 2014, MITOCHONDRION, V19, P252, DOI 10.1016/j.mito.2014.03.004; Koster KL, 2010, PLANT GROWTH REGUL, V62, P293, DOI 10.1007/s10725-010-9490-9; Lang D, 2005, PLANT BIOLOGY, V7, P238, DOI 10.1055/s-2005-837578; Lang D, 2016, ADV BOT RES, V78, P97, DOI 10.1016/bs.abr.2016.01.004; Lang D, 2010, GENOME BIOL EVOL, V2, P488, DOI 10.1093/gbe/evq032; Lang EGE, 2011, PLANT CELL REP, V30, P205, DOI 10.1007/s00299-010-0935-4; Lee CP, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00004; Lehtonen MT, 2012, MOL PLANT MICROBE IN, V25, P363, DOI 10.1094/MPMI-10-11-0265; Leitner A, 2016, METHODS MOL BIOL, V1355, P105, DOI 10.1007/978-1-4939-3049-4_7; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Lilley Kathryn S., 2008, V432, P373, DOI 10.1007/978-1-59745-028-7_25; Martin W, 2010, PHILOS T R SOC B, V365, P847, DOI 10.1098/rstb.2009.0252; Mehrshahi P, 2013, P NATL ACAD SCI USA, V110, P12126, DOI 10.1073/pnas.1306331110; Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043; Michalecka AM, 2003, PLANT PHYSIOL, V133, P642, DOI 10.1104/pp.103.024208; Millar AH, 2006, CURR OPIN PLANT BIOL, V9, P610, DOI 10.1016/j.pbi.2006.09.002; Millar AH, 2004, PLANT MOL BIOL, V56, P77, DOI 10.1007/s11103-004-2316-2; Mishler B. D., 2009, ANN PLANT REV, P1; Mitschke J, 2009, NEW PHYTOL, V183, P224, DOI 10.1111/j.1469-8137.2009.02832.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moller IM, 2016, PHYSIOL PLANTARUM, V157, P256, DOI 10.1111/ppl.12456; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561                                                ; Mueller SJ, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28993; Muller SJ, 2016, ANN FOREST SCI, V73, P135, DOI 10.1007/s13595-015-0468-7; Mueller Stefanie J, 2015, Front Cell Dev Biol, V3, P78, DOI 10.3389/fcell.2015.00078; Mueller SJ, 2014, PLANT PHYSIOL, V164, P2081, DOI 10.1104/pp.114.235754; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Oliver MJ, 2005, INTEGR COMP BIOL, V45, P788, DOI 10.1093/icb/45.5.788; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Peny A. J., 2006, CURR BIOL, V16, P221; Polyakov N.B., 2010, BSG BIOCH MOSC, V75, P1470; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rensing SA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-130                                                         ; Reski R, 1998, TRENDS PLANT SCI, V3, P209, DOI 10.1016/S1360-1385(98)01257-6                                                   ; Rudinger M, 2012, J MOL EVOL, V74, P37, DOI 10.1007/s00239-012-9486-3; Salvato F, 2014, PLANT PHYSIOL, V164, P637, DOI 10.1104/pp.113.229054; Schuessele C, 2016, NEW PHYTOL, V209, P1014, DOI 10.1111/nph.13656; Schwarzlander M, 2013, ANTIOXID REDOX SIGN, V18, P2122, DOI 10.1089/ars.2012.5104; Skripnikov AY, 2009, BIOCHEMISTRY-MOSCOW+, V74, P480, DOI 10.1134/S0006297909050022; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Sweetlove LJ, 2006, P NATL ACAD SCI USA, V103, P19587, DOI 10.1073/pnas.0607751103; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Vogtle FN, 2012, MOL CELL PROTEOMICS, V11, P1840, DOI 10.1074/mcp.M112.021105; Wang WQ, 2015, PLANT PHYSIOL BIOCH, V86, P1, DOI 10.1016/j.plaphy.2014.11.003; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Wang XQ, 2008, PLANTA, V228, P167, DOI 10.1007/s00425-008-0727-z; Wang XQ, 2014, J EXP BOT, V65, P2093, DOI 10.1093/jxb/eru082; Wang XQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-192; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wong Catherine C L, 2007, PLoS Biol, V5, pe258, DOI 10.1371/journal.pbio.0050258; Wu SZ, 2014, ELIFE, V3, DOI 10.7554/eLife.03498; Xu L, 2013, PLANT PHYSIOL, V161, P644, DOI 10.1104/pp.112.210997; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Zimmer AD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-498	88	0	0	4	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1567-7249	1872-8278		MITOCHONDRION	Mitochondrion	MAR	2017	33				SI		38	44		10.1016/j.mito.2016.07.007				7	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	EO4BN	WOS:000396639200005	27450107				2018-01-05	
J	Ackermann, AM; Zhang, J; Heller, A; Briker, A; Kaestner, KH				Ackermann, Amanda M.; Zhang, Jia; Heller, Aryel; Briker, Anna; Kaestner, Klaus H.			High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting	MOLECULAR METABOLISM			English	Article						Islet; a-cell; Enteroendocrine L-cell; Glucagon; GLP1; CRISPR	PANCREATIC ALPHA-CELLS; SECRETION; GLUCOSE; HYPOGLYCEMIA; EXPRESSION; CONVERSION; INSULIN; ISLETS	Objective: alpha-cells are the second most prominent cell type in pancreatic islets and are responsible for producing glucagon to increase plasma glucose levels in times of fasting. alpha-cell dysfunction and inappropriate glucagon secretion occur in both type 1 and type 2 diabetes. Thus, there is growing interest in studying both normal function and pathophysiology of alpha-cells. However, tools to target gene ablation or activation specifically of alpha-cells have been limited, compared to those available for beta-cells. Previous Glucagon-Cre and Glucagon-CreER transgenic mouse lines have suffered from transgene silencing, and the only available Glucagon-CreER "knock-in" mouse line results in glucagon haploinsufficiency, which can confound the interpretation of gene deletion analyses. Therefore, we sought to develop a Glucagon-CreER(T2) mouse line that would maintain normal glucagon expression and would be less susceptible to transgene silencing. Methods: We utilized CRISPR-Cas9 technology to insert an IRES-CreER(T2) sequence into the 30 UTR of the Glucagon (Gcg) locus in mouse embryonic stem cells (ESCs). Targeted ESC clones were then injected into mouse blastocysts to obtain Gcg-CreERT2 mice. Recombination efficiency in GCG(+) pancreatic alpha-cells and glucagon-like peptide 1 positive (GLP1(+)) enteroendocrine L-cells was measured in Gcg-CreER(T2); Rosa26-LSL-YFP mice injected with tamoxifen during fetal development and adulthood. Results: Tamoxifen injection of Gcg-CreERT2; Rosa26-LSL-YFP mice induced high recombination efficiency of the Rosa26-LSL-YFP locus in perinatal and adult alpha-cells (88% and 95%, respectively), as well as in first-wave fetal alpha-cells (36%) and adult enteroendocrine L-cells (33%). Mice homozygous for the Gcg-CreER(T2) allele were phenotypically normal. Conclusions: We successfully derived a Gcg-CreER(T2) mouse line that expresses CreER(T2) in pancreatic alpha-cells and enteroendocrine L-cells without disrupting preproglucagon gene expression. These mice will be a useful tool for performing temporally controlled genetic manipulation specifically in these cell types. (C) 2017 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND License	[Ackermann, Amanda M.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, 3400 Civ Ctr Blvd, Philadelphia, PA USA; [Ackermann, Amanda M.; Zhang, Jia; Heller, Aryel; Kaestner, Klaus H.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA USA; [Zhang, Jia; Heller, Aryel; Briker, Anna; Kaestner, Klaus H.] Univ Penn, Dept Genet, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA USA	Kaestner, KH (reprint author), 12-126 Translat Res Ctr,3400 Civ Ctr Blvd, Philadelphia, PA USA.	ackermanna@email.chop.edu; zhangjia@upenn.edu; aryelh@mail.med.upenn.edu; abriker@villanova.edu; kaestner@mail.med.upenn.edu			NIDDK [P30 DK019525, P30 DK050306]; Juvenile Diabetes Research Foundation [3-PDF-2014-186-A-N]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [UC4 DK104119]; American Diabetes Association [7-12-MN-37];  [P30 DK19525];  [P01 DK049210]	We thank the following core facilities at the University of Pennsylvania for their assistance: Gene Targeting Core and Laboratory, Transgenic and Chimeric Mouse Facility (supported by the NIDDK grants P30 DK019525 and P30 DK050306), Pancreatic Islet Cell Biology Core (supported by P30 DK19525), and Molecular Pathology and Imaging Core (supported by P30 DK050306 and P01 DK049210). We thank Tia Bernard-Banks for animal husbandry. This work was supported by the Juvenile Diabetes Research Foundation grant 3-PDF-2014-186-A-N to AMA, by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant UC4 DK104119 to KHK, and by the American Diabetes Association grant 7-12-MN-37 to KHK.	Beucher A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036449; Bramswig NC, 2011, DIABETES OBES METAB, V13, P13, DOI 10.1111/j.1463-1326.2011.01440.x; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; Drucker DJ, 2016, J CLIN ENDOCR METAB, V101, P778, DOI 10.1210/jc.2015-3449; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Habener JF, 2013, TRENDS ENDOCRIN MET, V24, P153, DOI 10.1016/j.tem.2012.10.009; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Imai Y, 2008, PHYSIOL GENOMICS, V36, P43, DOI 10.1152/physiolgenomics.00050.2008; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Knop FK, 2012, DIABETES OBES METAB, V14, P500, DOI 10.1111/j.1463-1326.2011.01549.x; Liu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Michaliszyn SF, 2014, DIABETES, V63, P3846, DOI 10.2337/db13-1951; QUESADA I, 2008, THE JOURNAL OF ENDOC, V199, P5, DOI DOI 10.1677/JOE-08-0290; Rickels MR, 2015, DIABETES, V64, P1713, DOI 10.2337/db14-1620; Sandhu U, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq868; Simoes AES, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-181; Solomou A, 2015, J BIOL CHEM, V290, P21432, DOI 10.1074/jbc.M115.645291; Sun G, 2015, MOL METAB, V4, P277, DOI 10.1016/j.molmet.2015.01.006; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tuduri E, 2014, AM J PHYSIOL-ENDOC M, V306, pE748, DOI 10.1152/ajpendo.00681.2013; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016	24	2	2	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2212-8778			MOL METAB	Mol. Metab.	MAR	2017	6	3					236	244		10.1016/j.molmet.2017.01.003				9	Endocrinology & Metabolism	Endocrinology & Metabolism	EO9RF	WOS:000397025100002	28271030	gold			2018-01-05	
J	Hale, M; Mesojednik, T; Ibarra, GSR; Sahni, J; Bernard, A; Sommer, K; Scharenberg, AM; Rawlings, DJ; Wagner, TA				Hale, Malika; Mesojednik, Taylor; Ibarra, Guillermo S. Romano; Sahni, Jaya; Bernard, Alison; Sommer, Karen; Scharenberg, Andrew M.; Rawlings, David J.; Wagner, Thor A.			Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells	MOLECULAR THERAPY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; BROADLY NEUTRALIZING ANTIBODIES; LOW-LEVEL VIREMIA; IN-VIVO; HEMATOLOGICAL MALIGNANCIES; INFECTED PATIENTS; MESSENGER-RNA; NEF PROTEIN; STEM-CELLS	The treatment or cure of HIV infection by cell and gene therapy has been a goal for decades. Recent advances in both gene editing and chimeric antigen receptor (CAR) technology have created new therapeutic possibilities for a variety of diseases. Broadly neutralizing monoclonal antibodies (bNAbs) with specificity for the HIV envelope glycoprotein provide a promising means of targeting HIV-infected cells. Here we show that primary human T cells engineered to express anti-HIV CARs based on bNAbs (HIVCAR) show specific activation and killing of HIV-infected versus uninfected cells in the absence of HIV replication. We also show that homology-directed recombination of the HIVCAR gene expression cassette into the CCR5 locus enhances suppression of replicating virus compared with HIVCAR expression alone. This work demonstrates that HIV immunotherapy utilizing potent bNAb-based single-chain variable fragments fused to second-generation CAR signaling domains, delivered directly into the CCR5 locus of T cells by homology-directed gene editing, is feasible and effective. This strategy has the potential to target HIV-infected cells in HIV-infected individuals, which might help in the effort to cure HIV.	[Hale, Malika; Ibarra, Guillermo S. Romano; Sahni, Jaya; Sommer, Karen; Scharenberg, Andrew M.; Rawlings, David J.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, 1900 Ninth Ave, Seattle, WA 98101 USA; [Hale, Malika; Ibarra, Guillermo S. Romano; Sahni, Jaya; Sommer, Karen; Scharenberg, Andrew M.; Rawlings, David J.] Seattle Childrens Res Inst, Program Cell & Gene Therapy, Seattle, WA 98101 USA; [Mesojednik, Taylor; Bernard, Alison; Wagner, Thor A.] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, 1900 Ninth Ave, Seattle, WA 98101 USA; [Scharenberg, Andrew M.; Rawlings, David J.; Wagner, Thor A.] Univ Washington, Dept Pediat, Seattle, WA 98101 USA; [Scharenberg, Andrew M.; Rawlings, David J.] Univ Washington, Dept Immunol, Seattle, WA 98101 USA	Rawlings, DJ (reprint author), Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, 1900 Ninth Ave, Seattle, WA 98101 USA.; Wagner, TA (reprint author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, 1900 Ninth Ave, Seattle, WA 98101 USA.	drawling@uw.edu; thor.wagner@seattlechildrens.org			Seattle Children's Research Institute Center for Immunity and Immunotherapies and Program for Cell and Gene Therapy; Children's Guild Association Endowed Chair in Pediatric Immunology; NIAID of the NIH [P30 AI027757, AI118500]	We thank bluebird bio for providing the CCR5 megaTAL. This work was supported by the Seattle Children's Research Institute Center for Immunity and Immunotherapies and Program for Cell and Gene Therapy, the Children's Guild Association Endowed Chair in Pediatric Immunology (to D.J.R.), and the NIAID of the NIH under awards P30 AI027757 (to T.A.W.) and AI118500 (to T.A.W.).	Ali A, 2016, J VIROL, V90, P6999, DOI 10.1128/JVI.00805-16; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Bhoj VG, 2016, DISCOV MED, V21, P283; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; BUTTKE TM, 1992, J BIOL CHEM, V267, P8819; CANN AJ, 1990, J VIROL, V64, P4735; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; CHALLITA PM, 1995, J VIROL, V69, P748; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Deeken JF, 2012, CLIN INFECT DIS, V55, P1228, DOI 10.1093/cid/cis613; Deeks SG, 2002, MOL THER, V5, P788, DOI 10.1006/mthe.2002.0611; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539                                                         ; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Ghorashian S, 2015, BRIT J HAEMATOL, V169, P463, DOI 10.1111/bjh.13340; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Hatano H, 2010, AIDS, V24, P2528, DOI 10.1097/QAD.0b013e32833dba03; Hill A.L., 2016, PLOS PATHOG, V12; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240                                                             ; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Ibarra GSR, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2016.56; Kolte L, 2009, CLIN EXP IMMUNOL, V155, P44, DOI 10.1111/j.1365-2249.2008.03803.x; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Liu L, 2015, J VIROL, V89, P6685, DOI 10.1128/JVI.00474-15; Liu Y., 2011, PLOS ONE, V6; Masiero S, 2005, GENE THER, V12, P299, DOI 10.1038/sj.gt.3302413; Maude S, 2016, BRIT J HAEMATOL, V172, P11, DOI 10.1111/bjh.13792; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; McClure J, 2007, JAIDS-J ACQ IMM DEF, V44, P254, DOI 10.1097/QAI.0b013e318030f5c5; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Mitsuyasu RT, 2000, BLOOD, V96, P785; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1                                                   ; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16                                              ; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Pasternak AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008490; Petrovas C, 2009, J IMMUNOL, V183, P1120, DOI 10.4049/jimmunol.0900182; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Porteus MH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0859-y; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; Rooney CM, 1998, BLOOD, V92, P1549; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Triant VA, 2012, CLIN INFECT DIS, V54, P408, DOI 10.1093/cid/cir829; UNAIDS, 2016, GLOB AIDS RESP PROGR; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wang CX, 2016, BLOOD, V127, P2546, DOI 10.1182/blood-2016-01-678144; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang JJ, 2004, MOL THER, V9, P577, DOI 10.1016/j.ymthe.2003.12.011; Yang OO, 1997, P NATL ACAD SCI USA, V94, P11478, DOI 10.1073/pnas.94.21.11478; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Zhen AJ, 2015, MOL THER, V23, P1358, DOI 10.1038/mt.2015.102; Zheng ZL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-29; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110	74	6	6	8	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	MAR 1	2017	25	3					570	579		10.1016/j.ymthe.2016.12.023				10	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	EO4AF	WOS:000396635500004	28143740	green_published			2018-01-05	
J	Schallenberg-Rudinger, M; Oldenkott, B; Hiss, M; Le Trinh, P; Knoop, V; Rensing, SA				Schallenberg-Ruedinger, Mareike; Oldenkott, Bastian; Hiss, Manuel; Le Trinh, Phuong; Knoop, Volker; Rensing, Stefan A.			A Single-Target Mitochondrial RNA Editing Factor of Funaria hygrometrica Can Fully Reconstitute RNA Editing at Two Sites in Physcomitrella patens	PLANT AND CELL PHYSIOLOGY			English	Article						DYW cytidine deaminase; Evolution; Funaria; hygrometrica; Pentatricopeptide repeat proteins; Physcomitrella patens; RNA editing	PENTATRICOPEPTIDE REPEAT PROTEIN; CHLOROPLAST MESSENGER-RNAS; PPR-DYW PROTEINS; GROUP-I INTRON; ARABIDOPSIS-THALIANA; MOSS PHYSCOMITRELLA; PLANT-MITOCHONDRIA; EVOLUTIONARY INSIGHTS; GENE-EXPRESSION; LAND PLANTS	Nuclear- encoded pentatricopeptide repeat (PPR) proteins are key factors for site- specific RNA editing, converting cytidines into uridines in plant mitochondria and chloroplasts. All editing factors in the model moss Physcomitrella patens have a C- terminal DYW domain with similarity to cytidine deaminase. However, numerous editing factors in flowering plants lack such a terminal DYW domain, questioning its immediate role in the pyrimidine base conversion process. Here we further investigate the Physcomitrella DYW- type PPR protein PPR_ 78, responsible for mitochondrial editing sites cox1eU755SL and rps14eU137SL. Complementation assays with truncated proteins demonstrate that the DYW domain is essential for full PPR_ 78 editing functionality. The DYW domain can be replaced, however, with its counterpart from another editing factor, PPR_ 79. The PPR_ 78 ortholog of the related moss Funaria hygrometrica fully complements the Physcomitrella mutant for editing at both sites, although the editing site in rps14 is lacking in Funaria. Editing factor orthologs in different taxa may thus retain editing capacity for multiple sites despite the absence of editing requirement.	[Schallenberg-Ruedinger, Mareike; Hiss, Manuel; Rensing, Stefan A.] Univ Marburg, Fac Biol, Plant Cell Biol, Karl von Frisch Str 8, D-35043 Marburg, Germany; [Schallenberg-Ruedinger, Mareike; Oldenkott, Bastian; Le Trinh, Phuong; Knoop, Volker] Univ Bonn, IZMB Inst Zellulare & Mol Bot, Abt Mol Evolut, Kirschallee 1, D-53115 Bonn, Germany; [Rensing, Stefan A.] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Le Trinh, Phuong] VNU Univ Sci, Key Lab Enzyme & Prot Technol KLEPT, 334 Nguyen Trai Thanh Xuan, Hanoi, Vietnam	Schallenberg-Rudinger, M (reprint author), Univ Marburg, Fac Biol, Plant Cell Biol, Karl von Frisch Str 8, D-35043 Marburg, Germany.; Schallenberg-Rudinger, M (reprint author), Univ Bonn, IZMB Inst Zellulare & Mol Bot, Abt Mol Evolut, Kirschallee 1, D-53115 Bonn, Germany.	mareike.ruedinger@uni-bonn.de		Hiss, Manuel/0000-0002-7876-783X	German Research Foundation [Kn411/7, SCHA1952/2-1]	This work was supported by the German Research Foundation [grant Nos. Kn411/7 and SCHA1952/2-1].	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Beike AK, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-158; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Brehme N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140680; Brehme N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00127; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Chateigner-Boutin AL, 2013, PLANT J, V74, P935, DOI 10.1111/tpj.12180; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343                                                           ; Cheng SF, 2016, PLANT J, V85, P532, DOI 10.1111/tpj.13121; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0                                                                ; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fujii S, 2013, PLANT CELL, V25, P3079, DOI 10.1105/tpc.113.112193; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Glass F, 2015, MOL PLANT, V8, P1466, DOI 10.1016/j.molp.2015.05.008; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Groth-Malonek M, 2007, MOL BIOL EVOL, V24, P1068, DOI 10.1093/molbev/msm026; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; Gully BS, 2015, NUCLEIC ACIDS RES, V43, P1918, DOI 10.1093/nar/gkv027; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; Hayes ML, 2015, J BIOL CHEM, V290, P10136, DOI 10.1074/jbc.M114.631630; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Hayes ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-66; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Hein A, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0589-0; HIESEL R, 1989, SCIENCE, V246, P1632, DOI 10.1126/science.2480644                                                         ; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Hiss M, 2014, PLANT J, V79, P530, DOI 10.1111/tpj.12572; HOCH B, 1991, NATURE, V353, P178, DOI 10.1038/353178a0; Hohe A, 2002, PLANT SCI, V163, P69, DOI 10.1016/S0168-9452(02)00059-6; Hohe A, 2004, CURR GENET, V44, P339, DOI 10.1007/s00294-003-0458-4; Horstmann V, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-13; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ichinose M, 2014, FEBS LETT, V588, P4060, DOI 10.1016/j.febslet.2014.09.031; Ichinose M, 2013, PLANT CELL PHYSIOL, V54, P1907, DOI 10.1093/pcp/pct132; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Kindgren P, 2015, PLANT CELL, V27, P403, DOI 10.1105/tpc.114.134189; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Liu Y, 2014, MOL BIOL EVOL, V31, P2586, DOI 10.1093/molbev/msu199; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Miyata Y, 2004, J PLANT PHYSIOL, V161, P113, DOI 10.1078/0176-1617-01220; Muren E, 2009, P NATL ACAD SCI USA, V106, P19444, DOI 10.1073/pnas.0908037106; Ohtani S, 2010, PLANT CELL PHYSIOL, V51, P1942, DOI 10.1093/pcp/pcq142; Okano Y, 2009, P NATL ACAD SCI USA, V106, P16321, DOI 10.1073/pnas.0906997106; Okuda K, 2008, NUCLEIC ACIDS RES, V36, P6155, DOI 10.1093/nar/gkn629; Okuda K, 2014, PLANT J, V80, P870, DOI 10.1111/tpj.12687; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; Ramos-Vega M, 2015, NEW PHYTOL, V208, P430, DOI 10.1111/nph.13468; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2012, J MOL EVOL, V74, P37, DOI 10.1007/s00239-012-9486-3; Rudinger M, 2011, PLANT J, V67, P370, DOI 10.1111/j.1365-313X.2011.04600.x; Rudinger M, 2009, MOL GENET GENOMICS, V281, P473, DOI 10.1007/s00438-009-0424-z; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schallenberg-Rudinger M, 2016, ADV BOT RES, V78, P37, DOI 10.1016/bs.abr.2016.01.002; Schallenberg-Rudinger M, 2013, PLANT J, V76, P420, DOI 10.1111/tpj.12304; Shi XW, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1167299; Sosso D, 2012, PLANT CELL, V24, P676, DOI 10.1105/tpc.111.091074; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2014, MITOCHONDRION, V19, P191, DOI 10.1016/j.mito.2014.04.005; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; Tillich M, 2006, EMBO REP, V7, P308, DOI 10.1038/sj.embor.7400619; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Uchida M, 2011, FEBS LETT, V585, P2367, DOI 10.1016/j.febslet.2011.06.009; Verbitskiy D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397992; Verbitskiy D, 2012, PLANT CELL PHYSIOL, V53, P358, DOI 10.1093/pcp/pcr182; Verbitskiy D, 2010, PLANT SIGNAL BEHAV, V5, P558, DOI 10.4161/psb.11095; Volkmar U, 2010, J MOL EVOL, V70, P506, DOI 10.1007/s00239-010-9348-9; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Wahrmund U, 2010, MOL PHYLOGENET EVOL, V54, P417, DOI 10.1016/j.ympev.2009.09.031; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Zehrmann A, 2015, J BIOL CHEM, V290, P6445, DOI 10.1074/jbc.M114.602086; Zehrmann A, 2012, RNA BIOL, V9, DOI 10.4161/rna.9.2.18644; Zehrmann A, 2010, FEBS LETT, V584, P4181, DOI 10.1016/j.febslet.2010.08.049; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	87	1	1	6	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAR	2017	58	3					496	507		10.1093/pcp/pcw229				12	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	EP1QK	WOS:000397159200009	28394399				2018-01-05	
J	Blanvillain-Baufume, S; Reschke, M; Sole, M; Auguy, F; Doucoure, H; Szurek, B; Meynard, D; Portefaix, M; Cunnac, S; Guiderdoni, E; Boch, J; Koebnik, R				Blanvillain-Baufume, Servane; Reschke, Maik; Sole, Montserrat; Auguy, Florence; Doucoure, Hinda; Szurek, Boris; Meynard, Donaldo; Portefaix, Murielle; Cunnac, Sebastien; Guiderdoni, Emmanuel; Boch, Jens; Koebnik, Ralf			Targeted promoter editing for rice resistance to Xanthomonas oryzae pv. oryzae reveals differential activities for SWEET14-inducing TAL effectors	PLANT BIOTECHNOLOGY JOURNAL			English	Article						bacterial leaf blight; susceptibility gene; genome engineering; TALEN; transgene-free plants	DISEASE-SUSCEPTIBILITY GENE; BACTERIAL LEAF-BLIGHT; RECESSIVE RESISTANCE; SUGAR TRANSPORTER; HIGHLY EFFICIENT; PATHOSYSTEM; MUTATIONS; INDUCTION; IMMUNITY; DEFENSE	As a key virulence strategy to cause bacterial leaf blight, Xanthomonas oryzae pv. oryzae (Xoo) injects into the plant cell DNA-binding proteins called transcription activator-like effectors (TALEs) that bind to effector-binding elements (EBEs) in a sequence-specific manner, resulting in host gene induction. TALEs AvrXa7, PthXo3, TalC and Tal5, found in geographically distant Xoo strains, all target OsSWEET14, thus considered as a pivotal TALE target acting as major susceptibility factor during rice-Xoo interactions. Here, we report the generation of an allele library of the OsSWEET14 promoter through stable expression of TALE-nuclease (TALEN) constructs in rice. The susceptibility level of lines carrying mutations in AvrXa7, Tal5 or TalC EBEs was assessed. Plants edited in AvrXa7 or Tal5 EBEs were resistant to bacterial strains relying on the corresponding TALE. Surprisingly, although indels within TalC EBE prevented OsSWEET14 induction in response to BAI3 wild-type bacteria relying on TalC, loss of TalC responsiveness failed to confer resistance to this strain. The TalC EBE mutant line was, however, resistant to a strain expressing an artificial SWEET14-inducing TALE whose EBE was also edited in this line. This work offers the first set of alleles edited in TalC EBE and uncovers a distinct, broader range of activities for TalC compared to AvrXa7 or Tal5. We propose the existence of additional targets for TalC beyond SWEET14, suggesting that TALE-mediated plant susceptibility may result from induction of several, genetically redundant, host susceptibility genes by a single effector.	[Blanvillain-Baufume, Servane; Auguy, Florence; Doucoure, Hinda; Szurek, Boris; Cunnac, Sebastien; Koebnik, Ralf] IRD CIRAD Univ, UMR Interact Plantes Microorganismes Environm IPE, Montpellier, France; [Reschke, Maik; Sole, Montserrat; Boch, Jens] Martin Luther Univ Halle Wittenberg, Inst Bereich Genet, Inst Biol, Halle, Saale, Germany; [Meynard, Donaldo; Portefaix, Murielle; Guiderdoni, Emmanuel] CIRAD, UMR AGAP Ameliorat Genet & Adaptat Plantes, Montpellier, France; [Blanvillain-Baufume, Servane] Univ Montpellier, LabEx CeMEB, Montpellier, France; [Reschke, Maik; Boch, Jens] Leibniz Univ Hannover, Inst Pflanzengenet, Hannover, Germany; [Sole, Montserrat] Sustainable Agro Solut SA, Almacelles, Lleida, Spain	Cunnac, S; Koebnik, R (reprint author), IRD CIRAD Univ, UMR Interact Plantes Microorganismes Environm IPE, Montpellier, France.	sebastien.cunnac@ird.fr; koebnik@gmx.de			Bill and Melinda Gates Foundation [OPP1060078]; Region Languedoc-Roussillon; European Regional Development Fund of the European Commission	This work was funded by a Phase I 'Grand Challenge Exploration Grant' of the Bill and Melinda Gates Foundation (OPP1060078), an IRD postdoctoral fellowship attributed to SB-B, a 'Chercheur d'Avenir' grant from the Region Languedoc-Roussillon attributed to SC and a grant from the European Regional Development Fund of the European Commission to JB. This work benefited from interactions promoted by COST Action FA 1208 (https://www.cost-sustain.org).	Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cernadas RA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003972; Chen HY, 2015, PLANT J, V83, P1046, DOI 10.1111/tpj.12948; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Chen LQ, 2014, NEW PHYTOL, V201, P1150, DOI 10.1111/nph.12445; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Cohn M, 2014, MOL PLANT MICROBE IN, V27, P1186, DOI 10.1094/MPMI-06-14-0161-R; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Gawehns F, 2013, MICROB BIOTECHNOL, V6, P223, DOI 10.1111/1751-7915.12023; Geibler R., 2011, PLOS ONE, V6; Gonzalez C, 2007, MOL PLANT MICROBE IN, V20, P534, DOI 10.1094/MPMI-20-5-0534; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Gust AA, 2010, CURR OPIN BIOTECH, V21, P204, DOI 10.1016/j.copbio.2010.02.004; HOPKINS CM, 1992, MOL PLANT MICROBE IN, V5, P451, DOI 10.1094/MPMI-5-451                                                              ; Hutin M, 2015, PLANT J, V84, P694, DOI 10.1111/tpj.13042; Hutin M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00535; Iyer-Pascuzzi AS, 2007, MOL PLANT MICROBE IN, V20, P731, DOI 10.1094/MPMI-20-7-0731; Kottapalli KR, 2007, BIOCHEM BIOPH RES CO, V355, P295, DOI 10.1016/j.bbrc.2007.01.134; Leach JE, 2001, ANNU REV PHYTOPATHOL, V39, P187, DOI 10.1146/annurev.phyto.39.1.187                                                  ; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Cruz C. Vera, 1989, BACT BLIGHT RIC P IN, P153; Poulin L, 2015, APPL ENVIRON MICROB, V81, P688, DOI 10.1128/AEM.02768-14; Richter A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4447; Romero LE, 2014, G3-GENES GENOM GENET, V4, P133, DOI 10.1534/g3.113.009373; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Streubel J, 2013, NEW PHYTOL, V200, P808, DOI 10.1111/nph.12411; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; van Schie CCN, 2014, ANNU REV PHYTOPATHOL, V52, P551, DOI 10.1146/annurev-phyto-102313-045854; Verdier V, 2012, J BIOTECHNOL, V159, P320, DOI 10.1016/j.jbiotec.2011.09.020; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254; Zhang HT, 2013, CURR OPIN PLANT BIOL, V16, P188, DOI 10.1016/j.pbi.2013.02.008; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang JL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00641; Zhang Y, 2013, MOL PLANT, V6, P1731, DOI 10.1093/mp/sst094; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838	42	7	7	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	MAR	2017	15	3					306	317		10.1111/pbi.12613				12	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	EL4DP	WOS:000394572200004	27539813	gold			2018-01-05	
J	Pulido-Quetglas, C; Aparicio-Prat, E; Arnan, C; Polidori, T; Hermoso, T; Palumbo, E; Ponomarenko, J; Guigo, R; Johnson, R				Pulido-Quetglas, Carlos; Aparicio-Prat, Estel; Arnan, Carme; Polidori, Taisia; Hermoso, Toni; Palumbo, Emilio; Ponomarenko, Julia; Guigo, Roderic; Johnson, Rory			Scalable Design of Paired CRISPR Guide RNAs for Genomic Deletion	PLOS COMPUTATIONAL BIOLOGY			English	Article							GENETIC SCREENS; HUMAN-CELLS; IN-VIVO; SYSTEM; ELEMENTS; IDENTIFICATION; MUTAGENESIS; SEQUENCES; DATABASE; SGRNAS	CRISPR-Cas9 technology can be used to engineer precise genomic deletions with pairs of single guide RNAs (sgRNAs). This approach has been widely adopted for diverse applications, from disease modelling of individual loci, to parallelized loss-of-function screens of thousands of regulatory elements. However, no solution has been presented for the unique bioinformatic design requirements of CRISPR deletion. We here present CRISPETa, a pipeline for flexible and scalable paired sgRNA design based on an empirical scoring model. Multiple sgRNA pairs are returned for each target, and any number of targets can be analyzed in parallel, making CRISPETa equally useful for focussed or high-throughput studies. Fast run-times are achieved using a pre-computed off-target database. sgRNA pair designs are output in a convenient format for visualisation and oligonucleotide ordering. We present pre-designed, high-coverage library designs for entire classes of protein-coding and non-coding elements in human, mouse, zebrafish, Drosophila melanogaster and Caenorhabditis elegans. In human cells, we reproducibly observe deletion efficiencies of >= 50% for CRISPETa designs targeting an enhancer and exonic fragment of the MALAT1 oncogene. In the latter case, deletion results in production of desired, truncated RNA. CRISPETa will be useful for researchers seeking to harness CRISPR for targeted genomic deletion, in a variety of model organisms, from single-target to high-throughput scales.	[Pulido-Quetglas, Carlos; Aparicio-Prat, Estel; Arnan, Carme; Polidori, Taisia; Hermoso, Toni; Palumbo, Emilio; Ponomarenko, Julia; Guigo, Roderic; Johnson, Rory] Barcelona Inst Sci & Technol, CRG, Dr Aiguader 88, Barcelona, Spain; [Pulido-Quetglas, Carlos; Aparicio-Prat, Estel; Arnan, Carme; Polidori, Taisia; Hermoso, Toni; Palumbo, Emilio; Ponomarenko, Julia; Guigo, Roderic; Johnson, Rory] UPF, Barcelona, Spain; [Pulido-Quetglas, Carlos; Aparicio-Prat, Estel; Arnan, Carme; Polidori, Taisia; Palumbo, Emilio; Guigo, Roderic; Johnson, Rory] Inst Hosp Mar Invest Med IMIM, Barcelona, Spain; [Johnson, Rory] Univ Bern, Dept Clin Res, Bern, Switzerland; [Johnson, Rory] Univ Hosp Bern, Inselspital, Dept Med Oncol, Bern, Switzerland; [Johnson, Rory] Univ Bern, Bern, Switzerland	Johnson, R (reprint author), Barcelona Inst Sci & Technol, CRG, Dr Aiguader 88, Barcelona, Spain.; Johnson, R (reprint author), UPF, Barcelona, Spain.; Johnson, R (reprint author), Inst Hosp Mar Invest Med IMIM, Barcelona, Spain.; Johnson, R (reprint author), Univ Bern, Dept Clin Res, Bern, Switzerland.; Johnson, R (reprint author), Univ Hosp Bern, Inselspital, Dept Med Oncol, Bern, Switzerland.; Johnson, R (reprint author), Univ Bern, Bern, Switzerland.	rory.johnson@dkf.unibe.ch	Guigo, Roderic/D-1303-2010	Guigo, Roderic/0000-0002-5738-4477; Johnson, Rory/0000-0003-4607-2782; Arnan, Carme/0000-0002-7431-2088; Hermoso Pulido, Toni/0000-0003-2016-6465	Spanish Ministry of Science [CSD2007-00050]; Catalan Government [SGR-1430]; European Community [ERC-2011-AdG-294653-RNA-MAPS]; National Human Genome Research Institute of the National Institutes of Health [R01MH101814]; Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa [SEV-2012-0208]; CERCA Programme / Generalitat de Catalunya; NCCR RNA & Disease - Swiss National Science Foundation	This work was financially supported by the following grants: CSD2007-00050 from the Spanish Ministry of Science (http://www.mineco.gob.es/portal/site/mineco/idi), grant SGR-1430 from the Catalan Government (http://web.gencat.cat/ca/temes/tecnologia/), grant ERC-2011-AdG-294653-RNA-MAPS from the European Community financial support under the FP7 (https://erc.europa.eu/) and grant R01MH101814 by the National Human Genome Research Institute of the National Institutes of Health (https://www.genome.gov/), to RG. Ramon y Cajal RYC-2011-08851 and Plan Nacional BIO2011-27220, both from the Spanish Ministry of Science (http://www.mineco.gob.es/portal/site/mineco/idi), to RJ. We also acknowledge support of the Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa 2013-2017, SEV-2012-0208 (http://www.mineco.gob.es/portal/site/mineco/idi). We also acknowledge the support of the CERCA Programme / Generalitat de Catalunya (http://web.gencat.cat/ca/temes/tecnologia/). This research was partly supported by the NCCR RNA & Disease funded by the Swiss National Science Foundation (http://www.nccr-rna-and-disease.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio-Prat E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2086-z; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Dimitrieva S, 2013, NUCLEIC ACIDS RES, V41, pD101, DOI 10.1093/nar/gks1092; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seruggia D, 2015, NUCLEIC ACIDS RES, V43, P4855, DOI 10.1093/nar/gkv375; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tarailo-Graovac M, 2009, CURR PROTOC BIOINFOR, V4, P4, DOI DOI 10.1002/0471250953.BI0410S25; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	33	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	MAR	2017	13	3							e1005341	10.1371/journal.pcbi.1005341				18	Biochemical Research Methods; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Mathematical & Computational Biology	EQ4FY	WOS:000398031900044	28253259	gold			2018-01-05	
J	Mitchell, AP				Mitchell, Aaron P. y			Location, location, location: Use of CRISPR-Cas9 for genome editing in human pathogenic fungi	PLOS PATHOGENS			English	Article							CANDIDA-ALBICANS; ASPERGILLUS-FUMIGATUS; GUIDE RNAS; SPECIFICITY; SYSTEM; CAS9		[Mitchell, Aaron P. y] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA	Mitchell, AP (reprint author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	apm1@cmu.edu		Mitchell, Aaron/0000-0002-0868-4000	NIH grant [1R01AI124566]	This work was supported by NIH grant 1R01AI124566. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arras SDM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164322; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Enkler L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35766; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Hirakawa MP, 2015, GENOME RES, V25, P413, DOI 10.1101/gr.174623.114; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Krappmann S, 2017, MED MYCOL, V55, P16, DOI 10.1093/mmy/myw097; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Min K, 2016, CANDIDA ALBICANS GEN, V1; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sasse C, 2012, MOL MICROBIOL, V86, P539, DOI 10.1111/j.1365-2958.2012.08210.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SLUTSKY B, 1985, SCIENCE, V230, P666, DOI 10.1126/science.3901258; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31145; Wu Xuebing, 2014, Quant Biol, V2, P59; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007	23	3	3	9	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	MAR	2017	13	3							e1006209	10.1371/journal.ppat.1006209				5	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	EQ5JZ	WOS:000398120300002	28358867	gold			2018-01-05	
J	Wu, WL; Orr-Burks, N; Karpilow, J; Tripp, RA				Wu, Weilin; Orr-Burks, Nichole; Karpilow, Jon; Tripp, Ralph A.			Development of improved vaccine cell lines against rotavirus	SCIENTIFIC DATA			English	Article; Data Paper								Rotavirus is a major cause of severe gastroenteritis among very young children. In developing countries, rotavirus is the major cause of mortality in children under five years old, causing up to 20% of all childhood deaths in countries with high diarrheal disease burden, with more than 90% of these deaths occurring in Africa and Asia. Rotavirus vaccination mimics the first infection without causing illness, thus inducing strong and broad heterotypic immunity against prospective rotavirus infections. Two live vaccines are available, Rotarix and RotaTeq, but vaccination efforts are hampered by high production costs. Here, we present a dataset containing a genome-wide RNA interference (RNAi) screen that identified silencing events that enhanced rotavirus replication. Evaluated against several rotavirus vaccine strains, hits were validated in a Vero vaccine cell line as well as CRISPR/Cas9 generated cells permanently and stably lacking the genes that affect RV replication. Knockout cells were dramatically more permissive to RV replication and permitted an increase in rotavirus replication. These data show a means to improve manufacturing of rotavirus vaccine.	[Wu, Weilin; Orr-Burks, Nichole; Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Karpilow, Jon] Proventus Bio, 220 Riverbend Rd, Athens, GA 30602 USA	Tripp, RA (reprint author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu			Georgia Research Alliance	We would like to thank Dr Baoming Jiang for providing the RV vaccine strains for this study, and Dr Carl Kirkwood for providing the RV3 virus used during the siRNA primary screen. We would like to thank the Georgia Research Alliance for their support to facilitate this project.	Angel J, 2007, NAT REV MICROBIOL, V5, P529, DOI 10.1038/nrmicro1692; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; CARLSON JAK, 1978, AM J DIS CHILD, V132, P477, DOI 10.1001/archpedi.1978.02120300037006                                            ; Gurwith M., 1981, INFECT DIS, V144, P218; MONTAGNON BJ, 1981, DEV BIOL STAND, V47, P151; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562                                                          ; Rippinger CM, 2010, VIROLOGY, V405, P201, DOI 10.1016/j.virol.2010.06.005; van der Sanden SMG, 2016, J VIROL, V90, P1694, DOI 10.1128/JVI.01464-15; WHO, 2016, GLOB NAT EST DEATHS; Organization W. H., 2007, ROTAVIRUS VACCINES, V32, P285; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XD, 2007, J BIOMOL SCREEN, V12, P497, DOI 10.1177/1087057107300646; [Anonymous], 2008, MMWR, V57, P1255; 2005, NATURE, V437, P69, DOI DOI 10.1038/NATURE04072	15	2	2	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-4463			SCI DATA	Sci. Data	MAR 1	2017	4								170021	10.1038/sdata.2017.21				12	Multidisciplinary Sciences	Science & Technology - Other Topics	EM1HK	WOS:000395068500004	28248921	gold			2018-01-05	
J	Gori, JL; Butler, JM; Kunar, B; Poulos, MG; Ginsberg, M; Nolan, DJ; Norgaard, ZK; Adair, JE; Rafil, S; Kiem, HP				Gori, Jennifer L.; Butler, Jason M.; Kunar, Balvir; Poulos, Michael G.; Ginsberg, Michael; Nolan, Daniel J.; Norgaard, Zachary K.; Adair, Jennifer E.; Rafil, Shahin; Kiem, Hans-Peter			Endothelial Cells Promote Expansion of Long-Term Engrafting Marrow Hematopoietic Stem and Progenitor Cells in Primates	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Hematopoietic stem progenitor cell; Bone marrow transplantation; Endothelial cells; Gene therapy; CD34(+) cells	CORD BLOOD TRANSPLANTATION; EX-VIVO EXPANSION; LETHALLY IRRADIATED BABOONS; SCID-REPOPULATING CELLS; COLONY-FORMING-UNITS; BONE-MARROW; SELF-RENEWAL; NONHUMAN PRIMATE; VASCULAR NICHE; GENE-THERAPY	Successful expansion of bone marrow (BM) hematopoietic stem and progenitor cells (HSPCs) would benefit many HSPC transplantation and gene therapy/editing applications. However, current expansion technologies have been limited by a loss of multipotency and self-renewal properties ex vivo. We hypothesized that an ex vivo vascular niche would provide prohematopoietic signals to expand HSPCs while maintaining multipotency and self-renewal. To test this hypothesis, BM autologous CD34(+) cells were expanded in endothelial cell (EC) coculture and transplanted in nonhuman primates. CD34(+) C382 HSPCs cocultured with ECs expanded up to 17-fold, with a significant increase in hematopoietic colony-forming activity compared with cells cultured with cytokines alone (colony-forming unit-granulocyte-erythroid-macrophage-monocyte; p < .005). BM CD34(+) cells that were transduced with green fluorescent protein lentivirus vector and expanded on ECs engrafted long term with multiline-age polyclonal reconstitution. Gene marking was observed in granulocytes, lymphocytes, platelets, and erythrocytes. Whole transcriptome analysis indicated that EC coculture altered the expression profile of 75 genes in the BM CD34(+) cells without impeding the long-term engraftment potential. These findings show that an ex vivo vascular niche is an effective platform for expansion of adult BM HSPCs. (C) STEM CELLS TRANSLATIONAL MEDICINE	[Gori, Jennifer L.; Norgaard, Zachary K.; Adair, Jennifer E.; Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Butler, Jason M.; Kunar, Balvir; Poulos, Michael G.; Rafil, Shahin] Howard Hughes Med Inst, Chevy Chase, MD USA; [Butler, Jason M.; Kunar, Balvir; Poulos, Michael G.; Rafil, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY USA; [Butler, Jason M.; Kunar, Balvir; Poulos, Michael G.; Rafil, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Butler, Jason M.; Kunar, Balvir; Poulos, Michael G.] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Kunar, Balvir] Weill Cornell Med Coll, Dept Physiol Biophys & Syst Biol, New York, NY USA; [Ginsberg, Michael; Nolan, Daniel J.] Angiocrine Biosci, New York, NY USA; [Kiem, Hans-Peter] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Kiem, Hans-Peter] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Kiem, HP (reprint author), Fred Hutchinson Canc Res Ctr Transplantat Biol, 1100 Fairview Ave North, Seattle, WA 98109 USA.	hkiem@fredhutch.org			NIH [HL115128, HL098489, HL084345, HL053750]	Wethank Grace Choi and Jacob Isenberg for help in preparing this report and Krystin Norman, Devikha Chandrasekaran, Yan Yi Chan, Emily Menard, and Christina McAllister for technical assistance at Fred Hutchinson Cancer Research Center (FHCRC). We also thank Veronica Nelson, Erica Curry, Kelvin Sze, and the University of Washington National Primate Research Center staff, members of the H.P. Kiem Laboratory, and the Flow Cytometry Shared Resource Facility at FHCRC. We thank Grant Trobridge at Washington State University for work on retroviral integration site data processing. We thank Olivier Elemento and the Genomics Resources Core Facility at Weill Cornell Medical College for performing the RNA sequencing. This work was supported in part by NIH Grants HL115128, HL098489, HL084345, and HL053750. H.-P.K. is a Markey Molecular Medicine Investigator and received support as the inaugural recipient of the Jose Carreras/E.D. Thomas Endowed Chair for Cancer Research. S.R. is a Howard Hughes Medical Institute Investigator.	Anguita-Compagnon AT, 2010, TRANSPL P, V42, P339, DOI 10.1016/j.transproceed.2009.11.003; Araki H, 2010, LEUKEMIA LYMPHOMA, V51, P1121, DOI 10.3109/10428191003786774; Beard BC, 2014, METHODS MOL BIOL, V1185, P321, DOI 10.1007/978-1-4939-1133-2_22; Beard BC, 2010, J CLIN INVEST, V120, P2345, DOI 10.1172/JCI40767; Bedi R, 2003, NATL MED J INDIA, V16, P255; Bernstein SH, 1998, BLOOD, V91, P3509; Blank U, 2012, EUR J HAEMATOL, V89, P198, DOI 10.1111/j.1600-0609.2012.01812.x; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brandt JE, 1999, BLOOD, V94, P106; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; Chute JP, 2004, STEM CELLS, V22, P202, DOI 10.1634/stemcells.22-2-202; Chute JP, 2005, BLOOD, V105, P576, DOI 10.1182/blood-2004-04-1467; Chute JP, 2002, BLOOD, V100, P4433, DOI 10.1182/blood-2002-04-1238; Csaszar E, 2014, BLOOD, V123, P650, DOI 10.1182/blood-2013-08-520445; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; Dahlberg A, 2014, LEUKEMIA, V28, P2097, DOI 10.1038/leu.2014.181; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Fan XB, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt460; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Goncalves TL, 2009, OXID MED CELL LONGEV, V2, P82, DOI 10.4161/oxim.2.2.8355                                                           ; Gori JL, 2015, J CLIN INVEST, V125, P1243, DOI 10.1172/JCI79328; Hayakawa J, 2009, HUM GENE THER, V20, P563, DOI 10.1089/hum.2008.186; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Hoggatt J, 2013, BLOOD, V122, P2997, DOI 10.1182/blood-2013-07-515288; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kiem HP, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.55; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lam AC, 2001, TRANSFUSION, V41, P1567, DOI 10.1046/j.1537-2995.2001.41121567.x; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Muramoto GG, 2006, BIOL BLOOD MARROW TR, V12, P530, DOI 10.1016/j.bbmt.2005.12.039; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Okada S, 1999, BLOOD, V93, P816; Page KM, 2011, BIOL BLOOD MARROW TR, V17, P1362, DOI 10.1016/j.bbmt.2011.01.011; Parekh C, 2013, J CLIN IMMUNOL, V33, P711, DOI 10.1007/s10875-012-9844-3; Perseghin P, 2009, TRANSFUS APHER SCI, V41, P33, DOI 10.1016/j.transci.2009.05.011; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x                                                ; Poulos MG, 2015, STEM CELL REP, V5, P881, DOI 10.1016/j.stemcr.2015.08.018; Schmitz N, 1996, LANCET, V347, P353, DOI 10.1016/S0140-6736(96)90536-X; Shimazu T, 2012, BLOOD, V119, P4889, DOI 10.1182/blood-2011-10-388736; Sun CL, 2010, BLOOD, V116, P3129, DOI 10.1182/blood-2009-06-229369; Sun CL, 2010, BLOOD, V116, P3377; Trobridge GD, 2008, BLOOD, V111, P5537, DOI 10.1182/blood-2007-09-115022; Trobridge GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007693; Watts KL, 2013, MOL THER, V21, P1270, DOI 10.1038/mt.2013.40; Watts KL, 2012, EXP HEMATOL, V40, P187, DOI 10.1016/j.exphem.2011.11.009; Watts KL, 2010, BLOOD, V116, P5859, DOI 10.1182/blood-2010-05-286062; Yoo KH, 2007, BONE MARROW TRANSPL, V39, P515, DOI 10.1038/sj.bmt.1705629	53	5	5	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	MAR	2017	6	3					864	876		10.5966/sctm.2016-0240				13	Cell & Tissue Engineering	Cell Biology	EQ6PK	WOS:000398204600018	28297579	gold			2018-01-05	
J	Bell, S; Peng, HS; Crapper, L; Kolobova, I; Maussion, G; Vasuta, C; Yerko, V; Wong, TP; Ernst, C				Bell, Scott; Peng, Huashan; Crapper, Liam; Kolobova, Ilaria; Maussion, Gilles; Vasuta, Cristina; Yerko, Volodymyr; Wong, Tak Pan; Ernst, Carl			A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Neurodevelopment; Gene editing; Induced pluripotent stem cells; Dopamine; Glutamate; Clinical utility	PLURIPOTENT STEM-CELLS; PARKINSONS-DISEASE; HUMAN FIBROBLASTS; INTEGRATION-FREE; HUMAN IPSCS; IN-VITRO; NEURONS; CULTURE; CHALLENGES; TALEN	The development of targeted therapeutics for rare neurodevelopmental disorders (NDDs) faces significant challenges due to the scarcity of subjects and the difficulty of obtaining human neural cells. Here, we illustrate a rapid, simple protocol by which patient derived cells can be reprogrammed to induced pluripotent stem cells (iPSCs) using an episomal vector and differentiated into neurons. Using this platform enables patient somatic cells to be converted to physiologically active neurons in less than two months with minimal labor. This platform includes a method to combine somatic cell reprogramming with CRISPR/Cas9 gene editing at single cell resolution, which enables the concurrent development of clonal knockout or knock-in models that can be used as isogenic control lines. This platform reduces the logistical barrier for using iPSC technology, allows for the development of appropriate control lines for use in rare neurodevelopmental disease research, and establishes a fundamental component to targeted therapeutics and precision medicine. (C) STEM CELLS TRANSLATIONAL MEDICINE	[Bell, Scott; Peng, Huashan; Crapper, Liam; Kolobova, Ilaria; Maussion, Gilles; Vasuta, Cristina; Yerko, Volodymyr; Ernst, Carl] Douglas Hosp, Res Inst, McGill Grp Suicide Studies, Verdun, PQ H4H 1R3, Canada; [Wong, Tak Pan; Ernst, Carl] McGill Univ, Dept Psychiat, Montreal, PQ H4H 1R3, Canada; [Ernst, Carl] McGill Univ, Dept Human Genet, Montreal, PQ H4H 1R3, Canada	Ernst, C (reprint author), McGill Univ, Douglas Hosp, Res Inst, 6875 LaSalle Blvd,Frank Common Bldg, Verdun, PQ H4H 1R3, Canada.	carl.ernst@mcgill.ca			Scottish Rite Charitable Foundation; CIHR; FRQS; Canada Research Chairs program	This work was funded by the Scottish Rite Charitable Foundation. S.B. and L.C. are funded by the CIHR and FRQS, respectively, and CE is supported by the Canada Research Chairs program. The authors would like to extend their gratitude to H.A. Jinnah for access to stocks of L.N.S. and L.N.V. patient fibroblasts.	Albani S, 2009, NAT MED, V15, P1006, DOI 10.1038/nm0909-1006; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Bishop DVM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015112; Boyer LF, 2012, CURR PROTOC STEM CEL; Brennand KJ, 2015, STEM CELL REP, V5, P933, DOI 10.1016/j.stemcr.2015.10.011; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P241, DOI 10.1007/s13311-012-0118-9; Deng XY, 2015, CURR STEM CELL RES T, V10, P153, DOI 10.2174/1574888X09666140923101914                                               ; Djuric U, 2015, NEUROBIOL DIS, V76, P37, DOI 10.1016/j.nbd.2015.01.001; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Hallett PJ, 2015, CELL STEM CELL, V16, P269, DOI 10.1016/j.stem.2015.01.018; Hamilton DR, 2015, J DEV BEHAV PEDIATR, V36, P425, DOI 10.1097/DBP.0000000000000183; Hartfield EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087388; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kumari D, 2015, STEM CELL TRANSL MED, V4, P800, DOI 10.5966/sctm.2014-0278; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207; Marchetto MC, 2011, HUM MOL GENET, V20, pR109, DOI 10.1093/hmg/ddr336; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marchetto MCN, 2010, HUM MOL GENET, V19, pR71, DOI 10.1093/hmg/ddq159; Mitchell KJ, 2015, GENETICS NEURODEVELO; Nityanandam A, 2015, STEM CELLS DEV, V24, P1265, DOI 10.1089/scd.2015.0044; Pappas SS, 2014, CURR TOP DEV BIOL, V109, P97, DOI 10.1016/B978-0-12-397920-9.00001-9; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Pasca SP, 2014, ANNU REV NEUROSCI, V37, P479, DOI 10.1146/annurev-neuro-062012-170328; Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Szpir M, 2006, ENVIRON HEALTH PERSP, V114, pA100, DOI 10.1289/ehp.114-a100                                                            ; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Watabe K, 2003, NEUROPATHOLOGY, V23, P68, DOI 10.1046/j.1440-1789.2003.00478.x; Wong GKY, 2011, BIOTECHNOL ADV, V29, P1, DOI 10.1016/j.biotechadv.2010.07.005; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Zhou Yiye, 2013, [Genomics, Proteomics & Bioinformatics, 基因组蛋白质组与生物信息学报], V11, P284, DOI 10.1016/j.gpb.2013.09.008	39	0	0	5	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	MAR	2017	6	3					886	896		10.1002/sctm.16-0158				11	Cell & Tissue Engineering	Cell Biology	EQ6PK	WOS:000398204600020	28170165	gold			2018-01-05	
J	Cho, HM; Kim, PH; Chang, HK; Shen, YM; Bonsra, K; Kang, BJ; Yum, SY; Kim, JH; Lee, SY; Choi, MC; Kim, H; Jang, G; Cho, JY				Cho, Hyun-Min; Kim, Pyung-Hwan; Chang, Hyun-Kyung; Shen, Yi-Ming; Bonsra, Kwaku; Kang, Byung-Jae; Yum, Soo-Young; Kim, Joo-Hyun; Lee, So-Yeong; Choi, Min-Cheol; Kim, Hyongbum (Henry); Jang, Goo; Cho, Je-Yoel			Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Myocardial infarction; Angiogenesis; Stem cells; Umbilical cord blood; Genome editing	ENDOTHELIAL GROWTH-FACTOR; IMPROVE CARDIAC-FUNCTION; HEART-FAILURE; GENE-TRANSFER; ANGIOGENESIS; THERAPY; DISEASE; TISSUE; TRANSPLANTATION; PERFORMANCE	Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) exhibit potency for the regeneration of infarcted hearts. Vascular endothelial growth factor (VEGF) is capable of inducing angiogenesis and can boost stem cell-based therapeutic effects. However, high levels of VEGF can cause abnormal blood vessel growth and hemangiomas. Thus, a controllable system to induce therapeutic levels of VEGF is required for cell therapy. We generated an inducible VEGF-secreting stem cell (VEGF/hUCB-MSC) that controls the expression of VEGF and tested the therapeutic efficacy in rat myocardial infarction (MI) model to apply functional stem cells to MI. To introduce the inducible VEGF gene cassette into a safe harbor site of the hUCB-MSC chromosome, the transcription activator-like effector nucleases system was used. After confirming the integration of the cassette into the locus, VEGF secretion in physiological concentration from VEGF/hUCB-MSCs after doxycycline (Dox) induction was proved in conditioned media. VEGF secretion was detected in mice implanted with VEGF/hUCB-MSCs grown via a cell sheet system. Vessel formation was induced in mice transplanted with Matrigel containing VEGF/hUCB-MSCs treated with Dox. Moreover, seeding of the VEGF/hUCB-MSCs onto the cardiac patch significantly improved the left ventricle ejection fraction and fractional shortening in a rat MI model upon VEGF induction. Induced VEGF/hUCB-MSC patches significantly decreased the MI size and fibrosis and increased muscle thickness, suggesting improved survival of cardiomyocytes and protection from MI damage. These results suggest that our inducible VEGF-secreting stem cell system is an effective therapeutic approach for the treatment of MI.	[Cho, Hyun-Min; Kim, Pyung-Hwan; Chang, Hyun-Kyung; Kang, Byung-Jae; Kim, Joo-Hyun; Cho, Je-Yoel] Seoul Natl Univ, Coll Vet Med, BK21 PLUS Program Creat Vet Sci Res & Res Inst Ve, Dept Biochem, Seoul, South Korea; [Shen, Yi-Ming; Lee, So-Yeong] Seoul Natl Univ, Coll Vet Med, Dept Vet Pharmacol, Seoul, South Korea; [Bonsra, Kwaku] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Yum, Soo-Young; Jang, Goo] Seoul Natl Univ, Coll Vet Med, Dept Vet Clin Sci, Seoul, South Korea; [Choi, Min-Cheol] Seoul Natl Univ, Coll Vet Med, Dept Vet Radiol, Seoul, South Korea; [Kim, Hyongbum (Henry)] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120749, South Korea	Cho, JY (reprint author), Seoul Natl Univ, Coll Vet Med, Dept Vet Med, 1 Gwanak Ro, Seoul, South Korea.	jeycho@snu.ac.kr			National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2012M3A9C6049716, 2014M3A9D5A01073598, 2016M3A9B6026771]	We thank Hyung-Jung Oh in Department of Veterinary Radiology, College of Veterinary Medicine, Seoul National University for her help with echocardiograph imaging. This research was supported by grants from the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9C6049716, 2014M3A9D5A01073598, 2016M3A9B6026771).	Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cashman TJ, 2013, STEM CELL REV REP, V9, P254, DOI 10.1007/s12015-012-9375-6; Chen HK, 2005, EUR J CLIN INVEST, V35, P677, DOI 10.1111/j.1365-2362.2005.01565.x; Coulombe KLK, 2014, ANNU REV BIOMED ENG, V16, P1, DOI 10.1146/annurev-bioeng-071812-152344; Cucina A, 2003, J SURG RES, V109, P16, DOI 10.1006/jsre.2002.6565; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Fedak PWM, 2008, SEMIN THORAC CARDIOV, V20, P87, DOI 10.1053/j.semtcvs.2008.04.001; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hata H, 2006, J THORAC CARDIOV SUR, V132, P918, DOI 10.1016/j.jtcvs.2006.01.024; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kang BJ, 2014, ACTA BIOMATER, V10, P3007, DOI 10.1016/j.actbio.2014.03.013; Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028; Kim PH, 2014, J CONTROL RELEASE, V187, P1, DOI 10.1016/j.jconrel.2014.05.010; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Lee JH, 2010, BONE, V46, P1522, DOI 10.1016/j.bone.2010.02.013; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Marsano A, 2013, BIOMATERIALS, V34, P393, DOI 10.1016/j.biomaterials.2012.09.038; Matsumoto R, 2005, ARTERIOSCL THROM VAS, V25, P1168, DOI 10.1161/01.ATV.0000165696.25680.ce; Misteli H, 2010, STEM CELLS, V28, P611, DOI 10.1002/stem.291; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Niu JW, 2014, MOL BIOTECHNOL, V56, P681, DOI 10.1007/s12033-014-9771-z; Obokata H, 2011, NAT PROTOC, V6, P1053, DOI 10.1038/nprot.2011.356; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Pagani FD, 2003, J AM COLL CARDIOL, V41, P879, DOI 10.1016/S0735-1097(03)00081-0; Roura S, 2015, STEM CELL TRANSL MED, V4, P956, DOI 10.5966/sctm.2014-0259; Roura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049447; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Seo Y, 2011, CELL TRANSPLANT, V20, P1033, DOI 10.3727/096368910X545086; Shi RZ, 2008, BIOCHEM BIOPH RES CO, V376, P247, DOI 10.1016/j.bbrc.2008.09.004; Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8; Suzuki K, 2004, CIRCULATION, V110, pII225, DOI 10.1161/01.CIR.0000138191.11580.e3; Vallee JP, 2012, STEM CELL TRANSL MED, V1, P248, DOI 10.5966/sctm.2011-0028; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Yu KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102426	41	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	MAR	2017	6	3					1040	1051		10.1002/sctm.16-0114				12	Cell & Tissue Engineering	Cell Biology	EQ6PK	WOS:000398204600033	28186692	gold			2018-01-05	
J	Schwartz, C; Shabbir-Hussain, M; Frogue, K; Blenner, M; Wheeldon, I				Schwartz, Cory; Shabbir-Hussain, Murtaza; Frogue, Keith; Blenner, Mark; Wheeldon, Ian			Standardized Markerless Gene Integration for Pathway Engineering in Yarrowia lipolytica	ACS SYNTHETIC BIOLOGY			English	Article						CRISPR-Cas9; genome editing; synthetic biology; metabolic engineering; standardized genetic tool; carotenoids	SACCHAROMYCES-CEREVISIAE; LIPID-ACCUMULATION; CHROMOSOMAL INTEGRATION; CRISPR-CAS9 SYSTEM; PROTEIN EXPRESSION; ESCHERICHIA-COLI; MULTIPLE GENES; YEAST; LYCOPENE; STRAINS	The yeast Yarrowia lipolytica is a promising microbial host due to its native capacity to produce lipid-based chemicals. Engineering stable production strains requires genomic integration of modified genes, avoiding episomal expression that requires specialized media to maintain selective pressures. Here, we develop a CRISPR-Cas9-based tool for targeted, markerless gene integration into the Y. lipolytica genome. A set of genomic loci was screened to identify sites that were accepting of gene integrations without impacting cell growth. Five sites were found to meet these criteria. Expression levels from a GFP expression cassette were consistent when inserted into AXP, XPR2, A08, and D17, with reduced expression from MFE1. The standardized tool is comprised of five pairs of plasmids (one homologous donor plasmid and a CRISPR-Cas9 expression plasmid), with each pair targeting gene integration into one of the characterized sites. To demonstrate the utility of the tool we rapidly engineered a semisynthetic lycopene biosynthesis pathway by integrating four different genes at different loci. The capability to integrate multiple genes without the need for marker recovery and into sites with known expression levels will enable more rapid and reliable pathway engineering in Y. lipolytica.	[Schwartz, Cory; Frogue, Keith; Wheeldon, Ian] Univ Calif Riverside, Chem & Environm Engn, Riverside, CA 92521 USA; [Shabbir-Hussain, Murtaza; Blenner, Mark] Clemson Univ, Chem & Biomol Engn, Clemson, SC 29634 USA	Wheeldon, I (reprint author), Univ Calif Riverside, Chem & Environm Engn, Riverside, CA 92521 USA.	iwheeldon@engr.ucr.edu		Wheeldon, Ian/0000-0002-3492-7539	NSF [CBET-1403264, 1403099]; Clemson University	This work was supported by NSF CBET-1403264 and -1403099, as well as Creative Inquiry and startup funds from Clemson University. The authors thank Dr. Meredith Morris for access to BD Accuri flow cytometer.	Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Beopoulos A, 2009, BIOCHIMIE, V91, P692, DOI 10.1016/j.biochi.2009.02.004; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Blazeck J, 2013, J BIOTECHNOL, V165, P184, DOI 10.1016/j.jbiotec.2013.04.003; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Bordes F, 2007, J MICROBIOL METH, V70, P493, DOI 10.1016/j.mimet.2007.06.008; Celinska E, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-102; Chen Y, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0509-4; Daer R., 2016, ACS SYNTH BIOL, DOI [10.1021/acssynbio.5b00299, DOI 10.1021/ACSSYNBIO.5B00299]; DiCarlo JE, 2013, ACS SYNTH BIOL, V2, P741, DOI 10.1021/sb400117c; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Donald KAG, 1997, APPL ENVIRON MICROB, V63, P3341; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dulermo T, 2011, METAB ENG, V13, P482, DOI 10.1016/j.ymben.2011.05.002; Fickers P, 2003, J MICROBIOL METH, V55, P727, DOI 10.1016/j.mimet.2003.07.003; Flagfeldt DB, 2009, YEAST, V26, P545, DOI 10.1002/yea.1705; GAILLARDIN C, 1985, CURR GENET, V10, P49, DOI 10.1007/BF00418493; Gao SL, 2016, J IND MICROBIOL BIOT, V43, P1085, DOI 10.1007/s10295-016-1789-8; Gao SL, 2014, BIOTECHNOL LETT, V36, P2523, DOI 10.1007/s10529-014-1634-y; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Hussain MS, 2016, ACS SYNTH BIOL, V5, P213, DOI 10.1021/acssynbio.5b00100; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jensen NB, 2014, FEMS YEAST RES, V14, P238, DOI 10.1111/1567-1364.12118; Jessop-Fabre MM, 2016, BIOTECHNOL J, V11, P1110, DOI 10.1002/biot.201600147; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kretzschmar A, 2013, CURR GENET, V59, P63, DOI 10.1007/s00294-013-0389-7; Lazar Z, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0370-4; LEDALL MT, 1994, CURR GENET, V26, P38, DOI 10.1007/BF00326302                                                              ; Li HB, 2016, BIOTECHNOL J, V11, P1230, DOI 10.1002/biot.201600210; Liu L, 2014, GENOME ANNOUNC, V2, DOI DOI 10.1128/GENOMEA.00652-14; Madzak C, 2000, J MOL MICROB BIOTECH, V2, P207; Magnan C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162363; Matthaus F, 2014, APPL ENVIRON MICROB, V80, P1660, DOI 10.1128/AEM.03167-13; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1016/S1567-1356(02)00082-X; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Qiao K, 2015, METAB ENG, V29, P56, DOI 10.1016/j.ymben.2015.02.005; Rodriguez GM, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0562-6; Ronda C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0288-3; Rutter CD, 2016, METAB ENG, V38, P139, DOI 10.1016/j.ymben.2016.07.011; Sabirova JS, 2011, MICROB BIOTECHNOL, V4, P47, DOI 10.1111/j.1751-7915.2010.00187.x; Sauer C, 2016, ACS SYNTH BIOL, V5, P942, DOI 10.1021/acssynbio.6b00065; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Sung WS, 2007, J MICROBIOL BIOTECHN, V17, P1797; Tsai CS, 2015, BIOTECHNOL BIOENG, V112, P2406, DOI 10.1002/bit.25632; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Verbeke J, 2013, BIOTECHNOL LETT, V35, P571, DOI 10.1007/s10529-012-1107-0; Verwaal R, 2010, YEAST, V27, P983, DOI 10.1002/yea.1807; Wang HJJ, 1999, J BACTERIOL, V181, P5140; Xu P, 2016, P NATL ACAD SCI USA, V113, P10848, DOI 10.1073/pnas.1607295113; Xue ZX, 2013, NAT BIOTECHNOL, V31, P734, DOI 10.1038/nbt.2622; Yamane S, 1998, J GEN APPL MICROBIOL, V44, P275, DOI 10.2323/jgam.44.275; Yoon KW, 2008, J BIOTECHNOL, V135, P291, DOI 10.1016/j.jbiotec.2008.04.001; Zhou JW, 2012, J BIOTECHNOL, V161, P257, DOI 10.1016/j.jbiotec.2012.05.025	61	8	8	12	18	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAR	2017	6	3					402	409		10.1021/acssynbio.6b00285				8	Biochemical Research Methods	Biochemistry & Molecular Biology	EP0MB	WOS:000397080300003	27989123				2018-01-05	
J	Daer, RM; Cutts, JP; Brafman, DA; Haynes, KA				Daer, Rene M.; Cutts, Josh P.; Brafman, David A.; Haynes, Karmella A.			The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells	ACS SYNTHETIC BIOLOGY			English	Article						Cas9-mediated editing; chromatin; INDEL	EMBRYONIC STEM-CELLS; CAS9; GENE; SPECIFICITY; BINDING; CANCER; DIFFERENTIATION; ENDONUCLEASE; CRISPR-CAS9; ACTIVATION	In order to efficiently edit eukaryotic genomes, it is critical to test the impact of chromatin dynamics on CRISPR/Cas9 function and develop strategies to adapt the system to eukaryotic contexts. So far, research has extensively characterized the relationship between the CRISPR endonuclease Cas9 and the composition of the RNA DNA duplex that mediates the system's precision. Evidence suggests that chromatin modifications and DNA packaging can block eukaryotic genome editing by custom-built DNA endonucleases like Cas9; however, the underlying mechanism of Cas9 inhibition is unclear. Here, we demonstrate that closed, gene-silencing-associated chromatin is a mechanism for the interference of Cas9-mediated DNA editing. Our assays use a transgenic cell line with a drug-inducible switch to control chromatin states (open and closed) at a single genomic locus. We show that closed chromatin inhibits binding and editing at specific target sites and that artificial reversal of the silenced state restores editing efficiency. These results provide new insights to improve Cas9-mediated editing in human and other mammalian cells.	[Daer, Rene M.; Cutts, Josh P.; Brafman, David A.; Haynes, Karmella A.] Arizona State Univ, Sch Biol & Hlth Syst Engn, 501 E Tyler Mall,ECG 344A, Tempe, AZ 85287 USA	Daer, RM (reprint author), Arizona State Univ, Sch Biol & Hlth Syst Engn, 501 E Tyler Mall,ECG 344A, Tempe, AZ 85287 USA.	rene.daer@asu.edu			NIH NCI [K01CA188164]; NSF/Synberc [EEC 0540879]; ARCS Foundation; NSF CBET [1404084]	The authors thank J. Steel (DNASU) for DNA sequencing services and the 2014 Cold Spring Harbor Synthetic Biology Summer Course for supporting our development of this study. The authors thank F. Ceroni, J. Eisenberg, C. Barrett, D. Nyer, D. Vargas, and K. Timms for critical review of the manuscript. KAH is supported by the NIH NCI (K01CA188164) and the NSF/Synberc (EEC 0540879). RMD is supported by the ARCS Foundation and NSF CBET (1404084).	Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Aoto T, 2008, J BIOL CHEM, V283, P18905, DOI 10.1074/jbc.M709322200; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chen XY, 2016, NUCLEIC ACIDS RES, V44, P6482, DOI 10.1093/nar/gkw524; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Haynes KA, 2011, J BIOL CHEM, V286, P27176, DOI 10.1074/jbc.C111.229567; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Kanduri M, 2013, EPIGENETICS-US, V8, P1280, DOI 10.4161/epi.26546; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Nakagawa Y, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0144-x; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrcd1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023	31	4	4	2	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAR	2017	6	3					428	438		10.1021/acssynbio.5b00299				11	Biochemical Research Methods	Biochemistry & Molecular Biology	EP0MB	WOS:000397080300007	27783893	green_accepted			2018-01-05	
J	Maurer, MJ; Sutardja, L; Pinel, D; Bauer, S; Muehlbauer, AL; Ames, TD; Skerker, JM; Arkin, AP				Maurer, Matthew J.; Sutardja, Lawrence; Pinel, Dominic; Bauer, Stefan; Muehlbauer, Amanda L.; Ames, Tyler D.; Skerker, Jeffrey M.; Arkin, Adam P.			Quantitative Trait Loci (QTL)-Guided Metabolic Engineering of a Complex Trait	ACS SYNTHETIC BIOLOGY			English	Article						biofuel; CRISPR-Cas9; genetic engineering; hydrolysate; strain development; quantitative trait loci	SACCHAROMYCES-CEREVISIAE STRAINS; RECIPROCAL SIGN EPISTASIS; SPENT SULFITE LIQUOR; GENETIC INTERACTIONS; FITNESS LANDSCAPES; ETHANOL-PRODUCTION; GENOME SEQUENCE; YEAST STRAINS; TOLERANCE; FERMENTATION	Engineering complex phenotypes for industrial and synthetic biology applications is difficult and often confounds rational design. Bioethanol production from lignocellulosic feedstocks is a complex trait that requires multiple host systems to utilize, detoxify, and metabolize a mixture of sugars and inhibitors present in plant hydrolysates. Here, we demonstrate an integrated approach to discovering and optimizing host factors that impact fitness of Saccharomyces cerevisiae during fermentation of a Miscanthus x giganteus plant hydrolysate. We first used high-resolution Quantitative Trait Loci (QTL) mapping and systematic bulk Reciprocal Hemizygosity Analysis (bRHA) to discover 17 loci that differentiate hydrolysate tolerance between an industrially related (JAY291) and a laboratory (S288C) strain. We then used this data to identify a subset of favorable allelic loci that were most amenable for strain engineering. Guided by this "genetic blueprint", and using a dual-guide Cas9-based method to efficiently perform multikilobase locus replacements, we engineered an S288C-derived strain with superior hydrolysate tolerance than JAY291. Our methods should be generalizable to engineering any complex trait in S. cerevisiae, as well as other organisms.	[Maurer, Matthew J.; Pinel, Dominic; Bauer, Stefan; Muehlbauer, Amanda L.; Ames, Tyler D.; Skerker, Jeffrey M.; Arkin, Adam P.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Sutardja, Lawrence; Skerker, Jeffrey M.; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Skerker, Jeffrey M.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Arkin, Adam P.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA; [Bauer, Stefan] Zymergen, Emeryville, CA USA; [Ames, Tyler D.] Phosplatin Therapeut, New York, NY USA	Skerker, JM; Arkin, AP (reprint author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.; Skerker, JM; Arkin, AP (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Skerker, JM (reprint author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.; Arkin, AP (reprint author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA.	skerker@berkeley.edu; aparkin@lbl.gov		Maurer, Matthew/0000-0002-9150-0240	Energy Biosciences Institute [007G02, 001605]	We thank Leopold Parts for providing code for iQTL analysis, and for helpful discussions during the early stages of this work. This work was supported by the Energy Biosciences Institute Grants 007G02 and 001605 (A.PA.).	Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Attfield PV, 1997, NAT BIOTECHNOL, V15, P1351, DOI 10.1038/nbt1297-1351; Basso LC, 2008, FEMS YEAST RES, V8, P1155, DOI 10.1111/j.1567-1364.2008.00428.x; Blazeck J, 2010, BIOTECHNOL J, V5, P647, DOI 10.1002/biot.200900247; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Chiotti KE, 2014, GENOMICS, V104, P431, DOI 10.1016/j.ygeno.2014.10.011; Cubillos FA, 2013, GENETICS, V195, P1141, DOI 10.1534/genetics.113.155515; Della-Bianca BE, 2013, APPL MICROBIOL BIOT, V97, P979, DOI 10.1007/s00253-012-4631-x; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Edwards MD, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S8; Ehrenreich IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002570; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Greer DR, 2014, GREEN CHEM, V16, P4206, DOI 10.1039/c4gc00756e; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233                                                       ; Hubmann G, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-87; Hubmann G, 2013, METAB ENG, V17, P68, DOI 10.1016/j.ymben.2013.02.006; Ibanez AB, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0145-3; Illingworth CJR, 2012, MOL BIOL EVOL, V29, P1187, DOI 10.1093/molbev/msr289; Kabel MA, 2007, BIORESOURCE TECHNOL, V98, P2034, DOI 10.1016/j.biortech.2006.08.006; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Leach DRF, 2007, GENET RES, V89, P281, DOI 10.1017/S0016672308009488; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Lee SY, 2015, NAT BIOTECHNOL, V33, P1061, DOI 10.1038/nbt.3365; Liu ZL, 2011, APPL MICROBIOL BIOT, V90, P809, DOI 10.1007/s00253-011-3167-9; Lynch M., 1998, GENET RES, V72, P73; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meijnen JP, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-015-0421-x; Mitchell VD, 2014, BIOENERG RES, V7, P654, DOI 10.1007/s12155-013-9392-6; Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3; Oud B, 2012, FEMS YEAST RES, V12, P183, DOI 10.1111/j.1567-1364.2011.00776.x; Pais TM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003548; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Petersson A, 2006, YEAST, V23, P455, DOI 10.1002/yea.1370; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pinel D, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0241-z; Pinel D, 2011, APPL ENVIRON MICROB, V77, P4736, DOI 10.1128/AEM.02769-10; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Poelwijk FJ, 2011, J THEOR BIOL, V272, P141, DOI 10.1016/j.jtbi.2010.12.015; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x                                                ; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Romano GH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.1; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; Skerker JM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.30; Snoek T, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0216-0; Solis-Escalante D, 2013, FEMS YEAST RES, V13, P126, DOI 10.1111/1567-1364.12024; Stanbury PF, 1995, PRINCIPLES FERMENTAT; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Treusch S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004913; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; WEHNER EP, 1993, MOL GEN GENET, V237, P351; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wilkening S, 2014, GENETICS, V196, P853, DOI 10.1534/genetics.113.160291; Zheng DQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-479; Zorgo E, 2012, MOL BIOL EVOL, V29, P1781, DOI 10.1093/molbev/mss019	71	1	1	2	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAR	2017	6	3					566	581		10.1021/acssynbio.6b00264				16	Biochemical Research Methods	Biochemistry & Molecular Biology	EP0MB	WOS:000397080300021	27936603	gold			2018-01-05	
J	He, NY; Li, Q; Wu, CY; Ren, Z; Gao, Y; Pan, LH; Wang, MM; Wen, HY; Jiang, ZS; Tang, ZH; Liu, LS				He, Ni-Ya; Li, Qing; Wu, Chun-Yan; Ren, Zhong; Gao, Ya; Pan, Li-Hong; Wang, Mei-Mei; Wen, Hong-Yan; Jiang, Zhi-Sheng; Tang, Zhi-Han; Liu, Lu-Shan			Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives	ACTA PHARMACOLOGICA SINICA			English	Review						PCSK9; LDL receptor; monoclonal antibodies; anti-sense oligonucleotide; mimetic peptides; adnectin; CRISPR/Cas9 platform; berberine; oleanolic acid; neuronal apoptosis; coronary artery disease; cholesterol metabolism	DENSITY-LIPOPROTEIN RECEPTOR; SUBTILISIN/KEXIN TYPE 9; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; ACTIVATED PROTEIN-KINASE; HEART-DISEASE RISK; LDL CHOLESTEROL; OLEANOLIC ACID; MONOCLONAL-ANTIBODY; HEPG2 CELLS	Proprotein convertase subtilisin/kexin type 9 (PCSK9), also known as neural apoptosis regulated convertase (NARC1), is a key modulator of cholesterol metabolism. PCSK9 increases the serum concentration of low-density lipoprotein cholesterol by escorting low-density lipoprotein receptors (LDLRs) from the membrane of hepatic cells into lysosomes, where the LDLRs are degraded. Owing to the importance of PCSK9 in lipid metabolism, considerable effort has been made over the past decade in developing drugs targeting PCSK9 to lower serum lipid levels. Nevertheless, some problems and challenges remain. In this review we first describes the structure and function of PCSK9 and its gene polymorphisms. We then discuss the various designs of pharmacological targets of PCSK9, including those that block the binding of PCSK9 to hepatic LDLRs (mimetic peptides, adnectins, and monoclonal antibodies), inhibit PCSK9 expression (the clustered regularly interspaced short palindromic repeats/Cas9 platform, small molecules, antisense oligonucleotides, and small interfering RNAs), and interfere with PCSK9 secretion. Finally, this review highlights future challenges in this field, including safety concerns associated with PCSK9 monoclonal antibodies, the limited utility of PCSK9 inhibitors in the central nervous system, and the cost-effectiveness of PCSK9 inhibitors.	[He, Ni-Ya; Li, Qing; Wu, Chun-Yan; Ren, Zhong; Gao, Ya; Pan, Li-Hong; Wang, Mei-Mei; Jiang, Zhi-Sheng; Tang, Zhi-Han; Liu, Lu-Shan] Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Peoples R China; [Wen, Hong-Yan] Hunan Univ Chinese Med, Coll Med, Changsha 410208, Peoples R China	Tang, ZH; Liu, LS (reprint author), Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Peoples R China.	tangzhihan98@163.com; liuls2000@163.com			National Natural Science Foundation of China [81200217, 81370376]; Natural Science Foundation of Hunan province [2015JJ4097]; Key Project of Science and Technology Department of Hunan Province [2015JC3081]; Key Project of the Educational Department of Hu-nan Province [15A137]; Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University); Ministry of Education [CQKLBST-2014-002, CQKLBST-2015-004]; Construct Program of the Key Discipline in Hunan Province	This work was supported by grants from the National Natural Science Foundation of China (No 81200217, 81370376), the Natural Science Foundation of Hunan province (No 2015JJ4097), the Key Project of Science and Technology Department of Hunan Province (No 2015JC3081), the Key Project of the Educational Department of Hu-nan Province (No 15A137), the Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University), the Ministry of Education (No CQKLBST-2014-002, CQKLBST-2015-004), and the Construct Program of the Key Discipline in Hunan Province.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Ae VDV, 2007, GASTROENTEROLOGY, V133, P967; Agarwal SK, 2011, CLIN CHEM, V57, P891, DOI 10.1373/clinchem.2010.159350; Ahmad Z, 2016, J CLIN LIPIDOL, V10; Alghamdi RH, 2015, EUR J MED CHEM, V92, P890, DOI 10.1016/j.ejmech.2015.01.022; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Avis HJ, 2010, J AM COLL CARDIOL, V55, P1121, DOI 10.1016/j.jacc.2009.10.042; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2014, J AM COLL CARDIOL, V63, pA1374, DOI 10.1016/S0735-1097(14)61374-7                                                   ; Bays H, 2015, J CLIN ENDOCR METAB, V100, P3140, DOI 10.1210/jc.2015-1520; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Carare RO, 2013, ACTA NEUROPATHOL COM, V1, P1; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Chorba JS, 2014, J BIOL CHEM, V289, P29030, DOI 10.1074/jbc.M114.594861; Cicero AFG, 2015, DRUG DES DEV THER, V9, P3073, DOI 10.2147/DDDT.S67498; Cicero AFG, 2014, EXPERT OPIN BIOL TH, V14, P863, DOI 10.1517/14712598.2014.902929; Cicero AF, 2014, EXPERT OPIN DRUG SAF, V13, P1023, DOI 10.1517/14740338.2014.932348; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c                                                             ; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dahagam C, 2016, FUTUR CARDIOL, V12, P139, DOI 10.2217/fca.15.89; Dahagam C, 2016, FUTUR CARDIOL, V12, P149, DOI 10.2217/fca.15.88; Dattoli G, 2008, J IMMUNOL, V181, P1978; Devay RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125127; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Dong B, 2015, J BIOL CHEM, V290, P4047, DOI 10.1074/jbc.M114.597229; Drewe E, 2002, J CLIN PATHOL, V55, P81, DOI 10.1136/jcp.55.2.81                                                             ; Du F, 2011, J BIOL CHEM, V286, P43054, DOI 10.1074/jbc.M111.273474; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Frederick R, 2013, J AM HEART ASSOC, V2; Geeganage C, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-36; Genser B, 2006, CLIN RES CARDIOL, V95, P393, DOI 10.1007/s00392-006-0403-x; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Gumbiner B, 2012, CIRCULATION, V126, P2782; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Huang JF, 2016, CELL REP, V15, P336, DOI 10.1016/j.celrep.2016.03.020; Humphries SE, 2006, J MED GENET, V43, P943, DOI 10.1136/jmg.2006.038356; Humphries SE, 2006, J MOL MED, V84, P203, DOI 10.1007/s00109-005-0019-z; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Jansen H, 2014, EUR HEART J, V35, P1917, DOI 10.1093/eurheartj/ehu208; Jia LY, 2012, J PHARM PHARMACOL, V64, P1510, DOI 10.1111/j.2042-7158.2012.01529.x; Jie LI, 2002, WORLD J GASTROENTERO, V8, P493; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Kastelein JJP, 2014, CARDIOVASC DRUG THER, V28, P281, DOI 10.1007/s10557-014-6523-z; Kauppinen Sakari, 2005, Drug Discov Today Technol, V2, P287, DOI 10.1016/j.ddtec.2005.08.012; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004; Kim NY, 2005, J MED FOOD, V8, P177, DOI 10.1089/jmf.2005.8.177; Koren MJ, 2014, CIRCULATION, V129, P234, DOI 10.1161/CIRCULATIONAHA.113.007012; Kysenius K, 2016, EXP CELL RES, V340, P238, DOI 10.1016/j.yexcr.2016.01.001; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573                                                         ; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Li XF, 2011, CHIN J ARTERIOSCLERO, V19, P264; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102                                                         ; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; MENDEL DB, 1991, J BIOL CHEM, V266, P677; Merega E, 2015, NEUROSCI LETT, V600, P50, DOI 10.1016/j.neulet.2015.06.001; Miao J, 2015, ARTERIOSCL THROM VAS, V35, P1589, DOI 10.1161/ATVBAHA.115.305688; Miranda MX, 2015, EUR HEART J, V36, P51, DOI 10.1093/eurheartj/ehu095; Mitchell T, 2014, J PHARMACOL EXP THER, V350, P412, DOI 10.1124/jpet.114.214221; Musunuru K, 2016, CIRC RES, V118, P579, DOI 10.1161/CIRCRESAHA.115.306398; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Ovesna Z, 2004, NEOPLASMA, V51, P327; Palmer-Smith H, 2010, CURR MED CHEM, V17, P2168, DOI 10.2174/092986710791299948                                                      ; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Pirillo A, 2015, ATHEROSCLEROSIS, V243, P449, DOI 10.1016/j.atherosclerosis.2015.09.032; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157230; Rashid S, 2014, CIRCULATION, V130, P431, DOI 10.1161/CIRCULATIONAHA.113.006720; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI 10.1093/eurheartj/ehr158; Rodriguez-Rodriguez R, 2008, BRIT J PHARMACOL, V155, P535, DOI 10.1038/bjp.2008.289; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schmitt C, 2015, J CARDIOVASC PHARM, V65, P611, DOI 10.1097/FJC.0000000000000233; Sehgal A, 2013, J HEPATOL, V59, P1354, DOI 10.1016/j.jhep.2013.05.045; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079                                                              ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Sniderman A, 2012, J CLIN LIPIDOL, V6, P303, DOI 10.1016/j.jacl.2012.05.004; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Sultana N, 2008, J ENZYM INHIB MED CH, V23, P739, DOI [10.1080/14756360701633187, 10.1080/14756360701633187 ]; Surdo P.L., 2011, EMBO REP, V12, P1300; Tang ZH, 2012, INT J MOL MED, V30, P931, DOI 10.3892/ijmm.2012.1072; Tsai SJ, 2008, J FOOD SCI, V73, pH174, DOI 10.1111/j.1750-3841.2008.00864.x; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; Weider E, 2016, J BIOL CHEM, V291, P16659, DOI 10.1074/jbc.M116.717736; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; Wilson EM, 2014, STEM CELL RES, V13, P404, DOI 10.1016/j.scr.2014.08.006; Winn CL, 2014, NEW ENGL J MED, V370, P1809; Wu CY, 2012, MOL CELL BIOCHEM, V359, P347, DOI 10.1007/s11010-011-1028-6; Xin W, 2013, MOL CELL ENDOCRINOL, V376, P70; Xue H, 2016, LIFE SCI, V153, P23, DOI 10.1016/j.lfs.2016.04.004; Yan H, 2014, ACTA PHARMACOL SIN, V35, P994, DOI 10.1038/aps.2014.52; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang TT, 2016, BIOMATER SCI-UK, V4, P219, DOI 10.1039/c5bm00383k; Zhang YN, 2014, J BIOL CHEM, V289, P942, DOI 10.1074/jbc.M113.514067; Zhao GL, 2016, ACTA PHARMACOL SIN, V37, P354, DOI 10.1038/aps.2015.136	112	1	1	5	9	ACTA PHARMACOLOGICA SINICA	SHANGHAI	294 TAI-YUAN RD, SHANGHAI, 200031, PEOPLES R CHINA	1671-4083	1745-7254		ACTA PHARMACOL SIN	Acta Pharmacol. Sin.	MAR	2017	38	3					301	311		10.1038/aps.2016.134				11	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	EN1TK	WOS:000395792800001	28112180	green_published			2018-01-05	
J	Driehuis, E; Clevers, H				Driehuis, Else; Clevers, Hans			CRISPR/Cas 9 genome editing and its applications in organoids	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Review						CRISPR/Cas9; gene editing; organoid	HUMAN INTESTINAL ORGANOIDS; SEQUENCE-SPECIFIC CONTROL; IN-VITRO EXPANSION; BASAL STEM-CELLS; MYCOBACTERIUM-TUBERCULOSIS; STRAIN DIFFERENTIATION; MODELING DEVELOPMENT; ESCHERICHIA-COLI; CORTICAL TISSUES; GENE-EXPRESSION	Organoids are three-dimensional (3D) structures derived from adult or embryonic stem cells that maintain many structural and functional features of their respective organ. Recently, genome editing based on the bacterial defense mechanism CRISPR/Cas9 has emerged as an easily applicable and reliable laboratory tool. Combining organoids and CRISPR/Cas9 creates exciting new opportunities to study organ development and human disease in vitro. The potential applications of CRISPR in organoids are only beginning to be explored.	[Driehuis, Else; Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [Driehuis, Else; Clevers, Hans] Univ Med Ctr UMC Utrecht, Utrecht, Netherlands; [Clevers, Hans] Princess Maxima Ctr, Utrecht, Netherlands	Clevers, H (reprint author), Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu			ZonMW [40-41405-98-208]	E. Driehuis is supported by a ZonMW grant (40-41405-98-208). H. Clevers is named inventor on several patents related to Lgr5 stem-cell-based organoid technology.	Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dekkers JF, 2012, J CYST FIBROS, V11, pS32; DeWard AD, 2014, CELL REP, V9, P701, DOI 10.1016/j.celrep.2014.09.027; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, NAT PROTOC, V7, P69, DOI 10.1038/nprot.2011.429; Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fessler E, 2016, EMBO MOL MED, V8, P745, DOI 10.15252/emmm.201606184; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Fujii M, 2015, NAT PROTOC, V10, P1474, DOI 10.1038/nprot.2015.088; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao X, 2015, J CELL BIOL, V211, P669, DOI 10.1083/jcb.201506014; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gjorevski N, 2016, NATURE, V539, P359; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; IJspeert JEG, 2015, NAT REV GASTRO HEPAT, V12, P401, DOI 10.1038/nrgastro.2015.73; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Kretzschmar K, 2016, DEV CELL, V38, P590, DOI 10.1016/j.devcel.2016.08.014; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Linnemann JR, 2015, DEVELOPMENT, V142, P3239, DOI 10.1242/dev.123554; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; NAKATA A, 1989, J BACTERIOL, V171, P3553, DOI 10.1128/jb.171.6.3553-3556.1989                                                 ; Nanduri LSY, 2014, STEM CELL REP, V3, P957, DOI 10.1016/j.stemcr.2014.09.015; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Garcia MSF, 2014, J BLOOD MED, V5, P157, DOI 10.2147/JBM.S47437; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Verissimo CS, 2016, ELIFE, V5, DOI 10.7554/eLife.18489; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zhang Z, 2016, CELL REP, V16, P3146, DOI 10.1016/j.celrep.2016.08.048	72	1	1	11	18	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	MAR	2017	312	3					G257	G265		10.1152/ajpgi.00410.2016				9	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	EQ2AU	WOS:000397871500002	28126704				2018-01-05	
J	Argov, T; Rabinovich, L; Sigal, N; Herskovits, AA				Argov, Tal; Rabinovich, Lev; Sigal, Nadejda; Herskovits, Anat A.			An Effective Counterselection System for Listeria monocytogenes and Its Use To Characterize the Monocin Genomic Region of Strain 10403S	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article						counterselection; Listeria monocytogenes; allelic exchange; bacteriocins; monocin; mutagenesis; pheS	ESCHERICHIA-COLI; CLONING VECTOR; GENE; GENERATION; CONSTRUCTION; MECHANISMS; EXPRESSION; PROPHAGES; BACTERIA; MARKER	Construction of Listeria monocytogenes mutants by allelic exchange has been laborious and time-consuming due to lack of proficient selection markers for the final recombination event, that is, a marker conveying substance sensitivity to the bacteria bearing it, enabling the exclusion of merodiploids and selection for plasmid loss. In order to address this issue, we engineered a counterselection marker based on a mutated phenylalanyl-tRNA synthetase gene (pheS*). This mutation renders the phenylalanine-binding site of the enzyme more promiscuous and allows the binding of the toxic p-chloro-phenylalanine analog (p-CI-phe) as a substrate. When pheS* is introduced into L. monocytogenes and highly expressed under control of a constitutively active promoter, the bacteria become sensitive to p-CI-phe supplemented in the medium. This enabled us to utilize pheS* as a negative selection marker and generate a novel, efficient suicide vector for allelic exchange in L. monocytogenes. We used this vector to investigate the monocin genomic region in L. monocytogenes strain 10403S by constructing deletion mutants of the region. We have found this region to be active and to cause bacterial lysis upon mitomycin C treatment. The future applications of such an effective counterselection system, which does not require any background genomic alterations, are vast, as it can be modularly used in various selection systems (e.g., genetic screens). We expect this counterselection marker to be a valuable genetic tool in research on L. monocytogenes. IMPORTANCE L. monocytogenes is an opportunistic intracellular pathogen and a widely studied model organism. An efficient counterselection marker is a longstanding need in Listeria research for improving the ability to design and perform various genetic manipulations and screening systems for different purposes. We report the construction and utilization of an efficient suicide vector for allelic exchange which can be conjugated, leaves no marker in the bacterial chromosome, and does not require the use of sometimes leaky inducible promoters. This highly efficient genome editing tool for L. monocytogenes will allow for rapid sequential mutagenesis, introduction of point mutations, and design of screening systems. We anticipate that it will be extensively used by the research community and yield novel insights into the diverse fields studied using this model organism.	[Argov, Tal; Rabinovich, Lev; Sigal, Nadejda; Herskovits, Anat A.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Tel Aviv, Israel	Herskovits, AA (reprint author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Tel Aviv, Israel.	anathe@post.tau.ac.il			European Research Council	We thank Ilya Borovok for his helpful insights during this study and the Herskovits group members for testing the pheS* plasmid in their projects.; This work was funded by the European Research Council FP7 program, ERC starting grant for A.A.H. (PathoPhageHost).	Abdelhamed H, 2015, PLASMID, V81, P1, DOI 10.1016/j.plasmid.2015.05.003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Behari J, 1998, INFECT IMMUN, V66, P3635; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; Carr JF, 2015, J BACTERIOL, V197, P1135, DOI 10.1128/JB.02384-14; Dong HN, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-63; Drevets DA, 2008, FEMS IMMUNOL MED MIC, V53, P151, DOI 10.1111/j.1574-695X.2008.00404.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOHMANN S, 1990, MOL MICROBIOL, V4, P1091, DOI 10.1111/j.1365-2958.1990.tb00683.x; Hain T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-144; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0                                                    ; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lauer P, 2008, INFECT IMMUN, V76, P3742, DOI 10.1128/IAI.00390-08; Lee G, 2016, J BACTERIOL, V198, P2784, DOI 10.1128/JB.00489-16; Li GJ, 2003, APPL ENVIRON MICROB, V69, P3020, DOI 10.1128/AEM.69.5.3020-3023.2003; Liu D., 2008, HDB LISTERIA MONOCYT; Mermershtain I, 2011, PROTEIN SCI, V20, P160, DOI 10.1002/pro.549; Miyazaki K, 2015, BIOTECHNIQUES, V58, P86, DOI 10.2144/000114257; Rabinovich L, 2012, CELL, V150, P792, DOI 10.1016/j.cell.2012.06.036; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; Rychli K, 2014, METHODS MOL BIOL, V1157, P187, DOI 10.1007/978-1-4939-0703-8_16; Schaferkordt S, 1997, J BACTERIOL, V179, P2707, DOI 10.1128/jb.179.8.2707-2716.1997                                                 ; Shen A, 2005, MOL MICROBIOL, V57, P1460, DOI 10.1111/j.1365-2958.2005.04780.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784                                                             ; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Xie ZJ, 2011, APPL ENVIRON MICROB, V77, P8025, DOI 10.1128/AEM.06362-11; ZINK R, 1995, MICROBIOL-SGM, V141, P2577, DOI 10.1099/13500872-141-10-2577                                                    	36	1	1	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	MAR	2017	83	6								10.1128/AEM.02927-16				11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	EN1YQ	WOS:000395806900009		gold			2018-01-05	
J	Deng, Y; Zhang, X; Zhang, XJ				Deng, Yu; Zhang, Xi; Zhang, Xiaojuan			Recent advances in genetic modification systems for Actinobacteria	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Actinobacteria; Genetic modifications; Transformation; Site-specific recombination; CRISPR/Cas9	SITE-SPECIFIC RECOMBINATION; STREPTOMYCES-COELICOLOR A3(2); PHAGE PHI-BT1 INTEGRASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MARKER REMOVAL; PLASMID DNA; IN-VITRO; INTERGENERIC CONJUGATION; HETEROLOGOUS EXPRESSION	Actinobacteria are extremely important to human health, agriculture, and forests. Because of the vast differences of the characteristics of Actinobacteria, a lot of genetic tools have been developed for efficiently manipulating the genetics. Although there are a lot of successful examples of engineering Actinobacteria, they are still more difficult to be genetically manipulated than other model microorganisms such as Saccharomyces cerevisiae, Escherichia coli, and Bacillus subtilis etc. due to the diverse genomics and biochemical machinery. Here, we review the methods to introduce heterologous DNA into Actinobacteria and the available genetic modification tools. The trends and problems existing in engineering Actinobacteria are also covered.	[Deng, Yu; Zhang, Xi; Zhang, Xiaojuan] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol NELCF, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China	Deng, Y; Zhang, XJ (reprint author), Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol NELCF, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China.	dengyu@jiangnan.edu.cn; 1275926738@qq.com; xzhang6@163.com			National Natural Science Foundation of China [31500070, 31600044]; Natural Science Foundation of Jiangsu Province [BK20150136, BK20150151]	This study was funded by the National Natural Science Foundation of China (grant number 31500070, 31600044) and the Natural Science Foundation of Jiangsu Province (BK20150136, BK20150151).	AIDOO DA, 1990, J GEN MICROBIOL, V136, P657, DOI 10.1099/00221287-136-4-657                                                      ; Anson CE, 2000, ANGEW CHEM INT EDIT, V39, P224, DOI 10.1002/(SICI)1521-3773(20000103)39:1<224::AID-ANIE224>3.3.CO;2-I; Avignone Rossa C., 2002, METAB ENG, V4, P138, DOI DOI 10.1006/MBEN.2001.0217; BALTZ RH, 1992, GENE, V115, P61, DOI 10.1016/0378-1119(92)90541-V; Baltz RH, 1997, ANTON LEEUW INT J G, V71, P179, DOI 10.1023/A:1000177808686; Baltz RH, 2012, J IND MICROBIOL BIOT, V39, P661, DOI 10.1007/s10295-011-1069-6; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BIBB MJ, 1978, NATURE, V274, P398, DOI 10.1038/274398a0                                                                ; Blaesing F, 2005, J BIOTECHNOL, V120, P146, DOI 10.1016/j.biotec.2005.06.023; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Bull AT, 2007, TRENDS MICROBIOL, V15, P491, DOI 10.1016/j.tim.2007.10.004; Burke J, 2001, P NATL ACAD SCI USA, V98, P6289, DOI 10.1073/pnas.101589398; Cane DE, 2003, P NATL ACAD SCI USA, V100, P1547, DOI 10.1073/pnas.0337625100; Chen WH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-243; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Deng Y, 2016, BIOTECHNOL PROGR, V32, P14, DOI 10.1002/btpr.2180; Deng Y, 2011, METAB ENG, V13, P570, DOI 10.1016/j.ymben.2011.06.007; Deng Y, 2010, APPL ENVIRON MICROB, V76, P2098, DOI 10.1128/AEM.02626-09; Du DY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08740; Du L, 2012, INT J MOL SCI, V13, P4797, DOI 10.3390/ijms13044797; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590                                                       ; Fayed B, 2015, APPL ENVIRON MICROB, V81, P8402, DOI 10.1128/AEM.02403-15; Fedoryshyn M, 2008, GENE, V419, P43, DOI 10.1016/j.gene.2008.04.011; Fogg PCM, 2014, J MOL BIOL, V426, P2703, DOI 10.1016/j.jmb.2014.05.014; Gehring AM, 2000, P NATL ACAD SCI USA, V97, P9642, DOI 10.1073/pnas.170059797; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gradman RJ, 2008, MOL MICROBIOL, V67, P528, DOI 10.1111/j.1365-2958.2007.06056.x; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; GRONOSTAJSKI RM, 1985, MOL CELL BIOL, V5, P3274, DOI 10.1128/MCB.5.11.3274                                                           ; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Gupta M, 2007, NUCLEIC ACIDS RES, V35, P3407, DOI 10.1093/nar/gkm206; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HARTLEY NM, 1994, GENE, V147, P29, DOI 10.1016/0378-1119(94)90035-3                                                    ; Herrmann S, 2012, APPL ENVIRON MICROB, V78, P1804, DOI 10.1128/AEM.06054-11; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hopwood DA, 1999, MICROBIOL-UK, V145, P2183, DOI 10.1099/00221287-145-9-2183                                                     ; Huang He, 2015, Acta Biochim Biophys Sin (Shanghai), V47, P231, DOI 10.1093/abbs/gmv007; Hughes SR, 2015, JALA-J LAB AUTOM, V20, P621, DOI 10.1177/2211068215573188; Hwang KS, 2014, BIOTECHNOL ADV, V32, P255, DOI 10.1016/j.biotechadv.2013.10.008; Jeong Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11605; Khodakaramian G, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj019; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Lacroix C, 2011, NAT PROTOC, V6, P1412, DOI 10.1038/nprot.2011.363; Landgraf D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163950; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041                                             ; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee CA, 2007, J BACTERIOL, V189, P7254, DOI 10.1128/JB.00932-07; LEE EC, 1990, J BACTERIOL, V172, P1529, DOI 10.1128/jb.172.3.1529-1538.1990                                                 ; Leibig M, 2008, APPL ENVIRON MICROB, V74, P1316, DOI 10.1128/AEM.02424-07; Lewin GR, 2016, ANNU REV MICROBIOL, V70, P235, DOI 10.1146/annurev-micro-102215-095748; LIEBL W, 1989, FEMS MICROBIOL LETT, V65, P299, DOI 10.1016/0378-1097(89)90234-6; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; MACNEIL DJ, 1987, FEMS MICROBIOL LETT, V42, P239; Manivasagan P, 2016, CRIT REV MICROBIOL, V42, P209, DOI 10.3109/1040841X.2014.917069; MATSUSHIMA P, 1994, GENE, V146, P39, DOI 10.1016/0378-1119(94)90831-1; MAZODIER P, 1989, J BACTERIOL, V171, P3583, DOI 10.1128/jb.171.6.3583-3585.1989                                                 ; Nawani N, 2013, BIOMED RES INT, DOI 10.1155/2013/687190; Negoda A, 2007, P NATL ACAD SCI USA, V104, P4342, DOI 10.1073/pnas.0700495104; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Novella IS, 1996, CAN J MICROBIOL, V42, P201, DOI 10.1139/m96-031                                                                 ; Olson DG, 2012, METHOD ENZYMOL, V510, P317, DOI 10.1016/B978-0-12-415931-0.00017-3; OLSON ER, 1988, J BACTERIOL, V170, P1955, DOI 10.1128/jb.170.4.1955-1957.1988                                                 ; Ortiz-Ortiz L, 1984, BIOL BIOCH BIOMEDICA; Petzke L, 2009, APPL MICROBIOL BIOT, V83, P979, DOI 10.1007/s00253-009-2047-z; PIDCOCK KA, 1985, APPL ENVIRON MICROB, V50, P693; PIGAC J, 1995, APPL ENVIRON MICROB, V61, P352; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Reuther J, 2006, MOL MICROBIOL, V61, P436, DOI 10.1111/j.1365-2958.05258.x; Reznikoff WS, 2008, ANNU REV GENET, V42, P269, DOI 10.1146/annurev.genet.42.110807.091656; Rodriguez E, 2003, J IND MICROBIOL BIOT, V30, P480, DOI 10.1007/s10295-003-0045-1; Rutherford K, 2014, CURR OPIN STRUC BIOL, V24, P125, DOI [10.1016/j.sbi.2014.01.003, 10.1016/ksbi.2014.01.003]; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; Siegl T, 2012, ANTON LEEUW INT J G, V102, P503, DOI 10.1007/s10482-012-9795-y; Siewers V, 2014, METHODS MOL BIOL, V1152, P3, DOI 10.1007/978-1-4939-0563-8_1; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x                                                ; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; SUAREZ JE, 1980, J BACTERIOL, V142, P8; SUAREZ JE, 1980, NATURE, V286, P527, DOI 10.1038/286527a0; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Thoma L, 2016, ENVIRON MICROBIOL, V18, P598, DOI 10.1111/1462-2920.13027; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Volff JN, 1997, GENE, V194, P81, DOI 10.1016/S0378-1119(97)00163-7; Vrancken K, 2010, METHODS MOL BIOL, V668, P97, DOI 10.1007/978-1-60761-823-2_6; Weaden J, 1998, MICROBIOL-UK, V144, P1963, DOI 10.1099/00221287-144-7-1963                                                     ; Widenbrant EM, 2007, J BACTERIOL, V189, P9108, DOI 10.1128/JB.00983-07; Wright G, 2014, NATURE, V509, pS13, DOI 10.1038/509S13a; Xu Z, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02889-16; Zhang L, 2008, J BACTERIOL, V190, P6392, DOI 10.1128/JB.00777-08	96	1	1	14	26	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	MAR	2017	101	6					2217	2226		10.1007/s00253-017-8156-1				10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	EM1DR	WOS:000395058800002	28184986				2018-01-05	
J	Li, YC; Li, CL; Lin, SR; Yang, B; Huang, WR; Wu, HW; Chen, YB; Yang, LH; Luo, ML; Guo, H; Chen, JB; Wang, TT; Ma, Q; Gu, YL; Mou, LS; Jiang, ZM; Xia, J; Gui, YT				Li, Yuchi; Li, Cailing; Lin, Shouren; Yang, Bo; Huang, Weiren; Wu, Hanwei; Chen, Yuanbin; Yang, Lihua; Luo, Manling; Guo, Huan; Chen, Jianbo; Wang, Tiantian; Ma, Qian; Gu, Yanli; Mou, Lisha; Jiang, Zhimao; Xia, Jun; Gui, Yaoting			A nonsense mutation in Ccdc62 gene is responsible for spermiogenesis defects and male infertility in repro29/repro29 mice	BIOLOGY OF REPRODUCTION			English	Article						repro29; spermiogenesis; CCDC62; acrosome; male infertility	COILED-COIL DOMAIN; CONTRACEPTIVE TARGETS; PARKINSONS-DISEASE; ACTIN CYTOSKELETON; CHINESE POPULATION; ACROSOME FORMATION; ENU MUTAGENESIS; GERM-CELLS; SPERM; SPERMATOGENESIS	Phenotype-driven mutagenesis is an unbiased method to identify novel genes involved in spermatogenesis and other reproductive processes. Male repro29/repro29 mice generated by the Reproductive Genomics Program at the Jackson Laboratory were infertile with deformed sperm and poor motility. Using selected exonic capture and massively parallel sequencing technologies, we identified a nonsense mutation in the exon 6 of coiled-coil domain-containing 62 gene (Ccdc62), which results in a formation of a premature stop codon and a truncated protein. Among the tissues examined, CCDC62 was found to be expressed at the highest level in mouse testis by reverse transcriptase-PCR (RT-PCR) and Western blot analysis. With immunofluorescent staining, we demonstrated that CCDC62 was expressed in the cytoplasm and the developing acrosome in the spematids of mouse testis, and was specifically localized at the acrosome in mature sperm. The complementation analysis by mating repro29/+ mice with Ccdc62(-/-) mice (generated by CRISPR-Cas9 strategy) further provided genetic proof that the infertility of repro29/repro29 mice was caused by Ccdc62 mutation. Finally, it was found that intracellular colocalization and interaction of CCDC62 and Golgi-associated PDZ and coiled-coil motif-containing protein may be important for acrosome formation. Taken together, this study identified a nonsense mutation in Ccdc62, which directly results in male infertility in repro29/repro29 mice.	[Li, Yuchi; Li, Cailing; Lin, Shouren; Yang, Bo; Chen, Yuanbin; Yang, Lihua; Luo, Manling; Guo, Huan; Chen, Jianbo; Wang, Tiantian; Ma, Qian; Gu, Yanli; Jiang, Zhimao; Gui, Yaoting] Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China; [Li, Cailing; Luo, Manling] Shantou Univ, Coll Med, Dept Physiol, Shantou, Peoples R China; [Huang, Weiren; Wu, Hanwei; Mou, Lisha] Shenzhen Second Peoples Hosp, Key Lab Med Reprogramming Technol, Shenzhen, Peoples R China; [Xia, Jun] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China	Xia, J (reprint author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.; Gui, YT (reprint author), Peking Univ, Shenzhen Hosp, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen 518036, Peoples R China.	jxia@ust.hk; guiyaoting2007@aliyun.com			National Natural Science Foundation of China [31471344, 81501311]; Guangdong Natural Science Foundation [2015A030310029]; Shenzhen Project of Science and Technology [JCYJ20140415162543017, 201506042]; Research Grants Council of the Hong Kong, China [16102914, 663613, HKUST10/CRF/12R, C4011-14R, T13-607/12R, AoE/M-05/12]	National Natural Science Foundation of China (31471344 and 81501311), Guangdong Natural Science Foundation (2015A030310029), the Shenzhen Project of Science and Technology (JCYJ20140415162543017 and 201506042), and the Research Grants Council of the Hong Kong, China (16102914, 663613, HKUST10/CRF/12R, C4011-14R, T13-607/12R, and AoE/M-05/12).	Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Chen JC, 2016, INT J HEAT MASS TRAN, V95, P1, DOI 10.1016/j.ijheatmasstransfer.2015.11.067; Chen M, 2008, PROSTATE, V68, P1273, DOI 10.1002/pros.20774; Chen M, 2009, CARCINOGENESIS, V30, P841, DOI 10.1093/carcin/bgn288; Cho C, 2003, BIOL REPROD, V69, P211, DOI 10.1095/biolreprod.102.015115; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Domae S, 2009, INT J CANCER, V124, P2347, DOI 10.1002/ijc.24220; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201                                                          ; Fujiwara Y, 2015, REPRODUCTION, V149, P67, DOI 10.1530/REP-14-0122; Furnes B, 2007, J PHYSIOL-LONDON, V578, P25, DOI 10.1113/jphysiol.2006.119164; Gagne V, 2009, CELL MOTIL CYTOSKEL, V66, P754, DOI 10.1002/cm.20405; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Geyer CB, 2009, DEV BIOL, V330, P142, DOI 10.1016/j.ydbio.2009.03.020; Handel MA, 2006, MOL CELL ENDOCRINOL, V250, P201, DOI 10.1016/j.mce.2005.12.046; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hao JJ, 2005, J BIOL CHEM, V280, P37988, DOI 10.1074/jbc.M504552200; Hargreave TB, 2000, CURR OPIN OBSTET GYN, V12, P207, DOI 10.1097/00001703-200006000-00008                                                ; Jamsai D, 2010, SYST BIOL REPROD MEC, V56, P246, DOI 10.3109/19396361003706424; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; La Salle S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095752; Lee TL, 2009, BIRTH DEFECTS RES C, V87, P43, DOI 10.1002/bdrc.20147; Lessard C, 2004, CYTOGENET GENOME RES, V105, P222, DOI 10.1159/000078192; Liu RR, 2014, EUR NEUROL, V71, P77, DOI 10.1159/000354333; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P1013, DOI 10.1210/jc.2009-1925; O'Bryan MK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003628; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shirley CR, 2004, BIOL REPROD, V71, P1220, DOI 10.1095/biolreprod.104.029363; Tamowski S, 2010, SYST BIOL REPROD MED, V56, P260, DOI 10.3109/19396368.2010.485244; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YQ, 2014, NEUROSCI LETT, V566, P206, DOI 10.1016/j.neulet.2014.03.007; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Xu X, 1999, NAT GENET, V23, P118; Yamaguchi A, 2014, J HISTOCHEM CYTOCHEM, V62, P286, DOI 10.1369/0022155413520607; Yang Y, 2011, MOL BIOL CELL, V22, P976, DOI 10.1091/mbc.E10-04-0331; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Yatsenko AN, 2010, J ANDROL, V31, P34, DOI 10.2164/jandrol.109.008227; Yu RL, 2015, J CLIN NEUROSCI, V22, P1002, DOI 10.1016/j.jocn.2014.11.024; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104	40	0	0	2	8	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	MAR	2017	96	3					587	597		10.1095/biolreprod.116.141408				11	Reproductive Biology	Reproductive Biology	EP3VB	WOS:000397308700009	28339613				2018-01-05	
J	Gassei, K; Sheng, Y; Fayomi, A; Mital, P; Sukhwani, M; Lin, CC; Peters, KA; Althouse, A; Valli, H; Orwig, KE				Gassei, Kathrin; Sheng, Yi; Fayomi, Adetunji; Mital, Payal; Sukhwani, Meena; Lin, Chih-Cheng; Peters, Karen A.; Althouse, Andrew; Valli, Hanna; Orwig, Kyle E.			DDX4-EGFP transgenic rat model for the study of germline development and spermatogenesis	BIOLOGY OF REPRODUCTION			English	Article						VASA; DDX4; transgenesis; rats; germline; spermatogonial stem cells; spermatogenesis	SPERMATOGONIAL STEM-CELLS; MOUSE MALE GERMLINE; SELF-RENEWAL; SEMINIFEROUS TUBULES; ADULT RATS; TRANSCRIPTION FACTOR; DROSOPHILA-VASA; MURINE HOMOLOG; EXPRESSION; GENE	Spermatogonial stem cells (SSC) are essential for spermatogenesis and male fertility. In addition, these adult tissue stem cells can be used as vehicles for germline modification in animal models and may have application for treating male infertility. To facilitate the investigation of SSCs and germ lineage development in rats, we generated a DEAD-box helicase 4 (DDX4) (VASA) promoter-enhanced green fluorescent protein (EGFP) reporter transgenic rat. Quantitative real-time polymerase chain reaction and immunofluorescence confirmed that EGFP was expressed in the germ cells of the ovaries and testes and was absent in somatic cells and tissues. Germ cell transplantation demonstrated that the EGFP-positive germ cell population from DDX4-EGFP rat testes contained SSCs capable of establishing spermatogenesis in experimentally infertile mouse recipient testes. EGFP-positive germ cells could be easily isolated by fluorescence-activated cells sorting, while simultaneously removing testicular somatic cells from DDX4-EGFP rat pup testes. The EGFP-positive fraction provided an optimal cell suspension to establish rat SSC cultures that maintained long-term expression of zinc finger and BTB domain containing 16 (ZBTB16) and spaltlike transcription factor 4 (SALL4), two markers ofmouse SSCs that are conserved in rats. The novel DDX4-EGFP germ cell reporter rat described here combined with previously described GCS-EGFP rats, rat SSC culture and gene editing tools will improve the utility of the rat model for studying stem cells and germ lineage development.	[Gassei, Kathrin; Sheng, Yi; Fayomi, Adetunji; Mital, Payal; Sukhwani, Meena; Lin, Chih-Cheng; Peters, Karen A.; Althouse, Andrew; Valli, Hanna; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA	Orwig, KE (reprint author), Univ Pittsburgh, Sch Med, Magee Womens Res Inst, 204 Craft Ave, Pittsburgh, PA 15213 USA.	orwigke@upmc.edu			Magee-Womens Research Institute and Foundation; NIH National Center for Research Resources (NCRR) [RR18500, RR031300]; Lalor Foundation Postdoctoral Fellowship; Eunice Kennedy Shriver National Institute for Child Health and Human Development [HD055475, HD076412, HD075795]	Funds for this project were from Magee-Womens Research Institute and Foundation and the NIH National Center for Research Resources (NCRR) grants RR18500 (KEO) and RR031300 (YS). KG was supported by a Lalor Foundation Postdoctoral Fellowship. During the course of these studies, the Orwig laboratory was also funded by the Eunice Kennedy Shriver National Institute for Child Health and Human Development grants HD055475, HD076412, and HD075795.	Albamonte MS, 2008, HUM REPROD, V23, P1895, DOI 10.1093/humrep/den197; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Ballow DJ, 2006, GENE EXPR PATTERNS, V6, P1014, DOI 10.1016/j.modgep.2006.04.007; Bhullar B, 2001, MOL REPROD DEV, V59, P25, DOI 10.1002/mrd.1003; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chan F, 2014, GENE DEV, V28, P1351, DOI 10.1101/gad.240465.114; Chapman KM, 2015, CELL REP, V10, P1828, DOI 10.1016/j.celrep.2015.02.040; CLERMONT Y, 1968, AM J ANAT, V122, P237, DOI 10.1002/aja.1001220205; CLERMONT Y, 1975, AM J ANAT, V142, P159, DOI 10.1002/aja.1001420203; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cronkhite JT, 2005, DEV BIOL, V284, P171, DOI 10.1016/j.ydbio.2005.; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X                                                   ; DEROOIJ DG, 1973, CELL TISSUE KINET, V6, P281; DYM M, 1970, AM J ANAT, V128, P265, DOI 10.1002/aja.1001280302; Eildermann K, 2012, CELLS TISSUES ORGANS, V196, P206, DOI 10.1159/000335031; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Encinas G, 2012, CELLS TISSUES ORGANS, V195, P443, DOI 10.1159/000329245; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gassei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053976; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; Han SY, 2004, BIOL REPROD, V71, P933, DOI 10.1095/biolreprod.104.030247; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Hu YC, 2013, P NATL ACAD SCI USA, V110, P12685, DOI 10.1073/pnas.1311548110; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; HUCKINS C, 1978, ANAT REC, V192, P519, DOI 10.1002/ar.1091920406; HUCKINS C, 1971, CELL TISSUE KINET, V4, P313, DOI 10.1111/j.1365-2184.1971.tb01543.x; HUCKINS C, 1971, CELL TISSUE KINET, V4, P335, DOI 10.1111/j.1365-2184.1971.tb01544.x; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI [10.1095/biolreprod.103.017012, 10.1095/biloreprod.103.017012]; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kaucher AV, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097386; Hamra FK, 2007, J BIOL CHEM, V282, P721, DOI 10.1074/jbc.M608398200; KOMIYA T, 1995, BIOCHEM BIOPH RES CO, V207, P405, DOI 10.1006/bbrc.1995.1202; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6                                                    ; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; NAYERNIA K, 1992, MOL REPROD DEV, V31, P241, DOI 10.1002/mrd.1080310403; Nayernia K, 2004, HUM MOL GENET, V13, P1451, DOI 10.1093/hmg/ddh166; Nicholas CR, 2009, GENESIS, V47, P74, DOI 10.1002/dvg.20460; OAKBERG EF, 1971, MUTAT RES, V11, P1, DOI 10.1016/0027-5107(71)90027-3; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohmura M, 2008, STEM CELLS, V26, P3237, DOI 10.1634/stemcells.2008-0506; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Onohara Y, 2010, HISTOCHEM CELL BIOL, V133, P627, DOI 10.1007/s00418-010-0699-5; Orwig KE, 2002, BIOL REPROD, V66, P944, DOI 10.1095/biolreprod66.4.944; Parker N, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119099; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Suzuki H, 2013, GENESIS, V51, P50, DOI 10.1002/dvg.22347; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Tanaka SS, 2000, GENE DEV, V14, P841; Tong C, 2012, J GENET GENOMICS, V39, P275, DOI 10.1016/j.jgg.2012.04.004; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Tyagi G, 2009, BIOL REPROD, V81, P258, DOI 10.1095/biolreprod.108.075200; VANKEULEN CJ, 1973, CELL TISSUE KINET, V6, P337; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3<274::AID-MRD6>3.3.CO;2-0; Yamaji M, 2010, REPRODUCTION, V139, P381, DOI 10.1530/REP-09-0373; Yang QE, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113159; Yang QE, 2013, J CELL SCI, V126, P1009, DOI 10.1242/jcs.119826; Yang QE, 2013, DEVELOPMENT, V140, P280, DOI 10.1242/dev.087403; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; ZAMBROWICZ BP, 1993, P NATL ACAD SCI USA, V90, P5071, DOI 10.1073/pnas.90.11.5071                                                         	82	0	0	2	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	MAR	2017	96	3					707	719		10.1095/biolreprod.116.142828				13	Reproductive Biology	Reproductive Biology	EP3VB	WOS:000397308700019	28339678	gold			2018-01-05	
J	Lee, YG; Jin, YS; Cha, YL; Seo, JH				Lee, Ye-Gi; Jin, Yong-Su; Cha, Young-Lok; Seo, Jin-Ho			Bioethanol production from cellulosic hydrolysates by engineered industrial Saccharomyces cerevisiae	BIORESOURCE TECHNOLOGY			English	Article						Industrial Saccharomyces cerevisiae; Hydrolysate fermentation; Lignocellulosic ethanol; Cas9 genome editing	YEAST PICHIA-STIPITIS; LACTOCOCCUS-LACTIS; ETHANOL-PRODUCTION; XYLOSE METABOLISM; NADH OXIDASE; GENOME; FERMENTATION; EXPRESSION; STRAINS; CONSTRUCTION	Even though industrial yeast strains exhibit numerous advantageous traits for the production of bioethanol, their genetic manipulation has been limited. This study demonstrates that an industrial polyploidy Saccharomyces cerevisiae JHS200 can be engineered through Cas9 (CRISPR associated protein 9)-based genome editing. Specifically, we generated auxotrophic mutants and introduced a xylose metabolic pathway into the auxotrophic mutants. As expected, the engineered strain (JX123) enhanced ethanol production from cellulosic hydrolysates as compared to other engineered haploid strains. However, the JX123 strain produced substantial amounts of xylitol as a by-product during xylose fermentation. Hypothesizing that the xylitol accumulation might be caused by intracellular redox imbalance from cofactor difference, the NADH oxidase from Lactococcus lactis was introduced into the JX123 strain. The resulting strain (JX123_noxE) not only produced more ethanol, but also produced xylitol less than the JX123 strain. These results suggest that industrial polyploidy yeast can be modified for producing biofuels and chemicals. (C) 2016 Elsevier Ltd. All rights reserved.	[Lee, Ye-Gi; Seo, Jin-Ho] Seoul Natl Univ, Dept Agr Biotechnol, Ctr Food & Bioconvergence, Seoul 151921, South Korea; [Jin, Yong-Su] Univ Illinois, Inst Genom Biol, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Cha, Young-Lok] Rural Dev Adm, Bioenergy Crop Res Inst, Natl Inst Crop Sci, Muan 58545, South Korea	Seo, JH (reprint author), Seoul Natl Univ, Dept Agr Biotechnol, Gwanak 599, Seoul 151921, South Korea.	jhseo94@snu.ac.kr			Advanced Biomass R&D Center (ABC) of Korea [2011-0031359]; Cooperative Research Program for Agriculture Science & Technology Development [2013M1A2A2072600, 00929801]; Ministry of Science, ICT & Future Planning and Technology; Rural Development Administration, Republic of Korea	This research was supported by The Advanced Biomass R&D Center (ABC) of Korea Grant (2011-0031359) and The Cooperative Research Program for Agriculture Science & Technology Development (2013M1A2A2072600 and 00929801) funded by the Ministry of Science, ICT & Future Planning and Technology and Rural Development Administration, Republic of Korea.	Akada R, 2002, J BIOSCI BIOENG, V94, P536, DOI 10.1016/S1389-1723(02)80192-X                                                   ; Reis VCB, 2012, J IND MICROBIOL BIOT, V39, P1673, DOI 10.1007/s10295-012-1170-5; Cha YL, 2016, FUEL, V164, P322, DOI 10.1016/j.fuel.2015.10.006; 진영욱, 2012, [Korean Journal of Microbiology and Biotechnology, 한국미생물Â·생명공학회지], V40, P220, DOI 10.4014/kjmb.1207.07024; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Felipe FL, 1998, J BACTERIOL, V180, P3804; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Greene N, 2004, GROWING ENERGY BIOFU; Hansen J, 1996, J BIOTECHNOL, V49, P1, DOI 10.1016/0168-1656(96)01523-4; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; Hughes SR, 2009, JALA-J ASSOC LAB AUT, V14, P190, DOI 10.1016/j.jala.2008.12.009; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeffries TW, 2006, CURR OPIN BIOTECH, V17, P320, DOI 10.1016/j.copbio.2006.05.008; Jeffries TW, 2004, APPL MICROBIOL BIOT, V63, P495, DOI 10.1007/s00253-003-1450-0; Kim JW, 2015, BIORESOURCE TECHNOL, V191, P512, DOI 10.1016/j.biortech.2015.02.077; Kim SR, 2013, BIOTECHNOL ADV, V31, P851, DOI 10.1016/j.biotechadv.2013.03.004; Kim SR, 2012, METAB ENG, V14, P336, DOI 10.1016/j.ymben.2012.04.001; Lee SH, 2012, J BIOTECHNOL, V158, P184, DOI 10.1016/j.jbiotec.2011.06.005; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsushika A, 2009, BIORESOURCE TECHNOL, V100, P2392, DOI 10.1016/j.biortech.2008.11.047; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; STEWART GG, 1981, CAN J MICROBIOL, V27, P973, DOI 10.1139/m81-155                                                                 ; VERDUYN C, 1985, BIOCHEM J, V226, P669, DOI 10.1042/bj2260669                                                               ; Yamada R, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-8; Yazdani SS, 2007, CURR OPIN BIOTECH, V18, P213, DOI 10.1016/j.copbio.2007.05.002; Zhang GC, 2014, APPL ENVIRON MICROB, V80, P7694, DOI 10.1128/AEM.02310-14	28	3	3	22	36	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	MAR	2017	228						355	361		10.1016/j.biortech.2016.12.042				7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	EQ2VC	WOS:000397928000045	28088640				2018-01-05	
